Citrus Sinensis ID: 014034

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430--
Protein Sequence
MKCFHYFKEKKLRRREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSFDKTFEEICEEDPVEAQTKQKQHEPSEAWKRRMAHLAKLGEHVEGASRRRLLIMQRAKVV
Secondary Structure (PSIPRED)
ccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHcccccccccHHHHHHHHHcccccccccccccccEEEEEEccccccccccccEEEEEEEccccccHHHHHHHHHcccccccccEEEEEccccccccEEEEEEEccccccHHHHccccccccccHHHHHHHHHHHcccHHccccccccccEEcccccccccccccccccccccccccccccccccccccccccccccccHHHHcccccccccccccHHHHHHHHHHccccccccccccccHHHHHHcccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHccccccccccccccccccccHHHHcccccccccHHHHHHHHHHHHccccccccHHHHHHHHHHcccc
Secondary Structure Prediction (SSPRO)
cccEEcEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHHccccccccEEEEEEEccccccccccccEEEEEEccccccEEHHEHHHHHHcccccHEEEEEEEEccccccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEEcccHcHEEccccccccHcHcccccccccccccEEEEEEEccccHccHHHHHHccccHHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHHccccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccHHHHHHcccccccccccccHHHHHHccccc
Coil and Loop (DISEMBL)
mkcfhyfkekklrrreersapelkeprksadysgaesdrfvksscsasvtsprgipelyEEKAHNLRVFSYSEMRQATNDFSRMLKigeggfgsvykssikpaagdgtsEATVVAIKKLNRDGLQWVAEVQFLgvlehpnlvKLIGYcavdgergIQRLLVYEFMLNRSLedhlfnrafpplpwktrLHIILGAAEGLAYLHEGLEVQVIYRDFkasnvlldenfrpklsdfglaregpmvghthVSTAVVgtfgyaapdyietghltaksDVWSFGVVLYEMLTgrrslernrpkTEQRLLEWVQqypadskkfglimdprlekeYSINEARKIGRladnclsksskdrpkmSQVVERLKQIVQVsnegdsfdKTFEEICeedpveaqtkqkqhepSEAWKRRMAHLAKLGEHVEGASRRRLLIMQRAKVV
Flexible Loop (DISEMBL)
mkcfhyfkekklrrreersapelkeprksadysgaesdrfvksscsasvtsprgipelyeeKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLtgrrslernrpkteqrllewvqqypadskkfglimdpRLEKEYSINearkigrladnclsksskdrpkmsqvVERLKQIvqvsnegdsfDKTFEEICEedpveaqtkqkqhepseAWKRRMAHLAKlgehvegasrrrlLIMQRAKVV
Low Complexity Region (SEG)
MKCFHYFkekklrrreerSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSFDKTFEEICEEDPVEAQTKQKQHEPSEAWKRRMAHLAKLGEHVEGASRRRLLIMQRAKVV
Disordered region (IsUnstruct)
**************************************************************AHNLRVFSYSEMR*ATNDFSRMLKIGEGGFGSVYKSSI********SEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR************RLLEWVQQYPADSKKFGLIMDPRLEKEYSIN******************************************************************************************************
Disordered Region (DISOPRED)
MKCFH*************************************************************RVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLER***KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ***************************************************************MQRAK**
Disordered Region (DISEMBL)
MKCFHYFKEKKL***************************************PRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSFDKTFEEICEED****************WKRRMAHLAKLGEHVEGASRRRLLIMQRAKVV
Disordered Region (DISPRO)
****************************************************************NLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ*******************************************************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKCFHYFKEKKLRRREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSFDKTFEEICEEDPVEAQTKQKQHEPSEAWKRRMAHLAKLGEHVEGASRRRLLIMQRAKVV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	432	2.2.26 [Sep-21-2011]
Q9LTC0	410	Probable receptor-like pr	yes	no	0.849	0.895	0.581	1e-120
Q9LFP7	493	Probable receptor-like pr	no	no	0.787	0.689	0.490	7e-90
Q9SRH7	490	Receptor-like serine/thre	no	no	0.733	0.646	0.511	5e-89
P43293	389	Probable serine/threonine	no	no	0.773	0.858	0.473	1e-85
P46573	412	Protein kinase APK1B, chl	no	no	0.726	0.762	0.498	7e-85
Q06548	410	Protein kinase APK1A, chl	no	no	0.759	0.8	0.491	2e-84
Q8GXZ3	410	Serine/threonine-protein	no	no	0.668	0.704	0.541	4e-83
Q8H186	389	Probable receptor-like pr	no	no	0.671	0.745	0.503	3e-81
O49840	426	Protein kinase 2B, chloro	no	no	0.703	0.713	0.492	1e-80
O48814	395	Serine/threonine-protein	no	no	0.678	0.741	0.5	3e-80

>sp|Q9LTC0|Y5707_ARATH Probable receptor-like protein kinase At5g47070 OS=Arabidopsis thaliana GN=At5g47070 PE=1 SV=1

 Score =  432 bits (1111), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 221/380 (58%), Positives = 279/380 (73%), Gaps = 13/380 (3%)

Query: 1   MKCFHYFKEKKLRRREERSAPELKEPRKSADYSGAE-SDRFVKSSCSA----SVTSPRGI 55
           M C   FK KK R++++ +    ++ ++    S  E ++R   SS +     S+ SPR I
Sbjct: 1   MNCLFLFKSKKPRKQQKDNNKNKRKGKELLQNSAPELTNRSETSSFNLQTPRSLPSPRSI 60

Query: 56  PELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVA 115
            +LY E+  NLRVFSY E+ +AT  FSR L IGEGGFG VYK  I  + GD +    VVA
Sbjct: 61  KDLYTEREQNLRVFSYEELSKATYVFSRKLVIGEGGFGIVYKGKIL-SNGDSSDPPLVVA 119

Query: 116 IKKLNRDGLQ----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE 171
           IKKLNR GLQ    W+AEVQFLGV+ HPN+VKLIGYC+ DGE GI+RLLVYE+M NRSLE
Sbjct: 120 IKKLNRQGLQGHKQWLAEVQFLGVVNHPNVVKLIGYCSEDGETGIERLLVYEYMSNRSLE 179

Query: 172 DHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD 231
           DHLF R    LPWK RL I+LGAAEGL YLH+   ++VIYRDFK+SNVLLD+ F PKLSD
Sbjct: 180 DHLFPRRSHTLPWKKRLEIMLGAAEGLTYLHD---LKVIYRDFKSSNVLLDDQFCPKLSD 236

Query: 232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 291
           FGLAREGP   +THV+TA VGT GYAAP+Y++TGHL  KSDV+SFGVVLYE++TGRR++E
Sbjct: 237 FGLAREGPDGDNTHVTTARVGTHGYAAPEYVQTGHLRLKSDVYSFGVVLYEIITGRRTIE 296

Query: 292 RNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP 351
           RN+P  E+RLL+WV++YPADS++F +I+DPRL   Y    AR + +LAD CL K+ K+RP
Sbjct: 297 RNKPVAERRLLDWVKEYPADSQRFSMIVDPRLRNNYPAAGARSLAKLADLCLKKNDKERP 356

Query: 352 KMSQVVERLKQIVQVSNEGD 371
            M  VVERLK+I++ S+  D
Sbjct: 357 TMEIVVERLKKIIEESDSED 376

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1

 Score =  331 bits (848), Expect = 7e-90,   Method: Compositional matrix adjust.
 Identities = 181/369 (49%), Positives = 238/369 (64%), Gaps = 29/369 (7%)

Query: 16  EERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMR 75
           E +SA E     KS D    +      +S + S +S   I E     +H LR F++++++
Sbjct: 83  ESKSANE-----KSNDQPVGQVSSTTTTSNAESSSSTPVISEELNISSH-LRKFTFNDLK 136

Query: 76  QATNDFSRMLKIGEGGFGSVYK--------SSIKPAAGDGTSEATVVAIKKLNRDGLQ-- 125
            +T +F     +GEGGFG V+K        + +KP  G        VA+K LN DGLQ  
Sbjct: 137 LSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTG------LTVAVKTLNPDGLQGH 190

Query: 126 --WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 183
             W+AE+ FLG L HPNLVKL+GYC  D     QRLLVYEFM   SLE+HLF R+ P LP
Sbjct: 191 KEWLAEINFLGNLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLP-LP 245

Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
           W  R+ I LGAA+GL++LHE     VIYRDFK SN+LLD ++  KLSDFGLA++ P  G 
Sbjct: 246 WSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGK 305

Query: 244 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE 303
           THVST V+GT+GYAAP+Y+ TGHLT+KSDV+SFGVVL EMLTGRRS+++NRP  E  L+E
Sbjct: 306 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 365

Query: 304 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
           W + +  D ++F  ++DPRLE  +SI  A+K+ +LA  CLS+  K RPKMS VVE LK +
Sbjct: 366 WARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPL 425

Query: 364 VQVSNEGDS 372
             + +   S
Sbjct: 426 PHLKDMASS 434

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1

 Score =  328 bits (841), Expect = 5e-89,   Method: Compositional matrix adjust.
 Identities = 175/342 (51%), Positives = 230/342 (67%), Gaps = 25/342 (7%)

Query: 34  GAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFG 93
           G  S     S+  +S+++P  I E     +H L+ FS+ +++ AT +F     +GEGGFG
Sbjct: 91  GPVSSTTTTSNAESSLSTPI-ISEELNIYSH-LKKFSFIDLKLATRNFRPESLLGEGGFG 148

Query: 94  SVYK--------SSIKPAAGDGTSEATVVAIKKLNRDGLQ----WVAEVQFLGVLEHPNL 141
            V+K        + +KP  G        VA+K LN DGLQ    W+AE+ +LG L HPNL
Sbjct: 149 CVFKGWVEENGTAPVKPGTG------LTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNL 202

Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 201
           VKL+GYC  D     QRLLVYEFM   SLE+HLF R+ P LPW  R+ I LGAA+GL++L
Sbjct: 203 VKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLSFL 257

Query: 202 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 261
           HE     VIYRDFK SN+LLD  +  KLSDFGLA++ P  G THVST V+GT+GYAAP+Y
Sbjct: 258 HEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEY 317

Query: 262 IETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDP 321
           + TGHLT+KSDV+SFGVVL EMLTGRRS+++NRP  E  L+EW + +  D ++F  ++DP
Sbjct: 318 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDP 377

Query: 322 RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
           RLE  +S+  A+K+ +LA  CLS+ SK RPKMS+VVE LK +
Sbjct: 378 RLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPL 419

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2

 Score =  317 bits (811), Expect = 1e-85,   Method: Compositional matrix adjust.
 Identities = 170/359 (47%), Positives = 241/359 (67%), Gaps = 25/359 (6%)

Query: 42  KSSCSASVT-SPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYK--- 97
           K S +AS +  PR   E+ +    NL+ FS SE++ AT +F     +GEGGFG V+K   
Sbjct: 30  KGSSTASFSYMPRTEGEILQNA--NLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWI 87

Query: 98  --SSIKPAAGDGTSEATVVAIKKLNRDGLQ----WVAEVQFLGVLEHPNLVKLIGYCAVD 151
             SS+ P+   GT    V+A+K+LN++G Q    W+AE+ +LG L+HPNLVKLIGYC  +
Sbjct: 88  DESSLAPSK-PGT--GIVIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEE 144

Query: 152 GERGIQRLLVYEFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGLAYLHEGLEVQV 209
                 RLLVYEFM   SLE+HLF R   + PL W TR+ + LGAA GLA+LH   + QV
Sbjct: 145 E----HRLLVYEFMTRGSLENHLFRRGTFYQPLSWNTRVRMALGAARGLAFLHNA-QPQV 199

Query: 210 IYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTA 269
           IYRDFKASN+LLD N+  KLSDFGLAR+GPM  ++HVST V+GT GYAAP+Y+ TGHL+ 
Sbjct: 200 IYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSV 259

Query: 270 KSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSI 329
           KSDV+SFGVVL E+L+GRR++++N+P  E  L++W + Y  + ++   +MDPRL+ +YS+
Sbjct: 260 KSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSL 319

Query: 330 NEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI---VQVSNEGDSFDKTFEEICEEDP 385
             A KI  LA +C+S  +K RP M+++V+ ++++    + S E  +   + + I  + P
Sbjct: 320 TRALKIAVLALDCISIDAKSRPTMNEIVKTMEELHIQKEASKEQQNPQISIDNIINKSP 378

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2

 Score =  314 bits (805), Expect = 7e-85,   Method: Compositional matrix adjust.
 Identities = 164/329 (49%), Positives = 222/329 (67%), Gaps = 15/329 (4%)

Query: 50  TSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTS 109
           T+PR   E+ +  + NL+ F+++E++ AT +F     +GEGGFGSV+K  I       + 
Sbjct: 40  TNPRTEGEILQ--SPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASK 97

Query: 110 EAT--VVAIKKLNRDGLQ----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYE 163
             T  V+A+KKLN+DG Q    W+AEV +LG   HPNLVKLIGYC  D      RLLVYE
Sbjct: 98  PGTGVVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDE----HRLLVYE 153

Query: 164 FMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL 221
           FM   SLE+HLF R   F PL W  RL + LGAA+GLA+LH   E  VIYRDFK SN+LL
Sbjct: 154 FMPRGSLENHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHNA-ETSVIYRDFKTSNILL 212

Query: 222 DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLY 281
           D  +  KLSDFGLA++GP    +HVST ++GT+GYAAP+Y+ TGHLT KSDV+S+GVVL 
Sbjct: 213 DSEYNAKLSDFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLL 272

Query: 282 EMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADN 341
           E+L+GRR++++NRP  EQ+L+EW +   A+ +K   ++D RL+ +YS+ EA K+  LA  
Sbjct: 273 EVLSGRRAVDKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALR 332

Query: 342 CLSKSSKDRPKMSQVVERLKQIVQVSNEG 370
           CL+   K RP M++VV  L+ I  ++  G
Sbjct: 333 CLTFEIKLRPNMNEVVSHLEHIQTLNEAG 361

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1

 Score =  313 bits (802), Expect = 2e-84,   Method: Compositional matrix adjust.
 Identities = 169/344 (49%), Positives = 228/344 (66%), Gaps = 16/344 (4%)

Query: 42  KSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIK 101
           K+S  +   SPR   E+ +    NL+ FS++E++ AT +F     +GEGGFG V+K  I 
Sbjct: 31  KASSVSVRPSPRTEGEILQSP--NLKSFSFAELKSATRNFRPDSVLGEGGFGCVFKGWID 88

Query: 102 PAAGDGTSEAT--VVAIKKLNRDGLQ----WVAEVQFLGVLEHPNLVKLIGYCAVDGERG 155
             +   +   T  V+A+KKLN+DG Q    W+AEV +LG   H +LVKLIGYC  D    
Sbjct: 89  EKSLTASRPGTGLVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDE--- 145

Query: 156 IQRLLVYEFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRD 213
             RLLVYEFM   SLE+HLF R   F PL WK RL + LGAA+GLA+LH   E +VIYRD
Sbjct: 146 -HRLLVYEFMPRGSLENHLFRRGLYFQPLSWKLRLKVALGAAKGLAFLHSS-ETRVIYRD 203

Query: 214 FKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDV 273
           FK SN+LLD  +  KLSDFGLA++GP+   +HVST V+GT GYAAP+Y+ TGHLT KSDV
Sbjct: 204 FKTSNILLDSEYNAKLSDFGLAKDGPIGDKSHVSTRVMGTHGYAAPEYLATGHLTTKSDV 263

Query: 274 WSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEAR 333
           +SFGVVL E+L+GRR++++NRP  E+ L+EW + Y  + +K   ++D RL+ +YS+ EA 
Sbjct: 264 YSFGVVLLELLSGRRAVDKNRPSGERNLVEWAKPYLVNKRKIFRVIDNRLQDQYSMEEAC 323

Query: 334 KIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNE-GDSFDKT 376
           K+  L+  CL+   K RP MS+VV  L+ I  ++   G + DKT
Sbjct: 324 KVATLSLRCLTTEIKLRPNMSEVVSHLEHIQSLNAAIGGNMDKT 367

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1

 Score =  308 bits (790), Expect = 4e-83,   Method: Compositional matrix adjust.
 Identities = 162/299 (54%), Positives = 203/299 (67%), Gaps = 10/299 (3%)

Query: 69  FSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--- 125
           F+  E+   T  F     +GEGGFG+VYK  I      G  ++  VA+K LN++GLQ   
Sbjct: 57  FTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGL-KSLPVAVKVLNKEGLQGHR 115

Query: 126 -WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW 184
            W+ EV FLG L HPNLVKLIGYC  D      RLLVYEFML  SLE+HLF +   PL W
Sbjct: 116 EWLTEVNFLGQLRHPNLVKLIGYCCEDD----HRLLVYEFMLRGSLENHLFRKTTAPLSW 171

Query: 185 KTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT 244
             R+ I LGAA+GLA+LH   E  VIYRDFK SN+LLD ++  KLSDFGLA+ GP    T
Sbjct: 172 SRRMMIALGAAKGLAFLHNA-ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET 230

Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW 304
           HVST V+GT+GYAAP+Y+ TGHLTA+SDV+SFGVVL EMLTGR+S+++ RP  EQ L++W
Sbjct: 231 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDW 290

Query: 305 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
            +    D +K   I+DPRLE +YS+  A+K   LA  CLS++ K RP MS VVE L+ +
Sbjct: 291 ARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 349

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1

 Score =  302 bits (773), Expect = 3e-81,   Method: Compositional matrix adjust.
 Identities = 156/310 (50%), Positives = 207/310 (66%), Gaps = 20/310 (6%)

Query: 66  LRVFSYSEMRQATNDFSRMLKIGEGGFGSVYK-----SSIKPAAGDGTSEATVVAIKKLN 120
           ++ FS++E++ AT +F     +GEGGFG V++     +++ P     +S   V+A+K+LN
Sbjct: 46  VKSFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTK---SSSGLVIAVKRLN 102

Query: 121 RDGLQ----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF- 175
            DG Q    W+ E+ +LG L HPNLVKLIGYC  D     QRLLVYEFM   SLE+HLF 
Sbjct: 103 PDGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDE----QRLLVYEFMHKGSLENHLFA 158

Query: 176 --NRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG 233
             N+ F PL W  R+ + L AA+GLA+LH    V+VIYRD KASN+LLD +F  KLSDFG
Sbjct: 159 NGNKDFKPLSWILRIKVALDAAKGLAFLHSD-PVKVIYRDIKASNILLDSDFNAKLSDFG 217

Query: 234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           LAR+GPM   ++VST V+GTFGYAAP+Y+ TGHL A+SDV+SFGVVL E+L GR++L+ N
Sbjct: 218 LARDGPMGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALDHN 277

Query: 294 RPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM 353
           RP  EQ L++W + Y    +K  LI+D RL  +Y    A ++  +A  CLS   K RP M
Sbjct: 278 RPAKEQNLVDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPTM 337

Query: 354 SQVVERLKQI 363
            QVV  L Q+
Sbjct: 338 DQVVRALVQL 347

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1

 Score =  300 bits (768), Expect = 1e-80,   Method: Compositional matrix adjust.
 Identities = 161/327 (49%), Positives = 213/327 (65%), Gaps = 23/327 (7%)

Query: 48  SVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDG 107
           S+ +PR   E+      NL+ F+++E++ AT +F     +GEGGFG V+K  I     DG
Sbjct: 52  SLPTPRTEGEILSSP--NLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWI-----DG 104

Query: 108 TS-------EATVVAIKKLNRDGLQ----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGI 156
           T+          VVA+KKL  +G Q    W+ EV +LG L HPNLVKL+GYC V+GE   
Sbjct: 105 TTLTASKPGSGIVVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYC-VEGE--- 160

Query: 157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKA 216
            RLLVYEFM   SLE+HLF R   PL W  R+ + +GAA+GL +LH+  + QVIYRDFKA
Sbjct: 161 NRLLVYEFMPKGSLENHLFRRGAQPLTWAIRMKVAIGAAKGLTFLHDA-KSQVIYRDFKA 219

Query: 217 SNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSF 276
           +N+LLD  F  KLSDFGLA+ GP    THVST V+GT GYAAP+Y+ TG LTAKSDV+SF
Sbjct: 220 ANILLDAEFNSKLSDFGLAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSF 279

Query: 277 GVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIG 336
           GVVL E+L+GRR++++++   EQ L++W   Y  D +K   IMD RL  +Y    A    
Sbjct: 280 GVVLLELLSGRRAVDKSKVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAA 339

Query: 337 RLADNCLSKSSKDRPKMSQVVERLKQI 363
            LA  CL+  +K RPKMS+V+ +L Q+
Sbjct: 340 SLALQCLNPDAKLRPKMSEVLAKLDQL 366

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1

 Score =  299 bits (765), Expect = 3e-80,   Method: Compositional matrix adjust.
 Identities = 153/306 (50%), Positives = 210/306 (68%), Gaps = 13/306 (4%)

Query: 66  LRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDG 123
           ++ F+++E++ AT +F     IGEGGFG V+K  +  +    T   T  V+A+KKLN++G
Sbjct: 52  VKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKLNQEG 111

Query: 124 LQ----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA- 178
            Q    W+ E+ +LG L HPNLVKLIGYC  D      RLLVYEFM   SLE+HLF R  
Sbjct: 112 FQGHREWLTEINYLGQLSHPNLVKLIGYCLEDE----HRLLVYEFMQKGSLENHLFRRGA 167

Query: 179 -FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE 237
            F PLPW  R+++ L AA+GLA+LH    V+VIYRD KASN+LLD ++  KLSDFGLAR+
Sbjct: 168 YFKPLPWFLRVNVALDAAKGLAFLHSD-PVKVIYRDIKASNILLDADYNAKLSDFGLARD 226

Query: 238 GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT 297
           GPM   ++VST V+GT+GYAAP+Y+ +GHL A+SDV+SFGV+L E+L+G+R+L+ NRP  
Sbjct: 227 GPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPAK 286

Query: 298 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 357
           E+ L++W + Y    +K  LI+D RL+ +Y   EA ++  +A  CLS   K RP M QVV
Sbjct: 287 EENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVV 346

Query: 358 ERLKQI 363
             L+Q+
Sbjct: 347 RALQQL 352

Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	432
156105187	429	ser/thr protein kinase [Malus x domestic	0.983	0.990	0.756	0.0
255571079	447	ATP binding protein, putative [Ricinus c	0.976	0.944	0.729	0.0
356522988	430	PREDICTED: probable receptor-like protei	0.976	0.981	0.697	1e-175
449432360	426	PREDICTED: probable receptor-like protei	0.974	0.988	0.678	1e-172
356504531	430	PREDICTED: probable receptor-like protei	0.976	0.981	0.693	1e-172
357512951	435	Protein kinase 2B [Medicago truncatula]	0.981	0.974	0.686	1e-170
225453299	427	PREDICTED: probable receptor-like protei	0.976	0.988	0.701	1e-168
449487562	453	PREDICTED: LOW QUALITY PROTEIN: probable	0.974	0.929	0.638	1e-168
224137090	404	predicted protein [Populus trichocarpa]	0.863	0.923	0.746	1e-164
90900944	412	NAK-type protein kinase [Nicotiana tabac	0.895	0.939	0.634	1e-143

>gi|156105187|gb|ABU49132.1| ser/thr protein kinase [Malus x domestica]

 Score =  671 bits (1730), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 330/436 (75%), Positives = 377/436 (86%), Gaps = 11/436 (2%)

Query: 1   MKCFHYFKEKKLRRREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYE 60
           MKCF+YFK+K  RRRE+RSAPELKE  KS DYSG   DR +KS+CSA+  SPRGIPE+YE
Sbjct: 1   MKCFNYFKDKA-RRREQRSAPELKEETKS-DYSGG-GDRVIKSTCSAN--SPRGIPEMYE 55

Query: 61  EKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN 120
           EKAHNLR F+++E+RQATNDFSR+LKIGEGGFG+VYK SIK AA D  S+  VVAIKKLN
Sbjct: 56  EKAHNLRAFTFAELRQATNDFSRLLKIGEGGFGNVYKGSIK-AADDKGSDPVVVAIKKLN 114

Query: 121 RDGLQ----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN 176
            DGLQ    WVAEVQFL V+EHPNLVKLIGYCAVDGERGIQRLLVYEFM NRSLEDHLFN
Sbjct: 115 NDGLQGHKQWVAEVQFLSVVEHPNLVKLIGYCAVDGERGIQRLLVYEFMPNRSLEDHLFN 174

Query: 177 RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 236
           + +  +PW+TRL IILGAA+GLAYLH+GLEVQVIYRDFK +NVLLD+NF+PKLSDFGLAR
Sbjct: 175 KVYSTVPWETRLQIILGAAQGLAYLHQGLEVQVIYRDFKCANVLLDDNFKPKLSDFGLAR 234

Query: 237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK 296
           EGPMVGHTHVSTAVVGT+GYAAPDYIETGHLTAKSDVWSFGVVLYE+LTGRRSLERNRP+
Sbjct: 235 EGPMVGHTHVSTAVVGTYGYAAPDYIETGHLTAKSDVWSFGVVLYEILTGRRSLERNRPR 294

Query: 297 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 356
            EQ+LLEWV+Q+P D KKFGLIMD RLE +YSI  ARKI  LA++CLSKS+KDRP MSQV
Sbjct: 295 REQKLLEWVKQFPCDGKKFGLIMDSRLENKYSITAARKIANLAESCLSKSAKDRPTMSQV 354

Query: 357 VERLKQIVQVSNEGDSFDKTFEEICEEDPVEAQTKQKQHEPSEAWKRRMAHLAKLGEHVE 416
           V++LKQI+Q S EG   D++ E + E D  ++ TK +Q E SE+W+RRMAHLAKLGEHVE
Sbjct: 355 VDKLKQIIQDSEEGIPSDRSPESV-ENDQADSVTKPRQLEASESWQRRMAHLAKLGEHVE 413

Query: 417 GASRRRLLIMQRAKVV 432
            ASRRR +IMQRA+V 
Sbjct: 414 SASRRRFMIMQRARVT 429

Source: Malus x domestica

Species: Malus x domestica

Genus: Malus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255571079|ref|XP_002526490.1| ATP binding protein, putative [Ricinus communis] gi|223534165|gb|EEF35881.1| ATP binding protein, putative [Ricinus communis]

 Score =  657 bits (1696), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 332/455 (72%), Positives = 376/455 (82%), Gaps = 33/455 (7%)

Query: 1   MKCFHYFKEKKLRRREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYE 60
           MKCF+YFK+K  R R++RSAPELKE  +  DYS  E+DR  KSSCS   TSPRGIPELY+
Sbjct: 1   MKCFYYFKDKS-RSRQQRSAPELKEKSRD-DYS--EADRITKSSCSE--TSPRGIPELYK 54

Query: 61  EKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN 120
           EKAHNLRVFS+SE+R AT+DFSR+LKIGEGGFGSVYK SIKP  G G  E TVVAIKKLN
Sbjct: 55  EKAHNLRVFSFSELRNATSDFSRLLKIGEGGFGSVYKGSIKPVGGKG--EPTVVAIKKLN 112

Query: 121 RDGLQ----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN 176
           RDGLQ    WVAEVQFLGV+EHPNLVKLIGYC VDGERGIQRLLVYEFM N+SLE+HLF+
Sbjct: 113 RDGLQGHKQWVAEVQFLGVVEHPNLVKLIGYCGVDGERGIQRLLVYEFMQNKSLEEHLFD 172

Query: 177 RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 236
           RA+P L WKTRL I+LGAA+GLAYLHEGLEVQVIYRDFK+SNVLLDENF+PKLSDFGLAR
Sbjct: 173 RAYPALAWKTRLQILLGAAQGLAYLHEGLEVQVIYRDFKSSNVLLDENFKPKLSDFGLAR 232

Query: 237 EGPMVGHTHVSTA-------------------VVGTFGYAAPDYIETGHLTAKSDVWSFG 277
           EGP+ G THVSTA                   VVGT+GYAAPDYIETGHLT KSDVWSFG
Sbjct: 233 EGPVAGRTHVSTAVALMPKYRANEELSILSDQVVGTYGYAAPDYIETGHLTTKSDVWSFG 292

Query: 278 VVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGR 337
           VVLYE+LTGRRSLERNRP+ EQ+LLEWV+ Y  +SKKFGLI+DPRLE +YSI+ ARKI +
Sbjct: 293 VVLYEILTGRRSLERNRPRVEQKLLEWVKHYTPESKKFGLIIDPRLENQYSISAARKIAK 352

Query: 338 LADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSFDKTFEEICEEDPVEAQTKQKQHEP 397
           LAD+CL KS+KDRP+MS+VVE LKQI+Q S+EGDS  K+FE  CE D  ++  K  Q E 
Sbjct: 353 LADSCLLKSAKDRPRMSEVVESLKQIIQDSDEGDSPKKSFES-CETDSADSSKKPNQPEA 411

Query: 398 SEAWKRRMAHLAKLGEHVEG-ASRRRLLIMQRAKV 431
           +E+WKRRM HLAKLGE+VEG ASRRR +IMQRAKV
Sbjct: 412 TESWKRRMVHLAKLGENVEGAASRRRFMIMQRAKV 446

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356522988|ref|XP_003530124.1| PREDICTED: probable receptor-like protein kinase At5g47070-like [Glycine max]

 Score =  619 bits (1597), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 305/437 (69%), Positives = 363/437 (83%), Gaps = 15/437 (3%)

Query: 1   MKCFHYFKEKKLRRREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYE 60
           MKCF+YF++K  R  ++RSAPELKE  K  ++SG E  R  KSSCS+  TSPRGIPELYE
Sbjct: 1   MKCFYYFRDKS-RSSKQRSAPELKEQEK-LEFSGPE--RVTKSSCSS--TSPRGIPELYE 54

Query: 61  EKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN 120
           EK HNLR FS++E+++AT+DFSR+LKIGEGGFGSV+K +IKPA  DG   + +VAIK+LN
Sbjct: 55  EKGHNLRDFSFTELKRATSDFSRLLKIGEGGFGSVFKGTIKPA--DGNRNSVLVAIKRLN 112

Query: 121 RDGLQ----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN 176
           ++ LQ    W+ EVQFLGV++HPNLVKLIGYCA+D ERGIQRLLVYE+M N+SLE HLFN
Sbjct: 113 KNALQGHKQWLTEVQFLGVVQHPNLVKLIGYCALDDERGIQRLLVYEYMPNKSLEFHLFN 172

Query: 177 RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 236
           +A+ PLPWKTRL I  GAA+GL YLHE LE+QVIYRDFKASNVLLDENF PKLSDFGLAR
Sbjct: 173 KAYDPLPWKTRLEIATGAAQGLTYLHEELEIQVIYRDFKASNVLLDENFNPKLSDFGLAR 232

Query: 237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK 296
           EGP  G THVSTAV+GT+GYAAPDYIETGHLTAKSDVWSFGVVLYE+LTGRRS+E+NRPK
Sbjct: 233 EGPAAGDTHVSTAVMGTYGYAAPDYIETGHLTAKSDVWSFGVVLYEILTGRRSMEKNRPK 292

Query: 297 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 356
           TE++LLEWV+QYP DSK+FG+IMDPRL+ EYSI  ARKI +LA +CL KS+KDRP MSQV
Sbjct: 293 TEKKLLEWVKQYPPDSKRFGMIMDPRLQGEYSIKGARKIAKLAQHCLRKSAKDRPSMSQV 352

Query: 357 VERLKQIVQVSNEGD--SFDKTFEEICEEDPVEAQTKQKQHEPSEAWKRRMAHLAKLGEH 414
           VERLKQI+Q S+E    + DK+  E+ E DPVEA+ +  Q   +E WK+RM HLAKLGE 
Sbjct: 353 VERLKQIIQDSDEEQHPADDKSI-EVSENDPVEAEEEANQSGSTELWKKRMEHLAKLGES 411

Query: 415 VEGASRRRLLIMQRAKV 431
           VE AS+RR + +QRA V
Sbjct: 412 VESASKRRFMTLQRANV 428

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449432360|ref|XP_004133967.1| PREDICTED: probable receptor-like protein kinase At5g47070-like [Cucumis sativus]

 Score =  610 bits (1574), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 295/435 (67%), Positives = 361/435 (82%), Gaps = 14/435 (3%)

Query: 1   MKCFHYFKEKKLRRREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYE 60
           MKCF+YFK+K  R R +RSAP+LKE ++S D+SG    R   SSCS  +TSPR +PELYE
Sbjct: 1   MKCFYYFKDKS-RSRRQRSAPQLKEQQES-DFSGC--SRTAASSCS--LTSPRSVPELYE 54

Query: 61  EKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN 120
           EKAHNLRVFS++E+RQAT DF+R+LKIG+GGFGSV+K SIKP   DG  +  VVAIK+L+
Sbjct: 55  EKAHNLRVFSFTELRQATQDFNRLLKIGQGGFGSVFKGSIKPV--DGNGDPLVVAIKQLS 112

Query: 121 RDGLQ----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN 176
           +DGLQ    W+AEVQFLG++EHPNLVKLIGYCAVDG RGIQRLLVYE+M NRSLEDHLFN
Sbjct: 113 KDGLQGHKQWLAEVQFLGIVEHPNLVKLIGYCAVDGSRGIQRLLVYEYMPNRSLEDHLFN 172

Query: 177 RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 236
           +A PPL W+TRLHI+LGAA+GLAYLHEGLEVQ+IYRDFK+SNVLLDENF PKLSDFGLAR
Sbjct: 173 KALPPLAWRTRLHIVLGAAQGLAYLHEGLEVQIIYRDFKSSNVLLDENFHPKLSDFGLAR 232

Query: 237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK 296
           EGP +G THVSTAV+GT GYAAPDYIETGHLTAKSDVWS GVVLYE+LTGRRSLERNR +
Sbjct: 233 EGPEIGRTHVSTAVMGTNGYAAPDYIETGHLTAKSDVWSLGVVLYEILTGRRSLERNRSR 292

Query: 297 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 356
            E +L+EWV+ +  DSKKF LI+DPRLE +Y IN ARK+ +LAD CL+K++KDRP M++V
Sbjct: 293 FEHKLVEWVKHFNPDSKKFSLIIDPRLENQYPINAARKLAKLADTCLAKNAKDRPSMAEV 352

Query: 357 VERLKQIVQVSNEGDSFDKTFEEICEEDPVEAQTKQKQHEPSEAWKRRMAHLAKLGEHVE 416
           V  LK+I++  +    ++K+ + + +E  +E + ++   E  ++W+RRM+HL KLGEHVE
Sbjct: 353 VNSLKEIIKSEDNSKPYEKSPDSVIDEPDMEREPEKM--EAPKSWRRRMSHLQKLGEHVE 410

Query: 417 GASRRRLLIMQRAKV 431
           GASRRR +IMQ AKV
Sbjct: 411 GASRRRFMIMQSAKV 425

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356504531|ref|XP_003521049.1| PREDICTED: probable receptor-like protein kinase At5g47070-like [Glycine max]

 Score =  610 bits (1572), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 303/437 (69%), Positives = 363/437 (83%), Gaps = 15/437 (3%)

Query: 1   MKCFHYFKEKKLRRREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYE 60
           MKCF+YF++K  R  ++RSAPELK+  K  + SG E  R  KSSCS++  SPRGI ELYE
Sbjct: 1   MKCFYYFRDKS-RSSKQRSAPELKDQEK-LELSGPE--RVTKSSCSSA--SPRGILELYE 54

Query: 61  EKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN 120
           EK HNLR FS++E+++AT+DFS +LKIGEGGFGSV+K SIKP  G+G S   +VAIK+LN
Sbjct: 55  EKGHNLRNFSFTELKRATSDFSSLLKIGEGGFGSVFKGSIKPVDGNGNS--VLVAIKRLN 112

Query: 121 RDGLQ----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN 176
           ++ LQ    W+ EVQFLG++EHPNLVKLIGYCA+D ERGIQRLLVYE+M N+SLE HLFN
Sbjct: 113 KNALQGHKQWLTEVQFLGIVEHPNLVKLIGYCALDDERGIQRLLVYEYMPNKSLEFHLFN 172

Query: 177 RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 236
           +A+ PLPWKTRL IIL AA+GL+YLHE LE+QVIYRDFKASNVLLDENF+PKLSDFGLAR
Sbjct: 173 KAYDPLPWKTRLEIILEAAQGLSYLHEELEIQVIYRDFKASNVLLDENFKPKLSDFGLAR 232

Query: 237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK 296
           EGP+ G THVSTAV+GT+GYAAPDYIETGHLTAKSDVWSFGVVLYE+LTGRRS+ERNRPK
Sbjct: 233 EGPVAGDTHVSTAVMGTYGYAAPDYIETGHLTAKSDVWSFGVVLYEILTGRRSMERNRPK 292

Query: 297 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 356
           TE++LLEWV+QYP DSK+F +I+DPRL+ EYSI  ARKI +LA +CL KS+KDRP MSQV
Sbjct: 293 TEKKLLEWVKQYPPDSKRFDMIVDPRLQGEYSIKGARKIAKLAAHCLRKSAKDRPSMSQV 352

Query: 357 VERLKQIVQVSNEGD--SFDKTFEEICEEDPVEAQTKQKQHEPSEAWKRRMAHLAKLGEH 414
           VERLK+I+  S+E    + DK+  E+ E DPVEA+ K  Q   +E WK+RM HLAKLGE 
Sbjct: 353 VERLKEIILDSDEEQQPADDKSI-EVSENDPVEAEDKTNQSGSTELWKKRMEHLAKLGES 411

Query: 415 VEGASRRRLLIMQRAKV 431
           VE ASRRR +I+QRA V
Sbjct: 412 VESASRRRFMILQRANV 428

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357512951|ref|XP_003626764.1| Protein kinase 2B [Medicago truncatula] gi|355520786|gb|AET01240.1| Protein kinase 2B [Medicago truncatula]

 Score =  603 bits (1554), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 302/440 (68%), Positives = 355/440 (80%), Gaps = 16/440 (3%)

Query: 1   MKCFHYFKEKKLRRREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYE 60
           MKCF YFK K  + R +RSAPEL+E  K   +SG+E    V  S  +S +SPRGIP+LYE
Sbjct: 1   MKCFSYFKYKH-KGRGQRSAPELEEQEKH-QFSGSER---VTKSSCSSTSSPRGIPKLYE 55

Query: 61  EKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN 120
           EK HNLRVFS+SE+ +AT+DF+R+LKIGEGGFGSV+K SIKP  G+G  +  +VAIK+LN
Sbjct: 56  EKGHNLRVFSFSELSRATSDFNRLLKIGEGGFGSVFKGSIKPVGGNG--DPVLVAIKRLN 113

Query: 121 RDGLQ----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN 176
           +D LQ    W+ EVQFLGV+EHPNLVKLIGYCAVDGERGIQRLLVYE+M NRSLE HLFN
Sbjct: 114 KDALQGHKQWLTEVQFLGVVEHPNLVKLIGYCAVDGERGIQRLLVYEYMPNRSLEAHLFN 173

Query: 177 RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 236
           +++ P+PWKTRL I LGAA+GL+YLHE LEVQ+IYRDFK SNVLLDENF+PKLSDFGLAR
Sbjct: 174 KSYDPVPWKTRLEIALGAAQGLSYLHEELEVQIIYRDFKCSNVLLDENFKPKLSDFGLAR 233

Query: 237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK 296
           EGP  G THVSTAV+GT GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL RNRPK
Sbjct: 234 EGPEAGDTHVSTAVMGTHGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLTRNRPK 293

Query: 297 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 356
           TEQ+LLEWV+ YP DSKKF +IMDPRLE +YSIN ARK+ +LAD+CL KSSKDRP+MSQV
Sbjct: 294 TEQKLLEWVKNYPPDSKKFDMIMDPRLEGQYSINAARKLAKLADHCLRKSSKDRPRMSQV 353

Query: 357 VERLKQIVQVSNE-----GDSFDKTFEEICEEDPVEAQTKQKQHEPSEAWKRRMAHLAKL 411
           VERLK+I+Q S++      D  +    E+ E D  E Q +      +E W++RM HLAKL
Sbjct: 354 VERLKEIIQASDKEQEEHHDPNEINSAEVSENDSFEHQEESNSSGSTELWRKRMEHLAKL 413

Query: 412 GEHVEGASRRRLLIMQRAKV 431
           GEHVEGA+R+  +I QRA V
Sbjct: 414 GEHVEGANRKMFMIQQRANV 433

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225453299|ref|XP_002268330.1| PREDICTED: probable receptor-like protein kinase At5g47070 [Vitis vinifera] gi|297734656|emb|CBI16707.3| unnamed protein product [Vitis vinifera]

 Score =  596 bits (1537), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 305/435 (70%), Positives = 357/435 (82%), Gaps = 13/435 (2%)

Query: 1   MKCFHYFKEKKLRRREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYE 60
           MKCF+YFK+K  R + +RSAPELK   KS  YSG  SD  +KSSCS +      IPELYE
Sbjct: 1   MKCFYYFKDKT-RLKVQRSAPELKNQSKSY-YSG--SDLVIKSSCSTTSRR--SIPELYE 54

Query: 61  EKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN 120
           EKA NLRVFS+SE+R AT+DFSRMLK+GEGGFG VYK SIKPA  DG  ++  VAIK+LN
Sbjct: 55  EKAQNLRVFSFSELRHATHDFSRMLKLGEGGFGCVYKGSIKPA--DGKGDSFEVAIKRLN 112

Query: 121 RDGLQ----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN 176
            DG+Q    WVAEVQFLG++EHPNLVKLIGYCAVDGERGIQRLLVYE+M N+SLEDHLFN
Sbjct: 113 PDGVQGHKQWVAEVQFLGIVEHPNLVKLIGYCAVDGERGIQRLLVYEYMPNKSLEDHLFN 172

Query: 177 RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 236
           +A P LPW+TRL  +LGAA+GLAYLHE LEVQVIYRDFK+SNVLLD++F PKLSDFGLAR
Sbjct: 173 KAIPALPWQTRLQTVLGAAQGLAYLHEELEVQVIYRDFKSSNVLLDKDFNPKLSDFGLAR 232

Query: 237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK 296
           EGP  G THVSTA VGTFGYAAPDYIETGHLT KSDVWSFGVVLYE+LTGRRS+ERN P+
Sbjct: 233 EGPADGFTHVSTAAVGTFGYAAPDYIETGHLTTKSDVWSFGVVLYEILTGRRSMERNHPR 292

Query: 297 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 356
            EQ+LLEWV+ +PA+SKKF +IMD RLE +Y I+ ARKI +LAD+CLSKS+KDRPKMS+V
Sbjct: 293 AEQKLLEWVKHFPANSKKFHMIMDWRLENQYPISTARKIAKLADSCLSKSAKDRPKMSEV 352

Query: 357 VERLKQIVQVSNEGDSFDKTFEEICEEDPVEAQTKQKQHEPSEAWKRRMAHLAKLGEHVE 416
           VE LKQI+Q+ +EG   +K+ E    +   +   K  Q  PS++WKRRMAHLA LGEHVE
Sbjct: 353 VETLKQIIQLPDEGGPSEKSPESFDNDS-DDKDKKADQPGPSDSWKRRMAHLASLGEHVE 411

Query: 417 GASRRRLLIMQRAKV 431
           G++R+R +IMQRAKV
Sbjct: 412 GSNRKRFMIMQRAKV 426

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449487562|ref|XP_004157688.1| PREDICTED: LOW QUALITY PROTEIN: probable receptor-like protein kinase At5g47070-like [Cucumis sativus]

 Score =  596 bits (1536), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 295/462 (63%), Positives = 362/462 (78%), Gaps = 41/462 (8%)

Query: 1   MKCFHYFKEKKLRRREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYE 60
           MKCF+YFK+K  R R +RSAP+LKE ++S D+SG    R   SSCS  +TSPR +PELYE
Sbjct: 1   MKCFYYFKDKS-RSRRQRSAPQLKEQQES-DFSGC--SRTAASSCS--LTSPRSVPELYE 54

Query: 61  EKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN 120
           EKAHNLRVFS++E+RQAT DF+R+LKIG+GGFGSV+K SIKP  G+G  +  VVAIK+L+
Sbjct: 55  EKAHNLRVFSFTELRQATQDFNRLLKIGQGGFGSVFKGSIKPVDGNG--DPLVVAIKQLS 112

Query: 121 RDGLQ----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN 176
           +DGLQ    W+AEVQFLG++EHPNLVKLIGYCAVDG RGIQRLLVYE+M NRSLEDHLFN
Sbjct: 113 KDGLQGHKQWLAEVQFLGIVEHPNLVKLIGYCAVDGSRGIQRLLVYEYMPNRSLEDHLFN 172

Query: 177 RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 236
           +A PPL W+TRLHI+LGAA+GLAYLHEGLEVQ+IYRDFK+SNVLLDENF PKLSDFGLAR
Sbjct: 173 KALPPLAWRTRLHIVLGAAQGLAYLHEGLEVQIIYRDFKSSNVLLDENFHPKLSDFGLAR 232

Query: 237 EGPMVGHTHVSTA---------------------------VVGTFGYAAPDYIETGHLTA 269
           EGP +G THVSTA                           V+GT GYAAPDYIETGHLTA
Sbjct: 233 EGPEIGRTHVSTAVSFFFFFSLNHFQAHCCLHXTTFCTTXVMGTNGYAAPDYIETGHLTA 292

Query: 270 KSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSI 329
           KSDVWS GVVLYE+LTGRRSLERNR + E +L+EWV+ +  DSKKF LI+DPRLE +Y I
Sbjct: 293 KSDVWSLGVVLYEILTGRRSLERNRSRFEHKLVEWVKHFNPDSKKFSLIIDPRLENQYPI 352

Query: 330 NEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSFDKTFEEICEEDPVEAQ 389
           N ARK+ +LAD CL+K++KDRP M++VV  LK+I++  +    ++K+ + + +E  +E +
Sbjct: 353 NAARKLAKLADTCLAKNAKDRPSMAEVVNSLKEIIKSEDNSKPYEKSPDSVIDEPDMERE 412

Query: 390 TKQKQHEPSEAWKRRMAHLAKLGEHVEGASRRRLLIMQRAKV 431
            ++   E  ++W+RRM+HL KLGEHVEGASRRR +IMQ AKV
Sbjct: 413 PEKM--EAPKSWRRRMSHLQKLGEHVEGASRRRFMIMQSAKV 452

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224137090|ref|XP_002327019.1| predicted protein [Populus trichocarpa] gi|222835334|gb|EEE73769.1| predicted protein [Populus trichocarpa]

 Score =  583 bits (1502), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 285/382 (74%), Positives = 322/382 (84%), Gaps = 9/382 (2%)

Query: 1   MKCFHYFKEKKLRRREERSAPELKEPRKS-ADYSGAESDRFVKSSCSASVTSPRGIPELY 59
           MKCF Y+ + K R R  RSAPELK+   +  D S   SD  +KSSCS   TS RGI E+Y
Sbjct: 1   MKCFQYYFKDKSRSRGRRSAPELKQRSITKTDDSLCTSDGMIKSSCSE--TSQRGISEMY 58

Query: 60  EEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL 119
           EEKAHNLRVFS+SE+R ATN FSR+ KIGEGGFG+VYK SIKPA G+G  +  VVAIKKL
Sbjct: 59  EEKAHNLRVFSFSELRNATNGFSRLFKIGEGGFGNVYKGSIKPAGGEG--DPIVVAIKKL 116

Query: 120 NRDGLQ----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF 175
           N DG Q    WV EVQFLGVLEHPNLVKL+GYCAVDGERGIQRLLVYEFM N+SL+DHLF
Sbjct: 117 NADGFQGHKQWVTEVQFLGVLEHPNLVKLLGYCAVDGERGIQRLLVYEFMRNKSLDDHLF 176

Query: 176 NRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA 235
           N+A+P LPWKTRL IILGAA+GLA+LHEGLEVQVIYRDFK SNVLLDE+ +PKLSDFGLA
Sbjct: 177 NKAYPVLPWKTRLQIILGAAQGLAFLHEGLEVQVIYRDFKTSNVLLDEDLKPKLSDFGLA 236

Query: 236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           REGPM G THVSTAVVGT+GYAAPDYIETGHLTA+SDVWSFGVVLYE+LTGRRSLERNRP
Sbjct: 237 REGPMAGRTHVSTAVVGTYGYAAPDYIETGHLTARSDVWSFGVVLYEILTGRRSLERNRP 296

Query: 296 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 355
           K EQ+LLEWV+Q+PADSKKFGLIMDPRLE +YS++ AR+I RLAD+CL KS+K RPKMSQ
Sbjct: 297 KVEQKLLEWVKQFPADSKKFGLIMDPRLENQYSMSAARRIARLADSCLLKSAKGRPKMSQ 356

Query: 356 VVERLKQIVQVSNEGDSFDKTF 377
           V E L+QI+Q S+EG     +F
Sbjct: 357 VAETLEQIIQDSSEGSPSKNSF 378

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|90900944|gb|ABE01834.1| NAK-type protein kinase [Nicotiana tabacum]

 Score =  514 bits (1323), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 253/399 (63%), Positives = 311/399 (77%), Gaps = 12/399 (3%)

Query: 1   MKCFHYFKEKKLRRREERSAPEL-KEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELY 59
           +KCF+ FK+K   RR   SAPEL  E R+  +   +E  +  KS+   SV+S R IP++Y
Sbjct: 2   LKCFYIFKDKSRSRRRGESAPELSNESRRDGN---SEGKKVAKST--GSVSSARSIPQMY 56

Query: 60  EEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL 119
            EK  NLRVFS SE+++AT  F+RMLKIGEGGFGSVYK +I+P +G G  +  VVAIKKL
Sbjct: 57  REKEQNLRVFSLSELKEATRSFNRMLKIGEGGFGSVYKGTIQPPSGRG--DPIVVAIKKL 114

Query: 120 NRDGLQ----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF 175
           N  GLQ    WVAEVQFLGVLEHPNLVKL+GYCA DGERGIQRLLVYE+M N+SLEDHLF
Sbjct: 115 NTLGLQGHRQWVAEVQFLGVLEHPNLVKLLGYCATDGERGIQRLLVYEYMQNKSLEDHLF 174

Query: 176 NRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA 235
           NRA P +PWKTRL IILGAA+G+AYLHEGLEVQVIYRDFK+SNVLLDE+F P LSDFGLA
Sbjct: 175 NRAVPVIPWKTRLKIILGAAQGMAYLHEGLEVQVIYRDFKSSNVLLDEDFNPWLSDFGLA 234

Query: 236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           REGP    +HVSTA VGT GYAAP+Y+ETGHL+ KSD+WSFGVVLYE+LTGRR+LERN P
Sbjct: 235 REGPAGDRSHVSTAPVGTLGYAAPEYVETGHLSVKSDIWSFGVVLYEILTGRRTLERNLP 294

Query: 296 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 355
             +Q+L++WV+Q+PADS+KF +I+DPRL  E+S+  AR+I +LAD+CL+K +K+RPKMS+
Sbjct: 295 VMQQKLIDWVKQFPADSRKFSMIIDPRLRNEFSLVAARRIAKLADSCLNKIAKERPKMSE 354

Query: 356 VVERLKQIVQVSNEGDSFDKTFEEICEEDPVEAQTKQKQ 394
           VV+ L Q VQ S E  S + T        P +  + ++Q
Sbjct: 355 VVQILTQAVQESQETTSLEITGPGPGPSRPTQLASPKQQ 393

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	432
TAIR|locus:2151992	410	AT5G47070 [Arabidopsis thalian	0.787	0.829	0.602	2.1e-107
TAIR|locus:2064920	435	AT2G39110 [Arabidopsis thalian	0.891	0.885	0.508	2.8e-98
TAIR|locus:2129326	388	AT4G17660 [Arabidopsis thalian	0.733	0.817	0.585	2.9e-96
TAIR|locus:2053250	462	AT2G28940 [Arabidopsis thalian	0.819	0.766	0.528	4.2e-95
TAIR|locus:2085069	418	AT3G09830 [Arabidopsis thalian	0.780	0.806	0.540	1.6e-93
TAIR|locus:2142639	420	AT5G03320 [Arabidopsis thalian	0.787	0.809	0.525	2.5e-90
TAIR|locus:2147805	493	AT5G15080 [Arabidopsis thalian	0.840	0.736	0.480	3.9e-83
TAIR|locus:2100282	490	AT3G01300 [Arabidopsis thalian	0.747	0.659	0.514	1.7e-82
TAIR|locus:2095517	453	AT3G28690 [Arabidopsis thalian	0.791	0.754	0.497	2.8e-82
TAIR|locus:2053240	423	PK1B "protein kinase 1B" [Arab	0.770	0.787	0.492	2.9e-80

TAIR|locus:2151992 AT5G47070 [Arabidopsis thaliana (taxid:3702)]

 Score = 1062 (378.9 bits), Expect = 2.1e-107, P = 2.1e-107
 Identities = 215/357 (60%), Positives = 268/357 (75%)

Query:    19 SAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQAT 78
             SAPEL    +++ ++  ++ R        S+ SPR I +LY E+  NLRVFSY E+ +AT
Sbjct:    33 SAPELTNRSETSSFN-LQTPR--------SLPSPRSIKDLYTEREQNLRVFSYEELSKAT 83

Query:    79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----WVAEVQFLG 134
               FSR L IGEGGFG VYK  I  + GD +    VVAIKKLNR GLQ    W+AEVQFLG
Sbjct:    84 YVFSRKLVIGEGGFGIVYKGKIL-SNGDSSDPPLVVAIKKLNRQGLQGHKQWLAEVQFLG 142

Query:   135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 194
             V+ HPN+VKLIGYC+ DGE GI+RLLVYE+M NRSLEDHLF R    LPWK RL I+LGA
Sbjct:   143 VVNHPNVVKLIGYCSEDGETGIERLLVYEYMSNRSLEDHLFPRRSHTLPWKKRLEIMLGA 202

Query:   195 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 254
             AEGL YLH+   ++VIYRDFK+SNVLLD+ F PKLSDFGLAREGP   +THV+TA VGT 
Sbjct:   203 AEGLTYLHD---LKVIYRDFKSSNVLLDDQFCPKLSDFGLAREGPDGDNTHVTTARVGTH 259

Query:   255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 314
             GYAAP+Y++TGHL  KSDV+SFGVVLYE++TGRR++ERN+P  E+RLL+WV++YPADS++
Sbjct:   260 GYAAPEYVQTGHLRLKSDVYSFGVVLYEIITGRRTIERNKPVAERRLLDWVKEYPADSQR 319

Query:   315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGD 371
             F +I+DPRL   Y    AR + +LAD CL K+ K+RP M  VVERLK+I++ S+  D
Sbjct:   320 FSMIVDPRLRNNYPAAGARSLAKLADLCLKKNDKERPTMEIVVERLKKIIEESDSED 376

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

TAIR|locus:2064920 AT2G39110 [Arabidopsis thaliana (taxid:3702)]

 Score = 976 (348.6 bits), Expect = 2.8e-98, P = 2.8e-98
 Identities = 203/399 (50%), Positives = 270/399 (67%)

Query:     1 MKCFHYFXXXXXXXXXXXSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYE 60
             MKCF YF           +  +      +   SG+E +    +S + S+TS   +  L E
Sbjct:    16 MKCF-YFSKDKTQDDEAKTR-KFGSATMARGGSGSEFNS--DTSTATSITSSLHV--LSE 69

Query:    61 EKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN 120
               ++NL+VF   +++ AT +FSR L IGEGGFG V++  I+    D   +  + A+K+L+
Sbjct:    70 THSNNLKVFVLDDLKTATKNFSRSLMIGEGGFGGVFRGVIQNPQ-DSRKKIDI-AVKQLS 127

Query:   121 RDGLQ----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN 176
             R GLQ    WV EV  LGV+EHPNLVKLIGYCA D ERGIQRLLVYE++ NRS++DHL N
Sbjct:   128 RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLVYEYVQNRSVQDHLSN 187

Query:   177 RAF-PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA 235
             R    PLPW TRL I    A GLAYLH+G+E Q+I+RDFK+SN+LLDEN+  KLSDFGLA
Sbjct:   188 RFIVTPLPWSTRLKIAQDTARGLAYLHQGMEFQIIFRDFKSSNILLDENWNAKLSDFGLA 247

Query:   236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
             R GP  G THVSTAVVGT GYAAP+YI+TGHLTAKSDVWS+G+ LYE++TGRR  +RNRP
Sbjct:   248 RMGPSDGITHVSTAVVGTIGYAAPEYIQTGHLTAKSDVWSYGIFLYELITGRRPFDRNRP 307

Query:   296 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 355
             + EQ +LEW++ + +D KKF +I+DPRLE  Y +  A K+  +A+ CL   +K RP MSQ
Sbjct:   308 RNEQNILEWIRPHLSDIKKFKMIIDPRLEGNYYLKSALKLAAVANRCLMVKAKARPTMSQ 367

Query:   356 VVERLKQIVQVSNEG-DSFDKTFEEICEEDPVEAQTKQK 393
             V E L++IV+ S++G  S     + +  +D  EA  +++
Sbjct:   368 VSEMLERIVETSSDGAPSGLPLMKSLTPKDAFEASRRER 406

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2129326 AT4G17660 [Arabidopsis thaliana (taxid:3702)]

 Score = 957 (341.9 bits), Expect = 2.9e-96, P = 2.9e-96
 Identities = 195/333 (58%), Positives = 244/333 (73%)

Query:    48 SVTSPRGIPELYEEKAHN----LRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIK-P 102
             S+ SP  I +LY ++  N    LRVFS+ E+  AT +FSR LKIGEGGFGSVYK++I  P
Sbjct:    54 SLPSPTSIKDLYTDREQNQNQNLRVFSFKELSDATCEFSRKLKIGEGGFGSVYKATINNP 113

Query:   103 AAGDGTSEATVVAIKKLNRDGLQ----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQR 158
               GD  S    VA+KKLNR  LQ    W+AEV FLGV+ HPN+V+L+GYC+ D ER    
Sbjct:   114 TVGDSHSSPLTVAVKKLNRQSLQGHKQWLAEVHFLGVVNHPNVVRLLGYCSEDRER---- 169

Query:   159 LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASN 218
             LLVYE M NRSLEDHLF      L WK RL I+LGAA+GLAYLHE   +QVIYRDFK+SN
Sbjct:   170 LLVYELMSNRSLEDHLFTLRTLTLSWKQRLEIMLGAAQGLAYLHE---IQVIYRDFKSSN 226

Query:   219 VLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGV 278
             VLL+E F PKLSDFGLAREGP   +THV+TA VGT GYAAP+Y+ TGHL    DV+SFGV
Sbjct:   227 VLLNEEFHPKLSDFGLAREGPEGDNTHVTTARVGTDGYAAPEYVITGHLKTHCDVYSFGV 286

Query:   279 VLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRL 338
             VLYE++TGRR+LER +P  EQ+LLEWV++YP +SK+F +I+D +L  +Y I   R++ +L
Sbjct:   287 VLYEIITGRRTLERMKPLAEQKLLEWVKKYPINSKRFKMIVDSKLCNKYPIAMVRRVAKL 346

Query:   339 ADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGD 371
             AD+C++K  K+RP M+ VVE L  I++ SN  D
Sbjct:   347 ADHCVNKIDKERPTMAFVVESLTNIIEESNSED 379

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2053250 AT2G28940 [Arabidopsis thaliana (taxid:3702)]

 Score = 946 (338.1 bits), Expect = 4.2e-95, P = 4.2e-95
 Identities = 194/367 (52%), Positives = 259/367 (70%)

Query:    51 SPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSE 110
             S R I  L  E  ++L+VF++ E++ AT  F+R L IGEGGFG VY+  +  +  +G   
Sbjct:    74 SQRWIGGLVPE--NDLKVFTFKELKIATKGFNRGLLIGEGGFGCVYRGVVDVSDSNGFDS 131

Query:   111 ATVVAIKKLNRDGLQ----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFML 166
                VA+K+LNR GLQ    W+ EV FLGV+ HPNLVKL+GYCA D ERG+QRLLVYE M 
Sbjct:   132 KINVAVKQLNRQGLQGHKEWINEVNFLGVVNHPNLVKLVGYCADDDERGMQRLLVYELMC 191

Query:   167 NRSLEDHLFNRAFP-PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF 225
             N+SLEDHL  R     LPW  RL I   AA+GLAYLHE ++ Q+I+RDFK+SN+LLDE F
Sbjct:   192 NKSLEDHLVGRVVSVSLPWMMRLKIAQDAAQGLAYLHEEMDFQLIFRDFKSSNILLDERF 251

Query:   226 RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
               KLSDFGLAR+GP  G  HVST+VVGT GYAAP+Y++TG LTAKSDVWSFGVVLYE++T
Sbjct:   252 GAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGKLTAKSDVWSFGVVLYELIT 311

Query:   286 GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEY-SINEARKIGRLADNCLS 344
             GRR+++RNRP+ EQ+LLEWV+ Y +DSKKF LI+DPRLE +Y  +   +++  LA+ CL 
Sbjct:   312 GRRAVDRNRPRGEQKLLEWVKPYVSDSKKFHLIVDPRLEGQYYCMKSVQRVAALANKCLM 371

Query:   345 KSSKDRPKMSQVVERLKQIVQVSNEG---DSFDKTFEEICEEDPVEAQTKQKQHEPSEAW 401
             K  K RPKMS+VV  L +I+    E       D+T EEI + + +  +++ +  +   ++
Sbjct:   372 KQPKSRPKMSEVVSLLGRIIDEEAENVPPPVADET-EEIIKAE-LNGESEPELKKQGSSY 429

Query:   402 KRRMAHL 408
             ++++  L
Sbjct:   430 RKKVLDL 436

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2085069 AT3G09830 [Arabidopsis thaliana (taxid:3702)]

 Score = 931 (332.8 bits), Expect = 1.6e-93, P = 1.6e-93
 Identities = 187/346 (54%), Positives = 251/346 (72%)

Query:    33 SGAE-SDRFVK-SSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEG 90
             SG+E + R V  +S  +S+      P +   +A NLR FS ++++ AT +FSR + IGEG
Sbjct:    35 SGSEFNSRDVSGTSTESSMGRKNSYPPV-STRASNLREFSITDLKSATKNFSRSVMIGEG 93

Query:    91 GFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----WVAEVQFLGVLEHPNLVKLIG 146
             GFG V++ +++    + +S    VA+K+L + GLQ    WV EV FLG++EH NLVKL+G
Sbjct:    94 GFGCVFRGTVRNL--EDSSVKIEVAVKQLGKRGLQGHKEWVTEVNFLGIVEHTNLVKLLG 151

Query:   147 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLE 206
             YCA D ERGIQRLLVYE+M NRS+E HL  R+   L W  RL I   AA GL YLHE +E
Sbjct:   152 YCAEDDERGIQRLLVYEYMPNRSVEFHLSPRSLTVLTWDLRLRIAQDAARGLTYLHEEME 211

Query:   207 VQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH 266
              Q+I+RDFK+SN+LLDE+++ KLSDFGLAR GP  G THVST VVGT GYAAP+YI+TG 
Sbjct:   212 FQIIFRDFKSSNILLDEDWKAKLSDFGLARLGPSEGLTHVSTDVVGTMGYAAPEYIQTGR 271

Query:   267 LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKE 326
             LT+KSDVW +GV LYE++TGRR ++RNRPK EQ+LLEWV+ Y +D++KF LI+DPRLE +
Sbjct:   272 LTSKSDVWGYGVFLYELITGRRPVDRNRPKGEQKLLEWVRPYLSDTRKFKLILDPRLEGK 331

Query:   327 YSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDS 372
             Y I   +K+  +A+ CL ++SK RPKMS+V+E + +IV+ S+   S
Sbjct:   332 YPIKSVQKLAVVANRCLVRNSKARPKMSEVLEMVNKIVEASSGNGS 377

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2142639 AT5G03320 [Arabidopsis thaliana (taxid:3702)]

 Score = 901 (322.2 bits), Expect = 2.5e-90, P = 2.5e-90
 Identities = 183/348 (52%), Positives = 248/348 (71%)

Query:    33 SGAE-SDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGG 91
             SG++ S R V  + + S T  R        + +NLR F+  +++ AT +FSR   IGEGG
Sbjct:    33 SGSDFSPRDVSGTSTVSSTG-RNSNTSMSARENNLREFTIGDLKSATRNFSRSGMIGEGG 91

Query:    92 FGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----WVAEVQFLGVLEHPNLVKLIGY 147
             FG V+  +IK    +  S+   VA+K+L + GLQ    WV EV FLGV+EH NLVKL+G+
Sbjct:    92 FGCVFWGTIKNL--EDPSKKIEVAVKQLGKRGLQGHKEWVTEVNFLGVVEHSNLVKLLGH 149

Query:   148 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEV 207
             CA D ERGIQRLLVYE+M N+S+E HL  R+   L W  RL I   AA GL YLHE ++ 
Sbjct:   150 CAEDDERGIQRLLVYEYMPNQSVEFHLSPRSPTVLTWDLRLRIAQDAARGLTYLHEEMDF 209

Query:   208 QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL 267
             Q+I+RDFK+SN+LLDEN+  KLSDFGLAR GP  G +HVST VVGT GYAAP+YI+TG L
Sbjct:   210 QIIFRDFKSSNILLDENWTAKLSDFGLARLGPSPGSSHVSTDVVGTMGYAAPEYIQTGRL 269

Query:   268 TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEY 327
             T+KSDVW +GV +YE++TGRR L+RN+PK EQ+LLEWV+ Y +D+++F LI+DPRLE +Y
Sbjct:   270 TSKSDVWGYGVFIYELITGRRPLDRNKPKGEQKLLEWVRPYLSDTRRFRLIVDPRLEGKY 329

Query:   328 SINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSFDK 375
              I   +K+  +A+ CL++++K RPKMS+V+E + +IV+ S+ G+   K
Sbjct:   330 MIKSVQKLAVVANLCLTRNAKARPKMSEVLEMVTKIVEASSPGNGGKK 377

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)]

 Score = 833 (298.3 bits), Expect = 3.9e-83, P = 3.9e-83
 Identities = 184/383 (48%), Positives = 247/383 (64%)

Query:    28 KSADYS-GAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLK 86
             KS D   G  S     S+  +S ++P  I E     +H LR F++++++ +T +F     
Sbjct:    90 KSNDQPVGQVSSTTTTSNAESSSSTPV-ISEELNISSH-LRKFTFNDLKLSTRNFRPESL 147

Query:    87 IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQ----WVAEVQFLGVLEHPN 140
             +GEGGFG V+K  I+          T   VA+K LN DGLQ    W+AE+ FLG L HPN
Sbjct:   148 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPN 207

Query:   141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
             LVKL+GYC  D     QRLLVYEFM   SLE+HLF R+ P LPW  R+ I LGAA+GL++
Sbjct:   208 LVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLSF 262

Query:   201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 260
             LHE     VIYRDFK SN+LLD ++  KLSDFGLA++ P  G THVST V+GT+GYAAP+
Sbjct:   263 LHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPE 322

Query:   261 YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMD 320
             Y+ TGHLT+KSDV+SFGVVL EMLTGRRS+++NRP  E  L+EW + +  D ++F  ++D
Sbjct:   323 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLD 382

Query:   321 PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDS--FDKTFE 378
             PRLE  +SI  A+K+ +LA  CLS+  K RPKMS VVE LK +  + +   S  + +T +
Sbjct:   383 PRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKDMASSSYYFQTMQ 442

Query:   379 -EICEEDPVEAQ---TKQKQHEP 397
              E  +     +Q   ++  QH+P
Sbjct:   443 AERLKNGSGRSQGFGSRNGQHQP 465

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)]

 Score = 827 (296.2 bits), Expect = 1.7e-82, P = 1.7e-82
 Identities = 173/336 (51%), Positives = 228/336 (67%)

Query:    34 GAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFG 93
             G  S     S+  +S+++P  I E     +H L+ FS+ +++ AT +F     +GEGGFG
Sbjct:    91 GPVSSTTTTSNAESSLSTPI-ISEELNIYSH-LKKFSFIDLKLATRNFRPESLLGEGGFG 148

Query:    94 SVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQ----WVAEVQFLGVLEHPNLVKLIGY 147
              V+K  ++          T   VA+K LN DGLQ    W+AE+ +LG L HPNLVKL+GY
Sbjct:   149 CVFKGWVEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGY 208

Query:   148 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEV 207
             C  D     QRLLVYEFM   SLE+HLF R+ P LPW  R+ I LGAA+GL++LHE    
Sbjct:   209 CIEDD----QRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLSFLHEEALK 263

Query:   208 QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL 267
              VIYRDFK SN+LLD  +  KLSDFGLA++ P  G THVST V+GT+GYAAP+Y+ TGHL
Sbjct:   264 PVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHL 323

Query:   268 TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEY 327
             T+KSDV+SFGVVL EMLTGRRS+++NRP  E  L+EW + +  D ++F  ++DPRLE  +
Sbjct:   324 TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHF 383

Query:   328 SINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
             S+  A+K+ +LA  CLS+ SK RPKMS+VVE LK +
Sbjct:   384 SVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPL 419

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)]

 Score = 825 (295.5 bits), Expect = 2.8e-82, P = 2.8e-82
 Identities = 178/358 (49%), Positives = 234/358 (65%)

Query:    23 LKEPRKSADYSGAESDRFVKSSCSASVTS-PRGIPEL-YEEKAHNLRVFSYSEMRQATND 80
             + EP+K  +           + C+ S +S P    EL Y  K   LR+F +++++ AT +
Sbjct:    46 IAEPKKVIEKLEGHPAPTKDTGCAESGSSTPLMSGELKYSSK---LRIFMFNDLKLATRN 102

Query:    81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQ----WVAEVQFLG 134
             F     +GEGGFG V+K  I+          T   VA+K LN DGLQ    W+AE+ FLG
Sbjct:   103 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLG 162

Query:   135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 194
              L HP+LVKL+GYC  +     QRLLVYEFM   SLE+HLF R  P LPW  R+ I LGA
Sbjct:   163 NLVHPSLVKLVGYCMEED----QRLLVYEFMPRGSLENHLFRRTLP-LPWSVRMKIALGA 217

Query:   195 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 254
             A+GLA+LHE  E  VIYRDFK SN+LLD  +  KLSDFGLA++ P    +HVST V+GT+
Sbjct:   218 AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEKKSHVSTRVMGTY 277

Query:   255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 314
             GYAAP+Y+ TGHLT KSDV+SFGVVL E+LTGRRS++++RP  EQ L+EWV+ +  D K+
Sbjct:   278 GYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGRRSVDKSRPNGEQNLVEWVRPHLLDKKR 337

Query:   315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDS 372
             F  ++DPRLE  YSI  A+K  ++A  CL++ SK RPKMS+VVE LK +  + +   S
Sbjct:   338 FYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDSKARPKMSEVVEALKPLPNLKDFASS 395

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)]

 Score = 806 (288.8 bits), Expect = 2.9e-80, P = 2.9e-80
 Identities = 173/351 (49%), Positives = 231/351 (65%)

Query:    29 SADYSGAES-DRFVKSSCSASV-TSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLK 86
             S  Y  +E+ D     S S S+ T+PR   E+ +    NL+ F+++E++ AT +F     
Sbjct:    28 SPKYMSSEANDSLGSKSSSVSIRTNPRTEGEILQSP--NLKSFTFAELKAATRNFRPDSV 85

Query:    87 IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQ----WVAEVQFLGVLEHPN 140
             +GEGGFGSV+K  I       +   T  V+A+KKLN+DG Q    W+AEV +LG   HPN
Sbjct:    86 LGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPN 145

Query:   141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGL 198
             LVKLIGYC  D  R    LLVYEFM   SLE+HLF R   F PL W  RL + LGAA+GL
Sbjct:   146 LVKLIGYCLEDEHR----LLVYEFMPRGSLENHLFRRGSYFQPLSWTLRLKVALGAAKGL 201

Query:   199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
             A+LH   E  VIYRDFK SN+LLD  +  KLSDFGLA++GP    +HVST ++GT+GYAA
Sbjct:   202 AFLHNA-ETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVSTRIMGTYGYAA 260

Query:   259 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 318
             P+Y+ TGHLT KSDV+S+GVVL E+L+GRR++++NRP  EQ+L+EW +   A+ +K   +
Sbjct:   261 PEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLVEWARPLLANKRKLFRV 320

Query:   319 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNE 369
             +D RL+ +YS+ EA K+  LA  CL+   K RP M++VV  L+ I Q  NE
Sbjct:   321 IDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHI-QTLNE 370

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9LTC0	Y5707_ARATH	2, ., 7, ., 1, 1, ., 1	0.5815	0.8495	0.8951	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00019023001 SubName- Full=Chromosome chr15 scaffold_19, whole genome shotgun sequence; (427 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	432
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-47
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-47
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-46
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-46
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-46
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-43
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-42
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-34
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-33
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-32
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-32
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-30
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-29
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-28
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-26
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-26
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-25
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-25
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-25
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-25
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-25
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-25
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-25
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-23
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-23
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-23
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-23
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-23
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-23
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	8e-23
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-22
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-22
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-21
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-21
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-21
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-21
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-21
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-21
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	7e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	8e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-20
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-20
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-20
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-20
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-20
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-20
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-20
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-20
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-20
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-20
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-20
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-20
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	8e-20
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	9e-20
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-19
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-19
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-19
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-19
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-19
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-19
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-19
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	9e-19
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-18
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-18
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-18
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-18
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-18
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-18
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-18
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	7e-18
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-18
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-18
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-18
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-18
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	9e-18
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-18
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-17
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-17
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-17
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-17
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-17
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-17
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	9e-17
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	9e-17
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-16
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-16
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-16
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-16
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-16
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-16
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-16
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-16
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-16
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-16
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	9e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	9e-16
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-15
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-15
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-15
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-15
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-15
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-15
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-15
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-15
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-15
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-15
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	7e-15
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	7e-15
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	8e-15
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	9e-15
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	9e-15
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	9e-15
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-14
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-14
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-14
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-14
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-14
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-14
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	9e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	9e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	9e-14
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-13
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-13
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-13
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-13
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-13
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-13
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-13
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-13
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-13
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-13
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-13
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-13
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-12
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-12
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-12
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-12
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-12
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-12
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-12
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-12
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-12
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	8e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	9e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-11
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-11
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	8e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-10
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-10
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	6e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	9e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-09
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-09
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-08
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-08
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-08
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	8e-08
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-07
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	8e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	9e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	7e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-05
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	7e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	8e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	5e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	7e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	0.001
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.001
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.003

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  162 bits (413), Expect = 2e-47
 Identities = 84/285 (29%), Positives = 129/285 (45%), Gaps = 43/285 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPN 140
           K+GEG FG VYK  +K   G        VA+K L  D       +++ E + +  L+HPN
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKK---VEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           +VKL+G C  +        +V E+M    L  +L     P L     L   L  A G+ Y
Sbjct: 63  VVKLLGVCTEEEPL----YIVMEYMEGGDLLSYLRKNR-PKLSLSDLLSFALQIARGMEY 117

Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP-----MVGHTHVSTAVVGTFG 255
           L        I+RD  A N L+ EN   K+SDFGL+R+             +         
Sbjct: 118 LES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR------ 168

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF 315
           + AP+ ++ G  T+KSDVWSFGV+L+E+ T           + + +LE+++         
Sbjct: 169 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPG--MSNEEVLEYLKN-------- 218

Query: 316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL 360
           G     RL +  +     ++  L   C ++  +DRP  S++VE L
Sbjct: 219 GY----RLPQPPNCPP--ELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  162 bits (413), Expect = 3e-47
 Identities = 81/280 (28%), Positives = 128/280 (45%), Gaps = 32/280 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPN 140
           K+GEG FG VYK ++K            VA+K L  D       +++ E + +  L+HPN
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKE---VEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           +VKL+G C  +       ++V E+M    L D+L       L     L   L  A G+ Y
Sbjct: 63  IVKLLGVCTEEE----PLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118

Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 260
           L        I+RD  A N L+ EN   K+SDFGL+R+       +          + AP+
Sbjct: 119 LES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYKVKGGKLPIRWMAPE 174

Query: 261 YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMD 320
            ++ G  T+KSDVWSFGV+L+E+ T           +   +LE++++        G  + 
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPG--MSNAEVLEYLKK--------GYRLP 224

Query: 321 PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL 360
                        ++ +L   C ++  +DRP  S++VE L
Sbjct: 225 KPPNCP------PELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  158 bits (403), Expect = 2e-46
 Identities = 71/204 (34%), Positives = 104/204 (50%), Gaps = 24/204 (11%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-----QWVAEVQFLGVLEHPNL 141
           +GEGGFG+VY +  K            VAIK + ++       + + E++ L  L HPN+
Sbjct: 1   LGEGGFGTVYLARDK-------KTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNI 53

Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 201
           VKL G    +    +    V E+    SL+D L       L     L I+L   EGL YL
Sbjct: 54  VKLYGVFEDENHLYL----VMEYCEGGSLKDLLKEN-EGKLSEDEILRILLQILEGLEYL 108

Query: 202 HEGLEVQVIYRDFKASNVLLDE-NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 260
           H      +I+RD K  N+LLD  N + KL+DFGL++   +     +   +VGT  Y AP+
Sbjct: 109 HS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPE 163

Query: 261 YIE-TGHLTAKSDVWSFGVVLYEM 283
            +   G+ + KSD+WS GV+LYE+
Sbjct: 164 VLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  160 bits (406), Expect = 3e-46
 Identities = 86/291 (29%), Positives = 135/291 (46%), Gaps = 45/291 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-----QWVAEVQFLGVLEHPN 140
           K+GEG FG VYK  +K        + T VA+K L  D        ++ E + +  L HPN
Sbjct: 2   KLGEGAFGEVYKGKLK----GKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPN 57

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-------FPPLPWKTRLHIILG 193
           +V+L+G C  +        LV E+M    L D+L              L  K  L   + 
Sbjct: 58  VVRLLGVCTEEEPL----YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
            A+G+ YL      + ++RD  A N L+ E+   K+SDFGL+R+     +    T     
Sbjct: 114 IAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLP 170

Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP---KTEQRLLEWVQQYPA 310
             + AP+ ++ G  T+KSDVWSFGV+L+E+ T   +     P    + + +LE++++   
Sbjct: 171 IRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGAT-----PYPGLSNEEVLEYLRK--- 222

Query: 311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 361
                G     RL K        ++  L  +C     +DRP  S++VERL+
Sbjct: 223 -----GY----RLPK--PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  159 bits (405), Expect = 4e-46
 Identities = 85/282 (30%), Positives = 124/282 (43%), Gaps = 40/282 (14%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFLGVLEHP 139
           K+G G FG+VYK+      G       +VA+K L +             E++ L  L HP
Sbjct: 6   KLGSGSFGTVYKA-KHKGTGK------IVAVKILKKRSEKSKKDQTARREIRILRRLSHP 58

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           N+V+LI              LV E+     L D+L      PL       I L    GL 
Sbjct: 59  NIVRLIDAFEDKDHL----YLVMEYCEGGDLFDYLSRG--GPLSEDEAKKIALQILRGLE 112

Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 259
           YLH      +I+RD K  N+LLDEN   K++DFGLA++  ++  +   T  VGT  Y AP
Sbjct: 113 YLHS---NGIIHRDLKPENILLDENGVVKIADFGLAKK--LLKSSSSLTTFVGTPWYMAP 167

Query: 260 DYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 318
           + +  G     K DVWS GV+LYE+LTG +         +Q             +    I
Sbjct: 168 EVLLGGNGYGPKVDVWSLGVILYELLTG-KPPFSGENILDQL------------QLIRRI 214

Query: 319 MDPRLE--KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
           + P LE  +    + + +   L   CL+K    RP   ++++
Sbjct: 215 LGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  152 bits (386), Expect = 2e-43
 Identities = 76/284 (26%), Positives = 114/284 (40%), Gaps = 50/284 (17%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGL-----QWVAEVQFLGVLEH 138
           K+GEG FG VY             + T  +VAIK + +  +     + + E++ L  L+H
Sbjct: 6   KLGEGSFGKVYL---------ARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKH 56

Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 198
           PN+V+L      + +      LV E+     L D L  +    L        +      L
Sbjct: 57  PNIVRLYDVFEDEDKL----YLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSAL 110

Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
            YLH      +++RD K  N+LLDE+   KL+DFGLAR+   +      T  VGT  Y A
Sbjct: 111 EYLHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQ---LDPGEKLTTFVGTPEYMA 164

Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 318
           P+ +         D+WS GV+LYE+LTG+       P            +P D +   L 
Sbjct: 165 PEVLLGKGYGKAVDIWSLGVILYELLTGK------PP------------FPGDDQLLELF 206

Query: 319 MDPRLEKEYSINEARKIGRLA----DNCLSKSSKDRPKMSQVVE 358
                 K         I   A       L K  + R    + ++
Sbjct: 207 KKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  150 bits (381), Expect = 1e-42
 Identities = 88/286 (30%), Positives = 132/286 (46%), Gaps = 44/286 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
           K+GEG FG VYK ++K   GDG    T VA+K L       +  +++ E   +  L HPN
Sbjct: 6   KLGEGAFGEVYKGTLK---GDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           +V+L+G C     +G    +V E+M    L D L       L  K  L + L  A+G+ Y
Sbjct: 63  IVRLLGVC----TQGEPLYIVTEYMPGGDLLDFLRKHG-EKLTLKDLLQMALQIAKGMEY 117

Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA--- 257
           L        ++RD  A N L+ EN   K+SDFGL+R+                 G     
Sbjct: 118 LES---KNFVHRDLAARNCLVTENLVVKISDFGLSRD-----IYEDDYYRKRGGGKLPIK 169

Query: 258 --APDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKK 314
             AP+ ++ G  T+KSDVWSFGV+L+E+ T G +        + + +LE ++        
Sbjct: 170 WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPG---MSNEEVLELLED------- 219

Query: 315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL 360
                  RL +    N   ++  L   C +   +DRP  S++VE L
Sbjct: 220 -----GYRLPR--PENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  128 bits (324), Expect = 2e-34
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 30/214 (14%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKK--LNRDGLQWVA----EVQFLGVLE 137
            +G G FGSVY             + T  ++A+K   L+ D  + +     E++ L  L+
Sbjct: 7   LLGRGSFGSVYL---------ALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ 57

Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKT-RLHI--ILGA 194
           HPN+V+  G    D E+     +  E++   SL   L  + F  LP    R +   IL  
Sbjct: 58  HPNIVRYYG-SERDEEKN-TLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQIL-- 111

Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 254
            EGLAYLH      +++RD K +N+L+D +   KL+DFG A+    +     + +V GT 
Sbjct: 112 -EGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP 167

Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRR 288
            + AP+ I        +D+WS G  + EM TG+ 
Sbjct: 168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  125 bits (316), Expect = 4e-33
 Identities = 87/294 (29%), Positives = 137/294 (46%), Gaps = 29/294 (9%)

Query: 83  RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVLE 137
            + ++GEG FG V      P  GD T E   VA+K LN  G +     +  E++ L  L+
Sbjct: 8   FIKQLGEGHFGKVELCRYDPL-GDNTGE--QVAVKSLNHSGEEQHRSDFEREIEILRTLD 64

Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-FNRAFPPLPWKTRLHIILGAAE 196
           H N+VK  G C   G R ++  L+ E++ + SL D+L  +R    +  K  L       +
Sbjct: 65  HENIVKYKGVCEKPGGRSLR--LIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICK 120

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG---T 253
           G+ YL      + I+RD  A N+L++     K+SDFGLA+  P     +      G    
Sbjct: 121 GMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPE-DKDYYYVKEPGESPI 176

Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS 312
           F YA P+ + T   ++ SDVWSFGV LYE+ T G  S     P    R++   Q     +
Sbjct: 177 FWYA-PECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS--PPAEFLRMIGIAQGQMIVT 233

Query: 313 KKFGLIMD-PRLEKEYSI-NEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV 364
           +   L+ +  RL +  S  +E   +  L   C     +DRP  + ++  + ++ 
Sbjct: 234 RLLELLKEGERLPRPPSCPDE---VYDLMKLCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  122 bits (309), Expect = 2e-32
 Identities = 68/212 (32%), Positives = 97/212 (45%), Gaps = 22/212 (10%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN----RDGLQWVAEVQFLGV 135
            F  + KIG+GGFG VYK+  K            VAIK +         + + E+Q L  
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKR-------TGKEVAIKVIKLESKEKKEKIINEIQILKK 53

Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
            +HPN+VK  G      E  I    V EF    SL+D L       L      ++     
Sbjct: 54  CKHPNIVKYYGSYLKKDELWI----VMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELL 108

Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
           +GL YLH      +I+RD KA+N+LL  +   KL DFGL+ +   +  T     +VGT  
Sbjct: 109 KGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQ---LSDTKARNTMVGTPY 162

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
           + AP+ I       K+D+WS G+   E+  G+
Sbjct: 163 WMAPEVINGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  121 bits (307), Expect = 5e-32
 Identities = 72/212 (33%), Positives = 106/212 (50%), Gaps = 32/212 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW------VAEVQFLGVLEHP 139
            IG G FG VYK          T +   VAIK+++ + ++       + E+  L  L+HP
Sbjct: 7   LIGRGAFGVVYK-----GLNLETGD--FVAIKQISLEKIKEEALKSIMQEIDLLKNLKHP 59

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP---WKTRLHIILGAAE 196
           N+VK IG         I    + E+  N SL   +  + F P P       ++ +L   +
Sbjct: 60  NIVKYIGSIETSDSLYI----ILEYAENGSLRQII--KKFGPFPESLVAVYVYQVL---Q 110

Query: 197 GLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
           GLAYLHE    Q VI+RD KA+N+L  ++   KL+DFG+A +   V       +VVGT  
Sbjct: 111 GLAYLHE----QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPY 164

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
           + AP+ IE    +  SD+WS G  + E+LTG 
Sbjct: 165 WMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  117 bits (296), Expect = 2e-30
 Identities = 68/207 (32%), Positives = 98/207 (47%), Gaps = 29/207 (14%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGVLEHPNLVK 143
           IG+G FG V           G      VA+K L  D      ++AE   +  L HPNLV+
Sbjct: 14  IGKGEFGDVML---------GDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQ 64

Query: 144 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE 203
           L+G         +   +V E+M   SL D+L +R    +    +L   L   EG+ YL E
Sbjct: 65  LLGVVLQGN--PL--YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE 120

Query: 204 GLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAAPDY 261
                 ++RD  A NVL+ E+   K+SDFGLA+E    G         G     + AP+ 
Sbjct: 121 K---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEA-SQGQD------SGKLPVKWTAPEA 170

Query: 262 IETGHLTAKSDVWSFGVVLYEMLT-GR 287
           +     + KSDVWSFG++L+E+ + GR
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  117 bits (292), Expect = 4e-29
 Identities = 87/337 (25%), Positives = 132/337 (39%), Gaps = 48/337 (14%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVL-E 137
           K+GEG FG VY +  +           +VA+K L +          +++ E+Q L  L  
Sbjct: 7   KLGEGSFGEVYLARDRK----------LVALKVLAKKLESKSKEVERFLREIQILASLNH 56

Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP-PLPWKTRLHIILGAAE 196
            PN+VKL  +   +G       LV E++   SLED L       PL     L I+     
Sbjct: 57  PPNIVKLYDFFQDEG----SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAR----EGPMVGHTHVSTAVV 251
            L YLH      +I+RD K  N+LLD +    KL DFGLA+     G       + +  V
Sbjct: 113 ALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV 169

Query: 252 GTFGYAAPDYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLER-NRPKTEQRLLEWVQQ 307
           GT GY AP+ +      + ++ SD+WS G+ LYE+LTG    E         + L+ + +
Sbjct: 170 GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229

Query: 308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS 367
            P  S    L          + ++      L    L+K  K+R   S  +          
Sbjct: 230 LPTPSLASPLSPSNPELISKAASD------LLKKLLAKDPKNRLSSSSDLSHDLLA---- 279

Query: 368 NEGDSFDKTFEEICEEDPVEAQTKQKQHEPSEAWKRR 404
                  K  +      P ++   +    PS      
Sbjct: 280 ---HLKLKESDLSDLLKPDDSAPLRLSLPPSLEALIS 313

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  112 bits (282), Expect = 2e-28
 Identities = 70/289 (24%), Positives = 127/289 (43%), Gaps = 43/289 (14%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN------RDGLQWVAEVQFL 133
            +  + +IG+G FG VY    K       S+  +  +K+++      ++    + EV+ L
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRK-------SDGKLYVLKEIDLSNMSEKEREDALNEVKIL 53

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHII 191
             L HPN++K       +  +     +V E+     L   +  +     P P +  L   
Sbjct: 54  KKLNHPNIIKYYE-SFEEKGK---LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF 109

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 251
           +     L YLH     ++++RD K  N+ L  N   KL DFG+++   +     ++  VV
Sbjct: 110 VQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVV 164

Query: 252 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYPA 310
           GT  Y +P+  +      KSD+WS G VLYE+ T +   E  N  +   ++L+   QYP 
Sbjct: 165 GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK--GQYPP 222

Query: 311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER 359
                       +  +YS     ++  L  + L K  ++RP ++Q+++ 
Sbjct: 223 ------------IPSQYS----SELRNLVSSLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  107 bits (268), Expect = 2e-26
 Identities = 100/300 (33%), Positives = 143/300 (47%), Gaps = 41/300 (13%)

Query: 83  RMLK----IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQ----WVAEVQFL 133
           R LK    +GEG FG V      PA  DGT E  +VA+K L R+ G Q    W  E+  L
Sbjct: 4   RYLKKIRVLGEGHFGKVSLYCYDPA-NDGTGE--MVAVKTLKRECGQQNTSGWKKEINIL 60

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L H N+VK  G C+  G +G+Q  L+ E++   SL D+L      P        ++L 
Sbjct: 61  KTLYHENIVKYKGCCSEQGGKGLQ--LIMEYVPLGSLRDYL------PKHKLNLAQLLLF 112

Query: 194 A---AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           A    EG+AYLH       I+RD  A NVLLD +   K+ DFGLA+  P  GH +     
Sbjct: 113 AQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP-EGHEYYRVRE 168

Query: 251 VG---TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 307
            G    F YA  + ++    +  SDVWSFGV LYE+LT   S +    K E+ ++     
Sbjct: 169 DGDSPVFWYA-VECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIG---- 222

Query: 308 YPADSKKFGLIMDPRLEKEYSI----NEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
            P   +   + +   LE+   +    N  +++  L  NC    +K RP    ++  LK++
Sbjct: 223 -PKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  106 bits (266), Expect = 3e-26
 Identities = 75/287 (26%), Positives = 127/287 (44%), Gaps = 38/287 (13%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFL 133
           +D   + ++G G  G V K   +P          ++A+K +  +       Q + E+  L
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTG-------KIMAVKTIRLEINEAIQKQILRELDIL 53

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
                P +V   G    +G+  I      E+M   SL D +       +P +    I + 
Sbjct: 54  HKCNSPYIVGFYGAFYNNGDISI----CMEYMDGGSL-DKILKEVQGRIPERILGKIAVA 108

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
             +GL YLHE    ++I+RD K SN+L++   + KL DFG++ +  +V    ++   VGT
Sbjct: 109 VLKGLTYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQ--LV--NSLAKTFVGT 162

Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL--ERNRPKTEQRLLEWVQQYPAD 311
             Y AP+ I+    + KSD+WS G+ L E+ TGR     E + P     LL+++   P  
Sbjct: 163 SSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP- 221

Query: 312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
                    PRL       + +      + CL K  ++RP   +++E
Sbjct: 222 ---------PRLPSGKFSPDFQD---FVNLCLIKDPRERPSYKELLE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 1e-25
 Identities = 79/293 (26%), Positives = 129/293 (44%), Gaps = 53/293 (18%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLNRDG------LQWVAEVQFLGVLEHP 139
           IG G FG V +  +K        +  + VAIK L + G      L ++ E   +G  +HP
Sbjct: 12  IGGGEFGEVCRGRLKL-----PGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHP 65

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           N+++L G       +    +++ E+M N SL+  L             + ++ G A G+ 
Sbjct: 66  NIIRLEGVVT----KSRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMK 120

Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG---- 255
           YL E   +  ++RD  A N+L++ N   K+SDFGL+R          S A   T G    
Sbjct: 121 YLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSR------RLEDSEATYTTKGGKIP 171

Query: 256 --YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS 312
             + AP+ I     T+ SDVWSFG+V++E+++ G R              +   Q    +
Sbjct: 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYW-----------DMSNQDVIKA 220

Query: 313 KKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV 364
                + D  RL        A  + +L  +C  K   +RP  SQ+V  L +++
Sbjct: 221 -----VEDGYRLPPPMDCPSA--LYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  104 bits (260), Expect = 2e-25
 Identities = 85/295 (28%), Positives = 125/295 (42%), Gaps = 65/295 (22%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIK--------KLNRDGLQWVAEVQFLGVLE 137
           KIG+G FG VYK  +K          T VA+K         L R  LQ   E + L   +
Sbjct: 2   KIGKGNFGDVYKGVLK--------GNTEVAVKTCRSTLPPDLKRKFLQ---EAEILKQYD 50

Query: 138 HPNLVKLIGYCAVDGERGIQR---LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 194
           HPN+VKLIG C        Q+    +V E +   SL   L  +    L  K  L + L A
Sbjct: 51  HPNIVKLIGVCV-------QKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDA 102

Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT- 253
           A G+ YL        I+RD  A N L+ EN   K+SDFG++RE        + T   G  
Sbjct: 103 AAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREE----EGGIYTVSDGLK 155

Query: 254 ---FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA 310
                + AP+ +  G  T++SDVWS+G++L+E  +   +        + R          
Sbjct: 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR---------- 205

Query: 311 DSKKFGLIMDPRLEKEYSINEAR----KIGRLADNCLSKSSKDRPKMSQVVERLK 361
                      R+E  Y +   +    +I RL   C +   ++RP  S++   L+
Sbjct: 206 ----------ERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  103 bits (259), Expect = 2e-25
 Identities = 72/237 (30%), Positives = 103/237 (43%), Gaps = 34/237 (14%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN------RDGLQWV-AEVQFLGVLEHP 139
           +G+G FG V     K           + A+K L       R  ++    E   L  + HP
Sbjct: 1   LGKGSFGKVLLVRKK-------DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHP 53

Query: 140 NLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE-- 196
            +VKL  + A   E    +L LV E+     L  HL            R +    AAE  
Sbjct: 54  FIVKL--HYAFQTEE---KLYLVLEYAPGGELFSHLSKEGRFSEER-ARFY----AAEIV 103

Query: 197 -GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
             L YLH    + +IYRD K  N+LLD +   KL+DFGLA+E    G    +    GT  
Sbjct: 104 LALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPE 158

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYPAD 311
           Y AP+ +         D WS GV+LYEMLTG+      +R +  +++L+   ++P  
Sbjct: 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEF 215

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 4e-25
 Identities = 69/206 (33%), Positives = 97/206 (47%), Gaps = 20/206 (9%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
           K+G G FG V+         +GT++  V  +K        ++ E Q +  L H  LV+L 
Sbjct: 13  KLGAGQFGEVWM-----GTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQL- 66

Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL 205
            Y     E  I   +V E+M   SL D L +     L     + +    AEG+AYL    
Sbjct: 67  -YAVCSEEEPI--YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES-- 121

Query: 206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDYI 262
               I+RD  A N+L+ EN   K++DFGLAR    +      TA  G      + AP+  
Sbjct: 122 -RNYIHRDLAARNILVGENLVCKIADFGLAR----LIEDDEYTAREGAKFPIKWTAPEAA 176

Query: 263 ETGHLTAKSDVWSFGVVLYEMLT-GR 287
             G  T KSDVWSFG++L E++T GR
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  103 bits (259), Expect = 5e-25
 Identities = 71/219 (32%), Positives = 113/219 (51%), Gaps = 35/219 (15%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKL----NRDGLQWVA--EVQF 132
           + ++ K+GEG +G VYK            + T  +VA+KK+      +G+   A  E+  
Sbjct: 1   YEKLEKLGEGTYGVVYK---------ARDKKTGEIVALKKIRLDNEEEGIPSTALREISL 51

Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
           L  L+HPN+VKL+       ER +   LV+E+  +  L+ +L ++   PL       I+ 
Sbjct: 52  LKELKHPNIVKLLDVIH--TERKL--YLVFEYC-DMDLKKYL-DKRPGPLSPNLIKSIMY 105

Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAV 250
               GLAY H     ++++RD K  N+L++ +   KL+DFGLAR    P+  +TH    V
Sbjct: 106 QLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE---V 159

Query: 251 VGTFGYAAPDYI--ETGHLTAKSDVWSFGVVLYEMLTGR 287
           V T  Y AP+ +     + TA  D+WS G +  EM+TG+
Sbjct: 160 V-TLWYRAPEILLGSKHYSTA-VDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  102 bits (256), Expect = 6e-25
 Identities = 78/290 (26%), Positives = 139/290 (47%), Gaps = 51/290 (17%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN------RDGLQWVAEVQFL 133
           DF  + KIG+G FG V+K   K       ++  V A+K+++      R+  + + E + L
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRK-------ADKRVYAMKQIDLSKMNRREREEAIDEARVL 53

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLP----WKTRL 188
             L+   +++      +D      +L +V E+  N  L   L  +   PLP    W+  +
Sbjct: 54  AKLDSSYIIRYYE-SFLDK----GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI 108

Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 248
            I+LG    LA+LH     ++++RD K+ N+ LD     K+ D G+A+   +  +T+ + 
Sbjct: 109 QILLG----LAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFAN 159

Query: 249 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQ 307
            +VGT  Y +P+  E      KSDVW+ GVVLYE  TG+   +  N+     +++  V  
Sbjct: 160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV-- 217

Query: 308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 357
           +P  S+ +                ++++ +L D CL+K  + RP   Q++
Sbjct: 218 FPPVSQMY----------------SQQLAQLIDQCLTKDYRQRPDTFQLL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  102 bits (256), Expect = 7e-25
 Identities = 62/206 (30%), Positives = 90/206 (43%), Gaps = 18/206 (8%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVLEHPN 140
           K+G+G FG V +     + G        VA+K L  D L      ++ E   +  L+H N
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIP----VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHEN 57

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           L++L G            ++V E     SL D L   A       T     +  A G+ Y
Sbjct: 58  LIRLYGVVLTH-----PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRY 112

Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT-FGYAAP 259
           L      + I+RD  A N+LL  + + K+ DFGL R  P     +V    +   F + AP
Sbjct: 113 LESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP 169

Query: 260 DYIETGHLTAKSDVWSFGVVLYEMLT 285
           + + T   +  SDVW FGV L+EM T
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 99.0 bits (247), Expect = 1e-23
 Identities = 78/293 (26%), Positives = 123/293 (41%), Gaps = 48/293 (16%)

Query: 87  IGEGGFGSVYK---SSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEH 138
           +G+G FG VY+     +     +       VAIK +N     R+ ++++ E   +     
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETR-----VAIKTVNENASMRERIEFLNEASVMKEFNC 68

Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-----NRAFPPLPWKTRLHIILG 193
            ++V+L+G  +     G   L+V E M    L+ +L          P L   T    I  
Sbjct: 69  HHVVRLLGVVS----TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124

Query: 194 AAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           AAE   G+AYL      + ++RD  A N ++ E+   K+ DFG+ R+     +       
Sbjct: 125 AAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKG 181

Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA 310
           +    + AP+ ++ G  T KSDVWSFGVVL+EM T               L E  Q Y  
Sbjct: 182 LLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT---------------LAE--QPYQG 224

Query: 311 DSKK--FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 361
            S +     ++D     +   N   K+  L   C   + K RP   ++V  LK
Sbjct: 225 LSNEEVLKFVIDGGH-LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 98.5 bits (245), Expect = 2e-23
 Identities = 84/289 (29%), Positives = 135/289 (46%), Gaps = 44/289 (15%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL----QWVAEVQFLG 134
           ++ + + +IG G FG V+             E   VAIK + R+G      ++ E Q + 
Sbjct: 4   SELTLVQEIGSGQFGLVWLGYWL--------EKRKVAIKTI-REGAMSEEDFIEEAQVMM 54

Query: 135 VLEHPNLVKLIGYCAVDGERGIQR---LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 191
            L HP LV+L G C        +R    LV+EFM +  L D+L  +       +T L + 
Sbjct: 55  KLSHPKLVQLYGVC-------TERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMC 106

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 251
           L   EG+AYL       VI+RD  A N L+ EN   K+SDFG+ R      +T  ST   
Sbjct: 107 LDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTK 162

Query: 252 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 311
               +++P+       ++KSDVWSFGV+++E+ +  ++   NR  +E      V+   A 
Sbjct: 163 FPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV-----VETINAG 217

Query: 312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL 360
            +    +  PRL        ++ +  L  +C  +  +DRP  S ++ +L
Sbjct: 218 FR----LYKPRL-------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 98.3 bits (245), Expect = 2e-23
 Identities = 72/210 (34%), Positives = 102/210 (48%), Gaps = 28/210 (13%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGVLEHPNLV 142
           K+G G FG V++        + T   T VA+K L    +    ++AE Q +  L HP L+
Sbjct: 13  KLGAGQFGEVWE-----GLWNNT---TPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLI 64

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +L   C +  E  I   +V E M   SL ++L   A   L     + +    A G+AYL 
Sbjct: 65  QLYAVCTL--EEPI--YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL- 119

Query: 203 EGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 258
              E Q  I+RD  A NVL+ EN   K++DFGLAR    V    +  A  G      + A
Sbjct: 120 ---EAQNYIHRDLAARNVLVGENNICKVADFGLAR----VIKEDIYEAREGAKFPIKWTA 172

Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLT-GR 287
           P+       + KSDVWSFG++L E++T GR
Sbjct: 173 PEAALYNRFSIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 98.3 bits (245), Expect = 2e-23
 Identities = 70/214 (32%), Positives = 101/214 (47%), Gaps = 29/214 (13%)

Query: 80  DFSRMLKIGEGGFGSVY----KSSIKPAAGDGTSEATVVAIKKLNRDGL----QWVAEVQ 131
           +F+   K+G G FG V+    K+ ++            VAIK L  D L     +  EVQ
Sbjct: 7   EFTLERKLGSGYFGEVWEGLWKNRVR------------VAIKILKSDDLLKQQDFQKEVQ 54

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 191
            L  L H +L+ L   C+V     I    + E M   SL   L +     LP  + + + 
Sbjct: 55  ALKRLRHKHLISLFAVCSVGEPVYI----ITELMEKGSLLAFLRSPEGQVLPVASLIDMA 110

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 251
              AEG+AYL E      I+RD  A N+L+ E+   K++DFGLAR      +      + 
Sbjct: 111 CQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI- 166

Query: 252 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
             + + AP+    G  + KSDVWSFG++LYEM T
Sbjct: 167 -PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 98.2 bits (245), Expect = 4e-23
 Identities = 68/217 (31%), Positives = 102/217 (47%), Gaps = 31/217 (14%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QWVA-----EVQFLG 134
           + ++ KIGEG +G VYK     A    T E  +VAIKK+      + +      E++ L 
Sbjct: 1   YQKLGKIGEGTYGVVYK-----ARDKLTGE--IVAIKKIKLRFESEGIPKTALREIKLLK 53

Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
            L HPN++KL+    V   +G   L LV+EFM        L       LP       +  
Sbjct: 54  ELNHPNIIKLL---DVFRHKG--DLYLVFEFMDTDLY--KLIKDRQRGLPESLIKSYLYQ 106

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVV 251
             +GLA+ H      +++RD K  N+L++     KL+DFGLAR    P+  +TH     V
Sbjct: 107 LLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH----YV 159

Query: 252 GTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGR 287
            T  Y AP+ +      +   D+WS G +  E+L+ R
Sbjct: 160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 98.0 bits (245), Expect = 4e-23
 Identities = 70/240 (29%), Positives = 108/240 (45%), Gaps = 45/240 (18%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN----RDGLQWVA--EVQFLG 134
           + ++ +IGEG +G VYK      A +  +   +VA+KK+     ++G    A  E++ L 
Sbjct: 1   YEKIAQIGEGTYGQVYK------ARNKKTGE-LVALKKIRMENEKEGFPITAIREIKLLQ 53

Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHII 191
            L HPN+V+L       G+  I   +V+E+M   L   L+          +  K  +  +
Sbjct: 54  KLRHPNIVRLKEIVTSKGKGSI--YMVFEYMDHDLTGLLDSPEVKFTESQI--KCYMKQL 109

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS-TAV 250
           L   EGL YLH      +++RD K SN+L++ +   KL+DFGLAR  P         T  
Sbjct: 110 L---EGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR--PYTKRNSADYTNR 161

Query: 251 VGTFGYAAP-------DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE 303
           V T  Y  P        Y        + D+WS G +L E+  G+      +  TE   LE
Sbjct: 162 VITLWYRPPELLLGATRY------GPEVDMWSVGCILAELFLGKPIF---QGSTELEQLE 212

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 96.9 bits (242), Expect = 8e-23
 Identities = 81/285 (28%), Positives = 123/285 (43%), Gaps = 41/285 (14%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFL 133
           +D  R+  +G+G  G VYK   KP     T +  + A+KK++ DG      Q + E++ L
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKP-----TGK--IYALKKIHVDGDEEFRKQLLRELKTL 53

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-FNRAFPPLPWKTRLHIIL 192
              E P +VK   Y A   E  I   +V E+M   SL D L      P          IL
Sbjct: 54  RSCESPYVVKC--YGAFYKEGEIS--IVLEYMDGGSLADLLKKVGKIPEPVLAYIARQIL 109

Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGHTHVSTAV 250
              +GL YLH      +I+RD K SN+L++     K++DFG+++  E  +      +T V
Sbjct: 110 ---KGLDYLHTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC---NTFV 161

Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA 310
            GT  Y +P+ I+    +  +D+WS G+ L E   G+         +   L++ +   P 
Sbjct: 162 -GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP 220

Query: 311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 355
                     P L  E    E R        CL K  K RP  ++
Sbjct: 221 ----------PSLPAEEFSPEFRDF---ISACLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 95.2 bits (237), Expect = 4e-22
 Identities = 69/241 (28%), Positives = 109/241 (45%), Gaps = 33/241 (13%)

Query: 83  RMLKI-GEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFL------GV 135
             +K+ G G FG+VYK    P   +G      VAIK L  +     A  + L        
Sbjct: 10  EKIKVLGSGAFGTVYKGVWIP---EGEKVKIPVAIKVLREETSP-KANKEILDEAYVMAS 65

Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN-----RAFPPLPWKTRLHI 190
           ++HP++V+L+G C        Q  L+ + M    L D++ N      +   L W  ++  
Sbjct: 66  VDHPHVVRLLGICL-----SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI-- 118

Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTA 249
               A+G++YL E    ++++RD  A NVL+      K++DFGLA+         H    
Sbjct: 119 ----AKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGG 171

Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQY 308
            V    + A + I     T KSDVWS+GV ++E++T G +  E         LLE  ++ 
Sbjct: 172 KV-PIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERL 230

Query: 309 P 309
           P
Sbjct: 231 P 231

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 95.0 bits (237), Expect = 5e-22
 Identities = 63/239 (26%), Positives = 97/239 (40%), Gaps = 50/239 (20%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQF------ 132
           +DF     IGEG F +V  +  K             AIK L++  L    +V++      
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEK-------ETNKEYAIKILDKRQLIKEKKVKYVKIEKE 53

Query: 133 -LGVLE-HPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 189
            L  L  HP ++KL  Y   D E     L  V E+  N  L  ++  R +  L  K    
Sbjct: 54  VLTRLNGHPGIIKLY-YTFQDEEN----LYFVLEYAPNGELLQYI--RKYGSLDEKCTRF 106

Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
                   L YLH      +I+RD K  N+LLD++   K++DFG A+   ++       +
Sbjct: 107 YAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAK---VLDPNSSPES 160

Query: 250 V---------------------VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
                                 VGT  Y +P+ +        SD+W+ G ++Y+MLTG+
Sbjct: 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 94.0 bits (234), Expect = 8e-22
 Identities = 82/297 (27%), Positives = 129/297 (43%), Gaps = 51/297 (17%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFL 133
           +D+  +  IG G    VY +   P      +E   VAIK+++ +  Q        EVQ +
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLP-----NNE--KVAIKRIDLEKCQTSVDELRKEVQAM 53

Query: 134 GVLEHPNLVKLIGYCA-VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPP--LPWKTRLHI 190
               HPN+VK   Y + V G+   +  LV  ++   SL D +   ++P   L       +
Sbjct: 54  SQCNHPNVVKY--YTSFVVGD---ELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATV 107

Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGHTHVST 248
           +    +GL YLH       I+RD KA N+LL E+   K++DFG++            V  
Sbjct: 108 LKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRK 164

Query: 249 AVVGTFGYAAPDYIETGH-LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 307
             VGT  + AP+ +E  H    K+D+WSFG+   E+ TG     +  P   + L+  +Q 
Sbjct: 165 TFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLMLTLQN 222

Query: 308 YP------ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
            P      AD KK+         K +     RK   +   CL K    RP   ++++
Sbjct: 223 DPPSLETGADYKKYS--------KSF-----RK---MISLCLQKDPSKRPTAEELLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 92.5 bits (230), Expect = 2e-21
 Identities = 76/300 (25%), Positives = 129/300 (43%), Gaps = 68/300 (22%)

Query: 80  DFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQF 132
           + + + ++G G FG V    ++  I             VAIK +    +    ++ E + 
Sbjct: 5   ELTFLKELGSGQFGVVHLGKWRGKID------------VAIKMIREGAMSEDDFIEEAKV 52

Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
           +  L HPNLV+L G C    +R I   +V E+M N  L ++L  R       K     +L
Sbjct: 53  MMKLSHPNLVQLYGVCT--KQRPI--FIVTEYMANGCLLNYLRER-----KGKLGTEWLL 103

Query: 193 GAA----EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV-- 246
                  E + YL        I+RD  A N L+ E+   K+SDFGLAR        +V  
Sbjct: 104 DMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLAR--------YVLD 152

Query: 247 --STAVVGT---FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL 301
              T+  GT     +A P+  +    ++KSDVWSFGV+++E+ +  +        +E  +
Sbjct: 153 DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--V 210

Query: 302 LEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL 360
           +E V          G  +  P+L          ++  +  +C  +  +DRP   +++ +L
Sbjct: 211 VESVSA--------GYRLYRPKL-------APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 66/209 (31%), Positives = 89/209 (42%), Gaps = 28/209 (13%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQ--WVAEVQFLGVLEHP 139
           +G GGFG V    +K        +    A+K + +      G Q    +E + L    HP
Sbjct: 1   LGVGGFGRVELVKVKS-------KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHP 53

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGL 198
            +VKL  Y     ++ I  L+  E+ L   L   L +R  F    +  R   I       
Sbjct: 54  FIVKL--YRTFKDKKYIYMLM--EYCLGGELWTILRDRGLFDE--YTARF-YIACVVLAF 106

Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
            YLH      +IYRD K  N+LLD N   KL DFG A++      T       GT  Y A
Sbjct: 107 EYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW---TFCGTPEYVA 160

Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
           P+ I         D WS G++LYE+LTGR
Sbjct: 161 PEIILNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 93.2 bits (232), Expect = 3e-21
 Identities = 80/297 (26%), Positives = 128/297 (43%), Gaps = 44/297 (14%)

Query: 86  KIGEGGFGSVY---------KSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQ 131
           K+GEG FG V+          S    A  D      +VA+K L  D           EV+
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLF-----NRAFPPL 182
            L  L  PN+ +L+G C VD    +    + E+M    LN+ L+ H+            L
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCM----IMEYMENGDLNQFLQKHVAETSGLACNSKSL 127

Query: 183 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 242
            + T L++    A G+ YL     +  ++RD    N L+ +N+  K++DFG++R      
Sbjct: 128 SFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184

Query: 243 HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK---TEQ 299
           +  V         + A + +  G  T KSDVW+FGV L+E+LT    L R +P    T+Q
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT----LCREQPYEHLTDQ 240

Query: 300 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 356
           +++E    +  D  +   +  P        N  + I  L   C  +  +DRP   ++
Sbjct: 241 QVIENAGHFFRDDGRQIYLPRPP-------NCPKDIYELMLECWRRDEEDRPTFREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 92.2 bits (229), Expect = 3e-21
 Identities = 73/227 (32%), Positives = 107/227 (47%), Gaps = 39/227 (17%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGVLEHPNLV 142
           K+G G FG V+               T VAIK L +  +    ++AE   +  L+HP LV
Sbjct: 13  KLGAGQFGEVWMGYYN--------GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLV 64

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +L  Y  V  E      ++ E+M N SL D L       L     + +    AEG+A++ 
Sbjct: 65  RL--YAVVTQE---PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119

Query: 203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAP 259
                  I+RD +A+N+L+ E    K++DFGLAR    +   +  TA  G      + AP
Sbjct: 120 R---KNYIHRDLRAANILVSETLCCKIADFGLAR----LIEDNEYTAREGAKFPIKWTAP 172

Query: 260 DYIETGHLTAKSDVWSFGVVLYEMLT-GR------------RSLERN 293
           + I  G  T KSDVWSFG++L E++T GR            ++LER 
Sbjct: 173 EAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG 219

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 92.6 bits (230), Expect = 4e-21
 Identities = 75/222 (33%), Positives = 114/222 (51%), Gaps = 35/222 (15%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EVQFLG 134
           F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+   A  E+  L 
Sbjct: 2   FQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTAIREISLLK 54

Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW---KTRLHII 191
            L HPN+VKL+    +  E  +   LV+EF L++ L+  +       +P    K+ L  +
Sbjct: 55  ELNHPNIVKLLD--VIHTENKL--YLVFEF-LHQDLKKFMDASPLSGIPLPLIKSYLFQL 109

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTA 249
           L   +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH    
Sbjct: 110 L---QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---- 159

Query: 250 VVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
            V T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 92.7 bits (231), Expect = 4e-21
 Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 38/216 (17%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL---NRDG---LQWVAEVQFLGVLEHP 139
           +IGEG  G V+K+  +      T E   VA+KK+     +G    Q + E++ L   +HP
Sbjct: 7   RIGEGAHGIVFKAKDR-----ETGE--TVALKKVALRRLEGGIPNQALREIKALQACQHP 59

Query: 140 NLVKLIGYCAV--DGERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAA 195
            +VKL+    V   G   +   LV E+M    L + L +  R  P    K+ + ++L   
Sbjct: 60  YVVKLL---DVFPHGSGFV---LVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLL--- 109

Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR---EGPMVGHTHVSTAVVG 252
           +G+AY+H      +++RD K +N+L+  +   K++DFGLAR   E     ++H     V 
Sbjct: 110 KGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH----QVA 162

Query: 253 TFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 287
           T  Y AP+ +          D+W+ G +  E+L G 
Sbjct: 163 TRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 91.8 bits (228), Expect = 4e-21
 Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 24/206 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGVLEHPNLV 142
           K+G G +G VY+   K         +  VA+K L  D +   +++ E   +  ++HPNLV
Sbjct: 13  KLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 65

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +L+G C  +    I    + EFM   +L D+L       +     L++    +  + YL 
Sbjct: 66  QLLGVCTREPPFYI----ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 121

Query: 203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAP 259
           +      I+RD  A N L+ EN   K++DFGL+R   M G T+  TA  G      + AP
Sbjct: 122 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTY--TAHAGAKFPIKWTAP 174

Query: 260 DYIETGHLTAKSDVWSFGVVLYEMLT 285
           + +     + KSDVW+FGV+L+E+ T
Sbjct: 175 ESLAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 91.7 bits (228), Expect = 6e-21
 Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 26/216 (12%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-----NRDGLQWVAEVQFLGVLEHPNL 141
           +GEG FG V+         +   +  +VA+K L     N     +  E + L   +H N+
Sbjct: 13  LGEGAFGKVFLGECYHLEPEN--DKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 142 VKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDH--LFNRAFPPLPWKTRL------H 189
           VK  G C      G   ++V+E+M    LN+ L  H         P      L       
Sbjct: 71  VKFYGVCT----EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126

Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
           I +  A G+ YL        ++RD    N L+  +   K+ DFG++R+     +  V   
Sbjct: 127 IAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGH 183

Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            +    +  P+ I     T +SDVWSFGVVL+E+ T
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 91.7 bits (228), Expect = 7e-21
 Identities = 73/291 (25%), Positives = 119/291 (40%), Gaps = 37/291 (12%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFL 133
                + ++GEG  GSV K  +K           + A+K +  D       Q + E++  
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTG-------MIFALKTITTDPNPDLQKQILRELEIN 53

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
              + P +VK  G    +    I   +  E+    SL D ++ +       +    ++  
Sbjct: 54  KSCKSPYIVKYYGAFLDESSSSIG--IAMEYCEGGSL-DSIYKKVKK-RGGRIGEKVLGK 109

Query: 194 AAE----GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
            AE    GL+YLH     ++I+RD K SN+LL    + KL DFG++  G +V    ++  
Sbjct: 110 IAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS--GELV--NSLAGT 162

Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL--LEWVQQ 307
             GT  Y AP+ I+    +  SDVWS G+ L E+   R       P+ E  L  +E +  
Sbjct: 163 FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLGPIELL-S 218

Query: 308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
           Y  +     L  +P       I  + +       CL K    RP    ++E
Sbjct: 219 YIVNMPNPELKDEP----GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 91.4 bits (227), Expect = 8e-21
 Identities = 68/206 (33%), Positives = 99/206 (48%), Gaps = 18/206 (8%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA----EVQFLGVLEHPNLV 142
           +G+G FGSV      P   D T E  VVA+KKL     + +     E++ L  L+H N+V
Sbjct: 12  LGKGNFGSVELCRYDPL-QDNTGE--VVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPLPWKTRLHIILGAAEGLAYL 201
           K  G C   G R ++  LV E++   SL D+L  +R    L  +  L       +G+ YL
Sbjct: 69  KYKGVCYSAGRRNLR--LVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYL 124

Query: 202 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST--AVVGTFGYAAP 259
                 + ++RD    N+L++   R K+ DFGL +  P     +          F YA P
Sbjct: 125 GS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA-P 180

Query: 260 DYIETGHLTAKSDVWSFGVVLYEMLT 285
           + +     +  SDVWSFGVVLYE+ T
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 90.7 bits (225), Expect = 1e-20
 Identities = 83/287 (28%), Positives = 129/287 (44%), Gaps = 48/287 (16%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA----------EVQFLGVL 136
           +G+G +G+VY           T++  ++A+K++  D    +A          EV  L  L
Sbjct: 8   LGKGAYGTVYCGL--------TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL 59

Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
           +H N+V+ +G C  D    I      EF+   S+   L NR F PLP            +
Sbjct: 60  KHVNIVQYLGTCLDDNTISI----FMEFVPGGSISSIL-NR-FGPLPEPVFCKYTKQILD 113

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG----HTHVSTAVVG 252
           G+AYLH      V++RD K +NV+L  N   KL DFG AR    VG    H+++  ++ G
Sbjct: 114 GVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170

Query: 253 TFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 311
           T  + AP+ I E+G+   KSD+WS G  ++EM TG+  L              +      
Sbjct: 171 TPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDR---------LAAMFYI 220

Query: 312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
               GL+  PRL   +S            +CL++   +RP   Q++ 
Sbjct: 221 GAHRGLM--PRLPDSFSAAAI----DFVTSCLTRDQHERPSALQLLR 261

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 70/298 (23%), Positives = 127/298 (42%), Gaps = 56/298 (18%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFL 133
           D+  +  IG+G FG+V K   K    DG     ++  K+++   +      Q V+EV  L
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKS---DGK----ILVWKEIDYGNMTEKEKQQLVSEVNIL 53

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRL-LVYEF--------MLNRSLEDHLFNRAFP-PLP 183
             L+HPN+V+   Y     +R  Q L +V E+        ++ +  ++  +         
Sbjct: 54  RELKHPNIVR---YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY---IEEEFI 107

Query: 184 WKTRLHIILGAAEGLAYLHEGLEV--QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMV 241
           W+    ++L     L   H   +    V++RD K +N+ LD N   KL DFGLA+   ++
Sbjct: 108 WRILTQLLLA----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK---IL 160

Query: 242 GHTHVSTAV-VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR 300
           GH        VGT  Y +P+ +       KSD+WS G ++YE+            + + +
Sbjct: 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT---ARNQLQ 217

Query: 301 LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
           L   +++        G     R+   YS     ++  +  + L+     RP   ++++
Sbjct: 218 LASKIKE--------GKF--RRIPYRYS----SELNEVIKSMLNVDPDKRPSTEELLQ 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 65/205 (31%), Positives = 98/205 (47%), Gaps = 20/205 (9%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVLEHPNL 141
           +G G FGSV K      +G    E  V A+K L ++ +      ++ E   +  L+HP +
Sbjct: 3   LGHGNFGSVVKGVYLMKSG---KEVEV-AVKTLKQEHIAAGKKEFLREASVMAQLDHPCI 58

Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 201
           V+LIG C     +G   +LV E      L  +L  R    +P      +    A G+AYL
Sbjct: 59  VRLIGVC-----KGEPLMLVMELAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYL 111

Query: 202 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAVVGTFGYAAPD 260
                   ++RD  A NVLL    + K+SDFG++R  G    +   +TA      + AP+
Sbjct: 112 ES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPE 168

Query: 261 YIETGHLTAKSDVWSFGVVLYEMLT 285
            I  G  ++KSDVWS+GV L+E  +
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 90.0 bits (223), Expect = 2e-20
 Identities = 77/279 (27%), Positives = 124/279 (44%), Gaps = 40/279 (14%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
            IGEG FG+V         G+ T +   V   K +     ++ E   +  L H NLV+L+
Sbjct: 13  IIGEGEFGAVL-------QGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLL 65

Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL 205
           G    +G       +V E M   +L + L  R    +     L   L  AEG+ YL    
Sbjct: 66  GVILHNG-----LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK- 119

Query: 206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG 265
             ++++RD  A N+L+ E+   K+SDFGLAR G M               + AP+ ++  
Sbjct: 120 --KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPEALKHK 172

Query: 266 HLTAKSDVWSFGVVLYEMLT-GRRSLERNRPK-TEQRLLEWVQQYPADSKKFGLIMDPRL 323
             ++KSDVWS+GV+L+E+ + GR       PK + + + E V++        G  M+P  
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAPY----PKMSLKEVKECVEK--------GYRMEPPE 220

Query: 324 EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ 362
                +        L  +C     K RP   ++ E+L++
Sbjct: 221 GCPADVYV------LMTSCWETEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 66/226 (29%), Positives = 102/226 (45%), Gaps = 49/226 (21%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQWVAEVQFLGVL 136
             F  + K+GEG +GSVYK+  K           VVAIK +  +    + + E+  L   
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETG-------QVVAIKVVPVEEDLQEIIKEISILKQC 55

Query: 137 EHPNLVKLIG-------------YCAVDGERGIQRLLVYEFMLNRSL-EDHLFNRAFPPL 182
           + P +VK  G             YC       I +      + N++L E+ +   A    
Sbjct: 56  DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMK------ITNKTLTEEEI---AA--- 103

Query: 183 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 242
                  I+    +GL YLH     + I+RD KA N+LL+E  + KL+DFG++  G +  
Sbjct: 104 -------ILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTD 151

Query: 243 HTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 287
                  V+GT  + AP+ I E G+   K+D+WS G+   EM  G+
Sbjct: 152 TMAKRNTVIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 90.2 bits (224), Expect = 3e-20
 Identities = 70/231 (30%), Positives = 120/231 (51%), Gaps = 29/231 (12%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW-----VAEVQFLGV 135
           F ++ K+GEG + +VYK       G   +   +VA+K+++ D  +      + E+  +  
Sbjct: 2   FKQLEKLGEGTYATVYK-------GRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKE 54

Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHIIL 192
           L+H N+V+L  +  +  E  +  +LV+E+M   L + ++ H    A  P   K+  + +L
Sbjct: 55  LKHENIVRL--HDVIHTENKL--MLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLL 110

Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
              +G+A+ HE    +V++RD K  N+L+++    KL+DFGLAR   +  +T  S  VV 
Sbjct: 111 ---KGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-FSNEVV- 162

Query: 253 TFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 302
           T  Y APD +      + S D+WS G ++ EM+TG R L       +Q L 
Sbjct: 163 TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG-RPLFPGTNNEDQLLK 212

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 89.9 bits (223), Expect = 3e-20
 Identities = 80/289 (27%), Positives = 133/289 (46%), Gaps = 42/289 (14%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-----NRDGLQWVAEVQFLGVLEHPNL 141
           IG G FG V +  +K     G  E  V AIK L      +    +++E   +G  +HPN+
Sbjct: 12  IGAGEFGEVCRGRLKLP---GKREIFV-AIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67

Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLA 199
           + L G   V   R +  +++ EFM N +L+  L      F  +     + ++ G A G+ 
Sbjct: 68  IHLEG--VVTKSRPV--MIITEFMENGALDSFLRQNDGQFTVI---QLVGMLRGIAAGMK 120

Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG---TFGY 256
           YL E   +  ++RD  A N+L++ N   K+SDFGL+R           T+ +G      +
Sbjct: 121 YLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177

Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKF 315
            AP+ I     T+ SDVWS+G+V++E+++ G R        + Q ++  ++Q        
Sbjct: 178 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY---WDMSNQDVINAIEQ-------- 226

Query: 316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV 364
               D RL        A  + +L  +C  K    RPK  Q+V  L +++
Sbjct: 227 ----DYRLPPPMDCPTA--LHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 90.1 bits (224), Expect = 4e-20
 Identities = 76/236 (32%), Positives = 109/236 (46%), Gaps = 42/236 (17%)

Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQWVA--EV 130
              D+  + K+GEG FG VYK+  +   G       VVA+KK+     +DG    A  E+
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKA-RQIKTG------RVVALKKILMHNEKDGFPITALREI 58

Query: 131 QFLGVLEHPNLVKLIGYCAVD--GERGIQRLLVYEFM------LNRSLEDHLFNRAFPPL 182
           + L  L+HPN+V LI   AV+   +   +R  VY         L+  LE+          
Sbjct: 59  KILKKLKHPNVVPLIDM-AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK--LTES 115

Query: 183 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR----EG 238
             K  +  +L   EG+ YLHE     +++RD KA+N+L+D     K++DFGLAR      
Sbjct: 116 QIKCYMLQLL---EGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPP 169

Query: 239 PMVGH-----THVSTAVVGTFGYAAPDYI--ETGHLTAKSDVWSFGVVLYEMLTGR 287
           P         T   T +V T  Y  P+ +  E  + TA  D+W  G V  EM T R
Sbjct: 170 PNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA-VDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 89.4 bits (222), Expect = 5e-20
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 26/218 (11%)

Query: 84  MLKIGEGGFGSVYKSSI-KPAAGDGTSEATVVAIKKLNRDGLQ--WVAEVQFLGVLEHPN 140
           + ++GEG FG VYK  +  P      +   +  +K+     +Q  +  E + +  L+HPN
Sbjct: 10  LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPN 69

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP---------------PLPWK 185
           +V L+G C  +        +++E++ +  L + L   + P                L   
Sbjct: 70  IVCLLGVCTKE----QPTCMLFEYLAHGDLHEFLVRNS-PHSDVGAESGDETVKSSLDCS 124

Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
             LHI +  A G+ YL        ++RD  A N L+ E    K+SDFGL+R+     +  
Sbjct: 125 DFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR 181

Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEM 283
           V +  +    +  P+ I  G  T +SD+WSFGVVL+E+
Sbjct: 182 VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 88.1 bits (218), Expect = 6e-20
 Identities = 79/286 (27%), Positives = 132/286 (46%), Gaps = 52/286 (18%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNL 141
           +G+G FG V+K ++K        + T VA+K    D      +++++E + L   +HPN+
Sbjct: 3   LGKGNFGEVFKGTLK--------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNI 54

Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEGLA 199
           VKLIG C        QR  +Y  M      D L    +    L  K  +   L AA G+A
Sbjct: 55  VKLIGVCT-------QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMA 107

Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT-FGYAA 258
           YL        I+RD  A N L+ EN   K+SDFG++R+       + S+ +      + A
Sbjct: 108 YLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQED--DGIYSSSGLKQIPIKWTA 162

Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 318
           P+ +  G  +++SDVWS+G++L+E      SL              V  YP  + +    
Sbjct: 163 PEALNYGRYSSESDVWSYGILLWETF----SLG-------------VCPYPGMTNQQA-- 203

Query: 319 MDPRLEKEYSINEARK----IGRLADNCLSKSSKDRPKMSQVVERL 360
              ++EK Y ++  +K    + ++   C     ++RPK S++ + L
Sbjct: 204 -REQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 88.7 bits (221), Expect = 7e-20
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 29/211 (13%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW-----VAEVQFLGVL-EHP 139
           ++G+G FGSVY                +VAIKK+ +    W     + EV+ L  L EHP
Sbjct: 6   QLGDGTFGSVYL-------ARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHP 58

Query: 140 NLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 198
           N+VKL      +  R    L  V+E+M   +L   + +R   P        II    +GL
Sbjct: 59  NIVKL-----KEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGL 112

Query: 199 AYLHE-GLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           A++H+ G      +RD K  N+L+      K++DFGLARE   +      T  V T  Y 
Sbjct: 113 AHIHKHGF----FHRDLKPENLLVSGPEVVKIADFGLARE---IRSRPPYTDYVSTRWYR 165

Query: 258 APDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 287
           AP+ +  +   ++  D+W+ G ++ E+ T R
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 88.7 bits (220), Expect = 7e-20
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 25/214 (11%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFLGVLEHPN 140
           +GEG FGSV +  +     DG+     VA+K +  D        ++++E   +   +HPN
Sbjct: 7   LGEGEFGSVMEGQLS--QDDGSQLK--VAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPN 62

Query: 141 LVKLIGYC--AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK----TRLHIILGA 194
           ++KLIG C  A   ++  + +++  FM +  L   L       LP K    T L  ++  
Sbjct: 63  VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122

Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE---GPMVGHTHVSTAVV 251
           A G+ YL        I+RD  A N +L E+    ++DFGL+++   G       ++   V
Sbjct: 123 ALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179

Query: 252 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
               + A + +     T+KSDVW+FGV ++E+ T
Sbjct: 180 K---WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 88.4 bits (220), Expect = 7e-20
 Identities = 66/216 (30%), Positives = 98/216 (45%), Gaps = 30/216 (13%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQ 131
             F+ +  IG+G FG VYK+  K      T++  VVAIK ++ +        +Q   E+Q
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDK-----RTNQ--VVAIKVIDLEEAEDEIEDIQ--QEIQ 51

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
           FL     P + K  G   + G     +L ++ E+    S  D L       L       I
Sbjct: 52  FLSQCRSPYITKYYG-SFLKG----SKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFI 103

Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +     GL YLHE      I+RD KA+N+LL E    KL+DFG++  G +          
Sbjct: 104 LREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS--GQLTSTMSKRNTF 158

Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           VGT  + AP+ I+      K+D+WS G+   E+  G
Sbjct: 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 88.2 bits (218), Expect = 8e-20
 Identities = 68/206 (33%), Positives = 101/206 (49%), Gaps = 25/206 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGVLEHPNLV 142
           K+G G FG V+            + +T VA+K L    +    ++ E   +  L+H  LV
Sbjct: 13  KLGAGQFGEVWMGYY--------NNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLV 64

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +L  Y  V  E  I   ++ E+M   SL D L +     +     +      AEG+AY+ 
Sbjct: 65  RL--YAVVTKEEPI--YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120

Query: 203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAP 259
                  I+RD +A+NVL+ E+   K++DFGLAR    V   +  TA  G      + AP
Sbjct: 121 RK---NYIHRDLRAANVLVSESLMCKIADFGLAR----VIEDNEYTAREGAKFPIKWTAP 173

Query: 260 DYIETGHLTAKSDVWSFGVVLYEMLT 285
           + I  G  T KSDVWSFG++LYE++T
Sbjct: 174 EAINFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 88.8 bits (221), Expect = 8e-20
 Identities = 69/223 (30%), Positives = 101/223 (45%), Gaps = 48/223 (21%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-----NRDGLQWVAEVQFLGV 135
           +  + KIGEG  G VYK+    A G        VAIKK+     N++ +  + E+  +  
Sbjct: 21  YKNLEKIGEGASGEVYKA-TDRATGK------EVAIKKMRLRKQNKELI--INEILIMKD 71

Query: 136 LEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI---- 190
            +HPN+V       V  E     L +V E+M   SL D +  + F  +       I    
Sbjct: 72  CKHPNIVDYYDSYLVGDE-----LWVVMEYMDGGSLTD-IITQNFVRM---NEPQIAYVC 122

Query: 191 --ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA----REGPMVGHT 244
             +L   +GL YLH      VI+RD K+ N+LL ++   KL+DFG A    +E       
Sbjct: 123 REVL---QGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK---- 172

Query: 245 HVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTG 286
               +VVGT  + AP+ I        K D+WS G++  EM  G
Sbjct: 173 --RNSVVGTPYWMAPEVI-KRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 89.1 bits (221), Expect = 9e-20
 Identities = 81/218 (37%), Positives = 106/218 (48%), Gaps = 42/218 (19%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----W---VAEVQFL 133
           F+ + +IG G FG+VY      A    T+E  VVAIKK++  G Q    W   + EV+FL
Sbjct: 17  FTDLREIGHGSFGAVYF-----ARDVRTNE--VVAIKKMSYSGKQSNEKWQDIIKEVRFL 69

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRS---LEDHLFNRAFPPLPWKTRLHI 190
             L HPN ++  G C +   R     LV E+ L  +   LE H       PL       I
Sbjct: 70  QQLRHPNTIEYKG-CYL---REHTAWLVMEYCLGSASDILEVHK-----KPLQEVEIAAI 120

Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA- 249
             GA +GLAYLH     + I+RD KA N+LL E    KL+DFG A        + VS A 
Sbjct: 121 CHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSA--------SLVSPAN 169

Query: 250 -VVGTFGYAAPDYI---ETGHLTAKSDVWSFGVVLYEM 283
             VGT  + AP+ I   + G    K DVWS G+   E+
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 88.4 bits (219), Expect = 1e-19
 Identities = 67/225 (29%), Positives = 103/225 (45%), Gaps = 36/225 (16%)

Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDG-LQWVAEVQ----FLGVLEHPN 140
           IG+G FG V+++    A G       T+VA+K L  +      A+ Q     +   +HPN
Sbjct: 13  IGQGAFGRVFQAR---APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPN 69

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA--------------------FP 180
           +VKL+G CAV    G    L++E+M    L + L +R+                      
Sbjct: 70  IVKLLGVCAV----GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125

Query: 181 PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           PL    +L I    A G+AYL E    + ++RD    N L+ EN   K++DFGL+R    
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182

Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
             +   S        +  P+ I     T +SDVW++GVVL+E+ +
Sbjct: 183 ADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 87.8 bits (218), Expect = 1e-19
 Identities = 63/214 (29%), Positives = 88/214 (41%), Gaps = 36/214 (16%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR---DGLQWVA----EVQFLGVLEHP 139
           IG+G FG V     +           + A+K +N+        V     E + L  L HP
Sbjct: 8   IGKGAFGKVCIVQKR-------DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-----FNRAFPPLPWKTRLHIILGA 194
            LV L  Y   D E      LV + +L   L  HL     F+        + +   I   
Sbjct: 61  FLVNLW-YSFQDEE---NMYLVVDLLLGGDLRYHLSQKVKFSEE------QVKF-WICEI 109

Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 254
              L YLH      +I+RD K  N+LLDE     ++DF +A     V    ++T+  GT 
Sbjct: 110 VLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIAT---KVTPDTLTTSTSGTP 163

Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRR 288
           GY AP+ +     +   D WS GV  YE L G+R
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 87.3 bits (216), Expect = 1e-19
 Identities = 79/283 (27%), Positives = 120/283 (42%), Gaps = 46/283 (16%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--WVAEVQFLGVLEHPNLVKL 144
           IG+G FG V           G      VA+K +  D     ++AE   +  L H NLV+L
Sbjct: 14  IGKGEFGDVML---------GDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL 64

Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
           +G   V+ + G+   +V E+M   SL D+L +R    L     L   L   E + YL   
Sbjct: 65  LG-VIVEEKGGL--YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121

Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET 264
                ++RD  A NVL+ E+   K+SDFGL +E      T           + AP+ +  
Sbjct: 122 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALRE 173

Query: 265 GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLE 324
              + KSDVWSFG++L+E+ +  R      P     L + V               PR+E
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVV---------------PRVE 213

Query: 325 KEYSINEARK----IGRLADNCLSKSSKDRPKMSQVVERLKQI 363
           K Y ++        +  +   C    +  RP   Q+ E+L+ I
Sbjct: 214 KGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 86.8 bits (215), Expect = 3e-19
 Identities = 70/212 (33%), Positives = 107/212 (50%), Gaps = 30/212 (14%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQWVAEVQFL--GVL----EHP 139
           IG+G FG VY  ++  + G         A+K LNR   L+ V   QFL  G++     HP
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIH----CAVKSLNRITDLEEVE--QFLKEGIIMKDFSHP 56

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           N++ L+G C      G   L+V  +M +  L + + +    P   K  +   L  A+G+ 
Sbjct: 57  NVLSLLGICLPS--EGSP-LVVLPYMKHGDLRNFIRSETHNPTV-KDLIGFGLQVAKGME 112

Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE------GPMVGHTHVSTAVVGT 253
           YL      + ++RD  A N +LDE+F  K++DFGLAR+        +  HT     V   
Sbjct: 113 YLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV--- 166

Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
             + A + ++T   T KSDVWSFGV+L+E++T
Sbjct: 167 -KWMALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 86.9 bits (216), Expect = 4e-19
 Identities = 65/208 (31%), Positives = 108/208 (51%), Gaps = 26/208 (12%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK----LNRDG--LQWVAEVQFLGVLE--- 137
           IGEG +G+VYK      A D  +    VA+KK    L+ +G  L  + E+  L  LE   
Sbjct: 7   IGEGAYGTVYK------ARD-LNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFE 59

Query: 138 HPNLVKLIGYCAV-DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
           HPN+V+L+  C     +R ++  LV+E + ++ L  +L     P LP +T   ++     
Sbjct: 60  HPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLR 118

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G+ +LH      +++RD K  N+L+  + + K++DFGLAR   +       T+VV T  Y
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVVVTLWY 172

Query: 257 AAPD-YIETGHLTAKSDVWSFGVVLYEM 283
            AP+  +++ + T   D+WS G +  E+
Sbjct: 173 RAPEVLLQSSYATP-VDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 86.1 bits (213), Expect = 6e-19
 Identities = 68/214 (31%), Positives = 101/214 (47%), Gaps = 23/214 (10%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-----QWVAEVQFLGVLEHPNL 141
           +G G FG VY+ +     G G+    V A+K L +        +++ E   +    HPN+
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRV-AVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 142 VKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPP-LPWKTRLHIILGAAE 196
           VKL+G C +  E    + ++ E M    L   L D    R  PP L  K  L I L  A+
Sbjct: 62  VKLLGVC-LLNE---PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDEN--FRP---KLSDFGLAREGPMVGHTHVSTAVV 251
           G  YL +   +  I+RD  A N L+ E         K+ DFGLAR+     +       +
Sbjct: 118 GCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174

Query: 252 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
               + AP+ +  G  T +SDVWSFGV+++E+LT
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 85.8 bits (213), Expect = 6e-19
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 35/216 (16%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQFLGVLEHP 139
           I +G +G V+  + K + GD      + AIK + +  +       Q + E   L   + P
Sbjct: 1   ISKGAYGRVF-LAKKKSTGD------IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSP 53

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLN---RSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
            +VKL  Y +  G++ +   LV E++      SL +++ +     L        I     
Sbjct: 54  YVVKL--YYSFQGKKNL--YLVMEYLPGGDLASLLENVGS-----LDEDVARIYIAEIVL 104

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA------V 250
            L YLH      +I+RD K  N+L+D N   KL+DFGL++ G +    +++        +
Sbjct: 105 ALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161

Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           VGT  Y AP+ I     +   D WS G +LYE L G
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 86.2 bits (213), Expect = 7e-19
 Identities = 68/224 (30%), Positives = 110/224 (49%), Gaps = 24/224 (10%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGL-----QWVAEVQFLGVL 136
           +IGEG +G V+K      A D  +    VA+K++      +G+     + VA ++ L   
Sbjct: 8   EIGEGAYGKVFK------ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61

Query: 137 EHPNLVKLIGYCAVD-GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
           EHPN+V+L   C V   +R  +  LV+E  +++ L  +L     P +P +T   ++    
Sbjct: 62  EHPNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120

Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
            GL +LH     +V++RD K  N+L+  + + KL+DFGLAR   +       T+VV T  
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLW 174

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ 299
           Y AP+ +         D+WS G +  EM   R+ L R     +Q
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ 217

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 7e-19
 Identities = 75/220 (34%), Positives = 111/220 (50%), Gaps = 36/220 (16%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EVQFLG 134
           + ++ KIGEG +G VYK      A D  +   +VA+KK+  +    G+   A  E+  L 
Sbjct: 1   YQKVEKIGEGTYGVVYK------ARDKLT-GEIVALKKIRLETEDEGVPSTAIREISLLK 53

Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLE---DHLFNRAFPPLPWKTRLHI 190
            L HPN+V+L     V  E    +L LV+EF L+  L+   D        P   K+ L+ 
Sbjct: 54  ELNHPNIVRL--LDVVHSE---NKLYLVFEF-LDLDLKKYMDSSPLTGLDPPLIKSYLYQ 107

Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-G-PMVGHTHVST 248
           +L   +G+AY H     +V++RD K  N+L+D     KL+DFGLAR  G P+  +TH   
Sbjct: 108 LL---QGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH--- 158

Query: 249 AVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGR 287
            VV T  Y AP+ +      +   D+WS G +  EM+  R
Sbjct: 159 EVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 85.3 bits (211), Expect = 8e-19
 Identities = 73/285 (25%), Positives = 127/285 (44%), Gaps = 43/285 (15%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLG 134
           + ++  +G G FG V+            ++  +V IK++  +       L    E Q L 
Sbjct: 2   YEKIRVVGRGAFGIVHLCR-------RKADQKLVIIKQIPVEQMTKDERLAAQNECQVLK 54

Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 194
           +L HPN+++       D    I    V E+    +L +++  R    L   T LH  +  
Sbjct: 55  LLSHPNIIEYYENFLEDKALMI----VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI 110

Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
              L ++H  L   +++RD K  N+LLD++    K+ DFG+++    +     +  VVGT
Sbjct: 111 LLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKI---LSSKSKAYTVVGT 164

Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYPADS 312
             Y +P+  E      KSD+W+ G VLYE+ + +R+ E  N P    +++         S
Sbjct: 165 PCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM---------S 215

Query: 313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 357
             F  I D      YS  + R   +L  + L+     RP++SQ++
Sbjct: 216 GTFAPISD-----RYS-PDLR---QLILSMLNLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 85.6 bits (212), Expect = 9e-19
 Identities = 76/291 (26%), Positives = 125/291 (42%), Gaps = 41/291 (14%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE--VQFLGVLE 137
           D   +  +G G  GSV K    P         TV+A K ++      V +  ++ L ++ 
Sbjct: 6   DLETISDLGAGNGGSVSKVKHIPTG-------TVMAKKVVHIGAKSSVRKQILRELQIMH 58

Query: 138 HPNLVKLIG-YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
                 ++  Y A   E  I   +  EFM   SL D ++ +   P+P +    I +   E
Sbjct: 59  ECRSPYIVSFYGAFLNENNI--CMCMEFMDCGSL-DRIY-KKGGPIPVEILGKIAVAVVE 114

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           GL YL+     ++++RD K SN+L++   + KL DFG++  G ++    ++   VGT  Y
Sbjct: 115 GLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVS--GELI--NSIADTFVGTSTY 168

Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR--------LLEWVQQY 308
            +P+ I+ G  T KSDVWS G+ + E+  G+     +    + +        LL+ + Q 
Sbjct: 169 MSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE 228

Query: 309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER 359
           P           PRL       + R      D CL K   +RP   Q+   
Sbjct: 229 PP----------PRLPSSDFPEDLR---DFVDACLLKDPTERPTPQQLCAM 266

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 70/218 (32%), Positives = 107/218 (49%), Gaps = 35/218 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-EVQFLGVLEHPNLVKL 144
           KIG G FG VY +++    G+  +    + I+  +   ++ +A E++ L +L+HPNLVK 
Sbjct: 7   KIGGGTFGKVY-TAVNLDTGELMA-VKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK- 63

Query: 145 IGYCAVDGERGIQRLLVY-EFMLNRSLEDHLFN-RAFPPLPWKTRLHIILGAAEGLAYLH 202
             Y  V+  R  +++ ++ E+    +LE+ L + R       +     +L   EGLAYLH
Sbjct: 64  --YYGVEVHR--EKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLL---EGLAYLH 116

Query: 203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA--------REGPMVGHTHVSTAVVGTF 254
                 +++RD K +N+ LD N   KL DFG A          G  V          GT 
Sbjct: 117 SH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL------AGTP 167

Query: 255 GYAAPDYI----ETGHLTAKSDVWSFGVVLYEMLTGRR 288
            Y AP+ I      GH  A +D+WS G V+ EM TG+R
Sbjct: 168 AYMAPEVITGGKGKGHGRA-ADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 85.3 bits (212), Expect = 1e-18
 Identities = 71/229 (31%), Positives = 106/229 (46%), Gaps = 62/229 (27%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-------NRDGLQWVA--EVQFLGVL 136
           K+GEG +  VYK      A D      +VAIKK+        +DG+ + A  E++ L  L
Sbjct: 7   KLGEGTYAVVYK------ARD-KETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL 59

Query: 137 EHPNLVKLIGYCAVDGERG-IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
           +HPN++ L+    V G +  I   LV+EFM    LE  + +++           I+L  A
Sbjct: 60  KHPNIIGLL---DVFGHKSNIN--LVFEFMET-DLEKVIKDKS-----------IVLTPA 102

Query: 196 E----------GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGH 243
           +          GL YLH      +++RD K +N+L+  +   KL+DFGLAR    P    
Sbjct: 103 DIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159

Query: 244 THVSTAVVGTFGYAAPDYIETGHLTAKS-----DVWSFGVVLYEMLTGR 287
           TH    VV T  Y AP+ +      A+      D+WS G +  E+L   
Sbjct: 160 TH---QVV-TRWYRAPELL----FGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 84.1 bits (208), Expect = 2e-18
 Identities = 68/243 (27%), Positives = 100/243 (41%), Gaps = 41/243 (16%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVL---------- 136
           I +G FGSVY +  K + GD        AIK L +  +  +A+ Q   V           
Sbjct: 4   ISKGAFGSVYLAK-KRSTGD------YFAIKVLKKSDM--IAKNQVTNVKAERAIMMIQG 54

Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
           E P + KL  Y +   +  +   LV E++        +      P  W  +       AE
Sbjct: 55  ESPYVAKL--YYSFQSKDYL--YLVMEYLNGGDCASLIKTLGGLPEDWAKQY-----IAE 105

Query: 197 ---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
              G+  LH+     +I+RD K  N+L+D+    KL+DFGL+R G        +   VGT
Sbjct: 106 VVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGT 156

Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-QRLLEWVQQYPADS 312
             Y AP+ I        SD WS G V++E L G        P      +L     +P + 
Sbjct: 157 PDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEV 216

Query: 313 KKF 315
           K+F
Sbjct: 217 KEF 219

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 84.5 bits (209), Expect = 2e-18
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 36/220 (16%)

Query: 87  IGEGGFGSVY--------------KSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQF 132
           IG+G +G VY              +  +               +K L        +E++ 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALR-------SEIET 61

Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVY-EFMLNRSLEDHLFNRA-FPPLPWKTRLHI 190
           L  L+H N+V+ +G+     E   + L ++ E++   S+   L     F     +     
Sbjct: 62  LKDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ 116

Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +L   EGLAYLH      +++RD KA N+L+D +   K+SDFG++++   +     + ++
Sbjct: 117 VL---EGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170

Query: 251 VGTFGYAAPDYIETGH--LTAKSDVWSFGVVLYEMLTGRR 288
            G+  + AP+ I +     +AK D+WS G V+ EM  GRR
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 85.5 bits (211), Expect = 2e-18
 Identities = 81/287 (28%), Positives = 134/287 (46%), Gaps = 33/287 (11%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEH 138
           +DF ++ ++G G  G V+K S KP+      +   + IK   R+  Q + E+Q L     
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRN--QIIRELQVLHECNS 62

Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 198
           P +V   G    DGE  I      E M   SL D +  +A   +P +    + +   +GL
Sbjct: 63  PYIVGFYGAFYSDGEISI----CMEHMDGGSL-DQVLKKA-GRIPEQILGKVSIAVIKGL 116

Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
            YL E  + ++++RD K SN+L++     KL DFG++  G ++    ++ + VGT  Y +
Sbjct: 117 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLI--DSMANSFVGTRSYMS 170

Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 318
           P+ ++  H + +SD+WS G+ L EM  GR  +                  P D+K+  L+
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP-----------------PPDAKELELM 213

Query: 319 MDPRLEKEYSINEARKIGRLADNCLSKSSKD-RPKMSQVVERLKQIV 364
               +E + + +E     R     LS    D RP M+ + E L  IV
Sbjct: 214 FGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMA-IFELLDYIV 259

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 84.6 bits (209), Expect = 3e-18
 Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 29/222 (13%)

Query: 86  KIGEGGFGSVY---KSSIKPAAGDGTSEAT----VVAIKKLNRDGLQ-----WVAEVQFL 133
           K+GEG FG V+      +    G+G  E      +VA+K L  D  +     ++ E++ +
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAF----------PPLP 183
             L++PN+++L+G C  D        ++ E+M N  L   L  R            P + 
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPL----CMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127

Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
               L++ +  A G+ YL     +  ++RD    N L+  ++  K++DFG++R      +
Sbjct: 128 IANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184

Query: 244 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
             +    V    + A + I  G  T  SDVW+FGV L+EM T
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 83.8 bits (207), Expect = 4e-18
 Identities = 73/213 (34%), Positives = 105/213 (49%), Gaps = 23/213 (10%)

Query: 83  RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWVA----EVQFLGVLE 137
           R+  +GEG FG V      P  GD T E   VA+K L    G   +A    E++ L  L 
Sbjct: 8   RIRDLGEGHFGKVELCRYDPE-GDNTGE--QVAVKSLKPESGGNHIADLKKEIEILRNLY 64

Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 197
           H N+VK  G C  DG  GI+  L+ EF+ + SL+++L  R    +  K +L   +   +G
Sbjct: 65  HENIVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKG 121

Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGHTHVSTAVVG 252
           + YL      Q ++RD  A NVL++   + K+ DFGL +     +        + + V  
Sbjct: 122 MDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV-- 176

Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            F YA P+ +        SDVWSFGV LYE+LT
Sbjct: 177 -FWYA-PECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 83.2 bits (206), Expect = 6e-18
 Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 35/221 (15%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQWVA--EVQFL 133
           D++++ KIGEG +G VYK       G       +VA+KK+      +G+   A  E+  L
Sbjct: 1   DYTKIEKIGEGTYGVVYK-------GRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLL 53

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFM---LNRSLEDHLFNRAFPPLPWKTRLH 189
             L+HPN+V L      +      RL L++EF+   L + L+     +       K+ L+
Sbjct: 54  KELQHPNIVCLQDVLMQE-----SRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLY 108

Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVS 247
            IL   +G+ + H     +V++RD K  N+L+D     KL+DFGLAR    P+  +TH  
Sbjct: 109 QIL---QGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH-- 160

Query: 248 TAVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
             VV T  Y AP+ +      +   D+WS G +  EM T +
Sbjct: 161 -EVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 83.1 bits (205), Expect = 6e-18
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 26/217 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNL 141
           ++GEG FG V+ +       +   +  +VA+K L          +  E + L VL+H ++
Sbjct: 12  ELGEGAFGKVFLAECHNLLPE--QDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI 69

Query: 142 VKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFN---------RAFPPLPWKTRL 188
           V+  G C  +G      L+V+E+M    LNR L  H  +          A   L     L
Sbjct: 70  VRFYGVCT-EGR---PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125

Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 248
            I    A G+ YL     +  ++RD    N L+ +    K+ DFG++R+     +  V  
Sbjct: 126 AIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 182

Query: 249 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
             +    +  P+ I     T +SD+WSFGVVL+E+ T
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 82.9 bits (205), Expect = 7e-18
 Identities = 68/240 (28%), Positives = 105/240 (43%), Gaps = 35/240 (14%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW-------VAEVQFLGVLEHP 139
           +G+GGFG V    +K       +   + A KKL++  L+        + E + L  +   
Sbjct: 1   LGKGGFGEVCACQVK-------ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSR 53

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE--- 196
            +V L    A   E      LV   M    L+ H++N   P  P       I  AA+   
Sbjct: 54  FIVSL----AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP---EARAIFYAAQIIC 106

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           GL +LH+    +++YRD K  NVLLD++   ++SD GLA E              GT GY
Sbjct: 107 GLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIK---GRAGTPGY 160

Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR-----RSLERNRPKTEQRLLEWVQQYPAD 311
            AP+ ++        D ++ G  LYEM+ GR     R  +  + + ++R LE   +YP  
Sbjct: 161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDK 220

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 83.6 bits (207), Expect = 7e-18
 Identities = 75/224 (33%), Positives = 109/224 (48%), Gaps = 41/224 (18%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGL--QWVAEVQFL 133
           +F ++ +IGEG +G VY+      A D TS   +VA+KK+     RDG+    + E+  L
Sbjct: 8   EFEKLNRIGEGTYGIVYR------ARDTTSG-EIVALKKVRMDNERDGIPISSLREITLL 60

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHI 190
             L HPN+V+L     V G+      LV E+    L   L++      F     K    +
Sbjct: 61  LNLRHPNIVELKE--VVVGKHLDSIFLVMEYCEQDLASLLDN--MPTPFSESQVKC---L 113

Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGHTH 245
           +L    GL YLHE     +I+RD K SN+LL +    K++DFGLAR       PM     
Sbjct: 114 MLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM----- 165

Query: 246 VSTAVVGTFGYAAPDYI--ETGHLTAKSDVWSFGVVLYEMLTGR 287
             T  V T  Y AP+ +   T + TA  D+W+ G +L E+L  +
Sbjct: 166 --TPKVVTLWYRAPELLLGCTTYTTA-IDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 83.6 bits (206), Expect = 7e-18
 Identities = 88/290 (30%), Positives = 130/290 (44%), Gaps = 48/290 (16%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----W---VAEVQFL 133
           F+ + +IG G FG+VY      A    T+E  VVAIKK++  G Q    W   + EV+FL
Sbjct: 27  FTDLREIGHGSFGAVYF-----ARDVRTNE--VVAIKKMSYSGKQSNEKWQDIIKEVKFL 79

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             ++HPN ++  G C +   R     LV E+ L  + +  L      PL       I  G
Sbjct: 80  QRIKHPNSIEYKG-CYL---REHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAITHG 133

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
           A +GLAYLH      +I+RD KA N+LL E  + KL+DFG A           + + VGT
Sbjct: 134 ALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA------SIASPANSFVGT 184

Query: 254 FGYAAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA 310
             + AP+ I   + G    K DVWS G+   E+       ER  P      +  +     
Sbjct: 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL------AERKPPLFNMNAMSALYHIAQ 238

Query: 311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL 360
           +         P L+     +  R      D+CL K  +DRP   ++++ +
Sbjct: 239 NES-------PTLQSNEWSDYFRN---FVDSCLQKIPQDRPTSEELLKHM 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 83.1 bits (205), Expect = 7e-18
 Identities = 69/209 (33%), Positives = 102/209 (48%), Gaps = 24/209 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGL--QWVAEVQFLGVLE-- 137
           +IG G +G+VYK+   P +G        VA+K +    N DGL    V EV  L  LE  
Sbjct: 7   EIGVGAYGTVYKAR-DPHSGH------FVALKSVRVQTNEDGLPLSTVREVALLKRLEAF 59

Query: 138 -HPNLVKLIGYCA-VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
            HPN+V+L+  CA    +R  +  LV+E  +++ L  +L     P LP +T   ++    
Sbjct: 60  DHPNIVRLMDVCATSRTDRETKVTLVFEH-VDQDLRTYLDKVPPPGLPAETIKDLMRQFL 118

Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
            GL +LH      +++RD K  N+L+    + KL+DFGLAR   +       T VV T  
Sbjct: 119 RGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMALTPVVVTLW 172

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEML 284
           Y AP+ +         D+WS G +  EM 
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 82.7 bits (204), Expect = 7e-18
 Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 33/224 (14%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
           +  ++   IG G FG V++  +K     G  E  V AIK L      +    +++E   +
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMP---GRKEVAV-AIKTLKPGYTEKQRQDFLSEASIM 60

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHII 191
           G   H N+++L G       +    +++ E+M N +L+ +L +    F        L   
Sbjct: 61  GQFSHHNIIRLEGVVT----KFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-- 114

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR------EGPMVGHTH 245
            G A G+ YL +   +  ++RD  A N+L++ N   K+SDFGL+R      EG     T+
Sbjct: 115 -GIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG-----TY 165

Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 288
            ++       + AP+ I     T+ SDVWSFG+V++E+++ G R
Sbjct: 166 TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGER 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 82.7 bits (204), Expect = 9e-18
 Identities = 64/222 (28%), Positives = 101/222 (45%), Gaps = 30/222 (13%)

Query: 84  MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN--RDGLQWV---AEVQFLGVLEH 138
           M ++GE  FG +YK  +      G   A +VAIK L    +  QW     E   +  L H
Sbjct: 10  MEELGECAFGKIYKGHLYLP---GMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHH 66

Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA---------------FPPLP 183
           PN+V L+G   V  E+ +   +++E++    L + L  R+                  L 
Sbjct: 67  PNIVCLLG--VVTQEQPV--CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLD 122

Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
               LHI +  A G+ YL        +++D  A N+L+ E    K+SD GL+RE     +
Sbjct: 123 HGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADY 179

Query: 244 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
             V    +    +  P+ I  G  ++ SD+WSFGVVL+E+ +
Sbjct: 180 YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 82.5 bits (204), Expect = 9e-18
 Identities = 79/289 (27%), Positives = 123/289 (42%), Gaps = 40/289 (13%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-----NRDGLQWVAEVQFLGVLEHPNL 141
           +G G FG VY+   +   GD       VA+K L      +D   ++ E   +    H N+
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQ--VAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-FNRAFP----PLPWKTRLHIILGAAE 196
           V+LIG   V  ER + R ++ E M    L+  L  NR  P     L  K  L      A+
Sbjct: 72  VRLIG---VSFER-LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAK 127

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLAREGPMVGHTHVSTAVVG 252
           G  YL E      I+RD  A N LL     P    K++DFG+AR+     +       + 
Sbjct: 128 GCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAML 183

Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 312
              +  P+    G  T+K+DVWSFGV+L+E+ +        R   E  ++E+V       
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEFV------- 234

Query: 313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 361
                    RL+          + R+  +C   + +DRP  + ++ER++
Sbjct: 235 -----TGGGRLDPPKGCPGP--VYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 82.3 bits (203), Expect = 1e-17
 Identities = 70/248 (28%), Positives = 115/248 (46%), Gaps = 35/248 (14%)

Query: 67  RVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-NRDGLQ 125
           R+   +E+R       ++  +G G FG+V+K    P   +G S    VAIK + +R G Q
Sbjct: 2   RILKETELR-------KLKLLGSGVFGTVHKGIWIP---EGDSIKIPVAIKTIQDRSGRQ 51

Query: 126 WVAEVQ----FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR--AF 179
              E+      +G L+H  +V+L+G C      G    LV +     SL DH+     + 
Sbjct: 52  TFQEITDHMLAMGSLDHAYIVRLLGICP-----GASLQLVTQLSPLGSLLDHVRQHRDSL 106

Query: 180 PP---LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 236
            P   L W  ++      A+G+ YL E    ++++R+  A N+LL  +   +++DFG+A 
Sbjct: 107 DPQRLLNWCVQI------AKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVAD 157

Query: 237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP 295
                   +  +       + A + I  G  T +SDVWS+GV ++EM++ G       RP
Sbjct: 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP 217

Query: 296 KTEQRLLE 303
                LLE
Sbjct: 218 HEVPDLLE 225

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 84.5 bits (209), Expect = 2e-17
 Identities = 74/284 (26%), Positives = 129/284 (45%), Gaps = 27/284 (9%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           I  G  G+ YK   K        +  V  I  +N      +A+   +G L+HPN+VKLIG
Sbjct: 698 ISRGKKGASYKG--KSIKNG--MQFVVKEINDVNSIPSSEIAD---MGKLQHPNIVKLIG 750

Query: 147 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLE 206
            C  +        L++E++  ++L + L N     L W+ R  I +G A+ L +LH    
Sbjct: 751 LCRSEKGA----YLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCS 801

Query: 207 VQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH 266
             V+  +     +++D    P L    L+  G +       T    +  Y AP+  ET  
Sbjct: 802 PAVVVGNLSPEKIIIDGKDEPHLR---LSLPGLLC----TDTKCFISSAYVAPETRETKD 854

Query: 267 LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKE 326
           +T KSD++ FG++L E+LTG+   +         ++EW  +Y        + +DP +  +
Sbjct: 855 ITEKSDIYGFGLILIELLTGKSPADAEFGVHGS-IVEWA-RYCYSDCHLDMWIDPSIRGD 912

Query: 327 YSIN--EARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN 368
            S+N  E  ++  LA +C +     RP  + V++ L+   + S+
Sbjct: 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956

Length = 968

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 65/218 (29%), Positives = 95/218 (43%), Gaps = 31/218 (14%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-------EVQFLGVLEH 138
            IG G +G VYK     A      +    AIKK   D  Q+         E+  L  L+H
Sbjct: 7   CIGRGTYGRVYK-----AKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 139 PNLVKLIGYCAVDGERGIQRLLVY-EFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAA 195
            N+V L+       ++ +  L  Y E  L + ++ H   +    PP   K+ L  IL   
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQIL--- 118

Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLL----DENFRPKLSDFGLAR--EGPMVGHTHVSTA 249
            G+ YLH      V++RD K +N+L+     E    K+ D GLAR    P+     +   
Sbjct: 119 NGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175

Query: 250 VVGTFGYAAPDYIETG--HLTAKSDVWSFGVVLYEMLT 285
           VV T  Y AP+ +  G  H T   D+W+ G +  E+LT
Sbjct: 176 VV-TIWYRAPELL-LGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 80.8 bits (199), Expect = 5e-17
 Identities = 88/290 (30%), Positives = 129/290 (44%), Gaps = 54/290 (18%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----W---VAEVQFL 133
           F  + +IG G FG+VY      A    T+E  VVA+KK++  G Q    W   + EV+FL
Sbjct: 23  FVGLHEIGHGSFGAVYF-----ATNSHTNE--VVAVKKMSYSGKQTNEKWQDIIKEVKFL 75

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRS---LEDHLFNRAFPPLPWKTRLHI 190
             L+HPN ++  G C +         LV E+ L  +   LE H       PL       I
Sbjct: 76  QQLKHPNTIEYKG-CYLKEHTA---WLVMEYCLGSASDLLEVHK-----KPLQEVEIAAI 126

Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
             GA +GLAYLH      +I+RD KA N+LL E  + KL+DFG A +      +  + + 
Sbjct: 127 THGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASK------SSPANSF 177

Query: 251 VGTFGYAAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 307
           VGT  + AP+ I   + G    K DVWS G+   E+       ER  P      +  +  
Sbjct: 178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL------AERKPPLFNMNAMSALYH 231

Query: 308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 357
              +         P L+     +  R      D CL K  ++RP  ++++
Sbjct: 232 IAQNDS-------PTLQSNEWTDSFR---GFVDYCLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 79.8 bits (197), Expect = 6e-17
 Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 51/222 (22%)

Query: 87  IGEGGFGSVYKS---------SIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLE 137
           +G G FGSVY+          ++K  +     +    A+K+L +       E+  L  L+
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQ-------EIALLSKLQ 60

Query: 138 HPNLVKLIGYCAVDGERGIQRLLVY-EFMLNRSLEDHLFNRAFPPLPWK-----TRLHII 191
           HPN+V+ +G      ER    L ++ E +   SL   L  + +   P       TR  I+
Sbjct: 61  HPNIVQYLG-----TEREEDNLYIFLELVPGGSLAKLL--KKYGSFPEPVIRLYTR-QIL 112

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST--- 248
           LG    L YLH+      ++RD K +N+L+D N   KL+DFG+A+         V     
Sbjct: 113 LG----LEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSF 157

Query: 249 --AVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 287
             +  G+  + AP+ I + G     +D+WS G  + EM TG+
Sbjct: 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 80.2 bits (198), Expect = 6e-17
 Identities = 74/292 (25%), Positives = 129/292 (44%), Gaps = 58/292 (19%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW--------------VAEVQF 132
           +G G FG VYK   K       +   ++A+K++N     +              V+EV  
Sbjct: 8   LGSGAFGCVYKVRKK------NNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 133 LG-VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN------RAFPPLP-W 184
           +   L HPN+V+      ++ +R     +V + +    L +H FN      + F     W
Sbjct: 62  IKEQLRHPNIVRYYK-TFLENDR---LYIVMDLIEGAPLGEH-FNSLKEKKQRFTEERIW 116

Query: 185 KTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT 244
              + ++L     L YLH+  E ++++RD   +N++L E+ +  ++DFGLA++       
Sbjct: 117 NIFVQMVLA----LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK---QPE 167

Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW 304
              T+VVGT  Y+ P+ ++      K+DVW+FG +LY+M T         P     +L  
Sbjct: 168 SKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSL 221

Query: 305 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 356
                  +K    + +P  E  YS +    I      CL+  ++ RP + QV
Sbjct: 222 A------TKIVEAVYEPLPEGMYSEDVTDVITS----CLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 80.2 bits (198), Expect = 6e-17
 Identities = 81/281 (28%), Positives = 121/281 (43%), Gaps = 48/281 (17%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFL 133
           + R+  IG G +G+VY+       G       VVA+K +N D        +Q   EV  L
Sbjct: 3   YQRLELIGRGAYGAVYR-------GKHVPTGRVVALKIINLDTPDDDVSDIQ--REVALL 53

Query: 134 GVLEH---PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
             L     PN+ K  G   + G R     ++ E+    S+   +  +A  P+  K    I
Sbjct: 54  SQLRQSQPPNITKYYG-SYLKGPR---LWIIMEYAEGGSVRTLM--KA-GPIAEKYISVI 106

Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           I      L Y+H+   V VI+RD KA+N+L+      KL DFG+A    +  ++   +  
Sbjct: 107 IREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAAL--LNQNSSKRSTF 161

Query: 251 VGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP 309
           VGT  + AP+ I  G     K+D+WS G+ +YEM TG      N P ++      +   P
Sbjct: 162 VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG------NPPYSDVDAFRAMMLIP 215

Query: 310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDR 350
             SK       PRLE        R+       CL +  K+R
Sbjct: 216 -KSKP------PRLEDNGYSKLLRE---FVAACLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 79.9 bits (197), Expect = 7e-17
 Identities = 72/287 (25%), Positives = 129/287 (44%), Gaps = 40/287 (13%)

Query: 87  IGEGGFGSVYKSSIK-PAAGDGTSEATVVAIKKL-----NRDGLQWVAEVQFLGVLEHPN 140
           IG G FG V    +K P   +       VAIK L      +    +++E   +G  +HPN
Sbjct: 12  IGAGEFGEVCSGRLKLPGKRE-----IPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPN 66

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           ++ L G       +    ++V E+M N SL D    +          + ++ G A G+ Y
Sbjct: 67  IIHLEGVVT----KSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKY 121

Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR---EGPMVGHTHVSTAVVGTFGYA 257
           L +   +  ++RD  A N+L++ N   K+SDFGL+R   + P   +T     +     + 
Sbjct: 122 LSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWT 176

Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGL 317
           AP+ I     T+ SDVWS+G+V++E+++            E+   E   Q    + + G 
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMS----------YGERPYWEMSNQDVIKAIEEGY 226

Query: 318 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV 364
            +   ++   ++++      L  +C  K   +RPK  Q+V  L +++
Sbjct: 227 RLPAPMDCPAALHQ------LMLDCWQKDRNERPKFEQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 80.0 bits (198), Expect = 9e-17
 Identities = 63/220 (28%), Positives = 108/220 (49%), Gaps = 33/220 (15%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQWVA--EVQFL 133
           ++ ++ +I EG +G VY+      A D  +   +VA+KKL     ++G    +  E+  L
Sbjct: 6   EYEKLNRIEEGTYGVVYR------ARDKKTG-EIVALKKLKMEKEKEGFPITSLREINIL 58

Query: 134 GVLEHPNLVKL--IGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLH 189
             L+HPN+V +  +    V G    +  +V E++ +  +SL +    + F     K  + 
Sbjct: 59  LKLQHPNIVTVKEV----VVGSNLDKIYMVMEYVEHDLKSLMET-MKQPFLQSEVKCLML 113

Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH-THVST 248
            +L    G+A+LH+     +++RD K SN+LL+     K+ DFGLARE    G      T
Sbjct: 114 QLL---SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLARE---YGSPLKPYT 164

Query: 249 AVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
            +V T  Y AP+  +     +   D+WS G +  E+LT +
Sbjct: 165 QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 79.7 bits (196), Expect = 9e-17
 Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 22/213 (10%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
           ++G+G FG VY+   K    D     T VAIK +N     R+ ++++ E   +      +
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKD--EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF--------NRAFPPLPWKTRLHIIL 192
           +V+L+G  +    +G   L++ E M    L+ +L         N    P   K  + +  
Sbjct: 71  VVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAG 126

Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
             A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+ R+     +       + 
Sbjct: 127 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183

Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
              + +P+ ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 80.1 bits (197), Expect = 9e-17
 Identities = 81/302 (26%), Positives = 132/302 (43%), Gaps = 45/302 (14%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVL-EHPN 140
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP--------------PLPWKT 186
           ++ L+G C  DG       ++ E+    +L ++L  R  P               + +K 
Sbjct: 83  IINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138

Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   + +   
Sbjct: 139 LVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195

Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWV 305
           +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E  +LL   
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL--- 252

Query: 306 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
                   K G  MD         N   ++  +  +C       RP   Q+VE L +I+ 
Sbjct: 253 --------KEGHRMDK------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298

Query: 366 VS 367
           ++
Sbjct: 299 LT 300

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 80.0 bits (197), Expect = 1e-16
 Identities = 65/230 (28%), Positives = 101/230 (43%), Gaps = 44/230 (19%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVLEHPNL 141
           +GEG FG V K++     G   +  T VA+K L  +         ++E   L  + HP++
Sbjct: 8   LGEGEFGKVVKATAFRLKG--RAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL----------------------FNRAF 179
           +KL G C+ DG      LL+ E+    SL   L                       N   
Sbjct: 66  IKLYGACSQDGPL----LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121

Query: 180 PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--- 236
             L     +      + G+ YL E   +++++RD  A NVL+ E  + K+SDFGL+R   
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY 178

Query: 237 -EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            E   V  +     V     + A + +     T +SDVWSFGV+L+E++T
Sbjct: 179 EEDSYVKRSKGRIPV----KWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 86/303 (28%), Positives = 131/303 (43%), Gaps = 63/303 (20%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK--LNRDGLQWVAEVQFLGVL 136
            D   + +IG G FG+V K   KP+        T++A+K+     D  +   + + L  L
Sbjct: 4   EDLKDLGEIGRGAFGTVNKMLHKPSG-------TIMAVKRIRSTVDEKE---QKRLLMDL 53

Query: 137 EH-------PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 189
           +        P +VK  G    +G+  I      E M + SL D  +   +       +  
Sbjct: 54  DVVMRSSDCPYIVKFYGALFREGDCWI----CMELM-DISL-DKFYKYVYE----VLKSV 103

Query: 190 I---ILGA-----AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMV 241
           I   ILG       + L YL E  E+++I+RD K SN+LLD N   KL DFG++      
Sbjct: 104 IPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS------ 155

Query: 242 GHTHVSTAV---VGTFGYAAPDYIETGHLTA---KSDVWSFGVVLYEMLTGRRSLERNRP 295
           G    S A     G   Y AP+ I+         +SDVWS G+ LYE+ TG+    +   
Sbjct: 156 GQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS 215

Query: 296 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 355
             +Q L + V+  P        I+    E+E+S +    I    + CL K    RPK  +
Sbjct: 216 VFDQ-LTQVVKGDPP-------ILSNSEEREFSPSFVNFI----NLCLIKDESKRPKYKE 263

Query: 356 VVE 358
           ++E
Sbjct: 264 LLE 266

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 80.0 bits (197), Expect = 1e-16
 Identities = 73/305 (23%), Positives = 130/305 (42%), Gaps = 52/305 (17%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSE---------ATVVAIKKLNRDGLQ-----WVAEVQ 131
           K+GEG FG V+   +       T +           +VA+K L  D  +     ++ EV+
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAF------------ 179
            L  L+ PN+++L+G C  +        ++ E+M N  L   L +               
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPL----CMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127

Query: 180 -----PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 234
                P + + + LH+ L  A G+ YL     +  ++RD    N L+ EN   K++DFG+
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGM 184

Query: 235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNR 294
           +R      +  +    V    + A + I  G  T  SDVW+FGV L+E+L     L + +
Sbjct: 185 SRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL----MLCKEQ 240

Query: 295 PK---TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP 351
           P    T+++++E   ++  D  +   +  P    +        +  L   C S+  ++RP
Sbjct: 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQ-------GLYELMLQCWSRDCRERP 293

Query: 352 KMSQV 356
             S +
Sbjct: 294 SFSDI 298

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 29/219 (13%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-----NRDGLQWVAEVQFLGVL-EHPN 140
           +GEG FG V K+       D  +E + VA+K L      +D    V+E++ + ++ +H N
Sbjct: 20  LGEGAFGQVVKAEAVGL--DNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG------- 193
           ++ L+G C  +G       +V E+  + +L D L  R  P                    
Sbjct: 78  IINLLGVCTQEGPL----YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133

Query: 194 -------AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
                   A G+ +L      + I+RD  A NVL+ E+   K++DFGLAR+   + +   
Sbjct: 134 LVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190

Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           +T       + AP+ +     T +SDVWSFGV+L+E+ T
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 78/283 (27%), Positives = 123/283 (43%), Gaps = 41/283 (14%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN----RDGLQWVA-EVQFLGV 135
           F+++ +IG+G FG V+K       G       VVAIK ++     D ++ +  E+  L  
Sbjct: 6   FTKLERIGKGSFGEVFK-------GIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ 58

Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
            + P + K  G       +G +  ++ E++   S  D L    F      T L  IL   
Sbjct: 59  CDSPYVTKYYGSYL----KGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL--- 111

Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
           +GL YLH     + I+RD KA+NVLL E    KL+DFG+A  G +          VGT  
Sbjct: 112 KGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPF 166

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF 315
           + AP+ I+     +K+D+WS G+   E+  G        P    R+L  + +        
Sbjct: 167 WMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP---MRVLFLIPKNNP----- 218

Query: 316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
                P L  E+S    +      D CL+K    RP   ++++
Sbjct: 219 -----PTLTGEFS----KPFKEFIDACLNKDPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 74/287 (25%), Positives = 126/287 (43%), Gaps = 47/287 (16%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN------RDGLQWVAEVQFL 133
           DF  + K+G+G +GSVYK           S+    A+K+++      ++    V E++ L
Sbjct: 1   DFKVLKKLGKGSYGSVYKV-------KRLSDNQFYALKEVDLGSMSQKEREDAVNEIRIL 53

Query: 134 GVLEHPNLVKLIGY--CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP--PLPWKTRLH 189
             + HPN+   I Y    +DG +     +V E+     L   +  R      +P +    
Sbjct: 54  ASVNHPNI---ISYKEAFLDGNK---LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR 107

Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
           I +    GL  LHE    ++++RD K++N+LL  N   K+ D G+++    V   +++  
Sbjct: 108 IFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISK----VLKKNMAKT 160

Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP 309
            +GT  Y AP+  +    + KSD+WS G +LYEM T     E    ++ Q L   VQ   
Sbjct: 161 QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE---ARSMQDLRYKVQ--- 214

Query: 310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 356
               K+     P +   YS    + +     + L    K RP   ++
Sbjct: 215 --RGKY-----PPIPPIYS----QDLQNFIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 84/302 (27%), Positives = 126/302 (41%), Gaps = 51/302 (16%)

Query: 72  SEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEV 130
            +   A  ND   + +IG G  G VYK   K           V+A+K++ R G     E 
Sbjct: 7   GQKYPADLNDLENLGEIGSGTCGQVYKMRFK-------KTGHVMAVKQMRRTG---NKEE 56

Query: 131 Q--FLGVLE-----H--PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPP 181
               L  L+     H  P +VK  GY   D +  I      E M   +  D L  R   P
Sbjct: 57  NKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI----CMELM--STCLDKLLKRIQGP 110

Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMV 241
           +P      + +   + L YL E  +  VI+RD K SN+LLD +   KL DFG++  G +V
Sbjct: 111 IPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGIS--GRLV 166

Query: 242 -GHTHVSTAVVGTFGYAAPDYIE----TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK 296
                  +A  G   Y AP+ I+          ++DVWS G+ L E+ TG+   +    K
Sbjct: 167 DSKAKTRSA--GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC--K 222

Query: 297 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 356
           TE  +L  + Q    S            + +S +         D CL+K  + RPK  ++
Sbjct: 223 TEFEVLTKILQEEPPS--------LPPNEGFSPD----FCSFVDLCLTKDHRKRPKYREL 270

Query: 357 VE 358
           ++
Sbjct: 271 LQ 272

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 80.1 bits (197), Expect = 1e-16
 Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 14/209 (6%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEH 138
           +DF R+ ++G G  G V K   KP+      +   + IK   R+  Q + E+Q L     
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRN--QIIRELQVLHECNS 62

Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 198
           P +V   G    DGE  I      E M   SL+  L  +    +P +    + +    GL
Sbjct: 63  PYIVGFYGAFYSDGEISI----CMEHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRGL 116

Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
           AYL E  + Q+++RD K SN+L++     KL DFG++  G ++    ++ + VGT  Y +
Sbjct: 117 AYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLI--DSMANSFVGTRSYMS 170

Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
           P+ ++  H + +SD+WS G+ L E+  GR
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 66/214 (30%), Positives = 90/214 (42%), Gaps = 34/214 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK-LNRDGLQWVA-----EVQFLGVLEHP 139
            +GEG +G V K   K      T E  +VAIKK    +  + V      EV+ L  L H 
Sbjct: 8   VVGEGAYGVVLKCRNK-----ATGE--IVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 140 NLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLED-HLFNRAFPPLPWKTRLHIILGAAEG 197
           N+V L       G     RL LV+E++    LE         PP     R   I    + 
Sbjct: 61  NIVNLKEAFRRKG-----RLYLVFEYVERTLLELLEASPGGLPPD--AVRS-YIWQLLQA 112

Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           +AY H      +I+RD K  N+L+ E+   KL DFG AR       + + T  V T  Y 
Sbjct: 113 IAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL-TDYVATRWYR 168

Query: 258 APD----YIETGHLTAKSDVWSFGVVLYEMLTGR 287
           AP+        G      DVW+ G ++ E+L G 
Sbjct: 169 APELLVGDTNYG---KPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 28/209 (13%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFLGVLEHP 139
           +IG G FG V+   ++       ++ T VA+K   R+ L      +++ E + L    HP
Sbjct: 2   RIGRGNFGEVFSGRLR-------ADNTPVAVKSC-RETLPPDLKAKFLQEARILKQYSHP 53

Query: 140 NLVKLIGYCAVDGERGIQRLLVY---EFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
           N+V+LIG C        Q+  +Y   E +        L     P L  K  + ++  AA 
Sbjct: 54  NIVRLIGVCT-------QKQPIYIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAA 105

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G+ YL        I+RD  A N L+ E    K+SDFG++RE     +            +
Sbjct: 106 GMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW 162

Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            AP+ +  G  +++SDVWSFG++L+E  +
Sbjct: 163 TAPEALNYGRYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 79.1 bits (196), Expect = 2e-16
 Identities = 67/220 (30%), Positives = 99/220 (45%), Gaps = 38/220 (17%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQ 131
           +DF  +  +G G FG V     K +           A+K L++  +         + E +
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGK-------YYALKILSKAKIVKLKQVEHVLNEKR 53

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
            L  + HP LV L G    D       L LV E++    L  HL      P P   R + 
Sbjct: 54  ILQSIRHPFLVNLYG-SFQDD----SNLYLVMEYVPGGELFSHLRKSGRFPEPV-ARFY- 106

Query: 191 ILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 247
              AA+    L YLH    + ++YRD K  N+LLD +   K++DFG A+   + G T+  
Sbjct: 107 ---AAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTY-- 156

Query: 248 TAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTG 286
             + GT  Y AP+ I   G+  A  D W+ G+++YEML G
Sbjct: 157 -TLCGTPEYLAPEIILSKGYGKA-VDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 27/216 (12%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN----------RDGLQWV 127
             +F    KIG+G F  VYK+           +  VVA+KK+           +D L+  
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLL-------DGRVVALKKVQIFEMMDAKARQDCLK-- 51

Query: 128 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTR 187
            E+  L  L+HPN++K +     + E  I   L     L+R ++   F +    +P +T 
Sbjct: 52  -EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKH--FKKQKRLIPERTI 108

Query: 188 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 247
               +     L ++H     ++++RD K +NV +      KL D GL R       T  +
Sbjct: 109 WKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAA 163

Query: 248 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEM 283
            ++VGT  Y +P+ I       KSD+WS G +LYEM
Sbjct: 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 86/281 (30%), Positives = 119/281 (42%), Gaps = 48/281 (17%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----W---VAEVQFL 133
           FS + +IG G FG+VY +            + VVAIKK++  G Q    W   + EV+FL
Sbjct: 17  FSDLREIGHGSFGAVYFAR-------DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L HPN ++  G C +   R     LV E+ L  + +  L      PL       +  G
Sbjct: 70  QKLRHPNTIQYRG-CYL---REHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHG 123

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
           A +GLAYLH      +I+RD KA N+LL E    KL DFG A           +   VGT
Sbjct: 124 ALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGT 174

Query: 254 FGYAAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA 310
             + AP+ I   + G    K DVWS G+   E+       ER  P      +  +     
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL------AERKPPLFNMNAMSALYHIAQ 228

Query: 311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP 351
           +         P L+  +     R      D+CL K  +DRP
Sbjct: 229 NES-------PALQSGHWSEYFRN---FVDSCLQKIPQDRP 259

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 79.5 bits (197), Expect = 2e-16
 Identities = 74/228 (32%), Positives = 107/228 (46%), Gaps = 57/228 (25%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-----NR-DGLQWVAEVQFLGVL-EH 138
           K+G+G +G V+K      A D  ++  VVA+KK+     N  D  +   E+ FL  L +H
Sbjct: 14  KLGKGAYGIVWK------AIDRRTK-EVVALKKIFDAFRNATDAQRTFREIMFLQELGDH 66

Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA--- 195
           PN+VKL+     + ++ I   LV+E+M                   +T LH ++ A    
Sbjct: 67  PNIVKLLNVIKAENDKDI--YLVFEYM-------------------ETDLHAVIRANILE 105

Query: 196 ------------EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR---EGPM 240
                       + L Y+H G    VI+RD K SN+LL+ + R KL+DFGLAR   E   
Sbjct: 106 DVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162

Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
                V T  V T  Y AP+ +       K  D+WS G +L EML G+
Sbjct: 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 78.2 bits (192), Expect = 4e-16
 Identities = 64/215 (29%), Positives = 99/215 (46%), Gaps = 24/215 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQWVAEVQFLGVLEHPNL 141
           ++GEG FG V+ +       +   +  +VA+K L    +     +  E + L  L+H ++
Sbjct: 12  ELGEGAFGKVFLAECYNLCPE--QDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69

Query: 142 VKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDH-----LFNRAFPP--LPWKTRLHI 190
           VK  G C V+G+  I   +V+E+M    LN+ L  H     L      P  L     LHI
Sbjct: 70  VKFYGVC-VEGDPLI---MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
               A G+ YL        ++RD    N L+ EN   K+ DFG++R+     +  V    
Sbjct: 126 AQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182

Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           +    +  P+ I     T +SDVWS GVVL+E+ T
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 78.9 bits (194), Expect = 4e-16
 Identities = 82/310 (26%), Positives = 134/310 (43%), Gaps = 47/310 (15%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVL-EHPN 140
           +GEG FG V  +       D  ++   VA+K L  D         V+E++ + ++ +H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPP---------------LPWK 185
           ++ L+G C  DG       ++ E+    +L ++L  R  PP               L +K
Sbjct: 80  IINLLGACTQDGPL----YVLVEYASKGNLREYLRARR-PPGMDYSFDTCKLPEEQLTFK 134

Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
             +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR+   + +  
Sbjct: 135 DLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK 191

Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEW 304
            +T       + AP+ +     T +SDVWSFGV+L+E+ T   S     P  E  +LL  
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL-- 249

Query: 305 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV 364
                    K G  MD         N   ++  +   C       RP   Q+VE L +++
Sbjct: 250 ---------KEGHRMDK------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294

Query: 365 QVSNEGDSFD 374
            V++  +  D
Sbjct: 295 TVTSTDEYLD 304

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 77.8 bits (191), Expect = 4e-16
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 18/206 (8%)

Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKL 144
           +K+G+G FG V+  +      +GT+   +  +K        ++ E Q +  L H  LV+L
Sbjct: 12  VKLGQGCFGEVWMGT-----WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 66

Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
               AV  E  I   +V E+M   SL D L       L     + +    A G+AY+   
Sbjct: 67  Y---AVVSEEPI--YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER- 120

Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAAPDYI 262
             +  ++RD +A+N+L+ EN   K++DFGLAR   ++     +      F   + AP+  
Sbjct: 121 --MNYVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAA 175

Query: 263 ETGHLTAKSDVWSFGVVLYEMLTGRR 288
             G  T KSDVWSFG++L E+ T  R
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 78.6 bits (194), Expect = 4e-16
 Identities = 68/211 (32%), Positives = 97/211 (45%), Gaps = 30/211 (14%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVV-AIKK---LNRDGLQWV-AEVQFLG-VLEHPN 140
           +G+G FG V  + +K     GT E   V  +KK   L  D ++    E + L    +HP 
Sbjct: 3   LGKGSFGKVLLAELK-----GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPF 57

Query: 141 LVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE--- 196
           L +L  +     +    RL  V E++    L  H+        P          AAE   
Sbjct: 58  LTQL--HSCFQTK---DRLFFVMEYVNGGDLMFHIQRSGRFDEP-----RARFYAAEIVL 107

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           GL +LHE     +IYRD K  NVLLD     K++DFG+ +EG + G T  ++   GT  Y
Sbjct: 108 GLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDY 162

Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            AP+ +         D W+ GV+LYEML G+
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 77.4 bits (190), Expect = 4e-16
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 20/206 (9%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
           K+G G FG V+  +      +G ++  V  +K        ++ E Q +  L H  LV+L 
Sbjct: 13  KLGNGQFGEVWMGT-----WNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLY 67

Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL 205
              AV  E  I   +V E+M   SL D L +     L     + +    A G+AY+    
Sbjct: 68  ---AVVSEEPI--YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER-- 120

Query: 206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDYI 262
            +  I+RD +++N+L+ +    K++DFGLAR    +   +  TA  G      + AP+  
Sbjct: 121 -MNYIHRDLRSANILVGDGLVCKIADFGLAR----LIEDNEYTARQGAKFPIKWTAPEAA 175

Query: 263 ETGHLTAKSDVWSFGVVLYEMLTGRR 288
             G  T KSDVWSFG++L E++T  R
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 77.4 bits (190), Expect = 5e-16
 Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 18/206 (8%)

Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKL 144
           +K+G+G FG V+  +      +GT++  +  +K        ++ E Q +  L H  LV L
Sbjct: 12  VKLGQGCFGEVWMGT-----WNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL 66

Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
               AV  E  I   +V EFM   SL D L       L     + +    A+G+AY+   
Sbjct: 67  Y---AVVSEEPI--YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER- 120

Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAAPDYI 262
             +  I+RD +A+N+L+ +N   K++DFGLAR   ++     +      F   + AP+  
Sbjct: 121 --MNYIHRDLRAANILVGDNLVCKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAA 175

Query: 263 ETGHLTAKSDVWSFGVVLYEMLTGRR 288
             G  T KSDVWSFG++L E++T  R
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 78.3 bits (194), Expect = 5e-16
 Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 44/221 (19%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLGVLEHPN 140
           IG G +G V       +A D  +    VAIKK++       D  + + E++ L  L H N
Sbjct: 8   IGSGAYGVVC------SAVDKRTG-RKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60

Query: 141 LVKL---IGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHI---- 190
           ++ L   +   + +    +   +V E M   L++ ++         PL   T  HI    
Sbjct: 61  IIGLLDILRPPSPEDFNDV--YIVTELMETDLHKVIKSPQ------PL---TDDHIQYFL 109

Query: 191 --ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVS 247
             IL    GL YLH      VI+RD K SN+L++ N   K+ DFGLAR   P        
Sbjct: 110 YQIL---RGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163

Query: 248 TAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 287
           T  V T  Y AP+ +  +   T   D+WS G +  E+LT +
Sbjct: 164 TEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 77.5 bits (191), Expect = 7e-16
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 18/210 (8%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHP 139
           DF ++ ++G G  G V K   +P+      +   + IK   R+  Q + E++ L     P
Sbjct: 2   DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRN--QIIRELKVLHECNSP 59

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
            +V   G    DGE  I      E M   SL D +  +A   +P      I +    GL 
Sbjct: 60  YIVGFYGAFYSDGEISI----CMEHMDGGSL-DQVLKKA-GRIPENILGKISIAVLRGLT 113

Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA--VVGTFGYA 257
           YL E  + ++++RD K SN+L++     KL DFG++      G    S A   VGT  Y 
Sbjct: 114 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDSMANSFVGTRSYM 165

Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
           +P+ ++  H T +SD+WS G+ L EM  GR
Sbjct: 166 SPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 77.7 bits (191), Expect = 7e-16
 Identities = 82/310 (26%), Positives = 134/310 (43%), Gaps = 57/310 (18%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTS-EATVVAIKKL--NRDGLQWVAEVQFLGV 135
           ND      IGEG FG V K+ IK    DG   +A +  +K+     D   +  E++ L  
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 63

Query: 136 L-EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------------FNRAFP 180
           L  HPN++ L+G C     RG   L + E+  + +L D L               N    
Sbjct: 64  LGHHPNIINLLGACE---HRGYLYLAI-EYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 119

Query: 181 PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
            L  +  LH     A G+ YL +    Q I+RD  A N+L+ EN+  K++DFGL+R   +
Sbjct: 120 TLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEV 176

Query: 241 -----VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
                +G   V    + +  Y+          T  SDVWS+GV+L+E+++         P
Sbjct: 177 YVKKTMGRLPVRWMAIESLNYSV--------YTTNSDVWSYGVLLWEIVS-----LGGTP 223

Query: 296 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 355
                  E  ++ P            RLEK  + ++  ++  L   C  +   +RP  +Q
Sbjct: 224 YCGMTCAELYEKLP---------QGYRLEKPLNCDD--EVYDLMRQCWREKPYERPSFAQ 272

Query: 356 VVERLKQIVQ 365
           ++  L ++++
Sbjct: 273 ILVSLNRMLE 282

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 77.4 bits (190), Expect = 8e-16
 Identities = 78/303 (25%), Positives = 133/303 (43%), Gaps = 45/303 (14%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVL-EHPN 140
           +GEG FG V  +       +  +  T VA+K L  D  +      ++E++ + ++ +H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW--------------KT 186
           ++ L+G C  DG       ++ E+    +L ++L  R  P + +              K 
Sbjct: 86  IINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR+   + +   
Sbjct: 142 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198

Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWV 305
           +T       + AP+ +     T +SDVWSFGV+L+E+ T   S     P  E  +LL   
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 255

Query: 306 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
                   K G  MD         N   ++  +  +C       RP   Q+VE L +I+ 
Sbjct: 256 --------KEGHRMDK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301

Query: 366 VSN 368
           +++
Sbjct: 302 LTS 304

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 77.5 bits (191), Expect = 9e-16
 Identities = 72/217 (33%), Positives = 105/217 (48%), Gaps = 42/217 (19%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQFLGV-LEH 138
           +G+G FG V  + +K     GT+E    AIK L +D +         + E + L +  EH
Sbjct: 3   LGKGSFGKVMLAELK-----GTNE--FFAIKALKKDVVLEDDDVECTMVERRVLALAWEH 55

Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-----FNRAFPPLPWKTRLHIILG 193
           P L  L  +C    +  +    V E++    L  H+     F+ A      + R +    
Sbjct: 56  PFLTHL--FCTFQTKEHL--FFVMEYLNGGDLMFHIQSSGRFDEA------RARFY---- 101

Query: 194 AAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           AAE   GL +LH+     +IYRD K  NVLLD++   K++DFG+ +E  M G    ST  
Sbjct: 102 AAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKEN-MNGEGKAST-F 156

Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            GT  Y AP+ ++        D WSFGV+LYEML G+
Sbjct: 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 77.0 bits (189), Expect = 9e-16
 Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 37/223 (16%)

Query: 86  KIGEGGFGSVYKS---SIKPAAGDGTSEATVVAIKKLNRDGL----QWVAEVQFLGVLEH 138
           ++GEG FG V+ +   ++ P     T +  +VA+K L    L     +  E + L  L+H
Sbjct: 12  ELGEGAFGKVFLAECYNLSP-----TKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH 66

Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPP----------------L 182
            ++VK  G C  DG+  I   +V+E+M +  L    F RA  P                L
Sbjct: 67  EHIVKFYGVC-GDGDPLI---MVFEYMKHGDLNK--FLRAHGPDAMILVDGQPRQAKGEL 120

Query: 183 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 242
                LHI    A G+ YL        ++RD    N L+  N   K+ DFG++R+     
Sbjct: 121 GLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 177

Query: 243 HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           +  V    +    +  P+ I     T +SDVWSFGV+L+E+ T
Sbjct: 178 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 76.5 bits (188), Expect = 1e-15
 Identities = 64/217 (29%), Positives = 109/217 (50%), Gaps = 21/217 (9%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHP 139
           D + + ++G G FG V     K     G  +  +  IK+ +    +++ E + +  L H 
Sbjct: 5   DLTFLKELGTGQFGVV-----KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHE 59

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
            LV+L G C    +R I   +V E+M N  L ++L        P +  L +     EG+A
Sbjct: 60  KLVQLYGVCTK--QRPI--YIVTEYMSNGCLLNYLREHGKRFQPSQL-LEMCKDVCEGMA 114

Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGY 256
           YL      Q I+RD  A N L+D+    K+SDFGL+R   ++   + S+  VG+     +
Sbjct: 115 YLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRW 167

Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLER 292
           + P+ +     ++KSDVW+FGV+++E+ + G+   ER
Sbjct: 168 SPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER 204

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 54/174 (31%), Positives = 83/174 (47%), Gaps = 26/174 (14%)

Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
           I +   + L YLH  L   VI+RD K SNVL++ N + KL DFG++  G +V  +   T 
Sbjct: 108 IAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGIS--GYLV-DSVAKTI 162

Query: 250 VVGTFGYAAPDYI----ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 305
             G   Y AP+ I           KSDVWS G+ + E+ TGR   +  +   +Q  L+ V
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ--LKQV 220

Query: 306 QQYPADSKKFGLIMDPRLEKE-YSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
            + P+          P+L  E +S           + CL K+ K+RP   ++++
Sbjct: 221 VEEPS----------PQLPAEKFSPE----FQDFVNKCLKKNYKERPNYPELLQ 260

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 66/229 (28%), Positives = 117/229 (51%), Gaps = 32/229 (13%)

Query: 66  LRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN----- 120
           LR+   +E++       R+  +G G FG+VYK    P   +G +    VAIK LN     
Sbjct: 1   LRILKETELK-------RVKVLGSGAFGTVYKGIWVP---EGETVKIPVAIKILNETTGP 50

Query: 121 RDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE--DHLFNRA 178
           +  ++++ E   +  ++HP+LV+L+G C     + + +L+ +  +L+   E  D++ ++ 
Sbjct: 51  KANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQL 110

Query: 179 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 238
              L W  ++      A+G+ YL E    ++++RD  A NVL+      K++DFGLAR  
Sbjct: 111 L--LNWCVQI------AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL- 158

Query: 239 PMVGHTHVSTAVVGTF--GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            + G      A  G     + A + I     T +SDVWS+GV ++E++T
Sbjct: 159 -LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 26/206 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWVA-EVQFLGVLEHPNLVK 143
           +IG G +G VYK+         T E   + + KL   D  + +  E+  L    HPN+V 
Sbjct: 10  RIGSGTYGDVYKARDIA-----TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 144 LIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
             G           +L +V E+    SL+D ++     PL      ++     +GLAYLH
Sbjct: 65  YFG-----SYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLH 118

Query: 203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS--TAVVGTFGYAAPD 260
           E      I+RD K +N+LL E+   KL+DFG++ +   +  T ++   + +GT  + AP+
Sbjct: 119 E---TGKIHRDIKGANILLTEDGDVKLADFGVSAQ---LTAT-IAKRKSFIGTPYWMAPE 171

Query: 261 YIE---TGHLTAKSDVWSFGVVLYEM 283
                  G    K D+W+ G+   E+
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 29/209 (13%)

Query: 86  KIGEGGFGSVYKS-SIKPAAGDGTSEATVVAIKKLNR--DGLQWV---AEVQFLGVLE-H 138
           KIGEG F  V K+ S K     G       AIK + +    L+ V    E+Q L  L  H
Sbjct: 6   KIGEGTFSEVLKAQSRK----TGKY----YAIKCMKKHFKSLEQVNNLREIQALRRLSPH 57

Query: 139 PNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 197
           PN+++LI     D + G  RL LV+E M + +L + +  R  P LP K     +    + 
Sbjct: 58  PNILRLIE-VLFDRKTG--RLALVFELM-DMNLYELIKGRKRP-LPEKRVKSYMYQLLKS 112

Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           L ++H      + +RD K  N+L+ ++   KL+DFG  R    +      T  + T  Y 
Sbjct: 113 LDHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRG---IYSKPPYTEYISTRWYR 165

Query: 258 APDYIET-GHLTAKSDVWSFGVVLYEMLT 285
           AP+ + T G+   K D+W+ G V +E+L+
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 74/301 (24%), Positives = 135/301 (44%), Gaps = 38/301 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
           ++G+G FG VY+ + +     G +E T VA+K +N     R+ ++++ E   +      +
Sbjct: 13  ELGQGSFGMVYEGNARDII-KGEAE-TRVAVKTVNESASLRERIEFLNEASVMKGFTCHH 70

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF--------NRAFPPLPWKTRLHIIL 192
           +V+L+G  +    +G   L+V E M +  L+ +L         N   PP   +  + +  
Sbjct: 71  VVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 126

Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
             A+G+AYL+     + ++RD  A N ++  +F  K+ DFG+ R+     +       + 
Sbjct: 127 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183

Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 312
              + AP+ ++ G  T  SD+WSFGVVL+E+ +               L E   Q  ++ 
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNE 228

Query: 313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDS 372
           +    +MD     +   N   ++  L   C   + K RP   ++V  LK  +  S    S
Sbjct: 229 QVLKFVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287

Query: 373 F 373
           F
Sbjct: 288 F 288

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 63/212 (29%), Positives = 93/212 (43%), Gaps = 32/212 (15%)

Query: 87  IGEGGFGSVY---------KSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLE 137
           +G+G FG VY         + ++K    D  S  T   +  L         E+Q L  L+
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALE-------CEIQLLKNLQ 62

Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK-TRLHI--ILGA 194
           H  +V+  G    D    I      E+M   S++D L  +A+  L    TR +   IL  
Sbjct: 63  HERIVQYYGCLRDDETLSI----FMEYMPGGSVKDQL--KAYGALTETVTRKYTRQIL-- 114

Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA-REGPMVGHTHVSTAVVGT 253
            EG+ YLH      +++RD K +N+L D     KL DFG + R   +        +V GT
Sbjct: 115 -EGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGT 170

Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
             + +P+ I       K+DVWS G  + EMLT
Sbjct: 171 PYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 65/285 (22%), Positives = 122/285 (42%), Gaps = 49/285 (17%)

Query: 87  IGEGGFGS--VYKSSIKPAAGDGTSEATVVAIKKLN---------RDGLQWVAEVQFLGV 135
           +G+G FG   +Y+          T + ++V  K++N         RD L    E+  L +
Sbjct: 8   LGKGAFGEATLYRR---------TEDDSLVVWKEVNLTRLSEKERRDALN---EIVILSL 55

Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
           L+HPN++    +   D    I+     E+    +L D +  +       +  L  +    
Sbjct: 56  LQHPNIIAYYNHFMDDNTLLIE----MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIV 111

Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
             ++Y+H+     +++RD K  N+ L +    KL DFG+++   +     ++  VVGT  
Sbjct: 112 SAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPY 166

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF 315
           Y +P+  +      KSD+W+ G VLYE+LT +R+ +   P      L  V +        
Sbjct: 167 YMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVK-------- 212

Query: 316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL 360
             I+        S+  +  I  L  + L +  + RP   +V+++ 
Sbjct: 213 --IVQGNYTPVVSVYSSELI-SLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 74.9 bits (184), Expect = 3e-15
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 29/214 (13%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQW------VAEVQFLGVL 136
           +G G F S Y       A D  +  T++A+K++    N    Q         E++ +  L
Sbjct: 8   LGTGAFSSCY------QARDVKT-GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
            HP++++++G    D    +      E+M   S+   L    +        ++       
Sbjct: 61  NHPHIIRMLGATCEDSHFNL----FVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLR 114

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLARE--GPMVGHTHVSTAVVGT 253
           GL+YLHE    Q+I+RD K +N+L+D   +  +++DFG A        G       ++GT
Sbjct: 115 GLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGT 171

Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
             + AP+ +         DVWS G V+ EM T +
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 75.4 bits (185), Expect = 4e-15
 Identities = 69/221 (31%), Positives = 101/221 (45%), Gaps = 39/221 (17%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK---LNRDGLQWVAEVQFLGVL-EHPNLV 142
           IGEG FG V ++ IK    DG      + + K      D   +  E++ L  L  HPN++
Sbjct: 10  IGEGNFGQVIRAMIKK---DGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 143 KLIGYCAVDGERGIQRLLV----YEFMLN-----RSLE-DHLFNRAF---PPLPWKTRLH 189
            L+G C     RG   + +    Y  +L+     R LE D  F +       L  +  L 
Sbjct: 67  NLLGACE---NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123

Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM-----VGHT 244
                A G+ YL E    Q I+RD  A NVL+ EN   K++DFGL+R   +     +G  
Sbjct: 124 FASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL 180

Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            V    + +  Y+          T KSDVWSFGV+L+E+++
Sbjct: 181 PVRWMAIESLNYSV--------YTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 74.8 bits (184), Expect = 5e-15
 Identities = 66/292 (22%), Positives = 125/292 (42%), Gaps = 43/292 (14%)

Query: 84  MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGVLEH 138
           +  +G G FG V+ +  K    +     T+V +K L +   + +      E+     L H
Sbjct: 10  ITTLGRGEFGEVFLAKAK--GIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH 67

Query: 139 PNLVKLIGYCAVDGERGIQRLLVY-------EFML-NRSLEDHLFNRAFPPLPWKTRLHI 190
            N+V+L+G C       +  +L Y       +F+   +S ++ L     PPL  K ++ +
Sbjct: 68  KNVVRLLGLCREAEPHYM--ILEYTDLGDLKQFLRATKSKDEKLKP---PPLSTKQKVAL 122

Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
               A G+ +L      + ++RD  A N L+      K+S   L+++     +  +  A+
Sbjct: 123 CTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL 179

Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA 310
           +    + AP+ ++    + KSDVWSFGV+++E+ T     +   P       E + +   
Sbjct: 180 I-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-----QGELPFYGLSDEEVLNR--L 231

Query: 311 DSKKFGLIMDPRLEKEYSINEA--RKIGRLADNCLSKSSKDRPKMSQVVERL 360
            + K           E  + E    ++ +L   C + + KDRP  S++V  L
Sbjct: 232 QAGKL----------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 74.9 bits (184), Expect = 6e-15
 Identities = 72/222 (32%), Positives = 112/222 (50%), Gaps = 39/222 (17%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EVQFLG 134
           + ++ KIGEG +G VYK      A D  +  T +A+KK+  +    G+   A  E+  L 
Sbjct: 4   YEKVEKIGEGTYGVVYK------ARDRVTNET-IALKKIRLEQEDEGVPSTAIREISLLK 56

Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-----FNRAFPPLPWKTRLH 189
            ++H N+V+L     V  E+ +   LV+E+ L+  L+ H+     F +   P   KT L+
Sbjct: 57  EMQHGNIVRL--QDVVHSEKRL--YLVFEY-LDLDLKKHMDSSPDFAKN--PRLIKTYLY 109

Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREG--PMVGHTHV 246
            IL    G+AY H     +V++RD K  N+L+D      KL+DFGLAR    P+   TH 
Sbjct: 110 QIL---RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH- 162

Query: 247 STAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
               V T  Y AP+  + + H +   D+WS G +  EM+  +
Sbjct: 163 ---EVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 74.2 bits (182), Expect = 6e-15
 Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 28/209 (13%)

Query: 86  KIGEGGFGSVYKSSIKPA-AGDGTSEATVVAIKKLN-RDGLQWVAEVQFLGVLEHPNLVK 143
           ++G+G FG+VY    K A A +       + + +LN  + +Q   E Q L  L+HP +VK
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66

Query: 144 LIG-------YCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGA 194
                     +C           ++ E+   R L+  L         L         +  
Sbjct: 67  FHASFLERDAFC-----------IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115

Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 254
             G+ Y+H+    ++++RD KA N+ L  N   K+ DFG++R   ++G   ++T   GT 
Sbjct: 116 LLGVHYMHQR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRL--LMGSCDLATTFTGTP 169

Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEM 283
            Y +P+ ++     +KSD+WS G +LYEM
Sbjct: 170 YYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 75.0 bits (184), Expect = 7e-15
 Identities = 69/212 (32%), Positives = 100/212 (47%), Gaps = 32/212 (15%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGV--------LEH 138
           +G+G FG V+ + +K     GT++    AIK L +D +    +V+   V         EH
Sbjct: 3   LGKGSFGKVFLAELK-----GTNQ--FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 55

Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE-- 196
           P L  L  YC    +  +    V E++    L  H+ +     LP  T       AAE  
Sbjct: 56  PFLTHL--YCTFQTKENL--FFVMEYLNGGDLMFHIQSCHKFDLPRAT-----FYAAEII 106

Query: 197 -GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
            GL +LH      ++YRD K  N+LLD +   K++DFG+ +E  M+G     T   GT  
Sbjct: 107 CGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKEN-MLGDAKTCT-FCGTPD 161

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
           Y AP+ +         D WSFGV+LYEML G+
Sbjct: 162 YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 74.7 bits (184), Expect = 7e-15
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 31/223 (13%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQWVA--EVQF 132
           + + ++ KIG+G FG V+K+  K           +VA+KK+     ++G    A  E++ 
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHK-------KTKQIVALKKVLMENEKEGFPITALREIKI 64

Query: 133 LGVLEHPNLVKLIGYC-----AVDGERGIQRLLVYEFMLNRSLEDHLFNRA--FPPLPWK 185
           L +L+H N+V LI  C       +  +G    LV+EF     L   L N+   F     K
Sbjct: 65  LQLLKHENVVNLIEICRTKATPYNRYKG-SFYLVFEF-CEHDLAGLLSNKNVKFTLSEIK 122

Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGH 243
             + ++L    GL Y+H     ++++RD KA+N+L+ ++   KL+DFGLAR         
Sbjct: 123 KVMKMLL---NGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK 176

Query: 244 THVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLT 285
            +  T  V T  Y  P+  +         D+W  G ++ EM T
Sbjct: 177 PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 75.2 bits (185), Expect = 7e-15
 Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 32/223 (14%)

Query: 75  RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQWVAEVQ 131
            ++ ++  R+ +IG G  G+VYK   +P     T     + +   N +     Q   E++
Sbjct: 70  AKSLSELERVNRIGSGAGGTVYKVIHRP-----TGRLYALKVIYGNHEDTVRRQICREIE 124

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED-HLFNRAFPPLPWKTRLHI 190
            L  + HPN+VK       +GE  IQ LL  EFM   SLE  H+ +  F          +
Sbjct: 125 ILRDVNHPNVVKCHDMFDHNGE--IQVLL--EFMDGGSLEGTHIADEQFLA-------DV 173

Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT-HVSTA 249
                 G+AYLH      +++RD K SN+L++     K++DFG++R   ++  T     +
Sbjct: 174 ARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSR---ILAQTMDPCNS 227

Query: 250 VVGTFGYAAPDYIETGHLTAK-----SDVWSFGVVLYEMLTGR 287
            VGT  Y +P+ I T            D+WS GV + E   GR
Sbjct: 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 74.8 bits (184), Expect = 7e-15
 Identities = 69/212 (32%), Positives = 103/212 (48%), Gaps = 33/212 (15%)

Query: 87  IGEGGFGSVY--KSSIKPAAGDGTSEATVVAIKKLN------RDGLQWVAEVQFLGVLEH 138
           +G+G FG V+  +    P AG       + A+K L       RD ++   E   L  + H
Sbjct: 4   LGQGSFGKVFLVRKITGPDAG------QLYAMKVLKKATLKVRDRVRTKMERDILAEVNH 57

Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE-- 196
           P +VKL      +G    +  L+ +F+        LF R    + + T   +    AE  
Sbjct: 58  PFIVKLHYAFQTEG----KLYLILDFLRG----GDLFTRLSKEVMF-TEEDVKFYLAELA 108

Query: 197 -GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
             L +LH    + +IYRD K  N+LLDE    KL+DFGL++E   + H   + +  GT  
Sbjct: 109 LALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKAYSFCGTVE 163

Query: 256 YAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTG 286
           Y AP+ +   GH T  +D WSFGV+++EMLTG
Sbjct: 164 YMAPEVVNRRGH-TQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 74.8 bits (184), Expect = 8e-15
 Identities = 68/221 (30%), Positives = 101/221 (45%), Gaps = 36/221 (16%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW-------VAEVQF 132
           DF+ ++ +G+G FG V  +  K     GT E  + AIK L +D +         + E + 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERK-----GTDE--LYAIKILKKDVIIQDDDVECTMVEKRV 53

Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHL--FNRAFPPLPWKTRLH 189
           L +   P  +  +  C     + + RL  V E++    L  H+    +   P       H
Sbjct: 54  LALPGKPPFLTQLHSCF----QTMDRLYFVMEYVNGGDLMYHIQQVGKFKEP-------H 102

Query: 190 IILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            +  AAE   GL +LH      +IYRD K  NV+LD     K++DFG+ +E    G T  
Sbjct: 103 AVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT-- 157

Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
           +    GT  Y AP+ I         D W+FGV+LYEML G+
Sbjct: 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 74.2 bits (182), Expect = 8e-15
 Identities = 65/236 (27%), Positives = 103/236 (43%), Gaps = 26/236 (11%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-------WVAEVQFLGVLEHP 139
           +G+GGFG V    +K       +   + A KKL++  L+        + E + L  +  P
Sbjct: 1   LGKGGFGEVCAVQVK-------NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSP 53

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
            +V L    A   E      LV   M    L+ H++N     L  +  +H       G+ 
Sbjct: 54  FIVNL----AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGIL 109

Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 259
           +LH    + ++YRD K  NVLLD+    +LSD GLA E          T   GT GY AP
Sbjct: 110 HLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK---DGKTITQRAGTNGYMAP 163

Query: 260 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF 315
           + ++    +   D ++ G  +YEM+ GR   + ++ K  +   E  ++   D  KF
Sbjct: 164 EILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE--ELKRRTLEDEVKF 217

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 74.7 bits (184), Expect = 9e-15
 Identities = 61/225 (27%), Positives = 96/225 (42%), Gaps = 48/225 (21%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQ------- 131
            DF  + ++G+GG+G V+ +  K      T E  +VA+K++ +  L  + EV+       
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKK-----DTGE--IVALKRMKKSLLFKLNEVRHVLTERD 53

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEF--------MLN--RSLEDHLFNRAFPP 181
            L   +   LVKL+ Y   D E      L  E+        +LN    L +         
Sbjct: 54  ILTTTKSEWLVKLL-YAFQDDE---YLYLAMEYVPGGDFRTLLNNLGVLSED-------- 101

Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMV 241
                R ++    AE    +    E+  I+RD K  N L+D +   KL+DFGL++     
Sbjct: 102 ---HARFYM----AEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY 154

Query: 242 GHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            ++     VVG+  Y AP+ +         D WS G +LYE L G
Sbjct: 155 ANS-----VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 73.9 bits (181), Expect = 9e-15
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 26/220 (11%)

Query: 84  MLKIGEGGFGSVYKSSI-KPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLGVLEHPN 140
           M ++GE  FG VYK  +   A G+ T    +  +K      L  ++  E      L+HPN
Sbjct: 10  MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPN 69

Query: 141 LVKLIGYCAVDGERGIQRLLVY-------EFMLNRSL--------EDHLFNRAFPPLPWK 185
           +V L+G   V  E+ +  +  Y       EF++ RS         +D        P  + 
Sbjct: 70  IVCLLG--VVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF- 126

Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
             +HI+   A G+ +L       V+++D    NVL+ +    K+SD GL RE     +  
Sbjct: 127 --VHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK 181

Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           +    +    + +P+ I  G  +  SD+WS+GVVL+E+ +
Sbjct: 182 LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 73.3 bits (180), Expect = 9e-15
 Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 37/221 (16%)

Query: 84  MLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGVL 136
           M ++G G FG V    +++ IK            VAIK +N   +    ++ E + +  L
Sbjct: 9   MKELGSGQFGVVHLGKWRAQIK------------VAIKAINEGAMSEEDFIEEAKVMMKL 56

Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVY---EFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
            HP LV+L G C        Q+  +Y   EFM N  L ++L  R    L     L +   
Sbjct: 57  SHPKLVQLYGVC-------TQQKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQD 108

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG- 252
             EG+ YL        I+RD  A N L+      K+SDFG+ R   ++   + S++    
Sbjct: 109 VCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKF 163

Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLER 292
              ++ P+       ++KSDVWSFGV+++E+ T G+   E+
Sbjct: 164 PVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 76/294 (25%), Positives = 129/294 (43%), Gaps = 66/294 (22%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLGVLEHP 139
           KIGEG FG +Y +  K       S++    IK+++   +          EV  L  ++HP
Sbjct: 7   KIGEGSFGKIYLAKAK-------SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59

Query: 140 NLVK-------------LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKT 186
           N+V              ++ YC  DG   ++R+     +L    ED +       L W  
Sbjct: 60  NIVTFFASFQENGRLFIVMEYC--DGGDLMKRINRQRGVLFS--EDQI-------LSWFV 108

Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR-PKLSDFGLAREGPMVGHTH 245
           ++ +      GL ++H+    ++++RD K+ N+ L +N    KL DFG+AR+  +     
Sbjct: 109 QISL------GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSME 157

Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 305
           ++   VGT  Y +P+  +      K+D+WS G VLYE+ T +   E N     Q +L+  
Sbjct: 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN--NLHQLVLKIC 215

Query: 306 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER 359
           Q Y A                 S N +R +  L       S +DRP ++ +++R
Sbjct: 216 QGYFA---------------PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 27/219 (12%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-----NRDGLQWVAEVQFLGVL-EHPN 140
           +GEG FG V ++           +   VA+K L     ++D    ++E++ + ++ +H N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP--------------PLPWKT 186
           ++ L+G C  +G       ++ E+    +L + L  R  P               L +K 
Sbjct: 80  IINLLGVCTQEGPL----YVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR    + +   
Sbjct: 136 LVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192

Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           ++       + AP+ +     T +SDVWSFG++++E+ T
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 35/222 (15%)

Query: 83  RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFLGVL 136
           RML  G+G FGSV ++ +K   G        VA+K L  D        +++ E   +   
Sbjct: 5   RML--GKGEFGSVREAQLKSEDGSFQK----VAVKMLKADIFSSSDIEEFLREAACMKEF 58

Query: 137 EHPNLVKLIGYCAVDGERGIQRLLV-------------YEFMLNRSLEDHLFNRAFPPLP 183
           +HPN++KLIG       R   RL +             + F+L   + +  F      LP
Sbjct: 59  DHPNVIKLIGVSL--RSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT-----LP 111

Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
            +T +  ++  A G+ YL        I+RD  A N +L+EN    ++DFGL+++     +
Sbjct: 112 LQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDY 168

Query: 244 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
                A      + A + +     T  SDVW+FGV ++E++T
Sbjct: 169 YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 50/221 (22%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLGVLEHPN 140
           +G G +G V  +         T     VAIKKL+R         +   E++ L  ++H N
Sbjct: 23  VGSGAYGQVCSAFDT-----KTGRK--VAIKKLSRPFQSAIHAKRTYRELRLLKHMDHEN 75

Query: 141 LVKLIG-YCAVDGERGIQRL-LVYEFM---LNRSL------EDHLFNRAFPPLPWKTRLH 189
           ++ L+  +         Q + LV   M   LN  +      +DH+          +  ++
Sbjct: 76  VIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHI----------QFLVY 125

Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGHTHVS 247
            IL    GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  +  M G+    
Sbjct: 126 QIL---RGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGY---- 175

Query: 248 TAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 287
              V T  Y AP+ +    H     D+WS G ++ E+LTG+
Sbjct: 176 ---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 74/234 (31%), Positives = 113/234 (48%), Gaps = 41/234 (17%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGVLEHPNLV 142
           K+G G FG V+ ++         ++ T VA+K +    +    ++AE   +  L+H  LV
Sbjct: 13  KLGAGQFGEVWMATY--------NKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLV 64

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           KL    AV  +  I   ++ EFM   SL D L +      P    +      AEG+A++ 
Sbjct: 65  KL---HAVVTKEPI--YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119

Query: 203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAP 259
           +      I+RD +A+N+L+  +   K++DFGLAR    V   +  TA  G      + AP
Sbjct: 120 QR---NYIHRDLRAANILVSASLVCKIADFGLAR----VIEDNEYTAREGAKFPIKWTAP 172

Query: 260 DYIETGHLTAKSDVWSFGVVLYEMLT-GR------------RSLERN--RPKTE 298
           + I  G  T KSDVWSFG++L E++T GR            R+LER    P+ E
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE 226

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 78/283 (27%), Positives = 108/283 (38%), Gaps = 52/283 (18%)

Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWV---AEV 130
           +   T  F  +  IGEG +G VYK               +VAIK ++    +      E 
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYK-------ARHKKTGQLVAIKIMDIIEDEEEEIKEEY 53

Query: 131 QFLGVL-EHPNLVKLIG--YCAVDGERGIQRLLVYEFMLNRSLED-----HLFNRAFPPL 182
             L     HPN+    G            Q  LV E     S+ D         +     
Sbjct: 54  NILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKE- 112

Query: 183 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 242
            W    +I+     GLAYLHE    +VI+RD K  N+LL +N   KL DFG++ +   + 
Sbjct: 113 EWIA--YILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ---LD 164

Query: 243 HT-HVSTAVVGTFGYAAPDYI-----ETGHLTAKSDVWSFGVVLYEMLTGR--------- 287
            T       +GT  + AP+ I           A+SDVWS G+   E+  G+         
Sbjct: 165 STLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM 224

Query: 288 RSL---ERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEY 327
           R+L    RN P T +    W       SKKF   +   L K Y
Sbjct: 225 RALFKIPRNPPPTLKSPENW-------SKKFNDFISECLIKNY 260

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 73.2 bits (179), Expect = 2e-14
 Identities = 68/221 (30%), Positives = 101/221 (45%), Gaps = 39/221 (17%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK---LNRDGLQWVAEVQFLGVL-EHPNLV 142
           IGEG FG V K+ IK    DG      +   K      D   +  E++ L  L  HPN++
Sbjct: 3   IGEGNFGQVLKARIKK---DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 59

Query: 143 KLIGYCAVDGERGIQRLLV----YEFMLN-----RSLE-DHLFNRAF---PPLPWKTRLH 189
            L+G C     RG   L +    +  +L+     R LE D  F  A      L  +  LH
Sbjct: 60  NLLGACE---HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116

Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM-----VGHT 244
                A G+ YL +    Q I+RD  A N+L+ EN+  K++DFGL+R   +     +G  
Sbjct: 117 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 173

Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            V    + +  Y+          T  SDVWS+GV+L+E+++
Sbjct: 174 PVRWMAIESLNYSV--------YTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 26/210 (12%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA----EVQFLGVLEHPNLV 142
           +G+G +G VY       A    S    +AIK++     ++V     E+     L+H N+V
Sbjct: 16  LGKGTYGIVY-------AARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIV 68

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA--EGLAY 200
           + +G  + +G   I      E +   SL   L    + PL    +  I       EGL Y
Sbjct: 69  QYLGSDSENGFFKI----FMEQVPGGSLSA-LLRSKWGPLKDNEQTIIFYTKQILEGLKY 123

Query: 201 LHEGLEVQVIYRDFKASNVLLDE-NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 259
           LH+    Q+++RD K  NVL++  +   K+SDFG ++   + G    +    GT  Y AP
Sbjct: 124 LHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR--LAGINPCTETFTGTLQYMAP 178

Query: 260 DYIETGH--LTAKSDVWSFGVVLYEMLTGR 287
           + I+ G     A +D+WS G  + EM TG+
Sbjct: 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 72.6 bits (178), Expect = 2e-14
 Identities = 75/291 (25%), Positives = 127/291 (43%), Gaps = 50/291 (17%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPN 140
           +G G FG + +  +K  +         VAI  L R G        ++AE   LG  +H N
Sbjct: 13  LGTGRFGELCRGCLKLPS----KRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSN 67

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           +V+L G       RG   ++V E+M N +L D    +    L     + ++ G A G+ Y
Sbjct: 68  IVRLEGVIT----RGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKY 122

Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG----- 255
           L E   +  +++   A  VL++ +   K+S F   +E           A+  T       
Sbjct: 123 LSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS-------EAIYTTMSGKSPV 172

Query: 256 -YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSK 313
            +AAP+ I+  H ++ SDVWSFG+V++E+++ G R       +   + +E   + PA   
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPA--- 229

Query: 314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV 364
                  PR       N    + +L  +C  K   +RP+ SQ+   L ++V
Sbjct: 230 -------PR-------NCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 79/283 (27%), Positives = 126/283 (44%), Gaps = 41/283 (14%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN----RDGLQWVA-EVQFLGV 135
           F+++ KIG+G FG V+K       G       VVAIK ++     D ++ +  E+  L  
Sbjct: 6   FTKLEKIGKGSFGEVFK-------GIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ 58

Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
            + P + K  G    D +  I    + E++   S  D L           T L  IL   
Sbjct: 59  CDSPYVTKYYGSYLKDTKLWI----IMEYLGGGSALDLLEPGPLDETQIATILREIL--- 111

Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
           +GL YLH     + I+RD KA+NVLL E+   KL+DFG+A  G +          VGT  
Sbjct: 112 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPF 166

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF 315
           + AP+ I+     +K+D+WS G+   E+  G        P +E   ++ +   P ++   
Sbjct: 167 WMAPEVIKQSAYDSKADIWSLGITAIELAKGE------PPHSELHPMKVLFLIPKNNP-- 218

Query: 316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
                P LE  YS    + +    + CL+K    RP   ++++
Sbjct: 219 -----PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 34/213 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIK--KLNRD-GLQWVA--EVQFLGVLEH 138
           K+GEG + +VYK         G S+ T  +VA+K  +L  + G  + A  E   L  L+H
Sbjct: 12  KLGEGSYATVYK---------GRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKH 62

Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
            N+V L  +  +  ++ +   LV+E++   L + ++D            +  L  +L   
Sbjct: 63  ANIVTL--HDIIHTKKTLT--LVFEYLDTDLKQYMDDC--GGGLSMHNVRLFLFQLL--- 113

Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
            GLAY H+    +V++RD K  N+L+ E    KL+DFGLAR   +   T+ S  VV T  
Sbjct: 114 RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY-SNEVV-TLW 168

Query: 256 YAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
           Y  PD  + +   +   D+W  G + YEM TGR
Sbjct: 169 YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 67/222 (30%), Positives = 105/222 (47%), Gaps = 35/222 (15%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EVQFLG 134
           + ++ KIGEG +G+V+K     A    T E  +VA+K++  D    G+   A  E+  L 
Sbjct: 2   YEKLEKIGEGTYGTVFK-----AKNRETHE--IVALKRVRLDDDDEGVPSSALREICLLK 54

Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII--- 191
            L+H N+V+L  Y  +  ++ +   LV+E+       D    + F          I+   
Sbjct: 55  ELKHKNIVRL--YDVLHSDKKL--TLVFEYC------DQDLKKYFDSCNGDIDPEIVKSF 104

Query: 192 -LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTA 249
                +GLA+ H      V++RD K  N+L+++N   KL+DFGLAR  G  V      +A
Sbjct: 105 MFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---RCYSA 158

Query: 250 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGRRSL 290
            V T  Y  PD +    L + S D+WS G +  E+    R L
Sbjct: 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 81/269 (30%), Positives = 119/269 (44%), Gaps = 50/269 (18%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGV--------LEH 138
           +G+G FG V  + +K     G  E    A+K L +D +    +V+   V         E+
Sbjct: 3   LGKGSFGKVLLAELK-----GKGE--YFAVKALKKDVVLIDDDVECTMVEKRVLALAWEN 55

Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE-- 196
           P L  L  YC    +  +    V EF+    L  H+ ++    L   T       AAE  
Sbjct: 56  PFLTHL--YCTFQTKEHL--FFVMEFLNGGDLMFHIQDKGRFDLYRAT-----FYAAEIV 106

Query: 197 -GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
            GL +LH      +IYRD K  NV+LD +   K++DFG+ +E  + G    ST   GT  
Sbjct: 107 CGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKEN-VFGDNRAST-FCGTPD 161

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ----YP-- 309
           Y AP+ ++    T   D WSFGV+LYEML G+     +    E  L E ++     YP  
Sbjct: 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD---DEDELFESIRVDTPHYPRW 218

Query: 310 --ADSKKFGLIMDPRLEKEYSINEARKIG 336
              +SK         LEK +  +  R++G
Sbjct: 219 ITKESKDI-------LEKLFERDPTRRLG 240

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 71.6 bits (175), Expect = 5e-14
 Identities = 60/227 (26%), Positives = 111/227 (48%), Gaps = 28/227 (12%)

Query: 66  LRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--- 122
           +R+   +E++       ++  +G G FG+VYK    P   DG +    VAIK L  +   
Sbjct: 1   MRILKETELK-------KVKVLGSGAFGTVYKGIWIP---DGENVKIPVAIKVLRENTSP 50

Query: 123 --GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRA 178
               + + E   +  +  P + +L+G C     + + +L+ Y  +L+  R  +D + ++ 
Sbjct: 51  KANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQD 110

Query: 179 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 238
              L W  ++      A+G++YL E   V++++RD  A NVL+      K++DFGLAR  
Sbjct: 111 L--LNWCVQI------AKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159

Query: 239 PMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            +    + +        + A + I     T +SDVWS+GV ++E++T
Sbjct: 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 74.1 bits (182), Expect = 5e-14
 Identities = 54/194 (27%), Positives = 88/194 (45%), Gaps = 25/194 (12%)

Query: 114 VAIKKLNRDGLQ-------WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLL-VYEFM 165
           VAIK L  D  +       +  E      L HPN+V L+      GE     L  V+E++
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLD----SGEAPPGLLFAVFEYV 61

Query: 166 LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---D 222
             R+L + L       LP      ++L   + LA  H      +++RD K  N+++    
Sbjct: 62  PGRTLREVLAADG--ALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTG 116

Query: 223 ENFRPKLSDFGLAREGPMVGHTHVSTA-----VVGTFGYAAPDYIETGHLTAKSDVWSFG 277
                K+ DFG+    P V    V+T      V+GT  Y AP+ +    +T  SD++++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176

Query: 278 VVLYEMLTGRRSLE 291
           ++  E LTG+R ++
Sbjct: 177 LIFLECLTGQRVVQ 190

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 71.7 bits (176), Expect = 5e-14
 Identities = 59/207 (28%), Positives = 87/207 (42%), Gaps = 25/207 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGV------LEHP 139
            IGEG FG VY+           +E   VA+K         V E +FL         +HP
Sbjct: 13  CIGEGQFGDVYQGVYM----SPENEKIAVAVKTCKNCTSPSVRE-KFLQEAYIMRQFDHP 67

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           ++VKLIG    +    +  L      L   L+ + ++     L   + +      +  LA
Sbjct: 68  HIVKLIGVITENPVWIVMELAPLG-ELRSYLQVNKYS-----LDLASLILYSYQLSTALA 121

Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYA 257
           YL      + ++RD  A NVL+      KL DFGL+R    +       A  G     + 
Sbjct: 122 YLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSR---YLEDESYYKASKGKLPIKWM 175

Query: 258 APDYIETGHLTAKSDVWSFGVVLYEML 284
           AP+ I     T+ SDVW FGV ++E+L
Sbjct: 176 APESINFRRFTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 71.7 bits (176), Expect = 7e-14
 Identities = 65/212 (30%), Positives = 94/212 (44%), Gaps = 34/212 (16%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQ--------FLGVLEH 138
           IG+G FG V  +  K       ++    A+K L +  +    E +         L  ++H
Sbjct: 3   IGKGSFGKVLLAKHK-------ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKH 55

Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-FNRAFPPLPWKTRLHIILGAAE- 196
           P LV L  Y     ++      V +++    L  HL   R+FP    + R +    AAE 
Sbjct: 56  PFLVGL-HYSFQTADK---LYFVLDYVNGGELFFHLQRERSFPEP--RARFY----AAEI 105

Query: 197 --GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 254
              L YLH    + +IYRD K  N+LLD      L+DFGL +EG  + H+  ++   GT 
Sbjct: 106 ASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEG--IEHSKTTSTFCGTP 160

Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            Y AP+ +         D W  G VLYEML G
Sbjct: 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 71.5 bits (175), Expect = 9e-14
 Identities = 72/233 (30%), Positives = 103/233 (44%), Gaps = 45/233 (19%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQ------WVAEVQFLGVL-EH 138
           +G+G FG V  + +K           + A+K L +D  LQ       + E + L +   H
Sbjct: 3   LGKGSFGKVMLARLK-------ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 55

Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-----FNRAFPPLPWKTRLHIILG 193
           P L +L   C    +R      V EF+    L  H+     F+ A      + R +    
Sbjct: 56  PFLTQLY-CCFQTPDR---LFFVMEFVNGGDLMFHIQKSRRFDEA------RARFY---- 101

Query: 194 AAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           AAE    L +LH+     +IYRD K  NVLLD     KL+DFG+ +EG   G T  ++  
Sbjct: 102 AAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTF 156

Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE 303
            GT  Y AP+ ++        D W+ GV+LYEML G    E    + E  L E
Sbjct: 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE---AENEDDLFE 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 70.9 bits (174), Expect = 9e-14
 Identities = 68/219 (31%), Positives = 104/219 (47%), Gaps = 37/219 (16%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL--NRDGLQ----WVAEVQFLG 134
           + ++ KIGEG +G V+K   +           +VAIKK   + D        + E++ L 
Sbjct: 3   YEKLSKIGEGSYGVVFKCRNR-------ETGQIVAIKKFVESEDDPVIKKIALREIRMLK 55

Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL-LVYEF----MLNRSLEDHLFNRAFPPLPWKTRLH 189
            L+HPNLV LI     +  R  ++L LV+E+    +LN  LE +   R  P    K  + 
Sbjct: 56  QLKHPNLVNLI-----EVFRRKRKLHLVFEYCDHTVLN-ELEKNP--RGVPEHLIKKIIW 107

Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
             L   + + + H+      I+RD K  N+L+ +  + KL DFG AR   + G     T 
Sbjct: 108 QTL---QAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFAR--ILTGPGDDYTD 159

Query: 250 VVGTFGYAAPDYI--ETGHLTAKSDVWSFGVVLYEMLTG 286
            V T  Y AP+ +  +T +     DVW+ G V  E+LTG
Sbjct: 160 YVATRWYRAPELLVGDTQYGPP-VDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 71.4 bits (175), Expect = 9e-14
 Identities = 66/219 (30%), Positives = 104/219 (47%), Gaps = 33/219 (15%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLN-------RDGLQWVAEVQF 132
           F + L  G G FG V +++   A G   S+A + VA+K L        R+ L  ++E++ 
Sbjct: 39  FGKTL--GAGAFGKVVEAT---AYGLSKSDAVMKVAVKMLKPTAHSSEREAL--MSELKI 91

Query: 133 LGVL-EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 191
           +  L  H N+V L+G C + G      L++ E+     L + L  +    L  +  L   
Sbjct: 92  MSHLGNHENIVNLLGACTIGGPI----LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFS 147

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 251
              A+G+A+L        I+RD  A NVLL      K+ DFGLAR+       + S  VV
Sbjct: 148 YQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARD-----IMNDSNYVV 199

Query: 252 --GTF---GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
                    + AP+ I     T +SDVWS+G++L+E+ +
Sbjct: 200 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 71/204 (34%), Positives = 92/204 (45%), Gaps = 18/204 (8%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK--LNRDGLQWV-AEVQ-FLGVLEHPNLV 142
           IG+G FG V  +  K    DG   A  V  KK  LNR   + + AE    L  ++HP LV
Sbjct: 3   IGKGSFGKVLLAKRKL---DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
            L  Y     E+      V +F+    L  HL      P P + R +     A  L YLH
Sbjct: 60  GL-HYSFQTTEK---LYFVLDFVNGGELFFHLQRERSFPEP-RARFYAA-EIASALGYLH 113

Query: 203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI 262
               + ++YRD K  N+LLD      L+DFGL +EG  +  +  +T   GT  Y AP+ I
Sbjct: 114 S---INIVYRDLKPENILLDSQGHVVLTDFGLCKEG--IAQSDTTTTFCGTPEYLAPEVI 168

Query: 263 ETGHLTAKSDVWSFGVVLYEMLTG 286
                    D W  G VLYEML G
Sbjct: 169 RKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 64/210 (30%), Positives = 95/210 (45%), Gaps = 29/210 (13%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK-LNRDGLQWVA-----EVQFLGVLEHP 139
            +GEG +G V K   K           +VAIKK L  +  + V      E++ L  L H 
Sbjct: 8   LVGEGSYGMVMKCKHK-------ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 140 NLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPP-LPWKTRLHIILGAAEG 197
           NLV LI        R  +RL LV+EF+ +  L+D      +P  L        +     G
Sbjct: 61  NLVNLIEVF-----RRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRG 112

Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           + + H      +I+RD K  N+L+ ++   KL DFG AR   +     V T  V T  Y 
Sbjct: 113 IEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFART--LAAPGEVYTDYVATRWYR 167

Query: 258 APDYIETGHLTAKS-DVWSFGVVLYEMLTG 286
           AP+ +       ++ D+W+ G ++ EMLTG
Sbjct: 168 APELLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 72/291 (24%), Positives = 120/291 (41%), Gaps = 35/291 (12%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-------RDGLQWVAEVQF 132
           +F    KIG G F  VY+++          +   VA+KK+        +     + E+  
Sbjct: 3   NFRIEKKIGRGQFSEVYRATC-------LLDGVPVALKKVQIFDLMDAKARADCIKEIDL 55

Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
           L  L HPN++K       D E  I   L     L+R ++   F +    +P KT     +
Sbjct: 56  LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH--FKKQKRLIPEKTVWKYFV 113

Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                L ++H     +V++RD K +NV +      KL D GL R       T  + ++VG
Sbjct: 114 QLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVG 168

Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 312
           T  Y +P+ I       KSD+WS G +LYEM   +     ++               +  
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----------MNLYSLC 217

Query: 313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
           KK      P L  ++   E R+   L + C++   + RP ++ V +  K++
Sbjct: 218 KKIEQCDYPPLPSDHYSEELRQ---LVNMCINPDPEKRPDITYVYDVAKRM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 68/243 (27%), Positives = 108/243 (44%), Gaps = 42/243 (17%)

Query: 59  YEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVV 114
           YE+ A  +      ++R    DF  +  IG G FG V    +KSS             V 
Sbjct: 28  YEKAAEKIT-----KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSS-----------KQVY 71

Query: 115 AIKKLNRDGLQWVAEVQFL----GVLEHPN---LVKLIGYCAVDGERGIQRLLVYEFMLN 167
           A+K L++  +   ++  F      ++ H N   +V+L  + A   ++ +   +V E+M  
Sbjct: 72  AMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL--HYAFQDDKYL--YMVMEYMPG 127

Query: 168 RSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP 227
             L + + N   P   W  R +        L  +H    +  I+RD K  N+LLD++   
Sbjct: 128 GDLVNLMSNYDIPE-KW-ARFYT-AEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHL 181

Query: 228 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET----GHLTAKSDVWSFGVVLYEM 283
           KL+DFG   +    G     TA VGT  Y +P+ +++    G+   + D WS GV LYEM
Sbjct: 182 KLADFGTCMKMDANGMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240

Query: 284 LTG 286
           L G
Sbjct: 241 LVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 68/223 (30%), Positives = 111/223 (49%), Gaps = 44/223 (19%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKL---NRDGLQWVA--EVQFL 133
           + ++ K+GEG + +VYK         G S+ T  +VA+K++   + +G    A  EV  L
Sbjct: 8   YIKLDKLGEGTYATVYK---------GRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLL 58

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLED-----HLFNRAFPPLPWK 185
             L+H N+V L  +  +  E+ +   LV+E++   L + L+D     ++ N        K
Sbjct: 59  KDLKHANIVTL--HDIIHTEKSLT--LVFEYLDKDLKQYLDDCGNSINMHNV-------K 107

Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
             L  +L    GL Y H     +V++RD K  N+L++E    KL+DFGLAR   +   T+
Sbjct: 108 LFLFQLL---RGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 161

Query: 246 VSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
            +  V  T  Y  PD  + +   + + D+W  G + YEM TGR
Sbjct: 162 SNEVV--TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 70.3 bits (172), Expect = 1e-13
 Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 43/223 (19%)

Query: 87  IGEGGFGSVY-------------KSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFL 133
           IG G FGSVY             K    P+    + +     +  L R       E+  L
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAR-------EIALL 60

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVY-EFMLNRSLEDHLFNR-AFPPLPWKTRLHII 191
             L+H N+V+ +G  ++D +     L ++ E++   S+   L N  AF     +  +  I
Sbjct: 61  KELQHENIVQYLG-SSLDADH----LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI 115

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA-- 249
           L   +GL YLH      +I+RD K +N+L+D     K+SDFG++++   +    +ST   
Sbjct: 116 L---KGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK---LEANSLSTKTN 166

Query: 250 -----VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
                + G+  + AP+ ++    T K+D+WS G ++ EMLTG+
Sbjct: 167 GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 73/247 (29%), Positives = 109/247 (44%), Gaps = 33/247 (13%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW-------VAEVQF 132
           DF+ ++ +G+G FG V  +  K     GT E  + AIK L +D +         + E + 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERK-----GTDE--LYAIKILKKDVVIQDDDVECTMVEKRV 53

Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 191
           L +   P  +  +  C     + + RL  V E++    L   +        P     H +
Sbjct: 54  LALSGKPPFLTQLHSCF----QTMDRLYFVMEYVNGGDLMYQIQQVGRFKEP-----HAV 104

Query: 192 LGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 248
             AAE   GL +LH      +IYRD K  NV+LD     K++DFG+ +E    G T  + 
Sbjct: 105 FYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TK 159

Query: 249 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQ 307
              GT  Y AP+ I         D W+FGV+LYEML G+   E  +  +  Q ++E    
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA 219

Query: 308 YPADSKK 314
           YP    K
Sbjct: 220 YPKSMSK 226

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 64/224 (28%), Positives = 95/224 (42%), Gaps = 43/224 (19%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQWVA-----EVQFLGVLEH 138
            IG G +G V        A D  S   V AIKK+    D    +A     E++ L   +H
Sbjct: 12  NIGSGAYGVVCS------AIDTRSGKKV-AIKKIPHAFDVPT-LAKRTLRELKILRHFKH 63

Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFM---------LNRSLEDHLFNRAFPPLPWKTRLH 189
            N++ +       G       +V + M          ++ L +    R F        L+
Sbjct: 64  DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHI-RYF--------LY 114

Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVS 247
            +L    GL Y+H      VI+RD K SN+L++E+   ++ DFG+AR        H +  
Sbjct: 115 QLL---RGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM 168

Query: 248 TAVVGTFGYAAPDYIETGH-LTAKSDVWSFGVVLYEMLTGRRSL 290
           T  V T  Y AP+ + +    T   D+WS G +  EML GRR L
Sbjct: 169 TEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 40/101 (39%), Positives = 55/101 (54%), Gaps = 8/101 (7%)

Query: 194 AAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           AAE    L +LH      VIYRD K  N+LLD     KL+DFG+ +EG + G T  +T  
Sbjct: 102 AAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTF 156

Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 291
            GT  Y AP+ ++        D W+ GV++YEM+ G+   E
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 37/90 (41%), Positives = 49/90 (54%), Gaps = 5/90 (5%)

Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           L YLH      V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y 
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYL 162

Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
           AP+ +E        D W  GVV+YEM+ GR
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 74/238 (31%), Positives = 106/238 (44%), Gaps = 29/238 (12%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK----LNRDGLQWV-AEVQFLG 134
           DF     +G G FG V  +  K     GT E   +   K    L    +Q V  E   L 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHK-----GTGEYYAIKCLKKREILKMKQVQHVAQEKSILM 73

Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILG 193
            L HP +V +   C+   E  +  LL  EF++   L  HL     FP    K     ++ 
Sbjct: 74  ELSHPFIVNM--MCSFQDENRVYFLL--EFVVGGELFTHLRKAGRFPNDVAKFYHAELVL 129

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
           A E   YLH      +IYRD K  N+LLD     K++DFG A++ P    T     + GT
Sbjct: 130 AFE---YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT-----LCGT 178

Query: 254 FGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRP-KTEQRLLEWVQQYP 309
             Y AP+ I++ GH  A  D W+ GV+LYE + G      + P +  +++L    ++P
Sbjct: 179 PEYLAPEVIQSKGHGKA-VDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP 235

Length = 329

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 69/236 (29%), Positives = 99/236 (41%), Gaps = 62/236 (26%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLG 134
            +  +  IGEG +G V  ++ KP           VAIKK++    Q        E++ L 
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVK-------VAIKKISPFEHQTFCQRTLREIKILR 58

Query: 135 VLEHPNLVKLIGYCAVDGERGIQR----------LLVYEFM---LNRSL------EDHL- 174
             +H N++ +           I R           +V E M   L + +       DH+ 
Sbjct: 59  RFKHENIIGI---------LDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQ 109

Query: 175 -FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG 233
            F            L+ IL    GL Y+H      V++RD K SN+LL+ N   K+ DFG
Sbjct: 110 YF------------LYQIL---RGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFG 151

Query: 234 LAR-EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
           LAR   P   HT   T  V T  Y AP+ +       K+ D+WS G +L EML+ R
Sbjct: 152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 61/217 (28%), Positives = 108/217 (49%), Gaps = 29/217 (13%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIK--------KLNRDGLQWVAEVQ 131
           +F ++  +G G FG+VYK    P   +G      VAIK        K N++ L    E  
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILD---EAY 61

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLH 189
            +  +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++ 
Sbjct: 62  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 118

Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-EGPMVGHTHVST 248
                A+G+ YL E    ++++RD  A NVL+      K++DFGLA+  G      H   
Sbjct: 119 -----AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG 170

Query: 249 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
             V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 171 GKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 68/230 (29%), Positives = 115/230 (50%), Gaps = 28/230 (12%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKL---NRDGLQWVA--EVQFL 133
           + ++ K+GEG + +V+K         G S+ T  +VA+K++   + +G    A  EV  L
Sbjct: 7   YVKLDKLGEGTYATVFK---------GRSKLTENLVALKEIRLEHEEGAPCTAIREVSLL 57

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L+H N+V L  +  +  ER +   LV+E+ L+  L+ +L N          ++  +  
Sbjct: 58  KNLKHANIVTL--HDIIHTERCLT--LVFEY-LDSDLKQYLDNCGNLMSMHNVKI-FMFQ 111

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
              GL+Y H+    ++++RD K  N+L++E    KL+DFGLAR   +   T+ +  V  T
Sbjct: 112 LLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--T 166

Query: 254 FGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 302
             Y  PD  + +   +   D+W  G +LYEM TGR     +  K E  L+
Sbjct: 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 77/283 (27%), Positives = 125/283 (44%), Gaps = 41/283 (14%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN----RDGLQWVA-EVQFLGV 135
           F+++ +IG+G FG VYK       G       VVAIK ++     D ++ +  E+  L  
Sbjct: 6   FTKLERIGKGSFGEVYK-------GIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ 58

Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
            + P + +  G       +G +  ++ E++   S  D L           T L  IL   
Sbjct: 59  CDSPYITRYYGSYL----KGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL--- 111

Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
           +GL YLH     + I+RD KA+NVLL E    KL+DFG+A  G +          VGT  
Sbjct: 112 KGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPF 166

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF 315
           + AP+ I+      K+D+WS G+   E+  G        P ++   +  +   P +S   
Sbjct: 167 WMAPEVIKQSAYDFKADIWSLGITAIELAKGE------PPNSDLHPMRVLFLIPKNSP-- 218

Query: 316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
                P LE +YS    +      + CL+K  + RP   ++++
Sbjct: 219 -----PTLEGQYS----KPFKEFVEACLNKDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 69.4 bits (170), Expect = 4e-13
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 43/221 (19%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----WVAEVQFLGV 135
                +KIGEG  G V  ++ K       S    VA+KK++    Q       EV  +  
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDK-------STGRQVAVKKMDLRKQQRRELLFNEVVIMRD 72

Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH------ 189
            +HPN+V++     V  E      +V EF+   +L D         +   TR++      
Sbjct: 73  YQHPNIVEMYSSYLVGDEL----WVVMEFLEGGALTD---------IVTHTRMNEEQIAT 119

Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG----LAREGPMVGHTH 245
           + L   + L++LH      VI+RD K+ ++LL  + R KLSDFG    +++E P      
Sbjct: 120 VCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR----- 171

Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
              ++VGT  + AP+ I       + D+WS G+++ EM+ G
Sbjct: 172 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 69.2 bits (169), Expect = 4e-13
 Identities = 67/303 (22%), Positives = 136/303 (44%), Gaps = 44/303 (14%)

Query: 86  KIGEGGFGSVYKSSIKP---------AAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQ 131
           K+GEG FG V+    +          +     ++  +VA+K L  D  +     ++ E++
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRA-----FPPL 182
            +  L+ PN+++L+  C           ++ E+M    LN+ L  H    A        +
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPL----CMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127

Query: 183 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 242
            + T + +    A G+ YL     +  ++RD    N L+ +N+  K++DFG++R      
Sbjct: 128 SYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD 184

Query: 243 HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK---TEQ 299
           +  +    V    + + + I  G  T  SDVW+FGV L+E+LT    L + +P    +++
Sbjct: 185 YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT----LCKEQPYSQLSDE 240

Query: 300 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER 359
           +++E   ++  D  +   +  P L  +        + +L  +C  +++K+RP   ++   
Sbjct: 241 QVIENTGEFFRDQGRQVYLPKPALCPD-------SLYKLMLSCWRRNAKERPSFQEIHAT 293

Query: 360 LKQ 362
           L +
Sbjct: 294 LLE 296

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 69.4 bits (170), Expect = 4e-13
 Identities = 71/227 (31%), Positives = 101/227 (44%), Gaps = 28/227 (12%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--------DGLQWVAEVQFLGVLEH 138
           +G+GG+G V++         G     + A+K L +        D     AE   L  ++H
Sbjct: 4   LGKGGYGKVFQVR----KVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKH 59

Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEG 197
           P +V LI      G    +  L+ E++    L  HL     F        L  I  A   
Sbjct: 60  PFIVDLIYAFQTGG----KLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA--- 112

Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           L +LH+     +IYRD K  N+LLD     KL+DFGL +E    G   V+    GT  Y 
Sbjct: 113 LEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TVTHTFCGTIEYM 167

Query: 258 APDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLL 302
           AP+ +  +GH  A  D WS G ++Y+MLTG       NR KT  ++L
Sbjct: 168 APEILMRSGHGKA-VDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL 213

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 69.9 bits (171), Expect = 5e-13
 Identities = 38/110 (34%), Positives = 52/110 (47%), Gaps = 3/110 (2%)

Query: 181 PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           PLP +  + I     E LAYLH      +I+RD K  N+ LDE     L DFG A +   
Sbjct: 181 PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237

Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
              T       GT    +P+ +      AK+D+WS G+VL+EM     +L
Sbjct: 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 69.0 bits (169), Expect = 5e-13
 Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 42/221 (19%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RD--GLQWVAEVQ----F 132
           D  R+  +G G FG V+         D  SE    A+K +   +   L+    V      
Sbjct: 2   DLERIKTVGTGTFGRVHL------VRDRISE-HYYALKVMAIPEVIRLKQEQHVHNEKRV 54

Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
           L  + HP +++L  +     +R +  L+  E++    L  +L N          R     
Sbjct: 55  LKEVSHPFIIRL--FWTEHDQRFLYMLM--EYVPGGELFSYLRNSG--------RFSNST 102

Query: 193 G---AAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
           G   A+E    L YLH     +++YRD K  N+LLD+    KL+DFG A++  +   T  
Sbjct: 103 GLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKK--LRDRTW- 156

Query: 247 STAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTG 286
              + GT  Y AP+ I+  GH  A  D W+ G+++YEML G
Sbjct: 157 --TLCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 68.3 bits (167), Expect = 5e-13
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 22/217 (10%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDG----TSEATVVAIKKLNRDGLQWVAEVQFLGVL 136
           + ++ KIGEG FG   K+ +  +  DG      E  +  +    R+  +   EV  L  +
Sbjct: 2   YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESR--KEVAVLSNM 56

Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
           +HPN+V+   Y     E G    +V ++     L   +  +     P    L   +    
Sbjct: 57  KHPNIVQ---YQESFEENG-NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL 112

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA--VVGTF 254
            L ++H+    ++++RD K+ N+ L ++   KL DFG+AR    V ++ V  A   +GT 
Sbjct: 113 ALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIAR----VLNSTVELARTCIGTP 165

Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 291
            Y +P+  E      KSD+W+ G VLYEM T + + E
Sbjct: 166 YYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 68.7 bits (168), Expect = 6e-13
 Identities = 72/244 (29%), Positives = 109/244 (44%), Gaps = 38/244 (15%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-------WVAEVQFLGVLEHP 139
           +G+GGFG V    ++ A G       + A KKL +  ++        + E Q L  +   
Sbjct: 8   LGKGGFGEVCACQVR-ATG------KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE--- 196
            +V L    A   E      LV   M    L+ H++N   P    +     +  AAE   
Sbjct: 61  FVVSL----AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEE---RAVFYAAEITC 113

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           GL  LH     +++YRD K  N+LLD+    ++SD GLA E P           VGT GY
Sbjct: 114 GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIP---EGETIRGRVGTVGY 167

Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR-----RSLERNRPKTEQRLLEWVQQYPAD 311
            AP+ ++    T   D W  G ++YEM+ G+     R  +  R + E+R+ E  ++Y   
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEY--- 224

Query: 312 SKKF 315
           S+KF
Sbjct: 225 SEKF 228

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 68.2 bits (166), Expect = 7e-13
 Identities = 85/297 (28%), Positives = 126/297 (42%), Gaps = 41/297 (13%)

Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFL 133
           +R     F  +  +G G +G VYK       G       + AIK ++  G +     Q +
Sbjct: 1   LRDPAGIFELVELVGNGTYGQVYK-------GRHVKTGQLAAIKVMDVTGDEEEEIKQEI 53

Query: 134 GVLE----HPNLVKLIGYCAVDGERGI--QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTR 187
            +L+    H N+    G        G+  Q  LV EF    S+ D + N     L  +  
Sbjct: 54  NMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI 113

Query: 188 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL-AREGPMVGHTHV 246
            +I      GL++LH+    +VI+RD K  NVLL EN   KL DFG+ A+    VG  + 
Sbjct: 114 AYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN- 169

Query: 247 STAVVGTFGYAAPDYI---ETGHLTA--KSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL 301
               +GT  + AP+ I   E    T   KSD+WS G+   EM  G   L    P    R 
Sbjct: 170 --TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---MRA 224

Query: 302 LEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
           L  + + PA          PRL+   S   ++K     ++CL K+   RP   Q+++
Sbjct: 225 LFLIPRNPA----------PRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 71/247 (28%), Positives = 111/247 (44%), Gaps = 33/247 (13%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW-------VAEVQF 132
           DF+ ++ +G+G FG V  +  K     GT E  + AIK L +D +         + E + 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERK-----GTDE--LYAIKILKKDVVIQDDDVECTMVEKRV 53

Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 191
           L + + P  +  +  C     + + RL  V E++    L  H+        P       +
Sbjct: 54  LALQDKPPFLTQLHSCF----QTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-----QAV 104

Query: 192 LGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 248
             AAE   GL +LH      +IYRD K  NV+LD     K++DFG+ +E  + G T  + 
Sbjct: 105 FYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TR 159

Query: 249 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQ 307
              GT  Y AP+ I         D W++GV+LYEML G+   +  +  +  Q ++E    
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS 219

Query: 308 YPADSKK 314
           YP    K
Sbjct: 220 YPKSLSK 226

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 67.2 bits (164), Expect = 1e-12
 Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 27/215 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
           +IG G FG V           G S+A VV +K+L       + L ++ EVQ    L HPN
Sbjct: 2   EIGNGWFGKVLLGEAH----RGMSKARVV-VKELRASATPDEQLLFLQEVQPYRELNHPN 56

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-FNRAFPPLPWKTRLHIILG--AAEG 197
           +++ +G C       I  LLV EF     L+++L  NR       +  +   +    A G
Sbjct: 57  VLQCLGQCI----ESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASG 112

Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           L +LH+      I+ D    N  L  +   K+ D+GLA E     +            + 
Sbjct: 113 LLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL 169

Query: 258 APDYIETGH-------LTAKSDVWSFGVVLYEMLT 285
           AP+ +E           T KS++WS GV ++E+ T
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 74/301 (24%), Positives = 130/301 (43%), Gaps = 58/301 (19%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATV--VAIKKL-----NRDGLQ-WVAEVQFLGVLEH 138
           +GEG FGSV +       G    + ++  VA+K +      R  ++ +++E   +   +H
Sbjct: 7   LGEGEFGSVME-------GQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDH 59

Query: 139 PNLVKLIGYC--AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPP----LPWKTRLHIIL 192
           PN+++LIG C   V+ E     +++  FM +  L   L           LP +  +  + 
Sbjct: 60  PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119

Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE---GPMVGHTHVSTA 249
             A G+ YL        I+RD  A N +L+EN    ++DFGL+++   G       ++  
Sbjct: 120 DIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176

Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWVQQ- 307
            V    + A + +     T KSDVWSFGV ++E+ T  ++     P  E   + ++++Q 
Sbjct: 177 PVK---WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQT---PYPGVENSEIYDYLRQG 230

Query: 308 ----YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
                P D           L+  YS         L  +C   + KDRP    +   L++ 
Sbjct: 231 NRLKQPPDC----------LDGLYS---------LMSSCWLLNPKDRPSFETLRCELEKA 271

Query: 364 V 364
           +
Sbjct: 272 L 272

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 26/210 (12%)

Query: 87  IGEGGFGSVY---------KSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLE 137
           +G G FG VY         + ++K    D  S+ T   +  L         E+Q L  L 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALE-------CEIQLLKNLR 62

Query: 138 HPNLVKLIGYCAVDGERGIQRLLVY-EFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
           H  +V+  G C  D E   ++L ++ E+M   S++D L  +A+  L             +
Sbjct: 63  HDRIVQYYG-CLRDPEE--KKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQ 117

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS-TAVVGTFG 255
           G++YLH  +   +++RD K +N+L D     KL DFG ++    +  +     +V GT  
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           + +P+ I       K+DVWS    + EMLT
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 36/90 (40%), Positives = 51/90 (56%), Gaps = 5/90 (5%)

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           GL YLHE    +++YRD K  N+LLD     K++DFGL +EG  +G    ++   GT  +
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEG--MGFGDRTSTFCGTPEF 167

Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            AP+ +     T   D W  GV++YEML G
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 5/90 (5%)

Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           L +LHE     +IYRD K  NVLLD     KL+D+G+ +EG   G T  ++   GT  Y 
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNYI 163

Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
           AP+ +         D W+ GV+++EM+ GR
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 67/245 (27%), Positives = 104/245 (42%), Gaps = 35/245 (14%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-------WVAEVQFL 133
           F +   +G+GGFG V    ++       +   + A K+L +  ++        + E Q L
Sbjct: 2   FRQYRVLGKGGFGEVCACQVR-------ATGKMYACKRLEKKRIKKRKGESMALNEKQIL 54

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             +    +V L    A   E      LV   M    L+ H++N   P    +     +  
Sbjct: 55  EKVNSQFVVNL----AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEE---RALFY 107

Query: 194 AAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           AAE   GL  LH       +YRD K  N+LLD+    ++SD GLA + P           
Sbjct: 108 AAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIP---EGESIRGR 161

Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR-----RSLERNRPKTEQRLLEWV 305
           VGT GY AP+ +     T   D W  G ++YEM+ G+     R  +  R + ++R+LE  
Sbjct: 162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE 221

Query: 306 QQYPA 310
           + Y A
Sbjct: 222 EVYSA 226

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 28/220 (12%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK----LNRDGLQWVA--EVQFLG 134
           + ++ KIGEG +G VYK+  K       +   +VA+KK    ++ +G+   A  E+  L 
Sbjct: 3   YEKLEKIGEGTYGKVYKARDK-------NTGKLVALKKTRLEMDEEGIPPTALREISLLQ 55

Query: 135 VLEH-PNLVKLIGYCAVDGERG-IQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHI 190
           +L     +V+L+    V+ + G     LV+E++ +  +   D        PLP KT    
Sbjct: 56  MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF 115

Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLAREG--PMVGHTHVS 247
           +    +G+A+ H   +  V++RD K  N+L+D +    K++D GL R    P+  +TH  
Sbjct: 116 MYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH-- 170

Query: 248 TAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTG 286
             +V T  Y AP+ +    H +   D+WS G +  EM   
Sbjct: 171 -EIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 32/217 (14%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKL---NRDGLQWVA--EVQFL 133
           + ++ K+GEG + +V+K         G S+ T  +VA+K++   + +G    A  EV  L
Sbjct: 8   YIKLEKLGEGTYATVFK---------GRSKLTENLVALKEIRLEHEEGAPCTAIREVSLL 58

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHII 191
             L+H N+V L      D        LV+E+ L++ L+ ++ +          K  L+ I
Sbjct: 59  KDLKHANIVTLHDIVHTDK----SLTLVFEY-LDKDLKQYMDDCGNIMSMHNVKIFLYQI 113

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 251
           L    GLAY H     +V++RD K  N+L++E    KL+DFGLAR   +   T+ +  V 
Sbjct: 114 L---RGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV- 166

Query: 252 GTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
            T  Y  PD  + +   + + D+W  G + +EM +GR
Sbjct: 167 -TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 75/280 (26%), Positives = 119/280 (42%), Gaps = 40/280 (14%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN------RDGLQWVAEVQFLGVLEHPN 140
           +G+G +G V   S+     DG        IKKLN      R+      E Q L  L+HPN
Sbjct: 8   VGKGSYGEV---SLVRHRTDGKQ----YVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           +V      + +GE G    +V  F     L   L  +    LP    +   +  A  L Y
Sbjct: 61  IVAYRE--SWEGEDG-LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117

Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 260
           LHE     +++RD K  NV L      K+ D G+AR   +     +++ ++GT  Y +P+
Sbjct: 118 LHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIAR--VLENQCDMASTLIGTPYYMSPE 172

Query: 261 YIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYPADSKKFGLIM 319
                    KSDVW+ G  +YEM T + +   ++      R++E            G + 
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE------------GKL- 219

Query: 320 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER 359
            P + K+YS     ++G L    LSK  + RP +  ++ +
Sbjct: 220 -PPMPKDYS----PELGELIATMLSKRPEKRPSVKSILRQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 67.4 bits (164), Expect = 3e-12
 Identities = 38/91 (41%), Positives = 50/91 (54%), Gaps = 4/91 (4%)

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH   E  V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y
Sbjct: 107 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEY 162

Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 24/211 (11%)

Query: 87  IGEGGFGSVY---------KSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLE 137
           +G+G FG VY         + + K    D  S  T   +  L         E+Q L  L+
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALE-------CEIQLLKNLQ 62

Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 197
           H  +V+  G      E+ +   +  E+M   S++D L  +A+  L             EG
Sbjct: 63  HERIVQYYGCLRDRAEKTLT--IFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEG 118

Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST-AVVGTFGY 256
           ++YLH  +   +++RD K +N+L D     KL DFG ++    +  +     +V GT  +
Sbjct: 119 MSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175

Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            +P+ I       K+DVWS G  + EMLT +
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 21/211 (9%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-------RDGLQWVAEVQF 132
           +F    KIG G F  VY+++          +   VA+KK+        +     V E+  
Sbjct: 3   NFQIEKKIGRGQFSEVYRATC-------LLDRKPVALKKVQIFEMMDAKARQDCVKEIDL 55

Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
           L  L HPN++K +     D E  I   L     L++ ++   F +    +P +T     +
Sbjct: 56  LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIK--YFKKQKRLIPERTVWKYFV 113

Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                + ++H     +V++RD K +NV +      KL D GL R       T  + ++VG
Sbjct: 114 QLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVG 168

Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEM 283
           T  Y +P+ I       KSD+WS G +LYEM
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 36/92 (39%), Positives = 51/92 (55%), Gaps = 8/92 (8%)

Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           L +LH+   + +IYRD K  N+LLD      L+DFGL++E  +      + +  GT  Y 
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF-LAEEEERAYSFCGTIEYM 173

Query: 258 APDYI---ETGHLTAKSDVWSFGVVLYEMLTG 286
           AP+ I     GH  A  D WS GV+ +E+LTG
Sbjct: 174 APEVIRGGSGGHDKA-VDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 24/206 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-WVAEVQFLGVLEHPNLVKL 144
           ++G+G FG VYK+  K       + A V+  K  + + L+ ++ E++ L    HP +VKL
Sbjct: 19  ELGDGAFGKVYKAKNKETGA--LAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKL 74

Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +G    DG+  I    + EF    +++  +   +R       +     +L   E L YLH
Sbjct: 75  LGAFYWDGKLWI----MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML---EALQYLH 127

Query: 203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI 262
               +++I+RD KA NVLL  +   KL+DFG++ +   V       + +GT  + AP+ +
Sbjct: 128 ---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKN--VKTLQRRDSFIGTPYWMAPEVV 182

Query: 263 --ETGHLTA---KSDVWSFGVVLYEM 283
             ET   T    K+D+WS G+ L EM
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 45/141 (31%), Positives = 70/141 (49%), Gaps = 20/141 (14%)

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L +LH+   + +IYRD K  N+LLD N    L+DFGL++E         + +  GT  Y
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-HEDEVERAYSFCGTIEY 172

Query: 257 AAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSL-----ERNRPKTEQRLLEWVQQY 308
            APD +   + GH  A  D WS GV++YE+LTG         + ++ +  +R+L+    Y
Sbjct: 173 MAPDIVRGGDGGHDKA-VDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 231

Query: 309 PADSKKFG-------LIMDPR 322
           P +            L+ DP+
Sbjct: 232 PQEMSALAKDIIQRLLMKDPK 252

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 66.4 bits (162), Expect = 3e-12
 Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 29/206 (14%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNL 141
           +G G  G+VYK+              ++A+K +  D       Q ++E++ L   + P +
Sbjct: 9   LGHGNGGTVYKAYHLLTR-------RILAVKVIPLDITVELQKQIMSELEILYKCDSPYI 61

Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 201
           +   G   V+    I      EFM   SL+       +  +P      I +   +GL YL
Sbjct: 62  IGFYGAFFVENRISI----CTEFMDGGSLD------VYRKIPEHVLGRIAVAVVKGLTYL 111

Query: 202 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 261
                +++++RD K SN+L++   + KL DFG++ +  +V    ++   VGT  Y AP+ 
Sbjct: 112 ---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQ--LV--NSIAKTYVGTNAYMAPER 164

Query: 262 IETGHLTAKSDVWSFGVVLYEMLTGR 287
           I        SDVWS G+   E+  GR
Sbjct: 165 ISGEQYGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 52/161 (32%), Positives = 77/161 (47%), Gaps = 14/161 (8%)

Query: 160 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNV 219
           LV   M    L+ H++N   P    +     I  AAE    L +    +++YRD K  N+
Sbjct: 77  LVLTIMNGGDLKFHIYNMGNPGFDEQ---RAIFYAAELCCGLEDLQRERIVYRDLKPENI 133

Query: 220 LLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVV 279
           LLD+    ++SD GLA + P           VGT GY AP+ I     T   D W  G +
Sbjct: 134 LLDDRGHIRISDLGLAVQIP---EGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCL 190

Query: 280 LYEMLTG----RRSLER-NRPKTEQRLLEWVQQYPADSKKF 315
           +YEM+ G    R+  ER  R + ++R+ E  ++Y   S+KF
Sbjct: 191 IYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEY---SEKF 228

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 42/121 (34%), Positives = 66/121 (54%), Gaps = 13/121 (10%)

Query: 194 AAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           AAE   GL  LH+    +++YRD K  N+LLD++   ++SD GLA   P           
Sbjct: 108 AAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGR 161

Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE----QRLLEWVQ 306
           VGT GY AP+ ++    T   D W+ G +LYEM+ G+   ++ + K +    +RL++ VQ
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ 221

Query: 307 Q 307
           +
Sbjct: 222 E 222

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 66.5 bits (163), Expect = 4e-12
 Identities = 68/249 (27%), Positives = 100/249 (40%), Gaps = 62/249 (24%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSE--ATVVAIKK--LNRDGLQWV-AEVQFLG 134
            F ++  +G+G  G V+   +K     GT +  A  V  KK  + R+ ++ V  E + L 
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLK-----GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILA 56

Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLPWKTRLHI 190
            L+HP L  L  Y +   E  +   LV ++     L R L+                   
Sbjct: 57  TLDHPFLPTL--YASFQTETYL--CLVMDYCPGGELFRLLQRQPGKC-LS------EEVA 105

Query: 191 ILGAAE---GLAYLH-EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
              AAE    L YLH  G    ++YRD K  N+LL E+    LSDF L+++  +      
Sbjct: 106 RFYAAEVLLALEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161

Query: 247 ---------------------------STAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGV 278
                                      S + VGT  Y AP+ I   GH  +  D W+ G+
Sbjct: 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGI 220

Query: 279 VLYEMLTGR 287
           +LYEML G 
Sbjct: 221 LLYEMLYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 66.3 bits (161), Expect = 5e-12
 Identities = 35/91 (38%), Positives = 50/91 (54%), Gaps = 5/91 (5%)

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH G   +++YRD K  N++LD++   K++DFGL +EG  +          GT  Y
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEG--ITDAATMKTFCGTPEY 161

Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 66.2 bits (161), Expect = 5e-12
 Identities = 44/128 (34%), Positives = 65/128 (50%), Gaps = 12/128 (9%)

Query: 189 HIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
           H    AAE    L +LHE     +IYRD K  NVLLD +   KL+D+G+ +EG   G T 
Sbjct: 97  HARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT- 152

Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE--RNRP--KTEQRL 301
            ++   GT  Y AP+ +         D W+ GV+++EM+ GR   +   + P   TE  L
Sbjct: 153 -TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL 211

Query: 302 LEWVQQYP 309
            + + + P
Sbjct: 212 FQVILEKP 219

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 65.9 bits (160), Expect = 6e-12
 Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 28/216 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA--EVQFLGVLEHPNLVK 143
           K+G G +G VYK+  K    DG  E    A+K++   G+   A  E+  L  L+HPN++ 
Sbjct: 8   KVGRGTYGHVYKAKRK----DGKDEKEY-ALKQIEGTGISMSACREIALLRELKHPNVIA 62

Query: 144 LIGYCAVDGERGIQRLLVY-EFMLNRSLEDHLFNRA------FPPLPWKTRLHIILGAAE 196
           L        +R +  L  Y E  L   ++ H  ++A       P    K+ L+ IL   +
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQIL---D 119

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLL----DENFRPKLSDFGLAR--EGPMVGHTHVSTAV 250
           G+ YLH      V++RD K +N+L+     E  R K++D G AR    P+     +   V
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176

Query: 251 VGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLT 285
           V TF Y AP+ +    H T   D+W+ G +  E+LT
Sbjct: 177 V-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 65.5 bits (159), Expect = 8e-12
 Identities = 65/216 (30%), Positives = 101/216 (46%), Gaps = 28/216 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA--EVQFLGVLEHPNLVK 143
           K+G G +G VYK+  K    D        A+K++   G+   A  E+  L  L+HPN++ 
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRD-----YALKQIEGTGISMSACREIALLRELKHPNVIS 62

Query: 144 LIGYCAVDGERGIQRLLVY-EFMLNRSLEDHLFNRA------FPPLPWKTRLHIILGAAE 196
           L        +R +  L  Y E  L   ++ H  ++A       P    K+ L+ IL   +
Sbjct: 63  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL---D 119

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLL----DENFRPKLSDFGLAR--EGPMVGHTHVSTAV 250
           G+ YLH      V++RD K +N+L+     E  R K++D G AR    P+     +   V
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176

Query: 251 VGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLT 285
           V TF Y AP+ +    H T   D+W+ G +  E+LT
Sbjct: 177 V-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 65.1 bits (158), Expect = 8e-12
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 24/211 (11%)

Query: 87  IGEGGFGSVY---------KSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLE 137
           +G+G FG VY         + ++K    D  S  T   +  L         E+Q L  L 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALE-------CEIQLLKNLL 62

Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 197
           H  +V+  G      ER +   +  E M   S++D L  +++  L             EG
Sbjct: 63  HERIVQYYGCLRDPMERTLS--IFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEG 118

Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS-TAVVGTFGY 256
           ++YLH  +   +++RD K +N+L D     KL DFG ++    +  +     +V GT  +
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175

Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            +P+ I       K+D+WS G  + EMLT +
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 65.8 bits (160), Expect = 9e-12
 Identities = 87/347 (25%), Positives = 153/347 (44%), Gaps = 48/347 (13%)

Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIK-----PAAGDGTSEATVVAIKKLNRDGLQWV 127
           + +    DF+ +  +G G FG V  ++ K     P A     ++ ++  K+++       
Sbjct: 24  KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVD----HVF 79

Query: 128 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPLPWKT 186
           +E + L  + HP  V L G    +        LV EF++       L  N+ FP      
Sbjct: 80  SERKILNYINHPFCVNLYGSFKDES----YLYLVLEFVIGGEFFTFLRRNKRFPN----- 130

Query: 187 RLHIILGAAEGLAYLHEGLE-VQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
              +    A  +  + E L+ + ++YRD K  N+LLD++   K++DFG A+    V  T 
Sbjct: 131 --DVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK----VVDTR 184

Query: 246 VSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP-KTEQRLLE 303
             T + GT  Y AP+  +  GH  A +D W+ G+ +YE+L G      N P    Q++LE
Sbjct: 185 TYT-LCGTPEYIAPEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE 242

Query: 304 WVQQYPADSKKFGLIMDPR----LEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV--V 357
            +  +P    KF   +D      ++K  S +  ++ G L     +++ K+ P    +  V
Sbjct: 243 GIIYFP----KF---LDNNCKHLMKKLLSHDLTKRYGNLKKG--AQNVKEHPWFGNIDWV 293

Query: 358 ERLKQIVQVSNE---GDSFDKTFEEICEEDPVEAQTKQKQHEPSEAW 401
             L + V+V  +    + FD +  E  +ED   A     +++P   W
Sbjct: 294 SLLHKNVEVPYKPKYKNVFDSSNFERVQEDLTIADKITNENDPFFDW 340

Length = 340

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 65/222 (29%), Positives = 97/222 (43%), Gaps = 39/222 (17%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQ 131
           TN +  +  +G G FG V       +A D  +   V AIKK+ +         +   E++
Sbjct: 9   TNRYVDLQPVGMGAFGLVC------SARDQLTGQNV-AIKKIMKPFSTPVLAKRTYRELK 61

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRL 188
            L  L H N+   I    +          V E +   L+R L      + F     +  L
Sbjct: 62  LLKHLRHENI---ISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFI----QYFL 114

Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGHTHV 246
           + IL    GL Y+H      V++RD K SN+L++EN   K+ DFGLAR  +  M G+   
Sbjct: 115 YQIL---RGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGY--- 165

Query: 247 STAVVGTFGYAAPDYIETGH-LTAKSDVWSFGVVLYEMLTGR 287
               V T  Y AP+ + T      + D+WS G +  EML G+
Sbjct: 166 ----VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 65/218 (29%), Positives = 96/218 (44%), Gaps = 33/218 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK---------LNRDGLQWVAEVQFLGVL 136
           ++G+G +G V   S + A    TSE   VAIKK         L +  L+ +  ++     
Sbjct: 7   ELGQGAYGIV--CSARNA---ETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFR-- 59

Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI---ILG 193
            H N+  L     V        L +YE ++   L  H   R+  PL   T  H    I  
Sbjct: 60  GHKNITCLYDMDIVFPG-NFNELYLYEELMEADL--HQIIRSGQPL---TDAHFQSFIYQ 113

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR---EGPMVGHTHVSTAV 250
              GL Y+H      V++RD K  N+L++ +   K+ DFGLAR   E P      + T  
Sbjct: 114 ILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEY 169

Query: 251 VGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
           V T  Y AP+ + +     K+ DVWS G +L E+L  +
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 37/90 (41%), Positives = 49/90 (54%), Gaps = 5/90 (5%)

Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           L YLH      V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y 
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYL 162

Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
           AP+ +E        D W  GVV+YEM+ GR
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 71/247 (28%), Positives = 101/247 (40%), Gaps = 34/247 (13%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN------RDGLQW-VAEVQFLGVLEHP 139
           +G+GGFG V    ++ A G       + A KKLN      R G +  + E + L  +   
Sbjct: 1   LGKGGFGEVSACQMR-ATG------KLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSR 53

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEG 197
            +V L    A   +      LV   M    L  H++N     P  P             G
Sbjct: 54  FIVSL----AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG 109

Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           L +LH+    ++IYRD K  NVLLD +   ++SD GLA E  +      +    GT G+ 
Sbjct: 110 LEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVE--LKDGQSKTKGYAGTPGFM 164

Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-----QRLLEWVQQYP--- 309
           AP+ ++        D ++ GV LYEM+  R        K E     QR+L     YP   
Sbjct: 165 APELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKF 224

Query: 310 -ADSKKF 315
              SK F
Sbjct: 225 SPASKSF 231

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 51/170 (30%), Positives = 75/170 (44%), Gaps = 13/170 (7%)

Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           E   L  ++HPN+V        DG   I    V E+     L   +  +     P  T L
Sbjct: 48  EAVLLAKMKHPNIVAFKESFEADGHLYI----VMEYCDGGDLMQKIKLQRGKLFPEDTIL 103

Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGHTHV 246
              +    G+ ++HE    +V++RD K+ N+ L +N + KL DFG AR    P       
Sbjct: 104 QWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA----Y 156

Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK 296
           +   VGT  Y  P+  E      KSD+WS G +LYE+ T +   + N  K
Sbjct: 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 66/236 (27%), Positives = 106/236 (44%), Gaps = 28/236 (11%)

Query: 59  YEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVV 114
           YE+    +R     +++    D+  +  IG G FG V    +KSS K  A    S+  ++
Sbjct: 28  YEKIVRKIR-----KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI 82

Query: 115 AIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL 174
              K +     W  E   +     P +V+L  +CA   ++ +   +V E+M    L + +
Sbjct: 83  ---KRSDSAFFW-EERDIMAFANSPWVVQL--FCAFQDDKYL--YMVMEYMPGGDLVNLM 134

Query: 175 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 234
            N   P   W          AE +  L     + +I+RD K  N+LLD++   KL+DFG 
Sbjct: 135 SNYDVPE-KWAK-----FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGT 188

Query: 235 AREGPMVGHTHVSTAVVGTFGYAAPDYIET----GHLTAKSDVWSFGVVLYEMLTG 286
             +    G     TA VGT  Y +P+ +++    G+   + D WS GV L+EML G
Sbjct: 189 CMKMDETGMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 36/95 (37%), Positives = 51/95 (53%), Gaps = 5/95 (5%)

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLHE     +IYRD K  NVLLD     KL+D+G+ +EG   G T  ++   GT  Y
Sbjct: 108 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNY 162

Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 291
            AP+ +         D W+ GV+++EM+ GR   +
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 28/208 (13%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQ-WVAEVQFLGVLEHPN 140
           ++G+G FG VYK+  K        E  V+A  K+    + + L+ ++ E+  L   +HPN
Sbjct: 12  ELGDGAFGKVYKAQNK--------ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 63

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           +VKL+   A   E  +  L+  EF    +++  +     P    + R+ +     E L Y
Sbjct: 64  IVKLLD--AFYYENNLWILI--EFCAGGAVDAVMLELERPLTEPQIRV-VCKQTLEALNY 118

Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 260
           LHE    ++I+RD KA N+L   +   KL+DFG++ +         S   +GT  + AP+
Sbjct: 119 LHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPE 173

Query: 261 YI--ETGH---LTAKSDVWSFGVVLYEM 283
            +  ET        K+DVWS G+ L EM
Sbjct: 174 VVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 29/213 (13%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW-------VAEVQFL 133
           ++R  KIG+G  G+VY ++I  A G        VAIK++N   LQ        + E+  +
Sbjct: 21  YTRFEKIGQGASGTVY-TAIDVATG------QEVAIKQMN---LQQQPKKELIINEILVM 70

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
              +HPN+V  +    V    G +  +V E++   SL D +                 L 
Sbjct: 71  RENKHPNIVNYLDSYLV----GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ 126

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
           A E   +LH     QVI+RD K+ N+LL  +   KL+DFG   +  +       + +VGT
Sbjct: 127 ALE---FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGT 178

Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
             + AP+ +       K D+WS G++  EM+ G
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 36/215 (16%)

Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLV--------YEFMLNRSLEDHLFNRAFP 180
           E   L  + HP+++++          G    +V        Y ++  RS           
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLV----SGAITCMVLPHYSSDLYTYLTKRS----------R 152

Query: 181 PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           PLP    L I     EGL YLH     ++I+RD K  N+ +++  +  + D G A+  P+
Sbjct: 153 PLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPV 208

Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT--- 297
           V    +  A  GT    AP+ +      +K+D+WS G+VL+EML    ++  + P T   
Sbjct: 209 VAPAFLGLA--GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEE 266

Query: 298 -----EQRLLEWVQQYPADSKKFGLIMDPRLEKEY 327
                   LL+ +       ++F      RL + +
Sbjct: 267 YVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGF 301

Length = 357

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 67/233 (28%), Positives = 95/233 (40%), Gaps = 66/233 (28%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-----NR-DGLQWVAEVQFLGVLEHPN 140
           IG G +G V  S+      +       VAIKK+     NR D  + + E++ L  L+H N
Sbjct: 13  IGRGAYGIVC-SAKNSETNEK------VAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65

Query: 141 LVKLIGYCAVDGERGIQR------LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 194
           ++ +      D      R       +VYE M                    T LH I+ +
Sbjct: 66  VIAIK-----DIMPPPHREAFNDVYIVYELM-------------------DTDLHQIIRS 101

Query: 195 AE----------------GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 238
           ++                GL Y+H      V++RD K SN+LL+ N   K+ DFGLAR  
Sbjct: 102 SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTT 158

Query: 239 PMVGHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
              G     T  V T  Y AP+ +      T   DVWS G +  E+L GR+ L
Sbjct: 159 SEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 63.4 bits (154), Expect = 5e-11
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 39/221 (17%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLG 134
           ++ + ++G G +GSV  S+I    G+       VAIKKL+R         +   E+  L 
Sbjct: 17  YTSLKQVGSGAYGSVC-SAIDKRTGEK------VAIKKLSRPFQSEIFAKRAYRELTLLK 69

Query: 135 VLEHPNLVKLIG-YCAVDGERGIQRL-LVYEFM---LNRSLEDHLFNRAFPPLPWKTRLH 189
            ++H N++ L+  + +       Q   LV  +M   L + +   L       L ++    
Sbjct: 70  HMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM--- 126

Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGHTHVS 247
                  GL Y+H      +I+RD K  N+ ++E+   K+ DFGLAR  +  M G+    
Sbjct: 127 -----LCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY---- 174

Query: 248 TAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGR 287
              V T  Y AP+ I    H     D+WS G ++ EMLTG+
Sbjct: 175 ---VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 38/212 (17%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFLGVLEHP 139
           ++G G FG+V K   K            VA+K L  D        + + E   +  L++P
Sbjct: 2   ELGSGNFGTVKKGMYKMKKS-----EKTVAVKILKNDNNDPALKDELLREANVMQQLDNP 56

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
            +V++IG C  + E     +LV E      LN+ L+    N+    +  K    ++   +
Sbjct: 57  YIVRMIGIC--EAE---SWMLVMELAELGPLNKFLQK---NKH---VTEKNITELVHQVS 105

Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGHTHVSTAV 250
            G+ YL E      ++RD  A NVLL      K+SDFGL++     E      TH    V
Sbjct: 106 MGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPV 162

Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYE 282
                + AP+ +     ++KSDVWSFGV+++E
Sbjct: 163 ----KWYAPECMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 63.0 bits (153), Expect = 6e-11
 Identities = 60/218 (27%), Positives = 93/218 (42%), Gaps = 25/218 (11%)

Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 254
           AE L  L    +  VIYRD K  N+LLD      L DFGL +    +     +    GT 
Sbjct: 100 AELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLN--MKDDDKTNTFCGTP 157

Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL-ERNRPKTEQRLLEWVQQYP--AD 311
            Y AP+ +     T   D W+ GV+LYEMLTG     + N  +  +++L+   ++P   D
Sbjct: 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFD 217

Query: 312 SKKFGLIM-----DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV 366
                L++     DP   +    N A++I        S+ S  +  M  +    K  V  
Sbjct: 218 RDAKDLLIGLLSRDPT--RRLGYNGAQEIKN--HPFFSQLSWKKLLMKGIQPPFKPAVSS 273

Query: 367 SNEGDSFDKTFEEICEEDPVE--------AQTKQKQHE 396
           + +  +FD   EE   E P++        ++T Q+Q  
Sbjct: 274 AIDTSNFD---EEFTREKPIDSVVDDSHLSETVQQQFG 308

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 24/209 (11%)

Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIK-------KLNRDGLQWVAEVQFLGVLE 137
           +++G G FG V K   K        +   VAIK       K  RD  + + E + +  L+
Sbjct: 1   VELGSGNFGCVKKGVYKM-----RKKQIDVAIKVLKNENEKSVRD--EMMREAEIMHQLD 53

Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 197
           +P +V++IG C  +       +LV E      L   L  +    +     + ++   + G
Sbjct: 54  NPYIVRMIGVCEAEA-----LMLVMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMG 107

Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAVVGTFGY 256
           + YL        ++RD  A NVLL      K+SDFGL++  G    +    +A      +
Sbjct: 108 MKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKW 164

Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            AP+ I     +++SDVWS+G+ ++E  +
Sbjct: 165 YAPECINFRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 35/92 (38%), Positives = 46/92 (50%), Gaps = 5/92 (5%)

Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 254
           A  L YLH    + ++YRD K  N+LLD      L+DFGL +E   + H   ++   GT 
Sbjct: 106 ASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN--IEHNGTTSTFCGTP 160

Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            Y AP+ +         D W  G VLYEML G
Sbjct: 161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 62.9 bits (153), Expect = 7e-11
 Identities = 58/227 (25%), Positives = 94/227 (41%), Gaps = 55/227 (24%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN------RDGLQWVAEVQFLGVLEHPN 140
           IG+G +G V        +   T     VAIKK+N       D  + + E++ L +L HP+
Sbjct: 8   IGKGSYGVV-------CSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60

Query: 141 LVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE--- 196
           +V++         R  + + +V+E M                   ++ LH ++ A +   
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELM-------------------ESDLHQVIKANDDLT 101

Query: 197 -------------GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
                         L Y+H      V +RD K  N+L + + + K+ DFGLAR       
Sbjct: 102 PEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158

Query: 244 THVS-TAVVGTFGYAAPDYIET--GHLTAKSDVWSFGVVLYEMLTGR 287
           T +  T  V T  Y AP+   +     T   D+WS G +  E+LTG+
Sbjct: 159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 8e-11
 Identities = 76/289 (26%), Positives = 115/289 (39%), Gaps = 61/289 (21%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN------RDGLQWV-AEVQ 131
           +DF  +  IG G FG V+        G       V A+K L       R+ +  V AE  
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVR-DKDTGQ------VYAMKVLRKSDMIKRNQIAHVRAERD 53

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 191
            L   + P +VKL  Y +   E  +   LV E+M    L + L  +   P     R +I 
Sbjct: 54  ILADADSPWIVKL--YYSFQDEEHL--YLVMEYMPGGDLMNLLIRKDVFPEET-ARFYI- 107

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA---------------- 235
              AE +  L    ++  I+RD K  N+L+D +   KL+DFGL                 
Sbjct: 108 ---AELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDS 164

Query: 236 -----REGPMVGHT------HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
                R+  +V           + + VGT  Y AP+ +       + D WS GV+LYEML
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224

Query: 285 TGRRSL-ERNRPKTEQRLLEWVQ--QYPAD---SKKF-----GLIMDPR 322
            G          +T  +++ W +  ++P D   S +       L+ DP 
Sbjct: 225 YGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPE 273

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 36/92 (39%), Positives = 46/92 (50%), Gaps = 5/92 (5%)

Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 254
           A  + YLH    + +IYRD K  N+LLD      L+DFGL +EG  V     ++   GT 
Sbjct: 106 ASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEG--VEPEETTSTFCGTP 160

Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            Y AP+ +         D W  G VLYEML G
Sbjct: 161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 36/104 (34%), Positives = 53/104 (50%), Gaps = 7/104 (6%)

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           GL YLH      +++RD K  N+L++ N   K+ DFGLAR        H++  VV  + Y
Sbjct: 115 GLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-Y 170

Query: 257 AAPDYIETG--HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE 298
            AP+ I  G  H T+  D+WS G +  E+L  R   +   P  +
Sbjct: 171 RAPE-ILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ 213

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 61.7 bits (149), Expect = 2e-10
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 29/213 (13%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-------WVAEVQFL 133
           ++R  KIG+G  G+V+ +          +    VAIK++N   LQ        + E+  +
Sbjct: 21  YTRYEKIGQGASGTVFTAI-------DVATGQEVAIKQIN---LQKQPKKELIINEILVM 70

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L++PN+V  +    V    G +  +V E++   SL D +                 L 
Sbjct: 71  KELKNPNIVNFLDSFLV----GDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQ 126

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
           A E   +LH     QVI+RD K+ NVLL  +   KL+DFG   +  +       + +VGT
Sbjct: 127 ALE---FLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGT 178

Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
             + AP+ +       K D+WS G++  EM+ G
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 44/143 (30%), Positives = 68/143 (47%), Gaps = 30/143 (20%)

Query: 194 AAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA----REGPMVGHTHV 246
           AAE   GL ++H      V+YRD K +N+LLDE+   ++SD GLA    ++ P     H 
Sbjct: 103 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HA 154

Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVW-SFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 305
           S   VGT GY AP+ ++ G     S  W S G +L+++L G     +++ K +  +    
Sbjct: 155 S---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---- 207

Query: 306 QQYPADSKKFGLIMDPRLEKEYS 328
                   +  L M   L   +S
Sbjct: 208 -------DRMTLTMAVELPDSFS 223

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 20/207 (9%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-WVAEVQFLGVLEHPNLVKLI 145
           +G+G FG VYK+  K       + A ++ I+  + + L+ ++ E+  L   +HPN+V L 
Sbjct: 13  LGDGAFGKVYKAQHKET--GLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLY 68

Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL 205
                + +  I    + EF    +L D +       L      ++     E L +LH   
Sbjct: 69  EAYFYENKLWI----LIEFCDGGAL-DSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK 123

Query: 206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI--E 263
              VI+RD KA N+LL  +   KL+DFG++ +         +   +GT  + AP+ +  E
Sbjct: 124 ---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACE 178

Query: 264 TGHLTA---KSDVWSFGVVLYEMLTGR 287
           T        K+D+WS G+ L E+    
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 74/272 (27%), Positives = 112/272 (41%), Gaps = 30/272 (11%)

Query: 58  LYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIK 117
           LY    +N  +     +   T+ +  +  IG+G +G VYK + K    DG S A V  + 
Sbjct: 1   LYGLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKK---DG-SLAAVKILD 56

Query: 118 KLNRDGLQWVAEVQFLGVL-EHPNLVKLIG-YCAVDGERGIQRLLVYEFMLNRSLEDHL- 174
            ++    +  AE   L  L  HPN+VK  G +   D   G Q  LV E     S+ + + 
Sbjct: 57  PISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVK 116

Query: 175 -FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG 233
                   L      +I+ GA  GL +LH     ++I+RD K +N+LL      KL DFG
Sbjct: 117 GLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFG 173

Query: 234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH-----LTAKSDVWSFGVVLYEMLTGRR 288
           ++ +  +          VGT  + AP+ I           A+ DVWS G+   E+  G  
Sbjct: 174 VSAQ--LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231

Query: 289 SL------------ERNRPKTEQRLLEWVQQY 308
            L             RN P T     +W + +
Sbjct: 232 PLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSF 263

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 73/245 (29%), Positives = 112/245 (45%), Gaps = 32/245 (13%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLG 134
           F  + +IGEG +G VYK     A    T E  +VA+KK+  D       +  + E++ L 
Sbjct: 9   FDIIGQIGEGTYGQVYK-----ARDKDTGE--LVALKKVRLDNEKEGFPITAIREIKILR 61

Query: 135 VLEHPNLVKLIGYC-----AVDGERGIQRL-LVYEFM---LNRSLEDHLFNRAFPPLPWK 185
            L H N+V L         A+D ++      LV+E+M   L   LE  L +  F     K
Sbjct: 62  QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH--FSEDHIK 119

Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
           + +  +L   EGL Y H+      ++RD K SN+LL+   + KL+DFGLAR       + 
Sbjct: 120 SFMKQLL---EGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLY-NSEESR 172

Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW 304
             T  V T  Y  P+ +        + DVWS G +L E+ T +   + N+   +  L+  
Sbjct: 173 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232

Query: 305 VQQYP 309
           +   P
Sbjct: 233 LCGSP 237

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 82/303 (27%), Positives = 129/303 (42%), Gaps = 75/303 (24%)

Query: 84  MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIK---------KLNRDGLQWVAEVQFLG 134
           + ++G+G +GSVYK   +P           +A+K         K N    Q + E+  L 
Sbjct: 6   LDELGKGNYGSVYKVLHRPTG-------VTMAMKEIRLELDESKFN----QIIMELDILH 54

Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVY---EFMLNRSLEDHLF--NRAFPPLPWKTRLH 189
               P +V   G   ++G        VY   E+M   SL D L+    A   +P      
Sbjct: 55  KAVSPYIVDFYGAFFIEGA-------VYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRR 106

Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
           I     +GL +L E  E  +I+RD K +NVL++ N + KL DFG++  G +V    ++  
Sbjct: 107 ITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS--GNLV--ASLAKT 160

Query: 250 VVGTFGYAAPDYIETGHLTA------KSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE 303
            +G   Y AP+ I++G          +SDVWS G+ + EM  GR                
Sbjct: 161 NIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP-------------- 206

Query: 304 WVQQYPADS-----KKFGLIMD---PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 355
               YP ++      +   I+D   P L   YS ++A+        CL+K    RP  +Q
Sbjct: 207 ----YPPETYANIFAQLSAIVDGDPPTLPSGYS-DDAQD---FVAKCLNKIPNRRPTYAQ 258

Query: 356 VVE 358
           ++E
Sbjct: 259 LLE 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 35/212 (16%)

Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----WVAEVQFLGVLEHPN 140
           +KIGEG  G V  +++K       S   +VA+KK++    Q       EV  +   +H N
Sbjct: 26  IKIGEGSTGIVCIATVK-------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH------IILGA 194
           +V++     V    G +  +V EF+   +L D + +         TR++      + L  
Sbjct: 79  VVEMYNSYLV----GDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAV 125

Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 254
            + L+ LH      VI+RD K+ ++LL  + R KLSDFG   +  +        ++VGT 
Sbjct: 126 LKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKSLVGTP 180

Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            + AP+ I       + D+WS G+++ EM+ G
Sbjct: 181 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 60.5 bits (146), Expect = 3e-10
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 30/217 (13%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL---NRDGLQWVA--EVQFL 133
           + + ++ K+GEG + +VYK       G       +VA+K +     +G  + A  E   L
Sbjct: 5   DSYEKLEKLGEGSYATVYK-------GKSKVNGKLVALKVIRLQEEEGTPFTAIREASLL 57

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHI 190
             L+H N+V L  +  +  +  +   LV+E++   L + ++ H       P   K  L  
Sbjct: 58  KGLKHANIVLL--HDIIHTKETLT--LVFEYVHTDLCQYMDKH--PGGLHPENVKLFLFQ 111

Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +L    GL+Y+H+     +++RD K  N+L+ +    KL+DFGLAR   +  HT+ +  V
Sbjct: 112 LL---RGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV 165

Query: 251 VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTG 286
             T  Y  PD  + +   +   D+W  G +  EM+ G
Sbjct: 166 --TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 62/228 (27%), Positives = 91/228 (39%), Gaps = 36/228 (15%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQ 131
            DF  +  I  G +G+VY    K             A+KK+N+  L       Q   E  
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHK-------ETRQRFAMKKINKQNLILRNQIQQVFVERD 53

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 191
            L   E+P +V +  +C+ + +R +   +V E++        L N     LP        
Sbjct: 54  ILTFAENPFVVSM--FCSFETKRHL--CMVMEYVEGGDCATLLKNIG--ALPVDMARMYF 107

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMV-------GHT 244
                 L YLH      +++RD K  N+L+      KL+DFGL++ G M        GH 
Sbjct: 108 AETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHI 164

Query: 245 HVST------AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
              T       V GT  Y AP+ I         D W+ G++LYE L G
Sbjct: 165 EKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 79/282 (28%), Positives = 120/282 (42%), Gaps = 35/282 (12%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVL-EHPNLVKLI 145
           IG+G +G V+K   K    +G S+A V  +  ++    +  AE   L  L +HPN+VK  
Sbjct: 26  IGKGTYGKVFKVLNKK---NG-SKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFY 81

Query: 146 G-YCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           G Y   D + G Q  LV E     S+ D +  F +    +      +I+  A  GL +LH
Sbjct: 82  GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH 141

Query: 203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI 262
                + I+RD K +N+LL      KL DFG++ +  +          VGT  + AP+ I
Sbjct: 142 VN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQ--LTSTRLRRNTSVGTPFWMAPEVI 196

Query: 263 ETGH-----LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGL 317
                      A+ DVWS G+   E+  G   L    P    R L  + + P        
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP---MRALFKIPRNPP------- 246

Query: 318 IMDPRLEK-EYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
              P L + E   NE          CL+K  + RP +S +++
Sbjct: 247 ---PTLHQPELWSNE---FNDFIRKCLTKDYEKRPTVSDLLQ 282

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 24/217 (11%)

Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN---RDGLQWVA--EVQ 131
           A   +  + K+GEG + +VYK       G       +VA+K ++    +G+ + A  E  
Sbjct: 3   AATSYLNLEKLGEGSYATVYK-------GISRINGQLVALKVISMKTEEGVPFTAIREAS 55

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 191
            L  L+H N+V L  +  +  +  +    V+E+M +  L  ++        P+  RL  +
Sbjct: 56  LLKGLKHANIVLL--HDIIHTKETLT--FVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FM 109

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 251
                GLAY+H      +++RD K  N+L+      KL+DFGLAR   +   T+ S  V 
Sbjct: 110 FQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV- 165

Query: 252 GTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
            T  Y  PD  +     ++  D+W  G +  EML G+
Sbjct: 166 -TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 83/299 (27%), Positives = 120/299 (40%), Gaps = 41/299 (13%)

Query: 72  SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN---RDGLQWVA 128
           S +R     F  +  +G G +G VYK       G       + AIK ++    +  +   
Sbjct: 9   SALRDPAGIFELVEVVGNGTYGQVYK-------GRHVKTGQLAAIKVMDVTEDEEEEIKL 61

Query: 129 EVQFLGVL-EHPNLVKLIGYCAVDGERGI--QRLLVYEFMLNRSLEDHLFNRAFPPLPWK 185
           E+  L     H N+    G        G   Q  LV EF    S+ D + N     L   
Sbjct: 62  EINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKED 121

Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL-AREGPMVGHT 244
              +I      GLA+LH     +VI+RD K  NVLL EN   KL DFG+ A+    VG  
Sbjct: 122 WIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 178

Query: 245 HVSTAVVGTFGYAAPDYI---ETGHLT--AKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ 299
           +     +GT  + AP+ I   E    T   +SD+WS G+   EM  G   L    P    
Sbjct: 179 N---TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP---M 232

Query: 300 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
           R L  + + P           P+L+   S   ++K     + CL K+   RP   Q+++
Sbjct: 233 RALFLIPRNPP----------PKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 59.0 bits (143), Expect = 9e-10
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 36/216 (16%)

Query: 89  EGGFGSVYKSSIKPAAGDGTSEATVVAIK----KLNRDGLQWVAEVQFLGVLEHPNLVKL 144
           EG FG ++   +         E  V  +K    ++    L  + E   L  L H N++ +
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLL--LQESCLLYGLSHQNILPI 73

Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN----RAFPPLPWKTR--LHIILGAAEGL 198
           +  C  DGE      ++Y +M   +L+  L       A  P    T+  +H+ +  A G+
Sbjct: 74  LHVCIEDGEP---PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130

Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAVVGTFG-- 255
           +YLH+     VI++D  A N ++DE  + K++D  L+R+  PM  H           G  
Sbjct: 131 SYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH---------CLGDN 178

Query: 256 ------YAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
                 + A + +     ++ SDVWSFGV+L+E++T
Sbjct: 179 ENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 59.0 bits (142), Expect = 1e-09
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 29/213 (13%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW-------VAEVQFL 133
           ++R  KIG+G  G+VY ++I  A G        VAIK++N   LQ        + E+  +
Sbjct: 21  YTRFEKIGQGASGTVY-TAIDIATGQE------VAIKQMN---LQQQPKKELIINEILVM 70

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
              ++PN+V  +    V    G +  +V E++   SL D +                 L 
Sbjct: 71  RENKNPNIVNYLDSYLV----GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ 126

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
           A   L +LH     QVI+RD K+ N+LL  +   KL+DFG   +  +       + +VGT
Sbjct: 127 A---LDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGT 178

Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
             + AP+ +       K D+WS G++  EM+ G
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 40/120 (33%), Positives = 66/120 (55%), Gaps = 12/120 (10%)

Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           L +LH+   + ++YRD K  N+LLD      L+DFGL++E  +      + +  GT  Y 
Sbjct: 118 LEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGTIEYM 173

Query: 258 APDYI--ETGHLTAKSDVWSFGVVLYEMLTGRRSL----ERN-RPKTEQRLLEWVQQYPA 310
           AP+ I  + GH  A  D WS G++++E+LTG        ERN + +  +R+L+    +P+
Sbjct: 174 APEIIRGKGGHGKA-VDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPS 232

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 37/110 (33%), Positives = 59/110 (53%), Gaps = 16/110 (14%)

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA----REGPMVGHTHVSTAVVG 252
           GL ++H      V+YRD K +N+LLDE+   ++SD GLA    ++ P     H S   VG
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HAS---VG 157

Query: 253 TFGYAAPDYIETGHLTAKSDVW-SFGVVLYEMLTGRRSLERNRPKTEQRL 301
           T GY AP+ ++ G     S  W S G +L+++L G     +++ K +  +
Sbjct: 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 58.6 bits (141), Expect = 2e-09
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 29/213 (13%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW-------VAEVQFL 133
           ++R  KIG+G  G+VY +++  A G        VAI+++N   LQ        + E+  +
Sbjct: 22  YTRFEKIGQGASGTVY-TAMDVATGQE------VAIRQMN---LQQQPKKELIINEILVM 71

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
              ++PN+V  +    V    G +  +V E++   SL D +                 L 
Sbjct: 72  RENKNPNIVNYLDSYLV----GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ 127

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
           A E   +LH     QVI+RD K+ N+LL  +   KL+DFG   +  +       + +VGT
Sbjct: 128 ALE---FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGT 179

Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
             + AP+ +       K D+WS G++  EM+ G
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 64/226 (28%), Positives = 96/226 (42%), Gaps = 48/226 (21%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R         +   E++ L 
Sbjct: 19  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 71

Query: 135 VLEHPNLVKLIGYC--AVDGERGIQRLLVYEFM---LN------RSLEDHLFNRAFPPLP 183
            ++H N++ L+     A   E      LV   M   LN      +  +DH+         
Sbjct: 72  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 122

Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
                 +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR      H
Sbjct: 123 ----QFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR------H 169

Query: 244 THVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
           T    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 170 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 52/186 (27%), Positives = 76/186 (40%), Gaps = 71/186 (38%)

Query: 210 IYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH--- 266
           I+RD  A N+LL EN   K+ DFGLAR+                  Y  PDY+  G    
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARD-----------------IYKDPDYVRKGDARL 237

Query: 267 --------------LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 312
                          T +SDVWSFGV+L+E+ +   S                  YP   
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS-----------------PYP--- 277

Query: 313 KKFGLIMDP----RLEK-------EYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 361
              G+ +D     RL++       EY+  E   I  +  +C   + +DRP  S++VE L 
Sbjct: 278 ---GVQIDEEFCRRLKEGTRMRAPEYATPE---IYSIMLDCWHNNPEDRPTFSELVEILG 331

Query: 362 QIVQVS 367
            ++Q +
Sbjct: 332 DLLQEN 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 67/236 (28%), Positives = 107/236 (45%), Gaps = 28/236 (11%)

Query: 59  YEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVV 114
           Y++  + +R     ++R    D+  +  IG G FG V    +KS+ K  A    S+  ++
Sbjct: 28  YKDTINKIR-----DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI 82

Query: 115 AIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL 174
              K +     W  E   +     P +V+L  + A   +R +   +V E+M    L + +
Sbjct: 83  ---KRSDSAFFW-EERDIMAFANSPWVVQL--FYAFQDDRYL--YMVMEYMPGGDLVNLM 134

Query: 175 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 234
            N   P   W  R +     AE +  L     +  I+RD K  N+LLD++   KL+DFG 
Sbjct: 135 SNYDVPE-KW-ARFY----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 188

Query: 235 AREGPMVGHTHVSTAVVGTFGYAAPDYIET----GHLTAKSDVWSFGVVLYEMLTG 286
             +    G     TA VGT  Y +P+ +++    G+   + D WS GV LYEML G
Sbjct: 189 CMKMNKEGMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 38/122 (31%), Positives = 62/122 (50%), Gaps = 3/122 (2%)

Query: 208 QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL 267
           ++++RD K++N+ L      KL DFG +++        V+++  GT  Y AP+  E    
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248

Query: 268 TAKSDVWSFGVVLYEMLTGRRSLE--RNRPKTEQRLLEWVQQYPAD-SKKFGLIMDPRLE 324
           + K+D+WS GV+LYE+LT  R  +    R   +Q L      +P   S     ++DP L 
Sbjct: 249 SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLS 308

Query: 325 KE 326
           K 
Sbjct: 309 KN 310

Length = 478

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 57.4 bits (138), Expect = 3e-09
 Identities = 64/227 (28%), Positives = 102/227 (44%), Gaps = 34/227 (14%)

Query: 68  VFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-- 125
           V S  + R+  + F   +KIGEG  G V  ++ K            VA+KK++    Q  
Sbjct: 14  VVSPGDPREYLDSF---IKIGEGSTGIVCIATEKHTGKQ-------VAVKKMDLRKQQRR 63

Query: 126 --WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 183
                EV  +    H N+V +     V    G +  +V EF+   +L D + +       
Sbjct: 64  ELLFNEVVIMRDYHHENVVDMYNSYLV----GDELWVVMEFLEGGALTDIVTHTRMNEEQ 119

Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG----LAREGP 239
             T   + L     L+YLH      VI+RD K+ ++LL  + R KLSDFG    +++E P
Sbjct: 120 IAT---VCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173

Query: 240 MVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
                    ++VGT  + AP+ I       + D+WS G+++ EM+ G
Sbjct: 174 K------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 40/222 (18%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLG 134
           +  + ++G G +G+V       +A D  + A V AIKKL R         +   E++ L 
Sbjct: 17  YRDLKQVGSGAYGTVC------SALDRRTGAKV-AIKKLYRPFQSELFAKRAYRELRLLK 69

Query: 135 VLEHPNLVKLIGYCAVDG--ERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLH 189
            ++H N++ L+     D   +R     LV  FM   L + ++    +        + R+ 
Sbjct: 70  HMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS--------EDRIQ 121

Query: 190 -IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGHTHV 246
            ++    +GL Y+H      +I+RD K  N+ ++E+   K+ DFGLAR  +  M G+   
Sbjct: 122 FLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGY--- 175

Query: 247 STAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGR 287
               V T  Y AP+ I    H T   D+WS G ++ EMLTG+
Sbjct: 176 ----VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 8/91 (8%)

Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           L +LH+     ++YRD K  N+LLD      L DFGL++    +     +    GT  Y 
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYL 163

Query: 258 APDYI--ETGHLTAKSDVWSFGVVLYEMLTG 286
           AP+ +  E G+ T   D WS GV+++EM  G
Sbjct: 164 APEVLLDEKGY-TKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 41/128 (32%), Positives = 60/128 (46%), Gaps = 10/128 (7%)

Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 254
           AE +  +H   ++  ++RD K  NVL+D     KL+DFG A           S   VGT 
Sbjct: 109 AELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTP 167

Query: 255 GYAAPDYIETGHLTAKS------DVWSFGVVLYEMLTGRRSL-ERNRPKTEQRLLEWVQ- 306
            Y AP+ + T +   K       D WS GV+ YEM+ GR    E    KT   ++ + + 
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF 227

Query: 307 -QYPADSK 313
            ++P D K
Sbjct: 228 LKFPEDPK 235

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 54/198 (27%), Positives = 89/198 (44%), Gaps = 38/198 (19%)

Query: 114 VAIKKL----NRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL---------- 159
           VA+KK+     +     + E++ +  L+H N+VK+       G    + +          
Sbjct: 33  VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVY 92

Query: 160 LVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHIILGAAE---GLAYLHEGLEVQVIYRD 213
           +V E+M   L   LE         PL  +   H  L   +   GL Y+H      V++RD
Sbjct: 93  IVQEYMETDLANVLEQG-------PLSEE---HARLFMYQLLRGLKYIHSA---NVLHRD 139

Query: 214 FKASNVLLD-ENFRPKLSDFGLAR-EGPMVGHT-HVSTAVVGTFGYAAPDYI-ETGHLTA 269
            K +NV ++ E+   K+ DFGLAR   P   H  ++S  +V  + Y +P  +    + T 
Sbjct: 140 LKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW-YRSPRLLLSPNNYTK 198

Query: 270 KSDVWSFGVVLYEMLTGR 287
             D+W+ G +  EMLTG+
Sbjct: 199 AIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 38/221 (17%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWV------AEVQFLG 134
           +  +  +G G +GSV        +   T     VA+KKL+R     +       E++ L 
Sbjct: 17  YQNLTPVGSGAYGSV-------CSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLK 69

Query: 135 VLEHPNLVKLIGYC--AVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLH 189
            ++H N++ L+     A   E   +  LV   M   LN  ++          L  +    
Sbjct: 70  HMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVK-------CQKLSDEHVQF 122

Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVS 247
           +I     GL Y+H      +I+RD K SNV ++E+   ++ DFGLAR+    M G+    
Sbjct: 123 LIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGY---- 175

Query: 248 TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
              V T  Y AP+  +   H     D+WS G ++ E+L G+
Sbjct: 176 ---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 53/173 (30%), Positives = 71/173 (41%), Gaps = 49/173 (28%)

Query: 210 IYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH--- 266
           I+RD  A N+LL EN   K+ DFGLAR+                  Y  PDY+  G    
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARD-----------------IYKDPDYVRKGSARL 238

Query: 267 --------------LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 312
                          T +SDVWSFGV+L+E+     SL  +     Q   E+ Q+     
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIF----SLGASPYPGVQINEEFCQRL---- 290

Query: 313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
            K G  M      E +  E   I R+   C     K+RP  S +VE L  ++Q
Sbjct: 291 -KDGTRMRA---PENATPE---IYRIMLACWQGDPKERPTFSALVEILGDLLQ 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 23/215 (10%)

Query: 75  RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN--RDGLQWVAEVQF 132
           R    DF  + +IG G +G VYK     A    T E   + + KL    D      E+  
Sbjct: 5   RNPQEDFELIQRIGSGTYGDVYK-----ARNVNTGELAAIKVIKLEPGEDFAVVQQEIIM 59

Query: 133 LGVLEHPNLVKLIG-YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 191
           +   +H N+V   G Y   D     +  +  EF    SL+D        PL      ++ 
Sbjct: 60  MKDCKHSNIVAYFGSYLRRD-----KLWICMEFCGGGSLQD--IYHVTGPLSESQIAYVS 112

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 251
               +GL YLH   +   ++RD K +N+LL +N   KL+DFG++ +  +        + +
Sbjct: 113 RETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQ--ITATIAKRKSFI 167

Query: 252 GTFGYAAPDYI---ETGHLTAKSDVWSFGVVLYEM 283
           GT  + AP+       G      D+W+ G+   E+
Sbjct: 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 28/211 (13%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           IG G FG VY+     A    TSE   VAIKK+ +D      E+  +  L H N++ L  
Sbjct: 74  IGNGSFGVVYE-----AICIDTSEK--VAIKKVLQDPQYKNRELLIMKNLNHINIIFLKD 126

Query: 147 Y----CAVDGERGIQRLLVYEFMLNRSLEDHL-----FNRAFPPLPWKTRLHIILGAAEG 197
           Y    C    E+ I   +V EF + +++  ++      N A P    K   + +  A   
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEF-IPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRA--- 182

Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           LAY+H      + +RD K  N+L+D N    KL DFG A+   ++      + +   F Y
Sbjct: 183 LAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKN--LLAGQRSVSYICSRF-Y 236

Query: 257 AAPD-YIETGHLTAKSDVWSFGVVLYEMLTG 286
            AP+  +   + T   D+WS G ++ EM+ G
Sbjct: 237 RAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 54.5 bits (131), Expect = 4e-08
 Identities = 48/170 (28%), Positives = 78/170 (45%), Gaps = 22/170 (12%)

Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 254
           A+G+++L        I+RD  A N+LL      K+ DFGLAR+     +  V        
Sbjct: 224 AKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280

Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 314
            + AP+ I     T +SDVWS+G++L+E+     SL  + P             P DSK 
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIF----SLG-SSP---------YPGMPVDSKF 326

Query: 315 FGLIMDP-RLEK-EYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ 362
           + +I +  R+   E + +E   I +   +C       RP   Q+V+ ++Q
Sbjct: 327 YKMIKEGYRMLSPECAPSEMYDIMK---SCWDADPLKRPTFKQIVQLIEQ 373

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 6/97 (6%)

Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 254
           AE +  +H   ++  ++RD K  NVLLD N   +L+DFG   +    G    S A VGT 
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA-VGTP 167

Query: 255 GYAAPDYIET-----GHLTAKSDVWSFGVVLYEMLTG 286
            Y +P+ ++      G    + D WS GV +YEML G
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 51/238 (21%), Positives = 104/238 (43%), Gaps = 31/238 (13%)

Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTR 187
           E++ L  ++  N++K+ G+  +D    + RL L+ E+     L + L       L +KT+
Sbjct: 68  EIKNLRRIDSNNILKIYGF-IIDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTK 124

Query: 188 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 247
           L + +   +GL  L++       Y++  + + L+ EN++ K+   GL +        +V+
Sbjct: 125 LDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN 182

Query: 248 TAVVGTFGYAAPDYIET--GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 305
             V     Y +   +       T K D++S GVVL+E+ TG+   E              
Sbjct: 183 FMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN------------- 224

Query: 306 QQYPADSKK-FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ 362
                 +K+ + LI++     +  ++   +I  + + C S  S  RP + +++  L  
Sbjct: 225 ----LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278

Length = 283

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 39/138 (28%), Positives = 58/138 (42%), Gaps = 44/138 (31%)

Query: 210 IYRDFKASNVLLDENFRPKLSDFGL------------------AREGPMV---------- 241
           I+RD K  N+L+D +   KL+DFGL                   R+  M           
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 242 ------------GHTHVST-AVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGR 287
                        H      ++VGT  Y AP+ +  TG+ T   D WS GV+LYEML G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLVGQ 241

Query: 288 RSLERNRP-KTEQRLLEW 304
                + P +T+ +++ W
Sbjct: 242 PPFLADTPAETQLKVINW 259

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 54.9 bits (132), Expect = 5e-08
 Identities = 30/81 (37%), Positives = 45/81 (55%)

Query: 208 QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL 267
            +I+RD K++N+LL  N   KL DFG ++         V     GT  Y AP+       
Sbjct: 163 HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY 222

Query: 268 TAKSDVWSFGVVLYEMLTGRR 288
           + K+D++S GV+LYE+LT +R
Sbjct: 223 SKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.0 bits (130), Expect = 6e-08
 Identities = 33/86 (38%), Positives = 45/86 (52%), Gaps = 14/86 (16%)

Query: 210 IYRDFKASNVLLDENFRPKLSDFG----LAREGPMVGHTHVSTAVVGTFGYAAPDYIE-- 263
           ++RD K  NVLLD+N   +L+DFG    L  +G     T  S   VGT  Y +P+ ++  
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-----TVQSNVAVGTPDYISPEILQAM 178

Query: 264 ---TGHLTAKSDVWSFGVVLYEMLTG 286
               G    + D WS GV +YEML G
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 54.1 bits (130), Expect = 7e-08
 Identities = 38/113 (33%), Positives = 56/113 (49%), Gaps = 11/113 (9%)

Query: 181 PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           PL     L      A+G+ +L        I+RD  A NVLL +    K+ DFGLAR+  M
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARD-IM 263

Query: 241 VGHTHVSTAVVGT----FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRS 289
               +V   V G       + AP+ I     T +SDVWS+G++L+E+ +  +S
Sbjct: 264 NDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 52.9 bits (127), Expect = 8e-08
 Identities = 56/213 (26%), Positives = 90/213 (42%), Gaps = 32/213 (15%)

Query: 87  IGEGGFGSVYKSSIKPAA---GDGTSEATVVAIKKLN---RDGLQWVAEVQFLGVLEHPN 140
           +G+G F ++YK  ++  +     G  +   V +K L    RD L +      +  L H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-FNRAFPPLPWKTRLHIILGAAEGLA 199
           LVKL G C  D       ++V E++    L+  L   +    L WK  L +    A  L 
Sbjct: 63  LVKLYGVCVRDEN-----IMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALH 115

Query: 200 YLHEGLEVQVIYRDFKASNVLL-----DENFRP--KLSDFGLAREGPMVGHTHVSTAVVG 252
           YL +    ++++ +    N+L+     +E + P  KLSD G+                V 
Sbjct: 116 YLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER------VE 166

Query: 253 TFGYAAPDYIETGH--LTAKSDVWSFGVVLYEM 283
              + AP+ I  G   LT  +D WSFG  L E+
Sbjct: 167 RIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 5/91 (5%)

Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
           + L YLH      VI+RD K+ ++LL  + R KLSDFG   +  +        ++VGT  
Sbjct: 128 QALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQ--ISKDVPKRKSLVGTPY 182

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           + AP+ I       + D+WS G+++ EM+ G
Sbjct: 183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 26/180 (14%)

Query: 116 IKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR----SLE 171
           +K  +R  +Q   E+  LG L H N++K+           I R     +M+ +     L 
Sbjct: 200 VKAGSRAAIQLENEILALGRLNHENILKI---------EEILRSEANTYMITQKYDFDLY 250

Query: 172 DHLFNRAFP----PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP 227
             +++ AF     PL  +TR  I+      + Y+H+     +I+RD K  N+ L+ + + 
Sbjct: 251 SFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKI 306

Query: 228 KLSDFGLAR--EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            L DFG A   E       +     VGT    +P+ +        +D+WS G++L +ML+
Sbjct: 307 VLGDFGTAMPFEKEREAFDY---GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 41/127 (32%), Positives = 63/127 (49%), Gaps = 19/127 (14%)

Query: 175 FNRAFPPLPWKTRLHIILGAAEGLAYLH-EGLEVQV------------IYRDFKASNVLL 221
           +++  P  P +TR   ++  +  L+Y+   G   QV            ++RD  A NVL+
Sbjct: 213 YDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI 272

Query: 222 DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF---GYAAPDYIETGHLTAKSDVWSFGV 278
            E    K+ DFGLAR+  M    ++S     TF    + AP+ I     T  SDVWSFG+
Sbjct: 273 CEGKLVKICDFGLARD-IMRDSNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGI 329

Query: 279 VLYEMLT 285
           +L+E+ T
Sbjct: 330 LLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 52/201 (25%), Positives = 80/201 (39%), Gaps = 74/201 (36%)

Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 254
           A+G+ +L      + I+RD  A N+LL EN   K+ DFGLAR+                 
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARD----------------- 228

Query: 255 GYAAPDYIETGH-----------------LTAKSDVWSFGVVLYEMLTGRRSLERNRPKT 297
            Y  PDY+  G                   T +SDVWSFGV+L+E+ +   S        
Sbjct: 229 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-------- 280

Query: 298 EQRLLEWVQQYPADSKKFGLIMDP----RLEK-------EYSINEARKIGRLADNCLSKS 346
                     YP      G+ +D     RL++       +Y+  E   + +   +C    
Sbjct: 281 ---------PYP------GVKIDEEFCRRLKEGTRMRAPDYTTPE---MYQTMLDCWHGE 322

Query: 347 SKDRPKMSQVVERLKQIVQVS 367
              RP  S++VE L  ++Q +
Sbjct: 323 PSQRPTFSELVEHLGNLLQAN 343

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 23/215 (10%)

Query: 75  RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQWVA-EVQF 132
           R   +D+  + ++G G +G VYK     A    T E   V I KL   D    +  E+  
Sbjct: 5   RNPQHDYELIQRVGSGTYGDVYK-----ARNLHTGELAAVKIIKLEPGDDFSLIQQEIFM 59

Query: 133 LGVLEHPNLVKLIG-YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 191
           +   +H N+V   G Y + +     +  +  E+    SL+D        PL      ++ 
Sbjct: 60  VKECKHCNIVAYFGSYLSRE-----KLWICMEYCGGGSLQD--IYHVTGPLSELQIAYVC 112

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 251
               +GLAYLH   +   ++RD K +N+LL +N   KL+DFG+A +  +        + +
Sbjct: 113 RETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAK--ITATIAKRKSFI 167

Query: 252 GTFGYAAPDYI---ETGHLTAKSDVWSFGVVLYEM 283
           GT  + AP+     + G      D+W+ G+   E+
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 30/86 (34%), Positives = 46/86 (53%), Gaps = 6/86 (6%)

Query: 206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET- 264
           ++  ++RD K  N+L+D N   +L+DFG   +  M   T  S+  VGT  Y +P+ ++  
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLK-LMEDGTVQSSVAVGTPDYISPEILQAM 178

Query: 265 ----GHLTAKSDVWSFGVVLYEMLTG 286
               G    + D WS GV +YEML G
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 58/219 (26%), Positives = 91/219 (41%), Gaps = 46/219 (21%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-------EVQFLGVLEHP 139
           IG G  G V        A   T     VAIKKL+R   Q V        E+  + ++ H 
Sbjct: 24  IGSGAQGIV-------CAAYDTVTGQNVAIKKLSRP-FQNVTHAKRAYRELVLMKLVNHK 75

Query: 140 NLVKLIGYCAVDGERGIQRL----LVYEFM-------LNRSLEDHLFNRAFPPLPWKTRL 188
           N++ L+       ++ ++      LV E M       +   L DH           +   
Sbjct: 76  NIIGLLN--VFTPQKSLEEFQDVYLVMELMDANLCQVIQMDL-DH-----------ERMS 121

Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 248
           +++     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T
Sbjct: 122 YLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMT 175

Query: 249 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
             V T  Y AP+ I         D+WS G ++ EM+ G 
Sbjct: 176 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 49/182 (26%), Positives = 72/182 (39%), Gaps = 23/182 (12%)

Query: 114 VAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM----LNRS 169
           V IK   R G     E   L  + HP++++L G               Y       L R 
Sbjct: 120 VVIKAGQRGGT--ATEAHILRAINHPSIIQLKG------------TFTYNKFTCLILPRY 165

Query: 170 LED-HLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK 228
             D + +  A   +     L I       + YLHE    ++I+RD KA N+ ++      
Sbjct: 166 KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVC 222

Query: 229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRR 288
           L DFG A   P+  + +      GT    AP+ +         D+WS G+VL+EM T   
Sbjct: 223 LGDFGAACF-PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHD 281

Query: 289 SL 290
           SL
Sbjct: 282 SL 283

Length = 391

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 49/218 (22%), Positives = 78/218 (35%), Gaps = 45/218 (20%)

Query: 90  GGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--------LQWVAEVQFLGVLEHPNL 141
                + K              T+VA+KK+N D         LQ   E+     L+HPN+
Sbjct: 13  LMIVHLAKH---------KPTNTLVAVKKINLDSCSKEDLKLLQ--QEIITSRQLQHPNI 61

Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL---FNRAFPPLPWKTRLHIILGAAEGL 198
           +       +      +  +V   M   S ED L   F    P L       I+      L
Sbjct: 62  LP-YVTSFIVDS---ELYVVSPLMAYGSCEDLLKTHFPEGLPELAIA---FILKDVLNAL 114

Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG--- 255
            Y+H       I+R  KAS++LL  + +  LS    +    M+ H      V   F    
Sbjct: 115 DYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSV--SMIKHGKRQRVVHD-FPKSS 168

Query: 256 -----YAAPDYIETGHL--TAKSDVWSFGVVLYEMLTG 286
                + +P+ ++        KSD++S G+   E+  G
Sbjct: 169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 50.5 bits (121), Expect = 7e-07
 Identities = 61/242 (25%), Positives = 96/242 (39%), Gaps = 68/242 (28%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----------------GLQWVA-- 128
           +GEG +G V K      A D T    +VAIKK+                   G+ +    
Sbjct: 17  LGEGTYGKVEK------AYD-TLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69

Query: 129 EVQFLGVLEHPNLVKLIG-YCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPW 184
           E++ +  ++H N++ L+  Y   D    I   LV + M   L + ++             
Sbjct: 70  ELKIMNEIKHENIMGLVDVYVEGDF---IN--LVMDIMASDLKKVVDR------------ 112

Query: 185 KTRLH------IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE- 237
           K RL       I+L    GL  LH+      ++RD   +N+ ++     K++DFGLAR  
Sbjct: 113 KIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRY 169

Query: 238 -GPMVGHTHVS----------TAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLT 285
             P    T             T+ V T  Y AP+ +          D+WS G +  E+LT
Sbjct: 170 GYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229

Query: 286 GR 287
           G+
Sbjct: 230 GK 231

Length = 335

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 50.0 bits (119), Expect = 8e-07
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 33/220 (15%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-NRDGLQWVAE-----VQF 132
           N F  +  +GEG +G V K   K      T E  +VAIKK  + +  + V E     ++ 
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKE-----TKE--IVAIKKFKDSEENEEVKETTLRELKM 53

Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE--DHLFNRAFPPLPWKTRLHI 190
           L  L+  N+V+L         R  +  LV+E++    LE  + + N   PP   ++ ++ 
Sbjct: 54  LRTLKQENIVEL----KEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV-PPEKVRSYIYQ 108

Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR---EGPMVGHTHVS 247
           ++ A   + + H+     +++RD K  N+L+  N   KL DFG AR   EG    +T   
Sbjct: 109 LIKA---IHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE-- 160

Query: 248 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
              V T  Y +P+ +         D+WS G +L E+  G+
Sbjct: 161 --YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 50.9 bits (121), Expect = 9e-07
 Identities = 75/314 (23%), Positives = 137/314 (43%), Gaps = 56/314 (17%)

Query: 71  YSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWVAE 129
           Y +     N++  + KIG G FG V+    K        +A  ++ + L  R+  Q V E
Sbjct: 5   YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKA--ISYRGLKEREKSQLVIE 62

Query: 130 VQFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFM----LNRSLEDHLFNRAFPPLPW 184
           V  +  L+H N+V+ I        +  Q+L ++ EF     L+R+++     + F  +  
Sbjct: 63  VNVMRELKHKNIVRYIDRFL---NKANQKLYILMEFCDAGDLSRNIQKCY--KMFGKIEE 117

Query: 185 KTRLHIILGAAEGLAYLHEGLE----VQVIYRDFKASNVLLDE---------------NF 225
              + I       LAY H   +     +V++RD K  N+ L                 N 
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177

Query: 226 RP--KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI--ETGHLTAKSDVWSFGVVLY 281
           RP  K+ DFGL++    +G   ++ + VGT  Y +P+ +  ET     KSD+W+ G ++Y
Sbjct: 178 RPIAKIGDFGLSKN---IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234

Query: 282 EMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADN 341
           E+ +G+     ++     +L+  +++ P    K                +++++  L  N
Sbjct: 235 ELCSGKTPF--HKANNFSQLISELKRGPDLPIK---------------GKSKELNILIKN 277

Query: 342 CLSKSSKDRPKMSQ 355
            L+ S+K+RP   Q
Sbjct: 278 LLNLSAKERPSALQ 291

Length = 1021

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 29/215 (13%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
           +IG G FG V    +      G + A VV +K+L      ++ ++++ E Q    L+H N
Sbjct: 2   EIGNGWFGKVILGEVN----SGYTPAQVV-VKELRVSASVQEQMKFLEEAQPYRSLQHSN 56

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
           L++ +G C          LLV EF     L   L          P P  T   +    A 
Sbjct: 57  LLQCLGQCT----EVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDP-TTLQRMACEIAL 111

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           GL +LH+      I+ D    N LL  +   K+ D+GL+       +      +     +
Sbjct: 112 GLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRW 168

Query: 257 AAPDYIETGH-------LTAKSDVWSFGVVLYEML 284
            AP+ ++  H        T +S+VWS GV ++E+ 
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 31/79 (39%), Positives = 45/79 (56%), Gaps = 6/79 (7%)

Query: 210 IYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF---GYAAPDYIETGH 266
           ++RD  A NVLL +    K+ DFGLAR+  M    +VS     TF    + AP+ I    
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARD-IMHDSNYVSKG--STFLPVKWMAPESIFDNL 315

Query: 267 LTAKSDVWSFGVVLYEMLT 285
            T  SDVWS+G++L+E+ +
Sbjct: 316 YTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 49.7 bits (118), Expect = 2e-06
 Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 6/91 (6%)

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  V T  Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191

Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            AP+ I         D+WS G ++ EM+ G 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 36/114 (31%), Positives = 47/114 (41%), Gaps = 38/114 (33%)

Query: 210 IYRDFKASNVLLDENFRPKLSDFGL--------------------------AREGPMVGH 243
           I+RD K  N+LLD     KLSDFGL                              PM   
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 244 THVST----------AVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTG 286
               T          + VGT  Y AP+ +++TG+   + D WS GV++YEML G
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 40/143 (27%), Positives = 68/143 (47%), Gaps = 22/143 (15%)

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  V T  Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 184

Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEML------TGRRSLER-NR---------PKTEQR 300
            AP+ I         D+WS G ++ EM+       GR  +++ N+         P+  ++
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244

Query: 301 LLEWVQQYPADSKKFGLIMDPRL 323
           L   V+ Y  +  K+  +  P+L
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKL 267

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 47.5 bits (113), Expect = 4e-06
 Identities = 37/124 (29%), Positives = 54/124 (43%), Gaps = 12/124 (9%)

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
           AAE +  L       ++ RD   +N+LLD+    +L+ F    E   V  +    AV   
Sbjct: 91  AAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSE---VEDSCDGEAVENM 147

Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK-----TEQRLLEWVQQY 308
             Y AP+       T   D WS G +L+E+LTG ++L    P      T   + EWV + 
Sbjct: 148 --YCAPEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSGINTHTTLNIPEWVSE- 203

Query: 309 PADS 312
            A S
Sbjct: 204 EARS 207

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 47.9 bits (115), Expect = 4e-06
 Identities = 35/100 (35%), Positives = 47/100 (47%), Gaps = 12/100 (12%)

Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPMVGHTHVS 247
            II    E L  LH+     +I+ D K  NVL D    R  L D+GL +           
Sbjct: 113 KIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK------IIGTP 163

Query: 248 TAVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 286
           +   GT  Y +P+ I+ GH    S D W+ GV+ YE+LTG
Sbjct: 164 SCYDGTLDYFSPEKIK-GHNYDVSFDWWAVGVLTYELLTG 202

Length = 267

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 6/90 (6%)

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G+ +LH      +I+RD K SN+++  +   K+ DFGLAR         + T  V T  Y
Sbjct: 135 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACT---NFMMTPYVVTRYY 188

Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            AP+ I         D+WS G ++ E++ G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 40/131 (30%), Positives = 57/131 (43%), Gaps = 38/131 (29%)

Query: 210 IYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH--------TH---------------- 245
           I+RD K  N+LLD     KLSDFGL   G    H        TH                
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLC-TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181

Query: 246 ----------VSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNR 294
                     ++ + VGT  Y AP+ +++TG+     D WS GV++YEML G        
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSET 240

Query: 295 PK-TEQRLLEW 304
           P+ T ++++ W
Sbjct: 241 PQETYRKVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 37/141 (26%), Positives = 56/141 (39%), Gaps = 46/141 (32%)

Query: 210 IYRDFKASNVLLDENFRPKLSDFGLA------------------REGPM----------- 240
           I+RD K  N+L+D +   KL+DFGL                   R+  M           
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 241 -------------VGHTH---VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
                            H   ++ ++VGT  Y AP+ +     T   D WS GV+LYEML
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 285 TGRRSLERNRP-KTEQRLLEW 304
            G+       P +T+ +++ W
Sbjct: 243 VGQPPFLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 44/161 (27%), Positives = 65/161 (40%), Gaps = 42/161 (26%)

Query: 210 IYRDFKASNVLLDENFRPKLSDFGLAR--------------------------------- 236
           I+RD K  N+LLD     KLSDFGL                                   
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 237 EGPMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           E        ++ + VGT  Y AP+ +++TG+     D WS GV++YEML G        P
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSETP 241

Query: 296 K-TEQRLLEWVQ------QYPADSKKFGLIMDPRLEKEYSI 329
           + T ++++ W +      + P   K   LI+    E E+ I
Sbjct: 242 QETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRI 282

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 43.7 bits (103), Expect = 7e-05
 Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 41/220 (18%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIK---KLNRDGLQWVAE-VQFLGVLEHPNLV 142
           +G+G F  ++K   +     G    T V +K   K +R+  +   E    +  L H +LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-FNRAFPPLPWKTRLHIILGAAEGLAY- 200
              G C    E     ++V E++   SL+ +L  N+    + WK      L  A+ LA+ 
Sbjct: 63  LNYGVCVCGDES----IMVQEYVKFGSLDTYLKKNKNLINISWK------LEVAKQLAWA 112

Query: 201 LHEGLEVQVIYRDFKASNVLL-----DENFRP---KLSDFG-----LAREGPMVGHTHVS 247
           LH   +  + + +  A NVLL      +   P   KLSD G     L +E          
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE---------- 162

Query: 248 TAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTG 286
             ++    +  P+ IE   +L+  +D WSFG  L+E+ +G
Sbjct: 163 -ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 43.7 bits (103), Expect = 8e-05
 Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 36/218 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
           +IG G FG V  S I       T  A VV +K+L      ++  +++ +     +L+HPN
Sbjct: 2   EIGNGWFGKVLLSEIYT----DTGVARVV-VKELKANASSKEQNEFLQQGDPYRILQHPN 56

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL-------G 193
           +++ +G C       I  LLV+E+     L+ +L         W  R   +L        
Sbjct: 57  ILQCLGQCV----EAIPYLLVFEYCELGDLKSYLSQEQ-----WHRRNSQLLLLQRMACE 107

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
            A G+ ++H   +   ++ D    N  L  +   K+ D+G+        +          
Sbjct: 108 IAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP 164

Query: 254 FGYAAPDYIETGH---LTAK----SDVWSFGVVLYEML 284
             + AP+ +   H   +TA+    S+VW+ GV L+E+ 
Sbjct: 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 42.8 bits (101), Expect = 3e-04
 Identities = 28/117 (23%), Positives = 46/117 (39%), Gaps = 19/117 (16%)

Query: 185 KTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA--------- 235
              L I       + Y+H      V++RD K  N+LL       + D+G A         
Sbjct: 113 GAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEED 169

Query: 236 -------REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
                            +   +VGT  Y AP+ +     +  +D+++ GV+LY+MLT
Sbjct: 170 LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.8 bits (98), Expect = 5e-04
 Identities = 68/290 (23%), Positives = 107/290 (36%), Gaps = 75/290 (25%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWV-AEVQFLGVLE 137
            DF  +  IG+G FG V +   K   G   +  T++  +   +D L  V AE   L   +
Sbjct: 1   EDFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD 59

Query: 138 HPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWK------TRLHI 190
            P +V L  Y   D     Q L L+ EF+    L   L         +       TR ++
Sbjct: 60  SPWVVSLY-YSFQDA----QYLYLIMEFLPGGDLMTMLIK-------YDTFSEDVTRFYM 107

Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA--------------- 235
               AE +  +    ++  I+RD K  N+L+D     KLSDFGL+               
Sbjct: 108 ----AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKL 163

Query: 236 ------------REGPMVGHTHVST------------------AVVGTFGYAAPDYIETG 265
                       R    V   +++                   + VGT  Y AP+ I   
Sbjct: 164 LQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQ 222

Query: 266 H-LTAKSDVWSFGVVLYEMLTGRRSL-ERNRPKTEQRLLEWVQ--QYPAD 311
                + D WS G +++E L G       N  +T ++++ W +   +P D
Sbjct: 223 QGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDD 272

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 36/141 (25%), Positives = 56/141 (39%), Gaps = 46/141 (32%)

Query: 210 IYRDFKASNVLLDENFRPKLSDFGLA------------------REGPM----------- 240
           I+RD K  N+L+D +   KL+DFGL                   R+  M           
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 241 -------------VGHTH---VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
                            H   ++ ++VGT  Y AP+ +     T   D WS GV+L+EML
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 285 TGRRSLERNRP-KTEQRLLEW 304
            G+       P +T+ +++ W
Sbjct: 243 VGQPPFLAPTPTETQLKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 41.1 bits (96), Expect = 7e-04
 Identities = 37/138 (26%), Positives = 63/138 (45%), Gaps = 19/138 (13%)

Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
           I+ GA  GL YLH+      I+R+ KAS++L+  +    LS  GL+    +V +   +  
Sbjct: 106 ILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKV 160

Query: 250 V-------VGTFGYAAPDYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ 299
           V            + +P+ +     G+   KSD++S G+   E+ TGR   + +  +T+ 
Sbjct: 161 VYDFPQFSTSVLPWLSPELLRQDLYGY-NVKSDIYSVGITACELATGRVPFQ-DMLRTQM 218

Query: 300 RL--LEWVQQYPADSKKF 315
            L  L+     P D   F
Sbjct: 219 LLQKLKGPPYSPLDITTF 236

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 28/115 (24%), Positives = 48/115 (41%), Gaps = 23/115 (20%)

Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD----------------ENFRPKLSDF 232
            II      L Y H   E+ +++ D K  N+L++                +  R ++ D 
Sbjct: 235 QIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292

Query: 233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
           G           H  TA+V T  Y +P+ +        +D+WS G ++YE+ TG+
Sbjct: 293 G-----GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 41/149 (27%), Positives = 62/149 (41%), Gaps = 13/149 (8%)

Query: 191 ILGAAEGLAYLH-EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
           +L A +   Y+H EG    +I+RD K  NVL++      L DFG A        T     
Sbjct: 269 LLSAID---YIHGEG----IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321

Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL-----ERNRPKTEQRLLEW 304
           + GT    AP+ +     T   D+WS G+V++E      SL        R   + ++L  
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRI 381

Query: 305 VQQYPADSKKFGLIMDPRLEKEYSINEAR 333
           ++Q      +F      RL  +Y    AR
Sbjct: 382 IRQAQVHVDEFPQHAGSRLVSQYRHRAAR 410

Length = 461

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 38.8 bits (90), Expect = 0.003
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 45/221 (20%)

Query: 87  IGEGGFGSVYKSSIKPAAGD-----GTSEATVVAIKKLN---RD-GLQWVAEVQFLGVLE 137
           +G G    +Y   +     D        +   V +K L+   RD  L +      +  + 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPL--PWKTRLHIILGAA 195
           H ++V L G C     R ++ ++V EF+    L D   +R    L  PWK ++   L +A
Sbjct: 63  HKHIVLLYGVCV----RDVENIMVEEFVEFGPL-DLFMHRKSDVLTTPWKFKVAKQLASA 117

Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLL-----DENFRP--KLSDFG-----LAREGPMVGH 243
             L+YL +     +++ +    N+LL     D    P  KLSD G     L+R+      
Sbjct: 118 --LSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ------ 166

Query: 244 THVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEM 283
                  V    + AP+ +E + +L+  +D WSFG  L+E+
Sbjct: 167 -----ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	432
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.98
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.98
KOG1152	772	consensus Signal transduction serine/threonine kin	99.98
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.87
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.86
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.85
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.85
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.85
PRK10345	210	hypothetical protein; Provisional	99.84
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.84
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.79
smart00090	237	RIO RIO-like kinase.	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.77
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.76
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.74
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.69
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.67
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.66
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.51
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.5
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.44
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.43
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.39
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.31
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.3
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.26
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.23
KOG3087	229	consensus Serine/threonine protein kinase [General	99.23
KOG1243	690	consensus Protein kinase [General function predict	99.21
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.16
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.13
COG4248	637	Uncharacterized protein with protein kinase and he	99.11
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.04
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.99
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.93
PRK09902	216	hypothetical protein; Provisional	98.9
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.87
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.75
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.71
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.51
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.46
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.38
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.36
PF01636	239	APH: Phosphotransferase enzyme family This family	98.35
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.28
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.27
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.21
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.15
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.1
PLN02876	822	acyl-CoA dehydrogenase	98.05
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.92
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.9
PRK10593	297	hypothetical protein; Provisional	97.89
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.84
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.77
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.73
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.62
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.54
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.5
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.46
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.35
PRK05231	319	homoserine kinase; Provisional	97.28
KOG2270	520	consensus Serine/threonine protein kinase involved	97.11
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.07
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.96
PLN02236	344	choline kinase	96.96
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.67
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.65
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.64
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.46
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.44
PLN02756	418	S-methyl-5-thioribose kinase	96.4
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.32
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.32
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.13
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	95.98
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.91
PTZ00384	383	choline kinase; Provisional	94.96
PRK06148	1013	hypothetical protein; Provisional	94.95
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.85
PRK12396	409	5-methylribose kinase; Reviewed	94.56
PTZ00296	442	choline kinase; Provisional	94.52
PRK10271	188	thiK thiamine kinase; Provisional	93.75
PHA03111	444	Ser/Thr kinase; Provisional	93.09

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-54  Score=419.97  Aligned_cols=288  Identities=55%  Similarity=0.923  Sum_probs=247.5

Q ss_pred             cCcccCHHHHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCc
Q 014034           65 NLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPN  140 (432)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpn  140 (432)
                      ..+.|++.++..+|++|...+.||+|+||.||+|.+.        ++..||||++....    .+|.+|+.++.+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~--------~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~N  132 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS--------DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPN  132 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC--------CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcC
Confidence            5778999999999999999999999999999999985        44889999987533    46999999999999999


Q ss_pred             cceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceE
Q 014034          141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVL  220 (432)
Q Consensus       141 iv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nil  220 (432)
                      +|+|+|||.+.+.   +.+|||||+++|+|.++|......+++|..+++|+.++|+||+|||..+.+.|+||||||+|||
T Consensus       133 lv~LlGyC~e~~~---~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNIL  209 (361)
T KOG1187|consen  133 LVKLLGYCLEGGE---HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNIL  209 (361)
T ss_pred             cccEEEEEecCCc---eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHee
Confidence            9999999997764   3599999999999999998765438999999999999999999999988788999999999999


Q ss_pred             EcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 014034          221 LDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR  300 (432)
Q Consensus       221 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~  300 (432)
                      ||+++++||+|||+|+..+.. .........||.+|+|||++..+..+.++|||||||+|+||+||+.+.+...+.....
T Consensus       210 LD~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~  288 (361)
T KOG1187|consen  210 LDEDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELS  288 (361)
T ss_pred             ECCCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccccc
Confidence            999999999999999764321 1111111179999999999999999999999999999999999999998766555556


Q ss_pred             HHHHHhhcccCccccccccCcccc-CcCCH-HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          301 LLEWVQQYPADSKKFGLIMDPRLE-KEYSI-NEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                      +..|........ .+..++|+.+. ..++. .....+..++.+|++.+|.+||+|.+|++.|+.+..
T Consensus       289 l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  289 LVEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            788876555444 67789999987 55554 677889999999999999999999999999966543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-51  Score=376.61  Aligned_cols=251  Identities=29%  Similarity=0.430  Sum_probs=210.2

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      .+.+.++.||+|..|+||++.|+       .+++.+|+|.+...     ..++.+|+++++.++|||||.+||.|..++.
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk-------~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~  151 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHK-------PTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE  151 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEc-------CCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence            35777889999999999999998       57899999999432     2357899999999999999999999998774


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ...++||||.+|+|++++..-  +.+++....+|+.+|++||.|||..  .+||||||||+||||+..|.+||||||
T Consensus       152 ---~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFG  224 (364)
T KOG0581|consen  152 ---EISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFG  224 (364)
T ss_pred             ---eEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEecccc
Confidence               359999999999999998654  4799999999999999999999963  399999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC--chhhHHHHHHHhhcccC
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNR--PKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~--~~~~~~~~~~~~~~~~~  311 (432)
                      .+......    ...+++||..|||||.+.+..|+.++||||||++++|+.+|+.||....  ......++.++..-+. 
T Consensus       225 VS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp-  299 (364)
T KOG0581|consen  225 VSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP-  299 (364)
T ss_pred             ccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC-
Confidence            99863221    4567899999999999999999999999999999999999999998642  2233444444433221 


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                               |.++..   ..+.++..+|..||++||.+|||+.|+++|-
T Consensus       300 ---------P~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp  336 (364)
T KOG0581|consen  300 ---------PRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQHP  336 (364)
T ss_pred             ---------CCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence                     112211   2557899999999999999999999999883

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-51  Score=390.23  Aligned_cols=254  Identities=33%  Similarity=0.518  Sum_probs=208.3

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEE-EEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~-vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      +.....||.|+||+||+|.++         ++. ||||++...      ...|.+|+.+|.+++|||||+++|+|.....
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~---------g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~  113 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWR---------GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG  113 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeC---------CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            444556999999999999986         444 999998753      2369999999999999999999999987652


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCc-eeecCCCCCceEEcCCC-ceeecc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENF-RPKLSD  231 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~-ivH~Dikp~Nill~~~~-~~kl~D  231 (432)
                         .+++||||+++|+|.+++.......+++..++.|+.|||+||.|||++   + ||||||||+||||+.++ ++||+|
T Consensus       114 ---~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~D  187 (362)
T KOG0192|consen  114 ---SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIAD  187 (362)
T ss_pred             ---ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECC
Confidence               358999999999999999875456899999999999999999999998   7 99999999999999998 999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccc--cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE--TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      ||+++......  ...+...||+.|||||++.  ...|+.++|||||||++|||+||..||.+..+..   ....+.   
T Consensus       188 FGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~---~~~~v~---  259 (362)
T KOG0192|consen  188 FGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ---VASAVV---  259 (362)
T ss_pred             Cccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH---HHHHHH---
Confidence            99998632211  2233368999999999999  5699999999999999999999999999876521   111111   


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhc
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  367 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  367 (432)
                                ........+..++..+..||.+||..||..||++.+|+..|+.+....
T Consensus       260 ----------~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  260 ----------VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             ----------hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence                      111111222335678889999999999999999999999999887644

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-50  Score=356.31  Aligned_cols=258  Identities=26%  Similarity=0.387  Sum_probs=208.0

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc------ChHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ..+|++++.||+|+||+||++...       .++..||.|.+.-      .......|+.+|++|+|||||++++...++
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~-------~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~   90 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCL-------LDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIE   90 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeec-------cCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc
Confidence            346999999999999999999865       6789999999863      233478899999999999999999844433


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-ceeecCCCCCceEEcCCCcee
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLAYLHEGLEV-QVIYRDFKASNVLLDENFRPK  228 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~-~ivH~Dikp~Nill~~~~~~k  228 (432)
                      +..  -++||||||..|+|.+.|..  ...+.+++..+|+++.|++.||..+|+.... .|+||||||.||+|+.+|.+|
T Consensus        91 ~~e--vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvK  168 (375)
T KOG0591|consen   91 DNE--VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVK  168 (375)
T ss_pred             cch--hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCcee
Confidence            322  25899999999999999863  3456799999999999999999999994322 399999999999999999999


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      |+|||+++..  ..........+|||.||+||.+.+.+|+.++||||+||++|||+.-+.||.+.+-..   +...+..-
T Consensus       169 LGDfGL~r~l--~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~---L~~KI~qg  243 (375)
T KOG0591|consen  169 LGDFGLGRFL--SSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS---LCKKIEQG  243 (375)
T ss_pred             eccchhHhHh--cchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH---HHHHHHcC
Confidence            9999999973  333444567899999999999999999999999999999999999999999874322   22222211


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  362 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  362 (432)
                                   .+........+..+..||..|+..||+.||+...++..+..
T Consensus       244 -------------d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  244 -------------DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             -------------CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence                         11111125567889999999999999999997666665544

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-50  Score=371.76  Aligned_cols=248  Identities=25%  Similarity=0.393  Sum_probs=203.9

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-----------HHHHHHHHhcccCCCccceeee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-----------QWVAEVQFLGVLEHPNLVKLIG  146 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----------~~~~E~~~l~~l~hpniv~l~~  146 (432)
                      .+.|.+.+.||+|+||.|-+|..+       .+++.||||++++...           ...+|+++|++|+|||||++++
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~-------~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d  243 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEK-------KTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKD  243 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEc-------ccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEee
Confidence            356888899999999999999865       6889999999975321           2579999999999999999999


Q ss_pred             EEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCC--
Q 014034          147 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN--  224 (432)
Q Consensus       147 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~--  224 (432)
                      ++..+...    |+||||+.||.|.+++..+.  .+.+.....++.|++.|+.|||++   ||+||||||+|||+..+  
T Consensus       244 ~f~~~ds~----YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e  314 (475)
T KOG0615|consen  244 FFEVPDSS----YMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAE  314 (475)
T ss_pred             eeecCCce----EEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCc
Confidence            99887654    99999999999999997654  578888899999999999999999   99999999999999765  


Q ss_pred             -CceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCC---CchhhhHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 014034          225 -FRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL---TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR  300 (432)
Q Consensus       225 -~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~  300 (432)
                       ..+||+|||+|+.   .+......+.+||+.|.|||++.+..+   ..++|+||+||+||-+++|.+||.+......  
T Consensus       315 ~~llKItDFGlAK~---~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--  389 (475)
T KOG0615|consen  315 DCLLKITDFGLAKV---SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--  389 (475)
T ss_pred             ceEEEecccchhhc---cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--
Confidence             7899999999986   335556678999999999999976543   3478999999999999999999986543321  


Q ss_pred             HHHHHh--hcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          301 LLEWVQ--QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       301 ~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      +.+.+.  .+.             +........++...+||.+||..||++|||+.|++++
T Consensus       390 l~eQI~~G~y~-------------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  390 LKEQILKGRYA-------------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             HHHHHhcCccc-------------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            111111  111             1112344566788899999999999999999999987

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-49  Score=365.96  Aligned_cols=248  Identities=30%  Similarity=0.457  Sum_probs=200.7

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|...+.||+|+||+||+|+++       .++..||||.+.+..      ..+..|+.+|+.++|||||.+++++..+
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~-------~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~   81 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHK-------KSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD   81 (429)
T ss_pred             cccceehhhccCcceEEEEEeEec-------cCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC
Confidence            468999999999999999999987       456899999987662      2367899999999999999999999876


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCC------C
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN------F  225 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~------~  225 (432)
                      +    ..|||||||.||+|.+||+.+.  .+++..+..++.|||.||++||++   +||||||||+||||+..      -
T Consensus        82 ~----~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~  152 (429)
T KOG0595|consen   82 D----FIYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSP  152 (429)
T ss_pred             C----eEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCc
Confidence            6    4599999999999999998765  799999999999999999999998   99999999999999764      4


Q ss_pred             ceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 014034          226 RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  305 (432)
Q Consensus       226 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  305 (432)
                      .+||+|||+|+...   ......+.+|++.|||||++..+.|+.|+|+||+|+|+|++++|..||...++.+....++..
T Consensus       153 ~LKIADFGfAR~L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~  229 (429)
T KOG0595|consen  153 VLKIADFGFARFLQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKG  229 (429)
T ss_pred             eEEecccchhhhCC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcc
Confidence            68999999999643   344556789999999999999999999999999999999999999999977665433322211


Q ss_pred             hhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          306 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ...               ....+......+.+|+...+..+|.+|-++.+...+
T Consensus       230 ~~~---------------~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~  268 (429)
T KOG0595|consen  230 NEI---------------VPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH  268 (429)
T ss_pred             ccc---------------cCchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence            111               111111222234467777777777777777665443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-49  Score=382.60  Aligned_cols=245  Identities=27%  Similarity=0.444  Sum_probs=208.1

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ..|...+.||+|||+.||.++..       .++..||+|++.+.       .....+|++|.+.|+|||||+++++|.+.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~-------~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs   90 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDL-------DTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS   90 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEc-------CCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC
Confidence            46999999999999999999854       57899999999763       23488999999999999999999999876


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      ..    .|+|.|+|..++|..+++.+  +++++.+++.++.||+.||.|||+.   +|+|||||..|+|++++.++||+|
T Consensus        91 ~n----VYivLELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgD  161 (592)
T KOG0575|consen   91 NN----VYIVLELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGD  161 (592)
T ss_pred             Cc----eEEEEEecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecc
Confidence            54    49999999999999999754  4899999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ||+|....  .......+.+|||.|+|||++.....+..+||||+||+||.||+|++||+...-.+.   ...+...   
T Consensus       162 FGLAt~le--~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket---y~~Ik~~---  233 (592)
T KOG0575|consen  162 FGLATQLE--YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET---YNKIKLN---  233 (592)
T ss_pred             cceeeeec--CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH---HHHHHhc---
Confidence            99998743  233455779999999999999999999999999999999999999999986533222   2111110   


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                              +-    ..|...+....+||.++|+.||.+|||+.+|+.+
T Consensus       234 --------~Y----~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  234 --------EY----SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             --------Cc----ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                    00    1122445678899999999999999999999987

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-48  Score=369.86  Aligned_cols=254  Identities=31%  Similarity=0.456  Sum_probs=210.3

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc---ChHHHHHHHHHhcccCCCccceeeeEEeecCCcce
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR---DGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~  156 (432)
                      .+..++.||+|-||.||.|.+.        ....||+|.+..   ....|.+|+++|+.|+|+|||+++|+|..+..   
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~--------~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p---  275 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWN--------GSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP---  275 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEc--------CCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCc---
Confidence            3556788999999999999986        345788888765   34568999999999999999999999987653   


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                       ++||||||+.|+|.++|+......+...+.+.++.|||+||+||+++   ++|||||...||||+++..+||+|||+|+
T Consensus       276 -iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr  351 (468)
T KOG0197|consen  276 -IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLAR  351 (468)
T ss_pred             -eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccc
Confidence             49999999999999999986677899999999999999999999998   99999999999999999999999999999


Q ss_pred             CCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcccc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKF  315 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  315 (432)
                      ... .+.........-...|.|||.+..+.++.++|||||||+||||+| |+.||.+.....-...++.           
T Consensus       352 ~~~-d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~-----------  419 (468)
T KOG0197|consen  352 LIG-DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLER-----------  419 (468)
T ss_pred             ccC-CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhc-----------
Confidence            421 222222222233568999999999999999999999999999999 9999987755433222221           


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       316 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                            ..+-..|..++..+.+||..||..+|++|||+..+...|+++...
T Consensus       420 ------GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  420 ------GYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             ------cCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence                  111133556778899999999999999999999999999887643

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=7e-48  Score=343.74  Aligned_cols=263  Identities=25%  Similarity=0.340  Sum_probs=208.1

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH------HHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      +.|+.+.++|+|+||.||+++++       .+|+.||||++.....      ...+|+++|++|+|||+|.++++|....
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk-------~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr   74 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNK-------DTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKR   74 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccC-------CcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc
Confidence            46888999999999999999976       6899999999865332      2789999999999999999999997544


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          .++||+|||+. ++.+-|.... .+++...+.+++.|++.|+.|+|++   +|+||||||+||||+.+|.+|||||
T Consensus        75 ----klhLVFE~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDF  145 (396)
T KOG0593|consen   75 ----KLHLVFEYCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDF  145 (396)
T ss_pred             ----eeEEEeeecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccc
Confidence                45999999965 5555554433 4789999999999999999999999   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh-c--
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ-Y--  308 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~-~--  308 (432)
                      |+|+...  ......+..+.|.+|+|||.+.| ..|+..+||||+||++.||++|.+.|.+..+.+....+..... +  
T Consensus       146 GFAR~L~--~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~p  223 (396)
T KOG0593|consen  146 GFARTLS--APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIP  223 (396)
T ss_pred             hhhHhhc--CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCH
Confidence            9999643  24445566889999999999987 7899999999999999999999999999877666544433221 1  


Q ss_pred             -----ccCccccccccCccccCcCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 -----PADSKKFGLIMDPRLEKEYS-----INEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 -----~~~~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                           .....-|..+.-|......+     +..+.-+.+|+..||..||.+|++.++++.+
T Consensus       224 rhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  224 RHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             HHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence                 11111222222222222111     1234467899999999999999999999876

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1e-47  Score=353.02  Aligned_cols=246  Identities=28%  Similarity=0.431  Sum_probs=203.4

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|++++.||+|+||+||.++.+       .+++.+|+|++++..       ....+|..||..++||+||+++-.|.+.
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~-------dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~   97 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKK-------DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE   97 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEc-------ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC
Confidence            57999999999999999999865       678999999997643       3478899999999999999998888765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      .    .+|||+||+.||.|..+|.+..  .+++..+.-++..|+.||.|||+.   |||||||||+|||||.+|+++|+|
T Consensus        98 ~----kLylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtD  168 (357)
T KOG0598|consen   98 E----KLYLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTD  168 (357)
T ss_pred             C----eEEEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEec
Confidence            5    4599999999999999997654  689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ||+++..  ........+++||+.|||||++.+..|+.++|+||||+++|||++|.+||.+.+...   +.+.+...+. 
T Consensus       169 FgL~k~~--~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~---~~~~I~~~k~-  242 (357)
T KOG0598|consen  169 FGLCKED--LKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK---MYDKILKGKL-  242 (357)
T ss_pred             cccchhc--ccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH---HHHHHhcCcC-
Confidence            9999863  223344566899999999999999999999999999999999999999998765432   2222222110 


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC----CHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP----KMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~eil~~  359 (432)
                               +    ..+...+....+++.++|..||++|.    ++.+|..+
T Consensus       243 ---------~----~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H  281 (357)
T KOG0598|consen  243 ---------P----LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH  281 (357)
T ss_pred             ---------C----CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence                     0    11112345677999999999999996    55555544

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-47  Score=359.73  Aligned_cols=268  Identities=27%  Similarity=0.369  Sum_probs=214.1

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH------HHHHHHHHhcccCCCccceeeeEEee
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      ..+.|+.+.+||+|.||.||+|+..       .+++.||+|+++.+..      ...+|+.||++|+||||++|.++..+
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~-------~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~  187 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDL-------ETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTS  187 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeec-------ccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEe
Confidence            3457999999999999999999854       7889999999976542      37899999999999999999999887


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      ..  ...+|||+||| ..+|..++.... -.+++.++..++.||+.||+|||++   ||+|||||.+|||||.+|.+||+
T Consensus       188 ~~--~~siYlVFeYM-dhDL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKia  260 (560)
T KOG0600|consen  188 KL--SGSIYLVFEYM-DHDLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIA  260 (560)
T ss_pred             cC--CceEEEEEecc-cchhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEec
Confidence            62  23569999999 459999886533 3689999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      |||+|+.+.... ....++.+-|++|.|||++.| ..|+.++|+||.||||.||++|++.|.+.+..+..+.+..+..-|
T Consensus       261 DFGLAr~y~~~~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP  339 (560)
T KOG0600|consen  261 DFGLARFYTPSG-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSP  339 (560)
T ss_pred             cccceeeccCCC-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCC
Confidence            999999653332 333566788999999999977 479999999999999999999999999998877776666555444


Q ss_pred             cCcc-ccc-----cccCccccCcC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ADSK-KFG-----LIMDPRLEKEY-----SINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~~~-~~~-----~~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .+.. ...     ..+.+......     -...+....+|+..+|..||.+|.|+.+++..
T Consensus       340 ~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  340 TEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             ChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            3321 100     11111110000     11223457789999999999999999998765

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-47  Score=359.93  Aligned_cols=266  Identities=27%  Similarity=0.362  Sum_probs=213.8

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-----HHHHHHHHhcccC-CCccceeeeEEee
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-----QWVAEVQFLGVLE-HPNLVKLIGYCAV  150 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~-hpniv~l~~~~~~  150 (432)
                      ..++|..+++||.|+||.||+|+.+       ..+..||||++++.-.     .-.+|++.|++|+ |||||++.+++.+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~-------~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d   80 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSK-------ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRD   80 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeec-------CCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhc
Confidence            4568999999999999999999865       5677899999976433     2468999999999 9999999999987


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .+.   .+++||||| ..+|++.++.+ ...+++..+..|+.||++||+|+|.+   |+.|||+||+|||+..+..+||+
T Consensus        81 ~~~---~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKia  152 (538)
T KOG0661|consen   81 NDR---ILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIA  152 (538)
T ss_pred             cCc---eEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEec
Confidence            653   579999999 66999999988 67999999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCcccc-ccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHH-HHHHhhc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL-LEWVQQY  308 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~-~~~~~~~  308 (432)
                      |||+|+..   ......+..+.|.+|+|||++ +.+.|+.+.||||+|||++|+.+-++.|.|.+..++... .+.+...
T Consensus       153 DFGLARev---~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP  229 (538)
T KOG0661|consen  153 DFGLAREV---RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTP  229 (538)
T ss_pred             cccccccc---ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCC
Confidence            99999963   233445678899999999987 567899999999999999999999999998876655433 3322222


Q ss_pred             ccCcccc----ccccCccccCc-------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          309 PADSKKF----GLIMDPRLEKE-------YSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       309 ~~~~~~~----~~~~~~~l~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                      ....+..    ...++-++...       .-...+.++.+||.+|+.+||.+|||+.+++++-
T Consensus       230 ~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  230 DKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             ccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence            2221111    11111111111       1122567788999999999999999999999873

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-46  Score=351.59  Aligned_cols=258  Identities=28%  Similarity=0.400  Sum_probs=205.1

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC----hHHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      .++...+.||+|+||.||++...       .++...|||.+...    ...+.+|+.+|.+++|||||+++|....... 
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~-------~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~-   88 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNK-------KTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN-   88 (313)
T ss_pred             chhhhhccccCccceEEEEEEec-------CCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC-
Confidence            35788889999999999999975       34789999998776    4457899999999999999999997443332 


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC-CCceeecccc
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE-NFRPKLSDFG  233 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~DfG  233 (432)
                       ..++++|||+++|+|.+++.+..+ .+++..+..+..||++||.|||++   ||+||||||+||||+. ++.+||+|||
T Consensus        89 -~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG  163 (313)
T KOG0198|consen   89 -DEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFG  163 (313)
T ss_pred             -eeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCc
Confidence             346899999999999999987765 799999999999999999999998   9999999999999999 7999999999


Q ss_pred             CCcCCCC-CCCcccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          234 LAREGPM-VGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       234 ~a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      +++.... ...........||+.|||||++..+ ....++|||||||++.||+||..||.....  ......++..    
T Consensus       164 ~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~--~~~~~~~ig~----  237 (313)
T KOG0198|consen  164 LAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE--EAEALLLIGR----  237 (313)
T ss_pred             cccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc--hHHHHHHHhc----
Confidence            9986432 1112223457899999999999853 334599999999999999999999986411  1111111111    


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  364 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  364 (432)
                              .. ..+..+...+....+++.+|+..||.+|||+.+++++.....
T Consensus       238 --------~~-~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  238 --------ED-SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             --------cC-CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence                    11 111334445677889999999999999999999999965443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-46  Score=357.01  Aligned_cols=251  Identities=25%  Similarity=0.356  Sum_probs=208.2

Q ss_pred             HHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-------HHHHHHHHhccc-CCCccceeee
Q 014034           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQFLGVL-EHPNLVKLIG  146 (432)
Q Consensus        75 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l-~hpniv~l~~  146 (432)
                      +...++|..++.||+|+|++|++|+.+       .+++.+|||++.+.-.       ....|-.+|.+| +||.|++||-
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~-------~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~  141 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREK-------ATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYF  141 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeec-------CCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEE
Confidence            556689999999999999999999965       5789999999876432       256788899999 8999999998


Q ss_pred             EEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCc
Q 014034          147 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR  226 (432)
Q Consensus       147 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~  226 (432)
                      .|.++..    +|+|+||+++|+|.++|.+.  +.+++.....++.+|+.||+|||++   |||||||||+|||||++|+
T Consensus       142 TFQD~~s----LYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmh  212 (604)
T KOG0592|consen  142 TFQDEES----LYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGH  212 (604)
T ss_pred             Eeecccc----eEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCc
Confidence            8876553    59999999999999999765  4799999999999999999999998   9999999999999999999


Q ss_pred             eeeccccCCcCCCCCCCc---------cc--ccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCc
Q 014034          227 PKLSDFGLAREGPMVGHT---------HV--STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP  295 (432)
Q Consensus       227 ~kl~DfG~a~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~  295 (432)
                      +||+|||.|+........         ..  ...++||..|.+||++..+..++.+|+|+||||||.|+.|.+||.+.+.
T Consensus       213 ikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne  292 (604)
T KOG0592|consen  213 IKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE  292 (604)
T ss_pred             EEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH
Confidence            999999999854322111         11  2568999999999999999999999999999999999999999987655


Q ss_pred             hhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          296 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ......   +...           +-.    ++...++.+.+||.+.|..||.+|+|.++|.+|
T Consensus       293 yliFqk---I~~l-----------~y~----fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  293 YLIFQK---IQAL-----------DYE----FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HHHHHH---HHHh-----------ccc----CCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            432221   1111           111    122223678899999999999999999999887

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.9e-45  Score=322.87  Aligned_cols=263  Identities=25%  Similarity=0.327  Sum_probs=208.8

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .+|..++.||+|.||.||+|+..       .+++.||||++....      ....+|++.|+.++||||+.++++|...+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~-------~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~   74 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDT-------ETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKS   74 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEec-------CCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCC
Confidence            36888899999999999999854       688999999987532      24789999999999999999999997655


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                      .    +.||+||++ .+|+..|+++. ..++..++..++.++++||+|||++   .|+||||||.|+|++.+|.+||+||
T Consensus        75 ~----l~lVfEfm~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADF  145 (318)
T KOG0659|consen   75 N----LSLVFEFMP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADF  145 (318)
T ss_pred             c----eEEEEEecc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecc
Confidence            4    489999995 59999987665 4789999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      |+|+.+...  .......+-|.+|.|||.+.| ..|+..+||||.|||+.||+-|.+-|.+.++.+....+-.+...|..
T Consensus       146 GLAr~f~~p--~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~  223 (318)
T KOG0659|consen  146 GLARFFGSP--NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTP  223 (318)
T ss_pred             cchhccCCC--CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCc
Confidence            999974322  223333478999999999876 57999999999999999999999999988776665554443333322


Q ss_pred             ccccc--------cc--cCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 SKKFG--------LI--MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~~~~~--------~~--~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ...-+        .+  .........-...+.++.+|+..||..||.+|+|+.|++++
T Consensus       224 ~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  224 DQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            11100        00  11111111222344566899999999999999999999887

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.9e-45  Score=355.17  Aligned_cols=264  Identities=28%  Similarity=0.405  Sum_probs=204.7

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhccc-CCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVL-EHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~hpniv~l~~~~~~~  151 (432)
                      .++|++.+.||+|+||.||+|.+...  +....+..||+|++....     ..+.+|+.++..+ +||||++++++|...
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGI--DKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEecc--CCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            35799999999999999999986421  122356789999986432     2478899999999 899999999988654


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCC-----------------------------------------------------
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRA-----------------------------------------------------  178 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------  178 (432)
                      +.   ..++||||+++|+|.+++....                                                     
T Consensus        84 ~~---~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          84 NG---PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             CC---ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence            32   3589999999999999986431                                                     


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCCCCCCcccccccc
Q 014034          179 -------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV  251 (432)
Q Consensus       179 -------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~  251 (432)
                             ..++++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...............
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~  237 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR  237 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCC
Confidence                   13477888999999999999999998   99999999999999999999999999997532221111222345


Q ss_pred             cCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHH
Q 014034          252 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSIN  330 (432)
Q Consensus       252 gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  330 (432)
                      +++.|+|||++.+..++.++|||||||++|||++ |..||.+......  +...+...    .      ..    ..+..
T Consensus       238 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~~~~~~~----~------~~----~~~~~  301 (338)
T cd05102         238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FCQRLKDG----T------RM----RAPEN  301 (338)
T ss_pred             CCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HHHHHhcC----C------CC----CCCCC
Confidence            6788999999998999999999999999999997 9999986543221  11111110    0      00    01122


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          331 EARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       331 ~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                      .+..+.+|+.+||+.||.+|||+.+|++.|+.+++
T Consensus       302 ~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         302 ATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            34578899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-45  Score=355.12  Aligned_cols=247  Identities=26%  Similarity=0.416  Sum_probs=204.9

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---------hHHHHHHHHHhcccC-CCccceeee
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---------GLQWVAEVQFLGVLE-HPNLVKLIG  146 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~-hpniv~l~~  146 (432)
                      ..+.|.+.+.||+|+||+|+.|.+.       .++..||+|.+++.         .....+|+.+++.+. ||||+++++
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~-------~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~e   87 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHR-------LTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLE   87 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeec-------cCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEE
Confidence            4568999999999999999999876       45689999987663         123568999999998 999999999


Q ss_pred             EEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCC-C
Q 014034          147 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-F  225 (432)
Q Consensus       147 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~  225 (432)
                      ++.....    .++||||+.||+|.+++.+.  +++.+..+..++.|++.|++|||+.   ||+||||||+|||++.+ +
T Consensus        88 v~~t~~~----~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~  158 (370)
T KOG0583|consen   88 VFATPTK----IYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEG  158 (370)
T ss_pred             EEecCCe----EEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCC
Confidence            9987654    59999999999999999873  4799999999999999999999998   99999999999999999 9


Q ss_pred             ceeeccccCCcCCCCCCCcccccccccCCCccCccccccCC-CC-chhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 014034          226 RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH-LT-AKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE  303 (432)
Q Consensus       226 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~  303 (432)
                      ++||+|||++....  .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||.......   +..
T Consensus       159 ~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~---l~~  233 (370)
T KOG0583|consen  159 NLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN---LYR  233 (370)
T ss_pred             CEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH---HHH
Confidence            99999999998642  3445567789999999999999877 86 68999999999999999999998743322   221


Q ss_pred             HHhhcccCccccccccCccccCcCCHHH-HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          304 WVQQYPADSKKFGLIMDPRLEKEYSINE-ARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .+....             +  .++... +..+..|+.+||..||.+|+|+.+|+.+
T Consensus       234 ki~~~~-------------~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h  275 (370)
T KOG0583|consen  234 KIRKGE-------------F--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH  275 (370)
T ss_pred             HHhcCC-------------c--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence            111110             0  111112 5678899999999999999999999944

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-45  Score=341.39  Aligned_cols=259  Identities=29%  Similarity=0.383  Sum_probs=211.2

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|++...||.|..+.||+|.+.       ..+..||||+++-+.     ..+++|+..|+.++||||++++..|..+..
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~-------p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~   98 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCI-------PTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE   98 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeec-------ccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence            57999999999999999999987       456899999997544     347899999999999999999999987664


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                          +|+||.||.+||+.+.+.......+++..+..|++++++||.|||.+   |.||||||+.||||+.+|.|||+|||
T Consensus        99 ----LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFg  171 (516)
T KOG0582|consen   99 ----LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFG  171 (516)
T ss_pred             ----eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCce
Confidence                59999999999999999877666799999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcc--cccccccCCCccCccccc--cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          234 LAREGPMVGHTH--VSTAVVGTFGYAAPDYIE--TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       234 ~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      .+-.....+...  ....++||+.|||||++.  ...|+.|+||||||++..||.+|..||....+...  ++..++..+
T Consensus       172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv--Ll~tLqn~p  249 (516)
T KOG0582|consen  172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV--LLLTLQNDP  249 (516)
T ss_pred             eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--HHHHhcCCC
Confidence            986543333221  125679999999999964  35799999999999999999999999998766432  222233322


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ....      ...+...........+..++..||..||.+|||+++++++
T Consensus       250 p~~~------t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  250 PTLL------TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             CCcc------cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            2111      0111112222334578899999999999999999999986

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-45  Score=345.27  Aligned_cols=263  Identities=26%  Similarity=0.349  Sum_probs=209.6

Q ss_pred             CHHHHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------------------HHHHHHHH
Q 014034           70 SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------------------LQWVAEVQ  131 (432)
Q Consensus        70 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------------------~~~~~E~~  131 (432)
                      .-.+-++..|+|++++.||+|.||.|-+|...       .+++.||||++.+..                  ....+|+.
T Consensus        88 ~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~-------~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIa  160 (576)
T KOG0585|consen   88 DDDQDRKQLNQYELIKEIGSGQYGKVKLARDE-------VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIA  160 (576)
T ss_pred             cCcccceehhheehhhhhcCCccceEEEEeec-------CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHH
Confidence            33444667799999999999999999999854       688999999987532                  13788999


Q ss_pred             HhcccCCCccceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCCcee
Q 014034          132 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPP-LPWKTRLHIILGAAEGLAYLHEGLEVQVI  210 (432)
Q Consensus       132 ~l~~l~hpniv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~l~~~l~~LH~~~~~~iv  210 (432)
                      +|++|+|||||+|+++..+....  .+|||+|||..|.+...-   ...+ +.+.+++.++.+++.||+|||.+   ||+
T Consensus       161 ilKkl~H~nVV~LiEvLDDP~s~--~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q---gii  232 (576)
T KOG0585|consen  161 ILKKLHHPNVVKLIEVLDDPESD--KLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ---GII  232 (576)
T ss_pred             HHHhcCCcCeeEEEEeecCcccC--ceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc---Cee
Confidence            99999999999999988765544  569999999998886542   2234 89999999999999999999999   999


Q ss_pred             ecCCCCCceEEcCCCceeeccccCCcCCCCC---CCcccccccccCCCccCccccccCC----CCchhhhHHHHHHHHHH
Q 014034          211 YRDFKASNVLLDENFRPKLSDFGLAREGPMV---GHTHVSTAVVGTFGYAAPDYIETGH----LTAKSDVWSFGVVLYEM  283 (432)
Q Consensus       211 H~Dikp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~el  283 (432)
                      ||||||+|+||+++|++||+|||.+......   +........+|||.|||||.+.++.    .+.+.||||+||+||+|
T Consensus       233 HRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCl  312 (576)
T KOG0585|consen  233 HRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCL  312 (576)
T ss_pred             ccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHh
Confidence            9999999999999999999999999754222   2233344578999999999997633    35679999999999999


Q ss_pred             HhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          284 LTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       284 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                      +.|+.||.+...   ..+.+.             +++..+.-....+....+.+||.+||.+||++|.++.+|..+..-.
T Consensus       313 lfG~~PF~~~~~---~~l~~K-------------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt  376 (576)
T KOG0585|consen  313 LFGQLPFFDDFE---LELFDK-------------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT  376 (576)
T ss_pred             hhccCCcccchH---HHHHHH-------------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence            999999986533   222222             2233333222334567889999999999999999999998886433

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-46  Score=354.63  Aligned_cols=243  Identities=27%  Similarity=0.462  Sum_probs=201.7

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHHHHHHHhcccCCCccceeeeEEeecCCcceeEEE
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLL  160 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~l  160 (432)
                      ...+.-||.|+.|.||+|+++         ++.||||+++.-.   ..+++-|+.|+||||+.|.|+|....    .+||
T Consensus       126 IsELeWlGSGaQGAVF~Grl~---------netVAVKKV~elk---ETdIKHLRkLkH~NII~FkGVCtqsP----cyCI  189 (904)
T KOG4721|consen  126 ISELEWLGSGAQGAVFLGRLH---------NETVAVKKVRELK---ETDIKHLRKLKHPNIITFKGVCTQSP----CYCI  189 (904)
T ss_pred             hhhhhhhccCcccceeeeecc---------CceehhHHHhhhh---hhhHHHHHhccCcceeeEeeeecCCc----eeEE
Confidence            334567999999999999875         7889999987533   35888999999999999999997654    4599


Q ss_pred             EEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCCC
Q 014034          161 VYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM  240 (432)
Q Consensus       161 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~  240 (432)
                      |||||..|-|+..|+...  +++......|..+||.||.|||.+   .|||||||+-||||+.+..+||+|||-++....
T Consensus       190 iMEfCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~  264 (904)
T KOG4721|consen  190 IMEFCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSD  264 (904)
T ss_pred             eeeccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence            999999999999997654  788899999999999999999998   999999999999999999999999999985321


Q ss_pred             CCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccC
Q 014034          241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMD  320 (432)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (432)
                         ......+.||..|||||+++..+.+.|+|||||||||||||||..||...+...   + -|  .          +-.
T Consensus       265 ---~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA---I-Iw--G----------VGs  325 (904)
T KOG4721|consen  265 ---KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA---I-IW--G----------VGS  325 (904)
T ss_pred             ---hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe---e-EE--e----------ccC
Confidence               233446889999999999999999999999999999999999999997543211   0 00  0          111


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          321 PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       321 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                      -.+.-..+..++..+.-|++.||+..|..||++.+|+.+|+-.
T Consensus       326 NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  326 NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            1222234556678888999999999999999999999999754

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.6e-45  Score=352.19  Aligned_cols=244  Identities=30%  Similarity=0.457  Sum_probs=207.6

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      ++|.+...||+|+||.||||+-+       .+...||+|.+.+..      ..+.+|++|++.++|||||.++++|....
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK-------~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~   74 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRK-------YTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSA   74 (808)
T ss_pred             cchhHHHHhcCCccceeeecccc-------cceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc
Confidence            57888899999999999999855       678999999986532      24789999999999999999999997655


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ++|+|.||+.| +|..+|....  .+++..+..++.|++.||.|||+.   +|+|||+||.|||++.+|.+|+|||
T Consensus        75 ----~~~vVte~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdF  144 (808)
T KOG0597|consen   75 ----HLWVVTEYAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDF  144 (808)
T ss_pred             ----eEEEEehhhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechh
Confidence                45999999976 9999997654  699999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      |+|+..  ...........|||.|||||+..+++|+..+|+||+|||+||+++|++||-..   ....++..+...+.  
T Consensus       145 g~Ar~m--~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~---si~~Lv~~I~~d~v--  217 (808)
T KOG0597|consen  145 GLARAM--STNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR---SITQLVKSILKDPV--  217 (808)
T ss_pred             hhhhhc--ccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH---HHHHHHHHHhcCCC--
Confidence            999973  33455666788999999999999999999999999999999999999999643   22233333222211  


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                   ..+...+..+..++...|.+||.+|.|..+++.+
T Consensus       218 -------------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  218 -------------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             -------------CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence                         1233556788899999999999999999999887

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.8e-45  Score=329.07  Aligned_cols=267  Identities=24%  Similarity=0.330  Sum_probs=214.0

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH------HHHHHHHHhcccCCCccceeeeEEee
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      ..++|+.++.|++|+||.||+|+.+       .+++.||+|+++.+..      ...+|+.+|.+++|||||.+-.+...
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk-------~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG  146 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDK-------KTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVG  146 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccC-------CcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec
Confidence            3457999999999999999999855       6889999999986543      36899999999999999999998876


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .+-.  ..|+|||||+ .+|...+.... .++...++..++.|+++|++|||.+   .|+|||||++|+|++..|.+||+
T Consensus       147 ~~~d--~iy~VMe~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKia  219 (419)
T KOG0663|consen  147 SNMD--KIYIVMEYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIA  219 (419)
T ss_pred             cccc--eeeeeHHHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEec
Confidence            5544  4699999995 58998887655 5789999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      |||+|+.+  .......+..+-|++|.|||++.| ..|++++|+||+|||+.||+++.+.|.+....+..+.+-.....|
T Consensus       220 DFGLAR~y--gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtP  297 (419)
T KOG0663|consen  220 DFGLAREY--GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTP  297 (419)
T ss_pred             ccchhhhh--cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCC
Confidence            99999974  223344566788999999999876 479999999999999999999999999987776665555444444


Q ss_pred             cCccccccccCc-------------cccCcCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ADSKKFGLIMDP-------------RLEKEYSIN-EARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~~~~~~~~~~~-------------~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .+...-+....+             .+...+... .+..-.+|+..+|..||.+|.|+.+.|++
T Consensus       298 te~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  298 SEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             ccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            332111100000             111112111 34567799999999999999999999887

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=8.1e-46  Score=339.86  Aligned_cols=267  Identities=26%  Similarity=0.336  Sum_probs=211.0

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHHHHHHHhcccCCCccceeeeEEeecCCc-cee
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGER-GIQ  157 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~-~~~  157 (432)
                      -.|...+++|.|+||.||+|...       .++..||||++-.+...-.+|+++|+.++|||||++.-+|....+. ...
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~-------e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLR-------ETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEc-------CCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence            35788899999999999999986       4478999999988777777899999999999999999888776554 455


Q ss_pred             EEEEEeecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCC-CceeeccccC
Q 014034          158 RLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGL  234 (432)
Q Consensus       158 ~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~DfG~  234 (432)
                      ..|||||++. +|.++++.  +.+..++.-.+.-+..||++||.|||+.   +|+||||||+|+|+|.+ |.+||||||.
T Consensus        97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGS  172 (364)
T KOG0658|consen   97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGS  172 (364)
T ss_pred             HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCc
Confidence            6799999965 99998873  2345688888889999999999999998   99999999999999966 9999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      |+...   ..........|..|+|||.+.| ..|+.+.||||.|||+.||+-|++-|.|.+..+....+-.+-..|....
T Consensus       173 AK~L~---~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~  249 (364)
T KOG0658|consen  173 AKVLV---KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRED  249 (364)
T ss_pred             ceeec---cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHH
Confidence            98632   2333456778999999999876 5799999999999999999999999999766655444333333332211


Q ss_pred             -----------ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          314 -----------KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       314 -----------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                 .+..+....+........+.++.+|+.++|..+|.+|.++.|++.+
T Consensus       250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence                       0111111111111333446778899999999999999999999876

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-45  Score=352.24  Aligned_cols=247  Identities=25%  Similarity=0.397  Sum_probs=207.2

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH----HHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL----QWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      ..|....+||+|+.|.||.|.-.       ..+..||||++.....    -..+|+.+|+.++|+|||.+++.+...+  
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~-------~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d--  343 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKI-------STKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD--  343 (550)
T ss_pred             hhhcchhhhccccccceeeeeec-------cCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc--
Confidence            45777889999999999999854       5677899999875432    2789999999999999999999888764  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        .+|.||||++||+|.+.+...   .+++.++..|+.+++.||+|||.+   +|+|||||.+|||++.+|.+||+|||+
T Consensus       344 --eLWVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGF  415 (550)
T KOG0578|consen  344 --ELWVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGF  415 (550)
T ss_pred             --eeEEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeee
Confidence              459999999999999998553   489999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      +....  .......+.+||+.|||||+.....|++++||||||++++||+-|.+||-..++.-...++   ...      
T Consensus       416 caqi~--~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI---a~n------  484 (550)
T KOG0578|consen  416 CAQIS--EEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATN------  484 (550)
T ss_pred             eeccc--cccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH---hhc------
Confidence            98643  2333567789999999999999999999999999999999999999999865443222111   111      


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                            ....-..+...+..+.+++.+||..|+++||++.|+|++
T Consensus       485 ------g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  485 ------GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             ------CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence                  111112344556789999999999999999999999988

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-45  Score=323.23  Aligned_cols=234  Identities=27%  Similarity=0.419  Sum_probs=199.8

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-------HHHHHHHHhcccCCCccceeeeEEee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .++|+.++.||.|+||.|.+++.+       .++..+|+|++++...       ...+|..+|+.+.||+++++++.+.+
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k-------~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d  115 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREK-------HSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD  115 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEc-------cCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence            357999999999999999999976       5688999999987543       36789999999999999999998876


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      ..    .+++||||++||.|..++++..  ++++..+.-++.||+.||+|||+.   +|++|||||+|||+|.+|.+||+
T Consensus       116 ~~----~lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKit  186 (355)
T KOG0616|consen  116 NS----NLYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKIT  186 (355)
T ss_pred             CC----eEEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEE
Confidence            54    4699999999999999997654  799999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      |||+|+..     .....+.+|||.|+|||++...+|+.++|+|||||++|||+.|.+||...++..   +.+.+..   
T Consensus       187 DFGFAK~v-----~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~---iY~KI~~---  255 (355)
T KOG0616|consen  187 DFGFAKRV-----SGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ---IYEKILE---  255 (355)
T ss_pred             eccceEEe-----cCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH---HHHHHHh---
Confidence            99999862     223567899999999999999999999999999999999999999998877632   2222211   


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCC
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDR  350 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R  350 (432)
                                ..+  .+|...+..+.+|+..+|+.|-.+|
T Consensus       256 ----------~~v--~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  256 ----------GKV--KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ----------Ccc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence                      111  2234445678899999999999999

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.3e-45  Score=366.86  Aligned_cols=265  Identities=30%  Similarity=0.492  Sum_probs=217.3

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-----HHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-----QWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      ..+....+.||+|.||+||+|......  .......||||.++....     +|++|+++|..|+|||||+|+|+|.+..
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~--p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLL--PGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCC--CCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            345667788999999999999876332  224568899999986433     4999999999999999999999998876


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceE
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRA------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVL  220 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nil  220 (432)
                      ..    ++|+|||..|+|.+||..+.            ..+|+..+.+.|+.|||.||.||-++   .+|||||..+|+|
T Consensus       563 P~----~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCL  635 (774)
T KOG1026|consen  563 PL----CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCL  635 (774)
T ss_pred             ee----EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhce
Confidence            54    99999999999999997432            22488899999999999999999998   9999999999999


Q ss_pred             EcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhH
Q 014034          221 LDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQ  299 (432)
Q Consensus       221 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~  299 (432)
                      |.++..|||+|||+++.....+.........-...|||||.|..+.|++++|||||||+|||+++ |..||.+....   
T Consensus       636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~---  712 (774)
T KOG1026|consen  636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ---  712 (774)
T ss_pred             eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH---
Confidence            99999999999999997543333333323344669999999999999999999999999999999 99999876543   


Q ss_pred             HHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhcc
Q 014034          300 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  368 (432)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  368 (432)
                      +.++.++.-.             + -..+..++..++.||..||+.+|.+||++.+|-..|+.+.+.+.
T Consensus       713 EVIe~i~~g~-------------l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~  767 (774)
T KOG1026|consen  713 EVIECIRAGQ-------------L-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP  767 (774)
T ss_pred             HHHHHHHcCC-------------c-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence            3333332211             1 13456677899999999999999999999999999998876544

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-43  Score=329.63  Aligned_cols=253  Identities=25%  Similarity=0.372  Sum_probs=209.8

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-------HHHHHHHHhcccCCCccceeeeEEe
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQFLGVLEHPNLVKLIGYCA  149 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~hpniv~l~~~~~  149 (432)
                      ...+|+.++.||.|.-|+||++..+       .++..+|+|++.+...       +.+.|-+||..++||.++.||..+.
T Consensus        75 ~l~~f~llk~LG~GdiG~VyL~~l~-------~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe  147 (459)
T KOG0610|consen   75 GLRHFRLLKRLGCGDIGTVYLVELR-------GTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFE  147 (459)
T ss_pred             CHHHHHHHHHcCCCCceeEEEEEec-------CCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheee
Confidence            3457899999999999999999976       4558999999986543       3678999999999999999999998


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      .+..    .|||||||+||+|+..++++..+.+++..+.-++..++.||+|||..   |||+|||||+||||.++|++.|
T Consensus       148 t~~~----~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIML  220 (459)
T KOG0610|consen  148 TDKY----SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIML  220 (459)
T ss_pred             ccce----eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEe
Confidence            7654    49999999999999999999989999999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCC--------------------------------C-C---------------------cccccccccCCC
Q 014034          230 SDFGLAREGPMV--------------------------------G-H---------------------THVSTAVVGTFG  255 (432)
Q Consensus       230 ~DfG~a~~~~~~--------------------------------~-~---------------------~~~~~~~~gt~~  255 (432)
                      +||.++......                                . .                     ...+..++||-.
T Consensus       221 sDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThE  300 (459)
T KOG0610|consen  221 SDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHE  300 (459)
T ss_pred             eeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccc
Confidence            999997532110                                0 0                     012235689999


Q ss_pred             ccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHH
Q 014034          256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKI  335 (432)
Q Consensus       256 y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l  335 (432)
                      |+|||++.|...+.++|+|+|||++||||.|..||.+.+.......                ++...+.-......+..+
T Consensus       301 YlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N----------------Iv~~~l~Fp~~~~vs~~a  364 (459)
T KOG0610|consen  301 YLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRN----------------IVGQPLKFPEEPEVSSAA  364 (459)
T ss_pred             cccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHH----------------HhcCCCcCCCCCcchhHH
Confidence            9999999999999999999999999999999999988765432211                122222222223556788


Q ss_pred             HHHHHHhccCCCCCCCC----HHHHHHH
Q 014034          336 GRLADNCLSKSSKDRPK----MSQVVER  359 (432)
Q Consensus       336 ~~li~~cl~~dP~~RPs----~~eil~~  359 (432)
                      .+||+++|.+||.+|..    +.||.+|
T Consensus       365 kDLIr~LLvKdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  365 KDLIRKLLVKDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             HHHHHHHhccChhhhhccccchHHhhcC
Confidence            99999999999999998    8888776

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.3e-43  Score=334.21  Aligned_cols=248  Identities=21%  Similarity=0.309  Sum_probs=198.5

Q ss_pred             ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeecCCcce
Q 014034           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        84 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~  156 (432)
                      ...||+|++|.||+|.+         ++..||||.+....       ..+.+|+.+|.+++||||++++|++.+......
T Consensus        25 ~~~i~~g~~~~v~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~   95 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF---------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP   95 (283)
T ss_pred             CeEEeeCCceEEEEEEE---------CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCC
Confidence            35799999999999986         47889999987532       346799999999999999999999876222233


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      ..++||||+.+|+|.+++...  ..+++.....++.|++.||.|||+.  .+++||||||+|||++.++.+||+|||+++
T Consensus        96 ~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~  171 (283)
T PHA02988         96 RLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEK  171 (283)
T ss_pred             ceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHh
Confidence            568999999999999999764  3689999999999999999999973  278899999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCccCcccccc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIET--GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      ....     ......|+..|+|||++.+  ..++.++|||||||++|||++|..||.+.....   +...+.....    
T Consensus       172 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~~~i~~~~~----  239 (283)
T PHA02988        172 ILSS-----PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IYDLIINKNN----  239 (283)
T ss_pred             hhcc-----ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHhcCC----
Confidence            5321     1123568899999999976  689999999999999999999999998764332   2221111000    


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                           ..    ..+...+..+.+|+.+||+.||.+|||+.++++.|+.+.+
T Consensus       240 -----~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        240 -----SL----KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             -----CC----CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence                 00    1122345678999999999999999999999999987653

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.7e-45  Score=335.26  Aligned_cols=244  Identities=22%  Similarity=0.389  Sum_probs=205.3

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-------HHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .+|++.+.||+|.||+|-+|...       ..++.||||.++++..       .+.+|++||..|+||||+.+|++|.+.
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~-------~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk  125 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEH-------KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK  125 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhc-------cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC
Confidence            46999999999999999998743       6789999999987543       378999999999999999999999765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ...|||||..+|.|++|+.++.  .|++.++..+++||+.|+.|+|.+   +++|||||.+|||+|.++++||+|
T Consensus       126 d----KIvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIAD  196 (668)
T KOG0611|consen  126 D----KIVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIAD  196 (668)
T ss_pred             c----eEEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeec
Confidence            5    3499999999999999997765  799999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLT-AKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      ||++..+   .......+++|++.|.+||++.|.+|. +.+|.|||||+||.|+.|..||++.+...   ++..+..-  
T Consensus       197 FGLSNly---~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---lvrQIs~G--  268 (668)
T KOG0611|consen  197 FGLSNLY---ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---LVRQISRG--  268 (668)
T ss_pred             cchhhhh---ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---HHHHhhcc--
Confidence            9999753   234456789999999999999999885 67999999999999999999999875432   22222111  


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                                 ...   .+..+.+..-||.+||..+|++|.|+.+|..+-
T Consensus       269 -----------aYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  269 -----------AYR---EPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             -----------ccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence                       000   011123466899999999999999999998873

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.9e-44  Score=342.37  Aligned_cols=251  Identities=24%  Similarity=0.367  Sum_probs=206.1

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-------HHHHHHHHhcccCCCccceeeeEEe
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQFLGVLEHPNLVKLIGYCA  149 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~hpniv~l~~~~~  149 (432)
                      ..++|+.++.||+|+||.||+|+-+       .++..+|+|++++..-       ....|-.+|...++|+||+||-.|.
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk-------~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ  211 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKK-------DTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQ  211 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEc-------cCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEec
Confidence            3478999999999999999999865       6889999999987532       3678999999999999999998887


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      +..    .+||||||++||++..+|.+..  .|++..+..++.+++.|++.||..   |+|||||||+|+|||..|++||
T Consensus       212 D~~----~LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKL  282 (550)
T KOG0605|consen  212 DKE----YLYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKL  282 (550)
T ss_pred             CCC----eeEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEee
Confidence            654    4699999999999999997665  799999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCC----------------------CCCcc----c-------------------ccccccCCCccCcccccc
Q 014034          230 SDFGLAREGPM----------------------VGHTH----V-------------------STAVVGTFGYAAPDYIET  264 (432)
Q Consensus       230 ~DfG~a~~~~~----------------------~~~~~----~-------------------~~~~~gt~~y~aPE~~~~  264 (432)
                      +||||+.-..-                      .....    .                   ....+|||-|||||++.+
T Consensus       283 SDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~  362 (550)
T KOG0605|consen  283 SDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG  362 (550)
T ss_pred             ccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc
Confidence            99999841100                      00000    0                   013479999999999999


Q ss_pred             CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhh-HHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhc
Q 014034          265 GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCL  343 (432)
Q Consensus       265 ~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl  343 (432)
                      ..|+..+|+||||||+||||.|.+||.+.++... ..++.|-..+.....               ...+....+||.+|+
T Consensus       363 kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~---------------~~~s~eA~DLI~rll  427 (550)
T KOG0605|consen  363 KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE---------------VDLSDEAKDLITRLL  427 (550)
T ss_pred             CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc---------------CcccHHHHHHHHHHh
Confidence            9999999999999999999999999998877544 455666544332211               122366789999999


Q ss_pred             cCCCCCCCC---HHHHHHH
Q 014034          344 SKSSKDRPK---MSQVVER  359 (432)
Q Consensus       344 ~~dP~~RPs---~~eil~~  359 (432)
                      . ||++|.-   +.||.+|
T Consensus       428 ~-d~~~RLG~~G~~EIK~H  445 (550)
T KOG0605|consen  428 C-DPENRLGSKGAEEIKKH  445 (550)
T ss_pred             c-CHHHhcCcccHHHHhcC
Confidence            9 9999975   6777665

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-44  Score=350.98  Aligned_cols=246  Identities=26%  Similarity=0.380  Sum_probs=210.0

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .+-|.+++.||.|+.|.|-+|++.       .+|+.+|||++.+.       ...+.+|+-||+.+.||||+.+|+++.+
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~-------~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~   83 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHA-------ETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN   83 (786)
T ss_pred             ccceeccccccCCCCceehhhhcc-------cccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc
Confidence            356889999999999999999876       68999999999876       3347899999999999999999999876


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      ..    ++|||.||++||-|.+++..++  ++++.++.++++||+.|+.|+|..   +|+||||||+|+|||..+++||+
T Consensus        84 ~~----~lylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIA  154 (786)
T KOG0588|consen   84 KQ----HLYLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIA  154 (786)
T ss_pred             Cc----eEEEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeee
Confidence            44    5699999999999999997765  899999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLT-AKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      |||+|..   ........+.||++.|.+||++.|.+|+ .++||||.|||||.||||..||++.+   ...++..++.-.
T Consensus       155 DFGMAsL---e~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---ir~LLlKV~~G~  228 (786)
T KOG0588|consen  155 DFGMASL---EVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---IRVLLLKVQRGV  228 (786)
T ss_pred             ccceeec---ccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---HHHHHHHHHcCc
Confidence            9999974   2234455678999999999999999985 68999999999999999999998433   333444443321


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                      .               ..|...+.+..+|+.+|+..||+.|.|+++|++|.
T Consensus       229 f---------------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  229 F---------------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             c---------------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence            1               11334457788999999999999999999999984

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-45  Score=341.99  Aligned_cols=246  Identities=26%  Similarity=0.383  Sum_probs=207.2

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ..|.....||+|+||.||+|...       .+++.||+|++.-+.     ...++|+.+|.+++++||.++|+.+.....
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~-------~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~   85 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDN-------KTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK   85 (467)
T ss_pred             cccccchhccccccceeeeeeec-------cccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc
Confidence            35777889999999999999855       678999999987543     347899999999999999999999876553


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                          ++++||||.||++.+.+...  ..+.+....-++++++.||.|||++   +.+|||||+.|||+..+|.+||+|||
T Consensus        86 ----LwiiMey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~Dfg  156 (467)
T KOG0201|consen   86 ----LWIIMEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFG  156 (467)
T ss_pred             ----HHHHHHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecc
Confidence                49999999999999999543  3558888888999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      ++-+..  .......+++||+.|||||++.+..|+.++||||||++.+||.+|.+|+....+.-                
T Consensus       157 Va~ql~--~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----------------  218 (467)
T KOG0201|consen  157 VAGQLT--NTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----------------  218 (467)
T ss_pred             eeeeee--chhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------------
Confidence            997633  23334478999999999999999899999999999999999999999998766521                


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                       +-.++....++......+..+.++|..||..||+.||++.+++++
T Consensus       219 -vlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  219 -VLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             -EEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence             111222333333334556789999999999999999999999987

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-44  Score=311.55  Aligned_cols=247  Identities=26%  Similarity=0.416  Sum_probs=210.8

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-------HHHHHHHHhcccCCCccceeeeEEee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .++|++++.||+|-||.||.|+.+       .+.-.||+|++.+...       ++.+|++|-..|+||||+++|++|.+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarek-------ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd   93 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREK-------KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD   93 (281)
T ss_pred             hhhccccccccCCccccEeEeeec-------cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec
Confidence            457999999999999999999976       5778999999876543       47899999999999999999999987


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      +..    .||++||..+|+|...|.......+++...+.++.|+|.||.|+|..   +++||||||+|+|++..+.+||+
T Consensus        94 ~~r----iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiA  166 (281)
T KOG0580|consen   94 SKR----IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIA  166 (281)
T ss_pred             cce----eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeecc
Confidence            654    49999999999999999877777899999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      |||.+...+    .....+.+||..|.+||...+..++..+|+|++|++.||++.|.+||......   .....+.... 
T Consensus       167 dfGwsV~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~---etYkrI~k~~-  238 (281)
T KOG0580|consen  167 DFGWSVHAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS---ETYKRIRKVD-  238 (281)
T ss_pred             CCCceeecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH---HHHHHHHHcc-
Confidence            999987532    44556789999999999999999999999999999999999999999876522   2222222111 


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                                -    .++...+....++|.+|+..+|.+|.+..|++++-
T Consensus       239 ----------~----~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  239 ----------L----KFPSTISGGAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             ----------c----cCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence                      0    12234456788999999999999999999998873

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=349.65  Aligned_cols=263  Identities=27%  Similarity=0.462  Sum_probs=208.8

Q ss_pred             HHHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceee
Q 014034           72 SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLI  145 (432)
Q Consensus        72 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~  145 (432)
                      .+.....+.+.+...||+|+||+||+|.|.          -.||||.++-+.      ..|.+|+.++++-+|.||+-+.
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh----------GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFM  454 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH----------GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFM  454 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc----------cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeee
Confidence            444455567888899999999999999986          249999987532      2489999999999999999999


Q ss_pred             eEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC
Q 014034          146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF  225 (432)
Q Consensus       146 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~  225 (432)
                      |+|..++.     .+|+.+|+|.+|+.+|+... ..+...+...|+.|+++||.|||.+   +|||||||..||++.+++
T Consensus       455 G~~~~p~~-----AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~  525 (678)
T KOG0193|consen  455 GACMNPPL-----AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDL  525 (678)
T ss_pred             hhhcCCce-----eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCC
Confidence            99987653     89999999999999997655 4688899999999999999999998   999999999999999999


Q ss_pred             ceeeccccCCcCCCCCCCcccccccccCCCccCcccccc---CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014034          226 RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET---GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  302 (432)
Q Consensus       226 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  302 (432)
                      .|||+|||++.....-..........|...|||||+++.   .+|+..+||||||+|+|||+||..||.....+  +.+.
T Consensus       526 kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d--qIif  603 (678)
T KOG0193|consen  526 KVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD--QIIF  603 (678)
T ss_pred             cEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh--heEE
Confidence            999999999864222122223344568889999999964   57899999999999999999999999843221  1110


Q ss_pred             HHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          303 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                      ...+.+          ..+++. .....++.++.+|+..||..++++||.+.+|+..|+.++..
T Consensus       604 mVGrG~----------l~pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  604 MVGRGY----------LMPDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             Eecccc----------cCccch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            000000          011111 11235567899999999999999999999999999888753

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.3e-43  Score=336.34  Aligned_cols=248  Identities=26%  Similarity=0.426  Sum_probs=198.8

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .|+..+.||+|+||.||+|...       .+++.||+|.+....       ..+.+|+.++..++|+||+++++++...+
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~   73 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVR-------ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD   73 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEe-------cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC
Confidence            3778889999999999999875       467899999876432       13678999999999999999999887654


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..++||||+++|+|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus        74 ----~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Df  146 (285)
T cd05631          74 ----ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDL  146 (285)
T ss_pred             ----eEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeC
Confidence                359999999999999888765545789999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHHHhhcccC
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWVQQYPAD  311 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~  311 (432)
                      |++.....   ........||..|+|||++.+..++.++|||||||++|+|++|..||......... .+...+...   
T Consensus       147 g~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~---  220 (285)
T cd05631         147 GLAVQIPE---GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED---  220 (285)
T ss_pred             CCcEEcCC---CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc---
Confidence            99875321   11223457899999999999999999999999999999999999999865432211 111111100   


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-----MSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  359 (432)
                                  ...++...+..+.+|+.+||+.||.+||+     +.+++++
T Consensus       221 ------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         221 ------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             ------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence                        00112223467889999999999999997     7888765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.8e-43  Score=346.56  Aligned_cols=261  Identities=25%  Similarity=0.379  Sum_probs=202.0

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhccc-CCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVL-EHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~hpniv~l~~~~~~~  151 (432)
                      .++|++.+.||+|+||.||+|++....  ...++..||+|+++...     ..+.+|+.++..+ +||||++++++|...
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~--~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLF--KSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccc--cCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            347999999999999999999864211  22456789999986432     2477899999999 899999999999776


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCC-----------------------------------------------------
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRA-----------------------------------------------------  178 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------  178 (432)
                      +.    .++||||+++|+|.+++....                                                     
T Consensus       112 ~~----~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  187 (375)
T cd05104         112 GP----TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR  187 (375)
T ss_pred             Cc----ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence            54    499999999999999986432                                                     


Q ss_pred             --------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCC
Q 014034          179 --------------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG  238 (432)
Q Consensus       179 --------------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~  238 (432)
                                          ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~  264 (375)
T cd05104         188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI  264 (375)
T ss_pred             ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceec
Confidence                                12478889999999999999999998   9999999999999999999999999999753


Q ss_pred             CCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcccccc
Q 014034          239 PMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGL  317 (432)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (432)
                      .............++..|+|||++.+..++.++|||||||++|||++ |..||.......  .....+.....       
T Consensus       265 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~~~~-------  335 (375)
T cd05104         265 RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIKEGYR-------  335 (375)
T ss_pred             cCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHHhCcc-------
Confidence            22221112223345678999999999999999999999999999998 889987643321  12222111000       


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          318 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       318 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                         .    ..+...+..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus       336 ---~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         336 ---M----LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             ---C----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence               0    00111235788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-44  Score=326.69  Aligned_cols=269  Identities=26%  Similarity=0.357  Sum_probs=210.4

Q ss_pred             HhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc------ChHHHHHHHHHhcccCCCccceeeeEEe
Q 014034           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLGVLEHPNLVKLIGYCA  149 (432)
Q Consensus        76 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~  149 (432)
                      .....|..++.||+|+||.|+.|..+       .++..||||++..      ...+..+|+++|+.++|+||+.+++++.
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~-------~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~   91 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDK-------RTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFR   91 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEc-------CCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecc
Confidence            34456777899999999999999866       5679999999873      2335788999999999999999999987


Q ss_pred             e-cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCcee
Q 014034          150 V-DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  228 (432)
Q Consensus       150 ~-~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k  228 (432)
                      . ........|+|+|+| +.+|...|+.+.  .++...+..++.|+++||.|+|+.   +|+||||||+|+|++.++.+|
T Consensus        92 p~~~~~f~DvYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lK  165 (359)
T KOG0660|consen   92 PPSRDKFNDVYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLK  165 (359)
T ss_pred             cccccccceeEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEE
Confidence            6 222344579999999 779999986543  599999999999999999999998   999999999999999999999


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCccccc-cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  307 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  307 (432)
                      |+|||+|+..........-+..+-|.+|.|||++. ...|+.+.||||.|||+.||++|++-|.|.+......++..+..
T Consensus       166 I~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lG  245 (359)
T KOG0660|consen  166 ICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLG  245 (359)
T ss_pred             eccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcC
Confidence            99999999753322233345678899999999874 56899999999999999999999999998776655444433322


Q ss_pred             cccCcccccccc---------------CccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          308 YPADSKKFGLIM---------------DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       308 ~~~~~~~~~~~~---------------~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .|.. ..+..+.               ...+...++ .......+|+.+||..||.+|+|++|.+.+
T Consensus       246 tP~~-e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  246 TPSE-EDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             CCCH-HHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            2211 1111111               000111112 334567799999999999999999999988

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.5e-43  Score=346.71  Aligned_cols=261  Identities=25%  Similarity=0.389  Sum_probs=202.8

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhccc-CCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVL-EHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  152 (432)
                      ++|++.+.||+|+||.||+|.......  ..+...||+|.+....     ..+.+|+.+++.+ +||||++++++|...+
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGK--EDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCc--ccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            479999999999999999998753321  2345689999986532     2477899999999 8999999999987655


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCC------------------------------------------------------
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRA------------------------------------------------------  178 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------  178 (432)
                      .    .++||||+++|+|.+++....                                                      
T Consensus       116 ~----~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         116 P----VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             C----eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            3    499999999999999985421                                                      


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCCCCCCc
Q 014034          179 --------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT  244 (432)
Q Consensus       179 --------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~  244 (432)
                                    ..++++..++.++.||+.||.|||++   +|+||||||+|||+++++.+||+|||+++........
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence                          12478889999999999999999998   9999999999999999999999999999753222111


Q ss_pred             ccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccccccccCccc
Q 014034          245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRL  323 (432)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  323 (432)
                      .......++..|||||++.+..++.++|||||||++|+|++ |..||........  ........              .
T Consensus       269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~~~~~~~--------------~  332 (374)
T cd05106         269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FYKMVKRG--------------Y  332 (374)
T ss_pred             eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HHHHHHcc--------------c
Confidence            12223345678999999998899999999999999999997 9999976533211  11111110              0


Q ss_pred             cCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 014034          324 EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  364 (432)
Q Consensus       324 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  364 (432)
                      ....+...+..+.+++.+||+.||.+|||+.+|++.|++++
T Consensus       333 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         333 QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            00011112467889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=9.4e-43  Score=333.36  Aligned_cols=266  Identities=26%  Similarity=0.427  Sum_probs=200.6

Q ss_pred             cCCccccccccCCceEEEEEEecCCCC---------CCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCcccee
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAG---------DGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKL  144 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~---------~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l  144 (432)
                      ++|.+.+.||+|+||.||+|.+.....         .....+..||+|.+....     ..+.+|+.++..++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578899999999999999998652210         112345689999986532     247889999999999999999


Q ss_pred             eeEEeecCCcceeEEEEEeecCCCCHHHHhhcCC-----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 014034          145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-----------------FPPLPWKTRLHIILGAAEGLAYLHEGLEV  207 (432)
Q Consensus       145 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~  207 (432)
                      ++++...+.    .++||||+.+++|.+++....                 ...+++..++.++.||+.||.|||+.   
T Consensus        85 ~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---  157 (304)
T cd05096          85 LGVCVDEDP----LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---  157 (304)
T ss_pred             EEEEecCCc----eEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---
Confidence            999976543    499999999999999985432                 12467889999999999999999998   


Q ss_pred             ceeecCCCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh--
Q 014034          208 QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT--  285 (432)
Q Consensus       208 ~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--  285 (432)
                      +|+||||||+|||++.++.+||+|||+++...............++..|+|||++.++.++.++||||||+++|+|++  
T Consensus       158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~  237 (304)
T cd05096         158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC  237 (304)
T ss_pred             CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence            999999999999999999999999999975322222222233456789999999988899999999999999999987  


Q ss_pred             CCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          286 GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       286 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                      +..||.......   ...............   ..    ...+..++..+.+|+.+||+.||.+|||+.+|.+.|+
T Consensus       238 ~~~p~~~~~~~~---~~~~~~~~~~~~~~~---~~----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         238 KEQPYGELTDEQ---VIENAGEFFRDQGRQ---VY----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCCCCcCCHHH---HHHHHHHHhhhcccc---cc----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            567777654322   111111110000000   00    0011223467889999999999999999999988875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=367.36  Aligned_cols=263  Identities=29%  Similarity=0.458  Sum_probs=212.9

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      +......||+|.||.||.|.+...+++..  ...||||.+.+..     ..|.+|..+|+.++|||||+++|+|...+..
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~--~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVS--PIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCcc--ceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            45567789999999999999985554322  5679999998653     3499999999999999999999999986544


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRA-----FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                          ++++|||.+|+|..||++..     ...++....+.++.|||+|+.||+++   ++|||||..+|+||+....+||
T Consensus       771 ----~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKI  843 (1025)
T KOG1095|consen  771 ----LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKI  843 (1025)
T ss_pred             ----EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEE
Confidence                99999999999999998751     34688999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhc
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      +|||+|+...............-...|||||.+..+.++.++|||||||++||++| |..||...+.......  +..  
T Consensus       844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~--~~~--  919 (1025)
T KOG1095|consen  844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD--VLE--  919 (1025)
T ss_pred             cccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH--HHh--
Confidence            99999995322222222221123458999999999999999999999999999999 9999987654332211  111  


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhcc
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  368 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  368 (432)
                                 ..++  ..+..++..+.+||..||+.+|++||++..|++++..+.+...
T Consensus       920 -----------ggRL--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~  966 (1025)
T KOG1095|consen  920 -----------GGRL--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL  966 (1025)
T ss_pred             -----------CCcc--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence                       1111  2245667889999999999999999999999999998876654

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-43  Score=346.44  Aligned_cols=242  Identities=26%  Similarity=0.426  Sum_probs=202.0

Q ss_pred             HHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhccc-CCCccceeee
Q 014034           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVL-EHPNLVKLIG  146 (432)
Q Consensus        75 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~hpniv~l~~  146 (432)
                      ....++|..++.||+|+||+|+++.++       .+++.+|||.++++.       .....|..|+... +||.++.++.
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k-------~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~  436 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELK-------GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFS  436 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEc-------CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccc
Confidence            445678999999999999999999987       567899999998753       2367788888776 4999999999


Q ss_pred             EEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCc
Q 014034          147 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR  226 (432)
Q Consensus       147 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~  226 (432)
                      .|....    ++|+||||+.||++..+++.   ..+++..+.-++..|+.||+|||++   +|||||||.+|||||.+|.
T Consensus       437 ~fQT~~----~l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh  506 (694)
T KOG0694|consen  437 CFQTKE----HLFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGH  506 (694)
T ss_pred             ccccCC----eEEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCc
Confidence            987655    45999999999996555432   3699999999999999999999999   9999999999999999999


Q ss_pred             eeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 014034          227 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  306 (432)
Q Consensus       227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  306 (432)
                      +||+|||+++....  ......+++||+.|||||++.+..|+.++|+|||||+|||||.|..||.+.+..+..+-     
T Consensus       507 ~kiADFGlcKe~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fds-----  579 (694)
T KOG0694|consen  507 VKIADFGLCKEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDS-----  579 (694)
T ss_pred             EEecccccccccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-----
Confidence            99999999997432  33456789999999999999999999999999999999999999999997654432211     


Q ss_pred             hcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 014034          307 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM  353 (432)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  353 (432)
                                 ++..  ...+|...+.+...|+.++|..+|++|.-+
T Consensus       580 -----------I~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  580 -----------IVND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -----------HhcC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence                       1111  113455566788899999999999999865

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.8e-42  Score=327.69  Aligned_cols=258  Identities=28%  Similarity=0.496  Sum_probs=205.7

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|++.+.||+|+||.||+|......  .......||+|.+....     ..+.+|+.++..++||||+++++++.....
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPN--ERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP   82 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCC--CCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence            47889999999999999999876322  12355789999986432     247889999999999999999999876543


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCce
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAF--------------PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNV  219 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Ni  219 (432)
                          .+++|||+++++|.+++.....              ..+++..++.++.|++.||.|||+.   +++|+||||+||
T Consensus        83 ----~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Ni  155 (283)
T cd05048          83 ----TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNC  155 (283)
T ss_pred             ----eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceE
Confidence                4899999999999999965421              4578899999999999999999998   999999999999


Q ss_pred             EEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhh
Q 014034          220 LLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTE  298 (432)
Q Consensus       220 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~  298 (432)
                      ++++++.++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.+..... 
T Consensus       156 l~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-  234 (283)
T cd05048         156 LVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-  234 (283)
T ss_pred             EEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-
Confidence            999999999999999875322222222334456889999999988899999999999999999998 999998765432 


Q ss_pred             HHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 014034          299 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  362 (432)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  362 (432)
                        +...+....              ....+...+..+.+|+.+||+.||.+||++.+|+++|+.
T Consensus       235 --~~~~i~~~~--------------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         235 --VIEMIRSRQ--------------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             --HHHHHHcCC--------------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence              222221110              001123345788999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.2e-42  Score=324.50  Aligned_cols=255  Identities=25%  Similarity=0.392  Sum_probs=202.5

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|++.+.||+|+||.||+|.+...    ...+..||+|.+....     ..+.+|+.++..++||||+++++++...+ 
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~----~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-   79 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLP----SKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN-   79 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecC----CCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC-
Confidence            4688999999999999999987522    2356899999987542     24788999999999999999999987654 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.++++|||
T Consensus        80 ---~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg  152 (266)
T cd05064          80 ---TMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFR  152 (266)
T ss_pred             ---CcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCc
Confidence               3599999999999999987643 4689999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      .+....... ........++..|+|||.+.+..++.++|||||||++||+++ |..||.......   ....+....   
T Consensus       153 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~~~~---  225 (266)
T cd05064         153 RLQEDKSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKAVEDGF---  225 (266)
T ss_pred             ccccccccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHHCCC---
Confidence            876421111 111112345678999999999999999999999999999875 999998664432   222221110   


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                             ..    ..+...+..+.+++.+||+.+|.+||++.+|++.|..+
T Consensus       226 -------~~----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         226 -------RL----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -------CC----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                   00    11223456788999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-43  Score=343.76  Aligned_cols=263  Identities=29%  Similarity=0.473  Sum_probs=209.7

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEe
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCA  149 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~  149 (432)
                      ..++....++||+|.||.||+|+++..++.   ....||||....+       ...+.+|+++|++++|||||++||++.
T Consensus       155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~---~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGF---KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             eccCccccceeecccccEEEEEEEEecCCc---eeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            345566678999999999999999844321   1223999998742       224899999999999999999999998


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      .....    ++|||+|.||+|.++|..... .++..++..++.+.|.||+|||++   +++||||..+|+|++.++.+||
T Consensus       232 ~~~Pl----~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKI  303 (474)
T KOG0194|consen  232 LEEPL----MLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKI  303 (474)
T ss_pred             CCCcc----EEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEe
Confidence            76654    999999999999999987653 699999999999999999999999   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCCccccc-ccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhh
Q 014034          230 SDFGLAREGPMVGHTHVST-AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQ  307 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~  307 (432)
                      +|||+++...   ...... ...-...|+|||.+..+.|+.++|||||||++||+++ |..||.+......   ..++..
T Consensus       304 SDFGLs~~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v---~~kI~~  377 (474)
T KOG0194|consen  304 SDFGLSRAGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV---KAKIVK  377 (474)
T ss_pred             CccccccCCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH---HHHHHh
Confidence            9999998642   111111 1234568999999999999999999999999999999 8899988765432   222211


Q ss_pred             cccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhccC
Q 014034          308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNE  369 (432)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~  369 (432)
                                   .......+...+..+..++.+||..+|++||||.++.+.|+.+......
T Consensus       378 -------------~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  378 -------------NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             -------------cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence                         0011112224456788899999999999999999999999998766543

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=9.3e-43  Score=330.87  Aligned_cols=264  Identities=26%  Similarity=0.388  Sum_probs=198.5

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|+..+.||.|+||.||+|...       .++..||+|.+...     ...+.+|+.+++.++||||+++++++....
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   76 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSK-------LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTER   76 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEEC-------CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            357999999999999999999865       46788999988632     224778999999999999999999987544


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        77 ----~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  147 (288)
T cd07871          77 ----CLTLVFEYLD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADF  147 (288)
T ss_pred             ----eEEEEEeCCC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcC
Confidence                4589999996 49999886543 3578999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      |+++.....  ........|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+................+..
T Consensus       148 G~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  225 (288)
T cd07871         148 GLARAKSVP--TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTE  225 (288)
T ss_pred             cceeeccCC--CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            998753211  112234568999999999865 56899999999999999999999999876544332222111111110


Q ss_pred             c--------cccccccCccccCc----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 S--------KKFGLIMDPRLEKE----YSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~--------~~~~~~~~~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .        ..+.....+.....    .....+..+.+|+.+||..||.+|||+.|++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         226 ETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             HHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0        00000111110000    001123567899999999999999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.6e-43  Score=330.67  Aligned_cols=264  Identities=25%  Similarity=0.324  Sum_probs=199.1

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      ++|.+.+.||+|+||.||+|+++       .++..||+|++...      ...+.+|+.+++.++||||+++++++..++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   73 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHK-------ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG   73 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEEC-------CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCC
Confidence            46899999999999999999875       46788999988643      224778999999999999999999987654


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..++||||+.++++..+...  ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus        74 ----~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Df  144 (287)
T cd07848          74 ----KLYLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDF  144 (287)
T ss_pred             ----EEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeec
Confidence                45999999998777655432  24689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH-hhcccC
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV-QQYPAD  311 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~  311 (432)
                      |++...... .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+............. ...+..
T Consensus       145 g~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  223 (287)
T cd07848         145 GFARNLSEG-SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAE  223 (287)
T ss_pred             cCccccccc-ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHH
Confidence            999753221 111223457899999999999888999999999999999999999999875543322111111 010000


Q ss_pred             -------ccccccccCccc------cCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 -------SKKFGLIMDPRL------EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 -------~~~~~~~~~~~l------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                             ...+.....+..      ........+..+.+|+.+||+.||++|||+.+++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         224 QMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             HHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                   000000000000      001111234678999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.1e-42  Score=332.87  Aligned_cols=258  Identities=23%  Similarity=0.374  Sum_probs=203.0

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      .+|+..+.||+|+||.||+|.+...   +......||+|.+...     ...+.+|+.+++.++||||++++++|.... 
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~-   82 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPE---GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   82 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecC---CCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCC-
Confidence            4799999999999999999987521   2233556999998643     234788999999999999999999987542 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                          .++|++|+++|+|.+++.... ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        83 ----~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG  154 (316)
T cd05108          83 ----VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFG  154 (316)
T ss_pred             ----ceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccc
Confidence                379999999999999997643 3588999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      +++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.+........+   ......  
T Consensus       155 ~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~---~~~~~~--  229 (316)
T cd05108         155 LAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---LEKGER--  229 (316)
T ss_pred             ccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HhCCCC--
Confidence            9986432222112222334678999999999999999999999999999998 9999986543322211   111100  


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                              .    ..+..++..+.+++.+||..+|.+||++.+++..|..+..
T Consensus       230 --------~----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         230 --------L----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             --------C----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence                    0    0011123467899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.2e-42  Score=334.91  Aligned_cols=261  Identities=26%  Similarity=0.386  Sum_probs=202.4

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|++++.||+|+||.||++...       .++..||+|.+....     ..+.+|+++++.++||||+++++++..++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHK-------PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG   76 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEEC-------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            368999999999999999999865       467889999886532     24789999999999999999999987654


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..++||||+++++|.+++....  .+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+||
T Consensus        77 ----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Df  148 (331)
T cd06649          77 ----EISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDF  148 (331)
T ss_pred             ----EEEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccC
Confidence                3599999999999999996543  689999999999999999999985  26999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      |++.....    .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........   +.......
T Consensus       149 g~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~---~~~~~~~~  221 (331)
T cd06649         149 GVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI---FGRPVVDG  221 (331)
T ss_pred             cccccccc----cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---hccccccc
Confidence            99875321    122345799999999999999999999999999999999999999976543222111   11100000


Q ss_pred             --cc-------------------------------cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          313 --KK-------------------------------FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       313 --~~-------------------------------~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                        ..                               ...+.............+..+.+||.+||+.||++|||+.+|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         222 EEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             ccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence              00                               000000000000111235678999999999999999999999987


Q ss_pred             H
Q 014034          360 L  360 (432)
Q Consensus       360 L  360 (432)
                      .
T Consensus       302 ~  302 (331)
T cd06649         302 T  302 (331)
T ss_pred             h
Confidence            4

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1e-42  Score=335.99  Aligned_cols=239  Identities=27%  Similarity=0.384  Sum_probs=193.8

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeecCCccee
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQ  157 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~  157 (432)
                      +.||+|+||.||++...       .+++.||+|.+....       ..+.+|+.+++.++||||+++++++...+    .
T Consensus         1 ~~lG~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~----~   69 (323)
T cd05571           1 KLLGKGTFGKVILVREK-------ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD----R   69 (323)
T ss_pred             CeeeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC----E
Confidence            36999999999999865       467899999986532       23678999999999999999999887654    4


Q ss_pred             EEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          158 RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       158 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      .++||||+.+++|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        70 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~  144 (323)
T cd05571          70 LCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKE  144 (323)
T ss_pred             EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcc
Confidence            59999999999999998654  3689999999999999999999998   999999999999999999999999999875


Q ss_pred             CCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccccc
Q 014034          238 GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGL  317 (432)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (432)
                      ...  .........||+.|+|||++.+..++.++|||||||++|||++|..||.......   +...+...         
T Consensus       145 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~~~~~---------  210 (323)
T cd05571         145 GIS--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELILME---------  210 (323)
T ss_pred             ccc--CCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HHHHHHcC---------
Confidence            221  1222334679999999999999999999999999999999999999997654322   11111110         


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 014034          318 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  359 (432)
Q Consensus       318 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  359 (432)
                        ...    ++...+..+.+|+.+||..||.+||     ++.+++++
T Consensus       211 --~~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         211 --EIR----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             --CCC----CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence              001    1122346688999999999999999     79998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.2e-42  Score=335.52  Aligned_cols=263  Identities=26%  Similarity=0.397  Sum_probs=204.6

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhccc-CCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVL-EHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  152 (432)
                      ++|++.+.||+|+||.||+|......  +..+++.||+|++....     ..+..|+.++..+ +||||++++++|...+
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~--~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIE--KSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccc--cccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            46999999999999999999764221  22456899999986422     2367899999999 8999999999887543


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCC------------------------------------------------------
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRA------------------------------------------------------  178 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------  178 (432)
                      .   ..+++|||+++++|.+++....                                                      
T Consensus        85 ~---~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          85 G---PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             C---CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            2   4589999999999999985422                                                      


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccC
Q 014034          179 -----FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT  253 (432)
Q Consensus       179 -----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt  253 (432)
                           ..++++..+..++.||+.||.|||+.   +|+||||||+|||++.++.++|+|||++................++
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~  238 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP  238 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence                 12688999999999999999999998   9999999999999999999999999999764222212222334567


Q ss_pred             CCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHH
Q 014034          254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEA  332 (432)
Q Consensus       254 ~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  332 (432)
                      ..|+|||++.+..++.++|||||||++|||++ |..||.+......  +...+....          ..    ..+...+
T Consensus       239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~~~~~~~----------~~----~~~~~~~  302 (337)
T cd05054         239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCRRLKEGT----------RM----RAPEYAT  302 (337)
T ss_pred             ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHHHHhccC----------CC----CCCccCC
Confidence            78999999999999999999999999999998 9999976433221  111111100          00    0111234


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          333 RKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       333 ~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                      ..+.+++.+||+.+|++||++.+|+++|+.+++
T Consensus       303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            568899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-43  Score=331.72  Aligned_cols=242  Identities=24%  Similarity=0.327  Sum_probs=197.5

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|+..+.||+|+||.||+|...       .+++.||+|.+...       ...+.+|+.+++.++||||+++++++.+.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   73 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDR-------ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ   73 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEc-------CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC
Confidence            36889999999999999999865       45788999998642       22377899999999999999999887654


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      .    ..++||||+++++|.+++....  .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        74 ~----~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~D  144 (291)
T cd05612          74 R----FLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTD  144 (291)
T ss_pred             C----eEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEe
Confidence            3    4599999999999999997543  689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ||++.....     ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+......   ...+....  
T Consensus       145 fg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~--  214 (291)
T cd05612         145 FGFAKKLRD-----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI---YEKILAGK--  214 (291)
T ss_pred             cCcchhccC-----CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhCC--
Confidence            999875321     12245699999999999998999999999999999999999999987544321   11111110  


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-----MSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  359 (432)
                               .    ..+...+..+.+|+.+||+.||.+||+     +.+++++
T Consensus       215 ---------~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         215 ---------L----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ---------c----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence                     0    011122456889999999999999995     8888766

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.3e-42  Score=348.38  Aligned_cols=269  Identities=23%  Similarity=0.301  Sum_probs=200.4

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHHHHHHHhcccCCCccceeeeEEeecC----
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDG----  152 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----  152 (432)
                      ...+|.+++.||+|+||.||+|...       .++..||||++........+|+.+|+.++||||+++++++....    
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~-------~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICI-------DTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEEC-------CCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            3467999999999999999999865       45788999998776666778999999999999999998875432    


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC-ceee
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF-RPKL  229 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl  229 (432)
                      .....+++||||++ ++|.+++..  .....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++ .+||
T Consensus       137 ~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL  212 (440)
T PTZ00036        137 EKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKL  212 (440)
T ss_pred             CCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceee
Confidence            22335679999996 477776643  2345789999999999999999999998   999999999999998665 6999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHHHhh
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR-LLEWVQQ  307 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~~~  307 (432)
                      +|||+++.....   .......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+........ +......
T Consensus       213 ~DFGla~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~  289 (440)
T PTZ00036        213 CDFGSAKNLLAG---QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT  289 (440)
T ss_pred             eccccchhccCC---CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            999999853221   12234578999999999865 468999999999999999999999998765433211 1111110


Q ss_pred             cccC-----cccc-----ccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          308 YPAD-----SKKF-----GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       308 ~~~~-----~~~~-----~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ....     ...+     ..+....+...++...+..+.+|+.+||..||.+|||+.+++.+
T Consensus       290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            0000     0000     00001111111222334678899999999999999999999977

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-42  Score=337.45  Aligned_cols=250  Identities=24%  Similarity=0.364  Sum_probs=201.2

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|++.+.||+|+||.||+|...       .++..||+|++....       ..+.+|+.++..++||||+++++++...
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~   73 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKK-------DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD   73 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEEC-------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC
Confidence            47899999999999999999875       456789999986532       2367899999999999999999988765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ..++||||+++++|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        74 ~----~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~D  144 (333)
T cd05600          74 E----YLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTD  144 (333)
T ss_pred             C----EEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEe
Confidence            4    459999999999999999654  3689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ||++.....     ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+   ......
T Consensus       145 fg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i---~~~~~~  216 (333)
T cd05600         145 FGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL---KYWKET  216 (333)
T ss_pred             CcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH---Hhcccc
Confidence            999975321     234467999999999999999999999999999999999999999876543322111   111000


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                            +..+... ......+..+.+|+.+||..+|.+||++.+++++
T Consensus       217 ------~~~~~~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         217 ------LQRPVYD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ------ccCCCCC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence                  0000000 0001234678899999999999999999999987

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.1e-42  Score=336.80  Aligned_cols=245  Identities=27%  Similarity=0.405  Sum_probs=190.8

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      .+|+.++.||+|+||.||+|.+.       .+++.||||.+....     ..+.+|+++++.++|+||+++++++...+ 
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-  145 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHR-------PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG-  145 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEEC-------CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC-
Confidence            45777889999999999999865       457889999985432     34788999999999999999999986654 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+.+++|.+..      ...+..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       146 ---~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG  213 (353)
T PLN00034        146 ---EIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFG  213 (353)
T ss_pred             ---eEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccc
Confidence               358999999999987542      356778889999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCcccccc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIET-----GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      +++.....  ........||..|+|||++..     ...+.++|||||||++|||++|..||..............+...
T Consensus       214 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  291 (353)
T PLN00034        214 VSRILAQT--MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS  291 (353)
T ss_pred             cceecccc--cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc
Confidence            98753211  112234579999999998843     23456899999999999999999999743332222222111100


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .          .+    ..+...+..+.+||.+||..||++|||+.+|+++
T Consensus       292 ~----------~~----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        292 Q----------PP----EAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             C----------CC----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0          00    1122334678899999999999999999999987

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.9e-42  Score=318.00  Aligned_cols=269  Identities=26%  Similarity=0.332  Sum_probs=207.6

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH------HHHHHHHHhcccCCCc-cceeeeEEee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFLGVLEHPN-LVKLIGYCAV  150 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~hpn-iv~l~~~~~~  150 (432)
                      ...|..+++||+|+||+||+|+.+       .++..||+|+++-+..      ...+|+.+|+.|+|+| |+.+++++..
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~-------~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~   82 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSK-------RTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHT   82 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEe-------cCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeee
Confidence            345778888999999999999976       5678999999876543      3689999999999999 9999999987


Q ss_pred             cCC--cceeEEEEEeecCCCCHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCc
Q 014034          151 DGE--RGIQRLLVYEFMLNRSLEDHLFNRAF--PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR  226 (432)
Q Consensus       151 ~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~  226 (432)
                      ...  ....+++|+||+ .-+|..++.....  ..++...+..++.||+.||+|||++   +|+||||||+||||+..|.
T Consensus        83 ~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~  158 (323)
T KOG0594|consen   83 SNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGV  158 (323)
T ss_pred             cccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCc
Confidence            652  223468999999 5699999976553  3677789999999999999999999   9999999999999999999


Q ss_pred             eeeccccCCcCCCCCCCcccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 014034          227 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  305 (432)
Q Consensus       227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  305 (432)
                      +||+|||+|+....  .....+..++|.+|.|||++.+. .|+...||||+|||++||++++.-|.+.........+-.+
T Consensus       159 lKlaDFGlAra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~  236 (323)
T KOG0594|consen  159 LKLADFGLARAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRL  236 (323)
T ss_pred             EeeeccchHHHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence            99999999985322  22234567899999999999876 7999999999999999999999999987765544333333


Q ss_pred             hhcccCccccccccCcc----ccCc-----CCHHH---HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          306 QQYPADSKKFGLIMDPR----LEKE-----YSINE---ARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       306 ~~~~~~~~~~~~~~~~~----l~~~-----~~~~~---~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ...|.....-....-+.    +...     .....   .....+++.+||+.+|.+|.|+..++.+
T Consensus       237 lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  237 LGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            33222211000000010    0000     01111   1367899999999999999999999887

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-42  Score=336.34  Aligned_cols=242  Identities=26%  Similarity=0.385  Sum_probs=197.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|.+.+.||+|+||.||+|.+.       .+++.||+|.+....       ..+.+|+.+++.++||||+++++++...
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   90 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHK-------GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE   90 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEEC-------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence            57999999999999999999875       457889999986432       2477899999999999999999998765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ..++||||+.+++|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        91 ~----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~D  161 (329)
T PTZ00263         91 N----RVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTD  161 (329)
T ss_pred             C----EEEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEee
Confidence            4    4599999999999999997643  688999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ||++.....     ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..+..   ....+....  
T Consensus       162 fg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~i~~~~--  231 (329)
T PTZ00263        162 FGFAKKVPD-----RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR---IYEKILAGR--  231 (329)
T ss_pred             ccCceEcCC-----CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH---HHHHHhcCC--
Confidence            999975321     1223579999999999999999999999999999999999999997654322   111111100  


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-----MSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  359 (432)
                               ..    .+...+..+.+|+.+||+.||.+||+     +.+++.+
T Consensus       232 ---------~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        232 ---------LK----FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             ---------cC----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                     00    11112356789999999999999997     6788766

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.9e-42  Score=339.36  Aligned_cols=263  Identities=21%  Similarity=0.340  Sum_probs=203.8

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccC-CCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLE-HPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-hpniv~l~~~~~~~  151 (432)
                      .++|++++.||+|+||.||+|++....  ....+..||||++....     ..+.+|+.++..+. ||||+++++++...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~--~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLS--RSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccC--CCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            468999999999999999999864221  22345679999986432     34788999999996 99999999999765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCC-----------------------------------------------------
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRA-----------------------------------------------------  178 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------  178 (432)
                      +    ..++||||+++|+|.++|....                                                     
T Consensus       114 ~----~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (400)
T cd05105         114 G----PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV  189 (400)
T ss_pred             C----ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence            4    3599999999999999885421                                                     


Q ss_pred             -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCC
Q 014034          179 -----------------------------------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKAS  217 (432)
Q Consensus       179 -----------------------------------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~  217 (432)
                                                               ...+++..+..++.|++.||.|||+.   +|+||||||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~  266 (400)
T cd05105         190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAAR  266 (400)
T ss_pred             hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChH
Confidence                                                     12478888999999999999999998   9999999999


Q ss_pred             ceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCch
Q 014034          218 NVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPK  296 (432)
Q Consensus       218 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~  296 (432)
                      |||++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus       267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~  346 (400)
T cd05105         267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD  346 (400)
T ss_pred             hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence            99999999999999999875322221112223456788999999998899999999999999999997 99999764322


Q ss_pred             hhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          297 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                      ..  ....+....          ..    ..+...+..+.+++.+||+.||++|||+.+|.+.|+.+..
T Consensus       347 ~~--~~~~~~~~~----------~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         347 ST--FYNKIKSGY----------RM----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HH--HHHHHhcCC----------CC----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            11  111111100          00    1122335678899999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.7e-43  Score=336.16  Aligned_cols=250  Identities=26%  Similarity=0.416  Sum_probs=211.9

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|..+++||+|+||.++..+++       .+...+++|.+.-..      ....+|+.+++++.|||||.+++.|..+
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk-------~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~   75 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHK-------SDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED   75 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhc-------cCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC
Confidence            357999999999999999998876       456789999986432      3478999999999999999999999876


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +.   ..+|||+||+||+|.+.|.+..+.-++++.+..|+.|++.|+.|||++   .|+|||||+.||+++.++.+||+|
T Consensus        76 ~~---~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgD  149 (426)
T KOG0589|consen   76 GQ---LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGD  149 (426)
T ss_pred             Cc---eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecc
Confidence            64   259999999999999999887777899999999999999999999987   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ||+|+....  ......+.+||+.||+||++.+.+|+.++|||||||++|||++-+++|...+...   ++..+..-   
T Consensus       150 fGlaK~l~~--~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~ki~~~---  221 (426)
T KOG0589|consen  150 FGLAKILNP--EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LILKINRG---  221 (426)
T ss_pred             hhhhhhcCC--chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHHHHhhc---
Confidence            999997432  2235567899999999999999999999999999999999999999998764432   22211110   


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                 .....+...+..+..||..|+..+|..||++.+++.+
T Consensus       222 -----------~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  222 -----------LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -----------cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                       1112344556789999999999999999999999987

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-42  Score=348.63  Aligned_cols=267  Identities=23%  Similarity=0.304  Sum_probs=213.2

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH----HHHHHHHHhcccC-CCccceeee-EEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL----QWVAEVQFLGVLE-HPNLVKLIG-YCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~-hpniv~l~~-~~~~~  151 (432)
                      ..++++.+.|.+|||+.||+|...       ..+..+|+|++--...    ...+|+.+|+.|. |+|||.+++ .....
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~-------~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~  108 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDV-------KGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR  108 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEec-------CCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence            346788899999999999999865       3338899998743322    3688999999996 999999999 33332


Q ss_pred             -CCc-ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          152 -GER-GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       152 -~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                       +.. ..+.+|.||||.||+|-+++..+....|++.++++|+.|+++|+.+||.. .++|||||||-+||||+.+|..||
T Consensus       109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KL  187 (738)
T KOG1989|consen  109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKL  187 (738)
T ss_pred             cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEe
Confidence             222 35678999999999999999877666799999999999999999999996 568999999999999999999999


Q ss_pred             ccccCCcCCCCCCCcc-------cccccccCCCccCcccc---ccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhH
Q 014034          230 SDFGLAREGPMVGHTH-------VSTAVVGTFGYAAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ  299 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~  299 (432)
                      ||||.+..........       .......|+.|+|||.+   .+.++++|+|||+|||+||-|+....||+......  
T Consensus       188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la--  265 (738)
T KOG1989|consen  188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA--  265 (738)
T ss_pred             CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee--
Confidence            9999987422111111       11233579999999987   57889999999999999999999999998642211  


Q ss_pred             HHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhccCCCC
Q 014034          300 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDS  372 (432)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~~  372 (432)
                                        +++..+........+..|.+||..||+.||++||++-+++..+..+........+
T Consensus       266 ------------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~  320 (738)
T KOG1989|consen  266 ------------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPD  320 (738)
T ss_pred             ------------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccc
Confidence                              3333333333456778999999999999999999999999999998876654433

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3e-42  Score=334.66  Aligned_cols=266  Identities=24%  Similarity=0.350  Sum_probs=197.7

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      +|++.+.||+|+||.||+|...       .++..||||.+...      ...+.+|+.+++.++||||+++++++.....
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   73 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDT-------HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR   73 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEEC-------CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCC
Confidence            4788899999999999999865       46789999988632      2247889999999999999999998865432


Q ss_pred             -cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          154 -RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       154 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                       .....++||||+ +++|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        74 ~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Df  147 (338)
T cd07859          74 REFKDIYVVFELM-ESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDF  147 (338)
T ss_pred             CCCceEEEEEecC-CCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccC
Confidence             223469999999 578999886543  689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCC-cccccccccCCCccCcccccc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          233 GLAREGPMVGH-THVSTAVVGTFGYAAPDYIET--GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       233 G~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      |+++....... ........||+.|+|||++.+  ..++.++|||||||++|+|++|..||.+.........+......+
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~  227 (338)
T cd07859         148 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTP  227 (338)
T ss_pred             ccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99975322111 111234579999999999865  678999999999999999999999998755432221111111100


Q ss_pred             cCcc-----------cccccc---CccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ADSK-----------KFGLIM---DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~~~-----------~~~~~~---~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ....           .+..+.   ...+...+ ...+..+.+++.+||+.||++|||+.+++++
T Consensus       228 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             CHHHHHHhhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0000           000000   00000000 0123567899999999999999999999987

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=5.4e-42  Score=325.67  Aligned_cols=268  Identities=25%  Similarity=0.398  Sum_probs=197.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhccc---CCCccceeeeEEe
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVL---EHPNLVKLIGYCA  149 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l---~hpniv~l~~~~~  149 (432)
                      ++|++.+.||+|+||.||+|....      ..+..||+|.+...      ...+.+|+.+++.+   +||||+++++++.
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~   74 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLK------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT   74 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcC------CCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEe
Confidence            368999999999999999998631      24678999987532      12356677776655   6999999999986


Q ss_pred             ecC-CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCcee
Q 014034          150 VDG-ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  228 (432)
Q Consensus       150 ~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k  228 (432)
                      ... ......++||||+. ++|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        75 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~k  150 (290)
T cd07862          75 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK  150 (290)
T ss_pred             cccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEE
Confidence            432 12334689999995 6999998766556789999999999999999999998   999999999999999999999


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHHHhh
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWVQQ  307 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~  307 (432)
                      |+|||++......   .......||+.|+|||.+.+..++.++|||||||++|||++|..||.+....... .+......
T Consensus       151 l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~  227 (290)
T cd07862         151 LADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL  227 (290)
T ss_pred             EccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC
Confidence            9999998753221   2233456899999999999889999999999999999999999999876543322 11111110


Q ss_pred             cccCccccc-----cccCcccc---CcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          308 YPADSKKFG-----LIMDPRLE---KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       308 ~~~~~~~~~-----~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .........     ....+...   .......+..+.+|+.+||+.||++|||+.+++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            000000000     00000000   00111234567899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.6e-42  Score=324.22  Aligned_cols=251  Identities=34%  Similarity=0.554  Sum_probs=195.0

Q ss_pred             cccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCCccee
Q 014034           83 RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQ  157 (432)
Q Consensus        83 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~  157 (432)
                      ..+.||.|.||.||+|.+..   .....+..|+||.+...     ...+.+|++.+++++||||++++|++...+.    
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~---~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~----   75 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQ---KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP----   75 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEES---TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS----
T ss_pred             EeeEEccCCCcEEEEEEEEc---ccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc----
Confidence            45679999999999999873   34457899999999542     2458899999999999999999999984443    


Q ss_pred             EEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          158 RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       158 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      .++||||+++|+|.++|.......+++..++.|+.|++.||.|||+.   +++|+||+++|||++.++.+||+|||++..
T Consensus        76 ~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~  152 (259)
T PF07714_consen   76 LFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRP  152 (259)
T ss_dssp             EEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence            58999999999999999887556799999999999999999999998   999999999999999999999999999976


Q ss_pred             CCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 014034          238 GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFG  316 (432)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (432)
                      ..............+...|+|||.+.+..++.++||||||+++|||++ |..||.......   +...+.....      
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~~~~~~~~~------  223 (259)
T PF07714_consen  153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---IIEKLKQGQR------  223 (259)
T ss_dssp             TTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HHHHHHTTEE------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccc------
Confidence            422222223334456789999999998889999999999999999999 789987663322   2222211110      


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       317 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                              ...+...+..+.++|..||..||.+|||+.+|++.|
T Consensus       224 --------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 --------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             --------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             --------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                    011122346788999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.5e-41  Score=318.20  Aligned_cols=253  Identities=26%  Similarity=0.410  Sum_probs=203.3

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh---HHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      .+|...+.||+|+||.||+|...       ..+..||+|.+..+.   ..+.+|+.+++.++||||+++++++..++.  
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-------~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--   76 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP--   76 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEe-------cCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCC--
Confidence            35888899999999999999875       457889999987553   347889999999999999999999876553  


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCC
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  235 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a  235 (432)
                        .++||||+++++|.+++.......+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++
T Consensus        77 --~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~  151 (263)
T cd05052          77 --FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS  151 (263)
T ss_pred             --cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccc
Confidence              48999999999999999765555789999999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      ....... ........++..|+|||.+.+..++.++|||||||++|+|++ |..||.+......   ...+...      
T Consensus       152 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~~~~~~~------  221 (263)
T cd05052         152 RLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELLEKG------  221 (263)
T ss_pred             cccccce-eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHHCC------
Confidence            7532211 111112234568999999998999999999999999999998 9999976543222   1111110      


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                              .....+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       222 --------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         222 --------YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             --------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                    00011222346788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=6e-42  Score=330.62  Aligned_cols=239  Identities=27%  Similarity=0.371  Sum_probs=192.7

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeecCCccee
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQ  157 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~  157 (432)
                      +.||+|+||.||++...       .++..||+|.+....       ..+.+|+.+++.++||||+++++++...+    .
T Consensus         1 ~~lG~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~----~   69 (323)
T cd05595           1 KLLGKGTFGKVILVREK-------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD----R   69 (323)
T ss_pred             CeeeeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC----E
Confidence            36999999999999865       467899999986532       23668999999999999999999887654    4


Q ss_pred             EEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          158 RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       158 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      .++||||+.+|+|..++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++..
T Consensus        70 ~~lv~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~  144 (323)
T cd05595          70 LCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE  144 (323)
T ss_pred             EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhcc
Confidence            599999999999999886543  689999999999999999999998   999999999999999999999999999874


Q ss_pred             CCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccccc
Q 014034          238 GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGL  317 (432)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (432)
                      ...  .........||+.|+|||++.+..++.++|||||||++|+|++|..||...........   +...         
T Consensus       145 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~---~~~~---------  210 (323)
T cd05595         145 GIS--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL---ILME---------  210 (323)
T ss_pred             ccC--CCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH---HhcC---------
Confidence            211  11222346799999999999999999999999999999999999999976543322111   1100         


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 014034          318 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  359 (432)
Q Consensus       318 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  359 (432)
                        ...    .+...+..+.+|+.+||..||.+||     ++.+++++
T Consensus       211 --~~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         211 --EIR----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             --CCC----CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence              001    1122345688999999999999998     88888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.5e-42  Score=338.06  Aligned_cols=262  Identities=21%  Similarity=0.272  Sum_probs=197.2

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHHHHHHHhcccCCCccceeeeEEeecCCccee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQ  157 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~  157 (432)
                      .++|.+++.||+|+||.||+|...       .+++.||+|....  ..+.+|+.+++.++||||+++++++....    .
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~-------~~~~~vaiK~~~~--~~~~~E~~il~~l~HpnIv~~~~~~~~~~----~  157 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDN-------KTCEHVVIKAGQR--GGTATEAHILRAINHPSIIQLKGTFTYNK----F  157 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEEC-------CCCCEEEEechhh--hhhHHHHHHHHhCCCCCCCCEeEEEEECC----e
Confidence            367999999999999999999865       5678899997653  34678999999999999999999987654    3


Q ss_pred             EEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          158 RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       158 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      .++|||++ +++|..++...  ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++..
T Consensus       158 ~~lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~  231 (391)
T PHA03212        158 TCLILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF  231 (391)
T ss_pred             eEEEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence            48999998 57888888654  3689999999999999999999998   999999999999999999999999999864


Q ss_pred             CCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchh-----hHHHHHHHhhcccCc
Q 014034          238 GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT-----EQRLLEWVQQYPADS  312 (432)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~-----~~~~~~~~~~~~~~~  312 (432)
                      .... .........||+.|+|||++.+..++.++|||||||++|||++|..||.......     ...+...+......+
T Consensus       232 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p  310 (391)
T PHA03212        232 PVDI-NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHP  310 (391)
T ss_pred             cccc-cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCCh
Confidence            2111 1112234579999999999999999999999999999999999998875432111     111111111110000


Q ss_pred             ccc--------ccc---------cCccccCc--CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          313 KKF--------GLI---------MDPRLEKE--YSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       313 ~~~--------~~~---------~~~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ..+        ...         ..+.....  .....+..+.+|+.+||+.||.+|||+.+++++
T Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        311 NEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             hhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            000        000         00000000  011235678899999999999999999999976

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=8.4e-42  Score=326.69  Aligned_cols=264  Identities=24%  Similarity=0.395  Sum_probs=196.3

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|.+.+.||+|+||.||+|...       .++..||+|.+....     ..+.+|+.+++.++||||+++++++....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   76 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSK-------VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKE   76 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEEC-------CCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCC
Confidence            468999999999999999999865       467889999986432     24678999999999999999999987654


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        77 ----~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Df  147 (303)
T cd07869          77 ----TLTLVFEYVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADF  147 (303)
T ss_pred             ----eEEEEEECCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCC
Confidence                4599999995 68888876543 4688999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHHHhhccc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWVQQYPA  310 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~~  310 (432)
                      |++.....  .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....... .........+.
T Consensus       148 g~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  225 (303)
T cd07869         148 GLARAKSV--PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPN  225 (303)
T ss_pred             CcceeccC--CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCC
Confidence            99874221  1122234568999999999865 45888999999999999999999999875432211 11111111110


Q ss_pred             Cc-------------cccccccCccccCcC-CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          311 DS-------------KKFGLIMDPRLEKEY-SINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       311 ~~-------------~~~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ..             ..+.......+.... ....+..+.+|+.+||+.||.+|||+.+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         226 EDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             hhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            00             000000000000000 00112457799999999999999999999876

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-41  Score=317.39  Aligned_cols=256  Identities=28%  Similarity=0.453  Sum_probs=203.1

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|...+.||+|+||.||+|.+...    ......||+|.+....     ..+.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLP----GKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccC----CCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence            5789999999999999999998622    1235689999986432     247789999999999999999998865443


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                          .++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.++|+|||
T Consensus        80 ----~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg  151 (266)
T cd05033          80 ----VMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFG  151 (266)
T ss_pred             ----eEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccc
Confidence                499999999999999997644 3689999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      ++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ....+...... 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~~~~~-  227 (266)
T cd05033         152 LSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAVEDGYRL-  227 (266)
T ss_pred             hhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHHHcCCCC-
Confidence            9986431111112222345678999999998899999999999999999998 999997654322   22222111000 


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                                   ..+...+..+.+|+.+||+.+|++||++.+|+++|+.+
T Consensus       228 -------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 -------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             -------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                         01112346788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=7e-42  Score=330.85  Aligned_cols=239  Identities=26%  Similarity=0.384  Sum_probs=192.9

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeecCCccee
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQ  157 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~  157 (432)
                      +.||+|+||.||++...       .++..||+|.+.+..       ..+.+|+.+++.++||||+++++++...+    .
T Consensus         1 ~~lG~G~~g~Vy~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~   69 (328)
T cd05593           1 KLLGKGTFGKVILVREK-------ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD----R   69 (328)
T ss_pred             CeeeeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC----E
Confidence            36999999999999865       467899999986532       23678999999999999999999887654    4


Q ss_pred             EEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          158 RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       158 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      .++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        70 ~~lv~Ey~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~  144 (328)
T cd05593          70 LCFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKE  144 (328)
T ss_pred             EEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCcc
Confidence            59999999999999988654  3689999999999999999999998   999999999999999999999999999875


Q ss_pred             CCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccccc
Q 014034          238 GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGL  317 (432)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (432)
                      ...  .........||+.|+|||++.+..++.++|||||||++|+|++|..||........   ...+...         
T Consensus       145 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~---~~~~~~~---------  210 (328)
T cd05593         145 GIT--DAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELILME---------  210 (328)
T ss_pred             CCC--cccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH---HHHhccC---------
Confidence            211  11222345799999999999999999999999999999999999999976543221   1111100         


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 014034          318 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  359 (432)
Q Consensus       318 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  359 (432)
                        ...    .+...+..+.+|+.+||..||.+||     ++.+++++
T Consensus       211 --~~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         211 --DIK----FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             --Ccc----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence              011    1122345688999999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.6e-41  Score=318.48  Aligned_cols=258  Identities=24%  Similarity=0.374  Sum_probs=200.8

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|+..+.||+|+||.||+|.+...   +......+++|.+....     ..+..|+.+++.++||||+++++++...  
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~---~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~--   81 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPE---GDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGA--   81 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCC---CCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCC--
Confidence            4688899999999999999987521   12233468899886432     2366778888999999999999987432  


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++++||+++|+|.+++.... ..+++..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||
T Consensus        82 ---~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg  154 (279)
T cd05111          82 ---SLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFG  154 (279)
T ss_pred             ---ccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCc
Confidence               2478999999999999997543 4689999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      +++...............++..|+|||.+.++.++.++|||||||++|||++ |..||.+..+.....+   +...... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~---~~~~~~~-  230 (279)
T cd05111         155 VADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL---LEKGERL-  230 (279)
T ss_pred             cceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HHCCCcC-
Confidence            9975432222222234457788999999998899999999999999999998 9999987654332222   2111100 


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                            ..+       ...+..+.+++.+||..||.+|||+.++++.|..+..
T Consensus       231 ------~~~-------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         231 ------AQP-------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             ------CCC-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence                  001       1123457789999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.9e-42  Score=334.79  Aligned_cols=243  Identities=25%  Similarity=0.348  Sum_probs=197.3

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|.+.+.||+|+||.||+|.+..      .....||+|.+...       ...+.+|+.+++.++||||+++++++...
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~  103 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKN------EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE  103 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEEC------CCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence            479999999999999999998651      23468999988542       22467899999999999999999999765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ..++||||+.+|+|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus       104 ~----~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~D  174 (340)
T PTZ00426        104 S----YLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTD  174 (340)
T ss_pred             C----EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEec
Confidence            4    4599999999999999997543  689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ||++.....     ......||+.|+|||++.+..++.++|||||||++|||++|..||.+..+...   ...+....  
T Consensus       175 FG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~---~~~i~~~~--  244 (340)
T PTZ00426        175 FGFAKVVDT-----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI---YQKILEGI--  244 (340)
T ss_pred             CCCCeecCC-----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH---HHHHhcCC--
Confidence            999975321     12345799999999999988899999999999999999999999987544321   11111100  


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  359 (432)
                               .    ..+...+..+.+++.+||+.||.+|+     ++.+++++
T Consensus       245 ---------~----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        245 ---------I----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             ---------C----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                     0    01112235678999999999999995     88888876

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-42  Score=324.12  Aligned_cols=248  Identities=27%  Similarity=0.419  Sum_probs=198.8

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .|+..+.||+|+||.||++...       .+++.||+|.+....       ..+.+|+.+++.++||||+++++.+...+
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   73 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVR-------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD   73 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEc-------CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC
Confidence            4788899999999999999864       457899999986532       23567999999999999999999886544


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..++||||+.+|+|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+||
T Consensus        74 ----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Df  146 (285)
T cd05605          74 ----ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDL  146 (285)
T ss_pred             ----eEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeC
Confidence                459999999999999988765555799999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHHHhhcccC
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWVQQYPAD  311 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~  311 (432)
                      |++.....   ........|++.|+|||++.+..++.++|||||||++|+|++|..||.+....... .+...+....  
T Consensus       147 g~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--  221 (285)
T cd05605         147 GLAVEIPE---GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ--  221 (285)
T ss_pred             CCceecCC---CCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc--
Confidence            99875321   11223457899999999999889999999999999999999999999865432211 1111111100  


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  359 (432)
                                   ...+...+..+.+|+.+||..||.+||     ++.+++.+
T Consensus       222 -------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         222 -------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             -------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence                         011223346688999999999999999     77787665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.4e-41  Score=322.59  Aligned_cols=266  Identities=27%  Similarity=0.440  Sum_probs=208.0

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhccc-CCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVL-EHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~hpniv~l~~~~~~~  151 (432)
                      ..+|.+.+.||+|+||.||+|.+..........+..||+|.+....     ..+.+|+.++..+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            3568889999999999999998653332333456789999986432     2478899999999 899999999998765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCC
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKAS  217 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~  217 (432)
                      ..    .++||||+.+++|.+++....              ...+++..+..++.||+.||.|||+.   +|+||||||+
T Consensus        94 ~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~  166 (304)
T cd05101          94 GP----LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAAR  166 (304)
T ss_pred             Cc----eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccc
Confidence            43    489999999999999997532              13578889999999999999999998   9999999999


Q ss_pred             ceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCch
Q 014034          218 NVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPK  296 (432)
Q Consensus       218 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~  296 (432)
                      |||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.+....
T Consensus       167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  246 (304)
T cd05101         167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  246 (304)
T ss_pred             eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence            99999999999999999976432222222233446678999999988889999999999999999998 78888765432


Q ss_pred             hhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhc
Q 014034          297 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  367 (432)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  367 (432)
                      .   +...+.....              ...+...+..+.+|+.+||..+|.+|||+.++++.|..+....
T Consensus       247 ~---~~~~~~~~~~--------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~  300 (304)
T cd05101         247 E---LFKLLKEGHR--------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT  300 (304)
T ss_pred             H---HHHHHHcCCc--------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence            2   2221111100              0011233467889999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.4e-41  Score=319.29  Aligned_cols=263  Identities=25%  Similarity=0.420  Sum_probs=206.5

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      ++|.+.+.||+|+||.||++......  ....+..+|+|.+....    ..+.+|+.+++.++||||+++++++...+  
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~--~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   80 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLC--PEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD--   80 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCC--CCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC--
Confidence            46888999999999999999864221  22456779999987543    24788999999999999999999987654  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRA-----------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  223 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~  223 (432)
                        ..++||||+++++|.+++....           ...+++..++.++.|++.||+|||+.   +++||||||+|||++.
T Consensus        81 --~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~  155 (288)
T cd05093          81 --PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGE  155 (288)
T ss_pred             --ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc
Confidence              3499999999999999986432           23589999999999999999999998   9999999999999999


Q ss_pred             CCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHH
Q 014034          224 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLL  302 (432)
Q Consensus       224 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~  302 (432)
                      ++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.......   ..
T Consensus       156 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~  232 (288)
T cd05093         156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VI  232 (288)
T ss_pred             CCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH
Confidence            99999999999975322221122223445778999999998899999999999999999998 999997654322   22


Q ss_pred             HHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhc
Q 014034          303 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  367 (432)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  367 (432)
                      ..+.....          ...    +...+..+.+|+.+||+.||.+|||+.++++.|+++...+
T Consensus       233 ~~i~~~~~----------~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~  283 (288)
T cd05093         233 ECITQGRV----------LQR----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS  283 (288)
T ss_pred             HHHHcCCc----------CCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence            21111100          000    1112356889999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-42  Score=327.91  Aligned_cols=237  Identities=26%  Similarity=0.345  Sum_probs=190.0

Q ss_pred             cccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeecCCcceeEE
Q 014034           87 IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  159 (432)
Q Consensus        87 lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~  159 (432)
                      ||+|+||.||+|...       .++..||+|.+....       ..+.+|+.++..++||||+++++++...+    ..+
T Consensus         1 lg~G~~g~Vy~~~~~-------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~   69 (312)
T cd05585           1 IGKGSFGKVMQVRKR-------DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE----KLY   69 (312)
T ss_pred             CCcCCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC----eEE
Confidence            799999999999865       457789999886421       23678999999999999999999887544    459


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCC
Q 014034          160 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP  239 (432)
Q Consensus       160 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~  239 (432)
                      +||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        70 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~  144 (312)
T cd05585          70 LVLAFINGGELFHHLQRE--GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNM  144 (312)
T ss_pred             EEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCc
Confidence            999999999999999654  3689999999999999999999998   99999999999999999999999999987521


Q ss_pred             CCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccccccc
Q 014034          240 MVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM  319 (432)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (432)
                      .  .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....   ....+...+          
T Consensus       145 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~---~~~~~~~~~----------  209 (312)
T cd05585         145 K--DDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE---MYRKILQEP----------  209 (312)
T ss_pred             c--CCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH---HHHHHHcCC----------
Confidence            1  1222344679999999999999999999999999999999999999998654322   111111100          


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHHHH
Q 014034          320 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPK---MSQVVER  359 (432)
Q Consensus       320 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil~~  359 (432)
                       .    ..+...+..+.+|+.+||..||.+||+   +.+++.+
T Consensus       210 -~----~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         210 -L----RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             -C----CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence             0    111223456889999999999999985   5666654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.9e-41  Score=319.90  Aligned_cols=260  Identities=27%  Similarity=0.414  Sum_probs=203.6

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      +|++.+.||+|+||.||+|......  +......+++|.+....     ..+.+|+.+++.++||||+++++.+...+. 
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~--~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLK--GRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP-   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCC--CCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC-
Confidence            4788899999999999999865222  12344679999876432     247889999999999999999999876654 


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeec
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRA----------------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYR  212 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~  212 (432)
                         .++||||+.+++|.+++....                      ...+++..++.++.|++.||.|||+.   +|+||
T Consensus        78 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~  151 (290)
T cd05045          78 ---LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHR  151 (290)
T ss_pred             ---cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehh
Confidence               489999999999999986421                      23578999999999999999999998   99999


Q ss_pred             CCCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 014034          213 DFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLE  291 (432)
Q Consensus       213 Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~  291 (432)
                      ||||+|||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus       152 dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~  231 (290)
T cd05045         152 DLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  231 (290)
T ss_pred             hhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence            9999999999999999999999875322222112223345678999999988889999999999999999998 999997


Q ss_pred             CCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          292 RNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                      +..+..   +........          ..    ..+...+..+.+++.+||+.+|.+||++.++++.|+++..
T Consensus       232 ~~~~~~---~~~~~~~~~----------~~----~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         232 GIAPER---LFNLLKTGY----------RM----ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             CCCHHH---HHHHHhCCC----------CC----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            654432   222221110          00    1112234578899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.9e-41  Score=320.05  Aligned_cols=257  Identities=25%  Similarity=0.434  Sum_probs=202.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|.+.+.||+|+||.||+|.+....  .......||+|.+...     ...+.+|++++..++||||+++++++.... 
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   81 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLE--PENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD-   81 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeecccc--CcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC-
Confidence            46888899999999999999875221  1245678999998653     234889999999999999999999987654 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEE
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRA------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL  221 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill  221 (432)
                         ..++||||+++++|.+++....            ...+++..+..++.|++.||.|||++   +++||||||+||++
T Consensus        82 ---~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili  155 (280)
T cd05049          82 ---PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLV  155 (280)
T ss_pred             ---CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEE
Confidence               3599999999999999996532            23578899999999999999999998   99999999999999


Q ss_pred             cCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 014034          222 DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQR  300 (432)
Q Consensus       222 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~  300 (432)
                      +.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.......   
T Consensus       156 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---  232 (280)
T cd05049         156 GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---  232 (280)
T ss_pred             cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---
Confidence            9999999999999875322211112233446788999999999999999999999999999998 999997654432   


Q ss_pred             HHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          301 LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                      ....+.....          .    ..+...+..+.+++.+||+.||.+||++.+|++.|+
T Consensus       233 ~~~~~~~~~~----------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         233 VIECITQGRL----------L----QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHHHHHcCCc----------C----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            2222211000          0    011123467889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=8.7e-42  Score=334.83  Aligned_cols=251  Identities=26%  Similarity=0.346  Sum_probs=193.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|+.++.||+|+||+||+|...       .+++.||+|++.+..       ..+..|+.++..++||||+++++.+.+.
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~   73 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKK-------DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK   73 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            47899999999999999999865       467899999986532       2367899999999999999999988765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      .    ..++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        74 ~----~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~D  144 (363)
T cd05628          74 L----NLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSD  144 (363)
T ss_pred             C----eEEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEee
Confidence            4    459999999999999999764  3689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCc---------------------------------ccccccccCCCccCccccccCCCCchhhhHHHHH
Q 014034          232 FGLAREGPMVGHT---------------------------------HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGV  278 (432)
Q Consensus       232 fG~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv  278 (432)
                      ||+++........                                 ......+||+.|+|||++.+..++.++|||||||
T Consensus       145 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGv  224 (363)
T cd05628         145 FGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV  224 (363)
T ss_pred             ccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHH
Confidence            9998743211000                                 0012357999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhcc--CCCCCCCCHHHH
Q 014034          279 VLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLS--KSSKDRPKMSQV  356 (432)
Q Consensus       279 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~ei  356 (432)
                      ++|||++|..||.+..+....   ..+......     ..+.+    .  ...+..+.+++.+|+.  .++..||++.+|
T Consensus       225 il~ell~G~~Pf~~~~~~~~~---~~i~~~~~~-----~~~p~----~--~~~s~~~~~li~~l~~~~~~r~~r~~~~ei  290 (363)
T cd05628         225 IMYEMLIGYPPFCSETPQETY---KKVMNWKET-----LIFPP----E--VPISEKAKDLILRFCCEWEHRIGAPGVEEI  290 (363)
T ss_pred             HHHHHHhCCCCCCCCCHHHHH---HHHHcCcCc-----ccCCC----c--CCCCHHHHHHHHHHcCChhhcCCCCCHHHH
Confidence            999999999999875543221   111111000     00011    0  1123456778877554  233456899999


Q ss_pred             HHH
Q 014034          357 VER  359 (432)
Q Consensus       357 l~~  359 (432)
                      +++
T Consensus       291 ~~h  293 (363)
T cd05628         291 KTN  293 (363)
T ss_pred             hCC
Confidence            887

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.1e-41  Score=316.64  Aligned_cols=251  Identities=27%  Similarity=0.417  Sum_probs=201.1

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---hHHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      ++|++.++||+|+||.||+|...        .+..||+|.+...   ...+.+|+.+++.++||||+++++++...+.  
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~--------~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--   75 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN--------NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP--   75 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec--------CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC--
Confidence            47999999999999999999854        3467999987653   2357889999999999999999998865443  


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCC
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  235 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a  235 (432)
                        .+++|||+++++|.+++.......+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++
T Consensus        76 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~  150 (261)
T cd05072          76 --IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLA  150 (261)
T ss_pred             --cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccc
Confidence              49999999999999999776556789999999999999999999998   9999999999999999999999999999


Q ss_pred             cCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      ....... ........++..|+|||.+.+..++.++|||||||++|+|+| |..||.......   ....+.....    
T Consensus       151 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~~~~----  222 (261)
T cd05072         151 RVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQRGYR----  222 (261)
T ss_pred             eecCCCc-eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHHcCCC----
Confidence            7532211 111222345678999999988889999999999999999998 999997654322   2222211100    


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  362 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  362 (432)
                           .+     .....+..+.+++.+||..+|++||++.++.+.|++
T Consensus       223 -----~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         223 -----MP-----RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             -----CC-----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                 00     011234568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7.6e-42  Score=337.38  Aligned_cols=249  Identities=22%  Similarity=0.330  Sum_probs=194.3

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .|..++.||+|+||+||+|...       .++..||+|++....       ..+.+|+.+++.++||||+++++++.+.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~-------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~   74 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKV-------DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD   74 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC
Confidence            5889999999999999999865       467899999986532       23678999999999999999999987654


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..++||||+++|+|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+||||+.++.+||+||
T Consensus        75 ----~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DF  145 (381)
T cd05626          75 ----NLYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDF  145 (381)
T ss_pred             ----EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeC
Confidence                4699999999999999986543  689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCC---------------------------------------------cccccccccCCCccCccccccCCC
Q 014034          233 GLAREGPMVGH---------------------------------------------THVSTAVVGTFGYAAPDYIETGHL  267 (432)
Q Consensus       233 G~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~  267 (432)
                      |++........                                             ........||+.|+|||++.+..+
T Consensus       146 Gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~  225 (381)
T cd05626         146 GLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY  225 (381)
T ss_pred             cCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCC
Confidence            99753210000                                             000123579999999999998899


Q ss_pred             CchhhhHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHH--hcc
Q 014034          268 TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR-LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADN--CLS  344 (432)
Q Consensus       268 ~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~--cl~  344 (432)
                      +.++|||||||++|||++|..||....+..... +..+....               ........+..+.+|+.+  |+.
T Consensus       226 ~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------~~~~~~~~s~~~~dli~~ll~~~  290 (381)
T cd05626         226 TQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL---------------HIPPQVKLSPEAVDLITKLCCSA  290 (381)
T ss_pred             CCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccccc---------------CCCCCCCCCHHHHHHHHHHccCc
Confidence            999999999999999999999998765432211 11110000               000011224567788888  445


Q ss_pred             CCCCCCCCHHHHHHH
Q 014034          345 KSSKDRPKMSQVVER  359 (432)
Q Consensus       345 ~dP~~RPs~~eil~~  359 (432)
                      .+|..||++.+++.+
T Consensus       291 ~~~~~R~~~~~~l~h  305 (381)
T cd05626         291 EERLGRNGADDIKAH  305 (381)
T ss_pred             ccccCCCCHHHHhcC
Confidence            566669999999987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.6e-41  Score=329.04  Aligned_cols=263  Identities=27%  Similarity=0.407  Sum_probs=199.3

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|+..+.||+|+||.||++.+.       .++..+|+|.+....     ..+.+|+++++.++||||+++++++..++
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~-------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHK-------PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG   76 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEEC-------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC
Confidence            368999999999999999999865       456789999876431     34789999999999999999999998755


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..++||||+.+++|.+++....  .+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+||
T Consensus        77 ----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Df  148 (333)
T cd06650          77 ----EISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDF  148 (333)
T ss_pred             ----EEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeC
Confidence                4599999999999999996543  688999999999999999999974  27999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh-hcccC
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ-QYPAD  311 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~  311 (432)
                      |++.....    .......||..|+|||++.+..++.++|||||||++|+|++|..||................ ..+..
T Consensus       149 g~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  224 (333)
T cd06650         149 GVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAE  224 (333)
T ss_pred             Ccchhhhh----hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccc
Confidence            99864311    11234568999999999998899999999999999999999999997644322111110000 00000


Q ss_pred             c------cc---------------------cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 S------KK---------------------FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~------~~---------------------~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .      ..                     ...+.............+..+.+|+.+||+.||++|||+.+++.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         225 SETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             cccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence            0      00                     000000000000001124568899999999999999999999876

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.3e-41  Score=319.24  Aligned_cols=261  Identities=25%  Similarity=0.421  Sum_probs=206.3

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      .+|...+.||+|+||.||+|......  .......+++|.+....    ..+.+|+.+++.++||||+++++++....  
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~--~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   80 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLS--PTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD--   80 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccC--CCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC--
Confidence            36888899999999999999864221  22456779999987543    34789999999999999999999987644  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceE
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVL  220 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nil  220 (432)
                        ..++||||+++++|.+++....              ...+++..++.++.||+.||.|||++   +|+||||||+|||
T Consensus        81 --~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil  155 (291)
T cd05094          81 --PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCL  155 (291)
T ss_pred             --ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEE
Confidence              3599999999999999996532              13478999999999999999999998   9999999999999


Q ss_pred             EcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhH
Q 014034          221 LDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQ  299 (432)
Q Consensus       221 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~  299 (432)
                      ++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|+| |..||.......  
T Consensus       156 ~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--  233 (291)
T cd05094         156 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--  233 (291)
T ss_pred             EccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence            99999999999999975322222222234556789999999999999999999999999999999 999987654432  


Q ss_pred             HHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          300 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                       ....+.....          .    ..+...+..+.+++.+||+.+|.+|||+.+|++.|+.+..
T Consensus       234 -~~~~~~~~~~----------~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         234 -VIECITQGRV----------L----ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             -HHHHHhCCCC----------C----CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence             2221111000          0    0011234568899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.3e-41  Score=344.64  Aligned_cols=250  Identities=22%  Similarity=0.299  Sum_probs=198.3

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      .|.+.+.||+|+||.||+|...      ...+..||+|.+....    ..+.+|+.+++.++||||+++++++...+   
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~------~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~---  138 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRG------SDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD---  138 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEc------CCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC---
Confidence            4889999999999999999854      1225678888764432    23678999999999999999999997654   


Q ss_pred             eeEEEEEeecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                       ..+|||||+++|+|.+++...  ...++++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       139 -~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFg  214 (478)
T PTZ00267        139 -KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFG  214 (478)
T ss_pred             -EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCc
Confidence             459999999999999988642  234688999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      +++..............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....   +...+.....   
T Consensus       215 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~~~~~~~~~~---  288 (478)
T PTZ00267        215 FSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---IMQQVLYGKY---  288 (478)
T ss_pred             CceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCC---
Confidence            9986432222222345679999999999999999999999999999999999999997654322   2211111000   


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                            .     ..+...+..+.+||.+||..||.+||++.+++.+
T Consensus       289 ------~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        289 ------D-----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             ------C-----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence                  0     0111234578899999999999999999998764

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-43  Score=346.89  Aligned_cols=260  Identities=27%  Similarity=0.455  Sum_probs=213.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc-----ChHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-----DGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      +...+.+.||.|.||.||+|+++...    .....||||.++.     ...+|..|+.||.+++||||++|.|+......
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pg----kre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P  704 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPG----KREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP  704 (996)
T ss_pred             hheEEEEEEecccccceecccccCCC----CcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence            34556788999999999999998433    4567899999974     33459999999999999999999999876544


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                          ..+|.|||++|+|+.||+.+.+ .+++.+...+++.||.||.||-+.   ++|||||...||||+.+..+|++|||
T Consensus       705 ----vMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFG  776 (996)
T KOG0196|consen  705 ----VMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFG  776 (996)
T ss_pred             ----eEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEecccc
Confidence                4899999999999999998774 599999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCccccccccc--CCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhccc
Q 014034          234 LAREGPMVGHTHVSTAVVG--TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      +++...... ....+...|  ...|.|||.+....++.++|||||||+|||.++ |..||......   +.+..+.    
T Consensus       777 LSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ---dVIkaIe----  848 (996)
T KOG0196|consen  777 LSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVIKAIE----  848 (996)
T ss_pred             ceeecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH---HHHHHHH----
Confidence            998643222 122222223  358999999999999999999999999999887 99999876443   2322221    


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhcc
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  368 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  368 (432)
                                ..+.-..|++++..|.+||..||++|-.+||.+.+|+..|+++....+
T Consensus       849 ----------~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~  896 (996)
T KOG0196|consen  849 ----------QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN  896 (996)
T ss_pred             ----------hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence                      111123367788999999999999999999999999999999875543

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.7e-41  Score=318.80  Aligned_cols=259  Identities=25%  Similarity=0.414  Sum_probs=200.7

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ..++|+..+.||+|+||.||+|.+....  ....+..||+|.+...     ...+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~--~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVV--KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCC--CCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            3567999999999999999999875321  1234678999988642     22477899999999999999999998654


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRA--------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  223 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~  223 (432)
                      .    ..++||||+++++|.+++....        ...+++..+..++.|++.||.|||+.   +++|+||||+|||++.
T Consensus        82 ~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~  154 (277)
T cd05062          82 Q----PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE  154 (277)
T ss_pred             C----CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcC
Confidence            4    3599999999999999986532        12467888999999999999999998   9999999999999999


Q ss_pred             CCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHH
Q 014034          224 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLL  302 (432)
Q Consensus       224 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~  302 (432)
                      ++.++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||.+.....   ..
T Consensus       155 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~  231 (277)
T cd05062         155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VL  231 (277)
T ss_pred             CCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH
Confidence            99999999999875322211122223345778999999998899999999999999999999 788987654332   22


Q ss_pred             HHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          303 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                      ..+.....          +    ..+...+..+.+++.+||+.||++|||+.++++.|+
T Consensus       232 ~~~~~~~~----------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         232 RFVMEGGL----------L----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHHcCCc----------C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            22111100          0    011123457889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.7e-41  Score=322.08  Aligned_cols=260  Identities=25%  Similarity=0.386  Sum_probs=204.4

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhccc-CCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVL-EHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  152 (432)
                      ++|...+.||+|+||.||+|......  ....+..||+|.++...     ..+.+|+.+++++ +||||+++++++...+
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLS--KSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCC--CCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            57999999999999999999864211  22356789999886432     2478899999999 7999999999987655


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                      .    .++||||+.+++|.+++.......+++.++..++.|++.||.|||++   +|+|+||||+|||++.++.++|+||
T Consensus       113 ~----~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~df  185 (302)
T cd05055         113 P----ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDF  185 (302)
T ss_pred             c----eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCC
Confidence            3    49999999999999999765444589999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      |++................++..|+|||.+.+..++.++|||||||++|+|++ |..||........  .........  
T Consensus       186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~~~~~--  261 (302)
T cd05055         186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLIKEGY--  261 (302)
T ss_pred             cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHHHcCC--
Confidence            99975332221112223456788999999998899999999999999999998 9999976543221  111111100  


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                                  ....+...+..+.+++.+||..+|++|||+.++++.|+++
T Consensus       262 ------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         262 ------------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                        0001112245788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-42  Score=336.63  Aligned_cols=250  Identities=24%  Similarity=0.351  Sum_probs=197.0

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|+.++.||+|+||.||+|...       .+++.||||++....       ..+.+|+.++..++||||+++++++...
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~   73 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKK-------DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE   73 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC
Confidence            47899999999999999999865       467889999986532       2367899999999999999999998765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ..++||||+.+|+|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|
T Consensus        74 ~----~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~D  144 (364)
T cd05599          74 N----YLYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSD  144 (364)
T ss_pred             C----eEEEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEee
Confidence            4    4599999999999999997543  689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCc------------------------------------ccccccccCCCccCccccccCCCCchhhhHH
Q 014034          232 FGLAREGPMVGHT------------------------------------HVSTAVVGTFGYAAPDYIETGHLTAKSDVWS  275 (432)
Q Consensus       232 fG~a~~~~~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS  275 (432)
                      ||++.........                                    ......+||+.|+|||++.+..++.++||||
T Consensus       145 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  224 (364)
T cd05599         145 FGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWS  224 (364)
T ss_pred             cccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeec
Confidence            9998642211000                                    0011246999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCC---
Q 014034          276 FGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK---  352 (432)
Q Consensus       276 lGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---  352 (432)
                      |||++|||++|..||........   ...+......   +  ....      ....+..+.+|+.+|+. +|.+|++   
T Consensus       225 lG~il~el~~G~~Pf~~~~~~~~---~~~i~~~~~~---~--~~~~------~~~~s~~~~~li~~ll~-~p~~R~~~~~  289 (364)
T cd05599         225 LGVIMYEMLVGYPPFCSDNPQET---YRKIINWKET---L--QFPD------EVPLSPEAKDLIKRLCC-EAERRLGNNG  289 (364)
T ss_pred             chhHHHHhhcCCCCCCCCCHHHH---HHHHHcCCCc---c--CCCC------CCCCCHHHHHHHHHHcc-CHhhcCCCCC
Confidence            99999999999999987654322   1111111100   0  0000      11124567799999997 9999998   


Q ss_pred             HHHHHHH
Q 014034          353 MSQVVER  359 (432)
Q Consensus       353 ~~eil~~  359 (432)
                      +.+++.+
T Consensus       290 ~~~ll~h  296 (364)
T cd05599         290 VNEIKSH  296 (364)
T ss_pred             HHHHhcC
Confidence            9998876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.7e-41  Score=322.85  Aligned_cols=265  Identities=27%  Similarity=0.433  Sum_probs=205.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhccc-CCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVL-EHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  152 (432)
                      ++|.+.+.||+|+||.||++...............+|+|.+..+.     ..+..|+.++..+ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            569999999999999999998753322233345689999987532     2367899999999 7999999999987654


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAF--------------PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASN  218 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~N  218 (432)
                          ..++||||+.+++|.+++.....              ..+++.+++.++.|++.||+|||+.   +++||||||+|
T Consensus        98 ----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N  170 (307)
T cd05098          98 ----PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  170 (307)
T ss_pred             ----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence                35999999999999999975421              2488999999999999999999998   99999999999


Q ss_pred             eEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchh
Q 014034          219 VLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKT  297 (432)
Q Consensus       219 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~  297 (432)
                      ||++.++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~  250 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  250 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence            9999999999999999875322111111122234568999999998889999999999999999998 888987654322


Q ss_pred             hHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhc
Q 014034          298 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  367 (432)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  367 (432)
                         +...+....              ....+...+..+.+|+.+||..+|.+|||+.+|++.|+.++...
T Consensus       251 ---~~~~~~~~~--------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         251 ---LFKLLKEGH--------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             ---HHHHHHcCC--------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence               111111110              00112223467889999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=9.3e-42  Score=346.28  Aligned_cols=258  Identities=22%  Similarity=0.266  Sum_probs=204.2

Q ss_pred             HHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEE
Q 014034           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYC  148 (432)
Q Consensus        75 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~  148 (432)
                      ....++|.+.+.||+|+||+||+|...       .+++.||||.+...      ...+.+|+.++..++|+||+++++.+
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~-------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~  100 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRV-------SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDF  100 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEc-------CCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecce
Confidence            344568999999999999999999865       46789999998543      12477899999999999999998877


Q ss_pred             eecCC----cceeEEEEEeecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc
Q 014034          149 AVDGE----RGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD  222 (432)
Q Consensus       149 ~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~  222 (432)
                      ...+.    .....++||||+++|+|.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||+|||++
T Consensus       101 ~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~  177 (496)
T PTZ00283        101 AKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLC  177 (496)
T ss_pred             ecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEe
Confidence            54332    112357999999999999998653  235789999999999999999999998   999999999999999


Q ss_pred             CCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014034          223 ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  302 (432)
Q Consensus       223 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  302 (432)
                      .++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|..||.+.....   +.
T Consensus       178 ~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~---~~  254 (496)
T PTZ00283        178 SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE---VM  254 (496)
T ss_pred             CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HH
Confidence            999999999999975332222222345679999999999999999999999999999999999999998654322   11


Q ss_pred             HHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          303 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .......         ..     ..+...+..+.+|+.+||+.||.+||++.+++.+
T Consensus       255 ~~~~~~~---------~~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        255 HKTLAGR---------YD-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHHhcCC---------CC-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1111100         00     1122334678899999999999999999999876

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=7.9e-41  Score=314.51  Aligned_cols=258  Identities=24%  Similarity=0.387  Sum_probs=197.3

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeecCC-
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE-  153 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-  153 (432)
                      |.+.+.||+|+||.||+|.+..     ......||+|.+...      ...+..|+.+++.++||||+++++++..... 
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~-----~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   75 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQ-----DDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVES   75 (272)
T ss_pred             CccccccCcccCceEEEeEEcc-----CCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcc
Confidence            3466789999999999998751     223357999987543      2347889999999999999999998754321 


Q ss_pred             -cceeEEEEEeecCCCCHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCcee
Q 014034          154 -RGIQRLLVYEFMLNRSLEDHLFNR----AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  228 (432)
Q Consensus       154 -~~~~~~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k  228 (432)
                       .....+++|||+.+|+|.+++...    ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        76 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~k  152 (272)
T cd05075          76 EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVC  152 (272)
T ss_pred             cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEE
Confidence             122458999999999999987432    223588999999999999999999998   999999999999999999999


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhh
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQ  307 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~  307 (432)
                      |+|||+++...............+++.|++||.+.+..++.++||||||+++|+|++ |..||.+....   .+...+..
T Consensus       153 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~~  229 (272)
T cd05075         153 VADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYDYLRQ  229 (272)
T ss_pred             ECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHc
Confidence            999999986432221111223346678999999999999999999999999999999 88999764432   22222221


Q ss_pred             cccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                      ...    .          ..+...+..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       230 ~~~----~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         230 GNR----L----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCC----C----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            100    0          01112345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.3e-41  Score=318.43  Aligned_cols=257  Identities=27%  Similarity=0.470  Sum_probs=201.7

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      .+|+..+.||+|+||.||+|.+...   +...+..|++|.+....     ..+.+|+.+++.++||||+++++++.....
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~---~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   81 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLP---GMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP   81 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecC---CCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence            4688889999999999999986422   22356889999986422     347889999999999999999999876543


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRA---------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASN  218 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~N  218 (432)
                          .++||||+.+++|.+++....               ...+++..+..++.|++.||.|||++   +|+||||||+|
T Consensus        82 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~n  154 (283)
T cd05090          82 ----VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARN  154 (283)
T ss_pred             ----eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---Ceehhccccce
Confidence                499999999999999985321               23478899999999999999999998   99999999999


Q ss_pred             eEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchh
Q 014034          219 VLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKT  297 (432)
Q Consensus       219 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~  297 (432)
                      ||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.+..+..
T Consensus       155 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~  234 (283)
T cd05090         155 ILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE  234 (283)
T ss_pred             EEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            9999999999999999975432222222334456778999999988889999999999999999998 999997654322


Q ss_pred             hHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 014034          298 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  362 (432)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  362 (432)
                         +.+.+......              ..+...+..+.+++.+||+.||.+||++.+|+++|..
T Consensus       235 ---~~~~~~~~~~~--------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         235 ---VIEMVRKRQLL--------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ---HHHHHHcCCcC--------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence               22222111100              0111224568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-41  Score=313.94  Aligned_cols=252  Identities=29%  Similarity=0.400  Sum_probs=201.1

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---hHHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      .++|++.+.||+|+||.||+|...        .+..||+|.+...   ...+.+|+.++++++||||+++++++...+. 
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--------~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-   75 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN--------NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP-   75 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec--------CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCC-
Confidence            356889999999999999999854        3467999998753   3458899999999999999999998876543 


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                         .++||||+.+++|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||+
T Consensus        76 ---~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~  149 (261)
T cd05068          76 ---IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGL  149 (261)
T ss_pred             ---eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcce
Confidence               49999999999999999766555789999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      +....... .........+..|+|||.+.+..++.++||||||+++|+|++ |..||.+......   ...+.....   
T Consensus       150 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~~~~~---  222 (261)
T cd05068         150 ARVIKEDI-YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV---LQQVDQGYR---  222 (261)
T ss_pred             EEEccCCc-ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHHcCCC---
Confidence            87532111 111111223457999999998899999999999999999999 9999976543221   111111000   


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  362 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  362 (432)
                                 ...+...+..+.+++.+||+.+|.+||++.++++.|++
T Consensus       223 -----------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         223 -----------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             -----------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence                       01112234678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.8e-41  Score=321.27  Aligned_cols=262  Identities=28%  Similarity=0.452  Sum_probs=205.1

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhccc-CCCccceeeeEEee
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVL-EHPNLVKLIGYCAV  150 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~hpniv~l~~~~~~  150 (432)
                      ..++|...+.||+|+||.||++.+.....  ......+|+|.+....     ..+.+|+.++..+ +||||+++++++..
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~--~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDN--PNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCC--CCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            34578999999999999999998763221  2355789999886532     2377899999999 89999999999876


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCC
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNR--------------AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKA  216 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp  216 (432)
                      .+.    .+++|||+++|+|..++...              ....+++..++.++.|++.||.|||+.   +|+||||||
T Consensus        88 ~~~----~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp  160 (293)
T cd05053          88 EGP----LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAA  160 (293)
T ss_pred             CCC----eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccce
Confidence            543    49999999999999998642              234688999999999999999999998   999999999


Q ss_pred             CceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCc
Q 014034          217 SNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP  295 (432)
Q Consensus       217 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~  295 (432)
                      +|||++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus       161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  240 (293)
T cd05053         161 RNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  240 (293)
T ss_pred             eeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence            999999999999999999975332221122222345678999999988899999999999999999998 9999976543


Q ss_pred             hhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 014034          296 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  364 (432)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  364 (432)
                      ......   .....              ....+...+..+.+|+.+||..||.+|||+.++++.|+.++
T Consensus       241 ~~~~~~---~~~~~--------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         241 EELFKL---LKEGY--------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHHHH---HHcCC--------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            322111   11100              00111223457889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=8e-42  Score=330.11  Aligned_cols=239  Identities=26%  Similarity=0.361  Sum_probs=192.1

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeecCCccee
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQ  157 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~  157 (432)
                      +.||+|+||.||++...       .++..||+|.+....       ..+..|++++..++||||+++++++...+    .
T Consensus         1 ~~lG~G~~g~V~~~~~~-------~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~----~   69 (325)
T cd05594           1 KLLGKGTFGKVILVKEK-------ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD----R   69 (325)
T ss_pred             CeeeeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC----E
Confidence            36999999999999865       467899999986532       23677999999999999999999887654    4


Q ss_pred             EEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          158 RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE-GLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       158 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      .++||||+.+|+|..++...  ..+++..+..++.||+.||.|||+ .   +|+||||||+|||++.++.+||+|||+++
T Consensus        70 ~~lv~E~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~  144 (325)
T cd05594          70 LCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCK  144 (325)
T ss_pred             EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCe
Confidence            59999999999999988654  368999999999999999999997 5   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  316 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (432)
                      ....  .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........   +...        
T Consensus       145 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~---i~~~--------  211 (325)
T cd05594         145 EGIK--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL---ILME--------  211 (325)
T ss_pred             ecCC--CCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHH---HhcC--------
Confidence            4221  11222345799999999999999999999999999999999999999976544322111   1110        


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 014034          317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  359 (432)
Q Consensus       317 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  359 (432)
                         ...+    +...+..+.+|+.+||+.||.+|+     ++.+++++
T Consensus       212 ---~~~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         212 ---EIRF----PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             ---CCCC----CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence               0011    112245688999999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.7e-41  Score=326.14  Aligned_cols=242  Identities=26%  Similarity=0.406  Sum_probs=193.0

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh--------HHHHHHHHHhcccCCCccceeeeEEeecCCcce
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~  156 (432)
                      +.||+|+||.||++....    +...++.||+|.+....        ..+..|+.+|+.++||||+++++++..++    
T Consensus         2 ~~lg~G~~g~V~~~~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~----   73 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVT----GADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG----   73 (323)
T ss_pred             ceeeecCCeEEEEEEEcc----cCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC----
Confidence            579999999999998641    22467899999986421        23678999999999999999999987654    


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      ..++||||+.+++|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  148 (323)
T cd05584          74 KLYLILEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK  148 (323)
T ss_pred             eEEEEEeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCe
Confidence            3599999999999999986543  678889999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  316 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (432)
                      ....  .........||+.|+|||++.+..++.++|||||||++|||++|..||........   ...+....       
T Consensus       149 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~---~~~~~~~~-------  216 (323)
T cd05584         149 ESIH--EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT---IDKILKGK-------  216 (323)
T ss_pred             eccc--CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH---HHHHHcCC-------
Confidence            4221  11222345799999999999988899999999999999999999999986543221   11111100       


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 014034          317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  359 (432)
Q Consensus       317 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  359 (432)
                          .    ..+...+..+.+|+.+||+.||++||     ++.+++.+
T Consensus       217 ----~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         217 ----L----NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             ----C----CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence                0    01112245688999999999999999     78888775

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=6.1e-41  Score=316.76  Aligned_cols=259  Identities=24%  Similarity=0.377  Sum_probs=202.1

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|+..+.||+|+||.||+|.+...   +......||+|.+...     ...+.+|+.++..++||||+++++++....
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~---~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPD---GENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTST   82 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecC---CCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCC
Confidence            35789999999999999999987522   2223456999988642     224778999999999999999999986432


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                           .+++|+|+++|+|.+++.... ..+++..++.++.|++.||.|||++   +|+||||||+|||+++++.+||+||
T Consensus        83 -----~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~df  153 (279)
T cd05109          83 -----VQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDF  153 (279)
T ss_pred             -----cEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCC
Confidence                 379999999999999987543 4689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      |+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   +..++......
T Consensus       154 G~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~~  230 (279)
T cd05109         154 GLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLEKGERL  230 (279)
T ss_pred             CceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHCCCcC
Confidence            99975432211111222345678999999998899999999999999999998 899987654322   22222211100


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                                    ..+...+..+.+++.+||..||++||++.++++.|..+..
T Consensus       231 --------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         231 --------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             --------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                          0011234568899999999999999999999999887754

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-42  Score=298.97  Aligned_cols=267  Identities=24%  Similarity=0.357  Sum_probs=208.9

Q ss_pred             HHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCccceeeeEEee
Q 014034           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        75 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      ....++|++.++||+|||+-||++.       +..++..+|+|++.-..    ...++|+...++++||||++++++...
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~-------~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~   89 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVK-------GLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLR   89 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeec-------ccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHH
Confidence            3445789999999999999999987       44788999999986433    347899999999999999999988765


Q ss_pred             cCC-cceeEEEEEeecCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCce
Q 014034          151 DGE-RGIQRLLVYEFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP  227 (432)
Q Consensus       151 ~~~-~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~  227 (432)
                      +.. .....||+++|...|+|.+.+....  +..+++.+.+.|+.+|++||.+||+. .+.+.||||||.|||+.+.+.+
T Consensus        90 ~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~  168 (302)
T KOG2345|consen   90 EEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLP  168 (302)
T ss_pred             hhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCce
Confidence            433 3345699999999999999997643  34689999999999999999999997 2359999999999999999999


Q ss_pred             eeccccCCcCCCCCCCccc-------ccccccCCCccCccccc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchh
Q 014034          228 KLSDFGLAREGPMVGHTHV-------STAVVGTFGYAAPDYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT  297 (432)
Q Consensus       228 kl~DfG~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~  297 (432)
                      +|.|||.+......-....       -.....|..|+|||.+.   +...+.++|||||||++|.|+.|..||+..-.  
T Consensus       169 vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--  246 (302)
T KOG2345|consen  169 VLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--  246 (302)
T ss_pred             EEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh--
Confidence            9999999975432211111       11345799999999985   45678999999999999999999999974211  


Q ss_pred             hHHHHHHHhhcccCcccccc-ccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 014034          298 EQRLLEWVQQYPADSKKFGL-IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  364 (432)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  364 (432)
                                   .+..+.. +.+..+........++.+.+||.+|++.||.+||++.+++..++++.
T Consensus       247 -------------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  247 -------------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             -------------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                         0111111 12222222222235688999999999999999999999999998764

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.9e-41  Score=327.66  Aligned_cols=264  Identities=26%  Similarity=0.385  Sum_probs=202.5

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhccc-CCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVL-EHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  152 (432)
                      ++|++.+.||+|+||.||+|.....  +...+++.||||.++...     ..+.+|+.++..+ +||||+++++++...+
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGI--DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccC--CccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            4799999999999999999985421  233467899999986532     2377899999999 6899999999886543


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCC------------------------------------------------------
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRA------------------------------------------------------  178 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------  178 (432)
                      .   ..++||||+.+|+|.+++....                                                      
T Consensus        85 ~---~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          85 G---PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             C---ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence            2   3589999999999999986421                                                      


Q ss_pred             -----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCCCCCCcccc
Q 014034          179 -----------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS  247 (432)
Q Consensus       179 -----------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  247 (432)
                                 ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++............
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  238 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK  238 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence                       12467888899999999999999998   9999999999999999999999999998753222111122


Q ss_pred             cccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCc
Q 014034          248 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKE  326 (432)
Q Consensus       248 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  326 (432)
                      ....++..|+|||.+.+..++.++||||||+++|+|++ |..||........  ....+....          ....   
T Consensus       239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~~~~~----------~~~~---  303 (343)
T cd05103         239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRLKEGT----------RMRA---  303 (343)
T ss_pred             CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHHHHhccC----------CCCC---
Confidence            22345678999999988899999999999999999997 9999876432211  111111000          0000   


Q ss_pred             CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          327 YSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       327 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                       +...+..+.+++.+||+.||.+|||+.+|+++|+.+++.
T Consensus       304 -~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         304 -PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             -CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence             111234688999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=7.1e-42  Score=337.14  Aligned_cols=250  Identities=24%  Similarity=0.305  Sum_probs=195.6

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|++++.||+|+||.||+|...       .+++.||+|.+...       ...+.+|+.+|+.++||||+++++.+...
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~   73 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKV-------DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK   73 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEEC-------CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence            37999999999999999999865       45789999998642       22467899999999999999999998765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ..++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        74 ~----~~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~D  144 (376)
T cd05598          74 D----NLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTD  144 (376)
T ss_pred             C----EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEe
Confidence            4    459999999999999999654  3688999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCC-----------------------------------------cccccccccCCCccCccccccCCCCch
Q 014034          232 FGLAREGPMVGH-----------------------------------------THVSTAVVGTFGYAAPDYIETGHLTAK  270 (432)
Q Consensus       232 fG~a~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~  270 (432)
                      ||++........                                         ........||+.|+|||++.+..++.+
T Consensus       145 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  224 (376)
T cd05598         145 FGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL  224 (376)
T ss_pred             CCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcc
Confidence            999742110000                                         000123579999999999999999999


Q ss_pred             hhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCC
Q 014034          271 SDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDR  350 (432)
Q Consensus       271 ~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R  350 (432)
                      +|||||||++|+|++|..||.+..+......   +......           +........+..+.+++.+|+ .+|.+|
T Consensus       225 ~DiwSlGvilyell~G~~Pf~~~~~~~~~~~---i~~~~~~-----------~~~~~~~~~s~~~~~li~~l~-~~p~~R  289 (376)
T cd05598         225 CDWWSVGVILYEMLVGQPPFLADTPAETQLK---VINWETT-----------LHIPSQAKLSREASDLILRLC-CGAEDR  289 (376)
T ss_pred             eeeeeccceeeehhhCCCCCCCCCHHHHHHH---HhccCcc-----------ccCCCCCCCCHHHHHHHHHHh-cCHhhc
Confidence            9999999999999999999987654332111   1111000           000001122356678888876 499999


Q ss_pred             C---CHHHHHHH
Q 014034          351 P---KMSQVVER  359 (432)
Q Consensus       351 P---s~~eil~~  359 (432)
                      +   ++.+++.+
T Consensus       290 ~~~~t~~ell~h  301 (376)
T cd05598         290 LGKNGADEIKAH  301 (376)
T ss_pred             CCCCCHHHHhCC
Confidence            9   89999877

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.2e-41  Score=315.25  Aligned_cols=251  Identities=31%  Similarity=0.470  Sum_probs=203.6

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH----HHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL----QWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ..+|...+.||.|+||.||+|...        .+..+++|.+.....    .+..|+.+++.++||||+++++++.....
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~--------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   76 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWK--------NRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP   76 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEec--------CCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCC
Confidence            356899999999999999999875        367899999875433    47889999999999999999999876543


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                          .++||||+++++|.+++.......+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||
T Consensus        77 ----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g  149 (261)
T cd05148          77 ----VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFG  149 (261)
T ss_pred             ----eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEcccc
Confidence                49999999999999999876656789999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      ++......  ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ....+....   
T Consensus       150 ~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~~~---  221 (261)
T cd05148         150 LARLIKED--VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQITAGY---  221 (261)
T ss_pred             chhhcCCc--cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHHHhCC---
Confidence            99753221  111123346778999999988899999999999999999998 899997654322   222111100   


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  362 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  362 (432)
                                 ....+...+..+.++|.+||+.||.+|||+.+|++.|+.
T Consensus       222 -----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         222 -----------RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             -----------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence                       001122334678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-42  Score=334.47  Aligned_cols=250  Identities=26%  Similarity=0.354  Sum_probs=200.3

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|.+.+.||+|+||.||+|...       .++..||+|++....       ..+..|+.++..++||||+++++++...
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   73 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDK-------DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDE   73 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEEC-------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecC
Confidence            47899999999999999999865       467899999986432       2477899999999999999999988765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ..++||||+.+++|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        74 ~----~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~D  144 (350)
T cd05573          74 E----HLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLAD  144 (350)
T ss_pred             C----eEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeec
Confidence            4    459999999999999999765  4789999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCC---------------------------CcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHH
Q 014034          232 FGLAREGPMVG---------------------------HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML  284 (432)
Q Consensus       232 fG~a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell  284 (432)
                      ||++.......                           .........||+.|+|||++.+..++.++|||||||++|+|+
T Consensus       145 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell  224 (350)
T cd05573         145 FGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML  224 (350)
T ss_pred             CCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhc
Confidence            99997532221                           001223457999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHH
Q 014034          285 TGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-MSQVVER  359 (432)
Q Consensus       285 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~~  359 (432)
                      +|..||.........   ..+..+...      ...+.     ....+..+.+||.+||. ||.+||+ +.+++++
T Consensus       225 ~g~~Pf~~~~~~~~~---~~i~~~~~~------~~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         225 YGFPPFYSDTLQETY---NKIINWKES------LRFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             cCCCCCCCCCHHHHH---HHHhccCCc------ccCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            999999876533221   111111000      00000     01134678899999997 9999999 9999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.3e-41  Score=335.93  Aligned_cols=249  Identities=23%  Similarity=0.311  Sum_probs=193.8

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .|+.++.||+|+||.||+|...       .++..||+|.+.+..       ..+.+|+.+++.++||||+++++.+...+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~-------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~   74 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKV-------DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD   74 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEEC-------CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC
Confidence            5889999999999999999865       467899999987532       24778999999999999999999987654


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..++||||+++|+|.+++.+.  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        75 ----~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DF  145 (382)
T cd05625          75 ----NLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDF  145 (382)
T ss_pred             ----EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeEC
Confidence                459999999999999998654  3688999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCC---------------------------------------------cccccccccCCCccCccccccCCC
Q 014034          233 GLAREGPMVGH---------------------------------------------THVSTAVVGTFGYAAPDYIETGHL  267 (432)
Q Consensus       233 G~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~  267 (432)
                      |++........                                             .......+||+.|+|||++.+..+
T Consensus       146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~  225 (382)
T cd05625         146 GLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY  225 (382)
T ss_pred             CCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCC
Confidence            99752110000                                             000123479999999999999999


Q ss_pred             CchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCC
Q 014034          268 TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSS  347 (432)
Q Consensus       268 ~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP  347 (432)
                      +.++|||||||++|||++|..||.+..+......   +.....           .+........+..+.+++.+|+ .+|
T Consensus       226 ~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~---i~~~~~-----------~~~~p~~~~~s~~~~~li~~l~-~~p  290 (382)
T cd05625         226 TQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMK---VINWQT-----------SLHIPPQAKLSPEASDLIIKLC-RGP  290 (382)
T ss_pred             CCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHH---HHccCC-----------CcCCCCcccCCHHHHHHHHHHc-cCH
Confidence            9999999999999999999999987654322111   111000           0000001122355678888876 599


Q ss_pred             CCCCC---HHHHHHH
Q 014034          348 KDRPK---MSQVVER  359 (432)
Q Consensus       348 ~~RPs---~~eil~~  359 (432)
                      .+|++   +.+++.+
T Consensus       291 ~~R~~~~~~~ei~~h  305 (382)
T cd05625         291 EDRLGKNGADEIKAH  305 (382)
T ss_pred             hHcCCCCCHHHHhcC
Confidence            99997   8888765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.2e-41  Score=319.22  Aligned_cols=257  Identities=25%  Similarity=0.409  Sum_probs=201.8

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      +|.+.+.||+|+||.||+|.+....  ....+..||+|.++...     ..+.+|+.++..++||||+++++++..... 
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~-   82 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTA--PGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP-   82 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCC--CCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc-
Confidence            5778889999999999999875321  12356789999987542     237789999999999999999999876543 


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceE
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVL  220 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nil  220 (432)
                         .++++||+.+++|.+++....              ...+++..+..++.|++.||.|||+.   +|+||||||+|||
T Consensus        83 ---~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil  156 (283)
T cd05091          83 ---LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVL  156 (283)
T ss_pred             ---eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheE
Confidence               489999999999999985321              23578889999999999999999998   9999999999999


Q ss_pred             EcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhH
Q 014034          221 LDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQ  299 (432)
Q Consensus       221 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~  299 (432)
                      +++++.+||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..||.+....   
T Consensus       157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---  233 (283)
T cd05091         157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---  233 (283)
T ss_pred             ecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence            99999999999999875322222222233456789999999988889999999999999999998 88888765432   


Q ss_pred             HHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 014034          300 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  362 (432)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  362 (432)
                      .+...+......              ..+...+..+.+|+.+||+.+|.+||++.+|+..|+.
T Consensus       234 ~~~~~i~~~~~~--------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         234 DVIEMIRNRQVL--------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHHHcCCcC--------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            223322221110              1122334668899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=8e-41  Score=311.02  Aligned_cols=244  Identities=27%  Similarity=0.473  Sum_probs=191.7

Q ss_pred             ccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCCcceeEEE
Q 014034           86 KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLL  160 (432)
Q Consensus        86 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~l  160 (432)
                      .||+|+||.||+|+..       .+++.||+|.+...     ...+.+|+++++.++||||+++++++.....    .++
T Consensus         2 ~lg~g~~g~vy~~~~~-------~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~l   70 (252)
T cd05084           2 RIGRGNFGEVFSGRLR-------ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP----IYI   70 (252)
T ss_pred             ccCcccCccEEEEEEe-------cCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCC----eEE
Confidence            6999999999999875       46788999987543     2348899999999999999999999876543    499


Q ss_pred             EEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCCC
Q 014034          161 VYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM  240 (432)
Q Consensus       161 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~  240 (432)
                      ||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        71 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  146 (252)
T cd05084          71 VMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEED  146 (252)
T ss_pred             EEeeccCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccc
Confidence            999999999999986543 4689999999999999999999998   999999999999999999999999999875321


Q ss_pred             CCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcccccccc
Q 014034          241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM  319 (432)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (432)
                      ...........++..|+|||.+.++.++.++||||||+++|+|++ |..||............   ...           
T Consensus       147 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~---~~~-----------  212 (252)
T cd05084         147 GVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI---EQG-----------  212 (252)
T ss_pred             ccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH---HcC-----------
Confidence            111111111123457999999998899999999999999999998 88888755432221111   110           


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          320 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       320 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                         .....+...+..+.+|+.+||+.+|++|||+.++++.|+
T Consensus       213 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         213 ---VRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             ---CCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence               000112223467889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=8.3e-41  Score=311.72  Aligned_cols=248  Identities=26%  Similarity=0.428  Sum_probs=196.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---hHHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      ++|...+.||+|+||.||++.++        ....+|+|.+...   ...+.+|+.+++.++||||+++++++.....  
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~--------~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--   73 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR--------AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKP--   73 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec--------cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCC--
Confidence            46888899999999999999875        3457999987643   3468889999999999999999999876543  


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCC
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  235 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a  235 (432)
                        .++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        74 --~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~  147 (256)
T cd05114          74 --LYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMT  147 (256)
T ss_pred             --EEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCc
Confidence              599999999999999987543 3589999999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      +...... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ....+.....    
T Consensus       148 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~~i~~~~~----  219 (256)
T cd05114         148 RYVLDDE-YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVEMISRGFR----  219 (256)
T ss_pred             cccCCCc-eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHCCCC----
Confidence            7532111 111122335668999999998889999999999999999999 899997654322   2222221100    


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                         ...       +...+..+.+++.+||+.+|.+|||+.++++.|
T Consensus       220 ---~~~-------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         220 ---LYR-------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ---CCC-------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence               000       111235688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.4e-41  Score=324.78  Aligned_cols=242  Identities=25%  Similarity=0.413  Sum_probs=191.3

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHH---hcccCCCccceeeeEEee
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQF---LGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~---l~~l~hpniv~l~~~~~~  150 (432)
                      |.+++.||+|+||.||+|.+.       .++..||||.+.+..       ..+..|..+   ++.++||||+++++++..
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~   73 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYK-------KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT   73 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc
Confidence            667889999999999999865       467889999986432       235556554   456789999999999875


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .+    ..++||||+.+++|..++..   ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        74 ~~----~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~  143 (324)
T cd05589          74 ED----HVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIA  143 (324)
T ss_pred             CC----EEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeC
Confidence            44    45999999999999988854   3689999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      |||++.....  .........||+.|+|||.+.+..++.++|||||||++|+|++|..||.+......   ...+...  
T Consensus       144 Dfg~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~---~~~i~~~--  216 (324)
T cd05589         144 DFGLCKEGMG--FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV---FDSIVND--  216 (324)
T ss_pred             cccCCccCCC--CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhC--
Confidence            9999874221  12223456799999999999999999999999999999999999999986544322   1111110  


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  359 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  359 (432)
                               ..    ..+...+..+.+++.+||..||.+||     ++.+++++
T Consensus       217 ---------~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         217 ---------EV----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             ---------CC----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence                     00    01122345678999999999999999     56777665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.1e-41  Score=330.11  Aligned_cols=251  Identities=24%  Similarity=0.355  Sum_probs=195.7

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh--------HHHHHHHHHhccc-CCCccceeeeEEee
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--------LQWVAEVQFLGVL-EHPNLVKLIGYCAV  150 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~hpniv~l~~~~~~  150 (432)
                      +|++++.||+|+||.||++...    .+..++..||+|.+.+..        ..+..|+.++..+ +||||+++++++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~   76 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKV----TGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT   76 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEc----ccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec
Confidence            4888999999999999998764    123467899999986421        2367899999999 59999999988865


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      ++    ..++||||+.+|+|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        77 ~~----~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~  147 (332)
T cd05614          77 EA----KLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLT  147 (332)
T ss_pred             CC----EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEe
Confidence            54    3589999999999999997543  689999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhh-HHHHHHHhhc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-QRLLEWVQQY  308 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~-~~~~~~~~~~  308 (432)
                      |||+++...... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||........ ..+...+...
T Consensus       148 DfG~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  226 (332)
T cd05614         148 DFGLSKEFLSEE-KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC  226 (332)
T ss_pred             eCcCCccccccC-CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC
Confidence            999987532211 1122346799999999999765 478899999999999999999999975432211 1111111111


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  359 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  359 (432)
                                 ++.+    +...+..+.+++.+||+.||.+||     ++.+++++
T Consensus       227 -----------~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         227 -----------DPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             -----------CCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence                       1111    122345678999999999999999     77788766

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.1e-40  Score=312.61  Aligned_cols=255  Identities=26%  Similarity=0.370  Sum_probs=202.2

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|++.+.||+|+||.||+|+..       .++..||||.+...       ...+.+|+.+++.++||||+++++++...
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCL-------LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED   74 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEe-------CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC
Confidence            57999999999999999999865       45788999976431       12478899999999999999999998765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      +    ..++||||+++++|.+++...  ....+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|
T Consensus        75 ~----~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l  147 (267)
T cd08228          75 N----ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKL  147 (267)
T ss_pred             C----eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEE
Confidence            4    358999999999999888532  234588999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      +|||++......  ........|++.|+|||.+.+..++.++||||||+++|+|++|..||....... ..+...+....
T Consensus       148 ~d~g~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~  224 (267)
T cd08228         148 GDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQKIEQCD  224 (267)
T ss_pred             Cccccceeccch--hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHHHhcCC
Confidence            999998753211  112234568899999999988889999999999999999999999996543221 11222211100


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                                .+   .......+..+.+++.+||..+|++||++.+|++.|+.+
T Consensus       225 ----------~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         225 ----------YP---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             ----------CC---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence                      00   011223346788999999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-41  Score=335.02  Aligned_cols=250  Identities=22%  Similarity=0.304  Sum_probs=194.3

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|.+++.||+|+||.||++...       .+++.||||.+.+..       ..+.+|+.+++.++||||+++++++...
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~   73 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKK-------DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA   73 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEEC-------CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence            47899999999999999999865       467889999886432       2367899999999999999999998765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      .    ..++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        74 ~----~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~D  144 (377)
T cd05629          74 Q----YLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSD  144 (377)
T ss_pred             C----eeEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEee
Confidence            4    459999999999999998654  4689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCC-----------cc----------------------------------cccccccCCCccCccccccCC
Q 014034          232 FGLAREGPMVGH-----------TH----------------------------------VSTAVVGTFGYAAPDYIETGH  266 (432)
Q Consensus       232 fG~a~~~~~~~~-----------~~----------------------------------~~~~~~gt~~y~aPE~~~~~~  266 (432)
                      ||+++.......           ..                                  .....+||+.|+|||++.+..
T Consensus       145 fGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  224 (377)
T cd05629         145 FGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG  224 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC
Confidence            999863211000           00                                  001246999999999999999


Q ss_pred             CCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCC
Q 014034          267 LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKS  346 (432)
Q Consensus       267 ~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~d  346 (432)
                      ++.++|||||||++|||++|..||.+.......   ..+......   +      .+..  ....+..+.+|+.+|+. +
T Consensus       225 ~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~---~~i~~~~~~---~------~~p~--~~~~s~~~~dli~~lL~-~  289 (377)
T cd05629         225 YGQECDWWSLGAIMFECLIGWPPFCSENSHETY---RKIINWRET---L------YFPD--DIHLSVEAEDLIRRLIT-N  289 (377)
T ss_pred             CCCceeeEecchhhhhhhcCCCCCCCCCHHHHH---HHHHccCCc---c------CCCC--CCCCCHHHHHHHHHHhc-C
Confidence            999999999999999999999999865543221   111111000   0      0000  11123567899999997 6


Q ss_pred             CCCC---CCHHHHHHH
Q 014034          347 SKDR---PKMSQVVER  359 (432)
Q Consensus       347 P~~R---Ps~~eil~~  359 (432)
                      |.+|   +++.+++.+
T Consensus       290 ~~~r~~r~~~~~~l~h  305 (377)
T cd05629         290 AENRLGRGGAHEIKSH  305 (377)
T ss_pred             HhhcCCCCCHHHHhcC
Confidence            7765   599999887

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.7e-41  Score=316.74  Aligned_cols=256  Identities=29%  Similarity=0.377  Sum_probs=201.3

Q ss_pred             HhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---hHHHHHHHHHhccc-CCCccceeeeEEeec
Q 014034           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQWVAEVQFLGVL-EHPNLVKLIGYCAVD  151 (432)
Q Consensus        76 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  151 (432)
                      .+++.|+..+.||+|+||.||+|...       ..++.||+|.+...   ...+..|+.++..+ +||||+++++++...
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~-------~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   75 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHV-------KTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   75 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEc-------CCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence            35677999999999999999999865       45789999998643   34578899999988 799999999998764


Q ss_pred             CCc--ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          152 GER--GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       152 ~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      ...  ....++||||+.+++|.+++.......+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|
T Consensus        76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l  152 (272)
T cd06637          76 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKL  152 (272)
T ss_pred             CCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEE
Confidence            332  23468999999999999999765555789999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCccccc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE-----TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  304 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  304 (432)
                      +|||++.....  .........|+..|+|||++.     +..++.++|||||||++|+|++|..||....+.......  
T Consensus       153 ~Dfg~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~--  228 (272)
T cd06637         153 VDFGVSAQLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--  228 (272)
T ss_pred             ccCCCceeccc--ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH--
Confidence            99999875321  112233467899999999986     346788999999999999999999999754432221111  


Q ss_pred             HhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          305 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                       ....          ...   ......+..+.+|+.+||..+|.+|||+.+++++
T Consensus       229 -~~~~----------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         229 -PRNP----------APR---LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             -hcCC----------CCC---CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence             0000          000   0111234568899999999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.2e-41  Score=317.34  Aligned_cols=272  Identities=30%  Similarity=0.436  Sum_probs=202.7

Q ss_pred             CC-ccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           80 DF-SRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        80 ~~-~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      +| ...+.||+|+||+||++.+...   ....+..||+|.+...     ...+.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~---~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPA---NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccc---cCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            44 8889999999999998775421   2245678999998753     2347889999999999999999998875433


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                      .  ..++||||+.+++|.+++...   .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||
T Consensus        81 ~--~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg  152 (283)
T cd05080          81 K--GLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFG  152 (283)
T ss_pred             c--eEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecc
Confidence            2  458999999999999998653   589999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcc-cccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          234 LAREGPMVGHTH-VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       234 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      ++.......... ......++..|+|||.+.+..++.++||||||+++|+|+||..||........ ......... ...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~-~~~  230 (283)
T cd05080         153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQ-MTV  230 (283)
T ss_pred             cccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccc-cch
Confidence            987543211111 11223456679999999888899999999999999999999999865432111 111100000 000


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  364 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  364 (432)
                      ..+...+........+...+..+.+++.+||+.+|++|||+.+|++.|+.+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         231 VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            0000011111111122334567899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.1e-40  Score=317.45  Aligned_cols=267  Identities=27%  Similarity=0.441  Sum_probs=204.7

Q ss_pred             hcCCccccccccCCceEEEEEEecCCC---------CCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccce
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAA---------GDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVK  143 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~---------~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~  143 (432)
                      .++|++.+.||+|+||.||+|.....+         ......+..||+|.+....     ..+.+|+.+++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            357999999999999999999876432         1223355789999987542     34778999999999999999


Q ss_pred             eeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCC
Q 014034          144 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA---------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDF  214 (432)
Q Consensus       144 l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Di  214 (432)
                      +++++..++.    .++||||+.+++|.+++....         ...+++..++.++.|++.||.|||+.   +|+|+||
T Consensus        84 ~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dl  156 (296)
T cd05051          84 LLGVCTVDPP----LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDL  156 (296)
T ss_pred             EEEEEecCCC----cEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Ccccccc
Confidence            9999876543    499999999999999986543         12689999999999999999999998   9999999


Q ss_pred             CCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh--CCCCCCC
Q 014034          215 KASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT--GRRSLER  292 (432)
Q Consensus       215 kp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~pf~~  292 (432)
                      ||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++  |..||..
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         157 ATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             chhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999875332222222334556789999999988889999999999999999998  6778865


Q ss_pred             CCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          293 NRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                      .....   ..............       ......+...+..+.+|+.+||+.||.+|||+.+|++.|+
T Consensus       237 ~~~~~---~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         237 LTDQQ---VIENAGHFFRDDGR-------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             cChHH---HHHHHHhccccccc-------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            43322   22222111110000       0000111223467899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.3e-40  Score=320.13  Aligned_cols=264  Identities=24%  Similarity=0.417  Sum_probs=204.7

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhccc-CCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVL-EHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  152 (432)
                      .+|.+.+.||+|+||.||++...............+|+|.+....     ..+..|+.+++.+ +||||+++++++...+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            468889999999999999998653332333456789999887432     2477899999999 6999999999987654


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASN  218 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~N  218 (432)
                          ..++||||+++|+|.+++....              ...+++..+..++.|++.||.|||+.   +|+||||||+|
T Consensus        92 ----~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N  164 (314)
T cd05099          92 ----PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN  164 (314)
T ss_pred             ----ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence                3599999999999999996532              23588999999999999999999998   99999999999


Q ss_pred             eEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchh
Q 014034          219 VLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKT  297 (432)
Q Consensus       219 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~  297 (432)
                      ||++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  244 (314)
T cd05099         165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE  244 (314)
T ss_pred             EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999975322111111122234568999999998899999999999999999999 889997654332


Q ss_pred             hHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          298 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                      .   ...+.....          .    ..+...+..+.+++.+||..+|.+|||+.++++.|..+...
T Consensus       245 ~---~~~~~~~~~----------~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         245 L---FKLLREGHR----------M----DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             H---HHHHHcCCC----------C----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence            2   221111100          0    11122345788999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-40  Score=312.20  Aligned_cols=259  Identities=25%  Similarity=0.411  Sum_probs=200.7

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecCC-
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE-  153 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-  153 (432)
                      |.+.+.||+|+||.||+|.+..    +...+..||+|.+..+.      ..+.+|+.+++.++||||+++++++..... 
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   76 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQ----DDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSL   76 (273)
T ss_pred             CccccccCcCCCceEEEEEEec----CCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcc
Confidence            5677899999999999998752    12245789999886431      247889999999999999999998865443 


Q ss_pred             -cceeEEEEEeecCCCCHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCcee
Q 014034          154 -RGIQRLLVYEFMLNRSLEDHLFNR----AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  228 (432)
Q Consensus       154 -~~~~~~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k  228 (432)
                       .....++||||+++++|..++...    ....+++..+..++.|++.||.|||+.   +++||||||+||++++++.+|
T Consensus        77 ~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~k  153 (273)
T cd05035          77 QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVC  153 (273)
T ss_pred             ccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEE
Confidence             112358999999999999998543    223689999999999999999999998   999999999999999999999


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhh
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQ  307 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~  307 (432)
                      |+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.+....   .+...+..
T Consensus       154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~~~  230 (273)
T cd05035         154 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYLRH  230 (273)
T ss_pred             ECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc
Confidence            999999975432221111222345678999999988899999999999999999999 88998764432   22222221


Q ss_pred             cccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                      ...          .    ..+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       231 ~~~----------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 GNR----------L----KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCC----------C----CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            110          0    11122346788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6.8e-41  Score=339.10  Aligned_cols=268  Identities=21%  Similarity=0.327  Sum_probs=196.5

Q ss_pred             HHHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh---HHHHHHHHHhcccC------CCccc
Q 014034           72 SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQWVAEVQFLGVLE------HPNLV  142 (432)
Q Consensus        72 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~------hpniv  142 (432)
                      +++....++|.+++.||+|+||.||+|.+.       ..+..||||+++...   ..+..|+.++..+.      |++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~  194 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDR-------KRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLM  194 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEc-------CCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCccee
Confidence            344455688999999999999999999865       457889999986432   23556777776665      45688


Q ss_pred             eeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc
Q 014034          143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD  222 (432)
Q Consensus       143 ~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~  222 (432)
                      .+++++....   ...++||+++ +++|.+++...  ..+++..+..|+.||+.||.|||++  .+|+||||||+|||++
T Consensus       195 ~i~~~~~~~~---~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~  266 (467)
T PTZ00284        195 KIQRYFQNET---GHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILME  266 (467)
T ss_pred             eeEEEEEcCC---ceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEe
Confidence            8888886543   2468999988 78899988654  3699999999999999999999973  2999999999999998


Q ss_pred             CCC----------------ceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhC
Q 014034          223 ENF----------------RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG  286 (432)
Q Consensus       223 ~~~----------------~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg  286 (432)
                      .++                .+||+|||++...     ........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG  341 (467)
T PTZ00284        267 TSDTVVDPVTNRALPPDPCRVRICDLGGCCDE-----RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG  341 (467)
T ss_pred             cCCcccccccccccCCCCceEEECCCCccccC-----ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhC
Confidence            765                4999999987542     1123456799999999999999999999999999999999999


Q ss_pred             CCCCCCCCchhhHHHHHHHh-hcccCcc---------cc-cc--ccCccccC-----------cCCHHHHHHHHHHHHHh
Q 014034          287 RRSLERNRPKTEQRLLEWVQ-QYPADSK---------KF-GL--IMDPRLEK-----------EYSINEARKIGRLADNC  342 (432)
Q Consensus       287 ~~pf~~~~~~~~~~~~~~~~-~~~~~~~---------~~-~~--~~~~~l~~-----------~~~~~~~~~l~~li~~c  342 (432)
                      +.||.+.........+.... .++....         .+ ..  ...+....           .........+.+||.+|
T Consensus       342 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m  421 (467)
T PTZ00284        342 KLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGL  421 (467)
T ss_pred             CCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHh
Confidence            99998766543332222111 1110000         00 00  00000000           00011234677999999


Q ss_pred             ccCCCCCCCCHHHHHHH
Q 014034          343 LSKSSKDRPKMSQVVER  359 (432)
Q Consensus       343 l~~dP~~RPs~~eil~~  359 (432)
                      |..||.+|||+.|+++|
T Consensus       422 L~~dP~~R~ta~e~L~H  438 (467)
T PTZ00284        422 LHYDRQKRLNARQMTTH  438 (467)
T ss_pred             CCcChhhCCCHHHHhcC
Confidence            99999999999999986

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=9.8e-41  Score=329.96  Aligned_cols=262  Identities=24%  Similarity=0.392  Sum_probs=202.7

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccC-CCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLE-HPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-hpniv~l~~~~~~~  151 (432)
                      .++|.+.+.||+|+||.||+|++....  ....+..||+|++....     ..+.+|+.+|..+. ||||+++++++...
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~--~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLS--HSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCC--CCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            346888899999999999999975221  22356789999997532     24778999999997 99999999999765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCC-----------------------------------------------------
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRA-----------------------------------------------------  178 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------  178 (432)
                      +.    .++||||+.+|+|.+++....                                                     
T Consensus       114 ~~----~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         114 GP----IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             CC----cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            53    499999999999999986431                                                     


Q ss_pred             -------------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCC
Q 014034          179 -------------------------------------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFK  215 (432)
Q Consensus       179 -------------------------------------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dik  215 (432)
                                                                 ...+++..++.++.||+.||.|||+.   +|+|||||
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlk  266 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLA  266 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCC
Confidence                                                       12367778899999999999999998   99999999


Q ss_pred             CCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCC
Q 014034          216 ASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNR  294 (432)
Q Consensus       216 p~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~  294 (432)
                      |+|||++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus       267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999999999975321111111223456788999999998889999999999999999998 889987543


Q ss_pred             chhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 014034          295 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  364 (432)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  364 (432)
                      ....  ....+...              .....+...+..+.+|+.+||..+|.+||++.+|++.|+.++
T Consensus       347 ~~~~--~~~~~~~~--------------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         347 MNEQ--FYNAIKRG--------------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             chHH--HHHHHHcC--------------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            3221  11111110              000111223467889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=9.6e-41  Score=311.30  Aligned_cols=247  Identities=28%  Similarity=0.445  Sum_probs=199.4

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh--HHHHHHHHHhcccCCCccceeeeEEeecCCcce
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~  156 (432)
                      .+|...+.||+|+||.||++...         +..||+|.+..+.  ..+.+|+.+++.++|||++++++++...+.   
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---   73 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR---------GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG---   73 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc---------CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCC---
Confidence            47889999999999999998753         6679999887543  358899999999999999999998754432   


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      ..++||||+++++|.+++.......+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.
T Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~  150 (256)
T cd05082          74 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK  150 (256)
T ss_pred             ceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccce
Confidence            358999999999999999876655689999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcccc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKF  315 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  315 (432)
                      .....     .....++..|+|||++.+..++.++|||||||++|+|++ |..||.......   +...+....      
T Consensus       151 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~~~~~------  216 (256)
T cd05082         151 EASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKGY------  216 (256)
T ss_pred             ecccc-----CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhcCC------
Confidence            53211     122345668999999998899999999999999999998 999987543322   222221110      


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 014034          316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  362 (432)
Q Consensus       316 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  362 (432)
                          .+    ..+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       217 ----~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         217 ----KM----DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             ----CC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence                00    1112234678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.8e-40  Score=309.79  Aligned_cols=245  Identities=26%  Similarity=0.421  Sum_probs=193.6

Q ss_pred             ccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecCCcceeEE
Q 014034           86 KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  159 (432)
Q Consensus        86 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~  159 (432)
                      .||+|+||.||+|.+.     ...++..+|+|++....      ..+..|+.+++.++||||+++++++..+     ..+
T Consensus         2 ~lg~G~~g~v~~~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   71 (257)
T cd05116           2 ELGSGNFGTVKKGMYK-----MKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAE-----SWM   71 (257)
T ss_pred             cCCCcCCcceEEeEEe-----cCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----CcE
Confidence            5899999999999765     23457889999986432      2478899999999999999999987532     248


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCC
Q 014034          160 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP  239 (432)
Q Consensus       160 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~  239 (432)
                      +||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus        72 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~  146 (257)
T cd05116          72 LVMELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALG  146 (257)
T ss_pred             EEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccC
Confidence            999999999999999654  3689999999999999999999998   99999999999999999999999999997532


Q ss_pred             CCCCcc-cccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcccccc
Q 014034          240 MVGHTH-VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGL  317 (432)
Q Consensus       240 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (432)
                      ...... ......++..|+|||.+....++.++|||||||++|||++ |..||.......   +...+....        
T Consensus       147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~i~~~~--------  215 (257)
T cd05116         147 ADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQMIESGE--------  215 (257)
T ss_pred             CCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHCCC--------
Confidence            221111 1122234678999999988889999999999999999998 999998654432   222222110        


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 014034          318 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  362 (432)
Q Consensus       318 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  362 (432)
                        .+    ..+...+..+.++|.+||+.||.+||++.+|.+.|++
T Consensus       216 --~~----~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         216 --RM----ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             --CC----CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence              00    1122234678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.7e-41  Score=317.88  Aligned_cols=242  Identities=26%  Similarity=0.383  Sum_probs=190.5

Q ss_pred             cccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeecCCcceeEE
Q 014034           87 IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  159 (432)
Q Consensus        87 lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~  159 (432)
                      ||+|+||+||++...       .+++.||+|.+....       ..+..|+.+++.++||||+++++++....    ..+
T Consensus         1 lg~G~~g~Vy~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~----~~~   69 (280)
T cd05608           1 LGKGGFGEVSACQMR-------ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT----DLC   69 (280)
T ss_pred             CCCCCceeEEEEEEc-------cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC----eEE
Confidence            799999999999865       467899999986532       23567999999999999999998886544    359


Q ss_pred             EEEeecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          160 LVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       160 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      +||||+++|+|.+++...  ....+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.++|+|||++..
T Consensus        70 lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  146 (280)
T cd05608          70 LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVE  146 (280)
T ss_pred             EEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcccee
Confidence            999999999999887542  234689999999999999999999998   999999999999999999999999999875


Q ss_pred             CCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhh-HHHHHHHhhcccCccccc
Q 014034          238 GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-QRLLEWVQQYPADSKKFG  316 (432)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~  316 (432)
                      ....  ........||+.|+|||++.+..++.++|||||||++|+|++|..||........ ......+.          
T Consensus       147 ~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~----------  214 (280)
T cd05608         147 LKDG--QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL----------  214 (280)
T ss_pred             cCCC--CccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc----------
Confidence            3221  1122345789999999999999999999999999999999999999976433211 11111110          


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 014034          317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  359 (432)
Q Consensus       317 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  359 (432)
                         ...  ...+...+..+.+++.+||+.||.+||     ++.+++++
T Consensus       215 ---~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         215 ---NDS--VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             ---ccC--CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence               000  011223446788999999999999999     66777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.8e-40  Score=316.60  Aligned_cols=257  Identities=30%  Similarity=0.412  Sum_probs=199.2

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhccc-CCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVL-EHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  152 (432)
                      ++|++.+.||+|+||.||+|....     ......+++|.+...     ...+.+|+.++.++ +||||+++++++...+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKK-----DGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecC-----CCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC
Confidence            478889999999999999998751     122345788877632     12478899999999 7999999999987654


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASN  218 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~N  218 (432)
                      .    .++||||+++++|.+++....              ...+++..+..++.|++.||+|||+.   +|+||||||+|
T Consensus        77 ~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~N  149 (297)
T cd05089          77 Y----LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARN  149 (297)
T ss_pred             c----ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcce
Confidence            3    499999999999999996532              13588999999999999999999998   99999999999


Q ss_pred             eEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchh
Q 014034          219 VLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKT  297 (432)
Q Consensus       219 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~  297 (432)
                      ||++.++.+||+|||++.....   .........+..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus       150 ill~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~  226 (297)
T cd05089         150 VLVGENLASKIADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE  226 (297)
T ss_pred             EEECCCCeEEECCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            9999999999999999863211   111111223557999999998899999999999999999998 999997654432


Q ss_pred             hHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhc
Q 014034          298 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  367 (432)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  367 (432)
                      .   ...+...          ...    ..+...+..+.+|+.+||+.+|.+|||+.+|++.|+.+.+..
T Consensus       227 ~---~~~~~~~----------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         227 L---YEKLPQG----------YRM----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             H---HHHHhcC----------CCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            1   1111100          000    111223457889999999999999999999999999888654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.1e-40  Score=314.85  Aligned_cols=258  Identities=26%  Similarity=0.428  Sum_probs=200.1

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|.+.+.||+|+||.||+|.+....+  ......||+|.+....     ..+..|+.+++.++||||+++++++....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~--~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDG--DAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCC--CCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            4578999999999999999999863221  2357889999876432     24788999999999999999999887654


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC--
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAF-----PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF--  225 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~--  225 (432)
                      .    .++||||+.+++|.+++.....     ..+++..+..++.||+.||.|||+.   +++||||||+|||++.++  
T Consensus        83 ~----~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~  155 (277)
T cd05036          83 P----RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPG  155 (277)
T ss_pred             C----cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCC
Confidence            3    3899999999999999865431     2589999999999999999999998   999999999999998654  


Q ss_pred             -ceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHH
Q 014034          226 -RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLE  303 (432)
Q Consensus       226 -~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~  303 (432)
                       .+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||........   ..
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~---~~  232 (277)
T cd05036         156 RVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV---ME  232 (277)
T ss_pred             cceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH
Confidence             599999999975321111111112234568999999998899999999999999999997 9999986544322   22


Q ss_pred             HHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          304 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                      .+.....              ...+...+..+.+++.+||+.+|++|||+.+|+++|.
T Consensus       233 ~~~~~~~--------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         233 FVTGGGR--------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHcCCc--------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            1111100              0111223467889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=7.2e-41  Score=317.54  Aligned_cols=266  Identities=27%  Similarity=0.397  Sum_probs=197.3

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhccc---CCCccceeeeEEee
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVL---EHPNLVKLIGYCAV  150 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~hpniv~l~~~~~~  150 (432)
                      +|++.+.||+|+||.||+|...       .+++.||+|.+....      ..+.+|+.+++.+   +||||+++++++..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~   73 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDP-------HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCAT   73 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEEC-------CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeecc
Confidence            4888899999999999999865       467899999886421      2356777777655   79999999998865


Q ss_pred             cC-CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          151 DG-ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       151 ~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      .. ......++||||+. ++|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||
T Consensus        74 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl  149 (288)
T cd07863          74 SRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKL  149 (288)
T ss_pred             ccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence            32 22345689999996 5898888765555689999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHHHhhc
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWVQQY  308 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~  308 (432)
                      +|||++.....   ........||..|+|||++.+..++.++|||||||++|+|++|.+||.+....... .+.......
T Consensus       150 ~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~  226 (288)
T cd07863         150 ADFGLARIYSC---QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP  226 (288)
T ss_pred             CccCccccccC---cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCC
Confidence            99999875321   11223456899999999999889999999999999999999999999765443221 122211111


Q ss_pred             ccCccccc-----cccCcccc---CcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 PADSKKFG-----LIMDPRLE---KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 ~~~~~~~~-----~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ........     ....+...   .......+..+.+|+.+||+.||.+|||+.+++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         227 PEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             ChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            00000000     00000000   01111234567899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-40  Score=325.80  Aligned_cols=262  Identities=22%  Similarity=0.343  Sum_probs=193.8

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHHHHHHHhcccCCCccceeeeEEeecCCcce
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~  156 (432)
                      ...+|.+++.||+|+||.||+|...       ..+..||+|.....  ....|+.+++.++||||+++++++.....   
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---  131 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKP-------GQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTLVSGAI---  131 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEEC-------CCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheEEeCCe---
Confidence            4467999999999999999999865       45678999986543  34579999999999999999999886543   


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                       .++||||+ .++|.+++.... ..+++..+..|+.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       132 -~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~  205 (357)
T PHA03209        132 -TCMVLPHY-SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ  205 (357)
T ss_pred             -eEEEEEcc-CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccc
Confidence             48999999 568888886543 4789999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchh--------hHHHHHHHhhc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT--------EQRLLEWVQQY  308 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~--------~~~~~~~~~~~  308 (432)
                      ....   ........||+.|+|||++.+..++.++|||||||++|||+++..|+....+..        ...+...+...
T Consensus       206 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~  282 (357)
T PHA03209        206 FPVV---APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTL  282 (357)
T ss_pred             cccc---CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHh
Confidence            4211   112234568999999999999999999999999999999998655553322211        11112211111


Q ss_pred             ccCccccc---------cccCc--cccCc-------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 PADSKKFG---------LIMDP--RLEKE-------YSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 ~~~~~~~~---------~~~~~--~l~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ...+..+.         ..++.  .....       .....+..+.+||.+||+.||.+|||+.|++.+
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        283 KVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             ccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence            11110000         00000  00000       001123456679999999999999999999876

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.2e-42  Score=300.49  Aligned_cols=253  Identities=23%  Similarity=0.347  Sum_probs=203.9

Q ss_pred             HHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------------HHHHHHHHHhccc-CCCcc
Q 014034           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------------LQWVAEVQFLGVL-EHPNL  141 (432)
Q Consensus        75 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l-~hpni  141 (432)
                      ...-+.|...+.||.|..+.|-++.++       .++..+|+|++.-..            ....+|+.||+++ .||||
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k-------~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~I   85 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHK-------ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYI   85 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhc-------ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcE
Confidence            445567888899999999999999877       456778888874211            1256799999998 69999


Q ss_pred             ceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEE
Q 014034          142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL  221 (432)
Q Consensus       142 v~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill  221 (432)
                      +.+.+++..+..    .++|+|.|+.|.|.|+|.+..  .++++...+|+.|+..|++|||..   +||||||||+|||+
T Consensus        86 I~l~D~yes~sF----~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILl  156 (411)
T KOG0599|consen   86 IDLQDVYESDAF----VFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILL  156 (411)
T ss_pred             EEeeeeccCcch----hhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheee
Confidence            999999876653    489999999999999997654  799999999999999999999998   99999999999999


Q ss_pred             cCCCceeeccccCCcCCCCCCCcccccccccCCCccCcccccc------CCCCchhhhHHHHHHHHHHHhCCCCCCCCCc
Q 014034          222 DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET------GHLTAKSDVWSFGVVLYEMLTGRRSLERNRP  295 (432)
Q Consensus       222 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltg~~pf~~~~~  295 (432)
                      +++.++||+|||+|+...   ........+|||+|+|||.+..      ..|+..+|+|++|||||.|+.|.+||.....
T Consensus       157 ddn~~i~isDFGFa~~l~---~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ  233 (411)
T KOG0599|consen  157 DDNMNIKISDFGFACQLE---PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ  233 (411)
T ss_pred             ccccceEEeccceeeccC---CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH
Confidence            999999999999998743   3445567899999999999854      4688899999999999999999999975433


Q ss_pred             hhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          296 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                      .....+   +..-.     +      .+......+.+....+||.+||+.||.+|.|+.|++.+-
T Consensus       234 mlMLR~---ImeGk-----y------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp  284 (411)
T KOG0599|consen  234 MLMLRM---IMEGK-----Y------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP  284 (411)
T ss_pred             HHHHHH---HHhcc-----c------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence            222222   11100     0      111122345567788999999999999999999999874

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-41  Score=324.69  Aligned_cols=248  Identities=27%  Similarity=0.336  Sum_probs=209.0

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-------HHHHHHHHhcccC-CCccceeeeEEe
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQFLGVLE-HPNLVKLIGYCA  149 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~-hpniv~l~~~~~  149 (432)
                      ...|++.+.||.|.||.||+++.+       .++..+|+|.+.+...       ...+|+++|+++. |||||.+++++.
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~-------~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e  106 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREK-------STGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE  106 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEec-------CCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            356888899999999999999976       4588999999875433       5889999999998 999999999998


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC----CC
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE----NF  225 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~----~~  225 (432)
                      ...    ..++|||++.||.|.+.|...   .+++..+..++.|++.++.|||+.   ||+||||||+|+|+..    ++
T Consensus       107 ~~~----~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~  176 (382)
T KOG0032|consen  107 DPD----SVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSG  176 (382)
T ss_pred             cCC----eEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCC
Confidence            766    359999999999999999876   299999999999999999999998   9999999999999953    35


Q ss_pred             ceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 014034          226 RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  305 (432)
Q Consensus       226 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  305 (432)
                      .+|++|||++.....   .......+||+.|+|||++...+|+..+||||+||++|.|++|..||.+.........+  .
T Consensus       177 ~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i--~  251 (382)
T KOG0032|consen  177 RIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI--L  251 (382)
T ss_pred             cEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH--H
Confidence            799999999987432   44556789999999999999999999999999999999999999999876643332211  1


Q ss_pred             hhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          306 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .            .+..+........+..+.++|..|+..||.+|+|+.++++|
T Consensus       252 ~------------~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  252 R------------GDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             c------------CCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            1            11122333445557789999999999999999999999997

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.4e-41  Score=323.23  Aligned_cols=244  Identities=26%  Similarity=0.407  Sum_probs=192.7

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCC-ccceeeeEEeec
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHP-NLVKLIGYCAVD  151 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hp-niv~l~~~~~~~  151 (432)
                      +|++++.||+|+||.||+|...       .++..||+|.+.+..       ..+..|..++..+.|+ +|+.+++++...
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~   73 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERK-------GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM   73 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC
Confidence            5888999999999999999865       456789999986432       2367788999988765 577888877654


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ..++||||+++|+|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        74 ~----~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~D  144 (324)
T cd05587          74 D----RLYFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIAD  144 (324)
T ss_pred             C----EEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEee
Confidence            4    4599999999999999986543  689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ||++......  ........||+.|+|||++.+..++.++|||||||++|+|+||..||.+.....   ....+....  
T Consensus       145 fg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i~~~~--  217 (324)
T cd05587         145 FGMCKENIFG--GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQSIMEHN--  217 (324)
T ss_pred             cCcceecCCC--CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHHcCC--
Confidence            9998642211  112334679999999999999999999999999999999999999998654322   222111110  


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM-----SQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~~  359 (432)
                               .    ..+...+..+.+++.+||..||.+|++.     .+++++
T Consensus       218 ---------~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         218 ---------V----SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             ---------C----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                     0    1111234567899999999999999986     555544

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.4e-41  Score=331.43  Aligned_cols=260  Identities=22%  Similarity=0.307  Sum_probs=206.1

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHH---HHHHHHHhcccC-C-----CccceeeeEEee
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGVLE-H-----PNLVKLIGYCAV  150 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~E~~~l~~l~-h-----pniv~l~~~~~~  150 (432)
                      +|.+++.||+|+||.|-+|...       .+++.||||+++.....   ...|+.+|..|+ |     -|+|+++++|..
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~-------~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f  259 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDH-------KTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF  259 (586)
T ss_pred             EEEEEEEecccccceeEEEEec-------CCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence            5788999999999999999855       67899999999887654   566899999886 4     489999999987


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCC--Ccee
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN--FRPK  228 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~--~~~k  228 (432)
                      .+    ++|||+|.+ .-+|+++|+.+...+++...+..|+.||+.||.+||+.   +|||+||||+||||.+.  ..+|
T Consensus       260 r~----HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vK  331 (586)
T KOG0667|consen  260 RN----HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIK  331 (586)
T ss_pred             cc----ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCcee
Confidence            66    459999988 67999999999999999999999999999999999998   99999999999999643  4699


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      |+|||.|...     .......+-+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+.+..+....+.-+...
T Consensus       332 VIDFGSSc~~-----~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~  406 (586)
T KOG0667|consen  332 VIDFGSSCFE-----SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGL  406 (586)
T ss_pred             EEeccccccc-----CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCC
Confidence            9999999752     11222567889999999999999999999999999999999999999988776654443322222


Q ss_pred             ccC----------------ccccc-----c-----------------ccCcccc-------CcCCHHHHHHHHHHHHHhc
Q 014034          309 PAD----------------SKKFG-----L-----------------IMDPRLE-------KEYSINEARKIGRLADNCL  343 (432)
Q Consensus       309 ~~~----------------~~~~~-----~-----------------~~~~~l~-------~~~~~~~~~~l~~li~~cl  343 (432)
                      |..                .....     .                 ..+....       ..........+.+++.+||
T Consensus       407 Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L  486 (586)
T KOG0667|consen  407 PPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCL  486 (586)
T ss_pred             CCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHh
Confidence            111                00000     0                 0000000       0111123456889999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 014034          344 SKSSKDRPKMSQVVER  359 (432)
Q Consensus       344 ~~dP~~RPs~~eil~~  359 (432)
                      .+||.+|+|..++++|
T Consensus       487 ~~dP~~R~tp~qal~H  502 (586)
T KOG0667|consen  487 EWDPAERITPAQALNH  502 (586)
T ss_pred             ccCchhcCCHHHHhcC
Confidence            9999999999999988

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5.1e-41  Score=323.74  Aligned_cols=239  Identities=26%  Similarity=0.407  Sum_probs=190.0

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhccc-CCCccceeeeEEeecCCcce
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVL-EHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~  156 (432)
                      +.||+|+||.||+|..+       .+++.||+|.+.+..       ..+..|..++..+ +||||+++++++...+    
T Consensus         1 ~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~----   69 (320)
T cd05590           1 RVLGKGSFGKVMLARLK-------ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD----   69 (320)
T ss_pred             CeeeeCCCeEEEEEEEc-------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC----
Confidence            36999999999999865       467889999986432       2356788888766 7999999999887654    


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      ..++||||+++|+|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.
T Consensus        70 ~~~iv~Ey~~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~  144 (320)
T cd05590          70 RLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK  144 (320)
T ss_pred             EEEEEEcCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCe
Confidence            4599999999999999886543  689999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  316 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (432)
                      ....  .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....   +...+....       
T Consensus       145 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~~i~~~~-------  212 (320)
T cd05590         145 EGIF--NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---LFEAILNDE-------  212 (320)
T ss_pred             ecCc--CCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHHHHhcCC-------
Confidence            5221  1122334679999999999999999999999999999999999999998654332   222221110       


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 014034          317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM------SQVVER  359 (432)
Q Consensus       317 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~eil~~  359 (432)
                          .    ..+...+..+.+|+.+||+.||.+||++      .+++.+
T Consensus       213 ----~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         213 ----V----VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             ----C----CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence                0    0111234567899999999999999998      556554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-40  Score=328.29  Aligned_cols=266  Identities=23%  Similarity=0.295  Sum_probs=201.0

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHHHHHHHhcccCCCccceeeeEEeecCCccee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQ  157 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~  157 (432)
                      ..+|.+++.||+|+||.||++...     +...+..||+|.+... ....+|+.+++.++||||+++++++....    .
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~-----~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~~~~~----~  160 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKH-----GDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAYRWKS----T  160 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEc-----CCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeEeeCC----E
Confidence            457999999999999999999754     3346788999998754 34578999999999999999999887654    3


Q ss_pred             EEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          158 RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       158 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      .++|||++. ++|.+++...  ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.++|+|||++..
T Consensus       161 ~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~  234 (392)
T PHA03207        161 VCMVMPKYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACK  234 (392)
T ss_pred             EEEEehhcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccc
Confidence            599999994 6888888433  4799999999999999999999998   999999999999999999999999999975


Q ss_pred             CCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHHHhhcccCccccc
Q 014034          238 GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWVQQYPADSKKFG  316 (432)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~  316 (432)
                      ..............||+.|+|||++.+..++.++|||||||++|||++|..||.+....... .+...+.........+.
T Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~  314 (392)
T PHA03207        235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP  314 (392)
T ss_pred             cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence            43322222233567999999999999999999999999999999999999999765433211 11111111110000000


Q ss_pred             c-----------ccCccccCcCC-------HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          317 L-----------IMDPRLEKEYS-------INEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       317 ~-----------~~~~~l~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .           .........+.       ...+..+.++|.+||..||.+|||+.+++.+
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0           00000000000       1123567889999999999999999999987

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.3e-41  Score=327.46  Aligned_cols=246  Identities=25%  Similarity=0.402  Sum_probs=190.2

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhccc-CCCccceeeeEEeecCCcce
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVL-EHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~  156 (432)
                      +.||+|+||.||+|.+.       .++..||+|.+++..       ..+..|..++..+ +||||+++++++....    
T Consensus         1 ~~lG~G~~g~V~~~~~~-------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~----   69 (329)
T cd05588           1 RVIGRGSYAKVLLVELK-------KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES----   69 (329)
T ss_pred             CeEeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC----
Confidence            36899999999999875       467889999987532       2367889999888 7999999999987654    


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      ..++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        70 ~~~lv~e~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~  144 (329)
T cd05588          70 RLFFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK  144 (329)
T ss_pred             EEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccc
Confidence            459999999999999988654  3699999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchh--hHHHHHHHhhcccCccc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT--EQRLLEWVQQYPADSKK  314 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~  314 (432)
                      ....  .........||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ......+....      
T Consensus       145 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~------  216 (329)
T cd05588         145 EGIR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV------  216 (329)
T ss_pred             cccc--CCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH------
Confidence            4211  1122334679999999999999999999999999999999999999996422111  00000010000      


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCC------HHHHHHH
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK------MSQVVER  359 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~eil~~  359 (432)
                         +....+  ..+...+..+.+++.+||+.||.+||+      +.+++++
T Consensus       217 ---~~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         217 ---ILEKQI--RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             ---HHcCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence               000000  011223456889999999999999997      6677665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=317.01  Aligned_cols=267  Identities=24%  Similarity=0.333  Sum_probs=210.1

Q ss_pred             HhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc-ChHHHHHHHHHhc--ccCCCccceeeeEEeecC
Q 014034           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQWVAEVQFLG--VLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        76 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~-~~~~~~~E~~~l~--~l~hpniv~l~~~~~~~~  152 (432)
                      ....+..+.+.||+|.||.||+|.|+         |..||||++.. +...+.+|.+|.+  .|+|+||+.+++.-..+.
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr---------Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~  278 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR---------GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDN  278 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc---------CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence            34457788899999999999999986         78899999875 4455888888876  569999999999877777


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-----CCCCceeecCCCCCceEEcCCCce
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE-----GLEVQVIYRDFKASNVLLDENFRP  227 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~-----~~~~~ivH~Dikp~Nill~~~~~~  227 (432)
                      ...-++|||.+|.+.|||+|||.+.   .++....++++..+|.||++||.     +.++.|.|||||+.||||..++.+
T Consensus       279 gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C  355 (513)
T KOG2052|consen  279 GSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  355 (513)
T ss_pred             CceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence            7778899999999999999999763   68999999999999999999995     346889999999999999999999


Q ss_pred             eeccccCCcCCCCCCC--cccccccccCCCccCccccccCC----C--CchhhhHHHHHHHHHHHhC----------CCC
Q 014034          228 KLSDFGLAREGPMVGH--THVSTAVVGTFGYAAPDYIETGH----L--TAKSDVWSFGVVLYEMLTG----------RRS  289 (432)
Q Consensus       228 kl~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwSlGvil~elltg----------~~p  289 (432)
                      .|+|+|+|........  .......+||..|||||++...-    +  -..+||||||+|+||+..+          ..|
T Consensus       356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P  435 (513)
T KOG2052|consen  356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP  435 (513)
T ss_pred             EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence            9999999976433321  22345678999999999996532    1  1358999999999999764          355


Q ss_pred             CCCCCchhhHHHHHHHhhcccCccccccccCccccCc-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 014034          290 LERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKE-----YSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  364 (432)
Q Consensus       290 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  364 (432)
                      |.+..+.           .|....+...++..++.+.     .+.+....+.+||+.||..+|.-|.|+-.|.+.|.++.
T Consensus       436 yyd~Vp~-----------DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  436 YYDVVPS-----------DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             cccCCCC-----------CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            5443222           1122222222333333322     24566778999999999999999999999999998886


Q ss_pred             h
Q 014034          365 Q  365 (432)
Q Consensus       365 ~  365 (432)
                      +
T Consensus       505 ~  505 (513)
T KOG2052|consen  505 N  505 (513)
T ss_pred             c
Confidence            5

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.2e-41  Score=329.53  Aligned_cols=250  Identities=22%  Similarity=0.288  Sum_probs=197.4

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-------HHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|.+.+.||+|+||.||++...       .++..||+|.++....       .+.+|+.+++.++||||+++++++...
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~   73 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREK-------ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK   73 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence            46899999999999999999865       4678999999875322       377899999999999999999988764


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        74 ~----~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~D  145 (330)
T cd05601          74 D----NLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLAD  145 (330)
T ss_pred             C----eEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEecc
Confidence            4    3599999999999999997642 3689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccc------cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE------TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  305 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  305 (432)
                      ||++....... ........||+.|+|||++.      +..++.++|||||||++|+|++|..||.........   ..+
T Consensus       146 fg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~---~~i  221 (330)
T cd05601         146 FGSAARLTANK-MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY---NNI  221 (330)
T ss_pred             CCCCeECCCCC-ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH---HHH
Confidence            99997532211 11223457899999999986      456788999999999999999999999765432211   111


Q ss_pred             hhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          306 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ......       .  .+  ......+..+.+|+..||. +|.+|||+.+++.+
T Consensus       222 ~~~~~~-------~--~~--~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         222 MNFQRF-------L--KF--PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             HcCCCc-------c--CC--CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            111000       0  00  0011234568899999998 99999999999876

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=328.13  Aligned_cols=258  Identities=26%  Similarity=0.403  Sum_probs=209.4

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ......+.||.|-||.||+|++....   ....-.||||..+.+     ...|..|+.+|++++|||||+++|+|.+.. 
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~---kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-  464 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPE---KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-  464 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccc---cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-
Confidence            34455678999999999999997441   234456999998763     345999999999999999999999998754 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                          .|+|||.++.|.|..||..+. ..++......++.||+.||.|||+.   .+|||||...||||.....+||+|||
T Consensus       465 ----~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFG  536 (974)
T KOG4257|consen  465 ----MWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFG  536 (974)
T ss_pred             ----eeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccc
Confidence                399999999999999998655 4789999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      +++........ ..+...-...|||||.+....++.++|||.|||++||++. |..||.+-...+--             
T Consensus       537 LSR~~ed~~yY-kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-------------  602 (974)
T KOG4257|consen  537 LSRYLEDDAYY-KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-------------  602 (974)
T ss_pred             hhhhccccchh-hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-------------
Confidence            99964322211 1122223458999999999999999999999999999887 99999875432210             


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                         . .+...-+-..+..++..|..|+.+||+.+|.+||++.+|...|+++++.
T Consensus       603 ---~-~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe  652 (974)
T KOG4257|consen  603 ---G-HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE  652 (974)
T ss_pred             ---E-EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence               0 0111112234667788999999999999999999999999999998873

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=9.1e-41  Score=321.37  Aligned_cols=238  Identities=25%  Similarity=0.413  Sum_probs=188.7

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcc-cCCCccceeeeEEeecCCcce
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGV-LEHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~~~  156 (432)
                      +.||+|+||.||+|...       .++..||+|.+....       .....|..++.. ++||||+++++++...+    
T Consensus         1 ~~lG~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~----   69 (316)
T cd05619           1 KMLGKGSFGKVFLAELK-------GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE----   69 (316)
T ss_pred             CeeeeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC----
Confidence            36999999999999865       457889999986532       235567777765 58999999999987654    


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      ..++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.
T Consensus        70 ~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~  144 (316)
T cd05619          70 NLFFVMEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCK  144 (316)
T ss_pred             EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcce
Confidence            359999999999999998654  3688999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  316 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (432)
                      .....  ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....   +...+...        
T Consensus       145 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~i~~~--------  211 (316)
T cd05619         145 ENMLG--DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQSIRMD--------  211 (316)
T ss_pred             ECCCC--CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhC--------
Confidence            42111  112234579999999999999999999999999999999999999998654322   22211111        


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHH
Q 014034          317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS-QVVE  358 (432)
Q Consensus       317 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~  358 (432)
                         .+.+    +...+..+.+++.+||+.||.+||++. +++.
T Consensus       212 ---~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         212 ---NPCY----PRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             ---CCCC----CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence               0111    112235678999999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.3e-40  Score=309.22  Aligned_cols=247  Identities=25%  Similarity=0.450  Sum_probs=194.2

Q ss_pred             ccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCCcceeEEE
Q 014034           86 KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLL  160 (432)
Q Consensus        86 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~l  160 (432)
                      .||+|+||.||+|.+..     ...+..||+|.+....     ..+.+|+.+++.++||||+++++++..+     ..++
T Consensus         2 ~ig~G~~g~v~~~~~~~-----~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~-----~~~l   71 (257)
T cd05115           2 ELGSGNFGCVKKGVYKM-----RKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE-----ALML   71 (257)
T ss_pred             ccCCCCcccEEEEEEec-----CCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC-----CeEE
Confidence            38999999999998752     2345679999986542     2478899999999999999999987432     3589


Q ss_pred             EEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCCC
Q 014034          161 VYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM  240 (432)
Q Consensus       161 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~  240 (432)
                      ||||+++++|.+++.... ..+++..++.++.|++.||.|||++   +++||||||+|||++.++.+||+|||++.....
T Consensus        72 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  147 (257)
T cd05115          72 VMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGA  147 (257)
T ss_pred             EEEeCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccC
Confidence            999999999999986543 4689999999999999999999998   999999999999999999999999999875322


Q ss_pred             CCCcc-cccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccccccc
Q 014034          241 VGHTH-VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI  318 (432)
Q Consensus       241 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (432)
                      ..... ......++..|+|||.+.+..++.++|||||||++|++++ |..||........   ...+....         
T Consensus       148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~~~~---------  215 (257)
T cd05115         148 DDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV---MSFIEQGK---------  215 (257)
T ss_pred             CccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHHHCCC---------
Confidence            21111 1112233578999999988889999999999999999996 9999986644322   22111110         


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          319 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       319 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                           ....+...+..+.+++.+||..+|++||++.+|.+.|+.+
T Consensus       216 -----~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         216 -----RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence                 0111223356788999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.9e-40  Score=310.62  Aligned_cols=252  Identities=28%  Similarity=0.381  Sum_probs=200.4

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---hHHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      ++|.+.+.||+|+||.||+|.+.        ....||+|.+...   ...+.+|+.+++.++||||+++++++...    
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--------~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~----   73 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWN--------GTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE----   73 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEec--------CCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECCC----
Confidence            56999999999999999999864        2245999998753   33588999999999999999999876432    


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCC
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  235 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a  235 (432)
                       ..++||||+.+++|.+++.......+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++
T Consensus        74 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~  149 (262)
T cd05071          74 -PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA  149 (262)
T ss_pred             -CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCce
Confidence             248999999999999999765545689999999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      ....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||........   ...+....     
T Consensus       150 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~---~~~~~~~~-----  220 (262)
T cd05071         150 RLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQVERGY-----  220 (262)
T ss_pred             eeccccc-cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH---HHHHhcCC-----
Confidence            7532211 111123346678999999988899999999999999999999 8889876543221   11111100     


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  364 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  364 (432)
                               ....+...+..+.+|+.+||+.+|.+||++.++++.|+...
T Consensus       221 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         221 ---------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             ---------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence                     00112234567889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=7.6e-41  Score=321.96  Aligned_cols=238  Identities=26%  Similarity=0.415  Sum_probs=187.1

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcc-cCCCccceeeeEEeecCCcce
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGV-LEHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~~~  156 (432)
                      +.||+|+||.||+|...       .++..||+|.+....       ..+..|..++.. .+||||+++++++...+    
T Consensus         1 ~~lG~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~----   69 (316)
T cd05592           1 KVLGKGSFGKVMLAELK-------GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE----   69 (316)
T ss_pred             CeeeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC----
Confidence            36999999999999875       457889999886532       124556666654 48999999999886544    


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      ..++||||+++|+|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.
T Consensus        70 ~~~lv~e~~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~  144 (316)
T cd05592          70 HLFFVMEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCK  144 (316)
T ss_pred             EEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCe
Confidence            4599999999999999986543  689999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  316 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (432)
                      .....  ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....   +...+...        
T Consensus       145 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~~~~i~~~--------  211 (316)
T cd05592         145 ENMNG--EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---LFDSILND--------  211 (316)
T ss_pred             ECCCC--CCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHcC--------
Confidence            53211  122344679999999999999999999999999999999999999998754322   11111110        


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHH
Q 014034          317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS-QVVE  358 (432)
Q Consensus       317 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~  358 (432)
                         .+    ..+...+..+.+|+.+||+.||.+||++. ++++
T Consensus       212 ---~~----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         212 ---RP----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             ---CC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence               01    11122345678999999999999999875 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-42  Score=331.11  Aligned_cols=243  Identities=35%  Similarity=0.484  Sum_probs=202.2

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-------HHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .-|..++.||.|+||.||-|+..       .+..+||||++.-..+       ++..|+.+|++++|||+|.+-|++..+
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~-------~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre   98 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDV-------RNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE   98 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeecc-------CccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc
Confidence            34777888999999999999854       6789999999975543       378899999999999999999999876


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      ...    |||||||. |+-.|.+.-.. +++.+..+..|+.+.+.||.|||+.   +.||||||..|||+++.|.|||+|
T Consensus        99 ~Ta----WLVMEYCl-GSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaD  169 (948)
T KOG0577|consen   99 HTA----WLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLAD  169 (948)
T ss_pred             chH----HHHHHHHh-ccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeecc
Confidence            654    99999995 57777775433 5899999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      ||.|...      .....++|||.|||||++.   .+.|+.++||||||++..||.-.++|+...+....  +....++-
T Consensus       170 FGSAsi~------~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA--LYHIAQNe  241 (948)
T KOG0577|consen  170 FGSASIM------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQNE  241 (948)
T ss_pred             ccchhhc------CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH--HHHHHhcC
Confidence            9998642      2345689999999999984   57899999999999999999999999987665432  22222221


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                 .|.+.   ..+.+..+.+++..||+.-|.+|||..+++.+
T Consensus       242 -----------sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  242 -----------SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             -----------CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence                       11121   34567789999999999999999999999876

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.5e-41  Score=332.10  Aligned_cols=252  Identities=24%  Similarity=0.287  Sum_probs=198.1

Q ss_pred             HhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEE
Q 014034           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYC  148 (432)
Q Consensus        76 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~  148 (432)
                      ...++|++.+.||+|+||.||++...       .++..||+|.+.+..       ..+.+|+.+++.++||||+++++++
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~  112 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHK-------SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF  112 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            34568999999999999999999865       467889999986421       2367899999999999999999888


Q ss_pred             eecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCcee
Q 014034          149 AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  228 (432)
Q Consensus       149 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k  228 (432)
                      ....    ..++||||+++|+|.+++...   .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+|
T Consensus       113 ~~~~----~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~k  182 (370)
T cd05596         113 QDDK----YLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLK  182 (370)
T ss_pred             ecCC----EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEE
Confidence            7544    459999999999999998643   578889999999999999999998   999999999999999999999


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCccccccC----CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG----HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  304 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  304 (432)
                      |+|||++....... ........||+.|+|||++.+.    .++.++|||||||++|||++|..||.+......   ...
T Consensus       183 L~DfG~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~~  258 (370)
T cd05596         183 LADFGTCMKMDANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---YSK  258 (370)
T ss_pred             EEeccceeeccCCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH---HHH
Confidence            99999987532111 1122346799999999998653    478899999999999999999999987544221   111


Q ss_pred             HhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 014034          305 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKD--RPKMSQVVER  359 (432)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~  359 (432)
                      +.....   .      ..+.  .....+..+.+|+.+||..+|.+  |||+.+++++
T Consensus       259 i~~~~~---~------~~~~--~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         259 IMDHKN---S------LTFP--DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             HHcCCC---c------CCCC--CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            111000   0      0000  01123467889999999999988  9999999887

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1e-40  Score=315.01  Aligned_cols=243  Identities=27%  Similarity=0.373  Sum_probs=190.9

Q ss_pred             cccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeecCCcceeEE
Q 014034           87 IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  159 (432)
Q Consensus        87 lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~  159 (432)
                      ||+|+||.||++...       .++..||+|.+....       ..+..|+++++.++||||+++++++....    ..+
T Consensus         1 lg~G~~g~Vy~~~~~-------~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~----~~~   69 (277)
T cd05607           1 LGKGGFGEVCAVQVK-------NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKT----HLC   69 (277)
T ss_pred             CCCCCceEEEEEEEc-------cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC----eEE
Confidence            799999999999865       467899999986422       12456999999999999999999886543    459


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCC
Q 014034          160 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP  239 (432)
Q Consensus       160 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~  239 (432)
                      +||||+.+++|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||++....
T Consensus        70 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~  146 (277)
T cd05607          70 LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELK  146 (277)
T ss_pred             EEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecC
Confidence            999999999999998766555789999999999999999999998   99999999999999999999999999987532


Q ss_pred             CCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhh-HHHHHHHhhcccCccccccc
Q 014034          240 MVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-QRLLEWVQQYPADSKKFGLI  318 (432)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  318 (432)
                      .   ........|+..|+|||++.+..++.++|||||||++|+|++|..||........ ........   ..       
T Consensus       147 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~---~~-------  213 (277)
T cd05607         147 D---GKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL---ED-------  213 (277)
T ss_pred             C---CceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhh---cc-------
Confidence            1   1122335689999999999988899999999999999999999999976433211 11111100   00       


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          319 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       319 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                         .+. ......+..+.+|+.+||+.||.+||++.++++.+
T Consensus       214 ---~~~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         214 ---EVK-FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             ---ccc-cccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence               000 00012345688999999999999999997766443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=7.6e-41  Score=320.97  Aligned_cols=263  Identities=25%  Similarity=0.385  Sum_probs=197.7

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|...+.||+|+||.||+|+..       .++..||+|.+....     ..+.+|+.+++.++||||+++++++..++ 
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   77 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSK-------LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK-   77 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEec-------CCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC-
Confidence            57999999999999999999865       456789999886432     24678999999999999999999987655 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+.+ +|.+++.... ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        78 ---~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg  149 (309)
T cd07872          78 ---SLTLVFEYLDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFG  149 (309)
T ss_pred             ---eEEEEEeCCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccc
Confidence               35999999964 8888876543 3588999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      ++......  ........+|+.|+|||.+.+ ..++.++|||||||++|+|+||..||.+................+...
T Consensus       150 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  227 (309)
T cd07872         150 LARAKSVP--TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEE  227 (309)
T ss_pred             cceecCCC--ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            98753211  112233567899999998865 468899999999999999999999998765543322222111111100


Q ss_pred             -c-------ccccccCccccC----cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          313 -K-------KFGLIMDPRLEK----EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       313 -~-------~~~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                       .       .+...-.+....    ......+..+.+|+.+||..||.+|||+.+++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         228 TWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             HHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence             0       000000000000    0011234567899999999999999999999886

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.6e-40  Score=309.97  Aligned_cols=249  Identities=27%  Similarity=0.399  Sum_probs=197.2

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---hHHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      .+|...+.||+|+||.||+|.+.        ....+|+|.+...   ...+.+|+.++..++||||+++++++.....  
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~--------~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--   73 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR--------GQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRP--   73 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec--------CCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCC--
Confidence            46888899999999999999764        2345999988753   3458899999999999999999999876543  


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCC
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  235 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a  235 (432)
                        .++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++
T Consensus        74 --~~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~  147 (256)
T cd05113          74 --IYIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLS  147 (256)
T ss_pred             --cEEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccc
Confidence              499999999999999987543 2689999999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      +...... ........++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   ....+.....    
T Consensus       148 ~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~~~~----  219 (256)
T cd05113         148 RYVLDDE-YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKVSQGLR----  219 (256)
T ss_pred             eecCCCc-eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHhcCCC----
Confidence            7532211 111122345678999999988889999999999999999999 999997654322   1111111100    


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                            .    ..+...+..+.+++.+||+.+|.+||++.+|+..|+
T Consensus       220 ------~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         220 ------L----YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ------C----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                  0    001112467889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.1e-40  Score=320.72  Aligned_cols=239  Identities=26%  Similarity=0.415  Sum_probs=188.9

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcc-cCCCccceeeeEEeecCCcce
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGV-LEHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~~~  156 (432)
                      +.||+|+||.||+|..+       .++..||+|.+....       .....|..++.. ++||||+++++++...+    
T Consensus         1 ~~lg~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~----   69 (316)
T cd05620           1 KVLGKGSFGKVLLAELK-------GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE----   69 (316)
T ss_pred             CeeeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC----
Confidence            36999999999999875       467889999986532       235667777765 48999999999987654    


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      ..++||||+.+|+|..++...  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        70 ~~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~  144 (316)
T cd05620          70 HLFFVMEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCK  144 (316)
T ss_pred             EEEEEECCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCe
Confidence            459999999999999998654  3689999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  316 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (432)
                      .....  ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....   +...+...        
T Consensus       145 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~~~~~~~--------  211 (316)
T cd05620         145 ENVFG--DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LFESIRVD--------  211 (316)
T ss_pred             ecccC--CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHHhC--------
Confidence            42111  122334679999999999999999999999999999999999999998654322   22211110        


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHHH
Q 014034          317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS-QVVER  359 (432)
Q Consensus       317 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~~  359 (432)
                         .+.+    +...+..+.+|+.+||+.||.+||++. +++++
T Consensus       212 ---~~~~----~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         212 ---TPHY----PRWITKESKDILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             ---CCCC----CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence               0111    111235678999999999999999984 56543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.1e-41  Score=324.90  Aligned_cols=238  Identities=26%  Similarity=0.396  Sum_probs=190.1

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhccc-CCCccceeeeEEeec
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVL-EHPNLVKLIGYCAVD  151 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~hpniv~l~~~~~~~  151 (432)
                      +|...+.||+|+||.||+|...       .++..||+|.+.+..       ..+..|..++..+ +||+|+.+++++...
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~   73 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERK-------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM   73 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC
Confidence            5888999999999999999865       456889999987532       1255677777766 589999999888665


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ..++||||+++|+|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        74 ~----~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~D  144 (323)
T cd05616          74 D----RLYFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIAD  144 (323)
T ss_pred             C----EEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEcc
Confidence            4    4599999999999999986543  689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ||+++.....  ........||+.|+|||++.+..++.++|||||||++|||++|..||.+.....   +...+....  
T Consensus       145 fG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~~i~~~~--  217 (323)
T cd05616         145 FGMCKENMWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIMEHN--  217 (323)
T ss_pred             CCCceecCCC--CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HHHHHHhCC--
Confidence            9998742211  122334679999999999999999999999999999999999999998754432   222111110  


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM  353 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  353 (432)
                               .    .++...+..+.+|+.+||+.||.+|++.
T Consensus       218 ---------~----~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 ---------V----AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ---------C----CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                     0    1112234567899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.4e-40  Score=318.30  Aligned_cols=258  Identities=29%  Similarity=0.432  Sum_probs=199.6

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhccc-CCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVL-EHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  151 (432)
                      .++|++.+.||+|+||.||+|.+..     ......+++|.+...     ...+.+|+.++.++ +||||+++++++...
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~   80 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKK-----DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   80 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEcc-----CCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence            3578899999999999999998751     123346788876542     12477899999999 899999999998765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCC
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKAS  217 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~  217 (432)
                      +.    .++||||+++++|.+++....              ...+++..++.++.|++.||+|||+.   +++||||||+
T Consensus        81 ~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~  153 (303)
T cd05088          81 GY----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAAR  153 (303)
T ss_pred             CC----ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---Cccccccchh
Confidence            43    499999999999999996432              23578999999999999999999998   9999999999


Q ss_pred             ceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCch
Q 014034          218 NVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPK  296 (432)
Q Consensus       218 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~  296 (432)
                      |||++.++.+||+|||++....   .........++..|+|||.+.+..++.++|||||||++|+|+| |..||......
T Consensus       154 Nili~~~~~~kl~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  230 (303)
T cd05088         154 NILVGENYVAKIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA  230 (303)
T ss_pred             eEEecCCCcEEeCccccCcccc---hhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH
Confidence            9999999999999999986321   1111112234567999999988889999999999999999998 99999755432


Q ss_pred             hhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhc
Q 014034          297 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  367 (432)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  367 (432)
                      ..   ...+.   ..           .....+...+..+.+|+.+||+.+|++||++.+++..|..++...
T Consensus       231 ~~---~~~~~---~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         231 EL---YEKLP---QG-----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             HH---HHHHh---cC-----------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            21   11111   00           000011123456889999999999999999999999998886543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-40  Score=314.75  Aligned_cols=272  Identities=25%  Similarity=0.394  Sum_probs=200.6

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH----HHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL----QWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      .+|++.+.||+|+||.||++.+...   +..++..||+|.+.....    .+.+|+++++.++||||+++++++...+..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~---~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPL---QDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCC---cCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            5788999999999999999986421   234678899999865432    478899999999999999999987654322


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        ..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        81 --~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~  154 (284)
T cd05081          81 --NLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGL  154 (284)
T ss_pred             --ceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcc
Confidence              4589999999999999986543 3589999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcc-cccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC--
Q 014034          235 AREGPMVGHTH-VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD--  311 (432)
Q Consensus       235 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--  311 (432)
                      +.......... ......++..|+|||.+.+..++.++|||||||++|||++|..|+......    ...........  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~  230 (284)
T cd05081         155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQM  230 (284)
T ss_pred             cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhccccccccc
Confidence            98643221111 111122345699999999889999999999999999999988776432211    00000000000  


Q ss_pred             -ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          312 -SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       312 -~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                       ...+...+........+...+..+.+|+.+||..+|++|||+.+|++.|+.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence             0000000000000011223346788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-40  Score=313.76  Aligned_cols=258  Identities=27%  Similarity=0.443  Sum_probs=202.8

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|.+.+.||+|+||.||+|.......  ......||+|.+....     ..+.+|+.++..++||||+++++++....
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVK--GEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCC--CCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            3578999999999999999998763221  2345889999986432     24778999999999999999999987654


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCC
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRA--------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN  224 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~  224 (432)
                      .    .++||||+++++|.+++....        ...+++..+..++.|++.||.|||+.   +++||||||+|||++.+
T Consensus        83 ~----~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~  155 (277)
T cd05032          83 P----TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAED  155 (277)
T ss_pred             C----cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCC
Confidence            3    499999999999999986532        22478889999999999999999998   99999999999999999


Q ss_pred             CceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHH
Q 014034          225 FRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLE  303 (432)
Q Consensus       225 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~  303 (432)
                      +.+||+|||+++...............++..|+|||.+.++.++.++|||||||++|++++ |..||........   ..
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~  232 (277)
T cd05032         156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---LK  232 (277)
T ss_pred             CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---HH
Confidence            9999999999875332222222234456789999999988889999999999999999998 9999976544332   22


Q ss_pred             HHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          304 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                      ......          ..    ..+...+..+.+++.+||+.+|++|||+.+++..|+
T Consensus       233 ~~~~~~----------~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         233 FVIDGG----------HL----DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HHhcCC----------CC----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            221100          00    011122467889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.6e-41  Score=325.28  Aligned_cols=246  Identities=25%  Similarity=0.404  Sum_probs=188.9

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhccc-CCCccceeeeEEeecCCcce
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVL-EHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~  156 (432)
                      +.||+|+||.||+|...       .++..||+|.+.+..       ..+..|+.++.++ +||||+++++++...+    
T Consensus         1 ~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~----   69 (329)
T cd05618           1 RVIGRGSYAKVLLVRLK-------KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES----   69 (329)
T ss_pred             CeeeeCCCeEEEEEEEC-------CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC----
Confidence            36999999999999865       467889999987532       1366788888766 8999999999987654    


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      ..++||||+++|+|..++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        70 ~~~lv~E~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~  144 (329)
T cd05618          70 RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK  144 (329)
T ss_pred             EEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccc
Confidence            459999999999999988654  3689999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchh--hHHHHHHHhhcccCccc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT--EQRLLEWVQQYPADSKK  314 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~  314 (432)
                      ....  .........||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ......++...      
T Consensus       145 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~------  216 (329)
T cd05618         145 EGLR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV------  216 (329)
T ss_pred             cccC--CCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH------
Confidence            4211  1122334679999999999999999999999999999999999999996321110  00000110000      


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCC------HHHHHHH
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK------MSQVVER  359 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~eil~~  359 (432)
                         +.....  ..+...+..+.+|+.+||+.||.+||+      +.+++++
T Consensus       217 ---i~~~~~--~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         217 ---ILEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             ---HhcCCC--CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence               000000  112223456789999999999999998      4676655

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.7e-40  Score=312.40  Aligned_cols=262  Identities=23%  Similarity=0.371  Sum_probs=206.1

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|...+.||+|+||.||+|.+...   +...+..|++|.+....     ..+.+|+.+++.++||||+++++++..++
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~---~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDE---KPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecC---CCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            45788999999999999999997621   12246889999886432     23778999999999999999999887643


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAF------PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR  226 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~  226 (432)
                      .   ..+++++|+.+++|.+++.....      ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.
T Consensus        82 ~---~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~  155 (280)
T cd05043          82 E---PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQ  155 (280)
T ss_pred             C---CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCc
Confidence            2   34899999999999999865321      4689999999999999999999998   9999999999999999999


Q ss_pred             eeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHH
Q 014034          227 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWV  305 (432)
Q Consensus       227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~  305 (432)
                      +||+|||+++...............++..|+|||++.+..++.++||||||+++|++++ |..||....+..   +..++
T Consensus       156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~  232 (280)
T cd05043         156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYL  232 (280)
T ss_pred             EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHH
Confidence            99999999975422221112223446778999999988889999999999999999999 999997654432   22222


Q ss_pred             hhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          306 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                      .....          .    ..+...+..+.+++.+||..||++|||+.++++.|+.+..
T Consensus       233 ~~~~~----------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         233 KDGYR----------L----AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             HcCCC----------C----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            21100          0    0111234578899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=9.7e-41  Score=321.53  Aligned_cols=239  Identities=26%  Similarity=0.420  Sum_probs=191.3

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhccc-CCCccceeeeEEeecCCcce
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVL-EHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~  156 (432)
                      +.||+|+||.||+|.+.       .++..||+|.+.+..       ..+..|..++..+ +||||+++++++...+    
T Consensus         1 ~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~----   69 (318)
T cd05570           1 KVLGKGSFGKVLLAELK-------GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD----   69 (318)
T ss_pred             CeeeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC----
Confidence            36999999999999865       456789999987532       2356788888877 7999999999887644    


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      ..++||||+++++|..++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.
T Consensus        70 ~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  144 (318)
T cd05570          70 RLFFVMEYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK  144 (318)
T ss_pred             EEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCe
Confidence            4599999999999999886543  689999999999999999999998   99999999999999999999999999986


Q ss_pred             CCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  316 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (432)
                      ....  .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....   ....+....       
T Consensus       145 ~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---~~~~i~~~~-------  212 (318)
T cd05570         145 EGIL--GGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---LFQSILEDE-------  212 (318)
T ss_pred             ecCc--CCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---HHHHHHcCC-------
Confidence            4211  1112234568999999999999999999999999999999999999997654322   211111110       


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 014034          317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM-----SQVVER  359 (432)
Q Consensus       317 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~~  359 (432)
                          .    ..+...+..+.+||.+||..||.+||++     .+++.+
T Consensus       213 ----~----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         213 ----V----RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             ----C----CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence                0    0111234568899999999999999999     777765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=7.3e-41  Score=322.86  Aligned_cols=239  Identities=26%  Similarity=0.397  Sum_probs=190.9

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhccc-CCCccceeeeEEeecCCcce
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVL-EHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~  156 (432)
                      +.||+|+||.||+|...       .++..||+|.+....       ..+..|..++..+ +||||+++++++...+    
T Consensus         1 ~~lG~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~----   69 (321)
T cd05591           1 KVLGKGSFGKVMLAELK-------GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD----   69 (321)
T ss_pred             CccccCCCeEEEEEEEC-------CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC----
Confidence            35999999999999865       456789999986532       2356788888765 7999999999987654    


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      ..++||||+++++|..++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.
T Consensus        70 ~~~lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~  144 (321)
T cd05591          70 RLFFVMEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK  144 (321)
T ss_pred             eEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccce
Confidence            359999999999999988654  3689999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  316 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (432)
                      .....  ........||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ....+....       
T Consensus       145 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~~~i~~~~-------  212 (321)
T cd05591         145 EGILN--GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LFESILHDD-------  212 (321)
T ss_pred             ecccC--CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HHHHHHcCC-------
Confidence            52211  122334579999999999999999999999999999999999999998665332   222111110       


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-------CHHHHHHH
Q 014034          317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-------KMSQVVER  359 (432)
Q Consensus       317 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~eil~~  359 (432)
                          .    ..+...+..+.+|+.+||..||.+||       ++.+++++
T Consensus       213 ----~----~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         213 ----V----LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             ----C----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence                0    01111235688999999999999999       78888766

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.1e-40  Score=310.79  Aligned_cols=255  Identities=26%  Similarity=0.380  Sum_probs=202.3

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|.+.+.||.|+||.||+|...       .++..+|+|.+...       ...+.+|+.+++.++||||+++++++...
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~-------~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   74 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCL-------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED   74 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeec-------CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC
Confidence            46888899999999999999865       45788999987532       12477899999999999999999998765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      +    ..+++|||+++++|.+++...  ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|
T Consensus        75 ~----~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l  147 (267)
T cd08229          75 N----ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKL  147 (267)
T ss_pred             C----eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEE
Confidence            4    348999999999999988632  234689999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      +|||++......  ........|+..|+|||.+.+..++.++||||||+++|+|++|..||.+..... ......+....
T Consensus       148 ~dfg~~~~~~~~--~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~  224 (267)
T cd08229         148 GDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIEQCD  224 (267)
T ss_pred             CcchhhhccccC--CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHHhhhhhcCC
Confidence            999998753211  111234568899999999998889999999999999999999999997543221 11111111100


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                                .+   .......+..+.+++.+||..||.+|||+.+|++.+.++
T Consensus       225 ----------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         225 ----------YP---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             ----------CC---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence                      01   011123456788999999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.8e-40  Score=325.14  Aligned_cols=266  Identities=23%  Similarity=0.301  Sum_probs=197.8

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEee
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      ..++|+..+.||+|+||.||++...       ..+..||+|.+...      ...+.+|+.+++.++||||+++++++..
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   91 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDT-------VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTP   91 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEc-------CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence            4578999999999999999999864       46789999998642      2347789999999999999999998865


Q ss_pred             cCC--cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCcee
Q 014034          151 DGE--RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  228 (432)
Q Consensus       151 ~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k  228 (432)
                      ...  .....++||||+.+ +|.+.+..    .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~k  163 (359)
T cd07876          92 QKSLEEFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK  163 (359)
T ss_pred             CCCccccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEE
Confidence            432  12346899999964 67666632    478899999999999999999998   999999999999999999999


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH-H----
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL-E----  303 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~-~----  303 (432)
                      |+|||+++....   ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+........ .    
T Consensus       164 l~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  240 (359)
T cd07876         164 ILDFGLARTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGT  240 (359)
T ss_pred             EecCCCcccccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            999999975221   11223457899999999999999999999999999999999999999876432211100 0    


Q ss_pred             ---------------HHhhcccCc-cccccccCccc---cCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          304 ---------------WVQQYPADS-KKFGLIMDPRL---EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       304 ---------------~~~~~~~~~-~~~~~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                                     +....+... ..+........   ........+..+.+|+.+||..||++|||+.|++.+-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  316 (359)
T cd07876         241 PSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP  316 (359)
T ss_pred             CcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence                           000000000 00000000000   0001111245688999999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6e-43  Score=303.58  Aligned_cols=250  Identities=24%  Similarity=0.354  Sum_probs=201.3

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc------ChHHHHHHHHHhcccCCCccceeeeEEee
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .++.|++...||+|.|+.||++.+.       .+++.+|+|.++.      +...+.+|+.|.+.|+||||++|.+.+..
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~-------~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~   81 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHK-------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE   81 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhc-------cchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc
Confidence            3457888889999999999998866       4667788887753      33458899999999999999999988876


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc---CCCce
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRP  227 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~---~~~~~  227 (432)
                      ++.    .++|+|++.|++|..-|-.+.  ..++..+-..+.||+.+|.|+|.+   +|||||+||+|+|+.   ..--+
T Consensus        82 ~~~----~ylvFe~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~v  152 (355)
T KOG0033|consen   82 ESF----HYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAV  152 (355)
T ss_pred             cce----eEEEEecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCce
Confidence            654    499999999999988776552  578888999999999999999998   999999999999994   34458


Q ss_pred             eeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 014034          228 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  307 (432)
Q Consensus       228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  307 (432)
                      ||+|||+|....   ....-....|||.|||||+++..+|+..+|||+.|||||-|+.|.+||.+.+..   .+.+.+..
T Consensus       153 KL~~FGvAi~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~I~~  226 (355)
T KOG0033|consen  153 KLADFGLAIEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQIKA  226 (355)
T ss_pred             eecccceEEEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHHHhc
Confidence            999999998643   233334578999999999999999999999999999999999999999874332   23322221


Q ss_pred             cccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      -.           -.+........++...+|+.+||..||.+|.|+.|.+++
T Consensus       227 g~-----------yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  227 GA-----------YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             cc-----------cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence            11           111122334455678899999999999999999999876

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.9e-41  Score=330.54  Aligned_cols=253  Identities=24%  Similarity=0.306  Sum_probs=197.0

Q ss_pred             HHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeE
Q 014034           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGY  147 (432)
Q Consensus        75 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~  147 (432)
                      ....++|++.+.||+|+||.||++...       .++..||+|.+.+.       ...+.+|+.+++.++||||++++++
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~  111 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHK-------SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA  111 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            344578999999999999999999875       46788999998642       2236789999999999999999998


Q ss_pred             EeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCce
Q 014034          148 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP  227 (432)
Q Consensus       148 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~  227 (432)
                      +..+.    ..++||||+++|+|.+++...   .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+
T Consensus       112 ~~~~~----~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~  181 (370)
T cd05621         112 FQDDK----YLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHL  181 (370)
T ss_pred             EEcCC----EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCE
Confidence            87654    459999999999999998643   578999999999999999999998   99999999999999999999


Q ss_pred             eeccccCCcCCCCCCCcccccccccCCCccCccccccC----CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 014034          228 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG----HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE  303 (432)
Q Consensus       228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~  303 (432)
                      ||+|||++....... ........||+.|+|||++.+.    .++.++|||||||++|+|++|..||.+......   ..
T Consensus       182 kL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~---~~  257 (370)
T cd05621         182 KLADFGTCMKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT---YS  257 (370)
T ss_pred             EEEecccceecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH---HH
Confidence            999999997532111 1122356799999999999654    378899999999999999999999986543221   11


Q ss_pred             HHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 014034          304 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKD--RPKMSQVVER  359 (432)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~  359 (432)
                      .+.....           .+........+..+.+++..||..++..  ||++.+++++
T Consensus       258 ~i~~~~~-----------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         258 KIMDHKN-----------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             HHHhCCc-----------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            1111000           0000111223456788999999865543  8999999987

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.8e-40  Score=309.02  Aligned_cols=247  Identities=30%  Similarity=0.449  Sum_probs=200.2

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      +|...+.||+|+||.||+|...       .++..|++|.+...      ...+.+|+.+++.++||||+++++++...+ 
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   72 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRK-------ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKG-   72 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEc-------CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC-
Confidence            4778889999999999999875       45788999987532      234788999999999999999999987654 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+++++|.+++.......+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        73 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~  146 (256)
T cd08529          73 ---KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLG  146 (256)
T ss_pred             ---EEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccc
Confidence               459999999999999999875456789999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      ++......  ........|++.|+|||++.+..++.++||||||+++|+|++|..||.......   ....+....    
T Consensus       147 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~----  217 (256)
T cd08529         147 VAKLLSDN--TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LILKIIRGV----  217 (256)
T ss_pred             cceeccCc--cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHcCC----
Confidence            98753221  122234568899999999999899999999999999999999999997654321   111111100    


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                            .+    ..+...+..+.+++.+||+.+|++||++.+++++
T Consensus       218 ------~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         218 ------FP----PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ------CC----CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                  00    1111334678899999999999999999999865

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.1e-40  Score=320.23  Aligned_cols=266  Identities=27%  Similarity=0.422  Sum_probs=205.8

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhccc-CCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVL-EHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  152 (432)
                      .+|.+.+.||+|+||.||+|.......+.......||+|.+....     ..+.+|+.+++++ +||||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            468899999999999999998754332333445679999886432     2478899999999 7999999999987654


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASN  218 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~N  218 (432)
                      .    .+++|||+++|+|.+++....              ...+++..+..++.|++.||.|||+.   +|+||||||+|
T Consensus        92 ~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N  164 (334)
T cd05100          92 P----LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN  164 (334)
T ss_pred             c----eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence            3    499999999999999987532              22478899999999999999999998   99999999999


Q ss_pred             eEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchh
Q 014034          219 VLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKT  297 (432)
Q Consensus       219 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~  297 (432)
                      ||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.+.....
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  244 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  244 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999875322111111222334568999999999999999999999999999998 889987654332


Q ss_pred             hHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhcc
Q 014034          298 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  368 (432)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  368 (432)
                      ..   ..+....              ....+...+..+.+|+.+||+.+|.+|||+.++++.|+.+.....
T Consensus       245 ~~---~~~~~~~--------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~  298 (334)
T cd05100         245 LF---KLLKEGH--------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS  298 (334)
T ss_pred             HH---HHHHcCC--------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence            21   1111100              001112234578899999999999999999999999999875443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-40  Score=308.91  Aligned_cols=247  Identities=28%  Similarity=0.415  Sum_probs=195.9

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---hHHHHHHHHHhcccCCCccceeeeEEeecCCcce
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~  156 (432)
                      +|++.+.||+|+||.||++.+.        .+..+|+|.+...   ...+.+|+.+++.++||||+++++++...+    
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~--------~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   72 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR--------GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR----   72 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec--------CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC----
Confidence            5888899999999999999764        3457899988653   345888999999999999999999886554    


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      ..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++
T Consensus        73 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~  148 (256)
T cd05059          73 PIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLAR  148 (256)
T ss_pred             ceEEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccce
Confidence            3599999999999999997544 3689999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcccc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKF  315 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  315 (432)
                      ..... .........++..|+|||.+.+..++.++||||||+++|+|++ |..||........   ...+....      
T Consensus       149 ~~~~~-~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~~~~------  218 (256)
T cd05059         149 YVLDD-QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---VESVSAGY------  218 (256)
T ss_pred             ecccc-cccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---HHHHHcCC------
Confidence            53211 1111112234457999999998899999999999999999999 8999976543322   11111110      


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       316 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                          ..    ..+...+..+.+++.+||..+|++|||+.++++.|
T Consensus       219 ----~~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         219 ----RL----YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ----cC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                00    11112346788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.8e-40  Score=308.86  Aligned_cols=250  Identities=27%  Similarity=0.404  Sum_probs=199.0

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---hHHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      ++|++.+.||+|+||.||+|...        .+..+|+|.+...   ...+.+|+.+++.++||||+++++++...    
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~--------~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~----   73 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN--------GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE----   73 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec--------CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECCC----
Confidence            47889999999999999999754        3456999988653   34588999999999999999999887432    


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCC
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  235 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a  235 (432)
                       ..+++|||+.+++|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++
T Consensus        74 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~  149 (260)
T cd05070          74 -PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLA  149 (260)
T ss_pred             -CcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceee
Confidence             248999999999999999765555689999999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      ....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.....   ....+....     
T Consensus       150 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~~~-----  220 (260)
T cd05070         150 RLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQVERGY-----  220 (260)
T ss_pred             eeccCcc-cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCC-----
Confidence            7532211 111122345668999999988889999999999999999999 899997654322   222221110     


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  362 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  362 (432)
                               ....+...+..+.+|+.+||..+|.+|||+.++++.|+.
T Consensus       221 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         221 ---------RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ---------CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                     001122334678899999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=7.7e-41  Score=327.20  Aligned_cols=266  Identities=23%  Similarity=0.293  Sum_probs=198.4

Q ss_pred             HhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEe
Q 014034           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCA  149 (432)
Q Consensus        76 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~  149 (432)
                      ...++|+..+.||+|+||.||++...       ..+..||+|.+...      ...+.+|+.+++.++||||+++++++.
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   86 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDA-------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT   86 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEec-------CCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeee
Confidence            34578999999999999999999854       46788999998642      124678999999999999999999886


Q ss_pred             ecCC--cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCce
Q 014034          150 VDGE--RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP  227 (432)
Q Consensus       150 ~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~  227 (432)
                      ....  .....++||||+.+ +|.+.+..    .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus        87 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~  158 (355)
T cd07874          87 PQKSLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTL  158 (355)
T ss_pred             ccccccccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCE
Confidence            5432  22346899999954 67776642    478899999999999999999998   99999999999999999999


Q ss_pred             eeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHH-HHHH-
Q 014034          228 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL-LEWV-  305 (432)
Q Consensus       228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~-~~~~-  305 (432)
                      ||+|||+++...   .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+......... .... 
T Consensus       159 kl~Dfg~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (355)
T cd07874         159 KILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG  235 (355)
T ss_pred             EEeeCcccccCC---CccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            999999997532   12222345789999999999999999999999999999999999999987553322110 0000 


Q ss_pred             --------------hhcccCcccccccc-----Cccc---cCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          306 --------------QQYPADSKKFGLIM-----DPRL---EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       306 --------------~~~~~~~~~~~~~~-----~~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                    ..+......+..+.     ...+   ...........+.+|+.+||..||++|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             CCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                          00000000000000     0000   001111224567899999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.7e-40  Score=310.30  Aligned_cols=251  Identities=28%  Similarity=0.410  Sum_probs=201.0

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh---HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      .++|++.+.||+|+||.||+|...        ++..||+|.+....   ..+.+|+.+++.++||||+++++++...   
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~--------~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---   73 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN--------GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE---   73 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC--------CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEccC---
Confidence            357899999999999999999754        45779999887533   4588999999999999999999886432   


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        ..+++|||+.+++|.+++.......+++.++..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||+
T Consensus        74 --~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~  148 (260)
T cd05067          74 --PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGL  148 (260)
T ss_pred             --CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcc
Confidence              248999999999999998766556789999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      +....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.+......   .........   
T Consensus       149 ~~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~~~~~---  221 (260)
T cd05067         149 ARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQNLERGYR---  221 (260)
T ss_pred             eeecCCCC-cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HHHHHcCCC---
Confidence            87532111 111223345678999999998889999999999999999999 9999976543322   111111000   


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  362 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  362 (432)
                             .    ..+...+..+.+++.+||..+|++|||+.+++..|+.
T Consensus       222 -------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         222 -------M----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -------C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                   0    0111224578899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=8.1e-41  Score=317.10  Aligned_cols=248  Identities=27%  Similarity=0.421  Sum_probs=197.0

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      |+..+.||+|+||.||++...       .+++.||+|.+....       ..+.+|+.+++.++|+||+.+++.+...+ 
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-   73 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVR-------ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD-   73 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEc-------CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC-
Confidence            677788999999999999875       467899999876431       23667999999999999999999887544 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+.+++|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||
T Consensus        74 ---~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg  147 (285)
T cd05630          74 ---ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLG  147 (285)
T ss_pred             ---EEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeecc
Confidence               459999999999999998765555789999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      ++......   .......|+..|+|||++.+..++.++||||||+++|+|++|..||..................     
T Consensus       148 ~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-----  219 (285)
T cd05630         148 LAVHVPEG---QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-----  219 (285)
T ss_pred             ceeecCCC---ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-----
Confidence            98653211   1123357899999999999999999999999999999999999999864332111111110000     


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-----MSQVVER  359 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  359 (432)
                           ...    ..+...+..+.+|+.+||+.||.+|||     +.+++++
T Consensus       220 -----~~~----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         220 -----VQE----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             -----hhh----hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence                 000    111223456789999999999999999     7888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.6e-40  Score=311.76  Aligned_cols=257  Identities=25%  Similarity=0.428  Sum_probs=199.6

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      .+|.....||+|+||.||++.....  .....+..+|+|.+....    ..+.+|+++++.++||||+++++++...+. 
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-   81 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNL--LPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP-   81 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecC--CCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc-
Confidence            4678889999999999999975421  122456789999886533    348889999999999999999998876543 


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCC-------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEE
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAF-------------PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL  221 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill  221 (432)
                         .+++|||+.+++|.+++.....             ..+++..++.++.|++.||.|||+.   +++||||||+|||+
T Consensus        82 ---~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~  155 (280)
T cd05092          82 ---LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLV  155 (280)
T ss_pred             ---eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEE
Confidence               4999999999999999865421             3588999999999999999999998   99999999999999


Q ss_pred             cCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 014034          222 DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQR  300 (432)
Q Consensus       222 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~  300 (432)
                      ++++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||........  
T Consensus       156 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--  233 (280)
T cd05092         156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--  233 (280)
T ss_pred             cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH--
Confidence            9999999999999874322211112223345778999999998999999999999999999998 8999875443222  


Q ss_pred             HHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          301 LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                       ........          ..    ..+...+..+.+|+.+||+.||.+||++.+|++.|+
T Consensus       234 -~~~~~~~~----------~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         234 -IECITQGR----------EL----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             -HHHHHcCc----------cC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence             11111100          00    011123456889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=318.92  Aligned_cols=261  Identities=27%  Similarity=0.422  Sum_probs=210.7

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .....+.++||+|-||.|.++...        .+..||+|.++.+.     ..|.+|+++|.+|+||||+.++|+|..++
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeve--------g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De  608 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVE--------GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD  608 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEec--------CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence            345677889999999999999864        46999999998653     35899999999999999999999999877


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                      ..    ++|+||+++|+|.+|+..+..+.+.-....+|+.||+.||+||.+.   ++|||||.+.|+|++.++++||+||
T Consensus       609 Pi----cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadf  681 (807)
T KOG1094|consen  609 PL----CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADF  681 (807)
T ss_pred             ch----HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCc
Confidence            65    9999999999999999887654545566778999999999999997   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh--CCCCCCCCCchhhHHHHHHHhhccc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT--GRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      |+++..............+-...|||||.+..+.++.++|||+||+++||+++  ...||.....   .+.++-...+..
T Consensus       682 gmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~  758 (807)
T KOG1094|consen  682 GMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFR  758 (807)
T ss_pred             ccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcC
Confidence            99996543433444444566789999999999999999999999999999765  7889876543   333333333322


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                      ....-..+       ..|.-++..+.+||.+||..|-.+||+++++...|.+.
T Consensus       759 ~~~~~~~l-------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  759 DQGRQVVL-------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             CCCcceec-------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            22111111       12334567889999999999999999999999888654

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.1e-40  Score=321.88  Aligned_cols=234  Identities=29%  Similarity=0.424  Sum_probs=185.1

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHH-HhcccCCCccceeeeEEeecCCcce
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQ-FLGVLEHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~~  156 (432)
                      +.||+|+||+||+|...       .++..||+|.+....       ..+..|.. +++.++||||+++++.+...+    
T Consensus         1 ~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~----   69 (323)
T cd05575           1 KVIGKGSFGKVLLAKHK-------ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD----   69 (323)
T ss_pred             CeeeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC----
Confidence            36999999999999865       467899999986432       12344444 567899999999999887654    


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      ..++||||+.+|+|..++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        70 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~  144 (323)
T cd05575          70 KLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK  144 (323)
T ss_pred             EEEEEEcCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCc
Confidence            459999999999999998654  3689999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  316 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (432)
                      ....  .........||+.|+|||++.+..++.++|||||||++|+|++|..||.......   +...+...+       
T Consensus       145 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~-------  212 (323)
T cd05575         145 EGIE--HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---MYDNILNKP-------  212 (323)
T ss_pred             cccc--CCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH---HHHHHHcCC-------
Confidence            4211  1222334679999999999999999999999999999999999999998654322   111111110       


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 014034          317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS  354 (432)
Q Consensus       317 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  354 (432)
                          ..+    +...+..+.+++.+||+.||.+||++.
T Consensus       213 ----~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         213 ----LRL----KPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             ----CCC----CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence                001    111245688999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.8e-40  Score=329.87  Aligned_cols=264  Identities=23%  Similarity=0.271  Sum_probs=195.7

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHHHHHHHhcccCCCccceeeeEEeecCCccee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQ  157 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~  157 (432)
                      ...|.+.+.||+|+||.||+|.+.       ..+..||||....  ..+.+|+.+|++++||||+++++++...+    .
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~-------~~~~~vavK~~~~--~~~~~E~~iL~~L~HpnIv~l~~~~~~~~----~  234 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHP-------DYPQRVVVKAGWY--ASSVHEARLLRRLSHPAVLALLDVRVVGG----L  234 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEEC-------CCCCEEEEecccc--cCHHHHHHHHHHCCCCCCCcEEEEEEECC----E
Confidence            447999999999999999999875       4567899997543  23578999999999999999999987654    3


Q ss_pred             EEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          158 RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       158 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      .++|||++ .++|.+++.... ..+++..++.|+.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+++.
T Consensus       235 ~~lv~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~  309 (461)
T PHA03211        235 TCLVLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACF  309 (461)
T ss_pred             EEEEEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCcee
Confidence            48999999 578988886543 3699999999999999999999998   999999999999999999999999999975


Q ss_pred             CCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCch-----hhHHHHHHHhhcccCc
Q 014034          238 GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK-----TEQRLLEWVQQYPADS  312 (432)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~-----~~~~~~~~~~~~~~~~  312 (432)
                      ..............||+.|+|||++.+..++.++|||||||++|||++|..|+......     ....+...+.......
T Consensus       310 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~  389 (461)
T PHA03211        310 ARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV  389 (461)
T ss_pred             cccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc
Confidence            32221222223457999999999999999999999999999999999988665332111     1112222222111000


Q ss_pred             ccccc----------------ccCccccCc-C--CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          313 KKFGL----------------IMDPRLEKE-Y--SINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       313 ~~~~~----------------~~~~~l~~~-~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ..+..                ...+..... .  .......+.+||.+||+.||.+|||+.|++++
T Consensus       390 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        390 DEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             ccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00000                000000000 0  00123467899999999999999999999986

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.6e-41  Score=323.82  Aligned_cols=238  Identities=26%  Similarity=0.383  Sum_probs=189.8

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecCCcceeE
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQR  158 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~  158 (432)
                      +.||+|+||.||++...    .+..++..||+|++....      ..+..|++++++++||||+++++++...+    ..
T Consensus         2 ~~lg~G~~g~Vy~~~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~   73 (318)
T cd05582           2 KVLGQGSFGKVFLVRKI----TGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG----KL   73 (318)
T ss_pred             ceeeeCCCEEEEEEEEe----ccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC----EE
Confidence            57999999999998753    122467899999987532      23667999999999999999999987654    45


Q ss_pred             EEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCC
Q 014034          159 LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG  238 (432)
Q Consensus       159 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~  238 (432)
                      ++||||+.+|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus        74 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  148 (318)
T cd05582          74 YLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES  148 (318)
T ss_pred             EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCccc
Confidence            9999999999999998654  3689999999999999999999998   9999999999999999999999999998753


Q ss_pred             CCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccc
Q 014034          239 PMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI  318 (432)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (432)
                      ...  ........||+.|+|||.+.+..++.++|||||||++|+|++|..||........   ...+....         
T Consensus       149 ~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~~~i~~~~---------  214 (318)
T cd05582         149 IDH--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET---MTMILKAK---------  214 (318)
T ss_pred             CCC--CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH---HHHHHcCC---------
Confidence            211  1222346799999999999988899999999999999999999999986543221   11111100         


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 014034          319 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ  355 (432)
Q Consensus       319 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  355 (432)
                        .    ..+...+..+.+|+.+||+.||.+||++.+
T Consensus       215 --~----~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 --L----GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             --C----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence              0    011123456789999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-40  Score=308.82  Aligned_cols=249  Identities=24%  Similarity=0.342  Sum_probs=198.3

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---------hHHHHHHHHHhcccCCCccceeeeEEe
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---------GLQWVAEVQFLGVLEHPNLVKLIGYCA  149 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~hpniv~l~~~~~  149 (432)
                      ++|...+.||+|+||.||+|...       .++..||+|.+...         ...+.+|+.+++.++||||+++++++.
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~-------~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   74 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDV-------DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR   74 (263)
T ss_pred             CcccccceecCCCceEEEEEEEc-------CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc
Confidence            46899999999999999999854       45788999987532         124778999999999999999999987


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      ...    ..++||||+++++|.+++....  .+++..+..++.|++.||.|||+.   +|+|+||+|+||+++.++.++|
T Consensus        75 ~~~----~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l  145 (263)
T cd06625          75 DDE----TLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKL  145 (263)
T ss_pred             cCC----eEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence            654    4699999999999999986543  688999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCCc-ccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          230 SDFGLAREGPMVGHT-HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      +|||++......... .......|+..|+|||.+.+..++.++||||||+++|+|++|..||.........   ......
T Consensus       146 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~~~  222 (263)
T cd06625         146 GDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---FKIATQ  222 (263)
T ss_pred             eecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---HHHhcc
Confidence            999998753211111 1113356788999999999988999999999999999999999999764332211   111110


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .             .....+...+..+.+++.+||..+|.+|||+.+++++
T Consensus       223 ~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         223 P-------------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             C-------------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            0             0011222334678899999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5e-40  Score=312.05  Aligned_cols=262  Identities=24%  Similarity=0.424  Sum_probs=202.0

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ..++|++.+.||+|+||.||+|..+...  ....+..||+|.+....     ..+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDII--KGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccC--CCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            3567999999999999999999865221  11245689999876432     2367899999999999999999998765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRA--------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  223 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~  223 (432)
                      ..    .++||||+.+|+|.+++....        ...+++..+..++.|++.||.|||++   +|+||||||+|||++.
T Consensus        82 ~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~  154 (288)
T cd05061          82 QP----TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAH  154 (288)
T ss_pred             CC----cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcC
Confidence            43    499999999999999996422        23456778899999999999999998   9999999999999999


Q ss_pred             CCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHH
Q 014034          224 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLL  302 (432)
Q Consensus       224 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~  302 (432)
                      ++.++|+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||.+.....   ..
T Consensus       155 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~  231 (288)
T cd05061         155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VL  231 (288)
T ss_pred             CCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH
Confidence            99999999999875322221111222345678999999998899999999999999999998 788987654322   22


Q ss_pred             HHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 014034          303 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  364 (432)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  364 (432)
                      ..+.....          .    ..+...+..+.+++.+||+.||.+|||+.++++.|.+.+
T Consensus       232 ~~~~~~~~----------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         232 KFVMDGGY----------L----DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHHHcCCC----------C----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            21111000          0    001122467889999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-40  Score=306.53  Aligned_cols=247  Identities=30%  Similarity=0.484  Sum_probs=201.4

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH---HHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      .++|+..+.||.|+||.||+|..         .+..||+|.+.....   .+.+|+.+++.++|+||+++++++...+  
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~---------~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   73 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY---------RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGN--   73 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe---------cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCC--
Confidence            35788999999999999999975         367899999976644   5888999999999999999999987643  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        ..++||||+++++|.+++.......+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+
T Consensus        74 --~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~  148 (256)
T cd05039          74 --PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGL  148 (256)
T ss_pred             --CeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccc
Confidence              359999999999999999776655789999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      ++.....     .....++..|+|||.+.++.++.++||||||+++|++++ |..||.......   +...+....    
T Consensus       149 ~~~~~~~-----~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~~~----  216 (256)
T cd05039         149 AKEASQG-----QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHVEKGY----  216 (256)
T ss_pred             ccccccc-----cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHhcCC----
Confidence            9763111     112334668999999988889999999999999999997 999997654322   222111100    


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  362 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  362 (432)
                            ..    ..+...+..+.+++.+||..+|.+|||+.++++.|+.
T Consensus       217 ------~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         217 ------RM----EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ------CC----CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence                  00    1112234678899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-40  Score=313.44  Aligned_cols=265  Identities=25%  Similarity=0.426  Sum_probs=198.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCC-------CCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeee
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAG-------DGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIG  146 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~-------~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~  146 (432)
                      ++|++.+.||+|+||.||++.......       ........||+|.++...     ..+.+|+++++.++||||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            479999999999999999987642110       011234569999987532     24788999999999999999999


Q ss_pred             EEeecCCcceeEEEEEeecCCCCHHHHhhcCC----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCC
Q 014034          147 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA----------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKA  216 (432)
Q Consensus       147 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp  216 (432)
                      ++...+.    .++||||+.+++|.+++....          ...+++..++.++.|++.||.|||+.   +++||||||
T Consensus        85 ~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp  157 (295)
T cd05097          85 VCVSDDP----LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLAT  157 (295)
T ss_pred             EEcCCCc----cEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccCh
Confidence            9876543    499999999999999985432          12468899999999999999999998   999999999


Q ss_pred             CceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh--CCCCCCCCC
Q 014034          217 SNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT--GRRSLERNR  294 (432)
Q Consensus       217 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~pf~~~~  294 (432)
                      +|||++.++.+||+|||++................++..|+|||.+.++.++.++|||||||++|+|++  |..||....
T Consensus       158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~  237 (295)
T cd05097         158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS  237 (295)
T ss_pred             hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence            999999999999999999875322221222223345778999999988899999999999999999998  667877544


Q ss_pred             chhhHHHHHHHhh-cccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          295 PKTEQRLLEWVQQ-YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       295 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                      ...   ....... +.......    ..    ..+...+..+.+|+.+||+.||++|||+.+|++.|+
T Consensus       238 ~~~---~~~~~~~~~~~~~~~~----~~----~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         238 DEQ---VIENTGEFFRNQGRQI----YL----SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             hHH---HHHHHHHhhhhccccc----cC----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            322   1111111 10000000    00    001122457899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2e-40  Score=314.45  Aligned_cols=248  Identities=26%  Similarity=0.413  Sum_probs=196.1

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      |+..+.||+|+||+||+|.+.       .+++.||+|.+....       ..+.+|+.+++.++|+||+.+++.+...+ 
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-   73 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVR-------ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD-   73 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEC-------CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC-
Confidence            677788999999999999865       467899999986432       23678999999999999999998886544 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+.+++|.+++......++++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||
T Consensus        74 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg  147 (285)
T cd05632          74 ---ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLG  147 (285)
T ss_pred             ---EEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCC
Confidence               459999999999999998765555799999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      ++......   .......|+..|+|||.+.+..++.++|+|||||++|+|++|..||.............  ........
T Consensus       148 ~~~~~~~~---~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~--~~~~~~~~  222 (285)
T cd05632         148 LAVKIPEG---ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD--RRVLETEE  222 (285)
T ss_pred             cceecCCC---CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hhhhcccc
Confidence            98653211   11234578999999999998899999999999999999999999998654322211111  11100000


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-----MSQVVER  359 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  359 (432)
                                  ..+...+..+.+|+..||+.||.+||+     +.+++.+
T Consensus       223 ------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         223 ------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ------------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence                        111222356789999999999999999     5666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.6e-40  Score=307.99  Aligned_cols=252  Identities=23%  Similarity=0.340  Sum_probs=188.6

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCCcceeEE
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  159 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~  159 (432)
                      +.||+|+||.||+|.+.     +...+..+|+|.+....     ..+.+|+.+++.++||||+++++++.....    .+
T Consensus         1 ~~lg~G~~g~Vy~~~~~-----~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~   71 (269)
T cd05087           1 KEIGNGWFGKVILGEVN-----SGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTP----YL   71 (269)
T ss_pred             CcccccCCceEEEEEEc-----CCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCC----cE
Confidence            35899999999999865     22356789999886432     247889999999999999999998876543    48


Q ss_pred             EEEeecCCCCHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          160 LVYEFMLNRSLEDHLFNRA---FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       160 lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      +||||+++|+|.+++....   ....++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.
T Consensus        72 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~  148 (269)
T cd05087          72 LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSH  148 (269)
T ss_pred             EEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccc
Confidence            9999999999999996532   22456778889999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCccCccccccC-------CCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIETG-------HLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      ...............++..|+|||++.+.       .++.++||||||+++|||++ |..||...........  .+...
T Consensus       149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~--~~~~~  226 (269)
T cd05087         149 NKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY--TVREQ  226 (269)
T ss_pred             cccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH--Hhhcc
Confidence            53222111222335578899999998642       35789999999999999996 9999976543322111  01100


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                      .      .....+.+.    ...+..+.+++..|| .+|++|||+.+|+..|+
T Consensus       227 ~------~~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         227 Q------LKLPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             c------CCCCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            0      001111111    122345778999999 68999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=6.1e-40  Score=307.91  Aligned_cols=257  Identities=24%  Similarity=0.424  Sum_probs=200.9

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|...+.||+|+||.||+|.....    ......+|+|.+...     ...+..|+++++.++||||+++++++...+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMP----GRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK   79 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecC----CCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence            35688889999999999999987521    123468999998654     234788999999999999999999987654


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                      .    .++||||+.+++|.+++.... ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+||
T Consensus        80 ~----~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~df  151 (268)
T cd05063          80 P----AMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDF  151 (268)
T ss_pred             C----cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCC
Confidence            3    499999999999999986543 4689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCccc-ccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhccc
Q 014034          233 GLAREGPMVGHTHV-STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       233 G~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      |++........... ......+..|+|||++.+..++.++|||||||++|+|++ |..||.......   ....+.....
T Consensus       152 g~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~~i~~~~~  228 (268)
T cd05063         152 GLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMKAINDGFR  228 (268)
T ss_pred             ccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHHhcCCC
Confidence            99875322111111 111223457999999988889999999999999999998 999997654322   2221111100


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                                    ...+...+..+.+++.+||+.+|.+||++.+|++.|.++
T Consensus       229 --------------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         229 --------------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             --------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                          001112345688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.1e-40  Score=316.27  Aligned_cols=200  Identities=28%  Similarity=0.428  Sum_probs=161.3

Q ss_pred             ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh--HHHHHHHHHhcccCCCccceeeeEEeecCCcceeEEEE
Q 014034           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLV  161 (432)
Q Consensus        84 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~lv  161 (432)
                      ..+||+|+||.||+|..+     +..++..||+|.+....  ..+.+|+.+++.++||||+++++++......  ..++|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--~~~lv   78 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRK-----DGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADR--KVWLL   78 (317)
T ss_pred             ccccccCCCeEEEEEEEc-----cCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCc--EEEEE
Confidence            467999999999999865     22456789999987542  3578899999999999999999988654332  46899


Q ss_pred             EeecCCCCHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEE----cCCCceeec
Q 014034          162 YEFMLNRSLEDHLFNR-------AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL----DENFRPKLS  230 (432)
Q Consensus       162 ~e~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill----~~~~~~kl~  230 (432)
                      |||+. ++|.+++...       ....+++..+..++.||+.||.|||+.   +|+||||||+|||+    +.++.+||+
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~  154 (317)
T cd07868          79 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA  154 (317)
T ss_pred             EeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEe
Confidence            99984 5888877532       123588999999999999999999998   99999999999999    466789999


Q ss_pred             cccCCcCCCCCCC-cccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Q 014034          231 DFGLAREGPMVGH-THVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNR  294 (432)
Q Consensus       231 DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~  294 (432)
                      |||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus       155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             ecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            9999975322111 112234678999999999876 458999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-41  Score=317.54  Aligned_cols=246  Identities=22%  Similarity=0.369  Sum_probs=208.9

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH------HHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .+=|.+.+.||+|.|+.|-+|++.       .+|..||||++.+...      .+.+|+..|+.++|||||+||++....
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHV-------FTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ   89 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHV-------FTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ   89 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhh-------cccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc
Confidence            345888889999999999999876       7889999999976432      478899999999999999999987654


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEE-cCCCceeec
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL-DENFRPKLS  230 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill-~~~~~~kl~  230 (432)
                      .    .+|||+|.-.+|+|++||.+.. ..+.+..+.+++.||+.|+.|+|..   .+|||||||+||.+ ..-|-+||+
T Consensus        90 T----KlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLT  161 (864)
T KOG4717|consen   90 T----KLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLT  161 (864)
T ss_pred             c----eEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEee
Confidence            4    4599999999999999998765 4799999999999999999999997   99999999999977 567899999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLT-AKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      |||++..+.   ......+.+|++.|-|||++.|..|+ +++||||||||||.|++|+.||+..++.+...+        
T Consensus       162 DFGFSNkf~---PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm--------  230 (864)
T KOG4717|consen  162 DFGFSNKFQ---PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM--------  230 (864)
T ss_pred             eccccccCC---CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh--------
Confidence            999997643   23455678999999999999998886 579999999999999999999997665433221        


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                              ++|-.  ...|...+.++.+||..||..||.+|.+.++|+..
T Consensus       231 --------ImDCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  231 --------IMDCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             --------hhccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence                    22322  23467788899999999999999999999999865

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=7.1e-41  Score=323.70  Aligned_cols=242  Identities=25%  Similarity=0.381  Sum_probs=189.6

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhccc-CCCccceeeeEEeecCCcce
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVL-EHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~  156 (432)
                      +.||+|+||.||+|...       .++..||+|.+.+..       ..+..|..++.++ +||||+.+++++...+    
T Consensus         1 ~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----   69 (327)
T cd05617           1 RVIGRGSYAKVLLVRLK-------KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS----   69 (327)
T ss_pred             CeeeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC----
Confidence            36999999999999865       467889999987532       2367888888887 6999999999887654    


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      ..++||||+++|+|..++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        70 ~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~  144 (327)
T cd05617          70 RLFLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCK  144 (327)
T ss_pred             EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccce
Confidence            459999999999999988654  3699999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhh----HHHHHHHhhcccCc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE----QRLLEWVQQYPADS  312 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~----~~~~~~~~~~~~~~  312 (432)
                      ....  .........||+.|+|||++.+..++.++|||||||++|+|++|..||........    ..+...+...+   
T Consensus       145 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---  219 (327)
T cd05617         145 EGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP---  219 (327)
T ss_pred             eccC--CCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC---
Confidence            4211  11223346799999999999999999999999999999999999999964322111    11111111000   


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM------SQVVER  359 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~eil~~  359 (432)
                              .    ..+...+..+.+++.+||..||.+||++      .+++++
T Consensus       220 --------~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         220 --------I----RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             --------C----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence                    0    1122234567899999999999999984      566654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.9e-40  Score=326.49  Aligned_cols=265  Identities=24%  Similarity=0.322  Sum_probs=197.7

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      +|+..+.||+|+||.||++...       .+++.||+|++...      ...+.+|+.+++.++||||+++++++...+.
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   73 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDP-------RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHI   73 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEEC-------CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCc
Confidence            4788999999999999999854       46788999988642      2347889999999999999999999876542


Q ss_pred             c-ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          154 R-GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       154 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                      . ....++||||+. ++|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        74 ~~~~~~~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Df  147 (372)
T cd07853          74 DPFEEIYVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDF  147 (372)
T ss_pred             cccceEEEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccc
Confidence            1 124689999995 6888887543  3689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      |+++..... .........+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+..+......+......+..
T Consensus       148 g~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~  226 (372)
T cd07853         148 GLARVEEPD-ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL  226 (372)
T ss_pred             cceeecccC-ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence            999753221 11122334688999999998764 5789999999999999999999999876654332222111110000


Q ss_pred             ccccc--------ccc-----CccccC--cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 SKKFG--------LIM-----DPRLEK--EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~~~~~--------~~~-----~~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                       ..+.        .+.     .+....  ......+..+.+|+.+||+.||.+|||+.+++.+
T Consensus       227 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         227 -EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             -HHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence             0000        000     000000  0111224568899999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=7.7e-40  Score=312.01  Aligned_cols=265  Identities=23%  Similarity=0.402  Sum_probs=199.3

Q ss_pred             cCCccccccccCCceEEEEEEecCCCC---------CCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCcccee
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAG---------DGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKL  144 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~---------~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l  144 (432)
                      ++|++.+.||+|+||.||++.......         ....+...||+|.+....     ..+.+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            469999999999999999986542110         122345679999987532     347889999999999999999


Q ss_pred             eeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCC---------CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCC
Q 014034          145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAF---------PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFK  215 (432)
Q Consensus       145 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dik  215 (432)
                      ++++...+.    .++||||+.+++|.+++.....         ..+++..+..++.|++.||.|||+.   +++|+|||
T Consensus        85 ~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlk  157 (296)
T cd05095          85 LAVCITSDP----LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLA  157 (296)
T ss_pred             EEEEecCCc----cEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCC
Confidence            999876554    4999999999999999865321         2467889999999999999999998   99999999


Q ss_pred             CCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh--CCCCCCCC
Q 014034          216 ASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT--GRRSLERN  293 (432)
Q Consensus       216 p~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~pf~~~  293 (432)
                      |+|||++.++.++|+|||++................++..|++||...++.++.++|||||||++|||++  |..||...
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            9999999999999999999875322211111222344678999999888889999999999999999998  77888654


Q ss_pred             CchhhHHHHHHHhh-cccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          294 RPKTEQRLLEWVQQ-YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       294 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                      .....   ...... +......   ...     ..+..++..+.+|+.+||+.||.+||++.+|++.|+
T Consensus       238 ~~~~~---~~~~~~~~~~~~~~---~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         238 SDEQV---IENTGEFFRDQGRQ---VYL-----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             ChHHH---HHHHHHHHhhcccc---ccC-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            33221   111110 0000000   000     011223467889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.6e-40  Score=324.62  Aligned_cols=263  Identities=22%  Similarity=0.294  Sum_probs=198.0

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEee
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      ..++|...+.||+|+||.||++...       ..+..||||++...      ...+.+|+.+++.++||||+++++++..
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~   94 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDA-------ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTP   94 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEEC-------CCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecc
Confidence            3568999999999999999999864       45678999998642      2346789999999999999999998765


Q ss_pred             cCC--cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCcee
Q 014034          151 DGE--RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  228 (432)
Q Consensus       151 ~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k  228 (432)
                      ...  .....++||||+. ++|.+++..    .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~k  166 (364)
T cd07875          95 QKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK  166 (364)
T ss_pred             cccccccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEE
Confidence            431  2234699999995 577777742    478899999999999999999998   999999999999999999999


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      |+|||+++...   .........||..|+|||++.+..++.++|||||||++|+|++|..||.+.........+  +...
T Consensus       167 L~DfG~a~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~--~~~~  241 (364)
T cd07875         167 ILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV--IEQL  241 (364)
T ss_pred             EEeCCCccccC---CCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhc
Confidence            99999997532   122223457899999999999999999999999999999999999999876543321111  1111


Q ss_pred             ccCc------------------c-----ccccccCccc---cCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 PADS------------------K-----KFGLIMDPRL---EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 ~~~~------------------~-----~~~~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ....                  .     .+..+.....   ...........+.+|+.+||+.||.+|||+.+++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         242 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             CCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0000                  0     0000000000   000111123567899999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-41  Score=314.82  Aligned_cols=277  Identities=24%  Similarity=0.352  Sum_probs=213.2

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-HHHHHHHHhcc--cCCCccceeeeEEeecCCcce
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QWVAEVQFLGV--LEHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~--l~hpniv~l~~~~~~~~~~~~  156 (432)
                      ..+.+.+||+|.||.||+|.+.         ++.||||+++.... .|++|-.|...  +.|+||+++++.-........
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~---------~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~  281 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD---------NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM  281 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc---------CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence            4556778999999999999874         68999999987554 48888888764  589999999987665554456


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCceeecCCCCCceEEcCCCceeec
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG------LEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~------~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .++||++|.+.|+|.+||..+   .++|....+|+..+++||+|||+.      .+++|+|||||+.||||..|+++.|+
T Consensus       282 eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa  358 (534)
T KOG3653|consen  282 EYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA  358 (534)
T ss_pred             ceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence            789999999999999999765   589999999999999999999974      35789999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCC-CC-----chhhhHHHHHHHHHHHhCCCCCC-CCCchhhHHHHH
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH-LT-----AKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLE  303 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwSlGvil~elltg~~pf~-~~~~~~~~~~~~  303 (432)
                      |||+|...............+||..|||||++.+.- +.     .+.||||+|.|||||+++...+. +..+.....+-.
T Consensus       359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~  438 (534)
T KOG3653|consen  359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA  438 (534)
T ss_pred             ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence            999998765444444445589999999999997642 22     36899999999999999876664 333322222222


Q ss_pred             HHhhcccCccccccccCccccCcCCH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhcc
Q 014034          304 WVQQYPADSKKFGLIMDPRLEKEYSI-----NEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  368 (432)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  368 (432)
                      .+...|........++..+.++.++.     ....-+.+.+..||..||+.|.|+.=+-+++..+....+
T Consensus       439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence            33333333333333333333333322     224568899999999999999999999999988876554

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.5e-40  Score=314.73  Aligned_cols=259  Identities=25%  Similarity=0.403  Sum_probs=201.9

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-----HHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-----QWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|+..+.||+|+||.||+|.+...+   ......||+|.+.....     .+.+|+.+++.++||||+++++++....
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~   82 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEG---ETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT   82 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCC---CcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCC
Confidence            357888999999999999999875221   12235789998875422     4778999999999999999999986432


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                           .++++||+++|+|.+++.... ..+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.+||+||
T Consensus        83 -----~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Df  153 (303)
T cd05110          83 -----IQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDF  153 (303)
T ss_pred             -----ceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccc
Confidence                 378999999999999986543 3588999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      |+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.+......   ..++......
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~---~~~~~~~~~~  230 (303)
T cd05110         154 GLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI---PDLLEKGERL  230 (303)
T ss_pred             cccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHCCCCC
Confidence            99975322211111223345778999999998999999999999999999997 9999976543322   2222211100


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                               +     .+...+..+.+++.+||..+|++||++.++++.|..+..
T Consensus       231 ---------~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         231 ---------P-----QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             ---------C-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                     0     011123567899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=7.2e-40  Score=306.19  Aligned_cols=250  Identities=29%  Similarity=0.400  Sum_probs=198.5

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh---HHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      ++|.+...||+|+||.||+|...        ....+|+|.+....   ..+.+|+.+++.++|||++++++++...    
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~--------~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----   73 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWN--------GTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE----   73 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEc--------CCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcCC----
Confidence            46888899999999999999864        22458999876532   3578899999999999999999887432    


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCC
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  235 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a  235 (432)
                       ..++||||+.+++|.+++.......+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++
T Consensus        74 -~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~  149 (260)
T cd05069          74 -PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLA  149 (260)
T ss_pred             -CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccc
Confidence             248999999999999999765555689999999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      ....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.....   ...+......    
T Consensus       150 ~~~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~----  221 (260)
T cd05069         150 RLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQVERGYR----  221 (260)
T ss_pred             eEccCCc-ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCC----
Confidence            7532111 111122346678999999988889999999999999999999 899997654322   2222211100    


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  362 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  362 (432)
                                ...+...+..+.+++.+||..||.+||++.+|++.|++
T Consensus       222 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         222 ----------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ----------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                      01122334678899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.1e-40  Score=327.69  Aligned_cols=258  Identities=24%  Similarity=0.303  Sum_probs=198.8

Q ss_pred             HHHHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccce
Q 014034           71 YSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVK  143 (432)
Q Consensus        71 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~  143 (432)
                      ..++....++|++.+.||+|+||.||++.+.       .++..||+|.+.+.       ...+.+|+.+++.++||||++
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~-------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~  107 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK-------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ  107 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEEC-------CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCe
Confidence            3444556689999999999999999999876       46788999998642       123678999999999999999


Q ss_pred             eeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC
Q 014034          144 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  223 (432)
Q Consensus       144 l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~  223 (432)
                      +++.+....    ..++||||+++|+|.+++...   .+++..+..++.||+.||.|||+.   +|+||||||+|||++.
T Consensus       108 ~~~~~~~~~----~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~  177 (371)
T cd05622         108 LFYAFQDDR----YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDK  177 (371)
T ss_pred             EEEEEEcCC----EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECC
Confidence            999887544    459999999999999998643   478889999999999999999998   9999999999999999


Q ss_pred             CCceeeccccCCcCCCCCCCcccccccccCCCccCccccccC----CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhH
Q 014034          224 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG----HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ  299 (432)
Q Consensus       224 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~  299 (432)
                      ++.+||+|||++....... ........||+.|+|||++.+.    .++.++|||||||++|||++|..||........ 
T Consensus       178 ~~~ikL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-  255 (371)
T cd05622         178 SGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-  255 (371)
T ss_pred             CCCEEEEeCCceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH-
Confidence            9999999999997532211 1122356799999999998654    378899999999999999999999986544221 


Q ss_pred             HHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHHH
Q 014034          300 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKD--RPKMSQVVERL  360 (432)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~L  360 (432)
                        ...+.....   .        +........+..+.++|..||..++.+  ||++.+|+++.
T Consensus       256 --~~~i~~~~~---~--------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         256 --YSKIMNHKN---S--------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             --HHHHHcCCC---c--------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence              111111000   0        000011123456789999999844433  78999998874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1e-39  Score=307.81  Aligned_cols=242  Identities=23%  Similarity=0.416  Sum_probs=187.0

Q ss_pred             ccccCCceEEEEEEecCCC-----------------CCCCcccEEEEEEecCcChH----HHHHHHHHhcccCCCcccee
Q 014034           86 KIGEGGFGSVYKSSIKPAA-----------------GDGTSEATVVAIKKLNRDGL----QWVAEVQFLGVLEHPNLVKL  144 (432)
Q Consensus        86 ~lg~G~fg~Vy~~~~~~~~-----------------~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~hpniv~l  144 (432)
                      .||+|+||.||+|.+....                 ..+......|++|.+.....    .+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            5999999999999864221                 11223446799999875432    46788999999999999999


Q ss_pred             eeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCC
Q 014034          145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN  224 (432)
Q Consensus       145 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~  224 (432)
                      ++++.....    .++||||+++|+|..++.... ..+++..+..++.|++.||+|||+.   +|+||||||+|||++..
T Consensus        82 ~~~~~~~~~----~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~  153 (274)
T cd05076          82 HGVCVRGSE----NIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL  153 (274)
T ss_pred             EEEEEeCCc----eEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence            999987653    489999999999999986533 4689999999999999999999998   99999999999999764


Q ss_pred             C-------ceeeccccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHH-hCCCCCCCCCc
Q 014034          225 F-------RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEML-TGRRSLERNRP  295 (432)
Q Consensus       225 ~-------~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell-tg~~pf~~~~~  295 (432)
                      +       .+|++|||++.....      .....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||....+
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  227 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP  227 (274)
T ss_pred             CcccCccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence            4       389999998864211      122357888999998865 56899999999999999985 69999976544


Q ss_pred             hhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          296 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                      ........   ...            .+..    .....+.++|.+||+.+|.+|||+.+|++.|
T Consensus       228 ~~~~~~~~---~~~------------~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         228 SEKERFYE---KKH------------RLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHHHHHHH---hcc------------CCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            33222111   000            0001    1124688999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1e-39  Score=305.87  Aligned_cols=256  Identities=25%  Similarity=0.383  Sum_probs=202.8

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc-------ChHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-------DGLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~-------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|...+.||+|+||.||+|...       .++..||+|.++.       ....+.+|+++++.++|+||+++++++...
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~   74 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICL-------LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN   74 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEc-------CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC
Confidence            57999999999999999999865       4578899998752       123578899999999999999999998765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      +    ..++||||+++++|..++...  ....+++..+..++.+++.||.|||+.   +|+||||+|+||+++.++.++|
T Consensus        75 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l  147 (267)
T cd08224          75 N----ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKL  147 (267)
T ss_pred             C----eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEE
Confidence            4    359999999999999998642  234689999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      +|||++......  ........++..|+|||.+.+..++.++|||||||++|+|++|..||....... .......... 
T Consensus       148 ~d~~~~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-  223 (267)
T cd08224         148 GDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIEKC-  223 (267)
T ss_pred             eccceeeeccCC--CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH-HHHHhhhhcC-
Confidence            999998753211  111233568899999999998889999999999999999999999996543211 1111111100 


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  364 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  364 (432)
                              ...+    ......+..+.++|.+||..+|++|||+.+|++.|+.+.
T Consensus       224 --------~~~~----~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         224 --------DYPP----LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             --------CCCC----CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                    0000    001133457889999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.7e-40  Score=311.57  Aligned_cols=252  Identities=23%  Similarity=0.346  Sum_probs=196.9

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC----hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      .++|++.+.||+|+||.||+|+..       .++..||+|.+...    ...+.+|+.+++.++||||+++++++...+ 
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~-------~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~-   79 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNL-------HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE-   79 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEEC-------CCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC-
Confidence            357999999999999999999864       46789999988643    224678999999999999999999987654 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+.+++|.+++...  .++++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||
T Consensus        80 ---~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg  151 (267)
T cd06646          80 ---KLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFG  151 (267)
T ss_pred             ---EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCc
Confidence               459999999999999998654  3689999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      ++......  ........|+..|+|||.+.   ...++.++|||||||++|+|++|..||....+....  ..    ...
T Consensus       152 ~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--~~----~~~  223 (267)
T cd06646         152 VAAKITAT--IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FL----MSK  223 (267)
T ss_pred             cceeeccc--ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--ee----eec
Confidence            98753211  11123356889999999884   345788999999999999999999999654322110  00    000


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                        ..   ...+.+.  .....+..+.+++.+||..+|++|||+.+|+++|
T Consensus       224 --~~---~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         224 --SN---FQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             --CC---CCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence              00   0001111  0112346788999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-40  Score=305.81  Aligned_cols=252  Identities=30%  Similarity=0.416  Sum_probs=201.5

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---hHHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      .++|.+.+.||+|+||.||+|...        .+..||+|.+...   ...+.+|+.+++.++||||+++++++..... 
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~--------~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-   75 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN--------GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEP-   75 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc--------CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCc-
Confidence            357999999999999999999864        3467999988753   3458899999999999999999998865443 


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                         .++||||+.+++|.+++.......+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||+
T Consensus        76 ---~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~  149 (261)
T cd05034          76 ---IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGL  149 (261)
T ss_pred             ---eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECcccc
Confidence               49999999999999999876556789999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      +...... .........++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.....   ....+.....   
T Consensus       150 ~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~~~~~---  222 (261)
T cd05034         150 ARLIEDD-EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQVERGYR---  222 (261)
T ss_pred             ceeccch-hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCC---
Confidence            8753211 1111122335678999999998889999999999999999999 999997654322   2221111100   


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  362 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  362 (432)
                             .    ..+...+..+.+++.+||..+|.+||++.++++.|+.
T Consensus       223 -------~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 -------M----PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -------C----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                   0    0111124578899999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=7.8e-41  Score=327.78  Aligned_cols=250  Identities=25%  Similarity=0.358  Sum_probs=194.2

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|+..+.||+|+||.||++...       .++..||+|.++...       ..+..|+.++..++||||+++++.+...
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   73 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKK-------DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK   73 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            36889999999999999999865       467899999986421       2367899999999999999999988765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      .    ..++||||+++|+|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        74 ~----~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~D  144 (360)
T cd05627          74 R----NLYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSD  144 (360)
T ss_pred             C----EEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEee
Confidence            4    4599999999999999996543  689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCC---------------------------------cccccccccCCCccCccccccCCCCchhhhHHHHH
Q 014034          232 FGLAREGPMVGH---------------------------------THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGV  278 (432)
Q Consensus       232 fG~a~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv  278 (432)
                      ||++........                                 .......+||+.|+|||++.+..++.++|||||||
T Consensus       145 fG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGv  224 (360)
T cd05627         145 FGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV  224 (360)
T ss_pred             ccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccc
Confidence            999864211100                                 00012357999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCC---HHH
Q 014034          279 VLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK---MSQ  355 (432)
Q Consensus       279 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~e  355 (432)
                      ++|||++|..||.+..+....   ..+......   +  ...+    .  ...+..+.+||.+|+. ||.+|++   +.+
T Consensus       225 ilyel~tG~~Pf~~~~~~~~~---~~i~~~~~~---~--~~p~----~--~~~s~~~~~li~~l~~-~p~~R~~~~~~~e  289 (360)
T cd05627         225 IMYEMLIGYPPFCSETPQETY---RKVMNWKET---L--VFPP----E--VPISEKAKDLILRFCT-DSENRIGSNGVEE  289 (360)
T ss_pred             eeeecccCCCCCCCCCHHHHH---HHHHcCCCc---e--ecCC----C--CCCCHHHHHHHHHhcc-ChhhcCCCCCHHH
Confidence            999999999999876543321   111111000   0  0011    0  1123567788888764 9999985   677


Q ss_pred             HHHH
Q 014034          356 VVER  359 (432)
Q Consensus       356 il~~  359 (432)
                      ++++
T Consensus       290 i~~h  293 (360)
T cd05627         290 IKSH  293 (360)
T ss_pred             HhcC
Confidence            7766

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=306.70  Aligned_cols=247  Identities=30%  Similarity=0.462  Sum_probs=191.5

Q ss_pred             ccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhccc-CCCccceeeeEEeecCCcceeEE
Q 014034           86 KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVL-EHPNLVKLIGYCAVDGERGIQRL  159 (432)
Q Consensus        86 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~~~  159 (432)
                      .||+|+||.||+|...     .......+++|.+...     ...+.+|+.++.++ +||||+++++++...+.    .+
T Consensus         2 ~lg~g~~g~v~~~~~~-----~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~----~~   72 (270)
T cd05047           2 VIGEGNFGQVLKARIK-----KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY----LY   72 (270)
T ss_pred             cCCCCCCceEEEEEEc-----CCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCC----ce
Confidence            5899999999999875     1122346788887642     12477899999999 89999999999876553    49


Q ss_pred             EEEeecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC
Q 014034          160 LVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF  225 (432)
Q Consensus       160 lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~  225 (432)
                      +||||+++++|.+++....              ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++
T Consensus        73 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~  149 (270)
T cd05047          73 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY  149 (270)
T ss_pred             EEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCC
Confidence            9999999999999986532              13578999999999999999999998   999999999999999999


Q ss_pred             ceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHH
Q 014034          226 RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEW  304 (432)
Q Consensus       226 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~  304 (432)
                      .+||+|||++....   ..........+..|+|||++.+..++.++|||||||++|||++ |..||.+.....   ....
T Consensus       150 ~~kl~dfgl~~~~~---~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~  223 (270)
T cd05047         150 VAKIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEK  223 (270)
T ss_pred             eEEECCCCCccccc---hhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHHH
Confidence            99999999986321   1111112234567999999988899999999999999999997 999997643322   1111


Q ss_pred             HhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 014034          305 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  364 (432)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  364 (432)
                      +.   .. ..      .    ..+...+..+.+|+.+||..+|.+|||+.+++..|..++
T Consensus       224 ~~---~~-~~------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         224 LP---QG-YR------L----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             Hh---CC-CC------C----CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            11   00 00      0    011123356889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.3e-40  Score=306.64  Aligned_cols=247  Identities=25%  Similarity=0.361  Sum_probs=198.5

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      +|++.+.||.|+||.||++...       .++..+|+|.++..     ...+.+|+.+++.++||||+++++.+...+  
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   71 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHV-------NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG--   71 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEc-------CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC--
Confidence            4788899999999999999865       45788999987532     234778999999999999999999987654  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        ..++||||+++++|.+++.......+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||+
T Consensus        72 --~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~  146 (255)
T cd08219          72 --HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGS  146 (255)
T ss_pred             --EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCc
Confidence              459999999999999998765555789999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      +......  ........|++.|+|||++.+..++.++|+||||+++|+|++|..||........   ...+....     
T Consensus       147 ~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~~~~~~~~-----  216 (255)
T cd08219         147 ARLLTSP--GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL---ILKVCQGS-----  216 (255)
T ss_pred             ceeeccc--ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH---HHHHhcCC-----
Confidence            8753221  1122345689999999999988899999999999999999999999986543221   11111000     


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .     .    ..+...+..+.+|+.+||+.||.+|||+.+|+..
T Consensus       217 ~-----~----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 Y-----K----PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             C-----C----CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            0     0    0112234568899999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-42  Score=307.61  Aligned_cols=248  Identities=28%  Similarity=0.399  Sum_probs=208.6

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC--hHHHHHHHHHhcccCCCccceeeeEEeecCCccee
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQ  157 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~  157 (432)
                      -|.++.+||+|+||.||+|.++       ..|.++|||++.-+  ..++..|+.||++++.|++|++||.+.....    
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~-------EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD----  102 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHR-------ESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD----  102 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHh-------ccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc----
Confidence            3667788999999999999987       68899999998654  4568999999999999999999998765543    


Q ss_pred             EEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          158 RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       158 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      +|+|||||--|++.+.++-+. +++.+.++..++.+-++||+|||..   .-+|||||..|||++.+|..||+|||++-+
T Consensus       103 LWIVMEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQ  178 (502)
T KOG0574|consen  103 LWIVMEYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQ  178 (502)
T ss_pred             eEeehhhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccch
Confidence            499999999999999987655 5899999999999999999999997   889999999999999999999999999975


Q ss_pred             CCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccccc
Q 014034          238 GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGL  317 (432)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (432)
                      .  .+.-....+..||+.|||||++..-.|+.++||||||++..||..|++||....+.-.               .|-.
T Consensus       179 L--TDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---------------IFMI  241 (502)
T KOG0574|consen  179 L--TDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---------------IFMI  241 (502)
T ss_pred             h--hhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---------------eEec
Confidence            3  3334456678999999999999999999999999999999999999999987655311               0000


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          318 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       318 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      -..|...-.-+...+..+.+++++||..+|++|-|+.+++++
T Consensus       242 PT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  242 PTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             cCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            111111122345567789999999999999999999999887

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=9.1e-40  Score=306.97  Aligned_cols=256  Identities=27%  Similarity=0.443  Sum_probs=199.6

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|.+.+.||+|+||.||+|.+....    ..+..||+|.+...     ...+..|+.+++.++||||+++++++.... 
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPG----KREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR-   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCC----CCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC-
Confidence            45888899999999999999976221    23467999998653     224888999999999999999999986554 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||
T Consensus        79 ---~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg  151 (269)
T cd05065          79 ---PVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFG  151 (269)
T ss_pred             ---ceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCc
Confidence               3499999999999999987543 4689999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccc-cc--cCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcc
Q 014034          234 LAREGPMVGHTHVSTA-VV--GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      ++.............. ..  .+..|+|||.+.+..++.++|||||||++||+++ |..||.......   ...++....
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~~~~  228 (269)
T cd05065         152 LSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIEQDY  228 (269)
T ss_pred             cccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHHcCC
Confidence            9874322111111111 11  2457999999998899999999999999999887 999997654332   222222110


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                      .          .    ..+...+..+.+++.+||+.+|.+||++.+|+..|+.+
T Consensus       229 ~----------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 R----------L----PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             c----------C----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0          0    01112345678999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-39  Score=307.70  Aligned_cols=258  Identities=24%  Similarity=0.392  Sum_probs=203.1

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      .+|+..+.||+|+||.||+|.+...   +......+|+|.+....     ..+.+|+.++..++||||+++++++.. . 
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~---~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~-   81 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPE---GEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-S-   81 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecC---CCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C-
Confidence            4688999999999999999987522   22234579999886542     347789999999999999999999875 2 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||
T Consensus        82 ---~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg  154 (279)
T cd05057          82 ---QVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFG  154 (279)
T ss_pred             ---ceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCc
Confidence               3589999999999999997643 3589999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      +++...............++..|+|||.+....++.++||||||+++||+++ |..||.+.....   +...+...... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~~~-  230 (279)
T cd05057         155 LAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPDLLEKGERL-  230 (279)
T ss_pred             ccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHhCCCCC-
Confidence            9975432211111122234568999999988889999999999999999999 999998765432   22222211000 


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                                   ..+...+..+.+++.+||..+|.+||++.++++.|..+..
T Consensus       231 -------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         231 -------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             -------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                         0011123467899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=9.5e-40  Score=313.25  Aligned_cols=260  Identities=26%  Similarity=0.388  Sum_probs=199.3

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|++.+.||+|+||.||++.+.       .++..+|+|.+....     ..+.+|+++++.++||||+++++++..++ 
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~-------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   72 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHR-------PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG-   72 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEc-------CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-
Confidence            36899999999999999999865       456789999876431     24778999999999999999999997755 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.  .+++|+||||+|||++.++.++|+|||
T Consensus        73 ---~~~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg  145 (308)
T cd06615          73 ---EISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFG  145 (308)
T ss_pred             ---EEEEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCC
Confidence               459999999999999999654  4689999999999999999999973  289999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      ++.....    .......|+..|+|||.+.+..++.++||||||+++|+|++|..||.........   .+.........
T Consensus       146 ~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~  218 (308)
T cd06615         146 VSGQLID----SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE---AMFGRPVSEGE  218 (308)
T ss_pred             Ccccccc----cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH---HhhcCcccccc
Confidence            9864321    1123457899999999998888999999999999999999999999754432221   11111100000


Q ss_pred             c-----------------------cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          314 K-----------------------FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       314 ~-----------------------~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                      .                       ...+.............+..+.+|+.+||..+|++|||+.+++.+.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         219 AKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             ccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence            0                       0000000000000011345688999999999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.2e-39  Score=305.97  Aligned_cols=256  Identities=26%  Similarity=0.428  Sum_probs=201.1

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|.+.+.||+|+||.||+|.+...    ......+|+|.+....     ..+.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLP----GKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP   79 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecC----CCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            4788899999999999999987522    1245689999886432     347889999999999999999999875543


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                          .++||||+++++|.+++.... ..+++.++..++.|++.||.|||+.   +++||||||+|||++.++.++|+|||
T Consensus        80 ----~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg  151 (267)
T cd05066          80 ----VMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFG  151 (267)
T ss_pred             ----cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCC
Confidence                499999999999999997643 4689999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcc-cccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          234 LAREGPMVGHTH-VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       234 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ++.......... ......++..|+|||.+.+..++.++||||||+++|++++ |..||.......   ....+..... 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~~~~~-  227 (267)
T cd05066         152 LSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIEEGYR-  227 (267)
T ss_pred             cccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHhCCCc-
Confidence            997543221111 1111223568999999998889999999999999999887 999997654332   2222211100 


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                                   ...+...+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus       228 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 -------------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                         001122345788999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.7e-40  Score=319.40  Aligned_cols=237  Identities=27%  Similarity=0.374  Sum_probs=185.9

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHH-HHhcccCCCccceeeeEEeecCCcce
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEV-QFLGVLEHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~-~~l~~l~hpniv~l~~~~~~~~~~~~  156 (432)
                      +.||+|+||.||+|...       .++..||+|.+....       ..+..|. .+++.++||||+++++++...+    
T Consensus         1 ~~lg~G~fg~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~----   69 (325)
T cd05602           1 KVIGKGSFGKVLLARHK-------AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD----   69 (325)
T ss_pred             CeeeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC----
Confidence            36999999999999865       456789999986432       1233343 3567889999999999887654    


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      ..++||||+.+++|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        70 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~  144 (325)
T cd05602          70 KLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK  144 (325)
T ss_pred             eEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCc
Confidence            359999999999999998654  3578888999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  316 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (432)
                      ....  .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....   ....+...+.      
T Consensus       145 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~------  213 (325)
T cd05602         145 ENIE--HNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNILNKPL------  213 (325)
T ss_pred             cccc--CCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HHHHHHhCCc------
Confidence            4211  1222345679999999999999999999999999999999999999998654332   2221111110      


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 014034          317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV  357 (432)
Q Consensus       317 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil  357 (432)
                               ......+..+.+++.+||+.||.+||++.+.+
T Consensus       214 ---------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         214 ---------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence                     01112345688999999999999999987433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.2e-40  Score=304.87  Aligned_cols=248  Identities=27%  Similarity=0.446  Sum_probs=195.6

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-----HHHHHHHHhcccCCCccceeeeEEeecCCcceeEE
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-----QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  159 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~  159 (432)
                      +.||+|+||.||+|.+...+    .....+|+|.+.....     .+.+|+.+++.++||||+++++++..+     ..+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~   71 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKS----GKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE-----PLM   71 (257)
T ss_pred             CccCccCceeEEEeEeeccC----CCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC-----ceE
Confidence            36999999999999875222    1347899999875432     478899999999999999999987532     348


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCC
Q 014034          160 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP  239 (432)
Q Consensus       160 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~  239 (432)
                      +||||+.+++|.+++....  .+++..+..++.|++.||.|||+.   +++|+||||+|||++.++.+||+|||+++...
T Consensus        72 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~  146 (257)
T cd05060          72 LVMELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALG  146 (257)
T ss_pred             EEEEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceee
Confidence            9999999999999997654  689999999999999999999998   99999999999999999999999999997532


Q ss_pred             CCCCcc-cccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcccccc
Q 014034          240 MVGHTH-VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGL  317 (432)
Q Consensus       240 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (432)
                      ...... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .+..++......      
T Consensus       147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~~~~~~------  217 (257)
T cd05060         147 AGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLESGERL------  217 (257)
T ss_pred             cCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHcCCcC------
Confidence            221111 1112224568999999998899999999999999999998 99999765432   233322221100      


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          318 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       318 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                              ..+...+..+.+++.+||..+|.+||++.++++.|+.+
T Consensus       218 --------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         218 --------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             --------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence                    11122346788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.4e-40  Score=319.41  Aligned_cols=238  Identities=25%  Similarity=0.404  Sum_probs=189.1

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccC-CCccceeeeEEeec
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLE-HPNLVKLIGYCAVD  151 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~-hpniv~l~~~~~~~  151 (432)
                      +|+..+.||+|+||.||+|..+       .++..||+|.+.+..       ..+..|..++..+. ||+|+++++++...
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~   73 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERK-------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV   73 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC
Confidence            4778889999999999999865       467899999986532       23667888888775 57788888887654


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ..++||||+++|+|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        74 ~----~~~lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~D  144 (323)
T cd05615          74 D----RLYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIAD  144 (323)
T ss_pred             C----EEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEec
Confidence            4    3599999999999999986543  689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ||+++.....  ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....   ....+....  
T Consensus       145 fg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i~~~~--  217 (323)
T cd05615         145 FGMCKEHMVD--GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQSIMEHN--  217 (323)
T ss_pred             cccccccCCC--CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHHhCC--
Confidence            9998753211  112334569999999999999999999999999999999999999998754322   222111110  


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM  353 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  353 (432)
                               .    ..+...+..+.+++.+||+.+|.+|++.
T Consensus       218 ---------~----~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 ---------V----SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ---------C----CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                     0    0111223567899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.6e-40  Score=310.70  Aligned_cols=258  Identities=29%  Similarity=0.476  Sum_probs=200.0

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|+..+.||+|+||.||+|......  ....+..||+|.+....     ..+.+|+.+++.++||||+++++++....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~   81 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLL--PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK   81 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccC--CCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence            467999999999999999999864211  12356789999986532     34788999999999999999999887654


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeec
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRA--------------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYR  212 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~  212 (432)
                      .    .++||||+++++|.+++....                    ...+++..++.++.|++.||.|||+.   +++||
T Consensus        82 ~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~  154 (288)
T cd05050          82 P----MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHR  154 (288)
T ss_pred             c----cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceecc
Confidence            3    499999999999999996422                    13478889999999999999999998   99999


Q ss_pred             CCCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 014034          213 DFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLE  291 (432)
Q Consensus       213 Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~  291 (432)
                      ||||+|||++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.
T Consensus       155 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~  234 (288)
T cd05050         155 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY  234 (288)
T ss_pred             cccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999874322111111222335668999999998899999999999999999998 888887


Q ss_pred             CCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          292 RNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                      +.....   ....+.....        .      ..+...+..+.+|+.+||+.+|.+|||+.|+++.|+
T Consensus       235 ~~~~~~---~~~~~~~~~~--------~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         235 GMAHEE---VIYYVRDGNV--------L------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             CCCHHH---HHHHHhcCCC--------C------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            554322   2221111000        0      011123467889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.7e-39  Score=303.76  Aligned_cols=252  Identities=28%  Similarity=0.415  Sum_probs=192.2

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCCcceeEE
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  159 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~  159 (432)
                      +.||+|+||.||+|.+..    .......||+|.+...     ...+.+|+.+++.++||||+++++++...+.   ..+
T Consensus         1 ~~lg~g~~g~v~~~~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~   73 (262)
T cd05058           1 RVIGKGHFGCVYHGTLID----SDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEG---SPL   73 (262)
T ss_pred             CcccccCCceEEEEEEec----CCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCC---CcE
Confidence            368999999999998752    1235678999998542     2347789999999999999999998764332   248


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCC
Q 014034          160 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP  239 (432)
Q Consensus       160 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~  239 (432)
                      +||||+.+++|.+++.... ..+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+++...
T Consensus        74 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~  149 (262)
T cd05058          74 VVLPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIY  149 (262)
T ss_pred             EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCcccccccc
Confidence            9999999999999997543 3467788899999999999999998   99999999999999999999999999987532


Q ss_pred             CCCCc--ccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhC-CCCCCCCCchhhHHHHHHHhhcccCccccc
Q 014034          240 MVGHT--HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG-RRSLERNRPKTEQRLLEWVQQYPADSKKFG  316 (432)
Q Consensus       240 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (432)
                      .....  .......++..|+|||.+.+..++.++|||||||++|||++| ..||.......   +...+....       
T Consensus       150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~~~~~-------  219 (262)
T cd05058         150 DKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYLLQGR-------  219 (262)
T ss_pred             CCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHhcCC-------
Confidence            11110  111223456789999999888999999999999999999995 56665443222   222221110       


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 014034          317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  364 (432)
Q Consensus       317 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  364 (432)
                         ...    .+...+..+.+++.+||..+|++||++.+|++.|+.+.
T Consensus       220 ---~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         220 ---RLL----QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             ---CCC----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence               000    01112356889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2e-40  Score=309.32  Aligned_cols=250  Identities=32%  Similarity=0.541  Sum_probs=199.1

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHH------HHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ------WVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      |+..+.||+|+||.||++...       .++..||+|.+......      ..+|+.+++.++||||+++++++....  
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~-------~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--   71 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNK-------KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN--   71 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEET-------TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS--
T ss_pred             CEEeEEEEeCCCEEEEEEEEC-------CCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc--
Confidence            567889999999999999976       56789999998765432      345899999999999999999998744  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        ..++||||+.+++|.+++...  ..+++..+..++.|++.||.+||+.   +|+|+||||+||+++.++.++|+|||+
T Consensus        72 --~~~~v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~  144 (260)
T PF00069_consen   72 --YLYIVMEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGS  144 (260)
T ss_dssp             --EEEEEEEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTT
T ss_pred             --ccccccccccccccccccccc--ccccccccccccccccccccccccc---ccccccccccccccccccccccccccc
Confidence              358999999999999999732  3689999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccc-cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      +...  ...........++..|+|||++. +..++.++||||||+++|+|++|..||.......................
T Consensus       145 ~~~~--~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  222 (260)
T PF00069_consen  145 SVKL--SENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS  222 (260)
T ss_dssp             TEES--TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH
T ss_pred             cccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc
Confidence            8642  12223344567899999999998 88899999999999999999999999987633333333222211100000


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                               .  .........+.+++.+||+.||++|||+.+++++
T Consensus       223 ---------~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  223 ---------S--QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             ---------T--TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             ---------c--cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                     0  0000012678899999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=6e-40  Score=313.54  Aligned_cols=263  Identities=24%  Similarity=0.390  Sum_probs=197.1

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|...+.||.|+||.||+|...       .++..||+|.+...     ...+.+|+.+++.++||||+++++++...+ 
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~-   77 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSK-------LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-   77 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEc-------CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCC-
Confidence            57999999999999999999865       45678999987642     234778999999999999999999987654 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.++|+|||
T Consensus        78 ---~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg  149 (301)
T cd07873          78 ---SLTLVFEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFG  149 (301)
T ss_pred             ---eEEEEEeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCc
Confidence               3599999996 58998886543 3688999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      ++......  ........+++.|+|||.+.+ ..++.++|||||||++|+|++|..||..................+...
T Consensus       150 ~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  227 (301)
T cd07873         150 LARAKSIP--TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEE  227 (301)
T ss_pred             chhccCCC--CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChh
Confidence            98753211  112233457899999999865 457889999999999999999999998765432221111111111100


Q ss_pred             -c-------ccccccCccccC----cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          313 -K-------KFGLIMDPRLEK----EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       313 -~-------~~~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                       .       .+.....+....    ......+..+.+||.+||..||.+|||+.+++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         228 TWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             hchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence             0       000000010000    0011234568899999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6.9e-40  Score=342.69  Aligned_cols=259  Identities=21%  Similarity=0.286  Sum_probs=201.1

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|++.+.||+|+||.||+|...       .+++.||+|++..+       ...+.+|+.+++.++||||+++++++...
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~-------~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~   74 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDP-------VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG   74 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEEC-------CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC
Confidence            57999999999999999999865       45788999998643       22478899999999999999999998765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRA---------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD  222 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~  222 (432)
                      +    ..++||||++|++|.+++....         ...+++..++.++.||+.||+|||+.   +|+||||||+|||++
T Consensus        75 ~----~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd  147 (932)
T PRK13184         75 D----PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLG  147 (932)
T ss_pred             C----EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEc
Confidence            4    3599999999999999886421         12456778899999999999999998   999999999999999


Q ss_pred             CCCceeeccccCCcCCCCCCC----------------cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhC
Q 014034          223 ENFRPKLSDFGLAREGPMVGH----------------THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG  286 (432)
Q Consensus       223 ~~~~~kl~DfG~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg  286 (432)
                      .++.++|+|||+++.......                ........||+.|+|||++.+..++.++|||||||++|||+||
T Consensus       148 ~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG  227 (932)
T PRK13184        148 LFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTL  227 (932)
T ss_pred             CCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHC
Confidence            999999999999975311100                0011235699999999999999999999999999999999999


Q ss_pred             CCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHhh
Q 014034          287 RRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-KMSQVVERLKQIVQ  365 (432)
Q Consensus       287 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~~~~  365 (432)
                      ..||........   ... ... ..+..        .  ......+..+.+++.+||..||.+|| +++++++.|+..++
T Consensus       228 ~~PF~~~~~~ki---~~~-~~i-~~P~~--------~--~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        228 SFPYRRKKGRKI---SYR-DVI-LSPIE--------V--APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             CCCCCCcchhhh---hhh-hhc-cChhh--------c--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            999976432211   000 000 00000        0  00112345688999999999999996 66778888888776


Q ss_pred             h
Q 014034          366 V  366 (432)
Q Consensus       366 ~  366 (432)
                      .
T Consensus       293 ~  293 (932)
T PRK13184        293 G  293 (932)
T ss_pred             c
Confidence            4

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1e-39  Score=304.27  Aligned_cols=248  Identities=25%  Similarity=0.372  Sum_probs=198.7

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      +|++.+.||+|+||.||++...       .+++.||+|.+....      ..+.+|+.+++.++|||++++++.+.... 
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   72 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHR-------TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGED-   72 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEc-------CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCC-
Confidence            4888999999999999999865       456789999985421      24778999999999999999998765322 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                        ...++||||+++++|.+++.......+++.++..++.+++.||.|||+.   +++||||||+||+++.++.++|+|||
T Consensus        73 --~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~  147 (257)
T cd08223          73 --GLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLG  147 (257)
T ss_pred             --CEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEeccc
Confidence              2458999999999999999765555789999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      ++......  ........|++.|+|||++.+..++.++||||||+++|+|++|..||.........  ........    
T Consensus       148 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~--~~~~~~~~----  219 (257)
T cd08223         148 IARVLENQ--CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV--YRIIEGKL----  219 (257)
T ss_pred             ceEEeccc--CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHHhcCC----
Confidence            98753211  12233456899999999999999999999999999999999999999765432211  11111100    


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                             +    ..+...+..+.+++.+||+.+|.+|||+.+++++
T Consensus       220 -------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         220 -------P----PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             -------C----CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                   0    1122344678899999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=7.2e-40  Score=309.53  Aligned_cols=246  Identities=26%  Similarity=0.380  Sum_probs=193.2

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      +|+..+.||+|+||.||+|...       .++..||+|.+..+     ...+.+|+.++.+++||||+++++++...+. 
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-   73 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHL-------LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENR-   73 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEc-------CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCE-
Confidence            6788899999999999999864       46788999998643     1247789999999999999999999987553 


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                         .++||||+++++|..+.      .+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.++|+|||+
T Consensus        74 ---~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~  141 (279)
T cd06619          74 ---ISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGV  141 (279)
T ss_pred             ---EEEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCc
Confidence               48999999999997652      478889999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHHHhhcccCcc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR-LLEWVQQYPADSK  313 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~  313 (432)
                      +.....    .......||..|+|||.+.+..++.++||||||+++|+|++|..||.......... ...........  
T Consensus       142 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--  215 (279)
T cd06619         142 STQLVN----SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE--  215 (279)
T ss_pred             ceeccc----ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc--
Confidence            875321    12234578999999999998899999999999999999999999997533221100 00100000000  


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                           ..+.+   .....+..+.+++.+||+.+|.+||++.+++++
T Consensus       216 -----~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         216 -----DPPVL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             -----CCCCC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence                 00000   011123568899999999999999999999876

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.8e-40  Score=310.95  Aligned_cols=264  Identities=27%  Similarity=0.413  Sum_probs=200.6

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      .|++++.||+|+||.||++.+..   .+..++..||+|.+....     ..+.+|+.+++.++||||+++++++...+..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDP---EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEcc---CCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            47888999999999999998642   233567889999986432     2478899999999999999999998765322


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        ..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||+
T Consensus        82 --~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~  155 (284)
T cd05079          82 --GIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL  155 (284)
T ss_pred             --ceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcc
Confidence              3589999999999999986543 3689999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCc-ccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchh---------hHHHHHH
Q 014034          235 AREGPMVGHT-HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT---------EQRLLEW  304 (432)
Q Consensus       235 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~---------~~~~~~~  304 (432)
                      +......... .......++..|+|||.+.+..++.++||||||+++|+|+++..|+.......         .......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05079         156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL  235 (284)
T ss_pred             ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence            9753222111 11223456778999999988889999999999999999999877653211100         0000000


Q ss_pred             HhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          305 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                      ..... ..        .  ....+...+..+.+|+.+||+.+|.+|||+.++++.|+.+
T Consensus       236 ~~~~~-~~--------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         236 VRVLE-EG--------K--RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHH-cC--------c--cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            00000 00        0  0011122356789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=9.4e-40  Score=304.27  Aligned_cols=244  Identities=30%  Similarity=0.470  Sum_probs=197.1

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC--hHHHHHHHHHhcccCCCccceeeeEEeecCCcce
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~  156 (432)
                      ++|.+.+.||+|+||.||++..         .+..||+|.+..+  ...+.+|+.+++.++||||+++++++..++    
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~---------~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----   72 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY---------TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG----   72 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc---------CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC----
Confidence            4688999999999999999753         4677999998654  235789999999999999999999886532    


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                       .++||||+.+++|.+++.......+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus        73 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~  148 (254)
T cd05083          73 -LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLAR  148 (254)
T ss_pred             -cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccce
Confidence             38999999999999999876555789999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcccc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKF  315 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  315 (432)
                      .....     ......+..|+|||.+.+..++.++||||||+++|+|++ |..||...........   +....      
T Consensus       149 ~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~---~~~~~------  214 (254)
T cd05083         149 VGSMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC---VEKGY------  214 (254)
T ss_pred             ecccc-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH---HhCCC------
Confidence            53211     112334568999999988899999999999999999998 9999976554322111   11100      


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       316 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                          ..    ..+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus       215 ----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         215 ----RM----EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             ----CC----CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence                00    011223467889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=8.4e-40  Score=311.84  Aligned_cols=248  Identities=24%  Similarity=0.382  Sum_probs=198.6

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC----hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ..+|+..+.||+|+||.||+|...       .++..|++|.+...    ...+.+|+.+++.++||||+++++.+.... 
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~-   90 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDV-------ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-   90 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEEC-------CCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC-
Confidence            357999999999999999999854       45678999988643    234788999999999999999999987644 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+++++|.+++...   .+++.++..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||
T Consensus        91 ---~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg  161 (296)
T cd06654          91 ---ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG  161 (296)
T ss_pred             ---EEEEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccc
Confidence               459999999999999998543   578999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      ++......  ........|++.|+|||.+.+..++.++|||||||++|+|++|..||....+...  ...... ...   
T Consensus       162 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~~~-~~~---  233 (296)
T cd06654         162 FCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIAT-NGT---  233 (296)
T ss_pred             cchhcccc--ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHHhc-CCC---
Confidence            98753211  1122335688999999999988899999999999999999999999976544221  111110 000   


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                             +.+  ..+...+..+.+++.+||..+|.+|||+.+|+.+
T Consensus       234 -------~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         234 -------PEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             -------CCC--CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence                   000  1122334668899999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=321.31  Aligned_cols=260  Identities=28%  Similarity=0.413  Sum_probs=215.1

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh---HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      ..+.....+||-|-||.||.|.|+       .....||||.++.+.   .+|..|+.+|+.++|||+|+|+|+|..+...
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWK-------kyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeee-------ccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            345556678999999999999998       456789999998765   4599999999999999999999999987654


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                          |||+|||..|+|.+||++.+...++.-..+.++.||..||.||..+   ++|||||...|+||.++-.+|++|||+
T Consensus       339 ----YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGL  411 (1157)
T KOG4278|consen  339 ----YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGL  411 (1157)
T ss_pred             ----EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccch
Confidence                9999999999999999988777788888999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      ++.+.....+. .....-...|.|||-+....++.++|||+|||+||||.| |..||.+.+-..--.+++          
T Consensus       412 sRlMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE----------  480 (1157)
T KOG4278|consen  412 SRLMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE----------  480 (1157)
T ss_pred             hhhhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh----------
Confidence            99743221111 111123458999999999999999999999999999998 889998764332222221          


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhccC
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNE  369 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~  369 (432)
                             ..+.-..+..++...++||..||+++|.+||++.+|-+.++.+.+.+..
T Consensus       481 -------kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSi  529 (1157)
T KOG4278|consen  481 -------KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSI  529 (1157)
T ss_pred             -------ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccc
Confidence                   2222233556678899999999999999999999999999999876543

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.7e-40  Score=317.21  Aligned_cols=234  Identities=27%  Similarity=0.370  Sum_probs=184.1

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHH-HHhcccCCCccceeeeEEeecCCcce
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEV-QFLGVLEHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~-~~l~~l~hpniv~l~~~~~~~~~~~~  156 (432)
                      +.||+|+||.||+|...       .++..||+|.+.+..       ..+..|. .+++.++||||+++++++...+    
T Consensus         1 ~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~----   69 (321)
T cd05603           1 KVIGKGSFGKVLLAKRK-------SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE----   69 (321)
T ss_pred             CeeeeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC----
Confidence            36999999999999865       467899999986432       1244444 4578899999999999886554    


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      ..++||||+++++|..++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        70 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  144 (321)
T cd05603          70 KLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK  144 (321)
T ss_pred             EEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCc
Confidence            459999999999999888654  3688899999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  316 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (432)
                      ....  .........||+.|+|||++.+..++.++|||||||++|+|++|..||...+...   ....+...+       
T Consensus       145 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~-------  212 (321)
T cd05603         145 EGVE--PEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---MYDNILHKP-------  212 (321)
T ss_pred             cCCC--CCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---HHHHHhcCC-------
Confidence            4211  1122334679999999999998899999999999999999999999998654321   222111110       


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 014034          317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS  354 (432)
Q Consensus       317 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  354 (432)
                          .    ..+...+..+.+++.+||+.||.+||++.
T Consensus       213 ----~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         213 ----L----QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             ----C----CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence                0    11122345688999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.5e-39  Score=303.21  Aligned_cols=249  Identities=28%  Similarity=0.429  Sum_probs=197.0

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-----HHHHHHHHhcccCCCccceeeeEEeecCCcceeEE
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-----QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  159 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~  159 (432)
                      +.||+|+||.||+|.+...    ......||+|.+.....     .+.+|+.++++++||||+++++++.. .    ..+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~----~~~   71 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTS----GGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-H----PLM   71 (257)
T ss_pred             CcCCccCcccEEeeeEecC----CCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-C----eEE
Confidence            3689999999999987521    12345799999876544     47889999999999999999998875 2    459


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCC
Q 014034          160 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP  239 (432)
Q Consensus       160 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~  239 (432)
                      +||||+++++|.+++.......+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++....
T Consensus        72 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~  148 (257)
T cd05040          72 MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALP  148 (257)
T ss_pred             EEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccc
Confidence            999999999999999775435789999999999999999999998   99999999999999999999999999997643


Q ss_pred             CCCCc-ccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcccccc
Q 014034          240 MVGHT-HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGL  317 (432)
Q Consensus       240 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (432)
                      ..... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   ....+......      
T Consensus       149 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~~------  219 (257)
T cd05040         149 QNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKIDKEGER------  219 (257)
T ss_pred             ccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHhcCCc------
Confidence            21111 11223457789999999998899999999999999999999 999997654432   22211111000      


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          318 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       318 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                         .    ..+...+..+.+++.+||+.+|.+|||+.++++.|.
T Consensus       220 ---~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         220 ---L----ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ---C----CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence               0    011123467889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.2e-39  Score=304.42  Aligned_cols=250  Identities=25%  Similarity=0.367  Sum_probs=185.8

Q ss_pred             ccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCCcceeEEE
Q 014034           86 KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLL  160 (432)
Q Consensus        86 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~l  160 (432)
                      .||+|+||.||+|...     .......+++|.+....     ..+.+|+.+++.++||||+++++.+.....    .++
T Consensus         2 ~lg~G~fg~v~~~~~~-----~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~----~~l   72 (269)
T cd05042           2 EIGNGWFGKVLLGEAH-----RGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIP----YLL   72 (269)
T ss_pred             cCCccCCceEEEEEEe-----cCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCc----eEE
Confidence            5999999999999764     12345679999875432     247789999999999999999999876543    599


Q ss_pred             EEeecCCCCHHHHhhcCCC---CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          161 VYEFMLNRSLEDHLFNRAF---PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       161 v~e~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      ||||+.+|+|.+++.....   ...++.....++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++..
T Consensus        73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  149 (269)
T cd05042          73 VLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALE  149 (269)
T ss_pred             EEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccc
Confidence            9999999999999976431   2346788899999999999999998   999999999999999999999999999864


Q ss_pred             CCCCCCcccccccccCCCccCcccccc-------CCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcc
Q 014034          238 GPMVGHTHVSTAVVGTFGYAAPDYIET-------GHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      ..............++..|+|||++..       ..++.++|||||||++|||++ |..||........  +...+....
T Consensus       150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~~~~~~~  227 (269)
T cd05042         150 QYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--LKQVVREQD  227 (269)
T ss_pred             cccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--HHHHhhccC
Confidence            322111111223445678999998742       456789999999999999999 7888876543221  111111110


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                      ..      +..+.+    +...+..+.+++..|| .||++|||+.+|++.|
T Consensus       228 ~~------~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         228 IK------LPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             cc------CCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            00      111111    2223456778899999 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.2e-39  Score=303.44  Aligned_cols=243  Identities=20%  Similarity=0.356  Sum_probs=187.0

Q ss_pred             cccccCCceEEEEEEecCCCC-----CCCcccEEEEEEecCcChH----HHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           85 LKIGEGGFGSVYKSSIKPAAG-----DGTSEATVVAIKKLNRDGL----QWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~-----~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      +.||+|+||.||+|++.....     ........|++|.+.....    .+..|+.++..++||||+++++++..+... 
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~-   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN-   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC-
Confidence            358999999999998642211     1123456799998765432    367789999999999999999998765543 


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCc-------ee
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR-------PK  228 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~-------~k  228 (432)
                         ++||||+.+++|..++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.       ++
T Consensus        80 ---~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          80 ---IMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             ---EEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence               89999999999999886543 4689999999999999999999998   9999999999999987664       89


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCccccc-cCCCCchhhhHHHHHHHHHHH-hCCCCCCCCCchhhHHHHHHHh
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEML-TGRRSLERNRPKTEQRLLEWVQ  306 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell-tg~~pf~~~~~~~~~~~~~~~~  306 (432)
                      ++|||++....      ......++..|+|||.+. +..++.++|||||||++|+|+ +|..||............   .
T Consensus       153 l~d~g~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~---~  223 (262)
T cd05077         153 LSDPGIPITVL------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY---E  223 (262)
T ss_pred             eCCCCCCcccc------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH---h
Confidence            99999986421      112345788999999986 567899999999999999998 588888654332211110   0


Q ss_pred             hcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          307 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                      ..      .. .         .......+.+||.+||+.||.+||++.+|++.|
T Consensus       224 ~~------~~-~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         224 GQ------CM-L---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             cC------cc-C---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            00      00 0         011235688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.2e-40  Score=319.86  Aligned_cols=265  Identities=24%  Similarity=0.312  Sum_probs=197.0

Q ss_pred             HHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEE
Q 014034           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYC  148 (432)
Q Consensus        75 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~  148 (432)
                      ....++|+.++.||.|+||.||+|...       .++..||+|.+....      ..+.+|+.+++.++||||+++++++
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDT-------RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVF   83 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEEC-------CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhh
Confidence            345578999999999999999999864       467889999986532      2367899999999999999999987


Q ss_pred             eecCC--cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCc
Q 014034          149 AVDGE--RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR  226 (432)
Q Consensus       149 ~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~  226 (432)
                      .....  .....+++++++ +++|.+++..   ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.
T Consensus        84 ~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~  156 (343)
T cd07878          84 TPATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCE  156 (343)
T ss_pred             cccccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCC
Confidence            64321  223458999988 8899888753   3589999999999999999999998   9999999999999999999


Q ss_pred             eeeccccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 014034          227 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  305 (432)
Q Consensus       227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  305 (432)
                      +||+|||+++....     ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.............
T Consensus       157 ~kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  231 (343)
T cd07878         157 LRILDFGLARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEV  231 (343)
T ss_pred             EEEcCCccceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence            99999999975321     1234578999999999876 57889999999999999999999999765432221111000


Q ss_pred             hhcccCcccccccc-------CccccCcC-------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          306 QQYPADSKKFGLIM-------DPRLEKEY-------SINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       306 ~~~~~~~~~~~~~~-------~~~l~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ...+.. .....+.       ...+....       .......+.+|+.+||..||.+|||+.+++.+
T Consensus       232 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         232 VGTPSP-EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             hCCCCH-HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000 0000000       00000000       00112357799999999999999999999987

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.5e-39  Score=307.70  Aligned_cols=247  Identities=26%  Similarity=0.425  Sum_probs=195.1

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCccceeeeEEeecCCcce
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~  156 (432)
                      |++.+.||.|+||.||+|...       .++..+++|.+....    ..+.+|+++++.++||||+++++++...+    
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~----   75 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNK-------ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN----   75 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEEC-------CCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC----
Confidence            677888999999999999865       457789999986532    24778999999999999999999987654    


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      ..++||||+.+++|..++.... .++++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++.
T Consensus        76 ~~~~v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~  151 (282)
T cd06643          76 NLWILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSA  151 (282)
T ss_pred             EEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccc
Confidence            4599999999999999876533 4789999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCccCccccc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIE-----TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ....  .........++..|+|||++.     +..++.++|||||||++|+|++|..||....+..  .........+. 
T Consensus       152 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~~~~~~~-  226 (282)
T cd06643         152 KNTR--TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLLKIAKSEPP-  226 (282)
T ss_pred             cccc--cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHHHHhhcCCC-
Confidence            5321  112223456899999999983     4567889999999999999999999997654322  11111111100 


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                .+  ..+...+..+.++|.+||+.||.+||++.+++++
T Consensus       227 ----------~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         227 ----------TL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             ----------CC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      00  0112234578899999999999999999998866

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=7.3e-40  Score=309.78  Aligned_cols=262  Identities=28%  Similarity=0.363  Sum_probs=203.1

Q ss_pred             CHHHHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh---HHHHHHHHHhccc-CCCccceee
Q 014034           70 SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQWVAEVQFLGVL-EHPNLVKLI  145 (432)
Q Consensus        70 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~hpniv~l~  145 (432)
                      +..++....+.|+..+.||.|+||.||+|...       ..+..+|+|.+....   ..+..|+.++..+ +||||++++
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~   79 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHV-------KTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYY   79 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEc-------CCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEe
Confidence            34455556778999999999999999999875       456789999886543   3467888988888 799999999


Q ss_pred             eEEeecC--CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC
Q 014034          146 GYCAVDG--ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  223 (432)
Q Consensus       146 ~~~~~~~--~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~  223 (432)
                      +++....  ......+++|||+.+|+|.+++.......+++..+..++.||+.||.|||+.   +|+|+||||+||+++.
T Consensus        80 ~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~  156 (282)
T cd06636          80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTE  156 (282)
T ss_pred             eehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECC
Confidence            9886432  1234569999999999999999765555688999999999999999999998   9999999999999999


Q ss_pred             CCceeeccccCCcCCCCCCCcccccccccCCCccCccccc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhh
Q 014034          224 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE-----TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE  298 (432)
Q Consensus       224 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~  298 (432)
                      ++.++|+|||++.....  .........|++.|+|||.+.     ...++.++|||||||++|+|++|..||....+...
T Consensus       157 ~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~  234 (282)
T cd06636         157 NAEVKLVDFGVSAQLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA  234 (282)
T ss_pred             CCCEEEeeCcchhhhhc--cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh
Confidence            99999999999874321  111223456899999999985     34678899999999999999999999975443221


Q ss_pred             HHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          299 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ...   ....          ..+.+   .....+..+.+||.+||+.||.+|||+.+|+++
T Consensus       235 ~~~---~~~~----------~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         235 LFL---IPRN----------PPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             hhh---HhhC----------CCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            111   0000          00000   011234578899999999999999999999764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-39  Score=301.49  Aligned_cols=249  Identities=33%  Similarity=0.517  Sum_probs=199.3

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCCcceeEE
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  159 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~  159 (432)
                      +.||+|+||.||+|......    ..+..|++|.+....     ..+.+|+.++..++|+||+++++++....    ..+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~----~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~~   72 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD----GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEE----PLY   72 (262)
T ss_pred             CccccCCceEEEEEEEecCC----CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCC----ceE
Confidence            36999999999999976211    337889999987542     35788999999999999999999987633    459


Q ss_pred             EEEeecCCCCHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          160 LVYEFMLNRSLEDHLFNRA-------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       160 lv~e~~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                      +||||+++++|.+++....       ...+++..++.++.|++.||.|||++   +++|+||||+||+++.++.++|+||
T Consensus        73 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~df  149 (262)
T cd00192          73 LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDF  149 (262)
T ss_pred             EEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccc
Confidence            9999999999999997642       35789999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      |.+................++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   +...+....  
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~~~--  224 (262)
T cd00192         150 GLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEYLRKGY--  224 (262)
T ss_pred             ccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCC--
Confidence            99986433222222344567889999999988889999999999999999999 699998764322   222222100  


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                                  ....+...+..+.+++.+||..+|.+|||+.+++++|+
T Consensus       225 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 ------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                        00112223567889999999999999999999998873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.2e-39  Score=299.78  Aligned_cols=242  Identities=29%  Similarity=0.478  Sum_probs=191.6

Q ss_pred             ccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCCcceeEEE
Q 014034           86 KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLL  160 (432)
Q Consensus        86 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~l  160 (432)
                      .||+|+||.||+|...        ++..+|+|.+....     ..+.+|+.+++.++||||+++++++...+.    .++
T Consensus         2 ~ig~g~~g~vy~~~~~--------~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~l   69 (250)
T cd05085           2 LLGKGNFGEVFKGTLK--------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQP----IYI   69 (250)
T ss_pred             ccCCCCCceEEEEEec--------CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCc----cEE
Confidence            6899999999999753        46789999876532     247789999999999999999999876553    499


Q ss_pred             EEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCCC
Q 014034          161 VYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM  240 (432)
Q Consensus       161 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~  240 (432)
                      ||||+++++|.+++.... ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        70 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  145 (250)
T cd05085          70 VMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDD  145 (250)
T ss_pred             EEECCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccc
Confidence            999999999999986543 3688999999999999999999998   999999999999999999999999999864221


Q ss_pred             CCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcccccccc
Q 014034          241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM  319 (432)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (432)
                      . .........++..|+|||++.+..++.++||||||+++|++++ |..||.........   ..+....          
T Consensus       146 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~---~~~~~~~----------  211 (250)
T cd05085         146 G-IYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR---EQVEKGY----------  211 (250)
T ss_pred             c-ccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH---HHHHcCC----------
Confidence            1 1111112234668999999998889999999999999999998 99999765433221   1111110          


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          320 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       320 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                      ..    ..+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       212 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         212 RM----SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            00    111223467889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=8.9e-40  Score=309.73  Aligned_cols=263  Identities=27%  Similarity=0.387  Sum_probs=202.2

Q ss_pred             HHHHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---hHHHHHHHHHhccc-CCCccceeee
Q 014034           71 YSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQWVAEVQFLGVL-EHPNLVKLIG  146 (432)
Q Consensus        71 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~hpniv~l~~  146 (432)
                      ++.+....++|++.+.||+|+||.||++...       ..+..+|+|.+...   ...+.+|+.+++.+ +||||+++++
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~   82 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNK-------KNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYG   82 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEEC-------CCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeee
Confidence            4445566789999999999999999999865       45678999987642   23577899999999 6999999999


Q ss_pred             EEeecC-CcceeEEEEEeecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC
Q 014034          147 YCAVDG-ERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  223 (432)
Q Consensus       147 ~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~  223 (432)
                      ++.... ..+...++||||+++++|.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||+||+++.
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~  159 (286)
T cd06638          83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTT  159 (286)
T ss_pred             eeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECC
Confidence            876432 2234579999999999999987532  234688999999999999999999998   9999999999999999


Q ss_pred             CCceeeccccCCcCCCCCCCcccccccccCCCccCcccccc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhh
Q 014034          224 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-----GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE  298 (432)
Q Consensus       224 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~  298 (432)
                      ++.++|+|||++......  ........|++.|+|||++..     ..++.++|||||||++|+|++|..||....+...
T Consensus       160 ~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~  237 (286)
T cd06638         160 EGGVKLVDFGVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA  237 (286)
T ss_pred             CCCEEEccCCceeecccC--CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH
Confidence            999999999998753221  112234568999999999853     4578899999999999999999999976543211


Q ss_pred             HHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          299 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                        +... ....          .+.+  ..+...+..+.+|+.+||+.||++|||+.+|++++
T Consensus       238 --~~~~-~~~~----------~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         238 --LFKI-PRNP----------PPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             --Hhhc-cccC----------CCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence              1110 0000          0000  01111235688999999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.2e-40  Score=318.10  Aligned_cols=235  Identities=28%  Similarity=0.397  Sum_probs=185.0

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHH-HhcccCCCccceeeeEEeecCCcce
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQ-FLGVLEHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~~  156 (432)
                      +.||+|+||.||+|...       .++..||+|.+.+..       ..+..|.. +++.++||||+++++++...+    
T Consensus         1 ~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~----   69 (325)
T cd05604           1 KVIGKGSFGKVLLAKRK-------LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE----   69 (325)
T ss_pred             CceeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC----
Confidence            36999999999999865       467899999986431       12444544 467899999999999887654    


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      ..++||||+.+|+|..++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        70 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~  144 (325)
T cd05604          70 KLYFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCK  144 (325)
T ss_pred             EEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcc
Confidence            459999999999999988654  3689999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  316 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (432)
                      ....  .........||+.|+|||++.+..++.++|||||||++|+|++|..||.......   +...+.....      
T Consensus       145 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~~~~~~~------  213 (325)
T cd05604         145 EGIA--QSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---MYDNILHKPL------  213 (325)
T ss_pred             cCCC--CCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---HHHHHHcCCc------
Confidence            4211  1222344679999999999999999999999999999999999999998654322   1111111000      


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 014034          317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ  355 (432)
Q Consensus       317 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  355 (432)
                       ...        ...+..+.+++.+||..+|.+||++.+
T Consensus       214 -~~~--------~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         214 -VLR--------PGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             -cCC--------CCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence             011        112356779999999999999998863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.8e-39  Score=302.22  Aligned_cols=251  Identities=26%  Similarity=0.405  Sum_probs=199.8

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh---HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      .++|.+.+.||+|+||.||++...        .+..+|+|.+....   ..+.+|+.+++.++|+||+++++++.. .  
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~--------~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~--   73 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN--------KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E--   73 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec--------CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-C--
Confidence            357899999999999999999754        34569999886543   347889999999999999999998765 2  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        ..+++|||+++++|.+++.......+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+
T Consensus        74 --~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~  148 (260)
T cd05073          74 --PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGL  148 (260)
T ss_pred             --CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcc
Confidence              348999999999999999775556789999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      +....... ........++..|+|||++.+..++.++|+|||||++|++++ |..||.......   ...++.....   
T Consensus       149 ~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~~~~---  221 (260)
T cd05073         149 ARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALERGYR---  221 (260)
T ss_pred             eeeccCCC-cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHhCCCC---
Confidence            87532211 111122345678999999998889999999999999999999 999997654322   2222111100   


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  362 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  362 (432)
                       .          ..+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       222 -~----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         222 -M----------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             -C----------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             0          0112234568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6e-40  Score=344.45  Aligned_cols=256  Identities=25%  Similarity=0.405  Sum_probs=198.4

Q ss_pred             HHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEE
Q 014034           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYC  148 (432)
Q Consensus        75 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~  148 (432)
                      ....++|.+++.||+|+||.||+|.+.       ..+..||+|.+...      ...+..|+.++..|+|||||+++++|
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk-------~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f   81 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHK-------RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRF   81 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEEC-------CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence            344568999999999999999999875       46788999987632      23478899999999999999999988


Q ss_pred             eecCCcceeEEEEEeecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCC----CceeecCCCCCceEEc
Q 014034          149 AVDGERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLE----VQVIYRDFKASNVLLD  222 (432)
Q Consensus       149 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~l~~~l~~LH~~~~----~~ivH~Dikp~Nill~  222 (432)
                      ......  .++|||||+.+++|.++|...  ....+++..++.|+.||+.||.|||+...    .+|+||||||+||||+
T Consensus        82 ~de~~~--~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~  159 (1021)
T PTZ00266         82 LNKANQ--KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS  159 (1021)
T ss_pred             EecCCC--EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence            764432  468999999999999998652  23469999999999999999999998421    2599999999999996


Q ss_pred             C-----------------CCceeeccccCCcCCCCCCCcccccccccCCCccCcccccc--CCCCchhhhHHHHHHHHHH
Q 014034          223 E-----------------NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET--GHLTAKSDVWSFGVVLYEM  283 (432)
Q Consensus       223 ~-----------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~el  283 (432)
                      .                 .+.+||+|||++.....   ........||+.|+|||++.+  ..++.++||||||||||+|
T Consensus       160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYEL  236 (1021)
T PTZ00266        160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL  236 (1021)
T ss_pred             cCccccccccccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHH
Confidence            4                 34589999999975321   112234579999999999854  4588999999999999999


Q ss_pred             HhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          284 LTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       284 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      +||..||.......  .+...+...+.            +.   ....+..+.+||..||..+|.+||++.+++.+
T Consensus       237 LTGk~PF~~~~~~~--qli~~lk~~p~------------lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        237 CSGKTPFHKANNFS--QLISELKRGPD------------LP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             HHCCCCCCcCCcHH--HHHHHHhcCCC------------CC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            99999997544322  12221111110            00   01123568899999999999999999999854

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.2e-39  Score=301.73  Aligned_cols=250  Identities=28%  Similarity=0.429  Sum_probs=201.4

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh--HHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      .++|+..+.||.|+||.||+|.+.       .++..+++|.+....  ..+.+|+.+++.++||||+++++++....   
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~---   71 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHK-------ETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNT---   71 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEc-------CCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC---
Confidence            367999999999999999999875       346889999987543  45889999999999999999999987654   


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCC
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  235 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a  235 (432)
                       ..++++||+.+++|.+++.... ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        72 -~~~l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~  146 (256)
T cd06612          72 -DLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVS  146 (256)
T ss_pred             -cEEEEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccc
Confidence             4599999999999999986533 4789999999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccc
Q 014034          236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF  315 (432)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  315 (432)
                      ......  ........|+..|+|||++.+..++.++||||||+++|+|++|..||....+......   ....       
T Consensus       147 ~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~---~~~~-------  214 (256)
T cd06612         147 GQLTDT--MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM---IPNK-------  214 (256)
T ss_pred             hhcccC--ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh---hccC-------
Confidence            753221  1122345588999999999988999999999999999999999999976543221100   0000       


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       316 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                         ..+.+  ..+...+..+.+++.+||+.||.+|||+.+++.+
T Consensus       215 ---~~~~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         215 ---PPPTL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             ---CCCCC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence               00000  1122334678899999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.7e-39  Score=307.56  Aligned_cols=249  Identities=27%  Similarity=0.420  Sum_probs=196.7

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH----HHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL----QWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      +.|++++.||.|+||.||+|...       .++..|++|.+.....    .+.+|+.+++.++||||+++++.+..++  
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   82 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNK-------ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG--   82 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEEC-------CCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC--
Confidence            56999999999999999999865       4578899999865432    3778999999999999999999987655  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        ..++||||+++++|..++.+.. ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||+
T Consensus        83 --~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~  156 (292)
T cd06644          83 --KLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGV  156 (292)
T ss_pred             --eEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCcc
Confidence              3599999999999988876533 4689999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIE-----TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      +....  ..........+++.|+|||++.     ...++.++|||||||++|+|++|..||.......  ..........
T Consensus       157 ~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~~  232 (292)
T cd06644         157 SAKNV--KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKIAKSEP  232 (292)
T ss_pred             ceecc--ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--HHHHHhcCCC
Confidence            86421  1112223456889999999984     3456789999999999999999999997654321  1111111100


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                 +.+  ..+...+..+.+++.+||..+|++||++.+++++
T Consensus       233 -----------~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         233 -----------PTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             -----------ccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                       000  1112234568899999999999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.5e-39  Score=307.99  Aligned_cols=263  Identities=24%  Similarity=0.344  Sum_probs=194.6

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      +|...+.||+|+||.||+|+..       .++..||+|.+...      ...+.+|+.+++.++||||+++++++..++ 
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   72 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNK-------KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQES-   72 (285)
T ss_pred             CceEeeEecccCceEEEEEEEC-------CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC-
Confidence            4788899999999999999865       45788999987542      234788999999999999999999987654 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                         ..++||||+. ++|.+++.... ...+++..+..++.||+.||.|||+.   +|+|+||||+|||++.++.++|+||
T Consensus        73 ---~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  145 (285)
T cd07861          73 ---RLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADF  145 (285)
T ss_pred             ---eEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcc
Confidence               4599999996 68888886533 25689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHHHhhccc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR-LLEWVQQYPA  310 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~~~~~~  310 (432)
                      |++......  ........+++.|+|||++.+ ..++.++|||||||++|+|+||+.||.+........ ..........
T Consensus       146 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~  223 (285)
T cd07861         146 GLARAFGIP--VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTE  223 (285)
T ss_pred             cceeecCCC--cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            998743211  112223457889999998865 457889999999999999999999998654322111 1111100000


Q ss_pred             Cc-------cccccccCcccc---CcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          311 DS-------KKFGLIMDPRLE---KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       311 ~~-------~~~~~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ..       ..+.........   .......+..+.++|.+||+.||.+|||+.+|+.+
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         224 DVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            00       000000000000   00011234567899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.7e-40  Score=305.03  Aligned_cols=242  Identities=22%  Similarity=0.375  Sum_probs=188.5

Q ss_pred             ccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCccceeeeEEeecCCcceeEEEE
Q 014034           86 KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLV  161 (432)
Q Consensus        86 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~lv  161 (432)
                      .||.|+||.||+|........+......|++|.+....    ..+..|+.+++.++||||+++++++.....    .++|
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~----~~lv   77 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDE----SIMV   77 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCC----cEEE
Confidence            69999999999998763332223456679999886543    247789999999999999999999987554    3899


Q ss_pred             EeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCc--------eeecccc
Q 014034          162 YEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR--------PKLSDFG  233 (432)
Q Consensus       162 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~--------~kl~DfG  233 (432)
                      |||+.+|+|.+++.... ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.        ++++|||
T Consensus        78 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          78 QEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             EecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence            99999999999997654 3689999999999999999999998   9999999999999987665        6999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCC-CCCCCCCchhhHHHHHHHhhcccC
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGR-RSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ++....      ......++..|+|||++.+ ..++.++||||||+++|+|++|. .||....+........   ..   
T Consensus       154 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~---~~---  221 (258)
T cd05078         154 ISITVL------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE---DR---  221 (258)
T ss_pred             cccccC------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH---cc---
Confidence            986421      1223568889999999976 45789999999999999999984 6665443322111110   00   


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                               .    ..+......+.+|+.+||+.||++|||+.+|++.|
T Consensus       222 ---------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         222 ---------H----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             ---------c----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                     0    01111235688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.5e-39  Score=304.86  Aligned_cols=257  Identities=24%  Similarity=0.407  Sum_probs=200.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      .+|+....||.|+||.||+|+.+...  .......|++|.+....     ..+.+|+.++++++||||+++++++...+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   82 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIE--EEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP   82 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCC--cCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence            47889999999999999999976432  22456789999886532     348889999999999999999998866543


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCC-------CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAF-------PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR  226 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~  226 (432)
                          .++||||+++++|.+++.....       ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.
T Consensus        83 ----~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~  155 (275)
T cd05046          83 ----HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQRE  155 (275)
T ss_pred             ----ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCc
Confidence                4999999999999999975431       2589999999999999999999998   9999999999999999999


Q ss_pred             eeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHH
Q 014034          227 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWV  305 (432)
Q Consensus       227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~  305 (432)
                      ++|+|||++...... .........++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   .....
T Consensus       156 ~~l~~~~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~  231 (275)
T cd05046         156 VKVSLLSLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRL  231 (275)
T ss_pred             EEEcccccccccCcc-cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHH
Confidence            999999998643211 1112223456778999999988888999999999999999999 888986543322   22211


Q ss_pred             hhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          306 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                      ......             ...+...+..+.+++.+||+.+|.+|||+.+++..|.
T Consensus       232 ~~~~~~-------------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         232 QAGKLE-------------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HcCCcC-------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            110000             0011123457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=8.7e-40  Score=306.69  Aligned_cols=250  Identities=24%  Similarity=0.380  Sum_probs=195.8

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      ++|...+.||+|+||.||+|...       .++..||+|.++...    ..+.+|+.+++.++||||+++++.+...+  
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~--   79 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNV-------NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD--   79 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEc-------CCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--
Confidence            47888999999999999999865       457889999876432    23678999999999999999999987654  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        ..++||||+++++|.+++....  .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+
T Consensus        80 --~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~  152 (267)
T cd06645          80 --KLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGV  152 (267)
T ss_pred             --EEEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccee
Confidence              3599999999999999986543  689999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      +.....  .........|+..|+|||++.   ...++.++|||||||++|+|++|..||....+........  ...   
T Consensus       153 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~--~~~---  225 (267)
T cd06645         153 SAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT--KSN---  225 (267)
T ss_pred             eeEccC--cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh--ccC---
Confidence            865321  112223457899999999974   4568899999999999999999999986544322111100  000   


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                            ...+.+..  ....+..+.+++.+||..+|++|||+.+|+++
T Consensus       226 ------~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         226 ------FQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             ------CCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence                  00010100  01123567899999999999999999998864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.8e-39  Score=314.00  Aligned_cols=261  Identities=20%  Similarity=0.315  Sum_probs=192.8

Q ss_pred             cccccccC--CceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           83 RMLKIGEG--GFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        83 ~~~~lg~G--~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      ++..||+|  +||+||++..+       .++..||+|.+....      ..+.+|+.+++.++||||+++++++..++. 
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~-   73 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYK-------PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE-   73 (327)
T ss_pred             hhhhccccccceEEEEEEeec-------ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCE-
Confidence            45679999  78999999865       578899999987532      236779999999999999999999987653 


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                         .++||||+++++|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++++||+.
T Consensus        74 ---~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~  147 (327)
T cd08227          74 ---LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRS  147 (327)
T ss_pred             ---EEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccch
Confidence               59999999999999999765445689999999999999999999998   999999999999999999999999987


Q ss_pred             CcCCCCCCCc-----ccccccccCCCccCcccccc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 014034          235 AREGPMVGHT-----HVSTAVVGTFGYAAPDYIET--GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  307 (432)
Q Consensus       235 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  307 (432)
                      .......+..     .......++..|+|||++.+  ..++.++|||||||++|+|++|..||.......  ........
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~  225 (327)
T cd08227         148 NLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNG  225 (327)
T ss_pred             hhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhcC
Confidence            5432111110     01122356788999999975  468999999999999999999999997543211  11111110


Q ss_pred             -cccC-------cccc-------------c--cccC-------ccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 014034          308 -YPAD-------SKKF-------------G--LIMD-------PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV  357 (432)
Q Consensus       308 -~~~~-------~~~~-------------~--~~~~-------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil  357 (432)
                       .+..       ...+             .  ....       ...........+..+.+|+.+||+.||++|||+.+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell  305 (327)
T cd08227         226 TVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLL  305 (327)
T ss_pred             CccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHh
Confidence             0000       0000             0  0000       0000011122345788999999999999999999998


Q ss_pred             HH
Q 014034          358 ER  359 (432)
Q Consensus       358 ~~  359 (432)
                      ++
T Consensus       306 ~~  307 (327)
T cd08227         306 NH  307 (327)
T ss_pred             cC
Confidence            76

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.5e-39  Score=303.20  Aligned_cols=256  Identities=25%  Similarity=0.368  Sum_probs=200.4

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|.+.+.||+|+||.||+|.+....    .....|++|......     ..+.+|+.+++.++||||+++++++...  
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--   79 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPE----NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN--   79 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCC----CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC--
Confidence            45888899999999999999875221    234579999876532     2478899999999999999999988643  


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.   +++||||||+|||++.++.++|+|||
T Consensus        80 ---~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g  152 (270)
T cd05056          80 ---PVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFG  152 (270)
T ss_pred             ---CcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCc
Confidence               2389999999999999996543 3589999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      +++...... ........++..|+|||.+.+..++.++||||||+++|++++ |..||........   ...+....   
T Consensus       153 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~~~~~~---  225 (270)
T cd05056         153 LSRYLEDES-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGRIENGE---  225 (270)
T ss_pred             eeeeccccc-ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHcCC---
Confidence            987532211 111122234568999999988889999999999999999986 9999976543322   11111100   


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                             ...    .+...+..+.+++.+||..+|.+|||+.++++.|+++..
T Consensus       226 -------~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         226 -------RLP----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             -------cCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                   000    112234578899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.3e-39  Score=311.53  Aligned_cols=265  Identities=24%  Similarity=0.355  Sum_probs=188.6

Q ss_pred             ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh--HHHHHHHHHhcccCCCccceeeeEEeecCCcceeEEEE
Q 014034           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLV  161 (432)
Q Consensus        84 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~lv  161 (432)
                      ..+||+|+||.||+|...     +...+..||+|.+....  ..+.+|+.+++.++||||+++++++......  ..++|
T Consensus         6 g~~lG~G~~g~Vy~~~~~-----~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--~~~lv   78 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRK-----DGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDR--KVWLL   78 (317)
T ss_pred             ceEeccCCCeeEEEEEec-----CCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCC--eEEEE
Confidence            357999999999999865     22356889999987543  3578899999999999999999988654332  46899


Q ss_pred             EeecCCCCHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEE----cCCCceeec
Q 014034          162 YEFMLNRSLEDHLFNR-------AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL----DENFRPKLS  230 (432)
Q Consensus       162 ~e~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill----~~~~~~kl~  230 (432)
                      |||+. ++|.+++...       ....+++..+..++.||+.||.|||+.   +|+||||||+|||+    +.++.+||+
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~  154 (317)
T cd07867          79 FDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA  154 (317)
T ss_pred             EeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEe
Confidence            99985 5777776421       123588999999999999999999998   99999999999999    567799999


Q ss_pred             cccCCcCCCCCCC-cccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchh-------hHHH
Q 014034          231 DFGLAREGPMVGH-THVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT-------EQRL  301 (432)
Q Consensus       231 DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~-------~~~~  301 (432)
                      |||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||+||..||.......       ...+
T Consensus       155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~  234 (317)
T cd07867         155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQL  234 (317)
T ss_pred             eccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHH
Confidence            9999975322111 112234578999999999876 457899999999999999999999997543211       0111


Q ss_pred             HHHHhhcccCc-----------------ccccc--ccCcccc---CcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          302 LEWVQQYPADS-----------------KKFGL--IMDPRLE---KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       302 ~~~~~~~~~~~-----------------~~~~~--~~~~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ...........                 ..+..  .....+.   ..........+.+|+.+||..||.+|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h  314 (317)
T cd07867         235 DRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD  314 (317)
T ss_pred             HHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence            11111100000                 00000  0000000   00011123457889999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.3e-39  Score=307.81  Aligned_cols=264  Identities=28%  Similarity=0.400  Sum_probs=204.6

Q ss_pred             cCHHHHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---hHHHHHHHHHhccc-CCCcccee
Q 014034           69 FSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQWVAEVQFLGVL-EHPNLVKL  144 (432)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~hpniv~l  144 (432)
                      +.+.++..++++|.....||+|+||.||++...       .+++.+|+|.+...   ...+.+|+.++.++ +|||++++
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~-------~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~   84 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNK-------KDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKF   84 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEEC-------CCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEE
Confidence            455666677889999999999999999999865       46788999998643   23567899999988 89999999


Q ss_pred             eeEEeecCC-cceeEEEEEeecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEE
Q 014034          145 IGYCAVDGE-RGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL  221 (432)
Q Consensus       145 ~~~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill  221 (432)
                      ++++...+. .....++||||+.+++|.+++...  ....+++..++.++.|++.||.|||+.   +++|+||||+||++
T Consensus        85 ~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili  161 (291)
T cd06639          85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILL  161 (291)
T ss_pred             EEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEE
Confidence            999876432 223569999999999999988532  234689999999999999999999998   99999999999999


Q ss_pred             cCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccC-----CCCchhhhHHHHHHHHHHHhCCCCCCCCCch
Q 014034          222 DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-----HLTAKSDVWSFGVVLYEMLTGRRSLERNRPK  296 (432)
Q Consensus       222 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltg~~pf~~~~~~  296 (432)
                      +.++.+||+|||++......  ........|+..|+|||.+...     .++.++|||||||++|+|++|..||....+.
T Consensus       162 ~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~  239 (291)
T cd06639         162 TTEGGVKLVDFGVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV  239 (291)
T ss_pred             cCCCCEEEeecccchhcccc--cccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH
Confidence            99999999999998753211  1122335688999999998543     3678999999999999999999999765432


Q ss_pred             hhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          297 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ..  +..+.....           +.+  ..+......+.+||.+||+.+|++||++.+|+++
T Consensus       240 ~~--~~~~~~~~~-----------~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         240 KT--LFKIPRNPP-----------PTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HH--HHHHhcCCC-----------CCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            11  111111100           000  0111223568899999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.9e-39  Score=302.25  Aligned_cols=250  Identities=24%  Similarity=0.378  Sum_probs=194.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---------hHHHHHHHHHhcccCCCccceeeeEEe
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---------GLQWVAEVQFLGVLEHPNLVKLIGYCA  149 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~hpniv~l~~~~~  149 (432)
                      .+|...+.||+|+||.||+|...       .++..|++|.+...         ...+.+|+.+++.++||||+++++++.
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   74 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDV-------DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLR   74 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEc-------CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEE
Confidence            47899999999999999999864       45788999987532         123778999999999999999999886


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      ....  ...+++|||+++++|.+++....  .+++...+.++.|++.||.|||+.   +|+||||||+||+++.++.++|
T Consensus        75 ~~~~--~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l  147 (266)
T cd06651          75 DRAE--KTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKL  147 (266)
T ss_pred             cCCC--CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEE
Confidence            5432  24589999999999999996543  588999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCC-cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          230 SDFGLAREGPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       230 ~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      +|||++........ ........++..|+|||.+.+..++.++|||||||++|+|++|..||........  +.. ....
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~--~~~-~~~~  224 (266)
T cd06651         148 GDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA--IFK-IATQ  224 (266)
T ss_pred             ccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH--HHH-HhcC
Confidence            99999875321111 1111234588999999999988899999999999999999999999976533211  111 1110


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .         ..+    ..+......+.+++ +||..+|++||++.+|+.+
T Consensus       225 ~---------~~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         225 P---------TNP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             C---------CCC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            0         011    12223345667777 6888999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2e-39  Score=304.42  Aligned_cols=252  Identities=31%  Similarity=0.488  Sum_probs=195.4

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCCcceeEE
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  159 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~  159 (432)
                      +.||+|+||.||+|++..... ....+..+|+|.+...     ...+.+|+.+++.++||||+++++++.....    .+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~-~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILG-PGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEP----QY   75 (269)
T ss_pred             CccccccceeEEeeeeccccc-CcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCC----eE
Confidence            359999999999998753221 1234578999987643     2347889999999999999999999876543    49


Q ss_pred             EEEeecCCCCHHHHhhcC-----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC-----ceee
Q 014034          160 LVYEFMLNRSLEDHLFNR-----AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF-----RPKL  229 (432)
Q Consensus       160 lv~e~~~~gsL~~~l~~~-----~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-----~~kl  229 (432)
                      +||||+++++|.+++...     ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++     .++|
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l  152 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKI  152 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEE
Confidence            999999999999999653     223478899999999999999999998   999999999999999877     8999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhc
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      +|||++................++..|+|||.+.++.++.++|||||||++|+|++ |..||.......   ....+...
T Consensus       153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~~~~  229 (269)
T cd05044         153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHVTAG  229 (269)
T ss_pred             CCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHHhcC
Confidence            99999875322222222233456788999999999999999999999999999998 999997554322   22211110


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                          .          ....+...+..+.+++.+||..+|.+||++.+|++.|+
T Consensus       230 ----~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         230 ----G----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ----C----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                0          00112233567889999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.9e-39  Score=309.45  Aligned_cols=247  Identities=25%  Similarity=0.396  Sum_probs=199.1

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC----hHHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      .+|+..+.||.|+||.||+|...       .++..|++|.+...    ...+.+|+.+++.++||||+++++++....  
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--   89 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDV-------ATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD--   89 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEc-------CCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc--
Confidence            46999999999999999999854       46788999987543    234788999999999999999999987644  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        ..++|+||+.+++|..++...   .+++.++..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||+
T Consensus        90 --~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~  161 (296)
T cd06655          90 --ELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGF  161 (296)
T ss_pred             --eEEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCcc
Confidence              459999999999999988543   589999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      +......  ........++..|+|||.+.+..++.++|||||||++|+|++|..||....+.......   .....    
T Consensus       162 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~---~~~~~----  232 (296)
T cd06655         162 CAQITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGT----  232 (296)
T ss_pred             chhcccc--cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhcCC----
Confidence            8753221  11223456889999999999888999999999999999999999999876543322111   11000    


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                            +.+  ..+...+..+.++|.+||..||.+||++.+|+++
T Consensus       233 ------~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         233 ------PEL--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             ------ccc--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                  000  0112234568899999999999999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=315.85  Aligned_cols=252  Identities=24%  Similarity=0.313  Sum_probs=192.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|++.+.||+|+||.||++...       .++..||+|.+.+.       ...+.+|..++..++||||+++++++...
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   73 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMK-------NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE   73 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEEC-------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC
Confidence            47899999999999999999875       45788999998642       12377899999999999999999988765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ..++||||+.+|+|.+++.... ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        74 ~----~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~D  145 (331)
T cd05597          74 N----NLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLAD  145 (331)
T ss_pred             C----eEEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEE
Confidence            4    4599999999999999996532 3689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCcccccc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-----GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  306 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  306 (432)
                      ||++....... ........||+.|+|||++.+     ..++.++|||||||++|+|++|..||.........   ..+.
T Consensus       146 fg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~---~~i~  221 (331)
T cd05597         146 FGSCLRLLADG-TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY---GKIM  221 (331)
T ss_pred             CCceeecCCCC-CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH---HHHH
Confidence            99986532111 112233569999999999863     45788999999999999999999999765432211   1111


Q ss_pred             hcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCC--CCCCHHHHHHH
Q 014034          307 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSK--DRPKMSQVVER  359 (432)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~eil~~  359 (432)
                      ....   .+.  +.+     .....+..+.+++.+|+..++.  .||++.+++++
T Consensus       222 ~~~~---~~~--~~~-----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         222 NHKE---HFQ--FPP-----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             cCCC---ccc--CCC-----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            1000   000  000     0111345678899998865443  37899999887

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-39  Score=304.26  Aligned_cols=246  Identities=30%  Similarity=0.421  Sum_probs=199.4

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|+..+.||.|+||.||+|...       .++..||+|.+....     ..+.+|+.+++.++||||+++++++..+. 
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   72 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDK-------RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS-   72 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEEC-------CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC-
Confidence            36888999999999999999865       467899999986432     24788999999999999999999987653 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++|+||+.+++|.+++...   ++++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||
T Consensus        73 ---~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g  143 (274)
T cd06609          73 ---KLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFG  143 (274)
T ss_pred             ---eEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccc
Confidence               459999999999999998653   689999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      ++......  ........++..|+|||.+.+..++.++||||||+++|+|+||..||....+...   ...+...     
T Consensus       144 ~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~---~~~~~~~-----  213 (274)
T cd06609         144 VSGQLTST--MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---LFLIPKN-----  213 (274)
T ss_pred             cceeeccc--ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH---HHHhhhc-----
Confidence            99764221  1223345788899999999988899999999999999999999999976543221   1111110     


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                           ..+.+...   ..+..+.+++.+||..+|++|||+.+++++
T Consensus       214 -----~~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         214 -----NPPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             -----CCCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                 01111111   134568899999999999999999999876

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-39  Score=304.39  Aligned_cols=256  Identities=31%  Similarity=0.421  Sum_probs=201.5

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh---HHHHHHHHHhccc-CCCccceeeeEEeecC
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQWVAEVQFLGVL-EHPNLVKLIGYCAVDG  152 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  152 (432)
                      .+++|++.+.||.|+||.||+|...       .++..+++|.+....   ..+.+|+.+++++ +||||+++++++....
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHK-------KTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKN   76 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEEC-------CCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence            4678999999999999999999865       356789999986543   3578899999998 7999999999997655


Q ss_pred             C--cceeEEEEEeecCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCcee
Q 014034          153 E--RGIQRLLVYEFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  228 (432)
Q Consensus       153 ~--~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k  228 (432)
                      .  .+...++||||+.+++|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++
T Consensus        77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~  153 (275)
T cd06608          77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVK  153 (275)
T ss_pred             CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEE
Confidence            2  3456799999999999999886533  45789999999999999999999998   999999999999999999999


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCcccccc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-----GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE  303 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~  303 (432)
                      |+|||++.....  .........|+..|+|||++..     ..++.++|||||||++|+|++|..||.......  ....
T Consensus       154 l~d~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~  229 (275)
T cd06608         154 LVDFGVSAQLDS--TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--ALFK  229 (275)
T ss_pred             ECCCccceeccc--chhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--HHHH
Confidence            999999865321  1222344568999999998753     346788999999999999999999997543321  1111


Q ss_pred             HHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          304 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ......           +.+  ..+...+..+.+|+.+||..||++|||+.+++++
T Consensus       230 ~~~~~~-----------~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         230 IPRNPP-----------PTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             hhccCC-----------CCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            111100           000  1122245678899999999999999999999864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6e-39  Score=301.87  Aligned_cols=259  Identities=25%  Similarity=0.413  Sum_probs=199.0

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      |.+.+.||+|+||.||+|.+..    ...++..||||.+..+      ...+.+|+.+++.++||||+++++++......
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   76 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKS----EDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAK   76 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeec----cCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCC
Confidence            5667889999999999998752    2245789999988653      12477899999999999999999988654322


Q ss_pred             c--eeEEEEEeecCCCCHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCcee
Q 014034          155 G--IQRLLVYEFMLNRSLEDHLFNRA----FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  228 (432)
Q Consensus       155 ~--~~~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k  228 (432)
                      +  ...+++++|+.+|+|.+++....    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        77 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~k  153 (273)
T cd05074          77 GRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVC  153 (273)
T ss_pred             CcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEE
Confidence            1  22468899999999998875321    22578899999999999999999998   999999999999999999999


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhh
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQ  307 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~  307 (432)
                      |+|||+++...............+++.|++||.+.+..++.++|||||||++|+|++ |..||.......   +..++..
T Consensus       154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~~  230 (273)
T cd05074         154 VADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLIK  230 (273)
T ss_pred             ECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHHc
Confidence            999999885422221112223445678999999998889999999999999999999 889987554322   2222211


Q ss_pred             cccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                      ...    .          ..+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       231 ~~~----~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 GNR----L----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCc----C----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            100    0          00112345788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-39  Score=331.10  Aligned_cols=275  Identities=18%  Similarity=0.300  Sum_probs=189.1

Q ss_pred             HhhcCCccccccccCCceEEEEEEecCCCCCCC------------cccEEEEEEecCcC---hHHHHHHHHHhcccCCCc
Q 014034           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGT------------SEATVVAIKKLNRD---GLQWVAEVQFLGVLEHPN  140 (432)
Q Consensus        76 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~------------~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~hpn  140 (432)
                      ...++|++++.||+|+||+||++.++...+...            .....++.|.+...   ...+.+|+.+|+.++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            345789999999999999999987652211100            00111122222221   224788999999999999


Q ss_pred             cceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCC
Q 014034          141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA---FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKAS  217 (432)
Q Consensus       141 iv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~  217 (432)
                      |+++++++...+.    .++|++++ +++|..++....   ........+..++.||+.||.|||++   +|+||||||+
T Consensus       225 Iv~l~~~~~~~~~----~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~  296 (501)
T PHA03210        225 ILKIEEILRSEAN----TYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLE  296 (501)
T ss_pred             cCcEeEEEEECCe----eEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence            9999999977653    48999998 567877775432   11234566788999999999999998   9999999999


Q ss_pred             ceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCC-CCCCCCch
Q 014034          218 NVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRR-SLERNRPK  296 (432)
Q Consensus       218 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~-pf~~~~~~  296 (432)
                      |||++.++.+||+|||+++..... .........||..|+|||++.+..++.++|||||||++|||++|.. |+......
T Consensus       297 NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~  375 (501)
T PHA03210        297 NIFLNCDGKIVLGDFGTAMPFEKE-REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK  375 (501)
T ss_pred             HEEECCCCCEEEEeCCCceecCcc-cccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence            999999999999999999753221 1122234679999999999999999999999999999999999875 44433333


Q ss_pred             hhHHHHHHHhhcccCccccc-------cccC-cccc---CcC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          297 TEQRLLEWVQQYPADSKKFG-------LIMD-PRLE---KEY-----SINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~-------~~~~-~~l~---~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ....+...+.........+.       ..+. ..+.   ...     ....+..+.+++.+||+.||.+|||+.|++.+
T Consensus       376 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            33333333222111110000       0000 0000   000     00123457788999999999999999999876

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-39  Score=300.29  Aligned_cols=251  Identities=26%  Similarity=0.405  Sum_probs=199.7

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC----hHHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      ++|+..+.||.|+||.||+|...       .++..+++|.+...    ...+.+|+.+++.++||||+++++++....  
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--   73 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDI-------ATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD--   73 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEec-------CCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC--
Confidence            57899999999999999999865       35678999987653    235788999999999999999999887654  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        ..+++|||+.+++|.+++.... ..+++..+..++.|++.||.|||+.   +|+|+||+|+||+++.++.++|+|||+
T Consensus        74 --~~~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~  147 (262)
T cd06613          74 --KLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGV  147 (262)
T ss_pred             --EEEEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECcccc
Confidence              4599999999999999886542 4689999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccC---CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETG---HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      +.....  .........++..|+|||.+.+.   .++.++||||||+++|+|++|..||....+......... ..+.  
T Consensus       148 ~~~~~~--~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~-~~~~--  222 (262)
T cd06613         148 SAQLTA--TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK-SNFP--  222 (262)
T ss_pred             chhhhh--hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-ccCC--
Confidence            875321  11122345688899999999776   789999999999999999999999986554322111110 0000  


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                              .+.+  ......+..+.+++.+||..+|.+|||+.+|+.+
T Consensus       223 --------~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         223 --------PPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             --------Cccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                    0000  1123345678899999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.6e-39  Score=299.80  Aligned_cols=248  Identities=23%  Similarity=0.362  Sum_probs=200.0

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      +|+.++.||.|+||.||.+...       .++..+++|.+...      ...+.+|+.++++++|+||+++++++.+.. 
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-   72 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRT-------EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN-   72 (256)
T ss_pred             CceEeeEecccCCceEEEEEEc-------CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC-
Confidence            5888999999999999998854       46788999986542      134788999999999999999999997654 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..+++|||+++++|.+++.......+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||
T Consensus        73 ---~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~  146 (256)
T cd08221          73 ---TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFG  146 (256)
T ss_pred             ---eEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCc
Confidence               459999999999999999776455789999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      ++.......  .......|++.|+|||.+.+..++.++||||||+++|+|++|..||........   ...+...     
T Consensus       147 ~~~~~~~~~--~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~---~~~~~~~-----  216 (256)
T cd08221         147 ISKILGSEY--SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL---VVKIVQG-----  216 (256)
T ss_pred             ceEEccccc--ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHHcC-----
Confidence            987532221  123345689999999999888889999999999999999999999976543221   1111100     


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                              .+. ..+...+..+.+++.+||..+|.+||++.++++++
T Consensus       217 --------~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         217 --------NYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             --------CCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence                    000 01122346788999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.5e-38  Score=298.78  Aligned_cols=251  Identities=20%  Similarity=0.329  Sum_probs=185.4

Q ss_pred             ccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCCcceeEEE
Q 014034           86 KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLL  160 (432)
Q Consensus        86 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~l  160 (432)
                      .||+|+||.||+|...     .......+++|.+...     ...+.+|+.+++.++||||+++++.+....    ..++
T Consensus         2 ~lg~G~~g~v~~~~~~-----~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~----~~~l   72 (268)
T cd05086           2 EIGNGWFGKVLLSEIY-----TDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI----PYLL   72 (268)
T ss_pred             cCCCCcCceEEEEEEE-----cCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCC----ccEE
Confidence            5999999999999754     1223456778876542     235888999999999999999999987654    3499


Q ss_pred             EEeecCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCC
Q 014034          161 VYEFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG  238 (432)
Q Consensus       161 v~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~  238 (432)
                      ||||+++|+|.+++....  ....++..+..++.||+.||.|||+.   +++||||||+|||++.++.++|+|||++...
T Consensus        73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~  149 (268)
T cd05086          73 VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSR  149 (268)
T ss_pred             EEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEeccccccccc
Confidence            999999999999997542  23467778889999999999999998   9999999999999999999999999998642


Q ss_pred             CCCCCcccccccccCCCccCcccccc-------CCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhccc
Q 014034          239 PMVGHTHVSTAVVGTFGYAAPDYIET-------GHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      .............++..|+|||++..       ..++.++|||||||++|||++ |..||........  +........ 
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~~~~~~~-  226 (268)
T cd05086         150 YKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV--LNHVIKDQQ-  226 (268)
T ss_pred             CcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHhhcc-
Confidence            11111122234568899999999853       245778999999999999997 5678865433221  111111110 


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                           ..+.++.+...    ....+.+++..|| .+|++||++.+|++.|.
T Consensus       227 -----~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         227 -----VKLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             -----cccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence                 01122222222    2356778999999 67999999999998773

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.9e-39  Score=300.92  Aligned_cols=247  Identities=23%  Similarity=0.395  Sum_probs=195.8

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------------HHHHHHHHHhcccCCCccceeee
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------------LQWVAEVQFLGVLEHPNLVKLIG  146 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------------~~~~~E~~~l~~l~hpniv~l~~  146 (432)
                      +|.+...||.|+||.||+|...       .++..||+|.+....             ..+.+|+.+++.++||||+++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   73 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNA-------SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLG   73 (267)
T ss_pred             CccccceeecCCCeEEEEEEec-------CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence            3677889999999999999854       456789999875321             23678999999999999999999


Q ss_pred             EEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCc
Q 014034          147 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR  226 (432)
Q Consensus       147 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~  226 (432)
                      ++...+.    .++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.
T Consensus        74 ~~~~~~~----~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~  144 (267)
T cd06628          74 SSLDADH----LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGG  144 (267)
T ss_pred             EEEeCCc----cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCC
Confidence            9876553    48999999999999999654  3688999999999999999999998   9999999999999999999


Q ss_pred             eeeccccCCcCCCCCCC----cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014034          227 PKLSDFGLAREGPMVGH----THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  302 (432)
Q Consensus       227 ~kl~DfG~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  302 (432)
                      ++|+|||+++.......    ........|+..|+|||.+.+..++.++|||||||++|+|++|..||.......  .+.
T Consensus       145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~  222 (267)
T cd06628         145 IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--AIF  222 (267)
T ss_pred             EEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--HHH
Confidence            99999999875431111    111123458899999999998889999999999999999999999998643321  111


Q ss_pred             HHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          303 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      . ....          ..+    ..+...+..+.+++.+||+.||.+||++.+|+++
T Consensus       223 ~-~~~~----------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         223 K-IGEN----------ASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             H-Hhcc----------CCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            1 1110          111    1122334678899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.2e-39  Score=304.45  Aligned_cols=262  Identities=28%  Similarity=0.438  Sum_probs=202.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      .+|...+.||+|+||.||+|.+...   +...+..||+|.+....     ..+.+|+.+++.+.||||+++++++...+.
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~---~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPL---GDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCC---CCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence            3577889999999999999987522   12457899999987543     348899999999999999999998876443


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                        ...++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        81 --~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  154 (284)
T cd05038          81 --RSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFG  154 (284)
T ss_pred             --CceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccc
Confidence              24589999999999999997643 3589999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCc-ccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchh------------hHH
Q 014034          234 LAREGPMVGHT-HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT------------EQR  300 (432)
Q Consensus       234 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~------------~~~  300 (432)
                      ++......... .......++..|++||.+.+..++.++||||||+++|+|++|..|+.......            ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd05038         155 LAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR  234 (284)
T ss_pred             cccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH
Confidence            99764311111 11112344567999999988889999999999999999999999986532211            011


Q ss_pred             HHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          301 LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                      +..++..              ......+...+..+.+|+.+||+.+|.+|||+.+|++.|+.+
T Consensus       235 ~~~~~~~--------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         235 LLELLKE--------------GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHc--------------CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1111111              001111223346788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.3e-39  Score=299.11  Aligned_cols=242  Identities=25%  Similarity=0.444  Sum_probs=188.5

Q ss_pred             cccccCCceEEEEEEecCCCCC---CCcccEEEEEEecCcCh---HHHHHHHHHhcccCCCccceeeeEEeecCCcceeE
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGD---GTSEATVVAIKKLNRDG---LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQR  158 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~---~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~  158 (432)
                      +.||+|+||.||+|.+......   .......|++|.+....   ..+.+|+.+++.++||||+++++++.. ..    .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~----~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DE----N   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CC----c
Confidence            3589999999999998632210   01223568888876443   358889999999999999999999876 33    3


Q ss_pred             EEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC-------ceeecc
Q 014034          159 LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF-------RPKLSD  231 (432)
Q Consensus       159 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-------~~kl~D  231 (432)
                      ++||||+.+++|.+++..... .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++       .+||+|
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence            899999999999999976432 689999999999999999999998   999999999999999887       799999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccC--CCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhc
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG--HLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      ||++.....      .....++..|+|||++.+.  .++.++||||||+++|+|++ |..||............   ...
T Consensus       152 fg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~---~~~  222 (259)
T cd05037         152 PGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY---QDQ  222 (259)
T ss_pred             CCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH---hcC
Confidence            999875321      2234577889999999876  78999999999999999999 57777665432211111   100


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                          .        ..    +......+.+++.+||..+|.+|||+.+|++.|
T Consensus       223 ----~--------~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         223 ----H--------RL----PMPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             ----C--------CC----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                0        00    000115788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.8e-39  Score=302.02  Aligned_cols=248  Identities=29%  Similarity=0.461  Sum_probs=195.6

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----------HHHHHHHHHhcccCCCccceeeeEEe
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----------LQWVAEVQFLGVLEHPNLVKLIGYCA  149 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~hpniv~l~~~~~  149 (432)
                      +|...+.||.|+||.||+|...        ++..+|+|.+....          ..+.+|+.+++.++|+||+++++++.
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~--------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   72 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN--------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL   72 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc--------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee
Confidence            4778899999999999999742        56789999875321          23778999999999999999999987


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      ..+    ..++||||+++++|.+++.+..  ++++..+..++.|++.||.|||+.   +|+|+||+|+||+++.++.++|
T Consensus        73 ~~~----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l  143 (265)
T cd06631          73 DDN----TISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKL  143 (265)
T ss_pred             cCC----eEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEe
Confidence            653    4599999999999999996543  688999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCC----CcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 014034          230 SDFGLAREGPMVG----HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  305 (432)
Q Consensus       230 ~DfG~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  305 (432)
                      +|||++.......    .........|+..|+|||.+.+..++.++||||||+++|+|++|..||.........  .. .
T Consensus       144 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--~~-~  220 (265)
T cd06631         144 IDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM--FY-I  220 (265)
T ss_pred             ccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH--HH-h
Confidence            9999987432111    111223456899999999999888999999999999999999999999764432211  11 1


Q ss_pred             hhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          306 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .....        ..+.    .+...+..+.+++.+||..+|.+||++.+++.+
T Consensus       221 ~~~~~--------~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         221 GAHRG--------LMPR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             hhccC--------CCCC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00000        0011    112234668899999999999999999998764

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.6e-39  Score=305.26  Aligned_cols=244  Identities=27%  Similarity=0.413  Sum_probs=196.1

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      .|+..+.||+|+||.||+|.+.       .++..||+|.+....     ..+.+|+.+++.++||||+++++++....  
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   75 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDN-------RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT--   75 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEc-------CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC--
Confidence            4667788999999999999864       457889999876432     24788999999999999999999987654  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        ..++||||+.+++|.+++..   ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+
T Consensus        76 --~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~  147 (277)
T cd06642          76 --KLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGV  147 (277)
T ss_pred             --ceEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccc
Confidence              35999999999999998854   3689999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      +.....  .........|+..|+|||.+.+..++.++|||||||++|+|++|..||....+...   ......   .   
T Consensus       148 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~~~~---~---  216 (277)
T cd06642         148 AGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LFLIPK---N---  216 (277)
T ss_pred             cccccC--cchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---Hhhhhc---C---
Confidence            875321  11222335688999999999988899999999999999999999999875433211   111000   0   


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                          ..+    ......+..+.+++.+||+.+|.+||++.+++.+
T Consensus       217 ----~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         217 ----SPP----TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             ----CCC----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                011    1112234668899999999999999999999986

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=7.2e-39  Score=302.34  Aligned_cols=245  Identities=27%  Similarity=0.389  Sum_probs=199.4

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ..|+..+.||.|+||.||+|...       ..+..||+|.+....     ..+.+|+.+++.++||||+++++++.... 
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   75 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDN-------RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT-   75 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEc-------cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-
Confidence            35788889999999999999865       457889999876432     24788999999999999999999987654 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+.+++|.+++..   .++++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||
T Consensus        76 ---~~~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg  146 (277)
T cd06640          76 ---KLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFG  146 (277)
T ss_pred             ---EEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccc
Confidence               45999999999999999864   3588999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      ++......  ........++..|+|||.+.+..++.++|+|||||++|+|++|..||....+......   .        
T Consensus       147 ~~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~---~--------  213 (277)
T cd06640         147 VAGQLTDT--QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL---I--------  213 (277)
T ss_pred             cceeccCC--ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh---h--------
Confidence            98753221  1122335688899999999988899999999999999999999999976543321111   0        


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                            ............+..+.+++.+||+.+|.+||++.+++.+
T Consensus       214 ------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         214 ------PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             ------hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence                  0000112233456778899999999999999999999887

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-39  Score=305.54  Aligned_cols=249  Identities=24%  Similarity=0.404  Sum_probs=197.6

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      ++|++.+.||.|+||.||++.+.       .++..||+|.+....    ..+..|+.+++.++||||+++++++....  
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   75 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHK-------ETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN--   75 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEc-------CCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC--
Confidence            46999999999999999999865       357889999986433    24778999999999999999999987654  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        ..++||||+.+++|.+++.... ..+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||+
T Consensus        76 --~~~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~  149 (280)
T cd06611          76 --KLWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGV  149 (280)
T ss_pred             --eEEEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCcc
Confidence              3599999999999999986543 4689999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIE-----TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      +.....  .........|++.|+|||.+.     ...++.++||||||+++|+|++|..||........  .... ....
T Consensus       150 ~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~~-~~~~  224 (280)
T cd06611         150 SAKNKS--TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLKI-LKSE  224 (280)
T ss_pred             chhhcc--cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHHH-hcCC
Confidence            865321  112223456899999999974     34577899999999999999999999976543221  1111 1110


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .          +.+  ..+...+..+.+++.+||+.+|.+||++.+++++
T Consensus       225 ~----------~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         225 P----------PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             C----------CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            0          000  0112234568899999999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-40  Score=317.23  Aligned_cols=238  Identities=25%  Similarity=0.362  Sum_probs=183.7

Q ss_pred             cccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-------HHHHHHHHhccc---CCCccceeeeEEeecCCcce
Q 014034           87 IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQFLGVL---EHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        87 lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l---~hpniv~l~~~~~~~~~~~~  156 (432)
                      ||+|+||.||+|...       .++..||+|.+.+...       .+..|..++..+   +||||+++++++....    
T Consensus         1 lG~G~~g~Vy~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~----   69 (330)
T cd05586           1 IGKGTFGQVYQVRKK-------DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS----   69 (330)
T ss_pred             CCCCCceEEEEEEEC-------CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC----
Confidence            799999999999865       4678999999864321       244566666554   6999999999887654    


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      ..++||||+.+|+|..++...  ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.
T Consensus        70 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~  144 (330)
T cd05586          70 DLYLVTDYMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK  144 (330)
T ss_pred             eEEEEEcCCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCc
Confidence            359999999999999998654  3689999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF  315 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  315 (432)
                      ....  .........||+.|+|||++.+. .++.++|||||||++|+|++|..||.......   +...+....      
T Consensus       145 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~---~~~~i~~~~------  213 (330)
T cd05586         145 ANLT--DNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ---MYRNIAFGK------  213 (330)
T ss_pred             CCCC--CCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH---HHHHHHcCC------
Confidence            5221  11223446799999999998754 58899999999999999999999997654322   111111100      


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC----CHHHHHHH
Q 014034          316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP----KMSQVVER  359 (432)
Q Consensus       316 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~eil~~  359 (432)
                           ..+..   ...+..+.+++.+||..||.+||    ++.+++++
T Consensus       214 -----~~~~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         214 -----VRFPK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             -----CCCCC---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence                 00110   11235677999999999999998    56666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.1e-39  Score=296.88  Aligned_cols=244  Identities=31%  Similarity=0.468  Sum_probs=193.1

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCCcceeEE
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  159 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~  159 (432)
                      +.||.|+||.||++...       . +..||+|.+...     ...+.+|+.++++++||||+++++++.....    .+
T Consensus         1 ~~lg~g~~g~v~~~~~~-------~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~   68 (251)
T cd05041           1 EKIGKGNFGDVYKGVLK-------G-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQP----IY   68 (251)
T ss_pred             CccccCCCceEEEEEEe-------C-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCC----eE
Confidence            36999999999999864       2 788999987643     2357889999999999999999999876553    49


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCC
Q 014034          160 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP  239 (432)
Q Consensus       160 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~  239 (432)
                      +||||+.+++|.+++.... ..+++..+..++.+++.||.|||++   +++||||||+|||++.++.++|+|||++....
T Consensus        69 ~v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~  144 (251)
T cd05041          69 IVMELVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEE  144 (251)
T ss_pred             EEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeecccccccc
Confidence            9999999999999996543 3688999999999999999999998   99999999999999999999999999987532


Q ss_pred             CCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccccccc
Q 014034          240 MVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI  318 (432)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (432)
                      ............++..|+|||.+.++.++.++||||||+++|+|+| |..||............   ....         
T Consensus       145 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~---~~~~---------  212 (251)
T cd05041         145 GGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI---ESGY---------  212 (251)
T ss_pred             CCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH---hcCC---------
Confidence            1111111112234567999999988899999999999999999999 88898766543222211   1100         


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          319 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       319 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                           ....+...+..+.+++.+||..+|.+|||+.++++.|+
T Consensus       213 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         213 -----RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             -----CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence                 00112223457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.3e-39  Score=307.89  Aligned_cols=247  Identities=24%  Similarity=0.370  Sum_probs=198.0

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC----hHHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      .+|...+.||.|+||.||+|...       .++..||+|.+...    ...+.+|+.+++.++||||+++++++....  
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--   89 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDI-------ATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD--   89 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEEC-------CCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--
Confidence            67999999999999999999854       46788999988642    234778999999999999999999987654  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        ..++||||+++++|.+++.+.   .+++..+..++.|++.||.|||+.   +++||||||+|||++.++.++|+|||+
T Consensus        90 --~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~  161 (297)
T cd06656          90 --ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF  161 (297)
T ss_pred             --EEEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCcc
Confidence              459999999999999998643   578999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      +......  ........+++.|+|||.+.+..++.++|||||||++|++++|..||....+......   ...       
T Consensus       162 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~---~~~-------  229 (297)
T cd06656         162 CAQITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IAT-------  229 (297)
T ss_pred             ceEccCC--ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee---ecc-------
Confidence            8753211  1122345688999999999988899999999999999999999999976543211000   000       


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                           ........+...+..+.+++.+||..+|.+||++.+|+++
T Consensus       230 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         230 -----NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             -----CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 0000001122334567899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.9e-39  Score=314.38  Aligned_cols=252  Identities=22%  Similarity=0.292  Sum_probs=193.8

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|.+.+.||+|+||.||++.++       .++..+|+|.+.+..       ..+..|+.++..++||||+++++++...
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   73 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLK-------NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE   73 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEEC-------CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC
Confidence            37899999999999999999875       456789999986421       1367889999999999999999988765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        74 ~----~~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~D  145 (332)
T cd05623          74 N----NLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD  145 (332)
T ss_pred             C----EEEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEee
Confidence            4    4599999999999999997533 3689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE-----TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  306 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  306 (432)
                      ||++...... .........||+.|+|||++.     ...++.++|||||||++|||++|..||........   ...+.
T Consensus       146 fG~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~---~~~i~  221 (332)
T cd05623         146 FGSCLKLMED-GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGKIM  221 (332)
T ss_pred             cchheecccC-CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH---HHHHh
Confidence            9998643211 112223457999999999986     34688899999999999999999999986543221   11111


Q ss_pred             hcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 014034          307 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKD--RPKMSQVVER  359 (432)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~  359 (432)
                      ....   .+      .+. ......+..+.+|+.+|+..++..  |+++.+++++
T Consensus       222 ~~~~---~~------~~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         222 NHKE---RF------QFP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CCCc---cc------cCC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            1100   00      000 001123467888999988665444  6899999887

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.6e-39  Score=314.77  Aligned_cols=252  Identities=23%  Similarity=0.305  Sum_probs=193.7

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|.+.+.||+|+||.||++...       .++..||+|.+.+..       ..+..|..++..++|+||+.+++++...
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~   73 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMK-------HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE   73 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            47899999999999999999865       467889999986421       2367889999999999999999988765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        74 ~----~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~D  145 (331)
T cd05624          74 N----YLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLAD  145 (331)
T ss_pred             C----EEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEe
Confidence            4    4599999999999999997533 3689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCcccccc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-----GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  306 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  306 (432)
                      ||++....... ........||+.|+|||++.+     +.++.++|||||||++|+|++|..||........   ...+.
T Consensus       146 fG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~---~~~i~  221 (331)
T cd05624         146 FGSCLKMNQDG-TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGKIM  221 (331)
T ss_pred             ccceeeccCCC-ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH---HHHHH
Confidence            99987532211 112234579999999999875     5678899999999999999999999976543221   11111


Q ss_pred             hcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 014034          307 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKD--RPKMSQVVER  359 (432)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~  359 (432)
                      ....   .+  .+...     ....+..+.+++.+|+..++.+  |+++.+++++
T Consensus       222 ~~~~---~~--~~p~~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         222 NHEE---RF--QFPSH-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             cCCC---cc--cCCCc-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            1000   00  00000     1123467889999999865544  4688888776

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.4e-38  Score=301.27  Aligned_cols=263  Identities=27%  Similarity=0.374  Sum_probs=196.8

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      ++|+....||+|+||.||+|...       .++..||+|++....      ..+.+|+.+++.++||||+++++++....
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   73 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNR-------ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR   73 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEEC-------CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC
Confidence            36888999999999999999865       457889999875321      23678999999999999999999987654


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..++||||+++++|..++...  ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+||
T Consensus        74 ----~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~df  144 (286)
T cd07847          74 ----KLHLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDF  144 (286)
T ss_pred             ----EEEEEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECcc
Confidence                458999999998888876543  3689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHH-HHhhccc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE-WVQQYPA  310 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~-~~~~~~~  310 (432)
                      |++.......  .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+........... .......
T Consensus       145 g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  222 (286)
T cd07847         145 GFARILTGPG--DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIP  222 (286)
T ss_pred             ccceecCCCc--ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            9987532211  12233457889999999876 567889999999999999999999998765433221111 1100000


Q ss_pred             C-------ccccccccCccccCcCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          311 D-------SKKFGLIMDPRLEKEYS-----INEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       311 ~-------~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .       ...+.....+......+     ...+..+.+|+.+||+.+|++|||+.+++.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         223 RHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             HHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            0       00000000011000000     1224678899999999999999999998764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6.5e-39  Score=301.01  Aligned_cols=252  Identities=24%  Similarity=0.365  Sum_probs=194.3

Q ss_pred             HhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        76 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .+++++.....||+|+||.||+|...       .++..|++|.+....    ..+.+|+.+++.++||||+++++++...
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~-------~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   77 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDL-------STQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN   77 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEec-------CCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC
Confidence            44556666678999999999999864       457889999876543    2478899999999999999999998765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC-CCcee
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPL--PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE-NFRPK  228 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~k  228 (432)
                      +    ..++|+||+++++|.+++.... ..+  ++..+..++.||+.||.|||+.   +|+||||||+||+++. ++.++
T Consensus        78 ~----~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~  149 (268)
T cd06624          78 G----FFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVK  149 (268)
T ss_pred             C----EEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEE
Confidence            4    4599999999999999997542 234  7888899999999999999998   9999999999999976 67999


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCccccccC--CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG--HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  306 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  306 (432)
                      |+|||++.....  .........|+..|+|||.+.+.  .++.++||||||+++|+|++|..||...........   ..
T Consensus       150 l~dfg~~~~~~~--~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~---~~  224 (268)
T cd06624         150 ISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF---KV  224 (268)
T ss_pred             Eecchhheeccc--CCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh---hh
Confidence            999999865321  11122334588999999998654  378899999999999999999999975432211100   00


Q ss_pred             hcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          307 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ...            ......+......+.+++.+||+.+|.+|||+.+++.+
T Consensus       225 ~~~------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         225 GMF------------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             hhh------------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            000            00011222344678899999999999999999999865

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.1e-38  Score=298.99  Aligned_cols=250  Identities=23%  Similarity=0.317  Sum_probs=195.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---------hHHHHHHHHHhcccCCCccceeeeEEe
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---------GLQWVAEVQFLGVLEHPNLVKLIGYCA  149 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~hpniv~l~~~~~  149 (432)
                      .+|.+.+.||+|+||.||+|...       .++..||+|.+...         ...+.+|+.+++.++||||+++++++.
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~-------~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   74 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDA-------DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLR   74 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEc-------CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEec
Confidence            47889999999999999999865       46789999987421         124678999999999999999999876


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      +...  ...++||||+++++|.+++....  .+++.....++.|++.||.|||+.   +++|+||||+||+++.++.++|
T Consensus        75 ~~~~--~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l  147 (265)
T cd06652          75 DPME--RTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKL  147 (265)
T ss_pred             cCCC--ceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEE
Confidence            5432  24589999999999999986543  578899999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCC-cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          230 SDFGLAREGPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       230 ~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      +|||++........ ........|+..|+|||.+.+..++.++|||||||++|+|++|..||........  ... ....
T Consensus       148 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~-~~~~  224 (265)
T cd06652         148 GDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--IFK-IATQ  224 (265)
T ss_pred             CcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--HHH-HhcC
Confidence            99999875321111 1112234688999999999888899999999999999999999999975432211  111 1110


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      +             .....+......+.+++.+||. +|.+||++.+|+++
T Consensus       225 ~-------------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         225 P-------------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             C-------------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            0             0111233445678889999995 89999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.1e-38  Score=297.32  Aligned_cols=248  Identities=31%  Similarity=0.511  Sum_probs=196.1

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---hHHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      .+|+..+.||.|+||.||+|.+.        .+..+|+|.+...   ...+.+|+++++.++||||+++++++....   
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~--------~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   72 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL--------EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERS---   72 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe--------CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCC---
Confidence            46888899999999999999764        3457999988653   346889999999999999999999886554   


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCC
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  235 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a  235 (432)
                       ..++||||+.+++|.+++.... ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++
T Consensus        73 -~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~  147 (256)
T cd05112          73 -PICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMT  147 (256)
T ss_pred             -ceEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcce
Confidence             3599999999999999987543 3688999999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      ...... .........++..|+|||.+.++.++.++||||||+++|+|++ |..||.......   +...+..   ... 
T Consensus       148 ~~~~~~-~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~---~~~-  219 (256)
T cd05112         148 RFVLDD-QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVETINA---GFR-  219 (256)
T ss_pred             eecccC-cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHHhC---CCC-
Confidence            743211 1111122335678999999998889999999999999999998 999997544322   2211110   000 


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                         ...+.       ..+..+.+|+.+||+.+|.+|||+.+++++|
T Consensus       220 ---~~~~~-------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         220 ---LYKPR-------LASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             ---CCCCC-------CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence               00111       1236788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-40  Score=320.53  Aligned_cols=253  Identities=25%  Similarity=0.372  Sum_probs=206.4

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      +....++||+|+||.|++|.|+..+    .+...||||.++.+.     ..|.+|+.+|.+|+|||+++|||+..+..  
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~ps----gk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp--  184 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPS----GKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQP--  184 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCC----CcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccch--
Confidence            4556678999999999999998644    345779999987643     35999999999999999999999987633  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                         ..+|||.++.|+|.+.|.......+.......++.|||.||.||.++   ++|||||...|+||.....+||+|||+
T Consensus       185 ---~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGL  258 (1039)
T KOG0199|consen  185 ---AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGL  258 (1039)
T ss_pred             ---hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccc
Confidence               37999999999999999885556788889999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcc-cccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          235 AREGPMVGHTH-VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       235 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      .+......... ......-...|+|||.++...++.++|||+|||++|||+| |..||-+.........++         
T Consensus       259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD---------  329 (1039)
T KOG0199|consen  259 MRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID---------  329 (1039)
T ss_pred             eeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc---------
Confidence            98643222211 1122233568999999999999999999999999999999 899998876644332222         


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                              ..-.-..+..+++++++++..||..+|.+|||+..|.+.+-
T Consensus       330 --------~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~  370 (1039)
T KOG0199|consen  330 --------AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV  370 (1039)
T ss_pred             --------ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence                    11111225567899999999999999999999999986543

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=9.3e-39  Score=298.56  Aligned_cols=249  Identities=24%  Similarity=0.348  Sum_probs=199.5

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      +|++.+.||.|+||.||++...       .++..||+|.+...      ...+..|+.+++.++||||+++++++.....
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRK-------SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN   73 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeec-------CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCC
Confidence            4788899999999999999865       45678999987532      2247789999999999999999998765432


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhh-----cCCCCceeecCCCCCceEEcCCCc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLH-----EGLEVQVIYRDFKASNVLLDENFR  226 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~l~~~l~~LH-----~~~~~~ivH~Dikp~Nill~~~~~  226 (432)
                        ...+++|||+++++|.+++...  ...++++..++.++.||+.||.|||     +.   +++|+||||+||+++.++.
T Consensus        74 --~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~  148 (265)
T cd08217          74 --QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNN  148 (265)
T ss_pred             --CEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCC
Confidence              2468999999999999998653  2357899999999999999999999     65   9999999999999999999


Q ss_pred             eeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 014034          227 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  306 (432)
Q Consensus       227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  306 (432)
                      +||+|||++......  ........|++.|+|||.+.+..++.++||||||+++|+|++|..||......   .+...+.
T Consensus       149 ~kl~d~g~~~~~~~~--~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~  223 (265)
T cd08217         149 VKLGDFGLAKILGHD--SSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKIK  223 (265)
T ss_pred             EEEecccccccccCC--cccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHHh
Confidence            999999998763221  11123456899999999999888999999999999999999999999865422   2222222


Q ss_pred             hcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          307 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ....          +    ..+...+..+.+++.+||+.+|.+||++.+|+++
T Consensus       224 ~~~~----------~----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         224 EGKF----------R----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             cCCC----------C----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            1110          1    1122334678899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=290.34  Aligned_cols=259  Identities=22%  Similarity=0.266  Sum_probs=209.9

Q ss_pred             HhhcCCccc-cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHHHHHHHhccc-CCCccceeeeEEeecCC
Q 014034           76 QATNDFSRM-LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVL-EHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        76 ~~~~~~~~~-~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~  153 (432)
                      ..+++|.+. +.||-|-.|+|-.+.++       .+++.+|+|++.. ....++|+++--.. .|||||.+++++.+...
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k-------~T~ekfALKvL~D-s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~  129 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHK-------RTQEKFALKVLLD-SPKARREVELHWMASGHPHIVSIIDVYENSYQ  129 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEec-------cchhhhHHHHHhc-CHHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence            356677774 57899999999999877       6788999999854 34578888876554 69999999999987665


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc---CCCceeec
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLS  230 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~---~~~~~kl~  230 (432)
                      .-..+++|||.|+||.|...|.++....+++.++..|+.||+.|+.|||+.   +|.||||||+|+|..   .|..+||+
T Consensus       130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEec
Confidence            566778999999999999999998888899999999999999999999998   999999999999996   45679999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhh-HHHHHHHhhcc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-QRLLEWVQQYP  309 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~-~~~~~~~~~~~  309 (432)
                      |||+|+...   ......+.+.|+.|.|||++....|+..+|+||+||++|-|++|.+||-....... ..+...+..  
T Consensus       207 DfGFAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~--  281 (400)
T KOG0604|consen  207 DFGFAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT--  281 (400)
T ss_pred             ccccccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc--
Confidence            999998632   22334567889999999999999999999999999999999999999976443211 011111110  


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                               -.-.+........++...++|+.+|..+|.+|.|+.+++++
T Consensus       282 ---------gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  282 ---------GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             ---------cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence                     01112223345678889999999999999999999999987

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=9.1e-39  Score=297.53  Aligned_cols=246  Identities=26%  Similarity=0.401  Sum_probs=197.4

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      +|+..+.||+|+||.||++...       .++..+|+|.+...      ...+.+|+.+++.++||||+++++.+...+ 
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-   72 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRK-------ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDK-   72 (256)
T ss_pred             CceEEEEecccCceEEEEEEEc-------CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCC-
Confidence            4888899999999999999865       46788999987643      224788999999999999999999886544 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCC-Cceeeccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDF  232 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~Df  232 (432)
                         ..++||||+++++|.+++.......+++..+..++.+++.||.|||++   +++|+||+|+||+++.+ +.++|+||
T Consensus        73 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~  146 (256)
T cd08220          73 ---ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDF  146 (256)
T ss_pred             ---EEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccC
Confidence               459999999999999999776555689999999999999999999998   99999999999999854 46899999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      |++.....   ........|+..|+|||.+.+..++.++||||||+++|+|++|..||........   .........  
T Consensus       147 ~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~--  218 (256)
T cd08220         147 GISKILSS---KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VLKIMSGTF--  218 (256)
T ss_pred             CCceecCC---CccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HHHHHhcCC--
Confidence            99875321   1122345688999999999988899999999999999999999999976543221   111111000  


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                              .    ..+...+..+.+++.+||..+|.+|||+.+++.+
T Consensus       219 --------~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         219 --------A----PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             --------C----CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                    0    0111234568899999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.4e-39  Score=304.93  Aligned_cols=253  Identities=29%  Similarity=0.422  Sum_probs=199.1

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|++++.||+|+||.||++...       .++..||+|.+...     ...+.+|+++++.++||||+++++++...+ 
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~-------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   76 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHI-------PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN-   76 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEc-------CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCC-
Confidence            57888999999999999999865       45788999987543     234788999999999999999999987654 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+++++|.+++...  +.+++..+..++.+++.||.|||+.  .+++||||||+||+++.++.++|+|||
T Consensus        77 ---~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~g  149 (284)
T cd06620          77 ---NICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFG  149 (284)
T ss_pred             ---EEEEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCC
Confidence               459999999999999988654  3689999999999999999999973  289999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchh-----hHHHHHHHhhc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT-----EQRLLEWVQQY  308 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~-----~~~~~~~~~~~  308 (432)
                      ++.....    .......|+..|+|||++.+..++.++|||||||++|+|++|..||.......     ...+..+....
T Consensus       150 l~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  225 (284)
T cd06620         150 VSGELIN----SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI  225 (284)
T ss_pred             cccchhh----hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHH
Confidence            9864211    11224578999999999988889999999999999999999999998654321     11111111111


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                      ....       .+.+   .....+..+.+|+.+||+.||.+|||+.+++++.
T Consensus       226 ~~~~-------~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         226 VQEP-------PPRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             hhcc-------CCCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            0000       0000   0112345788999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=8.3e-39  Score=298.06  Aligned_cols=247  Identities=26%  Similarity=0.417  Sum_probs=198.5

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      +|+..+.||+|+||.||++...       .++..||+|.+...      ...+.+|+.+++.++||||+++++++...+ 
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   72 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSK-------EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENG-   72 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEc-------CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC-
Confidence            4888999999999999999864       45778999987532      235788999999999999999999886544 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+.+++|.+++.......+++..+..++.|++.||.|||+.   +++|+||+|+|||++.++.++|+|||
T Consensus        73 ---~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~  146 (256)
T cd08218          73 ---NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFG  146 (256)
T ss_pred             ---eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeecc
Confidence               459999999999999998765545689999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      ++.....  .........|++.|+|||++.+..++.++|+|||||++++|++|..||........  .........    
T Consensus       147 ~~~~~~~--~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~--~~~~~~~~~----  218 (256)
T cd08218         147 IARVLNS--TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL--VLKIIRGSY----  218 (256)
T ss_pred             ceeecCc--chhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH--HHHHhcCCC----
Confidence            9875321  11122335688999999999988899999999999999999999999975433221  111111100    


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                             +    ..+...+..+.++|.+||+.+|.+||++.+|+++
T Consensus       219 -------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         219 -------P----PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             -------C----CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                   0    1122234678899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-39  Score=307.96  Aligned_cols=251  Identities=24%  Similarity=0.344  Sum_probs=198.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|+..+.||+|+||.||+|...       .++..||+|.+....       ..+..|+++++.++||||+++++.+...
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   73 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLK-------GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE   73 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEc-------CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC
Confidence            36888999999999999999865       357899999986532       2377899999999999999999988654


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      .    ..++||||+.+++|.+++.......+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|
T Consensus        74 ~----~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~d  146 (316)
T cd05574          74 T----YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSD  146 (316)
T ss_pred             C----EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEee
Confidence            3    459999999999999999765556799999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCc---------------------------ccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHH
Q 014034          232 FGLAREGPMVGHT---------------------------HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML  284 (432)
Q Consensus       232 fG~a~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell  284 (432)
                      ||++.........                           .......||..|+|||++.+..++.++||||||+++|+|+
T Consensus       147 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~  226 (316)
T cd05574         147 FDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML  226 (316)
T ss_pred             cchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHh
Confidence            9998643211100                           0112346889999999999888999999999999999999


Q ss_pred             hCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCC----HHHHHHH
Q 014034          285 TGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK----MSQVVER  359 (432)
Q Consensus       285 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~eil~~  359 (432)
                      +|..||.+......  ........              .........+..+.+++.+||..||.+|||    +.+++.+
T Consensus       227 ~g~~pf~~~~~~~~--~~~~~~~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         227 YGTTPFKGSNRDET--FSNILKKE--------------VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             hCCCCCCCCchHHH--HHHHhcCC--------------ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            99999976543321  11111000              000001114567899999999999999999    7777664

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=6.6e-39  Score=303.45  Aligned_cols=260  Identities=27%  Similarity=0.408  Sum_probs=195.4

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      +|+..+.||.|+||.||+|...       .++..||||.+..+.      ..+.+|++++++++||||+++++++...+ 
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   72 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-   72 (284)
T ss_pred             CceeeeeecCCCceEEEEEEEC-------CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCC-
Confidence            4888999999999999999865       457789999886432      34788999999999999999999987544 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+. ++|..++.......+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||
T Consensus        73 ---~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg  145 (284)
T cd07860          73 ---KLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFG  145 (284)
T ss_pred             ---cEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence               3599999995 6899988765556789999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH-LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      ++......  ........++..|+|||.+.+.. ++.++||||||+++|+|+||..||.+......  ............
T Consensus       146 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~  221 (284)
T cd07860         146 LARAFGVP--VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPD  221 (284)
T ss_pred             chhhcccC--ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCC
Confidence            98743211  11123345788999999887644 68899999999999999999999976543221  111111111000


Q ss_pred             c--------------ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          313 K--------------KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       313 ~--------------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .              .+.......+.. .....+..+.++|.+||+.||.+|||+.+++.+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         222 EVVWPGVTSLPDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             hhhhhhhhHHHHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            0              000000000000 011223567899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.7e-38  Score=348.86  Aligned_cols=265  Identities=26%  Similarity=0.450  Sum_probs=208.4

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHHHHHHHhcccCCCccceeeeEEeecCCcceeE
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQR  158 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~  158 (432)
                      ..|...+.||+|+||.||+|...       .++..||+|++.........|++++++++|||||+++++|.....    .
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~----~  758 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSI-------KNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKG----A  758 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEEC-------CCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCC----C
Confidence            45777889999999999999865       467889999987654445567999999999999999999987654    3


Q ss_pred             EEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCC
Q 014034          159 LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG  238 (432)
Q Consensus       159 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~  238 (432)
                      ++||||+++|+|.+++.     .++|..+..++.|++.||+|||..+..+|+||||||+||+++.++..++. ||.....
T Consensus       759 ~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~  832 (968)
T PLN00113        759 YLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL  832 (968)
T ss_pred             EEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence            99999999999999994     38999999999999999999996555699999999999999999888775 6655321


Q ss_pred             CCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccc
Q 014034          239 PMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI  318 (432)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (432)
                      .      ......||+.|||||++.+..++.++|||||||++|||+||+.||..... ....+..|....... .....+
T Consensus       833 ~------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~~~  904 (968)
T PLN00113        833 C------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD-CHLDMW  904 (968)
T ss_pred             c------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCc-cchhhe
Confidence            1      11223688999999999999999999999999999999999999954322 122344444332211 122334


Q ss_pred             cCccccCc--CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhcc
Q 014034          319 MDPRLEKE--YSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  368 (432)
Q Consensus       319 ~~~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  368 (432)
                      +++.+...  ........+.+++.+||+.||++|||+.+|++.|+.+.....
T Consensus       905 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~  956 (968)
T PLN00113        905 IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS  956 (968)
T ss_pred             eCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence            44444332  334556678899999999999999999999999998876544

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-38  Score=302.30  Aligned_cols=249  Identities=26%  Similarity=0.408  Sum_probs=195.5

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      +|++++.||+|+||.||++...       .++..||+|.+...     ...+.+|+.++++++||||+++++.+...+  
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~-------~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--   72 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHR-------PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG--   72 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEc-------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC--
Confidence            6888999999999999999865       45788999987642     124778999999999999999999887654  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                        ..++||||+++++|..++.... ...+++..+..++.|++.||.|||+.  .+|+|+||||+||+++.++.++|+|||
T Consensus        73 --~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg  148 (286)
T cd06622          73 --AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFG  148 (286)
T ss_pred             --eEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecC
Confidence              4599999999999999886531 23689999999999999999999963  289999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccC------CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETG------HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  307 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  307 (432)
                      ++.....    .......+++.|+|||.+.+.      .++.++|||||||++|+|++|..||..............+..
T Consensus       149 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  224 (286)
T cd06622         149 VSGNLVA----SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD  224 (286)
T ss_pred             CcccccC----CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhh
Confidence            9865311    122334688899999998554      347899999999999999999999975433222111111111


Q ss_pred             cccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ..              ....+...+..+.++|.+||..+|.+||++.+++.+
T Consensus       225 ~~--------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         225 GD--------------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             cC--------------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            00              011222345678899999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=9e-39  Score=302.93  Aligned_cols=264  Identities=27%  Similarity=0.386  Sum_probs=198.2

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      ++|+..+.||+|+||.||+|.+.       .++..||+|.++..      ...+.+|+++++.++||||+++++++...+
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~-------~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   73 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNK-------ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG   73 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeC-------CCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECC
Confidence            36889999999999999999865       45688999987642      234789999999999999999999997644


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..++||||+.++.+..++...  ..+++..+..++.||+.||.|||+.   +++|+||+|+||++++++.+||+||
T Consensus        74 ----~~~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~  144 (288)
T cd07833          74 ----RLYLVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDF  144 (288)
T ss_pred             ----EEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEee
Confidence                459999999887776665433  3589999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH-HHHhhccc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL-EWVQQYPA  310 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~-~~~~~~~~  310 (432)
                      |++........ .......++..|+|||++.+. .++.++||||||+++|+|++|..||.+.......... ......+.
T Consensus       145 g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  223 (288)
T cd07833         145 GFARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP  223 (288)
T ss_pred             ecccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            99876432221 122345688999999999887 8899999999999999999999999765433221111 11111110


Q ss_pred             Cc-------ccccccc--C----ccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          311 DS-------KKFGLIM--D----PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       311 ~~-------~~~~~~~--~----~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ..       ..+....  .    ..+...++...+..+.+||.+||..+|++|||+.+++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         224 SHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             HHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            00       0000000  0    000011122235778999999999999999999998764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.6e-38  Score=298.05  Aligned_cols=251  Identities=23%  Similarity=0.400  Sum_probs=197.8

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----------HHHHHHHHHhcccCCCccceeeeEEe
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----------LQWVAEVQFLGVLEHPNLVKLIGYCA  149 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~hpniv~l~~~~~  149 (432)
                      +|+..+.||+|+||.||++...       .++..||+|.+....          ..+.+|+.+++.++||||+++++++.
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   73 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDV-------KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC   73 (268)
T ss_pred             CccccceecCcCceEEEEEEEc-------CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec
Confidence            4788899999999999999754       467889999886422          34788999999999999999999987


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC-cee
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF-RPK  228 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~k  228 (432)
                      ..+    ..++||||+.+++|.+++...  .++++..+..++.|++.||.|||+.   +++|+||+|+||+++.++ .++
T Consensus        74 ~~~----~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~  144 (268)
T cd06630          74 EDS----HFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLR  144 (268)
T ss_pred             cCC----eEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence            554    359999999999999999654  3689999999999999999999998   999999999999998776 599


Q ss_pred             eccccCCcCCCCCCC--cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 014034          229 LSDFGLAREGPMVGH--THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  306 (432)
Q Consensus       229 l~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  306 (432)
                      |+|||++........  ........|+..|+|||.+.+..++.++||||||+++|+|++|..||................
T Consensus       145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  224 (268)
T cd06630         145 IADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA  224 (268)
T ss_pred             EcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh
Confidence            999999875432211  111223568899999999988889999999999999999999999997543322211111110


Q ss_pred             hcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          307 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ..             ......+...+..+.+++.+||..+|.+||++.+++++
T Consensus       225 ~~-------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         225 SA-------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             cc-------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence            00             00112233445678899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2e-38  Score=295.25  Aligned_cols=252  Identities=33%  Similarity=0.520  Sum_probs=197.4

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      +++.+.||.|+||.||++......   ...+..||+|.+....     ..+..|+.++..++||||+++++++...+   
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   74 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLS---GEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEE---   74 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCC---CCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC---
Confidence            356778999999999999976221   1235889999987543     35788999999999999999999987654   


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCC
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  235 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a  235 (432)
                       ..+++|||+++++|.+++.......+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++
T Consensus        75 -~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~  150 (258)
T smart00219       75 -PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLS  150 (258)
T ss_pred             -eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCc
Confidence             359999999999999999765433389999999999999999999998   9999999999999999999999999999


Q ss_pred             cCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      .......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   +...+.....    
T Consensus       151 ~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~~~~~~----  222 (258)
T smart00219      151 RDLYDDDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLEYLKKGYR----  222 (258)
T ss_pred             eecccccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhcCCC----
Confidence            7543221111 112336789999999988889999999999999999998 788887643322   2222211110    


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                            .    ..+...+..+.+++.+||..||++|||+.++++.|
T Consensus       223 ------~----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 ------L----PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ------C----CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                  0    01112356788999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.4e-39  Score=304.08  Aligned_cols=262  Identities=24%  Similarity=0.335  Sum_probs=191.6

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      +|+..+.||+|+||.||+|...       .++..||+|.+....      ..+.+|+.+++.++||||+++++++.+.. 
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~-------~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~-   72 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNR-------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDK-   72 (284)
T ss_pred             CceeEEEecccCCeEEEEEEEC-------CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCC-
Confidence            4788899999999999999865       457789999886431      24678999999999999999999987654 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++|+||+. ++|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.++|+|||
T Consensus        73 ---~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg  144 (284)
T cd07839          73 ---KLTLVFEYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFG  144 (284)
T ss_pred             ---ceEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccc
Confidence               3599999996 58888776533 4689999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchh-hHHHH-HHHhhccc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT-EQRLL-EWVQQYPA  310 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~-~~~~~-~~~~~~~~  310 (432)
                      ++......  ........+++.|+|||.+.+. .++.++|||||||++|+|+||..|+....... ....+ ........
T Consensus       145 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  222 (284)
T cd07839         145 LARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE  222 (284)
T ss_pred             hhhccCCC--CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence            98753211  1112334678899999998764 47899999999999999999998864332211 11110 00000000


Q ss_pred             Ccc-ccccc----cCccccC-----cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          311 DSK-KFGLI----MDPRLEK-----EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       311 ~~~-~~~~~----~~~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ... .....    ..+....     ......+..+.+++.+||+.||.+|||+.+++.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         223 ESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             HHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            000 00000    0000000     0111234678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.4e-38  Score=299.34  Aligned_cols=257  Identities=26%  Similarity=0.368  Sum_probs=200.6

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|...+.||.|++|.||++...       .++..+|+|.+....     ..+.+|+++++.++||||+++++++.....
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   73 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLK-------NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESS   73 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEEC-------CCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence            36888899999999999999975       367889999986432     247889999999999999999999865443


Q ss_pred             cceeEEEEEeecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                        ...++||||+++++|.+++..  .....+++..+..++.||+.||.|||+.   +++|+||+|+||+++.++.++|+|
T Consensus        74 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d  148 (287)
T cd06621          74 --SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCD  148 (287)
T ss_pred             --CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEee
Confidence              246899999999999988753  2234688999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCc--hhhHHHHHHHhhcc
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP--KTEQRLLEWVQQYP  309 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~--~~~~~~~~~~~~~~  309 (432)
                      ||++......    ......++..|+|||.+.+..++.++||||||+++|+|++|..||.....  ........++....
T Consensus       149 fg~~~~~~~~----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  224 (287)
T cd06621         149 FGVSGELVNS----LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP  224 (287)
T ss_pred             cccccccccc----ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC
Confidence            9998643211    11234578899999999989999999999999999999999999976532  11222333332211


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ..  .    ......  .....+..+.+++.+||..+|.+|||+.+++++
T Consensus       225 ~~--~----~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         225 NP--E----LKDEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             ch--h----hccCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            10  0    000000  011235678899999999999999999999886

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.9e-38  Score=297.14  Aligned_cols=254  Identities=28%  Similarity=0.408  Sum_probs=200.3

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|++.+.||.|+||.||+|...       .++..+++|.+...     ...+.+|+++++.++||||+++++.+.... 
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   72 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICL-------PNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD-   72 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEc-------CCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC-
Confidence            47899999999999999999865       35678999988643     234788999999999999999999887654 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAF-PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                         ..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+||
T Consensus        73 ---~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df  146 (267)
T cd06610          73 ---ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADF  146 (267)
T ss_pred             ---EEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccc
Confidence               45999999999999999976432 4689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCc--ccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          233 GLAREGPMVGHT--HVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       233 G~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      |++.........  .......|+..|+|||.+... .++.++|+|||||++|+|++|..||.......  .........+
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~~~  224 (267)
T cd06610         147 GVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTLQNDP  224 (267)
T ss_pred             chHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHhcCCC
Confidence            998753322221  122345689999999998776 78899999999999999999999997654321  1111111110


Q ss_pred             cCccccccccCccccCcC-CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEY-SINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                 +.+.... ....+..+.+++.+||..||++|||+.+|+++
T Consensus       225 -----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         225 -----------PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             -----------CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                       0010000 12334678899999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.3e-38  Score=295.99  Aligned_cols=249  Identities=28%  Similarity=0.444  Sum_probs=202.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|+..+.||.|+||.||+|+..       .++..|++|.+....     ..+.+|+..+..++||||+++++++.... 
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~-------~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   72 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHK-------PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG-   72 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEc-------CCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC-
Confidence            46888999999999999999875       467889999987652     35889999999999999999999987654 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE-GLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                         ..++||||+++++|.+++...  ..+++..++.++.|++.||.|||+ .   +++|+||+|+||+++.++.++|+||
T Consensus        73 ---~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df  144 (264)
T cd06623          73 ---EISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADF  144 (264)
T ss_pred             ---eEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccC
Confidence               459999999999999999754  478999999999999999999999 8   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      |++......  ........++..|+|||.+.+..++.++||||||+++|+|++|..||..............+.....  
T Consensus       145 ~~~~~~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--  220 (264)
T cd06623         145 GISKVLENT--LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP--  220 (264)
T ss_pred             ccceecccC--CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC--
Confidence            998753221  1122345688999999999988999999999999999999999999977643222223222221110  


Q ss_pred             cccccccCccccCcCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          313 KKFGLIMDPRLEKEYSIN-EARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                              +    ..+.. .+..+.+++.+||..+|++||++.+++++
T Consensus       221 --------~----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 --------P----SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             --------C----CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                    1    11112 34678899999999999999999999886

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-38  Score=301.62  Aligned_cols=264  Identities=25%  Similarity=0.384  Sum_probs=194.0

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|+..+.||.|+||.||+|..+       .+++.||+|.+....     ..+.+|+.+++.++||||+++++++....
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   76 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSK-------LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKK   76 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEc-------CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCC
Confidence            357999999999999999999864       456889999986432     24678999999999999999999987544


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus        77 ----~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df  147 (291)
T cd07844          77 ----TLTLVFEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADF  147 (291)
T ss_pred             ----eEEEEEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECcc
Confidence                4599999997 49999886544 3689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhh-HHHHHHHhhccc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-QRLLEWVQQYPA  310 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~-~~~~~~~~~~~~  310 (432)
                      |+++......  .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||........ ..........+.
T Consensus       148 g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  225 (291)
T cd07844         148 GLARAKSVPS--KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPT  225 (291)
T ss_pred             ccccccCCCC--ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCC
Confidence            9987532111  11122356889999999865 5688999999999999999999999976542211 111110000000


Q ss_pred             Ccc-------------ccccccCccccCcC-CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          311 DSK-------------KFGLIMDPRLEKEY-SINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       311 ~~~-------------~~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ...             .........+.... .......+.+++.+||+.+|.+|||+.+++.+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         226 EETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             hhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            000             00000000000000 01112567799999999999999999998754

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.5e-38  Score=303.18  Aligned_cols=262  Identities=26%  Similarity=0.334  Sum_probs=195.7

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh---------HHHHHHHHHhcccCCCccceeeeEEee
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---------LQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      +|...+.||+|+||.||+|...       .++..||+|.+....         ..+..|+.+++.++||||+++++++..
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   73 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDK-------ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH   73 (298)
T ss_pred             CceeeeeeeeccccEEEEEEEC-------CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec
Confidence            4778889999999999999865       457899999986532         135679999999999999999999876


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .+    ..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+.   +|+|+||||+|||++.++.++|+
T Consensus        74 ~~----~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~  144 (298)
T cd07841          74 KS----NINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLA  144 (298)
T ss_pred             CC----EEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEc
Confidence            43    459999999 999999996543 3689999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH-HHHhhc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL-EWVQQY  308 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~-~~~~~~  308 (432)
                      |||++.......  .......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+..+....... ......
T Consensus       145 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~  222 (298)
T cd07841         145 DFGLARSFGSPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTP  222 (298)
T ss_pred             cceeeeeccCCC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCC
Confidence            999997532221  12223456788999998854 46789999999999999999998888765443221111 110000


Q ss_pred             ccCcc----ccccccCccccC-----cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 PADSK----KFGLIMDPRLEK-----EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 ~~~~~----~~~~~~~~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .....    ............     ......+..+.++|.+||..||.+|||+.+++.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             chhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00000    000000000000     0112235678899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=286.25  Aligned_cols=251  Identities=27%  Similarity=0.480  Sum_probs=194.4

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-----HHHHHHHHhccc-CCCccceeeeEEee
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-----QWVAEVQFLGVL-EHPNLVKLIGYCAV  150 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l-~hpniv~l~~~~~~  150 (432)
                      ..++.+.+..||.|+.|.||+++++       .++..+|||.+.+...     ++...+.++... +.|+||+.+|+|..
T Consensus        90 dindl~~l~dlGsGtcG~V~k~~~r-------s~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~  162 (391)
T KOG0983|consen   90 DINDLENLGDLGSGTCGQVWKMRFR-------STGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT  162 (391)
T ss_pred             ChHHhhhHHhhcCCCccceEEEEEc-------ccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence            4466777888999999999999987       5789999999976432     355566666555 48999999999998


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      +...    ++.||.| ..-++.++ .+...++++..+-++...++.||.||..++  +|+|||+||+|||+|+.|++|||
T Consensus       163 n~dV----~IcMelM-s~C~ekLl-krik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlC  234 (391)
T KOG0983|consen  163 NTDV----FICMELM-STCAEKLL-KRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLC  234 (391)
T ss_pred             CchH----HHHHHHH-HHHHHHHH-HHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEee
Confidence            7655    7889988 33444444 444568999999999999999999999874  99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCcccccc---CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET---GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  307 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  307 (432)
                      |||++-+..   .+...+...|.+.|||||.+..   ..|+-++||||||++++||.||..||.+...+-  ..+..+..
T Consensus       235 DFGIsGrlv---dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~ltkvln  309 (391)
T KOG0983|consen  235 DFGISGRLV---DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EVLTKVLN  309 (391)
T ss_pred             cccccceee---cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HHHHHHHh
Confidence            999986532   2223344569999999999964   468889999999999999999999999865432  22222222


Q ss_pred             cccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ..          .|.+...  ...+..+.+++..||..|+.+||...+++++
T Consensus       310 ~e----------PP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  310 EE----------PPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             cC----------CCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            10          1122211  1145678899999999999999999999987

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2e-38  Score=300.19  Aligned_cols=263  Identities=23%  Similarity=0.347  Sum_probs=197.2

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      +|++.+.||.|+||.||+|...       .++..||+|.+....      ..+.+|+.+++.++||||+++++++.... 
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-   72 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDR-------ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGS-   72 (286)
T ss_pred             CceEEeecccCCCcEEEEEEEC-------CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCC-
Confidence            4788899999999999999865       457889999986432      35789999999999999999999987643 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+ +++|.+++.... .++++..+..++.||+.||.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        73 ---~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg  144 (286)
T cd07832          73 ---GFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFG  144 (286)
T ss_pred             ---eeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeee
Confidence               459999999 999999986544 5799999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHH-HHHHhhcccC
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL-LEWVQQYPAD  311 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~-~~~~~~~~~~  311 (432)
                      ++........ .......|+..|+|||.+.+. .++.++||||||+++|+|++|.+||.+......... ..........
T Consensus       145 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (286)
T cd07832         145 LARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEE  223 (286)
T ss_pred             ecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChH
Confidence            9875432211 122345689999999998654 468999999999999999999888876543222111 1100000000


Q ss_pred             c-------cccccccCcccc----CcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 S-------KKFGLIMDPRLE----KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~-------~~~~~~~~~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .       .....+..+.-.    .......+..+.+++.+||..+|.+|||+.+++.+
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         224 TWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             HHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0       000000000000    00011234678899999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.4e-38  Score=309.33  Aligned_cols=263  Identities=22%  Similarity=0.296  Sum_probs=198.4

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEee
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      ..++|+..+.||+|+||.||+|...       .++..||+|.+.+.      ...+.+|+.+++.++||||+++++++..
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   86 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDT-------VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTP   86 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEEC-------CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeecc
Confidence            4578999999999999999999865       46788999998642      2246789999999999999999998865


Q ss_pred             cCC--cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCcee
Q 014034          151 DGE--RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  228 (432)
Q Consensus       151 ~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k  228 (432)
                      ...  .....++||||+. ++|.+.+..    .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        87 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~k  158 (353)
T cd07850          87 QKSLEEFQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK  158 (353)
T ss_pred             CCCccccCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEE
Confidence            432  1234689999995 588888753    288899999999999999999998   999999999999999999999


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      |+|||++.....   ........++..|+|||.+.+..++.++|||||||++|+|++|..||...+.......+  ...+
T Consensus       159 L~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~--~~~~  233 (353)
T cd07850         159 ILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKI--IEQL  233 (353)
T ss_pred             EccCccceeCCC---CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH--HHhc
Confidence            999999975321   11123356889999999999999999999999999999999999999765432211110  0000


Q ss_pred             ccC-----------------------ccccccccCccc----cCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 PAD-----------------------SKKFGLIMDPRL----EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 ~~~-----------------------~~~~~~~~~~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ...                       ...+..+....+    ........+..+.+++.+||+.||.+|||+.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         234 GTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             CCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000                       000001111000    001112335568899999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-40  Score=317.20  Aligned_cols=249  Identities=23%  Similarity=0.412  Sum_probs=202.3

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      +.|.++..||.|+||+||+|..+       .++...|-|.+....    ..+.-|+.||..++||+||+|++.|..++. 
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nk-------et~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-  103 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNK-------ETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-  103 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcc-------cchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-
Confidence            34677778999999999999865       455666777775433    347889999999999999999998887664 


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                         +|+..|||.||-++..+..-. .+|++.++..++.|++.||.|||++   +|||||||..|||++-+|.++|+|||+
T Consensus       104 ---LwiliEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGV  176 (1187)
T KOG0579|consen  104 ---LWILIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGV  176 (1187)
T ss_pred             ---eEEEEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccc
Confidence               499999999999998887654 5899999999999999999999999   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCcccc-----ccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYI-----ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      +-.  ..........+.|||.|||||+.     ...+|+.++||||||++|.||..+.+|-...++.-   .+-.+..-.
T Consensus       177 SAK--n~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR---VllKiaKSe  251 (1187)
T KOG0579|consen  177 SAK--NKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---VLLKIAKSE  251 (1187)
T ss_pred             ccc--chhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH---HHHHHhhcC
Confidence            854  23334455678999999999987     45789999999999999999999999987655432   221121110


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                .|.+  -.|...+..+.+++.+||..||..||++.+++++
T Consensus       252 ----------PPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  252 ----------PPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             ----------CCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence                      1111  1244556788999999999999999999999986

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.4e-38  Score=303.00  Aligned_cols=253  Identities=26%  Similarity=0.348  Sum_probs=196.3

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|...+.||+|+||.||++.+.       ..+..|++|.+....       ..+.+|+.+++.++||||+++++.+...
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~-------~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   73 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHK-------ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETK   73 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEEC-------CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC
Confidence            46889999999999999999875       456889999886542       2367899999999999999999988754


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|
T Consensus        74 ~----~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~d  144 (305)
T cd05609          74 R----HLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTD  144 (305)
T ss_pred             C----EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEee
Confidence            4    459999999999999999654  3689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCc-------------ccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhh
Q 014034          232 FGLAREGPMVGHT-------------HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE  298 (432)
Q Consensus       232 fG~a~~~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~  298 (432)
                      ||+++........             .......|+..|+|||.+.+..++.++|||||||++|+|++|..||.+..... 
T Consensus       145 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-  223 (305)
T cd05609         145 FGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-  223 (305)
T ss_pred             CCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence            9998632111000             01112457889999999988889999999999999999999999997654322 


Q ss_pred             HHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 014034          299 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  362 (432)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  362 (432)
                        +........        ...+..    ....+..+.+++.+||+.||++||++.++.+.|+.
T Consensus       224 --~~~~~~~~~--------~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         224 --LFGQVISDD--------IEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             --HHHHHHhcc--------cCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence              111111000        000100    11234568899999999999999997655555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=317.24  Aligned_cols=242  Identities=26%  Similarity=0.419  Sum_probs=198.2

Q ss_pred             ccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH----HHHHHHHHhcccCCCccceeeeEEeecCCcceeEEEE
Q 014034           86 KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL----QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLV  161 (432)
Q Consensus        86 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~lv  161 (432)
                      .||+|.||+||-|+..       .+...+|||.+.....    -+..|+.+-+.|+|.|||+++|.+..++    ..-+.
T Consensus       582 VLGKGTYG~VYA~RD~-------~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG----f~kIF  650 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDM-------DTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG----FFKIF  650 (1226)
T ss_pred             EeecCceeEEEeeccc-------cceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC----eEEEE
Confidence            5999999999999854       6778999999875433    3778999999999999999999986655    34789


Q ss_pred             EeecCCCCHHHHhhcCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc-CCCceeeccccCCcCC
Q 014034          162 YEFMLNRSLEDHLFNRAFPPL--PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLAREG  238 (432)
Q Consensus       162 ~e~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~~kl~DfG~a~~~  238 (432)
                      ||-++||+|.+.|+... +++  ++.+..-+..||++||.|||++   .|||||||-+||||+ -.|.+||+|||-+++.
T Consensus       651 MEqVPGGSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRL  726 (1226)
T KOG4279|consen  651 MEQVPGGSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRL  726 (1226)
T ss_pred             eecCCCCcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhh
Confidence            99999999999997654 577  7888899999999999999998   999999999999996 6899999999999873


Q ss_pred             CCCCCcccccccccCCCccCccccccC--CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 014034          239 PMVGHTHVSTAVVGTFGYAAPDYIETG--HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  316 (432)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (432)
                        .+...-..++.||+.|||||++..+  .|+.++|||||||++.||.||++||-..... .. -+..+..+.       
T Consensus       727 --AginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp-qA-AMFkVGmyK-------  795 (1226)
T KOG4279|consen  727 --AGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP-QA-AMFKVGMYK-------  795 (1226)
T ss_pred             --ccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh-hH-hhhhhccee-------
Confidence              3444455678899999999999754  6899999999999999999999999643221 11 111111111       


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       317 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                            ..+..|.+.+.....+|.+|+..||.+||++.+++..
T Consensus       796 ------vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  796 ------VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             ------cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence                  1224466777889999999999999999999999875

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.7e-38  Score=302.19  Aligned_cols=265  Identities=24%  Similarity=0.359  Sum_probs=197.6

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      ++|+..+.||.|+||.||+|...       .+++.+++|.++...      ..+.+|+.++++++||||+++++++....
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   77 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDK-------KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN   77 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEEC-------CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC
Confidence            47899999999999999999865       456789999986432      13578999999999999999999987653


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                      .  ...++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.   +++|+||||+|||++.++.++|+||
T Consensus        78 ~--~~~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~  150 (293)
T cd07843          78 L--DKIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDF  150 (293)
T ss_pred             C--CcEEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeec
Confidence            2  24699999996 59998886543 3689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHH-HHHHh----
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL-LEWVQ----  306 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~-~~~~~----  306 (432)
                      |++.......  .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||........... .....    
T Consensus       151 g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~  228 (293)
T cd07843         151 GLAREYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTE  228 (293)
T ss_pred             CceeeccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Confidence            9987533221  122334578899999998754 468899999999999999999999986554322111 11100    


Q ss_pred             -------hcccCc-cccccccCccccCcCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          307 -------QYPADS-KKFGLIMDPRLEKEYSIN-EARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       307 -------~~~~~~-~~~~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                             ..+... ..........+...++.. .+..+.++|.+||+.+|++|||+.|++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         229 KIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             HHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence                   000000 000000011111122222 35678899999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3e-38  Score=297.02  Aligned_cols=252  Identities=23%  Similarity=0.407  Sum_probs=194.9

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh--------------HHHHHHHHHhcccCCCccceee
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--------------LQWVAEVQFLGVLEHPNLVKLI  145 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--------------~~~~~E~~~l~~l~hpniv~l~  145 (432)
                      +|...+.||.|+||.||+|...       .++..||+|.+....              ..+..|+.+++.++||||++++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~-------~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   74 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNV-------TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYL   74 (272)
T ss_pred             ceeecceecccCceEEEEEeec-------CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEE
Confidence            4778889999999999999854       457889999875311              1367799999999999999999


Q ss_pred             eEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC
Q 014034          146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF  225 (432)
Q Consensus       146 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~  225 (432)
                      +++...+    ..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++
T Consensus        75 ~~~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~  145 (272)
T cd06629          75 GFETTEE----YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADG  145 (272)
T ss_pred             EEeccCC----ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCC
Confidence            9886544    358999999999999999765  4789999999999999999999998   999999999999999999


Q ss_pred             ceeeccccCCcCCCCCCCcccccccccCCCccCccccccCC--CCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 014034          226 RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH--LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE  303 (432)
Q Consensus       226 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~  303 (432)
                      .++|+|||++................|+..|+|||.+....  ++.++|+||||+++|++++|..||.......  ....
T Consensus       146 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~  223 (272)
T cd06629         146 ICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--AMFK  223 (272)
T ss_pred             eEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH--HHHH
Confidence            99999999987532211111223456889999999987654  7899999999999999999999996433221  1111


Q ss_pred             HHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          304 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .....          ....+........+..+.+++.+||..+|.+|||+.+|+.+
T Consensus       224 ~~~~~----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         224 LGNKR----------SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             hhccc----------cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            00000          00111111112335678899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=9.3e-39  Score=304.05  Aligned_cols=245  Identities=26%  Similarity=0.394  Sum_probs=193.6

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCccceeeeEEeecCCcce
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~  156 (432)
                      |.....||+|+||.||++...       .++..||||.+....    ..+.+|+.+++.++||||+++++.+...+    
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~----   92 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEK-------HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD----   92 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEEC-------CCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC----
Confidence            444466999999999999864       457889999886432    24778999999999999999999887654    


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      ..++||||+++++|.+++..   ..+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.++|+|||++.
T Consensus        93 ~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~  166 (292)
T cd06658          93 ELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCA  166 (292)
T ss_pred             eEEEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchh
Confidence            45999999999999998854   2588999999999999999999998   99999999999999999999999999986


Q ss_pred             CCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  316 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (432)
                      ....  .........|+..|+|||.+.+..++.++||||||+++|||++|..||....+.......  ....        
T Consensus       167 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~--~~~~--------  234 (292)
T cd06658         167 QVSK--EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI--RDNL--------  234 (292)
T ss_pred             hccc--ccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhcC--------
Confidence            4321  111223456899999999998888999999999999999999999999765443221111  0111        


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       317 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                         .+.+..  ....+..+.+++.+||..||.+|||+.+++++
T Consensus       235 ---~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         235 ---PPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ---CCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence               111110  11234568899999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-40  Score=305.64  Aligned_cols=250  Identities=28%  Similarity=0.429  Sum_probs=204.1

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHH-------HHHHHHHhcccCCCccceeeeEEee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-------WVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .+.|..-+.||+|+||.||-+..+       .+|+.+|+|.+.+....       ..+|-.||.+++.+.||.+--.+..
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvr-------aTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT  256 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVR-------ATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET  256 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEe-------cchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC
Confidence            367888899999999999988865       68899999998765432       6789999999999999998555544


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .+    .+|||+..|+||+|.-+|++...+.+++..+.-++.+|+.||++||..   +||+||+||+|||+|+.|+++|+
T Consensus       257 kd----~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRIS  329 (591)
T KOG0986|consen  257 KD----ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRIS  329 (591)
T ss_pred             CC----ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEee
Confidence            33    469999999999999999998888999999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHHHhhcc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWVQQYP  309 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~  309 (432)
                      |+|+|...+.   .......+||.+|||||++.++.|+...|+|||||++|||+.|+.||......... .+...+... 
T Consensus       330 DLGLAvei~~---g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~-  405 (591)
T KOG0986|consen  330 DLGLAVEIPE---GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED-  405 (591)
T ss_pred             ccceEEecCC---CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc-
Confidence            9999986432   22234458999999999999999999999999999999999999999865443322 111111111 


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM-----SQVVER  359 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~~  359 (432)
                                    ...++...++++.+|....|..||.+|...     .++.+|
T Consensus       406 --------------~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H  446 (591)
T KOG0986|consen  406 --------------PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH  446 (591)
T ss_pred             --------------hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence                          123445556788899999999999999754     455554

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.4e-38  Score=294.93  Aligned_cols=245  Identities=24%  Similarity=0.381  Sum_probs=195.2

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh---------HHHHHHHHHhcccCCCccceeeeEEee
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---------LQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      +|+..+.||+|+||.||+|...       .++..|++|.+....         ..+.+|+.+++.++||||+++++++..
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   73 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNL-------DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE   73 (258)
T ss_pred             CccccceeeecCCceEEEEEEc-------CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec
Confidence            3677789999999999999864       357889999875422         347889999999999999999998875


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      ..    ..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+
T Consensus        74 ~~----~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~  144 (258)
T cd06632          74 ED----NLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLA  144 (258)
T ss_pred             CC----eEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEc
Confidence            54    359999999999999999654  3688999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH-LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      |||++.......   ......|+..|++||.+.... ++.++|+||||+++|+|++|..||........  .... ....
T Consensus       145 d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~~~~-~~~~  218 (258)
T cd06632         145 DFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--VFKI-GRSK  218 (258)
T ss_pred             cCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--HHHH-Hhcc
Confidence            999987532211   223456889999999987766 89999999999999999999999976542211  1111 1100


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .         .+    ..+......+.+++.+||+.+|.+||++.+++.+
T Consensus       219 ~---------~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         219 E---------LP----PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             c---------CC----CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence            0         00    1112234678899999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-39  Score=310.86  Aligned_cols=248  Identities=25%  Similarity=0.390  Sum_probs=195.0

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhccc-CCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVL-EHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l-~hpniv~l~~~~~~~  151 (432)
                      ..|+++++||+||.+.||++..        .+...+|+|++....      ..|.+|+..|.+| .|.+||.||+|-..+
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~--------s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d  432 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLN--------SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD  432 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeec--------CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence            4699999999999999999874        355778888765321      2389999999999 499999999998776


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    .+|+||||- ..+|..+|.........| .+..+..|++.++.++|.+   ||||.||||.|+|+- .|.+||+|
T Consensus       433 ~----~lYmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLID  502 (677)
T KOG0596|consen  433 G----YLYMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLID  502 (677)
T ss_pred             c----eEEEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeee
Confidence            5    459999987 679999998765433334 6778899999999999999   999999999999987 56899999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCC-----------CCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH-----------LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR  300 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~  300 (432)
                      ||+|.........-.....+||+.||+||.+....           .+.++||||||||||+|+.|+.||.....     
T Consensus       503 FGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----  577 (677)
T KOG0596|consen  503 FGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----  577 (677)
T ss_pred             echhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----
Confidence            99999776666666667789999999999985432           45789999999999999999999974321     


Q ss_pred             HHHHHhhcccCccccccccCccccCcCCHHH-HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          301 LLEWVQQYPADSKKFGLIMDPRLEKEYSINE-ARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ...          .+..+.+|...-.++... ...+.++++.||..||.+|||+.++|++
T Consensus       578 ~~a----------Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  578 QIA----------KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             HHH----------HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            111          112233443322222111 1238899999999999999999999987

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.1e-38  Score=300.06  Aligned_cols=264  Identities=24%  Similarity=0.342  Sum_probs=194.3

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++++|...+.||+|+||.||+|...       .++..||+|.+....     ..+.+|+.+++.++|+||+++++++...
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   75 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISR-------INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTK   75 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEc-------CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC
Confidence            4578999999999999999999865       456789999985432     2467899999999999999999998754


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      .    ..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.++|+|
T Consensus        76 ~----~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~D  146 (291)
T cd07870          76 E----TLTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLAD  146 (291)
T ss_pred             C----eEEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEec
Confidence            3    4589999995 67877775433 3578888999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc-
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP-  309 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~-  309 (432)
                      ||+++.....  ........+++.|+|||.+.+ ..++.++|||||||++|+|++|..||........ .+........ 
T Consensus       147 fg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~  223 (291)
T cd07870         147 FGLARAKSIP--SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKIWTVLGV  223 (291)
T ss_pred             cccccccCCC--CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHHHHHcCC
Confidence            9998753221  111233457899999999875 4578899999999999999999999986544221 1111111000 


Q ss_pred             -cCc---------cccccccCccccCc-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 -ADS---------KKFGLIMDPRLEKE-----YSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 -~~~---------~~~~~~~~~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                       ...         ..............     .....+..+.+++.+|+..||.+|||+.+++.+
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         224 PTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             CChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence             000         00000000000000     000113567899999999999999999998764

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.6e-38  Score=296.03  Aligned_cols=251  Identities=24%  Similarity=0.433  Sum_probs=195.1

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh--------------HHHHHHHHHhcc-cCCCcccee
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--------------LQWVAEVQFLGV-LEHPNLVKL  144 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--------------~~~~~E~~~l~~-l~hpniv~l  144 (432)
                      +|++.+.||+|+||.||+|....      ..+..+|+|.+....              ..+..|+.++.. ++||||+++
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~------~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~   74 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKN------NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRY   74 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcC------CCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeE
Confidence            47888999999999999999751      145789999874211              235678887764 799999999


Q ss_pred             eeEEeecCCcceeEEEEEeecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc
Q 014034          145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD  222 (432)
Q Consensus       145 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~  222 (432)
                      ++++..++    ..++||||+++++|.+++..  .....+++..++.++.|++.||.|||+.  .+++|+||+|+|||++
T Consensus        75 ~~~~~~~~----~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~  148 (269)
T cd08528          75 YKTFLEND----RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLG  148 (269)
T ss_pred             EeeEccCC----eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEEC
Confidence            99987654    35999999999999998753  2234689999999999999999999963  2899999999999999


Q ss_pred             CCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014034          223 ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  302 (432)
Q Consensus       223 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  302 (432)
                      .++.++|+|||++.......   ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.........   
T Consensus       149 ~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~---  222 (269)
T cd08528         149 EDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA---  222 (269)
T ss_pred             CCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH---
Confidence            99999999999997532211   234466899999999999888999999999999999999999999754332211   


Q ss_pred             HHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          303 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                      ..+....         ..+..    ....+..+.++|.+||+.||++||++.++..+++
T Consensus       223 ~~~~~~~---------~~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         223 TKIVEAV---------YEPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HHHhhcc---------CCcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            1111100         00000    1112356889999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7.5e-39  Score=303.31  Aligned_cols=263  Identities=26%  Similarity=0.376  Sum_probs=196.3

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      ++|+..+.||+|+||.||+|.+.       .+++.||+|.+...      ...+.+|+++++.++||||+++++++....
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   73 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHK-------ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK   73 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEEC-------CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCC
Confidence            36888999999999999999865       35688999987532      224778999999999999999999986544


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..++||||+.+++|..+....  ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+||
T Consensus        74 ----~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~df  144 (286)
T cd07846          74 ----RLYLVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDF  144 (286)
T ss_pred             ----eEEEEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEee
Confidence                459999999999998876543  3589999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHHHhhccc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWVQQYPA  310 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~~  310 (432)
                      |++......  ........++..|+|||++.+ ..++.++||||||+++|+|++|..||......... .+..+...+..
T Consensus       145 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  222 (286)
T cd07846         145 GFARTLAAP--GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIP  222 (286)
T ss_pred             eeeeeccCC--ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCch
Confidence            998753221  122233568899999999865 45788999999999999999999999765432211 11111111110


Q ss_pred             Ccc-------ccccccCccccC-----cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          311 DSK-------KFGLIMDPRLEK-----EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       311 ~~~-------~~~~~~~~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ...       .......+....     ......+..+.+|+.+||..+|++||++.+++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         223 RHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             hhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            000       000000000000     0011235678899999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.5e-38  Score=297.78  Aligned_cols=251  Identities=28%  Similarity=0.444  Sum_probs=198.0

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|+..+.||.|+||.||++.+.       .++..||+|.+....     ..+.+|+++++.++||||+++++++...+ 
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-   72 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHR-------PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG-   72 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEc-------CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCC-
Confidence            36788889999999999999875       467889999876542     24788999999999999999999987654 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE-GLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                         ..++++||+.+++|.+++.... ..+++..+..++.|++.||.|||+ .   +++|+||||+||+++.++.++|+||
T Consensus        73 ---~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~  145 (265)
T cd06605          73 ---DISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDF  145 (265)
T ss_pred             ---EEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeec
Confidence               4599999999999999987643 578999999999999999999999 7   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      |.+.....    .......++..|+|||.+.+..++.++||||||+++|+|++|..||........ ............ 
T Consensus       146 g~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~-  219 (265)
T cd06605         146 GVSGQLVN----SLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVNE-  219 (265)
T ss_pred             ccchhhHH----HHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhcC-
Confidence            99864211    111226788999999999988999999999999999999999999975432111 111111111000 


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                            ..+.+.   ....+..+.++|.+||..||.+|||+.+++.+
T Consensus       220 ------~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         220 ------PPPRLP---SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             ------CCCCCC---hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence                  001110   11145678899999999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.6e-38  Score=298.86  Aligned_cols=242  Identities=26%  Similarity=0.388  Sum_probs=196.7

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|+..+.||+|+||.||++...       .++..||+|.+...       ...+.+|++++++++||||+++++++...
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   73 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHK-------GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD   73 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEc-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC
Confidence            46889999999999999999875       35788999988642       23477899999999999999999998764


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      .    ..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +|+|+||+|+|||++.++.+||+|
T Consensus        74 ~----~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d  144 (290)
T cd05580          74 S----NLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITD  144 (290)
T ss_pred             C----eEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEee
Confidence            4    459999999999999998665  3789999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ||++......     .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.......   ....+...   
T Consensus       145 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~---  213 (290)
T cd05580         145 FGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ---IYEKILEG---  213 (290)
T ss_pred             CCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhcC---
Confidence            9998763221     234568999999999988888999999999999999999999997654321   11111110   


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  359 (432)
                              ..    ..+...+..+.+++.+||..||.+||     ++.+++.+
T Consensus       214 --------~~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         214 --------KV----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             --------Cc----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence                    00    01112246788999999999999999     77777655

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.5e-38  Score=300.36  Aligned_cols=260  Identities=18%  Similarity=0.216  Sum_probs=187.8

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHH---------------HHHHHHHhcccCCCccc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---------------WVAEVQFLGVLEHPNLV  142 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---------------~~~E~~~l~~l~hpniv  142 (432)
                      .++|.+.+.||+|+||.||+|.+...    ...+..+|+|........               ...+...+..+.|+||+
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~----~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~   86 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASD----HCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP   86 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCC----cccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence            35799999999999999999987521    112456677764322211               12233445677899999


Q ss_pred             eeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc
Q 014034          143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD  222 (432)
Q Consensus       143 ~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~  222 (432)
                      ++++++..........+++++++. .++.+.+...  ...++..+..++.|++.||.|||+.   +|+||||||+|||++
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~  160 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD  160 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence            999977655444344578888773 4666666432  2467888999999999999999998   999999999999999


Q ss_pred             CCCceeeccccCCcCCCCCCCc-----ccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchh
Q 014034          223 ENFRPKLSDFGLAREGPMVGHT-----HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT  297 (432)
Q Consensus       223 ~~~~~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~  297 (432)
                      .++.++|+|||+|+........     .......||+.|+|||++.+..++.++|||||||++|||++|..||.+.....
T Consensus       161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~  240 (294)
T PHA02882        161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG  240 (294)
T ss_pred             CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence            9999999999999753221111     11223469999999999999999999999999999999999999998763322


Q ss_pred             hHHH---HHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          298 EQRL---LEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       298 ~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                      ....   ..+......          ..+.   ....+..+.+++..||..+|++||++.+|++.|
T Consensus       241 ~~~~~~~~~~~~~~~~----------~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        241 NLIHAAKCDFIKRLHE----------GKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHHhHHHHHHHhhh----------hhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            1110   111111111          0000   111246788999999999999999999998875

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=6.2e-38  Score=295.96  Aligned_cols=244  Identities=29%  Similarity=0.436  Sum_probs=196.2

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      -|...+.||.|+||.||+|...       .++..||+|.+....     ..+.+|+.++..++||||+++++++....  
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--   75 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDN-------RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT--   75 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEEC-------CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC--
Confidence            4778889999999999999864       457899999875432     24778999999999999999999987654  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        ..++||||+.+++|.+++..   ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||+
T Consensus        76 --~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~  147 (277)
T cd06641          76 --KLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGV  147 (277)
T ss_pred             --eEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeeccc
Confidence              35999999999999999854   3589999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      +.....  .........++..|+|||.+.+..++.++|+|||||++|+|++|..||.......   ....+....     
T Consensus       148 ~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~-----  217 (277)
T cd06641         148 AGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---VLFLIPKNN-----  217 (277)
T ss_pred             ceeccc--chhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---HHHHHhcCC-----
Confidence            865321  1112233568889999999988888999999999999999999999997644322   111111100     


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                           .+.+    ....+..+.+++.+||+.+|.+||++.+++.+
T Consensus       218 -----~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         218 -----PPTL----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             -----CCCC----CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                 0111    12234568899999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.2e-38  Score=297.25  Aligned_cols=261  Identities=25%  Similarity=0.384  Sum_probs=195.4

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      +|+..+.||.|++|.||+|+..       .++..||+|.+...     ...+.+|+.+++.++||||+++++++...+. 
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-   72 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNR-------TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENK-   72 (284)
T ss_pred             CceEeeeeccCCceEEEEEEEC-------CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCc-
Confidence            5888999999999999999865       46789999988643     2346789999999999999999999987653 


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         .++||||+.+ +|.+++.... ...+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||
T Consensus        73 ---~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g  145 (284)
T cd07836          73 ---LMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFG  145 (284)
T ss_pred             ---EEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecc
Confidence               4999999975 8888876533 24689999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHHHhhcccC
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR-LLEWVQQYPAD  311 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~  311 (432)
                      ++......  ........++..|++||.+.+ ..++.++|||||||++|+|++|..||.+........ +..... .+..
T Consensus       146 ~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~  222 (284)
T cd07836         146 LARAFGIP--VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMG-TPTE  222 (284)
T ss_pred             hhhhhcCC--ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC-CCCh
Confidence            98743211  112233457889999998865 457889999999999999999999998655432211 111100 0000


Q ss_pred             cccccccc-Ccccc-----------CcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 SKKFGLIM-DPRLE-----------KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~-~~~l~-----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                       ..+..+. .+.+.           .......+..+.+++.+||+.||.+||++.+++.+
T Consensus       223 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         223 -STWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             -hhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             0000000 00000           00111234678899999999999999999998754

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-38  Score=299.18  Aligned_cols=261  Identities=26%  Similarity=0.384  Sum_probs=194.6

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      |+..+.||.|++|.||+|...       .++..||+|++....      ..+.+|+.+++.++||||+++++++...+  
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~--   71 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDK-------LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN--   71 (283)
T ss_pred             CchheEecCCCCeEEEEEEEc-------CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC--
Confidence            567889999999999999865       467889999886432      34778999999999999999999987653  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        ..+++|||+ +++|.+++.......+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||+
T Consensus        72 --~~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~  145 (283)
T cd07835          72 --KLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGL  145 (283)
T ss_pred             --eEEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeeccc
Confidence              459999999 56999998765545689999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHHHhhcccCc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWVQQYPADS  312 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~  312 (432)
                      +......  ........++..|+|||++.+. .++.++||||||+++|+|++|..||......... .+...........
T Consensus       146 ~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  223 (283)
T cd07835         146 ARAFGVP--VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDV  223 (283)
T ss_pred             ccccCCC--ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence            8753211  1112233568899999988654 5788999999999999999999999865543221 1111100000000


Q ss_pred             -----------cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          313 -----------KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       313 -----------~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                 ..+........ .......+..+.+++.+||+.||.+|||+.+++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         224 WPGVTSLPDYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhhhchhhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                       00000000000 00111233578899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.3e-38  Score=298.91  Aligned_cols=266  Identities=23%  Similarity=0.343  Sum_probs=195.5

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccC-CCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLE-HPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~-hpniv~l~~~~~~~  151 (432)
                      ++|+..+.||+|+||.||+|...       .++..||+|.+....      ..+.+|+.+++.+. ||||+++++++...
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~-------~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~   73 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDK-------NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVE   73 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEEC-------CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeec
Confidence            36889999999999999999865       467889999876432      34778999999995 69999999988765


Q ss_pred             CC-cceeEEEEEeecCCCCHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC-CCc
Q 014034          152 GE-RGIQRLLVYEFMLNRSLEDHLFNRA---FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE-NFR  226 (432)
Q Consensus       152 ~~-~~~~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~  226 (432)
                      .. .....++||||+.+ +|.+++....   ...+++..++.++.||+.||.|||+.   +|+||||||+||+++. ++.
T Consensus        74 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~  149 (295)
T cd07837          74 EKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGL  149 (295)
T ss_pred             CCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCe
Confidence            43 22335899999975 8888876432   24689999999999999999999998   9999999999999998 899


Q ss_pred             eeeccccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHH
Q 014034          227 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEW  304 (432)
Q Consensus       227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~  304 (432)
                      +||+|||++......  ........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+....... .+...
T Consensus       150 ~kl~dfg~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~  227 (295)
T cd07837         150 LKIADLGLGRAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKL  227 (295)
T ss_pred             EEEeecccceecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            999999998753221  111223357889999998865 45789999999999999999999999865443221 11111


Q ss_pred             HhhcccCcccccccc-------Ccccc----CcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          305 VQQYPADSKKFGLIM-------DPRLE----KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       305 ~~~~~~~~~~~~~~~-------~~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      +.. +.. ..+....       .+...    .......+..+.++|.+||..||.+||++.+++.+
T Consensus       228 ~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         228 LGT-PTE-QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hCC-CCh-hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            110 000 0000000       00000    00011235668899999999999999999999865

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.7e-38  Score=294.53  Aligned_cols=247  Identities=28%  Similarity=0.454  Sum_probs=197.1

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      +|...+.||+|+||.||++...       .++..+|+|.+...      ...+.+|+.+++.++||||+++++.+...+ 
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~-   72 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAK-------SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENG-   72 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEc-------CCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCC-
Confidence            4788899999999999999875       45678999998542      234778999999999999999999886654 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC-ceeeccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF-RPKLSDF  232 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~Df  232 (432)
                         ..++|+||+++++|.+++.......+++..+..++.|++.||.|||+.   +++|+||||+||++++++ .++|+||
T Consensus        73 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~  146 (257)
T cd08225          73 ---RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDF  146 (257)
T ss_pred             ---eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEeccc
Confidence               359999999999999999765555689999999999999999999998   999999999999998886 4699999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      |.+.....  .........|++.|+|||++.+..++.++|+||||+++|+|++|..||........  ........    
T Consensus       147 ~~~~~~~~--~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~----  218 (257)
T cd08225         147 GIARQLND--SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL--VLKICQGY----  218 (257)
T ss_pred             ccchhccC--CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH--HHHHhccc----
Confidence            99875321  11122335689999999999888899999999999999999999999975433211  11111110    


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                            ..     ......+..+.+++.+||..+|++|||+.+++++
T Consensus       219 ------~~-----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         219 ------FA-----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ------CC-----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                  00     0111223578899999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.1e-38  Score=300.62  Aligned_cols=247  Identities=25%  Similarity=0.382  Sum_probs=197.4

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC----hHHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      ++|...+.||+|+||.||++...       .++..||+|.+...    ...+.+|+.+++.++||||+++++++..... 
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~-   90 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDV-------ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDE-   90 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEc-------CCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCc-
Confidence            57999999999999999999754       35678999987542    2347889999999999999999999876543 


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                         .++|+||+++++|.+++.+.   .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+
T Consensus        91 ---~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~  161 (293)
T cd06647          91 ---LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF  161 (293)
T ss_pred             ---EEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcc
Confidence               49999999999999998653   478999999999999999999998   999999999999999999999999998


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      +......  ........|++.|++||.+.+..++.++||||||+++|++++|..||...........   ...       
T Consensus       162 ~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~---~~~-------  229 (293)
T cd06647         162 CAQITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IAT-------  229 (293)
T ss_pred             eeccccc--ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee---hhc-------
Confidence            8643221  1122345688999999999888899999999999999999999999976543221100   000       


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                           ........+...+..+.+++.+||..+|.+||++.+++.+
T Consensus       230 -----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         230 -----NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             -----CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 0000001122234568899999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.9e-38  Score=302.69  Aligned_cols=245  Identities=24%  Similarity=0.369  Sum_probs=194.1

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC----hHHHHHHHHHhcccCCCccceeeeEEeecCCcce
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~  156 (432)
                      |.....||+|+||.||+|...       .++..||+|.+...    ...+.+|+.++..++||||+++++++...+    
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~----   91 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREK-------HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE----   91 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEc-------CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCC----
Confidence            444557999999999999864       45678999998542    234778999999999999999999887654    


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      ..++||||+++++|..++..   ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.
T Consensus        92 ~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~  165 (297)
T cd06659          92 ELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCA  165 (297)
T ss_pred             eEEEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHh
Confidence            45999999999999998754   3589999999999999999999998   99999999999999999999999999986


Q ss_pred             CCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  316 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (432)
                      .....  ........|+..|+|||++.+..++.++|||||||++|+|++|..||....+....   ..+...+...    
T Consensus       166 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~~~~~~~~~~----  236 (297)
T cd06659         166 QISKD--VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---KRLRDSPPPK----  236 (297)
T ss_pred             hcccc--cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHhccCCCC----
Confidence            43211  11223456899999999999888999999999999999999999999765433221   1111111100    


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       317 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                            .  ......+..+.+++.+||+.+|.+||++.+++++
T Consensus       237 ------~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         237 ------L--KNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             ------c--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence                  0  0011223567899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6.6e-38  Score=298.30  Aligned_cols=264  Identities=23%  Similarity=0.323  Sum_probs=194.2

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      ++|+..+.||+|+||.||+|...       .+++.||+|.+....      ..+.+|+++++.++||||+++++++....
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   74 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDR-------VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK   74 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEec-------CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCC
Confidence            57899999999999999999865       467889999885431      34778999999999999999999987654


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC-CCceeecc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE-NFRPKLSD  231 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~D  231 (432)
                          ..++||||+. ++|.+++.......+++..+..++.||+.||.|||++   +++|+||+|+||+++. ++.+||+|
T Consensus        75 ----~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~d  146 (294)
T PLN00009         75 ----RLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLAD  146 (294)
T ss_pred             ----eEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcc
Confidence                4599999995 5888888665544568888999999999999999998   9999999999999985 56799999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      ||++......  ........+++.|+|||.+.+ ..++.++|||||||++|+|+||..||..................+.
T Consensus       147 fg~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  224 (294)
T PLN00009        147 FGLARAFGIP--VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPN  224 (294)
T ss_pred             cccccccCCC--ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999753211  111233467889999998866 4578999999999999999999999986544322111100000100


Q ss_pred             Cc-cc-c---cc--ccCccccC----cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          311 DS-KK-F---GL--IMDPRLEK----EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       311 ~~-~~-~---~~--~~~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .. .. +   ..  ...+....    ......+..+.+++.+||+.+|++||++.+++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        225 EETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             hhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00 00 0   00  00000000    0011234567899999999999999999999875

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.6e-38  Score=296.85  Aligned_cols=241  Identities=28%  Similarity=0.411  Sum_probs=189.9

Q ss_pred             cccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeecCCcceeEE
Q 014034           87 IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  159 (432)
Q Consensus        87 lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~  159 (432)
                      ||+|+||+||++...       .+++.||+|.+....       ..+..|+.+++.++||||+++++.+...+    ..+
T Consensus         1 lg~g~~g~vy~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~   69 (277)
T cd05577           1 LGKGGFGEVCACQVK-------ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD----DLC   69 (277)
T ss_pred             CCCCCceeEEEEEEc-------CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC----eEE
Confidence            699999999999865       457889999885422       23568999999999999999999887654    359


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCC
Q 014034          160 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP  239 (432)
Q Consensus       160 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~  239 (432)
                      +||||+++++|.+++.......+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++....
T Consensus        70 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~  146 (277)
T cd05577          70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELK  146 (277)
T ss_pred             EEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence            999999999999999766555789999999999999999999998   99999999999999999999999999987532


Q ss_pred             CCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHHHhhcccCccccccc
Q 014034          240 MVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWVQQYPADSKKFGLI  318 (432)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  318 (432)
                      .   ........++..|+|||.+.+..++.++||||||+++|+|++|..||......... .+.......          
T Consensus       147 ~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------  213 (277)
T cd05577         147 G---GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM----------  213 (277)
T ss_pred             c---CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccc----------
Confidence            1   12223456788999999998888999999999999999999999999765432111 111100000          


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 014034          319 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  359 (432)
Q Consensus       319 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  359 (432)
                       ..    ..+...+..+.+++.+||+.||.+||     ++.+++.+
T Consensus       214 -~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         214 -AV----EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             -cc----cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence             00    11122346788999999999999999     55556543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=6.2e-38  Score=300.73  Aligned_cols=266  Identities=28%  Similarity=0.384  Sum_probs=196.7

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|+..+.||+|+||.||+|...       .++..||+|.+....      ..+.+|+.++++++|+||+++++++...
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   78 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDT-------TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK   78 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEEC-------CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC
Confidence            457999999999999999999865       467889999985322      2356899999999999999999998754


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      ..  ...++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|
T Consensus        79 ~~--~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~d  151 (309)
T cd07845          79 HL--DSIFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIAD  151 (309)
T ss_pred             CC--CeEEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECc
Confidence            32  24599999995 58888876533 4689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      ||++.......  .......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||....+......+......+.
T Consensus       152 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~  229 (309)
T cd07845         152 FGLARTYGLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN  229 (309)
T ss_pred             cceeeecCCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            99997532211  11223345788999999865 5678999999999999999999999987654332221111100000


Q ss_pred             Cc-c-cc------ccc-cCc-cccC--cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          311 DS-K-KF------GLI-MDP-RLEK--EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       311 ~~-~-~~------~~~-~~~-~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .. . .+      ... ... ....  ......+..+.++|.+||+.||++|||+.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         230 ESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00 0 00      000 000 0000  0001124567899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=7.5e-38  Score=299.80  Aligned_cols=270  Identities=25%  Similarity=0.378  Sum_probs=198.0

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|...+.||+|+||.||+|...       .++..||+|.+....      ..+.+|+.+++.++||||+++++++...
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   83 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHK-------KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK   83 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEEC-------CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence            457999999999999999999865       467899999875321      2356899999999999999999988764


Q ss_pred             CC----cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCce
Q 014034          152 GE----RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP  227 (432)
Q Consensus       152 ~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~  227 (432)
                      ..    .....++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~  158 (310)
T cd07865          84 ATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGIL  158 (310)
T ss_pred             cccccCCCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcE
Confidence            32    1235699999995 58888876543 3689999999999999999999998   99999999999999999999


Q ss_pred             eeccccCCcCCCCCCCc--ccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 014034          228 KLSDFGLAREGPMVGHT--HVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  304 (432)
Q Consensus       228 kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  304 (432)
                      ||+|||++.........  .......++..|+|||.+.+. .++.++||||||+++|+|++|..||.+.........+..
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~  238 (310)
T cd07865         159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQ  238 (310)
T ss_pred             EECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99999999753222111  112234578899999988664 478899999999999999999999987665443333332


Q ss_pred             Hhhc-ccCcc----ccccccCccccCcC---------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          305 VQQY-PADSK----KFGLIMDPRLEKEY---------SINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       305 ~~~~-~~~~~----~~~~~~~~~l~~~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      +... +....    .+...-...+....         +......+.+||.+||..||.+|||+.+++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             HhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            2211 10000    00000000000000         00113456799999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.8e-38  Score=297.32  Aligned_cols=249  Identities=27%  Similarity=0.419  Sum_probs=190.2

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHH-hcccCCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQF-LGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~-l~~l~hpniv~l~~~~~~~~  152 (432)
                      ++|++.+.||+|+||.||++...       .++..||+|.++...     ..+..|+.+ ++.++||||+++++++..++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~   73 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHV-------PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG   73 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEc-------CCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC
Confidence            47889999999999999999865       468999999886532     235556654 66679999999999987654


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .    .++||||++ ++|.+++...  ....+++..++.++.|++.||.|||++  .+++||||||+|||++.++.+||+
T Consensus        74 ~----~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~  146 (283)
T cd06617          74 D----VWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLC  146 (283)
T ss_pred             c----EEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEe
Confidence            3    599999995 6888877542  234689999999999999999999984  389999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCcccccc----CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET----GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  306 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  306 (432)
                      |||++.....   ........|+..|+|||.+.+    ..++.++|+|||||++|+|++|..||....... ..+.....
T Consensus       147 dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~  222 (283)
T cd06617         147 DFGISGYLVD---SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQLKQVVE  222 (283)
T ss_pred             eccccccccc---ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHHHHHHh
Confidence            9999875321   111223568899999998865    456889999999999999999999997532211 11111111


Q ss_pred             hcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          307 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ...           +.+.   ....+..+.++|.+||..+|.+||++.+++++
T Consensus       223 ~~~-----------~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         223 EPS-----------PQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             cCC-----------CCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            100           0010   11134678899999999999999999999875

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2e-38  Score=295.94  Aligned_cols=245  Identities=25%  Similarity=0.355  Sum_probs=197.7

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      +|+..+.||.|+||.||+|...       .++..||+|.+.+.       ...+.+|++++++++||||+++++++....
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   73 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKR-------DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE   73 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEc-------cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC
Confidence            4888999999999999999864       45788999988643       234788999999999999999998886543


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..++|+||+.+++|.+++...  .++++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+||
T Consensus        74 ----~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~  144 (258)
T cd05578          74 ----NMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDF  144 (258)
T ss_pred             ----eEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeec
Confidence                459999999999999999665  4789999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      |++.......   ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..........+......   . 
T Consensus       145 ~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~-  217 (258)
T cd05578         145 NIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---A-  217 (258)
T ss_pred             ccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---c-
Confidence            9987532211   22345688899999999888899999999999999999999999987654322222221110   0 


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCH--HHHHH
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM--SQVVE  358 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~eil~  358 (432)
                                 ....+...+..+.+++.+||..||.+||++  .++++
T Consensus       218 -----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         218 -----------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             -----------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence                       011122234678899999999999999999  66543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-39  Score=291.47  Aligned_cols=247  Identities=26%  Similarity=0.379  Sum_probs=201.0

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-------HHHHHHHHhcccCCCccceeeeEEe
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQFLGVLEHPNLVKLIGYCA  149 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~hpniv~l~~~~~  149 (432)
                      ..++|..++.||+|.||+|.+++-+       .+++.+|||+++++..       ....|-.+|+..+||.+..|.-.|.
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEK-------at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ  238 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREK-------ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ  238 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeec-------ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc
Confidence            3468999999999999999999855       6789999999987543       2456788999999999998866665


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      ..+    .+|+||||..||.|.-+|.+.  ..+++....-+-..|+.||.|||++   +||+||||.+|+|+|.+|++||
T Consensus       239 t~d----rlCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKi  309 (516)
T KOG0690|consen  239 TQD----RLCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKI  309 (516)
T ss_pred             cCc----eEEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEe
Confidence            544    469999999999999998654  4788888889999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      +|||+++....  ......+++|||.|+|||++....|+.++|+|.+||++|||++|+.||...+......++-      
T Consensus       310 tDFGLCKE~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl------  381 (516)
T KOG0690|consen  310 TDFGLCKEEIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL------  381 (516)
T ss_pred             eecccchhccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH------
Confidence            99999986322  3345577999999999999999999999999999999999999999998654433222211      


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  359 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  359 (432)
                              +.+-    .+|...++....|+...|..||.+|.     .+.||..+
T Consensus       382 --------~ed~----kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  382 --------MEDL----KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             --------hhhc----cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence                    0111    12333345677899999999999996     45566554

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=9.3e-38  Score=299.28  Aligned_cols=244  Identities=34%  Similarity=0.473  Sum_probs=193.0

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ..|...+.||+|+||.||+|...       .++..||+|.+....       ..+.+|+.+++.++||||+++++++...
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~   87 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDV-------RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE   87 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEc-------CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC
Confidence            45888999999999999999865       357889999875321       2477899999999999999999999865


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +.    .++||||+. |+|.+++.... ..+++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++|+|
T Consensus        88 ~~----~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~d  158 (307)
T cd06607          88 HT----AWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLAD  158 (307)
T ss_pred             Ce----EEEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEee
Confidence            53    489999996 57777765433 3689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      ||++.....      .....++..|+|||++.   ...++.++||||||+++|+|++|..||...........   +...
T Consensus       159 fg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~---~~~~  229 (307)
T cd06607         159 FGSASLVSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---IAQN  229 (307)
T ss_pred             cCcceecCC------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH---HhcC
Confidence            999865321      12356888999999874   45688899999999999999999999976543322111   1100


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                      .          .+.+   .....+..+.+++.+||+.+|.+||++.+|+.+.
T Consensus       230 ~----------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         230 D----------SPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             C----------CCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence            0          0000   1122346789999999999999999999998763

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-38  Score=296.30  Aligned_cols=245  Identities=28%  Similarity=0.422  Sum_probs=194.2

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccC---CCccceeeeEEeec
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLE---HPNLVKLIGYCAVD  151 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~---hpniv~l~~~~~~~  151 (432)
                      .|+..+.||.|+||.||+|.+.       .++..||+|.++..     ...+.+|+.+++.+.   |||++++++++...
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~   74 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHV-------PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG   74 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEc-------CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence            4778889999999999999865       46788999987542     234778999999886   99999999988754


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      .    ..++||||+++++|.+++...   .+++..++.++.|++.||.|||+.   +|+|+||+|+||+++.++.++|+|
T Consensus        75 ~----~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~d  144 (277)
T cd06917          75 P----RLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCD  144 (277)
T ss_pred             C----EEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEcc
Confidence            4    459999999999999998543   689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      ||++......  ........|+..|+|||.+.+ ..++.++||||||+++|+|++|..||........   .......  
T Consensus       145 fg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~~~~~--  217 (277)
T cd06917         145 FGVAALLNQN--SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA---MMLIPKS--  217 (277)
T ss_pred             CCceeecCCC--ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh---hhccccC--
Confidence            9998753222  122234568999999998865 4578899999999999999999999976543211   1111000  


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                              ..+.+...   ..+..+.+++.+||..||.+||++.+++.+
T Consensus       218 --------~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         218 --------KPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             --------CCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence                    01111111   134578899999999999999999999875

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7.7e-38  Score=296.68  Aligned_cols=246  Identities=25%  Similarity=0.398  Sum_probs=194.9

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      .|...+.||+|+||.||++...       .++..+++|.+....    ..+.+|+.+++.++||||+++++++...+   
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~---   89 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDK-------STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD---   89 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEEC-------CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC---
Confidence            3555678999999999999864       456789999875332    23778999999999999999999887644   


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCC
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  235 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a  235 (432)
                       ..++|+||+.+++|.+++..   ..+++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++|+|||++
T Consensus        90 -~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~  162 (285)
T cd06648          90 -ELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFC  162 (285)
T ss_pred             -eEEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccc
Confidence             35999999999999999865   3689999999999999999999998   9999999999999999999999999987


Q ss_pred             cCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccc
Q 014034          236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF  315 (432)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  315 (432)
                      ......  ........|++.|+|||.+.+..++.++||||||+++|+|++|..||....+.....   .+.....     
T Consensus       163 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~---~~~~~~~-----  232 (285)
T cd06648         163 AQVSKE--VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK---RIRDNLP-----  232 (285)
T ss_pred             hhhccC--CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH---HHHhcCC-----
Confidence            643211  112233568999999999988889999999999999999999999997654332211   1111100     


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       316 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                           +.+.  .....+..+.+++.+||..+|.+|||+.+++++
T Consensus       233 -----~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         233 -----PKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             -----CCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence                 0000  011134578899999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.1e-37  Score=295.63  Aligned_cols=251  Identities=28%  Similarity=0.414  Sum_probs=201.8

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh---HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ..+.|+..+.||.|+||.||+|.+.       ..+..|++|.+....   ..+.+|+++++.++|+||+++++.+.... 
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   88 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDR-------ATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGD-   88 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEc-------cCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECC-
Confidence            4567889999999999999999875       356789999987543   35788999999999999999999988764 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++|+||+.+++|.+++.... ..+++..+..++.|++.||.|||+.   +|+|+||+|+||+++.++.++|+|||
T Consensus        89 ---~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~  161 (286)
T cd06614          89 ---ELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFG  161 (286)
T ss_pred             ---EEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccc
Confidence               4599999999999999997654 3789999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      ++......  ........++..|+|||.+.+..++.++||||||+++|+|++|..||....+......   +.....   
T Consensus       162 ~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~---~~~~~~---  233 (286)
T cd06614         162 FAAQLTKE--KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL---ITTKGI---  233 (286)
T ss_pred             hhhhhccc--hhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhcCC---
Confidence            88643211  1122334578899999999888899999999999999999999999976544322111   111000   


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                             +.+  ......+..+.++|.+||+.+|.+|||+.+|+.+
T Consensus       234 -------~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         234 -------PPL--KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             -------CCC--cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                   000  0011134678899999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.1e-38  Score=299.53  Aligned_cols=251  Identities=28%  Similarity=0.433  Sum_probs=190.3

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccC-CCccceeeeEEeecCC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLE-HPNLVKLIGYCAVDGE  153 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~  153 (432)
                      +|.....||+|+||.||++...       .++..||+|.+...     ...+.+|+.++.++. ||||+++++++..++.
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~   77 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHK-------PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGD   77 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEEC-------CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCc
Confidence            5667788999999999999865       45788999998643     224778999999986 9999999998876543


Q ss_pred             cceeEEEEEeecCCCCHHHHh---hcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          154 RGIQRLLVYEFMLNRSLEDHL---FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l---~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                          .+++|||+. ++|.++.   .......+++..+..++.|++.||.|||+.  .+++||||||+||+++.++.++|+
T Consensus        78 ----~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~  150 (288)
T cd06616          78 ----CWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLC  150 (288)
T ss_pred             ----EEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEe
Confidence                489999985 4555433   323335789999999999999999999973  289999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccC---CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG---HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  307 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  307 (432)
                      |||++......   .......|+..|+|||++.+.   .++.++|||||||++|+|++|..||...... ...+......
T Consensus       151 dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~  226 (288)
T cd06616         151 DFGISGQLVDS---IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-FDQLTQVVKG  226 (288)
T ss_pred             ecchhHHhccC---CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-HHHHhhhcCC
Confidence            99998643211   112334688999999999766   6899999999999999999999999754311 1111111100


Q ss_pred             cccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                         .        .+.+........+..+.+|+.+||+.+|.+|||+.+|+.+
T Consensus       227 ---~--------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         227 ---D--------PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             ---C--------CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0        0111111112345678899999999999999999999886

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.4e-37  Score=290.95  Aligned_cols=250  Identities=30%  Similarity=0.436  Sum_probs=195.2

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      +|...+.||+|+||.||+|...       .++..|++|.+....      ..+..|+.+++.++||||+++++++...+ 
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-   72 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNL-------DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE-   72 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEEC-------CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCC-
Confidence            4788899999999999999864       457889999976432      24788999999999999999999876543 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++|+||+.+++|.+++...  ..+++..+..++.+++.||.|||+.   +|+|+||+|+||+++.++.+||+|||
T Consensus        73 ---~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g  144 (264)
T cd06626          73 ---KVYIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFG  144 (264)
T ss_pred             ---EEEEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccc
Confidence               459999999999999998654  3578999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCccc--ccccccCCCccCccccccCC---CCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          234 LAREGPMVGHTHV--STAVVGTFGYAAPDYIETGH---LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       234 ~a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      ++...........  .....++..|+|||++.+..   ++.++||||||+++|++++|..||........  ....+...
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~~~~~~~~  222 (264)
T cd06626         145 CAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--IMFHVGAG  222 (264)
T ss_pred             cccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--HHHHHhcC
Confidence            9875322211110  12356788999999998766   88999999999999999999999975432211  11111110


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                       .         .+.+..  ....+..+.+++.+||+.+|.+|||+.+++.+
T Consensus       223 -~---------~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         223 -H---------KPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             -C---------CCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence             0         011111  11224567899999999999999999998754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=312.78  Aligned_cols=273  Identities=27%  Similarity=0.396  Sum_probs=203.3

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc-----ChHHHHHHHHHhcccCCCccceeeeEEeecC--
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-----DGLQWVAEVQFLGVLEHPNLVKLIGYCAVDG--  152 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--  152 (432)
                      .+.....||+|+||.||+|+++       .+|+.||||.++.     ....+.+|+++|++|+|||||+++++-....  
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnk-------etG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~   86 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNK-------ETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLG   86 (732)
T ss_pred             ceeehhhhcCCccceeeeeccc-------ccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccC
Confidence            3555678999999999999865       6889999999875     3456889999999999999999988754433  


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc--CCC--ce
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNR-AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD--ENF--RP  227 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~--~~~--~~  227 (432)
                      .......+|||||.+|+|...+.+- +..+|++.+.+.++.+++.||.|||++   +|+||||||.||++-  .+|  ..
T Consensus        87 ~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~Iy  163 (732)
T KOG4250|consen   87 LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIY  163 (732)
T ss_pred             cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEE
Confidence            0123458999999999999999763 355899999999999999999999998   999999999999983  334  47


Q ss_pred             eeccccCCcCCCCCCCcccccccccCCCccCccccc-cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH-
Q 014034          228 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV-  305 (432)
Q Consensus       228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~-  305 (432)
                      ||+|||.|+...   ........+||..|.+||+.. .+.|+..+|.|||||++|++.||..||..........-+.|. 
T Consensus       164 KLtDfG~Arel~---d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~  240 (732)
T KOG4250|consen  164 KLTDFGAARELD---DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHI  240 (732)
T ss_pred             eeecccccccCC---CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhh
Confidence            999999999632   333567789999999999998 488899999999999999999999999765433211111111 


Q ss_pred             -hhcccC---------ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC--CHHHHHHHHHHHhh
Q 014034          306 -QQYPAD---------SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP--KMSQVVERLKQIVQ  365 (432)
Q Consensus       306 -~~~~~~---------~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~eil~~L~~~~~  365 (432)
                       ...+..         ..++..-..-.............+..++..+|..+|.+|.  .+.+.-..+..++.
T Consensus       241 ~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  241 ITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             hccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence             111110         0011000000011122334445677888889999999999  77777777666654

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-38  Score=305.96  Aligned_cols=267  Identities=26%  Similarity=0.335  Sum_probs=196.3

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|.+.+.||+|+||.||+|...       .++..||+|.+...     ...+.+|+.+++.++||||+++++++....
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   76 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHK-------PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPS   76 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEc-------CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeeccc
Confidence            468999999999999999999865       46788999998632     223678999999999999999999876543


Q ss_pred             C-cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          153 E-RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       153 ~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      . .....++|+||+. ++|.+.+..   ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        77 ~~~~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~d  149 (336)
T cd07849          77 FESFNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICD  149 (336)
T ss_pred             ccccceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECc
Confidence            2 2234689999995 588887754   3689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCC-cccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          232 FGLAREGPMVGH-THVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       232 fG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      ||++........ ........||..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+................+
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~  229 (336)
T cd07849         150 FGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP  229 (336)
T ss_pred             ccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            999875322111 111233568999999998754 568899999999999999999999997654322111110000000


Q ss_pred             cCccccccccCcc-------c--cCcC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ADSKKFGLIMDPR-------L--EKEY-----SINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~~~~~~~~~~~~-------l--~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      . ......+....       .  ....     ....+..+.+++.+||+.+|.+|||+.+++++
T Consensus       230 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         230 S-QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             C-HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0 00000000000       0  0000     01124568899999999999999999999988

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=8.5e-38  Score=295.46  Aligned_cols=239  Identities=24%  Similarity=0.366  Sum_probs=184.2

Q ss_pred             ccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHH---hcccCCCccceeeeEEeecCCcc
Q 014034           86 KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQF---LGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        86 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~---l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      .||+|+||.||++...       .++..+|+|.+.+..       ..+.+|..+   +...+||||+.+++++...+   
T Consensus         1 ~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~---   70 (279)
T cd05633           1 IIGRGGFGEVYGCRKA-------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD---   70 (279)
T ss_pred             CcccCCCeEEEEEEEC-------CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC---
Confidence            4899999999999864       467899999875421       123444433   33457999999999887654   


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCC
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  235 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a  235 (432)
                       ..++||||+.+++|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||++
T Consensus        71 -~~~lv~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~  144 (279)
T cd05633          71 -KLCFILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA  144 (279)
T ss_pred             -eEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcc
Confidence             3489999999999999986543  699999999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCCCcccccccccCCCccCccccc-cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          236 REGPMVGHTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      ......    ......|+..|+|||.+. +..++.++|||||||++|+|++|..||..........+......       
T Consensus       145 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-------  213 (279)
T cd05633         145 CDFSKK----KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-------  213 (279)
T ss_pred             eecccc----CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc-------
Confidence            643211    122346899999999986 45688999999999999999999999976543322222111110       


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  359 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  359 (432)
                          ...    ..+...+..+.+++.+||..||.+||     |+.+++++
T Consensus       214 ----~~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         214 ----VNV----ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ----CCc----CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence                011    11223346788999999999999999     58888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-37  Score=290.42  Aligned_cols=250  Identities=22%  Similarity=0.306  Sum_probs=196.5

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---------hHHHHHHHHHhcccCCCccceeeeEEe
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---------GLQWVAEVQFLGVLEHPNLVKLIGYCA  149 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~hpniv~l~~~~~  149 (432)
                      .+|.+.+.||+|+||.||+|...       .++..||+|.+...         ...+.+|+++++.++||||+++++++.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~   74 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDA-------DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLR   74 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEc-------CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEE
Confidence            47899999999999999999864       46788999987421         124778999999999999999999876


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      ....  ...++||||+++++|.+++....  .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|
T Consensus        75 ~~~~--~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l  147 (264)
T cd06653          75 DPEE--KKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKL  147 (264)
T ss_pred             cCCC--CEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEE
Confidence            5432  24589999999999999986543  588999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCC-cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          230 SDFGLAREGPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       230 ~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      +|||+++....... ........|+..|+|||.+.+..++.++|||||||++|+|++|..||.......  ..... ...
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~-~~~  224 (264)
T cd06653         148 GDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--AIFKI-ATQ  224 (264)
T ss_pred             CccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--HHHHH-HcC
Confidence            99999975322111 111123568899999999998889999999999999999999999997543221  11111 111


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      +             .....+...+..+.+++.+||. +|..||++.+++.+
T Consensus       225 ~-------------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         225 P-------------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             C-------------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence            0             0112233445678899999999 57999999988764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.4e-37  Score=293.96  Aligned_cols=261  Identities=25%  Similarity=0.310  Sum_probs=191.0

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccC-CCccceeeeEEeecCCc
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLE-HPNLVKLIGYCAVDGER  154 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~  154 (432)
                      |.+.+.||+|+||.||+|...       .++..||+|.+....     ....+|+.++.++. ||||+++++++.+... 
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~-------~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-   72 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSR-------KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKT-   72 (282)
T ss_pred             CceEeeccccccceEEEEEEc-------CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCC-
Confidence            567788999999999999865       467889999886531     12457888888885 9999999999876521 


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                       ...++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.   +++||||||+||+++. +.+||+|||+
T Consensus        73 -~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~  145 (282)
T cd07831          73 -GRLALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGS  145 (282)
T ss_pred             -CcEEEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccc
Confidence             24599999996 58888886543 4689999999999999999999998   9999999999999999 9999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccc-cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC--
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD--  311 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--  311 (432)
                      +......   .......++..|+|||.+. +..++.++|||||||++|||++|..||.+.+..............+..  
T Consensus       146 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  222 (282)
T cd07831         146 CRGIYSK---PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV  222 (282)
T ss_pred             ccccccC---CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            9753211   1122346789999999764 456788999999999999999999999876543221111100000000  


Q ss_pred             ------ccccccccCccccC---cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 ------SKKFGLIMDPRLEK---EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ------~~~~~~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                            ..............   ......+..+.+||.+||..+|.+||++.+++.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         223 LKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             HHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence                  00000000000000   0011335789999999999999999999999865

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4.5e-38  Score=305.09  Aligned_cols=269  Identities=22%  Similarity=0.319  Sum_probs=200.8

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ..+|++.+.||.|+||.||+|...       .++..||+|.+....      ..+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   76 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDT-------RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPP   76 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEc-------CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhcccc
Confidence            367999999999999999999865       457889999986532      2367899999999999999999988765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      .......++||||+. ++|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus        77 ~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~d  150 (334)
T cd07855          77 GADFKDVYVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGD  150 (334)
T ss_pred             CCCCceEEEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecc
Confidence            555556799999995 6899988654  3589999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCC--cccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          232 FGLAREGPMVGH--THVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       232 fG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      ||++........  ........|+..|+|||.+.+ ..++.++|||||||++|+|++|..||..................
T Consensus       151 fg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~  230 (334)
T cd07855         151 FGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGS  230 (334)
T ss_pred             cccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCC
Confidence            999875322111  111234578899999999865 46889999999999999999999999765443222111111000


Q ss_pred             ccCcc-------ccccc---cCccccC---cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 PADSK-------KFGLI---MDPRLEK---EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 ~~~~~-------~~~~~---~~~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      +....       .....   .......   ......+..+.+++.+||+.+|.+|||+.+++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            00000       00000   0000000   0011235678999999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.1e-37  Score=299.59  Aligned_cols=259  Identities=22%  Similarity=0.293  Sum_probs=190.9

Q ss_pred             cccccC--CceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecCCcce
Q 014034           85 LKIGEG--GFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        85 ~~lg~G--~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~  156 (432)
                      ..||+|  +||+||+|.+.       ..++.||+|.+....      ..+.+|+.+++.++||||+++++++...+    
T Consensus         4 ~~ig~g~~~~~~v~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~----   72 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHT-------PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS----   72 (328)
T ss_pred             HHhCCcccCceeEEEEEEc-------CCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC----
Confidence            346666  99999999864       567899999986422      34778999999999999999999997654    


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      ..++||||+.+++|.+++.......+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++++||+.+.
T Consensus        73 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~  149 (328)
T cd08226          73 WLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLY  149 (328)
T ss_pred             ceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHh
Confidence            349999999999999998765545689999999999999999999998   99999999999999999999999998653


Q ss_pred             CCCCCCCcc-----cccccccCCCccCccccccC--CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          237 EGPMVGHTH-----VSTAVVGTFGYAAPDYIETG--HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       237 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      .........     ......++..|+|||++.+.  .++.++|||||||++|+|++|..||.......  .........+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~  227 (328)
T cd08226         150 SLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPP  227 (328)
T ss_pred             hhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCC
Confidence            211111000     01112356679999999763  47899999999999999999999997654321  1111111100


Q ss_pred             cCccc----------------------c---------ccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 014034          310 ADSKK----------------------F---------GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE  358 (432)
Q Consensus       310 ~~~~~----------------------~---------~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  358 (432)
                      ..+..                      .         ..+....+........+..+.+|+.+||+.||++|||+.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         228 YSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             CCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            00000                      0         0001111112223345678899999999999999999999987


Q ss_pred             H
Q 014034          359 R  359 (432)
Q Consensus       359 ~  359 (432)
                      +
T Consensus       308 ~  308 (328)
T cd08226         308 H  308 (328)
T ss_pred             C
Confidence            6

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.1e-37  Score=302.70  Aligned_cols=266  Identities=28%  Similarity=0.394  Sum_probs=197.0

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhccc-CCCccceeeeEEe
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVL-EHPNLVKLIGYCA  149 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l-~hpniv~l~~~~~  149 (432)
                      ..++|+..+.||+|+||.||+|...       .++..+|+|++...      ...+.+|+.+++++ +||||+++++++.
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~   77 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDR-------RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIK   77 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEc-------CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeec
Confidence            4567999999999999999999864       45788999987432      22367899999999 9999999999886


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      ..+.  ...++||||+. ++|..++...   .+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||
T Consensus        78 ~~~~--~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl  148 (337)
T cd07852          78 AEND--KDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKL  148 (337)
T ss_pred             cCCC--ceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEE
Confidence            5432  24599999996 5999988653   688999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCCc---ccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 014034          230 SDFGLAREGPMVGHT---HVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  305 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  305 (432)
                      +|||++.........   .......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.............
T Consensus       149 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~  228 (337)
T cd07852         149 ADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV  228 (337)
T ss_pred             eeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence            999999754322211   12233568999999998754 56788999999999999999999999765443221111110


Q ss_pred             hhcccC-----------cccccccc---CccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          306 QQYPAD-----------SKKFGLIM---DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       306 ~~~~~~-----------~~~~~~~~---~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ...+..           ...+..+.   ...+... ....+..+.++|.+||+.||.+|||+.+++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         229 IGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDEL-LPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             hCCCCHHHHHHHHhhhHHHhhhhcccccccchhhh-ccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            000000           00000000   0000000 01134678899999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.8e-37  Score=290.17  Aligned_cols=240  Identities=27%  Similarity=0.371  Sum_probs=191.0

Q ss_pred             cccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeecCCcceeEE
Q 014034           87 IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  159 (432)
Q Consensus        87 lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~  159 (432)
                      ||.|+||.||+|...       .++..||+|.+....       ..+.+|+.+++.++||||+++++++....    ..+
T Consensus         1 lg~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~   69 (262)
T cd05572           1 LGVGGFGRVELVKVK-------SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK----YIY   69 (262)
T ss_pred             CCCCCceEEEEEEEC-------CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC----ccE
Confidence            799999999999865       357889999986422       24788999999999999999999887554    349


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCC
Q 014034          160 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP  239 (432)
Q Consensus       160 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~  239 (432)
                      +||||+++++|.+++.+..  .+++..+..++.||+.||.|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        70 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~  144 (262)
T cd05572          70 MLMEYCLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK  144 (262)
T ss_pred             EEEecCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccC
Confidence            9999999999999997643  589999999999999999999998   99999999999999999999999999997642


Q ss_pred             CCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccccccc
Q 014034          240 MVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM  319 (432)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (432)
                      ...   ......|+..|++||.+.+..++.++|+||||+++|+|++|..||....... ......+....          
T Consensus       145 ~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~----------  210 (262)
T cd05572         145 SGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIYNDILKGN----------  210 (262)
T ss_pred             ccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHHHHHhccC----------
Confidence            221   2233568899999999988889999999999999999999999998665311 11111111000          


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 014034          320 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-----MSQVVER  359 (432)
Q Consensus       320 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  359 (432)
                         .....+...+..+.+++.+||+.+|.+||+     +.+++++
T Consensus       211 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         211 ---GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             ---CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence               001112222567889999999999999999     6777664

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-37  Score=296.50  Aligned_cols=269  Identities=22%  Similarity=0.281  Sum_probs=194.8

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .|.+.+.||+|+||.||+|....     ...+..||+|.+....       ..+.+|+.++..++||||+++++++....
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~-----~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKN-----GKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHA   75 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecC-----CCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence            37788899999999999999751     1257899999987632       34678999999999999999999997653


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC----CC
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNR---AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE----NF  225 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~----~~  225 (432)
                      .  ...++||||+.+ +|.+++...   ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.    ++
T Consensus        76 ~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~  149 (316)
T cd07842          76 D--KSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERG  149 (316)
T ss_pred             C--ceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccc
Confidence            2  256999999964 677766432   123688999999999999999999998   9999999999999999    99


Q ss_pred             ceeeccccCCcCCCCCCC-cccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchh------
Q 014034          226 RPKLSDFGLAREGPMVGH-THVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT------  297 (432)
Q Consensus       226 ~~kl~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~------  297 (432)
                      .+||+|||++........ ........++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.....      
T Consensus       150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~  229 (316)
T cd07842         150 VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPF  229 (316)
T ss_pred             eEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchh
Confidence            999999999875322211 112234567899999998866 457899999999999999999999998654432      


Q ss_pred             -hHHHHHHHhhcccCcc----------cccc----ccCcccc-----CcCCH--HHHHHHHHHHHHhccCCCCCCCCHHH
Q 014034          298 -EQRLLEWVQQYPADSK----------KFGL----IMDPRLE-----KEYSI--NEARKIGRLADNCLSKSSKDRPKMSQ  355 (432)
Q Consensus       298 -~~~~~~~~~~~~~~~~----------~~~~----~~~~~l~-----~~~~~--~~~~~l~~li~~cl~~dP~~RPs~~e  355 (432)
                       ...+...+........          .+..    .......     .....  ..+..+.+++.+||+.||.+|||+.+
T Consensus       230 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~e  309 (316)
T cd07842         230 QRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEE  309 (316)
T ss_pred             HHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence             0111111111100000          0000    0000000     00000  23356889999999999999999999


Q ss_pred             HHHH
Q 014034          356 VVER  359 (432)
Q Consensus       356 il~~  359 (432)
                      ++.+
T Consensus       310 il~~  313 (316)
T cd07842         310 ALEH  313 (316)
T ss_pred             HhcC
Confidence            9864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.3e-37  Score=285.52  Aligned_cols=247  Identities=30%  Similarity=0.445  Sum_probs=199.2

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      +|...+.||.|+||.||++...       .++..+++|.+....    ..+.+|+.+++.++||||+++++++..+.   
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   70 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHK-------RTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKD---   70 (253)
T ss_pred             CceeeeeeccCCceEEEEEEEC-------CCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC---
Confidence            4778889999999999999865       357889999987654    35889999999999999999999987654   


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCC
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  235 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a  235 (432)
                       ..++++||+++++|.+++.... ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||.+
T Consensus        71 -~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~  145 (253)
T cd05122          71 -ELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLS  145 (253)
T ss_pred             -eEEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccc
Confidence             3599999999999999987653 4789999999999999999999997   9999999999999999999999999998


Q ss_pred             cCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccc
Q 014034          236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF  315 (432)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  315 (432)
                      ........   .....++..|+|||.+.+..++.++||||||+++|+|++|..||............   ...  .    
T Consensus       146 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~--~----  213 (253)
T cd05122         146 AQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI---ATN--G----  213 (253)
T ss_pred             cccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---Hhc--C----
Confidence            75332211   34467889999999998888999999999999999999999999765432221111   100  0    


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       316 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                          .+.+.  .....+..+.+++.+||+.||.+|||+.+++++
T Consensus       214 ----~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         214 ----PPGLR--NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             ----CCCcC--cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                00000  011124568899999999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.2e-37  Score=286.79  Aligned_cols=251  Identities=26%  Similarity=0.388  Sum_probs=200.9

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      +|...+.||+|+||.||+|...       .++..|++|.+....      ..+.+|+.++++++||||+++++.+.... 
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   72 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDK-------DTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE-   72 (260)
T ss_pred             CceeeeEeeecCceEEEEEEEC-------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC-
Confidence            4777889999999999999865       467889999986543      34788999999999999999999987652 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                       ....++|+||+.+++|.+++....  .+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||
T Consensus        73 -~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~  146 (260)
T cd06606          73 -KNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFG  146 (260)
T ss_pred             -CCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccc
Confidence             124589999999999999997654  789999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      .+................++..|+|||.+.+..++.++||||||+++|+|++|..||........  .......      
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~------  218 (260)
T cd06606         147 CAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA--ALYKIGS------  218 (260)
T ss_pred             cEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HHHhccc------
Confidence            98764322211113345688999999999888899999999999999999999999986551111  1110000      


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                             .......+...+..+.+++.+||..+|.+||++.+++.+
T Consensus       219 -------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         219 -------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             -------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence                   000111222335789999999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-38  Score=307.72  Aligned_cols=246  Identities=25%  Similarity=0.377  Sum_probs=204.1

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH------HHHHHHHHhcccCCCccceeeeEEee
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      ..+.|.+.+.||+|.|++|.+|++.       .++..||||.+.+...      .+.+|+++|..|+|||||+++.+...
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~-------~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t  126 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHI-------LTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET  126 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEec-------CCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee
Confidence            3567999999999999999999976       5678899999976432      36889999999999999999999876


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      ...    +++||||+.+|.+.+++.+..  .+.+..+..++.|++.|++|||++   .|+|||||.+||||+.+.++||+
T Consensus       127 ~~~----lylV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIa  197 (596)
T KOG0586|consen  127 EAT----LYLVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIA  197 (596)
T ss_pred             cce----eEEEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeee
Confidence            553    599999999999999997765  577789999999999999999999   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      |||++....   ......+.+|++.|.|||++.+..| ++.+|+||+|+++|.|+.|..||++..-.....-        
T Consensus       198 DfgfS~~~~---~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r--------  266 (596)
T KOG0586|consen  198 DFGFSTFFD---YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR--------  266 (596)
T ss_pred             ccccceeec---ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch--------
Confidence            999998643   3445677899999999999998776 5789999999999999999999997543221100        


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                              .+...+  ..+...+.++.+|+.++|..+|.+|+++.+|.++
T Consensus       267 --------vl~gk~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  267 --------VLRGKY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             --------heeeee--cccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence                    000001  1122223457799999999999999999999876

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.6e-37  Score=295.19  Aligned_cols=269  Identities=26%  Similarity=0.352  Sum_probs=198.5

Q ss_pred             HhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEe
Q 014034           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCA  149 (432)
Q Consensus        76 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~  149 (432)
                      ...++|++.+.||+|+||.||+|...       .+++.||+|.++...      ..+.+|+.+++.++||||+++++++.
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~   76 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDK-------DTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVT   76 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEEC-------CCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheec
Confidence            34578999999999999999999975       356789999986432      24678999999999999999999887


Q ss_pred             ecCC------cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC
Q 014034          150 VDGE------RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  223 (432)
Q Consensus       150 ~~~~------~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~  223 (432)
                      ....      .....++|+||+.+ +|.+.+... ...+++..+..++.|++.||.|||+.   +|+|+||||+||++++
T Consensus        77 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~  151 (302)
T cd07864          77 DKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNN  151 (302)
T ss_pred             CcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence            6431      12256899999975 777777654 34689999999999999999999998   9999999999999999


Q ss_pred             CCceeeccccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014034          224 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  302 (432)
Q Consensus       224 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  302 (432)
                      ++.+||+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+
T Consensus       152 ~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~  230 (302)
T cd07864         152 KGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI  230 (302)
T ss_pred             CCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            99999999999875322211 11222346788999998865 45788999999999999999999999865543332222


Q ss_pred             HHHhhcccCccccccc--------------cCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          303 EWVQQYPADSKKFGLI--------------MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       303 ~~~~~~~~~~~~~~~~--------------~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ......+... .+..+              ........ ....+..+.+++.+||..||.+|||+.+++.+
T Consensus       231 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         231 SRLCGSPCPA-VWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             HHHhCCCChh-hcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            2211111100 00000              00000000 01124678899999999999999999998764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1e-37  Score=302.96  Aligned_cols=269  Identities=24%  Similarity=0.348  Sum_probs=200.4

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|.+.+.||+|+||.||+|...       .++..||||.+...      ...+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~   76 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNS-------ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPP   76 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEec-------CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecc
Confidence            457999999999999999999864       46789999987642      23467899999999999999999987654


Q ss_pred             CC-cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          152 GE-RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       152 ~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .. .....++||||+. ++|.+++...  ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+
T Consensus        77 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~  150 (337)
T cd07858          77 HREAFNDVYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKIC  150 (337)
T ss_pred             cccccCcEEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEC
Confidence            32 1234699999995 7899888654  4699999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      |||++.......  .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+................+
T Consensus       151 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  228 (337)
T cd07858         151 DFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSP  228 (337)
T ss_pred             cCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence            999997532221  22234568899999998864 568899999999999999999999997654322211111110000


Q ss_pred             cCcccccccc---------------CccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHH
Q 014034          310 ADSKKFGLIM---------------DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER--LKQI  363 (432)
Q Consensus       310 ~~~~~~~~~~---------------~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~~  363 (432)
                      ... ....+.               ...+. ......+..+.+++.+||+.+|.+|||+.+++++  +..+
T Consensus       229 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         229 SEE-DLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             ChH-HhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            000 000000               00000 0011235678899999999999999999999988  5444

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.8e-37  Score=296.39  Aligned_cols=247  Identities=33%  Similarity=0.463  Sum_probs=194.4

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .|...+.||+|+||.||++...       .++..||+|.+....       ..+.+|+++++.++|||++++++++..+.
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~-------~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   98 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDV-------RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH   98 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEc-------CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence            3778889999999999999865       457889999986321       24778999999999999999999987654


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                      .    .++||||+. |+|.+.+... ..++++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++|+||
T Consensus        99 ~----~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~df  169 (317)
T cd06635          99 T----AWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADF  169 (317)
T ss_pred             e----EEEEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecC
Confidence            3    489999996 5787777543 34689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      |++....      ......|+..|+|||.+.   .+.++.++|||||||++|+|++|..||.........  ..+.....
T Consensus       170 g~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~~~~~~~  241 (317)
T cd06635         170 GSASIAS------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIAQNES  241 (317)
T ss_pred             CCccccC------CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH--HHHHhccC
Confidence            9986422      123356889999999973   456889999999999999999999999764332211  11111100


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  364 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  364 (432)
                                 +   .......+..+.+++.+||+.+|.+||++.+|++++..+.
T Consensus       242 -----------~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         242 -----------P---TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             -----------C---CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence                       0   0011123456889999999999999999999998865543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.6e-37  Score=289.27  Aligned_cols=252  Identities=22%  Similarity=0.331  Sum_probs=192.8

Q ss_pred             HHHHHHhhcCCcccccc--ccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHHHHHHHhccc-CCCccceeeeE
Q 014034           71 YSEMRQATNDFSRMLKI--GEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVL-EHPNLVKLIGY  147 (432)
Q Consensus        71 ~~~~~~~~~~~~~~~~l--g~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~  147 (432)
                      ..+.....++|.+.+.+  |.|+||.||++..+       .++..+|+|.+...... ..|+.....+ +||||+++++.
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~-------~~~~~~~~k~~~~~~~~-~~e~~~~~~~~~h~~iv~~~~~   77 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHK-------PTQKLFVQKIIKAKNFN-AIEPMVHQLMKDNPNFIKLYYS   77 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEc-------CCCcEEEEEEEehhhcc-hhhHHHHHHhhcCCCEEEEEEE
Confidence            34445556777787776  99999999999865       46788999998653221 1133332222 79999999999


Q ss_pred             EeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC-c
Q 014034          148 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF-R  226 (432)
Q Consensus       148 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~  226 (432)
                      +...+    ..++||||+++++|.+++....  .+++..+..++.|++.||.|||+.   +++||||||+||+++.++ .
T Consensus        78 ~~~~~----~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~  148 (267)
T PHA03390         78 VTTLK----GHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDR  148 (267)
T ss_pred             EecCC----eeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCe
Confidence            87655    4599999999999999997653  799999999999999999999998   999999999999999988 9


Q ss_pred             eeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 014034          227 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  306 (432)
Q Consensus       227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  306 (432)
                      ++|+|||++....      ......|+..|+|||++.+..++.++||||||+++|+|++|..||....... .....+..
T Consensus       149 ~~l~dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~  221 (267)
T PHA03390        149 IYLCDYGLCKIIG------TPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLK  221 (267)
T ss_pred             EEEecCccceecC------CCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHH
Confidence            9999999987532      1123468999999999998899999999999999999999999998543321 11111111


Q ss_pred             hcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHH
Q 014034          307 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-MSQVVER  359 (432)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~~  359 (432)
                      ......             ......+..+.+++.+||+.+|.+||+ +.+++++
T Consensus       222 ~~~~~~-------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        222 RQQKKL-------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             hhcccC-------------CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence            111000             111134567889999999999999996 6888764

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-37  Score=291.69  Aligned_cols=264  Identities=26%  Similarity=0.383  Sum_probs=195.9

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      |.+.+.||.|+||.||+|...       .++..+|+|.+....      ..+.+|+.+++.++|||++++++++....  
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~-------~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   71 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNK-------KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG--   71 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEEC-------CCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC--
Confidence            567889999999999999865       356889999987642      24778999999999999999999987652  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                      ....++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+.   +++|+||+|+||++++++.++|+|||+
T Consensus        72 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~  146 (287)
T cd07840          72 KGSIYMVFEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGL  146 (287)
T ss_pred             CCcEEEEecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccc
Confidence            124699999996 48988886543 4789999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      +........ .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||..................+....
T Consensus       147 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~  225 (287)
T cd07840         147 ARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDEN  225 (287)
T ss_pred             eeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhh
Confidence            875422211 11233456889999998765 4678999999999999999999999987654332221111111110000


Q ss_pred             --cccc-----cc------CccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          314 --KFGL-----IM------DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       314 --~~~~-----~~------~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                        ....     ..      ...+........+..+.+++.+||+.+|.+||++.+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         226 WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             ccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence              0000     00      0000000111125678899999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6.7e-38  Score=323.03  Aligned_cols=257  Identities=27%  Similarity=0.407  Sum_probs=191.4

Q ss_pred             HhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-----HHHHHHHHhcccCCCccceeeeEEee
Q 014034           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-----QWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        76 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      ...++|+.+..||+||||.||+++.+       -+|+.+|||++.....     ...+|+.+|++|+|||||+++..+.+
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNK-------lDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVE  548 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNK-------LDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVE  548 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeec-------ccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhc
Confidence            45578999999999999999999966       7889999999976532     36789999999999999998765432


Q ss_pred             cCCc----------------------------------------------------------------------------
Q 014034          151 DGER----------------------------------------------------------------------------  154 (432)
Q Consensus       151 ~~~~----------------------------------------------------------------------------  154 (432)
                      ....                                                                            
T Consensus       549 s~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~  628 (1351)
T KOG1035|consen  549 STAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGR  628 (1351)
T ss_pred             cCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccc
Confidence            1100                                                                            


Q ss_pred             ---------------------------------------ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 014034          155 ---------------------------------------GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA  195 (432)
Q Consensus       155 ---------------------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~  195 (432)
                                                             ...+||-||||+..+|.+++.++.... .....++++++|+
T Consensus       629 ~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIl  707 (1351)
T KOG1035|consen  629 NLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREIL  707 (1351)
T ss_pred             ccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHH
Confidence                                                   023578899999988888876654321 4577899999999


Q ss_pred             HHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCC----C------------CCCcccccccccCCCccCc
Q 014034          196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP----M------------VGHTHVSTAVVGTFGYAAP  259 (432)
Q Consensus       196 ~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~----~------------~~~~~~~~~~~gt~~y~aP  259 (432)
                      +||.|+|+.   |||||||||.||+++.++.|||+|||+|+...    .            .......+..+||..|+||
T Consensus       708 EGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP  784 (1351)
T KOG1035|consen  708 EGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP  784 (1351)
T ss_pred             HHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence            999999998   99999999999999999999999999997511    0            0111234567899999999


Q ss_pred             cccccC---CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHH
Q 014034          260 DYIETG---HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIG  336 (432)
Q Consensus       260 E~~~~~---~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~  336 (432)
                      |++.+.   .|+.|+|+||||||++||+.   ||...  .+...++.-+.. +.-+..          ..+..+....-.
T Consensus       785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~LR~-g~iP~~----------~~f~~~~~~~e~  848 (1351)
T KOG1035|consen  785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS--MERASILTNLRK-GSIPEP----------ADFFDPEHPEEA  848 (1351)
T ss_pred             HHhcccccccccchhhhHHHHHHHHHHhc---cCCch--HHHHHHHHhccc-CCCCCC----------cccccccchHHH
Confidence            999765   49999999999999999996   45432  222222222111 000000          111222223345


Q ss_pred             HHHHHhccCCCCCCCCHHHHHHH
Q 014034          337 RLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       337 ~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .+|.+|++.||.+|||+.|+|..
T Consensus       849 slI~~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  849 SLIRWLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             HHHHHHhcCCCccCCCHHHHhhc
Confidence            89999999999999999999864

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-37  Score=287.21  Aligned_cols=238  Identities=27%  Similarity=0.324  Sum_probs=183.6

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-------HHHHHHHH-hcccCCCccceeeeEEeecCCcce
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQF-LGVLEHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~~  156 (432)
                      +.||.|+||.||+|...       ..+..||+|.+.+...       .+..|..+ ....+||||+++++++...+    
T Consensus         2 ~~l~~g~~~~v~~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----   70 (260)
T cd05611           2 KPISKGAFGSVYLAKKR-------STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD----   70 (260)
T ss_pred             ccCCcCCCeeEEEEEec-------CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC----
Confidence            56999999999999864       4567899999865321       13344444 34558999999999987544    


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      ..++||||+.+++|.+++...  .++++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.
T Consensus        71 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~  145 (260)
T cd05611          71 YLYLVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSR  145 (260)
T ss_pred             eEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccce
Confidence            459999999999999998654  3689999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  316 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (432)
                      ....      .....|+..|+|||.+.+..++.++||||||+++|+|++|..||........   .........      
T Consensus       146 ~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~------  210 (260)
T cd05611         146 NGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV---FDNILSRRI------  210 (260)
T ss_pred             eccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHHhccc------
Confidence            5221      2335688999999999888889999999999999999999999976544221   111111000      


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 014034          317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE  358 (432)
Q Consensus       317 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  358 (432)
                           ..........+..+.+++.+||+.+|++||++.++.+
T Consensus       211 -----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~  247 (260)
T cd05611         211 -----NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE  247 (260)
T ss_pred             -----CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence                 0000111123467889999999999999997754433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-37  Score=292.24  Aligned_cols=260  Identities=27%  Similarity=0.370  Sum_probs=194.6

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccC-CCccceeeeEEeecCCc
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLE-HPNLVKLIGYCAVDGER  154 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~  154 (432)
                      |.+.+.||.|+||.||+|...       .++..|+||.+....     ....+|+..+..++ ||||+++++++...+  
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~--   71 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNK-------ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND--   71 (283)
T ss_pred             CeeheeeccCCceEEEEEEEC-------CCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC--
Confidence            567788999999999999865       356889999876532     13457899999998 999999999987644  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        ..++||||+ +++|.+++.......+++..+..++.|++.+|.|||++   +++|+||+|+||+++.++.++|+|||+
T Consensus        72 --~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~  145 (283)
T cd07830          72 --ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGL  145 (283)
T ss_pred             --cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeeccc
Confidence              459999999 88999998766545789999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccc-cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHH-HHHHhhcccCc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL-LEWVQQYPADS  312 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~-~~~~~~~~~~~  312 (432)
                      +.....   ........++..|+|||.+. +..++.++|+||||+++|+|++|..||........... ...........
T Consensus       146 ~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (283)
T cd07830         146 AREIRS---RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQD  222 (283)
T ss_pred             ceeccC---CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhh
Confidence            875321   11223356888999999885 45578999999999999999999999976654332211 11111100000


Q ss_pred             c--------ccccccC----ccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          313 K--------KFGLIMD----PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       313 ~--------~~~~~~~----~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .        .....+.    ..+.... ...+..+.+++.+||+.+|++|||+.+++.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         223 WPEGYKLASKLGFRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             hhhHhhhhccccccccccccccHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            0        0000000    0000000 1114678899999999999999999998764

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4e-37  Score=292.77  Aligned_cols=242  Identities=26%  Similarity=0.419  Sum_probs=192.3

Q ss_pred             ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCccceeeeEEeecCCcceeEE
Q 014034           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  159 (432)
Q Consensus        84 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~  159 (432)
                      ...||+|+||.||++...       .++..||+|.+....    ..+.+|+.+++.++||||+++++++...+    ..+
T Consensus        25 ~~~lg~g~~g~v~~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~   93 (292)
T cd06657          25 FIKIGEGSTGIVCIATVK-------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD----ELW   93 (292)
T ss_pred             HHHcCCCCCeEEEEEEEc-------CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC----EEE
Confidence            457999999999999865       467899999875322    24788999999999999999999987654    459


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCC
Q 014034          160 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP  239 (432)
Q Consensus       160 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~  239 (432)
                      +||||+++++|.+++..   ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++....
T Consensus        94 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~  167 (292)
T cd06657          94 VVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  167 (292)
T ss_pred             EEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecc
Confidence            99999999999998753   2589999999999999999999998   99999999999999999999999999986532


Q ss_pred             CCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccccccc
Q 014034          240 MVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM  319 (432)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (432)
                      ..  ........|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+...........  ...+          
T Consensus       168 ~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~--~~~~----------  233 (292)
T cd06657         168 KE--VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR--DNLP----------  233 (292)
T ss_pred             cc--cccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hhCC----------
Confidence            11  112234568899999999988888999999999999999999999997654432211111  0111          


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          320 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       320 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                       +.+..  ....+..+.+++.+||..+|.+||++.+++.+
T Consensus       234 -~~~~~--~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         234 -PKLKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             -cccCC--cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence             00000  11223567899999999999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.4e-37  Score=295.39  Aligned_cols=269  Identities=29%  Similarity=0.345  Sum_probs=196.6

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|.+.+.||.|+||.||+|...       .++..+|+|.+...      ...+.+|+++++.++||||+++++++...
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQI-------KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVER   79 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEEC-------CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecc
Confidence            468999999999999999999865       45678999987532      12467899999999999999999987654


Q ss_pred             CC----cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCce
Q 014034          152 GE----RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP  227 (432)
Q Consensus       152 ~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~  227 (432)
                      ..    .....++||||+. ++|...+... ...+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.+
T Consensus        80 ~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~  154 (311)
T cd07866          80 PDKSKRKRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGIL  154 (311)
T ss_pred             cccccccCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence            32    2345689999985 4777776543 24699999999999999999999998   99999999999999999999


Q ss_pred             eeccccCCcCCCCCCC---------cccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchh
Q 014034          228 KLSDFGLAREGPMVGH---------THVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT  297 (432)
Q Consensus       228 kl~DfG~a~~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~  297 (432)
                      +|+|||++........         ........+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.....
T Consensus       155 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~  234 (311)
T cd07866         155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID  234 (311)
T ss_pred             EECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999999975322111         111223467889999998865 457899999999999999999999998765543


Q ss_pred             hHHHHHHHhhcccC-ccc----cccc--------cCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          298 EQRLLEWVQQYPAD-SKK----FGLI--------MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       298 ~~~~~~~~~~~~~~-~~~----~~~~--------~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ...........+.. ...    ....        ..+.+... .......+.+++.+||..||.+|||+.+++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER-FGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHH-cccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            32222111111100 000    0000        00000000 01122568899999999999999999998764

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.9e-37  Score=285.55  Aligned_cols=247  Identities=27%  Similarity=0.437  Sum_probs=199.3

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      +|...+.||.|+||.||++...       .++..|++|.+...      ...+.+|+++++.++|||++++++.+...+ 
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~-   72 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRK-------SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKG-   72 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEc-------CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCC-
Confidence            4788899999999999999865       35788999998643      234788999999999999999999887653 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                         ..++|+||+++++|.+++....  ...+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|
T Consensus        73 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d  146 (258)
T cd08215          73 ---KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGD  146 (258)
T ss_pred             ---EEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECC
Confidence               4599999999999999997643  35799999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ||++.......  .......|++.|+|||.+.+..++.++||||||+++++|++|..||.......   +........  
T Consensus       147 ~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~~~~~~--  219 (258)
T cd08215         147 FGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LALKILKGQ--  219 (258)
T ss_pred             ccceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHHHHhcCC--
Confidence            99987532221  12334568899999999988889999999999999999999999997654221   111111100  


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                              .+    ..+...+..+.+++.+||..+|++|||+.+++++
T Consensus       220 --------~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         220 --------YP----PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             --------CC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                    00    1111234678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.8e-37  Score=299.56  Aligned_cols=265  Identities=25%  Similarity=0.373  Sum_probs=196.3

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|...+.||+|+||.||+|...       .++..||+|.+...      ...+.+|+.+++.++||||+++++++...
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~   86 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDK-------RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSA   86 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeC-------CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheeccc
Confidence            478999999999999999999864       45788999988642      12477899999999999999999988654


Q ss_pred             CC--cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          152 GE--RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       152 ~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      ..  .....++|+||+. .+|..++.    ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL  158 (342)
T cd07879          87 VSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKI  158 (342)
T ss_pred             ccCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence            32  1234589999995 47776652    3589999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      +|||+++....     ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+................
T Consensus       159 ~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  233 (342)
T cd07879         159 LDFGLARHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV  233 (342)
T ss_pred             eeCCCCcCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999875321     1223467889999999876 46889999999999999999999999875433221111111000


Q ss_pred             ccCcccccc---------cc--Ccccc-CcC---CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHh
Q 014034          309 PADSKKFGL---------IM--DPRLE-KEY---SINEARKIGRLADNCLSKSSKDRPKMSQVVER--LKQIV  364 (432)
Q Consensus       309 ~~~~~~~~~---------~~--~~~l~-~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~~~  364 (432)
                      +  ...+..         ..  .+... ...   ....+..+.+||.+||+.||.+||++.+++.+  ++...
T Consensus       234 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         234 P--GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             C--CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence            0  000000         00  00000 000   01124568899999999999999999999976  55544

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=6.8e-37  Score=289.10  Aligned_cols=239  Identities=24%  Similarity=0.376  Sum_probs=184.2

Q ss_pred             ccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-------HHHHHH---HHhcccCCCccceeeeEEeecCCcc
Q 014034           86 KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEV---QFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        86 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~---~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      .||+|+||.||+|...       .+++.||+|.+.+...       .+..|.   .+++...||||+.+++++...+   
T Consensus         1 ~ig~g~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~---   70 (278)
T cd05606           1 IIGRGGFGEVYGCRKA-------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD---   70 (278)
T ss_pred             CcccCCCeEEEEEEEe-------cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC---
Confidence            4899999999999864       4578999998764321       133343   3445568999999998887654   


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCC
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  235 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a  235 (432)
                       ..++||||+.|++|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++
T Consensus        71 -~~~~v~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~  144 (278)
T cd05606          71 -KLSFILDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA  144 (278)
T ss_pred             -EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCc
Confidence             359999999999999988654  3699999999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCCCcccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          236 REGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      .....    .......|+..|+|||.+.++ .++.++||||||+++|+|++|..||.................       
T Consensus       145 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------  213 (278)
T cd05606         145 CDFSK----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-------  213 (278)
T ss_pred             cccCc----cCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc-------
Confidence            74321    112345789999999999754 689999999999999999999999976533222211111100       


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  359 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  359 (432)
                          ....    .+...+..+.+++.+||..+|.+||     ++.+++++
T Consensus       214 ----~~~~----~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         214 ----MAVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             ----cCCC----CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence                0111    1112346788999999999999999     89898764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-37  Score=290.16  Aligned_cols=259  Identities=26%  Similarity=0.354  Sum_probs=195.7

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      |...+.||.|++|.||+|...       .++..+++|.+....      ..+.+|+.+++.++||||+++++++....  
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   71 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDK-------LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG--   71 (283)
T ss_pred             CccceeeecCCCceEEEEEcC-------CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC--
Confidence            566788999999999999854       467889999886432      24778999999999999999999987653  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        ..++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||.
T Consensus        72 --~~~~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~  144 (283)
T cd05118          72 --DLYLVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGL  144 (283)
T ss_pred             --CEEEEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeee
Confidence              45999999965 8888886643 4789999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC-c
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD-S  312 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~  312 (432)
                      +.......  .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||............  ....... .
T Consensus       145 ~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~--~~~~~~~~~  220 (283)
T cd05118         145 ARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI--FRTLGTPDP  220 (283)
T ss_pred             eEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHHcCCCch
Confidence            87532221  122334678899999998776 7899999999999999999999999766543321111  1110000 0


Q ss_pred             cccccccC------cccc-------CcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          313 KKFGLIMD------PRLE-------KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       313 ~~~~~~~~------~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .....+..      ..+.       .......+..+.++|.+||+.||.+||++.+++.+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         221 EVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             HhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            00000000      0000       01112345688999999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6e-38  Score=305.10  Aligned_cols=242  Identities=21%  Similarity=0.343  Sum_probs=193.9

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc-----C---hHHHHHHHHHhcccCCCccceeeeEEeecCCcce
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-----D---GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~-----~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~  156 (432)
                      ..||+|+|-+||+|..       ..++..||.-.+..     .   ...|..|+.+|+.|+||||+++|.++.+....  
T Consensus        46 evLGrGafKtVYka~D-------e~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~--  116 (632)
T KOG0584|consen   46 EVLGRGAFKTVYKAFD-------EEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNK--  116 (632)
T ss_pred             hhcccccceeeeeccc-------cccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCc--
Confidence            4699999999999974       46677777655432     1   24588999999999999999999999887653  


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC-CCceeeccccCC
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE-NFRPKLSDFGLA  235 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~DfG~a  235 (432)
                      ...+|+|.+..|+|..|+.+..  .++.+.+..|++||++||.|||++ .++|+|||||.+||+|+. -|.|||+|+|+|
T Consensus       117 ~in~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLA  193 (632)
T KOG0584|consen  117 TINFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLA  193 (632)
T ss_pred             eeeeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHH
Confidence            4589999999999999997654  688899999999999999999997 579999999999999975 589999999999


Q ss_pred             cCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccc
Q 014034          236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF  315 (432)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  315 (432)
                      ....    .......+|||.|||||+.. ..|+..+||||||++++||+|+..||......  ..+...+..-. .+..+
T Consensus       194 tl~r----~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~--AQIYKKV~SGi-KP~sl  265 (632)
T KOG0584|consen  194 TLLR----KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP--AQIYKKVTSGI-KPAAL  265 (632)
T ss_pred             HHhh----ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH--HHHHHHHHcCC-CHHHh
Confidence            7521    12223478999999999997 88999999999999999999999999865432  33433332211 11122


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       316 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ..+-+            +.+.++|.+|+.. ..+|||+.|+|++
T Consensus       266 ~kV~d------------Pevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  266 SKVKD------------PEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             hccCC------------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence            22222            3577999999999 9999999999986

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=288.19  Aligned_cols=262  Identities=25%  Similarity=0.384  Sum_probs=194.6

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhccc---CCCccceeeeEEeec
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVL---EHPNLVKLIGYCAVD  151 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~hpniv~l~~~~~~~  151 (432)
                      |++.+.||.|+||.||+|.++       .++..||+|.+....      ..+.+|+.++..+   +||||+++++++...
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   73 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDL-------NTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGP   73 (287)
T ss_pred             CeEEEEecccCceEEEEEEEC-------CCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeec
Confidence            567789999999999999975       357889999986321      2355677776655   699999999998865


Q ss_pred             CC-cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          152 GE-RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       152 ~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .. .....+++|||+. ++|.+++.......+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+
T Consensus        74 ~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~  149 (287)
T cd07838          74 RTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIA  149 (287)
T ss_pred             cCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEe
Confidence            43 2234689999996 5899988765444689999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      |||++......   .......++..|+|||.+.+..++.++|||||||++|+|++|..||.........  .........
T Consensus       150 dfg~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~--~~~~~~~~~  224 (287)
T cd07838         150 DFGLARIYSFE---MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL--DKIFDVIGL  224 (287)
T ss_pred             ccCcceeccCC---cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH--HHHHHHcCC
Confidence            99998753221   1122345788999999999889999999999999999999999999865443221  111111100


Q ss_pred             --C-cc---------ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          311 --D-SK---------KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       311 --~-~~---------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                        . ..         .+........ .......+..+.+++.+||+.||.+||++.+++.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         225 PSEEEWPRNVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             CChHhcCCCcccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence              0 00         0000000000 11112345678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7e-39  Score=331.72  Aligned_cols=251  Identities=28%  Similarity=0.341  Sum_probs=199.5

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEee
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .+-+++....||.|.||.||-|...       .+|...|+|-+.-..      ..+.+|+.++..++|||+|++||+-..
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~-------~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH 1305 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNL-------DTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH 1305 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecC-------CccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec
Confidence            3456777889999999999999844       688999999875322      237889999999999999999999877


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      ....    +|.||||.+|+|.+.+...  +..++.....+..|++.|+.|||++   |||||||||.||+++.+|.+|++
T Consensus      1306 Rekv----~IFMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~ 1376 (1509)
T KOG4645|consen 1306 REKV----YIFMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYG 1376 (1509)
T ss_pred             HHHH----HHHHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEee
Confidence            6554    8899999999999998543  3567777788999999999999999   99999999999999999999999


Q ss_pred             cccCCcCCCCCC--CcccccccccCCCccCccccccC---CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 014034          231 DFGLAREGPMVG--HTHVSTAVVGTFGYAAPDYIETG---HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  305 (432)
Q Consensus       231 DfG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  305 (432)
                      |||.|.......  .........||+.|||||++.+.   ....+.||||||||+.||+||+.||...+.  ...++..+
T Consensus      1377 DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--e~aIMy~V 1454 (1509)
T KOG4645|consen 1377 DFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--EWAIMYHV 1454 (1509)
T ss_pred             cccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--hhHHHhHH
Confidence            999998533221  11223457899999999999764   356689999999999999999999986543  23333322


Q ss_pred             hhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          306 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ....          .|    ..|...+..-.+++..||..||..|+++.|++++
T Consensus      1455 ~~gh----------~P----q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1455 AAGH----------KP----QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             hccC----------CC----CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            2211          11    2233356677799999999999999999988876

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.6e-37  Score=297.04  Aligned_cols=271  Identities=24%  Similarity=0.332  Sum_probs=200.9

Q ss_pred             cCHHHHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccc
Q 014034           69 FSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLV  142 (432)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv  142 (432)
                      ....++....++|...+.||+|+||.||+|...       .++..||+|++....      ..+.+|+.+++.++||||+
T Consensus         7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv   79 (345)
T cd07877           7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDT-------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI   79 (345)
T ss_pred             hHHHHHhhccCceEEEEEeeecCCeEEEEEEEc-------CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCccc
Confidence            345567778899999999999999999999854       467899999986432      2467899999999999999


Q ss_pred             eeeeEEeecCC--cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceE
Q 014034          143 KLIGYCAVDGE--RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVL  220 (432)
Q Consensus       143 ~l~~~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nil  220 (432)
                      ++++++.....  .....+++++++ +++|.+++...   .+++..+..++.|++.||.|||+.   +|+||||||+||+
T Consensus        80 ~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl  152 (345)
T cd07877          80 GLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLA  152 (345)
T ss_pred             ceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEE
Confidence            99998864322  112357888876 88998887542   589999999999999999999998   9999999999999


Q ss_pred             EcCCCceeeccccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhH
Q 014034          221 LDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ  299 (432)
Q Consensus       221 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~  299 (432)
                      ++.++.+||+|||++....     .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.........
T Consensus       153 l~~~~~~kl~dfg~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~  227 (345)
T cd07877         153 VNEDCELKILDFGLARHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL  227 (345)
T ss_pred             EcCCCCEEEeccccccccc-----ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9999999999999987521     11234568899999999866 56889999999999999999999999765433221


Q ss_pred             HHHHHHhhcccCcccccccc----------CccccC-c---CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          300 RLLEWVQQYPADSKKFGLIM----------DPRLEK-E---YSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~----------~~~l~~-~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .........+.. .....+.          .+.... .   .....+..+.++|.+||+.||.+||++.+++.+
T Consensus       228 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         228 KLILRLVGTPGA-ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHHHHhCCCCH-HHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            111100000000 0000000          000000 0   000124567899999999999999999999987

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=6.5e-37  Score=284.89  Aligned_cols=245  Identities=26%  Similarity=0.365  Sum_probs=198.0

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      +|++.+.||+|+||.||++...       .++..+++|.+...      ...+.+|+.+++.++||||+++++++.... 
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   72 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRL-------SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGN-   72 (256)
T ss_pred             CceEeeeecCCCceeEEEEEEC-------CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCC-
Confidence            4788899999999999999865       45678999987642      224678999999999999999999887653 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                         ..++||||+++++|.+++...  ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|
T Consensus        73 ---~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d  146 (256)
T cd08530          73 ---KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGD  146 (256)
T ss_pred             ---EEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEee
Confidence               469999999999999998652  234689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ||++......    ......++..|+|||.+.+..++.++|+||||+++|+|++|..||........   .......   
T Consensus       147 ~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~~~~~~~---  216 (256)
T cd08530         147 LGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL---RYKVQRG---  216 (256)
T ss_pred             ccchhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHhcC---
Confidence            9998753222    22335688999999999988899999999999999999999999986543221   1111100   


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                 .....+...+..+.+++.+||..+|.+|||+.+++++
T Consensus       217 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         217 -----------KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             -----------CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                       0011122445678999999999999999999999865

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-36  Score=282.09  Aligned_cols=245  Identities=31%  Similarity=0.460  Sum_probs=197.1

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      +|...+.||+|+||.||++...       ..+..|++|.+....      ..+.+|++++..++|||++++++++.... 
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   72 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNL-------ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD-   72 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEc-------CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC-
Confidence            4788899999999999999865       456789999986543      24788999999999999999999987653 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+.+++|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++|+|||
T Consensus        73 ---~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~  144 (254)
T cd06627          73 ---SLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFG  144 (254)
T ss_pred             ---EEEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccc
Confidence               458999999999999998765  4789999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      ++.......  .......++..|+|||.+.+..++.++||||||+++|+|++|..||........  ..... ..     
T Consensus       145 ~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~--~~~~~-~~-----  214 (254)
T cd06627         145 VATKLNDVS--KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA--LFRIV-QD-----  214 (254)
T ss_pred             cceecCCCc--ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH--HHHHh-cc-----
Confidence            997542221  112335688999999999888889999999999999999999999976542211  11111 00     


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                           ..+    ..+...+..+.+++.+||..+|++|||+.+++.+
T Consensus       215 -----~~~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         215 -----DHP----PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             -----CCC----CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence                 001    1122234678899999999999999999998753

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.7e-36  Score=291.32  Aligned_cols=241  Identities=34%  Similarity=0.500  Sum_probs=189.9

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      |...+.||+|+||.||+|+..       .++..|++|.+....       ..+.+|+.+++.++|||++++++++.... 
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~-------~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   94 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNS-------HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH-   94 (313)
T ss_pred             hhcceeeccCCCeEEEEEEEC-------CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-
Confidence            666778999999999999864       467889999986321       24678999999999999999999987654 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+. ++|.+++.... .++++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||
T Consensus        95 ---~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg  166 (313)
T cd06633          95 ---TAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFG  166 (313)
T ss_pred             ---EEEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecC
Confidence               3599999995 57877775433 4689999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      ++....      ......|+..|+|||.+.   ...++.++|||||||++|+|++|..||............   .....
T Consensus       167 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~---~~~~~  237 (313)
T cd06633         167 SASKSS------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQNDS  237 (313)
T ss_pred             CCcccC------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HhcCC
Confidence            986421      123456889999999984   456888999999999999999999999765443222111   11000


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                +..   .....+..+.+|+.+||+.+|.+||++.+++.+
T Consensus       238 ----------~~~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         238 ----------PTL---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ----------CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      000   011123468899999999999999999999866

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.5e-36  Score=293.52  Aligned_cols=265  Identities=25%  Similarity=0.356  Sum_probs=197.8

Q ss_pred             HHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeee
Q 014034           73 EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIG  146 (432)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~  146 (432)
                      ++...+++|+..+.||.|+||.||+|...       .++..||+|.+.+.      ...+..|+.+++.++||||+++++
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~   76 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQ-------LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSD   76 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEEC-------CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEee
Confidence            34456789999999999999999999854       56788999987531      235778999999999999999999


Q ss_pred             EEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCc
Q 014034          147 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR  226 (432)
Q Consensus       147 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~  226 (432)
                      ++.....   ..++||||+ +++|..++..   .++++..+..++.|++.||.|||+.   +|+||||+|+|||++.++.
T Consensus        77 ~~~~~~~---~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~  146 (328)
T cd07856          77 IFISPLE---DIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCD  146 (328)
T ss_pred             eEecCCC---cEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCC
Confidence            8865332   358999998 6789888753   2578888899999999999999998   9999999999999999999


Q ss_pred             eeeccccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH-HH
Q 014034          227 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL-EW  304 (432)
Q Consensus       227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~-~~  304 (432)
                      ++|+|||++.....     ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||............ ..
T Consensus       147 ~~l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~  221 (328)
T cd07856         147 LKICDFGLARIQDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDL  221 (328)
T ss_pred             EEeCccccccccCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            99999999874211     1223467889999998865 57899999999999999999999999766543222111 11


Q ss_pred             HhhcccC-------ccccccccCccccCcCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          305 VQQYPAD-------SKKFGLIMDPRLEKEYS-----INEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       305 ~~~~~~~-------~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ....+..       ......+..-......+     ...+..+.++|.+||+.+|++|||+.+++.+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         222 LGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            1110000       00000000000000111     1124678899999999999999999999877

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.8e-37  Score=296.69  Aligned_cols=271  Identities=25%  Similarity=0.319  Sum_probs=201.4

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecC-
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDG-  152 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~-  152 (432)
                      +|.+.+.||.|+||.||+|...       .++..||+|.+....      ..+.+|+.+++.++||||+++++++.... 
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDK-------RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSP   73 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeC-------CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCc
Confidence            4788899999999999999864       457889999886532      34788999999999999999999987654 


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                      ......++||||+. ++|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus        74 ~~~~~~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~df  147 (330)
T cd07834          74 EDFNDVYIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDF  147 (330)
T ss_pred             ccccceEEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccc
Confidence            12234699999996 58988886543  799999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCC-cccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH-HHHhhcc
Q 014034          233 GLAREGPMVGH-THVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL-EWVQQYP  309 (432)
Q Consensus       233 G~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~-~~~~~~~  309 (432)
                      |++........ ........++..|+|||.+.+. .++.++||||||+++|+|++|..||.+.........+ .......
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  227 (330)
T cd07834         148 GLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS  227 (330)
T ss_pred             CceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCC
Confidence            99985432211 0122345678899999999887 8899999999999999999999999876543321111 1110000


Q ss_pred             cCcc------ccccccC---cccc---CcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHH
Q 014034          310 ADSK------KFGLIMD---PRLE---KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER--LKQI  363 (432)
Q Consensus       310 ~~~~------~~~~~~~---~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~~  363 (432)
                      ....      .....+.   ....   .......+..+.+++.+||+.+|.+|||+.+++.+  ++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  295 (330)
T cd07834         228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL  295 (330)
T ss_pred             hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence            0000      0000000   0000   00011235678899999999999999999999986  4444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.3e-36  Score=294.72  Aligned_cols=266  Identities=25%  Similarity=0.313  Sum_probs=193.2

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhccc-CCCccceeeeEEeecC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVL-EHPNLVKLIGYCAVDG  152 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  152 (432)
                      +|.+.+.||+|+||.||++....     ...+..||+|.+...      ...+.+|+.+++.+ +||||+++++.+....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   75 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAE-----TSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP   75 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCC-----CCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc
Confidence            47788899999999999998751     122678999987642      23467899999999 5999999998765443


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                      ......+++++|+. ++|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        76 ~~~~~~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Df  149 (332)
T cd07857          76 GNFNELYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDF  149 (332)
T ss_pred             ccCCcEEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcC
Confidence            33334588899884 6899988643  4689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCC--cccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHHHhhc
Q 014034          233 GLAREGPMVGH--THVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR-LLEWVQQY  308 (432)
Q Consensus       233 G~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~~~~  308 (432)
                      |++........  ........||..|+|||++.+ ..++.++|||||||++|+|++|..||.......... ...... .
T Consensus       150 g~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~  228 (332)
T cd07857         150 GLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG-T  228 (332)
T ss_pred             CCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC-C
Confidence            99975322111  111233578999999998765 568999999999999999999999997654322111 111000 0


Q ss_pred             ccCccccccc---------------cCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 PADSKKFGLI---------------MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 ~~~~~~~~~~---------------~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      +.. ..+..+               -...+.. .....+..+.+++.+||+.||.+|||+.+++.+
T Consensus       229 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         229 PDE-ETLSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             CCH-HHHHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            000 000000               0000000 001124578899999999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=5.7e-37  Score=286.47  Aligned_cols=242  Identities=26%  Similarity=0.375  Sum_probs=189.6

Q ss_pred             cccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-------HHHHHHHHhcccCCCccceeeeEEeecCCcceeEE
Q 014034           87 IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  159 (432)
Q Consensus        87 lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~  159 (432)
                      ||.|+||.||++...       .++..+++|.+.....       .+.+|+.+++.++||||+++++.+....    ..+
T Consensus         1 lg~g~~~~vy~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~~~   69 (265)
T cd05579           1 ISKGAYGRVFLAKKK-------STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK----NLY   69 (265)
T ss_pred             CCCCCceEEEEEEEC-------CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc----EEE
Confidence            689999999999865       4578899999865432       4788999999999999999998876543    459


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCC
Q 014034          160 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP  239 (432)
Q Consensus       160 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~  239 (432)
                      +||||+.+++|.+++....  .+++..+..++.||+.||.|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        70 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~  144 (265)
T cd05579          70 LVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGL  144 (265)
T ss_pred             EEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcc
Confidence            9999999999999997644  689999999999999999999998   99999999999999999999999999987532


Q ss_pred             CCCC------cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          240 MVGH------THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       240 ~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      ....      ........++..|++||.+.+..++.++||||||+++|+|++|..||........   .........   
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~~~~~~~~---  218 (265)
T cd05579         145 VRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI---FQNILNGKI---  218 (265)
T ss_pred             cCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHhcCCc---
Confidence            2211      1122345678899999999888889999999999999999999999976543321   111111000   


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                              ....  ....+..+.+++.+||+.+|.+|||+..+.+.|
T Consensus       219 --------~~~~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         219 --------EWPE--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             --------CCCc--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence                    0000  001246788999999999999999995554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1e-36  Score=292.28  Aligned_cols=245  Identities=33%  Similarity=0.435  Sum_probs=191.8

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ..|...+.||+|+||.||+|...       .++..+|+|.+...       ...+.+|+++++.++|||++++++++...
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   87 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDV-------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE   87 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEc-------CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC
Confidence            34777888999999999999865       45678999987532       12367899999999999999999998765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      .    ..++||||+. |+|.+.+.... .++++..+..++.|++.||.|||+.   +++||||+|+|||++.++.++|+|
T Consensus        88 ~----~~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~d  158 (308)
T cd06634          88 H----TAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGD  158 (308)
T ss_pred             C----eeEEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECC
Confidence            4    3489999996 68887775433 4689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      ||++.....      .....|+..|+|||.+.   ...++.++|||||||++|+|++|..||.........  ..+....
T Consensus       159 fg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~~~  230 (308)
T cd06634         159 FGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIAQNE  230 (308)
T ss_pred             cccceeecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH--HHHhhcC
Confidence            999864221      22356889999999974   356788999999999999999999998764332211  1111110


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                      .           +.   ......+..+.+||.+||..+|.+||++.+++.+..
T Consensus       231 ~-----------~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         231 S-----------PA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             C-----------CC---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence            0           00   011223466889999999999999999999998743

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-38  Score=288.23  Aligned_cols=262  Identities=23%  Similarity=0.317  Sum_probs=205.7

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh---HHHHHHHHHhcccCC--C----ccceeeeE
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQWVAEVQFLGVLEH--P----NLVKLIGY  147 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h--p----niv~l~~~  147 (432)
                      .+++|.+...+|+|.||.|-.+...       ..+..||+|+++.-.   ....-|+++|.++++  |    -+|.+.++
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~-------~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w  159 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDR-------ETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDW  159 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeec-------CCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence            3789999999999999999998854       347899999987533   336679999999842  2    36667777


Q ss_pred             EeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC----
Q 014034          148 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE----  223 (432)
Q Consensus       148 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~----  223 (432)
                      |...+.    .|+|+|.+ |-|+.++|..++..+++..++..|+.|++++++|||+.   +++|.||||+|||+..    
T Consensus       160 Fdyrgh----iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~  231 (415)
T KOG0671|consen  160 FDYRGH----ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYF  231 (415)
T ss_pred             hhccCc----eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceE
Confidence            765553    49999988 77999999998888999999999999999999999998   9999999999999832    


Q ss_pred             ----------------CCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCC
Q 014034          224 ----------------NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR  287 (432)
Q Consensus       224 ----------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~  287 (432)
                                      +..++|+|||.|+..     .......+.|..|.|||++.+-+++..+||||+||||+|+.||.
T Consensus       232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~-----~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~  306 (415)
T KOG0671|consen  232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFD-----HEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGE  306 (415)
T ss_pred             EEeccCCccceeccCCCcceEEEecCCccee-----ccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccc
Confidence                            345899999999752     12225678899999999999999999999999999999999999


Q ss_pred             CCCCCCCchhhHHHHHHHhhcccCccccccc-------------------------cCc-c-c--cCcCCHHHHHHHHHH
Q 014034          288 RSLERNRPKTEQRLLEWVQQYPADSKKFGLI-------------------------MDP-R-L--EKEYSINEARKIGRL  338 (432)
Q Consensus       288 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~-~-l--~~~~~~~~~~~l~~l  338 (432)
                      ..|+.+...+...+++.+... .+..+....                         .++ . +  .......+...|.+|
T Consensus       307 ~LFqtHen~EHLaMMerIlGp-~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDL  385 (415)
T KOG0671|consen  307 TLFQTHENLEHLAMMERILGP-IPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDL  385 (415)
T ss_pred             eecccCCcHHHHHHHHHhhCC-CcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHH
Confidence            999988866666666555442 111111000                         000 0 0  001223445679999


Q ss_pred             HHHhccCCCCCCCCHHHHHHH
Q 014034          339 ADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       339 i~~cl~~dP~~RPs~~eil~~  359 (432)
                      +++||..||.+|+|+.|++.+
T Consensus       386 l~~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  386 LRRMLEFDPARRITLREALSH  406 (415)
T ss_pred             HHHHHccCccccccHHHHhcC
Confidence            999999999999999999876

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.4e-36  Score=289.52  Aligned_cols=250  Identities=29%  Similarity=0.482  Sum_probs=188.9

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhccc-CCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVL-EHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~hpniv~l~~~~~~~  151 (432)
                      .++|...+.||+|+||.||+|.+.       .++..||||.+....     ..+..|+.++..+ .||||+++++++...
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~   86 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFK-------KTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD   86 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEEC-------CCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence            357899999999999999999875       357889999986431     2355677666666 599999999999765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      ..    .++||||+ +++|.+++.... ..+++..+..++.|++.||.|||+.  .+|+||||+|+||+++.++.+||+|
T Consensus        87 ~~----~~~v~e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~d  158 (296)
T cd06618          87 SD----VFICMELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCD  158 (296)
T ss_pred             Ce----EEEEeecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECc
Confidence            53    59999998 457777765433 3789999999999999999999973  2899999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCC----CCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH----LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  307 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  307 (432)
                      ||++......   .......++..|+|||.+.+..    ++.++||||||+++|+|++|..||....... ..+......
T Consensus       159 fg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~  234 (296)
T cd06618         159 FGISGRLVDS---KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVLTKILQE  234 (296)
T ss_pred             cccchhccCC---CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HHHHHHhcC
Confidence            9998753211   1122345788999999987553    7889999999999999999999997533211 111111111


Q ss_pred             cccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ..           +.+..  ....+..+.+|+.+||..||.+||++.+++.+
T Consensus       235 ~~-----------~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         235 EP-----------PSLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CC-----------CCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00           00000  01124568899999999999999999999877

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.4e-36  Score=290.33  Aligned_cols=259  Identities=22%  Similarity=0.270  Sum_probs=188.8

Q ss_pred             cccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeecCCcce
Q 014034           83 RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        83 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~  156 (432)
                      +.+.+|.|+++.||++.         .++..||+|++...      ...+.+|+.+++.++||||+++++++.....   
T Consensus         6 i~~~~~~~~~v~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~---   73 (314)
T cd08216           6 IGKCFEDLMIVHLAKHK---------PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE---   73 (314)
T ss_pred             hhHhhcCCceEEEEEec---------CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCe---
Confidence            33445555555555543         36789999998643      1247899999999999999999999876543   


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                       .+++|||+.+++|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||.+.
T Consensus        74 -~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~  149 (314)
T cd08216          74 -LYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSV  149 (314)
T ss_pred             -EEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccce
Confidence             59999999999999999865555789999999999999999999998   99999999999999999999999999886


Q ss_pred             CCCCCCC-----cccccccccCCCccCcccccc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          237 EGPMVGH-----THVSTAVVGTFGYAAPDYIET--GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       237 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      .......     ........++..|+|||++.+  ..++.++|||||||++|+|++|..||.......  ...+......
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~  227 (314)
T cd08216         150 SMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTV  227 (314)
T ss_pred             eeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccC
Confidence            4321111     111233457789999999865  458899999999999999999999998654321  1111111100


Q ss_pred             ----------cCcccccc----ccC----ccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ----------ADSKKFGL----IMD----PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ----------~~~~~~~~----~~~----~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                ........    ...    ..............+.+|+.+||..||++|||+.+++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         228 PCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             ccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence                      00000000    000    001111223345678899999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-36  Score=296.39  Aligned_cols=265  Identities=26%  Similarity=0.385  Sum_probs=197.6

Q ss_pred             HHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeE
Q 014034           74 MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGY  147 (432)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~  147 (432)
                      +....++|..++.||+|+||.||+|...       .++..||+|.+...      ...+.+|+.+++.++||||++++++
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   82 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDR-------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV   82 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEEC-------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeee
Confidence            3445678999999999999999999854       46788999988542      1246789999999999999999998


Q ss_pred             EeecCCc--ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC
Q 014034          148 CAVDGER--GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF  225 (432)
Q Consensus       148 ~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~  225 (432)
                      +..+...  ....++||||+ +++|.+++..   ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~  155 (343)
T cd07880          83 FTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDC  155 (343)
T ss_pred             ecCCccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence            8754322  12458999998 7899888754   3689999999999999999999998   999999999999999999


Q ss_pred             ceeeccccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 014034          226 RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  304 (432)
Q Consensus       226 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  304 (432)
                      .++|+|||++.....     ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||........  ....
T Consensus       156 ~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~--~~~~  228 (343)
T cd07880         156 ELKILDFGLARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ--LMEI  228 (343)
T ss_pred             CEEEeeccccccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH
Confidence            999999999875321     1223467889999999875 4588999999999999999999999986543221  1111


Q ss_pred             HhhcccCccccccccC-----------cccc----CcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          305 VQQYPADSKKFGLIMD-----------PRLE----KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       305 ~~~~~~~~~~~~~~~~-----------~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ..........+...+.           +...    .......+..+.+++.+|++.||.+|||+.+++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         229 MKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             HHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            1100000000000000           0000    00011234568899999999999999999999965

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.7e-36  Score=292.68  Aligned_cols=263  Identities=22%  Similarity=0.290  Sum_probs=193.1

Q ss_pred             cCCcc-ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH------------------HHHHHHHHhcccCCC
Q 014034           79 NDFSR-MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------------------QWVAEVQFLGVLEHP  139 (432)
Q Consensus        79 ~~~~~-~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~------------------~~~~E~~~l~~l~hp  139 (432)
                      ++|.. .+.||.|+||.||+|...       ..++.||+|.+.....                  .+.+|+.+++.++||
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   80 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDT-------LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHE   80 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEEC-------CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCc
Confidence            45654 467999999999999864       4678899998754211                  367899999999999


Q ss_pred             ccceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCce
Q 014034          140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNV  219 (432)
Q Consensus       140 niv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Ni  219 (432)
                      ||+++++++....    ..++||||+. ++|.+++...  ..+++.....++.|++.||.|||+.   +|+|+||+|+||
T Consensus        81 ~iv~~~~~~~~~~----~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~ni  150 (335)
T PTZ00024         81 NIMGLVDVYVEGD----FINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANI  150 (335)
T ss_pred             ceeeeeEEEecCC----cEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHe
Confidence            9999999987654    3599999996 6899988654  3689999999999999999999998   999999999999


Q ss_pred             EEcCCCceeeccccCCcCCCCCC------------CcccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhC
Q 014034          220 LLDENFRPKLSDFGLAREGPMVG------------HTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTG  286 (432)
Q Consensus       220 ll~~~~~~kl~DfG~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg  286 (432)
                      +++.++.++|+|||++.......            .........++..|+|||.+.+. .++.++|||||||++|+|++|
T Consensus       151 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg  230 (335)
T PTZ00024        151 FINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG  230 (335)
T ss_pred             EECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhC
Confidence            99999999999999987532100            01111234568899999998764 468999999999999999999


Q ss_pred             CCCCCCCCchhhHH-HHHHHhhcccCccc----------cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 014034          287 RRSLERNRPKTEQR-LLEWVQQYPADSKK----------FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ  355 (432)
Q Consensus       287 ~~pf~~~~~~~~~~-~~~~~~~~~~~~~~----------~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  355 (432)
                      ..||.+........ +.............          +.......+.. .....+..+.+++.+||+.+|++|||+.+
T Consensus       231 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~  309 (335)
T PTZ00024        231 KPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKE  309 (335)
T ss_pred             CCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHH
Confidence            99998765433221 11111111100000          00000000000 01122456889999999999999999999


Q ss_pred             HHHH
Q 014034          356 VVER  359 (432)
Q Consensus       356 il~~  359 (432)
                      ++.+
T Consensus       310 ~l~~  313 (335)
T PTZ00024        310 ALKH  313 (335)
T ss_pred             HhcC
Confidence            9875

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=9.1e-37  Score=287.73  Aligned_cols=247  Identities=25%  Similarity=0.353  Sum_probs=197.5

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccC-CCccceeeeEEee
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLE-HPNLVKLIGYCAV  150 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~-hpniv~l~~~~~~  150 (432)
                      ++|...+.||.|+||.||+|...       .++..||+|.+...       ...+..|+.+++++. ||||+++++++..
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~   73 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEK-------ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD   73 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEc-------CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC
Confidence            47889999999999999999865       46788999988652       124778999999998 9999999998865


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .+    ..++||||+.+++|.+++....  .+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+
T Consensus        74 ~~----~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~  144 (280)
T cd05581          74 EE----NLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKIT  144 (280)
T ss_pred             Cc----eEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEec
Confidence            44    3599999999999999997653  699999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCC------------------cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 014034          231 DFGLAREGPMVGH------------------THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLER  292 (432)
Q Consensus       231 DfG~a~~~~~~~~------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~  292 (432)
                      |||++........                  ........++..|+|||.+.+..++.++||||||++++++++|..||..
T Consensus       145 df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  224 (280)
T cd05581         145 DFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG  224 (280)
T ss_pred             CCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999875322111                  0222345678999999999888899999999999999999999999986


Q ss_pred             CCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCH----HHHHHH
Q 014034          293 NRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM----SQVVER  359 (432)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~eil~~  359 (432)
                      .....   ........           ..    ..+...+..+.+++.+||+.+|.+|||+    .+++.+
T Consensus       225 ~~~~~---~~~~~~~~-----------~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         225 SNEYL---TFQKILKL-----------EY----SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             ccHHH---HHHHHHhc-----------CC----CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            54221   11111100           00    1112224678899999999999999999    777654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-39  Score=281.26  Aligned_cols=253  Identities=28%  Similarity=0.448  Sum_probs=195.2

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHH-hcccCCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQF-LGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~  152 (432)
                      .+.+.+..||.|+||+|++..++       ..++.+|||+++..     ..++..|+.. ++.-+.||||++||.+..++
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk-------~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG  136 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHK-------PSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG  136 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcC-------ccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence            35666778999999999999987       57899999998643     3346777765 45558999999999998888


Q ss_pred             CcceeEEEEEeecCCCCHHHHh---hcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHL---FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l---~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      ..    |+.||.| .-||+.+.   +.-....+++...-+|....+.||.||-..  ..|+||||||+|||++..|.+||
T Consensus       137 dc----WiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKL  209 (361)
T KOG1006|consen  137 DC----WICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKL  209 (361)
T ss_pred             ce----eeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEee
Confidence            76    9999999 55776544   233345789999999999999999999986  58999999999999999999999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCcccccc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET--GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  307 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  307 (432)
                      ||||++-..   ..+...+.-.|...|||||.+..  ..|+-++||||||++|||+.||..||.++...- .++...+..
T Consensus       210 CDFGIcGqL---v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svf-eql~~Vv~g  285 (361)
T KOG1006|consen  210 CDFGICGQL---VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVF-EQLCQVVIG  285 (361)
T ss_pred             ecccchHhH---HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHH-HHHHHHHcC
Confidence            999998542   11222334568899999999953  458999999999999999999999999876522 222222222


Q ss_pred             cccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .+.       ++..   .....+.+..+..+|..|+.+|-++||.+.+++++
T Consensus       286 dpp-------~l~~---~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  286 DPP-------ILLF---DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             CCC-------eecC---cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            111       0111   11123345778999999999999999999998876

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.4e-36  Score=286.91  Aligned_cols=251  Identities=26%  Similarity=0.377  Sum_probs=191.8

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh--------HHHHHHHHHhccc-CCCccceeeeEEee
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--------LQWVAEVQFLGVL-EHPNLVKLIGYCAV  150 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~hpniv~l~~~~~~  150 (432)
                      +|++.+.||.|+||.||++....    +..++..||+|.+....        ..+.+|+.++..+ +||||+++++++..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~----~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~   76 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVS----GHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT   76 (290)
T ss_pred             CceeeeeeccCCcceEEEEEecc----CCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec
Confidence            47888999999999999998641    22367889999986422        2467899999999 59999999988865


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      +.    ..++||||+++++|.+++...  .++++..+..++.|++.||.|||+.   +++||||+|+|||++.++.+||+
T Consensus        77 ~~----~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~  147 (290)
T cd05613          77 DT----KLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLT  147 (290)
T ss_pred             CC----eEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEe
Confidence            44    358999999999999999754  3688999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccC--CCCchhhhHHHHHHHHHHHhCCCCCCCCCchh-hHHHHHHHhh
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG--HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT-EQRLLEWVQQ  307 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~~-~~~~~~~~~~  307 (432)
                      |||++...... .........|+..|+|||.+.+.  .++.++||||||+++|+|++|..||....... ...+...+..
T Consensus       148 dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~  226 (290)
T cd05613         148 DFGLSKEFHED-EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK  226 (290)
T ss_pred             eCccceecccc-cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc
Confidence            99998753221 11122245689999999998653  46789999999999999999999996432211 1112111111


Q ss_pred             cccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 014034          308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  359 (432)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  359 (432)
                      .           .+    ..+...+..+.+++.+||+.||.+||     ++.+++.+
T Consensus       227 ~-----------~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         227 S-----------EP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             c-----------CC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            0           00    11222345688999999999999997     66666554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=8.1e-37  Score=297.23  Aligned_cols=266  Identities=22%  Similarity=0.287  Sum_probs=193.9

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC----hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      .++|...+.||.|+||.||+|...       .++..||+|.+...    ...+.+|+++++.++||||+++++++.....
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~-------~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~   76 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDS-------DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS   76 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEEC-------CCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence            368999999999999999999865       46788999987543    2347789999999999999999987765432


Q ss_pred             cc----------eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc-
Q 014034          154 RG----------IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-  222 (432)
Q Consensus       154 ~~----------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~-  222 (432)
                      ..          ...++||||+. ++|.+++..   ..+++..+..++.||+.||.|||+.   +|+||||||+||+++ 
T Consensus        77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~  149 (342)
T cd07854          77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINT  149 (342)
T ss_pred             ccccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcC
Confidence            21          24689999996 589888753   2588999999999999999999998   999999999999997 


Q ss_pred             CCCceeeccccCCcCCCCCCC-cccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 014034          223 ENFRPKLSDFGLAREGPMVGH-THVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR  300 (432)
Q Consensus       223 ~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~  300 (432)
                      .++.++|+|||++........ ........++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+..+.....
T Consensus       150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~  229 (342)
T cd07854         150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ  229 (342)
T ss_pred             CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            456789999999875321111 111223457889999998754 567889999999999999999999998665433221


Q ss_pred             HHHHHhhcccCcc-ccc-------cccC-ccccCc-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          301 LLEWVQQYPADSK-KFG-------LIMD-PRLEKE-----YSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       301 ~~~~~~~~~~~~~-~~~-------~~~~-~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .  .....+.... ...       .... ......     .....+..+.+|+.+||+.||.+|||+.+++.+
T Consensus       230 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         230 L--ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             H--HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            1  1111111000 000       0000 000000     011234568899999999999999999999876

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-37  Score=307.25  Aligned_cols=255  Identities=26%  Similarity=0.399  Sum_probs=212.9

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc-----ChHHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-----DGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      ....++||+|+||+||+|.|.+.   +..-..+||||++..     ....+..|+-+|.+++|||+++|+|+|..+.   
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pe---ge~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~---  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPE---GENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST---  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecC---CceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch---
Confidence            45567899999999999999865   334567899999854     3456899999999999999999999998654   


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCC
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  235 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a  235 (432)
                        ..||++|++.|+|.++++... ..+.....+.|..|||+||.|||.+   .++||||...||||.....+||+|||++
T Consensus       772 --~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla  845 (1177)
T KOG1025|consen  772 --LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLA  845 (1177)
T ss_pred             --HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchh
Confidence              378999999999999998754 4788899999999999999999998   9999999999999999999999999999


Q ss_pred             cCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      +.....+.........-.+.|||=|.+....|+.++|||||||++||++| |..|+.+....+..++++.-.++      
T Consensus       846 ~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRL------  919 (1177)
T KOG1025|consen  846 KLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERL------  919 (1177)
T ss_pred             hccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccC------
Confidence            87554444333333344568999999999999999999999999999999 99999988766555444422111      


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  364 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  364 (432)
                                 ..+..++.++..++.+||..|+..||+++++...+..+.
T Consensus       920 -----------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a  958 (1177)
T KOG1025|consen  920 -----------SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA  958 (1177)
T ss_pred             -----------CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence                       224556678899999999999999999999999887764

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-37  Score=255.45  Aligned_cols=262  Identities=25%  Similarity=0.360  Sum_probs=200.5

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH------HHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      +|...++||+|.||+||+|+.+       .+.+.||+|.++.+..      ...+|+-+++.++|.|||+++++...+. 
T Consensus         3 ~ydkmekigegtygtvfkarn~-------~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdk-   74 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNR-------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-   74 (292)
T ss_pred             chHHHHhhcCCcceeeEecccC-------CccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCc-
Confidence            5677789999999999999854       6789999999875433      3789999999999999999999876554 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         .+-+|+||| ..+|..+...-+ +.+....+..++.|+++||.++|++   ++.|||+||.|+||+.+|.+||+|||
T Consensus        75 ---kltlvfe~c-dqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfg  146 (292)
T KOG0662|consen   75 ---KLTLVFEFC-DQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFG  146 (292)
T ss_pred             ---eeEEeHHHh-hHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccc
Confidence               348999999 558888875443 5788999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      +++.+..  ...-.+..+-|.+|.+|.++.|. -|+++.|+||.|||+.|+.. |++.|.+.+-.+....+.|....+..
T Consensus       147 larafgi--pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~e  224 (292)
T KOG0662|consen  147 LARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE  224 (292)
T ss_pred             hhhhcCC--ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcc
Confidence            9986321  12223456779999999999875 58899999999999999987 77777777666655555555444333


Q ss_pred             ccc--cccccCccccCcCC---------HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 SKK--FGLIMDPRLEKEYS---------INEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~~~--~~~~~~~~l~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ...  +..+-+-...+.++         +.....-.+|+++.+.-+|.+|.+++..+++
T Consensus       225 d~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  225 DQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             ccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            211  11111111111111         1112234588899999999999999987765

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.2e-36  Score=282.44  Aligned_cols=249  Identities=24%  Similarity=0.399  Sum_probs=188.6

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc------ChHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      +|.+.+.||+|+||.||++......    ......++|.+..      ....+..|+.+++.++||||+++++++.... 
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAV----AEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD-   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCC----CcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC-
Confidence            4778899999999999999865211    1122233343221      1224667999999999999999999886554 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                         ..++||||+++++|.+++..  .....+++..++.++.|++.||.|||+.   +++|+||+|+||+++. +.++|+|
T Consensus        76 ---~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d  148 (260)
T cd08222          76 ---AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGD  148 (260)
T ss_pred             ---ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecc
Confidence               34899999999999998864  2335789999999999999999999998   9999999999999975 5699999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ||++.....  .........|+..|+|||.+.+..++.++|+||||+++|+|++|..||.......   .........  
T Consensus       149 ~g~~~~~~~--~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---~~~~~~~~~--  221 (260)
T cd08222         149 FGVSRLLMG--SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS---VVLRIVEGP--  221 (260)
T ss_pred             cCceeecCC--CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHcCC--
Confidence            999875321  1222234568889999999988888999999999999999999999997543221   111111100  


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                              .+    ..+...+..+.++|.+||..+|++||++.+++++
T Consensus       222 --------~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         222 --------TP----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             --------CC----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence                    01    1123345678899999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2e-37  Score=277.72  Aligned_cols=272  Identities=26%  Similarity=0.363  Sum_probs=198.0

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ...|+.+..||+|.||.||+|.-+++++.   ....+|||+++...      ....+|+.+++.++||||+.|..++...
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~k---r~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~   99 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDK---RTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH   99 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcc---cchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence            34699999999999999999976543322   24589999997652      2478999999999999999999998864


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCC----
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNR---AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN----  224 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~----  224 (432)
                      +   ...++++||.+ .+|.+.|+-.   ..+.++...+..|++||+.|+.|||++   =|+||||||.||||..+    
T Consensus       100 d---~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgper  172 (438)
T KOG0666|consen  100 D---KKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPER  172 (438)
T ss_pred             C---ceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCcc
Confidence            2   24699999995 5888888532   234688899999999999999999998   79999999999999877    


Q ss_pred             CceeeccccCCcCCCCCCC-cccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchh-----
Q 014034          225 FRPKLSDFGLAREGPMVGH-THVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT-----  297 (432)
Q Consensus       225 ~~~kl~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~-----  297 (432)
                      |.|||+|||+++.+...-. .......+-|.+|.|||.+.| ..|+.+.|||+.|||+.||+|-.+.|.+.....     
T Consensus       173 G~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~P  252 (438)
T KOG0666|consen  173 GRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNP  252 (438)
T ss_pred             CeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCC
Confidence            9999999999986432211 112344567999999999877 478999999999999999999998887632211     


Q ss_pred             --hH---HHHHHHhhcccCc-cc-cc-------cccCcc--ccCcCCHH--------HHHHHHHHHHHhccCCCCCCCCH
Q 014034          298 --EQ---RLLEWVQQYPADS-KK-FG-------LIMDPR--LEKEYSIN--------EARKIGRLADNCLSKSSKDRPKM  353 (432)
Q Consensus       298 --~~---~~~~~~~~~~~~~-~~-~~-------~~~~~~--l~~~~~~~--------~~~~l~~li~~cl~~dP~~RPs~  353 (432)
                        ..   .+.+ +...|.+. +. +.       .+.+-+  .....+..        -++...+|+.++|..||-+|.|+
T Consensus       253 fq~dQl~rIf~-vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta  331 (438)
T KOG0666|consen  253 FQHDQLDRIFE-VLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITA  331 (438)
T ss_pred             chHHHHHHHHH-HcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccH
Confidence              11   1222 12222211 10 00       000000  00000000        01236789999999999999999


Q ss_pred             HHHHHHH
Q 014034          354 SQVVERL  360 (432)
Q Consensus       354 ~eil~~L  360 (432)
                      .+.+++.
T Consensus       332 ~qAleh~  338 (438)
T KOG0666|consen  332 EQALEHP  338 (438)
T ss_pred             HHHhccc
Confidence            9998873

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3e-36  Score=285.97  Aligned_cols=254  Identities=25%  Similarity=0.360  Sum_probs=193.7

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh--------HHHHHHHHHhccc-CCCccceeeeEEee
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--------LQWVAEVQFLGVL-EHPNLVKLIGYCAV  150 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~hpniv~l~~~~~~  150 (432)
                      +|.+.+.||+|+||.||++....    ...++..||+|.+....        ..+.+|+.++..+ +||||+++++.+..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~----~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~   76 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVG----GHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT   76 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEec----cccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec
Confidence            47788899999999999997541    22356789999886421        2367899999999 69999999988765


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      ..    ..++||||+.+++|.+++...  ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+
T Consensus        77 ~~----~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~  147 (288)
T cd05583          77 DT----KLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLT  147 (288)
T ss_pred             CC----EEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEE
Confidence            43    358999999999999998654  3688999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCC--CCchhhhHHHHHHHHHHHhCCCCCCCCCchh-hHHHHHHHhh
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH--LTAKSDVWSFGVVLYEMLTGRRSLERNRPKT-EQRLLEWVQQ  307 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~pf~~~~~~~-~~~~~~~~~~  307 (432)
                      |||++....... ........|+..|+|||.+.+..  .+.++||||||+++|+|++|..||....... ...+...+..
T Consensus       148 dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  226 (288)
T cd05583         148 DFGLSKEFLAEE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK  226 (288)
T ss_pred             ECcccccccccc-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc
Confidence            999987532221 11122356889999999987654  7889999999999999999999996432211 1111111110


Q ss_pred             cccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 014034          308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  362 (432)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  362 (432)
                      .           .+    ..+...+..+.+++.+||+.||++|||+.++.+.|..
T Consensus       227 ~-----------~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         227 S-----------KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             c-----------CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            0           01    1111233567899999999999999998877665543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-36  Score=283.51  Aligned_cols=260  Identities=28%  Similarity=0.410  Sum_probs=194.6

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      |+..+.||+|+||.||+|...       .++..||+|.+....      ..+..|+.+++.++||||+++++++...+  
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--   71 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDK-------KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER--   71 (282)
T ss_pred             CeeehcccccCcceEEEeeec-------CCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC--
Confidence            566778999999999999865       457899999987542      24678999999999999999999987653  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        ..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++|+|||+
T Consensus        72 --~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~  144 (282)
T cd07829          72 --KLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGL  144 (282)
T ss_pred             --ceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCc
Confidence              4599999997 59999997653 3689999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHHHhhcccC-
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR-LLEWVQQYPAD-  311 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~-  311 (432)
                      +......  ........++..|+|||.+.+. .++.++|||||||++|+|++|..||.......... +.......... 
T Consensus       145 ~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (282)
T cd07829         145 ARAFGIP--LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES  222 (282)
T ss_pred             ccccCCC--ccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHH
Confidence            8753221  1122334567889999998766 78999999999999999999999997654332211 11110000000 


Q ss_pred             ----------ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 ----------SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ----------~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                ...+........... ....+..+.+++.+||..||++||++.+++.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         223 WPGVTKLPDYKPTFPKFPPKDLEKV-LPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             HHhhcccccccccccccCccchHHh-cccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence                      000000000000000 01125678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-36  Score=311.26  Aligned_cols=264  Identities=30%  Similarity=0.454  Sum_probs=207.1

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhccc-CCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVL-EHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  151 (432)
                      .++..+.+.||+|.||.|++|...............||||.++..     ...+..|+++|..+ .||||+.++|+|...
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~  374 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD  374 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence            344455668999999999999987444332334788999998643     23488999999988 599999999999884


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCC------C--------CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCC
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRA------F--------PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKAS  217 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~------~--------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~  217 (432)
                      +.    .++|+||+..|+|..+++...      .        ..++....+.++.|||.|++||++.   +++||||...
T Consensus       375 ~~----~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR  447 (609)
T KOG0200|consen  375 GP----LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR  447 (609)
T ss_pred             Cc----eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence            43    499999999999999997654      1        1388899999999999999999998   9999999999


Q ss_pred             ceEEcCCCceeeccccCCcCCCCCCCccccccccc--CCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCC
Q 014034          218 NVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG--TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNR  294 (432)
Q Consensus       218 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~  294 (432)
                      |||+..+..+||+|||+++.......... ....|  ...|||||.+....|+.++|||||||+||||+| |..||.+..
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            99999999999999999985433222221 11222  235999999999999999999999999999999 899998743


Q ss_pred             chhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          295 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                      ....  +.+++..-              ..-..|..+..++.++|..||+.+|++||++.++++.|+..++
T Consensus       527 ~~~~--l~~~l~~G--------------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  527 PTEE--LLEFLKEG--------------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             cHHH--HHHHHhcC--------------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            2222  22222211              1112244556789999999999999999999999999998654

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=317.56  Aligned_cols=257  Identities=25%  Similarity=0.291  Sum_probs=205.5

Q ss_pred             HHHHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc-------ChHHHHHHHHHhcccCCCccce
Q 014034           71 YSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-------DGLQWVAEVQFLGVLEHPNLVK  143 (432)
Q Consensus        71 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~-------~~~~~~~E~~~l~~l~hpniv~  143 (432)
                      ..+++-...+|.+++.||+|+||.|..++++       .+++++|+|++++       +...|..|-.+|..-+.+=|+.
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k-------~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~  139 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHK-------STEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQ  139 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEee-------ccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHH
Confidence            4455566789999999999999999999987       6789999999976       2334889999999999999999


Q ss_pred             eeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC
Q 014034          144 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  223 (432)
Q Consensus       144 l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~  223 (432)
                      ++-.|.++.    ++|+||||++||+|...+.+-.  ++|+.-+.-++..|+-||.-||+.   |+|||||||+|||||.
T Consensus       140 LhyAFQD~~----~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~  210 (1317)
T KOG0612|consen  140 LHYAFQDER----YLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDK  210 (1317)
T ss_pred             HHHHhcCcc----ceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecc
Confidence            987777655    4599999999999999996554  799999999999999999999998   9999999999999999


Q ss_pred             CCceeeccccCCcCCCCCCCcccccccccCCCccCccccc----c-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhh
Q 014034          224 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE----T-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE  298 (432)
Q Consensus       224 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~  298 (432)
                      .|++||+|||.+-..... ....+...+|||-|++||++.    + +.|+..+|+||+||++|||+.|..||....-.  
T Consensus       211 ~GHikLADFGsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv--  287 (1317)
T KOG0612|consen  211 SGHIKLADFGSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV--  287 (1317)
T ss_pred             cCcEeeccchhHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH--
Confidence            999999999998764333 344566789999999999994    3 57899999999999999999999999643221  


Q ss_pred             HHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHHHH
Q 014034          299 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK---MSQVVER  359 (432)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil~~  359 (432)
                       .....+.....           .+.-+....++....+||.+.+. +|+.|..   +.+|..|
T Consensus       288 -eTY~KIm~hk~-----------~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  288 -ETYGKIMNHKE-----------SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             -HHHHHHhchhh-----------hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence             11111111100           01101113356778899998876 5888888   8888876

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=296.79  Aligned_cols=242  Identities=23%  Similarity=0.296  Sum_probs=198.0

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHHHHHHHhccc-CCCccceeeeEEeecCCcc
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVL-EHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~  155 (432)
                      ++..|.....+|.|+|+.|-.+.+.       .++...++|++.+...+..+|+.++... +||||+++.+.+.+..   
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~-------~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~---  389 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESS-------PTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGK---  389 (612)
T ss_pred             cchhhccccccCCCCccceeeeecc-------ccccchhheeccccccccccccchhhhhcCCCcceeecceecCCc---
Confidence            4567888888999999999998865       5678899999988766677788666554 7999999999986543   


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEE-cCCCceeeccccC
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL-DENFRPKLSDFGL  234 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill-~~~~~~kl~DfG~  234 (432)
                       +.++|||.+.|+-|.+.+....   .....+..|+.+|+.|+.|||++   |+|||||||+|||+ +..++++|+|||.
T Consensus       390 -~~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~  462 (612)
T KOG0603|consen  390 -EIYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGF  462 (612)
T ss_pred             -eeeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEech
Confidence             4599999999999988886543   33377788999999999999998   99999999999999 6999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      ++.....     ....+-|..|.|||++....|+.++||||||++||+|++|+.||......  ..+...+..       
T Consensus       463 a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~~-------  528 (612)
T KOG0603|consen  463 WSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQM-------  528 (612)
T ss_pred             hhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhcC-------
Confidence            9753211     33456788999999999999999999999999999999999999876544  222222111       


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                +.++...+....+|+.+||+.||.+||++.++..+
T Consensus       529 ----------~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  529 ----------PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             ----------CccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence                      11224456778899999999999999999999877

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-36  Score=295.25  Aligned_cols=265  Identities=23%  Similarity=0.343  Sum_probs=196.8

Q ss_pred             HhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEe
Q 014034           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCA  149 (432)
Q Consensus        76 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~  149 (432)
                      ...++|.....||+|+||.||+|...       .++..||+|.+...      ...+.+|+.+++.++||||+++++++.
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   84 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDT-------KTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFT   84 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEEC-------CCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhh
Confidence            34578999999999999999999875       45788999998642      123667999999999999999998776


Q ss_pred             ecCC--cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCce
Q 014034          150 VDGE--RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP  227 (432)
Q Consensus       150 ~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~  227 (432)
                      ....  .....++|+||+ +++|.+++..   ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~  157 (343)
T cd07851          85 PASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCEL  157 (343)
T ss_pred             ccccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCE
Confidence            5432  123368999998 7799998864   3689999999999999999999998   99999999999999999999


Q ss_pred             eeccccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHHH
Q 014034          228 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR-LLEWV  305 (432)
Q Consensus       228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~  305 (432)
                      +|+|||++.....     ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+........ +....
T Consensus       158 kL~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~  232 (343)
T cd07851         158 KILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLV  232 (343)
T ss_pred             EEccccccccccc-----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Confidence            9999999875321     1233567889999999865 467889999999999999999999997654432211 11110


Q ss_pred             hhcc--------cCc-cccccccCccccCc---CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          306 QQYP--------ADS-KKFGLIMDPRLEKE---YSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       306 ~~~~--------~~~-~~~~~~~~~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ...+        ... ..+...+.......   .....+..+.+++.+||+.||.+|||+.+|+.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            0000        000 00000000000000   001125678899999999999999999999876

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-36  Score=301.52  Aligned_cols=257  Identities=28%  Similarity=0.381  Sum_probs=211.9

Q ss_pred             HhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh---HHHHHHHHHhccc-CCCccceeeeEEee-
Q 014034           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQWVAEVQFLGVL-EHPNLVKLIGYCAV-  150 (432)
Q Consensus        76 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~hpniv~l~~~~~~-  150 (432)
                      ..++-|++...||.|.+|.||+++.+       .+++.+|+|+...+.   .+...|..+|+.+ +|||++.+||++.. 
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~-------~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHV-------KTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeee-------ecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            34567889999999999999999866       567778888876543   3477788888877 69999999998875 


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      +...+.++|||||||.+||..|.+++..+..+.|..+..|++.++.|+.+||.+   .++|||||-.|||++.++.|||+
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence            334567899999999999999999887777899999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCcccccc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-----GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  305 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  305 (432)
                      |||++.+.  ........+.+||+.|||||++..     ..|+..+|+||||++..||--|.+|+....+.-.       
T Consensus       166 DFGvSaQl--dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra-------  236 (953)
T KOG0587|consen  166 DFGVSAQL--DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA-------  236 (953)
T ss_pred             eeeeeeee--ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-------
Confidence            99999763  334455667899999999999954     3577889999999999999999999987655321       


Q ss_pred             hhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          306 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                              .|....+|...-.-+....+.+.++|..||..|..+||++.+++++
T Consensus       237 --------LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  237 --------LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             --------hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                    1111222333333456677889999999999999999999999876

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.2e-35  Score=311.43  Aligned_cols=143  Identities=27%  Similarity=0.388  Sum_probs=126.4

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .++|.+++.||+|+||.||+|.+.       ..++.||||++....       ..+..|+.++..++||||+++++++..
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~   75 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKK-------NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS   75 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEEC-------CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE
Confidence            357999999999999999999865       467899999987532       357889999999999999999988865


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      ..    ..++||||+.+++|.+++...  ..+++..++.|+.||+.||.|||+.   +|+||||||+||||+.++.+||+
T Consensus        76 ~~----~~~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~  146 (669)
T cd05610          76 AN----NVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLT  146 (669)
T ss_pred             CC----EEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEE
Confidence            44    459999999999999998654  3688999999999999999999998   99999999999999999999999


Q ss_pred             cccCCc
Q 014034          231 DFGLAR  236 (432)
Q Consensus       231 DfG~a~  236 (432)
                      |||+++
T Consensus       147 DFGls~  152 (669)
T cd05610         147 DFGLSK  152 (669)
T ss_pred             eCCCCc
Confidence            999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=282.16  Aligned_cols=240  Identities=27%  Similarity=0.406  Sum_probs=196.0

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-------HHHHHHHHhccc-CCCccceeeeEE
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQFLGVL-EHPNLVKLIGYC  148 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l-~hpniv~l~~~~  148 (432)
                      ...+|..+..||+|+||+|-+|.-+       .+.+.+|||+++++..       --..|-++|... +-|.++.+..+|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerk-------gtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF  419 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERK-------GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF  419 (683)
T ss_pred             eecccceEEEeccCccceeeeeccc-------CcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh
Confidence            3457999999999999999998754       5678999999987543       145677777766 467889998888


Q ss_pred             eecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCcee
Q 014034          149 AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  228 (432)
Q Consensus       149 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k  228 (432)
                      ..-+.    +|+||||+.||+|.-+|..-  +.+.+..+.-++..||-||-+||++   ||++||||.+|||+|.+|++|
T Consensus       420 QTmDR----LyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiK  490 (683)
T KOG0696|consen  420 QTMDR----LYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIK  490 (683)
T ss_pred             hhhhh----eeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceE
Confidence            76554    59999999999999998654  3688889999999999999999998   999999999999999999999


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHHHhh
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWVQQ  307 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~  307 (432)
                      |+|||+++.....  .....+++||+.|+|||++..++|+.++|+|||||+||||+.|++||++.+..+.. .+.+.-. 
T Consensus       491 i~DFGmcKEni~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv-  567 (683)
T KOG0696|consen  491 IADFGMCKENIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV-  567 (683)
T ss_pred             eeecccccccccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC-
Confidence            9999999864332  33456789999999999999999999999999999999999999999987554321 1211111 


Q ss_pred             cccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 014034          308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM  353 (432)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  353 (432)
                                        .++...+.+...+....|...|.+|...
T Consensus       568 ------------------syPKslSkEAv~ickg~ltK~P~kRLGc  595 (683)
T KOG0696|consen  568 ------------------SYPKSLSKEAVAICKGLLTKHPGKRLGC  595 (683)
T ss_pred             ------------------cCcccccHHHHHHHHHHhhcCCccccCC
Confidence                              2344455677789999999999999643

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-35  Score=274.88  Aligned_cols=233  Identities=29%  Similarity=0.395  Sum_probs=186.9

Q ss_pred             cccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeecCCcceeEE
Q 014034           87 IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  159 (432)
Q Consensus        87 lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~  159 (432)
                      ||.|+||.||++...       .++..+|+|.+....       ..+..|+.+++.++||||+++++.+....    ..+
T Consensus         1 lg~G~~~~v~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~   69 (250)
T cd05123           1 LGKGSFGKVLLVRKK-------DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE----KLY   69 (250)
T ss_pred             CCCCCceEEEEEEEC-------CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC----eeE
Confidence            699999999999865       356789999886532       24788999999999999999998886544    459


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCC
Q 014034          160 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP  239 (432)
Q Consensus       160 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~  239 (432)
                      +||||+.+++|.+++....  .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        70 ~v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~  144 (250)
T cd05123          70 LVLEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELS  144 (250)
T ss_pred             EEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecc
Confidence            9999999999999996543  689999999999999999999998   99999999999999999999999999987532


Q ss_pred             CCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccccccc
Q 014034          240 MVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM  319 (432)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (432)
                      ..  ........++..|++||.+.+..++.++|+||||+++|++++|..||......   .....+..   ..       
T Consensus       145 ~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~---~~-------  209 (250)
T cd05123         145 SE--GSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EIYEKILK---DP-------  209 (250)
T ss_pred             cC--CCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHhc---CC-------
Confidence            21  12234456888999999998888899999999999999999999999765431   12111111   00       


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 014034          320 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ  355 (432)
Q Consensus       320 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  355 (432)
                       .    ..+...+..+.+++.+||..||++||++.+
T Consensus       210 -~----~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         210 -L----RFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             -C----CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence             0    111122467889999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=8.6e-36  Score=274.89  Aligned_cols=220  Identities=20%  Similarity=0.212  Sum_probs=174.7

Q ss_pred             CCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHHHHHHHhcccCCCccceeeeEEeecCCcceeEEEEEeecCCCC
Q 014034           90 GGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRS  169 (432)
Q Consensus        90 G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~lv~e~~~~gs  169 (432)
                      |.||.||++...       .+++.||+|.+.... .+..|...+....||||+++++++....    ..++||||+++|+
T Consensus         4 g~~~~v~~~~~~-------~~~~~~~~K~i~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~----~~~lv~e~~~~~~   71 (237)
T cd05576           4 GVIDKVLLVMDT-------RTQQTFILKGLRKSS-EYSRERLTIIPHCVPNMVCLHKYIVSED----SVFLVLQHAEGGK   71 (237)
T ss_pred             cccceEEEEEEc-------cCCcEEEEEeecchh-hhhhHHHHHHhcCCCceeehhhheecCC----eEEEEEecCCCCC
Confidence            889999999865       567889999997654 3345555555667999999999887543    4599999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCCCCCCcccccc
Q 014034          170 LEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA  249 (432)
Q Consensus       170 L~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~  249 (432)
                      |.+++....  ++++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++++|||.+.....     ....
T Consensus        72 L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~~~  141 (237)
T cd05576          72 LWSHISKFL--NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDG  141 (237)
T ss_pred             HHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccc-----cccc
Confidence            999986543  589999999999999999999998   999999999999999999999999998764221     1223


Q ss_pred             cccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCH
Q 014034          250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSI  329 (432)
Q Consensus       250 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  329 (432)
                      ..++..|+|||.+.+..++.++||||+|+++|+|++|..|+........               .   ....    ..+.
T Consensus       142 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~---------------~---~~~~----~~~~  199 (237)
T cd05576         142 EAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN---------------T---HTTL----NIPE  199 (237)
T ss_pred             CCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc---------------c---cccc----CCcc
Confidence            4467789999999888899999999999999999999988753221100               0   0000    1122


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCH
Q 014034          330 NEARKIGRLADNCLSKSSKDRPKM  353 (432)
Q Consensus       330 ~~~~~l~~li~~cl~~dP~~RPs~  353 (432)
                      ..+..+.+++.+||+.||.+||++
T Consensus       200 ~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         200 WVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             cCCHHHHHHHHHHccCCHHHhcCC
Confidence            234678899999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-37  Score=271.76  Aligned_cols=271  Identities=25%  Similarity=0.379  Sum_probs=202.2

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .+.|....+||+|.||.||+|+.+       .+++.||+|++-.+.      ....+|+.+|..|+|+|++.++++|...
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~-------n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk   88 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSK-------NTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK   88 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhc-------CccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhc
Confidence            346788889999999999999865       567789999864322      2478999999999999999999988653


Q ss_pred             CCc----ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCce
Q 014034          152 GER----GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP  227 (432)
Q Consensus       152 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~  227 (432)
                      ...    ...+++||.+|+ .+|...|.+.. ..++..++.+++.++..||.|+|..   .|+|||+|+.|+||+.+|.+
T Consensus        89 ~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgil  163 (376)
T KOG0669|consen   89 ATPTNRDRATFYLVFDFCE-HDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGIL  163 (376)
T ss_pred             cCCcccccceeeeeHHHhh-hhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceE
Confidence            222    223699999995 58988886553 4688999999999999999999998   99999999999999999999


Q ss_pred             eeccccCCcCCCCCCCc--ccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 014034          228 KLSDFGLAREGPMVGHT--HVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  304 (432)
Q Consensus       228 kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  304 (432)
                      ||+|||+++.+......  ...++.+-|++|.+||.+.| ..|+++.|||..|||+.||+||.+.+++........++..
T Consensus       164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~  243 (376)
T KOG0669|consen  164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ  243 (376)
T ss_pred             EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence            99999999864333222  22345667999999998876 5789999999999999999999999998765444333333


Q ss_pred             Hhhc-ccCcc----c---cccccCccccCc-C--------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          305 VQQY-PADSK----K---FGLIMDPRLEKE-Y--------SINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       305 ~~~~-~~~~~----~---~~~~~~~~l~~~-~--------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                      +... ..+.+    .   +..+-.+.+... +        +..-.....+|+..++..||.+|+++.+++.+-
T Consensus       244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence            2211 11100    0   001101101110 0        001123567899999999999999999999873

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-35  Score=278.04  Aligned_cols=135  Identities=24%  Similarity=0.329  Sum_probs=121.4

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH---HHHHHHHHhcccC-----C---Cccceeee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGVLE-----H---PNLVKLIG  146 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~-----h---pniv~l~~  146 (432)
                      .++|.+.++||.|-|++||+|...       ...+.||+|+.+....   ....|+++|++++     |   .+||+|++
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDt-------q~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD  149 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDT-------QNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLD  149 (590)
T ss_pred             CceEEEEEeccccccceeEEEeec-------cCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence            378999999999999999999854       6789999999876433   3678999999873     2   47999999


Q ss_pred             EEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc
Q 014034          147 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD  222 (432)
Q Consensus       147 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~  222 (432)
                      .|...+..+.+.|+|+|++ |.+|..+|.....+.++...+..|+.||+.||.|||..|  ||||.||||+|||+.
T Consensus       150 ~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  150 HFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             cceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence            9999999999999999998 889999999888889999999999999999999999986  999999999999983

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=289.58  Aligned_cols=242  Identities=25%  Similarity=0.369  Sum_probs=196.8

Q ss_pred             ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc------ChHHHHHHHHHhcccCCCccceeeeEEeecCCccee
Q 014034           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQ  157 (432)
Q Consensus        84 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~  157 (432)
                      .+.||.|-||+||-|.++       .+|+-||||++.+      ....+++|+.||++++||.||.+.-.|...+.    
T Consensus       569 devLGSGQFG~VYgg~hR-------ktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~er----  637 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHR-------KTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPER----  637 (888)
T ss_pred             HhhccCCcceeeecceec-------ccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCce----
Confidence            467999999999999987       6788999999865      23458999999999999999999888766553    


Q ss_pred             EEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC---CCceeeccccC
Q 014034          158 RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE---NFRPKLSDFGL  234 (432)
Q Consensus       158 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~DfG~  234 (432)
                      .+.|||-+ .|+..+.|.....+.+++....-++.||+.||.|||.+   +|+|+||||+|||+..   -.++||||||+
T Consensus       638 vFVVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGf  713 (888)
T KOG4236|consen  638 VFVVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGF  713 (888)
T ss_pred             EEEEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccc
Confidence            49999999 55666777666677899999999999999999999998   9999999999999964   45799999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      |+..   +........+||+.|+|||+++...|...-|+||.|||+|.-++|..||....+..     +.+++-.     
T Consensus       714 ARiI---gEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn-----dQIQNAa-----  780 (888)
T KOG4236|consen  714 ARII---GEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN-----DQIQNAA-----  780 (888)
T ss_pred             eeec---chhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh-----HHhhccc-----
Confidence            9963   34445567899999999999999999999999999999999999999997543322     2222110     


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                        .+..    .....+.+....+||...|+..-++|.|..+.+.+
T Consensus       781 --FMyP----p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  781 --FMYP----PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             --cccC----CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence              0111    11223445667799999999999999999987765

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7e-36  Score=268.60  Aligned_cols=259  Identities=24%  Similarity=0.352  Sum_probs=202.7

Q ss_pred             cCHHHHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhccc-CCCccce
Q 014034           69 FSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVL-EHPNLVK  143 (432)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l-~hpniv~  143 (432)
                      -.+.++.+.+++     .||+|+|+.|--+...       .++..+|||++.+..    ....+|++++..+ .|+||+.
T Consensus        73 g~F~d~YkLt~e-----~LGeGAyasVqtcv~i-------~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilq  140 (463)
T KOG0607|consen   73 GKFEDMYKLTSE-----LLGEGAYASVQTCVSI-------QTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQ  140 (463)
T ss_pred             chHHHHHHhHHH-----HhcCccceeeeeeeee-------ccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHH
Confidence            346777776664     4999999999988744       678899999998753    3578999999988 5999999


Q ss_pred             eeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC
Q 014034          144 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  223 (432)
Q Consensus       144 l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~  223 (432)
                      |+++|.++..    .|||||-|.||+|..+|.++.  -+++.++..+..+|+.||.|||.+   ||.||||||+|||-..
T Consensus       141 LiefFEdd~~----FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~  211 (463)
T KOG0607|consen  141 LIEFFEDDTR----FYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCES  211 (463)
T ss_pred             HHHHhcccce----EEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecC
Confidence            9999987764    499999999999999998765  689999999999999999999998   9999999999999965


Q ss_pred             CC---ceeeccccCCcCCCCC-----CCcccccccccCCCccCccccc-----cCCCCchhhhHHHHHHHHHHHhCCCCC
Q 014034          224 NF---RPKLSDFGLAREGPMV-----GHTHVSTAVVGTFGYAAPDYIE-----TGHLTAKSDVWSFGVVLYEMLTGRRSL  290 (432)
Q Consensus       224 ~~---~~kl~DfG~a~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf  290 (432)
                      ..   -+|||||.+..-....     ..+....+.+|+..|||||+..     ...|+.++|.||||||+|-|++|.+||
T Consensus       212 pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPF  291 (463)
T KOG0607|consen  212 PNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPF  291 (463)
T ss_pred             CCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCc
Confidence            44   4799999887532111     1122334678999999999862     346889999999999999999999999


Q ss_pred             CCCCchh------------hHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 014034          291 ERNRPKT------------EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE  358 (432)
Q Consensus       291 ~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  358 (432)
                      .+....+            ...+.+-++.-.           -.++.....+.+....+||...+..|+.+|.++.+++.
T Consensus       292 vG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGk-----------YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  292 VGHCGADCGWDRGEVCRVCQNKLFESIQEGK-----------YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             cCccCCcCCccCCCccHHHHHHHHHHHhccC-----------CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            8754321            122222222110           01122334566778889999999999999999999988


Q ss_pred             H
Q 014034          359 R  359 (432)
Q Consensus       359 ~  359 (432)
                      +
T Consensus       361 h  361 (463)
T KOG0607|consen  361 H  361 (463)
T ss_pred             C
Confidence            4

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=268.16  Aligned_cols=243  Identities=26%  Similarity=0.435  Sum_probs=194.1

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-------HHHHHHHHhccc-CCCccceeeeEE
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQFLGVL-EHPNLVKLIGYC  148 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l-~hpniv~l~~~~  148 (432)
                      ..++|..++.||+|+|++|-.++++       .+.+.+|+|+++++..       -.+.|-.+..+. +||.+|.+..+|
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~-------~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf  320 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLK-------KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF  320 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehc-------ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh
Confidence            3578999999999999999999987       5678999999876322       256677777655 799999999988


Q ss_pred             eecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCcee
Q 014034          149 AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  228 (432)
Q Consensus       149 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k  228 (432)
                      ..+..    +++|.||++||+|.-++.++.  .+|+..+.-+...|..||.|||+.   ||++||||.+|||+|..|.+|
T Consensus       321 qtesr----lffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghik  391 (593)
T KOG0695|consen  321 QTESR----LFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIK  391 (593)
T ss_pred             cccce----EEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCcee
Confidence            77654    599999999999998886654  799999999999999999999998   999999999999999999999


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----chhhHHHHH
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNR-----PKTEQRLLE  303 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~-----~~~~~~~~~  303 (432)
                      |+|+|+++..  .......++++||+.|+|||++++..|..++|+|+|||+++||+.|+.||+-..     ..++..+.+
T Consensus       392 ltdygmcke~--l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfq  469 (593)
T KOG0695|consen  392 LTDYGMCKEG--LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQ  469 (593)
T ss_pred             ecccchhhcC--CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHH
Confidence            9999999863  333445678999999999999999999999999999999999999999996321     111222222


Q ss_pred             HHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCC
Q 014034          304 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK  352 (432)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs  352 (432)
                                   .++...+..  +...+-....+++..|++||.+|..
T Consensus       470 -------------vilekqiri--prslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  470 -------------VILEKQIRI--PRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             -------------HHhhhcccc--cceeehhhHHHHHHhhcCCcHHhcC
Confidence                         122222211  2222334557888889999999853

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-35  Score=270.61  Aligned_cols=267  Identities=22%  Similarity=0.325  Sum_probs=215.8

Q ss_pred             HHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHH-----HHHHHHHhcccCCCccceeeeE
Q 014034           73 EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVLEHPNLVKLIGY  147 (432)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~E~~~l~~l~hpniv~l~~~  147 (432)
                      ++.....+++....+-+|.||.||+|.|+..  +...+.+.|.+|.++....+     +..|.-.+..+.|||+..+.++
T Consensus       278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eE--dt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREE--DTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             hhhhhhhheechhhhhcCchhheeeeeeccc--CCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            3444445688888899999999999998733  23445566788887654432     6788888889999999999999


Q ss_pred             EeecCCcceeEEEEEeecCCCCHHHHhh-----c-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEE
Q 014034          148 CAVDGERGIQRLLVYEFMLNRSLEDHLF-----N-RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL  221 (432)
Q Consensus       148 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~-----~-~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill  221 (432)
                      +.++...   .+.+|.++.-|+|..||.     + .....++-.+...++.|++.|++|||..   ++||.||...|++|
T Consensus       356 ~ie~~~~---P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvI  429 (563)
T KOG1024|consen  356 SIEDYAT---PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVI  429 (563)
T ss_pred             EeeccCc---ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhccee
Confidence            9886543   478899999999999997     2 2234566778899999999999999998   99999999999999


Q ss_pred             cCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 014034          222 DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQR  300 (432)
Q Consensus       222 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~  300 (432)
                      |+..++||+|=.+++.....+......+......||+||.+....|+.++|||||||+||||+| |+.||...+|.+...
T Consensus       430 dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~  509 (563)
T KOG1024|consen  430 DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH  509 (563)
T ss_pred             hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH
Confidence            9999999999999997544444444445556779999999999999999999999999999999 999999887766544


Q ss_pred             HHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 014034          301 LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  364 (432)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  364 (432)
                      ++.       ++..          -..|.++++++..+|..||..+|++||+++|++.-|.+.-
T Consensus       510 ylk-------dGyR----------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  510 YLK-------DGYR----------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             HHh-------ccce----------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence            432       1111          1235567889999999999999999999999999987764

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-36  Score=280.72  Aligned_cols=255  Identities=26%  Similarity=0.393  Sum_probs=197.1

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecC--cC---------hHHHHHHHHHhcccCCCccceeeeE
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN--RD---------GLQWVAEVQFLGVLEHPNLVKLIGY  147 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~--~~---------~~~~~~E~~~l~~l~hpniv~l~~~  147 (432)
                      .+|-.+.+||+|||+.||+|..       ....+.||+|+-.  ++         .....+|..|-+.|+||.||++|++
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFD-------l~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDy  535 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFD-------LTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDY  535 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcc-------cchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeee
Confidence            4577788999999999999974       3678899999843  21         1126789999999999999999999


Q ss_pred             EeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc---CC
Q 014034          148 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---EN  224 (432)
Q Consensus       148 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~---~~  224 (432)
                      +..+...   .|-|+|||+|.+|+.||....  .+++.++..|+.||+.||.||... .++|||-||||.|||+-   ..
T Consensus       536 fslDtds---FCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gtac  609 (775)
T KOG1151|consen  536 FSLDTDS---FCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTAC  609 (775)
T ss_pred             eeecccc---ceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCccc
Confidence            9876543   589999999999999997654  689999999999999999999985 67999999999999994   56


Q ss_pred             CceeeccccCCcCCCCCCCc-----ccccccccCCCccCcccccc----CCCCchhhhHHHHHHHHHHHhCCCCCCCCCc
Q 014034          225 FRPKLSDFGLAREGPMVGHT-----HVSTAVVGTFGYAAPDYIET----GHLTAKSDVWSFGVVLYEMLTGRRSLERNRP  295 (432)
Q Consensus       225 ~~~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltg~~pf~~~~~  295 (432)
                      |.+||+|||+++.+......     .......||.+|++||.+.-    ...+.++||||+|||+|..+.|+.||.... 
T Consensus       610 GeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq-  688 (775)
T KOG1151|consen  610 GEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ-  688 (775)
T ss_pred             ceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch-
Confidence            88999999999975333222     22345679999999998743    356889999999999999999999998543 


Q ss_pred             hhhHHHHHHHhhcccCccccccccCcc-ccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          296 KTEQRLLEWVQQYPADSKKFGLIMDPR-LEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                       ..+++++.-.           ++... ..-..-+..+.....+|.+||+.--++|....++..+
T Consensus       689 -sQQdILqeNT-----------IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  689 -SQQDILQENT-----------ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             -hHHHHHhhhc-----------hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence             2333332110           11100 0001112234567799999999999999998887654

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=5.3e-35  Score=299.68  Aligned_cols=272  Identities=18%  Similarity=0.212  Sum_probs=171.1

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHHHHHHHhcccCCCccceeeeEEee-c-CCc
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAV-D-GER  154 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~-~~~  154 (432)
                      ..++|...+.||+|+||.||+|++....   ...+..||+|++......-....+.+....+.++..++..+.. . ...
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~---~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~  206 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQ---SKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKK  206 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCc---cccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhccccccc
Confidence            5678999999999999999999976221   1237889999986533210000111222223333333222111 0 122


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCC------------------CCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFP------------------PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKA  216 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp  216 (432)
                      ....++||||+.+++|.+++......                  ......+..++.||+.||.|||+.   +|+||||||
T Consensus       207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP  283 (566)
T PLN03225        207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKP  283 (566)
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCH
Confidence            34569999999999999998654311                  011234567999999999999998   999999999


Q ss_pred             CceEEcC-CCceeeccccCCcCCCCCCCcccccccccCCCccCccccccC----------------------CCCchhhh
Q 014034          217 SNVLLDE-NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG----------------------HLTAKSDV  273 (432)
Q Consensus       217 ~Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv  273 (432)
                      +|||++. ++.+||+|||+++..... .........+|+.|||||.+...                      .++.++||
T Consensus       284 ~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        284 QNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            9999985 689999999999753211 12223456789999999976322                      23446799


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccc----cCcC--CHHHHHHHHHHHHHhccCCC
Q 014034          274 WSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRL----EKEY--SINEARKIGRLADNCLSKSS  347 (432)
Q Consensus       274 wSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l----~~~~--~~~~~~~l~~li~~cl~~dP  347 (432)
                      |||||++|||+++..++...    ...+...+.....+...+.....+..    ...+  .........+|+.+||+.||
T Consensus       363 wSlGviL~el~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSN----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchH----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            99999999999977665421    11111111111000000000111110    0000  00112245589999999999


Q ss_pred             CCCCCHHHHHHH
Q 014034          348 KDRPKMSQVVER  359 (432)
Q Consensus       348 ~~RPs~~eil~~  359 (432)
                      .+|||+.+++++
T Consensus       439 ~kR~ta~e~L~H  450 (566)
T PLN03225        439 RQRISAKAALAH  450 (566)
T ss_pred             ccCCCHHHHhCC
Confidence            999999999987

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=286.57  Aligned_cols=247  Identities=24%  Similarity=0.361  Sum_probs=202.9

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      ..++..+..||-|+||.|-+....       .....+|+|.+++..       .....|-.||..++.|.||++|..|.+
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~-------~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd  491 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVN-------SQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD  491 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEec-------ccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc
Confidence            346777888999999999998865       222358888887532       236789999999999999999998876


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      +..    .|+.||-|.||.|...|+.+.  .+...+..-++..+++|++|||++   +||+|||||+|+|++.+|.+||.
T Consensus       492 ~ky----vYmLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLV  562 (732)
T KOG0614|consen  492 SKY----VYMLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLV  562 (732)
T ss_pred             chh----hhhhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEe
Confidence            553    489999999999999997765  688889999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      |||+|+.   .+......+++||+.|.|||++.+...+.++|.||||+++|||++|.+||.+.++...-.++-.  .   
T Consensus       563 DFGFAKk---i~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk--G---  634 (732)
T KOG0614|consen  563 DFGFAKK---IGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK--G---  634 (732)
T ss_pred             ehhhHHH---hccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh--h---
Confidence            9999986   3445667889999999999999999999999999999999999999999999877644322211  0   


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-----MSQVVER  359 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  359 (432)
                          ++.       -.+|........+||.+.+..+|.+|..     +.+|.+|
T Consensus       635 ----id~-------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  635 ----IDK-------IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             ----hhh-------hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence                000       0223344566779999999999999986     5566665

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-34  Score=277.35  Aligned_cols=203  Identities=26%  Similarity=0.375  Sum_probs=170.5

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-------HHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      -|..++.||-|+||+|.++.-.       .+...+|+|.+++...       ....|-.||..-+.+-||+||-.|.+.+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~Kv-------DT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd  702 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKV-------DTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD  702 (1034)
T ss_pred             ceEEEeeecccccceeEEEeec-------chhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC
Confidence            3667788999999999998743       4678999999876433       2567999999999999999998887665


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                      .    +|+||+|++||++..+|.+..  .+++..+.-++..+.+|+++.|..   |+|||||||+|||||.+|++||+||
T Consensus       703 n----LYFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDF  773 (1034)
T KOG0608|consen  703 N----LYFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDF  773 (1034)
T ss_pred             c----eEEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeec
Confidence            4    599999999999999998765  688999999999999999999997   9999999999999999999999999


Q ss_pred             cCCcCCCC--------CCC-cc-------------------------------cccccccCCCccCccccccCCCCchhh
Q 014034          233 GLAREGPM--------VGH-TH-------------------------------VSTAVVGTFGYAAPDYIETGHLTAKSD  272 (432)
Q Consensus       233 G~a~~~~~--------~~~-~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D  272 (432)
                      ||+.-+..        .+. ..                               ..-..+||+.|+|||++....|+..+|
T Consensus       774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cd  853 (1034)
T KOG0608|consen  774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCD  853 (1034)
T ss_pred             cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccch
Confidence            99851100        000 00                               001347999999999999999999999


Q ss_pred             hHHHHHHHHHHHhCCCCCCCCCchhh
Q 014034          273 VWSFGVVLYEMLTGRRSLERNRPKTE  298 (432)
Q Consensus       273 vwSlGvil~elltg~~pf~~~~~~~~  298 (432)
                      +||.|||||||+.|++||....+...
T Consensus       854 wws~gvil~em~~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  854 WWSVGVILYEMLVGQPPFLADTPGET  879 (1034)
T ss_pred             hhHhhHHHHHHhhCCCCccCCCCCcc
Confidence            99999999999999999987766543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=7.6e-33  Score=254.39  Aligned_cols=236  Identities=30%  Similarity=0.409  Sum_probs=188.1

Q ss_pred             CceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCCcceeEEEEEeec
Q 014034           91 GFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM  165 (432)
Q Consensus        91 ~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~lv~e~~  165 (432)
                      +||.||+|...       .++..+++|.+...     ...+.+|++.+++++|+||+++++++....    ..+++|||+
T Consensus         1 ~~g~v~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~l~~e~~   69 (244)
T smart00220        1 SFGKVYLARDK-------KTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDED----KLYLVMEYC   69 (244)
T ss_pred             CceEEEEEEEC-------CCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCC----EEEEEEeCC
Confidence            58999999875       35788999998754     356889999999999999999999987654    459999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCCCCCCcc
Q 014034          166 LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH  245 (432)
Q Consensus       166 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  245 (432)
                      .+++|..++....  .+++..++.++.+++.++.|||+.   +++|+||+|+||+++.++.++|+|||.+......   .
T Consensus        70 ~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~---~  141 (244)
T smart00220       70 DGGDLFDLLKKRG--RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPG---G  141 (244)
T ss_pred             CCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccc---c
Confidence            9999999986543  388999999999999999999998   9999999999999999999999999998753221   1


Q ss_pred             cccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccC
Q 014034          246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEK  325 (432)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  325 (432)
                      ......++..|++||.+.+..++.++||||||+++++|++|..||......  ..+.............           
T Consensus       142 ~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~-----------  208 (244)
T smart00220      142 LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKIGKPKPPFPP-----------  208 (244)
T ss_pred             ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHhccCCCCcc-----------
Confidence            234456888999999998888999999999999999999999999763221  2222222211111000           


Q ss_pred             cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          326 EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       326 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                       .....+..+.+++.+||..+|++||++.+++++
T Consensus       209 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      209 -PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             -ccccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence             000033578899999999999999999999863

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.4e-33  Score=277.84  Aligned_cols=268  Identities=19%  Similarity=0.237  Sum_probs=181.6

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCC---------CCCcccEEEEEEecCcChH----H--------------HHHH
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAG---------DGTSEATVVAIKKLNRDGL----Q--------------WVAE  129 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~---------~~~~~~~~vaiK~~~~~~~----~--------------~~~E  129 (432)
                      ..++|.+.++||+|+||.||+|.......         .....++.||||++.....    +              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            45689999999999999999997632211         1123457899999864321    1              2346


Q ss_pred             HHHhcccCCCcc-----ceeeeEEeecCC----cceeEEEEEeecCCCCHHHHhhcCCC---------------------
Q 014034          130 VQFLGVLEHPNL-----VKLIGYCAVDGE----RGIQRLLVYEFMLNRSLEDHLFNRAF---------------------  179 (432)
Q Consensus       130 ~~~l~~l~hpni-----v~l~~~~~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------  179 (432)
                      +.++.+++|.++     ++++++|.....    .....+|||||+.+++|.+++.....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            666667766544     677777764311    11245999999999999999864211                     


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccC
Q 014034          180 -PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA  258 (432)
Q Consensus       180 -~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~a  258 (432)
                       ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++...... .........+|+.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~-~~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG-INFNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccC-CccCccccCCCcceeC
Confidence             1245678889999999999999998   9999999999999999999999999999653211 1111122345789999


Q ss_pred             ccccccCC--------------------C--CchhhhHHHHHHHHHHHhCCC-CCCCCCchhh------HHHHHHHhhcc
Q 014034          259 PDYIETGH--------------------L--TAKSDVWSFGVVLYEMLTGRR-SLERNRPKTE------QRLLEWVQQYP  309 (432)
Q Consensus       259 PE~~~~~~--------------------~--~~~~DvwSlGvil~elltg~~-pf~~~~~~~~------~~~~~~~~~~~  309 (432)
                      ||.+....                    +  ..+.||||+||++++|++|.. ||........      .....|.. ..
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-~~  457 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-YK  457 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh-hc
Confidence            99885322                    1  124799999999999999875 6654221111      01111111 00


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCC---CCCCCHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSS---KDRPKMSQVVER  359 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~eil~~  359 (432)
                      .          ....-......+....+|+.+||..+|   .+|+|+.|+++|
T Consensus       458 ~----------~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        458 G----------QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             c----------cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            0          000001112234667899999999766   689999999987

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=240.46  Aligned_cols=200  Identities=26%  Similarity=0.397  Sum_probs=162.2

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcc-cCCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGV-LEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~  152 (432)
                      ++...+..||+|+||.|-+.++.       .++...|+|.+...     ..+...|+.+..+ ..+|++|.+||....++
T Consensus        46 d~L~~i~elGrGayG~vekmrh~-------~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg  118 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHI-------QSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG  118 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeec-------cCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence            44556677999999999988876       68899999998642     2346677777554 47999999999887666


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      ..    |+.||.| .-||+.+..+  ..+..+++...-+|+..++.||.|||++  ..++|||+||+|||++.+|++|+|
T Consensus       119 dv----wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiC  191 (282)
T KOG0984|consen  119 DV----WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKIC  191 (282)
T ss_pred             cE----EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEc
Confidence            54    9999999 5588776543  2345789999999999999999999998  689999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCcccccc----CCCCchhhhHHHHHHHHHHHhCCCCCCCCCc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET----GHLTAKSDVWSFGVVLYEMLTGRRSLERNRP  295 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltg~~pf~~~~~  295 (432)
                      |||++-..   .++...+...|...|||||.+..    ..|+-++||||||+++.||.+++.||..+..
T Consensus       192 DFGIsG~L---~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  192 DFGISGYL---VDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             ccccceee---hhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            99998532   11222233568889999999854    3688999999999999999999999987654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.98  E-value=2.2e-33  Score=280.29  Aligned_cols=245  Identities=25%  Similarity=0.362  Sum_probs=181.7

Q ss_pred             CccccccccCCceE-EEEEEecCCCCCCCcccEEEEEEecCcChH-HHHHHHHHhccc-CCCccceeeeEEeecCCccee
Q 014034           81 FSRMLKIGEGGFGS-VYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QWVAEVQFLGVL-EHPNLVKLIGYCAVDGERGIQ  157 (432)
Q Consensus        81 ~~~~~~lg~G~fg~-Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~  157 (432)
                      |...+.+|.|+-|+ ||+|.+         .++.||||++-.+.. .+.+|+..|+.. +|||||++|+.-.  +..  .
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y---------e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~--d~q--F  577 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY---------EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQ--DRQ--F  577 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee---------CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeecc--CCc--e
Confidence            33445688888764 889886         578999999987766 468999999988 5999999975543  332  5


Q ss_pred             EEEEEeecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC---C--Cceeec
Q 014034          158 RLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE---N--FRPKLS  230 (432)
Q Consensus       158 ~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~--~~~kl~  230 (432)
                      +|++.|.| ..+|.+++...  .......-..+.+..|++.||++||+.   +||||||||.||||+.   +  ..++|+
T Consensus       578 ~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iS  653 (903)
T KOG1027|consen  578 LYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKIS  653 (903)
T ss_pred             EEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEec
Confidence            69999999 67999999763  111111134577899999999999997   9999999999999975   3  468999


Q ss_pred             cccCCcCCCCCCCc-ccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhC-CCCCCCCCchhhHHHHHHHhhc
Q 014034          231 DFGLAREGPMVGHT-HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG-RRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       231 DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      |||+++........ .......||-+|+|||++....-+.++||||||||+|+.++| ..||+..-.... .++      
T Consensus       654 DfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-NIl------  726 (903)
T KOG1027|consen  654 DFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-NIL------  726 (903)
T ss_pred             ccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-hhh------
Confidence            99999975433222 234567899999999999998888899999999999999985 899985422111 111      


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                       .....+..+     ..  ..++  ...+||.+|++.+|..||++.+|+.|
T Consensus       727 -~~~~~L~~L-----~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  727 -TGNYTLVHL-----EP--LPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             -cCccceeee-----cc--CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence             000000000     00  0111  67799999999999999999999875

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.98  E-value=9.7e-33  Score=237.88  Aligned_cols=263  Identities=21%  Similarity=0.312  Sum_probs=195.7

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-HHHHHHHHhcccC-CCccceeeeEEeecCCc
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QWVAEVQFLGVLE-HPNLVKLIGYCAVDGER  154 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~  154 (432)
                      ..++|++.+++|+|.|+.||.|...       .+++.++||.+++-.. .+.+|+.||..|. ||||++++++..+....
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~-------~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk  108 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINI-------TNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK  108 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhccccc-------CCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence            4568999999999999999998744       5778999999987544 5889999999996 99999999988765443


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC-CCceeecccc
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE-NFRPKLSDFG  233 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~DfG  233 (432)
                        ...||+||+.+.+.....     +.++...+..++.+++.||.|+|+.   ||.|||+||.|++||. ...++|+|||
T Consensus       109 --tpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWG  178 (338)
T KOG0668|consen  109 --TPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWG  178 (338)
T ss_pred             --CchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecc
Confidence              347999999887776654     3578888999999999999999998   9999999999999985 5669999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhH-----------HH
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-----------RL  301 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-----------~~  301 (432)
                      +|........   ..-.+.+..|--||.+.. ..|+.+-|+|||||++..|+..+.||.......++           ++
T Consensus       179 LAEFYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el  255 (338)
T KOG0668|consen  179 LAEFYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDEL  255 (338)
T ss_pred             hHhhcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHH
Confidence            9986432211   223445677889999864 67899999999999999999999998654433322           12


Q ss_pred             HHHHhhcccC-ccccccccCccccC--------cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          302 LEWVQQYPAD-SKKFGLIMDPRLEK--------EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       302 ~~~~~~~~~~-~~~~~~~~~~~l~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ..++..+... ...+..++..-...        ....-.++...+|+.+.|..|..+|||+.|.+.+
T Consensus       256 ~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  256 YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence            2222222111 11111111111000        1111123567799999999999999999998876

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.98  E-value=8e-33  Score=265.90  Aligned_cols=194  Identities=27%  Similarity=0.416  Sum_probs=169.0

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHH------------HHHHHHHhcccC---CCccc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ------------WVAEVQFLGVLE---HPNLV  142 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------------~~~E~~~l~~l~---hpniv  142 (432)
                      ..+|..++.+|+|+||.|+.|.++       .++..|+||.+.+++.-            .-.|++||..|+   |+||+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K-------~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIl  632 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHK-------ENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENIL  632 (772)
T ss_pred             cccceeeeeccccccceEEEeeec-------ccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchh
Confidence            356999999999999999999987       46788999999876541            345999999997   99999


Q ss_pred             eeeeEEeecCCcceeEEEEEeec-CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEE
Q 014034          143 KLIGYCAVDGERGIQRLLVYEFM-LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL  221 (432)
Q Consensus       143 ~l~~~~~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill  221 (432)
                      +++++|.+++..    ||+||-. ++.+|.++|..+  +.+.+.++..|+.|++.|+++||++   +|||||||-+||.+
T Consensus       633 KlLdfFEddd~y----yl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenviv  703 (772)
T KOG1152|consen  633 KLLDFFEDDDYY----YLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIV  703 (772)
T ss_pred             hhhheeecCCee----EEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhcccccccc---CceecccccccEEE
Confidence            999999887654    8999876 667899999655  4799999999999999999999999   99999999999999


Q ss_pred             cCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCC-chhhhHHHHHHHHHHHhCCCCCC
Q 014034          222 DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLT-AKSDVWSFGVVLYEMLTGRRSLE  291 (432)
Q Consensus       222 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~pf~  291 (432)
                      +.+|.+||+|||.|-..    .......++||..|.|||++.|..|- ..-|||++|++||.++....||-
T Consensus       704 d~~g~~klidfgsaa~~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  704 DSNGFVKLIDFGSAAYT----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             ecCCeEEEeeccchhhh----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999999999998532    23445678999999999999998874 56899999999999999988875

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-33  Score=246.58  Aligned_cols=267  Identities=22%  Similarity=0.307  Sum_probs=196.4

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      +.+..+.||=|+||.||..+.       ..+++.||+|++..-      ...+.+|+++|..++|.|++..+++..-...
T Consensus        54 Di~PDRPIGYGAFGVVWsVTD-------PRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~  126 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTD-------PRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANP  126 (449)
T ss_pred             cCCCCCcccccceeEEEeccC-------CCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCc
Confidence            566778899999999998874       468899999998653      3457899999999999999999887654332


Q ss_pred             c-ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          154 R-GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       154 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                      . ...+|.++|.| ..+|+..|-.-  ..++...+.-++.||++||.|||+.   +|.||||||.|+|++.|..+|||||
T Consensus       127 dfFqEiYV~TELm-QSDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDF  200 (449)
T KOG0664|consen  127 SFFQELYVLTELM-QSDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDF  200 (449)
T ss_pred             hHHHHHHHHHHHH-HhhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccc
Confidence            2 12236778877 56888877543  3788889999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      |+++..... .....+..+-|..|.|||++.| ..|+.++||||.|||+.||+..+..|+...+....+++.-+...|..
T Consensus       201 GLARvee~d-~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~  279 (449)
T KOG0664|consen  201 GLARTWDQR-DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQ  279 (449)
T ss_pred             ccccccchh-hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcH
Confidence            999863222 2222334566889999999976 47999999999999999999999999887776555444322222111


Q ss_pred             --------cccccccc----CccccCc----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          312 --------SKKFGLIM----DPRLEKE----YSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       312 --------~~~~~~~~----~~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                              +..-..+.    .+.+.--    -+.........+...++..||++|.+..+.+.++
T Consensus       280 EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  280 EAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence                    00000000    0110000    0112233456788899999999999999888764

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-32  Score=246.52  Aligned_cols=263  Identities=24%  Similarity=0.312  Sum_probs=195.9

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ..+|..++.+|.|.- .|.-|.       +...+.+||+|++...      .....+|+.++..++|+||++++.++.-.
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~-------D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~   87 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAF-------DQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQ   87 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecc-------hhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcc
Confidence            357888889999987 555443       5578899999997543      23478899999999999999999998753


Q ss_pred             CCc--ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          152 GER--GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       152 ~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      ...  ....++|||+| .++|...+..    .+.-.+...|+.|+++|+.|||+.   +|+||||||+||++..++.+||
T Consensus        88 ~~l~~~~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi  159 (369)
T KOG0665|consen   88 KTLEEFQEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKI  159 (369)
T ss_pred             ccHHHHHhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheee
Confidence            221  22348999999 6799998863    467788899999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH-H-----
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL-E-----  303 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~-~-----  303 (432)
                      .|||+|+...   .....+..+.|..|.|||++.+..|...+||||+||++.||++|...|.+....+....+ +     
T Consensus       160 ~dfg~ar~e~---~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtp  236 (369)
T KOG0665|consen  160 LDFGLARTED---TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTP  236 (369)
T ss_pred             ccchhhcccC---cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCC
Confidence            9999998532   223445678899999999999888999999999999999999999999875443332111 0     


Q ss_pred             ----------HHhhcccCc-----ccccccc-CccccC--cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          304 ----------WVQQYPADS-----KKFGLIM-DPRLEK--EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       304 ----------~~~~~~~~~-----~~~~~~~-~~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                ....+-...     ..+...+ |..+..  ..+......+.+|+.+||..||++|.|+.++|.|
T Consensus       237 d~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  237 DPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             CHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                      001110000     0011111 111110  1111224457799999999999999999999987

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=7.6e-30  Score=228.71  Aligned_cols=208  Identities=38%  Similarity=0.602  Sum_probs=177.8

Q ss_pred             cccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCCcceeEEEE
Q 014034           87 IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLV  161 (432)
Q Consensus        87 lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~lv  161 (432)
                      ||+|.+|.||++...       .++..+++|.+....     ..+.+|+..++.+.|++|+++++++....    ..+++
T Consensus         1 l~~g~~~~v~~~~~~-------~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~~~   69 (215)
T cd00180           1 LGEGGFGTVYLARDK-------KTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDEN----HLYLV   69 (215)
T ss_pred             CCcCCceEEEEEEec-------CCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC----eEEEE
Confidence            689999999999864       357889999998764     35899999999999999999999987653    45999


Q ss_pred             EeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC-CCceeeccccCCcCCCC
Q 014034          162 YEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE-NFRPKLSDFGLAREGPM  240 (432)
Q Consensus       162 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~DfG~a~~~~~  240 (432)
                      |||+.+++|.+++.... ..+++..+..++.+++.++.+||+.   +++|+||+|.||+++. ++.++|+|||.+.....
T Consensus        70 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~  145 (215)
T cd00180          70 MEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTS  145 (215)
T ss_pred             EecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccC
Confidence            99999999999987542 3688999999999999999999998   9999999999999999 89999999999875322


Q ss_pred             CCCcccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccccccc
Q 014034          241 VGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM  319 (432)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (432)
                      ...  ......+...|++||.+... .++.++|+|++|+++++|                                    
T Consensus       146 ~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------  187 (215)
T cd00180         146 DKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------  187 (215)
T ss_pred             Ccc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------
Confidence            111  12335578899999999877 788999999999999999                                    


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          320 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       320 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                                   ..+.+++..|++.+|.+||++.++++++
T Consensus       188 -------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                         2366899999999999999999998653

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=4.2e-32  Score=264.91  Aligned_cols=251  Identities=24%  Similarity=0.353  Sum_probs=201.4

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH----HHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL----QWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ..+|..+..+|.|+||.||+|+.+       ..++..|+|.++.+..    ..++|+-+++..+|||||.++|.+.....
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~-------~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk   86 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDK-------RSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK   86 (829)
T ss_pred             ccchhheeeecCCcccchhhhccc-------ccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcC
Confidence            458999999999999999999865       6788999999875432    36789999999999999999998876654


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                      .    |++||||.+|+|.+..+-  ..++++.++..+++...+||+|||+.   +-+|||||-.|||+++.|.+|++|||
T Consensus        87 l----wicMEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfg  157 (829)
T KOG0576|consen   87 L----WICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFG  157 (829)
T ss_pred             c----EEEEEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccC
Confidence            4    999999999999997644  34899999999999999999999998   88999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCcccc---ccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      .+-..  ...-.+...+.||+.|||||+-   +.+.|...+|||++|+...|+---++|.....+.-...+...  ... 
T Consensus       158 vsaqi--tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk--S~~-  232 (829)
T KOG0576|consen  158 VSAQI--TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK--SGF-  232 (829)
T ss_pred             chhhh--hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc--cCC-
Confidence            98653  3334556778999999999986   467899999999999999999888887765444322111110  000 


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                              -.+.+..  .......+-++++.|+..+|.+||+++.++.+
T Consensus       233 --------qpp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  233 --------QPPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             --------CCCcccC--CccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence                    0111111  22334668899999999999999999988764

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=3.7e-31  Score=251.56  Aligned_cols=264  Identities=22%  Similarity=0.264  Sum_probs=195.4

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHH---HHHHHHHhcccC------CCccceeeeE
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGVLE------HPNLVKLIGY  147 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~E~~~l~~l~------hpniv~l~~~  147 (432)
                      .-+.|.+....|+|-|++|.+|...       ..+..||||++.....-   =+.|++||++|+      --|+++|+..
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~-------~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~  502 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQ-------ARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRH  502 (752)
T ss_pred             hcceeEEEeccccceeeeeeecccc-------CCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence            3467888888999999999999754       45568999999876542   467999999995      2488999888


Q ss_pred             EeecCCcceeEEEEEeecCCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC-
Q 014034          148 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF-  225 (432)
Q Consensus       148 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-  225 (432)
                      |...+    ++|||+|-+ .-+|.+.|..-+ +-+|....+..++.|+.-||..|-..   ||+|.||||+||||++.. 
T Consensus       503 F~hkn----HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~  574 (752)
T KOG0670|consen  503 FKHKN----HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKN  574 (752)
T ss_pred             hhhcc----eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcc
Confidence            76543    569999987 568888886532 34688899999999999999999987   999999999999998654 


Q ss_pred             ceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH-HH
Q 014034          226 RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL-EW  304 (432)
Q Consensus       226 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~-~~  304 (432)
                      .+||||||.|-...   .. ..+.+.-+..|.|||++.|-+|+...|+||.||+||||.||+.-|.+.+......+. +.
T Consensus       575 iLKLCDfGSA~~~~---en-eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~  650 (752)
T KOG0670|consen  575 ILKLCDFGSASFAS---EN-EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL  650 (752)
T ss_pred             eeeeccCccccccc---cc-cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence            57999999986421   11 122344566899999999999999999999999999999999999987654433221 11


Q ss_pred             Hhhccc---------------Ccccccc---------------ccCc------cccC--cC---CHHHHHHHHHHHHHhc
Q 014034          305 VQQYPA---------------DSKKFGL---------------IMDP------RLEK--EY---SINEARKIGRLADNCL  343 (432)
Q Consensus       305 ~~~~~~---------------~~~~~~~---------------~~~~------~l~~--~~---~~~~~~~l~~li~~cl  343 (432)
                      ...+|.               +-.-+..               .+.|      .+..  .+   .......|.+|+..||
T Consensus       651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml  730 (752)
T KOG0670|consen  651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML  730 (752)
T ss_pred             cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence            111111               0000000               0111      0000  11   2334567889999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 014034          344 SKSSKDRPKMSQVVER  359 (432)
Q Consensus       344 ~~dP~~RPs~~eil~~  359 (432)
                      ..||++|.|..+.|.+
T Consensus       731 ~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  731 ILDPEKRITVNQALKH  746 (752)
T ss_pred             ccChhhcCCHHHHhcC
Confidence            9999999999999876

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.6e-30  Score=226.53  Aligned_cols=250  Identities=22%  Similarity=0.375  Sum_probs=183.2

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH---HHHHHHHHhccc-CCCccceeeeEEeecC
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGVL-EHPNLVKLIGYCAVDG  152 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l-~hpniv~l~~~~~~~~  152 (432)
                      ..+.|.+.+.||+|.||.+-++.++       .+++.+++|-+.+...   +|.+|...--.| .|.||+.-|++.....
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr-------~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~   94 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHR-------QSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS   94 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeecc-------CCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence            3467999999999999999999987       5678999999987543   488887664444 5999999887544322


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc--CCCceeec
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD--ENFRPKLS  230 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~--~~~~~kl~  230 (432)
                      .   ..++++||++.|+|..-+..   .++.+.....++.|++.|+.|||++   ++||||||.+||||-  +.-.+|||
T Consensus        95 d---~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlc  165 (378)
T KOG1345|consen   95 D---AYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLC  165 (378)
T ss_pred             c---eEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEee
Confidence            2   45899999999999998754   3588889999999999999999999   999999999999993  34479999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCcccccc---C--CCCchhhhHHHHHHHHHHHhCCCCCCCCCch--hhHHHHH
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET---G--HLTAKSDVWSFGVVLYEMLTGRRSLERNRPK--TEQRLLE  303 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~--~~~~~~~  303 (432)
                      |||+++..   +.  ......-+..|.+||.+..   +  ...+.+|||.||+++|.++||+.||+...-.  .-.....
T Consensus       166 DFG~t~k~---g~--tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~  240 (378)
T KOG1345|consen  166 DFGLTRKV---GT--TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ  240 (378)
T ss_pred             eccccccc---Cc--eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH
Confidence            99998752   11  1222334667999998743   2  2467899999999999999999999843221  1233444


Q ss_pred             HHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          304 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      |......           .++..+. ..+..+.++.++-|..+|++|=-..++.+.
T Consensus       241 w~~rk~~-----------~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  241 WLKRKNP-----------ALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             HhcccCc-----------cCchhhc-ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence            4433221           1111111 123467789999999999999544444443

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=2.7e-28  Score=221.93  Aligned_cols=196  Identities=33%  Similarity=0.458  Sum_probs=165.6

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      |...+.||.|++|.||++...       .++..+++|.+...     ...+.+|++.++.++|+|++++++++....   
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~---   70 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDK-------GTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPE---   70 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEc-------CCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCC---
Confidence            456788999999999999875       34678999998764     345788999999999999999999887654   


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCC
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  235 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a  235 (432)
                       ..++++||+.+++|.+++..... .+++..+..++.+++.++.+||+.   +++|+||+|.||+++.++.++|+|||++
T Consensus        71 -~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~  145 (225)
T smart00221       71 -PLYLVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLA  145 (225)
T ss_pred             -ceEEEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCcee
Confidence             34899999999999999876432 288999999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCCCcccccccccCCCccCcccc-ccCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 014034          236 REGPMVGHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRSLER  292 (432)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltg~~pf~~  292 (432)
                      ....... ........++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus       146 ~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      146 RFIHRDL-AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eEecCcc-cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            7643221 0122345678899999998 667788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=1.3e-29  Score=236.75  Aligned_cols=271  Identities=25%  Similarity=0.362  Sum_probs=196.8

Q ss_pred             HHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC--hHHHHHHHHHhccc-CCCccceeeeEEe
Q 014034           73 EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQWVAEVQFLGVL-EHPNLVKLIGYCA  149 (432)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l-~hpniv~l~~~~~  149 (432)
                      .+....+.|..+++||+|+|+.||+++....    ......||+|.+...  .....+|+++|..+ .+.||+++.+++.
T Consensus        30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~----~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~r  105 (418)
T KOG1167|consen   30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQ----DTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFR  105 (418)
T ss_pred             hhhhhhhhhhhhccccccchhhhhhhhHhhh----ccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhc
Confidence            3455667899999999999999999987631    236789999998653  34588999999998 5999999999887


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC-CCcee
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE-NFRPK  228 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~k  228 (432)
                      ..+    +.++|+||++...-.+++.     .++...+..+++.+..||.++|.+   |||||||||+|+|.+. -+.-.
T Consensus       106 nnd----~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~  173 (418)
T KOG1167|consen  106 NND----QVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGV  173 (418)
T ss_pred             cCC----eeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCce
Confidence            655    4599999999988888874     467889999999999999999998   9999999999999974 56689


Q ss_pred             eccccCCcCC-----------------CC-CCC------------------------cccccccccCCCccCcccccc-C
Q 014034          229 LSDFGLAREG-----------------PM-VGH------------------------THVSTAVVGTFGYAAPDYIET-G  265 (432)
Q Consensus       229 l~DfG~a~~~-----------------~~-~~~------------------------~~~~~~~~gt~~y~aPE~~~~-~  265 (432)
                      |+|||+|...                 .. .+.                        ........||++|.|||++.. .
T Consensus       174 LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~  253 (418)
T KOG1167|consen  174 LVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP  253 (418)
T ss_pred             EEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc
Confidence            9999998610                 00 000                        000113469999999999854 5


Q ss_pred             CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhH--HHHHH--------HhhcccC------c---------cccccc--
Q 014034          266 HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ--RLLEW--------VQQYPAD------S---------KKFGLI--  318 (432)
Q Consensus       266 ~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~--~~~~~--------~~~~~~~------~---------~~~~~~--  318 (432)
                      .-++++||||.|||++.++++..||.....+...  ++...        ....+..      .         ..+..+  
T Consensus       254 ~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~  333 (418)
T KOG1167|consen  254 RQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHI  333 (418)
T ss_pred             CcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccCh
Confidence            6788999999999999999999999765443221  11100        1111110      0         001111  


Q ss_pred             --cCc----cccC-cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          319 --MDP----RLEK-EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       319 --~~~----~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                        +.+    .+.. ......+..+.+|+.+|+..||.+|.|+++.|++
T Consensus       334 ~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  334 ESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             hhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence              000    0000 1111223468899999999999999999999987

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=4.4e-29  Score=267.90  Aligned_cols=202  Identities=17%  Similarity=0.205  Sum_probs=142.2

Q ss_pred             cccCC-CccceeeeEEeecC---CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCce
Q 014034          134 GVLEH-PNLVKLIGYCAVDG---ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQV  209 (432)
Q Consensus       134 ~~l~h-pniv~l~~~~~~~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~i  209 (432)
                      +.++| +||++++++|....   ......++++||+ +++|.++|... ...+++..++.++.||+.||.|||++   +|
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---gI  101 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQ---GI  101 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            34566 68888888873322   1112347788887 67999999653 34699999999999999999999998   99


Q ss_pred             eecCCCCCceEEcC-------------------CCceeeccccCCcCCCCCCC--------------cccccccccCCCc
Q 014034          210 IYRDFKASNVLLDE-------------------NFRPKLSDFGLAREGPMVGH--------------THVSTAVVGTFGY  256 (432)
Q Consensus       210 vH~Dikp~Nill~~-------------------~~~~kl~DfG~a~~~~~~~~--------------~~~~~~~~gt~~y  256 (432)
                      +||||||+||||+.                   ++.+||+|||+++.......              ........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   44566667776653110000              0001124689999


Q ss_pred             cCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHH
Q 014034          257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIG  336 (432)
Q Consensus       257 ~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~  336 (432)
                      ||||++.+..++.++|||||||+||||++|..|+.....    .+.......          ..+..     ........
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~~~----------~~~~~-----~~~~~~~~  242 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRHRV----------LPPQI-----LLNWPKEA  242 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHHhh----------cChhh-----hhcCHHHH
Confidence            999999999999999999999999999998888653211    111110000          01100     01123355


Q ss_pred             HHHHHhccCCCCCCCCHHHHHHH
Q 014034          337 RLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       337 ~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .++.+||..+|.+||++.+|+++
T Consensus       243 ~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        243 SFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHHhCCCChhhCcChHHHhhc
Confidence            78899999999999999999886

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=3.5e-27  Score=207.09  Aligned_cols=169  Identities=24%  Similarity=0.277  Sum_probs=127.7

Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCCCCCCcccc
Q 014034          168 RSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS  247 (432)
Q Consensus       168 gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  247 (432)
                      |+|.+++..+. .++++..++.|+.|++.||.|||+.   +      ||+|||++.++.+|+  ||++.....       
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~-------   61 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTP-------   61 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecc-------
Confidence            68999997543 4699999999999999999999997   5      999999999999999  999875321       


Q ss_pred             cccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcC
Q 014034          248 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEY  327 (432)
Q Consensus       248 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  327 (432)
                      ....||+.|||||++.+..++.++|||||||++|||+||..||........ .+..+........        +. ....
T Consensus        62 ~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~--------~~-~~~~  131 (176)
T smart00750       62 EQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNGMPADD--------PR-DRSN  131 (176)
T ss_pred             ccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHHhccCC--------cc-cccc
Confidence            123689999999999999999999999999999999999999975432211 1111111111100        00 0001


Q ss_pred             CHHHHH--HHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          328 SINEAR--KIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       328 ~~~~~~--~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                      ......  .+.+++.+||..+|.+||++.++++++..+..
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            112222  58899999999999999999999999876643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.6e-26  Score=204.20  Aligned_cols=246  Identities=20%  Similarity=0.349  Sum_probs=189.8

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc------ChHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      +...+.+|.+...|..|+|+|.         +.-++.|+++-      ....|..|.-.|+.+.||||+.++|.|.....
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwq---------gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn  261 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQ---------GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN  261 (448)
T ss_pred             hhhhhhhhccCCCccccccccc---------CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC
Confidence            3445567888999999999986         33355566542      23358899999999999999999999987654


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec--c
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS--D  231 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~--D  231 (432)
                          +.++..||+.|+|+..|++...-...-.++.+++.++++|++|||+. .+-|.--.|.+..|+||++.+.+|+  |
T Consensus       262 ----lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad  336 (448)
T KOG0195|consen  262 ----LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMAD  336 (448)
T ss_pred             ----ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheeccc
Confidence                48999999999999999887766677889999999999999999996 3445555789999999999888764  2


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCC---chhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLT---AKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      --++.         ........+.||+||.+...+-+   .++|+|||++++|||.|...||....+.+-.-.       
T Consensus       337 ~kfsf---------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk-------  400 (448)
T KOG0195|consen  337 TKFSF---------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK-------  400 (448)
T ss_pred             ceeee---------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh-------
Confidence            22221         11223457899999999765543   479999999999999999999988766543211       


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  364 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  364 (432)
                               +.-..+....++..+..+.+|+.-|+..||.+||.+..|+-.|+++.
T Consensus       401 ---------ialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  401 ---------IALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ---------hhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                     11122333445566778889999999999999999999999998763

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=2e-25  Score=214.96  Aligned_cols=166  Identities=18%  Similarity=0.148  Sum_probs=127.5

Q ss_pred             HHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---------hHHHHHHHHHhcccCCCccce-
Q 014034           74 MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---------GLQWVAEVQFLGVLEHPNLVK-  143 (432)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~hpniv~-  143 (432)
                      +....++|...+.||+|+||+||+|.+..      .++..||||++...         ...+.+|+++|+.++|+|+++ 
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~------~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~   86 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAG------DPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQ   86 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcC------CCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcE
Confidence            34556789999999999999999998751      24567899986422         224789999999999999985 


Q ss_pred             eeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCC-CCCceEEc
Q 014034          144 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDF-KASNVLLD  222 (432)
Q Consensus       144 l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Di-kp~Nill~  222 (432)
                      ++++    +    ..++||||++|++|... .     ...   ...++.+++.||.|||+.   ||+|||| ||+|||++
T Consensus        87 l~~~----~----~~~LVmE~~~G~~L~~~-~-----~~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~  146 (365)
T PRK09188         87 LLAT----G----KDGLVRGWTEGVPLHLA-R-----PHG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMG  146 (365)
T ss_pred             EEEc----C----CcEEEEEccCCCCHHHh-C-----ccc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEc
Confidence            4331    2    24999999999999732 1     111   146789999999999998   9999999 99999999


Q ss_pred             CCCceeeccccCCcCCCCCCCccc------ccccccCCCccCccccccC
Q 014034          223 ENFRPKLSDFGLAREGPMVGHTHV------STAVVGTFGYAAPDYIETG  265 (432)
Q Consensus       223 ~~~~~kl~DfG~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~  265 (432)
                      .++.+||+|||+|+.....+....      .....+++.|+|||.+...
T Consensus       147 ~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        147 PDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             CCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            999999999999985433221111      1356788999999999643

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=2e-24  Score=196.07  Aligned_cols=264  Identities=20%  Similarity=0.227  Sum_probs=202.6

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc--ChHHHHHHHHHhcccC-CCccceeeeEEeecCCcce
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQWVAEVQFLGVLE-HPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~  156 (432)
                      +|.++++||+|+||..+.|+.       ..++++||||.-..  +..++..|....+.|. .++|..+|-|.    ..+.
T Consensus        29 hyrVGkKIGeGsFG~lf~G~N-------l~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG----qeG~   97 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKN-------LYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG----QEGK   97 (449)
T ss_pred             cceeccccccCcceeeecccc-------cccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec----cccc
Confidence            699999999999999999874       46899999998654  4456888999988885 68998887553    3344


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC-----ceeecc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF-----RPKLSD  231 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-----~~kl~D  231 (432)
                      +-.||+|.+ |.||+|+..-. .+.++.++++.++.|++.-++|+|++   .+|+|||||+|+||...+     .+.|+|
T Consensus        98 ~NiLVidLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiD  172 (449)
T KOG1165|consen   98 YNILVIDLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIID  172 (449)
T ss_pred             hhhhhhhhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEe
Confidence            558999988 88999876433 35799999999999999999999998   999999999999996443     489999


Q ss_pred             ccCCcCCCCCCC-----cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 014034          232 FGLAREGPMVGH-----THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  306 (432)
Q Consensus       232 fG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  306 (432)
                      ||+|+.......     ........||..||+--...|..-+..-|+=|||-++++.|-|..||++....+.....+.+.
T Consensus       173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG  252 (449)
T KOG1165|consen  173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG  252 (449)
T ss_pred             ccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc
Confidence            999986433221     122345679999999999999999999999999999999999999999987766555555443


Q ss_pred             hcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhccC
Q 014034          307 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNE  369 (432)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~  369 (432)
                      ...... .+..         .....+.++..-+.-.-..+-.+-|+..-+..-+.+++...+.
T Consensus       253 e~Kr~T-~i~~---------Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~  305 (449)
T KOG1165|consen  253 ETKRST-PIEV---------LCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE  305 (449)
T ss_pred             cccccC-CHHH---------HHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence            322111 1111         1112344555666666667778889998888888777766544

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=6.2e-24  Score=204.60  Aligned_cols=261  Identities=24%  Similarity=0.245  Sum_probs=193.9

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH----HHHHHHHHhcccCC----CccceeeeEEeec
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL----QWVAEVQFLGVLEH----PNLVKLIGYCAVD  151 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h----pniv~l~~~~~~~  151 (432)
                      +|.+.+.||+|+||.||.+.....      ....+|+|.......    .+..|..++..+..    +++..+++...  
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~------~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~--   90 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSE------KNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR--   90 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCC------CCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc--
Confidence            799999999999999999986411      146788888654321    47788888888863    58888887774  


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCC-----Cc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-----FR  226 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-----~~  226 (432)
                       ......++||+.+ |.+|.++......+.++..++..|+.|++.+|.+||+.   |++||||||+|+++...     ..
T Consensus        91 -~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~  165 (322)
T KOG1164|consen   91 -STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRT  165 (322)
T ss_pred             -CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccce
Confidence             1122348999987 89999987665557899999999999999999999998   99999999999999755     46


Q ss_pred             eeeccccCCcCCCC--CCCc---c--c-ccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhh
Q 014034          227 PKLSDFGLAREGPM--VGHT---H--V-STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE  298 (432)
Q Consensus       227 ~kl~DfG~a~~~~~--~~~~---~--~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~  298 (432)
                      +.|.|||+++....  ....   .  . .....||..|+++....+...+.+.|+||++.++.+++.|..||.+......
T Consensus       166 ~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~  245 (322)
T KOG1164|consen  166 LYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL  245 (322)
T ss_pred             EEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch
Confidence            99999999983221  1111   1  1 2245699999999999999999999999999999999999999976554322


Q ss_pred             HHHH-HHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhc
Q 014034          299 QRLL-EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  367 (432)
Q Consensus       299 ~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  367 (432)
                      .... .......         ...     .....+..+..+...+-..+..++|....+...|.......
T Consensus       246 ~~~~~~~~~~~~---------~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  246 KSKFEKDPRKLL---------TDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             HHHHHHHhhhhc---------ccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            1111 1111000         000     11112344556666666689999999999999988876654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=2.6e-24  Score=187.27  Aligned_cols=266  Identities=20%  Similarity=0.251  Sum_probs=201.8

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH--HHHHHHHHhcccCC-CccceeeeEEeecCC
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLGVLEH-PNLVKLIGYCAVDGE  153 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~E~~~l~~l~h-pniv~l~~~~~~~~~  153 (432)
                      ..+.|.++++||.|+||.+|.|...       .++..||||.-+....  ++..|..+.+.|++ ..|..+..+..+...
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i-------~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y   85 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISI-------TSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY   85 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeec-------cCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence            3468999999999999999999865       6789999998765443  47789999998865 556666656655443


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC---CCceeec
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE---NFRPKLS  230 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~  230 (432)
                      .    .+||+.+ |.+|.+...-.. +.++..+++-++-|++.-++|+|.+   +++||||||+|.|..-   ...+.|+
T Consensus        86 n----vlVMdLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LI  156 (341)
T KOG1163|consen   86 N----VLVMDLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLI  156 (341)
T ss_pred             c----eeeeecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEE
Confidence            3    8999988 899999875433 4688999999999999999999998   9999999999999963   4468999


Q ss_pred             cccCCcCCCCCCC-----cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 014034          231 DFGLAREGPMVGH-----THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  305 (432)
Q Consensus       231 DfG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  305 (432)
                      |||+|+.......     .....+..||..|.+--...+-..+..-|+-|+|.+|..+.-|..||++..+.+..+..+.+
T Consensus       157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI  236 (341)
T KOG1163|consen  157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI  236 (341)
T ss_pred             eccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH
Confidence            9999986433222     12234568999999988887777788999999999999999999999998887776666655


Q ss_pred             hhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhcc
Q 014034          306 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  368 (432)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  368 (432)
                      ....... ..+.+     -..    .+.++.-.+.-|-..--++-|+..-+-+.+.-+....+
T Consensus       237 ~EkK~s~-~ie~L-----C~G----~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln  289 (341)
T KOG1163|consen  237 SEKKMST-PIEVL-----CKG----FPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN  289 (341)
T ss_pred             HHhhcCC-CHHHH-----hCC----CcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence            4433211 11111     112    23456677888888888888888877766665554433

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=5.7e-25  Score=225.24  Aligned_cols=251  Identities=21%  Similarity=0.272  Sum_probs=180.8

Q ss_pred             cccccccCCceEEEEEEecCCCCCCCcccEEEEEEecC----c-ChH-----HHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           83 RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN----R-DGL-----QWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        83 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~----~-~~~-----~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      ....+|.|.+|.|+.+....       .....+.|...    . +..     .+..|+.+-..|.|||++..+..+....
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~-------~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~  394 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRS-------DLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID  394 (601)
T ss_pred             ccceeeecccCceEEEEecC-------CCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc
Confidence            45678999999777665441       22223333221    1 111     1456777788899999988776665433


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                      ..    .-+||||++ +|...+...  ..+....+-.++.|++.|+.|||+.   ||.|||||++|++++.+|.+||+||
T Consensus       395 ~~----~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Df  464 (601)
T KOG0590|consen  395 GI----LQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDF  464 (601)
T ss_pred             cc----hhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeec
Confidence            32    344999999 999998664  2577888899999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCc--ccccccccCCCccCccccccCCCCch-hhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          233 GLAREGPMVGHT--HVSTAVVGTFGYAAPDYIETGHLTAK-SDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       233 G~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      |.+..+......  ......+|+..|+|||++.+..|++. .||||.|+++..|++|+.||...........   -..+ 
T Consensus       465 g~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~---~~~~-  540 (601)
T KOG0590|consen  465 GAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK---TNNY-  540 (601)
T ss_pred             CcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh---hhcc-
Confidence            999765444333  55567889999999999999999874 8999999999999999999976544332210   0000 


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                        .........+   .......+.....+|.+||+.||.+|.|+.+|++.
T Consensus       541 --~~~~~~~~~~---~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  541 --SDQRNIFEGP---NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             --ccccccccCh---HHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence              0000000000   01122334567789999999999999999999865

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=1.6e-22  Score=193.29  Aligned_cols=256  Identities=33%  Similarity=0.511  Sum_probs=191.4

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCC-ccceeeeEEeecC
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHP-NLVKLIGYCAVDG  152 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~  152 (432)
                      |.....||.|+||.||++...          ..+++|.+...       ...+.+|+.++..+.|+ +|+++++++....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~----------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~   71 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR----------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG   71 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec----------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC
Confidence            667788999999999999853          67888887542       33488899999999988 7999999985433


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC-ceeec
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAF-PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF-RPKLS  230 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~  230 (432)
                      .    .+++++|+.++++.+++..... ..++......++.|++.++.|+|+.   +++||||||+||+++..+ .++++
T Consensus        72 ~----~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~  144 (384)
T COG0515          72 S----LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLI  144 (384)
T ss_pred             E----EEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEe
Confidence            2    5899999999999977654432 2688899999999999999999998   999999999999999988 79999


Q ss_pred             cccCCcCCCCCCCc----ccccccccCCCccCcccccc---CCCCchhhhHHHHHHHHHHHhCCCCCCCCCch-hhHHHH
Q 014034          231 DFGLAREGPMVGHT----HVSTAVVGTFGYAAPDYIET---GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK-TEQRLL  302 (432)
Q Consensus       231 DfG~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~-~~~~~~  302 (432)
                      |||++.........    .......||..|++||.+.+   ..++...|+||+|++++++++|..||...... ......
T Consensus       145 dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~  224 (384)
T COG0515         145 DFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL  224 (384)
T ss_pred             ccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHH
Confidence            99998743222211    13456789999999999987   57888999999999999999999998765431 011122


Q ss_pred             HHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          303 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ..+......      .................+.+++..|+..+|..|.+..+....
T Consensus       225 ~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         225 KIILELPTP------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHHHhcCCc------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            222211111      000000000002223567799999999999999999887765

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.90  E-value=7.1e-24  Score=207.88  Aligned_cols=271  Identities=25%  Similarity=0.380  Sum_probs=189.4

Q ss_pred             hcccCCCccceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCce-ee
Q 014034          133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQV-IY  211 (432)
Q Consensus       133 l~~l~hpniv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~i-vH  211 (432)
                      |+.+.|.|+.+++|.+.+.+    ..+.|.+||..|+|.+.+.... ..+.+.....++++|+.||.|||+.   .| .|
T Consensus         1 l~~l~h~n~~~f~g~~~~~~----~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~h   72 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGP----EMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNS---PIGYH   72 (484)
T ss_pred             CcccchhhhhhheeeEecCC----ceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcC---cceee
Confidence            46789999999999998774    3589999999999999998744 4688999999999999999999996   33 99


Q ss_pred             cCCCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCC-------CCchhhhHHHHHHHHHHH
Q 014034          212 RDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH-------LTAKSDVWSFGVVLYEML  284 (432)
Q Consensus       212 ~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwSlGvil~ell  284 (432)
                      +.+++.|+++|..+.+||+|||+.................-...|.|||.+.+..       .+.+.||||||++++|++
T Consensus        73 g~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~  152 (484)
T KOG1023|consen   73 GALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL  152 (484)
T ss_pred             eeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence            9999999999999999999999986532111111112222456799999997631       466799999999999999


Q ss_pred             hCCCCCCCCCchh-hHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          285 TGRRSLERNRPKT-EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       285 tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                      +...||....... ...++.++......      .+.|.+....  .....+..++..||..+|.+||++.+|-..++.+
T Consensus       153 ~r~~~~~~~~~~~~~~eii~~~~~~~~~------~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  153 FRSGPFDLRNLVEDPDEIILRVKKGGSN------PFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             hccCccccccccCChHHHHHHHHhcCCC------CcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            9999997633222 13444443331110      1222222111  2334688999999999999999999999999888


Q ss_pred             hhhccC----CCCCcchhhhhc--cCCchhhhhhcccCCc-------hHHHHHHHHHHHhhcccccccc
Q 014034          364 VQVSNE----GDSFDKTFEEIC--EEDPVEAQTKQKQHEP-------SEAWKRRMAHLAKLGEHVEGAS  419 (432)
Q Consensus       364 ~~~~~~----~~~~~~~~~~~~--~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~  419 (432)
                      ......    .+.+....+.+.  .+..+..++.....+.       .+..+..++..++.|..|.|+.
T Consensus       225 ~~~~~~~~nl~D~m~~~le~Y~~nLe~~v~eRt~~l~~e~~k~d~LL~~mLP~~VA~~lk~G~~v~pe~  293 (484)
T KOG1023|consen  225 NKGGSSKGNLMDSLFRMLESYADNLEKLVDERTAELEEEKKKTDTLLGQMLPKSVAESLKLGKTVDPES  293 (484)
T ss_pred             cccccccchhHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHhcCHHHhhHhhcCCcCCccc
Confidence            664322    222222223332  1333443443333322       4456667888888888888764

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=1.1e-22  Score=180.28  Aligned_cols=134  Identities=18%  Similarity=0.171  Sum_probs=104.9

Q ss_pred             ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-------------HH-----------------HHHHHHh
Q 014034           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------------QW-----------------VAEVQFL  133 (432)
Q Consensus        84 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------------~~-----------------~~E~~~l  133 (432)
                      ...||+|+||.||+|...        +++.||+|+++....             .|                 ..|++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~--------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   73 (190)
T cd05147           2 NGCISTGKEANVYHATTA--------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNL   73 (190)
T ss_pred             CCccccccceEEEEEECC--------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHH
Confidence            357999999999999853        578999999864311             12                 3499999


Q ss_pred             cccCCCccceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCceeec
Q 014034          134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL-HEGLEVQVIYR  212 (432)
Q Consensus       134 ~~l~hpniv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~L-H~~~~~~ivH~  212 (432)
                      ..+.++++.....+...  .    .++||||+.++++...+...  .+++...+..++.|++.+|.|| |+.   ||+||
T Consensus        74 ~~l~~~~v~~p~~~~~~--~----~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHr  142 (190)
T cd05147          74 KRLVTAGIPCPEPILLK--S----HVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDC---RLVHA  142 (190)
T ss_pred             HHHHHCCCCCCcEEEec--C----CEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence            99988876443332211  1    28999999988776553322  3688999999999999999999 687   99999


Q ss_pred             CCCCCceEEcCCCceeeccccCCcC
Q 014034          213 DFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       213 Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      ||||+|||++ ++.++|+|||+|..
T Consensus       143 DlkP~NIli~-~~~v~LiDFG~a~~  166 (190)
T cd05147         143 DLSEYNLLYH-DGKLYIIDVSQSVE  166 (190)
T ss_pred             CCCHHHEEEE-CCcEEEEEcccccc
Confidence            9999999998 57899999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.87  E-value=2.8e-22  Score=180.03  Aligned_cols=172  Identities=10%  Similarity=0.077  Sum_probs=130.2

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh---HH----------HHHHHHHhcccCCCccce
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQ----------WVAEVQFLGVLEHPNLVK  143 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~----------~~~E~~~l~~l~hpniv~  143 (432)
                      ..++|..++.||.|+||.||++..         ++..+|+|.+....   ..          +.+|+..+.++.||+|..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~---------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~   99 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT---------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLAS   99 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec---------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCc
Confidence            468999999999999999998642         24569999986421   11          578999999999999999


Q ss_pred             eeeEEeecCCc----ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCce
Q 014034          144 LIGYCAVDGER----GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNV  219 (432)
Q Consensus       144 l~~~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Ni  219 (432)
                      +..++......    ....+|||||++|.+|.++.      .++.    ....+++.+|..||..   |++||||||+||
T Consensus       100 ~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Ni  166 (232)
T PRK10359        100 LNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQH---GMVSGDPHKGNF  166 (232)
T ss_pred             ceEeeeecccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHHc---CCccCCCChHHE
Confidence            98886654321    12458999999999998874      2332    2466999999999998   999999999999


Q ss_pred             EEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh
Q 014034          220 LLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT  285 (432)
Q Consensus       220 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt  285 (432)
                      +++.+| ++|+|||........  .. .           ..+.....|..++|+||||+++..+..
T Consensus       167 li~~~g-i~liDfg~~~~~~e~--~a-~-----------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        167 IVSKNG-LRIIDLSGKRCTAQR--KA-K-----------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EEeCCC-EEEEECCCcccccch--hh-H-----------HHHHHHhHhcccccccceeEeehHHHH
Confidence            999988 999999988642111  00 0           013334456678999999999876553

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=5e-23  Score=211.59  Aligned_cols=242  Identities=19%  Similarity=0.277  Sum_probs=172.2

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHH---HHHHHHhcccCCCccceeeeEEeec
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQW---VAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~---~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      +|...+.||.+.|=+|.+|.+.        .|. |+||++-+..     ..+   ..|++ ...++|||++++..+...+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~--------eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~   93 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR--------EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTD   93 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC--------Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhh
Confidence            5777788999999999999864        444 8888864432     123   33444 5566899999987664443


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      ..    .|||-+|. ..+|+|.|..+.  -+..-+...|+.||+.||..+|..   ||+|||||.+||||+.-..+.|+|
T Consensus        94 kA----AylvRqyv-khnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtD  163 (1431)
T KOG1240|consen   94 KA----AYLVRQYV-KHNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTD  163 (1431)
T ss_pred             HH----HHHHHHHH-hhhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhc
Confidence            32    27788888 569999996654  577788899999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCC-Cc----ccccccccCCCccCccccccC----------C-CCchhhhHHHHHHHHHHHh-CCCCCCCCC
Q 014034          232 FGLAREGPMVG-HT----HVSTAVVGTFGYAAPDYIETG----------H-LTAKSDVWSFGVVLYEMLT-GRRSLERNR  294 (432)
Q Consensus       232 fG~a~~~~~~~-~~----~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwSlGvil~ellt-g~~pf~~~~  294 (432)
                      |..-+...... +.    ....+...-..|+|||.+...          . .+++.||||+||+++||++ |++||.-  
T Consensus       164 FAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L--  241 (1431)
T KOG1240|consen  164 FASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL--  241 (1431)
T ss_pred             ccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH--
Confidence            98766422111 11    112223344589999987431          2 5678999999999999998 6888752  


Q ss_pred             chhhHHHHHHHhhcccCccc-cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          295 PKTEQRLLEWVQQYPADSKK-FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                          ..+..+-.....++.. ++.+-+            ..+..|+..|++.||.+|.++++.|+.
T Consensus       242 ----SQL~aYr~~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  242 ----SQLLAYRSGNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             ----HHHHhHhccCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence                1122221111111100 111111            257799999999999999999999986

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=1.3e-21  Score=173.87  Aligned_cols=134  Identities=19%  Similarity=0.157  Sum_probs=106.6

Q ss_pred             ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH------------------------------HHHHHHHHh
Q 014034           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------------------------------QWVAEVQFL  133 (432)
Q Consensus        84 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~------------------------------~~~~E~~~l  133 (432)
                      ...||+|+||.||+|...        +++.||||.++....                              .+..|...+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~--------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   73 (190)
T cd05145           2 NGCISTGKEANVYHARTG--------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNL   73 (190)
T ss_pred             CceeecCCCcEEEEEEcC--------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHH
Confidence            467999999999999842        578999999875311                              135788999


Q ss_pred             cccCCCccceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCceeec
Q 014034          134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE-GLEVQVIYR  212 (432)
Q Consensus       134 ~~l~hpniv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~-~~~~~ivH~  212 (432)
                      .++.|+++.....+....      .+|||||+.|+++.......  ..++......++.|++.+|.+||+ .   ||+||
T Consensus        74 ~~l~~~~i~~p~~~~~~~------~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~---givHr  142 (190)
T cd05145          74 KRLYEAGVPVPEPILLKK------NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHG  142 (190)
T ss_pred             HHHHhCCCCCceEEEecC------CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecC
Confidence            999999875544433221      28999999888654432222  357788899999999999999999 7   99999


Q ss_pred             CCCCCceEEcCCCceeeccccCCcC
Q 014034          213 DFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       213 Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      ||||+|||++ ++.++|+|||++..
T Consensus       143 DlkP~NIll~-~~~~~liDFG~a~~  166 (190)
T cd05145         143 DLSEYNILYH-DGKPYIIDVSQAVE  166 (190)
T ss_pred             CCChhhEEEE-CCCEEEEEccccee
Confidence            9999999999 88999999999975

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1.5e-21  Score=181.29  Aligned_cols=202  Identities=20%  Similarity=0.265  Sum_probs=142.3

Q ss_pred             CCCccceeeeEEeecC-----------------------CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 014034          137 EHPNLVKLIGYCAVDG-----------------------ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG  193 (432)
Q Consensus       137 ~hpniv~l~~~~~~~~-----------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~  193 (432)
                      .|||||+++++|.+.-                       ..+..+|+||.-+ ..+|.+++-.+.   .+.....-|+.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence            5999999999886531                       1234568999887 459999986653   556677789999


Q ss_pred             HHHHHHHhhcCCCCceeecCCCCCceEE--cCCC--ceeeccccCCcCCCCCCC----cccccccccCCCccCccccccC
Q 014034          194 AAEGLAYLHEGLEVQVIYRDFKASNVLL--DENF--RPKLSDFGLAREGPMVGH----THVSTAVVGTFGYAAPDYIETG  265 (432)
Q Consensus       194 l~~~l~~LH~~~~~~ivH~Dikp~Nill--~~~~--~~kl~DfG~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~  265 (432)
                      +++|+.|||.+   ||.|||+|++||||  |+|+  .+.|+|||++-.....+-    ....-...|....||||+....
T Consensus       350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            99999999999   99999999999999  3333  479999999853222111    1111234578889999998643


Q ss_pred             C------CCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHH
Q 014034          266 H------LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLA  339 (432)
Q Consensus       266 ~------~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li  339 (432)
                      +      --.++|.|+.|-+.||+++...||-+...... +.           ..+..---|.+    +..++..+.+|+
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-~~-----------r~Yqe~qLPal----p~~vpp~~rqlV  490 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-DT-----------RTYQESQLPAL----PSRVPPVARQLV  490 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-ch-----------hhhhhhhCCCC----cccCChHHHHHH
Confidence            2      12489999999999999999999976221110 00           11111112222    334456788999


Q ss_pred             HHhccCCCCCCCCHHHHHHHHH
Q 014034          340 DNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       340 ~~cl~~dP~~RPs~~eil~~L~  361 (432)
                      ...|+.||++|++..-....|.
T Consensus       491 ~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  491 FDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHhcCCccccCCccHHHhHHH
Confidence            9999999999999876655544

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.85  E-value=2e-22  Score=197.82  Aligned_cols=224  Identities=28%  Similarity=0.410  Sum_probs=175.9

Q ss_pred             cccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH------HHHHHHHHhcccC-CCccceeeeEEeecCCcceeEE
Q 014034           87 IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFLGVLE-HPNLVKLIGYCAVDGERGIQRL  159 (432)
Q Consensus        87 lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~~~  159 (432)
                      +|.|+||.|+++.-.    .+...+..+|+|.+.+...      ....|..++..++ ||.++++.-.+..+...    +
T Consensus         2 lg~g~~gkvfLvrk~----~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl----~   73 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKA----GGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKL----Y   73 (612)
T ss_pred             CCcCCCcchHHHHHh----ccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccch----h
Confidence            799999999986432    2445678889988765322      3456788888886 99999998888766644    8


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCC
Q 014034          160 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP  239 (432)
Q Consensus       160 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~  239 (432)
                      ++++|..||.|...+....  .+.+.....+...++-+++++|..   +|+|||+|++||+++.+|.+++.|||+++...
T Consensus        74 l~ld~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v  148 (612)
T KOG0603|consen   74 LILDFLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAV  148 (612)
T ss_pred             HhhhhcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhH
Confidence            9999999999998886554  567777788899999999999998   99999999999999999999999999998531


Q ss_pred             CCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccccccc
Q 014034          240 MVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM  319 (432)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (432)
                      .      ....+||..|||||++.  ....++|.||||++++||+||..||.+   .....+    ..            
T Consensus       149 ~------~~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---~~~~~I----l~------------  201 (612)
T KOG0603|consen  149 K------EKIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---DTMKRI----LK------------  201 (612)
T ss_pred             h------hhhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---HHHHHH----hh------------
Confidence            1      12228999999999998  567899999999999999999999986   111111    11            


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 014034          320 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM  353 (432)
Q Consensus       320 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  353 (432)
                         .....+......+.+++..++..+|..|.-.
T Consensus       202 ---~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  202 ---AELEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             ---hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence               0112344455667789999999999999755

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=9.8e-21  Score=166.57  Aligned_cols=183  Identities=17%  Similarity=0.128  Sum_probs=136.7

Q ss_pred             ccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH--------HHHHHHHHhcccC-CCccceeeeEEeecC
Q 014034           82 SRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--------QWVAEVQFLGVLE-HPNLVKLIGYCAVDG  152 (432)
Q Consensus        82 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~~l~~l~-hpniv~l~~~~~~~~  152 (432)
                      .+...|++|+||+||.+.         ..+.+++.+.+.....        -+.+|+++|++|. |++|++++++.    
T Consensus         5 ~~~~~l~~~~f~~v~~~~---------~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~----   71 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVR---------GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD----   71 (218)
T ss_pred             ccceeecCCCcceEEEee---------cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc----
Confidence            345679999999999764         2567788777765433        3678999999995 58899998861    


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCC-CCCceEEcCCCceeecc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDF-KASNVLLDENFRPKLSD  231 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Di-kp~Nill~~~~~~kl~D  231 (432)
                          ..+++|+|+.|.+|.+.+..         ....++.|++.+|.++|+.   ||+|||| ||+|||++.++.++|+|
T Consensus        72 ----~~~lvmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LID  135 (218)
T PRK12274         72 ----GRHLDRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVID  135 (218)
T ss_pred             ----CEEEEEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEE
Confidence                13899999999999765311         1135788999999999998   9999999 79999999999999999


Q ss_pred             ccCCcCCCCCCCc----cc-------ccccccCCCccCccccccC-CCC-chhhhHHHHHHHHHHHhCCCCCCCC
Q 014034          232 FGLAREGPMVGHT----HV-------STAVVGTFGYAAPDYIETG-HLT-AKSDVWSFGVVLYEMLTGRRSLERN  293 (432)
Q Consensus       232 fG~a~~~~~~~~~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwSlGvil~elltg~~pf~~~  293 (432)
                      ||++......+.-    ..       ......++.|++|+...-. ..+ ...++++.|.-+|.++|+..+..+.
T Consensus       136 FG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        136 FQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             CCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            9999853322210    00       0112367788888755322 233 5689999999999999999887643

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.85  E-value=3.2e-21  Score=178.34  Aligned_cols=232  Identities=22%  Similarity=0.327  Sum_probs=145.5

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccC----------CCccce
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLE----------HPNLVK  143 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~----------hpniv~  143 (432)
                      +.....||.|+|+.||.+++.       .+++.+|+|......       ..+.+|.-....+.          |-.++-
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~-------~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~   86 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDV-------ETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLV   86 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-------TTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B--
T ss_pred             EEEccccccCCceEEEEEEEc-------cCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEe
Confidence            456678999999999999965       678999999874321       23455544433322          112222


Q ss_pred             eeeEEeecC----------Ccc---eeEEEEEeecCCCCHHHHhhc---CC--CCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 014034          144 LIGYCAVDG----------ERG---IQRLLVYEFMLNRSLEDHLFN---RA--FPPLPWKTRLHIILGAAEGLAYLHEGL  205 (432)
Q Consensus       144 l~~~~~~~~----------~~~---~~~~lv~e~~~~gsL~~~l~~---~~--~~~l~~~~~~~i~~~l~~~l~~LH~~~  205 (432)
                      .++.....+          ...   ...+++|+-+ .++|.+++..   ..  ...+....++.+..|+++.+++||+. 
T Consensus        87 P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~-  164 (288)
T PF14531_consen   87 PLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY-  164 (288)
T ss_dssp             -SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             eeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc-
Confidence            222222110          000   1236788877 5688887542   11  12344455677889999999999998 


Q ss_pred             CCceeecCCCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCcccccc--------CCCCchhhhHHHH
Q 014034          206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET--------GHLTAKSDVWSFG  277 (432)
Q Consensus       206 ~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlG  277 (432)
                        |++|+||+|+|++++.+|.+.|+||+.....   +.... . ...+..|.|||....        -.++.+.|.|+||
T Consensus       165 --GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~---g~~~~-~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG  237 (288)
T PF14531_consen  165 --GLVHGDIKPENFLLDQDGGVFLGDFSSLVRA---GTRYR-C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLG  237 (288)
T ss_dssp             --TEEEST-SGGGEEE-TTS-EEE--GGGEEET---TEEEE-G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHH
T ss_pred             --ceEecccceeeEEEcCCCCEEEcChHHHeec---Cceee-c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHH
Confidence              9999999999999999999999999887642   11111 1 345678999997743        2478899999999


Q ss_pred             HHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCC
Q 014034          278 VVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDR  350 (432)
Q Consensus       278 vil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R  350 (432)
                      +++|.|.+|..||....+....                    +..+. .+. +.++.+..||..+|+.||.+|
T Consensus       238 ~~ly~lWC~~lPf~~~~~~~~~--------------------~~~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  238 ITLYSLWCGRLPFGLSSPEADP--------------------EWDFS-RCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHHSS-STCCCGGGSTS--------------------GGGGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHHccCCCCCCCccccc--------------------cccch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999999999999865432110                    00122 233 778889999999999999988

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=5.3e-21  Score=200.10  Aligned_cols=249  Identities=18%  Similarity=0.219  Sum_probs=181.0

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-HHHHHHHHhcccC---CCccceeeeEEeecC
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QWVAEVQFLGVLE---HPNLVKLIGYCAVDG  152 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~l~---hpniv~l~~~~~~~~  152 (432)
                      ....|.+-+.||+|+||+||+|...        +++.||+|+-+.... +|.--.+++.+|+   -+.|..+.......+
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~--------~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~  767 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHS--------NGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQN  767 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecC--------CCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence            3456888889999999999999864        389999999776543 2333345555665   234444444444333


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc-------CCC
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-------ENF  225 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~-------~~~  225 (432)
                      ..    +||+||.+.|+|.+++.  ..+.++|..+..++.|++..++.||..   +||||||||+|.||.       +..
T Consensus       768 ~S----~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~  838 (974)
T KOG1166|consen  768 AS----VLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSK  838 (974)
T ss_pred             cc----eeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCccc
Confidence            33    89999999999999996  445899999999999999999999998   999999999999994       334


Q ss_pred             ceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 014034          226 RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  305 (432)
Q Consensus       226 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  305 (432)
                      .++|+|||.+..+.............+|-.+-.+|...|.+|+..+|.|.|+-+++.||.|+.-                
T Consensus       839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~----------------  902 (974)
T KOG1166|consen  839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM----------------  902 (974)
T ss_pred             ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH----------------
Confidence            5899999999876555555566778899999999999999999999999999999999998631                


Q ss_pred             hhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          306 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                      +......+    .++..+..-..   ..-..+++..+|..|-..=|...++...|+.++.
T Consensus       903 q~~~g~~~----~~~~~~~Ry~~---~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~  955 (974)
T KOG1166|consen  903 EVKNGSSW----MVKTNFPRYWK---RDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA  955 (974)
T ss_pred             HhcCCcce----eccccchhhhh---HHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence            11111111    11111111111   1234467777777555555777787777777653

>PRK10345 hypothetical protein; Provisional

Probab=99.84  E-value=3.4e-20  Score=166.02  Aligned_cols=137  Identities=16%  Similarity=0.216  Sum_probs=105.0

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC----hHHHHHHHHHhccc-----CCCccceeeeEEeec
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVAEVQFLGVL-----EHPNLVKLIGYCAVD  151 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l-----~hpniv~l~~~~~~~  151 (432)
                      +.....||+|+||.||.  +.       .++.. +||++...    ...+.+|+.+++.+     .||||++++|++..+
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp-------~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~   73 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HP-------EDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD   73 (210)
T ss_pred             cCCcceecCCCceEEEE--CC-------CCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC
Confidence            34556899999999995  32       23333 68887643    34589999999999     579999999999876


Q ss_pred             CCcceeEEEEEee--cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCCceeecCCCCCceEEcC----C
Q 014034          152 GERGIQRLLVYEF--MLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL-AYLHEGLEVQVIYRDFKASNVLLDE----N  224 (432)
Q Consensus       152 ~~~~~~~~lv~e~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l-~~LH~~~~~~ivH~Dikp~Nill~~----~  224 (432)
                      ...+....+|+||  +.+++|.+++.+.   .+++.  ..++.+++.++ .|||++   +|+||||||+|||++.    +
T Consensus        74 ~g~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~  145 (210)
T PRK10345         74 CGTGYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESE  145 (210)
T ss_pred             CCCeEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCC
Confidence            5433334589999  5579999999653   35555  35678888787 999998   9999999999999973    3


Q ss_pred             CceeeccccCC
Q 014034          225 FRPKLSDFGLA  235 (432)
Q Consensus       225 ~~~kl~DfG~a  235 (432)
                      +.++|+||+.+
T Consensus       146 ~~~~LiDg~G~  156 (210)
T PRK10345        146 VIPVVCDNIGE  156 (210)
T ss_pred             CcEEEEECCCC
Confidence            47999995544

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.84  E-value=3.4e-21  Score=198.03  Aligned_cols=209  Identities=27%  Similarity=0.401  Sum_probs=148.5

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHHHHHHHhcccCCCccceeeeEEeecCCccee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQ  157 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~  157 (432)
                      ..+|..++.|..|+||.||..+++       .+.+++|+ +++++..-.++   ++.....|.+|               
T Consensus        82 e~df~~IklisngAygavylvrh~-------~trqrfa~-kiNkq~lilRn---ilt~a~npfvv---------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHK-------ETRQRFAM-KINKQNLILRN---ILTFAGNPFVV---------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeecc-------ccccchhh-cccccchhhhc---cccccCCccee---------------
Confidence            468999999999999999999876       56788999 55554432222   22222233332               


Q ss_pred             EEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          158 RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       158 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                                |+-...+...  ++++..-        +.+++|||+-   +|+|||+||+|++|+.-|.+|++|||+++.
T Consensus       136 ----------gDc~tllk~~--g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~  192 (1205)
T KOG0606|consen  136 ----------GDCATLLKNI--GPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKK  192 (1205)
T ss_pred             ----------chhhhhcccC--CCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhh
Confidence                      3333444332  2444332        7889999997   999999999999999999999999999875


Q ss_pred             CCCCCCc-------------ccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHH-HH
Q 014034          238 GPMVGHT-------------HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL-LE  303 (432)
Q Consensus       238 ~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~-~~  303 (432)
                      +......             ......+||+.|+|||++.-..|...+|+|++|+|+||.+-|+.||.+..+...... +.
T Consensus       193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis  272 (1205)
T KOG0606|consen  193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS  272 (1205)
T ss_pred             hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh
Confidence            3221111             112345899999999999999999999999999999999999999998876543211 11


Q ss_pred             HHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC
Q 014034          304 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP  351 (432)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP  351 (432)
                      ....+++.                ....+.+..+++.++|..+|..|-
T Consensus       273 d~i~wpE~----------------dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  273 DDIEWPEE----------------DEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             hhcccccc----------------CcCCCHHHHHHHHHHHHhChHhhc
Confidence            11111111                112235677899999999999996

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.79  E-value=2.6e-20  Score=179.71  Aligned_cols=172  Identities=26%  Similarity=0.379  Sum_probs=128.0

Q ss_pred             eEEEEEeecCCCCHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCC
Q 014034          157 QRLLVYEFMLNRSLEDHLFNR-AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  235 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a  235 (432)
                      .+++.|++|...+|.+||.++ .....++...+.++.|++.|+.|   +   +.+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence            468999999999999999743 34457888999999999999999   5   8999999999999999999999999998


Q ss_pred             cCCCCCC----CcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhccc
Q 014034          236 REGPMVG----HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       236 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      .......    .....+...||..||+||.+.+..|+.++||||||+||+||++ =..++.......+      +.    
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d------~r----  473 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTD------IR----  473 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhh------hh----
Confidence            7543332    1234456789999999999999999999999999999999997 2222221110000      00    


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS  354 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  354 (432)
                           ..++++.....++     .-..|+.+++...|.+||++.
T Consensus       474 -----~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  474 -----DGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             -----cCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHH
Confidence                 0011211111222     233799999999999999443

>smart00090 RIO RIO-like kinase

Probab=99.79  E-value=3.6e-19  Score=163.13  Aligned_cols=137  Identities=18%  Similarity=0.127  Sum_probs=107.6

Q ss_pred             CCccccccccCCceEEEEEE-ecCCCCCCCcccEEEEEEecCcCh----------------------------HHHHHHH
Q 014034           80 DFSRMLKIGEGGFGSVYKSS-IKPAAGDGTSEATVVAIKKLNRDG----------------------------LQWVAEV  130 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~-~~~~~~~~~~~~~~vaiK~~~~~~----------------------------~~~~~E~  130 (432)
                      .|.+.+.||+|+||.||+|. ..       .++..||+|.++...                            ..+..|+
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~-------~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~  101 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFD-------GSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEF  101 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecC-------CCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHH
Confidence            58888999999999999997 32       367899999876431                            1246799


Q ss_pred             HHhcccCCC--ccceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCc
Q 014034          131 QFLGVLEHP--NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQ  208 (432)
Q Consensus       131 ~~l~~l~hp--niv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~  208 (432)
                      .++.++.+.  .+.+++++    ..    .++||||+.+++|.......  ..+.......++.|++.+|.+||+.   +
T Consensus       102 ~~L~~L~~~~i~~p~~~~~----~~----~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---g  168 (237)
T smart00090      102 RNLQRLYEAGVPVPKPIAW----RR----NVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKE---G  168 (237)
T ss_pred             HHHHHHHhcCCCCCeeeEe----cC----ceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhc---C
Confidence            999999753  33444432    11    28999999998887665322  2455666789999999999999998   8


Q ss_pred             -eeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          209 -VIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       209 -ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                       |+||||||+||+++ ++.++|+|||.+..
T Consensus       169 ~iiH~Dikp~NIli~-~~~i~LiDFg~a~~  197 (237)
T smart00090      169 ELVHGDLSEYNILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             CEEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence             99999999999999 88999999999864

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=2.6e-18  Score=155.30  Aligned_cols=130  Identities=19%  Similarity=0.199  Sum_probs=106.5

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------------HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------------LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      +.||+|++|.||+|.+         .+..|++|......            ..+.+|+.++..+.|++|.....++....
T Consensus         2 ~~l~~G~~~~vy~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~   72 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF---------LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE   72 (211)
T ss_pred             cccccCceEEEEEEee---------CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC
Confidence            5799999999999975         35568888754211            23678999999999999877666665444


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                      .    .++||||++|++|.+++....     . .+..++.+++.+|.+||+.   +++|+|++|.|||++ ++.++|+||
T Consensus        73 ~----~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf  138 (211)
T PRK14879         73 N----FIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDF  138 (211)
T ss_pred             C----CEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEEC
Confidence            3    389999999999999985422     2 7889999999999999998   999999999999999 788999999


Q ss_pred             cCCcC
Q 014034          233 GLARE  237 (432)
Q Consensus       233 G~a~~  237 (432)
                      |++..
T Consensus       139 ~~a~~  143 (211)
T PRK14879        139 GLAEF  143 (211)
T ss_pred             CcccC
Confidence            99863

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.76  E-value=4.2e-18  Score=152.53  Aligned_cols=126  Identities=17%  Similarity=0.254  Sum_probs=100.3

Q ss_pred             ccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------------hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           86 KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        86 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      .||+|+||.||+|.+         .+..|++|.....            ...+.+|++++..+.|+++.....++.....
T Consensus         1 ~ig~G~~~~vy~~~~---------~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~   71 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF---------LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN   71 (199)
T ss_pred             CCCCCceEEEEEeec---------CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC
Confidence            489999999999984         3567888875321            1236689999999988876544444444333


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                          .++||||++|++|.+++....  .       .++.+++.+|.+||+.   +++|+|++|.||+++ ++.++++|||
T Consensus        72 ----~~lv~e~~~g~~l~~~~~~~~--~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg  134 (199)
T TIGR03724        72 ----KTIVMEYIEGKPLKDVIEEGN--D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFG  134 (199)
T ss_pred             ----CEEEEEEECCccHHHHHhhcH--H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECC
Confidence                389999999999999874421  0       7899999999999998   999999999999999 8899999999


Q ss_pred             CCcC
Q 014034          234 LARE  237 (432)
Q Consensus       234 ~a~~  237 (432)
                      ++..
T Consensus       135 ~a~~  138 (199)
T TIGR03724       135 LGKY  138 (199)
T ss_pred             CCcC
Confidence            9865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=4e-18  Score=152.60  Aligned_cols=132  Identities=19%  Similarity=0.128  Sum_probs=104.2

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh--------------------------HHHHHHHHH
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--------------------------LQWVAEVQF  132 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--------------------------~~~~~E~~~  132 (432)
                      ..|...+.||+|+||.||++...        +++.||||+++...                          ..+..|..+
T Consensus        15 ~~~~~~~~i~~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   86 (198)
T cd05144          15 VVESLGNQIGVGKESDVYLALDP--------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA   86 (198)
T ss_pred             chhhcCCccccCcceEEEEEEcC--------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence            34888899999999999999753        57889999764321                          125678888


Q ss_pred             hcccCCCc--cceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcee
Q 014034          133 LGVLEHPN--LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVI  210 (432)
Q Consensus       133 l~~l~hpn--iv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~iv  210 (432)
                      +..+.|++  ++..++.    .    ..++||||++|++|......        .....++.+++.++.++|+.   +|+
T Consensus        87 l~~l~~~~i~v~~~~~~----~----~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~  147 (198)
T cd05144          87 LKALYEEGFPVPKPIDW----N----RHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GII  147 (198)
T ss_pred             HHHHHHcCCCCCceeec----C----CceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCC
Confidence            88888774  4444432    1    23899999999998765421        23457889999999999998   999


Q ss_pred             ecCCCCCceEEcCCCceeeccccCCcC
Q 014034          211 YRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       211 H~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      ||||||+||+++.++.++|+|||++..
T Consensus       148 H~Dl~p~Nill~~~~~~~liDfg~~~~  174 (198)
T cd05144         148 HGDLSEFNILVDDDEKIYIIDWPQMVS  174 (198)
T ss_pred             cCCCCcccEEEcCCCcEEEEECCcccc
Confidence            999999999999999999999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.74  E-value=9.4e-18  Score=172.43  Aligned_cols=134  Identities=22%  Similarity=0.253  Sum_probs=105.7

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEe-c----CcC-------hHHHHHHHHHhcccCCCcccee
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK-L----NRD-------GLQWVAEVQFLGVLEHPNLVKL  144 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~-~----~~~-------~~~~~~E~~~l~~l~hpniv~l  144 (432)
                      ....|...+.||+|+||.||+|.+.         +..+++|+ +    ...       ...+.+|++++..++|++++..
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~---------~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p  401 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYL---------GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTP  401 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeec---------CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCee
Confidence            3445567889999999999998864         11222222 1    111       1237789999999999999887


Q ss_pred             eeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCC
Q 014034          145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN  224 (432)
Q Consensus       145 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~  224 (432)
                      +.++.....    .++||||+++++|.+++.          ....++.+++.+|.|||+.   +++||||||+|||+ .+
T Consensus       402 ~~~~~~~~~----~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~  463 (535)
T PRK09605        402 VIYDVDPEE----KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RD  463 (535)
T ss_pred             EEEEEeCCC----CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-EC
Confidence            766655433    389999999999999874          3567899999999999998   99999999999999 67


Q ss_pred             CceeeccccCCcC
Q 014034          225 FRPKLSDFGLARE  237 (432)
Q Consensus       225 ~~~kl~DfG~a~~  237 (432)
                      +.++|+|||+++.
T Consensus       464 ~~~~liDFGla~~  476 (535)
T PRK09605        464 DRLYLIDFGLGKY  476 (535)
T ss_pred             CcEEEEeCccccc
Confidence            8899999999864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=2.8e-18  Score=176.08  Aligned_cols=254  Identities=25%  Similarity=0.289  Sum_probs=187.8

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh---H---HHHHHHHHhcccC-CCccceeeeEEeecC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---L---QWVAEVQFLGVLE-HPNLVKLIGYCAVDG  152 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~---~~~~E~~~l~~l~-hpniv~l~~~~~~~~  152 (432)
                      .|...+.||+|+|+.|-.....      ......+|+|.+....   .   ....|..+-..+. |+|++.+++......
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~------~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~   94 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNS------RDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR   94 (601)
T ss_pred             cccccccccccccchhhhhhhc------CCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCc
Confidence            5777778999999999876532      2345667777765432   1   2344777777776 999999998876655


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCceeecCCCCCceEEcCCC-ceeec
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH-EGLEVQVIYRDFKASNVLLDENF-RPKLS  230 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH-~~~~~~ivH~Dikp~Nill~~~~-~~kl~  230 (432)
                      .    .+++++|..++++.+.+........+......++.|+..++.|+| ..   ++.|+||||+|.+++..+ .++++
T Consensus        95 ~----~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~  167 (601)
T KOG0590|consen   95 S----YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIA  167 (601)
T ss_pred             c----cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCC
Confidence            4    389999999999999884333335666777889999999999999 66   999999999999999999 99999


Q ss_pred             cccCCcCCCC-CCCccccccccc-CCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 014034          231 DFGLAREGPM-VGHTHVSTAVVG-TFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  307 (432)
Q Consensus       231 DfG~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  307 (432)
                      |||+|..... .+........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........ ....|...
T Consensus       168 df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~  246 (601)
T KOG0590|consen  168 DFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSN  246 (601)
T ss_pred             CchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeeccc
Confidence            9999987655 455555566778 9999999999874 556789999999999999999999986544321 11111111


Q ss_pred             cccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .    ..+        .............+++.+++..+|..|.+..++...
T Consensus       247 ~----~~~--------~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  247 K----GRF--------TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             c----ccc--------ccCccccCChhhhhcccccccCCchhcccccccccc
Confidence            0    000        011112223456688899999999999999887544

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=2.1e-16  Score=134.16  Aligned_cols=133  Identities=21%  Similarity=0.191  Sum_probs=109.3

Q ss_pred             cccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh--HHHHHHHHHhcccCC--CccceeeeEEeecCCcceeE
Q 014034           83 RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQWVAEVQFLGVLEH--PNLVKLIGYCAVDGERGIQR  158 (432)
Q Consensus        83 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~~~~  158 (432)
                      +.+.||.|.++.||++...         +..+++|......  ..+..|+.++..+.|  +++++++++....+    ..
T Consensus         2 ~~~~i~~g~~~~v~~~~~~---------~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~----~~   68 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK---------DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDG----WS   68 (155)
T ss_pred             cceecccccccceEEEEec---------CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC----cc
Confidence            3567999999999999853         2679999987654  368899999999976  58888887765443    35


Q ss_pred             EEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          159 LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       159 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      +++|||+.++.+..+         +......++.+++.+|.+||.....+++|+|++|.||+++..+.++++|||.+..
T Consensus        69 ~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          69 YLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            999999988777654         4566678899999999999986444799999999999999989999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.67  E-value=7.4e-16  Score=141.54  Aligned_cols=134  Identities=22%  Similarity=0.206  Sum_probs=101.7

Q ss_pred             cccc-cCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----------------hHHHHHHHHHhcccCCCcc--cee
Q 014034           85 LKIG-EGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----------------GLQWVAEVQFLGVLEHPNL--VKL  144 (432)
Q Consensus        85 ~~lg-~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----------------~~~~~~E~~~l~~l~hpni--v~l  144 (432)
                      ..|| .|+.|+||.+..         .+..+++|.+...                 ...+.+|+.++..|.|++|  +..
T Consensus        37 ~~lg~~~g~gtv~~v~~---------~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~p  107 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT---------PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRP  107 (239)
T ss_pred             ceeecCCCCccEEEEEe---------CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCcee
Confidence            3577 788888888764         2567888876431                 1236789999999998875  667


Q ss_pred             eeEEeecCCcceeEEEEEeecCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC
Q 014034          145 IGYCAVDGERGIQRLLVYEFMLN-RSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  223 (432)
Q Consensus       145 ~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~  223 (432)
                      +++...........++||||++| .+|.+++...   +++..    .+.+|+.+|.+||+.   ||+||||||.|||++.
T Consensus       108 l~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~  177 (239)
T PRK01723        108 IAARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDP  177 (239)
T ss_pred             EeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcC
Confidence            77655433222233699999997 6899887542   35543    357899999999998   9999999999999999


Q ss_pred             CCceeeccccCCcC
Q 014034          224 NFRPKLSDFGLARE  237 (432)
Q Consensus       224 ~~~~kl~DfG~a~~  237 (432)
                      ++.++|+|||.+..
T Consensus       178 ~~~v~LIDfg~~~~  191 (239)
T PRK01723        178 DGKFWLIDFDRGEL  191 (239)
T ss_pred             CCCEEEEECCCccc
Confidence            99999999999864

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.66  E-value=4.1e-16  Score=138.16  Aligned_cols=131  Identities=21%  Similarity=0.162  Sum_probs=93.1

Q ss_pred             ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHH----------------------------HHHHHHHhcc
Q 014034           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----------------------------WVAEVQFLGV  135 (432)
Q Consensus        84 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~----------------------------~~~E~~~l~~  135 (432)
                      .+.||+|+||.||+|...        ++..||||.+......                            ...|...+..
T Consensus         2 ~~~lg~G~~g~Vy~a~~~--------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~   73 (187)
T cd05119           2 GGPIGTGKEADVYLALDG--------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKR   73 (187)
T ss_pred             CcccccccceeEEEEECC--------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHH
Confidence            467999999999999753        5678999987643211                            1245555555


Q ss_pred             cCCCc--cceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCceeec
Q 014034          136 LEHPN--LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE-GLEVQVIYR  212 (432)
Q Consensus       136 l~hpn--iv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~-~~~~~ivH~  212 (432)
                      +.+..  +.+.+++.        ..++||||++++.+........  ... .....++.+++.++.++|. .   +|+|+
T Consensus        74 l~~~~~~~~~~~~~~--------~~~lv~e~~~g~~~~~~~l~~~--~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~  139 (187)
T cd05119          74 LYEAGVPVPKPIDLN--------RHVLVMEFIGGDGIPAPRLKDV--RLL-EDPEELYDQILELMRKLYREA---GLVHG  139 (187)
T ss_pred             HHHcCCCCCceEecC--------CCEEEEEEeCCCCccChhhhhh--hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcC
Confidence            54332  44444321        1389999999854432111110  011 5678899999999999999 7   99999


Q ss_pred             CCCCCceEEcCCCceeeccccCCcC
Q 014034          213 DFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       213 Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      ||||+||+++ ++.++|+|||.+..
T Consensus       140 Dl~p~Nili~-~~~~~liDfg~a~~  163 (187)
T cd05119         140 DLSEYNILVD-DGKVYIIDVPQAVE  163 (187)
T ss_pred             CCChhhEEEE-CCcEEEEECccccc
Confidence            9999999999 89999999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.51  E-value=3.3e-14  Score=129.86  Aligned_cols=204  Identities=20%  Similarity=0.250  Sum_probs=141.8

Q ss_pred             hcccCCCccceeeeEEeecCC-cceeEEEEEeecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCce
Q 014034          133 LGVLEHPNLVKLIGYCAVDGE-RGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQV  209 (432)
Q Consensus       133 l~~l~hpniv~l~~~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~i  209 (432)
                      |-++.|.|||++..|+.+... ......++.|||..|+|..+|++.  ....+......+|+.||..||.|||+. .+.|
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppi  199 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCcc
Confidence            445679999999999876544 445568999999999999999763  234677788889999999999999994 7799


Q ss_pred             eecCCCCCceEEcCCCceeeccccCCcCCCCCC--CcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCC
Q 014034          210 IYRDFKASNVLLDENFRPKLSDFGLAREGPMVG--HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR  287 (432)
Q Consensus       210 vH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~  287 (432)
                      +|+++..+.|++..+|-+|+.--.-........  .........+.++|.+||.=...+.+.++|||+||+...+|..+.
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence            999999999999999988875321111100000  011112235678999999877777788999999999999998876


Q ss_pred             CCCCCCCch--hhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          288 RSLERNRPK--TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       288 ~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .--......  .+..+...+..          +-+            ..-..++.+|++..|..||+|..++-+
T Consensus       280 iq~tnseS~~~~ee~ia~~i~~----------len------------~lqr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  280 IQSTNSESKVEVEENIANVIIG----------LEN------------GLQRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             eccCCCcceeehhhhhhhheee----------ccC------------ccccCcCcccccCCCCCCcchhhhhcC
Confidence            432211110  00000000000          000            011268899999999999999998765

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.50  E-value=7.6e-14  Score=139.15  Aligned_cols=136  Identities=16%  Similarity=0.103  Sum_probs=93.6

Q ss_pred             ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH---------------------------------------
Q 014034           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---------------------------------------  124 (432)
Q Consensus        84 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---------------------------------------  124 (432)
                      .+.||.|++|.||+|+++        +|+.||||+.+....                                       
T Consensus       122 ~~plasaSigQVh~A~l~--------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~  193 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV--------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKT  193 (437)
T ss_pred             CcceeeeehhheEEEEec--------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHH
Confidence            357999999999999975        578999999865421                                       


Q ss_pred             -----HHHHHHHHhccc----CCCccceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 014034          125 -----QWVAEVQFLGVL----EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA  195 (432)
Q Consensus       125 -----~~~~E~~~l~~l----~hpniv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~  195 (432)
                           ++.+|+..+.++    .|.+-+.+-.++.+-.   ...+|||||++|++|.+....... ..   ....++..++
T Consensus       194 l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~---~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~  266 (437)
T TIGR01982       194 LRRELDLRREAANASELGENFKNDPGVYVPEVYWDRT---SERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLA  266 (437)
T ss_pred             HHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhc---CCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHH
Confidence                 133444444444    2222233323332111   123899999999999887643211 12   2334566665


Q ss_pred             H-HHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          196 E-GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       196 ~-~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      . .+..+|..   |++|+|++|.||+++.++.++++|||++..
T Consensus       267 ~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~  306 (437)
T TIGR01982       267 RSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGR  306 (437)
T ss_pred             HHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence            5 46788887   999999999999999999999999999864

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.44  E-value=1.9e-13  Score=134.92  Aligned_cols=249  Identities=21%  Similarity=0.265  Sum_probs=176.6

Q ss_pred             cCCcccccccc--CCceEEEEEEecCCCCCCCcccEEEEEEecCc------ChHHHHHHHHHhccc-CCCccceeeeEEe
Q 014034           79 NDFSRMLKIGE--GGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLGVL-EHPNLVKLIGYCA  149 (432)
Q Consensus        79 ~~~~~~~~lg~--G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l-~hpniv~l~~~~~  149 (432)
                      ..|.....+|.  |.+|.||.+...     ....+..+|+|+-..      ....-.+|+.-.+.+ .|+|.++.+..+.
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~-----~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e  188 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCT-----NSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE  188 (524)
T ss_pred             hhcccccccccCCCCCceeecccCC-----cccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence            45777788999  999999998763     246778899998432      122234566666666 4999999777776


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHH----HHHHhhcCCCCceeecCCCCCceEEcCC-
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE----GLAYLHEGLEVQVIYRDFKASNVLLDEN-  224 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~----~l~~LH~~~~~~ivH~Dikp~Nill~~~-  224 (432)
                      ..+.    .++-+|++ +.+|..+..... .-++....+..+.+...    ||.++|+.   +++|-|+||.||++..+ 
T Consensus       189 ~~~~----lfiqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~  259 (524)
T KOG0601|consen  189 GSGI----LFIQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDW  259 (524)
T ss_pred             cCCc----ceeeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccccc
Confidence            5554    37888888 678888876543 35788888999999988    99999998   99999999999999999 


Q ss_pred             CceeeccccCCcCCCCCCC---cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHH
Q 014034          225 FRPKLSDFGLAREGPMVGH---THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL  301 (432)
Q Consensus       225 ~~~kl~DfG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~  301 (432)
                      ..++++|||+.........   ........|...|++||... +-++...|+|++|.++.+..++..+.......     
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-----  333 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS-----  333 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC-----
Confidence            8899999999875432221   11222336788999999986 45788999999999999999887655432100     


Q ss_pred             HHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          302 LEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                       .|        ..+.   ...+..++.......+...+..|++.+|..|++.+.+...
T Consensus       334 -~W--------~~~r---~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  334 -SW--------SQLR---QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             -Cc--------cccc---cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence             00        0000   0001112222223455568899999999999998877653

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.43  E-value=5.6e-13  Score=115.94  Aligned_cols=127  Identities=17%  Similarity=0.164  Sum_probs=94.3

Q ss_pred             ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh---HHHHHHHHHhcccCCCccc-eeeeEEeecCCcceeEE
Q 014034           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQWVAEVQFLGVLEHPNLV-KLIGYCAVDGERGIQRL  159 (432)
Q Consensus        84 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~~~~~  159 (432)
                      ++.|+.|.++.||++..         .+..|++|......   ..+..|+.++..+.+.+++ +++.+..  ..    .+
T Consensus         3 ~~~l~~G~~~~vy~~~~---------~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~----~~   67 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV---------ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ET----GV   67 (170)
T ss_pred             eeecCCcccCceEEEEE---------CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CC----Ce
Confidence            45689999999999874         36779999976653   3467899999988655544 4544332  11    27


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          160 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL--EVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       160 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~--~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      +||||++|.++...-       .   ....++.+++.+|..||...  ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus        68 lv~e~i~G~~l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          68 LITEFIEGSELLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             EEEEecCCCcccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            999999998876530       1   11245678999999999972  12369999999999999 6789999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.39  E-value=1.1e-12  Score=132.52  Aligned_cols=138  Identities=16%  Similarity=0.140  Sum_probs=90.1

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH----------------------------------
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL----------------------------------  124 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~----------------------------------  124 (432)
                      .+|.. +.||+|++|.||+|+++       .+|+.||||+.++...                                  
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~-------~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~  191 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLK-------DNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVA  191 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEEC-------CCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHH
Confidence            34666 78999999999999986       2478999999875421                                  


Q ss_pred             ----------HHHHHHHHhcccC----CCccceeeeEEeecCCcceeEEEEEeecCCCCHHHHh--hcCCC--CCCCHHH
Q 014034          125 ----------QWVAEVQFLGVLE----HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAF--PPLPWKT  186 (432)
Q Consensus       125 ----------~~~~E~~~l~~l~----hpniv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l--~~~~~--~~l~~~~  186 (432)
                                ++.+|+..+.++.    +.+.+.+-.++.+-   ....+|||||+.|+.+.+.-  .....  ..+....
T Consensus       192 e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~---st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~  268 (537)
T PRK04750        192 EFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY---CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERG  268 (537)
T ss_pred             HHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc---CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHH
Confidence                      1334444444442    33333333333211   11348999999999998742  22110  0233333


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC----ceeeccccCCcC
Q 014034          187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF----RPKLSDFGLARE  237 (432)
Q Consensus       187 ~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~----~~kl~DfG~a~~  237 (432)
                      +..++.|+.       ..   |++|+|+||.||+++.++    .++++|||++..
T Consensus       269 v~~~~~Qif-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~  313 (537)
T PRK04750        269 VEVFFTQVF-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGS  313 (537)
T ss_pred             HHHHHHHHH-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence            444445543       34   999999999999999888    999999999865

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.31  E-value=6e-13  Score=138.01  Aligned_cols=245  Identities=21%  Similarity=0.244  Sum_probs=162.5

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      ...+.+.+.+-+|.|+.++.+.-.       ..+...++|.....       ......+-.++-...+|.++...--+. 
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa-------~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~-  874 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPA-------GSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP-  874 (1205)
T ss_pred             CccceecccccCCCCcccccCCcc-------ccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC-
Confidence            346777778889999999876522       23333344433221       111222222222233455554432211 


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                         ......||++|+.+++|...++...  ..+..-....+..+..+++|||+.   .+.|+|++|.|+|+..++..+++
T Consensus       875 ---~rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~  946 (1205)
T KOG0606|consen  875 ---CRSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLT  946 (1205)
T ss_pred             ---CCCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccC
Confidence               1223489999999999999986654  455556667788889999999996   69999999999999999999999


Q ss_pred             cccCCcC-CCC---CCC-------------------------cccccccccCCCccCccccccCCCCchhhhHHHHHHHH
Q 014034          231 DFGLARE-GPM---VGH-------------------------THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLY  281 (432)
Q Consensus       231 DfG~a~~-~~~---~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~  281 (432)
                      |||.... ...   .+.                         ........||+.|.+||.+.+......+|+|++|++++
T Consensus       947 ~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~ 1026 (1205)
T KOG0606|consen  947 DFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLF 1026 (1205)
T ss_pred             ccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhh
Confidence            9984321 100   000                         01122457899999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCcccc-CcCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 014034          282 EMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLE-KEYSINEARKIGRLADNCLSKSSKDRPKMS  354 (432)
Q Consensus       282 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  354 (432)
                      |.++|..||....+...   .+-+             ...... ...+...+....+++...+..+|.+|..+.
T Consensus      1027 e~l~g~pp~na~tpq~~---f~ni-------------~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1027 EVLTGIPPFNAETPQQI---FENI-------------LNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhhcCCCCCCCcchhhh---hhcc-------------ccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            99999999986654322   1111             111000 112233345567889999999999998776

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.30  E-value=2.1e-11  Score=107.39  Aligned_cols=137  Identities=15%  Similarity=0.078  Sum_probs=95.2

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------------------------H-H----HHHHHHHhc
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------------------------L-Q----WVAEVQFLG  134 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------------------------~-~----~~~E~~~l~  134 (432)
                      ..||.|--+.||.|.-.... .....+..+|||..+...                         . -    ..+|+..|.
T Consensus         3 g~i~~GKEa~V~~~~~~~~~-~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           3 GCISTGKESVVLHANGGSNE-TEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CccccCcceEEEEEecCccc-ccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            46899999999999732100 011245789999853110                         0 0    347999998


Q ss_pred             ccCC--CccceeeeEEeecCCcceeEEEEEeecCCCCHHH-HhhcCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCcee
Q 014034          135 VLEH--PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED-HLFNRAFPPLPWKTRLHIILGAAEGLAYL-HEGLEVQVI  210 (432)
Q Consensus       135 ~l~h--pniv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~l~~~l~~L-H~~~~~~iv  210 (432)
                      ++..  -++..++++  .  .    .+|||||+.+..+.. .+.+   ..++......+..+++.+|..| |..   +|+
T Consensus        82 rl~~~Gv~vP~pi~~--~--~----~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~---glV  147 (197)
T cd05146          82 RMQKAGIPCPEVVVL--K--K----HVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKEC---NLV  147 (197)
T ss_pred             HHHHcCCCCCeEEEe--c--C----CEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            8853  466666654  1  2    289999997654422 2221   1345556677889999999999 787   999


Q ss_pred             ecCCCCCceEEcCCCceeeccccCCcC
Q 014034          211 YRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       211 H~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      ||||++.|||++ ++.+.|+|||.+..
T Consensus       148 HGDLs~~NIL~~-~~~v~iIDF~qav~  173 (197)
T cd05146         148 HADLSEYNMLWH-DGKVWFIDVSQSVE  173 (197)
T ss_pred             cCCCCHHHEEEE-CCcEEEEECCCcee
Confidence            999999999997 46799999998864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.26  E-value=4.1e-12  Score=125.53  Aligned_cols=254  Identities=22%  Similarity=0.191  Sum_probs=173.8

Q ss_pred             ccCHHH-HHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHH------HHHHHHHhccc-CCC
Q 014034           68 VFSYSE-MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ------WVAEVQFLGVL-EHP  139 (432)
Q Consensus        68 ~~~~~~-~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~E~~~l~~l-~hp  139 (432)
                      +|.-.+ ....+.+|..+..||.|.|+.|+....      ...++..+++|.+.+....      -..|+.+...+ .|.
T Consensus       253 i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~------r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~  326 (524)
T KOG0601|consen  253 IFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSK------RPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHL  326 (524)
T ss_pred             eecccccceeecCCcceeEEccCCccccceeeee------cCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhccc
Confidence            444444 445667899999999999999998763      2346788999988664433      23455555555 478


Q ss_pred             ccceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCce
Q 014034          140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNV  219 (432)
Q Consensus       140 niv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Ni  219 (432)
                      +++..+..+.....    .++--||+.++++...+.-  ...+.....+.+..|++.++.++|+.   .++|+|+||+||
T Consensus       327 ~~~g~~~~W~~~r~----~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni  397 (524)
T KOG0601|consen  327 PSVGKNSSWSQLRQ----GYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNI  397 (524)
T ss_pred             ccCCCCCCcccccc----ccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccch---hhhcccccccce
Confidence            88876655544332    3688999999998877622  23467778899999999999999997   999999999999


Q ss_pred             EEcCC-CceeeccccCCcCCCCCCCcccccccccCCCc-cCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchh
Q 014034          220 LLDEN-FRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY-AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT  297 (432)
Q Consensus       220 ll~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~  297 (432)
                      ++..+ +..++.|||+.......    ......++..| .+|.......+..++|+||||..+.+.++|...-.....  
T Consensus       398 ~i~~~~~~~~~~~~~~~t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--  471 (524)
T KOG0601|consen  398 LISNDGFFSKLGDFGCWTRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--  471 (524)
T ss_pred             eeccchhhhhcccccccccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCccccc--
Confidence            99876 78899999998641111    11111223334 355566667888999999999999999998654332110  


Q ss_pred             hHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          298 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                            |           ..+....+ ...+.. ...+..+...+...++..||.+.++..+.+
T Consensus       472 ------~-----------~~i~~~~~-p~~~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  472 ------S-----------LTIRSGDT-PNLPGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             ------c-----------eeeecccc-cCCCch-HHhhhhhhhhhcCCccccchhhhhhcccch
Confidence                  0           00000000 011111 256677888899999999999988766543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.23  E-value=7.8e-11  Score=100.49  Aligned_cols=127  Identities=20%  Similarity=0.240  Sum_probs=92.2

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEec-CcC-----------hHHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-NRD-----------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~-~~~-----------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      ..+++|+-+.+|.+.+.         +..+++|.- ++.           .....+|+.++..+.--.|..-+=+..+.+
T Consensus         2 ~~i~~GAEa~i~~~~~~---------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~   72 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL---------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD   72 (204)
T ss_pred             chhhCCcceeEEeeecc---------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC
Confidence            35889999999998653         334566642 221           113677999998875443333222333333


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                      ..    .|+|||++|..|.+.+...         ...++..+-.-+.-||..   ||+|+||.++||++..++ +.++||
T Consensus        73 ~~----~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDf  135 (204)
T COG3642          73 NG----LIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDF  135 (204)
T ss_pred             CC----EEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEEC
Confidence            32    7999999999999888553         245778888889999998   999999999999998765 999999


Q ss_pred             cCCcC
Q 014034          233 GLARE  237 (432)
Q Consensus       233 G~a~~  237 (432)
                      |++..
T Consensus       136 GLg~~  140 (204)
T COG3642         136 GLGEF  140 (204)
T ss_pred             Ccccc
Confidence            99864

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.23  E-value=1e-10  Score=99.27  Aligned_cols=139  Identities=19%  Similarity=0.169  Sum_probs=100.0

Q ss_pred             cccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------------hHHHHHHHHHhcccCCCccceeeeEEee
Q 014034           83 RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------------GLQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        83 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------------~~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .+..|-+|+-+.|+++.+         .++...||.-...            .....+|+++|.++.--.|.--.-++.+
T Consensus        11 ~l~likQGAEArv~~~~~---------~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D   81 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF---------SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID   81 (229)
T ss_pred             cceeeeccceeeEeeecc---------CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe
Confidence            566788999999999875         4677777753211            1236789999988754343322223333


Q ss_pred             cCCcceeEEEEEeecCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC---c
Q 014034          151 DGERGIQRLLVYEFMLN-RSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF---R  226 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~---~  226 (432)
                      ....    .|+|||++| .++.+++...............++..|-+.+.-||.+   +|+|+||..+||++..++   .
T Consensus        82 ~~~~----~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~  154 (229)
T KOG3087|consen   82 TYGG----QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQIT  154 (229)
T ss_pred             cCCC----eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCc
Confidence            3333    899999976 4888888765544444444478999999999999998   999999999999996544   3


Q ss_pred             eeeccccCCcC
Q 014034          227 PKLSDFGLARE  237 (432)
Q Consensus       227 ~kl~DfG~a~~  237 (432)
                      +.++|||++..
T Consensus       155 ~~lIdfgls~~  165 (229)
T KOG3087|consen  155 PILIDFGLSSV  165 (229)
T ss_pred             eEEEeecchhc
Confidence            58999999853

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.21  E-value=7.4e-11  Score=117.93  Aligned_cols=160  Identities=19%  Similarity=0.278  Sum_probs=116.5

Q ss_pred             ccEEEEEEecCcChH----HHHHHHHHhcccCCCccceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHH
Q 014034          110 EATVVAIKKLNRDGL----QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK  185 (432)
Q Consensus       110 ~~~~vaiK~~~~~~~----~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~  185 (432)
                      ++.+|.|...+....    ...+-++.|+.++||||++++..+..++    ..|||+|-+  -.|..++.+     +...
T Consensus        36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~----~~ylvTErV--~Pl~~~lk~-----l~~~  104 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEG----TLYLVTERV--RPLETVLKE-----LGKE  104 (690)
T ss_pred             cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccC----ceEEEeecc--ccHHHHHHH-----hHHH
Confidence            445555555443322    2566788899999999999999887766    359999987  367777754     3356


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccC
Q 014034          186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG  265 (432)
Q Consensus       186 ~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  265 (432)
                      .+...+.||+.||.|||+.+  +++|++|.-+.|+|+..|..||++|-++........  ......--..|..|+.+...
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence            66778999999999999763  999999999999999999999999998764322111  11112222346666655432


Q ss_pred             CCCchhhhHHHHHHHHHHHhC
Q 014034          266 HLTAKSDVWSFGVVLYEMLTG  286 (432)
Q Consensus       266 ~~~~~~DvwSlGvil~elltg  286 (432)
                      .  -..|.|-|||++++++.|
T Consensus       181 ~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 E--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             c--cchhhhhHHHHHHHHhCc
Confidence            2  357999999999999999

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.16  E-value=2.8e-10  Score=103.26  Aligned_cols=141  Identities=20%  Similarity=0.208  Sum_probs=106.3

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCC--CccceeeeEEeecCCccee
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEH--PNLVKLIGYCAVDGERGIQ  157 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~~~  157 (432)
                      +.|+.|.++.||++...        ++..+++|.....     ...+..|++++..+.+  .++.+++.+...... ...
T Consensus         4 ~~l~~G~~n~~~~v~~~--------~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~-~~~   74 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG--------GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSV-LGT   74 (223)
T ss_pred             eecCCCccceEEEEEec--------CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCc-cCC
Confidence            56899999999998753        2467999987653     2357899999999875  445777776554321 112


Q ss_pred             EEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--------------------------------
Q 014034          158 RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL--------------------------------  205 (432)
Q Consensus       158 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~--------------------------------  205 (432)
                      .++||||++|.++.+.+..   ..++......++.+++++|..||+..                                
T Consensus        75 ~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (223)
T cd05154          75 PFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRT  151 (223)
T ss_pred             ceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcc
Confidence            4899999999988876532   24677778888889999998888521                                


Q ss_pred             ---------------------CCceeecCCCCCceEEcC--CCceeeccccCCcC
Q 014034          206 ---------------------EVQVIYRDFKASNVLLDE--NFRPKLSDFGLARE  237 (432)
Q Consensus       206 ---------------------~~~ivH~Dikp~Nill~~--~~~~kl~DfG~a~~  237 (432)
                                           ...++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         152 DEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                 246799999999999998  66789999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.13  E-value=3.1e-09  Score=103.39  Aligned_cols=216  Identities=16%  Similarity=0.212  Sum_probs=151.3

Q ss_pred             ceEEEEEEecCCCCCCCcccEEEEEEecCcChHH----HHHHHHHhcccCCCccceeeeEEeecCCcceeEEEEEeecCC
Q 014034           92 FGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN  167 (432)
Q Consensus        92 fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~lv~e~~~~  167 (432)
                      -.+.|++...       .+|..|++|+++-+...    ...-++..+++.|+|||++.+++.........++|||+|.++
T Consensus       289 ~~Ttyk~~s~-------~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~  361 (655)
T KOG3741|consen  289 SITTYKATSN-------VDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPS  361 (655)
T ss_pred             cceeEeeeec-------cCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCC
Confidence            4578888765       57888999999543322    234567889999999999999988555555677999999977


Q ss_pred             -CCHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          168 -RSLEDHLFNR-------------AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       168 -gsL~~~l~~~-------------~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                       ++|.++....             .+...++...|.++.|+..||.++|+.   |+.-+-|.|.+||++.+.+++|+..|
T Consensus       362 s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~  438 (655)
T KOG3741|consen  362 SPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCG  438 (655)
T ss_pred             CchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEeccc
Confidence             5777765322             123567899999999999999999998   99999999999999999999999888


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      +........         +       +-+.   --.+-|.=.||.+++.|.||..--...+...... ..          
T Consensus       439 i~Dvl~~d~---------~-------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~-~~----------  488 (655)
T KOG3741|consen  439 IMDVLQEDP---------T-------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSH-LT----------  488 (655)
T ss_pred             ceeeecCCC---------C-------cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHHHH-HH----------
Confidence            764321110         0       1111   1235788999999999999965322111100000 00          


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                                  ......+.++.+++.-....++++ -++.+++.++
T Consensus       489 ------------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  489 ------------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             ------------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence                        112233456778888888888887 6777777654

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.11  E-value=6.6e-09  Score=98.78  Aligned_cols=267  Identities=16%  Similarity=0.187  Sum_probs=158.2

Q ss_pred             ccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-HHHHHHHHhccc-CCCccceeeeEE---eecCCcce
Q 014034           82 SRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QWVAEVQFLGVL-EHPNLVKLIGYC---AVDGERGI  156 (432)
Q Consensus        82 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~l-~hpniv~l~~~~---~~~~~~~~  156 (432)
                      .....||+|+-+.+|-.--         -+- .+-|+...... .-.+-+..|... .||-+-.=+.+=   ......+.
T Consensus        14 ~~gr~LgqGgea~ly~l~e---------~~d-~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~   83 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGE---------VRD-QVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGK   83 (637)
T ss_pred             CCCccccCCccceeeecch---------hhc-hhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence            3456799999999995321         111 22344433221 112223333333 465443211110   01112222


Q ss_pred             eEEEEEeecCCC-CHHHHh----hcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          157 QRLLVYEFMLNR-SLEDHL----FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       157 ~~~lv~e~~~~g-sL~~~l----~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      ..-+.|..+.+. .+..++    +++..+...|...++.++.++.+.+-||..   |.+-+|+.++|+||++++.+.|.|
T Consensus        84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVd  160 (637)
T COG4248          84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVD  160 (637)
T ss_pred             eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEc
Confidence            234667766553 233332    234456688999999999999999999998   999999999999999999999998


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccc-----cCCCCchhhhHHHHHHHHHHHhC-CCCCCCCCchh------hH
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE-----TGHLTAKSDVWSFGVVLYEMLTG-RRSLERNRPKT------EQ  299 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg-~~pf~~~~~~~------~~  299 (432)
                      -..-..   ..+.......+|...|.+||...     +-.-+...|.|.||+++++++.| ++||.+.....      +.
T Consensus       161 sDsfqi---~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~  237 (637)
T COG4248         161 SDSFQI---NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET  237 (637)
T ss_pred             ccceee---ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence            543221   12333344568999999999865     33456779999999999998886 99998743211      11


Q ss_pred             HHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccC--CCCCCCCHHHHHHHHHHHhhhc
Q 014034          300 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSK--SSKDRPKMSQVVERLKQIVQVS  367 (432)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~--dP~~RPs~~eil~~L~~~~~~~  367 (432)
                      .+....-.+..+   -..-..+......-...+.++..|..+|+..  ++.-|||++-++..|..+.+..
T Consensus       238 ~Ia~g~f~ya~~---~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L  304 (637)
T COG4248         238 DIAHGRFAYASD---QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL  304 (637)
T ss_pred             hhhcceeeechh---ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence            111110001000   0000001101111112345677888889875  3678999999999888775543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.04  E-value=4.1e-09  Score=98.10  Aligned_cols=124  Identities=17%  Similarity=0.129  Sum_probs=88.8

Q ss_pred             ccEEEEEEecCcCh---------------HHHHHHHHHhcccCCCcc--ceeeeEEeec-CCcceeEEEEEeecCCC-CH
Q 014034          110 EATVVAIKKLNRDG---------------LQWVAEVQFLGVLEHPNL--VKLIGYCAVD-GERGIQRLLVYEFMLNR-SL  170 (432)
Q Consensus       110 ~~~~vaiK~~~~~~---------------~~~~~E~~~l~~l~hpni--v~l~~~~~~~-~~~~~~~~lv~e~~~~g-sL  170 (432)
                      .++.+.||......               ..+.+|...+..|..-+|  +.++++.... +......+||||++++. +|
T Consensus        44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL  123 (268)
T PRK15123         44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL  123 (268)
T ss_pred             CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence            46789999654322               136789888887743332  2334444321 11122348999999886 89


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC-------CCceeeccccCCc
Q 014034          171 EDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE-------NFRPKLSDFGLAR  236 (432)
Q Consensus       171 ~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~-------~~~~kl~DfG~a~  236 (432)
                      .+++......+.+......++.+++..+.-||..   ||+|+|++++|||++.       ++.+.|+||+.+.
T Consensus       124 ~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        124 EDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            9988543223456677789999999999999998   9999999999999975       4679999999875

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.99  E-value=2.7e-09  Score=93.67  Aligned_cols=96  Identities=21%  Similarity=0.270  Sum_probs=63.3

Q ss_pred             HHHHHHHhcccCCC--ccceeeeEEeecCCcceeEEEEEeecC--CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH-
Q 014034          126 WVAEVQFLGVLEHP--NLVKLIGYCAVDGERGIQRLLVYEFML--NRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY-  200 (432)
Q Consensus       126 ~~~E~~~l~~l~hp--niv~l~~~~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~-  200 (432)
                      ..+|++.|.++..-  ++.+++.+.    ..    +|||||+.  |..+.... ...   ++......++.+++..+.. 
T Consensus        55 ~~~E~~~L~~l~~~Gv~vP~p~~~~----~~----~ivME~I~~~G~~~~~l~-~~~---~~~~~~~~~~~~il~~~~~~  122 (188)
T PF01163_consen   55 AKKEFRNLKRLYEAGVPVPKPYDYN----RN----VIVMEYIGEDGVPLPRLK-DVD---LSPEEPKELLEEILEEIIKM  122 (188)
T ss_dssp             HHHHHHHHHHCCCTT-SS--EEEEE----TT----EEEEE--EETTEEGGCHH-HCG---GGGSTHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCccCCcEEEEe----CC----EEEEEecCCCccchhhHH-hcc---ccchhHHHHHHHHHHHHHHH
Confidence            57899999999765  566666542    12    89999998  54554432 221   1134455677778775655 


Q ss_pred             hhcCCCCceeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       201 LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      +|..   ||+|+||.+.|||++++ .+.|+|||.+..
T Consensus       123 ~~~~---givHGDLs~~NIlv~~~-~~~iIDf~qav~  155 (188)
T PF01163_consen  123 LHKA---GIVHGDLSEYNILVDDG-KVYIIDFGQAVD  155 (188)
T ss_dssp             HHCT---TEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred             HHhc---CceecCCChhhEEeecc-eEEEEecCccee
Confidence            4676   99999999999999987 899999998864

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.93  E-value=4e-09  Score=95.41  Aligned_cols=130  Identities=21%  Similarity=0.126  Sum_probs=92.1

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh--------------------------HHHHHHHHHhc
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--------------------------LQWVAEVQFLG  134 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--------------------------~~~~~E~~~l~  134 (432)
                      ..++..||-|--+.||.|...        .+.++|||.-+-..                          ...++|.++|.
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~--------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~  164 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP--------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQ  164 (304)
T ss_pred             HhhccccccCccceEEEEECC--------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHH
Confidence            455688999999999999753        67889999643110                          12678999999


Q ss_pred             ccCCC--ccceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeec
Q 014034          135 VLEHP--NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYR  212 (432)
Q Consensus       135 ~l~hp--niv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~  212 (432)
                      +|.-.  .|.+.+++-        ...+||||++|-.|...-       +.....-.++..|++-+.-+-..   ||||+
T Consensus       165 ~L~~~G~~VP~P~~~n--------RHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~---GiVHG  226 (304)
T COG0478         165 RLYPEGVKVPKPIAWN--------RHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR---GIVHG  226 (304)
T ss_pred             HhhhcCCCCCCccccc--------cceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc---Ccccc
Confidence            99644  677766542        238999999886665532       12222333444444444444344   99999


Q ss_pred             CCCCCceEEcCCCceeeccccCCc
Q 014034          213 DFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       213 Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      |+.+-||+++++|.+.++||--+.
T Consensus       227 DlSefNIlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         227 DLSEFNILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             CCchheEEEecCCCEEEEeCcccc
Confidence            999999999999999999997664

>PRK09902 hypothetical protein; Provisional

Probab=98.90  E-value=5.4e-08  Score=86.12  Aligned_cols=155  Identities=17%  Similarity=0.156  Sum_probs=112.9

Q ss_pred             HHHHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc----------ChHHHHHHHHHhcccCCC-
Q 014034           71 YSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR----------DGLQWVAEVQFLGVLEHP-  139 (432)
Q Consensus        71 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~----------~~~~~~~E~~~l~~l~hp-  139 (432)
                      ++.......++....--|+||.+.|++..+.         +..+-+|+-..          ....|.+|+..+..|..- 
T Consensus        10 f~~~w~~~~~wve~pN~~rgG~SgV~r~~~~---------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~G   80 (216)
T PRK09902         10 FNHWWATEGDWVEEPNYRRNGMSGVQCVERN---------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAG   80 (216)
T ss_pred             HHHHHhCCCceecCCCcCCCCcceEEEEEeC---------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcC
Confidence            4555555555655555688999999997653         34688887541          233589999999888532 


Q ss_pred             -ccceeeeEEeecCCcceeEEEEEeecCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCC
Q 014034          140 -NLVKLIGYCAVDGERGIQRLLVYEFMLN-RSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKAS  217 (432)
Q Consensus       140 -niv~l~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~  217 (432)
                       .+.++............+-+||+|-+.| -+|.+++.+....+.+...+..++.+++..+.-||+.   |+.|+|+-+.
T Consensus        81 vPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~k  157 (216)
T PRK09902         81 VIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVR  157 (216)
T ss_pred             CCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHh
Confidence             2444442222222233456899997754 5899998765555667888889999999999999998   9999999999


Q ss_pred             ceEEcCCCc--eeeccccCCcC
Q 014034          218 NVLLDENFR--PKLSDFGLARE  237 (432)
Q Consensus       218 Nill~~~~~--~kl~DfG~a~~  237 (432)
                      |||++.++.  ++++||--++.
T Consensus       158 hIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        158 HIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             heeecCCCCeeEEEEEhhccch
Confidence            999987677  99999987653

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.87  E-value=8.2e-10  Score=110.95  Aligned_cols=150  Identities=21%  Similarity=0.329  Sum_probs=103.4

Q ss_pred             HHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCCCCCC-------cccccccccCCCccCccccccC
Q 014034          193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH-------THVSTAVVGTFGYAAPDYIETG  265 (432)
Q Consensus       193 ~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~  265 (432)
                      +++.|+.|+|..  .++||++|.|++|.++.++.+||+.|+++........       ........-...|.|||++.+.
T Consensus       107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            344899999987  6999999999999999999999999998764322100       1111122345689999999998


Q ss_pred             CCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhcc
Q 014034          266 HLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLS  344 (432)
Q Consensus       266 ~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~  344 (432)
                      ..+.++|+||+||++|.+.. |+.-+...........    ...          .+..-...++...+.++.+=+.+++.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~----~~~----------~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF----SRN----------LLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhh----hhc----------ccccccccccccCcHHHHHHHHHHhc
Confidence            88999999999999999994 5554443322111000    000          01111112234556778888899999


Q ss_pred             CCCCCCCCHHHHHH
Q 014034          345 KSSKDRPKMSQVVE  358 (432)
Q Consensus       345 ~dP~~RPs~~eil~  358 (432)
                      .++.-||++..+..
T Consensus       251 ~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLS  264 (700)
T ss_pred             CCcccCcchhhhhc
Confidence            99999998877654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.75  E-value=7.2e-08  Score=86.65  Aligned_cols=108  Identities=23%  Similarity=0.216  Sum_probs=83.2

Q ss_pred             HHHHHHHHhcccCCC--ccceeeeEEeecCCcceeEEEEEeecCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 014034          125 QWVAEVQFLGVLEHP--NLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL  201 (432)
Q Consensus       125 ~~~~E~~~l~~l~hp--niv~l~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~L  201 (432)
                      .+.+|...+..|..-  .+.+.+++...........+||+|++++. +|.+++....  ..+......++.+++..+.-|
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHHHH
Confidence            467888887777432  34455555554333334558999999884 8999886533  255667788999999999999


Q ss_pred             hcCCCCceeecCCCCCceEEcCCC---ceeeccccCCcC
Q 014034          202 HEGLEVQVIYRDFKASNVLLDENF---RPKLSDFGLARE  237 (432)
Q Consensus       202 H~~~~~~ivH~Dikp~Nill~~~~---~~kl~DfG~a~~  237 (432)
                      |..   ||+|+|+++.|||++.++   .+.++||+-++.
T Consensus       135 H~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  135 HDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            998   999999999999999887   899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.71  E-value=6.1e-08  Score=97.68  Aligned_cols=134  Identities=16%  Similarity=0.160  Sum_probs=87.9

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH----------------------------------------
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL----------------------------------------  124 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~----------------------------------------  124 (432)
                      ..|+.++-|.||+|+++        +|+.||||+.++...                                        
T Consensus       131 ~PiAsASIaQVH~A~L~--------sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l  202 (517)
T COG0661         131 EPIASASIAQVHRAVLK--------SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRL  202 (517)
T ss_pred             CchhhhhHhhheeEEec--------CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHH
Confidence            57999999999999986        589999999865322                                        


Q ss_pred             ----HHHHHHHHhcccC-----CCccceeeeEEe-ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHH
Q 014034          125 ----QWVAEVQFLGVLE-----HPNLVKLIGYCA-VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA  194 (432)
Q Consensus       125 ----~~~~E~~~l~~l~-----hpniv~l~~~~~-~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l  194 (432)
                          ++.+|+..+.++.     .|++. +=.++. ..+.    .+|+|||+.|-.+.+...-.. .+.+.+.+.....++
T Consensus       203 ~~ElDy~~EA~n~~~~~~nf~~~~~v~-VP~V~we~t~~----~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~  276 (517)
T COG0661         203 REELDYRREAANAERFRENFKDDPDVY-VPKVYWEYTTR----RVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA  276 (517)
T ss_pred             HHHhCHHHHHHHHHHHHHHcCCCCCeE-eceeehhccCC----cEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH
Confidence                1445655555442     33332 222222 2222    389999999999988843222 234433333222222


Q ss_pred             HHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          195 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       195 ~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      .--.-+-|     |++|.|..|.||+++.+|.+.+.|||+...
T Consensus       277 f~~q~~~d-----gffHaDpHpGNi~v~~~g~i~~lDfGi~g~  314 (517)
T COG0661         277 FLRQLLRD-----GFFHADPHPGNILVRSDGRIVLLDFGIVGR  314 (517)
T ss_pred             HHHHHHhc-----CccccCCCccceEEecCCcEEEEcCcceec
Confidence            21111222     899999999999999999999999999864

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.51  E-value=7.2e-07  Score=80.17  Aligned_cols=146  Identities=18%  Similarity=0.184  Sum_probs=97.4

Q ss_pred             CHHHHHHhhcCCccccc---cccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHH---------------------
Q 014034           70 SYSEMRQATNDFSRMLK---IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---------------------  125 (432)
Q Consensus        70 ~~~~~~~~~~~~~~~~~---lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---------------------  125 (432)
                      +...+....+...+...   |..|--+.||+|.-        .++..+|+|+.......                     
T Consensus        36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~--------~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~r  107 (268)
T COG1718          36 TLETLRRLLSRGVITELVGCISTGKEANVYLAET--------GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNR  107 (268)
T ss_pred             HHHHHHHHhcCCceeeeEeeecCCcceEEEeecc--------CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCH
Confidence            34555555555555444   55677788999863        35788999997543221                     


Q ss_pred             -------HHHHHHHhcccC--CCccceeeeEEeecCCcceeEEEEEeecCCCCH-HHHhhcCCCCCCCHHHHHHHHHHHH
Q 014034          126 -------WVAEVQFLGVLE--HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-EDHLFNRAFPPLPWKTRLHIILGAA  195 (432)
Q Consensus       126 -------~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~~l~  195 (432)
                             ..+|+..|.++.  +=.+.+-+++..        ..|||||+....+ .-.|..   -++.......+..+++
T Consensus       108 r~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~--------nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v  176 (268)
T COG1718         108 RKLVFAWARKEFRNLKRAYEAGVRVPEPIAFRN--------NVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVV  176 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHHHcCCCCCCceeecC--------CeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHH
Confidence                   356777787773  445555555542        2899999954311 111111   1233335777888888


Q ss_pred             HHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       196 ~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      +.+.-|-..  .++||+||..-|||+. ++.+.|+|||-|..
T Consensus       177 ~~~~~l~~~--a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~  215 (268)
T COG1718         177 EYMRRLYKE--AGLVHGDLSEYNILVH-DGEPYIIDVSQAVT  215 (268)
T ss_pred             HHHHHHHHh--cCcccccchhhheEEE-CCeEEEEECccccc
Confidence            888888763  3999999999999999 88999999998864

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.46  E-value=2.8e-06  Score=75.65  Aligned_cols=137  Identities=12%  Similarity=0.067  Sum_probs=89.3

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHH-------------HHHHHHHhcccC---CCc
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-------------WVAEVQFLGVLE---HPN  140 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~E~~~l~~l~---hpn  140 (432)
                      ..++|...+.+-......|.+-..         ++..+++|..+.....             ..+++..+..+.   -..
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei---------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~   99 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI---------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTE   99 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE---------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccc
Confidence            456788888888777777777653         5788999987654322             223333333332   222


Q ss_pred             cceeeeEEeecC-CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCce
Q 014034          141 LVKLIGYCAVDG-ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNV  219 (432)
Q Consensus       141 iv~l~~~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Ni  219 (432)
                      ...++.+..-.. ......+++|||++|..|.+..      .++.    .+...++.++.-||..   |++|+|+.|.|+
T Consensus       100 ~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~------~i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNF  166 (229)
T PF06176_consen  100 PADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIE------DIDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNF  166 (229)
T ss_pred             cccceeeeeeeeccceeEEEEEEEEecCeecccch------hcCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcE
Confidence            222222222111 1122346899999998887753      1332    2446677889999998   999999999999


Q ss_pred             EEcCCCceeeccccCCc
Q 014034          220 LLDENFRPKLSDFGLAR  236 (432)
Q Consensus       220 ll~~~~~~kl~DfG~a~  236 (432)
                      ++++++ ++++||+..+
T Consensus       167 lv~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  167 LVSNNG-IRIIDTQGKR  182 (229)
T ss_pred             EEECCc-EEEEECcccc
Confidence            999655 9999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.38  E-value=1.4e-06  Score=87.63  Aligned_cols=133  Identities=16%  Similarity=0.119  Sum_probs=86.1

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH----------------------------------------
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL----------------------------------------  124 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~----------------------------------------  124 (432)
                      +.||.-+.|.||+|+.+        +|+.||||+-++.-.                                        
T Consensus       167 ~piaaASlaQVhrA~L~--------~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~E  238 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLK--------NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQE  238 (538)
T ss_pred             chhhhcchhheEEEEec--------CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhh
Confidence            57999999999999987        488999999765322                                        


Q ss_pred             -HHHHHHHHhcc----cCCCc------cceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 014034          125 -QWVAEVQFLGV----LEHPN------LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG  193 (432)
Q Consensus       125 -~~~~E~~~l~~----l~hpn------iv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~  193 (432)
                       +|.+|++...+    +.|-+      |.++|-.+.      ...+|+||||+|..+.+.-.-.. ..++...+..-+.+
T Consensus       239 LDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s------t~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~  311 (538)
T KOG1235|consen  239 LDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLS------TKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVE  311 (538)
T ss_pred             cchHHHHHhHHHHHHHHHhcccccceeCCeehhhcC------cceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHH
Confidence             14445544333    34555      445443322      13489999999988776532111 13444433333333


Q ss_pred             HHHHHHHhhcCCCCceeecCCCCCceEEc----CCCceeeccccCCcC
Q 014034          194 AAEGLAYLHEGLEVQVIYRDFKASNVLLD----ENFRPKLSDFGLARE  237 (432)
Q Consensus       194 l~~~l~~LH~~~~~~ivH~Dikp~Nill~----~~~~~kl~DfG~a~~  237 (432)
                      ...-+-+ +    .|++|+|-.|.||+++    .++.+.+.|||+...
T Consensus       312 ~~~~qIf-~----~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~  354 (538)
T KOG1235|consen  312 AYLEQIF-K----TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV  354 (538)
T ss_pred             HHHHHHH-h----cCCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence            2221222 2    2899999999999998    367899999999865

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.36  E-value=4.3e-06  Score=76.19  Aligned_cols=136  Identities=16%  Similarity=0.163  Sum_probs=78.9

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC--hHHHHHHHHHhcccCCCc--cceeeeEEeecCCcceeEEE
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQWVAEVQFLGVLEHPN--LVKLIGYCAVDGERGIQRLL  160 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~~~~~l  160 (432)
                      ..||.|..+.||+..           +..+++|.....  .....+|.++++.+..-.  +.+.+++....+.    ..+
T Consensus         7 ~~i~~G~t~~~y~~~-----------~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~----~gl   71 (226)
T TIGR02172         7 TQTGEGGNGESYTHK-----------TGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGR----LGL   71 (226)
T ss_pred             eeecCCCCcceeEec-----------CCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCe----eee
Confidence            568999999999731           234678876653  234788999998886433  4566666544333    367


Q ss_pred             EEeecCCCC-HHHHh---------------------hcCCCCCCCHHHHHH-HHH----------HHHH-HHHHhhcC-C
Q 014034          161 VYEFMLNRS-LEDHL---------------------FNRAFPPLPWKTRLH-IIL----------GAAE-GLAYLHEG-L  205 (432)
Q Consensus       161 v~e~~~~gs-L~~~l---------------------~~~~~~~l~~~~~~~-i~~----------~l~~-~l~~LH~~-~  205 (432)
                      |||++.|.+ +...+                     +.-.....+...... +..          .+.. ...+|... .
T Consensus        72 v~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~  151 (226)
T TIGR02172        72 IYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD  151 (226)
T ss_pred             eeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence            999998863 21111                     111001111111000 000          0000 11222111 1


Q ss_pred             CCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       206 ~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      ...++|+|+.|.||++++++ +.|+||+.+.
T Consensus       152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            23678999999999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.35  E-value=3.5e-06  Score=76.84  Aligned_cols=143  Identities=20%  Similarity=0.210  Sum_probs=82.7

Q ss_pred             ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC--hHHHHHHHHHhcccCCC--ccceeeeEEeecCCcceeEE
Q 014034           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQWVAEVQFLGVLEHP--NLVKLIGYCAVDGERGIQRL  159 (432)
Q Consensus        84 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~hp--niv~l~~~~~~~~~~~~~~~  159 (432)
                      ++.|+.|..+.||+....         +..+++|.....  ...+..|..+++.+...  .+.+++.+...... ....+
T Consensus         2 i~~l~~G~~n~~~~v~~~---------~~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~-~~~~~   71 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTD---------DGRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEF-NGFPY   71 (239)
T ss_dssp             EEEEEESSSSEEEEEEET---------TSEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEE-TSEEE
T ss_pred             CccCCCCCeeeEEEEEEC---------CcEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccc-cccce
Confidence            456899999999998753         248999998765  33577899898887533  35667665533332 22368


Q ss_pred             EEEeecCCCCHHH----------------Hh---hcC--CCCCCCHHH---------HHHH------------HHHHHH-
Q 014034          160 LVYEFMLNRSLED----------------HL---FNR--AFPPLPWKT---------RLHI------------ILGAAE-  196 (432)
Q Consensus       160 lv~e~~~~gsL~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~~~l~~-  196 (432)
                      ++|++++|..+..                .+   +..  ...+.....         ....            ...+.. 
T Consensus        72 ~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (239)
T PF01636_consen   72 LLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEER  151 (239)
T ss_dssp             EEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred             EEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHH
Confidence            9999999988877                11   111  111111110         0000            111222 


Q ss_pred             HHHHhhc----CCCCceeecCCCCCceEEc-CCCceeeccccCCc
Q 014034          197 GLAYLHE----GLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLAR  236 (432)
Q Consensus       197 ~l~~LH~----~~~~~ivH~Dikp~Nill~-~~~~~kl~DfG~a~  236 (432)
                      .+..++.    .....++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  152 LLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            2333332    1234799999999999999 66667899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.28  E-value=2.7e-06  Score=75.04  Aligned_cols=102  Identities=27%  Similarity=0.304  Sum_probs=80.7

Q ss_pred             HHHHHHhcccCC-CccceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 014034          127 VAEVQFLGVLEH-PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN-RAFPPLPWKTRLHIILGAAEGLAYLHEG  204 (432)
Q Consensus       127 ~~E~~~l~~l~h-pniv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~l~~~l~~LH~~  204 (432)
                      ..|.-+|+.+.+ +++++++|+|-    .    ++|.||...+++...... ......+|..+.+|+.++++.+.+|+..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~   78 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----R----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHG   78 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----C----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence            357888888876 69999999982    2    889999987665421000 0112468999999999999999999986


Q ss_pred             CCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       205 ~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      ....+.-.|++++|+-++++|.+|++|...+.
T Consensus        79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             CCCcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence            54468889999999999999999999998764

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.27  E-value=1.3e-07  Score=94.49  Aligned_cols=190  Identities=18%  Similarity=0.123  Sum_probs=127.5

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHHHHHHHhcccCCCc-cceeeeEEeecCCcce
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPN-LVKLIGYCAVDGERGI  156 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~~  156 (432)
                      +.-+....-+++|++++++|.+-.       .+.. ...+.+... ....-++++|.+++||| .+..++-+..+    .
T Consensus       241 ~kws~~fh~fvK~altknpKkRpt-------aekl-L~h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~d~~~E----~  307 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPT-------AEKL-LQHPFVSQT-LSRRLAIELLDKVNNPNPVVRYLEDYDGE----D  307 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCC-------hhhh-eeceeeccc-hhhHHHHHHHHHccCCCCcccccccCCcc----c
Confidence            334444556899999999987532       2222 225555443 44566889999999999 45444433322    3


Q ss_pred             eEEEEEeecCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCC
Q 014034          157 QRLLVYEFMLNR-SLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  235 (432)
Q Consensus       157 ~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a  235 (432)
                      ..+++++++.++ +...-.... .-.+...+...+.+.-++++++||+.   .=+|+|    ||+..+ +..+.+||+..
T Consensus       308 ~~~i~~~i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~  378 (829)
T KOG0576|consen  308 YLWIPMRICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVP  378 (829)
T ss_pred             ccchhhhhhcCCccccccCChh-hHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCC
Confidence            458999999776 222111000 00123334455667778899999985   458888    887765 67899999998


Q ss_pred             cCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 014034          236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLER  292 (432)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~  292 (432)
                      .....   ........+|+.++|||+.....+....|+|++|+--.++--|-+|-..
T Consensus       379 ~~L~~---~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  379 PQLTR---TMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             cccCc---ccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence            65322   2234567899999999999999999999999999876667667666543

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.21  E-value=7.4e-06  Score=69.82  Aligned_cols=127  Identities=18%  Similarity=0.160  Sum_probs=86.8

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH--HHHHHHHHhcccCCCccce-eeeEEeecCCccee
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLGVLEHPNLVK-LIGYCAVDGERGIQ  157 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~E~~~l~~l~hpniv~-l~~~~~~~~~~~~~  157 (432)
                      ....+.||+|++|.||++.+.         +..+|+|+-+.+..  .+..|+++|..+.--++.+ +|.+-.    .   
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~---------~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~---   87 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR---------GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGE----D---   87 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc---------CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEech----h---
Confidence            345667999999999999875         55899998766544  5899999999998666643 444322    1   


Q ss_pred             EEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCC-CCceEEcCCCceeeccccCCc
Q 014034          158 RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFK-ASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       158 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dik-p~Nill~~~~~~kl~DfG~a~  236 (432)
                       ++.|||+.|-.|..+-..     ..-.+.    ..+++.---|...   ||-|+.|. |...+|..++.+.|+||..|+
T Consensus        88 -~i~me~i~G~~L~~~~~~-----~~rk~l----~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112          88 -FIRMEYIDGRPLGKLEIG-----GDRKHL----LRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             -hhhhhhhcCcchhhhhhc-----ccHHHH----HHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchh
Confidence             567999999888876532     122233    3344443333333   99999987 444444445589999999886

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.15  E-value=3e-05  Score=71.57  Aligned_cols=137  Identities=17%  Similarity=0.136  Sum_probs=79.9

Q ss_pred             cccCCc-eEEEEEEecCCCCCCCcccEEEEEEecCcC-hHHHHHHHHHhcccC-CCccceeeeEEeecCCcceeEEEEEe
Q 014034           87 IGEGGF-GSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQWVAEVQFLGVLE-HPNLVKLIGYCAVDGERGIQRLLVYE  163 (432)
Q Consensus        87 lg~G~f-g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~~~lv~e  163 (432)
                      |..|.. ..||+...         .+..+.+|..... .....+|+++++.+. +--+.+++++....+.    .++||+
T Consensus         6 ~~~g~~~~~v~~~~~---------~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~----~~lv~e   72 (244)
T cd05150           6 VTEGQSGATVYRLDG---------KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDDGR----AWLLTS   72 (244)
T ss_pred             cCCCCCcCeEEEEcC---------CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecCCc----cEEEEE
Confidence            445554 78898753         2356888887653 124678999988873 3445667766654322    389999


Q ss_pred             ecCCCCHHHHh-------------------hcCCCC--CCCH--HHHHHH-----------------------HHHHHHH
Q 014034          164 FMLNRSLEDHL-------------------FNRAFP--PLPW--KTRLHI-----------------------ILGAAEG  197 (432)
Q Consensus       164 ~~~~gsL~~~l-------------------~~~~~~--~l~~--~~~~~i-----------------------~~~l~~~  197 (432)
                      +++|.+|....                   +.....  ++..  ......                       +.++...
T Consensus        73 ~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (244)
T cd05150          73 AVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAE  152 (244)
T ss_pred             eeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHH
Confidence            99998876432                   111000  1110  000000                       1111111


Q ss_pred             HHHhh-cCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          198 LAYLH-EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       198 l~~LH-~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      |.... ......++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       153 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         153 LEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             HHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            11111 1113469999999999999998888999999874

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.10  E-value=7.9e-06  Score=87.22  Aligned_cols=202  Identities=21%  Similarity=0.208  Sum_probs=139.1

Q ss_pred             HHHHHHHhcccCCCccceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 014034          126 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL  205 (432)
Q Consensus       126 ~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~  205 (432)
                      ...|+..+....|+|++.++.+....-..+....+..+++...++...+..-.  .++..+.+.+..++.+||.|+|+. 
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~~-  305 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHSL-  305 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHHh-
Confidence            34466778888999999999888776555434445678888888888886543  688899999999999999999996 


Q ss_pred             CCceeecCCCCC---ceEEcCCCceeec--cccCCcCCCCCCCcccccccccCCCccCccccccCCCCch--hhhHHHHH
Q 014034          206 EVQVIYRDFKAS---NVLLDENFRPKLS--DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAK--SDVWSFGV  278 (432)
Q Consensus       206 ~~~ivH~Dikp~---Nill~~~~~~kl~--DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~DvwSlGv  278 (432)
                        ...|.-+..+   +-.++..+.+.++  ||+.+.......   ......-+..+.+||......++.+  .|+|.+|.
T Consensus       306 --~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~---~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  306 --SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE---KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             --ccceeEEecccccccccCccceeecchhhhcccccCCCcc---cchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence              4444444443   4444566677777  888887533222   2223344567788888876665554  79999999


Q ss_pred             HHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 014034          279 VLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE  358 (432)
Q Consensus       279 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  358 (432)
                      ....+..|..+-.......                   .+++     ...   ...+.+...+|+..++++|+++.+++.
T Consensus       381 l~~~~~~~~~i~~~~~~~~-------------------~~l~-----~~~---~~~~~d~~~~~~~~~~~~Rl~~~~ll~  433 (1351)
T KOG1035|consen  381 LLLQLSQGEDISEKSAVPV-------------------SLLD-----VLS---TSELLDALPKCLDEDSEERLSALELLT  433 (1351)
T ss_pred             HHhhhhhcCcccccccchh-------------------hhhc-----ccc---chhhhhhhhhhcchhhhhccchhhhhh
Confidence            9999998765533211000                   0000     001   014557888999999999999999998


Q ss_pred             HHHH
Q 014034          359 RLKQ  362 (432)
Q Consensus       359 ~L~~  362 (432)
                      +...
T Consensus       434 ~~f~  437 (1351)
T KOG1035|consen  434 HPFL  437 (1351)
T ss_pred             chhc
Confidence            8543

>PLN02876 acyl-CoA dehydrogenase

Probab=98.05  E-value=7.9e-05  Score=80.88  Aligned_cols=81  Identities=15%  Similarity=0.212  Sum_probs=54.6

Q ss_pred             ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc-----ChHHHHHHHHHhcccC-CCcc--ceeeeEEeecCCcc
Q 014034           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-----DGLQWVAEVQFLGVLE-HPNL--VKLIGYCAVDGERG  155 (432)
Q Consensus        84 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~-----~~~~~~~E~~~l~~l~-hpni--v~l~~~~~~~~~~~  155 (432)
                      +..|+.|.+..+|+.....     ......+++|+...     ....+.+|+.+|+.+. |+++  .+++.+|.+.... 
T Consensus        43 v~~l~gG~sn~ty~l~~~~-----~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~-  116 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGN-----GGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVI-  116 (822)
T ss_pred             EEEeCCCCcCceEEEEECC-----CCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcC-
Confidence            5678999999999976531     11123567776543     2245789999999995 6665  7777777653221 


Q ss_pred             eeEEEEEeecCCCCH
Q 014034          156 IQRLLVYEFMLNRSL  170 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL  170 (432)
                      ...|+||||++|..+
T Consensus       117 G~~flVME~v~G~~~  131 (822)
T PLN02876        117 GTAFYIMEYLEGRIF  131 (822)
T ss_pred             CCceEEEEecCCccc
Confidence            234899999988653

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.92  E-value=7.3e-05  Score=68.62  Aligned_cols=31  Identities=19%  Similarity=0.234  Sum_probs=26.5

Q ss_pred             CceeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          207 VQVIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       207 ~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      ..++|+|+.+.|||+++++..-|+||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            4689999999999999776667999998753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.90  E-value=0.00023  Score=63.11  Aligned_cols=125  Identities=22%  Similarity=0.281  Sum_probs=85.6

Q ss_pred             cccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh--------------------HHHHHHHHHhcccC-----
Q 014034           83 RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--------------------LQWVAEVQFLGVLE-----  137 (432)
Q Consensus        83 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--------------------~~~~~E~~~l~~l~-----  137 (432)
                      ....||.|+.=.||.-          ..+...+||+.....                    .+..+|+.....+.     
T Consensus         5 ~~~~i~~G~~R~cy~H----------P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~   74 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQH----------PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGV   74 (199)
T ss_pred             CCcccccCCCceEEEC----------CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCC
Confidence            3457999999999962          244557888877655                    34667776665555     


Q ss_pred             -CCccceeeeEEeecCCcceeEEEEEeecCC------CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcee
Q 014034          138 -HPNLVKLIGYCAVDGERGIQRLLVYEFMLN------RSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVI  210 (432)
Q Consensus       138 -hpniv~l~~~~~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~iv  210 (432)
                       +.+|.+++|+...+-..    -+|+|.+.+      -+|.+++.+.   .++. .....+.++   ..||-..   +|+
T Consensus        75 ~~~~i~r~~G~veT~~G~----Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L~~f---~~~l~~~---~Iv  140 (199)
T PF10707_consen   75 DWSHIPRFYGFVETNLGL----GLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQALDEF---KRYLLDH---HIV  140 (199)
T ss_pred             cccccccEeEEEecCCce----EEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHHHHH---HHHHHHc---CCe
Confidence             88999999998876544    566766532      3688888543   3554 444444444   4566666   899


Q ss_pred             ecCCCCCceEEcCC--C--ceeecc
Q 014034          211 YRDFKASNVLLDEN--F--RPKLSD  231 (432)
Q Consensus       211 H~Dikp~Nill~~~--~--~~kl~D  231 (432)
                      .+|++|.||++...  +  .+.|+|
T Consensus       141 ~~dl~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  141 IRDLNPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCcccEEEEecCCCceEEEEEe
Confidence            99999999999532  2  477777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK10593 hypothetical protein; Provisional

Probab=97.89  E-value=0.00018  Score=68.41  Aligned_cols=80  Identities=14%  Similarity=0.047  Sum_probs=54.3

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc--ChHHHHHHHHHhcccCC---CccceeeeEEeecCCcc
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQWVAEVQFLGVLEH---PNLVKLIGYCAVDGERG  155 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h---pniv~l~~~~~~~~~~~  155 (432)
                      ....+.||.|..+.||+....        ++ .+.+|..+.  ....+..|+..|+.|.-   -.+.++++++..... .
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~--------~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~-~   85 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDS--------QG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS-P   85 (297)
T ss_pred             hheeeecCCccceeEEEEEcC--------CC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc-C
Confidence            334567999999999987531        23 466666543  23468899999988843   467888887754321 1


Q ss_pred             eeEEEEEeecCCCCH
Q 014034          156 IQRLLVYEFMLNRSL  170 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL  170 (432)
                      ...+||||++++.++
T Consensus        86 g~~~LVmE~i~G~~~  100 (297)
T PRK10593         86 GPDVLLLERLRGVSV  100 (297)
T ss_pred             CCeEEEEeccCCEec
Confidence            224999999998765

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.84  E-value=0.00028  Score=62.27  Aligned_cols=125  Identities=27%  Similarity=0.377  Sum_probs=88.7

Q ss_pred             cCCccccccccCCc-eEEEEEEecCCCCCCCcccEEEEEEecCc----------------C---------hHHHHHHHHH
Q 014034           79 NDFSRMLKIGEGGF-GSVYKSSIKPAAGDGTSEATVVAIKKLNR----------------D---------GLQWVAEVQF  132 (432)
Q Consensus        79 ~~~~~~~~lg~G~f-g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~----------------~---------~~~~~~E~~~  132 (432)
                      .+++.++.||.|.- |.||++.+         .+..+|+|.+..                .         ...|..|.+.
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I---------~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRA  107 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI---------DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRA  107 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE---------CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHh
Confidence            68899999999999 99999986         477999999311                0         0126778888


Q ss_pred             hcccC---CCcc--ceeeeEEeecC--------------CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 014034          133 LGVLE---HPNL--VKLIGYCAVDG--------------ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG  193 (432)
Q Consensus       133 l~~l~---hpni--v~l~~~~~~~~--------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~  193 (432)
                      ..+|+   +.++  |+++|+..-..              .......||.||++...           .+...    -+.+
T Consensus       108 fgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~----~~~~  172 (207)
T PF13095_consen  108 FGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIR----DIPQ  172 (207)
T ss_pred             hHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchh----HHHH
Confidence            77764   5566  89999885442              11223457888775533           12223    3455


Q ss_pred             HHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCC
Q 014034          194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  235 (432)
Q Consensus       194 l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a  235 (432)
                      |.+-|..+|..   ||+-+|+++.|..     .-+|+|||.+
T Consensus       173 ~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  173 MLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            66667889987   9999999999976     3489999865

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.77  E-value=0.00022  Score=65.25  Aligned_cols=74  Identities=22%  Similarity=0.261  Sum_probs=46.6

Q ss_pred             ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH---HHHHHHHHhcccCCCc-cceeeeEEeecCCcceeEE
Q 014034           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGVLEHPN-LVKLIGYCAVDGERGIQRL  159 (432)
Q Consensus        84 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~~~~~  159 (432)
                      ++.|..|-...+|+....      ...+..|++|.......   ...+|+.+++.+...+ .+++++.+  +  .    .
T Consensus         3 i~~l~gG~tN~~~~v~~~------~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~--~----~   68 (235)
T cd05157           3 FKRFTGGITNKLVKVSNK------EDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF--Q--N----G   68 (235)
T ss_pred             EEEcCCcccceEEEEEcC------CCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe--C--C----c
Confidence            356778888899987632      00245788887754322   2357888888885333 34444332  1  1    4


Q ss_pred             EEEeecCCCCHH
Q 014034          160 LVYEFMLNRSLE  171 (432)
Q Consensus       160 lv~e~~~~gsL~  171 (432)
                      ++|||++|.++.
T Consensus        69 ~l~e~i~G~~l~   80 (235)
T cd05157          69 LIYEFIPGRTLE   80 (235)
T ss_pred             EEEEeeCCCcCC
Confidence            799999987763

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.73  E-value=0.00023  Score=66.23  Aligned_cols=134  Identities=18%  Similarity=0.135  Sum_probs=76.7

Q ss_pred             ccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH----HHHHHHHHhcccCCCcc-ceeeeEEeecCCcceeEEE
Q 014034           86 KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL----QWVAEVQFLGVLEHPNL-VKLIGYCAVDGERGIQRLL  160 (432)
Q Consensus        86 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~~~~~l  160 (432)
                      .+..|-.+.+|+...         ++..+++|.......    ...+|..+++.+..-.+ .+++..+  .  .    ++
T Consensus         3 ~~~~G~tn~~y~~~~---------~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~----~~   65 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH---------PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--H----WL   65 (256)
T ss_pred             cCCCcCcCCeEEEEe---------CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--C----EE
Confidence            356677889998752         355788887654322    35789999988854333 3444332  1  1    78


Q ss_pred             EEeecCCCCHHHH-----------------hhcCC--CCCCCHHH-HHHHHHHH---------HHHHHHhhc-----CCC
Q 014034          161 VYEFMLNRSLEDH-----------------LFNRA--FPPLPWKT-RLHIILGA---------AEGLAYLHE-----GLE  206 (432)
Q Consensus       161 v~e~~~~gsL~~~-----------------l~~~~--~~~l~~~~-~~~i~~~l---------~~~l~~LH~-----~~~  206 (432)
                      ||||++|..+...                 |+...  ..++.... ...+..++         ...+..+-.     ...
T Consensus        66 v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (256)
T TIGR02721        66 LVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLP  145 (256)
T ss_pred             EEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCC
Confidence            9999998766421                 11111  11112111 11111111         111111111     112


Q ss_pred             CceeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          207 VQVIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       207 ~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      ..++|+|+.|.||++++++ +.|+||..+..
T Consensus       146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            4689999999999999877 78999998753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.62  E-value=0.00032  Score=66.63  Aligned_cols=145  Identities=19%  Similarity=0.154  Sum_probs=82.0

Q ss_pred             cccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc-ChHHHHHHHHHhcccCCCc--cceeeeEEeec--CCccee
Q 014034           83 RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQWVAEVQFLGVLEHPN--LVKLIGYCAVD--GERGIQ  157 (432)
Q Consensus        83 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~-~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~--~~~~~~  157 (432)
                      ....|..|....+|+...         .+..+++|.... .......|+.++..+.+-.  +.+++......  ......
T Consensus        18 ~i~~i~~G~~n~~y~v~~---------~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~   88 (296)
T cd05153          18 SFEGISAGIENTNYFVTT---------DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGK   88 (296)
T ss_pred             heecccCccccceEEEEe---------CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCc
Confidence            355678888889998753         233588888764 3345677888888774322  44443311000  001113


Q ss_pred             EEEEEeecCCCCHHH----Hh----------hc--CC--C-----CCCCHHHHH----------HHHHHHHHHHHHhhc-
Q 014034          158 RLLVYEFMLNRSLED----HL----------FN--RA--F-----PPLPWKTRL----------HIILGAAEGLAYLHE-  203 (432)
Q Consensus       158 ~~lv~e~~~~gsL~~----~l----------~~--~~--~-----~~l~~~~~~----------~i~~~l~~~l~~LH~-  203 (432)
                      .++|++|++|..+..    .+          +.  ..  .     ....|....          .....+..++.++.. 
T Consensus        89 ~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~  168 (296)
T cd05153          89 PAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAF  168 (296)
T ss_pred             eEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhh
Confidence            488999998877532    00          10  00  0     011111110          011112333444442 


Q ss_pred             ---CCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          204 ---GLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       204 ---~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                         ....+++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       169 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         169 DPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence               123479999999999999998778999999874

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.54  E-value=7.3e-05  Score=69.82  Aligned_cols=130  Identities=18%  Similarity=0.115  Sum_probs=90.2

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh--------------------------HHHHHHHHHh
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--------------------------LQWVAEVQFL  133 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--------------------------~~~~~E~~~l  133 (432)
                      =+.++++||-|--+.||.+..        ..+.+.++|.-+...                          ....+|+..|
T Consensus        93 v~svGnqIGVGKESDIY~v~d--------~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafm  164 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVAD--------EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFM  164 (465)
T ss_pred             hhhhccccccccccceEEEec--------CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHH
Confidence            367788999999999999864        367888888632111                          1256788888


Q ss_pred             cccC-CC-ccceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceee
Q 014034          134 GVLE-HP-NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIY  211 (432)
Q Consensus       134 ~~l~-hp-niv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH  211 (432)
                      +.|. |- -+.+.++++        ..++|||++.|..|.+.-.-.     ...   .+...+..-+--|..+   |+||
T Consensus       165 kaL~e~gfpVPkpiD~~--------RH~Vvmelv~g~Pl~~v~~v~-----d~~---~ly~~lm~~Iv~la~~---GlIH  225 (465)
T KOG2268|consen  165 KALYERGFPVPKPIDHN--------RHCVVMELVDGYPLRQVRHVE-----DPP---TLYDDLMGLIVRLANH---GLIH  225 (465)
T ss_pred             HHHHHcCCCCCCccccc--------ceeeHHHhhcccceeeeeecC-----ChH---HHHHHHHHHHHHHHHc---Ccee
Confidence            8884 33 234444443        248999999998887653211     122   2333444445556566   9999


Q ss_pred             cCCCCCceEEcCCCceeeccccCCc
Q 014034          212 RDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       212 ~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      +|..-=||+|++++.++++||--..
T Consensus       226 gDFNEFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  226 GDFNEFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             cccchheeEEecCCCEEEeechHhh
Confidence            9999999999999999999997543

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.50  E-value=0.0016  Score=64.03  Aligned_cols=73  Identities=18%  Similarity=0.144  Sum_probs=49.4

Q ss_pred             ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc-----------ChHHHHHHHHHhcccC---CCccceeeeEEe
Q 014034           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-----------DGLQWVAEVQFLGVLE---HPNLVKLIGYCA  149 (432)
Q Consensus        84 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~-----------~~~~~~~E~~~l~~l~---hpniv~l~~~~~  149 (432)
                      .+.||.|.+..||+....       ..++.|+||.-..           .......|.+.|..+.   -.++++++.+..
T Consensus        31 ~~elggGn~N~VyrV~~~-------~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~  103 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDT-------EGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE  103 (401)
T ss_pred             eeEcCCCceEEEEEEEeC-------CCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC
Confidence            356999999999998753       1225799998431           2234677888887762   346777876633


Q ss_pred             ecCCcceeEEEEEeecCCCC
Q 014034          150 VDGERGIQRLLVYEFMLNRS  169 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gs  169 (432)
                        ..    .++||||+++..
T Consensus       104 --~~----~~lVME~L~~~~  117 (401)
T PRK09550        104 --EL----AVTVMEDLSDHK  117 (401)
T ss_pred             --CC----CEEEEecCCCcc
Confidence              21    389999998754

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.46  E-value=0.00091  Score=63.78  Aligned_cols=143  Identities=27%  Similarity=0.319  Sum_probs=81.6

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh---HHHHHHHHHhcccCCCc-cceeeeEEeecCCcceeEEE
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQWVAEVQFLGVLEHPN-LVKLIGYCAVDGERGIQRLL  160 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~~~~~l  160 (432)
                      +.|..|-...||+....... .....+..+++|......   ....+|..++..+.... ..++++++.  +      .+
T Consensus         4 ~~l~gGltN~~y~v~~~~~~-~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~------~~   74 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDED-ALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP--N------GR   74 (302)
T ss_pred             EEecCcccceeEEEEcCCcc-cccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC--C------Cc
Confidence            34666777789987643110 012235778899876532   24578888888875332 345555442  1      45


Q ss_pred             EEeecCCCCHHHH-----------------hhcCCCC-------CCC--HHHHHH-------------------------
Q 014034          161 VYEFMLNRSLEDH-----------------LFNRAFP-------PLP--WKTRLH-------------------------  189 (432)
Q Consensus       161 v~e~~~~gsL~~~-----------------l~~~~~~-------~l~--~~~~~~-------------------------  189 (432)
                      |++|++|..+...                 ++.....       ..+  +.....                         
T Consensus        75 v~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (302)
T cd05156          75 IEEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELS  154 (302)
T ss_pred             hhheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHH
Confidence            8999988776431                 1111110       011  111100                         


Q ss_pred             -HHHHHHHHHHHhhc------CCCCceeecCCCCCceEEcCC----CceeeccccCCc
Q 014034          190 -IILGAAEGLAYLHE------GLEVQVIYRDFKASNVLLDEN----FRPKLSDFGLAR  236 (432)
Q Consensus       190 -i~~~l~~~l~~LH~------~~~~~ivH~Dikp~Nill~~~----~~~kl~DfG~a~  236 (432)
                       +...+..-+..|-.      .....++|+|+.+.|||++++    +.+.++||..|.
T Consensus       155 ~~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         155 LFLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence             11122222333331      234589999999999999985    889999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.35  E-value=0.0029  Score=60.50  Aligned_cols=144  Identities=19%  Similarity=0.176  Sum_probs=79.5

Q ss_pred             ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC--hHHHHHHHHHhcccCCCc--cceeeeEEeec--CCccee
Q 014034           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQWVAEVQFLGVLEHPN--LVKLIGYCAVD--GERGIQ  157 (432)
Q Consensus        84 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~--~~~~~~  157 (432)
                      ++.++.|....+|+...         ++..+++|.....  ......|++++..|....  +.+++......  ......
T Consensus        27 i~~~~~G~~n~~y~v~t---------~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~   97 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTT---------DVGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK   97 (307)
T ss_pred             ccccCCccccceEEEEe---------CCCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence            55677787789998752         1235778876543  345566777777764222  34443321100  001123


Q ss_pred             EEEEEeecCCCCHHH----H----------hhc--CCC-CC-------CCHHHHH------------HHHHHHHHHHHHh
Q 014034          158 RLLVYEFMLNRSLED----H----------LFN--RAF-PP-------LPWKTRL------------HIILGAAEGLAYL  201 (432)
Q Consensus       158 ~~lv~e~~~~gsL~~----~----------l~~--~~~-~~-------l~~~~~~------------~i~~~l~~~l~~L  201 (432)
                      .+++++|++|..+..    .          ++.  ... .+       -.|....            .....+...++++
T Consensus        98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l  177 (307)
T TIGR00938        98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL  177 (307)
T ss_pred             EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence            589999998865421    0          111  000 00       0111100            0111223345555


Q ss_pred             hc----CCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          202 HE----GLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       202 H~----~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      ..    ....+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            32    224589999999999999998877999999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=97.28  E-value=0.0023  Score=61.51  Aligned_cols=32  Identities=28%  Similarity=0.279  Sum_probs=27.3

Q ss_pred             CCceeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          206 EVQVIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       206 ~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      ..+++|+|+.|.|||++++...-|+||+.+..
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            45899999999999999776668999998753

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.11  E-value=0.0031  Score=60.27  Aligned_cols=132  Identities=17%  Similarity=0.114  Sum_probs=89.2

Q ss_pred             ccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hH------------------------HHHHHHHHhcc
Q 014034           86 KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GL------------------------QWVAEVQFLGV  135 (432)
Q Consensus        86 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~------------------------~~~~E~~~l~~  135 (432)
                      .|..|--+.||.|+-        .+|..+|||+.+..      ..                        -...|+..|.+
T Consensus       151 CiSTGKEANVYHat~--------~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkR  222 (520)
T KOG2270|consen  151 CISTGKEANVYHATE--------EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKR  222 (520)
T ss_pred             ccccCccceeEeeec--------CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHH
Confidence            466778889999864        35667999986421      11                        14668888888


Q ss_pred             cCCCccceeeeEEeecCCcceeEEEEEeecCCCCHH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCC
Q 014034          136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE-DHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDF  214 (432)
Q Consensus       136 l~hpniv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Di  214 (432)
                      ++...|...--+..-      ..+|||+|+-..... -.|.   .-.++...+..+-.+++.-+.-|...|  ++||.||
T Consensus       223 l~~aGIP~PePIlLk------~hVLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADL  291 (520)
T KOG2270|consen  223 LNNAGIPCPEPILLK------NHVLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADL  291 (520)
T ss_pred             HHhcCCCCCCceeee------cceEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccch
Confidence            876554322211111      238999999432211 1121   124666677788888888888888775  8999999


Q ss_pred             CCCceEEcCCCceeeccccCCcC
Q 014034          215 KASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       215 kp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      .--|+|+- +|.+.|+|-+-+..
T Consensus       292 SEfN~Lyh-dG~lyiIDVSQSVE  313 (520)
T KOG2270|consen  292 SEFNLLYH-DGKLYIIDVSQSVE  313 (520)
T ss_pred             hhhhheEE-CCEEEEEEcccccc
Confidence            99999996 56799999987753

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.07  E-value=0.0059  Score=57.41  Aligned_cols=31  Identities=26%  Similarity=0.442  Sum_probs=25.9

Q ss_pred             CceeecCCCCCceEEcCCCc-eeeccccCCcC
Q 014034          207 VQVIYRDFKASNVLLDENFR-PKLSDFGLARE  237 (432)
Q Consensus       207 ~~ivH~Dikp~Nill~~~~~-~kl~DfG~a~~  237 (432)
                      ..++|+|+.|.|||+++++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            35899999999999997555 56999998854

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.96  E-value=0.00021  Score=78.64  Aligned_cols=159  Identities=12%  Similarity=-0.042  Sum_probs=112.2

Q ss_pred             HHHHhcccCCCccceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCC-
Q 014034          129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGLAYLHEGL-  205 (432)
Q Consensus       129 E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~l~~~l~~LH~~~-  205 (432)
                      |...++...|+++...+.-..  +......+.+++|+.+|.+.+.|.+..  .+++...-+.....+.+.+..-+|+.. 
T Consensus      1279 e~de~~~~~h~~~~~~p~rI~--ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIP--PSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhhceeeecccccCC--CCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence            444455567988877644332  223334488999999999999986532  223333333333333355566666542 


Q ss_pred             -CCceeecCCCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHH
Q 014034          206 -EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML  284 (432)
Q Consensus       206 -~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell  284 (432)
                       ..-.+|+++|+-|.+|..+-.+|++++|+.+.-  ...........+++.|+.|++...-.++.++|+|..|+-+|+..
T Consensus      1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk--np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK--NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             CCccchhhhhhhhccceecCCccccccccccccc--CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence             224689999999999999999999999999821  12233445677889999999998888888899999999999998


Q ss_pred             hCCCCCC
Q 014034          285 TGRRSLE  291 (432)
Q Consensus       285 tg~~pf~  291 (432)
                      -|..+|-
T Consensus      1435 ~~n~~fi 1441 (2724)
T KOG1826|consen 1435 DGNAYFI 1441 (2724)
T ss_pred             cccHHHH
Confidence            8887763

>PLN02236 choline kinase

Probab=96.96  E-value=0.0086  Score=58.22  Aligned_cols=143  Identities=15%  Similarity=0.223  Sum_probs=82.0

Q ss_pred             cccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHH---HHHHHHHhcccCCCcc-ceeeeEEeecCCcceeE
Q 014034           83 RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGVLEHPNL-VKLIGYCAVDGERGIQR  158 (432)
Q Consensus        83 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~~~~  158 (432)
                      .+..|-.|-.-.+|+..+...   ....+..|++|........   -.+|..++..+..-++ .++++.+.  +      
T Consensus        40 ~i~~l~gGlTN~~y~v~~~~~---~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~--~------  108 (344)
T PLN02236         40 QVIPLKGAMTNEVFQIKWPTK---EGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFP--N------  108 (344)
T ss_pred             EEEEcCCcccceeEEEEeCCC---CCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEEC--C------
Confidence            345566688889999865311   1123467889987654332   3678888888854333 34555542  1      


Q ss_pred             EEEEeecCCCCHHHH-----------------hhcCCC--C--CCCHHHHHHHHHHH-----------------HHHHHH
Q 014034          159 LLVYEFMLNRSLEDH-----------------LFNRAF--P--PLPWKTRLHIILGA-----------------AEGLAY  200 (432)
Q Consensus       159 ~lv~e~~~~gsL~~~-----------------l~~~~~--~--~l~~~~~~~i~~~l-----------------~~~l~~  200 (432)
                      ..|++|+++.+|...                 ++....  .  +..+.....+..++                 ...+..
T Consensus       109 g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~  188 (344)
T PLN02236        109 GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINL  188 (344)
T ss_pred             ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHH
Confidence            248999987776421                 111110  0  11233333332211                 111111


Q ss_pred             ----hhc-CCCCceeecCCCCCceEEcC-CCceeeccccCCc
Q 014034          201 ----LHE-GLEVQVIYRDFKASNVLLDE-NFRPKLSDFGLAR  236 (432)
Q Consensus       201 ----LH~-~~~~~ivH~Dikp~Nill~~-~~~~kl~DfG~a~  236 (432)
                          +.. .....++|+|+++.|||+++ ++.+.++||..+.
T Consensus       189 L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        189 LEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             HHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence                221 22347899999999999986 5789999998874

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.67  E-value=0.0043  Score=61.65  Aligned_cols=170  Identities=25%  Similarity=0.347  Sum_probs=96.3

Q ss_pred             cChHHHHHHHHHhcccCCCccceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 014034          121 RDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY  200 (432)
Q Consensus       121 ~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~  200 (432)
                      ....++..-.++++.+.|+|....+.+.......   ..+|||++ +-+|++.+..+..   .....          +  
T Consensus        24 ~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r---~IVV~e~~-~~Sled~~~~~~l---~~~s~----------~--   84 (725)
T KOG1093|consen   24 PNSIQILGRFQYLKSLQHDNLCQYLDFSRGKHER---VIVVMEHY-TMSLEDILKTGNL---KDESL----------L--   84 (725)
T ss_pred             CcHHHHhhhhHHHHhhcCccceeeEeeecCccce---EEEEehhh-ccchHHHHHhccc---chhhh----------c--
Confidence            4455666778889999999999998877654443   57899999 7799998865431   11110          0  


Q ss_pred             hhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHH
Q 014034          201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVL  280 (432)
Q Consensus       201 LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil  280 (432)
                      -|     ++.|-     |+       .+++| .++..      .              |-     +..+++||||+|.++
T Consensus        85 ~~-----~~~~~-----~~-------~~~td-~~~t~------~--------------~~-----~~~pKsdVwsl~~i~  121 (725)
T KOG1093|consen   85 AH-----GVLHL-----NI-------IYITD-HFLTK------Y--------------PS-----PIGPKSDVWSLGFII  121 (725)
T ss_pred             cc-----cccee-----hh-------hhccc-ccccc------C--------------CC-----CCCcchhhhhHHHHH
Confidence            11     33322     22       33344 11100      0              10     111499999999999


Q ss_pred             HHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 014034          281 YEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE  358 (432)
Q Consensus       281 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  358 (432)
                      .++.-|..-+.....   ......+..+...+.....+.   ..............++...|+-..|..||...++.+
T Consensus       122 ~el~L~~~l~~~~~~---s~~l~~i~k~~~~d~~~~~~a---~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k  193 (725)
T KOG1093|consen  122 LELYLGISLEAELTE---SEYLEILLKYYTDDQELLSTA---MEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK  193 (725)
T ss_pred             HHHHHhhHHHHHHHH---HHHHHHHHHhccCchhHHHHH---HHHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence            999998766543222   222222333322221111000   001222344556778999999999999886655443

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.65  E-value=0.02  Score=54.46  Aligned_cols=31  Identities=19%  Similarity=0.355  Sum_probs=28.4

Q ss_pred             CceeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          207 VQVIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       207 ~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      ..++|+|+.+.||+++.++-+-+.||+++..
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            4799999999999999988899999999865

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.64  E-value=0.0091  Score=56.31  Aligned_cols=75  Identities=17%  Similarity=0.287  Sum_probs=45.3

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-HHHHHHHHHhcccC---CCccceeeeEEeecCCcce
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQWVAEVQFLGVLE---HPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~~  156 (432)
                      ....+.|+.|....+|+..         .++..+.+|.-.... ..|..|++-|+.|.   --.+.+++++....+..  
T Consensus        19 i~~~~~v~GG~i~~a~~~~---------~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~--   87 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD---------TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA--   87 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE---------TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC--
T ss_pred             eeeeEecCCCChhheEEEE---------CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc--
Confidence            3445678989999999876         356788999876432 34788888887773   44577888877665544  


Q ss_pred             eEEEEEeecCCC
Q 014034          157 QRLLVYEFMLNR  168 (432)
Q Consensus       157 ~~~lv~e~~~~g  168 (432)
                        +|||||++.+
T Consensus        88 --fLlle~l~~~   97 (288)
T PF03881_consen   88 --FLLLEFLEMG   97 (288)
T ss_dssp             --EEEEE-----
T ss_pred             --eEEEEeecCC
Confidence              9999999776

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.46  E-value=0.023  Score=54.32  Aligned_cols=29  Identities=21%  Similarity=0.299  Sum_probs=25.6

Q ss_pred             CceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          207 VQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       207 ~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            58999999999999987 678999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.44  E-value=0.0095  Score=57.74  Aligned_cols=61  Identities=16%  Similarity=0.083  Sum_probs=44.2

Q ss_pred             EEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCC
Q 014034          159 LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN  224 (432)
Q Consensus       159 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~  224 (432)
                      .|+-+|..|.++..++....   .++..+..++.-.+.|+--+---  -+.+|.|+.|.||++.-+
T Consensus       321 vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  321 VLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             eeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEEec
Confidence            67888899999999986543   55566666666666666444322  179999999999999543

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.40  E-value=0.058  Score=53.13  Aligned_cols=77  Identities=14%  Similarity=0.142  Sum_probs=50.2

Q ss_pred             cccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc-----------ChHHHHHHHHHhcccC---CCccceeeeEE
Q 014034           83 RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-----------DGLQWVAEVQFLGVLE---HPNLVKLIGYC  148 (432)
Q Consensus        83 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~-----------~~~~~~~E~~~l~~l~---hpniv~l~~~~  148 (432)
                      ..+.||.|....||+...         .+..++||+-..           .......|+..|+.+.   ..++.+++.++
T Consensus        36 ~~~eiggGn~N~VyrV~~---------~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d  106 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVS---------SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD  106 (418)
T ss_pred             eEEEcCCCceeeEEEEEc---------CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC
Confidence            356789999999999763         234588987541           2223455666666553   35788888887


Q ss_pred             eecCCcceeEEEEEeecCC--CCHHHHh
Q 014034          149 AVDGERGIQRLLVYEFMLN--RSLEDHL  174 (432)
Q Consensus       149 ~~~~~~~~~~~lv~e~~~~--gsL~~~l  174 (432)
                      .+..      +++|||+++  ..+.+.+
T Consensus       107 ed~~------vlvME~L~~~~~ilr~~L  128 (418)
T PLN02756        107 RTMA------LIGMRYLEPPHIILRKGL  128 (418)
T ss_pred             CCCC------EEEEeecCCcceehhhhh
Confidence            6332      889999977  2454443

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.32  E-value=0.01  Score=56.77  Aligned_cols=73  Identities=18%  Similarity=0.163  Sum_probs=57.9

Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                      ....|++|++. |++|.-.      ....+.+...++++.+.-+.-+..+  ...-|||+.-.||||+ +|++-|+||-+
T Consensus       298 ~~y~yl~~kdh-gt~is~i------k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkl  367 (488)
T COG5072         298 TLYLYLHFKDH-GTPISII------KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKL  367 (488)
T ss_pred             ceEEEEEEecC-Cceeeee------ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeee
Confidence            34457777765 5555322      2356889999999998888877776  4789999999999999 99999999999


Q ss_pred             CcC
Q 014034          235 ARE  237 (432)
Q Consensus       235 a~~  237 (432)
                      ++.
T Consensus       368 sRl  370 (488)
T COG5072         368 SRL  370 (488)
T ss_pred             eec
Confidence            984

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.32  E-value=0.023  Score=54.39  Aligned_cols=32  Identities=19%  Similarity=0.160  Sum_probs=28.7

Q ss_pred             CCceeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          206 EVQVIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       206 ~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      ..+++|+|+.+.|||+++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            35899999999999999999999999988754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.13  E-value=0.088  Score=50.99  Aligned_cols=76  Identities=13%  Similarity=0.101  Sum_probs=46.0

Q ss_pred             ccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc-----------ChHHHHHHHHHhcccC--CC-ccceeeeEEeec
Q 014034           86 KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-----------DGLQWVAEVQFLGVLE--HP-NLVKLIGYCAVD  151 (432)
Q Consensus        86 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~-----------~~~~~~~E~~~l~~l~--hp-niv~l~~~~~~~  151 (432)
                      .||.|...-||++...       ..+..|+||.-..           ...+..-|...|+...  -| .++++|.+-.+ 
T Consensus         2 EigdGnlN~VfrV~~~-------~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e-   73 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQ-------EGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTE-   73 (370)
T ss_pred             cCCCCceEEEEEEEcC-------CCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEccc-
Confidence            4799999999999742       2235799997432           1123456777776553  34 56666654322 


Q ss_pred             CCcceeEEEEEeecCCCC-HHHHh
Q 014034          152 GERGIQRLLVYEFMLNRS-LEDHL  174 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gs-L~~~l  174 (432)
                           ...+|||+++... |...|
T Consensus        74 -----~~~~vMEdL~~~~ilR~~L   92 (370)
T TIGR01767        74 -----MAVTVMEDLSHHKIARKGL   92 (370)
T ss_pred             -----cceehHhhCccchHHHHHH
Confidence                 1278999996543 33444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=95.98  E-value=0.045  Score=51.89  Aligned_cols=74  Identities=20%  Similarity=0.254  Sum_probs=45.0

Q ss_pred             ccCCceEEEEEEecC-CCCCCCcccEEEEEEecCcChH---------HHHHHHHHhcccC---------C----Ccccee
Q 014034           88 GEGGFGSVYKSSIKP-AAGDGTSEATVVAIKKLNRDGL---------QWVAEVQFLGVLE---------H----PNLVKL  144 (432)
Q Consensus        88 g~G~fg~Vy~~~~~~-~~~~~~~~~~~vaiK~~~~~~~---------~~~~E~~~l~~l~---------h----pniv~l  144 (432)
                      |.|-.|.+|+.+... ....+......++||.......         .|.+|+.+...+-         +    ..+.++
T Consensus         2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~   81 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC   81 (294)
T ss_pred             CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence            778889999998864 1223455667899999863221         2677877655431         1    234455


Q ss_pred             eeEEeecCCcceeEEEEEeec
Q 014034          145 IGYCAVDGERGIQRLLVYEFM  165 (432)
Q Consensus       145 ~~~~~~~~~~~~~~~lv~e~~  165 (432)
                      +......+    ..+||||-+
T Consensus        82 ~~~~~~~~----~~~lvlEDL   98 (294)
T PF02958_consen   82 YYADEDPG----DEVLVLEDL   98 (294)
T ss_pred             EEeccCCC----ceeeehhhh
Confidence            54443222    238899877

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.91  E-value=0.061  Score=51.97  Aligned_cols=140  Identities=19%  Similarity=0.285  Sum_probs=77.9

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH---HHHHHHHHhcccCCCcc-ceeeeEEeecCCcceeEEE
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGVLEHPNL-VKLIGYCAVDGERGIQRLL  160 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~~~~~l  160 (432)
                      +.|..|=...+|+......    ..+...|+++.......   .-.+|..+++.+..-++ .++++++.  +      -+
T Consensus        20 ~~l~gGlTN~~~~v~~~~~----~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~--~------G~   87 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEE----NGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG--N------GM   87 (330)
T ss_pred             EEeCCcccceEEEEEecCC----CCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC--C------cE
Confidence            4455577788898765311    11234788888765433   24678888888865444 34555441  1      24


Q ss_pred             EEeecCCCCHHHH-----------------hhcCCCC----CCCHHHHHHHHHHH----------------------HHH
Q 014034          161 VYEFMLNRSLEDH-----------------LFNRAFP----PLPWKTRLHIILGA----------------------AEG  197 (432)
Q Consensus       161 v~e~~~~gsL~~~-----------------l~~~~~~----~l~~~~~~~i~~~l----------------------~~~  197 (432)
                      |.+|+++..|...                 ++.....    +-.+.....+..++                      ..-
T Consensus        88 i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  167 (330)
T PLN02421         88 IQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDE  167 (330)
T ss_pred             eehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHH
Confidence            8999877765321                 1111100    11233322222221                      111


Q ss_pred             HH----Hhhc-CCCCceeecCCCCCceEEcC-CCceeeccccCCc
Q 014034          198 LA----YLHE-GLEVQVIYRDFKASNVLLDE-NFRPKLSDFGLAR  236 (432)
Q Consensus       198 l~----~LH~-~~~~~ivH~Dikp~Nill~~-~~~~kl~DfG~a~  236 (432)
                      +.    ++.. ..+.-.+|+|+.+.|||+++ ++.++++||..|-
T Consensus       168 ~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        168 IVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             HHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            11    1111 11235799999999999974 5789999999874

>PTZ00384 choline kinase; Provisional

Probab=94.96  E-value=0.28  Score=48.39  Aligned_cols=80  Identities=18%  Similarity=0.233  Sum_probs=46.5

Q ss_pred             cccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH---HHHHHHHHhcccCCCcc-ceeeeEEeecCCcceeE
Q 014034           83 RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGVLEHPNL-VKLIGYCAVDGERGIQR  158 (432)
Q Consensus        83 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~~~~  158 (432)
                      .++.|..|-...+|++......+ .....+.|.+........   .-.+|+.+++.+..-++ .++++.+.    .    
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~-~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~----  124 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDK-DRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----D----  124 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCC-CccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----C----
Confidence            34556668889999987531110 011112355544322211   23568999999865444 45555542    1    


Q ss_pred             EEEEeecCCCCHH
Q 014034          159 LLVYEFMLNRSLE  171 (432)
Q Consensus       159 ~lv~e~~~~gsL~  171 (432)
                      .+++||++|.+|.
T Consensus       125 g~l~efIeGr~l~  137 (383)
T PTZ00384        125 FTIQEWVEGNTMG  137 (383)
T ss_pred             EEEEEEeccccCC
Confidence            6899999988765

>PRK06148 hypothetical protein; Provisional

Probab=94.95  E-value=0.25  Score=55.07  Aligned_cols=32  Identities=41%  Similarity=0.453  Sum_probs=26.8

Q ss_pred             CCceeecCCCCCceEEcCCC--cee-eccccCCcC
Q 014034          206 EVQVIYRDFKASNVLLDENF--RPK-LSDFGLARE  237 (432)
Q Consensus       206 ~~~ivH~Dikp~Nill~~~~--~~k-l~DfG~a~~  237 (432)
                      ..++||+|+.+.|||++.++  .+. |+|||-+..
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            45899999999999999775  454 999998764

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.85  E-value=0.078  Score=47.41  Aligned_cols=121  Identities=15%  Similarity=0.124  Sum_probs=72.7

Q ss_pred             HHHHHHHHhcccCCCccceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 014034          125 QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG  204 (432)
Q Consensus       125 ~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~  204 (432)
                      .|..+..++++++  .|+++.    .+  .+...-++.|+|-...           ..+   .-.|... +.+|.-.|+.
T Consensus       104 ~y~nky~v~Armh--GilrL~----ND--n~~~yGvIlE~Cy~~~-----------i~~---~N~i~ag-i~~L~~fH~~  160 (308)
T PF07387_consen  104 LYFNKYRVFARMH--GILRLK----ND--NNYKYGVILERCYKIK-----------INF---SNFITAG-IKDLMDFHSE  160 (308)
T ss_pred             hhhhhhhHHHHhh--heeEee----cC--CCceeEEEEeeccCcc-----------cch---hHHHHHh-HHHHHHhhcc
Confidence            3677888888763  366654    12  2223457888883211           111   1112222 3678888964


Q ss_pred             CCCceeecCCCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHH
Q 014034          205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML  284 (432)
Q Consensus       205 ~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell  284 (432)
                       ..+.+|||..|+||+-|..|.+||.|-+.--.              .+..|.--|   ....++++.+=+|=.-++++.
T Consensus       161 -~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN~~---Y~~lT~~aE~~~fv~s~l~~v  222 (308)
T PF07387_consen  161 -NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVNIE---YESLTQEAEVKVFVKSCLKLV  222 (308)
T ss_pred             -CCCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeEEeee---ccccChHHHHHHHHHHHHHHH
Confidence             35899999999999999999999999876421              111122211   123456667766666666665


Q ss_pred             hC
Q 014034          285 TG  286 (432)
Q Consensus       285 tg  286 (432)
                      ..
T Consensus       223 ~~  224 (308)
T PF07387_consen  223 EK  224 (308)
T ss_pred             HH
Confidence            53

The function of this family is unknown.

>PRK12396 5-methylribose kinase; Reviewed

Probab=94.56  E-value=0.21  Score=49.08  Aligned_cols=78  Identities=21%  Similarity=0.241  Sum_probs=48.6

Q ss_pred             ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc----------ChHHHHHHHHHhcccC--CC-ccceeeeEEee
Q 014034           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR----------DGLQWVAEVQFLGVLE--HP-NLVKLIGYCAV  150 (432)
Q Consensus        84 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~----------~~~~~~~E~~~l~~l~--hp-niv~l~~~~~~  150 (432)
                      .+.||.|.-.-||++...       ..+..|+||.-..          ...+..-|.++|+.+.  -| +++++|.+-.+
T Consensus        34 ~~eigdGnlN~VfrV~~~-------~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e  106 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDE-------QKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSV  106 (409)
T ss_pred             eeEcCCCceEEEEEEeeC-------CCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcH
Confidence            457899999999999752       1235699987421          2234566777777653  34 56667654322


Q ss_pred             cCCcceeEEEEEeecCCCC-HHHHh
Q 014034          151 DGERGIQRLLVYEFMLNRS-LEDHL  174 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gs-L~~~l  174 (432)
                            ...+|||+++... |.+.|
T Consensus       107 ------~~~~vMEdL~~~~ilR~~L  125 (409)
T PRK12396        107 ------MNCCVMEDLSDHTILRTAL  125 (409)
T ss_pred             ------HhhHHHHhCcccHHHHHHH
Confidence                  1278999996533 44443

>PTZ00296 choline kinase; Provisional

Probab=94.52  E-value=0.38  Score=48.37  Aligned_cols=81  Identities=16%  Similarity=0.215  Sum_probs=48.8

Q ss_pred             cccccccCCceEEEEEEecCCC-CCCCcccEEEEEEecCcChHH---HHHHHHHhcccCCCccc-eeeeEEeecCCccee
Q 014034           83 RMLKIGEGGFGSVYKSSIKPAA-GDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGVLEHPNLV-KLIGYCAVDGERGIQ  157 (432)
Q Consensus        83 ~~~~lg~G~fg~Vy~~~~~~~~-~~~~~~~~~vaiK~~~~~~~~---~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~~~  157 (432)
                      .++.|..|=.-.+|+....... ......+..|.+++.......   -..|..+++.+..-+|- ++++.+.  +     
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~--g-----  181 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS--G-----  181 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC--C-----
Confidence            4456767777888988754211 011122467888887655433   35688888877544443 4555442  2     


Q ss_pred             EEEEEeecCCCCHH
Q 014034          158 RLLVYEFMLNRSLE  171 (432)
Q Consensus       158 ~~lv~e~~~~gsL~  171 (432)
                       ..|.+|++|.+|.
T Consensus       182 -g~I~efi~g~~l~  194 (442)
T PTZ00296        182 -GRIEEWLYGDPLR  194 (442)
T ss_pred             -CEEEEeeCCccCC
Confidence             5689999887553

>PRK10271 thiK thiamine kinase; Provisional

Probab=93.75  E-value=0.047  Score=47.78  Aligned_cols=30  Identities=20%  Similarity=0.255  Sum_probs=26.1

Q ss_pred             CceeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          207 VQVIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       207 ~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      ...+|+|+.|.||++++++ ++|+||+.+-.
T Consensus        77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            3579999999999998887 89999998853

>PHA03111 Ser/Thr kinase; Provisional

Probab=93.09  E-value=0.1  Score=49.36  Aligned_cols=51  Identities=22%  Similarity=0.167  Sum_probs=33.7

Q ss_pred             HHHHHHHHHHHHHHhhcC-CCCceeecCCCCCceEEcCCC------------------ceeeccccCCcC
Q 014034          187 RLHIILGAAEGLAYLHEG-LEVQVIYRDFKASNVLLDENF------------------RPKLSDFGLARE  237 (432)
Q Consensus       187 ~~~i~~~l~~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~------------------~~kl~DfG~a~~  237 (432)
                      +..++.||+.-.-.+-.. +..+.+|-||||+||||-+..                  .++|.||.+|+.
T Consensus       281 ikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv  350 (444)
T PHA03111        281 IKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQV  350 (444)
T ss_pred             HHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHH
Confidence            455777876544334222 234799999999999994322                  366778887764

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	432
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-50
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-49
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-49
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-47
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-37
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-37
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-36
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-34
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-20
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-20
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-20
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-19
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-19
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-19
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-19
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-19
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-19
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-19
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-18
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-18
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-18
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		6e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		8e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		9e-18
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-17
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-17
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-17
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-17
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-17
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-17
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-17
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-17
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-17
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-17
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-17
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-17
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-17
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-17
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-17
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-17
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-17
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-17
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-17
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-17
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-17
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-17
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-17
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-17
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-17
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-17
3b2t_A	311	Structure Of Phosphotransferase Length = 311		6e-17
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-17
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-17
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-17
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-17
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-17
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		7e-17
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		7e-17
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-17
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-17
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		7e-17
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		7e-17
1oec_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-17
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		7e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-17
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-17
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-17
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		8e-17
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		8e-17
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		9e-17
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-17
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-17
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		9e-17
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		9e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		9e-17
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		9e-17
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		9e-17
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-17
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-16
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-16
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-16
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-16
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-16
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-16
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-16
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-16
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-16
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-16
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-16
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-16
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-16
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-16
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-16
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-16
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-16
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-16
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-16
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-16
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-16
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-16
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-16
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-16
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-16
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-16
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		6e-16
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-16
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		6e-16
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-16
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-16
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-16
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-16
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-16
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-16
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		7e-16
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		7e-16
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-16
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-16
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-16
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-16
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-16
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		8e-16
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		8e-16
4h58_A	275	Braf In Complex With Compound 3 Length = 275		8e-16
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		9e-16
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-15
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-15
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-15
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-15
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-15
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-15
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-15
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-15
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-15
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-15
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-15
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-15
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-15
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-15
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-15
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-15
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-15
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-15
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-15
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-15
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-15
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-15
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-15
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-15
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-15
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-15
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-15
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-15
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		8e-15
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		8e-15
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		9e-15
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		9e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		9e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		9e-15
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-14
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-14
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-14
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-14
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-14
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-14
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-14
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-14
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		7e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		7e-14
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-13
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-13
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-13
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-13
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-13
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		7e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		7e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		7e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		7e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		9e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-12
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-12
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-12
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-12
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-12
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-12
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-12
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-12
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-12
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-12
3soa_A	444	Full-Length Human Camkii Length = 444		6e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-12
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		7e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		7e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		7e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		8e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		8e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		8e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-11
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-11
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-11
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		6e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		6e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-11
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		8e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		8e-11
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		8e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		8e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		8e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		8e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		9e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		9e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		9e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		9e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		9e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		9e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-10
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-10
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-10
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-10
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-10
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-10
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-10
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-10
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-10
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-10
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-10
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-10
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-10
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-10
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-10
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-10
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-10
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-10
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-10
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-10
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-10
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-10
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-10
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-10
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-10
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-10
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-10
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-10
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-10
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-10
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-10
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-10
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-10
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-10
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-10
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-10
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-10
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-10
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-10
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-10
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-10
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-10
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		5e-10
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-10
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		6e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-10
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		7e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-10
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		8e-10
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		8e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-10
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		8e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		9e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		9e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-09
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-09
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-09
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-09
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-09
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-09
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		7e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		8e-09
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		8e-09
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		8e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		8e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		8e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		8e-09
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		9e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		9e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		9e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		9e-09
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		9e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-08
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-08
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-08
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-08
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-08
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		7e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		7e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		7e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		7e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		7e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		7e-08
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		8e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		8e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		8e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		9e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		9e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		9e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		9e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		9e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		9e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-07
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-07
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-07
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-07
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-07
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-07
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-07
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-07
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-07
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-07
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		5e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		5e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		6e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		7e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		7e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		7e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		7e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		8e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		8e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		8e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		9e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		9e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		9e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		9e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		9e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-06
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-06
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-06
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-06
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-06
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		4e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		5e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		7e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		8e-06
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-05

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  196 bits (499), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 114/295 (38%), Positives = 171/295 (57%), Gaps = 22/295 (7%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----WVA 128
           ++ +ATN+F     IG G FG VYK  ++  A         VA+K+   +  Q    +  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK--------VALKRRTPESSQGIEEFET 84
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP--WKT 186
           E++ L    HP+LV LIG+C    ER  + +L+Y++M N +L+ HL+    P +   W+ 
Sbjct: 85  EIETLSFCRHPHLVSLIGFC---DERN-EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
           RL I +GAA GL YLH      +I+RD K+ N+LLDENF PK++DFG++++G  +G TH+
Sbjct: 141 RLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHL 197
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 306
              V GT GY  P+Y   G LT KSDV+SFGVVL+E+L  R ++ ++ P+    L EW  
Sbjct: 198 XXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257
Query: 307 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 361
           +   ++ +   I+DP L  +      RK G  A  CL+ SS+DRP M  V+ +L+
Sbjct: 258 E-SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  194 bits (492), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 113/295 (38%), Positives = 170/295 (57%), Gaps = 22/295 (7%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----WVA 128
           ++ +ATN+F     IG G FG VYK  ++  A         VA+K+   +  Q    +  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK--------VALKRRTPESSQGIEEFET 84
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP--WKT 186
           E++ L    HP+LV LIG+C    ER  + +L+Y++M N +L+ HL+    P +   W+ 
Sbjct: 85  EIETLSFCRHPHLVSLIGFC---DERN-EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
           RL I +GAA GL YLH      +I+RD K+ N+LLDENF PK++DFG++++G  +  TH+
Sbjct: 141 RLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 306
              V GT GY  P+Y   G LT KSDV+SFGVVL+E+L  R ++ ++ P+    L EW  
Sbjct: 198 XXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257
Query: 307 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 361
           +   ++ +   I+DP L  +      RK G  A  CL+ SS+DRP M  V+ +L+
Sbjct: 258 E-SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  192 bits (488), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 122/329 (37%), Positives = 186/329 (56%), Gaps = 31/329 (9%)
Query: 65  NLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-- 122
            L+ FS  E++ A+++FS    +G GGFG VYK  +        ++ T+VA+K+L  +  
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL--------ADGTLVAVKRLKEERX 75
Query: 123 ---GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-- 177
               LQ+  EV+ + +  H NL++L G+C    ER    LLVY +M N S+   L  R  
Sbjct: 76  QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER----LLVYPYMANGSVASCLRERPE 131
Query: 178 AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE 237
           + PPL W  R  I LG+A GLAYLH+  + ++I+RD KA+N+LLDE F   + DFGLA+ 
Sbjct: 132 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 191
Query: 238 GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT 297
                  HV  AV GT G+ AP+Y+ TG  + K+DV+ +GV+L E++TG+R+ +  R   
Sbjct: 192 MD-YKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 250
Query: 298 EQ--RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 355
           +    LL+WV+    + KK   ++D  L+  Y   E  ++ ++A  C   S  +RPKMS+
Sbjct: 251 DDDVMLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE 309
Query: 356 VVERLKQIVQVSNEGDSFDKTFEEICEED 384
           VV  L        EGD   + +EE  +E+
Sbjct: 310 VVRML--------EGDGLAERWEEWQKEE 330

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  186 bits (472), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 119/329 (36%), Positives = 183/329 (55%), Gaps = 31/329 (9%)
Query: 65  NLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-- 122
            L+ FS  E++ A+++F     +G GGFG VYK  +        ++  +VA+K+L  +  
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRL--------ADGXLVAVKRLKEERT 67
Query: 123 ---GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-- 177
               LQ+  EV+ + +  H NL++L G+C    ER    LLVY +M N S+   L  R  
Sbjct: 68  QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER----LLVYPYMANGSVASCLRERPE 123
Query: 178 AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE 237
           + PPL W  R  I LG+A GLAYLH+  + ++I+RD KA+N+LLDE F   + DFGLA+ 
Sbjct: 124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183
Query: 238 GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT 297
                  HV  AV G  G+ AP+Y+ TG  + K+DV+ +GV+L E++TG+R+ +  R   
Sbjct: 184 MD-YKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242
Query: 298 EQ--RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 355
           +    LL+WV+    + KK   ++D  L+  Y   E  ++ ++A  C   S  +RPKMS+
Sbjct: 243 DDDVMLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE 301
Query: 356 VVERLKQIVQVSNEGDSFDKTFEEICEED 384
           VV  L        EGD   + +EE  +E+
Sbjct: 302 VVRML--------EGDGLAERWEEWQKEE 322

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  154 bits (389), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 109/311 (35%), Positives = 165/311 (53%), Gaps = 35/311 (11%)
Query: 69  FSYSEMRQATNDFSRM------LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL--- 119
           FS+ E++  TN+F          K+GEGGFG VYK         G    T VA+KKL   
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYK---------GYVNNTTVAVKKLAAM 65
Query: 120 ---NRDGL--QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL 174
                + L  Q+  E++ +   +H NLV+L+G+ + DG+      LVY +M N SL D L
Sbjct: 66  VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS-DGD---DLCLVYVYMPNGSLLDRL 121
Query: 175 FN-RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG 233
                 PPL W  R  I  GAA G+ +LHE      I+RD K++N+LLDE F  K+SDFG
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFG 178
Query: 234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           LAR       T + + +VGT  Y AP+ +  G +T KSD++SFGVVL E++TG  +++ +
Sbjct: 179 LARASEKFAQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH 237
Query: 294 RPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM 353
           R    Q LL+  ++   + K     +D ++    S +    +  +A  CL +    RP +
Sbjct: 238 REP--QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTS-VEAMYSVASQCLHEKKNKRPDI 294
Query: 354 SQVVERLKQIV 364
            +V + L+++ 
Sbjct: 295 KKVQQLLQEMT 305

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 109/311 (35%), Positives = 164/311 (52%), Gaps = 35/311 (11%)
Query: 69  FSYSEMRQATNDFSRM------LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL--- 119
           FS+ E++  TN+F          K+GEGGFG VYK         G    T VA+KKL   
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYK---------GYVNNTTVAVKKLAAM 65
Query: 120 ---NRDGL--QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL 174
                + L  Q+  E++ +   +H NLV+L+G+ + DG+      LVY +M N SL D L
Sbjct: 66  VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS-DGD---DLCLVYVYMPNGSLLDRL 121
Query: 175 FN-RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG 233
                 PPL W  R  I  GAA G+ +LHE      I+RD K++N+LLDE F  K+SDFG
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFG 178
Query: 234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           LAR       T +   +VGT  Y AP+ +  G +T KSD++SFGVVL E++TG  +++ +
Sbjct: 179 LARASEKFAQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH 237
Query: 294 RPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM 353
           R    Q LL+  ++   + K     +D ++    S +    +  +A  CL +    RP +
Sbjct: 238 REP--QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTS-VEAMYSVASQCLHEKKNKRPDI 294
Query: 354 SQVVERLKQIV 364
            +V + L+++ 
Sbjct: 295 KKVQQLLQEMT 305

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 108/311 (34%), Positives = 163/311 (52%), Gaps = 35/311 (11%)
Query: 69  FSYSEMRQATNDFSRM------LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL--- 119
           FS+ E++  TN+F          K+GEGGFG VYK         G    T VA+KKL   
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYK---------GYVNNTTVAVKKLAAM 59
Query: 120 ---NRDGL--QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL 174
                + L  Q+  E++ +   +H NLV+L+G+ + DG+      LVY +M N SL D L
Sbjct: 60  VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS-DGD---DLCLVYVYMPNGSLLDRL 115
Query: 175 FN-RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG 233
                 PPL W  R  I  GAA G+ +LHE      I+RD K++N+LLDE F  K+SDFG
Sbjct: 116 SCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFG 172
Query: 234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           LAR         +   +VGT  Y AP+ +  G +T KSD++SFGVVL E++TG  +++ +
Sbjct: 173 LARASEKFAQXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH 231
Query: 294 RPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM 353
           R    Q LL+  ++   + K     +D ++    S +    +  +A  CL +    RP +
Sbjct: 232 REP--QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTS-VEAMYSVASQCLHEKKNKRPDI 288
Query: 354 SQVVERLKQIV 364
            +V + L+++ 
Sbjct: 289 KKVQQLLQEMT 299

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 107/309 (34%), Positives = 157/309 (50%), Gaps = 35/309 (11%)
Query: 69  FSYSEMRQATNDFSRM------LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL--- 119
           FS+ E++  TN+F          K GEGGFG VYK         G    T VA+KKL   
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYK---------GYVNNTTVAVKKLAAM 56
Query: 120 ---NRDGL--QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL 174
                + L  Q+  E++     +H NLV+L+G+ + DG+      LVY +  N SL D L
Sbjct: 57  VDITTEELKQQFDQEIKVXAKCQHENLVELLGFSS-DGD---DLCLVYVYXPNGSLLDRL 112
Query: 175 FN-RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG 233
                 PPL W  R  I  GAA G+ +LHE      I+RD K++N+LLDE F  K+SDFG
Sbjct: 113 SCLDGTPPLSWHXRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFG 169
Query: 234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           LAR           + +VGT  Y AP+ +  G +T KSD++SFGVVL E++TG  +++ +
Sbjct: 170 LARASEKFAQXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH 228
Query: 294 RPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM 353
           R    Q LL+  ++   + K     +D +     S +       +A  CL +    RP +
Sbjct: 229 REP--QLLLDIKEEIEDEEKTIEDYIDKKXNDADSTS-VEAXYSVASQCLHEKKNKRPDI 285
Query: 354 SQVVERLKQ 362
            +V + L++
Sbjct: 286 KKVQQLLQE 294

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 126/292 (43%), Gaps = 50/292 (17%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWV----AEVQFLGVLEHPNLV 142
           IG GGFG VY+     A   G   A   A    + D  Q +     E +   +L+HPN++
Sbjct: 15  IGIGGFGKVYR-----AFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPP---LPWKTRLHIILGAAEGLA 199
            L G C     +     LV EF     L   L  +  PP   + W  ++      A G+ 
Sbjct: 70  ALRGVCL----KEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQI------ARGMN 119
Query: 200 YLHEGLEVQVIYRDFKASNVLLDE--------NFRPKLSDFGLAREGPMVGHTHVSTAVV 251
           YLH+   V +I+RD K+SN+L+ +        N   K++DFGLARE     H     +  
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW----HRTTKMSAA 175
Query: 252 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 311
           G + + AP+ I     +  SDVWS+GV+L+E+LTG                   +     
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF---------------RGIDGL 220
Query: 312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
           +  +G+ M+ +L             +L ++C +     RP  + ++++L  I
Sbjct: 221 AVAYGVAMN-KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 95/295 (32%), Positives = 133/295 (45%), Gaps = 31/295 (10%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQ----WVAEVQFLGV 135
             ++  +GEG FG V      P   DGT E  +VA+K L  D G Q    W  E+  L  
Sbjct: 16  LKKIRDLGEGHFGKVSLYCYDPT-NDGTGE--MVAVKALKADCGPQHRSGWKQEIDILRT 72
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
           L H +++K  G C   GE+ +Q  LV E++   SL D+L   +   +     L       
Sbjct: 73  LYHEHIIKYKGCCEDQGEKSLQ--LVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQIC 127
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG--- 252
           EG+AYLH       I+R+  A NVLLD +   K+ DFGLA+  P  GH +      G   
Sbjct: 128 EGMAYLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSP 183
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 312
            F YA P+ ++       SDVWSFGV LYE+LT   S     P T  + LE +    A  
Sbjct: 184 VFWYA-PECLKEYKFYYASDVWSFGVTLYELLTHCDS--SQSPPT--KFLELIGI--AQG 236
Query: 313 KKFGLIMDPRLEKEYSINEARK----IGRLADNCLSKSSKDRPKMSQVVERLKQI 363
           +   L +   LE+   +    K    +  L  NC    +  RP    ++  LK +
Sbjct: 237 QMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTV 291

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 95/295 (32%), Positives = 133/295 (45%), Gaps = 31/295 (10%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQ----WVAEVQFLGV 135
             ++  +GEG FG V      P   DGT E  +VA+K L  D G Q    W  E+  L  
Sbjct: 16  LKKIRDLGEGHFGKVSLYCYDPT-NDGTGE--MVAVKALKADCGPQHRSGWKQEIDILRT 72
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
           L H +++K  G C   GE+ +Q  LV E++   SL D+L   +   +     L       
Sbjct: 73  LYHEHIIKYKGCCEDQGEKSLQ--LVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQIC 127
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG--- 252
           EG+AYLH       I+R+  A NVLLD +   K+ DFGLA+  P  GH +      G   
Sbjct: 128 EGMAYLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSP 183
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 312
            F YA P+ ++       SDVWSFGV LYE+LT   S     P T  + LE +    A  
Sbjct: 184 VFWYA-PECLKEYKFYYASDVWSFGVTLYELLTHCDS--SQSPPT--KFLELIGI--AQG 236
Query: 313 KKFGLIMDPRLEKEYSINEARK----IGRLADNCLSKSSKDRPKMSQVVERLKQI 363
           +   L +   LE+   +    K    +  L  NC    +  RP    ++  LK +
Sbjct: 237 QMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTV 291

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/218 (36%), Positives = 106/218 (48%), Gaps = 31/218 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-------RDGLQWVAEVQFL 133
             ++  +GEG FG V      P   DGT E  +VA+K L        R G  W  E++ L
Sbjct: 11  LKKIRDLGEGHFGKVSLYCYDPT-NDGTGE--MVAVKALKEGCGPQLRSG--WQREIEIL 65
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L H ++VK  G C   GE+ +Q  LV E++   SL D+L      P        ++L 
Sbjct: 66  RTLYHEHIVKYKGCCEDQGEKSVQ--LVMEYVPLGSLRDYL------PRHCVGLAQLLLF 117
Query: 194 A---AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           A    EG+AYLH       I+R   A NVLLD +   K+ DFGLA+  P  GH +     
Sbjct: 118 AQQICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVRE 173
Query: 251 VG---TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            G    F YA P+ ++       SDVWSFGV LYE+LT
Sbjct: 174 DGDSPVFWYA-PECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/218 (36%), Positives = 106/218 (48%), Gaps = 31/218 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-------RDGLQWVAEVQFL 133
             ++  +GEG FG V      P   DGT E  +VA+K L        R G  W  E++ L
Sbjct: 10  LKKIRDLGEGHFGKVSLYCYDPT-NDGTGE--MVAVKALKEGCGPQLRSG--WQREIEIL 64
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L H ++VK  G C   GE+ +Q  LV E++   SL D+L      P        ++L 
Sbjct: 65  RTLYHEHIVKYKGCCEDQGEKSVQ--LVMEYVPLGSLRDYL------PRHCVGLAQLLLF 116
Query: 194 A---AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           A    EG+AYLH       I+R   A NVLLD +   K+ DFGLA+  P  GH +     
Sbjct: 117 AQQICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVRE 172
Query: 251 VG---TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            G    F YA P+ ++       SDVWSFGV LYE+LT
Sbjct: 173 DGDSPVFWYA-PECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/304 (27%), Positives = 134/304 (44%), Gaps = 42/304 (13%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGV 135
            D +   K+G G FG VY+   K         +  VA+K L  D ++   ++ E   +  
Sbjct: 11  TDITMKHKLGGGQFGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 63
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
           ++HPNLV+L+G C     R     ++ EFM   +L D+L       +     L++    +
Sbjct: 64  IKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 119
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT-- 253
             + YL +      I+RD  A N L+ EN   K++DFGL+R   M G T   TA  G   
Sbjct: 120 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGDT--XTAHAGAKF 172
Query: 254 -FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD 311
              + AP+ +     + KSDVW+FGV+L+E+ T G        P     LLE        
Sbjct: 173 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE-------- 224
Query: 312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGD 371
                   D R+E+     E  K+  L   C   +  DRP  +++ +  + + Q S+  D
Sbjct: 225 -------KDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 275
Query: 372 SFDK 375
             +K
Sbjct: 276 EVEK 279

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 125/255 (49%), Gaps = 28/255 (10%)
Query: 114 VAIKKLNRDGLQ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL 170
           VAIK +    +    ++ E + +  L HP LV+L G C           LV+EFM +  L
Sbjct: 34  VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA----PICLVFEFMEHGCL 89
Query: 171 EDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS 230
            D+L  +       +T L + L   EG+AYL E     VI+RD  A N L+ EN   K+S
Sbjct: 90  SDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVS 145
Query: 231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
           DFG+ R      +T  ST       +A+P+       ++KSDVWSFGV+++E+ +  +  
Sbjct: 146 DFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 204
Query: 291 ERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDR 350
             NR  +E  ++E +      S  F L   PRL   +       + ++ ++C  +  +DR
Sbjct: 205 YENRSNSE--VVEDI------STGFRL-YKPRLASTH-------VYQIMNHCWKERPEDR 248
Query: 351 PKMSQVVERLKQIVQ 365
           P  S+++ +L +I +
Sbjct: 249 PAFSRLLRQLAEIAE 263

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 125/255 (49%), Gaps = 28/255 (10%)
Query: 114 VAIKKLNRDGLQ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL 170
           VAIK +    +    ++ E + +  L HP LV+L G C           LV+EFM +  L
Sbjct: 32  VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA----PICLVFEFMEHGCL 87
Query: 171 EDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS 230
            D+L  +       +T L + L   EG+AYL E     VI+RD  A N L+ EN   K+S
Sbjct: 88  SDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVS 143
Query: 231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
           DFG+ R      +T  ST       +A+P+       ++KSDVWSFGV+++E+ +  +  
Sbjct: 144 DFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 202
Query: 291 ERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDR 350
             NR  +E  ++E +      S  F L   PRL   +       + ++ ++C  +  +DR
Sbjct: 203 YENRSNSE--VVEDI------STGFRL-YKPRLASTH-------VYQIMNHCWKERPEDR 246
Query: 351 PKMSQVVERLKQIVQ 365
           P  S+++ +L +I +
Sbjct: 247 PAFSRLLRQLAEIAE 261

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 87/316 (27%), Positives = 144/316 (45%), Gaps = 48/316 (15%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---W 126
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++   +
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEEF 58
Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPW 184
           + E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR       
Sbjct: 59  LKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQ------ 108
Query: 185 KTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
           +    ++L  A  ++   E LE +  I+RD  A N L+ EN   K++DFGL+R   M G 
Sbjct: 109 EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGD 166
Query: 244 THVSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 302
           T+ + A       + AP+ +     + KSDVW+FGV+L+E+ T   S             
Sbjct: 167 TYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------- 213
Query: 303 EWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER 359
                YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ + 
Sbjct: 214 ----PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQA 267
Query: 360 LKQIVQVSNEGDSFDK 375
            + + Q S+  D  +K
Sbjct: 268 FETMFQESSISDEVEK 283

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 87/316 (27%), Positives = 144/316 (45%), Gaps = 48/316 (15%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---W 126
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++   +
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEEF 61
Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPW 184
           + E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR       
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQ------ 111
Query: 185 KTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
           +    ++L  A  ++   E LE +  I+RD  A N L+ EN   K++DFGL+R   M G 
Sbjct: 112 EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGD 169
Query: 244 THVSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 302
           T+ + A       + AP+ +     + KSDVW+FGV+L+E+ T   S             
Sbjct: 170 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------- 216
Query: 303 EWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER 359
                YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ + 
Sbjct: 217 ----PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQA 270
Query: 360 LKQIVQVSNEGDSFDK 375
            + + Q S+  D  +K
Sbjct: 271 FETMFQESSISDEVEK 286

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 87/316 (27%), Positives = 144/316 (45%), Gaps = 48/316 (15%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---W 126
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++   +
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEEF 57
Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPW 184
           + E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR       
Sbjct: 58  LKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQ------ 107
Query: 185 KTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
           +    ++L  A  ++   E LE +  I+RD  A N L+ EN   K++DFGL+R   M G 
Sbjct: 108 EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGD 165
Query: 244 THVSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 302
           T+ + A       + AP+ +     + KSDVW+FGV+L+E+ T   S             
Sbjct: 166 TYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------- 212
Query: 303 EWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER 359
                YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ + 
Sbjct: 213 ----PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQA 266
Query: 360 LKQIVQVSNEGDSFDK 375
            + + Q S+  D  +K
Sbjct: 267 FETMFQESSISDEVEK 282

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 120/255 (47%), Gaps = 28/255 (10%)
Query: 114 VAIKKLNRDGLQ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL 170
           VAIK +    +    ++ E + +  L HP LV+L G C           LV+EFM +  L
Sbjct: 37  VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA----PICLVFEFMEHGCL 92
Query: 171 EDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS 230
            D+L  +       +T L + L   EG+AYL E     VI+RD  A N L+ EN   K+S
Sbjct: 93  SDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVS 148
Query: 231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
           DFG+ R      +T  ST       +A+P+       ++KSDVWSFGV+++E+ +  +  
Sbjct: 149 DFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 207
Query: 291 ERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDR 350
             NR  +E            D      +  PRL   +       + ++ ++C  +  +DR
Sbjct: 208 YENRSNSE---------VVEDISTGFRLYKPRLASTH-------VYQIMNHCWRERPEDR 251
Query: 351 PKMSQVVERLKQIVQ 365
           P  S+++ +L +I +
Sbjct: 252 PAFSRLLRQLAEIAE 266

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 83/313 (26%), Positives = 140/313 (44%), Gaps = 42/313 (13%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---W 126
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++   +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEEF 56
Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKT 186
           + E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L       +    
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCT----REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVV 112
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            L++    +  + YL +      I+RD  A N L+ EN   K++DFGL+R   M G T+ 
Sbjct: 113 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGDTYT 167
Query: 247 STAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 305
           + A       + AP+ +     + KSDVW+FGV+L+E+ T   S                
Sbjct: 168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------- 211
Query: 306 QQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ 362
             YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ +  + 
Sbjct: 212 -PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFET 268
Query: 363 IVQVSNEGDSFDK 375
           + Q S+  D  +K
Sbjct: 269 MFQESSISDEVEK 281

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 83/313 (26%), Positives = 140/313 (44%), Gaps = 42/313 (13%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---W 126
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++   +
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEEF 61
Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKT 186
           + E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L       +    
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 117
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            L++    +  + YL +      I+RD  A N L+ EN   K++DFGL+R   M G T+ 
Sbjct: 118 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGDTYT 172
Query: 247 STAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 305
           + A       + AP+ +     + KSDVW+FGV+L+E+ T   S                
Sbjct: 173 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------- 216
Query: 306 QQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ 362
             YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ +  + 
Sbjct: 217 -PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFET 273
Query: 363 IVQVSNEGDSFDK 375
           + Q S+  D  +K
Sbjct: 274 MFQESSISDEVEK 286

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 95/295 (32%), Positives = 130/295 (44%), Gaps = 31/295 (10%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQ----WVAEVQFLGV 135
             ++  +GEG FG V      P   DGT E  +VA+K L  D G Q    W  E+  L  
Sbjct: 33  LKKIRDLGEGHFGKVSLYCYDPT-NDGTGE--MVAVKALKADAGPQHRSGWKQEIDILRT 89
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
           L H +++K  G C   G   +Q  LV E++   SL D+L   +   +     L       
Sbjct: 90  LYHEHIIKYKGCCEDAGAASLQ--LVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQIC 144
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG--- 252
           EG+AYLH       I+RD  A NVLLD +   K+ DFGLA+  P  GH        G   
Sbjct: 145 EGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEXYRVREDGDSP 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 312
            F YA P+ ++       SDVWSFGV LYE+LT   S     P T  + LE +    A  
Sbjct: 201 VFWYA-PECLKEYKFYYASDVWSFGVTLYELLTHCDS--SQSPPT--KFLELIGI--AQG 253
Query: 313 KKFGLIMDPRLEKEYSINEARK----IGRLADNCLSKSSKDRPKMSQVVERLKQI 363
           +   L +   LE+   +    K    +  L  NC    +  RP    ++  LK +
Sbjct: 254 QMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 83/313 (26%), Positives = 140/313 (44%), Gaps = 42/313 (13%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---W 126
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++   +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEEF 56
Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKT 186
           + E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L       +    
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 112
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            L++    +  + YL +      I+RD  A N L+ EN   K++DFGL+R   M G T+ 
Sbjct: 113 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGDTYT 167
Query: 247 STAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 305
           + A       + AP+ +     + KSDVW+FGV+L+E+ T   S                
Sbjct: 168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------- 211
Query: 306 QQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ 362
             YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ +  + 
Sbjct: 212 -PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFET 268
Query: 363 IVQVSNEGDSFDK 375
           + Q S+  D  +K
Sbjct: 269 MFQESSISDEVEK 281

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 83/313 (26%), Positives = 140/313 (44%), Gaps = 42/313 (13%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---W 126
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++   +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEEF 56
Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKT 186
           + E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L       +    
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCT----REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVV 112
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            L++    +  + YL +      I+RD  A N L+ EN   K++DFGL+R   M G T+ 
Sbjct: 113 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGDTYT 167
Query: 247 STAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 305
           + A       + AP+ +     + KSDVW+FGV+L+E+ T   S                
Sbjct: 168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------- 211
Query: 306 QQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ 362
             YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ +  + 
Sbjct: 212 -PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFET 268
Query: 363 IVQVSNEGDSFDK 375
           + Q S+  D  +K
Sbjct: 269 MFQESSISDEVEK 281

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 133/302 (44%), Gaps = 38/302 (12%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGV 135
            D +   K+G G +G VY+   K         +  VA+K L  D ++   ++ E   +  
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 63
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
           ++HPNLV+L+G C     R     ++ EFM   +L D+L       +     L++    +
Sbjct: 64  IKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 119
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG-TF 254
             + YL +      I+RD  A N L+ EN   K++DFGL+R   M G T  + A      
Sbjct: 120 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGDTFTAHAGAKFPI 174
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSK 313
            + AP+ +     + KSDVW+FGV+L+E+ T G        P     LLE          
Sbjct: 175 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE---------- 224
Query: 314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSF 373
                 D R+E+     E  K+  L   C   +  DRP  +++ +  + + Q S+  D  
Sbjct: 225 -----KDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 277
Query: 374 DK 375
           +K
Sbjct: 278 EK 279

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 125/255 (49%), Gaps = 28/255 (10%)
Query: 114 VAIKKLNRDGLQ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL 170
           VAIK +    +    ++ E + +  L HP LV+L G C           LV+EFM +  L
Sbjct: 54  VAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQA----PICLVFEFMEHGCL 109
Query: 171 EDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS 230
            D+L  +       +T L + L   EG+AYL E     VI+RD  A N L+ EN   K+S
Sbjct: 110 SDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVS 165
Query: 231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
           DFG+ R      +T  ST       +A+P+       ++KSDVWSFGV+++E+ +  +  
Sbjct: 166 DFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 224
Query: 291 ERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDR 350
             NR  +E  ++E +      S  F L   PRL   +       + ++ ++C  +  +DR
Sbjct: 225 YENRSNSE--VVEDI------STGFRL-YKPRLASTH-------VYQIMNHCWKERPEDR 268
Query: 351 PKMSQVVERLKQIVQ 365
           P  S+++ +L +I +
Sbjct: 269 PAFSRLLRQLAEIAE 283

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 83/313 (26%), Positives = 140/313 (44%), Gaps = 42/313 (13%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---W 126
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++   +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEEF 56
Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKT 186
           + E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L       +    
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 112
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            L++    +  + YL +      I+RD  A N L+ EN   K++DFGL+R   M G T+ 
Sbjct: 113 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGDTYT 167
Query: 247 STAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 305
           + A       + AP+ +     + KSDVW+FGV+L+E+ T   S                
Sbjct: 168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------- 211
Query: 306 QQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ 362
             YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ +  + 
Sbjct: 212 -PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFET 268
Query: 363 IVQVSNEGDSFDK 375
           + Q S+  D  +K
Sbjct: 269 MFQESSISDEVEK 281

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 87/316 (27%), Positives = 144/316 (45%), Gaps = 48/316 (15%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---W 126
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++   +
Sbjct: 17  NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEEF 69
Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPW 184
           + E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR       
Sbjct: 70  LKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQ------ 119
Query: 185 KTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
           +    ++L  A  ++   E LE +  I+RD  A N L+ EN   K++DFGL+R   M G 
Sbjct: 120 EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGD 177
Query: 244 THVSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 302
           T+ + A       + AP+ +     + KSDVW+FGV+L+E+ T   S             
Sbjct: 178 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------- 224
Query: 303 EWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER 359
                YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ + 
Sbjct: 225 ----PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQA 278
Query: 360 LKQIVQVSNEGDSFDK 375
            + + Q S+  D  +K
Sbjct: 279 FETMFQESSISDEVEK 294

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 87/316 (27%), Positives = 144/316 (45%), Gaps = 48/316 (15%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---W 126
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++   +
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEEF 58
Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPW 184
           + E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR       
Sbjct: 59  LKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQ------ 108
Query: 185 KTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
           +    ++L  A  ++   E LE +  I+RD  A N L+ EN   K++DFGL+R   M G 
Sbjct: 109 EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGD 166
Query: 244 THVSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 302
           T+ + A       + AP+ +     + KSDVW+FGV+L+E+ T   S             
Sbjct: 167 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------- 213
Query: 303 EWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER 359
                YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ + 
Sbjct: 214 ----PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQA 267
Query: 360 LKQIVQVSNEGDSFDK 375
            + + Q S+  D  +K
Sbjct: 268 FETMFQESSISDEVEK 283

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 87/316 (27%), Positives = 144/316 (45%), Gaps = 48/316 (15%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---W 126
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++   +
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEEF 58
Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPW 184
           + E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR       
Sbjct: 59  LKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQ------ 108
Query: 185 KTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
           +    ++L  A  ++   E LE +  I+RD  A N L+ EN   K++DFGL+R   M G 
Sbjct: 109 EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGD 166
Query: 244 THVSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 302
           T+ + A       + AP+ +     + KSDVW+FGV+L+E+ T   S             
Sbjct: 167 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------- 213
Query: 303 EWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER 359
                YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ + 
Sbjct: 214 ----PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQA 267
Query: 360 LKQIVQVSNEGDSFDK 375
            + + Q S+  D  +K
Sbjct: 268 FETMFQESSISDEVEK 283

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 77/253 (30%), Positives = 123/253 (48%), Gaps = 28/253 (11%)
Query: 114 VAIKKLNRDGLQ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL 170
           VAIK +    +    ++ E + +  L HP LV+L G C           LV+EFM +  L
Sbjct: 34  VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA----PICLVFEFMEHGCL 89
Query: 171 EDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS 230
            D+L  +       +T L + L   EG+AYL E     VI+RD  A N L+ EN   K+S
Sbjct: 90  SDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---SVIHRDLAARNCLVGENQVIKVS 145
Query: 231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
           DFG+ R      +T  ST       +A+P+       ++KSDVWSFGV+++E+ +  +  
Sbjct: 146 DFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 204
Query: 291 ERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDR 350
             NR  +E  ++E +      S  F L   PRL   +       + ++ ++C  +  +DR
Sbjct: 205 YENRSNSE--VVEDI------STGFRL-YKPRLASTH-------VYQIMNHCWKERPEDR 248
Query: 351 PKMSQVVERLKQI 363
           P  S+++ +L  I
Sbjct: 249 PAFSRLLRQLAAI 261

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 89/318 (27%), Positives = 144/318 (45%), Gaps = 52/318 (16%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---W 126
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++   +
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEEF 57
Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPW 184
           + E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR       
Sbjct: 58  LKEAAVMKEIKHPNLVQLLGVCT----REPPFYIIIEFMTYGNLLDYLRECNRQ------ 107
Query: 185 KTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
           +    ++L  A  ++   E LE +  I+RD  A N L+ EN   K++DFGL+R   M G 
Sbjct: 108 EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGD 165
Query: 244 THVSTAVVGT---FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR 300
           T   TA  G      + AP+ +     + KSDVW+FGV+L+E+ T   S           
Sbjct: 166 T--XTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS----------- 212
Query: 301 LLEWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 357
                  YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ 
Sbjct: 213 ------PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIH 264
Query: 358 ERLKQIVQVSNEGDSFDK 375
           +  + + Q S+  D  +K
Sbjct: 265 QAFETMFQESSISDEVEK 282

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 82/289 (28%), Positives = 136/289 (47%), Gaps = 40/289 (13%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQ-WVAEVQFLGVLEHP 139
           +IG G FG+VYK       GD       VA+K LN        LQ +  EV  L    H 
Sbjct: 31  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           N++  +GY         Q  +V ++    SL  HL + +      K  + I    A G+ 
Sbjct: 81  NILLFMGYSTAP-----QLAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMD 134
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 259
           YLH      +I+RD K++N+ L E+   K+ DFGLA E      +H    + G+  + AP
Sbjct: 135 YLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 260 DYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG 316
           + I   ++   + +SDV++FG+VLYE++TG+  L  +      +++E V +         
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEMVGRGS------- 242
Query: 317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
             + P L K  S N  +++ RL   CL K   +RP   +++  ++++ +
Sbjct: 243 --LSPDLSKVRS-NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 134/302 (44%), Gaps = 45/302 (14%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGV 135
            D +   K+G G +G VY+   K         +  VA+K L  D ++   ++ E   +  
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 63
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
           ++HPNLV+L+G C     R     ++ EFM   +L D+L       +     L++    +
Sbjct: 64  IKHPNLVQLLGVCT----REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 119
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT-- 253
             + YL +      I+RD  A N L+ EN   K++DFGL+R   M G T   TA  G   
Sbjct: 120 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGDT--XTAHAGAKF 172
Query: 254 -FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD 311
              + AP+ +     + KSDVW+FGV+L+E+ T G        P     LLE        
Sbjct: 173 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE-------- 224
Query: 312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ---VSN 368
                   D R+E+     E  K+  L   C   +  DRP  +++ +  + + Q   +S+
Sbjct: 225 -------KDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 275
Query: 369 EG 370
           EG
Sbjct: 276 EG 277

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 119/255 (46%), Gaps = 28/255 (10%)
Query: 114 VAIKKLNRDGLQ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL 170
           VAIK +    +    ++ E + +  L HP LV+L G C           LV EFM +  L
Sbjct: 35  VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA----PICLVTEFMEHGCL 90
Query: 171 EDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS 230
            D+L  +       +T L + L   EG+AYL E     VI+RD  A N L+ EN   K+S
Sbjct: 91  SDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVS 146
Query: 231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
           DFG+ R      +T  ST       +A+P+       ++KSDVWSFGV+++E+ +  +  
Sbjct: 147 DFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
Query: 291 ERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDR 350
             NR  +E            D      +  PRL   +       + ++ ++C  +  +DR
Sbjct: 206 YENRSNSE---------VVEDISTGFRLYKPRLASTH-------VYQIMNHCWRERPEDR 249
Query: 351 PKMSQVVERLKQIVQ 365
           P  S+++ +L +I +
Sbjct: 250 PAFSRLLRQLAEIAE 264

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/318 (25%), Positives = 141/318 (44%), Gaps = 35/318 (11%)
Query: 56  PELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIK-PAAGDGTSEATVV 114
           PE YE+    +  F+  E+  +     R+  IG G FG V    +K P   D       +
Sbjct: 23  PETYEDPNRAVHQFA-KELDASCIKIERV--IGAGEFGEVCSGRLKLPGKRDVAVAIKTL 79
Query: 115 AIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL 174
            +    +    ++ E   +G  +HPN+V L G       RG   ++V EFM N +L D  
Sbjct: 80  KVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVT----RGKPVMIVIEFMENGAL-DAF 134
Query: 175 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 234
             +          + ++ G A G+ YL    ++  ++RD  A N+L++ N   K+SDFGL
Sbjct: 135 LRKHDGQFTVIQLVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGL 191
Query: 235 AR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSL 290
           +R   + P   +T     +     + AP+ I+    T+ SDVWS+G+V++E+++ G R  
Sbjct: 192 SRVIEDDPEAVYTTTGGKI--PVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 249
Query: 291 ERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDR 350
                +   + +E   + PA                  ++    + +L  +C  K   +R
Sbjct: 250 WDMSNQDVIKAIEEGYRLPA-----------------PMDCPAGLHQLMLDCWQKERAER 292
Query: 351 PKMSQVVERLKQIVQVSN 368
           PK  Q+V  L ++++  N
Sbjct: 293 PKFEQIVGILDKMIRNPN 310

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/289 (28%), Positives = 136/289 (47%), Gaps = 40/289 (13%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQ-WVAEVQFLGVLEHP 139
           +IG G FG+VYK       GD       VA+K LN        LQ +  EV  L    H 
Sbjct: 31  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           N++  +GY         Q  +V ++    SL  HL + +      K  + I    A G+ 
Sbjct: 81  NILLFMGYSTKP-----QLAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMD 134
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 259
           YLH      +I+RD K++N+ L E+   K+ DFGLA E      +H    + G+  + AP
Sbjct: 135 YLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 260 DYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG 316
           + I   ++   + +SDV++FG+VLYE++TG+  L  +      +++E V +         
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEMVGRGS------- 242
Query: 317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
             + P L K  S N  +++ RL   CL K   +RP   +++  ++++ +
Sbjct: 243 --LSPDLSKVRS-NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/306 (26%), Positives = 140/306 (45%), Gaps = 54/306 (17%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL---NRDG--------LQ 125
           A N+     +IG+GGFG V+K  +         + +VVAIK L   + +G         +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRL-------VKDKSVVAIKSLILGDSEGETEMIEKFQE 69
Query: 126 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 185
           +  EV  +  L HPN+VKL G             +V EF+    L   L ++A P + W 
Sbjct: 70  FQREVFIMSNLNHPNIVKLYGLMHNPPR------MVMEFVPCGDLYHRLLDKAHP-IKWS 122
Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DEN--FRPKLSDFGLAREGPM 240
            +L ++L  A G+ Y+ +     +++RD ++ N+ L   DEN     K++DFGL+++   
Sbjct: 123 VKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-- 179
Query: 241 VGHTHVSTAVVGTFGYAAPDYI--ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE 298
               H  + ++G F + AP+ I  E    T K+D +SF ++LY +LTG    +       
Sbjct: 180 ---VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD------- 229
Query: 299 QRLLEWVQQYPADSKKF-GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 357
                   +Y     KF  +I +  L      +   ++  + + C S   K RP  S +V
Sbjct: 230 --------EYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIV 281
Query: 358 ERLKQI 363
           + L ++
Sbjct: 282 KELSEL 287

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/313 (26%), Positives = 140/313 (44%), Gaps = 42/313 (13%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---W 126
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++   +
Sbjct: 211 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEEF 263
Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKT 186
           + E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L       +    
Sbjct: 264 LKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 319
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            L++    +  + YL +      I+R+  A N L+ EN   K++DFGL+R   M G T+ 
Sbjct: 320 LLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRL--MTGDTYT 374
Query: 247 STAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 305
           + A       + AP+ +     + KSDVW+FGV+L+E+ T   S                
Sbjct: 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------- 418
Query: 306 QQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ 362
             YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ +  + 
Sbjct: 419 -PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFET 475
Query: 363 IVQVSNEGDSFDK 375
           + Q S+  D  +K
Sbjct: 476 MFQESSISDEVEK 488

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 86/316 (27%), Positives = 144/316 (45%), Gaps = 48/316 (15%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---W 126
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++   +
Sbjct: 250 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEEF 302
Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPW 184
           + E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR       
Sbjct: 303 LKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQ------ 352
Query: 185 KTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
           +    ++L  A  ++   E LE +  I+R+  A N L+ EN   K++DFGL+R   M G 
Sbjct: 353 EVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL--MTGD 410
Query: 244 THVSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 302
           T+ + A       + AP+ +     + KSDVW+FGV+L+E+ T   S             
Sbjct: 411 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------- 457
Query: 303 EWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER 359
                YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ + 
Sbjct: 458 ----PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQA 511
Query: 360 LKQIVQVSNEGDSFDK 375
            + + Q S+  D  +K
Sbjct: 512 FETMFQESSISDEVEK 527

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 85/308 (27%), Positives = 140/308 (45%), Gaps = 48/308 (15%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---W 126
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++   +
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEEF 60
Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPW 184
           + E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR       
Sbjct: 61  LKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQ------ 110
Query: 185 KTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
           +    ++L  A  ++   E LE +  I+RD  A N L+ EN   K++DFGL+R   M G 
Sbjct: 111 EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGD 168
Query: 244 THVSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 302
           T+ + A       + AP+ +     + KSDVW+FGV+L+E+ T   S             
Sbjct: 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------- 215
Query: 303 EWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER 359
                YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ + 
Sbjct: 216 ----PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQA 269
Query: 360 LKQIVQVS 367
            + + Q S
Sbjct: 270 FETMFQES 277

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 85/308 (27%), Positives = 140/308 (45%), Gaps = 48/308 (15%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---W 126
           +Y +      D +   K+G G +G VY+       G     +  VA+K L  D ++   +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYE-------GVWKKYSLTVAVKTLKEDTMEVEEF 56
Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPW 184
           + E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR       
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQ------ 106
Query: 185 KTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
           +    ++L  A  ++   E LE +  I+RD  A N L+ EN   K++DFGL+R   M G 
Sbjct: 107 EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGD 164
Query: 244 THVSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 302
           T+ + A       + AP+ +     + KSDVW+FGV+L+E+ T   S             
Sbjct: 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------- 211
Query: 303 EWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER 359
                YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ + 
Sbjct: 212 ----PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQA 265
Query: 360 LKQIVQVS 367
            + + Q S
Sbjct: 266 FETMFQES 273

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 139/306 (45%), Gaps = 48/306 (15%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---W 126
           +Y +      D +   K+G G +G VY+       G     +  VA+K L  D ++   +
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYE-------GVWKKYSLTVAVKTLKEDTMEVEEF 61
Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPW 184
           + E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR       
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCT----REPPFYIIIEFMTYGNLLDYLRECNRQ------ 111
Query: 185 KTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
           +    ++L  A  ++   E LE +  I+RD  A N L+ EN   K++DFGL+R   M G 
Sbjct: 112 EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGD 169
Query: 244 THVSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 302
           T+ + A       + AP+ +     + KSDVW+FGV+L+E+ T   S             
Sbjct: 170 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------- 216
Query: 303 EWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER 359
                YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ + 
Sbjct: 217 ----PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQA 270
Query: 360 LKQIVQ 365
            + + Q
Sbjct: 271 FETMFQ 276

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 139/306 (45%), Gaps = 48/306 (15%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---W 126
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++   +
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEEF 61
Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPW 184
           + E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR       
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQ------ 111
Query: 185 KTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
           +    ++L  A  ++   E LE +  I+RD  A N L+ EN   K++DFGL+R   M G 
Sbjct: 112 EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGD 169
Query: 244 THVSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 302
           T+ + A       + AP+ +     + KSDVW+FGV+L+E+ T   S             
Sbjct: 170 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------- 216
Query: 303 EWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER 359
                YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ + 
Sbjct: 217 ----PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQA 270
Query: 360 LKQIVQ 365
            + + Q
Sbjct: 271 FETMFQ 276

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 83/319 (26%), Positives = 143/319 (44%), Gaps = 49/319 (15%)
Query: 69  FSYSEMRQATNDFSRMLKI---------GEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL 119
           F++ +  +A  +F++ + I         G G FG V    +K            VAIK L
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPG----KREIFVAIKTL 69
Query: 120 N-----RDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL 174
                 +    +++E   +G  +HPN++ L G       +    +++ EFM N SL D  
Sbjct: 70  KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT----KSTPVMIITEFMENGSL-DSF 124
Query: 175 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 234
             +          + ++ G A G+ YL +   +  ++RD  A N+L++ N   K+SDFGL
Sbjct: 125 LRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGL 181
Query: 235 AR--EGPMVGHTHVSTAVVGTFG--YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRS 289
           +R  E      T+ S A+ G     + AP+ I+    T+ SDVWS+G+V++E+++ G R 
Sbjct: 182 SRFLEDDTSDPTYTS-ALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 240
Query: 290 LERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKD 349
                  T Q ++  ++Q            D RL        A  + +L  +C  K    
Sbjct: 241 YWD---MTNQDVINAIEQ------------DYRLPPPMDCPSA--LHQLMLDCWQKDRNH 283
Query: 350 RPKMSQVVERLKQIVQVSN 368
           RPK  Q+V  L ++++  N
Sbjct: 284 RPKFGQIVNTLDKMIRNPN 302

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 75/318 (23%), Positives = 145/318 (45%), Gaps = 49/318 (15%)
Query: 69  FSYSEMRQATNDFSRMLK---------IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL 119
           F++ +  QA  +F++ +          IG G FG V    +K            VAIK L
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPG----KREICVAIKTL 65
Query: 120 -----NRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL 174
                ++    +++E   +G  +HPN++ L G       +    +++ E+M N SL D  
Sbjct: 66  KAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVT----KCKPVMIITEYMENGSL-DAF 120
Query: 175 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 234
             +          + ++ G   G+ YL +   +  ++RD  A N+L++ N   K+SDFG+
Sbjct: 121 LRKNDGRFTVIQLVGMLRGIGSGMKYLSD---MSAVHRDLAARNILVNSNLVCKVSDFGM 177
Query: 235 AR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSL 290
           +R   + P   +T     +     + AP+ I     T+ SDVWS+G+V++E+++ G R  
Sbjct: 178 SRVLEDDPEAAYTTRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 235
Query: 291 ERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDR 350
                 + Q +++ +++        G  + P ++   ++++      L  +C  K   DR
Sbjct: 236 ---WDMSNQDVIKAIEE--------GYRLPPPMDCPIALHQ------LMLDCWQKERSDR 278
Query: 351 PKMSQVVERLKQIVQVSN 368
           PK  Q+V  L ++++  N
Sbjct: 279 PKFGQIVNMLDKLIRNPN 296

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 139/306 (45%), Gaps = 54/306 (17%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL---NRDG--------LQ 125
           A N+     +IG+GGFG V+K  +         + +VVAIK L   + +G         +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRL-------VKDKSVVAIKSLILGDSEGETEMIEKFQE 69
Query: 126 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 185
           +  EV  +  L HPN+VKL G             +V EF+    L   L ++A P + W 
Sbjct: 70  FQREVFIMSNLNHPNIVKLYGLMHNPPR------MVMEFVPCGDLYHRLLDKAHP-IKWS 122
Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DEN--FRPKLSDFGLAREGPM 240
            +L ++L  A G+ Y+ +     +++RD ++ N+ L   DEN     K++DFG +++   
Sbjct: 123 VKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQS-- 179
Query: 241 VGHTHVSTAVVGTFGYAAPDYI--ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE 298
               H  + ++G F + AP+ I  E    T K+D +SF ++LY +LTG    +       
Sbjct: 180 ---VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD------- 229
Query: 299 QRLLEWVQQYPADSKKF-GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 357
                   +Y     KF  +I +  L      +   ++  + + C S   K RP  S +V
Sbjct: 230 --------EYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIV 281
Query: 358 ERLKQI 363
           + L ++
Sbjct: 282 KELSEL 287

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 87/310 (28%), Positives = 140/310 (45%), Gaps = 52/310 (16%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---W 126
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++   +
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEEF 61
Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPW 184
           + E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR       
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQ------ 111
Query: 185 KTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
           +    ++L  A  ++   E LE +  I+RD  A N L+ EN   K++DFGL+R   M G 
Sbjct: 112 EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGD 169
Query: 244 THVSTAVVGT---FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR 300
           T   TA  G      + AP+ +     + KSDVW+FGV+L+E+ T   S           
Sbjct: 170 T--XTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS----------- 216
Query: 301 LLEWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 357
                  YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ 
Sbjct: 217 ------PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIH 268
Query: 358 ERLKQIVQVS 367
           +  + + Q S
Sbjct: 269 QAFETMFQES 278

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 82/306 (26%), Positives = 139/306 (45%), Gaps = 54/306 (17%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL---NRDG--------LQ 125
           A N+     +IG+GGFG V+K       G    + +VVAIK L   + +G         +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHK-------GRLVKDKSVVAIKSLILGDSEGETEMIEKFQE 69
Query: 126 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 185
           +  EV  +  L HPN+VKL G             +V EF+    L   L ++A P + W 
Sbjct: 70  FQREVFIMSNLNHPNIVKLYGLMHNPPR------MVMEFVPCGDLYHRLLDKAHP-IKWS 122
Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DEN--FRPKLSDFGLAREGPM 240
            +L ++L  A G+ Y+ +     +++RD ++ N+ L   DEN     K++DF L+++   
Sbjct: 123 VKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQS-- 179
Query: 241 VGHTHVSTAVVGTFGYAAPDYI--ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE 298
               H  + ++G F + AP+ I  E    T K+D +SF ++LY +LTG    +       
Sbjct: 180 ---VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD------- 229
Query: 299 QRLLEWVQQYPADSKKF-GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 357
                   +Y     KF  +I +  L      +   ++  + + C S   K RP  S +V
Sbjct: 230 --------EYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIV 281
Query: 358 ERLKQI 363
           + L ++
Sbjct: 282 KELSEL 287

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 112/234 (47%), Gaps = 24/234 (10%)
Query: 76  QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK---------LNRDGLQW 126
           +A   +  + +IGEG +G V+K      A D  +    VA+K+         +    ++ 
Sbjct: 8   RADQQYECVAEIGEGAYGKVFK------ARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE 61
Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVD-GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 185
           VA ++ L   EHPN+V+L   C V   +R  +  LV+E + ++ L  +L     P +P +
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTE 120
Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
           T   ++     GL +LH     +V++RD K  N+L+  + + KL+DFGLAR   +     
Sbjct: 121 TIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQM 174
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ 299
             T+VV T  Y AP+ +         D+WS G +  EM   R+ L R     +Q
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ 227

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 135/289 (46%), Gaps = 40/289 (13%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQ-WVAEVQFLGVLEHP 139
           +IG G FG+VYK       GD       VA+K LN        LQ +  EV  L    H 
Sbjct: 19  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 68
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           N++  +GY         Q  +V ++    SL  HL + +      K  + I    A G+ 
Sbjct: 69  NILLFMGYSTKP-----QLAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMD 122
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 259
           YLH      +I+RD K++N+ L E+   K+ DFGLA        +H    + G+  + AP
Sbjct: 123 YLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 179
Query: 260 DYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG 316
           + I   ++   + +SDV++FG+VLYE++TG+  L  +      +++E V +         
Sbjct: 180 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEMVGRGS------- 230
Query: 317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
             + P L K  S N  +++ RL   CL K   +RP   +++  ++++ +
Sbjct: 231 --LSPDLSKVRS-NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 276

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 112/234 (47%), Gaps = 24/234 (10%)
Query: 76  QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN---------RDGLQW 126
           +A   +  + +IGEG +G V+K      A D  +    VA+K++             ++ 
Sbjct: 8   RADQQYECVAEIGEGAYGKVFK------ARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE 61
Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVD-GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 185
           VA ++ L   EHPN+V+L   C V   +R  +  LV+E + ++ L  +L     P +P +
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTE 120
Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
           T   ++     GL +LH     +V++RD K  N+L+  + + KL+DFGLAR   +     
Sbjct: 121 TIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQM 174
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ 299
             T+VV T  Y AP+ +         D+WS G +  EM   R+ L R     +Q
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ 227

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 136/291 (46%), Gaps = 34/291 (11%)
Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFL 133
           M    +DF ++ ++G G  G V+K S KP+      +   + IK   R+  Q + E+Q L
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVL 58
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
                P +V   G    DGE  I      E M   SL D +  +A   +P +    + + 
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSL-DQVLKKA-GRIPEQILGKVSIA 112
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
             +GL YL E  + ++++RD K SN+L++     KL DFG++  G ++    ++ + VGT
Sbjct: 113 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLI--DSMANSFVGT 166
Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR-------LLEWVQ 306
             Y +P+ ++  H + +SD+WS G+ L EM  GR  +     K + R       LL+++ 
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIV 226
Query: 307 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 357
             P      G+     LE +  +N+          CL K+  +R  + Q++
Sbjct: 227 NEPPPKLPSGVF---SLEFQDFVNK----------CLIKNPAERADLKQLM 264

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 135/297 (45%), Gaps = 48/297 (16%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---W 126
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++   +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEEF 56
Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPW 184
           + E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR       
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQ------ 106
Query: 185 KTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
           +    ++L  A  ++   E LE +  I+RD  A N L+ EN   K++DFGL+R   M G 
Sbjct: 107 EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGD 164
Query: 244 THVSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 302
           T+ + A       + AP+ +     + KSDVW+FGV+L+E+ T   S             
Sbjct: 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------- 211
Query: 303 EWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 356
                YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++
Sbjct: 212 ----PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEI 262

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 112/234 (47%), Gaps = 24/234 (10%)
Query: 76  QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN---------RDGLQW 126
           +A   +  + +IGEG +G V+K      A D  +    VA+K++             ++ 
Sbjct: 8   RADQQYECVAEIGEGAYGKVFK------ARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE 61
Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVD-GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 185
           VA ++ L   EHPN+V+L   C V   +R  +  LV+E + ++ L  +L     P +P +
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTE 120
Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
           T   ++     GL +LH     +V++RD K  N+L+  + + KL+DFGLAR   +     
Sbjct: 121 TIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQM 174
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ 299
             T+VV T  Y AP+ +         D+WS G +  EM   R+ L R     +Q
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ 227

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/221 (33%), Positives = 112/221 (50%), Gaps = 25/221 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EV 130
           +  +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+   A  E+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTAIREI 53
Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
             L  L HPN+VKL+     +     +  LV+EF L++ L+D +   A   +P       
Sbjct: 54  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKDFMDASALTGIPLPLIKSY 108
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+    V
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 251 VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
             T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 130/287 (45%), Gaps = 40/287 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEV-QFL--GVL----EHP 139
           IG G FG VY  ++     D   +    A+K LNR  +  + EV QFL  G++     HP
Sbjct: 37  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHP 90
Query: 140 NLVKLIGYCA-VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 198
           N++ L+G C   +G      L+V  +M +  L + + N    P   K  +   L  A+G+
Sbjct: 91  NVLSLLGICLRSEGSP----LVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGM 145
Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGY 256
            YL      + ++RD  A N +LDE F  K++DFGLAR+         H  T       +
Sbjct: 146 KYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKW 202
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG 316
            A + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++  
Sbjct: 203 MALESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL- 255
Query: 317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
                 L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 256 ------LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 109/216 (50%), Gaps = 17/216 (7%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATV------VAIKKLNRDGLQWVAEV 130
           AT+ +  + +IG G +G+VYK+   P +G   +  +V           L    ++ VA +
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKAR-DPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 131 QFLGVLEHPNLVKLIGYCAVD-GERGIQRLLVYEFMLNRSLEDHLFNRAFPP-LPWKTRL 188
           + L   EHPN+V+L+  CA    +R I+  LV+E + ++ L  +L ++A PP LP +T  
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIK 123
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 248
            ++     GL +LH      +++RD K  N+L+      KL+DFGLAR   +  +    T
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALT 177
Query: 249 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
            VV T  Y AP+ +         D+WS G +  EM 
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 124/284 (43%), Gaps = 34/284 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-----DGLQWVAEVQFLGVLEHPNL 141
           IG G FG VY  ++     D   +    A+K LNR     +  Q++ E   +    HPN+
Sbjct: 36  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 201
           + L+G C          L+V  +M +  L + + N    P   K  +   L  A+G+ YL
Sbjct: 92  LSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKYL 147
Query: 202 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYAAP 259
                 + ++RD  A N +LDE F  K++DFGLAR+         H  T       + A 
Sbjct: 148 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 204
Query: 260 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM 319
           + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++     
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL---- 254
Query: 320 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
              L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 255 ---LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 126/285 (44%), Gaps = 36/285 (12%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-----DGLQWVAEVQFLGVLEHPNL 141
           IG G FG VY  ++     D   +    A+K LNR     +  Q++ E   +    HPN+
Sbjct: 30  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 85
Query: 142 VKLIGYCA-VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           + L+G C   +G      L+V  +M +  L + + N    P   K  +   L  A+G+ Y
Sbjct: 86  LSLLGICLRSEGSP----LVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKY 140
Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYAA 258
           L      + ++RD  A N +LDE F  K++DFGLAR+         H  T       + A
Sbjct: 141 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 197
Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 318
            + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++    
Sbjct: 198 LESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL--- 248
Query: 319 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
               L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 249 ----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 286

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 126/285 (44%), Gaps = 36/285 (12%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-----DGLQWVAEVQFLGVLEHPNL 141
           IG G FG VY  ++     D   +    A+K LNR     +  Q++ E   +    HPN+
Sbjct: 38  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 142 VKLIGYCA-VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           + L+G C   +G      L+V  +M +  L + + N    P   K  +   L  A+G+ Y
Sbjct: 94  LSLLGICLRSEGSP----LVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKY 148
Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYAA 258
           L      + ++RD  A N +LDE F  K++DFGLAR+         H  T       + A
Sbjct: 149 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 318
            + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++    
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL--- 256
Query: 319 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
               L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 257 ----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 130/287 (45%), Gaps = 40/287 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEV-QFL--GVL----EHP 139
           IG G FG VY  ++     D   +    A+K LNR  +  + EV QFL  G++     HP
Sbjct: 35  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHP 88
Query: 140 NLVKLIGYCA-VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 198
           N++ L+G C   +G      L+V  +M +  L + + N    P   K  +   L  A+G+
Sbjct: 89  NVLSLLGICLRSEGSP----LVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGM 143
Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGY 256
            YL      + ++RD  A N +LDE F  K++DFGLAR+         H  T       +
Sbjct: 144 KYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 200
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG 316
            A + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++  
Sbjct: 201 MALESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL- 253
Query: 317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
                 L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 254 ------LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 291

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 126/285 (44%), Gaps = 36/285 (12%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-----DGLQWVAEVQFLGVLEHPNL 141
           IG G FG VY  ++     D   +    A+K LNR     +  Q++ E   +    HPN+
Sbjct: 38  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 142 VKLIGYCA-VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           + L+G C   +G      L+V  +M +  L + + N    P   K  +   L  A+G+ Y
Sbjct: 94  LSLLGICLRSEGSP----LVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKY 148
Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYAA 258
           L      + ++RD  A N +LDE F  K++DFGLAR+         H  T       + A
Sbjct: 149 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 318
            + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++    
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL--- 256
Query: 319 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
               L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 257 ----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 110/221 (49%), Gaps = 25/221 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EV 130
           +  +F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+   A  E+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTAIREI 55
Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
             L  L HPN+VKL+     +     +  LV+EF L+  L+D +   A   +P       
Sbjct: 56  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LSMDLKDFMDASALTGIPLPLIKSY 110
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+    V
Sbjct: 111 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 251 VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
             T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 126/285 (44%), Gaps = 36/285 (12%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-----DGLQWVAEVQFLGVLEHPNL 141
           IG G FG VY  ++     D   +    A+K LNR     +  Q++ E   +    HPN+
Sbjct: 37  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 142 VKLIGYCA-VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           + L+G C   +G      L+V  +M +  L + + N    P   K  +   L  A+G+ Y
Sbjct: 93  LSLLGICLRSEGSP----LVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKY 147
Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYAA 258
           L      + ++RD  A N +LDE F  K++DFGLAR+         H  T       + A
Sbjct: 148 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 204
Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 318
            + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++    
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL--- 255
Query: 319 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
               L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 256 ----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 124/284 (43%), Gaps = 34/284 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-----DGLQWVAEVQFLGVLEHPNL 141
           IG G FG VY  ++     D   +    A+K LNR     +  Q++ E   +    HPN+
Sbjct: 33  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 201
           + L+G C          L+V  +M +  L + + N    P   K  +   L  A+G+ YL
Sbjct: 89  LSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKYL 144
Query: 202 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYAAP 259
                 + ++RD  A N +LDE F  K++DFGLAR+         H  T       + A 
Sbjct: 145 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 201
Query: 260 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM 319
           + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++     
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL---- 251
Query: 320 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
              L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 252 ---LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 289

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 128/286 (44%), Gaps = 38/286 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEV-QFL--GVL----EHP 139
           IG G FG VY  ++     D   +    A+K LNR  +  + EV QFL  G++     HP
Sbjct: 56  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHP 109
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           N++ L+G C          L+V  +M +  L + + N    P   K  +   L  A+G+ 
Sbjct: 110 NVLSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMK 165
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYA 257
           YL      + ++RD  A N +LDE F  K++DFGLAR+         H  T       + 
Sbjct: 166 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 222
Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGL 317
           A + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++   
Sbjct: 223 ALESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL-- 274
Query: 318 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
                L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 275 -----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 312

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 134/309 (43%), Gaps = 45/309 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVL-EHPN 140
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP--------------PLPWKT 186
           ++ L+G C  DG   +    + E+    +L ++L  R  P               + +K 
Sbjct: 103 IINLLGACTQDGPLYV----IVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKD 158
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   +     
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 306
           +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E        
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 268
Query: 307 QYPADSKKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
                   F L+ +  R++K    N   ++  +  +C       RP   Q+VE L +I+ 
Sbjct: 269 --------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 366 VSNEGDSFD 374
           ++   +  D
Sbjct: 319 LTTNEEYLD 327

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 134/309 (43%), Gaps = 45/309 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVL-EHPN 140
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP--------------PLPWKT 186
           ++ L+G C  DG   +    + E+    +L ++L  R  P               + +K 
Sbjct: 103 IINLLGACTQDGPLYV----IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   +     
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 306
           +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E        
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 268
Query: 307 QYPADSKKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
                   F L+ +  R++K    N   ++  +  +C       RP   Q+VE L +I+ 
Sbjct: 269 --------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 366 VSNEGDSFD 374
           ++   +  D
Sbjct: 319 LTTNEEYLD 327

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/221 (33%), Positives = 111/221 (50%), Gaps = 25/221 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EV 130
           +  +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+   A  E+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTAIREI 56
Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
             L  L HPN+VKL+     +     +  LV+EF L+  L+D +   A   +P       
Sbjct: 57  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LSMDLKDFMDASALTGIPLPLIKSY 111
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+    V
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 251 VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
             T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 130/287 (45%), Gaps = 40/287 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEV-QFL--GVL----EHP 139
           IG G FG VY  ++     D   +    A+K LNR  +  + EV QFL  G++     HP
Sbjct: 57  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHP 110
Query: 140 NLVKLIGYCA-VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 198
           N++ L+G C   +G      L+V  +M +  L + + N    P   K  +   L  A+G+
Sbjct: 111 NVLSLLGICLRSEGSP----LVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGM 165
Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGY 256
            YL      + ++RD  A N +LDE F  K++DFGLAR+         H  T       +
Sbjct: 166 KYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 222
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG 316
            A + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++  
Sbjct: 223 MALESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL- 275
Query: 317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
                 L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 276 ------LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 313

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 128/286 (44%), Gaps = 38/286 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEV-QFL--GVL----EHP 139
           IG G FG VY  ++     D   +    A+K LNR  +  + EV QFL  G++     HP
Sbjct: 97  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHP 150
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           N++ L+G C          L+V  +M +  L + + N    P   K  +   L  A+G+ 
Sbjct: 151 NVLSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMK 206
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYA 257
           +L      + ++RD  A N +LDE F  K++DFGLAR+         H  T       + 
Sbjct: 207 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 263
Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGL 317
           A + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++   
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL-- 315
Query: 318 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
                L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 316 -----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 353

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/235 (31%), Positives = 109/235 (46%), Gaps = 38/235 (16%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEA-TVVAIKKLNRDG-----LQWVAEVQF 132
           N+   +  IGEG FG V+++    A G    E  T+VA+K L  +        +  E   
Sbjct: 47  NNIEYVRDIGEGAFGRVFQAR---APGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 103
Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM----LN---RSLEDH---------LFN 176
           +   ++PN+VKL+G CAV    G    L++E+M    LN   RS+  H         L  
Sbjct: 104 MAEFDNPNIVKLLGVCAV----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 159
Query: 177 RAF------PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS 230
           RA       PPL    +L I    A G+AYL E    + ++RD    N L+ EN   K++
Sbjct: 160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIA 216
Query: 231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           DFGL+R      +            +  P+ I     T +SDVW++GVVL+E+ +
Sbjct: 217 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/322 (23%), Positives = 146/322 (45%), Gaps = 45/322 (13%)
Query: 62  KAHNLRVF----SYSEMRQATNDFSRMLK---------IGEGGFGSVYKSSIK-PAAGDG 107
           K   LR F    +Y +  Q  ++F++ L          +G G FG V    +K P+  + 
Sbjct: 15  KLPGLRTFVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEI 74
Query: 108 TSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN 167
           +     + +    +    ++ E   +G  +HPN+++L G       +    ++V E+M N
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEYMEN 130
Query: 168 RSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP 227
            SL D    +          + ++ G A G+ YL +   +  ++RD  A N+L++ N   
Sbjct: 131 GSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVC 186
Query: 228 KLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
           K+SDFGL+R   + P   +T     +     + +P+ I     T+ SDVWS+G+VL+E++
Sbjct: 187 KVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244
Query: 285 T-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCL 343
           + G R        + Q +++ V +        G  + P ++   ++ +      L  +C 
Sbjct: 245 SYGERPYWE---MSNQDVIKAVDE--------GYRLPPPMDCPAALYQ------LMLDCW 287
Query: 344 SKSSKDRPKMSQVVERLKQIVQ 365
            K   +RPK  Q+V  L ++++
Sbjct: 288 QKDRNNRPKFEQIVSILDKLIR 309

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 128/286 (44%), Gaps = 38/286 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEV-QFL--GVL----EHP 139
           IG G FG VY  ++     D   +    A+K LNR  +  + EV QFL  G++     HP
Sbjct: 38  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHP 91
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           N++ L+G C          L+V  +M +  L + + N    P   K  +   L  A+G+ 
Sbjct: 92  NVLSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMK 147
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYA 257
           +L      + ++RD  A N +LDE F  K++DFGLAR+         H  T       + 
Sbjct: 148 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGL 317
           A + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++   
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL-- 256
Query: 318 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
                L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 257 -----LQPEYCPDPLYEVML---KCWHPKAEMRPSFSELVSRISAI 294

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 128/286 (44%), Gaps = 38/286 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEV-QFL--GVL----EHP 139
           IG G FG VY  ++     D   +    A+K LNR  +  + EV QFL  G++     HP
Sbjct: 38  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHP 91
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           N++ L+G C          L+V  +M +  L + + N    P   K  +   L  A+G+ 
Sbjct: 92  NVLSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMK 147
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYA 257
           +L      + ++RD  A N +LDE F  K++DFGLAR+         H  T       + 
Sbjct: 148 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGL 317
           A + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++   
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL-- 256
Query: 318 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
                L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 257 -----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 133/303 (43%), Gaps = 45/303 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVL-EHPN 140
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP--------------PLPWKT 186
           ++ L+G C  DG   +    + E+    +L ++L  R  P               + +K 
Sbjct: 103 IINLLGACTQDGPLYV----IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   + +   
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 306
           +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E        
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 268
Query: 307 QYPADSKKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
                   F L+ +  R++K    N   ++  +  +C       RP   Q+VE L +I+ 
Sbjct: 269 --------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 366 VSN 368
           ++ 
Sbjct: 319 LTT 321

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/315 (24%), Positives = 144/315 (45%), Gaps = 35/315 (11%)
Query: 56  PELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIK-PAAGDGTSEATVV 114
           P  YE+      V  +++   ATN  S    +G G FG V    +K P+  + +     +
Sbjct: 25  PHTYEDPTQT--VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 115 AIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL 174
            +    +    ++ E   +G  +HPN+++L G       +    ++V E+M N SL D  
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEYMENGSL-DSF 136
Query: 175 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 234
             +          + ++ G A G+ YL +   +  ++RD  A N+L++ N   K+SDFGL
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 235 AR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSL 290
           +R   + P   +T     +     + +P+ I     T+ SDVWS+G+VL+E+++ G R  
Sbjct: 194 SRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251
Query: 291 ERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDR 350
                 + Q +++ V +        G  + P ++   ++ +      L  +C  K   +R
Sbjct: 252 WE---MSNQDVIKAVDE--------GYRLPPPMDCPAALYQ------LMLDCWQKDRNNR 294
Query: 351 PKMSQVVERLKQIVQ 365
           PK  Q+V  L ++++
Sbjct: 295 PKFEQIVSILDKLIR 309

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 128/286 (44%), Gaps = 38/286 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEV-QFL--GVL----EHP 139
           IG G FG VY  ++     D   +    A+K LNR  +  + EV QFL  G++     HP
Sbjct: 36  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHP 89
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           N++ L+G C          L+V  +M +  L + + N    P   K  +   L  A+G+ 
Sbjct: 90  NVLSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMK 145
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYA 257
           +L      + ++RD  A N +LDE F  K++DFGLAR+         H  T       + 
Sbjct: 146 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 202
Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGL 317
           A + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++   
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL-- 254
Query: 318 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
                L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 255 -----LQPEYCPDPLYEVML---KCWHPKAEMRPSFSELVSRISAI 292

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 128/286 (44%), Gaps = 38/286 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEV-QFL--GVL----EHP 139
           IG G FG VY  ++     D   +    A+K LNR  +  + EV QFL  G++     HP
Sbjct: 39  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHP 92
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           N++ L+G C          L+V  +M +  L + + N    P   K  +   L  A+G+ 
Sbjct: 93  NVLSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMK 148
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYA 257
           +L      + ++RD  A N +LDE F  K++DFGLAR+         H  T       + 
Sbjct: 149 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWM 205
Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGL 317
           A + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++   
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL-- 257
Query: 318 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
                L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 258 -----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 128/286 (44%), Gaps = 38/286 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEV-QFL--GVL----EHP 139
           IG G FG VY  ++     D   +    A+K LNR  +  + EV QFL  G++     HP
Sbjct: 39  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHP 92
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           N++ L+G C          L+V  +M +  L + + N    P   K  +   L  A+G+ 
Sbjct: 93  NVLSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMK 148
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYA 257
           +L      + ++RD  A N +LDE F  K++DFGLAR+         H  T       + 
Sbjct: 149 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 205
Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGL 317
           A + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++   
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL-- 257
Query: 318 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
                L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 258 -----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 133/303 (43%), Gaps = 45/303 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVL-EHPN 140
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP--------------PLPWKT 186
           ++ L+G C  DG   +    + E+    +L ++L  R  P               + +K 
Sbjct: 103 IITLLGACTQDGPLYV----IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   + +   
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 306
           +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E        
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 268
Query: 307 QYPADSKKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
                   F L+ +  R++K    N   ++  +  +C       RP   Q+VE L +I+ 
Sbjct: 269 --------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 366 VSN 368
           ++ 
Sbjct: 319 LTT 321

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 116/234 (49%), Gaps = 17/234 (7%)
Query: 57  ELYEEKAHNLRVFSYSEMRQA---TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATV 113
           EL E++   L  F   + +      +DF ++ ++G G  G V+K S KP+      +   
Sbjct: 8   ELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH 67
Query: 114 VAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDH 173
           + IK   R+  Q + E+Q L     P +V   G    DGE  I      E M   SL D 
Sbjct: 68  LEIKPAIRN--QIIRELQVLHECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSL-DQ 120
Query: 174 LFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG 233
           +  +A   +P +    + +   +GL YL E  + ++++RD K SN+L++     KL DFG
Sbjct: 121 VLKKA-GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFG 177
Query: 234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
           ++  G ++    ++ + VGT  Y +P+ ++  H + +SD+WS G+ L EM  GR
Sbjct: 178 VS--GQLI--DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/315 (24%), Positives = 144/315 (45%), Gaps = 35/315 (11%)
Query: 56  PELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIK-PAAGDGTSEATVV 114
           P  YE+      V  +++   ATN  S    +G G FG V    +K P+  + +     +
Sbjct: 23  PHTYEDPTQT--VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 79
Query: 115 AIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL 174
            +    +    ++ E   +G  +HPN+++L G       +    ++V E+M N SL D  
Sbjct: 80  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEYMENGSL-DSF 134
Query: 175 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 234
             +          + ++ G A G+ YL +   +  ++RD  A N+L++ N   K+SDFGL
Sbjct: 135 LRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGL 191
Query: 235 AR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSL 290
           +R   + P   +T     +     + +P+ I     T+ SDVWS+G+VL+E+++ G R  
Sbjct: 192 SRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 249
Query: 291 ERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDR 350
                 + Q +++ V +        G  + P ++   ++ +      L  +C  K   +R
Sbjct: 250 WE---MSNQDVIKAVDE--------GYRLPPPMDCPAALYQ------LMLDCWQKDRNNR 292
Query: 351 PKMSQVVERLKQIVQ 365
           PK  Q+V  L ++++
Sbjct: 293 PKFEQIVSILDKLIR 307

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 133/303 (43%), Gaps = 45/303 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVL-EHPN 140
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP--------------PLPWKT 186
           ++ L+G C  DG   +    + E+    +L ++L  R  P               + +K 
Sbjct: 103 IINLLGACTQDGPLYV----IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   + +   
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKN 215
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 306
           +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E        
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 268
Query: 307 QYPADSKKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
                   F L+ +  R++K    N   ++  +  +C       RP   Q+VE L +I+ 
Sbjct: 269 --------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 366 VSN 368
           ++ 
Sbjct: 319 LTT 321

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/322 (23%), Positives = 146/322 (45%), Gaps = 45/322 (13%)
Query: 62  KAHNLRVF----SYSEMRQATNDFSRMLK---------IGEGGFGSVYKSSIK-PAAGDG 107
           K   LR F    ++ +  Q  ++F++ L          +G G FG V    +K P+  + 
Sbjct: 15  KLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEI 74
Query: 108 TSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN 167
           +     + +    +    ++ E   +G  +HPN+++L G       +    ++V E+M N
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEYMEN 130
Query: 168 RSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP 227
            SL D    +          + ++ G A G+ YL +   +  ++RD  A N+L++ N   
Sbjct: 131 GSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVC 186
Query: 228 KLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
           K+SDFGLAR   + P   +T     +     + +P+ I     T+ SDVWS+G+VL+E++
Sbjct: 187 KVSDFGLARVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244
Query: 285 T-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCL 343
           + G R        + Q +++ V +        G  + P ++   ++ +      L  +C 
Sbjct: 245 SYGERPYWE---MSNQDVIKAVDE--------GYRLPPPMDCPAALYQ------LMLDCW 287
Query: 344 SKSSKDRPKMSQVVERLKQIVQ 365
            K   +RPK  Q+V  L ++++
Sbjct: 288 QKDRNNRPKFEQIVSILDKLIR 309

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 135/290 (46%), Gaps = 42/290 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPNL 141
           IG G FG V +  +K     G  E + VAIK L      R   ++++E   +G  EHPN+
Sbjct: 24  IGAGEFGEVCRGRLK---APGKKE-SCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 79
Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLED--HLFNRAFPPLPWKTRLHIILGAAEGLA 199
           ++L G         +  +++ EFM N +L+    L +  F  +     + ++ G A G+ 
Sbjct: 80  IRLEGVVT----NSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMR 132
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG---TFGY 256
           YL E   +  ++RD  A N+L++ N   K+SDFGL+R           T+ +G      +
Sbjct: 133 YLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRW 189
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKF 315
            AP+ I     T+ SD WS+G+V++E+++ G R        + Q ++  ++Q        
Sbjct: 190 TAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWD---MSNQDVINAIEQ-------- 238
Query: 316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
               D RL        +  + +L  +C  K    RP+  QVV  L ++++
Sbjct: 239 ----DYRLPPPPDCPTS--LHQLMLDCWQKDRNARPRFPQVVSALDKMIR 282

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 128/286 (44%), Gaps = 38/286 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEV-QFL--GVL----EHP 139
           IG G FG VY  ++     D   +    A+K LNR  +  + EV QFL  G++     HP
Sbjct: 43  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHP 96
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           N++ L+G C          L+V  +M +  L + + N    P   K  +   L  A+G+ 
Sbjct: 97  NVLSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMK 152
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYA 257
           +L      + ++RD  A N +LDE F  K++DFGLAR+         H  T       + 
Sbjct: 153 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 209
Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGL 317
           A + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++   
Sbjct: 210 ALESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL-- 261
Query: 318 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
                L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 262 -----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 299

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 133/303 (43%), Gaps = 45/303 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVL-EHPN 140
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP--------------PLPWKT 186
           ++ L+G C  DG   +    + E+    +L ++L  R  P               + +K 
Sbjct: 103 IIHLLGACTQDGPLYV----IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   + +   
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 306
           +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E        
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 268
Query: 307 QYPADSKKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
                   F L+ +  R++K    N   ++  +  +C       RP   Q+VE L +I+ 
Sbjct: 269 --------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 366 VSN 368
           ++ 
Sbjct: 319 LTT 321

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 133/303 (43%), Gaps = 45/303 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVL-EHPN 140
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP--------------PLPWKT 186
           ++ L+G C  DG   +    + E+    +L ++L  R  P               + +K 
Sbjct: 90  IINLLGACTQDGPLYV----IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 145
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   + +   
Sbjct: 146 LVSCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKK 202
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 306
           +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E        
Sbjct: 203 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 255
Query: 307 QYPADSKKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
                   F L+ +  R++K    N   ++  +  +C       RP   Q+VE L +I+ 
Sbjct: 256 --------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 305
Query: 366 VSN 368
           ++ 
Sbjct: 306 LTT 308

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 112/220 (50%), Gaps = 29/220 (13%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EVQFL 133
           +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+   A  E+  L
Sbjct: 4   NFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLL 56
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +  
Sbjct: 57  KELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTAVV 251
             +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH     V
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH----EV 164
Query: 252 GTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
            T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 112/220 (50%), Gaps = 29/220 (13%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EVQFL 133
           +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+   A  E+  L
Sbjct: 3   NFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLL 55
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +  
Sbjct: 56  KELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTAVV 251
             +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH     V
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH----EV 163
Query: 252 GTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
            T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 112/220 (50%), Gaps = 29/220 (13%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EVQFL 133
           +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+   A  E+  L
Sbjct: 3   NFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLL 55
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +  
Sbjct: 56  KELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTAVV 251
             +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH     V
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH----EV 163
Query: 252 GTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
            T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 109/213 (51%), Gaps = 14/213 (6%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAI---KKLNRDGLQWVAEVQFL 133
           AT+ +  + +IG G +G+VYK+   P +G   +  +V      + L    ++ VA ++ L
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKAR-DPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 134 GVLEHPNLVKLIGYCAVD-GERGIQRLLVYEFMLNRSLEDHLFNRAFPP-LPWKTRLHII 191
              EHPN+V+L+  CA    +R I+  LV+E  +++ L  +L ++A PP LP +T   ++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEH-VDQDLRTYL-DKAPPPGLPAETIKDLM 118
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 251
                GL +LH      +++RD K  N+L+      KL+DFGLAR   +  +      VV
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALAPVV 172
Query: 252 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
            T  Y AP+ +         D+WS G +  EM 
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 133/303 (43%), Gaps = 45/303 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVL-EHPN 140
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP--------------PLPWKT 186
           ++ L+G C  DG   +    + E+    +L ++L  R  P               + +K 
Sbjct: 149 IINLLGACTQDGPLYV----IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   + +   
Sbjct: 205 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 306
           +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E        
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 314
Query: 307 QYPADSKKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
                   F L+ +  R++K    N   ++  +  +C       RP   Q+VE L +I+ 
Sbjct: 315 --------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364
Query: 366 VSN 368
           ++ 
Sbjct: 365 LTT 367

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 133/303 (43%), Gaps = 45/303 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVL-EHPN 140
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP--------------PLPWKT 186
           ++ L+G C  DG   +    + E+    +L ++L  R  P               + +K 
Sbjct: 92  IINLLGACTQDGPLYV----IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 147
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   + +   
Sbjct: 148 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 204
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 306
           +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E        
Sbjct: 205 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 257
Query: 307 QYPADSKKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
                   F L+ +  R++K    N   ++  +  +C       RP   Q+VE L +I+ 
Sbjct: 258 --------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 307
Query: 366 VSN 368
           ++ 
Sbjct: 308 LTT 310

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 113/223 (50%), Gaps = 29/223 (13%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EV 130
           +  +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+   A  E+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTAIREI 54
Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
             L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       
Sbjct: 55  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSY 109
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVST 248
           +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH   
Sbjct: 110 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--- 163
Query: 249 AVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
             V T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 164 -EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 14/209 (6%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEH 138
           +DF ++ ++G G  G V+K S KP+      +   + IK   R+  Q + E+Q L     
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNS 125
Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 198
           P +V   G    DGE  I      E M   SL D +  +A   +P +    + +   +GL
Sbjct: 126 PYIVGFYGAFYSDGEISI----CMEHMDGGSL-DQVLKKAGR-IPEQILGKVSIAVIKGL 179
Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
            YL E  + ++++RD K SN+L++     KL DFG++  G ++    ++ + VGT  Y +
Sbjct: 180 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLI--DSMANSFVGTRSYMS 233
Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
           P+ ++  H + +SD+WS G+ L EM  GR
Sbjct: 234 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 84/309 (27%), Positives = 136/309 (44%), Gaps = 45/309 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVL-EHPN 140
           +GEG FG V  +       D  +  T VA+K L  D  +      ++E++ + ++ +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW--------------KT 186
           ++ L+G C  DG   +    + E+    +L ++L  R  P L +              K 
Sbjct: 96  IINLLGACTQDGPLYV----IVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 151
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR+   + +   
Sbjct: 152 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWV 305
           +T       + AP+ +     T +SDVWSFGV+L+E+ T   S     P  E  +LL   
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 265
Query: 306 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
                   K G  MD   +     NE   + R   +C       RP   Q+VE L +IV 
Sbjct: 266 --------KEGHRMD---KPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRIVA 311
Query: 366 VSNEGDSFD 374
           +++  +  D
Sbjct: 312 LTSNQEYLD 320

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 112/220 (50%), Gaps = 29/220 (13%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EVQFL 133
           +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+   A  E+  L
Sbjct: 4   NFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLL 56
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +  
Sbjct: 57  KELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTAVV 251
             +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH     V
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH----EV 164
Query: 252 GTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
            T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 165 VTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 111/220 (50%), Gaps = 29/220 (13%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EVQFL 133
           +F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+   A  E+  L
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTAIREISLL 60
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +  
Sbjct: 61  KELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYLFQ 115
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTAVV 251
             +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH     V
Sbjct: 116 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH----EV 168
Query: 252 GTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
            T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 169 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 207

>pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 133/303 (43%), Gaps = 45/303 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVL-EHPN 140
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP--------------PLPWKT 186
           ++ L+G C  DG   +    + E+    +L ++L  R  P               + +K 
Sbjct: 95  IINLLGACTQDGPLYV----IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 150
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   + +   
Sbjct: 151 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 207
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 306
           +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E        
Sbjct: 208 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 260
Query: 307 QYPADSKKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
                   F L+ +  R++K    N   ++  +  +C       RP   Q+VE L +I+ 
Sbjct: 261 --------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 310
Query: 366 VSN 368
           ++ 
Sbjct: 311 LTT 313

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 112/220 (50%), Gaps = 29/220 (13%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EVQFL 133
           +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+   A  E+  L
Sbjct: 4   NFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLL 56
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +  
Sbjct: 57  KELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTAVV 251
             +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH     V
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH----EV 164
Query: 252 GTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
            T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 81/283 (28%), Positives = 121/283 (42%), Gaps = 46/283 (16%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           IG+G FG V         GD       V   K +     ++AE   +  L H NLV+L+G
Sbjct: 201 IGKGEFGDV-------MLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 147 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLE 206
              V+ + G+   +V E+M   SL D+L +R    L     L   L   E + YL     
Sbjct: 254 -VIVEEKGGL--YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-- 308
Query: 207 VQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAAPDYIET 264
              ++RD  A NVL+ E+   K+SDFGL +E         ST   G     + AP+ +  
Sbjct: 309 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEALRE 360
Query: 265 GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLE 324
              + KSDVWSFG++L+E+ +  R                   YP    K    + PR+E
Sbjct: 361 KKFSTKSDVWSFGILLWEIYSFGRV-----------------PYPRIPLK---DVVPRVE 400
Query: 325 KEYSINEAR----KIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
           K Y ++        +  +  NC    +  RP   Q+ E+L+ I
Sbjct: 401 KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 136/309 (44%), Gaps = 45/309 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVL-EHPN 140
           +GEG FG V  +       D  +  T VA+K L  D  +      ++E++ + ++ +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-----------FNRAFPP---LPWKT 186
           ++ L+G C  DG   +    + E+    +L ++L           FN +  P   L  K 
Sbjct: 96  IINLLGACTQDGPLYV----IVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKD 151
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR+   +     
Sbjct: 152 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKK 208
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWV 305
           +T       + AP+ +     T +SDVWSFGV+L+E+ T   S     P  E  +LL   
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 265
Query: 306 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
                   K G  MD   +     NE   + R   +C       RP   Q+VE L +IV 
Sbjct: 266 --------KEGHRMD---KPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRIVA 311
Query: 366 VSNEGDSFD 374
           +++  +  D
Sbjct: 312 LTSNQEXLD 320

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 109/213 (51%), Gaps = 14/213 (6%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAI---KKLNRDGLQWVAEVQFL 133
           AT+ +  + +IG G +G+VYK+   P +G   +  +V      + L    ++ VA ++ L
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKAR-DPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 134 GVLEHPNLVKLIGYCAVD-GERGIQRLLVYEFMLNRSLEDHLFNRAFPP-LPWKTRLHII 191
              EHPN+V+L+  CA    +R I+  LV+E  +++ L  +L ++A PP LP +T   ++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEH-VDQDLRTYL-DKAPPPGLPAETIKDLM 118
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 251
                GL +LH      +++RD K  N+L+      KL+DFGLAR   +  +      VV
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALDPVV 172
Query: 252 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
            T  Y AP+ +         D+WS G +  EM 
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
           ++G G FG V+         +G ++  V ++K+ +     ++AE   +  L+H  LV+L 
Sbjct: 26  RLGAGQFGEVWMGYY-----NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL- 79
Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL 205
            Y  V  E      ++ E+M N SL D L   +   L     L +    AEG+A++ E  
Sbjct: 80  -YAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 134
Query: 206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDYI 262
               I+RD +A+N+L+ +    K++DFGLAR    +   +  TA  G      + AP+ I
Sbjct: 135 --NYIHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEXTAREGAKFPIKWTAPEAI 188
Query: 263 ETGHLTAKSDVWSFGVVLYEMLTGRR 288
             G  T KSDVWSFG++L E++T  R
Sbjct: 189 NYGTFTIKSDVWSFGILLTEIVTHGR 214

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 135/290 (46%), Gaps = 42/290 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPNL 141
           IG G FG V +  +K     G  E + VAIK L      R   ++++E   +G  EHPN+
Sbjct: 22  IGAGEFGEVCRGRLK---APGKKE-SCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 77
Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLED--HLFNRAFPPLPWKTRLHIILGAAEGLA 199
           ++L G         +  +++ EFM N +L+    L +  F  +     + ++ G A G+ 
Sbjct: 78  IRLEGVVT----NSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMR 130
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG---TFGY 256
           YL E   +  ++RD  A N+L++ N   K+SDFGL+R           T+ +G      +
Sbjct: 131 YLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRW 187
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKF 315
            AP+ I     T+ SD WS+G+V++E+++ G R        + Q ++  ++Q        
Sbjct: 188 TAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWD---MSNQDVINAIEQ-------- 236
Query: 316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
               D RL        +  + +L  +C  K    RP+  QVV  L ++++
Sbjct: 237 ----DYRLPPPPDCPTS--LHQLMLDCWQKDRNARPRFPQVVSALDKMIR 280

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
           ++G G FG V+         +G ++  V ++K+ +     ++AE   +  L+H  LV+L 
Sbjct: 28  RLGAGQFGEVWMGYY-----NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL- 81
Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL 205
            Y  V  E      ++ E+M N SL D L   +   L     L +    AEG+A++ E  
Sbjct: 82  -YAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 136
Query: 206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDYI 262
               I+RD +A+N+L+ +    K++DFGLAR    +   +  TA  G      + AP+ I
Sbjct: 137 --NYIHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEXTAREGAKFPIKWTAPEAI 190
Query: 263 ETGHLTAKSDVWSFGVVLYEMLTGRR 288
             G  T KSDVWSFG++L E++T  R
Sbjct: 191 NYGTFTIKSDVWSFGILLTEIVTHGR 216

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 75/322 (23%), Positives = 146/322 (45%), Gaps = 45/322 (13%)
Query: 62  KAHNLRVF----SYSEMRQATNDFSRMLK---------IGEGGFGSVYKSSIK-PAAGDG 107
           K   LR F    ++ +  Q  ++F++ L          +G G FG V    +K P+  + 
Sbjct: 15  KLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEI 74
Query: 108 TSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN 167
           +     + +    +    ++ E   +G  +HPN+++L G       +    ++V E+M N
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEYMEN 130
Query: 168 RSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP 227
            SL D    +          + ++ G A G+ YL +   +  ++RD  A N+L++ N   
Sbjct: 131 GSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGFVHRDLAARNILINSNLVC 186
Query: 228 KLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
           K+SDFGL+R   + P   +T     +     + +P+ I     T+ SDVWS+G+VL+E++
Sbjct: 187 KVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244
Query: 285 T-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCL 343
           + G R        + Q +++ V +        G  + P ++   ++ +      L  +C 
Sbjct: 245 SYGERPYWE---MSNQDVIKAVDE--------GYRLPPPMDCPAALYQ------LMLDCW 287
Query: 344 SKSSKDRPKMSQVVERLKQIVQ 365
            K   +RPK  Q+V  L ++++
Sbjct: 288 QKDRNNRPKFEQIVSILDKLIR 309

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 87/331 (26%), Positives = 142/331 (42%), Gaps = 61/331 (18%)
Query: 56  PELYEEKAHNLRVFSYSEMRQATNDFSRMLK---------IGEGGFGSVYKSSIK-PAAG 105
           P+ Y E        +Y E  +A   F+R ++         IG G  G V    ++ P   
Sbjct: 23  PQFYAEP------HTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQR 76
Query: 106 DGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLL 160
           D       VAIK L      R    +++E   +G  +HPN+++L G       RG   ++
Sbjct: 77  D-----VPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT----RGRLAMI 127
Query: 161 VYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASN 218
           V E+M N SL+  L   +  F  +     + ++ G   G+ YL +   +  ++RD  A N
Sbjct: 128 VTEYMENGSLDTFLRTHDGQFTIM---QLVGMLRGVGAGMRYLSD---LGYVHRDLAARN 181
Query: 219 VLLDENFRPKLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWS 275
           VL+D N   K+SDFGL+R   + P   +T     +     + AP+ I     ++ SDVWS
Sbjct: 182 VLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI--PIRWTAPEAIAFRTFSSASDVWS 239
Query: 276 FGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARK 334
           FGVV++E+L  G R       +     +E   + PA                  +     
Sbjct: 240 FGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA-----------------PMGCPHA 282
Query: 335 IGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
           + +L  +C  K    RP+ SQ+V  L  +++
Sbjct: 283 LHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 111/220 (50%), Gaps = 29/220 (13%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EVQFL 133
           +F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+   A  E+  L
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTAIREISLL 63
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +  
Sbjct: 64  KELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTAVV 251
             +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH     V
Sbjct: 119 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH----EV 171
Query: 252 GTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
            T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 172 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 210

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 101/206 (49%), Gaps = 25/206 (12%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGVLEHPNLV 142
           K+G G FG V+            + +T VA+K L    +    ++ E   +  L+H  LV
Sbjct: 19  KLGAGQFGEVWMGYY--------NNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLV 70
Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +L  Y  V  E  I   ++ EFM   SL D L +     +     +      AEG+AY+ 
Sbjct: 71  RL--YAVVTKEEPI--YIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 126
Query: 203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAP 259
                  I+RD +A+NVL+ E+   K++DFGLAR    V   +  TA  G      + AP
Sbjct: 127 RK---NYIHRDLRAANVLVSESLMCKIADFGLAR----VIEDNEYTAREGAKFPIKWTAP 179
Query: 260 DYIETGHLTAKSDVWSFGVVLYEMLT 285
           + I  G  T KS+VWSFG++LYE++T
Sbjct: 180 EAINFGCFTIKSNVWSFGILLYEIVT 205

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 75/227 (33%), Positives = 105/227 (46%), Gaps = 30/227 (13%)
Query: 74  MRQATNDFSRMLK----IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA- 128
           MR  T    R LK    +G+G FGSV      P   D T E  VVA+KKL     + +  
Sbjct: 1   MRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRD 57
Query: 129 ---EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 185
              E++ L  L+H N+VK  G C   G R ++  L+ E++   SL D+L          K
Sbjct: 58  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-------K 108
Query: 186 TRL-HIIL-----GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP 239
            R+ HI L        +G+ YL      + I+RD    N+L++   R K+ DFGL +  P
Sbjct: 109 ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 165
Query: 240 MVGHT-HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
                  V         + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 166 QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 114/221 (51%), Gaps = 27/221 (12%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW-----VAEVQ 131
           +++ F ++ K+G G + +VYK       G   +    VA+K++  D  +      + E+ 
Sbjct: 3   SSSQFKQLEKLGNGTYATVYK-------GLNKTTGVYVALKEVKLDSEEGTPSTAIREIS 55
Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 191
            +  L+H N+V+L  Y  +  E  +   LV+EFM N  L+ ++ +R     P    L+++
Sbjct: 56  LMKELKHENIVRL--YDVIHTENKLT--LVFEFMDN-DLKKYMDSRTVGNTPRGLELNLV 110
Query: 192 ----LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 247
                   +GLA+ HE    ++++RD K  N+L+++  + KL DFGLAR   +  +T  S
Sbjct: 111 KYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS 167
Query: 248 TAVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
             V  T  Y APD +      + S D+WS G +L EM+TG+
Sbjct: 168 EVV--TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 129/310 (41%), Gaps = 39/310 (12%)
Query: 70  SYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-----NRDG 123
           S S++++    + + +  +G G FG VY+  +     D +     VA+K L      +D 
Sbjct: 38  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVCSEQDE 95
Query: 124 LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPL 182
           L ++ E   +    H N+V+ IG       + + R ++ E M    L+  L   R  P  
Sbjct: 96  LDFLMEALIISKFNHQNIVRCIGVSL----QSLPRFILLELMAGGDLKSFLRETRPRPSQ 151
Query: 183 PWKTR----LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLA 235
           P        LH+    A G  YL E      I+RD  A N LL         K+ DFG+A
Sbjct: 152 PSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 208
Query: 236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           R+    G+       +    +  P+    G  T+K+D WSFGV+L+E+ +          
Sbjct: 209 RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPS 266
Query: 296 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 355
           K+ Q +LE+V          G  MDP        N    + R+   C     +DRP  + 
Sbjct: 267 KSNQEVLEFVTS--------GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAI 312
Query: 356 VVERLKQIVQ 365
           ++ER++   Q
Sbjct: 313 ILERIEYCTQ 322

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 134/291 (46%), Gaps = 40/291 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-----NRDGLQWVAEVQFLGVLEHPNL 141
           IG G FG V    +K            VAIK L     ++    +++E   +G  +HPN+
Sbjct: 22  IGVGEFGEVCSGRLKVPG----KREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNI 77
Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 201
           + L G       +    +++ E+M N SL D    +          + ++ G   G+ YL
Sbjct: 78  IHLEGVVT----KCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYL 132
Query: 202 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAA 258
            +   +  ++RD  A N+L++ N   K+SDFG++R   + P   +T     +     + A
Sbjct: 133 SD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI--PIRWTA 187
Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGL 317
           P+ I     T+ SDVWS+G+V++E+++ G R        + Q +++ +++        G 
Sbjct: 188 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY---WDMSNQDVIKAIEE--------GY 236
Query: 318 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN 368
            + P ++   ++++      L  +C  K   DRPK  Q+V  L ++++  N
Sbjct: 237 RLPPPMDCPIALHQ------LMLDCWQKERSDRPKFGQIVNMLDKLIRNPN 281

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFL 133
           M    +DF ++ ++G G  G V+K S KP+      +   + IK   R+  Q + E+Q L
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVL 58
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
                P +V   G    DGE  I      E M   SL D +  +A   +P +    + + 
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSL-DQVLKKA-GRIPEQILGKVSIA 112
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
             +GL YL E  + ++++RD K SN+L++     KL DFG++  G ++    ++ + VGT
Sbjct: 113 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLI--DSMANSFVGT 166
Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
             Y +P+ ++  H + +SD+WS G+ L EM  GR
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 129/310 (41%), Gaps = 39/310 (12%)
Query: 70  SYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-----NRDG 123
           S S++++    + + +  +G G FG VY+  +     D +     VA+K L      +D 
Sbjct: 61  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVCSEQDE 118
Query: 124 LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPL 182
           L ++ E   +    H N+V+ IG       + + R ++ E M    L+  L   R  P  
Sbjct: 119 LDFLMEALIISKFNHQNIVRCIGVSL----QSLPRFILLELMAGGDLKSFLRETRPRPSQ 174
Query: 183 PWKTR----LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLA 235
           P        LH+    A G  YL E      I+RD  A N LL         K+ DFG+A
Sbjct: 175 PSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
Query: 236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           R+    G+       +    +  P+    G  T+K+D WSFGV+L+E+ +          
Sbjct: 232 RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPS 289
Query: 296 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 355
           K+ Q +LE+V          G  MDP        N    + R+   C     +DRP  + 
Sbjct: 290 KSNQEVLEFVTS--------GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAI 335
Query: 356 VVERLKQIVQ 365
           ++ER++   Q
Sbjct: 336 ILERIEYCTQ 345

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 133/303 (43%), Gaps = 45/303 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVL-EHPN 140
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP--------------PLPWKT 186
           ++ L+G C  DG   +    + E+    +L ++L  R  P               + +K 
Sbjct: 103 IINLLGACTQDGPLYV----IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            +      A G+ YL      + I+RD  A NVL+ EN   +++DFGLAR+   + +   
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKK 215
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 306
           +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E        
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 268
Query: 307 QYPADSKKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
                   F L+ +  R++K    N   ++  +  +C       RP   Q+VE L +I+ 
Sbjct: 269 --------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 366 VSN 368
           ++ 
Sbjct: 319 LTT 321

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/229 (33%), Positives = 106/229 (46%), Gaps = 30/229 (13%)
Query: 72  SEMRQATNDFSRMLK----IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWV 127
           SE R  T    R LK    +G+G FGSV      P   D T E  VVA+KKL     + +
Sbjct: 2   SEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHL 58
Query: 128 A----EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 183
                E++ L  L+H N+VK  G C   G R ++  L+ E++   SL D+L         
Sbjct: 59  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH------ 110
Query: 184 WKTRL-HIIL-----GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE 237
            K R+ HI L        +G+ YL      + I+RD    N+L++   R K+ DFGL + 
Sbjct: 111 -KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 166
Query: 238 GPMVGHT-HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            P       V         + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 167 LPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFL 133
           M    +DF ++ ++G G  G V+K S KP+      +   + IK   R+  Q + E+Q L
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVL 58
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
                P +V   G    DGE  I      E M   SL D +  +A   +P +    + + 
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSL-DQVLKKA-GRIPEQILGKVSIA 112
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
             +GL YL E  + ++++RD K SN+L++     KL DFG++  G ++    ++ + VGT
Sbjct: 113 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLI--DSMANSFVGT 166
Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
             Y +P+ ++  H + +SD+WS G+ L EM  GR
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 129/287 (44%), Gaps = 44/287 (15%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQ-WVAEVQFLGVLEHP 139
           +IG G FG+VYK       GD       VA+K LN        LQ +  EV  L    H 
Sbjct: 35  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 84
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEG 197
           N++  +GY         Q  +V ++    SL  HL      F  +     + I    A+G
Sbjct: 85  NILLFMGYSTKP-----QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQG 136
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           + YLH      +I+RD K++N+ L E+   K+ DFGLA E      +H    + G+  + 
Sbjct: 137 MDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 193
Query: 258 APDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 314
           AP+ I   +    + +SDV++FG+VLYE++TG+     N    +Q +    + Y      
Sbjct: 194 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGY------ 246
Query: 315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 361
               + P L K  S N  + + RL   CL K   +RP   Q++  ++
Sbjct: 247 ----LSPDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIE 288

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFL 133
           M    +DF ++ ++G G  G V+K S KP+      +   + IK   R+  Q + E+Q L
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVL 58
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
                P +V   G    DGE  I      E M   SL D +  +A   +P +    + + 
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSL-DQVLKKA-GRIPEQILGKVSIA 112
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
             +GL YL E  + ++++RD K SN+L++     KL DFG++  G ++    ++ + VGT
Sbjct: 113 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLI--DSMANSFVGT 166
Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
             Y +P+ ++  H + +SD+WS G+ L EM  GR
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFL 133
           M    +DF ++ ++G G  G V+K S KP+      +   + IK   R+  Q + E+Q L
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVL 58
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
                P +V   G    DGE  I      E M   SL D +  +A   +P +    + + 
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSL-DQVLKKA-GRIPEQILGKVSIA 112
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
             +GL YL E  + ++++RD K SN+L++     KL DFG++  G ++    ++ + VGT
Sbjct: 113 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLI--DSMANSFVGT 166
Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
             Y +P+ ++  H + +SD+WS G+ L EM  GR
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 14/209 (6%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEH 138
           +DF ++ ++G G  G V+K S KP+      +   + IK   R+  Q + E+Q L     
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNS 82
Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 198
           P +V   G    DGE  I      E M   SL D +  +A   +P +    + +   +GL
Sbjct: 83  PYIVGFYGAFYSDGEISI----CMEHMDGGSL-DQVLKKA-GRIPEQILGKVSIAVIKGL 136
Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
            YL E  + ++++RD K SN+L++     KL DFG++  G ++    ++ + VGT  Y +
Sbjct: 137 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLI--DSMANSFVGTRSYMS 190
Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
           P+ ++  H + +SD+WS G+ L EM  GR
Sbjct: 191 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 111/221 (50%), Gaps = 25/221 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EV 130
           +  +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+   A  E+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTAIREI 53
Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
             L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       
Sbjct: 54  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSY 108
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+    V
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 251 VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
             T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 134/291 (46%), Gaps = 40/291 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-----NRDGLQWVAEVQFLGVLEHPNL 141
           IG G FG V    +K            VAIK L     ++    +++E   +G  +HPN+
Sbjct: 16  IGVGEFGEVCSGRLKVPG----KREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNI 71
Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 201
           + L G       +    +++ E+M N SL D    +          + ++ G   G+ YL
Sbjct: 72  IHLEGVVT----KCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYL 126
Query: 202 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAA 258
            +   +  ++RD  A N+L++ N   K+SDFG++R   + P   +T     +     + A
Sbjct: 127 SD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI--PIRWTA 181
Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGL 317
           P+ I     T+ SDVWS+G+V++E+++ G R        + Q +++ +++        G 
Sbjct: 182 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY---WDMSNQDVIKAIEE--------GY 230
Query: 318 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN 368
            + P ++   ++++      L  +C  K   DRPK  Q+V  L ++++  N
Sbjct: 231 RLPPPMDCPIALHQ------LMLDCWQKERSDRPKFGQIVNMLDKLIRNPN 275

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
           ++G G FG V+         +G ++  V ++K+ +     ++AE   +  L+H  LV+L 
Sbjct: 29  RLGAGQFGEVWMGYY-----NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL- 82
Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL 205
            Y  V  E      ++ E+M N SL D L   +   L     L +    AEG+A++ E  
Sbjct: 83  -YAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 137
Query: 206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDYI 262
               I+RD +A+N+L+ +    K++DFGLAR    +   +  TA  G      + AP+ I
Sbjct: 138 --NYIHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEXTAREGAKFPIKWTAPEAI 191
Query: 263 ETGHLTAKSDVWSFGVVLYEMLTGRR 288
             G  T KSDVWSFG++L E++T  R
Sbjct: 192 NYGTFTIKSDVWSFGILLTEIVTHGR 217

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 111/220 (50%), Gaps = 29/220 (13%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EVQFL 133
           +F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+   A  E+  L
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTAIREISLL 63
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +  
Sbjct: 64  KELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTAVV 251
             +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH     V
Sbjct: 119 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH----EV 171
Query: 252 GTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
            T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 172 VTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT-RRAL 210

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 111/221 (50%), Gaps = 25/221 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EV 130
           +  +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+   A  E+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTAIREI 53
Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
             L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       
Sbjct: 54  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSY 108
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+    V
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 251 VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
             T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 110/221 (49%), Gaps = 25/221 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EV 130
           +  +F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+   A  E+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTAIREI 53
Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
             L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       
Sbjct: 54  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSY 108
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+    V
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 251 VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
             T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 132/286 (46%), Gaps = 45/286 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--WVAEVQFLGVLEHPNLVKL 144
           +G G FG V K+  +         A  VAIK++  +  +  ++ E++ L  + HPN+VKL
Sbjct: 17  VGRGAFGVVCKAKWR---------AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKL 67
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII---LGAAEGLAYL 201
            G C           LV E+    SL + L      PLP+ T  H +   L  ++G+AYL
Sbjct: 68  YGACLNP------VCLVMEYAEGGSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 202 HEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 260
           H      +I+RD K  N+LL       K+ DFG A +      TH+ T   G+  + AP+
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHM-TNNKGSAAWMAPE 174
Query: 261 YIETGHLTAKSDVWSFGVVLYEMLTGRRSL-ERNRPKTEQRLLEWVQQYPADSKKFGLIM 319
             E  + + K DV+S+G++L+E++T R+   E   P    R++  V              
Sbjct: 175 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVHNG----------T 222
Query: 320 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
            P L K    N  + I  L   C SK    RP M ++V+ +  +++
Sbjct: 223 RPPLIK----NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 264

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/212 (33%), Positives = 104/212 (49%), Gaps = 17/212 (8%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQWVA----EVQFLGV 135
             R+  +GEG FG V      P  GD T E   VA+K L  + G   +A    E++ L  
Sbjct: 23  LKRIRDLGEGHFGKVELCRYDPE-GDNTGEQ--VAVKSLKPESGGNHIADLKKEIEILRN 79
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
           L H N+VK  G C  DG  GI+  L+ EF+ + SL+++L  +    +  K +L   +   
Sbjct: 80  LYHENIVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQIC 136
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGHTHVSTAVVGT 253
           +G+ YL      Q ++RD  A NVL++   + K+ DFGL +  E      T         
Sbjct: 137 KGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPV 193
Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           F YA P+ +        SDVWSFGV L+E+LT
Sbjct: 194 FWYA-PECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 111/221 (50%), Gaps = 25/221 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EV 130
           +  +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+   A  E+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTAIREI 53
Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
             L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       
Sbjct: 54  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSY 108
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+    V
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 251 VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
             T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
           ++G G FG V+         +G ++  V ++K+ +     ++AE   +  L+H  LV+L 
Sbjct: 20  RLGAGQFGEVWMGYY-----NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL- 73
Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL 205
            Y  V  E      ++ E+M N SL D L   +   L     L +    AEG+A++ E  
Sbjct: 74  -YAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 128
Query: 206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDYI 262
               I+RD +A+N+L+ +    K++DFGLAR    +   +  TA  G      + AP+ I
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEXTAREGAKFPIKWTAPEAI 182
Query: 263 ETGHLTAKSDVWSFGVVLYEMLTGRR 288
             G  T KSDVWSFG++L E++T  R
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 110/221 (49%), Gaps = 25/221 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EV 130
           +  +F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+   A  E+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTAIREI 55
Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
             L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       
Sbjct: 56  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSY 110
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+    V
Sbjct: 111 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 251 VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
             T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/322 (23%), Positives = 146/322 (45%), Gaps = 45/322 (13%)
Query: 62  KAHNLRVF----SYSEMRQATNDFSRMLK---------IGEGGFGSVYKSSIK-PAAGDG 107
           K   LR F    ++ +  Q  ++F++ L          +G G FG V    +K P+  + 
Sbjct: 15  KLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEI 74
Query: 108 TSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN 167
           +     + +    +    ++ E   +G  +HPN+++L G       +    ++V E+M N
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEYMEN 130
Query: 168 RSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP 227
            SL D    +          + ++ G A G+ YL +   +  ++RD  A N+L++ N   
Sbjct: 131 GSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVC 186
Query: 228 KLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
           K+SDFGL+R   + P   +T     +     + +P+ I     T+ SDVWS+G+VL+E++
Sbjct: 187 KVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244
Query: 285 T-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCL 343
           + G R        + Q +++ V +        G  + P ++   ++ +      L  +C 
Sbjct: 245 SYGERPYWE---MSNQDVIKAVDE--------GYRLPPPMDCPAALYQ------LMLDCW 287
Query: 344 SKSSKDRPKMSQVVERLKQIVQ 365
            K   +RPK  Q+V  L ++++
Sbjct: 288 QKDRNNRPKFEQIVSILDKLIR 309

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 110/218 (50%), Gaps = 25/218 (11%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EVQFL 133
           +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+   A  E+  L
Sbjct: 3   NFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLL 55
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +  
Sbjct: 56  KELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
             +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+    V  T
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 165
Query: 254 FGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
             Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 135/297 (45%), Gaps = 41/297 (13%)
Query: 82  SRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVL 136
           +R   IG G FG VYK  +K ++G    +   VAIK L      +  + ++ E   +G  
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSG---KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGA 194
            H N+++L G  +    +    +++ E+M N +L+  L  +   F  L     + ++ G 
Sbjct: 104 SHHNIIRLEGVIS----KYKPMMIITEYMENGALDKFLREKDGEFSVL---QLVGMLRGI 156
Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR---EGPMVGHTHVSTAVV 251
           A G+ YL     +  ++RD  A N+L++ N   K+SDFGL+R   + P   +T     + 
Sbjct: 157 AAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI- 212
Query: 252 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 311
               + AP+ I     T+ SDVWSFG+V++E++T        RP  E    E V +   D
Sbjct: 213 -PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT-----YGERPYWELSNHE-VMKAIND 265
Query: 312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN 368
             +    MD              I +L   C  +    RPK + +V  L ++++  +
Sbjct: 266 GFRLPTPMDC----------PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 129/287 (44%), Gaps = 44/287 (15%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQ-WVAEVQFLGVLEHP 139
           +IG G FG+VYK       GD       VA+K LN        LQ +  EV  L    H 
Sbjct: 43  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 92
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEG 197
           N++  +GY         Q  +V ++    SL  HL      F  +     + I    A+G
Sbjct: 93  NILLFMGYSTKP-----QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQG 144
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           + YLH      +I+RD K++N+ L E+   K+ DFGLA E      +H    + G+  + 
Sbjct: 145 MDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 201
Query: 258 APDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 314
           AP+ I   +    + +SDV++FG+VLYE++TG+     N    +Q +    + Y      
Sbjct: 202 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGY------ 254
Query: 315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 361
               + P L K  S N  + + RL   CL K   +RP   Q++  ++
Sbjct: 255 ----LSPDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIE 296

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 109/213 (51%), Gaps = 14/213 (6%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAI---KKLNRDGLQWVAEVQFL 133
           AT+ +  + +IG G +G+VYK+   P +G   +  +V      + L    ++ VA ++ L
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKAR-DPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 134 GVLEHPNLVKLIGYCAVD-GERGIQRLLVYEFMLNRSLEDHLFNRAFPP-LPWKTRLHII 191
              EHPN+V+L+  CA    +R I+  LV+E  +++ L  +L ++A PP LP +T   ++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEH-VDQDLRTYL-DKAPPPGLPAETIKDLM 118
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 251
                GL +LH      +++RD K  N+L+      KL+DFGLAR   +  +      VV
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALFPVV 172
Query: 252 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
            T  Y AP+ +         D+WS G +  EM 
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 110/221 (49%), Gaps = 25/221 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EV 130
           +  +F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+   A  E+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTAIREI 55
Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
             L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       
Sbjct: 56  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSY 110
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+    V
Sbjct: 111 LFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 251 VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
             T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 110/221 (49%), Gaps = 25/221 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EV 130
           +  +F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+   A  E+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTAIREI 54
Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
             L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       
Sbjct: 55  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSY 109
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+    V
Sbjct: 110 LFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 251 VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
             T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 167 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
           ++G G FG V+         +G ++  V ++K+ +     ++AE   +  L+H  LV+L 
Sbjct: 30  RLGAGQFGEVWMGYY-----NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL- 83
Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL 205
            Y  V  E      ++ E+M N SL D L   +   L     L +    AEG+A++ E  
Sbjct: 84  -YAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 138
Query: 206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDYI 262
               I+RD +A+N+L+ +    K++DFGLAR    +   +  TA  G      + AP+ I
Sbjct: 139 --NYIHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEYTAREGAKFPIKWTAPEAI 192
Query: 263 ETGHLTAKSDVWSFGVVLYEMLTGRR 288
             G  T KSDVWSFG++L E++T  R
Sbjct: 193 NYGTFTIKSDVWSFGILLTEIVTHGR 218

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/212 (33%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWVA----EVQFLGV 135
             R+  +GEG FG V      P  GD T E   VA+K L    G   +A    E++ L  
Sbjct: 11  LKRIRDLGEGHFGKVELCRYDPE-GDNTGEQ--VAVKSLKPESGGNHIADLKKEIEILRN 67
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
           L H N+VK  G C  DG  GI+  L+ EF+ + SL+++L  +    +  K +L   +   
Sbjct: 68  LYHENIVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQIC 124
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGHTHVSTAVVGT 253
           +G+ YL      Q ++RD  A NVL++   + K+ DFGL +  E      T         
Sbjct: 125 KGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPV 181
Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           F YA P+ +        SDVWSFGV L+E+LT
Sbjct: 182 FWYA-PECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 132/286 (46%), Gaps = 45/286 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--WVAEVQFLGVLEHPNLVKL 144
           +G G FG V K+  +         A  VAIK++  +  +  ++ E++ L  + HPN+VKL
Sbjct: 16  VGRGAFGVVCKAKWR---------AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKL 66
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII---LGAAEGLAYL 201
            G C           LV E+    SL + L      PLP+ T  H +   L  ++G+AYL
Sbjct: 67  YGACLNP------VCLVMEYAEGGSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 202 HEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 260
           H      +I+RD K  N+LL       K+ DFG A +      TH+ T   G+  + AP+
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHM-TNNKGSAAWMAPE 173
Query: 261 YIETGHLTAKSDVWSFGVVLYEMLTGRRSL-ERNRPKTEQRLLEWVQQYPADSKKFGLIM 319
             E  + + K DV+S+G++L+E++T R+   E   P    R++  V              
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVHNG----------T 221
Query: 320 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
            P L K    N  + I  L   C SK    RP M ++V+ +  +++
Sbjct: 222 RPPLIK----NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
           ++G G FG V+         +G ++  V ++K+ +     ++AE   +  L+H  LV+L 
Sbjct: 22  RLGAGQFGEVWMGYY-----NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL- 75
Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL 205
            Y  V  E      ++ E+M N SL D L   +   L     L +    AEG+A++ E  
Sbjct: 76  -YAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 130
Query: 206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDYI 262
               I+RD +A+N+L+ +    K++DFGLAR    +   +  TA  G      + AP+ I
Sbjct: 131 --NYIHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEXTAREGAKFPIKWTAPEAI 184
Query: 263 ETGHLTAKSDVWSFGVVLYEMLTGRR 288
             G  T KSDVWSFG++L E++T  R
Sbjct: 185 NYGTFTIKSDVWSFGILLTEIVTHGR 210

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 123/285 (43%), Gaps = 50/285 (17%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--WVAEVQFLGVLEHPNLVKL 144
           IG+G FG V           G      VA+K +  D     ++AE   +  L H NLV+L
Sbjct: 29  IGKGEFGDVML---------GDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL 79
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
           +G   V+ + G+   +V E+M   SL D+L +R    L     L   L   E + YL   
Sbjct: 80  LG-VIVEEKGGL--YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAAPDYI 262
                ++RD  A NVL+ E+   K+SDFGL +E         ST   G     + AP+ +
Sbjct: 137 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEAL 186
Query: 263 ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPR 322
                + KSDVWSFG++L+E+ +  R                   YP    K    + PR
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYSFGRV-----------------PYPRIPLK---DVVPR 226
Query: 323 LEKEYSINEAR----KIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
           +EK Y ++        +  +  NC    +  RP   Q+ E+L+ I
Sbjct: 227 VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 110/221 (49%), Gaps = 25/221 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EV 130
           +  +F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+   A  E+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTAIREI 56
Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
             L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       
Sbjct: 57  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSY 111
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+    V
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 251 VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
             T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 110/221 (49%), Gaps = 25/221 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EV 130
           +  +F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+   A  E+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTAIREI 55
Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
             L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       
Sbjct: 56  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSY 110
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+    V
Sbjct: 111 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 251 VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
             T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 110/218 (50%), Gaps = 25/218 (11%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EVQFL 133
           +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+   A  E+  L
Sbjct: 3   NFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLL 55
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +  
Sbjct: 56  KELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
             +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+    V  T
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 165
Query: 254 FGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
             Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 129/287 (44%), Gaps = 44/287 (15%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQ-WVAEVQFLGVLEHP 139
           +IG G FG+VYK       GD       VA+K LN        LQ +  EV  L    H 
Sbjct: 15  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEG 197
           N++  +GY         Q  +V ++    SL  HL      F  +     + I    A+G
Sbjct: 65  NILLFMGYSTKP-----QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQG 116
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           + YLH      +I+RD K++N+ L E+   K+ DFGLA E      +H    + G+  + 
Sbjct: 117 MDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 173
Query: 258 APDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 314
           AP+ I   +    + +SDV++FG+VLYE++TG+     N    +Q +    + Y      
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGY------ 226
Query: 315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 361
               + P L K  S N  + + RL   CL K   +RP   Q++  ++
Sbjct: 227 ----LSPDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
           ++G G FG V+         +G ++  V ++K+ +     ++AE   +  L+H  LV+L 
Sbjct: 21  RLGAGQFGEVWMGYY-----NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL- 74
Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL 205
            Y  V  E      ++ E+M N SL D L   +   L     L +    AEG+A++ E  
Sbjct: 75  -YAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 129
Query: 206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDYI 262
               I+RD +A+N+L+ +    K++DFGLAR    +   +  TA  G      + AP+ I
Sbjct: 130 --NYIHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEXTAREGAKFPIKWTAPEAI 183
Query: 263 ETGHLTAKSDVWSFGVVLYEMLTGRR 288
             G  T KSDVWSFG++L E++T  R
Sbjct: 184 NYGTFTIKSDVWSFGILLTEIVTHGR 209

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 123/285 (43%), Gaps = 50/285 (17%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--WVAEVQFLGVLEHPNLVKL 144
           IG+G FG V           G      VA+K +  D     ++AE   +  L H NLV+L
Sbjct: 20  IGKGEFGDVML---------GDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL 70
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
           +G   V+ + G+   +V E+M   SL D+L +R    L     L   L   E + YL   
Sbjct: 71  LG-VIVEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 127
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAAPDYI 262
                ++RD  A NVL+ E+   K+SDFGL +E         ST   G     + AP+ +
Sbjct: 128 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEAL 177
Query: 263 ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPR 322
                + KSDVWSFG++L+E+ +  R                   YP    K    + PR
Sbjct: 178 REAAFSTKSDVWSFGILLWEIYSFGRV-----------------PYPRIPLK---DVVPR 217
Query: 323 LEKEYSINEAR----KIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
           +EK Y ++        +  +  NC    +  RP   Q+ E+L+ I
Sbjct: 218 VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 262

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 110/221 (49%), Gaps = 25/221 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EV 130
           +  +F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+   A  E+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTAIREI 54
Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
             L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       
Sbjct: 55  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSY 109
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+    V
Sbjct: 110 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 251 VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
             T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 167 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 113/219 (51%), Gaps = 36/219 (16%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EVQFLG 134
           + ++ K+GEG +G VYK+          S+  +VA+K++  D    G+   A  E+  L 
Sbjct: 23  YQKLEKVGEGTYGVVYKAK--------DSQGRIVALKRIRLDAEDEGIPSTAIREISLLK 74
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHII 191
            L HPN+V LI    +  ER +   LV+EFM   L + L+++           K  L+ +
Sbjct: 75  ELHHPNIVSLID--VIHSERCLT--LVFEFMEKDLKKVLDEN--KTGLQDSQIKIYLYQL 128
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTA 249
           L    G+A+ H+    ++++RD K  N+L++ +   KL+DFGLAR    P+  +TH    
Sbjct: 129 L---RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---- 178
Query: 250 VVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGR 287
            V T  Y APD +  +   +   D+WS G +  EM+TG+
Sbjct: 179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/315 (23%), Positives = 144/315 (45%), Gaps = 35/315 (11%)
Query: 56  PELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIK-PAAGDGTSEATVV 114
           P  +E+      V  +++   ATN  S    +G G FG V    +K P+  + +     +
Sbjct: 25  PHTFEDPTQT--VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 115 AIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL 174
            +    +    ++ E   +G  +HPN+++L G       +    ++V E+M N SL D  
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEYMENGSL-DSF 136
Query: 175 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 234
             +          + ++ G A G+ YL +   +  ++RD  A N+L++ N   K+SDFGL
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 235 AR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSL 290
           +R   + P   +T     +     + +P+ I     T+ SDVWS+G+VL+E+++ G R  
Sbjct: 194 SRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251
Query: 291 ERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDR 350
                 + Q +++ V +        G  + P ++   ++ +      L  +C  K   +R
Sbjct: 252 WE---MSNQDVIKAVDE--------GYRLPPPMDCPAALYQ------LMLDCWQKDRNNR 294
Query: 351 PKMSQVVERLKQIVQ 365
           PK  Q+V  L ++++
Sbjct: 295 PKFEQIVSILDKLIR 309

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
           ++G G FG V+         +G ++  V ++K+ +     ++AE   +  L+H  LV+L 
Sbjct: 26  RLGAGQFGEVWMGYY-----NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL- 79
Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL 205
            Y  V  E      ++ E+M N SL D L   +   L     L +    AEG+A++ E  
Sbjct: 80  -YAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 134
Query: 206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDYI 262
               I+RD +A+N+L+ +    K++DFGLAR    +   +  TA  G      + AP+ I
Sbjct: 135 --NYIHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEYTAREGAKFPIKWTAPEAI 188
Query: 263 ETGHLTAKSDVWSFGVVLYEMLTGRR 288
             G  T KSDVWSFG++L E++T  R
Sbjct: 189 NYGTFTIKSDVWSFGILLTEIVTHGR 214

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 123/285 (43%), Gaps = 50/285 (17%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--WVAEVQFLGVLEHPNLVKL 144
           IG+G FG V           G      VA+K +  D     ++AE   +  L H NLV+L
Sbjct: 14  IGKGEFGDVML---------GDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL 64
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
           +G   V+ + G+   +V E+M   SL D+L +R    L     L   L   E + YL   
Sbjct: 65  LG-VIVEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 121
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAAPDYI 262
                ++RD  A NVL+ E+   K+SDFGL +E         ST   G     + AP+ +
Sbjct: 122 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEAL 171
Query: 263 ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPR 322
                + KSDVWSFG++L+E+ +  R                   YP    K    + PR
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRV-----------------PYPRIPLK---DVVPR 211
Query: 323 LEKEYSINEAR----KIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
           +EK Y ++        +  +  NC    +  RP   Q+ E+L+ I
Sbjct: 212 VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 256

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 110/221 (49%), Gaps = 25/221 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EV 130
           +  +F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+   A  E+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTAIREI 56
Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
             L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       
Sbjct: 57  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSY 111
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+    V
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 251 VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
             T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/220 (33%), Positives = 112/220 (50%), Gaps = 29/220 (13%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EVQFL 133
           +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+   A  E+  L
Sbjct: 4   NFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLL 56
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +  
Sbjct: 57  KELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTAVV 251
             +GL++ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH     V
Sbjct: 112 LLQGLSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH----EV 164
Query: 252 GTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
            T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 110/221 (49%), Gaps = 25/221 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EV 130
           +  +F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+   A  E+
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTAIREI 57
Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
             L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       
Sbjct: 58  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSY 112
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+    V
Sbjct: 113 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 169
Query: 251 VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
             T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 170 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 207

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 110/221 (49%), Gaps = 25/221 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EV 130
           +  +F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+   A  E+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTAIREI 56
Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
             L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       
Sbjct: 57  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKTFMDASALTGIPLPLIKSY 111
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+    V
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 251 VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
             T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
           ++G G FG V+         +G ++  V ++K+ +     ++AE   +  L+H  LV+L 
Sbjct: 25  RLGAGQFGEVWMGYY-----NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL- 78
Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL 205
            Y  V  E      ++ E+M N SL D L   +   L     L +    AEG+A++ E  
Sbjct: 79  -YAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 133
Query: 206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDYI 262
               I+RD +A+N+L+ +    K++DFGLAR    +   +  TA  G      + AP+ I
Sbjct: 134 --NYIHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEYTAREGAKFPIKWTAPEAI 187
Query: 263 ETGHLTAKSDVWSFGVVLYEMLTGRR 288
             G  T KSDVWSFG++L E++T  R
Sbjct: 188 NYGTFTIKSDVWSFGILLTEIVTHGR 213

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
           ++G G FG V+         +G ++  V ++K+ +     ++AE   +  L+H  LV+L 
Sbjct: 20  RLGAGQFGEVWMGYY-----NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL- 73
Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL 205
            Y  V  E      ++ E+M N SL D L   +   L     L +    AEG+A++ E  
Sbjct: 74  -YAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 128
Query: 206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDYI 262
               I+RD +A+N+L+ +    K++DFGLAR    +   +  TA  G      + AP+ I
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEXTAREGAKFPIKWTAPEAI 182
Query: 263 ETGHLTAKSDVWSFGVVLYEMLTGRR 288
             G  T KSDVWSFG++L E++T  R
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 109/218 (50%), Gaps = 25/218 (11%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EVQFL 133
           +F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+   A  E+  L
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTAIREISLL 57
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +  
Sbjct: 58  KELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
             +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+    V  T
Sbjct: 113 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 167
Query: 254 FGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
             Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/322 (23%), Positives = 145/322 (45%), Gaps = 45/322 (13%)
Query: 62  KAHNLRVF----SYSEMRQATNDFSRMLK---------IGEGGFGSVYKSSIK-PAAGDG 107
           K   LR F    ++ +  Q  ++F++ L          +G G FG V    +K P+  + 
Sbjct: 15  KLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEI 74
Query: 108 TSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN 167
           +     + +    +    ++ E   +G  +HPN+++L G       +    ++V E+M N
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEYMEN 130
Query: 168 RSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP 227
            SL D    +          + ++ G A G+ YL +   +  ++RD  A N+L++ N   
Sbjct: 131 GSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVC 186
Query: 228 KLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
           K+SDFGL R   + P   +T     +     + +P+ I     T+ SDVWS+G+VL+E++
Sbjct: 187 KVSDFGLGRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244
Query: 285 T-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCL 343
           + G R        + Q +++ V +        G  + P ++   ++ +      L  +C 
Sbjct: 245 SYGERPYWE---MSNQDVIKAVDE--------GYRLPPPMDCPAALYQ------LMLDCW 287
Query: 344 SKSSKDRPKMSQVVERLKQIVQ 365
            K   +RPK  Q+V  L ++++
Sbjct: 288 QKDRNNRPKFEQIVSILDKLIR 309

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 113/219 (51%), Gaps = 36/219 (16%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EVQFLG 134
           + ++ K+GEG +G VYK+          S+  +VA+K++  D    G+   A  E+  L 
Sbjct: 23  YQKLEKVGEGTYGVVYKAK--------DSQGRIVALKRIRLDAEDEGIPSTAIREISLLK 74
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHII 191
            L HPN+V LI    +  ER +   LV+EFM   L + L+++           K  L+ +
Sbjct: 75  ELHHPNIVSLID--VIHSERCLT--LVFEFMEKDLKKVLDEN--KTGLQDSQIKIYLYQL 128
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTA 249
           L    G+A+ H+    ++++RD K  N+L++ +   KL+DFGLAR    P+  +TH    
Sbjct: 129 L---RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---- 178
Query: 250 VVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGR 287
            V T  Y APD +  +   +   D+WS G +  EM+TG+
Sbjct: 179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 134/303 (44%), Gaps = 45/303 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVL-EHPN 140
           +GEG FG V  +       D  +  T VA+K L  D  +      ++E++ + ++ +H N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW--------------KT 186
           ++ L+G C  DG   +    + E+    +L ++L  R  P L +              K 
Sbjct: 81  IINLLGACTQDGPLYV----IVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 136
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR+   + +   
Sbjct: 137 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWV 305
           +T       + AP+ +     T +SDVWSFGV+L+E+ T   S     P  E  +LL   
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 250
Query: 306 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
                   K G  MD   +     NE   + R   +C       RP   Q+VE L +IV 
Sbjct: 251 --------KEGHRMD---KPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRIVA 296
Query: 366 VSN 368
           +++
Sbjct: 297 LTS 299

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/315 (24%), Positives = 143/315 (45%), Gaps = 35/315 (11%)
Query: 56  PELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIK-PAAGDGTSEATVV 114
           P  YE+      V  +++   ATN  S    +G G FG V    +K P+  + +     +
Sbjct: 25  PHTYEDPTQT--VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 115 AIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL 174
            +    +    ++ E   +G  +HPN+++L G       +    ++V E M N SL D  
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEXMENGSL-DSF 136
Query: 175 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 234
             +          + ++ G A G+ YL +   +  ++RD  A N+L++ N   K+SDFGL
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 235 AR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSL 290
           +R   + P   +T     +     + +P+ I     T+ SDVWS+G+VL+E+++ G R  
Sbjct: 194 SRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251
Query: 291 ERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDR 350
                 + Q +++ V +        G  + P ++   ++ +      L  +C  K   +R
Sbjct: 252 WE---MSNQDVIKAVDE--------GYRLPPPMDCPAALYQ------LMLDCWQKDRNNR 294
Query: 351 PKMSQVVERLKQIVQ 365
           PK  Q+V  L ++++
Sbjct: 295 PKFEQIVSILDKLIR 309

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 133/307 (43%), Gaps = 53/307 (17%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVL-EHPN 140
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 141 LVKLIGYCAVDG---------ERGIQRLLV---------YEFMLNRSLEDHLFNRAFPPL 182
           ++ L+G C  DG          +G  R  +         Y + +NR  E+ +        
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM-------- 154
Query: 183 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 242
            +K  +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   + 
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 243 HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 302
           +   +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E    
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--- 268
Query: 303 EWVQQYPADSKKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 361
                       F L+ +  R++K    N   ++  +  +C       RP   Q+VE L 
Sbjct: 269 ------------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314
Query: 362 QIVQVSN 368
           +I+ ++ 
Sbjct: 315 RILTLTT 321

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA----EVQFLGVLEHPNL 141
           ++G+G FGSV      P   D T E  VVA+KKL     + +     E++ L  L+H N+
Sbjct: 16  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 72
Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL-HIIL-----GAA 195
           VK  G C   G R ++  L+ E++   SL D+L          K R+ HI L        
Sbjct: 73  VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-------KERIDHIKLLQYTSQIC 123
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT-HVSTAVVGTF 254
           +G+ YL      + I+RD    N+L++   R K+ DFGL +  P       V        
Sbjct: 124 KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 180
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 181 FWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
           ++G G FG V+         +G ++  V ++K+ +     ++AE   +  L+H  LV+L 
Sbjct: 15  RLGAGQFGEVWMGYY-----NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL- 68
Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL 205
            Y  V  E      ++ E+M N SL D L   +   L     L +    AEG+A++ E  
Sbjct: 69  -YAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 123
Query: 206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDYI 262
               I+RD +A+N+L+ +    K++DFGLAR    +   +  TA  G      + AP+ I
Sbjct: 124 --NYIHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEYTAREGAKFPIKWTAPEAI 177
Query: 263 ETGHLTAKSDVWSFGVVLYEMLTGRR 288
             G  T KSDVWSFG++L E++T  R
Sbjct: 178 NYGTFTIKSDVWSFGILLTEIVTHGR 203

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 129/279 (46%), Gaps = 30/279 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEH 138
           +DF ++ ++G G  G V+K S KP+      +   + IK   R+  Q + E+Q L     
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNS 66
Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 198
           P +V   G    DGE  I      E M   SL D +  +A   +P +    + +   +GL
Sbjct: 67  PYIVGFYGAFYSDGEISI----CMEHMDGGSL-DQVLKKA-GRIPEQILGKVSIAVIKGL 120
Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
            YL E  + ++++RD K SN+L++     KL DFG++  G ++    ++   VGT  Y +
Sbjct: 121 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLI--DEMANEFVGTRSYMS 174
Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 318
           P+ ++  H + +SD+WS G+ L EM  GR       P     LL+++   P         
Sbjct: 175 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYP---RPPMAIFELLDYIVNEPP-------- 223
Query: 319 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 357
             P+L       E +      + CL K+  +R  + Q++
Sbjct: 224 --PKLPSAVFSLEFQD---FVNKCLIKNPAERADLKQLM 257

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 134/303 (44%), Gaps = 45/303 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVL-EHPN 140
           +GEG FG V  +       D  +  T VA+K L  D  +      ++E++ + ++ +H N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW--------------KT 186
           ++ L+G C  DG   +    + E+    +L ++L  R  P L +              K 
Sbjct: 89  IINLLGACTQDGPLYV----IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 144
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR+   + +   
Sbjct: 145 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 201
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWV 305
           +T       + AP+ +     T +SDVWSFGV+L+E+ T   S     P  E  +LL   
Sbjct: 202 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 258
Query: 306 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
                   K G  MD   +     NE   + R   +C       RP   Q+VE L +IV 
Sbjct: 259 --------KEGHRMD---KPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRIVA 304
Query: 366 VSN 368
           +++
Sbjct: 305 LTS 307

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 134/303 (44%), Gaps = 45/303 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVL-EHPN 140
           +GEG FG V  +       D  +  T VA+K L  D  +      ++E++ + ++ +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW--------------KT 186
           ++ L+G C  DG   +    + E+    +L ++L  R  P L +              K 
Sbjct: 96  IINLLGACTQDGPLYV----IVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKD 151
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR+   + +   
Sbjct: 152 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWV 305
           +T       + AP+ +     T +SDVWSFGV+L+E+ T   S     P  E  +LL   
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 265
Query: 306 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
                   K G  MD   +     NE   + R   +C       RP   Q+VE L +IV 
Sbjct: 266 --------KEGHRMD---KPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRIVA 311
Query: 366 VSN 368
           +++
Sbjct: 312 LTS 314

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA----EVQFLGVLEHPNL 141
           ++G+G FGSV      P   D T E  VVA+KKL     + +     E++ L  L+H N+
Sbjct: 20  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 201
           VK  G C   G R ++  L+ E++   SL D+L   A   +     L       +G+ YL
Sbjct: 77  VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQAHA-ERIDHIKLLQYTSQICKGMEYL 133
Query: 202 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT-HVSTAVVGTFGYAAPD 260
                 + I+RD    N+L++   R K+ DFGL +  P       V         + AP+
Sbjct: 134 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 261 YIETGHLTAKSDVWSFGVVLYEMLT 285
            +     +  SDVWSFGVVLYE+ T
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 127/300 (42%), Gaps = 44/300 (14%)
Query: 65  NLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL 124
           NL   S  +      D +   K+G G +G VY        G     +  VA+K L  D +
Sbjct: 18  NLYFQSMDKWEMERTDITMKHKLGGGQYGEVY-------VGVWKKYSLTVAVKTLKEDTM 70
Query: 125 Q---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPP 181
           +   ++ E   +  ++HPNLV+L+G C ++    I    V E+M   +L D+L       
Sbjct: 71  EVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYI----VTEYMPYGNLLDYLRECNREE 126
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMV 241
           +     L++    +  + YL +      I+RD  A N L+ EN   K++DFGL+R   M 
Sbjct: 127 VTAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHVVKVADFGLSR--LMT 181
Query: 242 GHTHVSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR 300
           G T+ + A       + AP+ +     + KSDVW+FGV+L+E+ T   S           
Sbjct: 182 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMS----------- 230
Query: 301 LLEWVQQYPADSKKFGLIMDPRLEKEYSINEAR----KIGRLADNCLSKSSKDRPKMSQV 356
                   P        + D  LEK Y + +      K+  L   C   S  DRP  ++ 
Sbjct: 231 --------PYPGIDLSQVYD-LLEKGYRMEQPEGCPPKVYELMRACWKWSPADRPSFAET 281

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 134/303 (44%), Gaps = 45/303 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVL-EHPN 140
           +GEG FG V  +       D  +  T VA+K L  D  +      ++E++ + ++ +H N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW--------------KT 186
           ++ L+G C  DG   +    + E+    +L ++L  R  P L +              K 
Sbjct: 85  IINLLGACTQDGPLYV----IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 140
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR+   + +   
Sbjct: 141 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 197
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWV 305
           +T       + AP+ +     T +SDVWSFGV+L+E+ T   S     P  E  +LL   
Sbjct: 198 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 254
Query: 306 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
                   K G  MD   +     NE   + R   +C       RP   Q+VE L +IV 
Sbjct: 255 --------KEGHRMD---KPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRIVA 300
Query: 366 VSN 368
           +++
Sbjct: 301 LTS 303

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 101/206 (49%), Gaps = 25/206 (12%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGVLEHPNLV 142
           ++G G FG V+            + +T VA+K L    +    ++ E   +  L+H  LV
Sbjct: 20  RLGAGQFGEVWMGYY--------NNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLV 71
Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +L  Y  V  E  I   ++ E+M   SL D L +     +     +      AEG+AY+ 
Sbjct: 72  RL--YAVVTREEPI--YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 127
Query: 203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAP 259
                  I+RD +A+NVL+ E+   K++DFGLAR    V   +  TA  G      + AP
Sbjct: 128 RK---NYIHRDLRAANVLVSESLMCKIADFGLAR----VIEDNEYTAREGAKFPIKWTAP 180
Query: 260 DYIETGHLTAKSDVWSFGVVLYEMLT 285
           + I  G  T KSDVWSFG++LYE++T
Sbjct: 181 EAINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 133/307 (43%), Gaps = 53/307 (17%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVL-EHPN 140
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 141 LVKLIGYCAVDG---------ERGIQRLLV---------YEFMLNRSLEDHLFNRAFPPL 182
           ++ L+G C  DG          +G  R  +         Y + +NR  E+ +        
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM-------- 154
Query: 183 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 242
            +K  +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   + 
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 243 HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 302
           +   +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E    
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--- 268
Query: 303 EWVQQYPADSKKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 361
                       F L+ +  R++K    N   ++  +  +C       RP   Q+VE L 
Sbjct: 269 ------------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314
Query: 362 QIVQVSN 368
           +I+ ++ 
Sbjct: 315 RILTLTT 321

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
           ++G G FG V+         +G ++  V ++K+ +     ++AE   +  L+H  LV+L 
Sbjct: 20  RLGAGQFGEVWMGYY-----NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL- 73
Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL 205
            Y  V  E      ++ E+M N SL D L   +   L     L +    AEG+A++ E  
Sbjct: 74  -YAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 128
Query: 206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDYI 262
               I+RD +A+N+L+ +    K++DFGLAR    +   +  TA  G      + AP+ I
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 263 ETGHLTAKSDVWSFGVVLYEMLTGRR 288
             G  T KSDVWSFG++L E++T  R
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 87/282 (30%), Positives = 120/282 (42%), Gaps = 50/282 (17%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----W---VAEVQFL 133
           FS + +IG G FG+VY +            + VVAIKK++  G Q    W   + EV+FL
Sbjct: 17  FSDLREIGHGSFGAVYFAR-------DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L HPN ++  G C +   R     LV E+ L  + +  L      PL       +  G
Sbjct: 70  QKLRHPNTIQYRG-CYL---REHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHG 123
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-EGPMVGHTHVSTAVVG 252
           A +GLAYLH      +I+RD KA N+LL E    KL DFG A    P       +   VG
Sbjct: 124 ALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVG 173
Query: 253 TFGYAAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP 309
           T  + AP+ I   + G    K DVWS G+   E+       ER  P      +  +    
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL------AERKPPLFNMNAMSALYHIA 227
Query: 310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP 351
            +         P L+  +     R      D+CL K  +DRP
Sbjct: 228 QNES-------PALQSGHWSEYFRN---FVDSCLQKIPQDRP 259

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 131/292 (44%), Gaps = 40/292 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPNL 141
           IG G FG V    +K            VAIK L      +    +++E   +G  +HPN+
Sbjct: 15  IGAGEFGEVCSGHLKLPG----KREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 70
Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 201
           + L G       +    +++ EFM N SL D    +          + ++ G A G+ YL
Sbjct: 71  IHLEGVVT----KSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 125
Query: 202 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGHTHVSTAVVGTFG--YA 257
            +   +  ++R   A N+L++ N   K+SDFGL+R  E      T+ S A+ G     + 
Sbjct: 126 AD---MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTS-ALGGKIPIRWT 181
Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFG 316
           AP+ I+    T+ SDVWS+G+V++E+++ G R        T Q ++  ++Q         
Sbjct: 182 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD---MTNQDVINAIEQ--------- 229
Query: 317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN 368
              D RL        A  + +L  +C  K    RPK  Q+V  L ++++  N
Sbjct: 230 ---DYRLPPPMDCPSA--LHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 276

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 134/303 (44%), Gaps = 45/303 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVL-EHPN 140
           +GEG FG V  +       D  +  T VA+K L  D  +      ++E++ + ++ +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW--------------KT 186
           ++ L+G C  DG   +    + E+    +L ++L  R  P L +              K 
Sbjct: 96  IINLLGACTQDGPLYV----IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 151
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR+   + +   
Sbjct: 152 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWV 305
           +T       + AP+ +     T +SDVWSFGV+L+E+ T   S     P  E  +LL   
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 265
Query: 306 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
                   K G  MD   +     NE   + R   +C       RP   Q+VE L +IV 
Sbjct: 266 --------KEGHRMD---KPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRIVA 311
Query: 366 VSN 368
           +++
Sbjct: 312 LTS 314

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA----EVQFLGVLEHPNL 141
           ++G+G FGSV      P   D T E  VVA+KKL     + +     E++ L  L+H N+
Sbjct: 15  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 71
Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL-HIIL-----GAA 195
           VK  G C   G R ++  L+ E++   SL D+L          K R+ HI L        
Sbjct: 72  VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-------KERIDHIKLLQYTSQIC 122
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT-HVSTAVVGTF 254
           +G+ YL      + I+RD    N+L++   R K+ DFGL +  P       V        
Sbjct: 123 KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 179
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 180 FWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 110/221 (49%), Gaps = 25/221 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EV 130
           +  +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+   A  E+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTAIREI 54
Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
             L  L HPN+VKL+     +     +  LV+EF L+  L+  +   A   +P       
Sbjct: 55  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LSMDLKKFMDASALTGIPLPLIKSY 109
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+    V
Sbjct: 110 LFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 251 VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
             T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 167 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 119/281 (42%), Gaps = 48/281 (17%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----W---VAEVQFL 133
           FS + +IG G FG+VY +            + VVAIKK++  G Q    W   + EV+FL
Sbjct: 56  FSDLREIGHGSFGAVYFAR-------DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 108
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L HPN ++  G C +   R     LV E+ L  + +  L      PL       +  G
Sbjct: 109 QKLRHPNTIQYRG-CYL---REHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHG 162
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
           A +GLAYLH      +I+RD KA N+LL E    KL DFG A           +   VGT
Sbjct: 163 ALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGT 213
Query: 254 FGYAAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA 310
             + AP+ I   + G    K DVWS G+   E+       ER  P      +  +     
Sbjct: 214 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL------AERKPPLFNMNAMSALYHIAQ 267
Query: 311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP 351
           +         P L+  +     R      D+CL K  +DRP
Sbjct: 268 NES-------PALQSGHWSEYFRN---FVDSCLQKIPQDRP 298

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA----EVQFLGVLEHPNL 141
           ++G+G FGSV      P   D T E  VVA+KKL     + +     E++ L  L+H N+
Sbjct: 21  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 77
Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL-HIIL-----GAA 195
           VK  G C   G R ++  L+ E++   SL D+L          K R+ HI L        
Sbjct: 78  VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-------KERIDHIKLLQYTSQIC 128
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT-HVSTAVVGTF 254
           +G+ YL      + I+RD    N+L++   R K+ DFGL +  P       V        
Sbjct: 129 KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 185
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 186 FWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 134/303 (44%), Gaps = 45/303 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVL-EHPN 140
           +GEG FG V  +       D  +  T VA+K L  D  +      ++E++ + ++ +H N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW--------------KT 186
           ++ L+G C  DG   +    + E+    +L ++L  R  P L +              K 
Sbjct: 88  IINLLGACTQDGPLYV----IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 143
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR+   + +   
Sbjct: 144 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 200
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWV 305
           +T       + AP+ +     T +SDVWSFGV+L+E+ T   S     P  E  +LL   
Sbjct: 201 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 257
Query: 306 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
                   K G  MD   +     NE   + R   +C       RP   Q+VE L +IV 
Sbjct: 258 --------KEGHRMD---KPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRIVA 303
Query: 366 VSN 368
           +++
Sbjct: 304 LTS 306

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 110/221 (49%), Gaps = 25/221 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EV 130
           +  +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+   A  E+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTAIREI 56
Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
             L  L HPN+VKL+     +     +  LV+EF L+  L+  +   A   +P       
Sbjct: 57  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LSMDLKKFMDASALTGIPLPLIKSY 111
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+    V
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 251 VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
             T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 87/331 (26%), Positives = 141/331 (42%), Gaps = 61/331 (18%)
Query: 56  PELYEEKAHNLRVFSYSEMRQATNDFSRMLK---------IGEGGFGSVYKSSIK-PAAG 105
           P+ Y E        +Y E  +A   F+R ++         IG G  G V    ++ P   
Sbjct: 23  PQFYAEP------HTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQR 76
Query: 106 DGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLL 160
           D       VAIK L      R    +++E   +G  +HPN+++L G       RG   ++
Sbjct: 77  D-----VPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT----RGRLAMI 127
Query: 161 VYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASN 218
           V E+M N SL+  L   +  F  +     + ++ G   G+ YL +   +  ++RD  A N
Sbjct: 128 VTEYMENGSLDTFLRTHDGQFTIM---QLVGMLRGVGAGMRYLSD---LGYVHRDLAARN 181
Query: 219 VLLDENFRPKLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWS 275
           VL+D N   K+SDFGL+R   + P    T     +     + AP+ I     ++ SDVWS
Sbjct: 182 VLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKI--PIRWTAPEAIAFRTFSSASDVWS 239
Query: 276 FGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARK 334
           FGVV++E+L  G R       +     +E   + PA                  +     
Sbjct: 240 FGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA-----------------PMGCPHA 282
Query: 335 IGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
           + +L  +C  K    RP+ SQ+V  L  +++
Sbjct: 283 LHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA----EVQFLGVLEHPNL 141
           ++G+G FGSV      P   D T E  VVA+KKL     + +     E++ L  L+H N+
Sbjct: 48  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL-HIIL-----GAA 195
           VK  G C   G R ++  L+ E++   SL D+L          K R+ HI L        
Sbjct: 105 VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-------KERIDHIKLLQYTSQIC 155
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT-HVSTAVVGTF 254
           +G+ YL      + I+RD    N+L++   R K+ DFGL +  P       V        
Sbjct: 156 KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 212
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 213 FWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/311 (26%), Positives = 130/311 (41%), Gaps = 41/311 (13%)
Query: 70  SYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-----NRDG 123
           S S++++    + + +  +G G FG VY+  +     D +     VA+K L      +D 
Sbjct: 21  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVCSEQDE 78
Query: 124 LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPL 182
           L ++ E   +  L H N+V+ IG       + + R ++ E M    L+  L   R  P  
Sbjct: 79  LDFLMEALIISKLNHQNIVRCIGVSL----QSLPRFILLELMAGGDLKSFLRETRPRPSQ 134
Query: 183 PWKTR----LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLA 235
           P        LH+    A G  YL E      I+RD  A N LL         K+ DFG+A
Sbjct: 135 PSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 191
Query: 236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNR 294
           R+     +       +    +  P+    G  T+K+D WSFGV+L+E+ + G        
Sbjct: 192 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-- 249
Query: 295 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS 354
            K+ Q +LE+V          G  MDP        N    + R+   C     +DRP  +
Sbjct: 250 -KSNQEVLEFVTS--------GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFA 294
Query: 355 QVVERLKQIVQ 365
            ++ER++   Q
Sbjct: 295 IILERIEYCTQ 305

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA----EVQFLGVLEHPNL 141
           ++G+G FGSV      P   D T E  VVA+KKL     + +     E++ L  L+H N+
Sbjct: 23  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 79
Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL-HIIL-----GAA 195
           VK  G C   G R ++  L+ E++   SL D+L          K R+ HI L        
Sbjct: 80  VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-------KERIDHIKLLQYTSQIC 130
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT-HVSTAVVGTF 254
           +G+ YL      + I+RD    N+L++   R K+ DFGL +  P       V        
Sbjct: 131 KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 187
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 188 FWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA----EVQFLGVLEHPNL 141
           ++G+G FGSV      P   D T E  VVA+KKL     + +     E++ L  L+H N+
Sbjct: 24  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 80
Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL-HIIL-----GAA 195
           VK  G C   G R ++  L+ E++   SL D+L          K R+ HI L        
Sbjct: 81  VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-------KERIDHIKLLQYTSQIC 131
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT-HVSTAVVGTF 254
           +G+ YL      + I+RD    N+L++   R K+ DFGL +  P       V        
Sbjct: 132 KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 188
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 189 FWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/319 (24%), Positives = 143/319 (44%), Gaps = 42/319 (13%)
Query: 52  PRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIK-PAAGDGTSE 110
           PRG  +   E A  L          ATN  S    +G G FG V    +K P+  + +  
Sbjct: 16  PRGSTQTVHEFAKEL---------DATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVA 65
Query: 111 ATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL 170
              + +    +    ++ E   +G  +HPN+++L G       +    ++V E+M N SL
Sbjct: 66  IKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEYMENGSL 121
Query: 171 EDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS 230
            D    +          + ++ G A G+ YL +   +  ++RD  A N+L++ N   K+S
Sbjct: 122 -DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVS 177
Query: 231 DFGLAR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-G 286
           DFGL+R   + P   +T     +     + +P+ I     T+ SDVWS+G+VL+E+++ G
Sbjct: 178 DFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 235
Query: 287 RRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKS 346
            R        + Q +++ V +        G  + P ++   ++ +      L  +C  K 
Sbjct: 236 ERPYWE---MSNQDVIKAVDE--------GYRLPPPMDCPAALYQ------LMLDCWQKD 278
Query: 347 SKDRPKMSQVVERLKQIVQ 365
             +RPK  Q+V  L ++++
Sbjct: 279 RNNRPKFEQIVSILDKLIR 297

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/220 (33%), Positives = 111/220 (50%), Gaps = 29/220 (13%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EVQFL 133
           +F ++ KIGEG +G VYK     A    T E  VVA+ K+  D    G+   A  E+  L
Sbjct: 4   NFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALXKIRLDTETEGVPSTAIREISLL 56
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +  
Sbjct: 57  KELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTAVV 251
             +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH     V
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH----EV 164
Query: 252 GTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
            T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/220 (33%), Positives = 111/220 (50%), Gaps = 29/220 (13%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EVQFL 133
           +F ++ KIGEG +G VYK     A    T E  VVA+ K+  D    G+   A  E+  L
Sbjct: 3   NFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALXKIRLDTETEGVPSTAIREISLL 55
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +  
Sbjct: 56  KELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTAVV 251
             +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH     V
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH----EV 163
Query: 252 GTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
            T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA----EVQFLGVLEHPNL 141
           ++G+G FGSV      P   D T E  VVA+KKL     + +     E++ L  L+H N+
Sbjct: 22  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 78
Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL-HIIL-----GAA 195
           VK  G C   G R ++  L+ E++   SL D+L          K R+ HI L        
Sbjct: 79  VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-------KERIDHIKLLQYTSQIC 129
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT-HVSTAVVGTF 254
           +G+ YL      + I+RD    N+L++   R K+ DFGL +  P       V        
Sbjct: 130 KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 186
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 187 FWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 81/313 (25%), Positives = 131/313 (41%), Gaps = 45/313 (14%)
Query: 70  SYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-----NRDG 123
           S S++++    + + +  +G G FG VY+  +     D +     VA+K L      +D 
Sbjct: 35  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVCSEQDE 92
Query: 124 LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 183
           L ++ E   +  L H N+V+ IG       + + R ++ E M    L+  L  R   P P
Sbjct: 93  LDFLMEALIISKLNHQNIVRCIGVSL----QSLPRFILLELMAGGDLKSFL--RETRPRP 146
Query: 184 WKTR-------LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFG 233
            +         LH+    A G  YL E      I+RD  A N LL         K+ DFG
Sbjct: 147 SQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG 203
Query: 234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLER 292
           +AR+     +       +    +  P+    G  T+K+D WSFGV+L+E+ + G      
Sbjct: 204 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 263
Query: 293 NRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK 352
              K+ Q +LE+V          G  MDP        N    + R+   C     +DRP 
Sbjct: 264 ---KSNQEVLEFVTS--------GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPN 306
Query: 353 MSQVVERLKQIVQ 365
            + ++ER++   Q
Sbjct: 307 FAIILERIEYCTQ 319

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA----EVQFLGVLEHPNL 141
           ++G+G FGSV      P   D T E  VVA+KKL     + +     E++ L  L+H N+
Sbjct: 17  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL-HIIL-----GAA 195
           VK  G C   G R ++  L+ E++   SL D+L          K R+ HI L        
Sbjct: 74  VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-------KERIDHIKLLQYTSQIC 124
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT-HVSTAVVGTF 254
           +G+ YL      + I+RD    N+L++   R K+ DFGL +  P       V        
Sbjct: 125 KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 181
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/322 (23%), Positives = 145/322 (45%), Gaps = 45/322 (13%)
Query: 62  KAHNLRVF----SYSEMRQATNDFSRMLK---------IGEGGFGSVYKSSIK-PAAGDG 107
           K   LR F    ++ +  Q  ++F++ L          +G G FG V    +K P+  + 
Sbjct: 15  KLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEI 74
Query: 108 TSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN 167
           +     + +    +    ++ E   +G  +HPN+++L G       +    ++V E M N
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEXMEN 130
Query: 168 RSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP 227
            SL D    +          + ++ G A G+ YL +   +  ++RD  A N+L++ N   
Sbjct: 131 GSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGAVHRDLAARNILINSNLVC 186
Query: 228 KLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
           K+SDFGL+R   + P   +T     +     + +P+ I     T+ SDVWS+G+VL+E++
Sbjct: 187 KVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244
Query: 285 T-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCL 343
           + G R        + Q +++ V +        G  + P ++   ++ +      L  +C 
Sbjct: 245 SYGERPYWE---MSNQDVIKAVDE--------GYRLPPPMDCPAALYQ------LMLDCW 287
Query: 344 SKSSKDRPKMSQVVERLKQIVQ 365
            K   +RPK  Q+V  L ++++
Sbjct: 288 QKDRNNRPKFEQIVSILDKLIR 309

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 112/232 (48%), Gaps = 18/232 (7%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEH 138
           +DF R+ ++G G  G V K   +P+      +   + IK   R+  Q + E+Q L     
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRN--QIIRELQVLHECNS 73
Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 198
           P +V   G    DGE  I      E M   SL D +   A   +P +    + +    GL
Sbjct: 74  PYIVGFYGAFYSDGEISI----CMEHMDGGSL-DQVLKEA-KRIPEEILGKVSIAVLRGL 127
Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
           AYL E  + Q+++RD K SN+L++     KL DFG++  G ++    ++ + VGT  Y A
Sbjct: 128 AYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLI--DSMANSFVGTRSYMA 181
Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA 310
           P+ ++  H + +SD+WS G+ L E+  GR  +    P  + + LE +   P 
Sbjct: 182 PERLQGTHYSVQSDIWSMGLSLVELAVGRYPI----PPPDAKELEAIFGRPV 229

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 132/284 (46%), Gaps = 32/284 (11%)
Query: 87  IGEGGFGSVYKSSIK-PAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
           +G G FG V    +K P+  + +     + +    +    ++ E   +G  +HPN+++L 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL 205
           G       +    ++V E+M N SL D    +          + ++ G A G+ YL +  
Sbjct: 84  GVVT----KSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD-- 136
Query: 206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAAPDYI 262
            +  ++RD  A N+L++ N   K+SDFGL+R   + P   +T     +     + +P+ I
Sbjct: 137 -MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAI 193
Query: 263 ETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDP 321
                T+ SDVWS+G+VL+E+++ G R        + Q +++ V +        G  + P
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMSYGERPYWE---MSNQDVIKAVDE--------GYRLPP 242
Query: 322 RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
            ++   ++ +      L  +C  K   +RPK  Q+V  L ++++
Sbjct: 243 PMDCPAALYQ------LMLDCWQKDRNNRPKFEQIVSILDKLIR 280

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA----EVQFLGVLEHPNL 141
           ++G+G FGSV      P   D T E  VVA+KKL     + +     E++ L  L+H N+
Sbjct: 20  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL-HIIL-----GAA 195
           VK  G C   G R ++  L+ EF+   SL ++L          K R+ HI L        
Sbjct: 77  VKYKGVCYSAGRRNLK--LIMEFLPYGSLREYLQKH-------KERIDHIKLLQYTSQIC 127
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT-HVSTAVVGTF 254
           +G+ YL      + I+RD    N+L++   R K+ DFGL +  P       V        
Sbjct: 128 KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 184
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 185 FWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA----EVQFLGVLEHPNL 141
           ++G+G FGSV      P   D T E  VVA+KKL     + +     E++ L  L+H N+
Sbjct: 35  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL-HIIL-----GAA 195
           VK  G C   G R ++  L+ E++   SL D+L          K R+ HI L        
Sbjct: 92  VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-------KERIDHIKLLQYTSQIC 142
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT-HVSTAVVGTF 254
           +G+ YL      + I+RD    N+L++   R K+ DFGL +  P       V        
Sbjct: 143 KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 199
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 200 FWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 128/287 (44%), Gaps = 44/287 (15%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQ-WVAEVQFLGVLEHP 139
           +IG G FG+VYK       GD       VA+K LN        LQ +  EV  L    H 
Sbjct: 15  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEG 197
           N++  +GY         Q  +V ++    SL  HL      F  +     + I    A+G
Sbjct: 65  NILLFMGYSTAP-----QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQG 116
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           + YLH      +I+RD K++N+ L E+   K+ DFGLA        +H    + G+  + 
Sbjct: 117 MDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 258 APDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 314
           AP+ I   +    + +SDV++FG+VLYE++TG+     N    +Q +    + Y      
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGY------ 226
Query: 315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 361
               + P L K  S N  + + RL   CL K   +RP   Q++  ++
Sbjct: 227 ----LSPDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 30/206 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGVLEHPNLV 142
           K+G G FG V+ ++         ++ T VA+K +    +    ++AE   +  L+H  LV
Sbjct: 189 KLGAGQFGEVWMATY--------NKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLV 240
Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           KL    AV  +  I   ++ EFM   SL D L +      P    +      AEG+A++ 
Sbjct: 241 KL---HAVVTKEPI--YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 295
Query: 203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI 262
           +      I+RD +A+N+L+  +   K++DFGLAR G                 + AP+ I
Sbjct: 296 QR---NYIHRDLRAANILVSASLVCKIADFGLARVGAKF-----------PIKWTAPEAI 341
Query: 263 ETGHLTAKSDVWSFGVVLYEMLTGRR 288
             G  T KSDVWSFG++L E++T  R
Sbjct: 342 NFGSFTIKSDVWSFGILLMEIVTYGR 367

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 26/209 (12%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGVLEHPNLV 142
           K+G G FG V+ ++         ++ T VA+K +    +    ++AE   +  L+H  LV
Sbjct: 195 KLGAGQFGEVWMATY--------NKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           KL    AV  +  I   ++ EFM   SL D L +      P    +      AEG+A++ 
Sbjct: 247 KL---HAVVTKEPI--YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAP 259
           +      I+RD +A+N+L+  +   K++DFGLAR    V   +  TA  G      + AP
Sbjct: 302 QR---NYIHRDLRAANILVSASLVCKIADFGLAR----VIEDNEYTAREGAKFPIKWTAP 354
Query: 260 DYIETGHLTAKSDVWSFGVVLYEMLTGRR 288
           + I  G  T KSDVWSFG++L E++T  R
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVTYGR 383

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA----EVQFLGVLEHPNL 141
           ++G+G FGSV      P   D T E  VVA+KKL     + +     E++ L  L+H N+
Sbjct: 35  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL-HIIL-----GAA 195
           VK  G C   G R ++  L+ E++   SL D+L          K R+ HI L        
Sbjct: 92  VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-------KERIDHIKLLQYTSQIC 142
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT-HVSTAVVGTF 254
           +G+ YL      + I+RD    N+L++   R K+ DFGL +  P       V        
Sbjct: 143 KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 199
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 200 FWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA----EVQFLGVLEHPNL 141
           ++G+G FGSV      P   D T E  VVA+KKL     + +     E++ L  L+H N+
Sbjct: 17  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL-HIIL-----GAA 195
           VK  G C   G R ++  L+ E++   SL D+L          K R+ HI L        
Sbjct: 74  VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-------KERIDHIKLLQYTSQIC 124
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT-HVSTAVVGTF 254
           +G+ YL      + I+RD    N+L++   R K+ DFGL +  P       V        
Sbjct: 125 KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI 181
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 26/209 (12%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGVLEHPNLV 142
           K+G G FG V+ ++         ++ T VA+K +    +    ++AE   +  L+H  LV
Sbjct: 22  KLGAGQFGEVWMATY--------NKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLV 73
Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           KL    AV  +  I   ++ EFM   SL D L +      P    +      AEG+A++ 
Sbjct: 74  KL---HAVVTKEPI--YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 128
Query: 203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAP 259
           +      I+RD +A+N+L+  +   K++DFGLAR    V   +  TA  G      + AP
Sbjct: 129 QR---NYIHRDLRAANILVSASLVCKIADFGLAR----VIEDNEYTAREGAKFPIKWTAP 181
Query: 260 DYIETGHLTAKSDVWSFGVVLYEMLTGRR 288
           + I  G  T KSDVWSFG++L E++T  R
Sbjct: 182 EAINFGSFTIKSDVWSFGILLMEIVTYGR 210

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 120/293 (40%), Gaps = 40/293 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-----NRDGLQWVAEVQFLGVLEHPNL 141
           +G G FG VY+  +     D +     VA+K L      +D L ++ E   +    H N+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 122
Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPLPWKTR----LHIILGAAE 196
           V+ IG       + + R ++ E M    L+  L   R  P  P        LH+    A 
Sbjct: 123 VRCIGVSL----QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 178
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
           G  YL E      I+RD  A N LL         K+ DFG+AR+     +       +  
Sbjct: 179 GCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 235
Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS 312
             +  P+    G  T+K+D WSFGV+L+E+ + G         K+ Q +LE+V       
Sbjct: 236 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFVTS----- 287
Query: 313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
              G  MDP        N    + R+   C     +DRP  + ++ER++   Q
Sbjct: 288 ---GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 331

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 134/303 (44%), Gaps = 45/303 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVL-EHPN 140
           +GEG FG V  +       D  +  T VA+K L  D  +      ++E++ + ++ +H N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW--------------KT 186
           ++ L+G C  DG   +    + E+    +L ++L  R  P L +              K 
Sbjct: 137 IINLLGACTQDGPLYV----IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR+   + +   
Sbjct: 193 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWV 305
           +T       + AP+ +     T +SDVWSFGV+L+E+ T   S     P  E  +LL   
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 306
Query: 306 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
                   K G  MD   +     NE   + R   +C       RP   Q+VE L +IV 
Sbjct: 307 --------KEGHRMD---KPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRIVA 352
Query: 366 VSN 368
           +++
Sbjct: 353 LTS 355

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA----EVQFLGVLEHPNL 141
           ++G+G FGSV      P   D T E  VVA+KKL     + +     E++ L  L+H N+
Sbjct: 18  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 74
Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL-HIIL-----GAA 195
           VK  G C   G R ++  L+ E++   SL D+L          K R+ HI L        
Sbjct: 75  VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-------KERIDHIKLLQYTSQIC 125
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH-VSTAVVGTF 254
           +G+ YL      + I+R+    N+L++   R K+ DFGL +  P     + V        
Sbjct: 126 KGMEYLGTK---RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI 182
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 183 FWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 128/310 (41%), Gaps = 39/310 (12%)
Query: 70  SYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-----NRDG 123
           S S++++    + + +  +G G FG VY+  +     D +     VA+K L      +D 
Sbjct: 20  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVCSEQDE 77
Query: 124 LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPL 182
           L ++ E   +    H N+V+ IG       + + R ++ E M    L+  L   R  P  
Sbjct: 78  LDFLMEALIISKFNHQNIVRCIGV----SLQSLPRFILMELMAGGDLKSFLRETRPRPSQ 133
Query: 183 PWKTR----LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLA 235
           P        LH+    A G  YL E      I+RD  A N LL         K+ DFG+A
Sbjct: 134 PSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
Query: 236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           R+     +       +    +  P+    G  T+K+D WSFGV+L+E+ +          
Sbjct: 191 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPS 248
Query: 296 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 355
           K+ Q +LE+V          G  MDP        N    + R+   C     +DRP  + 
Sbjct: 249 KSNQEVLEFVTS--------GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAI 294
Query: 356 VVERLKQIVQ 365
           ++ER++   Q
Sbjct: 295 ILERIEYCTQ 304

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 129/311 (41%), Gaps = 41/311 (13%)
Query: 70  SYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-----NRDG 123
           S S++++    + + +  +G G FG VY+  +     D +     VA+K L      +D 
Sbjct: 20  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVCSEQDE 77
Query: 124 LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPL 182
           L ++ E   +    H N+V+ IG       + + R ++ E M    L+  L   R  P  
Sbjct: 78  LDFLMEALIISKFNHQNIVRCIGV----SLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 133
Query: 183 PWKTR----LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLA 235
           P        LH+    A G  YL E      I+RD  A N LL         K+ DFG+A
Sbjct: 134 PSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
Query: 236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNR 294
           R+     +       +    +  P+    G  T+K+D WSFGV+L+E+ + G        
Sbjct: 191 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-- 248
Query: 295 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS 354
            K+ Q +LE+V          G  MDP        N    + R+   C     +DRP  +
Sbjct: 249 -KSNQEVLEFVTS--------GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFA 293
Query: 355 QVVERLKQIVQ 365
            ++ER++   Q
Sbjct: 294 IILERIEYCTQ 304

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 129/311 (41%), Gaps = 41/311 (13%)
Query: 70  SYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-----NRDG 123
           S S++++    + + +  +G G FG VY+  +     D +     VA+K L      +D 
Sbjct: 37  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVCSEQDE 94
Query: 124 LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPL 182
           L ++ E   +    H N+V+ IG       + + R ++ E M    L+  L   R  P  
Sbjct: 95  LDFLMEALIISKFNHQNIVRCIGVSL----QSLPRFILLELMAGGDLKSFLRETRPRPSQ 150
Query: 183 PWKTR----LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLA 235
           P        LH+    A G  YL E      I+RD  A N LL         K+ DFG+A
Sbjct: 151 PSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 207
Query: 236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNR 294
           R+     +       +    +  P+    G  T+K+D WSFGV+L+E+ + G        
Sbjct: 208 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-- 265
Query: 295 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS 354
            K+ Q +LE+V          G  MDP        N    + R+   C     +DRP  +
Sbjct: 266 -KSNQEVLEFVTS--------GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFA 310
Query: 355 QVVERLKQIVQ 365
            ++ER++   Q
Sbjct: 311 IILERIEYCTQ 321

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKL 144
           +K+G+G FG V+  +      +GT+   +  +K        ++ E Q +  L H  LV+L
Sbjct: 14  VKLGQGCFGEVWMGT-----WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 68
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
               AV  E  I   +V E+M   SL D L       L     + +    A G+AY+   
Sbjct: 69  Y---AVVSEEPIX--IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER- 122
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDY 261
             +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + AP+ 
Sbjct: 123 --MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEXTARQGAKFPIKWTAPEA 176
Query: 262 IETGHLTAKSDVWSFGVVLYEMLTGRR 288
              G  T KSDVWSFG++L E+ T  R
Sbjct: 177 ALYGRFTIKSDVWSFGILLTELTTKGR 203

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 129/311 (41%), Gaps = 41/311 (13%)
Query: 70  SYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-----NRDG 123
           S S++++    + + +  +G G FG VY+  +     D +     VA+K L      +D 
Sbjct: 21  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVCSEQDE 78
Query: 124 LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPL 182
           L ++ E   +    H N+V+ IG       + + R ++ E M    L+  L   R  P  
Sbjct: 79  LDFLMEALIISKFNHQNIVRCIGVSL----QSLPRFILLELMAGGDLKSFLRETRPRPSQ 134
Query: 183 PWKTR----LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLA 235
           P        LH+    A G  YL E      I+RD  A N LL         K+ DFG+A
Sbjct: 135 PSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 191
Query: 236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNR 294
           R+     +       +    +  P+    G  T+K+D WSFGV+L+E+ + G        
Sbjct: 192 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-- 249
Query: 295 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS 354
            K+ Q +LE+V          G  MDP        N    + R+   C     +DRP  +
Sbjct: 250 -KSNQEVLEFVTS--------GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFA 294
Query: 355 QVVERLKQIVQ 365
            ++ER++   Q
Sbjct: 295 IILERIEYCTQ 305

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 130/313 (41%), Gaps = 45/313 (14%)
Query: 70  SYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-----NRDG 123
           S S++++    + + +  +G G FG VY+  +     D +     VA+K L      +D 
Sbjct: 35  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVCSEQDE 92
Query: 124 LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 183
           L ++ E   +    H N+V+ IG       + + R ++ E M    L+  L  R   P P
Sbjct: 93  LDFLMEALIISKFNHQNIVRCIGVSL----QSLPRFILMELMAGGDLKSFL--RETRPRP 146
Query: 184 WKTR-------LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFG 233
            +         LH+    A G  YL E      I+RD  A N LL         K+ DFG
Sbjct: 147 SQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG 203
Query: 234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLER 292
           +AR+     +       +    +  P+    G  T+K+D WSFGV+L+E+ + G      
Sbjct: 204 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 263
Query: 293 NRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK 352
              K+ Q +LE+V          G  MDP        N    + R+   C     +DRP 
Sbjct: 264 ---KSNQEVLEFVTS--------GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPN 306
Query: 353 MSQVVERLKQIVQ 365
            + ++ER++   Q
Sbjct: 307 FAIILERIEYCTQ 319

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 128/286 (44%), Gaps = 42/286 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFLGVLEHP 139
           +IG G FG V+   ++       ++ T+VA+K   R+ L      +++ E + L    HP
Sbjct: 121 QIGRGNFGEVFSGRLR-------ADNTLVAVKSC-RETLPPDLKAKFLQEARILKQYSHP 172
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-FNRA-FPPLPWKTRLHIILGAAEG 197
           N+V+LIG C        Q+  +Y  M      D L F R     L  KT L ++  AA G
Sbjct: 173 NIVRLIGVCT-------QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           + YL        I+RD  A N L+ E    K+SDFG++RE     +            + 
Sbjct: 226 MEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT 282
Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGL 317
           AP+ +  G  +++SDVWSFG++L+E  +   S   N    + R  E+V+       K G 
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR--EFVE-------KGGR 333
Query: 318 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
           +  P L  +        + RL + C +     RP  S + + L+ I
Sbjct: 334 LPCPELCPD-------AVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
           ++G G FG V+         +G ++  V ++K+ +     ++AE   +  L+H  LV+L 
Sbjct: 16  RLGAGQFGEVWMGYY-----NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL- 69
Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL 205
            Y  V  E      ++ E+M N SL D L   +   L     L +    AEG+A++ E  
Sbjct: 70  -YAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 124
Query: 206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDYI 262
               I+R+ +A+N+L+ +    K++DFGLAR    +   +  TA  G      + AP+ I
Sbjct: 125 --NYIHRNLRAANILVSDTLSCKIADFGLAR----LIEDNEYTAREGAKFPIKWTAPEAI 178
Query: 263 ETGHLTAKSDVWSFGVVLYEMLTGRR 288
             G  T KSDVWSFG++L E++T  R
Sbjct: 179 NYGTFTIKSDVWSFGILLTEIVTHGR 204

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 129/311 (41%), Gaps = 41/311 (13%)
Query: 70  SYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-----NRDG 123
           S S++++    + + +  +G G FG VY+  +     D +     VA+K L      +D 
Sbjct: 27  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVCSEQDE 84
Query: 124 LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPL 182
           L ++ E   +    H N+V+ IG       + + R ++ E M    L+  L   R  P  
Sbjct: 85  LDFLMEALIISKFNHQNIVRCIGVSL----QSLPRFILLELMAGGDLKSFLRETRPRPSQ 140
Query: 183 PWKTR----LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLA 235
           P        LH+    A G  YL E      I+RD  A N LL         K+ DFG+A
Sbjct: 141 PSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 197
Query: 236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNR 294
           R+     +       +    +  P+    G  T+K+D WSFGV+L+E+ + G        
Sbjct: 198 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-- 255
Query: 295 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS 354
            K+ Q +LE+V          G  MDP        N    + R+   C     +DRP  +
Sbjct: 256 -KSNQEVLEFVTS--------GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFA 300
Query: 355 QVVERLKQIVQ 365
            ++ER++   Q
Sbjct: 301 IILERIEYCTQ 311

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 128/287 (44%), Gaps = 44/287 (15%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQ-WVAEVQFLGVLEHP 139
           +IG G FG+VYK       GD       VA+K LN        LQ +  EV  L    H 
Sbjct: 20  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 69
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEG 197
           N++  +GY         Q  +V ++    SL  HL      F  +     + I    A+G
Sbjct: 70  NILLFMGYSTKP-----QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQG 121
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           + YLH      +I+RD K++N+ L E+   K+ DFGLA        +H    + G+  + 
Sbjct: 122 MDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 178
Query: 258 APDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 314
           AP+ I   +    + +SDV++FG+VLYE++TG+     N    +Q +    + Y      
Sbjct: 179 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGY------ 231
Query: 315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 361
               + P L K  S N  + + RL   CL K   +RP   Q++  ++
Sbjct: 232 ----LSPDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIE 273

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 130/313 (41%), Gaps = 45/313 (14%)
Query: 70  SYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-----NRDG 123
           S S++++    + + +  +G G FG VY+  +     D +     VA+K L      +D 
Sbjct: 35  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVYSEQDE 92
Query: 124 LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 183
           L ++ E   +    H N+V+ IG       + + R ++ E M    L+  L  R   P P
Sbjct: 93  LDFLMEALIISKFNHQNIVRCIGVSL----QSLPRFILLELMAGGDLKSFL--RETRPRP 146
Query: 184 WKTR-------LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFG 233
            +         LH+    A G  YL E      I+RD  A N LL         K+ DFG
Sbjct: 147 SQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG 203
Query: 234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLER 292
           +AR+     +       +    +  P+    G  T+K+D WSFGV+L+E+ + G      
Sbjct: 204 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 263
Query: 293 NRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK 352
              K+ Q +LE+V          G  MDP        N    + R+   C     +DRP 
Sbjct: 264 ---KSNQEVLEFVTS--------GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPN 306
Query: 353 MSQVVERLKQIVQ 365
            + ++ER++   Q
Sbjct: 307 FAIILERIEYCTQ 319

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 128/310 (41%), Gaps = 39/310 (12%)
Query: 70  SYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-----NRDG 123
           S S++++    + + +  +G G FG VY+  +     D +     VA+K L      +D 
Sbjct: 12  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVCSEQDE 69
Query: 124 LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPL 182
           L ++ E   +    H N+V+ IG       + + R ++ E M    L+  L   R  P  
Sbjct: 70  LDFLMEALIISKFNHQNIVRCIGV----SLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 125
Query: 183 PWKTR----LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLA 235
           P        LH+    A G  YL E      I+RD  A N LL         K+ DFG+A
Sbjct: 126 PSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 182
Query: 236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           R+     +       +    +  P+    G  T+K+D WSFGV+L+E+ +          
Sbjct: 183 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPS 240
Query: 296 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 355
           K+ Q +LE+V          G  MDP        N    + R+   C     +DRP  + 
Sbjct: 241 KSNQEVLEFVTS--------GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAI 286
Query: 356 VVERLKQIVQ 365
           ++ER++   Q
Sbjct: 287 ILERIEYCTQ 296

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKL 144
           +K+G+G FG V+  +      +GT+   +  +K  N     ++ E Q +  L H  LV+L
Sbjct: 191 VKLGQGCFGEVWMGTW-----NGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQL 245
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
               AV  E  I   +V E+M   SL D L       L     + +    A G+AY+   
Sbjct: 246 Y---AVVSEEPI--YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER- 299
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAAPDYI 262
             +  ++RD +A+N+L+ EN   K++DFGL R   ++     +      F   + AP+  
Sbjct: 300 --MNYVHRDLRAANILVGENLVCKVADFGLGR---LIEDNEYTARQGAKFPIKWTAPEAA 354
Query: 263 ETGHLTAKSDVWSFGVVLYEMLTGRR 288
             G  T KSDVWSFG++L E+ T  R
Sbjct: 355 LYGRFTIKSDVWSFGILLTELTTKGR 380

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 128/287 (44%), Gaps = 44/287 (15%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQ-WVAEVQFLGVLEHP 139
           +IG G FG+VYK       GD       VA+K LN        LQ +  EV  L    H 
Sbjct: 42  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 91
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEG 197
           N++  +GY         Q  +V ++    SL  HL      F  +     + I    A+G
Sbjct: 92  NILLFMGYSTKP-----QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQG 143
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           + YLH      +I+RD K++N+ L E+   K+ DFGLA        +H    + G+  + 
Sbjct: 144 MDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 200
Query: 258 APDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 314
           AP+ I   +    + +SDV++FG+VLYE++TG+     N    +Q +    + Y      
Sbjct: 201 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGY------ 253
Query: 315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 361
               + P L K  S N  + + RL   CL K   +RP   Q++  ++
Sbjct: 254 ----LSPDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIE 295

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 130/289 (44%), Gaps = 48/289 (16%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFLGVLEHP 139
           +IG G FG V+   ++       ++ T+VA+K   R+ L      +++ E + L    HP
Sbjct: 121 QIGRGNFGEVFSGRLR-------ADNTLVAVKSC-RETLPPDLKAKFLQEARILKQYSHP 172
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-FNRA-FPPLPWKTRLHIILGAAEG 197
           N+V+LIG C        Q+  +Y  M      D L F R     L  KT L ++  AA G
Sbjct: 173 NIVRLIGVCT-------QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE---GPMVGHTHVSTAVVGTF 254
           + YL        I+RD  A N L+ E    K+SDFG++RE   G       +    V   
Sbjct: 226 MEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVK-- 280
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 314
            + AP+ +  G  +++SDVWSFG++L+E  +   S   N    + R  E+V+       K
Sbjct: 281 -WTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR--EFVE-------K 330
Query: 315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
            G +  P L  +        + RL + C +     RP  S + + L+ I
Sbjct: 331 GGRLPCPELCPD-------AVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 128/287 (44%), Gaps = 44/287 (15%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQ-WVAEVQFLGVLEHP 139
           +IG G FG+VYK       GD       VA+K LN        LQ +  EV  L    H 
Sbjct: 17  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 66
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEG 197
           N++  +GY         Q  +V ++    SL  HL      F  +     + I    A+G
Sbjct: 67  NILLFMGYSTKP-----QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQG 118
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           + YLH      +I+RD K++N+ L E+   K+ DFGLA        +H    + G+  + 
Sbjct: 119 MDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 175
Query: 258 APDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 314
           AP+ I   +    + +SDV++FG+VLYE++TG+     N    +Q +    + Y      
Sbjct: 176 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGY------ 228
Query: 315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 361
               + P L K  S N  + + RL   CL K   +RP   Q++  ++
Sbjct: 229 ----LSPDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIE 270

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 128/287 (44%), Gaps = 44/287 (15%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQ-WVAEVQFLGVLEHP 139
           +IG G FG+VYK       GD       VA+K LN        LQ +  EV  L    H 
Sbjct: 20  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 69
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEG 197
           N++  +GY         Q  +V ++    SL  HL      F  +     + I    A+G
Sbjct: 70  NILLFMGYSTKP-----QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQG 121
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           + YLH      +I+RD K++N+ L E+   K+ DFGLA        +H    + G+  + 
Sbjct: 122 MDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 178
Query: 258 APDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 314
           AP+ I   +    + +SDV++FG+VLYE++TG+     N    +Q +    + Y      
Sbjct: 179 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGY------ 231
Query: 315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 361
               + P L K  S N  + + RL   CL K   +RP   Q++  ++
Sbjct: 232 ----LSPDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIE 273

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 128/287 (44%), Gaps = 44/287 (15%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQ-WVAEVQFLGVLEHP 139
           +IG G FG+VYK       GD       VA+K LN        LQ +  EV  L    H 
Sbjct: 43  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 92
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEG 197
           N++  +GY         Q  +V ++    SL  HL      F  +     + I    A+G
Sbjct: 93  NILLFMGYSTKP-----QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQG 144
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           + YLH      +I+RD K++N+ L E+   K+ DFGLA        +H    + G+  + 
Sbjct: 145 MDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 201
Query: 258 APDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 314
           AP+ I   +    + +SDV++FG+VLYE++TG+     N    +Q +    + Y      
Sbjct: 202 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGY------ 254
Query: 315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 361
               + P L K  S N  + + RL   CL K   +RP   Q++  ++
Sbjct: 255 ----LSPDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIE 296

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKL 144
           +K+G+G FG V+  +      +GT+   +  +K        ++ E Q +  L H  LV+L
Sbjct: 273 VKLGQGCFGEVWMGTW-----NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 327
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
               AV  E  I   +V E+M   SL D L       L     + +    A G+AY+   
Sbjct: 328 Y---AVVSEEPI--YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER- 381
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAAPDYI 262
             +  ++RD +A+N+L+ EN   K++DFGLAR   ++     +      F   + AP+  
Sbjct: 382 --MNYVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAA 436
Query: 263 ETGHLTAKSDVWSFGVVLYEMLTGRR 288
             G  T KSDVWSFG++L E+ T  R
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGR 462

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKL 144
           +K+G+G FG V+  +      +GT+   +  +K        ++ E Q +  L H  LV+L
Sbjct: 24  VKLGQGCFGEVWMGT-----WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 78
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
               AV  E  I   +V E+M   SL D L       L     + +    A G+AY+   
Sbjct: 79  Y---AVVSEEPI--YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER- 132
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDY 261
             +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + AP+ 
Sbjct: 133 --MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEXTARQGAKFPIKWTAPEA 186
Query: 262 IETGHLTAKSDVWSFGVVLYEMLTGRR 288
              G  T KSDVWSFG++L E+ T  R
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 128/287 (44%), Gaps = 44/287 (15%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQ-WVAEVQFLGVLEHP 139
           +IG G FG+VYK       GD       VA+K LN        LQ +  EV  L    H 
Sbjct: 15  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEG 197
           N++  +GY         Q  +V ++    SL  HL      F  +     + I    A+G
Sbjct: 65  NILLFMGYSTKP-----QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQG 116
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           + YLH      +I+RD K++N+ L E+   K+ DFGLA        +H    + G+  + 
Sbjct: 117 MDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 258 APDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 314
           AP+ I   +    + +SDV++FG+VLYE++TG+     N    +Q +    + Y      
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGY------ 226
Query: 315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 361
               + P L K  S N  + + RL   CL K   +RP   Q++  ++
Sbjct: 227 ----LSPDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKL 144
           +K+G+G FG V+  +      +GT+   +  +K        ++ E Q +  L H  LV+L
Sbjct: 190 VKLGQGCFGEVWMGTW-----NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 244
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
               AV  E  I   +V E+M   SL D L       L     + +    A G+AY+   
Sbjct: 245 Y---AVVSEEPI--YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER- 298
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAAPDYI 262
             +  ++RD +A+N+L+ EN   K++DFGLAR   ++     +      F   + AP+  
Sbjct: 299 --MNYVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAA 353
Query: 263 ETGHLTAKSDVWSFGVVLYEMLTGRR 288
             G  T KSDVWSFG++L E+ T  R
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKL 144
           +K+G+G FG V+  +      +GT+   +  +K        ++ E Q +  L H  LV+L
Sbjct: 190 VKLGQGCFGEVWMGTW-----NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 244
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
               AV  E  I   +V E+M   SL D L       L     + +    A G+AY+   
Sbjct: 245 Y---AVVSEEPI--YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER- 298
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAAPDYI 262
             +  ++RD +A+N+L+ EN   K++DFGLAR   ++     +      F   + AP+  
Sbjct: 299 --MNYVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAA 353
Query: 263 ETGHLTAKSDVWSFGVVLYEMLTGRR 288
             G  T KSDVWSFG++L E+ T  R
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKL 144
           +K+G+G FG V+  +      +GT+   +  +K        ++ E Q +  L H  LV+L
Sbjct: 17  VKLGQGCFGEVWMGT-----WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 71
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
               AV  E  I   +V E+M   SL D L       L     + +    A G+AY+   
Sbjct: 72  Y---AVVSEEPI--YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER- 125
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDY 261
             +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + AP+ 
Sbjct: 126 --MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWTAPEA 179
Query: 262 IETGHLTAKSDVWSFGVVLYEMLTGRR 288
              G  T KSDVWSFG++L E+ T  R
Sbjct: 180 ALYGRFTIKSDVWSFGILLTELTTKGR 206

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKL 144
           +K+G+G FG V+  +      +GT+   +  +K        ++ E Q +  L H  LV+L
Sbjct: 24  VKLGQGCFGEVWMGTW-----NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 78
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
               AV  E  I   +V E+M   SL D L       L     + +    A G+AY+   
Sbjct: 79  Y---AVVSEEPI--YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER- 132
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDY 261
             +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + AP+ 
Sbjct: 133 --MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWTAPEA 186
Query: 262 IETGHLTAKSDVWSFGVVLYEMLTGRR 288
              G  T KSDVWSFG++L E+ T  R
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 111/220 (50%), Gaps = 29/220 (13%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EVQFL 133
           +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+   A  E+  L
Sbjct: 3   NFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLL 55
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L HPN+VKL+     +     +  LV+E + ++ L+  +   A   +P       +  
Sbjct: 56  KELNHPNIVKLLDVIHTEN----KLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQ 110
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTAVV 251
             +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH     V
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH----EV 163
Query: 252 GTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
            T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKL 144
           +K+G+G FG V+  +      +GT+   +  +K        ++ E Q +  L H  LV+L
Sbjct: 24  VKLGQGCFGEVWMGT-----WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 78
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
               AV  E  I   +V E+M   SL D L       L     + +    A G+AY+   
Sbjct: 79  Y---AVVSEEPI--YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER- 132
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDY 261
             +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + AP+ 
Sbjct: 133 --MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWTAPEA 186
Query: 262 IETGHLTAKSDVWSFGVVLYEMLTGRR 288
              G  T KSDVWSFG++L E+ T  R
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 131/284 (46%), Gaps = 32/284 (11%)
Query: 87  IGEGGFGSVYKSSIK-PAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
           +G G FG V    +K P+  + +     + +    +    ++ E   +G  +HPN+++L 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL 205
           G       +    ++V E M N SL D    +          + ++ G A G+ YL +  
Sbjct: 84  GVVT----KSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD-- 136
Query: 206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAAPDYI 262
            +  ++RD  A N+L++ N   K+SDFGL+R   + P   +T     +     + +P+ I
Sbjct: 137 -MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAI 193
Query: 263 ETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDP 321
                T+ SDVWS+G+VL+E+++ G R        + Q +++ V +        G  + P
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMSYGERPYWE---MSNQDVIKAVDE--------GYRLPP 242
Query: 322 RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
            ++   ++ +      L  +C  K   +RPK  Q+V  L ++++
Sbjct: 243 PMDCPAALYQ------LMLDCWQKDRNNRPKFEQIVSILDKLIR 280

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKL 144
           +K+G+G FG V+  +      +GT+   +  +K        ++ E Q +  L H  LV+L
Sbjct: 15  VKLGQGCFGEVWMGT-----WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 69
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
               AV  E  I   +V E+M   SL D L       L     + +    A G+AY+   
Sbjct: 70  Y---AVVSEEPI--YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER- 123
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDY 261
             +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + AP+ 
Sbjct: 124 --MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWTAPEA 177
Query: 262 IETGHLTAKSDVWSFGVVLYEMLTGRR 288
              G  T KSDVWSFG++L E+ T  R
Sbjct: 178 ALYGRFTIKSDVWSFGILLTELTTKGR 204

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 116/230 (50%), Gaps = 32/230 (13%)
Query: 65  NLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN---- 120
            LR+   +E++       R+  +G G FG+VYK    P   +G +    VAIK LN    
Sbjct: 31  QLRILKETELK-------RVKVLGSGAFGTVYKGIWVP---EGETVKIPVAIKILNETTG 80
Query: 121 -RDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE--DHLFNR 177
            +  ++++ E   +  ++HP+LV+L+G C     + + +L+ +  +L    E  D++ ++
Sbjct: 81  PKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQ 140
Query: 178 AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE 237
               L W  ++      A+G+ YL E    ++++RD  A NVL+      K++DFGLAR 
Sbjct: 141 LL--LNWCVQI------AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 189
Query: 238 GPMVGHTHVSTAVVG--TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
             + G      A  G     + A + I     T +SDVWS+GV ++E++T
Sbjct: 190 --LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKL 144
           +K+G+G FG V+  +      +GT+   +  +K        ++ E Q +  L H  LV+L
Sbjct: 24  VKLGQGCFGEVWMGTW-----NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 78
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
               AV  E  I   +V E+M   SL D L       L     + +    A G+AY+   
Sbjct: 79  Y---AVVSEEPI--YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER- 132
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDY 261
             +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + AP+ 
Sbjct: 133 --MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWTAPEA 186
Query: 262 IETGHLTAKSDVWSFGVVLYEMLTGRR 288
              G  T KSDVWSFG++L E+ T  R
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKL 144
           +K+G+G FG V+  +      +GT+   +  +K        ++ E Q +  L H  LV+L
Sbjct: 13  VKLGQGCFGEVWMGT-----WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 67
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
               AV  E  I   +V E+M   SL D L       L     + +    A G+AY+   
Sbjct: 68  Y---AVVSEEPI--YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER- 121
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDY 261
             +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + AP+ 
Sbjct: 122 --MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWTAPEA 175
Query: 262 IETGHLTAKSDVWSFGVVLYEMLTGRR 288
              G  T KSDVWSFG++L E+ T  R
Sbjct: 176 ALYGRFTIKSDVWSFGILLTELTTKGR 202

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/310 (23%), Positives = 138/310 (44%), Gaps = 41/310 (13%)
Query: 70  SYSEMRQATNDFSRMLK---------IGEGGFGSVYKSSIK-PAAGDGTSEATVVAIKKL 119
           +Y +  QA ++F++ ++         IG G FG V    +K P   +       + +   
Sbjct: 4   TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 120 NRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAF 179
            +    ++ E   +G  +HPN++ L G       +    ++V E+M N SL D    +  
Sbjct: 64  EKQRRDFLGEASIMGQFDHPNIIHLEGVVT----KSKPVMIVTEYMENGSL-DTFLKKND 118
Query: 180 PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--- 236
                   + ++ G + G+ YL +   +  ++RD  A N+L++ N   K+SDFGL+R   
Sbjct: 119 GQFTVIQLVGMLRGISAGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 175
Query: 237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP 295
           + P   +T     +     + AP+ I     T+ SDVWS+G+V++E+++ G R       
Sbjct: 176 DDPEAAYTTRGGKI--PIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWE--- 230
Query: 296 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 355
            T Q +++ V++              RL        A  + +L  +C  K    RPK  +
Sbjct: 231 MTNQDVIKAVEE------------GYRLPSPMDCPAA--LYQLMLDCWQKERNSRPKFDE 276
Query: 356 VVERLKQIVQ 365
           +V  L ++++
Sbjct: 277 IVNMLDKLIR 286

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 125/282 (44%), Gaps = 34/282 (12%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA---EVQFLGVLEHPNLV 142
           +IG G FG+VYK       G    +  V  +K ++    Q+ A   EV  L    H N++
Sbjct: 43  RIGSGSFGTVYK-------GKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNIL 95
Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
             +GY   D        +V ++    SL  HL  +          + I    A+G+ YLH
Sbjct: 96  LFMGYMTKDN-----LAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLH 149
Query: 203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI 262
                 +I+RD K++N+ L E    K+ DFGLA        +       G+  + AP+ I
Sbjct: 150 AK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVI 206
Query: 263 ---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM 319
              +    + +SDV+S+G+VLYE++TG   L  +      +++  V +  A         
Sbjct: 207 RMQDNNPFSFQSDVYSYGIVLYELMTGE--LPYSHINNRDQIIFMVGRGYA--------- 255
Query: 320 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 361
            P L K Y  N  + + RL  +C+ K  ++RP   Q++  ++
Sbjct: 256 SPDLSKLYK-NCPKAMKRLVADCVKKVKEERPLFPQILSSIE 296

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 142/316 (44%), Gaps = 38/316 (12%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
           ++G+G FG VY+   K    D     T VAIK +N     R+ ++++ E   +      +
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 82
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------FNRAFPPLPWKTRLHIIL 192
           +V+L+G  +    +G   L++ E M    L+ +L         N    P      + +  
Sbjct: 83  VVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 138
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
             A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+ R+     +       + 
Sbjct: 139 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 195
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 312
              + +P+ ++ G  T  SDVWSFGVVL+E+ T   + +  +  + +++L +V +     
Sbjct: 196 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT--LAEQPYQGLSNEQVLRFVME----- 248
Query: 313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDS 372
              GL+  P        N    +  L   C   + K RP   +++  +K+ ++      S
Sbjct: 249 --GGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 299
Query: 373 FDKTFEEICEEDPVEA 388
           F  + E   E +PV A
Sbjct: 300 FYYSEENKMENNPVLA 315

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 116/229 (50%), Gaps = 32/229 (13%)
Query: 66  LRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN----- 120
           LR+   +E++       R+  +G G FG+VYK    P   +G +    VAIK LN     
Sbjct: 9   LRILKETELK-------RVKVLGSGAFGTVYKGIWVP---EGETVKIPVAIKILNETTGP 58
Query: 121 RDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE--DHLFNRA 178
           +  ++++ E   +  ++HP+LV+L+G C     + + +L+ +  +L    E  D++ ++ 
Sbjct: 59  KANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQL 118
Query: 179 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 238
              L W  ++      A+G+ YL E    ++++RD  A NVL+      K++DFGLAR  
Sbjct: 119 L--LNWCVQI------AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL- 166
Query: 239 PMVGHTHVSTAVVG--TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            + G      A  G     + A + I     T +SDVWS+GV ++E++T
Sbjct: 167 -LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKL 144
           +K+G+G FG V+  +      +GT+   +  +K        ++ E Q +  L H  LV+L
Sbjct: 21  VKLGQGCFGEVWMGT-----WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 75
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
               AV  E  I   +V E+M   SL D L       L     + +    A G+AY+   
Sbjct: 76  Y---AVVSEEPI--YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER- 129
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDY 261
             +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + AP+ 
Sbjct: 130 --MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWTAPEA 183
Query: 262 IETGHLTAKSDVWSFGVVLYEMLTGRR 288
              G  T KSDVWSFG++L E+ T  R
Sbjct: 184 ALYGRFTIKSDVWSFGILLTELTTKGR 210

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKL 144
           +K+G+G FG V+  +      +GT+   +  +K        ++ E Q +  L H  LV+L
Sbjct: 190 VKLGQGCFGEVWMGTW-----NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 244
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
               AV  E  I   +V E+M   SL D L       L     + +    A G+AY+   
Sbjct: 245 Y---AVVSEEPI--YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER- 298
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAAPDYI 262
             +  ++RD +A+N+L+ EN   K++DFGLAR   ++     +      F   + AP+  
Sbjct: 299 --MNYVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAA 353
Query: 263 ETGHLTAKSDVWSFGVVLYEMLTGRR 288
             G  T KSDVWSFG++L E+ T  R
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 107/231 (46%), Gaps = 22/231 (9%)
Query: 68  VFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RD 122
           VF   E   A    +   ++G+G FG VY+   K    D     T VAIK +N     R+
Sbjct: 5   VFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEAASMRE 62
Query: 123 GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-------- 174
            ++++ E   +      ++V+L+G  +    +G   L++ E M    L+ +L        
Sbjct: 63  RIEFLNEASVMKEFNCHHVVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPEME 118
Query: 175 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 234
            N    P      + +    A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+
Sbjct: 119 NNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 175
Query: 235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            R+     +       +    + +P+ ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 176 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
           ++G G  G V+         +G ++  V ++K+ +     ++AE   +  L+H  LV+L 
Sbjct: 20  RLGAGQAGEVWMGYY-----NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL- 73
Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL 205
            Y  V  E      ++ E+M N SL D L   +   L     L +    AEG+A++ E  
Sbjct: 74  -YAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 128
Query: 206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAAPDYIE 263
               I+RD +A+N+L+ +    K++DFGLAR   ++     +      F   + AP+ I 
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLAR---LIEDAEXTAREGAKFPIKWTAPEAIN 183
Query: 264 TGHLTAKSDVWSFGVVLYEMLTGRR 288
            G  T KSDVWSFG++L E++T  R
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKL 144
           +K+G+G FG V+  +      +GT+   +  +K        ++ E Q +  L H  LV+L
Sbjct: 21  VKLGQGCFGEVWMGT-----WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 75
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
               AV  E  I   +V E+M   SL D L       L     + +    A G+AY+   
Sbjct: 76  Y---AVVSEEPI--YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER- 129
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDY 261
             +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + AP+ 
Sbjct: 130 --MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEWTARQGAKFPIKWTAPEA 183
Query: 262 IETGHLTAKSDVWSFGVVLYEMLTGRR 288
              G  T KSDVWSFG++L E+ T  R
Sbjct: 184 ALYGRFTIKSDVWSFGILLTELTTKGR 210

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 129/311 (41%), Gaps = 41/311 (13%)
Query: 70  SYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-----NRDG 123
           S S++++    + + +  +G G FG VY+  +     D +     VA+K L      +D 
Sbjct: 21  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVCSEQDE 78
Query: 124 LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPL 182
           L ++ E   +    H N+V+ IG       + + R ++ E M    L+  L   R  P  
Sbjct: 79  LDFLMEALIISKFNHQNIVRCIGVSL----QSLPRFILLELMAGGDLKSFLRETRPRPSQ 134
Query: 183 PWKTR----LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLA 235
           P        LH+    A G  YL E      I+RD  A N LL         K+ DFG+A
Sbjct: 135 PSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 191
Query: 236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNR 294
           ++     +       +    +  P+    G  T+K+D WSFGV+L+E+ + G        
Sbjct: 192 QDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-- 249
Query: 295 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS 354
            K+ Q +LE+V          G  MDP        N    + R+   C     +DRP  +
Sbjct: 250 -KSNQEVLEFVTS--------GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFA 294
Query: 355 QVVERLKQIVQ 365
            ++ER++   Q
Sbjct: 295 IILERIEYCTQ 305

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 9/211 (4%)
Query: 91  GFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQWVAEVQFLGVLEHPNLVKLIGY 147
           GFG + +  +     D    A  V    L RD    L++  E Q    L HP +V +   
Sbjct: 21  GFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDT 80
Query: 148 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEV 207
              +   G    +V E++   +L D +      P+  K  + +I  A + L + H+    
Sbjct: 81  GEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN--- 135
Query: 208 QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA-VVGTFGYAAPDYIETGH 266
            +I+RD K +N+++      K+ DFG+AR     G++   TA V+GT  Y +P+      
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 195
Query: 267 LTAKSDVWSFGVVLYEMLTGRRSLERNRPKT 297
           + A+SDV+S G VLYE+LTG      + P +
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPFTGDSPDS 226

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 109/221 (49%), Gaps = 25/221 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EV 130
           +  +F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+   A  E+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTAIREI 56
Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
             L  L HPN+VKL+     +     +  LV+E + ++ L+  +   A   +P       
Sbjct: 57  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSY 111
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+    V
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 251 VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 290
             T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQWVAEVQFLGVLEHPNL 141
           ++GEG FG V+ +       +   +  +VA+K L    +     +  E + L  L+H ++
Sbjct: 20  ELGEGAFGKVFLAECYNLCPE--QDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 77
Query: 142 VKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDH-----LFNRAFPP--LPWKTRLHI 190
           VK  G C V+G+  I   +V+E+M    LN+ L  H     L     PP  L     LHI
Sbjct: 78  VKFYGVC-VEGDPLI---MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI 133
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
               A G+ YL        ++RD    N L+ EN   K+ DFG++R+     +  V    
Sbjct: 134 AQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 190
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           +    +  P+ I     T +SDVWS GVVL+E+ T
Sbjct: 191 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 9/209 (4%)
Query: 91  GFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQWVAEVQFLGVLEHPNLVKLIGY 147
           GFG + +  +     D    A  V    L RD    L++  E Q    L HP +V +   
Sbjct: 21  GFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDT 80
Query: 148 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEV 207
              +   G    +V E++   +L D +      P+  K  + +I  A + L + H+    
Sbjct: 81  GEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN--- 135
Query: 208 QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA-VVGTFGYAAPDYIETGH 266
            +I+RD K +N+L+      K+ DFG+AR     G++   TA V+GT  Y +P+      
Sbjct: 136 GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDS 195
Query: 267 LTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           + A+SDV+S G VLYE+LTG      + P
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKL 144
           +K+G+G FG V+  +      +GT+   +  +K        ++ E Q +  + H  LV+L
Sbjct: 24  VKLGQGCFGEVWMGT-----WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQL 78
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
               AV  E  I   +V E+M   SL D L       L     + +    A G+AY+   
Sbjct: 79  Y---AVVSEEPI--YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER- 132
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDY 261
             +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + AP+ 
Sbjct: 133 --MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWTAPEA 186
Query: 262 IETGHLTAKSDVWSFGVVLYEMLTGRR 288
              G  T KSDVWSFG++L E+ T  R
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 84/312 (26%), Positives = 133/312 (42%), Gaps = 61/312 (19%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-----DGLQWVAEVQFL 133
           ND      IGEG FG V K+ IK    DG       AIK++       D   +  E++ L
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKK---DGLR--MDAAIKRMKEYASKDDHRDFAGELEVL 69
Query: 134 GVL-EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------------FNRA 178
             L  HPN++ L+G C     RG   L + E+  + +L D L               N  
Sbjct: 70  CKLGHHPNIINLLGACE---HRGYLYLAI-EYAPHGNLLDFLRKSRVLETDPAFAIANST 125
Query: 179 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 238
              L  +  LH     A G+ YL +    Q I+RD  A N+L+ EN+  K++DFGL+R  
Sbjct: 126 ASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQ 182
Query: 239 PM-----VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
            +     +G   V    + +  Y+          T  SDVWS+GV+L+E+++   +    
Sbjct: 183 EVYVKKTMGRLPVRWMAIESLNYSV--------YTTNSDVWSYGVLLWEIVSLGGT---- 230
Query: 294 RPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM 353
            P       E  ++ P            RLEK   +N   ++  L   C  +   +RP  
Sbjct: 231 -PYCGMTCAELYEKLPQGY---------RLEK--PLNCDDEVYDLMRQCWREKPYERPSF 278
Query: 354 SQVVERLKQIVQ 365
           +Q++  L ++++
Sbjct: 279 AQILVSLNRMLE 290

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/319 (24%), Positives = 141/319 (44%), Gaps = 38/319 (11%)
Query: 68  VFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RD 122
           VF   E   +    + + ++G+G FG VY+ + +     G +E T VA+K +N     R+
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDII-KGEAE-TRVAVKTVNESASLRE 63
Query: 123 GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-------- 174
            ++++ E   +      ++V+L+G  +    +G   L+V E M +  L+ +L        
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAE 119
Query: 175 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 234
            N   PP   +  + +    A+G+AYL+     + ++RD  A N ++  +F  K+ DFG+
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGM 176
Query: 235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNR 294
            R+     +       +    + AP+ ++ G  T  SD+WSFGVVL+E+ +         
Sbjct: 177 TRDIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--------- 227
Query: 295 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS 354
                 L E   Q  ++ +    +MD     +   N   ++  L   C   + K RP   
Sbjct: 228 ------LAEQPYQGLSNEQVLKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFL 280
Query: 355 QVVERLKQIVQVSNEGDSF 373
           ++V  LK  +  S    SF
Sbjct: 281 EIVNLLKDDLHPSFPEVSF 299

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 9/209 (4%)
Query: 91  GFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQWVAEVQFLGVLEHPNLVKLIGY 147
           GFG + +  +     D    A  V    L RD    L++  E Q    L HP +V +   
Sbjct: 21  GFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDT 80
Query: 148 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEV 207
              +   G    +V E++   +L D +      P+  K  + +I  A + L + H+    
Sbjct: 81  GEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN--- 135
Query: 208 QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA-VVGTFGYAAPDYIETGH 266
            +I+RD K +N+++      K+ DFG+AR     G++   TA V+GT  Y +P+      
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 195
Query: 267 LTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           + A+SDV+S G VLYE+LTG      + P
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKL 144
           +K+G+G FG V+  +      +GT+   +  +K        ++ E Q +  L H  LV+L
Sbjct: 24  VKLGQGCFGEVWMGTW-----NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 78
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
               AV  E  I   +V E+M   SL D L       L     + +    A G+AY+   
Sbjct: 79  Y---AVVSEEPI--YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER- 132
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDY 261
             +  ++RD  A+N+L+ EN   K++DFGLAR    +   +  TA  G      + AP+ 
Sbjct: 133 --MNYVHRDLAAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWTAPEA 186
Query: 262 IETGHLTAKSDVWSFGVVLYEMLTGRR 288
              G  T KSDVWSFG++L E+ T  R
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 91/190 (47%), Gaps = 13/190 (6%)
Query: 114 VAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFML 166
           VA+K L  D        L++  E Q    L HP +V +      +   G    +V E++ 
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVD 99
Query: 167 NRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR 226
             +L D +      P+  K  + +I  A + L + H+     +I+RD K +N+++     
Sbjct: 100 GVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNA 154
Query: 227 PKLSDFGLAREGPMVGHTHVSTA-VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            K+ DFG+AR     G++   TA V+GT  Y +P+      + A+SDV+S G VLYE+LT
Sbjct: 155 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
Query: 286 GRRSLERNRP 295
           G      + P
Sbjct: 215 GEPPFTGDSP 224

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/319 (24%), Positives = 140/319 (43%), Gaps = 38/319 (11%)
Query: 68  VFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RD 122
           VF   E   +    + + ++G+G FG VY+ + +     G +E T VA+K +N     R+
Sbjct: 3   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDII-KGEAE-TRVAVKTVNESASLRE 60
Query: 123 GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-------- 174
            ++++ E   +      ++V+L+G  +    +G   L+V E M +  L+ +L        
Sbjct: 61  RIEFLNEASVMKGFTCHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAE 116
Query: 175 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 234
            N   PP   +  + +    A+G+AYL+     + ++RD  A N ++  +F  K+ DFG+
Sbjct: 117 NNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGM 173
Query: 235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNR 294
            R+             +    + AP+ ++ G  T  SD+WSFGVVL+E+ +         
Sbjct: 174 TRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--------- 224
Query: 295 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS 354
                 L E   Q  ++ +    +MD     +   N   ++  L   C   + K RP   
Sbjct: 225 ------LAEQPYQGLSNEQVLKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFL 277
Query: 355 QVVERLKQIVQVSNEGDSF 373
           ++V  LK  +  S    SF
Sbjct: 278 EIVNLLKDDLHPSFPEVSF 296

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKL 144
           +K+G+G FG V+  +      +GT+   +  +K        ++ E Q +  L H  LV+L
Sbjct: 24  VKLGQGCFGEVWMGT-----WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 78
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
               AV  E  I   +V E+M    L D L       L     + +    A G+AY+   
Sbjct: 79  Y---AVVSEEPI--YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER- 132
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDY 261
             +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + AP+ 
Sbjct: 133 --MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWTAPEA 186
Query: 262 IETGHLTAKSDVWSFGVVLYEMLTGRR 288
              G  T KSDVWSFG++L E+ T  R
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 84/312 (26%), Positives = 133/312 (42%), Gaps = 61/312 (19%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-----DGLQWVAEVQFL 133
           ND      IGEG FG V K+ IK    DG       AIK++       D   +  E++ L
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKK---DGLR--MDAAIKRMKEYASKDDHRDFAGELEVL 79
Query: 134 GVL-EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------------FNRA 178
             L  HPN++ L+G C     RG   L + E+  + +L D L               N  
Sbjct: 80  CKLGHHPNIINLLGACE---HRGYLYLAI-EYAPHGNLLDFLRKSRVLETDPAFAIANST 135
Query: 179 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 238
              L  +  LH     A G+ YL +    Q I+RD  A N+L+ EN+  K++DFGL+R  
Sbjct: 136 ASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQ 192
Query: 239 PM-----VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
            +     +G   V    + +  Y+          T  SDVWS+GV+L+E+++   +    
Sbjct: 193 EVYVKKTMGRLPVRWMAIESLNYSV--------YTTNSDVWSYGVLLWEIVSLGGT---- 240
Query: 294 RPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM 353
            P       E  ++ P            RLEK   +N   ++  L   C  +   +RP  
Sbjct: 241 -PYCGMTCAELYEKLPQGY---------RLEK--PLNCDDEVYDLMRQCWREKPYERPSF 288
Query: 354 SQVVERLKQIVQ 365
           +Q++  L ++++
Sbjct: 289 AQILVSLNRMLE 300

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
           ++G+G FG VY+   K    D     T VAIK +N     R+ ++++ E   +      +
Sbjct: 17  ELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 74
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------FNRAFPPLPWKTRLHIIL 192
           +V+L+G  +    +G   L++ E M    L+ +L         N    P      + +  
Sbjct: 75  VVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 130
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
             A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+ R+             + 
Sbjct: 131 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLL 187
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
              + +P+ ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 188 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKL 144
           +K+G+G FG V+  +      +GT+   +  +K        ++ E Q +  L H  LV+L
Sbjct: 24  VKLGQGCFGEVWMGT-----WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 78
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
               AV  E  I   +V E+M    L D L       L     + +    A G+AY+   
Sbjct: 79  Y---AVVSEEPI--YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER- 132
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDY 261
             +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + AP+ 
Sbjct: 133 --MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWTAPEA 186
Query: 262 IETGHLTAKSDVWSFGVVLYEMLTGRR 288
              G  T KSDVWSFG++L E+ T  R
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/319 (24%), Positives = 140/319 (43%), Gaps = 38/319 (11%)
Query: 68  VFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RD 122
           VF   E   +    + + ++G+G FG VY+ + +     G +E T VA+K +N     R+
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDII-KGEAE-TRVAVKTVNESASLRE 63
Query: 123 GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-------- 174
            ++++ E   +      ++V+L+G  +    +G   L+V E M +  L+ +L        
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAE 119
Query: 175 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 234
            N   PP   +  + +    A+G+AYL+     + ++RD  A N ++  +F  K+ DFG+
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGM 176
Query: 235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNR 294
            R+             +    + AP+ ++ G  T  SD+WSFGVVL+E+ +         
Sbjct: 177 TRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--------- 227
Query: 295 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS 354
                 L E   Q  ++ +    +MD     +   N   ++  L   C   + K RP   
Sbjct: 228 ------LAEQPYQGLSNEQVLKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFL 280
Query: 355 QVVERLKQIVQVSNEGDSF 373
           ++V  LK  +  S    SF
Sbjct: 281 EIVNLLKDDLHPSFPEVSF 299

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
           ++G+G FG VY+   K    D     T VAIK +N     R+ ++++ E   +      +
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 76
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------FNRAFPPLPWKTRLHIIL 192
           +V+L+G  +    +G   L++ E M    L+ +L         N    P      + +  
Sbjct: 77  VVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 132
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
             A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+ R+     +       + 
Sbjct: 133 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 189
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
              + +P+ ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 190 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 111/232 (47%), Gaps = 22/232 (9%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN---RDGLQWVAEVQFLGV 135
           + F  +  +G+G FG V+    K +  D      +  +KK     RD ++   E   L  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVK-KISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE 82
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
           + HP +VKL      +G    +  L+ +F+    L    F R    + + T   +    A
Sbjct: 83  VNHPFIVKLHYAFQTEG----KLYLILDFLRGGDL----FTRLSKEVMF-TEEDVKFYLA 133
Query: 196 E---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
           E    L +LH    + +IYRD K  N+LLDE    KL+DFGL++E   + H   + +  G
Sbjct: 134 ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKAYSFCG 188
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLE 303
           T  Y AP+ +     T  +D WSFGV+++EMLTG    + ++R +T   +L+
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 111/229 (48%), Gaps = 20/229 (8%)
Query: 81  FSRMLKIGEGGFGSVY--KSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEH 138
           F  +  +G+G FG V+  +   +P +G   +   +       RD ++   E   L  + H
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNH 89
Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE-- 196
           P +VKL      +G    +  L+ +F+    L    F R    + + T   +    AE  
Sbjct: 90  PFVVKLHYAFQTEG----KLYLILDFLRGGDL----FTRLSKEVMF-TEEDVKFYLAELA 140
Query: 197 -GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
            GL +LH    + +IYRD K  N+LLDE    KL+DFGL++E   + H   + +  GT  
Sbjct: 141 LGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEA--IDHEKKAYSFCGTVE 195
Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLE 303
           Y AP+ +     +  +D WS+GV+++EMLTG    + ++R +T   +L+
Sbjct: 196 YMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILK 244

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/319 (24%), Positives = 141/319 (44%), Gaps = 38/319 (11%)
Query: 68  VFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RD 122
           VF   E   +    + + ++G+G FG VY+ + +     G +E T VA+K +N     R+
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDII-KGEAE-TRVAVKTVNESASLRE 63
Query: 123 GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-------- 174
            ++++ E   +      ++V+L+G  +    +G   L+V E M +  L+ +L        
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAE 119
Query: 175 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 234
            N   PP   +  + +    A+G+AYL+     + ++RD  A N ++  +F  K+ DFG+
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGM 176
Query: 235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNR 294
            R+     +       +    + AP+ ++ G  T  SD+WSFGVVL+E+ +         
Sbjct: 177 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--------- 227
Query: 295 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS 354
                 L E   Q  ++ +    +MD     +   N   ++  L   C   + K RP   
Sbjct: 228 ------LAEQPYQGLSNEQVLKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFL 280
Query: 355 QVVERLKQIVQVSNEGDSF 373
           ++V  LK  +  S    SF
Sbjct: 281 EIVNLLKDDLHPSFPEVSF 299

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
           ++G+G FG VY+   K    D     T VAIK +N     R+ ++++ E   +      +
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------FNRAFPPLPWKTRLHIIL 192
           +V+L+G  +    +G   L++ E M    L+ +L         N    P      + +  
Sbjct: 90  VVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 145
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
             A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+ R+     +       + 
Sbjct: 146 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 202
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
              + +P+ ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
           ++G+G FG VY+   K    D     T VAIK +N     R+ ++++ E   +      +
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 83
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------FNRAFPPLPWKTRLHIIL 192
           +V+L+G  +    +G   L++ E M    L+ +L         N    P      + +  
Sbjct: 84  VVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 139
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
             A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+ R+             + 
Sbjct: 140 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLL 196
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
              + +P+ ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 197 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
           ++G+G FG VY+   K    D     T VAIK +N     R+ ++++ E   +      +
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 82
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------FNRAFPPLPWKTRLHIIL 192
           +V+L+G  +    +G   L++ E M    L+ +L         N    P      + +  
Sbjct: 83  VVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 138
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
             A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+ R+     +       + 
Sbjct: 139 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 195
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
              + +P+ ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 196 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 91/190 (47%), Gaps = 13/190 (6%)
Query: 114 VAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFML 166
           VA+K L  D        L++  E Q    L HP +V +      +   G    +V E++ 
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99
Query: 167 NRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR 226
             +L D +      P+  K  + +I  A + L + H+     +I+RD K +N+++     
Sbjct: 100 GVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNA 154
Query: 227 PKLSDFGLAREGPMVGHTHVSTA-VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            K+ DFG+AR     G++   TA V+GT  Y +P+      + A+SDV+S G VLYE+LT
Sbjct: 155 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
Query: 286 GRRSLERNRP 295
           G      + P
Sbjct: 215 GEPPFTGDSP 224

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
           ++G+G FG VY+   K    D     T VAIK +N     R+ ++++ E   +      +
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 83
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------FNRAFPPLPWKTRLHIIL 192
           +V+L+G  +    +G   L++ E M    L+ +L         N    P      + +  
Sbjct: 84  VVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 139
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
             A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+ R+     +       + 
Sbjct: 140 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 196
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
              + +P+ ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 197 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
           ++G+G FG VY+   K    D     T VAIK +N     R+ ++++ E   +      +
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------FNRAFPPLPWKTRLHIIL 192
           +V+L+G  +    +G   L++ E M    L+ +L         N    P      + +  
Sbjct: 90  VVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
             A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+ R+     +       + 
Sbjct: 146 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 202
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
              + +P+ ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 111/232 (47%), Gaps = 22/232 (9%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN---RDGLQWVAEVQFLGV 135
           + F  +  +G+G FG V+    K +  D      +  +KK     RD ++   E   L  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVK-KISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE 82
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
           + HP +VKL      +G    +  L+ +F+    L    F R    + + T   +    A
Sbjct: 83  VNHPFIVKLHYAFQTEG----KLYLILDFLRGGDL----FTRLSKEVMF-TEEDVKFYLA 133
Query: 196 E---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
           E    L +LH    + +IYRD K  N+LLDE    KL+DFGL++E   + H   + +  G
Sbjct: 134 ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKAYSFCG 188
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLE 303
           T  Y AP+ +     T  +D WSFGV+++EMLTG    + ++R +T   +L+
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 111/232 (47%), Gaps = 22/232 (9%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN---RDGLQWVAEVQFLGV 135
           + F  +  +G+G FG V+    K +  D      +  +KK     RD ++   E   L  
Sbjct: 25  SQFELLKVLGQGSFGKVFLVK-KISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE 83
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
           + HP +VKL      +G    +  L+ +F+    L    F R    + + T   +    A
Sbjct: 84  VNHPFIVKLHYAFQTEG----KLYLILDFLRGGDL----FTRLSKEVMF-TEEDVKFYLA 134
Query: 196 E---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
           E    L +LH    + +IYRD K  N+LLDE    KL+DFGL++E   + H   + +  G
Sbjct: 135 ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKAYSFCG 189
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLE 303
           T  Y AP+ +     T  +D WSFGV+++EMLTG    + ++R +T   +L+
Sbjct: 190 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 241

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 133/288 (46%), Gaps = 41/288 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFLGVLEHP 139
           KIG G FG+V+++             + VA+K L           +++ EV  +  L HP
Sbjct: 44  KIGAGSFGTVHRAEW---------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-AFPPLPWKTRLHIILGAAEGL 198
           N+V  +G  AV     +   +V E++   SL   L    A   L  + RL +    A+G+
Sbjct: 95  NIVLFMG--AVTQPPNLS--IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST-AVVGTFGYA 257
            YLH      +++R+ K+ N+L+D+ +  K+ DFGL+R   +   T +S+ +  GT  + 
Sbjct: 151 NYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR---LKASTFLSSKSAAGTPEWM 206
Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGL 317
           AP+ +       KSDV+SFGV+L+E+ T ++               W    PA       
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQP--------------WGNLNPAQVVAAVG 252
Query: 318 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
               RLE   ++N   ++  + + C +     RP  + +++ L+ +++
Sbjct: 253 FKCKRLEIPRNLNP--QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
           ++G+G FG VY+   K    D     T VAIK +N     R+ ++++ E   +      +
Sbjct: 22  ELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 79
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------FNRAFPPLPWKTRLHIIL 192
           +V+L+G  +    +G   L++ E M    L+ +L         N    P      + +  
Sbjct: 80  VVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 135
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
             A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+ R+     +       + 
Sbjct: 136 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 192
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
              + +P+ ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 193 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
           ++G+G FG VY+   K    D     T VAIK +N     R+ ++++ E   +      +
Sbjct: 54  ELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 111
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------FNRAFPPLPWKTRLHIIL 192
           +V+L+G  +    +G   L++ E M    L+ +L         N    P      + +  
Sbjct: 112 VVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 167
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
             A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+ R+     +       + 
Sbjct: 168 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 224
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
              + +P+ ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 225 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 91/190 (47%), Gaps = 13/190 (6%)
Query: 114 VAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFML 166
           VA+K L  D        L++  E Q    L HP +V +      +   G    +V E++ 
Sbjct: 57  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 116
Query: 167 NRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR 226
             +L D +      P+  K  + +I  A + L + H+     +I+RD K +N+++     
Sbjct: 117 GVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNA 171
Query: 227 PKLSDFGLAREGPMVGHTHVSTA-VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            K+ DFG+AR     G++   TA V+GT  Y +P+      + A+SDV+S G VLYE+LT
Sbjct: 172 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 231
Query: 286 GRRSLERNRP 295
           G      + P
Sbjct: 232 GEPPFTGDSP 241

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 128/287 (44%), Gaps = 39/287 (13%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFLGVLEHP 139
           KIG G FG+V+++             + VA+K L           +++ EV  +  L HP
Sbjct: 44  KIGAGSFGTVHRAEW---------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-AFPPLPWKTRLHIILGAAEGL 198
           N+V  +G  AV     +   +V E++   SL   L    A   L  + RL +    A+G+
Sbjct: 95  NIVLFMG--AVTQPPNLS--IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
            YLH      +++RD K+ N+L+D+ +  K+ DFGL+R          S    GT  + A
Sbjct: 151 NYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK--ASXFLXSKXAAGTPEWMA 207
Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 318
           P+ +       KSDV+SFGV+L+E+ T ++               W    PA        
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELATLQQP--------------WGNLNPAQVVAAVGF 253
Query: 319 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
              RLE   ++N   ++  + + C +     RP  + +++ L+ +++
Sbjct: 254 KCKRLEIPRNLNP--QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 135/301 (44%), Gaps = 38/301 (12%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
           ++G+G FG VY+ + +     G +E T VA+K +N     R+ ++++ E   +      +
Sbjct: 23  ELGQGSFGMVYEGNARDII-KGEAE-TRVAVKTVNESASLRERIEFLNEASVMKGFTCHH 80
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------FNRAFPPLPWKTRLHIIL 192
           +V+L+G  +    +G   L+V E M +  L+ +L         N   PP   +  + +  
Sbjct: 81  VVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 136
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
             A+G+AYL+     + ++RD  A N ++  +F  K+ DFG+ R+     +       + 
Sbjct: 137 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 193
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 312
              + AP+ ++ G  T  SD+WSFGVVL+E+ +               L E   Q  ++ 
Sbjct: 194 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNE 238
Query: 313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDS 372
           +    +MD     +   N   ++  L   C   + K RP   ++V  LK  +  S    S
Sbjct: 239 QVLKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 297
Query: 373 F 373
           F
Sbjct: 298 F 298

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
           ++G+G FG VY+   K    D     T VAIK +N     R+ ++++ E   +      +
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 76
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------FNRAFPPLPWKTRLHIIL 192
           +V+L+G  +    +G   L++ E M    L+ +L         N    P      + +  
Sbjct: 77  VVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 132
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
             A+G+AYL+     + ++RD  A N  + E+F  K+ DFG+ R+     +       + 
Sbjct: 133 EIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 189
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
              + +P+ ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 190 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 37/223 (16%)
Query: 86  KIGEGGFGSVYKS---SIKPAAGDGTSEATVVAIKKLNRDGL----QWVAEVQFLGVLEH 138
           ++GEG FG V+ +   ++ P     T +  +VA+K L    L     +  E + L  L+H
Sbjct: 22  ELGEGAFGKVFLAECYNLSP-----TKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH 76
Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPP----------------L 182
            ++VK  G C  DG+  I   +V+E+M +  L    F RA  P                L
Sbjct: 77  EHIVKFYGVCG-DGDPLI---MVFEYMKHGDLNK--FLRAHGPDAMILVDGQPRQAKGEL 130
Query: 183 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 242
                LHI    A G+ YL        ++RD    N L+  N   K+ DFG++R+     
Sbjct: 131 GLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187
Query: 243 HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           +  V    +    +  P+ I     T +SDVWSFGV+L+E+ T
Sbjct: 188 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN----RDGLQWVAEVQFLGVLEHPNLV 142
           +GEG FGSV + ++K    DGTS    V   KL+    R+  ++++E   +    HPN++
Sbjct: 42  LGEGEFGSVMEGNLKQE--DGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 143 KLIGYCAVDGERGIQR-LLVYEFMLNRSLEDHLFNRAFPP----LPWKTRLHIILGAAEG 197
           +L+G C     +GI + +++  FM    L  +L           +P +T L  ++  A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           + YL        ++RD  A N +L ++    ++DFGL+++     +            + 
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLT 285
           A + +     T+KSDVW+FGV ++E+ T
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 133/312 (42%), Gaps = 61/312 (19%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-----DGLQWVAEVQFL 133
           ND      IGEG FG V K+ IK    DG       AIK++       D   +  E++ L
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKK---DGLRMDA--AIKRMKEYASKDDHRDFAGELEVL 76
Query: 134 GVL-EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------------FNRA 178
             L  HPN++ L+G C     RG   L + E+  + +L D L               N  
Sbjct: 77  CKLGHHPNIINLLGACE---HRGYLYLAI-EYAPHGNLLDFLRKSRVLETDPAFAIANST 132
Query: 179 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 238
              L  +  LH     A G+ YL +    Q I+R+  A N+L+ EN+  K++DFGL+R  
Sbjct: 133 ASTLSSQQLLHFAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSRGQ 189
Query: 239 PM-----VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
            +     +G   V    + +  Y+          T  SDVWS+GV+L+E+++   +    
Sbjct: 190 EVYVKKTMGRLPVRWMAIESLNYSV--------YTTNSDVWSYGVLLWEIVSLGGT---- 237
Query: 294 RPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM 353
            P       E  ++ P            RLEK   +N   ++  L   C  +   +RP  
Sbjct: 238 -PYCGMTCAELYEKLPQGY---------RLEK--PLNCDDEVYDLMRQCWREKPYERPSF 285
Query: 354 SQVVERLKQIVQ 365
           +Q++  L ++++
Sbjct: 286 AQILVSLNRMLE 297

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 111/249 (44%), Gaps = 33/249 (13%)
Query: 55  IPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSI-KPAAGDGTSEATV 113
           +P + + K   L+  S S +R        M ++GE  FG VYK  +  PA G+ T    +
Sbjct: 9   MPLINQHKQAKLKEISLSAVR-------FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAI 61
Query: 114 VAIKKLNRDGL--QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVY-------EF 164
             +K      L  ++  E      L+HPN+V L+G   V  ++ +  +  Y       EF
Sbjct: 62  KTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLG--VVTKDQPLSMIFSYCSHGDLHEF 119
Query: 165 MLNRSL--------EDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKA 216
           ++ RS         +D     A  P      +H++   A G+ YL       V+++D   
Sbjct: 120 LVMRSPHSDVGSTDDDRTVKSALEP---PDFVHLVAQIAAGMEYLSSH---HVVHKDLAT 173
Query: 217 SNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSF 276
            NVL+ +    K+SD GL RE     +  +    +    + AP+ I  G  +  SD+WS+
Sbjct: 174 RNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSY 233
Query: 277 GVVLYEMLT 285
           GVVL+E+ +
Sbjct: 234 GVVLWEVFS 242

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 24/225 (10%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-------EVQF 132
           DF     +G+G F  VY++       +       VAIK +++  +           EV+ 
Sbjct: 12  DFKVGNLLGKGSFAGVYRA-------ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
              L+HP++++L  Y     E      LV E   N  +  +L NR  P    + R H + 
Sbjct: 65  HCQLKHPSILELYNYF----EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMH 119
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
               G+ YLH      +++RD   SN+LL  N   K++DFGLA +  M    H +  + G
Sbjct: 120 QIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCG 174
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT 297
           T  Y +P+         +SDVWS G + Y +L GR   + +  K 
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN 219

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 20/215 (9%)
Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFL 133
           M     + + + ++G G FG V     K     G  +  V  IK+ +    ++  E Q +
Sbjct: 3   MELKREEITLLKELGSGQFGVV-----KLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTM 57
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L HP LVK  G C+    +     +V E++ N  L ++L +      P    L +   
Sbjct: 58  MKLSHPKLVKFYGVCS----KEYPIYIVTEYISNGCLLNYLRSHGKGLEP-SQLLEMCYD 112
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
             EG+A+L      Q I+RD  A N L+D +   K+SDFG+ R   ++   +VS+  VGT
Sbjct: 113 VCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSS--VGT 165
Query: 254 ---FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
                ++AP+       ++KSDVW+FG++++E+ +
Sbjct: 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 112/231 (48%), Gaps = 22/231 (9%)
Query: 68  VFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RD 122
           V+   E   +    + + ++G+G FG VY+ + +     G +E T VA+K +N     R+
Sbjct: 6   VYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDII-KGEAE-TRVAVKTVNESASLRE 63
Query: 123 GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-------- 174
            ++++ E   +      ++V+L+G  +    +G   L+V E M +  L+ +L        
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAE 119
Query: 175 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 234
            N   PP   +  + +    A+G+AYL+     + ++RD  A N ++  +F  K+ DFG+
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGM 176
Query: 235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            R+             +    + AP+ ++ G  T  SD+WSFGVVL+E+ +
Sbjct: 177 TRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 102/232 (43%), Gaps = 47/232 (20%)
Query: 72  SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL--NRDGLQWVAE 129
           S  +Q    F  + K+GEG +GSVYK+  K           +VAIK++    D  + + E
Sbjct: 22  SLTKQPEEVFDVLEKLGEGSYGSVYKAIHK-------ETGQIVAIKQVPVESDLQEIIKE 74
Query: 130 VQFLGVLEHPNLVKLIG-------------YCAVDGERGIQRLLVYEFMLNRSL-EDHLF 175
           +  +   + P++VK  G             YC       I RL       N++L ED + 
Sbjct: 75  ISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR------NKTLTEDEIA 128
Query: 176 NRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA 235
                         I+    +GL YLH    ++ I+RD KA N+LL+     KL+DFG+A
Sbjct: 129 T-------------ILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVA 172
Query: 236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
             G +         V+GT  + AP+ I+       +D+WS G+   EM  G+
Sbjct: 173 --GQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 130/291 (44%), Gaps = 34/291 (11%)
Query: 75  RQATNDFSRMLKIGEGGFGSVY----KSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEV 130
           + +  DF  +  +G G FG V+    + + +  A     +  VV +K++         E 
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN----DER 57
Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
             L ++ HP ++++ G      +   Q  ++ +++    L   L      P P       
Sbjct: 58  LMLSIVTHPFIIRMWGTF----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAK---- 109
Query: 191 ILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 247
              AAE    L YLH      +IYRD K  N+LLD+N   K++DFG A+  P      V+
Sbjct: 110 -FYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVT 160
Query: 248 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL-ERNRPKTEQRLLEWVQ 306
             + GT  Y AP+ + T       D WSFG+++YEML G     + N  KT +++L    
Sbjct: 161 YXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL 220
Query: 307 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 357
           ++P     F   +   L +  + + ++++G L +   ++  K+ P   +VV
Sbjct: 221 RFPP---FFNEDVKDLLSRLITRDLSQRLGNLQNG--TEDVKNHPWFKEVV 266

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 113/250 (45%), Gaps = 29/250 (11%)
Query: 75  RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK----LNRDGLQW-VAE 129
           R    DF+ ++ +G+G FG V  +  K     GT E   + I K    +  D ++  + E
Sbjct: 15  RVKLTDFNFLMVLGKGSFGKVMLADRK-----GTEELYAIKILKKDVVIQDDDVECTMVE 69
Query: 130 VQFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
            + L +L+ P  +  +  C     + + RL  V E++    L  H+        P     
Sbjct: 70  KRVLALLDKPPFLTQLHSCF----QTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP----- 120
Query: 189 HIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
             +  AAE   GL +LH+     +IYRD K  NV+LD     K++DFG+ +E  M G T 
Sbjct: 121 QAVFYAAEISIGLFFLHKR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVT- 176
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEW 304
            +    GT  Y AP+ I         D W++GV+LYEML G+   +  +  +  Q ++E 
Sbjct: 177 -TREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH 235
Query: 305 VQQYPADSKK 314
              YP    K
Sbjct: 236 NVSYPKSLSK 245

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 100/219 (45%), Gaps = 30/219 (13%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN------RDGLQWVAEVQFLGVLEHP 139
           ++GEG FG V+ +       +   +  +VA+K L       R   Q   E + L +L+H 
Sbjct: 25  ELGEGAFGKVFLAECHNLLPE--QDKMLVAVKALKEASESARQDFQ--REAELLTMLQHQ 80
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDH-----LF----NRAFPPLPWKT 186
           ++V+  G C      G   L+V+E+M    LNR L  H     L     + A  PL    
Sbjct: 81  HIVRFFGVCT----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 136
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            L +    A G+ YL  GL    ++RD    N L+ +    K+ DFG++R+     +  V
Sbjct: 137 LLAVASQVAAGMVYL-AGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 193
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
               +    +  P+ I     T +SDVWSFGVVL+E+ T
Sbjct: 194 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 32/210 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-------RDGLQWVA--EVQFLGVLE 137
           +GEG F +VYK+  K       +   +VAIKK+        +DG+   A  E++ L  L 
Sbjct: 18  LGEGQFATVYKARDK-------NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 197
           HPN++ L+   A   +  I   LV++FM    LE  + + +    P   + ++++   +G
Sbjct: 71  HPNIIGLLD--AFGHKSNIS--LVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLM-TLQG 124
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFG 255
           L YLH+     +++RD K +N+LLDEN   KL+DFGLA+    P   + H     V T  
Sbjct: 125 LEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXH----QVVTRW 177
Query: 256 YAAPDYIETGHLTAKS-DVWSFGVVLYEML 284
           Y AP+ +    +     D+W+ G +L E+L
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 26/220 (11%)
Query: 84  MLKIGEGGFGSVYKSSI-KPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLGVLEHPN 140
           M ++GE  FG VYK  +  PA G+ T    +  +K      L  ++  E      L+HPN
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 141 LVKLIGYCAVDGERGIQRLLVY-------EFMLNRSL--------EDHLFNRAFPPLPWK 185
           +V L+G   V  ++ +  +  Y       EF++ RS         +D     A  P    
Sbjct: 74  VVCLLG--VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP---P 128
Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
             +H++   A G+ YL       V+++D    NVL+ +    K+SD GL RE     +  
Sbjct: 129 DFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           +    +    + AP+ I  G  +  SD+WS+GVVL+E+ +
Sbjct: 186 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 107/249 (42%), Gaps = 27/249 (10%)
Query: 75  RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK----LNRDGLQW-VAE 129
           R    DF+ ++ +G+G FG V  S  K     GT E   V I K    +  D ++  + E
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERK-----GTDELYAVKILKKDVVIQDDDVECTMVE 391
Query: 130 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 189
            + L +   P  +  +  C    +R      V E++    L  H+        P     H
Sbjct: 392 KRVLALPGKPPFLTQLHSCFQTMDR---LYFVMEYVNGGDLMYHIQQVGRFKEP-----H 443
Query: 190 IILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            +  AAE   GL +L       +IYRD K  NV+LD     K++DFG+ +E    G T  
Sbjct: 444 AVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT-- 498
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWV 305
           +    GT  Y AP+ I         D W+FGV+LYEML G+   E  +  +  Q ++E  
Sbjct: 499 TKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 558
Query: 306 QQYPADSKK 314
             YP    K
Sbjct: 559 VAYPKSMSK 567

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 101/225 (44%), Gaps = 30/225 (13%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN------RDGLQWVAEVQFL 133
           D     ++GEG FG V+ +       +   +  +VA+K L       R   Q   E + L
Sbjct: 13  DIVLKWELGEGAFGKVFLAECHNLLPE--QDKMLVAVKALKEASESARQDFQ--REAELL 68
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDH-----LF----NRAFP 180
            +L+H ++V+  G C      G   L+V+E+M    LNR L  H     L     + A  
Sbjct: 69  TMLQHQHIVRFFGVCT----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 124
Query: 181 PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           PL     L +    A G+ YL  GL    ++RD    N L+ +    K+ DFG++R+   
Sbjct: 125 PLGLGQLLAVASQVAAGMVYL-AGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 181
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
             +  V    +    +  P+ I     T +SDVWSFGVVL+E+ T
Sbjct: 182 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 108/251 (43%), Gaps = 31/251 (12%)
Query: 75  RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK----LNRDGLQW-VAE 129
           R    DF+ ++ +G+G FG V  S  K     GT E   V I K    +  D ++  + E
Sbjct: 16  RMKLTDFNFLMVLGKGSFGKVMLSERK-----GTDELYAVKILKKDVVIQDDDVECTMVE 70
Query: 130 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTR 187
            + L +   P  +  +  C    +R      V E++    L  H+    R   P      
Sbjct: 71  KRVLALPGKPPFLTQLHSCFQTMDR---LYFVMEYVNGGDLMYHIQQVGRFKEP------ 121
Query: 188 LHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT 244
            H +  AAE   GL +L       +IYRD K  NV+LD     K++DFG+ +E    G T
Sbjct: 122 -HAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 177
Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLE 303
             +    GT  Y AP+ I         D W+FGV+LYEML G+   E  +  +  Q ++E
Sbjct: 178 --TKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 235
Query: 304 WVQQYPADSKK 314
               YP    K
Sbjct: 236 HNVAYPKSMSK 246

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 102/229 (44%), Gaps = 44/229 (19%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-------NRDGLQWVAEVQFLGVLEH 138
           ++G GGFG V +  I    G+       VAIK+        NR+  +W  E+Q +  L H
Sbjct: 22  RLGTGGFGYVLRW-IHQDTGEQ------VAIKQCRQELSPKNRE--RWCLEIQIMKKLNH 72
Query: 139 PNLVKLIGYCAVDGERGIQRL-------LVYEFMLNRSLEDHL--FNRA--FPPLPWKTR 187
           PN+V      A +   G+Q+L       L  E+     L  +L  F         P +T 
Sbjct: 73  PNVVS-----AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 127
Query: 188 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLAREGPMVGHT 244
           L  I  A   L YLHE    ++I+RD K  N++L    +    K+ D G A+E   +   
Sbjct: 128 LSDISSA---LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE---LDQG 178
Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
            + T  VGT  Y AP+ +E    T   D WSFG + +E +TG R    N
Sbjct: 179 ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 227

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 124/283 (43%), Gaps = 41/283 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           F+++ KIG+G FG V+K       G       VVAIK ++ +  +        E+  L  
Sbjct: 24  FTKLEKIGKGSFGEVFK-------GIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ 76
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
            + P + K  G    D +  I    + E++   S  D L           T L  IL   
Sbjct: 77  CDSPYVTKYYGSYLKDTKLWI----IMEYLGGGSALDLLEPGPLDETQIATILREIL--- 129
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
           +GL YLH     + I+RD KA+NVLL E+   KL+DFG+A  G +          VGT  
Sbjct: 130 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFVGTPF 184
Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF 315
           + AP+ I+     +K+D+WS G+   E+  G        P +E   ++ +   P ++   
Sbjct: 185 WMAPEVIKQSAYDSKADIWSLGITAIELARGE------PPHSELHPMKVLFLIPKNNP-- 236
Query: 316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
                P LE  YS    + +    + CL+K    RP   ++++
Sbjct: 237 -----PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLK 270

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 102/229 (44%), Gaps = 44/229 (19%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-------NRDGLQWVAEVQFLGVLEH 138
           ++G GGFG V +  I    G+       VAIK+        NR+  +W  E+Q +  L H
Sbjct: 21  RLGTGGFGYVLRW-IHQDTGEQ------VAIKQCRQELSPKNRE--RWCLEIQIMKKLNH 71
Query: 139 PNLVKLIGYCAVDGERGIQRL-------LVYEFMLNRSLEDHL--FNRA--FPPLPWKTR 187
           PN+V      A +   G+Q+L       L  E+     L  +L  F         P +T 
Sbjct: 72  PNVVS-----AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126
Query: 188 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLAREGPMVGHT 244
           L  I  A   L YLHE    ++I+RD K  N++L    +    K+ D G A+E   +   
Sbjct: 127 LSDISSA---LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE---LDQG 177
Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
            + T  VGT  Y AP+ +E    T   D WSFG + +E +TG R    N
Sbjct: 178 ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 115/237 (48%), Gaps = 36/237 (15%)
Query: 61  EKAHNL--RVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIK- 117
           EKA+ +  R+F  +E+R       ++  +G G FG+V+K    P   +G S    V IK 
Sbjct: 18  EKANKVLARIFKETELR-------KLKVLGSGVFGTVHKGVWIP---EGESIKIPVCIKV 67
Query: 118 ---KLNRDGLQWVAEVQF-LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDH 173
              K  R   Q V +    +G L+H ++V+L+G C      G    LV +++   SL DH
Sbjct: 68  IEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-----GSSLQLVTQYLPLGSLLDH 122
Query: 174 LFNR--AFPP---LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK 228
           +     A  P   L W  ++      A+G+ YL E     +++R+  A NVLL    + +
Sbjct: 123 VRQHRGALGPQLLLNWGVQI------AKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQ 173
Query: 229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           ++DFG+A   P      + +       + A + I  G  T +SDVWS+GV ++E++T
Sbjct: 174 VADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 113/231 (48%), Gaps = 22/231 (9%)
Query: 68  VFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RD 122
           V+   E   +    + + ++G+G FG VY+ + +     G +E T VA+K +N     R+
Sbjct: 6   VYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDII-KGEAE-TRVAVKTVNESASLRE 63
Query: 123 GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-------- 174
            ++++ E   +      ++V+L+G  +    +G   L+V E M +  L+ +L        
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAE 119
Query: 175 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 234
            N   PP   +  + +    A+G+AYL+     + ++R+  A N ++  +F  K+ DFG+
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGM 176
Query: 235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            R+     +       +    + AP+ ++ G  T  SD+WSFGVVL+E+ +
Sbjct: 177 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 101/225 (44%), Gaps = 30/225 (13%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN------RDGLQWVAEVQFL 133
           D     ++GEG FG V+ +       +   +  +VA+K L       R   Q   E + L
Sbjct: 42  DIVLKWELGEGAFGKVFLAECHNLLPE--QDKMLVAVKALKEASESARQDFQ--REAELL 97
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDH-----LF----NRAFP 180
            +L+H ++V+  G C      G   L+V+E+M    LNR L  H     L     + A  
Sbjct: 98  TMLQHQHIVRFFGVCT----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 153
Query: 181 PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           PL     L +    A G+ YL  GL    ++RD    N L+ +    K+ DFG++R+   
Sbjct: 154 PLGLGQLLAVASQVAAGMVYL-AGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 210
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
             +  V    +    +  P+ I     T +SDVWSFGVVL+E+ T
Sbjct: 211 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 124/283 (43%), Gaps = 41/283 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           F+++ KIG+G FG V+K       G       VVAIK ++ +  +        E+  L  
Sbjct: 9   FTKLEKIGKGSFGEVFK-------GIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ 61
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
            + P + K  G    D +  I    + E++   S  D L           T L  IL   
Sbjct: 62  CDSPYVTKYYGSYLKDTKLWI----IMEYLGGGSALDLLEPGPLDETQIATILREIL--- 114
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
           +GL YLH     + I+RD KA+NVLL E+   KL+DFG+A  G +          VGT  
Sbjct: 115 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPF 169
Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF 315
           + AP+ I+     +K+D+WS G+   E+  G        P +E   ++ +   P ++   
Sbjct: 170 WMAPEVIKQSAYDSKADIWSLGITAIELARGE------PPHSELHPMKVLFLIPKNNP-- 221
Query: 316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
                P LE  YS    + +    + CL+K    RP   ++++
Sbjct: 222 -----PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLK 255

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
           ++G G FG V+  +      +G ++  +  +K        ++ E Q +  L+H  LV+L 
Sbjct: 16  RLGNGQFGEVWMGT-----WNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLY 70
Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL 205
              AV  E  I   +V E+M   SL D L +     L     + +    A G+AY+    
Sbjct: 71  ---AVVSEEPI--YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER-- 123
Query: 206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDYI 262
            +  I+RD +++N+L+      K++DFGLAR    +   +  TA  G      + AP+  
Sbjct: 124 -MNYIHRDLRSANILVGNGLICKIADFGLAR----LIEDNEXTARQGAKFPIKWTAPEAA 178
Query: 263 ETGHLTAKSDVWSFGVVLYEMLTGRR 288
             G  T KSDVWSFG++L E++T  R
Sbjct: 179 LYGRFTIKSDVWSFGILLTELVTKGR 204

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 100/215 (46%), Gaps = 36/215 (16%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQ----------FLGVL 136
           IG+G FG VY         D        AIK L+R     + E+Q           +  L
Sbjct: 29  IGKGHFGVVYHGEYI----DQAQNRIQCAIKSLSR-----ITEMQQVEAFLREGLLMRGL 79
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
            HPN++ LIG        G+  +L+  +M +  L   + +    P   K  +   L  A 
Sbjct: 80  NHPNVLALIGIML--PPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTV-KDLISFGLQVAR 135
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE------GPMVGHTHVSTAV 250
           G+ YL E    + ++RD  A N +LDE+F  K++DFGLAR+        +  H H    V
Sbjct: 136 GMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
                + A + ++T   T KSDVWSFGV+L+E+LT
Sbjct: 193 ----KWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 113/231 (48%), Gaps = 22/231 (9%)
Query: 68  VFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RD 122
           V+   E   +    + + ++G+G FG VY+ + +     G +E T VA+K +N     R+
Sbjct: 7   VYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDII-KGEAE-TRVAVKTVNESASLRE 64
Query: 123 GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-------- 174
            ++++ E   +      ++V+L+G  +    +G   L+V E M +  L+ +L        
Sbjct: 65  RIEFLNEASVMKGFTCHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAE 120
Query: 175 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 234
            N   PP   +  + +    A+G+AYL+     + ++R+  A N ++  +F  K+ DFG+
Sbjct: 121 NNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGM 177
Query: 235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            R+     +       +    + AP+ ++ G  T  SD+WSFGVVL+E+ +
Sbjct: 178 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 124/283 (43%), Gaps = 41/283 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           F+++ KIG+G FG V+K       G       VVAIK ++ +  +        E+  L  
Sbjct: 9   FTKLEKIGKGSFGEVFK-------GIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ 61
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
            + P + K  G    D +  I    + E++   S  D L           T L  IL   
Sbjct: 62  CDSPYVTKYYGSYLKDTKLWI----IMEYLGGGSALDLLEPGPLDETQIATILREIL--- 114
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
           +GL YLH     + I+RD KA+NVLL E+   KL+DFG+A  G +          VGT  
Sbjct: 115 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFVGTPF 169
Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF 315
           + AP+ I+     +K+D+WS G+   E+  G        P +E   ++ +   P ++   
Sbjct: 170 WMAPEVIKQSAYDSKADIWSLGITAIELARGE------PPHSELHPMKVLFLIPKNNP-- 221
Query: 316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
                P LE  YS    + +    + CL+K    RP   ++++
Sbjct: 222 -----PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLK 255

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 124/283 (43%), Gaps = 41/283 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           F+++ KIG+G FG V+K       G       VVAIK ++ +  +        E+  L  
Sbjct: 29  FTKLEKIGKGSFGEVFK-------GIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ 81
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
            + P + K  G    D +  I    + E++   S  D L           T L  IL   
Sbjct: 82  CDSPYVTKYYGSYLKDTKLWI----IMEYLGGGSALDLLEPGPLDETQIATILREIL--- 134
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
           +GL YLH     + I+RD KA+NVLL E+   KL+DFG+A  G +          VGT  
Sbjct: 135 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPF 189
Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF 315
           + AP+ I+     +K+D+WS G+   E+  G        P +E   ++ +   P ++   
Sbjct: 190 WMAPEVIKQSAYDSKADIWSLGITAIELARGE------PPHSELHPMKVLFLIPKNNP-- 241
Query: 316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
                P LE  YS    + +    + CL+K    RP   ++++
Sbjct: 242 -----PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLK 275

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 102/230 (44%), Gaps = 28/230 (12%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------ 124
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L      
Sbjct: 17  SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 69
Query: 125 -QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 183
            Q   EV+    L HPN+++L GY   D  R     L+ E+    ++   L  +      
Sbjct: 70  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFD 123
Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
            +     I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    
Sbjct: 124 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 176
Query: 244 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           +   T + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 177 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 226

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 101/230 (43%), Gaps = 28/230 (12%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------ 124
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L      
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 57
Query: 125 -QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 183
            Q   EV+    L HPN+++L GY   D  R     L+ E+     +   L  +      
Sbjct: 58  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPRGEVYKEL--QKLSKFD 111
Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
            +     I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    
Sbjct: 112 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 164
Query: 244 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           +   T + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 165 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL---NRDGLQWVA--EVQFLGV 135
           + ++ K+GEG + +VYK       G       +VA+K++   + +G    A  EV  L  
Sbjct: 4   YIKLDKLGEGTYATVYK-------GKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKD 56
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
           L+H N+V L  +  +  E+ +   LV+E+ L++ L+ +L +          +L  +    
Sbjct: 57  LKHANIVTL--HDIIHTEKSLT--LVFEY-LDKDLKQYLDDCGNIINMHNVKL-FLFQLL 110
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
            GLAY H     +V++RD K  N+L++E    KL+DFGLAR   +   T+ +  V  T  
Sbjct: 111 RGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLW 165
Query: 256 YAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
           Y  PD  + +   + + D+W  G + YEM TGR
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 108/251 (43%), Gaps = 29/251 (11%)
Query: 50  TSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTS 109
           ++P   PE  EE A   +     + + A  DF     +G+G FG+VY +  K        
Sbjct: 7   SAPENNPE--EELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREK-------Q 57
Query: 110 EATVVAIKKLNRDGL-------QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVY 162
              ++A+K L +  L       Q   EV+    L HPN+++L GY   D  R     L+ 
Sbjct: 58  SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LIL 113
Query: 163 EFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD 222
           E+    ++   L  +       +     I   A  L+Y H     +VI+RD K  N+LL 
Sbjct: 114 EYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLG 168
Query: 223 ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYE 282
                K++DFG +   P    +   T + GT  Y  P+ IE      K D+WS GV+ YE
Sbjct: 169 SAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYE 224
Query: 283 MLTGRRSLERN 293
            L G+   E N
Sbjct: 225 FLVGKPPFEAN 235

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 34/229 (14%)
Query: 67  RVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIK----KLNRD 122
           R+F  +E+R       ++  +G G FG+V+K    P   +G S    V IK    K  R 
Sbjct: 8   RIFKETELR-------KLKVLGSGVFGTVHKGVWIP---EGESIKIPVCIKVIEDKSGRQ 57
Query: 123 GLQWVAEVQF-LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR--AF 179
             Q V +    +G L+H ++V+L+G C      G    LV +++   SL DH+     A 
Sbjct: 58  SFQAVTDHMLAIGSLDHAHIVRLLGLCP-----GSSLQLVTQYLPLGSLLDHVRQHRGAL 112
Query: 180 PP---LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 236
            P   L W  ++      A+G+ YL E     +++R+  A NVLL    + +++DFG+A 
Sbjct: 113 GPQLLLNWGVQI------AKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVAD 163
Query: 237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
             P      + +       + A + I  G  T +SDVWS+GV ++E++T
Sbjct: 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 128/308 (41%), Gaps = 41/308 (13%)
Query: 63  AHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD 122
           A +L     S +R     F  +  +G G +G VYK       G       + AIK ++  
Sbjct: 8   ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYK-------GRHVKTGQLAAIKVMDVT 60
Query: 123 GLQWVAEVQFLGVLE----HPNLVKLIGYCAVDGERGI--QRLLVYEFMLNRSLEDHLFN 176
           G +     Q + +L+    H N+    G        G+  Q  LV EF    S+ D + N
Sbjct: 61  GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN 120
Query: 177 RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL-A 235
                L  +   +I      GL++LH+    +VI+RD K  NVLL EN   KL DFG+ A
Sbjct: 121 TKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 236 REGPMVGHTHVSTAVVGTFGYAAPDYIET-----GHLTAKSDVWSFGVVLYEMLTGRRSL 290
           +    VG  +     +GT  + AP+ I            KSD+WS G+   EM  G   L
Sbjct: 178 QLDRTVGRRNT---FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234
Query: 291 ERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDR 350
               P    R L  + + PA          PRL+   S   ++K     ++CL K+   R
Sbjct: 235 CDMHP---MRALFLIPRNPA----------PRLK---SKKWSKKFQSFIESCLVKNHSQR 278
Query: 351 PKMSQVVE 358
           P   Q+++
Sbjct: 279 PATEQLMK 286

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 102/230 (44%), Gaps = 28/230 (12%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------ 124
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L      
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 57
Query: 125 -QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 183
            Q   EV+    L HPN+++L GY   D  R     L+ E+    ++   L  +      
Sbjct: 58  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFD 111
Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
            +     I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    
Sbjct: 112 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 164
Query: 244 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           +   T + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 165 SSRRTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 95/222 (42%), Gaps = 37/222 (16%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQF 132
           D   + K+G+G FG V +      +G   S    VA+K L  D L        ++ EV  
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVS----VAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
           +  L+H NL++L G       + +  L     +L+R L  H             + H +L
Sbjct: 75  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-LRKH-------------QGHFLL 120
Query: 193 GA--------AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG-H 243
           G         AEG+ YL      + I+RD  A N+LL      K+ DFGL R  P    H
Sbjct: 121 GTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177
Query: 244 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
             +       F + AP+ ++T   +  SD W FGV L+EM T
Sbjct: 178 XVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 30/213 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNL 141
           ++G+G FGSV      P  GD T    +VA+K+L   G      +  E+Q L  L    +
Sbjct: 17  QLGKGNFGSVELCRYDPL-GDNT--GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 73
Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY- 200
           VK  G     G + ++  LV E++ +  L D L            R    L A+  L Y 
Sbjct: 74  VKYRGVSYGPGRQSLR--LVMEYLPSGCLRDFL-----------QRHRARLDASRLLLYS 120
Query: 201 --LHEGLEV----QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV--STAVVG 252
             + +G+E     + ++RD  A N+L++     K++DFGLA+  P+    +V        
Sbjct: 121 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 180
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            F YA P+ +     + +SDVWSFGVVLYE+ T
Sbjct: 181 IFWYA-PESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 95/222 (42%), Gaps = 37/222 (16%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQF 132
           D   + K+G+G FG V +      +G   S    VA+K L  D L        ++ EV  
Sbjct: 13  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVS----VAVKCLKPDVLSQPEAMDDFIREVNA 68
Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
           +  L+H NL++L G       + +  L     +L+R L  H             + H +L
Sbjct: 69  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-LRKH-------------QGHFLL 114
Query: 193 GA--------AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT 244
           G         AEG+ YL      + I+RD  A N+LL      K+ DFGL R  P     
Sbjct: 115 GTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 171
Query: 245 HVSTAVVGT-FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           +V        F + AP+ ++T   +  SD W FGV L+EM T
Sbjct: 172 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 102/230 (44%), Gaps = 28/230 (12%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------ 124
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L      
Sbjct: 3   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 55
Query: 125 -QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 183
            Q   EV+    L HPN+++L GY   D  R     L+ E+    ++   L  +      
Sbjct: 56  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFD 109
Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
            +     I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    
Sbjct: 110 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 162
Query: 244 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           +   T + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 163 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 95/222 (42%), Gaps = 37/222 (16%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQF 132
           D   + K+G+G FG V +      +G   S    VA+K L  D L        ++ EV  
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVS----VAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
           +  L+H NL++L G       + +  L     +L+R L  H             + H +L
Sbjct: 65  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-LRKH-------------QGHFLL 110
Query: 193 GA--------AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG-H 243
           G         AEG+ YL      + I+RD  A N+LL      K+ DFGL R  P    H
Sbjct: 111 GTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167
Query: 244 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
             +       F + AP+ ++T   +  SD W FGV L+EM T
Sbjct: 168 XVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 30/213 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNL 141
           ++G+G FGSV      P  GD T    +VA+K+L   G      +  E+Q L  L    +
Sbjct: 30  QLGKGNFGSVELCRYDPL-GDNT--GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY- 200
           VK  G     G + ++  LV E++ +  L D L            R    L A+  L Y 
Sbjct: 87  VKYRGVSYGPGRQSLR--LVMEYLPSGCLRDFL-----------QRHRARLDASRLLLYS 133
Query: 201 --LHEGLEV----QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV--STAVVG 252
             + +G+E     + ++RD  A N+L++     K++DFGLA+  P+    +V        
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            F YA P+ +     + +SDVWSFGVVLYE+ T
Sbjct: 194 IFWYA-PESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 102/230 (44%), Gaps = 28/230 (12%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------ 124
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L      
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 57
Query: 125 -QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 183
            Q   EV+    L HPN+++L GY   D  R     L+ E+    ++   L  +      
Sbjct: 58  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFD 111
Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
            +     I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    
Sbjct: 112 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 164
Query: 244 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           +   T + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 165 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 30/213 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNL 141
           ++G+G FGSV      P  GD T    +VA+K+L   G      +  E+Q L  L    +
Sbjct: 18  QLGKGNFGSVELCRYDPL-GDNT--GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 74
Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY- 200
           VK  G     G + ++  LV E++ +  L D L            R    L A+  L Y 
Sbjct: 75  VKYRGVSYGPGRQSLR--LVMEYLPSGCLRDFL-----------QRHRARLDASRLLLYS 121
Query: 201 --LHEGLEV----QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV--STAVVG 252
             + +G+E     + ++RD  A N+L++     K++DFGLA+  P+    +V        
Sbjct: 122 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 181
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            F YA P+ +     + +SDVWSFGVVLYE+ T
Sbjct: 182 IFWYA-PESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQFLGVLEH 138
           KIG G F  VY+++      DG      VA+KK+    L         + E+  L  L H
Sbjct: 39  KIGRGQFSEVYRAA---CLLDGVP----VALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 198
           PN++K       D E  I   L     L+R ++   F +    +P +T     +     L
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKH--FKKQKRLIPERTVWKYFVQLCSAL 149
Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
            ++H     +V++RD K +NV +      KL D GL R       T  + ++VGT  Y +
Sbjct: 150 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMS 204
Query: 259 PDYIETGHLTAKSDVWSFGVVLYEM 283
           P+ I       KSD+WS G +LYEM
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEM 229

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 100/226 (44%), Gaps = 32/226 (14%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQF 132
           +++    DF     +G+G FG V+ +  K             AIK L +D +    +V+ 
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTN-------QFFAIKALKKDVVLMDDDVEC 64
Query: 133 LGV--------LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW 184
             V         EHP L  +  +C    +  +    V E++    L  H+ +     L  
Sbjct: 65  TMVEKRVLSLAWEHPFLTHM--FCTFQTKENL--FFVMEYLNGGDLMYHIQSCHKFDLSR 120
Query: 185 KTRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMV 241
            T       AAE   GL +LH      ++YRD K  N+LLD++   K++DFG+ +E  M+
Sbjct: 121 AT-----FYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN-ML 171
Query: 242 GHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
           G    +    GT  Y AP+ +         D WSFGV+LYEML G+
Sbjct: 172 GDAK-TNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 95/222 (42%), Gaps = 37/222 (16%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQF 132
           D   + K+G+G FG V +      +G   S    VA+K L  D L        ++ EV  
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVS----VAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
           +  L+H NL++L G       + +  L     +L+R L  H             + H +L
Sbjct: 75  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-LRKH-------------QGHFLL 120
Query: 193 GA--------AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT 244
           G         AEG+ YL      + I+RD  A N+LL      K+ DFGL R  P     
Sbjct: 121 GTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177
Query: 245 HVSTAVVGT-FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           +V        F + AP+ ++T   +  SD W FGV L+EM T
Sbjct: 178 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 95/222 (42%), Gaps = 37/222 (16%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQF 132
           D   + K+G+G FG V +      +G   S    VA+K L  D L        ++ EV  
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVS----VAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
           +  L+H NL++L G       + +  L     +L+R L  H             + H +L
Sbjct: 65  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-LRKH-------------QGHFLL 110
Query: 193 GA--------AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT 244
           G         AEG+ YL      + I+RD  A N+LL      K+ DFGL R  P     
Sbjct: 111 GTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167
Query: 245 HVSTAVVGT-FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           +V        F + AP+ ++T   +  SD W FGV L+EM T
Sbjct: 168 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 95/222 (42%), Gaps = 37/222 (16%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQF 132
           D   + K+G+G FG V +      +G   S    VA+K L  D L        ++ EV  
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVS----VAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
           +  L+H NL++L G       + +  L     +L+R L  H             + H +L
Sbjct: 65  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-LRKH-------------QGHFLL 110
Query: 193 GA--------AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT 244
           G         AEG+ YL      + I+RD  A N+LL      K+ DFGL R  P     
Sbjct: 111 GTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167
Query: 245 HVSTAVVGT-FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           +V        F + AP+ ++T   +  SD W FGV L+EM T
Sbjct: 168 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLN-------RDGLQWVAEVQFLGVL-E 137
           +G G FG V +++   A G G  +A + VA+K L        ++ L  ++E++ +  L +
Sbjct: 54  LGAGAFGKVVEAT---AFGLGKEDAVLKVAVKMLKSTAHADEKEAL--MSELKIMSHLGQ 108
Query: 138 HPNLVKLIGYCAVDGE-RGIQRLLVYEFMLN---RSLEDHLFNRAFPPLPWKTRLHIILG 193
           H N+V L+G C   G    I     Y  +LN   R  E  L      PL  +  LH    
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 168
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
            A+G+A+L        I+RD  A NVLL      K+ DFGLAR+     +  V       
Sbjct: 169 VAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 225
Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
             + AP+ I     T +SDVWS+G++L+E+ +
Sbjct: 226 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 108/225 (48%), Gaps = 24/225 (10%)
Query: 66  LRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--- 122
           LR+   +E+R+          +G G FG+VYK    P   DG +    VAIK L  +   
Sbjct: 11  LRILKETELRKVK-------VLGSGAFGTVYKGIWIP---DGENVKIPVAIKVLRENTSP 60
Query: 123 --GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP 180
               + + E   +  +  P + +L+G C     + + +L+ Y  +L+   E    NR   
Sbjct: 61  KANKEILDEAYVMAGVGSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRE----NRGR- 115
Query: 181 PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
            L  +  L+  +  A+G++YL +   V++++RD  A NVL+      K++DFGLAR   +
Sbjct: 116 -LGSQDLLNWCMQIAKGMSYLED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 171
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
               + +        + A + I     T +SDVWS+GV ++E++T
Sbjct: 172 DETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 95/222 (42%), Gaps = 37/222 (16%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQF 132
           D   + K+G+G FG V +      +G   S    VA+K L  D L        ++ EV  
Sbjct: 13  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVS----VAVKCLKPDVLSQPEAMDDFIREVNA 68
Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
           +  L+H NL++L G       + +  L     +L+R L  H             + H +L
Sbjct: 69  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-LRKH-------------QGHFLL 114
Query: 193 GA--------AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT 244
           G         AEG+ YL      + I+RD  A N+LL      K+ DFGL R  P     
Sbjct: 115 GTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 171
Query: 245 HVSTAVVGT-FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           +V        F + AP+ ++T   +  SD W FGV L+EM T
Sbjct: 172 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 103/235 (43%), Gaps = 18/235 (7%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQWVAEVQFLGVL 136
           F  +  +G+GG+G V++      A  G   A  V  K +     +D     AE   L  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
           +HP +V LI      G    +  L+ E++    L   L           T    +   + 
Sbjct: 79  KHPFIVDLIYAFQTGG----KLYLILEYLSGGELFMQLEREGI--FMEDTACFYLAEISM 132
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L +LH+     +IYRD K  N++L+     KL+DFGL +E    G   V+    GT  Y
Sbjct: 133 ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--TVTHTFCGTIEY 187
Query: 257 AAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYP 309
            AP+ +  +GH  A  D WS G ++Y+MLTG       NR KT  ++L+     P
Sbjct: 188 MAPEILMRSGHNRA-VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP 241

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 127/295 (43%), Gaps = 42/295 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLN-------RDGLQWVAEVQFLGVL-E 137
           +G G FG V +++   A G G  +A + VA+K L        ++ L  ++E++ +  L +
Sbjct: 46  LGAGAFGKVVEAT---AFGLGKEDAVLKVAVKMLKSTAHADEKEAL--MSELKIMSHLGQ 100
Query: 138 HPNLVKLIGYCAVDGE-RGIQRLLVYEFMLN---RSLEDHLFNRAFPPLPWKTRLHIILG 193
           H N+V L+G C   G    I     Y  +LN   R  E  L      PL  +  LH    
Sbjct: 101 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 160
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
            A+G+A+L        I+RD  A NVLL      K+ DFGLAR+     +  V       
Sbjct: 161 VAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 217
Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA--- 310
             + AP+ I     T +SDVWS+G++L+E+     SL  N              YP    
Sbjct: 218 VKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN-------------PYPGILV 260
Query: 311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
           +SK + L+ D     + +    + I  +   C +     RP   Q+   L++  Q
Sbjct: 261 NSKFYKLVKDGYQMAQPAF-APKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 314

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 106/236 (44%), Gaps = 42/236 (17%)
Query: 72  SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW----- 126
           S  R   ++F  +  +G+G FG V  + +K   GD      + A+K L +D +       
Sbjct: 16  SSNRLGIDNFEFIRVLGKGSFGKVMLARVK-ETGD------LYAVKVLKKDVILQDDDVE 68
Query: 127 --VAEVQFLGVL-EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-----FNRA 178
             + E + L +   HP L +L  +C    +   +   V EF+    L  H+     F+ A
Sbjct: 69  CTMTEKRILSLARNHPFLTQL--FCCF--QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA 124
Query: 179 FPPLPWKTRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA 235
                 + R +    AAE    L +LH+     +IYRD K  NVLLD     KL+DFG+ 
Sbjct: 125 ------RARFY----AAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMC 171
Query: 236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 291
           +EG   G T  +    GT  Y AP+ ++        D W+ GV+LYEML G    E
Sbjct: 172 KEGICNGVT--TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 103/235 (43%), Gaps = 18/235 (7%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQWVAEVQFLGVL 136
           F  +  +G+GG+G V++      A  G   A  V  K +     +D     AE   L  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
           +HP +V LI      G    +  L+ E++    L   L           T    +   + 
Sbjct: 79  KHPFIVDLIYAFQTGG----KLYLILEYLSGGELFMQLEREGI--FMEDTACFYLAEISM 132
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L +LH+     +IYRD K  N++L+     KL+DFGL +E    G   V+    GT  Y
Sbjct: 133 ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--TVTHXFCGTIEY 187
Query: 257 AAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYP 309
            AP+ +  +GH  A  D WS G ++Y+MLTG       NR KT  ++L+     P
Sbjct: 188 MAPEILMRSGHNRA-VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP 241

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-------EVQFLGVLEHP 139
           +G G FG V         G        VA+K LNR  ++ +        E+Q L +  HP
Sbjct: 24  LGVGTFGKV-------KVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           +++KL  Y  +     I   +V E++    L D++       L  K    +      G+ 
Sbjct: 77  HIIKL--YQVISTPSDI--FMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVD 130
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 259
           Y H  +   V++RD K  NVLLD +   K++DFGL+    M+          G+  YAAP
Sbjct: 131 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSN---MMSDGEFLRXSCGSPNYAAP 184
Query: 260 DYIETGHLTA--KSDVWSFGVVLYEMLTG 286
           + I +G L A  + D+WS GV+LY +L G
Sbjct: 185 EVI-SGRLYAGPEVDIWSSGVILYALLCG 212

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 102/230 (44%), Gaps = 28/230 (12%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------ 124
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L      
Sbjct: 3   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 55
Query: 125 -QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 183
            Q   EV+    L HPN+++L GY   D  R     L+ E+    ++   L  +      
Sbjct: 56  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFD 109
Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
            +     I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    
Sbjct: 110 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 162
Query: 244 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           +   T + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 163 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 102/230 (44%), Gaps = 28/230 (12%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------ 124
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L      
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 53
Query: 125 -QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 183
            Q   EV+    L HPN+++L GY   D  R     L+ E+    ++   L  +      
Sbjct: 54  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFD 107
Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
            +     I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    
Sbjct: 108 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 160
Query: 244 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           +   T + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 161 SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 102/230 (44%), Gaps = 28/230 (12%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------ 124
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L      
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 57
Query: 125 -QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 183
            Q   EV+    L HPN+++L GY   D  R     L+ E+    ++   L  +      
Sbjct: 58  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFD 111
Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
            +     I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    
Sbjct: 112 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 164
Query: 244 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           +   T + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 165 SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 104/239 (43%), Gaps = 12/239 (5%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEH 138
           N F +   +G+GGFG V    ++        +       K  +     + E Q L  +  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 198
             +V L    A   E      LV   M    L+ H+++      P       +  AAE  
Sbjct: 244 RFVVSL----AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---EARAVFYAAEIC 296
Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
             L +    +++YRD K  N+LLD++   ++SD GLA   P           VGT GY A
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRVGTVGYMA 353
Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE-WVQQYPAD-SKKF 315
           P+ ++    T   D W+ G +LYEM+ G+   ++ + K ++  +E  V++ P + S++F
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERF 412

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 27/224 (12%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAE 129
           A  DF     +G+G FG+VY +  K +         ++A+K L +  L       Q   E
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVEHQLRRE 58
Query: 130 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 189
           V+    L HPN+++L GY   D  R     L+ E+    ++   L  +       +    
Sbjct: 59  VEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFDEQRTAT 112
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
            I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +   T 
Sbjct: 113 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTT 165
Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 129/293 (44%), Gaps = 34/293 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           F+++ +IG+G FG V+K       G       VVAIK ++ +  +        E+  L  
Sbjct: 25  FTKLERIGKGSFGEVFK-------GIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ 77
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
            +   + K  G       +G +  ++ E++   S  D L    F      T L  IL   
Sbjct: 78  CDSSYVTKYYGSYL----KGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL--- 130
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
           +GL YLH     + I+RD KA+NVLL E    KL+DFG+A  G +          VGT  
Sbjct: 131 KGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPF 185
Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV-QQYPAD--- 311
           + AP+ I+     +K+D+WS G+   E+  G        P    R+L  + +  P     
Sbjct: 186 WMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP---MRVLFLIPKNNPPTLVG 242
Query: 312 --SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ 362
             +K F   +D  L K+ S     K   L    + K+SK    ++++++R K+
Sbjct: 243 DFTKSFKEFIDACLNKDPSFRPTAK-ELLKHKFIVKNSKKTSYLTELIDRFKR 294

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 100/226 (44%), Gaps = 32/226 (14%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQF 132
           +++    DF     +G+G FG V+ +  K             AIK L +D +    +V+ 
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTN-------QFFAIKALKKDVVLMDDDVEC 63
Query: 133 LGV--------LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW 184
             V         EHP L  +  +C    +  +    V E++    L  H+ +     L  
Sbjct: 64  TMVEKRVLSLAWEHPFLTHM--FCTFQTKENL--FFVMEYLNGGDLMYHIQSCHKFDLSR 119
Query: 185 KTRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMV 241
            T       AAE   GL +LH      ++YRD K  N+LLD++   K++DFG+ +E  M+
Sbjct: 120 AT-----FYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN-ML 170
Query: 242 GHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
           G    +    GT  Y AP+ +         D WSFGV+LYEML G+
Sbjct: 171 GDAK-TNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQWVA-EVQFLGVL 136
           D+  +  +GEG +G V     + A    T EA  V I  + R  D  + +  E+    +L
Sbjct: 7   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 61
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
            H N+VK  G+     E  IQ L + E+     L D +      P P   R    L A  
Sbjct: 62  NHENVVKFYGH---RREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-- 115
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 257 AAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 286
            AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQWVA-EVQFLGVL 136
           D+  +  +GEG +G V     + A    T EA  V I  + R  D  + +  E+    +L
Sbjct: 8   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAML 62
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP----PLPWKTRLHIIL 192
            H N+VK  G+     E  IQ L      L       LF+R  P    P P   R    L
Sbjct: 63  NHENVVKFYGH---RREGNIQYLF-----LEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
            A  G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + G
Sbjct: 115 MA--GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 253 TFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 286
           T  Y AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 104/239 (43%), Gaps = 12/239 (5%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEH 138
           N F +   +G+GGFG V    ++        +       K  +     + E Q L  +  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 198
             +V L    A   E      LV   M    L+ H+++      P       +  AAE  
Sbjct: 244 RFVVSL----AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---EARAVFYAAEIC 296
Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
             L +    +++YRD K  N+LLD++   ++SD GLA   P           VGT GY A
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRVGTVGYMA 353
Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE-WVQQYPAD-SKKF 315
           P+ ++    T   D W+ G +LYEM+ G+   ++ + K ++  +E  V++ P + S++F
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERF 412

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 101/229 (44%), Gaps = 27/229 (11%)
Query: 72  SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------- 124
           S+ + A  DF     +G+G FG+VY +  K +         ++A+K L +  L       
Sbjct: 5   SKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVEH 57
Query: 125 QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW 184
           Q   EV+    L HPN+++L GY   D  R     L+ E+    ++   L  +       
Sbjct: 58  QLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFDE 111
Query: 185 KTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT 244
           +     I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +
Sbjct: 112 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----S 164
Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
              T + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 165 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 213

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 99/210 (47%), Gaps = 24/210 (11%)
Query: 88  GEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQF---LGVLEHPNLVKL 144
           G+G FG+V         G   S    VAIKK+ +D      E+Q    L VL HPN+V+L
Sbjct: 32  GQGTFGTV-------QLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQL 84
Query: 145 IGYCAVDGE---RGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 198
             Y    GE   R I   +V E++   L+R   ++ + R   P P   ++  +      +
Sbjct: 85  QSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNY-YRRQVAPPPILIKV-FLFQLIRSI 142
Query: 199 AYLHEGLEVQVIYRDFKASNVLLDE-NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
             LH    V V +RD K  NVL++E +   KL DFG A++   +  +  + A + +  Y 
Sbjct: 143 GCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK---LSPSEPNVAYICSRYYR 198
Query: 258 APDYI-ETGHLTAKSDVWSFGVVLYEMLTG 286
           AP+ I    H T   D+WS G +  EM+ G
Sbjct: 199 APELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 98/224 (43%), Gaps = 27/224 (12%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAE 129
           A  DF     +G+G FG+VY +  K +         ++A+K L +  L       Q   E
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVEHQLRRE 59
Query: 130 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 189
           V+    L HPN+++L GY   D  R     L+ E+    ++   L  +       +    
Sbjct: 60  VEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFDEQRTAT 113
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
            I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    T +S  
Sbjct: 114 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS-- 168
Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
             GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 169 --GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 27/224 (12%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAE 129
           A  DF     +G+G FG+VY +  K +         ++A+K L +  L       Q   E
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVEHQLRRE 58
Query: 130 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 189
           V+    L HPN+++L GY   D  R     L+ E+    ++   L  +       +    
Sbjct: 59  VEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFDEQRTAT 112
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
            I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +   T 
Sbjct: 113 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTE 165
Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 27/224 (12%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAE 129
           A  DF     +G+G FG+VY +  K +         ++A+K L +  L       Q   E
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVEHQLRRE 57
Query: 130 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 189
           V+    L HPN+++L GY   D  R     L+ E+    ++   L  +       +    
Sbjct: 58  VEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFDEQRTAT 111
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
            I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +   T 
Sbjct: 112 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTT 164
Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 165 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 208

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 27/224 (12%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAE 129
           A  DF     +G+G FG+VY +  K +         ++A+K L +  L       Q   E
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVEHQLRRE 58
Query: 130 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 189
           V+    L HPN+++L GY   D  R     L+ E+    ++   L  +       +    
Sbjct: 59  VEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFDEQRTAT 112
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
            I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +   T 
Sbjct: 113 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTD 165
Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 27/224 (12%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAE 129
           A  DF     +G+G FG+VY +  K +         ++A+K L +  L       Q   E
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVEHQLRRE 61
Query: 130 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 189
           V+    L HPN+++L GY   D  R     L+ E+    ++   L  +       +    
Sbjct: 62  VEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFDEQRTAT 115
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
            I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +    A
Sbjct: 116 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAA 168
Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQWVA-EVQFLGVL 136
           D+  +  +GEG +G V     + A    T EA  V I  + R  D  + +  E+    +L
Sbjct: 7   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
            H N+VK  G+     E  IQ L + E+     L D +      P P   R    L A  
Sbjct: 62  NHENVVKFYGH---RREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-- 115
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 257 AAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 286
            AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQWVA-EVQFLGVL 136
           D+  +  +GEG +G V     + A    T EA  V I  + R  D  + +  E+    +L
Sbjct: 6   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 60
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
            H N+VK  G+     E  IQ L + E+     L D +      P P   R    L A  
Sbjct: 61  NHENVVKFYGH---RREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-- 114
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT  Y
Sbjct: 115 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171
Query: 257 AAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 286
            AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 202

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 129/299 (43%), Gaps = 46/299 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLN-------RDGLQWVAEVQFLGVL-E 137
           +G G FG V +++   A G G  +A + VA+K L        ++ L  ++E++ +  L +
Sbjct: 54  LGAGAFGKVVEAT---AFGLGKEDAVLKVAVKMLKSTAHADEKEAL--MSELKIMSHLGQ 108
Query: 138 HPNLVKLIGYCAVDGE-RGIQRLLVYEFMLN------RSLE-DHLFNRAFPPLPWKTRLH 189
           H N+V L+G C   G    I     Y  +LN      R LE D  F  A   L  +  LH
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLH 168
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
                A+G+A+L        I+RD  A NVLL      K+ DFGLAR+     +  V   
Sbjct: 169 FSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP 309
                 + AP+ I     T +SDVWS+G++L+E+     SL  N              YP
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN-------------PYP 268
Query: 310 A---DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
               +SK + L+ D     + +    + I  +   C +     RP   Q+   L++  Q
Sbjct: 269 GILVNSKFYKLVKDGYQMAQPAF-APKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQWVA-EVQFLGVL 136
           D+  +  +GEG +G V     + A    T EA  V I  + R  D  + +  E+    +L
Sbjct: 7   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
            H N+VK  G+     E  IQ L + E+     L D +      P P   R    L A  
Sbjct: 62  NHENVVKFYGH---RREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-- 115
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 257 AAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 286
            AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQWVA-EVQFLGVL 136
           D+  +  +GEG +G V     + A    T EA  V I  + R  D  + +  E+    +L
Sbjct: 8   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
            H N+VK  G+     E  IQ L + E+     L D +      P P   R    L A  
Sbjct: 63  NHENVVKFYGH---RREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-- 116
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT  Y
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 257 AAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 286
            AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 27/224 (12%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAE 129
           A  DF     +G+G FG+VY +  K +         ++A+K L +  L       Q   E
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVEHQLRRE 58
Query: 130 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 189
           V+    L HPN+++L GY   D  R     L+ E+    ++   L  +       +    
Sbjct: 59  VEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFDEQRTAT 112
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
            I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +   T 
Sbjct: 113 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTD 165
Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 27/224 (12%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAE 129
           A  DF     +G+G FG+VY +  K       +   ++A+K L +  L       Q   E
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREK-------NSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 130 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 189
           V+    L HPN+++L GY   D  R     L+ E+    ++   L  +       +    
Sbjct: 59  VEIQSHLRHPNILRLYGYFH-DSTRVY---LILEYAPLGTVYREL--QKLSKFDEQRTAT 112
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
            I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +    A
Sbjct: 113 YITELANALSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAA 165
Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQWVA-EVQFLGVL 136
           D+  +  +GEG +G V     + A    T EA  V I  + R  D  + +  E+    +L
Sbjct: 7   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 61
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
            H N+VK  G+     E  IQ L + E+     L D +      P P   R    L A  
Sbjct: 62  NHENVVKFYGH---RREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-- 115
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 257 AAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 286
            AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQWVA-EVQFLGVL 136
           D+  +  +GEG +G V     + A    T EA  V I  + R  D  + +  E+    +L
Sbjct: 7   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP----PLPWKTRLHIIL 192
            H N+VK  G+     E  IQ L      L       LF+R  P    P P   R    L
Sbjct: 62  NHENVVKFYGH---RREGNIQYLF-----LEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
            A  G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + G
Sbjct: 114 MA--GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 253 TFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 286
           T  Y AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 27/224 (12%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAE 129
           A  DF     +G+G FG+VY +  K +         ++A+K L +  L       Q   E
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVEHQLRRE 58
Query: 130 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 189
           V+    L HPN+++L GY   D  R     L+ E+    ++   L  +       +    
Sbjct: 59  VEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFDEQRTAT 112
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
            I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +   T 
Sbjct: 113 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTX 165
Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQWVA-EVQFLGVL 136
           D+  +  +GEG +G V     + A    T EA  V I  + R  D  + +  E+    +L
Sbjct: 7   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
            H N+VK  G+     E  IQ L + E+     L D +      P P   R    L A  
Sbjct: 62  NHENVVKFYGH---RREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-- 115
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 257 AAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 286
            AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 102/230 (44%), Gaps = 28/230 (12%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------ 124
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L      
Sbjct: 2   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 54
Query: 125 -QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 183
            Q   EV+    L HPN+++L GY   D  R     L+ E+    ++   L  +      
Sbjct: 55  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFD 108
Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
            +     I   A  L+Y H     +VI+RD K  N+LL      K+++FG +   P    
Sbjct: 109 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAP---- 161
Query: 244 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           +   T + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 162 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 211

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQWVA-EVQFLGVL 136
           D+  +  +GEG +G V     + A    T EA  V I  + R  D  + +  E+    +L
Sbjct: 7   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
            H N+VK  G+     E  IQ L + E+     L D +      P P   R    L A  
Sbjct: 62  NHENVVKFYGH---RREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-- 115
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 257 AAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 286
            AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQWVA-EVQFLGVL 136
           D+  +  +GEG +G V     + A    T EA  V I  + R  D  + +  E+    +L
Sbjct: 8   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
            H N+VK  G+     E  IQ L + E+     L D +      P P   R    L A  
Sbjct: 63  NHENVVKFYGH---RREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-- 116
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT  Y
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 257 AAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 286
            AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 97/224 (43%), Gaps = 27/224 (12%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAE 129
           A  DF     +G+G FG+VY +  K           ++A+K L +  L       Q   E
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREK-------QSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 130 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 189
           V+    L HPN+++L GY   D  R     L+ E+    ++   L  +       +    
Sbjct: 59  VEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFDEQRTAT 112
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
            I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +    A
Sbjct: 113 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAA 165
Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQWVA-EVQFLGVL 136
           D+  +  +GEG +G V     + A    T EA  V I  + R  D  + +  E+    +L
Sbjct: 8   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 62
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP----PLPWKTRLHIIL 192
            H N+VK  G+     E  IQ L      L       LF+R  P    P P   R    L
Sbjct: 63  NHENVVKFYGH---RREGNIQYLF-----LEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
            A  G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + G
Sbjct: 115 MA--GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXG 169
Query: 253 TFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 286
           T  Y AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/303 (23%), Positives = 135/303 (44%), Gaps = 65/303 (21%)
Query: 76  QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN------RDGLQWVAE 129
           Q+   + R+ KIGEG FG       K      T +     IK++N      ++  +   E
Sbjct: 21  QSMEKYVRLQKIGEGSFG-------KAILVKSTEDGRQYVIKEINISRMSSKEREESRRE 73
Query: 130 VQFLGVLEHPNLVK-------------LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN 176
           V  L  ++HPN+V+             ++ YC  +G    +R+   + +L +  ED +  
Sbjct: 74  VAVLANMKHPNIVQYRESFEENGSLYIVMDYC--EGGDLFKRINAQKGVLFQ--EDQI-- 127
Query: 177 RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 236
                L W  ++ +       L ++H+    ++++RD K+ N+ L ++   +L DFG+AR
Sbjct: 128 -----LDWFVQICL------ALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIAR 173
Query: 237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK 296
              +     ++ A +GT  Y +P+  E      KSD+W+ G VLYE+ T + + E    K
Sbjct: 174 --VLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK 231
Query: 297 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 356
               +L+ +      S  F     P +   YS +    +  L      ++ +DRP ++ +
Sbjct: 232 N--LVLKII------SGSF-----PPVSLHYSYD----LRSLVSQLFKRNPRDRPSVNSI 274
Query: 357 VER 359
           +E+
Sbjct: 275 LEK 277

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 113/235 (48%), Gaps = 26/235 (11%)
Query: 83  RMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAI---KKLNRDGLQ-WVAEVQFLGVLE 137
           R+LK IG+G F  V     K A    T     + I    +LN   LQ    EV+ + +L 
Sbjct: 18  RLLKTIGKGNFAKV-----KLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN 72
Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAE 196
           HPN+VKL  +  ++ E+ +   L+ E+     + D+L           +++   I+ A +
Sbjct: 73  HPNIVKL--FEVIETEKTL--YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ 128
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
              Y H+    ++++RD KA N+LLD +   K++DFG + E  + G      A  G   Y
Sbjct: 129 ---YCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DAFCGAPPY 179
Query: 257 AAPDYIETGHLTA-KSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYP 309
           AAP+  +       + DVWS GV+LY +++G    + +N  +  +R+L    + P
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP 234

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 97/224 (43%), Gaps = 27/224 (12%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAE 129
           A  DF     +G+G FG+VY +  K           ++A+K L +  L       Q   E
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREK-------QRKFILALKVLFKAQLEKAGVEHQLRRE 55
Query: 130 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 189
           V+    L HPN+++L GY   D  R     L+ E+    ++   L  +       +    
Sbjct: 56  VEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFDEQRTAT 109
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
            I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +   T 
Sbjct: 110 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTT 162
Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 163 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 206

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQWVA-EVQFLGVL 136
           D+  +  +GEG +G V     + A    T EA  V I  + R  D  + +  E+    +L
Sbjct: 8   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP----PLPWKTRLHIIL 192
            H N+VK  G+     E  IQ L      L       LF+R  P    P P   R    L
Sbjct: 63  NHENVVKFYGH---RREGNIQYLF-----LEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
            A  G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + G
Sbjct: 115 MA--GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 253 TFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 286
           T  Y AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQWVA-EVQFLGVL 136
           D+  +  +GEG +G V     + A    T EA  V I  + R  D  + +  E+    +L
Sbjct: 8   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
            H N+VK  G+     E  IQ L + E+     L D +      P P   R    L A  
Sbjct: 63  NHENVVKFYGH---RREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-- 116
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT  Y
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 257 AAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 286
            AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQWVA-EVQFLGVL 136
           D+  +  +GEG +G V     + A    T EA  V I  + R  D  + +  E+    +L
Sbjct: 8   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
            H N+VK  G+     E  IQ L + E+     L D +      P P   R    L A  
Sbjct: 63  NHENVVKFYGH---RREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-- 116
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT  Y
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 257 AAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 286
            AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQWVA-EVQFLGVL 136
           D+  +  +GEG +G V     + A    T EA  V I  + R  D  + +  E+    +L
Sbjct: 7   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP----PLPWKTRLHIIL 192
            H N+VK  G+     E  IQ L      L       LF+R  P    P P   R    L
Sbjct: 62  NHENVVKFYGH---RREGNIQYLF-----LEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
            A  G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + G
Sbjct: 114 MA--GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 253 TFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 286
           T  Y AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQWVA-EVQFLGVL 136
           D+  +  +GEG +G V     + A    T EA  V I  + R  D  + +  E+    +L
Sbjct: 8   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
            H N+VK  G+     E  IQ L + E+     L D +      P P   R    L A  
Sbjct: 63  NHENVVKFYGH---RREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-- 116
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT  Y
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 257 AAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 286
            AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQWVA-EVQFLGVL 136
           D+  +  +GEG +G V     + A    T EA  V I  + R  D  + +  E+    +L
Sbjct: 7   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
            H N+VK  G+     E  IQ L + E+     L D +      P P   R    L A  
Sbjct: 62  NHENVVKFYGH---RREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-- 115
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 257 AAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 286
            AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 126/294 (42%), Gaps = 37/294 (12%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFL 133
           +D+     IG G    V  +   P       +   VAIK++N +  Q      + E+Q +
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAP-------KKEKVAIKRINLEKCQTSMDELLKEIQAM 67
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED---HLFNRA---FPPLPWKTR 187
               HPN+V       V  E      LV + +   S+ D   H+  +       L   T 
Sbjct: 68  SQCHHPNIVSYYTSFVVKDEL----WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123
Query: 188 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA---REGPMVGHT 244
             I+    EGL YLH+  +   I+RD KA N+LL E+   +++DFG++     G  +   
Sbjct: 124 ATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 180
Query: 245 HVSTAVVGTFGYAAPDYIETGH-LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE 303
            V    VGT  + AP+ +E       K+D+WSFG+   E+ TG     +  P    ++L 
Sbjct: 181 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP---MKVLM 237
Query: 304 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 357
              Q    S + G + D  + K+Y     +   ++   CL K  + RP  ++++
Sbjct: 238 LTLQNDPPSLETG-VQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 107/251 (42%), Gaps = 29/251 (11%)
Query: 50  TSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTS 109
           ++P   PE  EE A   +     + + A  DF     +G+G FG+VY +  K        
Sbjct: 7   SAPENNPE--EELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREK-------Q 57
Query: 110 EATVVAIKKLNRDGL-------QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVY 162
              ++A+K L +  L       Q   EV+    L HPN+++L GY   D  R     L+ 
Sbjct: 58  SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LIL 113
Query: 163 EFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD 222
           E+    ++   L  +       +     I   A  L+Y H     +VI+RD K  N+LL 
Sbjct: 114 EYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLG 168
Query: 223 ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYE 282
                K++DFG +   P    +     + GT  Y  P+ IE      K D+WS GV+ YE
Sbjct: 169 SAGELKIADFGWSVHAP----SSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYE 224
Query: 283 MLTGRRSLERN 293
            L G+   E N
Sbjct: 225 FLVGKPPFEAN 235

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 101/230 (43%), Gaps = 28/230 (12%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------ 124
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L      
Sbjct: 2   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 54
Query: 125 -QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 183
            Q   EV+    L HPN+++L GY   D  R     L+ E+    ++   L  +      
Sbjct: 55  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFD 108
Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
            +     I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    
Sbjct: 109 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 161
Query: 244 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           +     + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 162 SSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 211

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 100/230 (43%), Gaps = 28/230 (12%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------ 124
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L      
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 57
Query: 125 -QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 183
            Q   EV+    L HPN+++L GY   D  R     L+ E+     +   L  +      
Sbjct: 58  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPRGEVYKEL--QKLSKFD 111
Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
            +     I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    
Sbjct: 112 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 164
Query: 244 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           +     + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 165 SSRRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNL 141
           ++G+G FGSV      P  GD T    +VA+K+L   G      +  E+Q L  L    +
Sbjct: 14  QLGKGNFGSVELCRYDPL-GDNT--GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 70
Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY- 200
           VK  G     G   ++  LV E++ +  L D L            R    L A+  L Y 
Sbjct: 71  VKYRGVSYGPGRPELR--LVMEYLPSGCLRDFL-----------QRHRARLDASRLLLYS 117
Query: 201 --LHEGLEV----QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV--STAVVG 252
             + +G+E     + ++RD  A N+L++     K++DFGLA+  P+     V        
Sbjct: 118 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSP 177
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            F YA P+ +     + +SDVWSFGVVLYE+ T
Sbjct: 178 IFWYA-PESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQWVA-EVQFLGVL 136
           D+  +  +GEG +G V     + A    T EA  V I  + R  D  + +  E+    +L
Sbjct: 7   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
            H N+VK  G+     E  IQ L + E+     L D +      P P   R    L A  
Sbjct: 62  NHENVVKFYGH---RREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-- 115
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 257 AAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 286
            AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 101/230 (43%), Gaps = 28/230 (12%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------ 124
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L      
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 53
Query: 125 -QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 183
            Q   EV+    L HPN+++L GY   D  R     L+ E+    ++   L  +      
Sbjct: 54  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFD 107
Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
            +     I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    
Sbjct: 108 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 160
Query: 244 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           +     + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 161 SSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQWVA-EVQFLGVL 136
           D+  +  +GEG +G V     + A    T EA  V I  + R  D  + +  E+    +L
Sbjct: 7   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP----PLPWKTRLHIIL 192
            H N+VK  G+     E  IQ L      L       LF+R  P    P P   R    L
Sbjct: 62  NHENVVKFYGH---RREGNIQYLF-----LEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
            A  G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + G
Sbjct: 114 MA--GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXG 168
Query: 253 TFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 286
           T  Y AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 102/230 (44%), Gaps = 28/230 (12%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------ 124
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L      
Sbjct: 3   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 55
Query: 125 -QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 183
            Q   EV+    L HPN+++L GY   D  R     L+ E+    ++   L  +      
Sbjct: 56  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFD 109
Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
            +     I   A  L+Y H     +VI+RD K  N+LL      K+++FG +   P    
Sbjct: 110 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAP---- 162
Query: 244 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           +   T + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 163 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 126/294 (42%), Gaps = 37/294 (12%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFL 133
           +D+     IG G    V  +   P       +   VAIK++N +  Q      + E+Q +
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAP-------KKEKVAIKRINLEKCQTSMDELLKEIQAM 62
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED---HLFNRA---FPPLPWKTR 187
               HPN+V       V  E      LV + +   S+ D   H+  +       L   T 
Sbjct: 63  SQCHHPNIVSYYTSFVVKDEL----WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 118
Query: 188 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA---REGPMVGHT 244
             I+    EGL YLH+  +   I+RD KA N+LL E+   +++DFG++     G  +   
Sbjct: 119 ATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 175
Query: 245 HVSTAVVGTFGYAAPDYIETGH-LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE 303
            V    VGT  + AP+ +E       K+D+WSFG+   E+ TG     +  P    ++L 
Sbjct: 176 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP---MKVLM 232
Query: 304 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 357
              Q    S + G + D  + K+Y     +   ++   CL K  + RP  ++++
Sbjct: 233 LTLQNDPPSLETG-VQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 108/215 (50%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 68
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 69  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 123
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              AEG+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 124 ---AEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 177
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 178 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 120/255 (47%), Gaps = 35/255 (13%)
Query: 83  RMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAI---KKLNRDGLQ-WVAEVQFLGVLE 137
           R+LK IG+G F  V     K A    T +   V I    +LN   LQ    EV+ + VL 
Sbjct: 17  RLLKTIGKGNFAKV-----KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLN 71
Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAE 196
           HPN+VKL  +  ++ E+ +   LV E+     + D+L           + +   I+ A +
Sbjct: 72  HPNIVKL--FEVIETEKTL--YLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
              Y H+     +++RD KA N+LLD +   K++DFG + E       +   A  G   Y
Sbjct: 128 ---YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNE---FTFGNKLDAFCGAPPY 178
Query: 257 AAPDYIETGHLTA-KSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYP----A 310
           AAP+  +       + DVWS GV+LY +++G    + +N  +  +R+L    + P     
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 238
Query: 311 DS----KKFGLIMDP 321
           D     KKF LI++P
Sbjct: 239 DCENLLKKF-LILNP 252

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 123/291 (42%), Gaps = 40/291 (13%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLE-- 137
           D   + +IG G +GSV K   KP+         ++A+K++ R  +    + Q L  L+  
Sbjct: 23  DLKDLGEIGRGAYGSVNKMVHKPSG-------QIMAVKRI-RSTVDEKEQKQLLMDLDVV 74
Query: 138 -----HPNLVKLIGYCAVDGERGI-QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 191
                 P +V+  G    +G+  I   L+   F        ++++     +P +    I 
Sbjct: 75  MRSSDCPYIVQFYGALFREGDCWICMELMSTSF---DKFYKYVYSVLDDVIPEEILGKIT 131
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 251
           L   + L +L E L  ++I+RD K SN+LLD +   KL DFG++  G +V      T   
Sbjct: 132 LATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGIS--GQLVDSI-AKTRDA 186
Query: 252 GTFGYAAPDYIETGH----LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 307
           G   Y AP+ I+          +SDVWS G+ LYE+ TGR       PK      +  Q 
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY----PKWNSVFDQLTQV 242
Query: 308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
              D         P+L        +       + CL+K    RPK  ++++
Sbjct: 243 VKGDP--------PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 113/235 (48%), Gaps = 26/235 (11%)
Query: 83  RMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAI---KKLNRDGLQ-WVAEVQFLGVLE 137
           R+LK IG+G F  V     K A    T     + I    +LN   LQ    EV+ + +L 
Sbjct: 15  RLLKTIGKGNFAKV-----KLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN 69
Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAE 196
           HPN+VKL  +  ++ E+ +   L+ E+     + D+L           +++   I+ A +
Sbjct: 70  HPNIVKL--FEVIETEKTL--YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ 125
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
              Y H+    ++++RD KA N+LLD +   K++DFG + E  + G         G+  Y
Sbjct: 126 ---YCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DTFCGSPPY 176
Query: 257 AAPDYIETGHLTA-KSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYP 309
           AAP+  +       + DVWS GV+LY +++G    + +N  +  +R+L    + P
Sbjct: 177 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP 231

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 99/225 (44%), Gaps = 28/225 (12%)
Query: 75  RQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QW 126
           RQ T  DF     +G+G FG+VY +  + +         ++A+K L +  L       Q 
Sbjct: 7   RQWTLEDFDIGRPLGKGKFGNVYLARERQSK-------FILALKVLFKTQLEKAGVEHQL 59
Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKT 186
             EV+    L HPN+++L GY   D  R +  +L Y  +     E    +R       + 
Sbjct: 60  RREVEIQSHLRHPNILRLYGYFH-DATR-VYLILEYAPLGTVYRELQKLSR----FDEQR 113
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
               I   A  L+Y H     +VI+RD K  N+LL  N   K++DFG +   P    +  
Sbjct: 114 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAP----SSR 166
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 291
            T + GT  Y  P+ IE      K D+WS GV+ YE L G    E
Sbjct: 167 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 101/230 (43%), Gaps = 28/230 (12%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------ 124
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L      
Sbjct: 3   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 55
Query: 125 -QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 183
            Q   EV+    L HPN+++L GY   D  R     L+ E+    ++   L  +      
Sbjct: 56  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFD 109
Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
            +     I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    
Sbjct: 110 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 162
Query: 244 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           +     + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 163 SSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 134/281 (47%), Gaps = 38/281 (13%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEH 138
            DF  +  +G GGFG V+++  K    +   +   +  ++L R+ +  + EV+ L  LEH
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKV--MREVKALAKLEH 62
Query: 139 PNLVKLI-GYCAVDGERGIQ----RLLVY-EFMLNR--SLEDHLFNRAFPPLPWKTR--- 187
           P +V+    +   +    +Q    ++ +Y +  L R  +L+D +  R    +  + R   
Sbjct: 63  PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC--TIEERERSVC 120
Query: 188 LHIILGAAEGLAYLH-EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--------- 237
           LHI L  AE + +LH +GL    ++RD K SN+    +   K+ DFGL            
Sbjct: 121 LHIFLQIAEAVEFLHSKGL----MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 238 --GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRS-LERNR 294
              PM  +    T  VGT  Y +P+ I     + K D++S G++L+E+L    + +ER R
Sbjct: 177 VLTPMPAYAR-HTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVR 235
Query: 295 PKTEQRLLE----WVQQYPADSKKFGLIMDPR-LEKEYSIN 330
             T+ R L+    + Q+YP +      ++ P  +E+  +IN
Sbjct: 236 TLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAIN 276

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 103/245 (42%), Gaps = 26/245 (10%)
Query: 54  GIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATV 113
           GI E  E++A N R    +       DF  +  IG G +  V    +K    D      V
Sbjct: 29  GIEE--EKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKT--DRIYAMRV 84
Query: 114 VAIKKLNRD-GLQWVAEVQ--FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL 170
           V  + +N D  + WV   +  F     HP LV L      +     +   V E++    L
Sbjct: 85  VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES----RLFFVIEYVNGGDL 140
Query: 171 EDHL-FNRAFPPLPWKTRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFR 226
             H+   R  P        H    +AE    L YLHE     +IYRD K  NVLLD    
Sbjct: 141 MFHMQRQRKLP------EEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGH 191
Query: 227 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            KL+D+G+ +EG   G T  ++   GT  Y AP+ +         D W+ GV+++EM+ G
Sbjct: 192 IKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 249
Query: 287 RRSLE 291
           R   +
Sbjct: 250 RSPFD 254

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 122/283 (43%), Gaps = 41/283 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           F+++ +IG+G FG VYK       G       VVAIK ++ +  +        E+  L  
Sbjct: 21  FTKLDRIGKGSFGEVYK-------GIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ 73
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
            + P + +  G       +  +  ++ E++   S  D L           T L  IL   
Sbjct: 74  CDSPYITRYFGSYL----KSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL--- 126
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
           +GL YLH     + I+RD KA+NVLL E    KL+DFG+A  G +          VGT  
Sbjct: 127 KGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNXFVGTPF 181
Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF 315
           + AP+ I+      K+D+WS G+   E+  G        P ++   +  +   P +S   
Sbjct: 182 WMAPEVIKQSAYDFKADIWSLGITAIELAKG------EPPNSDLHPMRVLFLIPKNSP-- 233
Query: 316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
                P LE ++S    +      + CL+K  + RP   ++++
Sbjct: 234 -----PTLEGQHS----KPFKEFVEACLNKDPRFRPTAKELLK 267

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 100/239 (41%), Gaps = 24/239 (10%)
Query: 60  EEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL 119
           E++A N R    +       DF  +  IG G +  V    +K    D      VV  + +
Sbjct: 1   EKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKT--DRIYAMKVVKKELV 58
Query: 120 NRD-GLQWVAEVQ--FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-F 175
           N D  + WV   +  F     HP LV L      +     +   V E++    L  H+  
Sbjct: 59  NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES----RLFFVIEYVNGGDLMFHMQR 114
Query: 176 NRAFPPLPWKTRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF 232
            R  P        H    +AE    L YLHE     +IYRD K  NVLLD     KL+D+
Sbjct: 115 QRKLP------EEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDY 165
Query: 233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 291
           G+ +EG   G T  ++   GT  Y AP+ +         D W+ GV+++EM+ GR   +
Sbjct: 166 GMCKEGLRPGDT--TSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 81
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 82  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 136
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 137 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 190
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 191 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQWVA-EVQFLGVL 136
           D+  +  +GEG  G V     + A    T EA  V I  + R  D  + +  E+    +L
Sbjct: 7   DWDLVQTLGEGAAGEV-----QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
            H N+VK  G+     E  IQ L + E+     L D +      P P   R    L A  
Sbjct: 62  NHENVVKFYGH---RREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-- 115
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 257 AAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 286
            AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 128/299 (42%), Gaps = 46/299 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLN-------RDGLQWVAEVQFLGVL-E 137
           +G G FG V +++   A G G  +A + VA+K L        ++ L  ++E++ +  L +
Sbjct: 54  LGAGAFGKVVEAT---AFGLGKEDAVLKVAVKMLKSTAHADEKEAL--MSELKIMSHLGQ 108
Query: 138 HPNLVKLIGYCAVDGE-RGIQRLLVYEFMLN------RSLE-DHLFNRAFPPLPWKTRLH 189
           H N+V L+G C   G    I     Y  +LN      R LE D  F  A      +  LH
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
                A+G+A+L        I+RD  A NVLL      K+ DFGLAR+     +  V   
Sbjct: 169 FSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP 309
                 + AP+ I     T +SDVWS+G++L+E+     SL  N              YP
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN-------------PYP 268
Query: 310 A---DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
               +SK + L+ D     + +    + I  +   C +     RP   Q+   L++  Q
Sbjct: 269 GILVNSKFYKLVKDGYQMAQPAF-APKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 37/217 (17%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR----DGLQWVAEVQFLGVLEHPNLV 142
           +G+G FG   K + +           V+ +K+L R        ++ EV+ +  LEHPN++
Sbjct: 18  LGKGCFGQAIKVTHR-------ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVL 70
Query: 143 KLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 201
           K IG    D     +RL  + E++   +L   +        PW  R+      A G+AYL
Sbjct: 71  KFIGVLYKD-----KRLNFITEYIKGGTLRG-IIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 202 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA------------ 249
           H    + +I+RD  + N L+ EN    ++DFGLAR   MV                    
Sbjct: 125 HS---MNIIHRDLNSHNCLVRENKNVVVADFGLARL--MVDEKTQPEGLRSLKKPDRKKR 179
Query: 250 --VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
             VVG   + AP+ I       K DV+SFG+VL E++
Sbjct: 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 126
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 127 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 181 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 126
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 127 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 181 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH   E  V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y
Sbjct: 263 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEY 318
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 319 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 77
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 78  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 132
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 133 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 186
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 187 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH   E  V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y
Sbjct: 260 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEY 315
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 72
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 73  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 127
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 128 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 181
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 182 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 72
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 73  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYL--LNWCVQI--- 127
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 128 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 181
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 182 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 75
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 76  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 130
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 131 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 184
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 185 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 126
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 127 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 181 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 129
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 130 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 184 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 129
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 130 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 184 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 128
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 129 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 182
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 183 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYL--LNWCVQI--- 126
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 127 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 181 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 120/255 (47%), Gaps = 35/255 (13%)
Query: 83  RMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAI---KKLNRDGLQ-WVAEVQFLGVLE 137
           R+LK IG+G F  V     K A    T +   V I    +LN   LQ    EV+ + VL 
Sbjct: 17  RLLKTIGKGNFAKV-----KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLN 71
Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAE 196
           HPN+VKL  +  ++ E+ +   LV E+     + D+L           + +   I+ A +
Sbjct: 72  HPNIVKL--FEVIETEKTL--YLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
              Y H+     +++RD KA N+LLD +   K++DFG + E       +      G+  Y
Sbjct: 128 ---YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNE---FTFGNKLDTFCGSPPY 178
Query: 257 AAPDYIETGHLTA-KSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYP----A 310
           AAP+  +       + DVWS GV+LY +++G    + +N  +  +R+L    + P     
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 238
Query: 311 DS----KKFGLIMDP 321
           D     KKF LI++P
Sbjct: 239 DCENLLKKF-LILNP 252

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 128
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 129 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 182
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 183 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 97/224 (43%), Gaps = 27/224 (12%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAE 129
           A  DF     +G+G FG+VY +  K +         ++A+K L +  L       Q   E
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVEHQLRRE 58
Query: 130 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 189
           V+    L HPN+++L GY   D  R     L+ E+    ++   L  +       +    
Sbjct: 59  VEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFDEQRTAT 112
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
            I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +     
Sbjct: 113 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRXX 165
Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 120/255 (47%), Gaps = 35/255 (13%)
Query: 83  RMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAI---KKLNRDGLQ-WVAEVQFLGVLE 137
           R+LK IG+G F  V     K A    T +   V I    +LN   LQ    EV+ + VL 
Sbjct: 17  RLLKTIGKGNFAKV-----KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLN 71
Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAE 196
           HPN+VKL  +  ++ E+ +   LV E+     + D+L           + +   I+ A +
Sbjct: 72  HPNIVKL--FEVIETEKTL--YLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
              Y H+     +++RD KA N+LLD +   K++DFG + E       +      G+  Y
Sbjct: 128 ---YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNE---FTFGNKLDTFCGSPPY 178
Query: 257 AAPDYIETGHLTA-KSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYP----A 310
           AAP+  +       + DVWS GV+LY +++G    + +N  +  +R+L    + P     
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 238
Query: 311 DS----KKFGLIMDP 321
           D     KKF LI++P
Sbjct: 239 DCENLLKKF-LILNP 252

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 66  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 120
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 121 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 175 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 129
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 130 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 184 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 133
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 134 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 188 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 129
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 130 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 184 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 96
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 97  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 151
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 152 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 205
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 206 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 120/255 (47%), Gaps = 35/255 (13%)
Query: 83  RMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAI---KKLNRDGLQ-WVAEVQFLGVLE 137
           R+LK IG+G F  V     K A    T +   V I    +LN   LQ    EV+ + VL 
Sbjct: 17  RLLKTIGKGNFAKV-----KLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLN 71
Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAE 196
           HPN+VKL  +  ++ E+ +   LV E+     + D+L           + +   I+ A +
Sbjct: 72  HPNIVKL--FEVIETEKTL--YLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
              Y H+     +++RD KA N+LLD +   K++DFG + E       +      G+  Y
Sbjct: 128 ---YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNE---FTFGNKLDTFCGSPPY 178
Query: 257 AAPDYIETGHLTA-KSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYP----A 310
           AAP+  +       + DVWS GV+LY +++G    + +N  +  +R+L    + P     
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 238
Query: 311 DS----KKFGLIMDP 321
           D     KKF LI++P
Sbjct: 239 DCENLLKKF-LILNP 252

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL------NRDGLQ-WVAEVQFLGVLEH 138
           K+G GG  +VY         + T     VAIK +        + L+ +  EV     L H
Sbjct: 18  KLGGGGMSTVY-------LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 198
            N+V +I    VD E      LV E++   +L +++   +  PL   T ++      +G+
Sbjct: 71  QNIVSMID---VDEEDDC-YYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGI 124
Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
            + H+   +++++RD K  N+L+D N   K+ DFG+A+       T  +  V+GT  Y +
Sbjct: 125 KHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFS 180
Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           P+  +       +D++S G+VLYEML G
Sbjct: 181 PEQAKGEATDECTDIYSIGIVLYEMLVG 208

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-----DGLQWVAEVQFLGVLEHP 139
           +++G G FGSV +   +        +   VAIK L +     D  + + E Q +  L++P
Sbjct: 16  IELGCGNFGSVRQGVYRM-----RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 70
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
            +V+LIG C  +       +LV E      L   L  +    +P      ++   + G+ 
Sbjct: 71  YIVRLIGVCQAEA-----LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMK 124
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAVVGTFGYAA 258
           YL E      ++RD  A NVLL      K+SDFGL++  G    +    +A      + A
Sbjct: 125 YLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 181
Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLT 285
           P+ I     +++SDVWS+GV ++E L+
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 32/211 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQFLGVLEHP 139
           +GEG FG V            T+    VA+K +N+  L       +   E+ +L +L HP
Sbjct: 21  LGEGSFGKV-------KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-AFPPLPWKTRLHIILGAAEGL 198
           +++KL  Y  +  +  I  ++V E+  N  L D++  R        +     I+ A E  
Sbjct: 74  HIIKL--YDVIKSKDEI--IMVIEYAGNE-LFDYIVQRDKMSEQEARRFFQQIISAVE-- 126
Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
            Y H     ++++RD K  N+LLDE+   K++DFGL+    M     + T+  G+  YAA
Sbjct: 127 -YCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLS--NIMTDGNFLKTS-CGSPNYAA 179
Query: 259 PDYIETGHLTA--KSDVWSFGVVLYEMLTGR 287
           P+ I +G L A  + DVWS GV+LY ML  R
Sbjct: 180 PEVI-SGKLYAGPEVDVWSCGVILYVMLCRR 209

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 32/211 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQFLGVLEHP 139
           +GEG FG V            T+    VA+K +N+  L       +   E+ +L +L HP
Sbjct: 22  LGEGSFGKV-------KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-AFPPLPWKTRLHIILGAAEGL 198
           +++KL  Y  +  +  I  ++V E+  N  L D++  R        +     I+ A E  
Sbjct: 75  HIIKL--YDVIKSKDEI--IMVIEYAGNE-LFDYIVQRDKMSEQEARRFFQQIISAVE-- 127
Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
            Y H     ++++RD K  N+LLDE+   K++DFGL+    M     + T+  G+  YAA
Sbjct: 128 -YCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLS--NIMTDGNFLKTS-CGSPNYAA 180
Query: 259 PDYIETGHLTA--KSDVWSFGVVLYEMLTGR 287
           P+ I +G L A  + DVWS GV+LY ML  R
Sbjct: 181 PEVI-SGKLYAGPEVDVWSCGVILYVMLCRR 210

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHP 139
           D + + ++G G FG V     K     G  +  +  IK+ +    +++ E + +  L H 
Sbjct: 5   DLTFLKELGTGQFGVV-----KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE 59
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEG 197
            LV+L G C    +R I   ++ E+M N  L ++L      F     +  L +     E 
Sbjct: 60  KLVQLYGVCT--KQRPI--FIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEA 112
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG-- 255
           + YL      Q ++RD  A N L+++    K+SDFGL+R    V     +++V   F   
Sbjct: 113 MEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSKFPVR 166
Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLER 292
           ++ P+ +     ++KSD+W+FGV+++E+ + G+   ER
Sbjct: 167 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 204

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 30/210 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-------EVQFLGVLEHP 139
           +GEG FG V     K A    T +   VA+K ++R  L+          E+ +L +L HP
Sbjct: 17  LGEGSFGKV-----KLATHYKTQQK--VALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           +++KL  Y  +     I  ++V E+      +  +  +       +     I+ A E   
Sbjct: 70  HIIKL--YDVITTPTDI--VMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE--- 122
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 259
           Y H     ++++RD K  N+LLD+N   K++DFGL+    M     + T+  G+  YAAP
Sbjct: 123 YCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLS--NIMTDGNFLKTS-CGSPNYAAP 176
Query: 260 DYIETGHLTA--KSDVWSFGVVLYEMLTGR 287
           + I  G L A  + DVWS G+VLY ML GR
Sbjct: 177 EVI-NGKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 110/228 (48%), Gaps = 26/228 (11%)
Query: 83  RMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAI---KKLNRDGLQ-WVAEVQFLGVLE 137
           R+LK IG+G F  V     K A    T +   V I    +LN   LQ    EV+ + VL 
Sbjct: 10  RLLKTIGKGNFAKV-----KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLN 64
Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAF-PPLPWKTRLHIILGAAE 196
           HPN+VKL  +  ++ E+ +   LV E+     + D+L    +      + +   I+ A +
Sbjct: 65  HPNIVKL--FEVIETEKTLY--LVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQ 120
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
              Y H+     +++RD KA N+LLD +   K++DFG + E       +      G+  Y
Sbjct: 121 ---YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNE---FTFGNKLDTFCGSPPY 171
Query: 257 AAPDYIETGHLTA-KSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLL 302
           AAP+  +       + DVWS GV+LY +++G    + +N  +  +R+L
Sbjct: 172 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL 219

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHP 139
           D + + ++G G FG V     K     G  +  +  IK+ +    +++ E + +  L H 
Sbjct: 9   DLTFLKELGTGQFGVV-----KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE 63
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEG 197
            LV+L G C    +R I   ++ E+M N  L ++L      F     +  L +     E 
Sbjct: 64  KLVQLYGVCT--KQRPI--FIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEA 116
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG-- 255
           + YL      Q ++RD  A N L+++    K+SDFGL+R    V     +++V   F   
Sbjct: 117 MEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSKFPVR 170
Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLER 292
           ++ P+ +     ++KSD+W+FGV+++E+ + G+   ER
Sbjct: 171 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 208

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH   E  V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y
Sbjct: 121 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEY 176
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 32/211 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQFLGVLEHP 139
           +GEG FG V            T+    VA+K +N+  L       +   E+ +L +L HP
Sbjct: 12  LGEGSFGKV-------KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-AFPPLPWKTRLHIILGAAEGL 198
           +++KL  Y  +  +  I  ++V E+  N  L D++  R        +     I+ A E  
Sbjct: 65  HIIKL--YDVIKSKDEI--IMVIEYAGNE-LFDYIVQRDKMSEQEARRFFQQIISAVE-- 117
Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
            Y H     ++++RD K  N+LLDE+   K++DFGL+    M     + T+  G+  YAA
Sbjct: 118 -YCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLS--NIMTDGNFLKTS-CGSPNYAA 170
Query: 259 PDYIETGHLTA--KSDVWSFGVVLYEMLTGR 287
           P+ I +G L A  + DVWS GV+LY ML  R
Sbjct: 171 PEVI-SGKLYAGPEVDVWSCGVILYVMLCRR 200

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH   E  V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y
Sbjct: 122 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEY 177
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 178 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH   E  V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y
Sbjct: 120 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEY 175
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 176 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWVAEVQFLGVLEHPNLVKL 144
           ++G+G F SV +  +K  AG   + A ++  KKL+ RD  +   E +   +L+HPN+V+L
Sbjct: 29  ELGKGAF-SVVRRCVKVLAGQEYA-AKIINTKKLSARDHQKLEREARICRLLKHPNIVRL 86
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
               + +G       L+++ +    L + +  R +         H I    E + + H+ 
Sbjct: 87  HDSISEEG----HHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQ- 139
Query: 205 LEVQVIYRDFKASNVLLDENFRP---KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 261
             + V++RD K  N+LL    +    KL+DFGLA E  + G         GT GY +P+ 
Sbjct: 140 --MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAWFGFAGTPGYLSPEV 195
Query: 262 IETGHLTAKSDVWSFGVVLYEMLTG 286
           +         D+W+ GV+LY +L G
Sbjct: 196 LRKDPYGKPVDLWACGVILYILLVG 220

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 96/224 (42%), Gaps = 27/224 (12%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAE 129
           A  DF     +G+G FG+VY +  K           ++A+K L +  L       Q   E
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREK-------QSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 130 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 189
           V+    L HPN+++L GY   D  R     L+ E+    ++   L  +       +    
Sbjct: 62  VEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFDEQRTAT 115
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
            I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +     
Sbjct: 116 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRDD 168
Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 120/255 (47%), Gaps = 35/255 (13%)
Query: 83  RMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAI---KKLNRDGLQ-WVAEVQFLGVLE 137
           R+LK IG+G F  V     K A    T +   V I    +LN   LQ    EV+ + VL 
Sbjct: 17  RLLKTIGKGNFAKV-----KLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLN 71
Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAE 196
           HPN+VKL  +  ++ E+ +   LV E+     + D+L           + +   I+ A +
Sbjct: 72  HPNIVKL--FEVIETEKTL--YLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
              Y H+     +++RD KA N+LLD +   K++DFG + E       +      G+  Y
Sbjct: 128 ---YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNE---FTFGNKLDEFCGSPPY 178
Query: 257 AAPDYIETGHLTA-KSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYP----A 310
           AAP+  +       + DVWS GV+LY +++G    + +N  +  +R+L    + P     
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 238
Query: 311 DS----KKFGLIMDP 321
           D     KKF LI++P
Sbjct: 239 DCENLLKKF-LILNP 252

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 106/233 (45%), Gaps = 38/233 (16%)
Query: 72  SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWVAEV 130
           S  R    D + +  +G+G +G V++         G+ +   VA+K  + RD   W  E 
Sbjct: 1   SMQRTVARDITLLECVGKGRYGEVWR---------GSWQGENVAVKIFSSRDEKSWFRET 51
Query: 131 QFLG--VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           +     +L H N++  I           Q  L+  +    SL D+L       L   + L
Sbjct: 52  ELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCL 108
Query: 189 HIILGAAEGLAYLH-EGLEVQ----VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
            I+L  A GLA+LH E    Q    + +RD K+ N+L+ +N +  ++D GLA     V H
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-----VMH 163
Query: 244 THVSTAV-------VGTFGYAAPDYI-ETGHLTA-----KSDVWSFGVVLYEM 283
           +  +  +       VGT  Y AP+ + ET  +       + D+W+FG+VL+E+
Sbjct: 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 112/250 (44%), Gaps = 32/250 (12%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLG 134
           DF  +L  G G F  V  +  K           +VAIK + ++ L+        E+  L 
Sbjct: 21  DFRDVL--GTGAFSEVILAEDK-------RTQKLVAIKCIAKEALEGKEGSMENEIAVLH 71
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 194
            ++HPN+V L        E G    L+ + +    L D +  + F      +RL  I   
Sbjct: 72  KIKHPNIVALDDIY----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--IFQV 125
Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVL---LDENFRPKLSDFGLAREGPMVGHTHVSTAVV 251
            + + YLH+   + +++RD K  N+L   LDE+ +  +SDFGL++   M     V +   
Sbjct: 126 LDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTAC 179
Query: 252 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL-ERNRPKTEQRLLEWVQQYPA 310
           GT GY AP+ +     +   D WS GV+ Y +L G     + N  K  +++L+   +Y  
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK--AEYEF 237
Query: 311 DSKKFGLIMD 320
           DS  +  I D
Sbjct: 238 DSPYWDDISD 247

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 17/213 (7%)
Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWVAEVQFLGVL 136
           T ++    ++G+G F SV +  +K  AG   + A ++  KKL+ RD  +   E +   +L
Sbjct: 10  TEEYQLFEELGKGAF-SVVRRCVKVLAGQEYA-AMIINTKKLSARDHQKLEREARICRLL 67
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
           +HPN+V+L    + +G       L+++ +    L + +  R +         H I    E
Sbjct: 68  KHPNIVRLHDSISEEG----HHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQILE 121
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFR---PKLSDFGLAREGPMVGHTHVSTAVVGT 253
            + + H+   + V++R+ K  N+LL    +    KL+DFGLA E  + G         GT
Sbjct: 122 AVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAWFGFAGT 176
Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            GY +P+ +         D+W+ GV+LY +L G
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 106/236 (44%), Gaps = 56/236 (23%)
Query: 87  IGEGGFGSVYKSS---IKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEH 138
           +GEG FG V K++   +K  AG      T VA+K L  +         ++E   L  + H
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAG-----YTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE-------------------------DH 173
           P+++KL G C+ DG      LL+ E+    SL                          DH
Sbjct: 86  PHVIKLYGACSQDGPL----LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 174 LFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG 233
              RA   L     +      ++G+ YL E   +++++RD  A N+L+ E  + K+SDFG
Sbjct: 142 PDERA---LTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 234 LAR----EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           L+R    E   V  +     V      +  D+I     T +SDVWSFGV+L+E++T
Sbjct: 196 LSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHI----YTTQSDVWSFGVLLWEIVT 247

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 112/250 (44%), Gaps = 32/250 (12%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLG 134
           DF  +L  G G F  V  +  K           +VAIK + ++ L+        E+  L 
Sbjct: 21  DFRDVL--GTGAFSEVILAEDK-------RTQKLVAIKCIAKEALEGKEGSMENEIAVLH 71
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 194
            ++HPN+V L        E G    L+ + +    L D +  + F      +RL  I   
Sbjct: 72  KIKHPNIVALDDIY----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--IFQV 125
Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVL---LDENFRPKLSDFGLAREGPMVGHTHVSTAVV 251
            + + YLH+   + +++RD K  N+L   LDE+ +  +SDFGL++   M     V +   
Sbjct: 126 LDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTAC 179
Query: 252 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL-ERNRPKTEQRLLEWVQQYPA 310
           GT GY AP+ +     +   D WS GV+ Y +L G     + N  K  +++L+   +Y  
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK--AEYEF 237
Query: 311 DSKKFGLIMD 320
           DS  +  I D
Sbjct: 238 DSPYWDDISD 247

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHP 139
           D + + ++G G FG V     K     G  +  +  IK+ +    +++ E + +  L H 
Sbjct: 10  DLTFLKELGTGQFGVV-----KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE 64
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEG 197
            LV+L G C    +R I   ++ E+M N  L ++L      F     +  L +     E 
Sbjct: 65  KLVQLYGVCT--KQRPI--FIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEA 117
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG-- 255
           + YL      Q ++RD  A N L+++    K+SDFGL+R    V     +++V   F   
Sbjct: 118 MEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSKFPVR 171
Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLER 292
           ++ P+ +     ++KSD+W+FGV+++E+ + G+   ER
Sbjct: 172 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 209

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 112/250 (44%), Gaps = 32/250 (12%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLG 134
           DF  +L  G G F  V  +  K           +VAIK + ++ L+        E+  L 
Sbjct: 21  DFRDVL--GTGAFSEVILAEDK-------RTQKLVAIKCIAKEALEGKEGSMENEIAVLH 71
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 194
            ++HPN+V L        E G    L+ + +    L D +  + F      +RL  I   
Sbjct: 72  KIKHPNIVALDDIY----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--IFQV 125
Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVL---LDENFRPKLSDFGLAREGPMVGHTHVSTAVV 251
            + + YLH+   + +++RD K  N+L   LDE+ +  +SDFGL++   M     V +   
Sbjct: 126 LDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTAC 179
Query: 252 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL-ERNRPKTEQRLLEWVQQYPA 310
           GT GY AP+ +     +   D WS GV+ Y +L G     + N  K  +++L+   +Y  
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK--AEYEF 237
Query: 311 DSKKFGLIMD 320
           DS  +  I D
Sbjct: 238 DSPYWDDISD 247

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 17/226 (7%)
Query: 65  NLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDG 123
           NL     +   + T+D+    ++G+G F SV +  +K       + A ++  KKL+ RD 
Sbjct: 17  NLYFQXMATCTRFTDDYQLFEELGKGAF-SVVRRCVKKTPTQEYA-AKIINTKKLSARDH 74
Query: 124 LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 183
            +   E +   +L+HPN+V+L    + +G       LV++ +    L + +  R +    
Sbjct: 75  QKLEREARICRLLKHPNIVRLHDSISEEGFH----YLVFDLVTGGELFEDIVAREY--YS 128
Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR---PKLSDFGLAREGPM 240
                H I    E + ++H+     +++RD K  N+LL    +    KL+DFGLA E  +
Sbjct: 129 EADASHCIHQILESVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLAIE--V 183
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            G         GT GY +P+ +         D+W+ GV+LY +L G
Sbjct: 184 QGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHP 139
           D + + ++G G FG V     K     G  +  +  IK+ +    +++ E + +  L H 
Sbjct: 25  DLTFLKELGTGQFGVV-----KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE 79
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEG 197
            LV+L G C    +R I   ++ E+M N  L ++L      F     +  L +     E 
Sbjct: 80  KLVQLYGVCT--KQRPI--FIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEA 132
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG-- 255
           + YL      Q ++RD  A N L+++    K+SDFGL+R    V     +++V   F   
Sbjct: 133 MEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSKFPVR 186
Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLER 292
           ++ P+ +     ++KSD+W+FGV+++E+ + G+   ER
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 224

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 32/211 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQFLGVLEHP 139
           +GEG FG V            T+    VA+K +N+  L       +   E+ +L +L HP
Sbjct: 16  LGEGSFGKV-------KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-AFPPLPWKTRLHIILGAAEGL 198
           +++KL  Y  +  +  I  ++V E+  N  L D++  R        +     I+ A E  
Sbjct: 69  HIIKL--YDVIKSKDEI--IMVIEYAGNE-LFDYIVQRDKMSEQEARRFFQQIISAVE-- 121
Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
            Y H     ++++RD K  N+LLDE+   K++DFGL+    M     + T+  G+  YAA
Sbjct: 122 -YCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLS--NIMTDGNFLKTS-CGSPNYAA 174
Query: 259 PDYIETGHLTA--KSDVWSFGVVLYEMLTGR 287
           P+ I +G L A  + DVWS GV+LY ML  R
Sbjct: 175 PEVI-SGKLYAGPEVDVWSCGVILYVMLCRR 204

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 106/236 (44%), Gaps = 56/236 (23%)
Query: 87  IGEGGFGSVYKSS---IKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEH 138
           +GEG FG V K++   +K  AG      T VA+K L  +         ++E   L  + H
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAG-----YTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE-------------------------DH 173
           P+++KL G C+ DG      LL+ E+    SL                          DH
Sbjct: 86  PHVIKLYGACSQDGPL----LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 174 LFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG 233
              RA   L     +      ++G+ YL E   +++++RD  A N+L+ E  + K+SDFG
Sbjct: 142 PDERA---LTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 234 LAR----EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           L+R    E   V  +     V      +  D+I     T +SDVWSFGV+L+E++T
Sbjct: 196 LSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI----YTTQSDVWSFGVLLWEIVT 247

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 98/225 (43%), Gaps = 28/225 (12%)
Query: 75  RQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QW 126
           RQ T  DF     +G+G FG+VY +  + +         ++A+K L +  L       Q 
Sbjct: 7   RQWTLEDFDIGRPLGKGKFGNVYLARERQSK-------FILALKVLFKTQLEKAGVEHQL 59
Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKT 186
             EV+    L HPN+++L GY   D  R +  +L Y  +     E    +R       + 
Sbjct: 60  RREVEIQSHLRHPNILRLYGYFH-DATR-VYLILEYAPLGTVYRELQKLSR----FDEQR 113
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
               I   A  L+Y H     +VI+RD K  N+LL  N   K++DFG +   P    +  
Sbjct: 114 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAP----SSR 166
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 291
              + GT  Y  P+ IE      K D+WS GV+ YE L G    E
Sbjct: 167 RDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 130/302 (43%), Gaps = 38/302 (12%)
Query: 90  GGFGSVYKSSIKPAAGDGTSEATVVAIKKL-NRDGLQWVAEVQFLGVLEHPNLVKLIGYC 148
           G FG V+K+ +        +E   V I  + ++   Q   EV  L  ++H N+++ IG  
Sbjct: 35  GRFGCVWKAQL-------LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAE 87
Query: 149 AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE----- 203
                  +   L+  F    SL D L       + W    HI    A GLAYLHE     
Sbjct: 88  KRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHEDIPGL 144
Query: 204 --GLEVQVIYRDFKASNVLLDENFRPKLSDFGLA---REGPMVGHTHVSTAVVGTFGYAA 258
             G +  + +RD K+ NVLL  N    ++DFGLA     G   G TH     VGT  Y A
Sbjct: 145 KDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTH---GQVGTRRYMA 201
Query: 259 PDYIETG-----HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL--EWVQQYPAD 311
           P+ +E           + D+++ G+VL+E+ +  R    + P  E  L   E + Q+P+ 
Sbjct: 202 PEVLEGAINFQRDAFLRIDMYAMGLVLWELAS--RCTAADGPVDEYMLPFEEEIGQHPSL 259
Query: 312 SKKFGLIMDPR---LEKEYSINEA--RKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV 366
                +++  +   + ++Y    A    +    + C    ++ R     V ER+ Q+ ++
Sbjct: 260 EDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319
Query: 367 SN 368
           +N
Sbjct: 320 TN 321

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 94/220 (42%), Gaps = 32/220 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           ++++  IGEG +G V       ++       T VAIKK++    Q        E+Q L  
Sbjct: 45  YTQLQYIGEGAYGMV-------SSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLR 97
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL------H 189
             H N++         G R I R    E M +  +   L       L    +L      +
Sbjct: 98  FRHENVI---------GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICY 148
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-EGPMVGHTHVST 248
            +     GL Y+H      V++RD K SN+L++     K+ DFGLAR   P   HT   T
Sbjct: 149 FLYQILRGLKYIHSA---NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLT 205
Query: 249 AVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
             V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 206 EXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHP 139
           D + + ++G G FG V     K     G  +  +  IK+ +    +++ E + +  L H 
Sbjct: 16  DLTFLKELGTGQFGVV-----KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE 70
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEG 197
            LV+L G C    +R I   ++ E+M N  L ++L      F     +  L +     E 
Sbjct: 71  KLVQLYGVCT--KQRPI--FIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEA 123
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG-- 255
           + YL      Q ++RD  A N L+++    K+SDFGL+R    V     +++V   F   
Sbjct: 124 MEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSKFPVR 177
Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLER 292
           ++ P+ +     ++KSD+W+FGV+++E+ + G+   ER
Sbjct: 178 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 215

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 105/236 (44%), Gaps = 56/236 (23%)
Query: 87  IGEGGFGSVYKSS---IKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEH 138
           +GEG FG V K++   +K  AG      T VA+K L  +         ++E   L  + H
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAG-----YTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE-------------------------DH 173
           P+++KL G C+ DG      LL+ E+    SL                          DH
Sbjct: 86  PHVIKLYGACSQDGPL----LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 174 LFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG 233
              RA   L     +      ++G+ YL E   + +++RD  A N+L+ E  + K+SDFG
Sbjct: 142 PDERA---LTMGDLISFAWQISQGMQYLAE---MSLVHRDLAARNILVAEGRKMKISDFG 195
Query: 234 LAR----EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           L+R    E   V  +     V      +  D+I     T +SDVWSFGV+L+E++T
Sbjct: 196 LSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHI----YTTQSDVWSFGVLLWEIVT 247

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 107/215 (49%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAI +L      +   + + E   +
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIMELREATSPKANKEILDEAYVM 105
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 106 ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 160
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 161 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 214
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 215 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHP 139
           D + + ++G G FG V     K     G  +  +  IK+ +    +++ E + +  L H 
Sbjct: 25  DLTFLKELGTGQFGVV-----KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE 79
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEG 197
            LV+L G C    +R I   ++ E+M N  L ++L      F     +  L +     E 
Sbjct: 80  KLVQLYGVCT--KQRPI--FIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEA 132
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG-- 255
           + YL      Q ++RD  A N L+++    K+SDFGL+R    V     +++V   F   
Sbjct: 133 MEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR---YVLDDEETSSVGSKFPVR 186
Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLER 292
           ++ P+ +     ++KSD+W+FGV+++E+ + G+   ER
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 224

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 102/225 (45%), Gaps = 40/225 (17%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWVAEVQFLG--VLEHPNLVK 143
           +G+G +G V++         G      VA+K  + RD   W  E +     +L H N++ 
Sbjct: 16  VGKGRYGEVWR---------GLWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILG 66
Query: 144 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH- 202
            I           Q  L+  +  + SL D L  +   P      L + + AA GLA+LH 
Sbjct: 67  FIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEP---HLALRLAVSAACGLAHLHV 123
Query: 203 EGLEVQ----VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV-------V 251
           E    Q    + +RDFK+ NVL+  N +  ++D GLA     V H+  S  +       V
Sbjct: 124 EIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA-----VMHSQGSDYLDIGNNPRV 178
Query: 252 GTFGYAAPDYIETGHLT------AKSDVWSFGVVLYEMLTGRRSL 290
           GT  Y AP+ ++    T        +D+W+FG+VL+E+   RR++
Sbjct: 179 GTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRTI 221

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 32/214 (14%)
Query: 90  GGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGV--LEHPNLVKLIGY 147
           G FG V+K+ +        ++   V I  L +D   W +E +      ++H NL++ I  
Sbjct: 26  GRFGCVWKAQL-------MNDFVAVKIFPL-QDKQSWQSEREIFSTPGMKHENLLQFIAA 77
Query: 148 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE---- 203
                   ++  L+  F    SL D+L       + W    H+    + GL+YLHE    
Sbjct: 78  EKRGSNLEVELWLITAFHDKGSLTDYLKGNI---ITWNELCHVAETMSRGLSYLHEDVPW 134
Query: 204 ----GLEVQVIYRDFKASNVLLDENFRPKLSDFGLA---REGPMVGHTHVSTAVVGTFGY 256
               G +  + +RDFK+ NVLL  +    L+DFGLA     G   G TH     VGT  Y
Sbjct: 135 CRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTH---GQVGTRRY 191
Query: 257 AAPDYIETG-----HLTAKSDVWSFGVVLYEMLT 285
            AP+ +E           + D+++ G+VL+E+++
Sbjct: 192 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 93/219 (42%), Gaps = 24/219 (10%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQWVAEVQ--FLGVL 136
           DF  +  IG G +  V    +K    D      VV  + +N D  + WV   +  F    
Sbjct: 6   DFDLLRVIGRGSYAKVLLVRLKKT--DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 63
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-FNRAFPPLPWKTRLHIILGAA 195
            HP LV L      +     +   V E++    L  H+   R  P        H    +A
Sbjct: 64  NHPFLVGLHSCFQTES----RLFFVIEYVNGGDLMFHMQRQRKLP------EEHARFYSA 113
Query: 196 E---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
           E    L YLHE     +IYRD K  NVLLD     KL+D+G+ +EG   G T  ++   G
Sbjct: 114 EISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCG 168
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 291
           T  Y AP+ +         D W+ GV+++EM+ GR   +
Sbjct: 169 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 23/217 (10%)
Query: 113 VVAIKKLNRDGLQ-----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN 167
           +VAIK + +  L+        E+  L  ++HPN+V L        E G    L+ + +  
Sbjct: 45  LVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY----ESGGHLYLIMQLVSG 100
Query: 168 RSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVL---LDEN 224
             L D +  + F      +RL  I    + + YLH+   + +++RD K  N+L   LDE+
Sbjct: 101 GELFDRIVEKGFYTERDASRL--IFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDED 155
Query: 225 FRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
            +  +SDFGL++   M     V +   GT GY AP+ +     +   D WS GV+ Y +L
Sbjct: 156 SKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILL 212
Query: 285 TGRRSL-ERNRPKTEQRLLEWVQQYPADSKKFGLIMD 320
            G     + N  K  +++L+   +Y  DS  +  I D
Sbjct: 213 CGYPPFYDENDAKLFEQILK--AEYEFDSPYWDDISD 247

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 119/255 (46%), Gaps = 35/255 (13%)
Query: 83  RMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAI---KKLNRDGLQ-WVAEVQFLGVLE 137
           R+LK IG+G F  V     K A    T +   V I    +LN   LQ    EV+   VL 
Sbjct: 17  RLLKTIGKGNFAKV-----KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLN 71
Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAE 196
           HPN+VKL  +  ++ E+ +   LV E+     + D+L           + +   I+ A +
Sbjct: 72  HPNIVKL--FEVIETEKTL--YLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ 127
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
              Y H+     +++RD KA N+LLD +   K++DFG + E       +   A  G   Y
Sbjct: 128 ---YCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNE---FTFGNKLDAFCGAPPY 178
Query: 257 AAPDYIETGHLTA-KSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYP----A 310
           AAP+  +       + DVWS GV+LY +++G    + +N  +  +R+L    + P     
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYXST 238
Query: 311 DS----KKFGLIMDP 321
           D     KKF LI++P
Sbjct: 239 DCENLLKKF-LILNP 252

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 129/306 (42%), Gaps = 58/306 (18%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLN-------RDGLQWVAEVQFLGVL-E 137
           +G G FG V +++   A G G  +A + VA+K L        ++ L  ++E++ +  L +
Sbjct: 54  LGAGAFGKVVEAT---AFGLGKEDAVLKVAVKMLKSTAHADEKEAL--MSELKIMSHLGQ 108
Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPP---------------L 182
           H N+V L+G C      G   L++ E+     L + L  R  PP               L
Sbjct: 109 HENIVNLLGACT----HGGPVLVITEYCCYGDLLNFL-RRKRPPGLEYSYNPSHNPEEQL 163
Query: 183 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 242
             +  LH     A+G+A+L        I+RD  A NVLL      K+ DFGLAR+     
Sbjct: 164 SSRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 220
Query: 243 HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 302
           +  V         + AP+ I     T +SDVWS+G++L+E+     SL  N         
Sbjct: 221 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN--------- 267
Query: 303 EWVQQYPA---DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER 359
                YP    +SK + L+ D     + +    + I  +   C +     RP   Q+   
Sbjct: 268 ----PYPGILVNSKFYKLVKDGYQMAQPAF-APKNIYSIMQACWALEPTHRPTFQQICSF 322
Query: 360 LKQIVQ 365
           L++  Q
Sbjct: 323 LQEQAQ 328

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 107/215 (49%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +  G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 133
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 134 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 188 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 24/206 (11%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
           ++G+G FG VYK+  K     G   A  V   K   +   ++ E++ L   +HP +VKL+
Sbjct: 26  ELGDGAFGKVYKAKNKET---GALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLL 82
Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL-GAAEGLAYLH 202
           G    DG+  I    + EF    +++  +   +R       + ++ ++     E L +LH
Sbjct: 83  GAYYHDGKLWI----MIEFCPGGAVDAIMLELDRGLT----EPQIQVVCRQMLEALNFLH 134
Query: 203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI 262
                ++I+RD KA NVL+      +L+DFG++ +   +       + +GT  + AP+ +
Sbjct: 135 SK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKN--LKTLQKRDSFIGTPYWMAPEVV 189
Query: 263 --ETGHLTA---KSDVWSFGVVLYEM 283
             ET   T    K+D+WS G+ L EM
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 107/215 (49%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +  G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 133
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 134 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 188 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 107/215 (49%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +  G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 126
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 127 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 181 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 94/220 (42%), Gaps = 32/220 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q        E++ L  
Sbjct: 45  YTNLSYIGEGAYGMVC------SAYDNVNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 97
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL------H 189
             H N++         G   I R    E M +  L  HL       L     L      +
Sbjct: 98  FRHENII---------GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICY 148
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVST 248
            +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T
Sbjct: 149 FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 205
Query: 249 AVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
             V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 206 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 107/215 (49%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 128
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFG A+  G      H     
Sbjct: 129 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 183 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 107/215 (49%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 75
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 76  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 130
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFG A+  G      H     
Sbjct: 131 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 184
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 185 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 83/308 (26%), Positives = 128/308 (41%), Gaps = 55/308 (17%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLN-------RDGLQWVAEVQFLGVL-E 137
           +G G FG V +++   A G G  +A + VA+K L        ++ L  ++E++ +  L +
Sbjct: 39  LGAGAFGKVVEAT---AFGLGKEDAVLKVAVKMLKSTAHADEKEAL--MSELKIMSHLGQ 93
Query: 138 HPNLVKLIGYCAVDGE-RGIQRLLVYEFMLN---RSLEDHLFNRAFP------------- 180
           H N+V L+G C   G    I     Y  +LN   R  E  L     P             
Sbjct: 94  HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGR 153
Query: 181 PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           PL  +  LH     A+G+A+L        I+RD  A NVLL      K+ DFGLAR+   
Sbjct: 154 PLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 210
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR 300
             +  V         + AP+ I     T +SDVWS+G++L+E+     SL  N       
Sbjct: 211 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN------- 259
Query: 301 LLEWVQQYPA---DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 357
                  YP    +SK + L+ D     + +    + I  +   C +     RP   Q+ 
Sbjct: 260 ------PYPGILVNSKFYKLVKDGYQMAQPAF-APKNIYSIMQACWALEPTHRPTFQQIC 312
Query: 358 ERLKQIVQ 365
             L++  Q
Sbjct: 313 SFLQEQAQ 320

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 93/219 (42%), Gaps = 24/219 (10%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQWVAEVQ--FLGVL 136
           DF  +  IG G +  V    +K    D      VV  + +N D  + WV   +  F    
Sbjct: 10  DFDLLRVIGRGSYAKVLLVRLKKT--DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-FNRAFPPLPWKTRLHIILGAA 195
            HP LV L      +     +   V E++    L  H+   R  P        H    +A
Sbjct: 68  NHPFLVGLHSCFQTES----RLFFVIEYVNGGDLMFHMQRQRKLP------EEHARFYSA 117
Query: 196 E---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
           E    L YLHE     +IYRD K  NVLLD     KL+D+G+ +EG   G T  ++   G
Sbjct: 118 EISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCG 172
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 291
           T  Y AP+ +         D W+ GV+++EM+ GR   +
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 107/215 (49%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 128
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFG A+  G      H     
Sbjct: 129 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 183 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 107/219 (48%), Gaps = 29/219 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EVQFLG 134
           + ++ KIGEG +G+V+K     A    T E  +VA+K++  D    G+   A  E+  L 
Sbjct: 4   YEKLEKIGEGTYGTVFK-----AKNRETHE--IVALKRVRLDDDDEGVPSSALREICLLK 56
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            L+H N+V+L      D     +  LV+EF  ++ L+ +    N    P   K+ L  +L
Sbjct: 57  ELKHKNIVRLHDVLHSDK----KLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLL 111
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
              +GL + H      V++RD K  N+L++ N   KL+DFGLAR   +    +  +A V 
Sbjct: 112 ---KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY--SAEVV 163
Query: 253 TFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGRRSL 290
           T  Y  PD +    L + S D+WS G +  E+    R L
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 107/215 (49%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 126
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFG A+  G      H     
Sbjct: 127 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 180
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 181 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 107/215 (49%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 133
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFG A+  G      H     
Sbjct: 134 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 187
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 188 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 107/215 (49%), Gaps = 23/215 (10%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAIK+L      +   + + E   +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 191
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 128
Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 250
              A+G+ YL +    ++++RD  A NVL+      K++DFG A+  G      H     
Sbjct: 129 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 183 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 93/218 (42%), Gaps = 30/218 (13%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQ------- 131
           +DF  +  IG+G FG V  +  K       +E    A+K L +  +    E +       
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHK-------AEEVFYAVKVLQKKAILKKKEEKHIMSERN 90
Query: 132 -FLGVLEHPNLVKL-IGYCAVDGERGIQRLLVYEFMLNRSLEDHL-FNRAFPPLPWKTRL 188
             L  ++HP LV L   +   D     +   V +++    L  HL   R F  L  + R 
Sbjct: 91  VLLKNVKHPFLVGLHFSFQTAD-----KLYFVLDYINGGELFYHLQRERCF--LEPRARF 143
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 248
           +     A  L YLH    + ++YRD K  N+LLD      L+DFGL +E   + H   ++
Sbjct: 144 YAA-EIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN--IEHNSTTS 197
Query: 249 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
              GT  Y AP+ +         D W  G VLYEML G
Sbjct: 198 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-----DGLQWVAEVQFLGVLEHP 139
           +++G G FGSV +   +        +   VAIK L +     D  + + E Q +  L++P
Sbjct: 342 IELGCGNFGSVRQGVYR-----MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 396
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
            +V+LIG C  +       +LV E      L   L  +    +P      ++   + G+ 
Sbjct: 397 YIVRLIGVCQAEA-----LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMK 450
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAVVGTFGYAA 258
           YL E      ++R+  A NVLL      K+SDFGL++  G    +    +A      + A
Sbjct: 451 YLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 507
Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLT 285
           P+ I     +++SDVWS+GV ++E L+
Sbjct: 508 PECINFRKFSSRSDVWSYGVTMWEALS 534

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 80  DFSRML-KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEH 138
           DF  ++ ++G+G FG VYK+  K  +      A  V   K   +   ++ E+  L   +H
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETS---VLAAAKVIDTKSEEELEDYMVEIDILASCDH 93
Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA-EG 197
           PN+VKL+     +    I    + EF    +++  +     P    ++++ ++     + 
Sbjct: 94  PNIVKLLDAFYYENNLWI----LIEFCAGGAVDAVMLELERPLT--ESQIQVVCKQTLDA 147
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           L YLH+    ++I+RD KA N+L   +   KL+DFG++ +         S   +GT  + 
Sbjct: 148 LNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWM 202
Query: 258 APDYI--ETGH---LTAKSDVWSFGVVLYEM 283
           AP+ +  ET        K+DVWS G+ L EM
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 24/206 (11%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
           ++G+G FG VYK+  K     G   A  V   K   +   ++ E++ L   +HP +VKL+
Sbjct: 18  ELGDGAFGKVYKAKNKET---GALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLL 74
Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL-GAAEGLAYLH 202
           G    DG+  I    + EF    +++  +   +R       + ++ ++     E L +LH
Sbjct: 75  GAYYHDGKLWI----MIEFCPGGAVDAIMLELDRGLT----EPQIQVVCRQMLEALNFLH 126
Query: 203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI 262
                ++I+RD KA NVL+      +L+DFG++ +   +       + +GT  + AP+ +
Sbjct: 127 SK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKN--LKTLQKRDSFIGTPYWMAPEVV 181
Query: 263 --ETGHLTA---KSDVWSFGVVLYEM 283
             ET   T    K+D+WS G+ L EM
Sbjct: 182 MCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 31/210 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-------EVQFLGVLEHP 139
           +G G FG V         G+       VA+K LNR  ++ +        E+Q L +  HP
Sbjct: 19  LGVGTFGKV-------KIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGL 198
           +++KL    +   +      +V E++    L D++        +  +     IL A +  
Sbjct: 72  HIIKLYQVISTPTDF----FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD-- 125
Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
            Y H  +   V++RD K  NVLLD +   K++DFGL+    M+          G+  YAA
Sbjct: 126 -YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSN---MMSDGEFLRTSCGSPNYAA 178
Query: 259 PDYIETGHLTA--KSDVWSFGVVLYEMLTG 286
           P+ I +G L A  + D+WS GV+LY +L G
Sbjct: 179 PEVI-SGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 30/210 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGL--QWVAEVQFLGVLEHP 139
           KIGEG +G VYK+          +     A+KK+      +G+    + E+  L  L+H 
Sbjct: 9   KIGEGTYGVVYKAQ--------NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           N+VKL  Y  +  ++ +  +LV+E  L++ L+  L +     L   T    +L    G+A
Sbjct: 61  NIVKL--YDVIHTKKRL--VLVFEH-LDQDLKK-LLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTAVVGTFGYA 257
           Y H+    +V++RD K  N+L++     K++DFGLAR    P+  +TH     V T  Y 
Sbjct: 115 YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH----EVVTLWYR 167
Query: 258 APDYIE-TGHLTAKSDVWSFGVVLYEMLTG 286
           APD +  +   +   D+WS G +  EM+ G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 30/210 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGL--QWVAEVQFLGVLEHP 139
           KIGEG +G VYK+          +     A+KK+      +G+    + E+  L  L+H 
Sbjct: 9   KIGEGTYGVVYKAQ--------NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           N+VKL  Y  +  ++ +  +LV+E  L++ L+  L +     L   T    +L    G+A
Sbjct: 61  NIVKL--YDVIHTKKRL--VLVFEH-LDQDLKK-LLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTAVVGTFGYA 257
           Y H+    +V++RD K  N+L++     K++DFGLAR    P+  +TH     V T  Y 
Sbjct: 115 YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH----EVVTLWYR 167
Query: 258 APDYIE-TGHLTAKSDVWSFGVVLYEMLTG 286
           APD +  +   +   D+WS G +  EM+ G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 98/219 (44%), Gaps = 27/219 (12%)
Query: 76  QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK-LNRDGLQWVA-----E 129
           Q+   +  +  +GEG +G V K   K           +VAIKK L  D  + V      E
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNK-------DTGRIVAIKKFLESDDDKMVKKIAMRE 74
Query: 130 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPP-LPWKTRL 188
           ++ L  L H NLV L+  C    ++  +  LV+EF+ +  L+D      FP  L ++   
Sbjct: 75  IKLLKQLRHENLVNLLEVC----KKKKRWYLVFEFVDHTILDDL---ELFPNGLDYQVVQ 127
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 248
             +     G+ + H      +I+RD K  N+L+ ++   KL DFG AR     G  +   
Sbjct: 128 KYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE 184
Query: 249 AVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 286
             V T  Y AP+ +       K+ DVW+ G ++ EM  G
Sbjct: 185 --VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 31/222 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFLG 134
             RML  G+G FGSV ++ +K   G        VA+K L  D +      +++ E   + 
Sbjct: 27  LGRML--GKGEFGSVREAQLKQEDGSFVK----VAVKMLKADIIASSDIEEFLREAACMK 80
Query: 135 VLEHPNLVKLIGYCAVDGERG---IQRLLV--------YEFMLNRSLEDHLFNRAFPPLP 183
             +HP++ KL+G       +G   I  +++        + F+L   + ++ FN     LP
Sbjct: 81  EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN-----LP 135
Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
            +T +  ++  A G+ YL        I+RD  A N +L E+    ++DFGL+R+     +
Sbjct: 136 LQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192
Query: 244 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
                A      + A + +     T  SDVW+FGV ++E++T
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 82/306 (26%), Positives = 131/306 (42%), Gaps = 49/306 (16%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLN-------RDGLQWVAEVQFLGVL-E 137
           +G G FG V +++   A G   S+A + VA+K L        R+ L  ++E++ L  L  
Sbjct: 47  LGAGAFGKVVEAT---AYGLIKSDAAMTVAVKMLKPSAHLTEREAL--MSELKVLSYLGN 101
Query: 138 HPNLVKLIGYCAVDGER-GIQRLLVYEFMLN---RSLEDHLFNRAFPPL--------PWK 185
           H N+V L+G C + G    I     Y  +LN   R  +  + ++  P +          +
Sbjct: 102 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 161
Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
             L      A+G+A+L        I+RD  A N+LL      K+ DFGLAR+     +  
Sbjct: 162 DLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 218
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 305
           V         + AP+ I     T +SDVWS+G+ L+E+ +   S                
Sbjct: 219 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM----------- 267
Query: 306 QQYPADSKKFGLIMDP--RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL-KQ 362
              P DSK + +I +    L  E++  E   I +    C       RP   Q+V+ + KQ
Sbjct: 268 ---PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQ 321
Query: 363 IVQVSN 368
           I + +N
Sbjct: 322 ISESTN 327

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 30/211 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLGVLEHPNLVK 143
           ++G G FG+V K   +      T    ++   + N   L  + +AE   +  L++P +V+
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 144 LIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           +IG C  +       +LV E      LN+ L+    NR       K  + ++   + G+ 
Sbjct: 77  MIGICEAES-----WMLVMEMAELGPLNKYLQQ---NRHVKD---KNIIELVHQVSMGMK 125
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGHTHVSTAVVGTF 254
           YL E      ++RD  A NVLL      K+SDFGL++     E      TH    V    
Sbjct: 126 YLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPV---- 178
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            + AP+ I     ++KSDVWSFGV+++E  +
Sbjct: 179 KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 80  DFSRML-KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEH 138
           DF  ++ ++G+G FG VYK+  K  +      A  V   K   +   ++ E+  L   +H
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETS---VLAAAKVIDTKSEEELEDYMVEIDILASCDH 93
Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA-EG 197
           PN+VKL+     +    I    + EF    +++  +     P    ++++ ++     + 
Sbjct: 94  PNIVKLLDAFYYENNLWI----LIEFCAGGAVDAVMLELERPLT--ESQIQVVCKQTLDA 147
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           L YLH+    ++I+RD KA N+L   +   KL+DFG++ +           + +GT  + 
Sbjct: 148 LNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN--TRXIQRRDSFIGTPYWM 202
Query: 258 APDYI--ETGH---LTAKSDVWSFGVVLYEM 283
           AP+ +  ET        K+DVWS G+ L EM
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 82/306 (26%), Positives = 131/306 (42%), Gaps = 49/306 (16%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLN-------RDGLQWVAEVQFLGVL-E 137
           +G G FG V +++   A G   S+A + VA+K L        R+ L  ++E++ L  L  
Sbjct: 49  LGAGAFGKVVEAT---AYGLIKSDAAMTVAVKMLKPSAHLTEREAL--MSELKVLSYLGN 103
Query: 138 HPNLVKLIGYCAVDGER-GIQRLLVYEFMLN---RSLEDHLFNRAFPPL--------PWK 185
           H N+V L+G C + G    I     Y  +LN   R  +  + ++  P +          +
Sbjct: 104 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 163
Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
             L      A+G+A+L        I+RD  A N+LL      K+ DFGLAR+     +  
Sbjct: 164 DLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 220
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 305
           V         + AP+ I     T +SDVWS+G+ L+E+ +   S                
Sbjct: 221 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM----------- 269
Query: 306 QQYPADSKKFGLIMDP--RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL-KQ 362
              P DSK + +I +    L  E++  E   I +    C       RP   Q+V+ + KQ
Sbjct: 270 ---PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQ 323
Query: 363 IVQVSN 368
           I + +N
Sbjct: 324 ISESTN 329

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/123 (36%), Positives = 65/123 (52%), Gaps = 13/123 (10%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L +LH+   + +IYRD K  N+LLD N    L+DFGL++E  +   T  +    GT  Y
Sbjct: 171 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDFCGTIEY 226
Query: 257 AAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-----RLLEWVQQY 308
            APD +   ++GH  A  D WS GV++YE+LTG      +  K  Q     R+L+    Y
Sbjct: 227 MAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 285
Query: 309 PAD 311
           P +
Sbjct: 286 PQE 288

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 30/211 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLGVLEHPNLVK 143
           ++G G FG+V K   +      T    ++   + N   L  + +AE   +  L++P +V+
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 144 LIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           +IG C  +       +LV E      LN+ L+    NR       K  + ++   + G+ 
Sbjct: 93  MIGICEAES-----WMLVMEMAELGPLNKYLQQ---NRHVKD---KNIIELVHQVSMGMK 141
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGHTHVSTAVVGTF 254
           YL E      ++RD  A NVLL      K+SDFGL++     E      TH    V    
Sbjct: 142 YLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV---- 194
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            + AP+ I     ++KSDVWSFGV+++E  +
Sbjct: 195 KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 30/211 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLGVLEHPNLVK 143
           ++G G FG+V K   +      T    ++   + N   L  + +AE   +  L++P +V+
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 144 LIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           +IG C  +       +LV E      LN+ L+    NR       K  + ++   + G+ 
Sbjct: 93  MIGICEAES-----WMLVMEMAELGPLNKYLQQ---NRHVKD---KNIIELVHQVSMGMK 141
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGHTHVSTAVVGTF 254
           YL E      ++RD  A NVLL      K+SDFGL++     E      TH    V    
Sbjct: 142 YLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV---- 194
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            + AP+ I     ++KSDVWSFGV+++E  +
Sbjct: 195 KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH      V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y
Sbjct: 120 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEY 174
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 175 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 82/306 (26%), Positives = 131/306 (42%), Gaps = 49/306 (16%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLN-------RDGLQWVAEVQFLGVL-E 137
           +G G FG V +++   A G   S+A + VA+K L        R+ L  ++E++ L  L  
Sbjct: 54  LGAGAFGKVVEAT---AYGLIKSDAAMTVAVKMLKPSAHLTEREAL--MSELKVLSYLGN 108
Query: 138 HPNLVKLIGYCAVDGER-GIQRLLVYEFMLN---RSLEDHLFNRAFPPL--------PWK 185
           H N+V L+G C + G    I     Y  +LN   R  +  + ++  P +          +
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
             L      A+G+A+L        I+RD  A N+LL      K+ DFGLAR+     +  
Sbjct: 169 DLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 225
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 305
           V         + AP+ I     T +SDVWS+G+ L+E+ +   S                
Sbjct: 226 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM----------- 274
Query: 306 QQYPADSKKFGLIMDP--RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL-KQ 362
              P DSK + +I +    L  E++  E   I +    C       RP   Q+V+ + KQ
Sbjct: 275 ---PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQ 328
Query: 363 IVQVSN 368
           I + +N
Sbjct: 329 ISESTN 334

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH      V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEY 171
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 30/211 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLGVLEHPNLVK 143
           ++G G FG+V K   +      T    ++   + N   L  + +AE   +  L++P +V+
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 144 LIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           +IG C  +       +LV E      LN+ L+    NR       K  + ++   + G+ 
Sbjct: 73  MIGICEAES-----WMLVMEMAELGPLNKYLQQ---NRHVKD---KNIIELVHQVSMGMK 121
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGHTHVSTAVVGTF 254
           YL E      ++RD  A NVLL      K+SDFGL++     E      TH    V    
Sbjct: 122 YLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV---- 174
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            + AP+ I     ++KSDVWSFGV+++E  +
Sbjct: 175 KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 132/307 (42%), Gaps = 49/307 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLN-------RDGLQWVAEVQFLGVL-E 137
           +G G FG V +++   A G   S+A + VA+K L        R+ L  ++E++ L  L  
Sbjct: 31  LGAGAFGKVVEAT---AYGLIKSDAAMTVAVKMLKPSAHLTEREAL--MSELKVLSYLGN 85
Query: 138 HPNLVKLIGYCAVDGER-GIQRLLVYEFMLN---RSLEDHLFNRAFPPL--------PWK 185
           H N+V L+G C + G    I     Y  +LN   R  +  + ++  P +          +
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
             L      A+G+A+L        I+RD  A N+LL      K+ DFGLAR+     +  
Sbjct: 146 DLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 305
           V         + AP+ I     T +SDVWS+G+ L+E+ +   S     P          
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-----PYPGM------ 251
Query: 306 QQYPADSKKFGLIMDP--RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL-KQ 362
              P DSK + +I +    L  E++  E   I +    C       RP   Q+V+ + KQ
Sbjct: 252 ---PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQ 305
Query: 363 IVQVSNE 369
           I + +N 
Sbjct: 306 ISESTNH 312

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH      V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEY 171
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 30/211 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLGVLEHPNLVK 143
           ++G G FG+V K   +      T    ++   + N   L  + +AE   +  L++P +V+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 144 LIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           +IG C  +       +LV E      LN+ L+    NR       K  + ++   + G+ 
Sbjct: 83  MIGICEAES-----WMLVMEMAELGPLNKYLQQ---NRHVKD---KNIIELVHQVSMGMK 131
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGHTHVSTAVVGTF 254
           YL E      ++RD  A NVLL      K+SDFGL++     E      TH    V    
Sbjct: 132 YLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV---- 184
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            + AP+ I     ++KSDVWSFGV+++E  +
Sbjct: 185 KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 30/219 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q        E++ L  
Sbjct: 27  YTNLSYIGEGAYGMVC------SAYDNVNKVRV-AIKKISPFEHQTYCQRTLREIKILLA 79
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 190
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 131
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 249
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 132 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 188
Query: 250 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 189 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 30/211 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLGVLEHPNLVK 143
           ++G G FG+V K   +      T    ++   + N   L  + +AE   +  L++P +V+
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVMQQLDNPYIVR 90
Query: 144 LIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           +IG C  +       +LV E      LN+ L+    NR       K  + ++   + G+ 
Sbjct: 91  MIGICEAES-----WMLVMEMAELGPLNKYLQQ---NRHVKD---KNIIELVHQVSMGMK 139
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGHTHVSTAVVGTF 254
           YL E      ++RD  A NVLL      K+SDFGL++     E      TH    V    
Sbjct: 140 YLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV---- 192
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            + AP+ I     ++KSDVWSFGV+++E  +
Sbjct: 193 KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 30/210 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGL--QWVAEVQFLGVLEHP 139
           KIGEG +G VYK+          +     A+KK+      +G+    + E+  L  L+H 
Sbjct: 9   KIGEGTYGVVYKAQ--------NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           N+VKL  Y  +  ++ +  +LV+E  L++ L+  L +     L   T    +L    G+A
Sbjct: 61  NIVKL--YDVIHTKKRL--VLVFEH-LDQDLKK-LLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTAVVGTFGYA 257
           Y H+    +V++RD K  N+L++     K++DFGLAR    P+  +TH     + T  Y 
Sbjct: 115 YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH----EIVTLWYR 167
Query: 258 APDYIE-TGHLTAKSDVWSFGVVLYEMLTG 286
           APD +  +   +   D+WS G +  EM+ G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH      V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y
Sbjct: 122 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEY 176
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH      V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEY 171
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 38/233 (16%)
Query: 72  SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWVAEV 130
           S  R   +  + +  +G+G +G V++         G+ +   VA+K  + RD   W  E 
Sbjct: 1   SMQRTVAHQITLLECVGKGRYGEVWR---------GSWQGENVAVKIFSSRDEKSWFRET 51
Query: 131 QFLG--VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           +     +L H N++  I           Q  L+  +    SL D+L       L   + L
Sbjct: 52  ELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCL 108
Query: 189 HIILGAAEGLAYLH-EGLEVQ----VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
            I+L  A GLA+LH E    Q    + +RD K+ N+L+ +N +  ++D GLA     V H
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-----VMH 163
Query: 244 THVSTAV-------VGTFGYAAPDYI-ETGHLTA-----KSDVWSFGVVLYEM 283
           +  +  +       VGT  Y AP+ + ET  +       + D+W+FG+VL+E+
Sbjct: 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 31/210 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-------EVQFLGVLEHP 139
           +G G FG V         G+       VA+K LNR  ++ +        E+Q L +  HP
Sbjct: 19  LGVGTFGKV-------KIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGL 198
           +++KL    +   +      +V E++    L D++        +  +     IL A +  
Sbjct: 72  HIIKLYQVISTPTDF----FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD-- 125
Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
            Y H  +   V++RD K  NVLLD +   K++DFGL+    M+          G+  YAA
Sbjct: 126 -YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSN---MMSDGEFLRDSCGSPNYAA 178
Query: 259 PDYIETGHLTA--KSDVWSFGVVLYEMLTG 286
           P+ I +G L A  + D+WS GV+LY +L G
Sbjct: 179 PEVI-SGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 92/209 (44%), Gaps = 28/209 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           +G+G FG V     K    +   +       K   D    + EVQ L  L+HPN++KL  
Sbjct: 40  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 99
Query: 147 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYLHEGL 205
           +    G       LV E      L D + +R  F  +       II     G+ Y+H+  
Sbjct: 100 FFEDKG----YFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSGITYMHKN- 151
Query: 206 EVQVIYRDFKASNVLL-----DENFRPKLSDFGLAREGPMVGHTHVSTAV---VGTFGYA 257
             ++++RD K  N+LL     D N R  + DFGL+       H   S  +   +GT  Y 
Sbjct: 152 --KIVHRDLKPENLLLESKSKDANIR--IIDFGLST------HFEASKKMKDKIGTAYYI 201
Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           AP+ +  G    K DVWS GV+LY +L+G
Sbjct: 202 APEVLH-GTYDEKCDVWSTGVILYILLSG 229

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 23/221 (10%)
Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWV 127
           M     D+  +  IG G +G   K   K       S+  ++  K+L+   +        V
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRK-------SDGKILVWKELDYGSMTEAEKQMLV 53
Query: 128 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLP 183
           +EV  L  L+HPN+V+   Y  +         +V E+     L   +      R +    
Sbjct: 54  SEVNLLRELKHPNIVRY--YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
           +  R+   L  A    +        V++RD K +NV LD     KL DFGLAR   ++ H
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR---ILNH 168
Query: 244 -THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEM 283
            T  + A VGT  Y +P+ +       KSD+WS G +LYE+
Sbjct: 169 DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH      V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEY 171
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 30/211 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLGVLEHPNLVK 143
           ++G G FG+V K   +      T    ++   + N   L  + +AE   +  L++P +V+
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVMQQLDNPYIVR 70
Query: 144 LIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           +IG C  +       +LV E      LN+ L+    NR       K  + ++   + G+ 
Sbjct: 71  MIGICEAE-----SWMLVMEMAELGPLNKYLQQ---NRHVKD---KNIIELVHQVSMGMK 119
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGHTHVSTAVVGTF 254
           YL E      ++RD  A NVLL      K+SDFGL++     E      TH    V    
Sbjct: 120 YLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV---- 172
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            + AP+ I     ++KSDVWSFGV+++E  +
Sbjct: 173 KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH      V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEY 171
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 92/209 (44%), Gaps = 28/209 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           +G+G FG V     K    +   +       K   D    + EVQ L  L+HPN++KL  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 147 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYLHEGL 205
           +    G       LV E      L D + +R  F  +       II     G+ Y+H+  
Sbjct: 94  FFEDKG----YFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSGITYMHKN- 145
Query: 206 EVQVIYRDFKASNVLL-----DENFRPKLSDFGLAREGPMVGHTHVSTAV---VGTFGYA 257
             ++++RD K  N+LL     D N R  + DFGL+       H   S  +   +GT  Y 
Sbjct: 146 --KIVHRDLKPENLLLESKSKDANIR--IIDFGLST------HFEASKKMKDKIGTAYYI 195
Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           AP+ +  G    K DVWS GV+LY +L+G
Sbjct: 196 APEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 30/211 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLGVLEHPNLVK 143
           ++G G FG+V K   +      T    ++   + N   L  + +AE   +  L++P +V+
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 144 LIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           +IG C  +       +LV E      LN+ L+    NR       K  + ++   + G+ 
Sbjct: 77  MIGICEAES-----WMLVMEMAELGPLNKYLQQ---NRHVKD---KNIIELVHQVSMGMK 125
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGHTHVSTAVVGTF 254
           YL E      ++RD  A NVLL      K+SDFGL++     E      TH    V    
Sbjct: 126 YLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV---- 178
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            + AP+ I     ++KSDVWSFGV+++E  +
Sbjct: 179 KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 17/213 (7%)
Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWVAEVQFLGVL 136
           T+++     IG+G F SV +  +K   G   + A ++  KKL+ RD  +   E +   +L
Sbjct: 3   TDEYQLYEDIGKGAF-SVVRRCVKLCTGHEYA-AKIINTKKLSARDHQKLEREARICRLL 60
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
           +H N+V+L    + +G       LV++ +    L + +  R +         H I    E
Sbjct: 61  KHSNIVRLHDSISEEGFH----YLVFDLVTGGELFEDIVAREY--YSEADASHCIQQILE 114
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFR---PKLSDFGLAREGPMVGHTHVSTAVVGT 253
            + + H+   + V++RD K  N+LL    +    KL+DFGLA E  + G         GT
Sbjct: 115 AVLHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIE--VQGDQQAWFGFAGT 169
Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            GY +P+ +         D+W+ GV+LY +L G
Sbjct: 170 PGYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 108/230 (46%), Gaps = 25/230 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAI---KKLNRDGLQ-WVAEVQFLGVLEHPNLV 142
           IG+G F  V     K A    T     V I    +LN   LQ    EV+ + +L HPN+V
Sbjct: 23  IGKGNFAKV-----KLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYL 201
           KL  +  ++ E+ +   LV E+     + D+L           + +   I+ A +   Y 
Sbjct: 78  KL--FEVIETEKTL--YLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YC 130
Query: 202 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 261
           H+     +++RD KA N+LLD +   K++DFG + E   VG+        G+  YAAP+ 
Sbjct: 131 HQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEF-TVGNK--LDTFCGSPPYAAPEL 184
Query: 262 IETGHLTA-KSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYP 309
            +       + DVWS GV+LY +++G    + +N  +  +R+L    + P
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP 234

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 80  DFSRML-KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEH 138
           DF  ++ ++G+G FG VYK+  K  +      A  V   K   +   ++ E+  L   +H
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETS---VLAAAKVIDTKSEEELEDYMVEIDILASCDH 93
Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA-EG 197
           PN+VKL+   A   E  +  L+  EF    +++  +     P    ++++ ++     + 
Sbjct: 94  PNIVKLLD--AFYYENNLWILI--EFCAGGAVDAVMLELERPLT--ESQIQVVCKQTLDA 147
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           L YLH+    ++I+RD KA N+L   +   KL+DFG++ +             +GT  + 
Sbjct: 148 LNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN--TRXIQRRDXFIGTPYWM 202
Query: 258 APDYI--ETGH---LTAKSDVWSFGVVLYEM 283
           AP+ +  ET        K+DVWS G+ L EM
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 89/206 (43%), Gaps = 23/206 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL---NRDGLQWVAEVQFLGVLEHPNLVK 143
           +G+G FG V K   +        E  V  I K    N+D    + EV+ L  L+HPN++K
Sbjct: 30  LGKGSFGEVLKCKDRITQ----QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 144 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE 203
           L        E      +V E      L D +  R            II     G+ Y+H+
Sbjct: 86  LFEIL----EDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHK 139
Query: 204 GLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 260
                +++RD K  N+LL+   ++   K+ DFGL+               +GT  Y AP+
Sbjct: 140 H---NIVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYIAPE 193
Query: 261 YIETGHLTAKSDVWSFGVVLYEMLTG 286
            +  G    K DVWS GV+LY +L+G
Sbjct: 194 VLR-GTYDEKCDVWSAGVILYILLSG 218

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 30/219 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q        E++ L  
Sbjct: 25  YTNLSYIGEGAYGMVC------SAYDNVNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 77
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 190
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 129
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 249
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 130 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 186
Query: 250 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 187 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 30/219 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q        E++ L  
Sbjct: 27  YTNLSYIGEGAYGMVC------SAYDNVNKVRV-AIKKISPFEHQTYCQRTLREIKILLA 79
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 190
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 131
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 249
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 132 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTE 188
Query: 250 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 189 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 82/306 (26%), Positives = 130/306 (42%), Gaps = 49/306 (16%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLN-------RDGLQWVAEVQFLGVL-E 137
           +G G FG V +++   A G   S+A + VA+K L        R+ L  ++E++ L  L  
Sbjct: 54  LGAGAFGKVVEAT---AYGLIKSDAAMTVAVKMLKPSAHLTEREAL--MSELKVLSYLGN 108
Query: 138 HPNLVKLIGYCAVDGER-GIQRLLVYEFMLN---RSLEDHLFNRAFPPL--------PWK 185
           H N+V L+G C + G    I     Y  +LN   R  +  + ++  P +          +
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
             L      A+G+A+L        I+RD  A N+LL      K+ DFGLAR      +  
Sbjct: 169 DLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYV 225
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 305
           V         + AP+ I     T +SDVWS+G+ L+E+ +   S                
Sbjct: 226 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM----------- 274
Query: 306 QQYPADSKKFGLIMDP--RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL-KQ 362
              P DSK + +I +    L  E++  E   I +    C       RP   Q+V+ + KQ
Sbjct: 275 ---PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQ 328
Query: 363 IVQVSN 368
           I + +N
Sbjct: 329 ISESTN 334

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 30/219 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q        E++ L  
Sbjct: 25  YTNLSYIGEGAYGMVC------SAYDNVNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 77
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 190
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 129
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 249
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 130 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTE 186
Query: 250 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 187 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHP 139
           D + + ++G G FG V     K     G  +  +  IK+ +    +++ E + +  L H 
Sbjct: 10  DLTFLKELGTGQFGVV-----KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE 64
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEG 197
            LV+L G C    +R I   ++ E+M N  L ++L      F     +  L +     E 
Sbjct: 65  KLVQLYGVCT--KQRPI--FIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEA 117
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG-- 255
           + YL      Q ++RD  A N L+++    K+SDFGL+R    V     +++    F   
Sbjct: 118 MEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSRGSKFPVR 171
Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLER 292
           ++ P+ +     ++KSD+W+FGV+++E+ + G+   ER
Sbjct: 172 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 209

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 30/211 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLGVLEHPNLVK 143
           ++G G FG+V K   +      T    ++   + N   L  + +AE   +  L++P +V+
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVMQQLDNPYIVR 434
Query: 144 LIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           +IG C  +       +LV E      LN+ L+    NR       K  + ++   + G+ 
Sbjct: 435 MIGICEAE-----SWMLVMEMAELGPLNKYLQQ---NRHVKD---KNIIELVHQVSMGMK 483
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGHTHVSTAVVGTF 254
           YL E      ++RD  A NVLL      K+SDFGL++     E      TH    V    
Sbjct: 484 YLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV---- 536
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            + AP+ I     ++KSDVWSFGV+++E  +
Sbjct: 537 KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 35/216 (16%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----WVAEVQFLGVL 136
               +KIGEG  G V  ++++       S   +VA+KK++    Q       EV  +   
Sbjct: 153 LDNFIKIGEGSTGIVCIATVR-------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 205
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH------I 190
           +H N+V++     V    G +  +V EF+   +L D + +         TR++      +
Sbjct: 206 QHENVVEMYNSYLV----GDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAV 252
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
            L   + L+ LH      VI+RD K+ ++LL  + R KLSDFG   +  +         +
Sbjct: 253 CLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXL 307
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           VGT  + AP+ I       + D+WS G+++ EM+ G
Sbjct: 308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 343

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 92/209 (44%), Gaps = 28/209 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           +G+G FG V     K    +   +       K   D    + EVQ L  L+HPN++KL  
Sbjct: 57  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 116
Query: 147 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYLHEGL 205
           +    G       LV E      L D + +R  F  +       II     G+ Y+H+  
Sbjct: 117 FFEDKG----YFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSGITYMHKN- 168
Query: 206 EVQVIYRDFKASNVLL-----DENFRPKLSDFGLAREGPMVGHTHVSTAV---VGTFGYA 257
             ++++RD K  N+LL     D N R  + DFGL+       H   S  +   +GT  Y 
Sbjct: 169 --KIVHRDLKPENLLLESKSKDANIR--IIDFGLST------HFEASKKMKDKIGTAYYI 218
Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           AP+ +  G    K DVWS GV+LY +L+G
Sbjct: 219 APEVLH-GTYDEKCDVWSTGVILYILLSG 246

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 104/236 (44%), Gaps = 46/236 (19%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL--NRDGLQWV-AEVQFLGV 135
           +DF  +  +G+G FG V K+           ++   AIKK+    + L  + +EV  L  
Sbjct: 6   SDFEEIAVLGQGAFGQVVKAR-------NALDSRYYAIKKIRHTEEKLSTILSEVMLLAS 58
Query: 136 LEHPNLVKLIGYCAVDGERGIQR-----------LLVYEFMLNRSLEDHLFNRAFPPLP- 183
           L H  +V+   Y A    R   +            +  E+  NR+L D + +        
Sbjct: 59  LNHQYVVRY--YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRD 116
Query: 184 --WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE---- 237
             W+    I+    E L+Y+H      +I+RD K  N+ +DE+   K+ DFGLA+     
Sbjct: 117 EYWRLFRQIL----EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 238 --------GPMVGHTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEML 284
                     + G +   T+ +GT  Y A + ++ TGH   K D++S G++ +EM+
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 30/219 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q        E++ L  
Sbjct: 25  YTNLSYIGEGAYGMVC------SAYDNVNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 77
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 190
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 129
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 249
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 130 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTE 186
Query: 250 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 187 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 30/219 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q        E++ L  
Sbjct: 27  YTNLSYIGEGAYGMVC------SAYDNVNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 79
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 190
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 131
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-EGPMVGHTHVSTA 249
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 132 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 188
Query: 250 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 189 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 92/209 (44%), Gaps = 28/209 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           +G+G FG V     K    +   +       K   D    + EVQ L  L+HPN++KL  
Sbjct: 58  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 117
Query: 147 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYLHEGL 205
           +    G       LV E      L D + +R  F  +       II     G+ Y+H+  
Sbjct: 118 FFEDKG----YFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSGITYMHKN- 169
Query: 206 EVQVIYRDFKASNVLL-----DENFRPKLSDFGLAREGPMVGHTHVSTAV---VGTFGYA 257
             ++++RD K  N+LL     D N R  + DFGL+       H   S  +   +GT  Y 
Sbjct: 170 --KIVHRDLKPENLLLESKSKDANIR--IIDFGLST------HFEASKKMKDKIGTAYYI 219
Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           AP+ +  G    K DVWS GV+LY +L+G
Sbjct: 220 APEVLH-GTYDEKCDVWSTGVILYILLSG 247

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 126/291 (43%), Gaps = 43/291 (14%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE--VQFLGVL 136
           ND   + ++G G  G V+K   +           V+A+K++ R G +   +  +  L V+
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFR-------KTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 137 ----EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
               + P +V+  G    + +      +  E M   +  + L  R   P+P +    + +
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDV----FIAMELM--GTCAEKLKKRMQGPIPERILGKMTV 131
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
              + L YL E  +  VI+RD K SN+LLDE  + KL DFG++  G +V          G
Sbjct: 132 AIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGIS--GRLV-DDKAKDRSAG 186
Query: 253 TFGYAAPDYIETGHLTA-----KSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 307
              Y AP+ I+    T      ++DVWS G+ L E+ TG+   +  +   E  L + +Q+
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV-LTKVLQE 245
Query: 308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
            P           P L        +        +CL+K  + RPK ++++E
Sbjct: 246 EP-----------PLLPGHMGF--SGDFQSFVKDCLTKDHRKRPKYNKLLE 283

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 30/219 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q        E++ L  
Sbjct: 33  YTNLSYIGEGAYGMVC------SAYDNVNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 85
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 190
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 86  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 137
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-EGPMVGHTHVSTA 249
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 138 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 194
Query: 250 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 195 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 30/219 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q        E++ L  
Sbjct: 25  YTNLSYIGEGAYGMVC------SAYDNVNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 77
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 190
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 129
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-EGPMVGHTHVSTA 249
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 130 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 186
Query: 250 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 187 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 43/240 (17%)
Query: 75  RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL------NRDGLQWVA 128
           R     +  + K+G+G +G V+KS I    G+      VVA+KK+      + D  +   
Sbjct: 5   RHVLRKYELVKKLGKGAYGIVWKS-IDRRTGE------VVAVKKIFDAFQNSTDAQRTFR 57
Query: 129 EVQFLGVLE-HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTR 187
           E+  L  L  H N+V L+     D +R +   LV+++M     + H   RA    P   +
Sbjct: 58  EIMILTELSGHENIVNLLNVLRADNDRDV--YLVFDYM---ETDLHAVIRANILEPVHKQ 112
Query: 188 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR----------E 237
            +++    + + YLH G    +++RD K SN+LL+     K++DFGL+R           
Sbjct: 113 -YVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168
Query: 238 GPMVGHTH---------VSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
            P+  + +         + T  V T  Y AP+  + +   T   D+WS G +L E+L G+
Sbjct: 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 30/211 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLGVLEHPNLVK 143
           ++G G FG+V K   +      T    ++   + N   L  + +AE   +  L++P +V+
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVMQQLDNPYIVR 435
Query: 144 LIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           +IG C  +       +LV E      LN+ L+    NR       K  + ++   + G+ 
Sbjct: 436 MIGICEAE-----SWMLVMEMAELGPLNKYLQQ---NRHVKD---KNIIELVHQVSMGMK 484
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGHTHVSTAVVGTF 254
           YL E      ++RD  A NVLL      K+SDFGL++     E      TH    V    
Sbjct: 485 YLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV---- 537
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            + AP+ I     ++KSDVWSFGV+++E  +
Sbjct: 538 KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 30/219 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q        E++ L  
Sbjct: 45  YTNLSYIGEGAYGMVC------SAYDNVNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 97
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 190
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 98  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 149
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 249
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 150 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 206
Query: 250 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 207 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 38/218 (17%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWVAEVQFLG--VLEHPNLVK 143
           +G+G +G V++         G+ +   VA+K  + RD   W  E +     +L H N++ 
Sbjct: 45  VGKGRYGEVWR---------GSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILG 95
Query: 144 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH- 202
            I           Q  L+  +    SL D+L       L   + L I+L  A GLA+LH 
Sbjct: 96  FIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHI 152
Query: 203 EGLEVQ----VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV-------V 251
           E    Q    + +RD K+ N+L+ +N +  ++D GLA     V H+  +  +       V
Sbjct: 153 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-----VMHSQSTNQLDVGNNPRV 207
Query: 252 GTFGYAAPDYI-ETGHLTA-----KSDVWSFGVVLYEM 283
           GT  Y AP+ + ET  +       + D+W+FG+VL+E+
Sbjct: 208 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 30/219 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q        E++ L  
Sbjct: 25  YTNLSYIGEGAYGMVC------SAYDNVNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 77
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 190
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 129
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 249
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 130 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTE 186
Query: 250 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 187 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 30/219 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q        E++ L  
Sbjct: 30  YTNLSYIGEGAYGMVC------SAYDNLNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 82
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 190
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 83  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 134
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 249
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 135 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 191
Query: 250 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 192 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 30/219 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q        E++ L  
Sbjct: 31  YTNLSYIGEGAYGMVC------SAYDNLNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 83
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 190
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 84  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 135
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 249
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 136 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 192
Query: 250 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 193 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 30/219 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q        E++ L  
Sbjct: 22  YTNLSYIGEGAYGMVC------SAYDNLNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 74
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 190
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 75  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 126
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 249
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 127 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 183
Query: 250 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 184 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 30/219 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q        E++ L  
Sbjct: 29  YTNLSYIGEGAYGMVC------SAYDNLNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 81
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 190
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 133
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 249
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 134 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 250 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 100/225 (44%), Gaps = 30/225 (13%)
Query: 74  MRQATNDFSRMLKI----GEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWVA 128
           M  A+  FS    +    G+G F SV +  +    G   + A ++  KKL+ RD  +   
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAF-SVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLER 77
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQ----RLLVYEFMLNRSLEDHLFNRAFPPLPW 184
           E +    L+HPN+V+L           IQ      LV++ +    L + +  R F     
Sbjct: 78  EARICRKLQHPNIVRL--------HDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSE 127
Query: 185 KTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP---KLSDFGLAREGPMV 241
               H I    E +AY H      +++R+ K  N+LL    +    KL+DFGLA E   V
Sbjct: 128 ADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---V 181
Query: 242 GHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
             +       GT GY +P+ ++    +   D+W+ GV+LY +L G
Sbjct: 182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 102/227 (44%), Gaps = 22/227 (9%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGVLEHPNLVK 143
           IG+G F SV +  I    G   +   V   K  +  GL       E     +L+HP++V+
Sbjct: 32  IGKGAF-SVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 144 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL--HIILGAAEGLAYL 201
           L+   + DG       +V+EFM    L   +  RA     +   +  H +    E L Y 
Sbjct: 91  LLETYSSDG----MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 202 HEGLEVQVIYRDFKASNVLL--DENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
           H+     +I+RD K  NVLL   EN  P KL DFG+A +    G   V+   VGT  + A
Sbjct: 147 HDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGL--VAGGRVGTPHFMA 201
Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 305
           P+ ++        DVW  GV+L+ +L+G          T++RL E +
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLPFY----GTKERLFEGI 244

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLGVLEHPNLVKL 144
           IGEG FG V++  I  +  +      +   K    D +  +++ E   +   +HP++VKL
Sbjct: 18  IGEGQFGDVHQG-IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
           IG   V  E  +   ++ E      L   L  R F  L   + +      +  LAYL   
Sbjct: 77  IG---VITENPV--WIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLESK 130
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG-----YAAP 259
              + ++RD  A NVL+  N   KL DFGL+R      +   ST    + G     + AP
Sbjct: 131 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSR------YMEDSTXXKASKGKLPIKWMAP 181
Query: 260 DYIETGHLTAKSDVWSFGVVLYEML 284
           + I     T+ SDVW FGV ++E+L
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 30/219 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q        E++ L  
Sbjct: 23  YTNLSYIGEGAYGMVC------SAYDNLNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 75
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 190
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 76  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 127
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 249
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 128 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 184
Query: 250 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 185 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 80/308 (25%), Positives = 129/308 (41%), Gaps = 50/308 (16%)
Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQ-----WVAEVQFL-GVLEHP 139
           +G G FG V ++    A G D T+    VA+K L            ++E++ L  +  H 
Sbjct: 36  LGRGAFGQVIEAD---AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 92
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKT----------RLH 189
           N+V L+G C    + G   +++ EF    +L  +L ++    +P+KT            H
Sbjct: 93  NVVNLLGACT---KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEH 149
Query: 190 II---LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
           +I      A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+         
Sbjct: 150 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 206
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ---RLLE 303
                    + AP+ I     T +SDVWSFGV+L+E+ +   S        E+   RL E
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 266
Query: 304 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
             +    D               Y+  E  +      +C       RP  S++VE L  +
Sbjct: 267 GTRMRAPD---------------YTTPEMYQTML---DCWHGEPSQRPTFSELVEHLGNL 308
Query: 364 VQVSNEGD 371
           +Q + + D
Sbjct: 309 LQANAQQD 316

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 30/219 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q        E++ L  
Sbjct: 23  YTNLSYIGEGAYGMVC------SAYDNLNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 75
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 190
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 76  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 127
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-EGPMVGHTHVSTA 249
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 128 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 184
Query: 250 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 185 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 30/219 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q        E++ L  
Sbjct: 29  YTNLSYIGEGAYGMVC------SAYDNLNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 81
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 190
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 133
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 249
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 134 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTE 190
Query: 250 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 25/209 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           IG G FG V+++ +         E+  VAIKK+ +D      E+Q + +++HPN+V L  
Sbjct: 48  IGNGSFGVVFQAKL--------VESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKA 99
Query: 147 YCAVDGERGIQRLL------VYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           +   +G++  +  L      V E +   S       +  P L  K  ++ +L     LAY
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLL---RSLAY 156
Query: 201 LHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 259
           +H    + + +RD K  N+LLD  +   KL DFG A+   + G  +VS   + +  Y AP
Sbjct: 157 IH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-IAGEPNVSX--ICSRYYRAP 210
Query: 260 DYI-ETGHLTAKSDVWSFGVVLYEMLTGR 287
           + I    + T   D+WS G V+ E++ G+
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 30/219 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q        E++ L  
Sbjct: 29  YTNLSYIGEGAYGMVC------SAYDNLNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 81
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE-----DHLFNRAFPPLPWKTRLHI 190
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHI--------CYF 133
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-EGPMVGHTHVSTA 249
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 134 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 250 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 36/224 (16%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW-------------- 126
           + ++ K+G G +G V     K    +G SE  +  IKK   D  ++              
Sbjct: 38  YFKVRKLGSGAYGEVLLCKEK----NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-AFPPLPWK 185
             E+  L  L+HPN++KL        E      LV EF     L + + NR  F      
Sbjct: 94  YNEISLLKSLDHPNIIKLFDVF----EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA 149
Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN---FRPKLSDFGLAREGPMVG 242
             +  IL    G+ YLH+     +++RD K  N+LL+        K+ DFGL+       
Sbjct: 150 NIMKQILS---GICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLS---SFFS 200
Query: 243 HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
             +     +GT  Y AP+ ++  +   K DVWS GV++Y +L G
Sbjct: 201 KDYKLRDRLGTAYYIAPEVLKKKY-NEKCDVWSCGVIMYILLCG 243

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 107/219 (48%), Gaps = 29/219 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVA--EVQFLG 134
           + ++ KIGEG +G+V+K     A    T E  +VA+K++  D    G+   A  E+  L 
Sbjct: 4   YEKLEKIGEGTYGTVFK-----AKNRETHE--IVALKRVRLDDDDEGVPSSALREICLLK 56
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            L+H N+V+L      D     +  LV+EF  ++ L+ +    N    P   K+ L  +L
Sbjct: 57  ELKHKNIVRLHDVLHSDK----KLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLL 111
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
              +GL + H      V++RD K  N+L++ N   KL++FGLAR   +    +  +A V 
Sbjct: 112 ---KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVV 163
Query: 253 TFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGRRSL 290
           T  Y  PD +    L + S D+WS G +  E+    R L
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 17/213 (7%)
Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWVAEVQFLGVL 136
           T+++    ++G+G F SV +  +K   G   + A ++  KKL+ RD  +   E +   +L
Sbjct: 3   TDEYQLFEELGKGAF-SVVRRCMKIPTGQEYA-AKIINTKKLSARDHQKLEREARICRLL 60
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
           +HPN+V+L    + +G       LV++ +    L + +  R +         H I    E
Sbjct: 61  KHPNIVRLHDSISEEG----FHYLVFDLVTGGELFEDIVAREY--YSEADASHCIQQILE 114
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRP---KLSDFGLAREGPMVGHTHVSTAVVGT 253
            + + H      +++RD K  N+LL    +    KL+DFGLA E  + G         GT
Sbjct: 115 SVNHCHLN---GIVHRDLKPENLLLASKSKGAAVKLADFGLAIE--VQGDQQAWFGFAGT 169
Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            GY +P+ +         D+W+ GV+LY +L G
Sbjct: 170 PGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 27/217 (12%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLG 134
             +DF  +  +G+G FG+VY +  K           V+   +L ++G+  Q   E++   
Sbjct: 12  TIDDFDIVRPLGKGKFGNVYLAREK--QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDH-LFNRAFPPLPWKTRLH 189
            L HPN++++  Y   D +R     L+ EF     L + L+ H  F+        +    
Sbjct: 70  HLRHPNILRMYNYFH-DRKRIY---LMLEFAPRGELYKELQKHGRFDE-------QRSAT 118
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
            +   A+ L Y HE    +VI+RD K  N+L+      K++DFG +   P +        
Sbjct: 119 FMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRX 171
Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           + GT  Y  P+ IE      K D+W  GV+ YE L G
Sbjct: 172 MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 30/219 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW-----VAEVQFLGV 135
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q      + E++ L  
Sbjct: 29  YTNLSYIGEGAYGMVC------SAYDNLNKVRV-AIKKISPFEHQTYXQRTLREIKILLR 81
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 190
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 133
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 249
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 134 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTE 190
Query: 250 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 89/204 (43%), Gaps = 21/204 (10%)
Query: 87  IGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLGVLEHPN 140
           IGEG FG V    Y S   PA         +   K    D +  +++ E   +   +HP+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMA-----VAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           +VKLIG   V  E  +   ++ E      L   L  R F  L   + +      +  LAY
Sbjct: 453 IVKLIG---VITENPV--WIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAY 506
Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 260
           L      + ++RD  A NVL+  N   KL DFGL+R      +   S   +    + AP+
Sbjct: 507 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPE 562
Query: 261 YIETGHLTAKSDVWSFGVVLYEML 284
            I     T+ SDVW FGV ++E+L
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEIL 586

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQ-----WVAEVQFL-GVLEHP 139
           +G G FG V ++    A G D T+    VA+K L            ++E++ L  +  H 
Sbjct: 35  LGRGAFGQVIEAD---AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK-----------TRL 188
           N+V L+G C    + G   +++ EF    +L  +L ++    +P+K           T  
Sbjct: 92  NVVNLLGACT---KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 189 HII---LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
           H+I      A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+        
Sbjct: 149 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 205
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
                     + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWVAEVQFLGVL 136
           ++++    ++G+G F SV +  +    G   + A ++  KKL+ RD  +   E +    L
Sbjct: 4   SDNYDVKEELGKGAF-SVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREARICRKL 61
Query: 137 EHPNLVKLIGYCAVDGERGIQ----RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
           +HPN+V+L           IQ      LV++ +    L + +  R F         H I 
Sbjct: 62  QHPNIVRL--------HDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQ 111
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR---PKLSDFGLAREGPMVGHTHVSTA 249
              E +AY H      +++R+ K  N+LL    +    KL+DFGLA E   V  +     
Sbjct: 112 QILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHG 165
Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
             GT GY +P+ ++    +   D+W+ GV+LY +L G
Sbjct: 166 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 93/221 (42%), Gaps = 23/221 (10%)
Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWV 127
           M     D+  +  IG G +G   K   K       S+  ++  K+L+   +        V
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRK-------SDGKILVWKELDYGSMTEAEKQMLV 53
Query: 128 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLP 183
           +EV  L  L+HPN+V+   Y  +         +V E+     L   +      R +    
Sbjct: 54  SEVNLLRELKHPNIVRY--YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
           +  R+   L  A    +        V++RD K +NV LD     KL DFGLAR   ++ H
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR---ILNH 168
Query: 244 -THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEM 283
            T  +   VGT  Y +P+ +       KSD+WS G +LYE+
Sbjct: 169 DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWVAEVQFLGVL 136
           ++++    ++G+G F SV +  +    G   + A ++  KKL+ RD  +   E +    L
Sbjct: 5   SDNYDVKEELGKGAF-SVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREARICRKL 62
Query: 137 EHPNLVKLIGYCAVDGERGIQ----RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
           +HPN+V+L           IQ      LV++ +    L + +  R F         H I 
Sbjct: 63  QHPNIVRL--------HDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQ 112
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR---PKLSDFGLAREGPMVGHTHVSTA 249
              E +AY H      +++R+ K  N+LL    +    KL+DFGLA E   V  +     
Sbjct: 113 QILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHG 166
Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
             GT GY +P+ ++    +   D+W+ GV+LY +L G
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 93/230 (40%), Gaps = 16/230 (6%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           +G GGFG V+   +K A G   +   +   +   R G Q     + +    H   +  + 
Sbjct: 193 LGRGGFGEVFACQMK-ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 147 YCAVDGERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLAYLHEG 204
           Y     E      LV   M    +  H++N     P       +        GL +LH+ 
Sbjct: 252 YAF---ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ- 307
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET 264
               +IYRD K  NVLLD++   ++SD GLA E    G T  +    GT G+ AP+ +  
Sbjct: 308 --RNIIYRDLKPENVLLDDDGNVRISDLGLAVE-LKAGQTK-TKGYAGTPGFMAPELLLG 363
Query: 265 GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-----QRLLEWVQQYP 309
                  D ++ GV LYEM+  R        K E     QR+LE    YP
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 93/230 (40%), Gaps = 16/230 (6%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           +G GGFG V+   +K A G   +   +   +   R G Q     + +    H   +  + 
Sbjct: 193 LGRGGFGEVFACQMK-ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 147 YCAVDGERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLAYLHEG 204
           Y     E      LV   M    +  H++N     P       +        GL +LH+ 
Sbjct: 252 YAF---ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ- 307
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET 264
               +IYRD K  NVLLD++   ++SD GLA E    G T  +    GT G+ AP+ +  
Sbjct: 308 --RNIIYRDLKPENVLLDDDGNVRISDLGLAVE-LKAGQTK-TKGYAGTPGFMAPELLLG 363
Query: 265 GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-----QRLLEWVQQYP 309
                  D ++ GV LYEM+  R        K E     QR+LE    YP
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 23/212 (10%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL---NRDGLQWVAEVQFLGVLE 137
           ++ +  +G+G FG V K   +        E  V  I K    N+D    + EV+ L  L+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQ----QEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 197
           HPN++KL        E      +V E      L D +  R            II     G
Sbjct: 80  HPNIMKLFEIL----EDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSG 133
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 254
           + Y+H+     +++RD K  N+LL+   ++   K+ DFGL+               +GT 
Sbjct: 134 ITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTA 187
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            Y AP+ +  G    K DVWS GV+LY +L+G
Sbjct: 188 YYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQ-----WVAEVQFL-GVLEHP 139
           +G G FG V ++    A G D T+    VA+K L            ++E++ L  +  H 
Sbjct: 26  LGRGAFGQVIEAD---AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK-----------TRL 188
           N+V L+G C    + G   +++ EF    +L  +L ++    +P+K           T  
Sbjct: 83  NVVNLLGACT---KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 139
Query: 189 HII---LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
           H+I      A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+        
Sbjct: 140 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 196
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
                     + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWVAEVQFLGVL 136
           ++++    ++G+G F SV +  +    G   + A ++  KKL+ RD  +   E +    L
Sbjct: 5   SDNYDVKEELGKGAF-SVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREARICRKL 62
Query: 137 EHPNLVKLIGYCAVDGERGIQ----RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
           +HPN+V+L           IQ      LV++ +    L + +  R F         H I 
Sbjct: 63  QHPNIVRL--------HDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQ 112
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR---PKLSDFGLAREGPMVGHTHVSTA 249
              E +AY H      +++R+ K  N+LL    +    KL+DFGLA E   V  +     
Sbjct: 113 QILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHG 166
Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
             GT GY +P+ ++    +   D+W+ GV+LY +L G
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 115/285 (40%), Gaps = 29/285 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-WVAEVQFLGVLEHPNLVKLI 145
           +GEG FG VY+       G+  + A     K    D  + +++E   +  L+HP++VKLI
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL 205
           G    +    I  L  Y  +       H   R    L   T +   L   + +AYL    
Sbjct: 76  GIIEEEPTWIIMELYPYGEL------GHYLERNKNSLKVLTLVLYSLQICKAMAYLES-- 127
Query: 206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG 265
            +  ++RD    N+L+      KL DFGL+R      +   S   +    + +P+ I   
Sbjct: 128 -INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL-PIKWMSPESINFR 185
Query: 266 HLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLE 324
             T  SDVW F V ++E+L+ G++       K    +LE   + P        +  P L 
Sbjct: 186 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPD-----LCPPVL- 239
Query: 325 KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNE 369
             Y+         L   C      DRP+ +++V  L  + Q+  +
Sbjct: 240 --YT---------LMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 273

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 93/230 (40%), Gaps = 16/230 (6%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           +G GGFG V+   +K A G   +   +   +   R G Q     + +    H   +  + 
Sbjct: 193 LGRGGFGEVFACQMK-ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 147 YCAVDGERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLAYLHEG 204
           Y     E      LV   M    +  H++N     P       +        GL +LH+ 
Sbjct: 252 YAF---ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ- 307
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET 264
               +IYRD K  NVLLD++   ++SD GLA E    G T  +    GT G+ AP+ +  
Sbjct: 308 --RNIIYRDLKPENVLLDDDGNVRISDLGLAVE-LKAGQTK-TKGYAGTPGFMAPELLLG 363
Query: 265 GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-----QRLLEWVQQYP 309
                  D ++ GV LYEM+  R        K E     QR+LE    YP
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 74  MRQATNDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE 129
           ++    D+  +  IG G FG V    +K+S K  A    S+  ++   K +     W  E
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMI---KRSDSAFFW-EE 125
Query: 130 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 189
              +     P +V+L  +CA   ++ +   +V E+M    L + + N   P   W     
Sbjct: 126 RDIMAFANSPWVVQL--FCAFQDDKYL--YMVMEYMPGGDLVNLMSNYDVPE-KWAK--- 177
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
                AE +  L     + +I+RD K  N+LLD++   KL+DFG   +    G  H  TA
Sbjct: 178 --FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA 235
Query: 250 VVGTFGYAAPDYIET----GHLTAKSDVWSFGVVLYEMLTG 286
            VGT  Y +P+ +++    G+   + D WS GV L+EML G
Sbjct: 236 -VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 93/230 (40%), Gaps = 16/230 (6%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           +G GGFG V+   +K A G   +   +   +   R G Q     + +    H   +  + 
Sbjct: 193 LGRGGFGEVFACQMK-ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 147 YCAVDGERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLAYLHEG 204
           Y     E      LV   M    +  H++N     P       +        GL +LH+ 
Sbjct: 252 YAF---ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ- 307
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET 264
               +IYRD K  NVLLD++   ++SD GLA E    G T  +    GT G+ AP+ +  
Sbjct: 308 --RNIIYRDLKPENVLLDDDGNVRISDLGLAVE-LKAGQTK-TKGYAGTPGFMAPELLLG 363
Query: 265 GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-----QRLLEWVQQYP 309
                  D ++ GV LYEM+  R        K E     QR+LE    YP
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 115/285 (40%), Gaps = 29/285 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-WVAEVQFLGVLEHPNLVKLI 145
           +GEG FG VY+       G+  + A     K    D  + +++E   +  L+HP++VKLI
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL 205
           G    +    I  L  Y  +       H   R    L   T +   L   + +AYL    
Sbjct: 80  GIIEEEPTWIIMELYPYGEL------GHYLERNKNSLKVLTLVLYSLQICKAMAYLES-- 131
Query: 206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG 265
            +  ++RD    N+L+      KL DFGL+R      +   S   +    + +P+ I   
Sbjct: 132 -INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL-PIKWMSPESINFR 189
Query: 266 HLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLE 324
             T  SDVW F V ++E+L+ G++       K    +LE   + P        +  P L 
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPD-----LCPPVL- 243
Query: 325 KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNE 369
             Y+         L   C      DRP+ +++V  L  + Q+  +
Sbjct: 244 --YT---------LMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 75  RQATNDFSRM-LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFL 133
           R A +DF  +  ++G G    VY+   K     GT +   + + K   D      E+  L
Sbjct: 48  RDALSDFFEVESELGRGATSIVYRCKQK-----GTQKPYALKVLKKTVDKKIVRTEIGVL 102
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L HPN++KL        E      LV E +    L D +  + +     +     +  
Sbjct: 103 LRLSHPNIIKLKEIFETPTEIS----LVLELVTGGELFDRIVEKGY--YSERDAADAVKQ 156
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDE---NFRPKLSDFGLAREGPMVGHTHVSTAV 250
             E +AYLHE     +++RD K  N+L      +   K++DFGL++   +V H  +   V
Sbjct: 157 ILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSK---IVEHQVLMKTV 210
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            GT GY AP+ +       + D+WS G++ Y +L G
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQ-----WVAEVQFL-GVLEHP 139
           +G G FG V ++    A G D T+    VA+K L            ++E++ L  +  H 
Sbjct: 26  LGRGAFGQVIEAD---AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK-----------TRL 188
           N+V L+G C    + G   +++ EF    +L  +L ++    +P+K           T  
Sbjct: 83  NVVNLLGACT---KPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 139
Query: 189 HII---LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
           H+I      A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+        
Sbjct: 140 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 196
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
                     + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 23/212 (10%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL---NRDGLQWVAEVQFLGVLE 137
           ++ +  +G+G FG V K   +        E  V  I K    N+D    + EV+ L  L+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQ----QEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 197
           HPN++KL        E      +V E      L D +  R            II     G
Sbjct: 80  HPNIMKLFEIL----EDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSG 133
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 254
           + Y+H+     +++RD K  N+LL+   ++   K+ DFGL+               +GT 
Sbjct: 134 ITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTA 187
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            Y AP+ +  G    K DVWS GV+LY +L+G
Sbjct: 188 YYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 115/285 (40%), Gaps = 29/285 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-WVAEVQFLGVLEHPNLVKLI 145
           +GEG FG VY+       G+  + A     K    D  + +++E   +  L+HP++VKLI
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL 205
           G    +    I  L  Y  +       H   R    L   T +   L   + +AYL    
Sbjct: 92  GIIEEEPTWIIMELYPYGEL------GHYLERNKNSLKVLTLVLYSLQICKAMAYLES-- 143
Query: 206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG 265
            +  ++RD    N+L+      KL DFGL+R      +   S   +    + +P+ I   
Sbjct: 144 -INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL-PIKWMSPESINFR 201
Query: 266 HLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLE 324
             T  SDVW F V ++E+L+ G++       K    +LE   + P        +  P L 
Sbjct: 202 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPD-----LCPPVL- 255
Query: 325 KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNE 369
             Y+         L   C      DRP+ +++V  L  + Q+  +
Sbjct: 256 --YT---------LMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 289

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 29/213 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-------WVAEVQFL 133
           ++R  KIG+G  G+VY +++  A G        VAI+++N   LQ        + E+  +
Sbjct: 22  YTRFEKIGQGASGTVY-TAMDVATGQE------VAIRQMN---LQQQPKKELIINEILVM 71
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
              ++PN+V  +    V    G +  +V E++   SL D +                 L 
Sbjct: 72  RENKNPNIVNYLDSYLV----GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ 127
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
           A E   +LH     QVI+RD K+ N+LL  +   KL+DFG   +  +       + +VGT
Sbjct: 128 ALE---FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGT 179
Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
             + AP+ +       K D+WS G++  EM+ G
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQ-----WVAEVQFL-GVLEHP 139
           +G G FG V ++    A G D T+    VA+K L            ++E++ L  +  H 
Sbjct: 35  LGRGAFGQVIEAD---AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK-----------TRL 188
           N+V L+G C    + G   +++ EF    +L  +L ++    +P+K           T  
Sbjct: 92  NVVNLLGACT---KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 189 HII---LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
           H+I      A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+        
Sbjct: 149 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXV 205
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
                     + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 29/213 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-------WVAEVQFL 133
           ++R  KIG+G  G+VY +++  A G        VAI+++N   LQ        + E+  +
Sbjct: 23  YTRFEKIGQGASGTVY-TAMDVATGQE------VAIRQMN---LQQQPKKELIINEILVM 72
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
              ++PN+V  +    V    G +  +V E++   SL D +                 L 
Sbjct: 73  RENKNPNIVNYLDSYLV----GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ 128
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
           A E   +LH     QVI+RD K+ N+LL  +   KL+DFG   +  +       + +VGT
Sbjct: 129 ALE---FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSXMVGT 180
Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
             + AP+ +       K D+WS G++  EM+ G
Sbjct: 181 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 213

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQ-----WVAEVQFL-GVLEHP 139
           +G G FG V ++    A G D T+    VA+K L            ++E++ L  +  H 
Sbjct: 37  LGRGAFGQVIEAD---AFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK---------TRLHI 190
           N+V L+G C    + G   +++ EF    +L  +L ++    +P+K         T  H+
Sbjct: 94  NVVNLLGACT---KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHL 150
Query: 191 I---LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 247
           I      A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+          
Sbjct: 151 IXYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 248 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
                   + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 29/213 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-------WVAEVQFL 133
           ++R  KIG+G  G+VY +++  A G        VAI+++N   LQ        + E+  +
Sbjct: 22  YTRFEKIGQGASGTVY-TAMDVATGQE------VAIRQMN---LQQQPKKELIINEILVM 71
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
              ++PN+V  +    V    G +  +V E++   SL D +                 L 
Sbjct: 72  RENKNPNIVNYLDSYLV----GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ 127
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
           A E   +LH     QVI+RD K+ N+LL  +   KL+DFG   +  +       + +VGT
Sbjct: 128 ALE---FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSXMVGT 179
Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
             + AP+ +       K D+WS G++  EM+ G
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 17/213 (7%)
Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWVAEVQFLGVL 136
           T+++    ++G+G F SV +  +K   G   + A ++  KKL+ RD  +   E +   +L
Sbjct: 3   TDEYQLFEELGKGAF-SVVRRCMKIPTGQEYA-AKIINTKKLSARDHQKLEREARICRLL 60
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
           +HPN+V+L    + +G       LV++ +    L + +  R +         H I    E
Sbjct: 61  KHPNIVRLHDSISEEG----FHYLVFDLVTGGELFEDIVAREY--YSEADASHCIQQILE 114
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFR---PKLSDFGLAREGPMVGHTHVSTAVVGT 253
            + + H      +++RD K  N+LL    +    KL+DFGLA E  + G         GT
Sbjct: 115 SVNHCHLN---GIVHRDLKPENLLLASKSKGAAVKLADFGLAIE--VQGDQQAWFGFAGT 169
Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            GY +P+ +         D+W+ GV+LY +L G
Sbjct: 170 PGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 30/219 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           ++ +  IGEG +G V       +A D  ++  V AI+K++    Q        E++ L  
Sbjct: 29  YTNLSYIGEGAYGMVC------SAYDNLNKVRV-AIRKISPFEHQTYCQRTLREIKILLR 81
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 190
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 133
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-EGPMVGHTHVSTA 249
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 134 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 250 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 35/216 (16%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----WVAEVQFLGVL 136
               +KIGEG  G V  ++++       S   +VA+KK++    Q       EV  +   
Sbjct: 31  LDNFIKIGEGSTGIVCIATVR-------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 83
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH------I 190
           +H N+V++     V  E  +    V EF+   +L D + +         TR++      +
Sbjct: 84  QHENVVEMYNSYLVGDELWV----VMEFLEGGALTDIVTH---------TRMNEEQIAAV 130
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
            L   + L+ LH      VI+RD K+ ++LL  + R KLSDFG   +  +         +
Sbjct: 131 CLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXL 185
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           VGT  + AP+ I       + D+WS G+++ EM+ G
Sbjct: 186 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 221

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 35/216 (16%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----WVAEVQFLGVL 136
               +KIGEG  G V  ++++       S   +VA+KK++    Q       EV  +   
Sbjct: 76  LDNFIKIGEGSTGIVCIATVR-------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 128
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH------I 190
           +H N+V++     V    G +  +V EF+   +L D + +         TR++      +
Sbjct: 129 QHENVVEMYNSYLV----GDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAV 175
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
            L   + L+ LH      VI+RD K+ ++LL  + R KLSDFG   +  +         +
Sbjct: 176 CLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXL 230
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           VGT  + AP+ I       + D+WS G+++ EM+ G
Sbjct: 231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 266

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 29/213 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW-------VAEVQFL 133
           ++R  KIG+G  G+VY +++  A G        VAI+++N   LQ        + E+  +
Sbjct: 22  YTRFEKIGQGASGTVY-TAMDVATGQE------VAIRQMN---LQQQPKKELIINEILVM 71
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
              ++PN+V  +    V    G +  +V E++   SL D +                 L 
Sbjct: 72  RENKNPNIVNYLDSYLV----GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ 127
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
           A E   +LH     QVI+RD K+ N+LL  +   KL+DFG   +  +       + +VGT
Sbjct: 128 ALE---FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSEMVGT 179
Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
             + AP+ +       K D+WS G++  EM+ G
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQ-----WVAEVQFL-GVLEHP 139
           +G G FG V ++    A G D T+    VA+K L            ++E++ L  +  H 
Sbjct: 35  LGRGAFGQVIEAD---AFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           N+V L+G C    + G   +++ EF    +L  +L ++    +P+K      L     + 
Sbjct: 92  NVVNLLGACT---KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIC 148
Query: 200 Y---LHEGLEV----QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
           Y   + +G+E     + I+RD  A N+LL E    K+ DFGLAR+               
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
              + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 35/216 (16%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----WVAEVQFLGVL 136
               +KIGEG  G V  ++++       S   +VA+KK++    Q       EV  +   
Sbjct: 33  LDNFIKIGEGSTGIVCIATVR-------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 85
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH------I 190
           +H N+V++     V  E  +    V EF+   +L D + +         TR++      +
Sbjct: 86  QHENVVEMYNSYLVGDELWV----VMEFLEGGALTDIVTH---------TRMNEEQIAAV 132
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
            L   + L+ LH      VI+RD K+ ++LL  + R KLSDFG   +  +         +
Sbjct: 133 CLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXL 187
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           VGT  + AP+ I       + D+WS G+++ EM+ G
Sbjct: 188 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 223

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 129/309 (41%), Gaps = 51/309 (16%)
Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQ-----WVAEVQFL-GVLEHP 139
           +G G FG V ++    A G D T+    VA+K L            ++E++ L  +  H 
Sbjct: 37  LGRGAFGQVIEAD---AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK-----------TRL 188
           N+V L+G C    + G   +++ EF    +L  +L ++    +P+K           T  
Sbjct: 94  NVVNLLGACT---KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLE 150
Query: 189 HII---LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
           H+I      A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+        
Sbjct: 151 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 207
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ---RLL 302
                     + AP+ I     T +SDVWSFGV+L+E+ +   S        E+   RL 
Sbjct: 208 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 267
Query: 303 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ 362
           E  +    D               Y+  E  +      +C       RP  S++VE L  
Sbjct: 268 EGTRMRAPD---------------YTTPEMYQTML---DCWHGEPSQRPTFSELVEHLGN 309
Query: 363 IVQVSNEGD 371
           ++Q + + D
Sbjct: 310 LLQANAQQD 318

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 127/288 (44%), Gaps = 43/288 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQWVAEVQFLGVLEHPNLV 142
           +G+G +G VY       AG   S    +AIK++    +R       E+     L+H N+V
Sbjct: 30  LGKGTYGIVY-------AGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIV 82
Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP--WKTRLHIILGAAEGLAY 200
           + +G  +   E G  ++ + E +   SL   L    + PL    +T         EGL Y
Sbjct: 83  QYLGSFS---ENGFIKIFM-EQVPGGSLS-ALLRSKWGPLKDNEQTIGFYTKQILEGLKY 137
Query: 201 LHEGLEVQVIYRDFKASNVLLDE-NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 259
           LH+    Q+++RD K  NVL++  +   K+SDFG ++   + G    +    GT  Y AP
Sbjct: 138 LHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAP 192
Query: 260 DYIETG--HLTAKSDVWSFGVVLYEMLTGRRSL-ERNRPKTEQRLLEWVQQYP------- 309
           + I+ G       +D+WS G  + EM TG+    E   P+     +   + +P       
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMS 252
Query: 310 ADSKKFGL-IMDPRLEKEYSINEARKIGRLADNCL---SKSSKDRPKM 353
           A++K F L   +P  +K    N+      L D  L   SK  K +PK+
Sbjct: 253 AEAKAFILKCFEPDPDKRACANDL-----LVDEFLKVSSKKKKTQPKL 295

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 90/218 (41%), Gaps = 29/218 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQFL 133
           F  +  IG+G FG V                 + A+K +N+              E+Q +
Sbjct: 17  FEILRAIGKGSFGKV-------CIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIM 69
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             LEHP LV L  Y   D E      +V + +L   L  HL          +T    I  
Sbjct: 70  QGLEHPFLVNL-WYSFQDEE---DMFMVVDLLLGGDLRYHLQQNVH--FKEETVKLFICE 123
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
               L YL      ++I+RD K  N+LLDE+    ++DF +A   P    T ++T + GT
Sbjct: 124 LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP--RETQITT-MAGT 177
Query: 254 FGYAAPDYIETGHLTAKS---DVWSFGVVLYEMLTGRR 288
             Y AP+   +      S   D WS GV  YE+L GRR
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 129/309 (41%), Gaps = 51/309 (16%)
Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQ-----WVAEVQFL-GVLEHP 139
           +G G FG V ++    A G D T+    VA+K L            ++E++ L  +  H 
Sbjct: 35  LGRGAFGQVIEAD---AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK-----------TRL 188
           N+V L+G C    + G   +++ EF    +L  +L ++    +P+K           T  
Sbjct: 92  NVVNLLGACT---KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 189 HII---LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
           H+I      A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+        
Sbjct: 149 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ---RLL 302
                     + AP+ I     T +SDVWSFGV+L+E+ +   S        E+   RL 
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265
Query: 303 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ 362
           E  +    D               Y+  E  +      +C       RP  S++VE L  
Sbjct: 266 EGTRMRAPD---------------YTTPEMYQTML---DCWHGEPSQRPTFSELVEHLGN 307
Query: 363 IVQVSNEGD 371
           ++Q + + D
Sbjct: 308 LLQANAQQD 316

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 112/244 (45%), Gaps = 36/244 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQWVA--EVQFLG 134
           + ++ KIG+G FG V+K+  +            VA+KK+     ++G    A  E++ L 
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQK-------VALKKVLMENEKEGFPITALREIKILQ 72
Query: 135 VLEHPNLVKLIGYCAVDGE-----RGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKT 186
           +L+H N+V LI  C          +G    LV++F    L   L + L       +  K 
Sbjct: 73  LLKHENVVNLIEICRTKASPYNRCKG-SIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KR 129
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            + ++L    GL Y+H     ++++RD KA+NVL+  +   KL+DFGLAR   +  ++  
Sbjct: 130 VMQMLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 247 STAV--VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE 303
           +     V T  Y  P+  +         D+W  G ++ EM T    ++ N   TEQ  L 
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN---TEQHQLA 240
Query: 304 WVQQ 307
            + Q
Sbjct: 241 LISQ 244

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQ-----WVAEVQFL-GVLEHP 139
           +G G FG V ++    A G D T+    VA+K L            ++E++ L  +  H 
Sbjct: 26  LGRGAFGQVIEAD---AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK-----------TRL 188
           N+V L+G C    + G   +++ EF    +L  +L ++    +P+K           T  
Sbjct: 83  NVVNLLGACT---KPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 139
Query: 189 HII---LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
           H+I      A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+        
Sbjct: 140 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 196
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
                     + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  IG G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 29  YQNLSPIGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 82  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 125
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR---- 178
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 179 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 90/211 (42%), Gaps = 32/211 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           +G+G FG V     K    +   +       K   D    + EVQ L  L+HPN+ KL  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYE 93
Query: 147 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYLHEGL 205
           +    G       LV E      L D + +R  F  +       II     G+ Y H+  
Sbjct: 94  FFEDKG----YFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSGITYXHKN- 145
Query: 206 EVQVIYRDFKASNVLL-----DENFRPKLSDFGLAREGPMVGHTHVSTAV-----VGTFG 255
             ++++RD K  N+LL     D N R  + DFGL+        TH   +      +GT  
Sbjct: 146 --KIVHRDLKPENLLLESKSKDANIR--IIDFGLS--------THFEASKKXKDKIGTAY 193
Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           Y AP+ +  G    K DVWS GV+LY +L+G
Sbjct: 194 YIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQ-----WVAEVQFL-GVLEHP 139
           +G G FG V ++    A G D T+    VA+K L            ++E++ L  +  H 
Sbjct: 26  LGRGAFGQVIEAD---AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK-----------TRL 188
           N+V L+G C    + G   +++ EF    +L  +L ++    +P+K           T  
Sbjct: 83  NVVNLLGACT---KPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 139
Query: 189 HII---LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
           H+I      A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+        
Sbjct: 140 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 196
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
                     + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLGVLEHPNLVKL 144
           IGEG FG V++  I  +  +      +   K    D +  +++ E   +   +HP++VKL
Sbjct: 18  IGEGQFGDVHQG-IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
           IG   V  E  +   ++ E      L   L  R +  L   + +      +  LAYL   
Sbjct: 77  IG---VITENPV--WIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESK 130
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET 264
              + ++RD  A NVL+  N   KL DFGL+R      +   S   +    + AP+ I  
Sbjct: 131 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINF 186
Query: 265 GHLTAKSDVWSFGVVLYEML 284
              T+ SDVW FGV ++E+L
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQ 120
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 53/96 (55%), Gaps = 8/96 (8%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR---EGPMVGHTHVSTAVVGT 253
           GL Y+H     QVI+RD K SN+L++EN   K+ DFG+AR     P   H +  T  V T
Sbjct: 171 GLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP-AEHQYFMTEYVAT 226
Query: 254 FGYAAPDYIETGH-LTAKSDVWSFGVVLYEMLTGRR 288
             Y AP+ + + H  T   D+WS G +  EML  R+
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 129/309 (41%), Gaps = 51/309 (16%)
Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQ-----WVAEVQFL-GVLEHP 139
           +G G FG V ++    A G D T+    VA+K L            ++E++ L  +  H 
Sbjct: 72  LGRGAFGQVIEAD---AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 128
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK-----------TRL 188
           N+V L+G C    + G   +++ EF    +L  +L ++    +P+K           T  
Sbjct: 129 NVVNLLGACT---KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 185
Query: 189 HII---LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
           H+I      A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+        
Sbjct: 186 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 242
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ---RLL 302
                     + AP+ I     T +SDVWSFGV+L+E+ +   S        E+   RL 
Sbjct: 243 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 302
Query: 303 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ 362
           E  +    D               Y+  E  +      +C       RP  S++VE L  
Sbjct: 303 EGTRMRAPD---------------YTTPEMYQT---MLDCWHGEPSQRPTFSELVEHLGN 344
Query: 363 IVQVSNEGD 371
           ++Q + + D
Sbjct: 345 LLQANAQQD 353

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQ 120
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR---- 173
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 89/204 (43%), Gaps = 21/204 (10%)
Query: 87  IGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLGVLEHPN 140
           IGEG FG V    Y S   PA         +   K    D +  +++ E   +   +HP+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALA-----VAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 69
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           +VKLIG   V  E  +   ++ E      L   L  R +  L   + +      +  LAY
Sbjct: 70  IVKLIG---VITENPV--WIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAY 123
Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 260
           L      + ++RD  A NVL+  N   KL DFGL+R      +   S   +    + AP+
Sbjct: 124 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPE 179
Query: 261 YIETGHLTAKSDVWSFGVVLYEML 284
            I     T+ SDVW FGV ++E+L
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEIL 203

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 53/96 (55%), Gaps = 8/96 (8%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR---EGPMVGHTHVSTAVVGT 253
           GL Y+H     QVI+RD K SN+L++EN   K+ DFG+AR     P   H +  T  V T
Sbjct: 170 GLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP-AEHQYFMTEYVAT 225
Query: 254 FGYAAPDYIETGH-LTAKSDVWSFGVVLYEMLTGRR 288
             Y AP+ + + H  T   D+WS G +  EML  R+
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 89/204 (43%), Gaps = 21/204 (10%)
Query: 87  IGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLGVLEHPN 140
           IGEG FG V    Y S   PA         +   K    D +  +++ E   +   +HP+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALA-----VAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 74
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           +VKLIG   V  E  +   ++ E      L   L  R +  L   + +      +  LAY
Sbjct: 75  IVKLIG---VITENPV--WIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAY 128
Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 260
           L      + ++RD  A NVL+  N   KL DFGL+R      +   S   +    + AP+
Sbjct: 129 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPE 184
Query: 261 YIETGHLTAKSDVWSFGVVLYEML 284
            I     T+ SDVW FGV ++E+L
Sbjct: 185 SINFRRFTSASDVWMFGVCMWEIL 208

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 35/216 (16%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----WVAEVQFLGVL 136
               +KIGEG  G V  ++++       S   +VA+KK++    Q       EV  +   
Sbjct: 22  LDNFIKIGEGSTGIVCIATVR-------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 74
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH------I 190
           +H N+V++     V  E  +    V EF+   +L D + +         TR++      +
Sbjct: 75  QHENVVEMYNSYLVGDELWV----VMEFLEGGALTDIVTH---------TRMNEEQIAAV 121
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
            L   + L+ LH      VI+RD K+ ++LL  + R KLSDFG   +  +         +
Sbjct: 122 CLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXL 176
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           VGT  + AP+ I       + D+WS G+++ EM+ G
Sbjct: 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQ-----WVAEVQFL-GVLEHP 139
           +G G FG V ++    A G D T+    VA+K L            ++E++ L  +  H 
Sbjct: 35  LGRGAFGQVIEAD---AFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK-------TRLHII- 191
           N+V L+G C    + G   +++ EF    +L  +L ++    +P+K       T  H+I 
Sbjct: 92  NVVNLLGACT---KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIX 148
Query: 192 --LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
                A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+            
Sbjct: 149 YSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGD 205
Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
                 + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 206 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 123/294 (41%), Gaps = 49/294 (16%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHP 139
           DF  +  IG GGFG V+K+  +    DG +      IK++  +  +   EV+ L  L+H 
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRI---DGKT----YVIKRVKYNNEKAEREVKALAKLDHV 64
Query: 140 NLVKLIG----------YCAVDGERGIQRLLV--YEFMLNRSLEDHLFNRAFPPLPWKTR 187
           N+V   G            + +  R   + L    EF    +LE  +  R    L     
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 188 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 247
           L +     +G+ Y+H     ++I RD K SN+ L +  + K+ DFGL       G    S
Sbjct: 125 LELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS 181
Query: 248 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML-TGRRSLERNRPKTEQRLLEWVQ 306
               GT  Y +P+ I +     + D+++ G++L E+L     + E ++  T+ R      
Sbjct: 182 K---GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLR------ 232
Query: 307 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL 360
                    G+I D   +KE +         L    LSK  +DRP  S+++  L
Sbjct: 233 --------DGIISDIFDKKEKT---------LLQKLLSKKPEDRPNTSEILRTL 269

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 34  YQNLAPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 86
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 87  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 130
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 131 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 183
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 184 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 112/244 (45%), Gaps = 36/244 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQWVA--EVQFLG 134
           + ++ KIG+G FG V+K+  +            VA+KK+     ++G    A  E++ L 
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQK-------VALKKVLMENEKEGFPITALREIKILQ 71
Query: 135 VLEHPNLVKLIGYCAVDGE-----RGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKT 186
           +L+H N+V LI  C          +G    LV++F    L   L + L       +  K 
Sbjct: 72  LLKHENVVNLIEICRTKASPYNRCKG-SIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KR 128
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            + ++L    GL Y+H     ++++RD KA+NVL+  +   KL+DFGLAR   +  ++  
Sbjct: 129 VMQMLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 247 STAV--VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE 303
           +     V T  Y  P+  +         D+W  G ++ EM T    ++ N   TEQ  L 
Sbjct: 183 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN---TEQHQLA 239
Query: 304 WVQQ 307
            + Q
Sbjct: 240 LISQ 243

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 56/230 (24%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 30  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 83  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 126
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 238
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 183
Query: 239 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 184 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 30/219 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q        E++ L  
Sbjct: 29  YTNLSYIGEGAYGMVC------SAYDNLNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 81
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 190
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 133
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 249
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT     
Sbjct: 134 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXE 190
Query: 250 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 191 XVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 43/220 (19%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----WVAEVQFLGVL 136
               +KIGEG  G V  ++++       S   +VA+KK++    Q       EV  +   
Sbjct: 26  LDNFIKIGEGSTGIVCIATVR-------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 78
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH------I 190
           +H N+V++     V  E  +    V EF+   +L D + +         TR++      +
Sbjct: 79  QHENVVEMYNSYLVGDELWV----VMEFLEGGALTDIVTH---------TRMNEEQIAAV 125
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG----LAREGPMVGHTHV 246
            L   + L+ LH      VI+RD K+ ++LL  + R KLSDFG    +++E P       
Sbjct: 126 CLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------ 176
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
              +VGT  + AP+ I       + D+WS G+++ EM+ G
Sbjct: 177 RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 216

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 30/219 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGV 135
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q        E++ L  
Sbjct: 30  YTNLSYIGEGAYGMVC------SAYDNLNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 82
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 190
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 83  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 134
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 249
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT     
Sbjct: 135 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXE 191
Query: 250 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 287
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 192 XVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 28/240 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA--EVQFLGVLEH 138
           + ++ KIG+G FG V+K+  +     G   A    + +  ++G    A  E++ L +L+H
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKT---GQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 139 PNLVKLIGYCAVDGE-----RGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHI 190
            N+V LI  C          +G    LV++F    L   L + L       +  K  + +
Sbjct: 77  ENVVNLIEICRTKASPYNRCKG-SIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQM 133
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +L    GL Y+H     ++++RD KA+NVL+  +   KL+DFGLAR   +  ++  +   
Sbjct: 134 LLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 251 --VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 307
             V T  Y  P+  +         D+W  G ++ EM T    ++ N   TEQ  L  + Q
Sbjct: 188 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN---TEQHQLALISQ 244

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 31  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 84  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 127
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 180
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 181 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 89/204 (43%), Gaps = 21/204 (10%)
Query: 87  IGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLGVLEHPN 140
           IGEG FG V    Y S   PA         +   K    D +  +++ E   +   +HP+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALA-----VAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 72
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           +VKLIG   V  E  +   ++ E      L   L  R +  L   + +      +  LAY
Sbjct: 73  IVKLIG---VITENPV--WIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAY 126
Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 260
           L      + ++RD  A NVL+  N   KL DFGL+R      +   S   +    + AP+
Sbjct: 127 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPE 182
Query: 261 YIETGHLTAKSDVWSFGVVLYEML 284
            I     T+ SDVW FGV ++E+L
Sbjct: 183 SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 35  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 87
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 88  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 131
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 132 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 184
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 185 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 100/239 (41%), Gaps = 28/239 (11%)
Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQF 132
           ++DF     +GEG +G V  ++ KP          +VAIKK+         L+ + E++ 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTG-------EIVAIKKIEPFDKPLFALRTLREIKI 62
Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
           L   +H N++ +      D       + + + ++   L   +  +    L      + I 
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM---LSDDHIQYFIY 119
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--------EGPMVGHT 244
                +  LH      VI+RD K SN+L++ N   K+ DFGLAR             G  
Sbjct: 120 QTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 302
              T  V T  Y AP+ + T    +++ DVWS G +L E+   RR +   R    Q LL
Sbjct: 177 SGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLLL 234

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 29  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 82  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 125
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 178
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 179 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 23  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 75
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 76  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 119
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 120 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 172
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 173 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 100/239 (41%), Gaps = 28/239 (11%)
Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQF 132
           ++DF     +GEG +G V  ++ KP          +VAIKK+         L+ + E++ 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTG-------EIVAIKKIEPFDKPLFALRTLREIKI 62
Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
           L   +H N++ +      D       + + + ++   L   +  +    L      + I 
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM---LSDDHIQYFIY 119
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--------EGPMVGHT 244
                +  LH      VI+RD K SN+L++ N   K+ DFGLAR             G  
Sbjct: 120 QTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 302
              T  V T  Y AP+ + T    +++ DVWS G +L E+   RR +   R    Q LL
Sbjct: 177 SGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLLL 234

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 89/204 (43%), Gaps = 21/204 (10%)
Query: 87  IGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLGVLEHPN 140
           IGEG FG V    Y S   PA         +   K    D +  +++ E   +   +HP+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALA-----VAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 75
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           +VKLIG   V  E  +   ++ E      L   L  R +  L   + +      +  LAY
Sbjct: 76  IVKLIG---VITENPV--WIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAY 129
Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 260
           L      + ++RD  A NVL+  N   KL DFGL+R      +   S   +    + AP+
Sbjct: 130 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPE 185
Query: 261 YIETGHLTAKSDVWSFGVVLYEML 284
            I     T+ SDVW FGV ++E+L
Sbjct: 186 SINFRRFTSASDVWMFGVCMWEIL 209

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 56/230 (24%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 238
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 239 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 178 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 30  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 83  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 126
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 179
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 180 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 26  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 79  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 122
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 175
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 176 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 36  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 88
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 89  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 132
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 133 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 185
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 186 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 36  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 88
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 89  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 132
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 133 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 185
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 186 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 110/243 (45%), Gaps = 34/243 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQWVA--EVQFLG 134
           + ++ KIG+G FG V+K+  +            VA+KK+     ++G    A  E++ L 
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQK-------VALKKVLMENEKEGFPITALREIKILQ 72
Query: 135 VLEHPNLVKLIGYCAVDGER----GIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTR 187
           +L+H N+V LI  C               LV++F    L   L + L       +  K  
Sbjct: 73  LLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRV 130
Query: 188 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 247
           + ++L    GL Y+H     ++++RD KA+NVL+  +   KL+DFGLAR   +  ++  +
Sbjct: 131 MQMLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 248 TAV--VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW 304
                V T  Y  P+  +         D+W  G ++ EM T    ++ N   TEQ  L  
Sbjct: 185 RYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN---TEQHQLAL 241
Query: 305 VQQ 307
           + Q
Sbjct: 242 ISQ 244

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 31  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 84  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 127
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 180
Query: 241 VGHT-HVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 181 --HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 26  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 79  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 122
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 175
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 176 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 27/217 (12%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLG 134
             +DF     +G+G FG+VY +  K           V+   +L ++G+  Q   E++   
Sbjct: 13  TIDDFDIGRPLGKGKFGNVYLAREK--QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 70
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDH-LFNRAFPPLPWKTRLH 189
            L HPN++++  Y   D +R     L+ EF     L + L+ H  F+        +    
Sbjct: 71  HLRHPNILRMYNYFH-DRKRIY---LMLEFAPRGELYKELQKHGRFDE-------QRSAT 119
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
            +   A+ L Y HE    +VI+RD K  N+L+      K++DFG +   P +        
Sbjct: 120 FMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRX 172
Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           + GT  Y  P+ IE      K D+W  GV+ YE L G
Sbjct: 173 MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 31  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 84  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 127
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 180
Query: 241 VGHT-HVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 181 --HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA--EVQFLGVLEHPNLVK 143
           K+G G +G VYK+  K        +    A+K++   G+   A  E+  L  L+HPN++ 
Sbjct: 28  KVGRGTYGHVYKAKRK-----DGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVIS 82
Query: 144 LIGYCAVDGERGIQRLLVY-EFMLNRSLEDHLFNRA------FPPLPWKTRLHIILGAAE 196
           L        +R +  L  Y E  L   ++ H  ++A       P    K+ L+ IL   +
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL---D 139
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLL----DENFRPKLSDFGLAR--EGPMVGHTHVSTAV 250
           G+ YLH      V++RD K +N+L+     E  R K++D G AR    P+     +   V
Sbjct: 140 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 251 VGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTG 286
           V TF Y AP+ +    H T   D+W+ G +  E+LT 
Sbjct: 197 V-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 26  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 79  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 122
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 175
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 176 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 29  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 82  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 125
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR---- 178
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 179 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 35  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 87
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 88  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 131
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 132 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR---- 184
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 185 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 31  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 84  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 127
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 180
Query: 241 VGHT-HVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 181 --HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 43  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 95
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 96  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 139
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 140 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 192
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 193 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 56/230 (24%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 30  YQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 83  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 126
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 238
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 183
Query: 239 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 184 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           IG G FG VY++ +            +VAIKK+ +D      E+Q +  L+H N+V+L  
Sbjct: 62  IGNGSFGVVYQAKL-------CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRY 114
Query: 147 YCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +    GE+     +  +L Y       +  H ++RA   LP       +      LAY+H
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 203 EGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 261
                 + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y AP+ 
Sbjct: 174 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYRAPEL 227
Query: 262 I-ETGHLTAKSDVWSFGVVLYEMLTGR 287
           I      T+  DVWS G VL E+L G+
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 44  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 97  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 140
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 141 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 193
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 194 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 89/204 (43%), Gaps = 21/204 (10%)
Query: 87  IGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLGVLEHPN 140
           IGEG FG V    Y S   PA         +   K    D +  +++ E   +   +HP+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALA-----VAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 77
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           +VKLIG   V  E  +   ++ E      L   L  R +  L   + +      +  LAY
Sbjct: 78  IVKLIG---VITENPV--WIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAY 131
Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 260
           L      + ++RD  A NVL+  N   KL DFGL+R      +   S   +    + AP+
Sbjct: 132 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPE 187
Query: 261 YIETGHLTAKSDVWSFGVVLYEML 284
            I     T+ SDVW FGV ++E+L
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEIL 211

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 89/204 (43%), Gaps = 21/204 (10%)
Query: 87  IGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLGVLEHPN 140
           IGEG FG V    Y S   PA         +   K    D +  +++ E   +   +HP+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALA-----VAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 100
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           +VKLIG   V  E  +   ++ E      L   L  R +  L   + +      +  LAY
Sbjct: 101 IVKLIG---VITENPV--WIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAY 154
Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 260
           L      + ++RD  A NVL+  N   KL DFGL+R      +   S   +    + AP+
Sbjct: 155 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPE 210
Query: 261 YIETGHLTAKSDVWSFGVVLYEML 284
            I     T+ SDVW FGV ++E+L
Sbjct: 211 SINFRRFTSASDVWMFGVCMWEIL 234

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 47  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 99
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 100 HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 143
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 144 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 196
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 197 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           IG G FG VY++ +            +VAIKK+ +D      E+Q +  L+H N+V+L  
Sbjct: 36  IGNGSFGVVYQAKL-------CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRY 88
Query: 147 YCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +    GE+     +  +L Y       +  H ++RA   LP       +      LAY+H
Sbjct: 89  FFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIH 147
Query: 203 EGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 261
                 + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y AP+ 
Sbjct: 148 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYRAPEL 201
Query: 262 I-ETGHLTAKSDVWSFGVVLYEMLTGR 287
           I      T+  DVWS G VL E+L G+
Sbjct: 202 IFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQWVA--EVQFLG 134
           + ++ KIGEG +G V+K               +VAIKK     +   ++ +A  E++ L 
Sbjct: 5   YEKIGKIGEGSYGVVFKCR-------NRDTGQIVAIKKFLESEDDPVIKKIALREIRMLK 57
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
            L+HPNLV L+     +  R  +RL LV+E+  +  L  H  +R    +P      I   
Sbjct: 58  QLKHPNLVNLL-----EVFRRKRRLHLVFEYCDHTVL--HELDRYQRGVPEHLVKSITWQ 110
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
             + + + H+      I+RD K  N+L+ ++   KL DFG AR   + G +      V T
Sbjct: 111 TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARL--LTGPSDYYDDEVAT 165
Query: 254 FGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTG 286
             Y +P+  +         DVW+ G V  E+L+G
Sbjct: 166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           IG G FG VY++ +            +VAIKK+ +D      E+Q +  L+H N+V+L  
Sbjct: 56  IGNGSFGVVYQAKL-------CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRY 108
Query: 147 YCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +    GE+     +  +L Y       +  H ++RA   LP       +      LAY+H
Sbjct: 109 FFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIH 167
Query: 203 EGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 261
                 + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y AP+ 
Sbjct: 168 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVS--YICSRYYRAPEL 221
Query: 262 I-ETGHLTAKSDVWSFGVVLYEMLTGR 287
           I      T+  DVWS G VL E+L G+
Sbjct: 222 IFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           IG G FG VY++ +            +VAIKK+ +D      E+Q +  L+H N+V+L  
Sbjct: 62  IGNGSFGVVYQAKL-------CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRY 114
Query: 147 YCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +    GE+     +  +L Y       +  H ++RA   LP       +      LAY+H
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 203 EGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 261
                 + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y AP+ 
Sbjct: 174 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVS--YICSRYYRAPEL 227
Query: 262 I-ETGHLTAKSDVWSFGVVLYEMLTGR 287
           I      T+  DVWS G VL E+L G+
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 56/230 (24%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 21  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 73
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 74  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 117
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 238
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 118 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 174
Query: 239 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 175 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 --HTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 56/230 (24%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 238
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 239 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 178 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 56/230 (24%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 29  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 82  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 125
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 238
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 182
Query: 239 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 183 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 56/230 (24%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 21  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 73
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 74  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 117
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 238
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 118 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 174
Query: 239 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 175 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           IG G FG VY++ +            +VAIKK+ +D      E+Q +  L+H N+V+L  
Sbjct: 40  IGNGSFGVVYQAKL-------CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRY 92
Query: 147 YCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +    GE+     +  +L Y       +  H ++RA   LP       +      LAY+H
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIH 151
Query: 203 EGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 261
                 + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y AP+ 
Sbjct: 152 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYRAPEL 205
Query: 262 I-ETGHLTAKSDVWSFGVVLYEMLTGR 287
           I      T+  DVWS G VL E+L G+
Sbjct: 206 IFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 44  YQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 97  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 140
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 141 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 193
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 194 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 71/133 (53%), Gaps = 14/133 (10%)
Query: 160 LVYEFMLNRSL---EDHLF--NRAFPP-LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRD 213
           ++YE+M N S+   +++ F  ++ +   +P +    II       +Y+H   E  + +RD
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRD 177
Query: 214 FKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI--ETGHLTAKS 271
            K SN+L+D+N R KLSDFG   E   +    +  +  GT+ +  P++   E+ +  AK 
Sbjct: 178 VKPSNILMDKNGRVKLSDFG---ESEYMVDKKIKGS-RGTYEFMPPEFFSNESSYNGAKV 233
Query: 272 DVWSFGVVLYEML 284
           D+WS G+ LY M 
Sbjct: 234 DIWSLGICLYVMF 246

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           IG G FG VY++ +            +VAIKK+ +D      E+Q +  L+H N+V+L  
Sbjct: 47  IGNGSFGVVYQAKL-------CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRY 99
Query: 147 YCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +    GE+     +  +L Y       +  H ++RA   LP       +      LAY+H
Sbjct: 100 FFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIH 158
Query: 203 EGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 261
                 + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y AP+ 
Sbjct: 159 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYRAPEL 212
Query: 262 I-ETGHLTAKSDVWSFGVVLYEMLTGR 287
           I      T+  DVWS G VL E+L G+
Sbjct: 213 IFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           IG G FG VY++ +            +VAIKK+ +D      E+Q +  L+H N+V+L  
Sbjct: 64  IGNGSFGVVYQAKL-------CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRY 116
Query: 147 YCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +    GE+     +  +L Y       +  H ++RA   LP       +      LAY+H
Sbjct: 117 FFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIH 175
Query: 203 EGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 261
                 + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y AP+ 
Sbjct: 176 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVS--YICSRYYRAPEL 229
Query: 262 I-ETGHLTAKSDVWSFGVVLYEMLTGR 287
           I      T+  DVWS G VL E+L G+
Sbjct: 230 IFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 26  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 79  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 122
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLAR---- 175
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 176 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 56/230 (24%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 20  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 73  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 116
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 238
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173
Query: 239 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 241 VGHTHVSTA-VVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    A  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 --HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 30  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 83  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 126
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLAR---- 179
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 180 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 241 VGHTHVSTA-VVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    A  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 --HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           IG G FG VY++ +            +VAIKK+ +D      E+Q +  L+H N+V+L  
Sbjct: 40  IGNGSFGVVYQAKL-------CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRY 92
Query: 147 YCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +    GE+     +  +L Y       +  H ++RA   LP       +      LAY+H
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIH 151
Query: 203 EGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 261
                 + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y AP+ 
Sbjct: 152 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYRAPEL 205
Query: 262 I-ETGHLTAKSDVWSFGVVLYEMLTGR 287
           I      T+  DVWS G VL E+L G+
Sbjct: 206 IFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 43  YQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 95
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 96  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 139
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 140 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 192
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 193 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 99/231 (42%), Gaps = 21/231 (9%)
Query: 76  QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGV 135
           Q T+ +     IG G + SV K  I  A      E  V  I K  RD  + +  +   G 
Sbjct: 19  QFTDGYEVKEDIGVGSY-SVCKRCIHKAT---NMEFAVKIIDKSKRDPTEEIEILLRYG- 73
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
            +HPN++ L        + G    +V E M    L D +  + F     +    ++    
Sbjct: 74  -QHPNIITLKDVY----DDGKYVYVVTELMKGGELLDKILRQKF--FSEREASAVLFTIT 126
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVL-LDENFRP---KLSDFGLAREGPMVGHTHVSTAVV 251
           + + YLH      V++RD K SN+L +DE+  P   ++ DFG A++  +     +     
Sbjct: 127 KTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ--LRAENGLLMTPC 181
Query: 252 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 302
            T  + AP+ +E     A  D+WS GV+LY MLTG          T + +L
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL 232

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 56/230 (24%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 22  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 74
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 75  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 118
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 238
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 119 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 175
Query: 239 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 176 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           IG G FG VY++ +            +VAIKK+ +D      E+Q +  L+H N+V+L  
Sbjct: 28  IGNGSFGVVYQAKL-------CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 147 YCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +    GE+     +  +L Y       +  H ++RA   LP       +      LAY+H
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 203 EGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 261
                 + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y AP+ 
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYRAPEL 193
Query: 262 I-ETGHLTAKSDVWSFGVVLYEMLTGR 287
           I      T+  DVWS G VL E+L G+
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 56/230 (24%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 47  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 99
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 100 HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 143
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 238
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 144 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 200
Query: 239 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 201 EMXGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 56/230 (24%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 20  YQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 73  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCA 116
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 238
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173
Query: 239 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 92/221 (41%), Gaps = 23/221 (10%)
Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWV 127
           M     D+  +  IG G +G   K   K       S+  ++  K+L+   +        V
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRK-------SDGKILVWKELDYGSMTEAEKQMLV 53
Query: 128 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLP 183
           +EV  L  L+HPN+V+   Y  +         +V E+     L   +      R +    
Sbjct: 54  SEVNLLRELKHPNIVRY--YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
           +  R+   L  A    +        V++RD K +NV LD     KL DFGLAR   ++ H
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR---ILNH 168
Query: 244 TH-VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEM 283
               +   VGT  Y +P+ +       KSD+WS G +LYE+
Sbjct: 169 DEDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 29/213 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-------WVAEVQFL 133
           ++R  KIG+G  G+VY +++  A G        VAI+++N   LQ        + E+  +
Sbjct: 23  YTRFEKIGQGASGTVY-TAMDVATGQE------VAIRQMN---LQQQPKKELIINEILVM 72
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
              ++PN+V  +    V    G +  +V E++   SL D +                 L 
Sbjct: 73  RENKNPNIVNYLDSYLV----GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ 128
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
           A E   +LH     QVI+R+ K+ N+LL  +   KL+DFG   +  +       + +VGT
Sbjct: 129 ALE---FLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGT 180
Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
             + AP+ +       K D+WS G++  EM+ G
Sbjct: 181 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 213

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 46/236 (19%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL--NRDGLQWV-AEVQFLGV 135
           +DF  +  +G+G FG V K+           ++   AIKK+    + L  + +EV  L  
Sbjct: 6   SDFEEIAVLGQGAFGQVVKAR-------NALDSRYYAIKKIRHTEEKLSTILSEVMLLAS 58
Query: 136 LEHPNLVKLIGYCAVDGERGIQR-----------LLVYEFMLNRSLEDHLFNRAFPPLP- 183
           L H  +V+   Y A    R   +            +  E+  N +L D + +        
Sbjct: 59  LNHQYVVRY--YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 184 --WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE---- 237
             W+    I+    E L+Y+H      +I+RD K  N+ +DE+   K+ DFGLA+     
Sbjct: 117 EYWRLFRQIL----EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 238 --------GPMVGHTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEML 284
                     + G +   T+ +GT  Y A + ++ TGH   K D++S G++ +EM+
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 21/204 (10%)
Query: 87  IGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLGVLEHPN 140
           IGEG FG V    Y S   PA         +   K    D +  +++ E   +   +HP+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMA-----VAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           +VKLIG   V  E  +   ++ E      L   L  R F  L   + +      +  LAY
Sbjct: 453 IVKLIG---VITENPV--WIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAY 506
Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 260
           L      + ++RD  A NVL+      KL DFGL+R      +   S   +    + AP+
Sbjct: 507 LESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPE 562
Query: 261 YIETGHLTAKSDVWSFGVVLYEML 284
            I     T+ SDVW FGV ++E+L
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEIL 586

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           IG G FG VY++ +            +VAIKK+ +D      E+Q +  L+H N+V+L  
Sbjct: 66  IGNGSFGVVYQAKL-------CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRY 118
Query: 147 YCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +    GE+     +  +L Y       +  H ++RA   LP       +      LAY+H
Sbjct: 119 FFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIH 177
Query: 203 EGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 261
                 + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y AP+ 
Sbjct: 178 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVS--YICSRYYRAPEL 231
Query: 262 I-ETGHLTAKSDVWSFGVVLYEMLTGR 287
           I      T+  DVWS G VL E+L G+
Sbjct: 232 IFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           IG G FG VY++ +            +VAIKK+ +D      E+Q +  L+H N+V+L  
Sbjct: 28  IGNGSFGVVYQAKL-------CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 147 YCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +    GE+     +  +L Y       +  H ++RA   LP       +      LAY+H
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 203 EGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 261
                 + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y AP+ 
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYRAPEL 193
Query: 262 I-ETGHLTAKSDVWSFGVVLYEMLTGR 287
           I      T+  DVWS G VL E+L G+
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           IG G FG VY++ +            +VAIKK+ +D      E+Q +  L+H N+V+L  
Sbjct: 41  IGNGSFGVVYQAKL-------CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRY 93
Query: 147 YCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +    GE+     +  +L Y       +  H ++RA   LP       +      LAY+H
Sbjct: 94  FFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIH 152
Query: 203 EGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 261
                 + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y AP+ 
Sbjct: 153 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVS--YICSRYYRAPEL 206
Query: 262 I-ETGHLTAKSDVWSFGVVLYEMLTGR 287
           I      T+  DVWS G VL E+L G+
Sbjct: 207 IFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           IG G FG VY++ +            +VAIKK+ +D      E+Q +  L+H N+V+L  
Sbjct: 107 IGNGSFGVVYQAKL-------CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRY 159
Query: 147 YCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +    GE+     +  +L Y       +  H ++RA   LP       +      LAY+H
Sbjct: 160 FFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIH 218
Query: 203 EGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 261
                 + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y AP+ 
Sbjct: 219 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVS--YICSRYYRAPEL 272
Query: 262 I-ETGHLTAKSDVWSFGVVLYEMLTGR 287
           I      T+  DVWS G VL E+L G+
Sbjct: 273 IFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 56/230 (24%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 20  YQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 73  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 116
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 238
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173
Query: 239 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           IG G FG VY++ +            +VAIKK+ +D      E+Q +  L+H N+V+L  
Sbjct: 29  IGNGSFGVVYQAKL-------CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRY 81
Query: 147 YCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +    GE+     +  +L Y       +  H ++RA   LP       +      LAY+H
Sbjct: 82  FFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIH 140
Query: 203 EGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 261
                 + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y AP+ 
Sbjct: 141 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYRAPEL 194
Query: 262 I-ETGHLTAKSDVWSFGVVLYEMLTGR 287
           I      T+  DVWS G VL E+L G+
Sbjct: 195 IFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           IG G FG VY++ +            +VAIKK+ +D      E+Q +  L+H N+V+L  
Sbjct: 28  IGNGSFGVVYQAKL-------CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 147 YCAVDGERGIQRLLVYEFMLNRSLED-----HLFNRAFPPLPWKTRLHIILGAAEGLAYL 201
           +    GE+  + ++    +L+   E        ++RA   LP       +      LAY+
Sbjct: 81  FFYSSGEK--KDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 202 HEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 260
           H      + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y AP+
Sbjct: 139 H---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYRAPE 192
Query: 261 YI-ETGHLTAKSDVWSFGVVLYEMLTGR 287
            I      T+  DVWS G VL E+L G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLGVLEHPNLVKL 144
           IGEG FG V++  I  +  +      +   K    D +  +++ E   +   +HP++VKL
Sbjct: 18  IGEGQFGDVHQG-IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG 204
           IG   V  E  +   ++ E      L   L  R F  L   + +      +  LAYL   
Sbjct: 77  IG---VITENPV--WIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLESK 130
Query: 205 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET 264
              + ++RD  A NVL+      KL DFGL+R      +   S   +    + AP+ I  
Sbjct: 131 ---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINF 186
Query: 265 GHLTAKSDVWSFGVVLYEML 284
              T+ SDVW FGV ++E+L
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           IG G FG VY++ +            +VAIKK+ +D      E+Q +  L+H N+V+L  
Sbjct: 32  IGNGSFGVVYQAKL-------CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRY 84
Query: 147 YCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +    GE+     +  +L Y       +  H ++RA   LP       +      LAY+H
Sbjct: 85  FFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIH 143
Query: 203 EGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 261
                 + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y AP+ 
Sbjct: 144 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYRAPEL 197
Query: 262 I-ETGHLTAKSDVWSFGVVLYEMLTGR 287
           I      T+  DVWS G VL E+L G+
Sbjct: 198 IFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 94/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQ 120
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGL R    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLCR---- 173
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           IG G FG VY++ +            +VAIKK+ +D      E+Q +  L+H N+V+L  
Sbjct: 28  IGNGSFGVVYQAKL-------CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 147 YCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +    GE+     +  +L Y       +  H ++RA   LP       +      LAY+H
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 203 EGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 261
                 + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y AP+ 
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVS--YICSRYYRAPEL 193
Query: 262 I-ETGHLTAKSDVWSFGVVLYEMLTGR 287
           I      T+  DVWS G VL E+L G+
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           IG G FG VY++ +            +VAIKK+ +D      E+Q +  L+H N+V+L  
Sbjct: 33  IGNGSFGVVYQAKL-------CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRY 85
Query: 147 YCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +    GE+     +  +L Y       +  H ++RA   LP       +      LAY+H
Sbjct: 86  FFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIH 144
Query: 203 EGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 261
                 + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y AP+ 
Sbjct: 145 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVS--YICSRYYRAPEL 198
Query: 262 I-ETGHLTAKSDVWSFGVVLYEMLTGR 287
           I      T+  DVWS G VL E+L G+
Sbjct: 199 IFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ D+GLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDYGLAR---- 173
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 20  YQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 73  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 116
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 169
Query: 241 VGHTHVSTA-VVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    A  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 170 --HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL++     +       E++ L 
Sbjct: 36  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLK 88
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 89  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 132
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 133 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 185
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 186 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 45/123 (36%), Positives = 61/123 (49%), Gaps = 14/123 (11%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRP--KLSDFGLAREGPMVGHTHVSTAVVGTF 254
           G++Y H    +Q+ +RD K  N LLD +  P  K+ DFG ++    V H+    + VGT 
Sbjct: 128 GVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS--VLHSQ-PKSTVGTP 181
Query: 255 GYAAPDYIETGHLTAK-SDVWSFGVVLYEMLTGRRSLE-----RNRPKTEQRLLEWVQQY 308
            Y AP+ +       K +DVWS GV LY ML G    E     R+  KT QR+L      
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSI 241
Query: 309 PAD 311
           P D
Sbjct: 242 PDD 244

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 95/226 (42%), Gaps = 48/226 (21%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV  S               +A+KKL+R     +       E++ L 
Sbjct: 53  YQTLSPVGSGAYGSVCSSY-------DVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLK 105
Query: 135 VLEHPNLVKLIGYC--AVDGERGIQRLLVYEFM---LNRSL------EDHLFNRAFPPLP 183
            ++H N++ L+     A   E      LV   M   LN  +      +DH+         
Sbjct: 106 HMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 156
Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
                 +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR      H
Sbjct: 157 ----QFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR------H 203
Query: 244 THVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
           T    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 204 TDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 26/210 (12%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQWVAEVQFLGVLEHPNLV 142
           +G+G +G VY       AG   S    +AIK++    +R       E+     L+H N+V
Sbjct: 16  LGKGTYGIVY-------AGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIV 68
Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP--WKTRLHIILGAAEGLAY 200
           + +G  +   E G  ++ + E +   SL   L    + PL    +T         EGL Y
Sbjct: 69  QYLGSFS---ENGFIKIFM-EQVPGGSLS-ALLRSKWGPLKDNEQTIGFYTKQILEGLKY 123
Query: 201 LHEGLEVQVIYRDFKASNVLLDE-NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 259
           LH+    Q+++RD K  NVL++  +   K+SDFG ++   + G    +    GT  Y AP
Sbjct: 124 LHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAP 178
Query: 260 DYIETG--HLTAKSDVWSFGVVLYEMLTGR 287
           + I+ G       +D+WS G  + EM TG+
Sbjct: 179 EIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 81/174 (46%), Gaps = 21/174 (12%)
Query: 128 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPLPWKT 186
            E++ L  L HP ++K+  +   D E      +V E M    L D +  N+       K 
Sbjct: 64  TEIEILKKLNHPCIIKIKNF--FDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCKL 118
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGH 243
             + +L A +   YLHE     +I+RD K  NVLL   +E+   K++DFG ++   ++G 
Sbjct: 119 YFYQMLLAVQ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGE 169
Query: 244 THVSTAVVGTFGYAAPDY---IETGHLTAKSDVWSFGVVLYEMLTGRRSLERNR 294
           T +   + GT  Y AP+    + T       D WS GV+L+  L+G      +R
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 99/239 (41%), Gaps = 28/239 (11%)
Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQF 132
           ++DF     +GEG +G V  ++ KP          +VAIKK+         L+ + E++ 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTG-------EIVAIKKIEPFDKPLFALRTLREIKI 62
Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
           L   +H N++ +      D       + + + ++   L   +  +    L      + I 
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM---LSDDHIQYFIY 119
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--------EGPMVGHT 244
                +  LH      VI+RD K SN+L++ N   K+ DFGLAR             G  
Sbjct: 120 QTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 302
                 V T  Y AP+ + T    +++ DVWS G +L E+   RR +   R    Q LL
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLLL 234

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 32/224 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGVL-EHPNLV 142
           +G G FG V  ++    +  G S    V + K   D  +    ++E++ +  L  H N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR---------------------AFPP 181
            L+G C + G       L++E+     L ++L ++                         
Sbjct: 113 NLLGACTLSG----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMV 241
           L ++  L      A+G+ +L        ++RD  A NVL+      K+ DFGLAR+    
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 242 GHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            +  V         + AP+ +  G  T KSDVWS+G++L+E+ +
Sbjct: 226 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 33/212 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLGVLEHPN 140
           +G G +GSV  S+I   +G+       VAIKKL+R     +       E+  L  ++H N
Sbjct: 32  VGSGAYGSVC-SAIDKRSGEK------VAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 141 LVKLIG-YCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 198
           ++ L+  +      R      LV  FM  ++    +    F     +   +++    +GL
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFM--QTDLQKIMGLKFSE---EKIQYLVYQMLKGL 139
Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGHTHVSTAVVGTFGY 256
            Y+H      V++RD K  N+ ++E+   K+ DFGLAR  +  M G+       V T  Y
Sbjct: 140 KYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY-------VVTRWY 189
Query: 257 AAPDYIETG-HLTAKSDVWSFGVVLYEMLTGR 287
            AP+ I +  H     D+WS G ++ EMLTG+
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 35/214 (16%)
Query: 91  GFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQWVAEVQ------FLGVLEHPNLVK 143
           G  SV +  +  A G +   +   V  ++L+ + L+ V E           V  HP+++ 
Sbjct: 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164
Query: 144 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE 203
           LI       E      LV++ M    L D+L  +    L  K    I+    E +++LH 
Sbjct: 165 LID----SYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHA 218
Query: 204 GLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA-----VVGTFGYAA 258
                +++RD K  N+LLD+N + +LSDFG +         H+        + GT GY A
Sbjct: 219 N---NIVHRDLKPENILLDDNMQIRLSDFGFS--------CHLEPGEKLRELCGTPGYLA 267
Query: 259 PDYIETGH------LTAKSDVWSFGVVLYEMLTG 286
           P+ ++            + D+W+ GV+L+ +L G
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 21/177 (11%)
Query: 128 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPLPWKT 186
            E++ L  L HP ++K+  +   D E      +V E M    L D +  N+       K 
Sbjct: 64  TEIEILKKLNHPCIIKIKNF--FDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCKL 118
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGH 243
             + +L A +   YLHE     +I+RD K  NVLL   +E+   K++DFG ++   ++G 
Sbjct: 119 YFYQMLLAVQ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGE 169
Query: 244 THVSTAVVGTFGYAAPDY---IETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT 297
           T +   + GT  Y AP+    + T       D WS GV+L+  L+G      +R + 
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 226

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 21/177 (11%)
Query: 128 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPLPWKT 186
            E++ L  L HP ++K+  +   D E      +V E M    L D +  N+       K 
Sbjct: 63  TEIEILKKLNHPCIIKIKNF--FDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCKL 117
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGH 243
             + +L A +   YLHE     +I+RD K  NVLL   +E+   K++DFG ++   ++G 
Sbjct: 118 YFYQMLLAVQ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGE 168
Query: 244 THVSTAVVGTFGYAAPDY---IETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT 297
           T +   + GT  Y AP+    + T       D WS GV+L+  L+G      +R + 
Sbjct: 169 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 225

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 32/220 (14%)
Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK----LNRDGLQWVAEVQFL 133
           ++ + R+ K+G G +G V     K       +E  +  IKK       +    + EV  L
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTG----AERAIKIIKKSSVTTTSNSGALLDEVAVL 58
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIIL 192
             L+HPN++KL  Y   + +R     LV E      L D +  R  F  +     +  +L
Sbjct: 59  KQLDHPNIMKL--YEFFEDKRNY--YLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVL 114
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP---KLSDFGLAREGPMVGHTHVSTA 249
               G  YLH+     +++RD K  N+LL+   R    K+ DFGL+       H  V   
Sbjct: 115 S---GTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLS------AHFEVGGK 162
Query: 250 V---VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           +   +GT  Y AP+ +   +   K DVWS GV+LY +L G
Sbjct: 163 MKERLGTAYYIAPEVLRKKY-DEKCDVWSCGVILYILLCG 201

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 21/177 (11%)
Query: 128 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPLPWKT 186
            E++ L  L HP ++K+  +   D E      +V E M    L D +  N+       K 
Sbjct: 64  TEIEILKKLNHPCIIKIKNF--FDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCKL 118
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGH 243
             + +L A +   YLHE     +I+RD K  NVLL   +E+   K++DFG ++   ++G 
Sbjct: 119 YFYQMLLAVQ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGE 169
Query: 244 THVSTAVVGTFGYAAPDY---IETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT 297
           T +   + GT  Y AP+    + T       D WS GV+L+  L+G      +R + 
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 226

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 5/95 (5%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G  YLH     +VI+RD K  N+ L+E+   K+ DFGLA +    G       + GT  Y
Sbjct: 129 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKTLCGTPNY 183
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 291
            AP+ +     + + DVWS G ++Y +L G+   E
Sbjct: 184 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 5/95 (5%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G  YLH     +VI+RD K  N+ L+E+   K+ DFGLA +    G       + GT  Y
Sbjct: 153 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNY 207
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 291
            AP+ +     + + DVWS G ++Y +L G+   E
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 5/95 (5%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G  YLH     +VI+RD K  N+ L+E+   K+ DFGLA +    G       + GT  Y
Sbjct: 133 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKTLCGTPNY 187
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 291
            AP+ +     + + DVWS G ++Y +L G+   E
Sbjct: 188 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 222

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 33/212 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLGVLEHPN 140
           +G G +GSV  S+I   +G+       VAIKKL+R     +       E+  L  ++H N
Sbjct: 50  VGSGAYGSVC-SAIDKRSGEK------VAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 102
Query: 141 LVKLIG-YCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 198
           ++ L+  +      R      LV  FM  ++    +    F     +   +++    +GL
Sbjct: 103 VIGLLDVFTPASSLRNFYDFYLVMPFM--QTDLQKIMGMEFSE---EKIQYLVYQMLKGL 157
Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGHTHVSTAVVGTFGY 256
            Y+H      V++RD K  N+ ++E+   K+ DFGLAR  +  M G+       V T  Y
Sbjct: 158 KYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY-------VVTRWY 207
Query: 257 AAPDYIETG-HLTAKSDVWSFGVVLYEMLTGR 287
            AP+ I +  H     D+WS G ++ EMLTG+
Sbjct: 208 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 108/242 (44%), Gaps = 28/242 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIK-----KLNRDGL--QWVAE 129
             +DF     +G+G FG+VY +  K +         +VA+K     ++ ++G+  Q   E
Sbjct: 21  TIDDFEIGRPLGKGKFGNVYLAREKKSH-------FIVALKVLFKSQIEKEGVEHQLRRE 73
Query: 130 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 189
           ++    L HPN+++L  Y   D  R     L+ E+     L   L          +    
Sbjct: 74  IEIQAHLHHPNILRLYNY-FYDRRRI---YLILEYAPRGELYKELQKSC--TFDEQRTAT 127
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
           I+   A+ L Y H     +VI+RD K  N+LL      K++DFG +   P +        
Sbjct: 128 IMEELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLR----RKT 180
Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLER-NRPKTEQRLLEWVQQY 308
           + GT  Y  P+ IE      K D+W  GV+ YE+L G    E  +  +T +R+++   ++
Sbjct: 181 MCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKF 240
Query: 309 PA 310
           PA
Sbjct: 241 PA 242

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 5/95 (5%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G  YLH     +VI+RD K  N+ L+E+   K+ DFGLA +    G       + GT  Y
Sbjct: 151 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNY 205
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 291
            AP+ +     + + DVWS G ++Y +L G+   E
Sbjct: 206 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 240

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 5/95 (5%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G  YLH     +VI+RD K  N+ L+E+   K+ DFGLA +    G       + GT  Y
Sbjct: 129 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKTLCGTPNY 183
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 291
            AP+ +     + + DVWS G ++Y +L G+   E
Sbjct: 184 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 105/241 (43%), Gaps = 47/241 (19%)
Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL--NRDGLQWV-AEV 130
           +R A+ DF  +  +G+G FG V K+           ++   AIKK+    + L  + +EV
Sbjct: 2   LRYAS-DFEEIAVLGQGAFGQVVKAR-------NALDSRYYAIKKIRHTEEKLSTILSEV 53
Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQR-----------LLVYEFMLNRSLEDHLFNRAF 179
             L  L H  +V+   Y A    R   +            +  E+  NR+L D + +   
Sbjct: 54  XLLASLNHQYVVRY--YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENL 111
Query: 180 PPLP---WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 236
                  W+    I+    E L+Y+H      +I+R+ K  N+ +DE+   K+ DFGLA+
Sbjct: 112 NQQRDEYWRLFRQIL----EALSYIHSQ---GIIHRNLKPXNIFIDESRNVKIGDFGLAK 164
Query: 237 E------------GPMVGHTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEM 283
                          + G +   T+ +GT  Y A + ++ TGH   K D +S G++ +E 
Sbjct: 165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEX 224
Query: 284 L 284
           +
Sbjct: 225 I 225

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 5/95 (5%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G  YLH     +VI+RD K  N+ L+E+   K+ DFGLA +    G       + GT  Y
Sbjct: 127 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNY 181
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 291
            AP+ +     + + DVWS G ++Y +L G+   E
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 81/174 (46%), Gaps = 21/174 (12%)
Query: 128 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPLPWKT 186
            E++ L  L HP ++K+  +   D E      +V E M    L D +  N+       K 
Sbjct: 70  TEIEILKKLNHPCIIKIKNF--FDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCKL 124
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGH 243
             + +L A +   YLHE     +I+RD K  NVLL   +E+   K++DFG ++   ++G 
Sbjct: 125 YFYQMLLAVQ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGE 175
Query: 244 THVSTAVVGTFGYAAPDY---IETGHLTAKSDVWSFGVVLYEMLTGRRSLERNR 294
           T +   + GT  Y AP+    + T       D WS GV+L+  L+G      +R
Sbjct: 176 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 229

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 84/192 (43%), Gaps = 30/192 (15%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRP--KLSDFGLAREGPMVGHTHVSTAVVGTF 254
           G++Y H    +QV +RD K  N LLD +  P  K++DFG ++    V H+   +AV GT 
Sbjct: 127 GVSYAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKAS--VLHSQPKSAV-GTP 180
Query: 255 GYAAPDYIETGHLTAK-SDVWSFGVVLYEMLTGRRSLE-----RNRPKTEQRLL------ 302
            Y AP+ +       K +DVWS GV LY ML G    E     +N  KT  R+L      
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAI 240
Query: 303 -EWVQQYPADSKKFGLIMDPRLEKEYSINEARK---------IGRLADNCLSKSSKDRPK 352
            ++V   P        I      K  SI E R             + DN ++    +  +
Sbjct: 241 PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQ 300
Query: 353 MSQVVERLKQIV 364
             Q +E + QI+
Sbjct: 301 PGQSIEEIMQII 312

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 101/222 (45%), Gaps = 23/222 (10%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA 128
           ++R    D+  +  IG G FG V    +KS+ K  A    S+  ++   K +     W  
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI---KRSDSAFFW-E 118
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           E   +     P +V+L  + A   +R +   +V E+M    L + + N   P   W  R 
Sbjct: 119 ERDIMAFANSPWVVQL--FYAFQDDRYL--YMVMEYMPGGDLVNLMSNYDVPE-KW-ARF 172
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 248
           +     AE +  L     +  I+RD K  N+LLD++   KL+DFG   +    G     T
Sbjct: 173 Y----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 228
Query: 249 AVVGTFGYAAPDYIET----GHLTAKSDVWSFGVVLYEMLTG 286
           A VGT  Y +P+ +++    G+   + D WS GV LYEML G
Sbjct: 229 A-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 95/230 (41%), Gaps = 56/230 (24%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 44  YQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 97  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 140
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 238
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 141 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 197
Query: 239 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
            M G        V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 198 EMXG-------XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 101/222 (45%), Gaps = 23/222 (10%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA 128
           ++R    D+  +  IG G FG V    +KS+ K  A    S+  ++   K +     W  
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI---KRSDSAFFW-E 123
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           E   +     P +V+L  + A   +R +   +V E+M    L + + N   P   W  R 
Sbjct: 124 ERDIMAFANSPWVVQL--FYAFQDDRYL--YMVMEYMPGGDLVNLMSNYDVPE-KW-ARF 177
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 248
           +     AE +  L     +  I+RD K  N+LLD++   KL+DFG   +    G     T
Sbjct: 178 Y----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 233
Query: 249 AVVGTFGYAAPDYIET----GHLTAKSDVWSFGVVLYEMLTG 286
           A VGT  Y +P+ +++    G+   + D WS GV LYEML G
Sbjct: 234 A-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 101/222 (45%), Gaps = 23/222 (10%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA 128
           ++R    D+  +  IG G FG V    +KS+ K  A    S+  ++   K +     W  
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI---KRSDSAFFW-E 123
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           E   +     P +V+L  + A   +R +   +V E+M    L + + N   P   W  R 
Sbjct: 124 ERDIMAFANSPWVVQL--FYAFQDDRYL--YMVMEYMPGGDLVNLMSNYDVPE-KW-ARF 177
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 248
           +     AE +  L     +  I+RD K  N+LLD++   KL+DFG   +    G     T
Sbjct: 178 Y----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 233
Query: 249 AVVGTFGYAAPDYIET----GHLTAKSDVWSFGVVLYEMLTG 286
           A VGT  Y +P+ +++    G+   + D WS GV LYEML G
Sbjct: 234 A-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 32/220 (14%)
Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK----LNRDGLQWVAEVQFL 133
           ++ + R+ K+G G +G V     K       +E  +  IKK       +    + EV  L
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTG----AERAIKIIKKSSVTTTSNSGALLDEVAVL 75
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-AFPPLPWKTRLHIIL 192
             L+HPN++KL  Y   + +R     LV E      L D +  R  F  +     +  +L
Sbjct: 76  KQLDHPNIMKL--YEFFEDKRNY--YLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVL 131
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP---KLSDFGLAREGPMVGHTHVSTA 249
               G  YLH+     +++RD K  N+LL+   R    K+ DFGL+       H  V   
Sbjct: 132 S---GTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLS------AHFEVGGK 179
Query: 250 V---VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           +   +GT  Y AP+ +   +   K DVWS GV+LY +L G
Sbjct: 180 MKERLGTAYYIAPEVLRKKY-DEKCDVWSCGVILYILLCG 218

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 7/97 (7%)
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
           +G+ YLH     +VI+RD K  N+ L+++   K+ DFGLA +    G       + GT  
Sbjct: 153 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKTLCGTPN 207
Query: 256 YAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRSLE 291
           Y AP+ + + GH + + D+WS G +LY +L G+   E
Sbjct: 208 YIAPEVLCKKGH-SFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 82/192 (42%), Gaps = 30/192 (15%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRP--KLSDFGLAREGPMVGHTHVSTAVVGTF 254
           G++Y H    +QV +RD K  N LLD +  P  K+ DFG ++    V H+    + VGT 
Sbjct: 127 GVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS--VLHSQ-PKSTVGTP 180
Query: 255 GYAAPDYIETGHLTAK-SDVWSFGVVLYEMLTGRRSLE-----RNRPKTEQRLL------ 302
            Y AP+ +       K +DVWS GV LY ML G    E     +N  KT  R+L      
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAI 240
Query: 303 -EWVQQYPADSKKFGLIMDPRLEKEYSINEARK---------IGRLADNCLSKSSKDRPK 352
            ++V   P        I      K  SI E R             + DN ++    +  +
Sbjct: 241 PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQ 300
Query: 353 MSQVVERLKQIV 364
             Q +E + QI+
Sbjct: 301 PGQSIEEIMQII 312

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 7/97 (7%)
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
           +G+ YLH     +VI+RD K  N+ L+++   K+ DFGLA +    G       + GT  
Sbjct: 153 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKXLCGTPN 207
Query: 256 YAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRSLE 291
           Y AP+ + + GH + + D+WS G +LY +L G+   E
Sbjct: 208 YIAPEVLCKKGH-SFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
           ++G G FG V++ + + A G+  +   V+   + +++ ++   E+Q + VL HP LV L 
Sbjct: 58  ELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHESDKETVR--KEIQTMSVLRHPTLVNLH 114
Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL 205
                D E     +++YEFM    L + + +     +     +  +    +GL ++HE  
Sbjct: 115 DAFEDDNEM----VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN- 168
Query: 206 EVQVIYRDFKASNVLLD--ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE 263
               ++ D K  N++     +   KL DFGL           V+T   GT  +AAP+  E
Sbjct: 169 --NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAE 223
Query: 264 TGHLTAKSDVWSFGVVLYEMLTG 286
              +   +D+WS GV+ Y +L+G
Sbjct: 224 GKPVGYYTDMWSVGVLSYILLSG 246

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 21/177 (11%)
Query: 128 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPLPWKT 186
            E++ L  L HP ++K+  +   D E      +V E M    L D +  N+       K 
Sbjct: 189 TEIEILKKLNHPCIIKIKNF--FDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCKL 243
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGH 243
             + +L A +   YLHE     +I+RD K  NVLL   +E+   K++DFG ++   ++G 
Sbjct: 244 YFYQMLLAVQ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGE 294
Query: 244 THVSTAVVGTFGYAAPDY---IETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT 297
           T +   + GT  Y AP+    + T       D WS GV+L+  L+G      +R + 
Sbjct: 295 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 351

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 21/177 (11%)
Query: 128 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPLPWKT 186
            E++ L  L HP ++K+  +   D E      +V E M    L D +  N+       K 
Sbjct: 203 TEIEILKKLNHPCIIKIKNF--FDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCKL 257
Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGH 243
             + +L A +   YLHE     +I+RD K  NVLL   +E+   K++DFG ++   ++G 
Sbjct: 258 YFYQMLLAVQ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGE 308
Query: 244 THVSTAVVGTFGYAAPDY---IETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT 297
           T +   + GT  Y AP+    + T       D WS GV+L+  L+G      +R + 
Sbjct: 309 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 365

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 43/220 (19%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----WVAEVQFLGVL 136
            +  +KIGEG  G V  ++ K            VA+KK++    Q       EV  +   
Sbjct: 47  LANFIKIGEGSTGIVCIATEKHTGKQ-------VAVKKMDLRKQQRRELLFNEVVIMRDY 99
Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH------I 190
            H N+V +     V  E  +    V EF+   +L D + +         TR++      +
Sbjct: 100 HHDNVVDMYSSYLVGDELWV----VMEFLEGGALTDIVTH---------TRMNEEQIATV 146
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG----LAREGPMVGHTHV 246
            L     L+YLH      VI+RD K+ ++LL  + R KLSDFG    +++E P       
Sbjct: 147 CLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK------ 197
Query: 247 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
              +VGT  + AP+ I       + D+WS G+++ EM+ G
Sbjct: 198 RKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 237

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 94/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+  FGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILGFGLAR---- 173
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           IG G FG VY++ +            +VAIKK+ +       E+Q +  L+H N+V+L  
Sbjct: 28  IGNGSFGVVYQAKL-------CDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRY 80
Query: 147 YCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +    GE+     +  +L Y       +  H ++RA   LP       +      LAY+H
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPATVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 203 EGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 261
                 + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y AP+ 
Sbjct: 140 S---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYRAPEL 193
Query: 262 I-ETGHLTAKSDVWSFGVVLYEMLTGR 287
           I      T+  DVWS G VL E+L G+
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 40/185 (21%)
Query: 188 LHIILGAAEGLAYLH-EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--------- 237
           LHI +  AE + +LH +GL    ++RD K SN+    +   K+ DFGL            
Sbjct: 167 LHIFIQIAEAVEFLHSKGL----MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222
Query: 238 --GPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML-TGRRSLERN 293
              PM  + TH     VGT  Y +P+ I   + + K D++S G++L+E+L +    +ER 
Sbjct: 223 VLTPMPAYATHXGQ--VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV 280
Query: 294 RPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM 353
           R  T+ R L           KF L+   +  +E+          +  + LS S  +RP+ 
Sbjct: 281 RIITDVRNL-----------KFPLLFTQKYPQEH---------MMVQDMLSPSPTERPEA 320
Query: 354 SQVVE 358
           + ++E
Sbjct: 321 TDIIE 325

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 7/97 (7%)
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
           +G+ YLH     +VI+RD K  N+ L+++   K+ DFGLA +    G       + GT  
Sbjct: 137 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPN 191
Query: 256 YAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRSLE 291
           Y AP+ + + GH + + D+WS G +LY +L G+   E
Sbjct: 192 YIAPEVLCKKGH-SFEVDIWSLGCILYTLLVGKPPFE 227

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 18/155 (11%)
Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 197
           HPN+++L        E      LV++ M    L D+L  +    L  K    I+    E 
Sbjct: 83  HPNIIQL----KDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEV 136
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           +  LH+   + +++RD K  N+LLD++   KL+DFG + +   +       +V GT  Y 
Sbjct: 137 ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLRSVCGTPSYL 190
Query: 258 APDYIETGH------LTAKSDVWSFGVVLYEMLTG 286
           AP+ IE            + D+WS GV++Y +L G
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 107/241 (44%), Gaps = 30/241 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN---RDGLQWVAEVQFLGVLE 137
           + R+ K+G G +G V     K        E  +  I+K +       + + EV  L +L+
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTH----VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAE 196
           HPN++KL  +     E      LV E      L D + +R  F  +       II     
Sbjct: 95  HPNIMKLYDFF----EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV---IIKQVLS 147
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRP---KLSDFGLAREGPMVGHTHVSTAVVGT 253
           G+ YLH+     +++RD K  N+LL+   +    K+ DFGL+    +  +       +GT
Sbjct: 148 GVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLS---AVFENQKKMKERLGT 201
Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ--QYPAD 311
             Y AP+ +   +   K DVWS GV+L+ +L G         +T+Q +L  V+  +Y  D
Sbjct: 202 AYYIAPEVLRKKY-DEKCDVWSIGVILFILLAGYPPF---GGQTDQEILRKVEKGKYTFD 257
Query: 312 S 312
           S
Sbjct: 258 S 258

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 7/97 (7%)
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
           +G+ YLH     +VI+RD K  N+ L+++   K+ DFGLA +    G       + GT  
Sbjct: 153 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPN 207
Query: 256 YAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRSLE 291
           Y AP+ + + GH + + D+WS G +LY +L G+   E
Sbjct: 208 YIAPEVLCKKGH-SFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 108/262 (41%), Gaps = 40/262 (15%)
Query: 67  RVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAG----DGTSEATVVAIKKLNRD 122
           ++F + E    T  FS ++   E   G ++     P       + + E  +  ++K+  +
Sbjct: 22  KIFEFKETL-GTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHE 80
Query: 123 GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPL 182
            +     V    + E PN + L+      GE           + +R +E   +       
Sbjct: 81  NI-----VALEDIYESPNHLYLVMQLVSGGE-----------LFDRIVEKGFYTE----- 119
Query: 183 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGP 239
             K    +I    + + YLH    + +++RD K  N+L    DE  +  +SDFGL++   
Sbjct: 120 --KDASTLIRQVLDAVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSK--- 171
Query: 240 MVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL-ERNRPKTE 298
           M G   V +   GT GY AP+ +     +   D WS GV+ Y +L G     + N  K  
Sbjct: 172 MEGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLF 231
Query: 299 QRLLEWVQQYPADSKKFGLIMD 320
           +++L+   +Y  DS  +  I D
Sbjct: 232 EQILK--AEYEFDSPYWDDISD 251

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 94/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ D GLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDAGLAR---- 173
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 77  ATNDFSRMLK---IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFL 133
           A N F  + K   +G G FG V+K         G   A  +   +  +D  +   E+  +
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCE---ETATGLKLAAKIIKTRGMKDKEEVKNEISVM 140
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L+H NL++L  Y A + +  I  +LV E++    L D + + ++      T L  +  
Sbjct: 141 NQLDHANLIQL--YDAFESKNDI--VLVMEYVDGGELFDRIIDESYNLTELDTIL-FMKQ 195
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLL--DENFRPKLSDFGLAREGPMVGHTHVSTAVV 251
             EG+ ++H+   + +++ D K  N+L    +  + K+ DFGLAR         V+    
Sbjct: 196 ICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN---F 249
Query: 252 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           GT  + AP+ +    ++  +D+WS GV+ Y +L+G
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 95/230 (41%), Gaps = 56/230 (24%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 238
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DF LAR  + 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFYLARHTDD 177
Query: 239 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 178 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 94/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ D GLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDRGLAR---- 173
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 98/233 (42%), Gaps = 25/233 (10%)
Query: 77  ATNDFSRMLKIGEGGFGSVY---KSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFL 133
             NDFS    IG GGFG VY   K+           +   + +K+     L     +  +
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
              + P +V     C         +L  + + M    L  HL           +   +  
Sbjct: 247 STGDCPFIV-----CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-----FSEADMRF 296
Query: 193 GAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
            AAE   GL ++H      V+YRD K +N+LLDE+   ++SD GLA +           A
Sbjct: 297 YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHA 349
Query: 250 VVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL 301
            VGT GY AP+ ++ G    + +D +S G +L+++L G     +++ K +  +
Sbjct: 350 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
           ++G G FG V++ + + A G+  +   V+   + +++ ++   E+Q + VL HP LV L 
Sbjct: 164 ELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHESDKETVR--KEIQTMSVLRHPTLVNLH 220
Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL 205
                D E     +++YEFM    L + + +     +     +  +    +GL ++HE  
Sbjct: 221 DAFEDDNEM----VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN- 274
Query: 206 EVQVIYRDFKASNVLLD--ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE 263
               ++ D K  N++     +   KL DFGL           V+T   GT  +AAP+  E
Sbjct: 275 --NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAE 329
Query: 264 TGHLTAKSDVWSFGVVLYEMLTG 286
              +   +D+WS GV+ Y +L+G
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSG 352

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 98/233 (42%), Gaps = 25/233 (10%)
Query: 77  ATNDFSRMLKIGEGGFGSVY---KSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFL 133
             NDFS    IG GGFG VY   K+           +   + +K+     L     +  +
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
              + P +V     C         +L  + + M    L  HL           +   +  
Sbjct: 247 STGDCPFIV-----CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-----FSEADMRF 296
Query: 193 GAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
            AAE   GL ++H      V+YRD K +N+LLDE+   ++SD GLA +           A
Sbjct: 297 YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHA 349
Query: 250 VVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL 301
            VGT GY AP+ ++ G    + +D +S G +L+++L G     +++ K +  +
Sbjct: 350 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 85/194 (43%), Gaps = 34/194 (17%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRP--KLSDFGLAREGPMVGHTHVSTAVVGTF 254
           G++Y H    +QV +RD K  N LLD +  P  K+ DFG ++    V H+    + VGT 
Sbjct: 126 GVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS--VLHSQ-PKSTVGTP 179
Query: 255 GYAAPDYIETGHLTAK-SDVWSFGVVLYEMLTGRRSLE-----RNRPKTEQRLL------ 302
            Y AP+ +       K +DVWS GV LY ML G    E     +N  KT  R+L      
Sbjct: 180 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAI 239
Query: 303 -EWVQQYPADSKKFGLIMDPRLEKEYSINEARK---------IGRLADNCLSK--SSKDR 350
            ++V   P        I      K  SI E R             + DN ++   ++ D+
Sbjct: 240 PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFAASDQ 299
Query: 351 PKMSQVVERLKQIV 364
           P   Q +E + QI+
Sbjct: 300 P--GQSIEEIMQII 311

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 40/217 (18%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVLEHPN 140
           K+G G FG V+         +  S      IK +N+D  Q       AE++ L  L+HPN
Sbjct: 29  KLGSGAFGDVHLV-------EERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 141 LVKLIG--------YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
           ++K+          Y  ++   G +       +L R +      +A         +  ++
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGE-------LLERIVSAQARGKALSEGYVAELMKQMM 134
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN--FRP-KLSDFGLAREGPMVGHTHVSTA 249
            A   LAY H      V+++D K  N+L  +     P K+ DFGLA    +      ST 
Sbjct: 135 NA---LAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKSDEHSTN 185
Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
             GT  Y AP+  +   +T K D+WS GVV+Y +LTG
Sbjct: 186 AAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTG 221

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 98/233 (42%), Gaps = 25/233 (10%)
Query: 77  ATNDFSRMLKIGEGGFGSVY---KSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFL 133
             NDFS    IG GGFG VY   K+           +   + +K+     L     +  +
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
              + P +V     C         +L  + + M    L  HL           +   +  
Sbjct: 247 STGDCPFIV-----CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-----FSEADMRF 296
Query: 193 GAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
            AAE   GL ++H      V+YRD K +N+LLDE+   ++SD GLA +           A
Sbjct: 297 YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHA 349
Query: 250 VVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL 301
            VGT GY AP+ ++ G    + +D +S G +L+++L G     +++ K +  +
Sbjct: 350 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 98/233 (42%), Gaps = 25/233 (10%)
Query: 77  ATNDFSRMLKIGEGGFGSVY---KSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFL 133
             NDFS    IG GGFG VY   K+           +   + +K+     L     +  +
Sbjct: 186 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 245
Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
              + P +V     C         +L  + + M    L  HL           +   +  
Sbjct: 246 STGDCPFIV-----CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-----FSEADMRF 295
Query: 193 GAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
            AAE   GL ++H      V+YRD K +N+LLDE+   ++SD GLA +           A
Sbjct: 296 YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHA 348
Query: 250 VVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL 301
            VGT GY AP+ ++ G    + +D +S G +L+++L G     +++ K +  +
Sbjct: 349 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 401

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           IG G FG VY++ +            +VAIKK+ +       E+Q +  L+H N+V+L  
Sbjct: 28  IGNGSFGVVYQAKL-------CDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRY 80
Query: 147 YCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +    GE+     +  +L Y       +  H ++RA   LP       +      LAY+H
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 203 EGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 261
                 + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y AP+ 
Sbjct: 140 S---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVS--YICSRYYRAPEL 193
Query: 262 I-ETGHLTAKSDVWSFGVVLYEMLTGR 287
           I      T+  DVWS G VL E+L G+
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 18/155 (11%)
Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 197
           HPN+++L        E      LV++ M    L D+L  +    L  K    I+    E 
Sbjct: 70  HPNIIQL----KDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEV 123
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           +  LH+   + +++RD K  N+LLD++   KL+DFG + +   +        V GT  Y 
Sbjct: 124 ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTPSYL 177
Query: 258 APDYIETGH------LTAKSDVWSFGVVLYEMLTG 286
           AP+ IE            + D+WS GV++Y +L G
Sbjct: 178 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 94/229 (41%), Gaps = 54/229 (23%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLG 134
           +  +  +G G +GSV        A   T     VA+KKL+R     +       E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 186
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 187 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ D GLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDGGLAR---- 173
Query: 241 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           IG G FG VY++ +            +VAIKK+ +       E+Q +  L+H N+V+L  
Sbjct: 28  IGNGSFGVVYQAKL-------CDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRY 80
Query: 147 YCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +    GE+     +  +L Y       +  H ++RA   LP       +      LAY+H
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 203 EGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 261
                 + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y AP+ 
Sbjct: 140 S---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVS--YICSRYYRAPEL 193
Query: 262 I-ETGHLTAKSDVWSFGVVLYEMLTGR 287
           I      T+  DVWS G VL E+L G+
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 125/308 (40%), Gaps = 64/308 (20%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHP 139
           DF  +  IG GGFG V+K+  +    DG +      I+++  +  +   EV+ L  L+H 
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRI---DGKT----YVIRRVKYNNEKAEREVKALAKLDHV 65
Query: 140 NLVKLIGYC------------------------AVDGERGIQRLLV--YEFMLNRSLEDH 173
           N+V   G C                        + +  R   + L    EF    +LE  
Sbjct: 66  NIVHYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQW 124
Query: 174 LFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG 233
           +  R    L     L +     +G+ Y+H     ++I+RD K SN+ L +  + K+ DFG
Sbjct: 125 IEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFG 181
Query: 234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML-TGRRSLER 292
           L       G     T   GT  Y +P+ I +     + D+++ G++L E+L     + E 
Sbjct: 182 LVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET 238
Query: 293 NRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK 352
           ++  T+ R               G+I D   +KE +         L    LSK  +DRP 
Sbjct: 239 SKFFTDLR--------------DGIISDIFDKKEKT---------LLQKLLSKKPEDRPN 275
Query: 353 MSQVVERL 360
            S+++  L
Sbjct: 276 TSEILRTL 283

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K S    A     +  VV +K++       + E + L 
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 83
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 84  AVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 139
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+DE    +++DFG A+   + G T     + G
Sbjct: 140 T----FEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKR--VKGRT---WXLCG 187
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 188 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 230

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K S    A     +  VV +K++       + E + L 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 18/155 (11%)
Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 197
           HPN+++L        E      LV++ M    L D+L  +    L  K    I+    E 
Sbjct: 83  HPNIIQLKD----TYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEV 136
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           +  LH+   + +++RD K  N+LLD++   KL+DFG + +   +        V GT  Y 
Sbjct: 137 ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTPSYL 190
Query: 258 APDYIETGH------LTAKSDVWSFGVVLYEMLTG 286
           AP+ IE            + D+WS GV++Y +L G
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 37/222 (16%)
Query: 87  IGEGGFGSVYKSSI--KPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKL 144
           IG G +G+VYK S+  +P A        V      NR        +  + ++EH N+ + 
Sbjct: 21  IGRGRYGAVYKGSLDERPVA--------VKVFSFANRQNFINEKNIYRVPLMEHDNIARF 72
Query: 145 I-GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE 203
           I G   V  +  ++ LLV E+  N SL  +L   +     W +   +      GLAYLH 
Sbjct: 73  IVGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRLAHSVTRGLAYLHT 129
Query: 204 GL------EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV--------STA 249
            L      +  + +RD  + NVL+  +    +SDFGL+    + G+  V        + +
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR--LTGNRLVRPGEEDNAAIS 187
Query: 250 VVGTFGYAAPDYIETG-------HLTAKSDVWSFGVVLYEML 284
            VGT  Y AP+ +E             + D+++ G++ +E+ 
Sbjct: 188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K S    A     +  VV +K++       + E + L 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K S    A     +  VV +K++       + E + L 
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 91
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 92  AVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL 147
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 148 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 195
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 196 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 238

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K S    A     +  VV +K++       + E + L 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 80/166 (48%), Gaps = 13/166 (7%)
Query: 125 QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW 184
           Q   E+  L  L+HPN+VKL+    +D        +V+E +    + +        PL  
Sbjct: 82  QVYQEIAILKKLDHPNVVKLVE--VLDDPNEDHLYMVFELVNQGPVME---VPTLKPLSE 136
Query: 185 KTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT 244
                      +G+ YLH     ++I+RD K SN+L+ E+   K++DFG++ E    G  
Sbjct: 137 DQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE--FKGSD 191
Query: 245 HVSTAVVGTFGYAAPDYI-ETGHLTAKS--DVWSFGVVLYEMLTGR 287
            + +  VGT  + AP+ + ET  + +    DVW+ GV LY  + G+
Sbjct: 192 ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K S    A     +  VV +K++       + E + L 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 117
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 118 AVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL 173
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 174 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 221
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 94/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  IG G FG V    +  +    A     +  VV +K++       + E + L 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E+M    +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    K++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K S    A     +  VV +K++       + E + L 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 32/212 (15%)
Query: 87  IGEGGFGSV---YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLGVLE 137
           +G G +GSV   Y + ++            VA+KKL+R     +       E++ L  L+
Sbjct: 36  VGSGAYGSVCSAYDARLRQK----------VAVKKLSRPFQSLIHARRTYRELRLLKHLK 85
Query: 138 HPNLVKLIG-YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
           H N++ L+  +           + +   ++   L + + ++A      +  ++ +L    
Sbjct: 86  HENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLL---R 142
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           GL Y+H      +I+RD K SNV ++E+   ++ DFGLAR+          T  V T  Y
Sbjct: 143 GLKYIHSA---GIIHRDLKPSNVAVNEDSELRILDFGLARQA-----DEEMTGYVATRWY 194
Query: 257 AAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
            AP+  +   H     D+WS G ++ E+L G+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 94/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  IG G FG V    +  +    A     +  VV +K++       + E + L 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E+M    +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    K++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K S    A     +  VV +K++       + E + L 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 102/228 (44%), Gaps = 24/228 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGVLEHPNLVK 143
           IG+G F SV +  I    G   +   V   K  +  GL       E     +L+HP++V+
Sbjct: 34  IGKGPF-SVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 144 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL--HIILGAAEGLAYL 201
           L+   + DG       +V+EFM    L   +  RA     +   +  H +    E L Y 
Sbjct: 93  LLETYSSDG----MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 148
Query: 202 HEGLEVQVIYRDFKASNVLL--DENFRP-KLSDFGLAREGPMVGHTH-VSTAVVGTFGYA 257
           H+     +I+RD K   VLL   EN  P KL  FG+A +   +G +  V+   VGT  + 
Sbjct: 149 HDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ---LGESGLVAGGRVGTPHFM 202
Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 305
           AP+ ++        DVW  GV+L+ +L+G          T++RL E +
Sbjct: 203 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFY----GTKERLFEGI 246

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 101/235 (42%), Gaps = 52/235 (22%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLGVLEHPN 140
           IG G +G V ++  K        E  VVAIKK+ R      D  + + E+  L  L H +
Sbjct: 61  IGTGSYGHVCEAYDK-------LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDH 113
Query: 141 LVKLIGYCAV-DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI---ILGAAE 196
           +VK++      D E+  +  +V E      + D  F + F    + T LHI   +     
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLE------IADSDFKKLFRTPVYLTELHIKTLLYNLLV 167
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGHTHVS------- 247
           G+ Y+H      +++RD K +N L++++   K+ DFGLAR  + P  G++ +        
Sbjct: 168 GVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 248 ----------------TAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLT 285
                           T  V T  Y AP+ I    + T   DVWS G +  E+L 
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K S    A     +  VV +K++       + E + L 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K S    A     +  VV +K++       + E + L 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K S    A     +  VV +K++       + E + L 
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 97
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 98  AVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 154 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 201
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 102/228 (44%), Gaps = 24/228 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGVLEHPNLVK 143
           IG+G F SV +  I    G   +   V   K  +  GL       E     +L+HP++V+
Sbjct: 32  IGKGPF-SVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 144 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL--HIILGAAEGLAYL 201
           L+   + DG       +V+EFM    L   +  RA     +   +  H +    E L Y 
Sbjct: 91  LLETYSSDG----MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 202 HEGLEVQVIYRDFKASNVLL--DENFRP-KLSDFGLAREGPMVGHTH-VSTAVVGTFGYA 257
           H+     +I+RD K   VLL   EN  P KL  FG+A +   +G +  V+   VGT  + 
Sbjct: 147 HDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ---LGESGLVAGGRVGTPHFM 200
Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 305
           AP+ ++        DVW  GV+L+ +L+G          T++RL E +
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFY----GTKERLFEGI 244

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K S    A     +  VV +K++       + E + L 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K S    A     +  VV +K++       + E + L 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL  +   D        +V E++    +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLAG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 32/212 (15%)
Query: 87  IGEGGFGSV---YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLGVLE 137
           +G G +GSV   Y + ++            VA+KKL+R     +       E++ L  L+
Sbjct: 28  VGSGAYGSVCSAYDARLRQK----------VAVKKLSRPFQSLIHARRTYRELRLLKHLK 77
Query: 138 HPNLVKLIG-YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
           H N++ L+  +           + +   ++   L + +  +A      +  ++ +L    
Sbjct: 78  HENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL---R 134
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           GL Y+H      +I+RD K SNV ++E+   ++ DFGLAR+          T  V T  Y
Sbjct: 135 GLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQA-----DEEMTGYVATRWY 186
Query: 257 AAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
            AP+  +   H     D+WS G ++ E+L G+
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 77/190 (40%), Gaps = 26/190 (13%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G++Y H    +QV +RD K  N LLD +  P+L           V H+    + VGT  Y
Sbjct: 127 GVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQ-PKSTVGTPAY 182
Query: 257 AAPDYIETGHLTAK-SDVWSFGVVLYEMLTGRRSLE-----RNRPKTEQRLL-------E 303
            AP+ +       K +DVWS GV LY ML G    E     +N  KT  R+L       +
Sbjct: 183 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPD 242
Query: 304 WVQQYPADSKKFGLIMDPRLEKEYSINEARK---------IGRLADNCLSKSSKDRPKMS 354
           +V   P        I      K  SI E R             + DN ++    +  +  
Sbjct: 243 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPG 302
Query: 355 QVVERLKQIV 364
           Q +E + QI+
Sbjct: 303 QSIEEIMQII 312

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K S    A     +  VV +K++       + E + L 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 117
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 118 AVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 173
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 174 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGAT---WTLCG 221
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 97/231 (41%), Gaps = 21/231 (9%)
Query: 76  QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGV 135
           Q T+ +     IG G + SV K  I  A      E  V  I K  RD  + +  +   G 
Sbjct: 19  QFTDGYEVKEDIGVGSY-SVCKRCIHKAT---NXEFAVKIIDKSKRDPTEEIEILLRYG- 73
Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
            +HPN++ L        + G    +V E      L D +  + F     +    ++    
Sbjct: 74  -QHPNIITLKDVY----DDGKYVYVVTELXKGGELLDKILRQKF--FSEREASAVLFTIT 126
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVL-LDENFRP---KLSDFGLAREGPMVGHTHVSTAVV 251
           + + YLH      V++RD K SN+L +DE+  P   ++ DFG A++  +     +     
Sbjct: 127 KTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ--LRAENGLLXTPC 181
Query: 252 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 302
            T  + AP+ +E     A  D+WS GV+LY  LTG          T + +L
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEIL 232

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 38/218 (17%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWV--AEVQFLGVLEHPNLVK 143
           IG+G FG V++         G      VA+K  + R+   W   AE+    +L H N++ 
Sbjct: 11  IGKGRFGEVWR---------GKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 144 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH- 202
            I     D     Q  LV ++  + SL D+L NR    +  +  + + L  A GLA+LH 
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTV--EGMIKLALSTASGLAHLHM 118
Query: 203 EGLEVQ----VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV-------V 251
           E +  Q    + +RD K+ N+L+ +N    ++D GLA     V H   +  +       V
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-----VRHDSATDTIDIAPNHRV 173
Query: 252 GTFGYAAP----DYIETGHLTA--KSDVWSFGVVLYEM 283
           GT  Y AP    D I   H  +  ++D+++ G+V +E+
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K +    A     +  VV +K++       + E + L 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL  Y   D        +V E++    +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL-EYSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K S    A     +  VV +K++       + E + L 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLXG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K +    A     +  VV +K++       + E + L 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL  Y   D        +V E++    +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL-EYSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 38/218 (17%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWV--AEVQFLGVLEHPNLVK 143
           IG+G FG V++         G      VA+K  + R+   W   AE+    +L H N++ 
Sbjct: 12  IGKGRFGEVWR---------GKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 62
Query: 144 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH- 202
            I     D     Q  LV ++  + SL D+L NR    +  +  + + L  A GLA+LH 
Sbjct: 63  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTV--EGMIKLALSTASGLAHLHM 119
Query: 203 EGLEVQ----VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV-------V 251
           E +  Q    + +RD K+ N+L+ +N    ++D GLA     V H   +  +       V
Sbjct: 120 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-----VRHDSATDTIDIAPNHRV 174
Query: 252 GTFGYAAP----DYIETGHLTA--KSDVWSFGVVLYEM 283
           GT  Y AP    D I   H  +  ++D+++ G+V +E+
Sbjct: 175 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K +    A     +  VV +K++       + E + L 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL  Y   D        +V E++    +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL-EYSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K S    A     +  VV +K++       + E + L 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      + P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEP 243

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 38/218 (17%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWV--AEVQFLGVLEHPNLVK 143
           IG+G FG V++         G      VA+K  + R+   W   AE+    +L H N++ 
Sbjct: 17  IGKGRFGEVWR---------GKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 67
Query: 144 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH- 202
            I     D     Q  LV ++  + SL D+L NR    +  +  + + L  A GLA+LH 
Sbjct: 68  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTV--EGMIKLALSTASGLAHLHM 124
Query: 203 EGLEVQ----VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV-------V 251
           E +  Q    + +RD K+ N+L+ +N    ++D GLA     V H   +  +       V
Sbjct: 125 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-----VRHDSATDTIDIAPNHRV 179
Query: 252 GTFGYAAP----DYIETGHLTA--KSDVWSFGVVLYEM 283
           GT  Y AP    D I   H  +  ++D+++ G+V +E+
Sbjct: 180 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 55/101 (54%), Gaps = 9/101 (8%)
Query: 188 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF---RPKLSDFGLAREGPMVGHT 244
           + +I    EG+ YLH+     +++ D K  N+LL   +     K+ DFG++R+   +GH 
Sbjct: 134 IRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK---IGHA 187
Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
                ++GT  Y AP+ +    +T  +D+W+ G++ Y +LT
Sbjct: 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 32/212 (15%)
Query: 87  IGEGGFGSV---YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLGVLE 137
           +G G +GSV   Y + ++            VA+KKL+R     +       E++ L  L+
Sbjct: 36  VGSGAYGSVCSAYDARLRQK----------VAVKKLSRPFQSLIHARRTYRELRLLKHLK 85
Query: 138 HPNLVKLIG-YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
           H N++ L+  +           + +   ++   L + +  +A      +  ++ +L    
Sbjct: 86  HENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL---R 142
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           GL Y+H      +I+RD K SNV ++E+   ++ DFGLAR+          T  V T  Y
Sbjct: 143 GLKYIHSA---GIIHRDLKPSNVAVNEDSELRILDFGLARQA-----DEEMTGYVATRWY 194
Query: 257 AAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 287
            AP+  +   H     D+WS G ++ E+L G+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 38/218 (17%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWV--AEVQFLGVLEHPNLVK 143
           IG+G FG V++         G      VA+K  + R+   W   AE+    +L H N++ 
Sbjct: 14  IGKGRFGEVWR---------GKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 64
Query: 144 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH- 202
            I     D     Q  LV ++  + SL D+L NR    +  +  + + L  A GLA+LH 
Sbjct: 65  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTV--EGMIKLALSTASGLAHLHM 121
Query: 203 EGLEVQ----VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV-------V 251
           E +  Q    + +RD K+ N+L+ +N    ++D GLA     V H   +  +       V
Sbjct: 122 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-----VRHDSATDTIDIAPNHRV 176
Query: 252 GTFGYAAP----DYIETGHLTA--KSDVWSFGVVLYEM 283
           GT  Y AP    D I   H  +  ++D+++ G+V +E+
Sbjct: 177 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 38/218 (17%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWV--AEVQFLGVLEHPNLVK 143
           IG+G FG V++         G      VA+K  + R+   W   AE+    +L H N++ 
Sbjct: 50  IGKGRFGEVWR---------GKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 100
Query: 144 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH- 202
            I     D     Q  LV ++  + SL D+L NR    +  +  + + L  A GLA+LH 
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTV--EGMIKLALSTASGLAHLHM 157
Query: 203 EGLEVQ----VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV-------V 251
           E +  Q    + +RD K+ N+L+ +N    ++D GLA     V H   +  +       V
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-----VRHDSATDTIDIAPNHRV 212
Query: 252 GTFGYAAP----DYIETGHLTA--KSDVWSFGVVLYEM 283
           GT  Y AP    D I   H  +  ++D+++ G+V +E+
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K S    A     +  VV +K++       + E + L 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+++D+    +++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          + A VGT  Y
Sbjct: 142 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQY 198
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 36/219 (16%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLG 134
           +  +  IG G  G V       AA D   E  V AIKKL+R         +   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVV------AAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFM---LNRSLEDHLFNRAFPPLPWKTR 187
           V+ H N++ L+       ++ ++      +V E M   L++ ++  L +     L ++  
Sbjct: 79  VVNHKNIIGLLNVFT--PQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 188 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 247
           +        G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + 
Sbjct: 137 V--------GIKHLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMM 182
Query: 248 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           T  V T  Y AP+ I         D+WS GV++ EM+ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 38/218 (17%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWV--AEVQFLGVLEHPNLVK 143
           IG+G FG V++         G      VA+K  + R+   W   AE+    +L H N++ 
Sbjct: 37  IGKGRFGEVWR---------GKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 87
Query: 144 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH- 202
            I     D     Q  LV ++  + SL D+L NR    +  +  + + L  A GLA+LH 
Sbjct: 88  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTV--EGMIKLALSTASGLAHLHM 144
Query: 203 EGLEVQ----VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV-------V 251
           E +  Q    + +RD K+ N+L+ +N    ++D GLA     V H   +  +       V
Sbjct: 145 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-----VRHDSATDTIDIAPNHRV 199
Query: 252 GTFGYAAP----DYIETGHLTA--KSDVWSFGVVLYEM 283
           GT  Y AP    D I   H  +  ++D+++ G+V +E+
Sbjct: 200 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K S    A     +  VV +K++       + E + L 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++Y+M  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQP 243

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K S    A     +  VV +K++       + E + L 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP  I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 8/102 (7%)
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTH 245
           +I+      ++++H+   V V++RD K  N+L    ++N   K+ DFG AR  P      
Sbjct: 110 YIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            +     T  YAAP+ +         D+WS GV+LY ML+G+
Sbjct: 167 KTPCF--TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 121/281 (43%), Gaps = 45/281 (16%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPN 140
           +G G +G+V       +A DG + A V AIKKL R         +   E++ L  + H N
Sbjct: 33  VGSGAYGAVC------SAVDGRTGAKV-AIKKLYRPFQSELFAKRAYRELRLLKHMRHEN 85
Query: 141 LVKLIGYCAVDG--ERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLH-IILGA 194
           ++ L+     D   +      LV  FM   L + ++             + R+  ++   
Sbjct: 86  VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLG--------EDRIQFLVYQM 137
Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 254
            +GL Y+H      +I+RD K  N+ ++E+   K+ DFGLAR+      + +   VV T 
Sbjct: 138 LKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ----ADSEMXGXVV-TR 189
Query: 255 GYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRR---------SLERNRPKTEQRLLEW 304
            Y AP+ I      T   D+WS G ++ EM+TG+           L+     T     E+
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249
Query: 305 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSK 345
           VQ+  +D  K  +   P LEK+   +       LA N L K
Sbjct: 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK 290

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 36/219 (16%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLG 134
           +  +  IG G  G V       AA D   E  V AIKKL+R         +   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVC------AAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFM---LNRSLEDHLFNRAFPPLPWKTR 187
           V+ H N++ L+       ++ ++      +V E M   L++ ++  L +     L ++  
Sbjct: 79  VVNHKNIIGLLN--VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 188 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 247
           +        G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + 
Sbjct: 137 V--------GIKHLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMM 182
Query: 248 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           T  V T  Y AP+ I         D+WS GV++ EM+ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 76/190 (40%), Gaps = 26/190 (13%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G++Y H    +QV +RD K  N LLD +  P+L           V H+      VGT  Y
Sbjct: 127 GVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQ-PKDTVGTPAY 182
Query: 257 AAPDYIETGHLTAK-SDVWSFGVVLYEMLTGRRSLE-----RNRPKTEQRLL-------E 303
            AP+ +       K +DVWS GV LY ML G    E     +N  KT  R+L       +
Sbjct: 183 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPD 242
Query: 304 WVQQYPADSKKFGLIMDPRLEKEYSINEARK---------IGRLADNCLSKSSKDRPKMS 354
           +V   P        I      K  SI E R             + DN ++    +  +  
Sbjct: 243 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPG 302
Query: 355 QVVERLKQIV 364
           Q +E + QI+
Sbjct: 303 QSIEEIMQII 312

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K +    A     +  VV +K++       + E + L 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 89
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 90  AVNFPFLVKL----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL 145
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 146 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 193
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 19/212 (8%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK----LNRDGLQWVA-EVQFLG 134
           DF     +GEG F     S++  A    TS    + I +    +  + + +V  E   + 
Sbjct: 38  DFKFGKILGEGSF-----STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 92
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 194
            L+HP  VKL  +C  D E+     L +     ++ E   + R                 
Sbjct: 93  RLDHPFFVKLY-FCFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 146
Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 254
              L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT 
Sbjct: 147 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 203
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            Y +P+ +        SD+W+ G ++Y+++ G
Sbjct: 204 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  IG G FG V    +  +    A     +  VV +K++       + E + L 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    K++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K +    A     +  VV +K++       + E + L 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 97
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 98  AVNFPFLVKL----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 154 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 201
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 3/90 (3%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          + + VGT  Y
Sbjct: 144 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 200
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            +P+ +     +  SD+W+ G ++Y+++ G
Sbjct: 201 VSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K +    A     +  VV +K++       + E + L 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 97
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 98  AVNFPFLVKL----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 154 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 201
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K +    A     +  VV +K++       + E + L 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 97
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 98  AVNFPFLVKL----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 154 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 201
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K +    A     +  VV +K++       + E + L 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 97
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E+     +  HL    R   P        I+L
Sbjct: 98  AVNFPFLVKL----EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+++D+    K++DFG A+   + G T     + G
Sbjct: 154 T----FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRT---WXLCG 201
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 64  EVSILKEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKE--SLTEEEAT 117
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 244
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 171
Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 172 NEFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K +    A     +  VV +K++       + E + L 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 89
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 90  AVNFPFLVKL----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 145
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 146 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 193
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K +    A     +  VV +K++       + E + L 
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 117
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 118 AVNFPFLVKL----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 173
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 174 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 221
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 89/201 (44%), Gaps = 52/201 (25%)
Query: 181 PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--- 237
           P+  +  +      A G+ +L      + I+RD  A N+LL EN   K+ DFGLAR+   
Sbjct: 195 PITMEDLISYSFQVARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYK 251
Query: 238 GPMV---GHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNR 294
            P     G T +         + AP+ I     + KSDVWS+GV+L+E+ +   S     
Sbjct: 252 NPDYVRKGDTRL------PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGS----- 300
Query: 295 PKTEQRLLEWVQQYPADSKKFGLIMD----PRLEK-------EYSINEARKIGRLADNCL 343
                        YP      G+ MD     RL +       EYS  E   I ++  +C 
Sbjct: 301 ------------PYP------GVQMDEDFCSRLREGMRMRAPEYSTPE---IYQIMLDCW 339
Query: 344 SKSSKDRPKMSQVVERLKQIV 364
            +  K+RP+ +++VE+L  ++
Sbjct: 340 HRDPKERPRFAELVEKLGDLL 360

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 121 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 177
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 178 VSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 120 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 176
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 122 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 178
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 179 VSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          + + VGT  Y
Sbjct: 145 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 201
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 119 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 175
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 176 VSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          + + VGT  Y
Sbjct: 141 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 197
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 7/92 (7%)
Query: 196 EGLAYLH-EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 254
           + LAYLH +G    VI+RD K+ ++LL  + R KLSDFG   +  +         +VGT 
Sbjct: 152 QALAYLHAQG----VIHRDIKSDSILLTLDGRVKLSDFGFCAQ--ISKDVPKRKXLVGTP 205
Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            + AP+ I       + D+WS G+++ EM+ G
Sbjct: 206 YWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 94/233 (40%), Gaps = 45/233 (19%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLGVLEHPN 140
           IG G +G VY       A D  +E  V AIKK+NR      D  + + E+  L  L+   
Sbjct: 34  IGRGSYGYVY------LAYDKNTEKNV-AIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI---ILGAAEG 197
           +++L      D       L +        + D    + F    + T  HI   +     G
Sbjct: 87  IIRLYDLIIPDDLLKFDELYIV-----LEIADSDLKKLFKTPIFLTEEHIKTILYNLLLG 141
Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS---------- 247
             ++HE     +I+RD K +N LL+++   K+ DFGLAR       T++           
Sbjct: 142 ENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 248 ----------TAVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGRRS 289
                     T+ V T  Y AP+ I       KS D+WS G +  E+L   +S
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 82/182 (45%), Gaps = 19/182 (10%)
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           E+  L  ++H N+V L        E      LV + +    L D +  R       K   
Sbjct: 56  EIAVLKKIKHENIVTLEDI----YESTTHYYLVMQLVSGGELFDRILERGV--YTEKDAS 109
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTH 245
            +I      + YLHE     +++RD K  N+L    +EN +  ++DFGL++   M  +  
Sbjct: 110 LVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGI 163
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 305
           +STA  GT GY AP+ +     +   D WS GV+ Y +L G         +TE +L E +
Sbjct: 164 MSTAC-GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE---ETESKLFEKI 219
Query: 306 QQ 307
           ++
Sbjct: 220 KE 221

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 36/219 (16%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLG 134
           +  +  IG G  G V       AA D   E  V AIKKL+R         +   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVC------AAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFM---LNRSLEDHLFNRAFPPLPWKTR 187
           V+ H N++ L+       ++ ++      +V E M   L++ ++  L +     L ++  
Sbjct: 79  VVNHKNIIGLLN--VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 188 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 247
           +        G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + 
Sbjct: 137 V--------GIKHLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMM 182
Query: 248 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           T  V T  Y AP+ I         D+WS G ++ EM+ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 126 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 182
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 183 VSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 64  EVSILKEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKE--SLTEEEAT 117
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 244
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 171
Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 142 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 144 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 142 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 142 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 145 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 201
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 144 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 144 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 144 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 64  EVSILKEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKE--SLTEEEAT 117
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 244
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 171
Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 31/115 (26%), Positives = 56/115 (48%), Gaps = 4/115 (3%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 147 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 203
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLER-NRPKTEQRLLEWVQQYPA 310
            +P+ +        SD+W+ G ++Y+++ G       N     Q++++    +PA
Sbjct: 204 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPA 258

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 141 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 197
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 64  EVSILKEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKE--SLTEEEAT 117
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 244
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 171
Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +  +    A     +  VV +K++       + E + L 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E+     +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+++D+    K++DFGLA+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 64  EVSILKEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKE--SLTEEEAT 117
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 244
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 171
Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 63  EVSILKEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKE--SLTEEEAT 116
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 244
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 117 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 170
Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 171 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 144 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 201 VSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 64  EVSILKEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKE--SLTEEEAT 117
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 244
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 171
Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 64  EVSILKEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKE--SLTEEEAT 117
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 244
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 171
Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 63  EVSILKEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKE--SLTEEEAT 116
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 244
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 117 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 170
Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 171 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 36/219 (16%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLG 134
           +  +  IG G  G V       AA D   E  V AIKKL+R         +   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVC------AAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFM---LNRSLEDHLFNRAFPPLPWKTR 187
           V+ H N++ L+       ++ ++      +V E M   L++ ++  L +     L ++  
Sbjct: 79  VVNHKNIIGLLN--VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 188 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 247
                    G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + 
Sbjct: 137 C--------GIKHLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMM 182
Query: 248 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           T  V T  Y AP+ I         D+WS G ++ EM+ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 64  EVSILKEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKE--SLTEEEAT 117
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 244
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 171
Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 64  EVSILKEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKE--SLTEEEAT 117
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 244
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 171
Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 30/219 (13%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVAEVQFLGVLEHPNLVK 143
           K+GEGGF  V    +     DG   A   ++  ++ +R+  Q  A++  L    HPN+++
Sbjct: 36  KLGEGGFSYV---DLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL--FNHPNILR 90
Query: 144 LIGYCAVDGERGIQR--LLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEGLA 199
           L+ YC    ERG +    L+  F    +L + +         L     L ++LG   GL 
Sbjct: 91  LVAYCL--RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG------- 252
            +H        +RD K +N+LL +  +P L D G   +  +  H   S   +        
Sbjct: 149 AIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI--HVEGSRQALTLQDWAAQ 203
Query: 253 --TFGYAAPDYIETGH---LTAKSDVWSFGVVLYEMLTG 286
             T  Y AP+         +  ++DVWS G VLY M+ G
Sbjct: 204 RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 64  EVSILKEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKE--SLTEEEAT 117
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 244
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 171
Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +  +    A     +  VV +K++       + E + L 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 84/197 (42%), Gaps = 17/197 (8%)
Query: 110 EATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRS 169
           E  V  I K  RD  + +  +   G  +HPN++ L        + G    LV E M    
Sbjct: 54  EYAVKVIDKSKRDPSEEIEILLRYG--QHPNIITLKDVY----DDGKHVYLVTELMRGGE 107
Query: 170 LEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVL-LDENFRP- 227
           L D +  + F     +    ++    + + YLH      V++RD K SN+L +DE+  P 
Sbjct: 108 LLDKILRQKF--FSEREASFVLHTIGKTVEYLHSQ---GVVHRDLKPSNILYVDESGNPE 162
Query: 228 --KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
             ++ DFG A++  +     +      T  + AP+ ++        D+WS G++LY ML 
Sbjct: 163 CLRICDFGFAKQ--LRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLA 220
Query: 286 GRRSLERNRPKTEQRLL 302
           G          T + +L
Sbjct: 221 GYTPFANGPSDTPEEIL 237

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +  +    A     +  VV +K++       + E + L 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K S    A     +  VV +K++       + E + L 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T    AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 84/197 (42%), Gaps = 17/197 (8%)
Query: 110 EATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRS 169
           E  V  I K  RD  + +  +   G  +HPN++ L        + G    LV E M    
Sbjct: 54  EYAVKVIDKSKRDPSEEIEILLRYG--QHPNIITLKDVY----DDGKHVYLVTELMRGGE 107
Query: 170 LEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVL-LDENFRP- 227
           L D +  + F     +    ++    + + YLH      V++RD K SN+L +DE+  P 
Sbjct: 108 LLDKILRQKF--FSEREASFVLHTIGKTVEYLHSQ---GVVHRDLKPSNILYVDESGNPE 162
Query: 228 --KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
             ++ DFG A++  +     +      T  + AP+ ++        D+WS G++LY ML 
Sbjct: 163 CLRICDFGFAKQ--LRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLA 220
Query: 286 GRRSLERNRPKTEQRLL 302
           G          T + +L
Sbjct: 221 GYTPFANGPSDTPEEIL 237

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +  +    A     +  VV +K++       + E + L 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 97
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 98  AVNFPFLVKL----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL 153
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 154 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 201
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 93/223 (41%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +  +    A     +  VV +K++       + E + L 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E+     +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+++D+    K++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +  +    A     +  VV +K++       + E + L 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 30/216 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLG 134
           +  +  IG G  G V       AA D   E  V AIKKL+R         +   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVC------AAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
            + H N++ L+       ++ ++      +V E M     + +L       L  +   ++
Sbjct: 79  CVNHKNIIGLLN--VFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYL 131
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 132 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 185
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           V T  Y AP+ I         D+WS G ++ EM+ G
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 64  EVSILKEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKE--SLTEEEAT 117
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 244
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 171
Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 30/216 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLG 134
           +  +  IG G  G V       AA D   E  V AIKKL+R         +   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVC------AAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
            + H N++ L+       ++ ++      +V E M     + +L       L  +   ++
Sbjct: 79  CVNHKNIIGLLN--VFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYL 131
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 132 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 185
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           V T  Y AP+ I         D+WS G ++ EM+ G
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +  +    A     +  VV +K++       + E + L 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 97
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 98  AVNFPFLVKL----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 154 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WTLCG 201
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +K +    A     +  VV +K++       + E +   
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT----LNEKRIQQ 97
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E+     +  HL    R   P        I+L
Sbjct: 98  AVNFPFLVKL----EFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    K++DFG A+   + G T     + G
Sbjct: 154 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKR--VKGRT---WXLCG 201
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 30/216 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLG 134
           +  +  IG G  G V       AA D   E  V AIKKL+R         +   E+  + 
Sbjct: 27  YQNLKPIGSGAQGIVC------AAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMK 79
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
            + H N++ L+       ++ ++      +V E M     + +L       L  +   ++
Sbjct: 80  CVNHKNIIGLLN--VFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYL 132
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 133 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 186
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           V T  Y AP+ I         D+WS G ++ EM+ G
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA----EVQFLGVLEHPNLV 142
           +G GG G V+      +A D   +  V AIKK+     Q V     E++ +  L+H N+V
Sbjct: 19  LGCGGNGLVF------SAVDNDCDKRV-AIKKIVLTDPQSVKHALREIKIIRRLDHDNIV 71
Query: 143 KLIGYCAVDGER-----GIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAA 195
           K+       G +     G    L   +++   +E  L N     P L    RL  +    
Sbjct: 72  KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL-FMYQLL 130
Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLAR-EGPMVGHT-HVSTAVVG 252
            GL Y+H      V++RD K +N+ ++ E+   K+ DFGLAR   P   H  H+S  +V 
Sbjct: 131 RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            +  +    +   + T   D+W+ G +  EMLTG+
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 6/90 (6%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  V T  Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            AP+ I         D+WS G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +  +    A     +  VV +K++       + E + L 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 97
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 98  AVNFPFLVKL----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 154 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 201
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +  +    A     +  VV +K++       + E + L 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +  +    A     +  VV +K++       + E + L 
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 82
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 83  AVNFPFLVKL----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 138
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 139 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WTLCG 186
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 187 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 229

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +  +    A     +  VV +K++       + E + L 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +  +    A     +  VV +K++       + E + L 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E++    +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 93/223 (41%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +  +    A     +  VV +K++       + E + L 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E+     +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+++D+    K++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQF 132
           +MR    DF  +  IG G FG V    +K A         V A+K LN+  +   AE   
Sbjct: 68  QMRLHREDFEILKVIGRGAFGEVAVVKLKNAD-------KVFAMKILNKWEMLKRAETAC 120
Query: 133 L----GVLEHPN--LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPW 184
                 VL + +   +  + Y   D        LV ++ +   L   L  F    P    
Sbjct: 121 FREERDVLVNGDSKWITTLHYAFQDDN---NLYLVMDYYVGGDLLTLLSKFEDRLPEEMA 177
Query: 185 KTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT 244
           +  L  ++ A + +  LH       ++RD K  N+L+D N   +L+DFG   +  M   T
Sbjct: 178 RFYLAEMVIAIDSVHQLH------YVHRDIKPDNILMDMNGHIRLADFGSCLK-LMEDGT 230
Query: 245 HVSTAVVGTFGYAAPDYIET-----GHLTAKSDVWSFGVVLYEMLTG 286
             S+  VGT  Y +P+ ++      G    + D WS GV +YEML G
Sbjct: 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 64  EVSILKEIQHPNVITLHEVY----ENKTDVILIGELVAGGELFDFLAEKE--SLTEEEAT 117
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 244
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 171
Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 6/90 (6%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  V T  Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            AP+ I         D+WS G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 6/90 (6%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  V T  Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPEVVTRYY 191
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            AP+ I         D+WS G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 259
           YLH    + +IYRD K  N+++D+    K++DFG A+   + G T     + GT  Y AP
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRT---WXLCGTPEYLAP 208
Query: 260 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           + I +       D W+ GV++YEM  G      ++P
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +  +    A     +  VV +K++       + E + L 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E+     +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+++D+    +++DFGLA+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 259
           YLH    + +IYRD K  N+++D+    K++DFG A+   + G T     + GT  Y AP
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRT---WXLCGTPEYLAP 208
Query: 260 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           + I +       D W+ GV++YEM  G      ++P
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 259
           YLH    + +IYRD K  N+++D+    K++DFG A+   + G T     + GT  Y AP
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRT---WXLCGTPEYLAP 208
Query: 260 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           + I +       D W+ GV++YEM  G      ++P
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLAREGPMVGHTH 245
           I+    E + YLH    + + +RD K  N+L     RP    KL+DFG A+E     H  
Sbjct: 166 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKET--TSHNS 219
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           ++T     + Y AP+ +         D+WS GV++Y +L G
Sbjct: 220 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLAREGPMVGHTH 245
           I+    E + YLH    + + +RD K  N+L     RP    KL+DFG A+E     H  
Sbjct: 172 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKET--TSHNS 225
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           ++T     + Y AP+ +         D+WS GV++Y +L G
Sbjct: 226 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 265

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/86 (37%), Positives = 45/86 (52%), Gaps = 6/86 (6%)
Query: 206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET- 264
           ++  ++RD K  NVLLD N   +L+DFG   +    G    S A VGT  Y +P+ ++  
Sbjct: 209 QLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA-VGTPDYISPEILQAM 267
Query: 265 ----GHLTAKSDVWSFGVVLYEMLTG 286
               G    + D WS GV +YEML G
Sbjct: 268 EDGMGKYGPECDWWSLGVCMYEMLYG 293

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 30/216 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLG 134
           + ++  IG G  G V        A   T     VA+KKL+R         +   E+  L 
Sbjct: 26  YQQLKPIGSGAQGIV-------CAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLK 78
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 79  CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLCQVIHMELDHERMSYL 131
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR         + T  
Sbjct: 132 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPY 185
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           V T  Y AP+ I      A  D+WS G ++ E++ G
Sbjct: 186 VVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/86 (37%), Positives = 45/86 (52%), Gaps = 6/86 (6%)
Query: 206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET- 264
           ++  ++RD K  NVLLD N   +L+DFG   +    G    S A VGT  Y +P+ ++  
Sbjct: 193 QLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA-VGTPDYISPEILQAM 251
Query: 265 ----GHLTAKSDVWSFGVVLYEMLTG 286
               G    + D WS GV +YEML G
Sbjct: 252 EDGMGKYGPECDWWSLGVCMYEMLYG 277

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 32/177 (18%)
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
           I +   + L +LH  L V  I+RD K SNVL++   + K+ DFG++  G +V      T 
Sbjct: 158 IAVSIVKALEHLHSKLSV--IHRDVKPSNVLINALGQVKMCDFGIS--GYLVDSV-AKTI 212
Query: 250 VVGTFGYAAPDYI-----ETGHLTAKSDVWSFGVVLYEMLTGRRSLER-NRP--KTEQRL 301
             G   Y AP+ I     + G+ + KSD+WS G+ + E+   R   +    P  + +Q +
Sbjct: 213 DAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 271
Query: 302 LEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
            E   Q PAD  KF                + +       CL K+SK+RP   ++++
Sbjct: 272 EEPSPQLPAD--KF----------------SAEFVDFTSQCLKKNSKERPTYPELMQ 310

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLAREGPMVGHTH 245
           I+    E + YLH    + + +RD K  N+L     RP    KL+DFG A+E     H  
Sbjct: 128 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKE--TTSHNS 181
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           ++T     + Y AP+ +         D+WS GV++Y +L G
Sbjct: 182 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 221

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLAREGPMVGHTH 245
           I+    E + YLH    + + +RD K  N+L     RP    KL+DFG A+E     H  
Sbjct: 122 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKE--TTSHNS 175
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           ++T     + Y AP+ +         D+WS GV++Y +L G
Sbjct: 176 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 215

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLAREGPMVGHTH 245
           I+    E + YLH    + + +RD K  N+L     RP    KL+DFG A+E     H  
Sbjct: 126 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKET--TSHNS 179
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           ++T     + Y AP+ +         D+WS GV++Y +L G
Sbjct: 180 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 219

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLAREGPMVGHTH 245
           I+    E + YLH    + + +RD K  N+L     RP    KL+DFG A+E     H  
Sbjct: 127 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKET--TSHNS 180
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           ++T     + Y AP+ +         D+WS GV++Y +L G
Sbjct: 181 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 220

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLAREGPMVGHTH 245
           I+    E + YLH    + + +RD K  N+L     RP    KL+DFG A+E     H  
Sbjct: 120 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKE--TTSHNS 173
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           ++T     + Y AP+ +         D+WS GV++Y +L G
Sbjct: 174 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 213

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLAREGPMVGHTH 245
           I+    E + YLH    + + +RD K  N+L     RP    KL+DFG A+E     H  
Sbjct: 121 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKE--TTSHNS 174
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           ++T     + Y AP+ +         D+WS GV++Y +L G
Sbjct: 175 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 214

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLAREGPMVGHTH 245
           I+    E + YLH    + + +RD K  N+L     RP    KL+DFG A+E     H  
Sbjct: 122 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKET--TSHNS 175
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           ++T     + Y AP+ +         D+WS GV++Y +L G
Sbjct: 176 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 215

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + +    V T  Y
Sbjct: 140 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMVPFVVTRYY 193
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            AP+ I         D+WS G ++ EM+ G
Sbjct: 194 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLAREGPMVGHTH 245
           I+    E + YLH    + + +RD K  N+L     RP    KL+DFG A+E     H  
Sbjct: 136 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKE--TTSHNS 189
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           ++T     + Y AP+ +         D+WS GV++Y +L G
Sbjct: 190 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 229

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLG 134
           +  +  IG G  G V       AA D   +  V AIKKL+R         +   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 79  CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLXQVIQMELDHERMSYL 131
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 132 LYQMLXGIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPY 185
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 103/218 (47%), Gaps = 18/218 (8%)
Query: 73  EMRQAT-NDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEV 130
           E++Q +  D+  +L+ +G G FG V++  ++ A G       +     L++  ++   E+
Sbjct: 43  EVKQGSVYDYYDILEELGSGAFGVVHRC-VEKATGRVFVAKFINTPYPLDKYTVK--NEI 99
Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
             +  L HP L+ L        E   + +L+ EF+    L D +    +  +     ++ 
Sbjct: 100 SIMNQLHHPKLINLHDAF----EDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINY 154
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD--ENFRPKLSDFGLAREGPMVGHTHVST 248
           +  A EGL ++HE     +++ D K  N++ +  +    K+ DFGLA +   +    +  
Sbjct: 155 MRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK---LNPDEIVK 208
Query: 249 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
               T  +AAP+ ++   +   +D+W+ GV+ Y +L+G
Sbjct: 209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 26/223 (11%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG 134
           + F R+  +G G FG V    +  +    A     +  VV +K++       + E + L 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT----LNEKRILQ 96
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL 192
            +  P LVKL        +      +V E+     +  HL    R   P        I+L
Sbjct: 97  AVNFPFLVKL----EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
                  YLH    + +IYRD K  N+++D+    +++DFG A+   + G T     + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKR--VKGRT---WXLCG 200
Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
           T  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLG 134
           +  +  IG G  G V       AA D   +  V AIKKL+R         +   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 79  CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYL 131
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 132 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 185
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLG 134
           +  +  IG G  G V       AA D   +  V AIKKL+R         +   E+  + 
Sbjct: 27  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 79
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 80  CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYL 132
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 133 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 186
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLG 134
           +  +  IG G  G V       AA D   +  V AIKKL+R         +   E+  + 
Sbjct: 64  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 116
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 117 CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYL 169
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 170 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 223
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLG 134
           +  +  IG G  G V       AA D   +  V AIKKL+R         +   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 79  CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYL 131
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 132 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 185
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLG 134
           +  +  IG G  G V       AA D   +  V AIKKL+R         +   E+  + 
Sbjct: 19  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 71
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 72  CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLXQVIQMELDHERMSYL 124
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 125 LYQMLXGIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPY 178
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLG 134
           +  +  IG G  G V       AA D   +  V AIKKL+R         +   E+  + 
Sbjct: 25  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 77
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 78  CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYL 130
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 131 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 184
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 185 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLG 134
           +  +  IG G  G V       AA D   +  V AIKKL+R         +   E+  + 
Sbjct: 64  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 116
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 117 CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYL 169
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 170 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 223
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLG 134
           +  +  IG G  G V       AA D   +  V AIKKL+R         +   E+  + 
Sbjct: 27  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 79
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 80  CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYL 132
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 133 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 186
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQF 132
           E R+  +  +   ++G G FG V++   K             A+KK+  +  + V E+  
Sbjct: 52  EYREEVHWMTHQPRVGRGSFGEVHRMKDK-------QTGFQCAVKKVRLEVFR-VEELVA 103
Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
              L  P +V L G  AV    G    +  E +   SL   +  +    LP    L+ + 
Sbjct: 104 CAGLSSPRIVPLYG--AV--REGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLG 157
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFG--LAREGPMVGHTHVSTA 249
            A EGL YLH     ++++ D KA NVLL  +  R  L DFG  L  +   +G + ++  
Sbjct: 158 QALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 214
Query: 250 VV-GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            + GT  + AP+ +      AK D+WS   ++  ML G
Sbjct: 215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 37/223 (16%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQWVA--EV 130
           + + + R+ K+GEG +G VYK      A D  +  T VAIK++      +G+   A  EV
Sbjct: 32  SIDRYRRITKLGEGTYGEVYK------AIDTVTNET-VAIKRIRLEHEEEGVPGTAIREV 84
Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 189
             L  L+H N+++L      +      RL L++E+  N  L+ ++     P +  +    
Sbjct: 85  SLLKELQHRNIIELKSVIHHN-----HRLHLIFEYAEN-DLKKYMDKN--PDVSMRVIKS 136
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRP--KLSDFGLAREG--PMVG 242
            +     G+ + H     + ++RD K  N+LL   D +  P  K+ DFGLAR    P+  
Sbjct: 137 FLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ 193
Query: 243 HTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEML 284
            TH     + T  Y  P+  + + H +   D+WS   +  EML
Sbjct: 194 FTH----EIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLG 134
           +  +  IG G  G V       AA D   +  V AIKKL+R         +   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 79  XVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLXQVIQMELDHERMSYL 131
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 132 LYQMLXGIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPY 185
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 110/270 (40%), Gaps = 73/270 (27%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    E                 
Sbjct: 44  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 130 -------VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 181
                  ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 148
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 240
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 149 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 192
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 291
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 193 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 251
Query: 292 ----RNRPKTE-QRLLEWVQQY-PADSKKF 315
               R R  +E Q L+ W     P+D   F
Sbjct: 252 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 281

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLG 134
           +  +  IG G  G V       AA D   +  V AIKKL+R         +   E+  + 
Sbjct: 20  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 72
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 73  CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYL 125
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 126 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 179
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 180 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 110/270 (40%), Gaps = 73/270 (27%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    E                 
Sbjct: 31  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 130 -------VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 181
                  ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 135
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 240
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 136 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 179
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 291
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 180 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 238
Query: 292 ----RNRPKTE-QRLLEWVQQY-PADSKKF 315
               R R  +E Q L+ W     P+D   F
Sbjct: 239 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 268

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLG 134
           +  +  IG G  G V       AA D   +  V AIKKL+R         +   E+  + 
Sbjct: 20  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 72
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 73  CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYL 125
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 126 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 179
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 180 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQF 132
           E R+  +  +   ++G G FG V++   K             A+KK+  +  + V E+  
Sbjct: 68  EYREEVHWMTHQPRVGRGSFGEVHRMKDK-------QTGFQCAVKKVRLEVFR-VEELVA 119
Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
              L  P +V L G  AV    G    +  E +   SL   +  +    LP    L+ + 
Sbjct: 120 CAGLSSPRIVPLYG--AV--REGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLG 173
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFG--LAREGPMVGHTHVSTA 249
            A EGL YLH     ++++ D KA NVLL  +  R  L DFG  L  +   +G + ++  
Sbjct: 174 QALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 230
Query: 250 VV-GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            + GT  + AP+ +      AK D+WS   ++  ML G
Sbjct: 231 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLG 134
           +  +  IG G  G V       AA D   +  V AIKKL+R         +   E+  + 
Sbjct: 19  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 71
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 72  CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYL 124
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 125 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 178
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 284
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 110/270 (40%), Gaps = 73/270 (27%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    E                 
Sbjct: 44  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 130 -------VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 181
                  ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 148
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 240
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 149 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 192
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 291
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 193 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG 251
Query: 292 ----RNRPKTE-QRLLEWVQQY-PADSKKF 315
               R R  +E Q L+ W     P+D   F
Sbjct: 252 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 281

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 110/270 (40%), Gaps = 73/270 (27%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    E                 
Sbjct: 45  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 130 -------VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 181
                  ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 149
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 240
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 150 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 193
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 291
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 194 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG 252
Query: 292 ----RNRPKTE-QRLLEWVQQY-PADSKKF 315
               R R  +E Q L+ W     P+D   F
Sbjct: 253 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 282

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 110/270 (40%), Gaps = 73/270 (27%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    E                 
Sbjct: 45  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 130 -------VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 181
                  ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 149
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 240
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 150 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 193
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 291
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 194 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG 252
Query: 292 ----RNRPKTE-QRLLEWVQQY-PADSKKF 315
               R R  +E Q L+ W     P+D   F
Sbjct: 253 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 282

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 110/270 (40%), Gaps = 73/270 (27%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    E                 
Sbjct: 44  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 130 -------VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 181
                  ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 148
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 240
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 149 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 192
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 291
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 193 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG 251
Query: 292 ----RNRPKTE-QRLLEWVQQY-PADSKKF 315
               R R  +E Q L+ W     P+D   F
Sbjct: 252 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 281

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 96/237 (40%), Gaps = 50/237 (21%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLGVLEHPN 140
           IG G +G VY +  K A  +       VAIKK+NR      D  + + E+  L  L+   
Sbjct: 36  IGRGSYGYVYLAYDKNANKN-------VAIKKVNRMFEDLIDCKRILREITILNRLKSDY 88
Query: 141 LVKLIGYCAVDGERGIQRLLVY-EFMLNRSLEDHLFNRAFPPLPWKTRLH---IILGAAE 196
           +++L      +       LL + E  +   + D    + F    + T  H   I+     
Sbjct: 89  IIRLHDLIIPED------LLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLL 142
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS--------- 247
           G  ++HE     +I+RD K +N LL+++   K+ DFGLAR        H+          
Sbjct: 143 GEKFIHES---GIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEEN 199
Query: 248 --------------TAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRS 289
                         T+ V T  Y AP+ I    + T   D+WS G +  E+L   +S
Sbjct: 200 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKS 256

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQF 132
           E R+  +  +   ++G G FG V++   K             A+KK+  +  + V E+  
Sbjct: 66  EYREEVHWMTHQPRLGRGSFGEVHRMKDK-------QTGFQCAVKKVRLEVFR-VEELVA 117
Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
              L  P +V L G  AV    G    +  E +   SL   +  +    LP    L+ + 
Sbjct: 118 CAGLSSPRIVPLYG--AV--REGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLG 171
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFG--LAREGPMVGHTHVSTA 249
            A EGL YLH     ++++ D KA NVLL  +  R  L DFG  L  +   +G + ++  
Sbjct: 172 QALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 228
Query: 250 VV-GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            + GT  + AP+ +      AK D+WS   ++  ML G
Sbjct: 229 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 24/214 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLG 134
           +  +  IG G  G V       AA D   E  V AIKKL+R         +   E+  + 
Sbjct: 20  YQNLKPIGSGAQGIVC------AAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMK 72
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLL-VYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
            + H N++ L+       ++ ++    VY  M    ++ +L       L  +   +++  
Sbjct: 73  CVNHKNIIGLLN--VFTPQKSLEEFQDVYIVM--ELMDANLCQVIQMELDHERMSYLLYQ 128
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
              G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  V T
Sbjct: 129 MLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVT 182
Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
             Y AP+ I         D+WS G ++ EM+  +
Sbjct: 183 RYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 110/270 (40%), Gaps = 73/270 (27%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    E                 
Sbjct: 32  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 130 -------VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 181
                  ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 136
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 240
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 137 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 180
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 291
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 181 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 239
Query: 292 ----RNRPKTE-QRLLEWVQQY-PADSKKF 315
               R R  +E Q L+ W     P+D   F
Sbjct: 240 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 269

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLG 134
           +  +  IG G  G V       AA D   E  V AIKKL+R         +   E+  + 
Sbjct: 31  YQNLKPIGSGAQGIVC------AAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMK 83
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
            + H N++ L+       ++ ++      +V E M     + +L       L  +   ++
Sbjct: 84  CVNHKNIIGLLN--VFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYL 136
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 137 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 190
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
           V T  Y AP+ I         D+WS G ++ EM+  +
Sbjct: 191 VVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 110/270 (40%), Gaps = 73/270 (27%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    E                 
Sbjct: 17  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 130 -------VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 181
                  ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 121
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 240
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 122 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 165
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 291
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 166 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 224
Query: 292 ----RNRPKTE-QRLLEWVQQY-PADSKKF 315
               R R  +E Q L+ W     P+D   F
Sbjct: 225 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 254

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  V T  Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEML 284
            AP+ I         D+WS G ++ EM+
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 110/270 (40%), Gaps = 73/270 (27%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    E                 
Sbjct: 59  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 130 -------VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 181
                  ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 163
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 240
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 164 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 207
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 291
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 208 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 266
Query: 292 ----RNRPKTE-QRLLEWVQQY-PADSKKF 315
               R R  +E Q L+ W     P+D   F
Sbjct: 267 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 296

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 110/270 (40%), Gaps = 73/270 (27%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    E                 
Sbjct: 51  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 130 -------VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 181
                  ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 155
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 240
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 156 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 199
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 291
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 200 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 258
Query: 292 ----RNRPKTE-QRLLEWVQQY-PADSKKF 315
               R R  +E Q L+ W     P+D   F
Sbjct: 259 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 288

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 110/270 (40%), Gaps = 73/270 (27%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    E                 
Sbjct: 16  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 130 -------VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 181
                  ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 120
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 240
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 121 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 164
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 291
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 165 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 223
Query: 292 ----RNRPKTE-QRLLEWVQQY-PADSKKF 315
               R R  +E Q L+ W     P+D   F
Sbjct: 224 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 253

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  V T  Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEML 284
            AP+ I         D+WS G ++ EM+
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 110/270 (40%), Gaps = 73/270 (27%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    E                 
Sbjct: 17  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 130 -------VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 181
                  ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 121
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 240
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 122 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 165
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 291
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 166 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 224
Query: 292 ----RNRPKTE-QRLLEWVQQY-PADSKKF 315
               R R  +E Q L+ W     P+D   F
Sbjct: 225 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 254

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 111/244 (45%), Gaps = 48/244 (19%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR----------DGLQWVAEVQFLGVL 136
           +G+GGFG+V+       AG   ++   VAIK + R          D +    EV  L  +
Sbjct: 39  LGKGGFGTVF-------AGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 137 E----HPNLVKLIGYCAVDGERGIQRLLVYEFMLN-RSLEDHLFNRAFPPL---PWKTRL 188
                HP +++L+ +   + + G   +LV E  L  + L D++  +   PL   P +   
Sbjct: 92  GAGGGHPGVIRLLDW--FETQEGF--MLVLERPLPAQDLFDYITEKG--PLGEGPSRCFF 145
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLAREGPMVGHTHVS 247
             ++ A +   + H      V++RD K  N+L+D      KL DFG    G ++ H    
Sbjct: 146 GQVVAAIQ---HCHS---RGVVHRDIKDENILIDLRRGCAKLIDFG---SGALL-HDEPY 195
Query: 248 TAVVGTFGYAAPDYIETGHLTA-KSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 306
           T   GT  Y+ P++I      A  + VWS G++LY+M+ G    ER+     Q +LE   
Sbjct: 196 TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-----QEILEAEL 250
Query: 307 QYPA 310
            +PA
Sbjct: 251 HFPA 254

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 110/270 (40%), Gaps = 73/270 (27%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    E                 
Sbjct: 17  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 130 -------VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 181
                  ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 121
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 240
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 122 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 165
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 291
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 166 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 224
Query: 292 ----RNRPKTE-QRLLEWVQQY-PADSKKF 315
               R R  +E Q L+ W     P+D   F
Sbjct: 225 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 254

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 109/270 (40%), Gaps = 73/270 (27%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    E                 
Sbjct: 45  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 130 -------VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 181
                  ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 149
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 240
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 150 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 193
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 291
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 194 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG 252
Query: 292 ----RNRPKTE-QRLLEWVQQY-PADSKKF 315
               R R   E Q L+ W     P+D   F
Sbjct: 253 QVFFRQRVSXECQHLIRWCLALRPSDRPTF 282

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 99/234 (42%), Gaps = 59/234 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    E                 
Sbjct: 31  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 130 -------VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 181
                  ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 135
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 240
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 136 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 179
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLERN 293
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E +
Sbjct: 180 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 232

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 109/270 (40%), Gaps = 73/270 (27%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    E                 
Sbjct: 44  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 130 -------VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 181
                  ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 148
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 240
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 149 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 192
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 291
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 193 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG 251
Query: 292 ----RNRPKTE-QRLLEWVQQY-PADSKKF 315
               R R   E Q L+ W     P+D   F
Sbjct: 252 QVFFRQRVSXECQHLIRWCLALRPSDRPTF 281

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 99/234 (42%), Gaps = 59/234 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    E                 
Sbjct: 59  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 130 -------VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 181
                  ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 163
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 240
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 164 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 207
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLERN 293
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E +
Sbjct: 208 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 260

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 109/270 (40%), Gaps = 73/270 (27%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    E                 
Sbjct: 45  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 130 -------VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 181
                  ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 149
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 240
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 150 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 193
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 291
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 194 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG 252
Query: 292 ----RNRPKTE-QRLLEWVQQY-PADSKKF 315
               R R   E Q L+ W     P+D   F
Sbjct: 253 QVFFRQRVSXECQHLIRWCLALRPSDRPTF 282

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 110/270 (40%), Gaps = 73/270 (27%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    E                 
Sbjct: 15  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 67
Query: 130 -------VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 181
                  ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 68  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 119
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 240
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 120 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 163
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 291
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 164 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 222
Query: 292 ----RNRPKTE-QRLLEWVQQY-PADSKKF 315
               R R  +E Q L+ W     P+D   F
Sbjct: 223 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 252

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 99/234 (42%), Gaps = 59/234 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    E                 
Sbjct: 32  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 130 -------VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 181
                  ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 136
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 240
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 137 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 180
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLERN 293
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E +
Sbjct: 181 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 233

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 16/162 (9%)
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           EV  L  + HPN++ L        E     +L+ E +    L D L  +    L      
Sbjct: 58  EVNILREIRHPNIITLHDIF----ENKTDVVLILELVSGGELFDFLAEKE--SLTEDEAT 111
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 244
             +    +G+ YLH     ++ + D K  N+ LLD+N    R KL DFG+A +   +   
Sbjct: 112 QFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK---IEAG 165
Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 166 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 16/162 (9%)
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           EV  L  + HPN++ L        E     +L+ E +    L D L  +    L      
Sbjct: 65  EVNILREIRHPNIITLHDIF----ENKTDVVLILELVSGGELFDFLAEKE--SLTEDEAT 118
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 244
             +    +G+ YLH     ++ + D K  N+ LLD+N    R KL DFG+A +   +   
Sbjct: 119 QFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK---IEAG 172
Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 173 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 109/270 (40%), Gaps = 73/270 (27%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    E                 
Sbjct: 64  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 116
Query: 130 -------VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 181
                  ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 117 SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 168
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 240
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 169 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 212
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 291
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 213 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 271
Query: 292 ----RNRPKTE-QRLLEWVQQY-PADSKKF 315
               R R   E Q L+ W     P+D   F
Sbjct: 272 QVFFRQRVSXECQHLIRWCLALRPSDRPTF 301

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 99/234 (42%), Gaps = 59/234 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    E                 
Sbjct: 32  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 130 -------VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 181
                  ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 136
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 240
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 137 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 180
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLERN 293
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E +
Sbjct: 181 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 233

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 110/270 (40%), Gaps = 73/270 (27%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    E                 
Sbjct: 16  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 130 -------VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 181
                  ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLI----LERMEPVQDL--FDFITERGALQEELARSFF-- 120
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 240
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 121 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 164
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 291
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 165 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 223
Query: 292 ----RNRPKTE-QRLLEWVQQY-PADSKKF 315
               R R  +E Q L+ W     P+D   F
Sbjct: 224 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 253

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 35/205 (17%)
Query: 107 GTSEATVVAIKKLNRDGLQW-VAEVQFLG-VLEHPNLVKLIGYCAVDGERGIQRLLVYEF 164
           G+ +   VA+K++  D     + E++ L    +HPN+++   YC+   +R    L +   
Sbjct: 53  GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY--YCSETTDRF---LYIALE 107
Query: 165 MLNRSLEDHLFNRAFPPLPWKTR-----LHIILGAAEGLAYLHEGLEVQVIYRDFKASNV 219
           + N +L+D + ++       K +     + ++   A G+A+LH    +++I+RD K  N+
Sbjct: 108 LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNI 164
Query: 220 LLD-------------ENFRPKLSDFGLARE---GPMVGHTHVSTAVVGTFGYAAPDYIE 263
           L+              EN R  +SDFGL ++   G      +++    GT G+ AP+ +E
Sbjct: 165 LVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP-SGTSGWRAPELLE 223
Query: 264 TG---HLTAKSDVWSFGVVLYEMLT 285
                 LT   D++S G V Y +L+
Sbjct: 224 ESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 16/162 (9%)
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           EV  L  + HPN++ L        E     +L+ E +    L D L  +    L      
Sbjct: 79  EVNILREIRHPNIITLHDIF----ENKTDVVLILELVSGGELFDFLAEKE--SLTEDEAT 132
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 244
             +    +G+ YLH     ++ + D K  N+ LLD+N    R KL DFG+A +   +   
Sbjct: 133 QFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK---IEAG 186
Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 187 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 35/205 (17%)
Query: 107 GTSEATVVAIKKLNRDGLQW-VAEVQFLG-VLEHPNLVKLIGYCAVDGERGIQRLLVYEF 164
           G+ +   VA+K++  D     + E++ L    +HPN+++   YC+   +R    L +   
Sbjct: 53  GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY--YCSETTDRF---LYIALE 107
Query: 165 MLNRSLEDHLFNRAFPPLPWKTR-----LHIILGAAEGLAYLHEGLEVQVIYRDFKASNV 219
           + N +L+D + ++       K +     + ++   A G+A+LH    +++I+RD K  N+
Sbjct: 108 LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNI 164
Query: 220 LLD-------------ENFRPKLSDFGLARE---GPMVGHTHVSTAVVGTFGYAAPDYIE 263
           L+              EN R  +SDFGL ++   G      +++    GT G+ AP+ +E
Sbjct: 165 LVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP-SGTSGWRAPELLE 223
Query: 264 TG---HLTAKSDVWSFGVVLYEMLT 285
                 LT   D++S G V Y +L+
Sbjct: 224 ESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 110/270 (40%), Gaps = 73/270 (27%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    E                 
Sbjct: 12  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 130 -------VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 181
                  ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 116
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 240
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 117 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 160
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 291
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 161 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 219
Query: 292 ----RNRPKTE-QRLLEWVQQY-PADSKKF 315
               R R  +E Q L+ W     P+D   F
Sbjct: 220 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 249

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 73/162 (45%), Gaps = 16/162 (9%)
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           EV  L  + HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 65  EVSILRQVLHPNIITLHDVY----ENRTDVVLILELVSGGELFDFLAQKE--SLSEEEAT 118
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 244
             I    +G+ YLH     ++ + D K  N+ LLD+N      KL DFGLA E   +   
Sbjct: 119 SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDG 172
Query: 245 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
                + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 106/229 (46%), Gaps = 47/229 (20%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW-VAEVQFLG-VLEHPNLVKL 144
           +G G  G+V           G+ +   VA+K++  D     + E++ L    +HPN+++ 
Sbjct: 23  LGYGSSGTV--------VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY 74
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTR-----LHIILGAAEGLA 199
             YC+   +R    L +   + N +L+D + ++       K +     + ++   A G+A
Sbjct: 75  --YCSETTDRF---LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 200 YLHEGLEVQVIYRDFKASNVLLD-------------ENFRPKLSDFGLARE---GPMVGH 243
           +LH    +++I+RD K  N+L+              EN R  +SDFGL ++   G     
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 244 THVSTAVVGTFGYAAPDYIETGH-------LTAKSDVWSFGVVLYEMLT 285
           T+++    GT G+ AP+ +E  +       LT   D++S G V Y +L+
Sbjct: 187 TNLNNP-SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 110/270 (40%), Gaps = 73/270 (27%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    E                 
Sbjct: 12  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 130 -------VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 181
                  ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 116
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 240
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 117 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 160
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 291
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 161 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG 219
Query: 292 ----RNRPKTE-QRLLEWVQQY-PADSKKF 315
               R R  +E Q L+ W     P+D   F
Sbjct: 220 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 249

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 30/216 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLG 134
           + ++  IG G  G V        A   T     VA+KKL+R         +   E+  L 
Sbjct: 24  YQQLKPIGSGAQGIV-------CAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLK 76
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 77  CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLCQVIHMELDHERMSYL 129
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR         + T  
Sbjct: 130 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---STNFMMTPY 183
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           V T  Y AP+ I         D+WS G ++ E++ G
Sbjct: 184 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 48/101 (47%), Gaps = 11/101 (10%)
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLAREGPMVGHTH 245
           I+    E + YLH    + + +RD K  N+L     RP    KL+DFG A+E     H  
Sbjct: 120 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKE--TTSHNS 173
Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           ++      + Y AP+ +         D+WS GV++Y +L G
Sbjct: 174 LTEPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 213

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 45/96 (46%), Gaps = 11/96 (11%)
Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLAREGPMVGHTHVSTAV 250
            E + YLH    + + +RD K  N+L     RP    KL+DFG A+E     H  ++T  
Sbjct: 171 GEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKE--TTSHNSLTTPC 224
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
              + Y AP+ +         D WS GV+ Y +L G
Sbjct: 225 YTPY-YVAPEVLGPEKYDKSCDXWSLGVIXYILLCG 259

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 99/234 (42%), Gaps = 59/234 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    E                 
Sbjct: 39  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 91
Query: 130 -------VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 181
                  ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 92  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 143
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 240
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 144 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 187
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLERN 293
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E +
Sbjct: 188 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 240

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 81/177 (45%), Gaps = 32/177 (18%)
Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
           I +   + L +LH  L V  I+RD K SNVL++   + K+ DFG++  G +V        
Sbjct: 114 IAVSIVKALEHLHSKLSV--IHRDVKPSNVLINALGQVKMCDFGIS--GYLVDDV-AKDI 168
Query: 250 VVGTFGYAAPDYI-----ETGHLTAKSDVWSFGVVLYEMLTGRRSLER-NRP--KTEQRL 301
             G   Y AP+ I     + G+ + KSD+WS G+ + E+   R   +    P  + +Q +
Sbjct: 169 DAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 227
Query: 302 LEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
            E   Q PAD  KF                + +       CL K+SK+RP   ++++
Sbjct: 228 EEPSPQLPAD--KF----------------SAEFVDFTSQCLKKNSKERPTYPELMQ 266

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 47/228 (20%)
Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWV---------A 128
           +  +S M  +G G FG V+ +  K    +   E  V  IKK       W+          
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDK----EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL 78
Query: 129 EVQFLGVLEHPNLVKLI------GYCAVDGERGIQRLLVYEFM-----LNRSLEDHLFNR 177
           E+  L  +EH N++K++      G+  +  E+    L ++ F+     L+  L  ++F +
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 178 AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE 237
                         L +A G   L +     +I+RD K  N+++ E+F  KL DFG A  
Sbjct: 139 --------------LVSAVGYLRLKD-----IIHRDIKDENIVIAEDFTIKLIDFGSAA- 178
Query: 238 GPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEML 284
              +    +     GT  Y AP+ +    +   + ++WS GV LY ++
Sbjct: 179 --YLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 21/218 (9%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQF 132
           E R+  +  +  L++G G FG V++   K             A+KK+  +  +   E+  
Sbjct: 87  EYREEVHWATHQLRLGRGSFGEVHRMEDK-------QTGFQCAVKKVRLEVFR-AEELMA 138
Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
              L  P +V L G  AV    G    +  E +   SL   +  +    LP    L+ + 
Sbjct: 139 CAGLTSPRIVPLYG--AV--REGPWVNIFMELLEGGSLGQLVKEQGC--LPEDRALYYLG 192
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFG--LAREGPMVGHTHVSTA 249
            A EGL YLH     ++++ D KA NVLL  +     L DFG  +  +   +G + ++  
Sbjct: 193 QALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGD 249
Query: 250 VV-GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            + GT  + AP+ +      AK DVWS   ++  ML G
Sbjct: 250 YIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 30/217 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLG 134
           +  +  IG G  G V       AA D   E  V AIKKL+R         +   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVC------AAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
            + H N++ L+       ++ ++      +V E M     + +L       L  +   ++
Sbjct: 79  CVNHKNIIGLLN--VFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYL 131
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + +    
Sbjct: 132 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMEPE 185
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
           V T  Y AP+ I         D+WS G ++ EM+  +
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
            A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+                
Sbjct: 207 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
             + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
            A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+                
Sbjct: 202 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
             + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
            A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+                
Sbjct: 200 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
             + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
            A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+                
Sbjct: 209 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
             + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 99/234 (42%), Gaps = 59/234 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    E                 
Sbjct: 12  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 130 -------VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 181
                  ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 116
Query: 182 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 240
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 117 --WQV--------LEAVRHCHN---XGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 160
Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLERN 293
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E +
Sbjct: 161 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 74/168 (44%), Gaps = 15/168 (8%)
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           E++ L    HPN++ L        E  + +L +   ++   L   + ++     P   + 
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQY 138
Query: 189 ---HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
              HI+LG    L  LHE     V++RD    N+LL +N    + DF LARE     +  
Sbjct: 139 FMYHILLG----LHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADAN-- 189
Query: 246 VSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRSLER 292
             T  V    Y AP+ + +    T   D+WS G V+ EM   R++L R
Sbjct: 190 -KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKALFR 235

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 105/229 (45%), Gaps = 47/229 (20%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW-VAEVQFLG-VLEHPNLVKL 144
           +G G  G+V           G+ +   VA+K++  D     + E++ L    +HPN+++ 
Sbjct: 23  LGYGSSGTV--------VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY 74
Query: 145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTR-----LHIILGAAEGLA 199
             YC+   +R    L +   + N +L+D + ++       K +     + ++   A G+A
Sbjct: 75  --YCSETTDRF---LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 200 YLHEGLEVQVIYRDFKASNVLLD-------------ENFRPKLSDFGLARE---GPMVGH 243
           +LH    +++I+RD K  N+L+              EN R  +SDFGL ++   G     
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFR 186
Query: 244 THVSTAVVGTFGYAAPDYIETGH-------LTAKSDVWSFGVVLYEMLT 285
            +++    GT G+ AP+ +E  +       LT   D++S G V Y +L+
Sbjct: 187 XNLNNP-SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 30/217 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLG 134
           +  +  IG G  G V       AA D   E  V AIKKL+R         +   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVC------AAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
            + H N++ L+       ++ ++      +V E M     + +L       L  +   ++
Sbjct: 79  CVNHKNIIGLLN--VFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYL 131
Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + +    
Sbjct: 132 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMEPE 185
Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
           V T  Y AP+ I         D+WS G ++ EM+  +
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 74/168 (44%), Gaps = 15/168 (8%)
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           E++ L    HPN++ L        E  + +L +   ++   L   + ++     P   + 
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQY 138
Query: 189 ---HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
              HI+LG    L  LHE     V++RD    N+LL +N    + DF LARE     +  
Sbjct: 139 FMYHILLG----LHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADAN-- 189
Query: 246 VSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRSLER 292
             T  V    Y AP+ + +    T   D+WS G V+ EM   R++L R
Sbjct: 190 -KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKALFR 235

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 91/218 (41%), Gaps = 21/218 (9%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQF 132
           E R+  +  +  L++G G FG V++   K             A+KK+  +  +   E+  
Sbjct: 68  EYREEVHWATHQLRLGRGSFGEVHRMEDK-------QTGFQCAVKKVRLEVFR-AEELMA 119
Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
              L  P +V L G  AV    G    +  E +   SL   +  +    LP    L+ + 
Sbjct: 120 CAGLTSPRIVPLYG--AV--REGPWVNIFMELLEGGSLGQLVKEQGC--LPEDRALYYLG 173
Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLA---REGPMVGHTHVST 248
            A EGL YLH     ++++ D KA NVLL  +     L DFG A   +   +        
Sbjct: 174 QALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGD 230
Query: 249 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            + GT  + AP+ +      AK DVWS   ++  ML G
Sbjct: 231 YIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 101/247 (40%), Gaps = 45/247 (18%)
Query: 71  YSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL--NRDGLQWVA 128
           Y  + Q +N F    KIGEG F SVY ++ +   G        +A+K L      ++  A
Sbjct: 13  YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEK----IALKHLIPTSHPIRIAA 68
Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           E+Q L V    + V  + YC    +  +   +   ++ + S  D L + +F  +      
Sbjct: 69  ELQCLTVAGGQDNVMGVKYCFRKNDHVV---IAMPYLEHESFLDILNSLSFQEV-----R 120
Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAR----------- 236
             +L   + L  +H   +  +++RD K SN L +   +   L DFGLA+           
Sbjct: 121 EYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLK 177
Query: 237 ------EGPMVGHTHVSTAV---------VGTFGYAAPDYI-ETGHLTAKSDVWSFGVVL 280
                 +         S  +          GT G+ AP+ + +  + T   D+WS GV+ 
Sbjct: 178 FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIF 237
Query: 281 YEMLTGR 287
             +L+GR
Sbjct: 238 LSLLSGR 244

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 87/211 (41%), Gaps = 35/211 (16%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           IG G +G V    I    G     A     K    D  ++  E++ +  L+HPN+++L  
Sbjct: 17  IGRGSWGEV---KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL-- 71
Query: 147 YCAVDGERGIQRLLVYEF-----MLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 201
           Y   +    I   LV E      +  R +   +F  +           I+      +AY 
Sbjct: 72  YETFEDNTDI--YLVMELCTGGELFERVVHKRVFRES-------DAARIMKDVLSAVAYC 122
Query: 202 HEGLEVQVIYRDFKASNVLL--DENFRP-KLSDFGLA---REGPMVGHTHVSTAVVGTFG 255
           H   ++ V +RD K  N L   D    P KL DFGLA   + G M+         VGT  
Sbjct: 123 H---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM------RTKVGTPY 173
Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           Y +P  +E G    + D WS GV++Y +L G
Sbjct: 174 YVSPQVLE-GLYGPECDEWSAGVMMYVLLCG 203

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 70/304 (23%), Positives = 130/304 (42%), Gaps = 44/304 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-NRDGLQWVAEVQFLG--VLEHPNLV 142
           +IG+G +G V+          G      VA+K     +   W  E +     ++ H N++
Sbjct: 44  QIGKGRYGEVWM---------GKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENIL 94
Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
             I           Q  L+ ++  N SL D+L +     L  K+ L +   +  GL +LH
Sbjct: 95  GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLH 151
Query: 203 -EGLEVQ----VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH----VSTAVVGT 253
            E    Q    + +RD K+ N+L+ +N    ++D GLA +   +  T+         VGT
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK--FISDTNEVDIPPNTRVGT 209
Query: 254 FGYAAPDYIET----GHLTA--KSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 307
             Y  P+ ++      H  +   +D++SFG++L+E+   RR +       E+  L +   
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCVSGG--IVEEYQLPYHDL 265
Query: 308 YPADS-----KKFGLI--MDPRLEKEYSINEA-RKIGRLADNCLSKSSKDRPKMSQVVER 359
            P+D      ++   I  + P     +S +E  R++G+L   C + +   R    +V + 
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325
Query: 360 LKQI 363
           L ++
Sbjct: 326 LAKM 329

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 87/211 (41%), Gaps = 35/211 (16%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIG 146
           IG G +G V    I    G     A     K    D  ++  E++ +  L+HPN+++L  
Sbjct: 34  IGRGSWGEV---KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL-- 88
Query: 147 YCAVDGERGIQRLLVYEF-----MLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 201
           Y   +    I   LV E      +  R +   +F  +           I+      +AY 
Sbjct: 89  YETFEDNTDI--YLVMELCTGGELFERVVHKRVFRES-------DAARIMKDVLSAVAYC 139
Query: 202 HEGLEVQVIYRDFKASNVLL--DENFRP-KLSDFGLA---REGPMVGHTHVSTAVVGTFG 255
           H   ++ V +RD K  N L   D    P KL DFGLA   + G M+         VGT  
Sbjct: 140 H---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM------RTKVGTPY 190
Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           Y +P  +E G    + D WS GV++Y +L G
Sbjct: 191 YVSPQVLE-GLYGPECDEWSAGVMMYVLLCG 220

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 27/76 (35%), Positives = 39/76 (51%), Gaps = 1/76 (1%)
Query: 211 YRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAK 270
           +RD K  N+L+  +    L DFG+A        T +    VGT  Y AP+     H T +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYXAPERFSESHATYR 215
Query: 271 SDVWSFGVVLYEMLTG 286
           +D+++   VLYE LTG
Sbjct: 216 ADIYALTCVLYECLTG 231

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 84/213 (39%), Gaps = 22/213 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLE-HPNLVKLI 145
           + EGGF  VY++      G G   A    +          + EV F+  L  HPN+V+  
Sbjct: 36  LAEGGFAFVYEAQ---DVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 146 GYCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 201
              ++  E       + LL+ E    + +E      +  PL   T L I       + ++
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 202 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA---REGPMVGHTHVSTAVV------- 251
           H   +  +I+RD K  N+LL      KL DFG A      P    +    A+V       
Sbjct: 153 HRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 252 GTFGYAAPDYIE---TGHLTAKSDVWSFGVVLY 281
            T  Y  P+ I+      +  K D+W+ G +LY
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILY 244

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 58/123 (47%), Gaps = 20/123 (16%)
Query: 209 VIYRDFKASNVLLDEN-FRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL 267
           V++RD K  N+L+D N    KL DFG    G ++  T V T   GT  Y+ P++I     
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRY 233
Query: 268 TAKSD-VWSFGVVLYEMLTGRRSLE------------RNRPKTE-QRLLEWVQQY-PADS 312
             +S  VWS G++LY+M+ G    E            R R  +E Q L+ W     P+D 
Sbjct: 234 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDR 293
Query: 313 KKF 315
             F
Sbjct: 294 PTF 296

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 115/287 (40%), Gaps = 39/287 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW----VAEVQFLGVLEHPNLV 142
           +G+G F  ++K   +     G    T V +K L++    +          +  L H +LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPLPWKTRLHIILGAAEGLAYL 201
              G C      G + +LV EF+   SL+ +L  N+    + WK  +   L AA     +
Sbjct: 76  LNYGVCVC----GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA-----M 126
Query: 202 HEGLEVQVIYRDFKASNVLL--DENFRPKLSDFGLAREGPMVGHTHVSTAVVGT-FGYAA 258
           H   E  +I+ +  A N+LL  +E+ +     F +    P +  T +   ++     +  
Sbjct: 127 HFLEENTLIHGNVCAKNILLIREEDRKTGNPPF-IKLSDPGISITVLPKDILQERIPWVP 185
Query: 259 PDYIET-GHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFG 316
           P+ IE   +L   +D WSFG  L+E+ + G + L     + + +  E   Q PA      
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAP----- 240
Query: 317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
                         +A ++  L +NC+      RP    ++  L  +
Sbjct: 241 --------------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 48/96 (50%), Gaps = 9/96 (9%)
Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDEN--FRPKLSDFGLAREGPMV--GHTHVSTAVVG 252
            L YLH      + +RD K  N L   N  F  KL DFGL++E   +  G  +  T   G
Sbjct: 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236
Query: 253 TFGYAAPDYIETGHLT--AKSDVWSFGVVLYEMLTG 286
           T  + AP+ + T + +   K D WS GV+L+ +L G
Sbjct: 237 TPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMG 272
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	432
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-157
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-148
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-133
3soc_A	322	Activin receptor type-2A; structural genomics cons	9e-85
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-63
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-56
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-54
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-54
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-54
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-53
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-53
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-53
3q4u_A	301	Activin receptor type-1; structural genomics conso	8e-53
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	9e-53
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-52
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-51
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-50
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-46
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-39
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-39
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-38
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-38
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-38
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-38
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-38
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-37
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-37
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-37
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-37
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-36
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-36
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-36
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-36
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-36
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-35
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-35
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-35
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-35
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-35
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-35
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-34
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-34
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-34
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-34
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-34
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-34
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-34
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-34
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-34
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-34
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-34
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-34
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	9e-34
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-33
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-33
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-33
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-33
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-32
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-32
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-32
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-32
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-32
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-32
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-32
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-32
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-32
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	9e-32
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-31
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-31
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-31
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-31
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-31
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-31
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-31
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-31
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	9e-31
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-30
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-30
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-30
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-30
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	7e-30
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	7e-30
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-30
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-29
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-29
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-29
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-28
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-28
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-28
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-28
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-28
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-28
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-28
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-28
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-27
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-27
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-27
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-27
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-27
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-27
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-27
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-26
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-26
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-26
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-26
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-26
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-26
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-26
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-26
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-26
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-26
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-26
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-26
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	8e-26
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-26
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-25
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-25
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-25
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-25
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-25
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	8e-25
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-24
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-24
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	7e-24
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-24
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-23
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-23
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-23
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-22
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-22
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-22
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-22
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	8e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-21
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-21
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-21
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-21
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-21
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-21
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-20
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-20
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-20
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-20
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-20
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-20
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-20
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-20
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	8e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-19
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-19
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-19
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-19
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-19
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-19
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-19
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-19
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-19
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-19
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	9e-19
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-18
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-18
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-18
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-18
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-18
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-18
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-18
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-18
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-18
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-18
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-18
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-18
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-18
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-18
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-18
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	8e-18
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	8e-18
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	8e-18
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-18
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	9e-18
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-17
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-17
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-17
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-17
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-17
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-17
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-17
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-17
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-17
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-17
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-17
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-17
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-17
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-16
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-16
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	9e-16
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-16
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-14
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	8e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	8e-10
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-08
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-06

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  445 bits (1148), Expect = e-157
 Identities = 107/323 (33%), Positives = 166/323 (51%), Gaps = 35/323 (10%)

Query: 57  ELYEEKAHNLRVFSYSEMRQATNDFSRML------KIGEGGFGSVYKSSIKPAAGDGTSE 110
           +  E        FS+ E++  TN+F          K+GEGGFG VYK         G   
Sbjct: 3   KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYK---------GYVN 53

Query: 111 ATVVAIKKL----NRDGLQ----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVY 162
            T VA+KKL    +    +    +  E++ +   +H NLV+L+G+ + DG+      LVY
Sbjct: 54  NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS-DGD---DLCLVY 109

Query: 163 EFMLNRSLEDHLFNR-AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL 221
            +M N SL D L      PPL W  R  I  GAA G+ +LHE      I+RD K++N+LL
Sbjct: 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166

Query: 222 DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLY 281
           DE F  K+SDFGLAR       T +++ +VGT  Y AP+ +  G +T KSD++SFGVVL 
Sbjct: 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLL 225

Query: 282 EMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADN 341
           E++TG  +++ +R    Q LL+  ++   + K     +D ++  +        +  +A  
Sbjct: 226 EIITGLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQ 282

Query: 342 CLSKSSKDRPKMSQVVERLKQIV 364
           CL +    RP + +V + L+++ 
Sbjct: 283 CLHEKKNKRPDIKKVQQLLQEMT 305

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  423 bits (1091), Expect = e-148
 Identities = 117/334 (35%), Positives = 179/334 (53%), Gaps = 22/334 (6%)

Query: 41  VKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSI 100
           + S  S +  S                     ++ +ATN+F     IG G FG VYK  +
Sbjct: 1   MGSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL 60

Query: 101 KPAAGDGTSEATVVAIKKLNRDGLQ----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGI 156
           +    DG      VA+K+   +  Q    +  E++ L    HP+LV LIG+C        
Sbjct: 61  R----DGA----KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN---- 108

Query: 157 QRLLVYEFMLNRSLEDHLFNRAFP--PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDF 214
           + +L+Y++M N +L+ HL+    P   + W+ RL I +GAA GL YLH      +I+RD 
Sbjct: 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDV 165

Query: 215 KASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVW 274
           K+ N+LLDENF PK++DFG++++G  +  TH+ST V GT GY  P+Y   G LT KSDV+
Sbjct: 166 KSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVY 225

Query: 275 SFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARK 334
           SFGVVL+E+L  R ++ ++ P+    L EW  +   ++ +   I+DP L  +      RK
Sbjct: 226 SFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES-HNNGQLEQIVDPNLADKIRPESLRK 284

Query: 335 IGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN 368
            G  A  CL+ SS+DRP M  V+ +L+  +++  
Sbjct: 285 FGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  385 bits (990), Expect = e-133
 Identities = 126/338 (37%), Positives = 190/338 (56%), Gaps = 31/338 (9%)

Query: 56  PELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVA 115
            E  E     L+ FS  E++ A+++FS    +G GGFG VYK  +     DGT    +VA
Sbjct: 7   EEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----DGT----LVA 58

Query: 116 IKKLNRDGLQ-----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL 170
           +K+L  +  Q     +  EV+ + +  H NL++L G+C        +RLLVY +M N S+
Sbjct: 59  VKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM----TPTERLLVYPYMANGSV 114

Query: 171 EDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK 228
              L  R  + PPL W  R  I LG+A GLAYLH+  + ++I+RD KA+N+LLDE F   
Sbjct: 115 ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174

Query: 229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRR 288
           + DFGLA+       THV+TAV GT G+ AP+Y+ TG  + K+DV+ +GV+L E++TG+R
Sbjct: 175 VGDFGLAKLMD-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 233

Query: 289 SLERNRPKTEQR--LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKS 346
           + +  R   +    LL+WV+    + KK   ++D  L+  Y   E  ++ ++A  C   S
Sbjct: 234 AFDLARLANDDDVMLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSS 292

Query: 347 SKDRPKMSQVVERLKQIVQVSNEGDSFDKTFEEICEED 384
             +RPKMS+VV  L        EGD   + +EE  +E+
Sbjct: 293 PMERPKMSEVVRML--------EGDGLAERWEEWQKEE 322

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  261 bits (669), Expect = 9e-85
 Identities = 71/320 (22%), Positives = 122/320 (38%), Gaps = 32/320 (10%)

Query: 69  FSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWV 127
                +   +     +     G FG V+K                VA+K    +D   W 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWK---------AQLLNEYVAVKIFPIQDKQSWQ 64

Query: 128 AE--VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 185
            E  V  L  ++H N+++ IG         +   L+  F    SL D L       + W 
Sbjct: 65  NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWN 121

Query: 186 TRLHIILGAAEGLAYLHEGLEVQ-------VIYRDFKASNVLLDENFRPKLSDFGLAREG 238
              HI    A GLAYLHE +          + +RD K+ NVLL  N    ++DFGLA + 
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181

Query: 239 PMVGHTHVSTAVVGTFGYAAPDYIETGHL-----TAKSDVWSFGVVLYEMLTGRRSLERN 293
                   +   VGT  Y AP+ +E           + D+++ G+VL+E+ +   + +  
Sbjct: 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241

Query: 294 RPKTEQRLLEWVQQYPADSKKFGLI----MDPRLEKEYSINEA-RKIGRLADNCLSKSSK 348
             +      E + Q+P+      ++      P L   +  +     +    + C    ++
Sbjct: 242 VDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301

Query: 349 DRPKMSQVVERLKQIVQVSN 368
            R     V ER+ Q+ +++N
Sbjct: 302 ARLSAGCVGERITQMQRLTN 321

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  206 bits (526), Expect = 2e-63
 Identities = 67/332 (20%), Positives = 131/332 (39%), Gaps = 43/332 (12%)

Query: 69  FSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWV 127
            + SE     ++   +  IG G +G+VYK         G+ +   VA+K  +  +   ++
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYK---------GSLDERPVAVKVFSFANRQNFI 53

Query: 128 AE--VQFLGVLEHPNLVKLIGYCA-VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW 184
            E  +  + ++EH N+ + I     V  +  ++ LLV E+  N SL  +L         W
Sbjct: 54  NEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDW 110

Query: 185 KTRLHIILGAAEGLAYLHEGLEV------QVIYRDFKASNVLLDENFRPKLSDFGLAR-- 236
            +   +      GLAYLH  L         + +RD  + NVL+  +    +SDFGL+   
Sbjct: 111 VSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170

Query: 237 ----EGPMVGHTHVSTAVVGTFGYAAPDYIE-------TGHLTAKSDVWSFGVVLYEMLT 285
                       + + + VGT  Y AP+ +E             + D+++ G++ +E+  
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230

Query: 286 GRRSLERNRPKTEQRL--LEWVQQYPADSKKFGLI----MDPRLEKEYSINEA--RKIGR 337
               L       E ++     V  +P       L+      P+  + +  N    R +  
Sbjct: 231 RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKE 290

Query: 338 LADNCLSKSSKDRPKMSQVVERLKQIVQVSNE 369
             ++C  + ++ R       ER+ +++ +   
Sbjct: 291 TIEDCWDQDAEARLTAQXAEERMAELMMIWER 322

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  187 bits (476), Expect = 3e-56
 Identities = 76/329 (23%), Positives = 125/329 (37%), Gaps = 54/329 (16%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLGVL 136
            +      +G G FG V K             A  VAIK++  +     ++ E++ L  +
Sbjct: 8   KEIEVEEVVGRGAFGVVCK---------AKWRAKDVAIKQIESESERKAFIVELRQLSRV 58

Query: 137 EHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFN-RAFPPLPWKTRLHIILGA 194
            HPN+VKL G C       +  + LV E+    SL + L      P       +   L  
Sbjct: 59  NHPNIVKLYGAC-------LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC 111

Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFR-PKLSDFGLAREGPMVGHTHVSTAVVGT 253
           ++G+AYLH      +I+RD K  N+LL       K+ DFG A +          T   G+
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGS 166

Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK 313
             + AP+  E  + + K DV+S+G++L+E++T R+      P  E  +     +      
Sbjct: 167 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK------PFDE--IGGPAFRIMWAVH 218

Query: 314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSF 373
                   R     ++ +   I  L   C SK    RP M ++V+ +  ++         
Sbjct: 219 N-----GTRPPLIKNLPKP--IESLMTRCWSKDPSQRPSMEEIVKIMTHLM--------- 262

Query: 374 DKTFEEICEEDPVEAQTKQKQHEPSEAWK 402
                     D       Q    P E  +
Sbjct: 263 ----RYFPGADEPLQYPCQHSLPPGEDGR 287

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  182 bits (465), Expect = 1e-54
 Identities = 73/287 (25%), Positives = 127/287 (44%), Gaps = 39/287 (13%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFLGVLEHP 139
           KIG G FG+V++              + VA+K L           +++ EV  +  L HP
Sbjct: 44  KIGAGSFGTVHR---------AEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-AFPPLPWKTRLHIILGAAEGL 198
           N+V  +G       +     +V E++   SL   L    A   L  + RL +    A+G+
Sbjct: 95  NIVLFMGAVT----QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150

Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
            YLH      +++R+ K+ N+L+D+ +  K+ DFGL+R          S +  GT  + A
Sbjct: 151 NYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMA 207

Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 318
           P+ +       KSDV+SFGV+L+E+ T +      +P      L   Q   A   K    
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELATLQ------QPWGN---LNPAQVVAAVGFK-CK- 256

Query: 319 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
              RLE   ++N    +  + + C +     RP  + +++ L+ +++
Sbjct: 257 ---RLEIPRNLNPQ--VAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  182 bits (464), Expect = 4e-54
 Identities = 63/304 (20%), Positives = 124/304 (40%), Gaps = 34/304 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWV--AEVQFLGVLEHPNLV 142
           +IG+G +G V+          G      VA+K     +   W    E+    ++ H N++
Sbjct: 44  QIGKGRYGEVWM---------GKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENIL 94

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
             I           Q  L+ ++  N SL D+L +     L  K+ L +   +  GL +LH
Sbjct: 95  GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLH 151

Query: 203 EGLEVQ-----VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH--VSTAVVGTFG 255
             +        + +RD K+ N+L+ +N    ++D GLA +     +         VGT  
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211

Query: 256 YAAP----DYIETGHLTA--KSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP 309
           Y  P    + +   H  +   +D++SFG++L+E+   R        + +    + V   P
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPYHDLVPSDP 270

Query: 310 ADSKKFGLI----MDPRLEKEYSINEA-RKIGRLADNCLSKSSKDRPKMSQVVERLKQIV 364
           +      ++    + P     +S +E  R++G+L   C + +   R    +V + L ++ 
Sbjct: 271 SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330

Query: 365 QVSN 368
           +  +
Sbjct: 331 ESQD 334

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  181 bits (462), Expect = 7e-54
 Identities = 80/367 (21%), Positives = 142/367 (38%), Gaps = 55/367 (14%)

Query: 21  PELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPEL-YEEKAHNLRVFSYSEMRQATN 79
           P L  P  S   +  +    + +S S S     G+P L     A  + +           
Sbjct: 3   PSLDRPFISEGTTLKDLIYDMTTSGSGS-----GLPLLVQRTIARTIVLQE--------- 48

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWVAE--VQFLGVL 136
                  IG+G FG V++         G      VA+K  + R+   W  E  +    +L
Sbjct: 49  ------SIGKGRFGEVWR---------GKWRGEEVAVKIFSSREERSWFREAEIYQTVML 93

Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
            H N++  I     D     Q  LV ++  + SL D+L       +  +  + + L  A 
Sbjct: 94  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTAS 150

Query: 197 GLAYLHEGLEVQ-----VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH--VSTA 249
           GLA+LH  +        + +RD K+ N+L+ +N    ++D GLA        T       
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210

Query: 250 VVGTFGYAAP----DYIETGHLTA--KSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE 303
            VGT  Y AP    D I   H  +  ++D+++ G+V +E+   R S+       +    +
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYD 269

Query: 304 WVQQYPADSKKFGLIMD----PRLEKEYSINEA-RKIGRLADNCLSKSSKDRPKMSQVVE 358
            V   P+  +   ++ +    P +   +   EA R + ++   C   +   R    ++ +
Sbjct: 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329

Query: 359 RLKQIVQ 365
            L Q+ Q
Sbjct: 330 TLSQLSQ 336

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  178 bits (454), Expect = 2e-53
 Identities = 74/297 (24%), Positives = 122/297 (41%), Gaps = 58/297 (19%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA--------EVQFLGVLE 137
            IG GGFG VY+                VA+K    D  + ++        E +   +L+
Sbjct: 14  IIGIGGFGKVYR---------AFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64

Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 197
           HPN++ L G C  +    +    V EF     L   L  +    +P    ++  +  A G
Sbjct: 65  HPNIIALRGVCLKEPNLCL----VMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARG 117

Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRP--------KLSDFGLAREGPMVGHTHVSTA 249
           + YLH+   V +I+RD K+SN+L+ +            K++DFGLARE     H     +
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW----HRTTKMS 173

Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP---KTEQRLLEWVQ 306
             G + + AP+ I     +  SDVWS+GV+L+E+LTG        P        +   V 
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE------VPFRGIDGLAVAYGV- 226

Query: 307 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
                      +    L    +  E     +L ++C +     RP  + ++++L  I
Sbjct: 227 ----------AMNKLALPIPSTCPEP--FAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  178 bits (454), Expect = 3e-53
 Identities = 76/298 (25%), Positives = 129/298 (43%), Gaps = 56/298 (18%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----------EVQFLG 134
           +IG+GGFG V+K       G    + +VVAIK L     +              EV  + 
Sbjct: 26  QIGKGGFGLVHK-------GRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 135 VLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
            L HPN+VKL G              +V EF+    L   L ++A  P+ W  +L ++L 
Sbjct: 79  NLNHPNIVKLYGLM-------HNPPRMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLD 130

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDE-----NFRPKLSDFGLAREGPMVGHTHVST 248
            A G+ Y+       +++RD ++ N+ L           K++DFGL+++       H  +
Sbjct: 131 IALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVS 184

Query: 249 AVVGTFGYAAPDYIETGHL--TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 306
            ++G F + AP+ I       T K+D +SF ++LY +LTG        P  E     + +
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE------GPFDE---YSYGK 235

Query: 307 -QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
            ++    ++ GL    R           ++  + + C S   K RP  S +V+ L ++
Sbjct: 236 IKFINMIREEGL----RPTIPEDCPP--RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  177 bits (452), Expect = 8e-53
 Identities = 64/299 (21%), Positives = 119/299 (39%), Gaps = 34/299 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQWVAE--VQFLGVLEHPNLV 142
            +G+G +G V++         G+ +   VA+K  + RD   W  E  +    +L H N++
Sbjct: 15  CVGKGRYGEVWR---------GSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENIL 65

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
             I           Q  L+  +    SL D+L       L   + L I+L  A GLA+LH
Sbjct: 66  GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLH 122

Query: 203 EGLEVQ-----VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV--STAVVGTFG 255
             +        + +RD K+ N+L+ +N +  ++D GLA       +     +   VGT  
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182

Query: 256 YAAP------DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP 309
           Y AP        ++      + D+W+FG+VL+E+   R          +    + V   P
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYKPPFYDVVPNDP 241

Query: 310 ADSKKFGLIMD----PRLEKEYSINEA-RKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
           +      ++      P +   +  +     + +L   C  ++   R    ++ + L +I
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  178 bits (453), Expect = 9e-53
 Identities = 73/335 (21%), Positives = 123/335 (36%), Gaps = 59/335 (17%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNL 141
            +G+G FG   K + +      T E  V+ +K+L R        ++ EV+ +  LEHPN+
Sbjct: 17  VLGKGCFGQAIKVTHR-----ETGE--VMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69

Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 201
           +K IG    D     +   + E++   +L   + +      PW  R+      A G+AYL
Sbjct: 70  LKFIGVLYKDK----RLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYL 124

Query: 202 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR------------EGPMVGHTHVSTA 249
           H    + +I+RD  + N L+ EN    ++DFGLAR                         
Sbjct: 125 HS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181

Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP 309
           VVG   + AP+ I       K DV+SFG+VL E++    +     P+T    L       
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL- 240

Query: 310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNE 369
                             +   +     +   C     + RP   ++   L+ +      
Sbjct: 241 ------------DRYCPPNCPPS--FFPITVRCCDLDPEKRPSFVKLEHWLETL------ 280

Query: 370 GDSFDKTFEEICEEDPVEAQTKQKQHEPSEAWKRR 404
                     +    P+  Q +Q      E ++R 
Sbjct: 281 -------RMHLAGHLPLGPQLEQLDRGFWETYRRG 308

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  175 bits (447), Expect = 2e-52
 Identities = 53/287 (18%), Positives = 106/287 (36%), Gaps = 44/287 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFLGVLEHP 139
           K+ E   G ++K         G  +   + +K L            +  E   L +  HP
Sbjct: 17  KLNENHSGELWK---------GRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           N++ ++G C           L+  +M   SL + L       +     +   L  A G+A
Sbjct: 68  NVLPVLGAC--QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125

Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 259
           +LH  LE  +      + +V++DE+   ++S   +            S   +    + AP
Sbjct: 126 FLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFS-------FQSPGRMYAPAWVAP 177

Query: 260 DYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG 316
           + ++          +D+WSF V+L+E++T         P  +   +E   +         
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTRE------VPFADLSNMEIGMKV-------- 223

Query: 317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
            +   R      I+    + +L   C+++    RPK   +V  L+++
Sbjct: 224 ALEGLRPTIPPGISPH--VSKLMKICMNEDPAKRPKFDMIVPILEKM 268

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  174 bits (442), Expect = 2e-51
 Identities = 75/289 (25%), Positives = 127/289 (43%), Gaps = 40/289 (13%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFLGVLEHP 139
           +IG G FG+VYK       GD       VA+K LN           +  EV  L    H 
Sbjct: 31  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           N++  +GY         Q  +V ++    SL  HL          K  + I    A G+ 
Sbjct: 81  NILLFMGYS-----TAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMD 134

Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 259
           YLH      +I+RD K++N+ L E+   K+ DFGLA E      +H    + G+  + AP
Sbjct: 135 YLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

Query: 260 DYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG 316
           + I   ++   + +SDV++FG+VLYE++TG+        +   +++E V          G
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEMVG--------RG 241

Query: 317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
            +     +   +  +   + RL   CL K   +RP   +++  ++++ +
Sbjct: 242 SLSPDLSKVRSNCPKR--MKRLMAECLKKKRDERPSFPRILAEIEELAR 288

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  162 bits (411), Expect = 1e-46
 Identities = 52/296 (17%), Positives = 105/296 (35%), Gaps = 53/296 (17%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFLGVLEHP 139
            IG+G FG VY        G+       VAI+ ++ +         +  EV       H 
Sbjct: 40  LIGKGRFGQVYHGRWH---GE-------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           N+V  +G C       I    +      R+L   + +     L       I     +G+ 
Sbjct: 90  NVVLFMGACMSPPHLAI----ITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMG 144

Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE---GPMVGHTHVSTAVVGTFGY 256
           YLH      ++++D K+ NV  D   +  ++DFGL                    G   +
Sbjct: 145 YLHA---KGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200

Query: 257 AAPDYI---------ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 307
            AP+ I         +    +  SDV++ G + YE+       +       + ++  +  
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---EAIIWQMGT 257

Query: 308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
                   G+  +     +  + +   I  +   C +   ++RP  +++++ L+++
Sbjct: 258 --------GMKPNLS---QIGMGKE--ISDILLFCWAFEQEERPTFTKLMDMLEKL 300

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  144 bits (365), Expect = 2e-39
 Identities = 75/292 (25%), Positives = 124/292 (42%), Gaps = 50/292 (17%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
           +IG G FG V+        G   ++ T+VA+K            +++ E + L    HPN
Sbjct: 121 QIGRGNFGEVFS-------GRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           +V+LIG C     +     +V E +        L       L  KT L ++  AA G+ Y
Sbjct: 174 IVRLIGVCT----QKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEY 228

Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY--AA 258
           L        I+RD  A N L+ E    K+SDFG++RE       + ++  +        A
Sbjct: 229 LES---KCCIHRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQVPVKWTA 283

Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---KTEQRLLEWVQQ-YPADSK 313
           P+ +  G  +++SDVWSFG++L+E  + G        P    + Q+  E+V++       
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGA------SPYPNLSNQQTREFVEKGG----- 332

Query: 314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
                   RL       +A  + RL + C +     RP  S + + L+ I +
Sbjct: 333 --------RLPCPELCPDA--VFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  141 bits (358), Expect = 4e-39
 Identities = 72/305 (23%), Positives = 120/305 (39%), Gaps = 55/305 (18%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVLEHPN 140
            +GEG FG V      P   +G +    VA+K L  +           E++ L  L H N
Sbjct: 28  DLGEGHFGKVELCRYDP---EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           +VK  G C  DG  GI+  L+ EF+ + SL+++L       +  K +L   +   +G+ Y
Sbjct: 85  IVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDY 141

Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG----- 255
           L      Q ++RD  A NVL++   + K+ DFGL +       T      V         
Sbjct: 142 LGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK----AIETDKEYYTVKDDRDSPVF 194

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTE-----------QRLLE 303
           + AP+ +        SDVWSFGV L+E+LT             +            RL+ 
Sbjct: 195 WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254

Query: 304 WVQQYPADSKKFGLIMD-PRL--EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL 360
            +++        G  +  P    ++ Y +            C      +R     ++E  
Sbjct: 255 TLKE--------GKRLPCPPNCPDEVYQLMR---------KCWEFQPSNRTSFQNLIEGF 297

Query: 361 KQIVQ 365
           + +++
Sbjct: 298 EALLK 302

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  141 bits (357), Expect = 1e-38
 Identities = 77/301 (25%), Positives = 127/301 (42%), Gaps = 42/301 (13%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----WVAEVQFLGVLEHPNL 141
           ++G+G FGSV      P    G +   +VA+K+L   G      +  E+Q L  L    +
Sbjct: 30  QLGKGNFGSVELCRYDP---LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 201
           VK  G     G + ++  LV E++ +  L D L       L     L       +G+ YL
Sbjct: 87  VKYRGVSYGPGRQSLR--LVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYL 143

Query: 202 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG-----Y 256
                 + ++RD  A N+L++     K++DFGLA+    +        VV   G     +
Sbjct: 144 GS---RRCVHRDLAARNILVESEAHVKIADFGLAK----LLPLDKDYYVVREPGQSPIFW 196

Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKF 315
            AP+ +     + +SDVWSFGVVLYE+ T   +S   +      R++   +  PA S+  
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLL 254

Query: 316 GLIMD-PRLEK-------EYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS 367
            L+ +  RL          + + +          C + S +DRP  S +  +L  +   S
Sbjct: 255 ELLEEGQRLPAPPACPAEVHELMK---------LCWAPSPQDRPSFSALGPQLDMLWSGS 305

Query: 368 N 368
            
Sbjct: 306 R 306

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  140 bits (356), Expect = 1e-38
 Identities = 83/298 (27%), Positives = 116/298 (38%), Gaps = 43/298 (14%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVLEHPN 140
            +GEG FG V      P          +VA+K L  D        W  E+  L  L H +
Sbjct: 38  DLGEGHFGKVSLYCYDP---TNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           ++K  G C   G   +Q  LV E++   SL D+L   +   +     L       EG+AY
Sbjct: 95  IIKYKGCCEDAGAASLQ--LVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAY 149

Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG----- 255
           LH       I+RD  A NVLLD +   K+ DFGLA+    V   H     V   G     
Sbjct: 150 LHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA---VPEGH-EYYRVREDGDSPVF 202

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKK 314
           + AP+ ++       SDVWSFGV LYE+LT    S        E   +   Q       +
Sbjct: 203 WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262

Query: 315 FGLIMDPRLEK-------EYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
             L    RL +        Y + +         NC    +  RP    ++  LK + +
Sbjct: 263 L-LERGERLPRPDKCPAEVYHLMK---------NCWETEASFRPTFENLIPILKTVHE 310

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  139 bits (353), Expect = 1e-38
 Identities = 65/299 (21%), Positives = 119/299 (39%), Gaps = 47/299 (15%)

Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAE 129
           +++  ++   DF  +  IG GGFG V+K+  +        +     IK++  +  +   E
Sbjct: 2   AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHR-------IDGKTYVIKRVKYNNEKAERE 54

Query: 130 VQFLGVLEHPNLVKLIGY---------CAVDGERGIQRLLVY---EFMLNRSLEDHLFNR 177
           V+ L  L+H N+V   G           +       +   ++   EF    +LE  +  R
Sbjct: 55  VKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 114

Query: 178 AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE 237
               L     L +     +G+ Y+H     ++I RD K SN+ L +  + K+ DFGL   
Sbjct: 115 RGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVT- 170

Query: 238 GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT 297
              + +    T   GT  Y +P+ I +     + D+++ G++L E+L    +        
Sbjct: 171 --SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-------- 220

Query: 298 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 356
                         SK F  + D  +   +   + +    L    LSK  +DRP  S++
Sbjct: 221 ----------AFETSKFFTDLRDGIISDIFD-KKEKT---LLQKLLSKKPEDRPNTSEI 265

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  139 bits (353), Expect = 3e-38
 Identities = 61/296 (20%), Positives = 111/296 (37%), Gaps = 45/296 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL---NRDGLQWV-AEVQFLGVLEHPNL 141
           K+GEGGF  V          +G  +    A+K++    +   +    E     +  HPN+
Sbjct: 36  KLGEGGFSYVDL-------VEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88

Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEGLA 199
           ++L+ YC  +     +  L+  F    +L + +         L     L ++LG   GL 
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148

Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS-------TAVVG 252
            +H        +RD K +N+LL +  +P L D G   +  +               A   
Sbjct: 149 AIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205

Query: 253 TFGYAAPDYIET---GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY- 308
           T  Y AP+         +  ++DVWS G VLY M+ G    +    K +   L    Q  
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265

Query: 309 -PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
            P   +             +S +   +   L ++ ++     RP +  ++ +L+ +
Sbjct: 266 IPQSPR-------------HS-SALWQ---LLNSMMTVDPHQRPHIPLLLSQLEAL 304

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  138 bits (351), Expect = 4e-38
 Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 18/207 (8%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----WVAEVQFLGVLEHPNL 141
           ++G+G FGSV      P   +      VVA+KKL     +    +  E++ L  L+H N+
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDN---TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 201
           VK  G C   G R ++  L+ E++   SL D+L       +     L       +G+ YL
Sbjct: 74  VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYL 130

Query: 202 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 258
                 + I+RD    N+L++   R K+ DFGL +   +                  + A
Sbjct: 131 GT---KRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEFFKVKEPGESPIFWYA 185

Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLT 285
           P+ +     +  SDVWSFGVVLYE+ T
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT 212

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  138 bits (350), Expect = 1e-37
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 22/209 (10%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----WVAEVQFLGVLEHPNL 141
           ++G+G FGSV      P   +      VVA+KKL     +    +  E++ L  L+H N+
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDN---TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104

Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 201
           VK  G C   G R ++  L+ E++   SL D+L       +     L       +G+ YL
Sbjct: 105 VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYL 161

Query: 202 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG-----Y 256
                 + I+RD    N+L++   R K+ DFGL +   ++         V   G     +
Sbjct: 162 GT---KRYIHRDLATRNILVENENRVKIGDFGLTK---VLPQDK-EYYKVKEPGESPIFW 214

Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
            AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELFT 243

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  139 bits (351), Expect = 1e-37
 Identities = 66/353 (18%), Positives = 129/353 (36%), Gaps = 51/353 (14%)

Query: 65  NLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL 124
                 +  M      + R+ KIGEG FG                +     IK++N   +
Sbjct: 14  GTENLYFQSM----EKYVRLQKIGEGSFGKAILVKST-------EDGRQYVIKEINISRM 62

Query: 125 ------QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA 178
                 +   EV  L  ++HPN+V+       +G   I    V ++     L   +  + 
Sbjct: 63  SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI----VMDYCEGGDLFKRINAQK 118

Query: 179 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 238
                    L   +     L ++H+    ++++RD K+ N+ L ++   +L DFG+AR  
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARV- 174

Query: 239 PMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKT 297
            +     ++ A +GT  Y +P+  E      KSD+W+ G VLYE+ T + + E  +    
Sbjct: 175 -LNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL 233

Query: 298 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP------ 351
             +++     +            P +   YS  + R    L      ++ +DRP      
Sbjct: 234 VLKIIS--GSF------------PPVSLHYS-YDLRS---LVSQLFKRNPRDRPSVNSIL 275

Query: 352 KMSQVVERLKQIVQVSNEGDSFDKTFEEICEEDPVEAQTKQKQHEPSEAWKRR 404
           +   + +R+++ +      + F           P+ A+              +
Sbjct: 276 EKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQ 328

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  141 bits (358), Expect = 1e-37
 Identities = 76/302 (25%), Positives = 134/302 (44%), Gaps = 44/302 (14%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGVLEHPNLV 142
           K+G G +G VY+       G     +  VA+K L  D ++   ++ E   +  ++HPNLV
Sbjct: 227 KLGGGQYGEVYE-------GVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 279

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +L+G C  +        ++ EFM   +L D+L       +     L++    +  + YL 
Sbjct: 280 QLLGVCTREP----PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335

Query: 203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY--AAPD 260
           +      I+R+  A N L+ EN   K++DFGL+R   M G T+ + A    F     AP+
Sbjct: 336 K---KNFIHRNLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAG-AKFPIKWTAPE 389

Query: 261 YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMD 320
            +     + KSDVW+FGV+L+E+ T   S       ++  + E +++           M+
Sbjct: 390 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEK--------DYRME 439

Query: 321 -PRL--EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSFDKTF 377
            P    EK Y +            C   +  DRP  +++ +  + + Q S+  D  +K  
Sbjct: 440 RPEGCPEKVYELMR---------ACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 490

Query: 378 EE 379
            +
Sbjct: 491 GK 492

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  139 bits (352), Expect = 6e-37
 Identities = 65/235 (27%), Positives = 97/235 (41%), Gaps = 28/235 (11%)

Query: 56  PELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVA 115
           P++ E        F  S       +   +  IG+G FG V           G      VA
Sbjct: 170 PKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVML---------GDYRGNKVA 220

Query: 116 IKKLNRDGLQW--VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDH 173
           +K +  D      +AE   +  L H NLV+L+G    +        +V E+M   SL D+
Sbjct: 221 VKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG---GLYIVTEYMAKGSLVDY 277

Query: 174 LFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG 233
           L +R    L     L   L   E + YL        ++RD  A NVL+ E+   K+SDFG
Sbjct: 278 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFG 334

Query: 234 LAREGPMVGHTHVSTAVVGT-FGY--AAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           L +E         S+            AP+ +     + KSDVWSFG++L+E+ +
Sbjct: 335 LTKE--------ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  136 bits (345), Expect = 6e-37
 Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 24/219 (10%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW-----VAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAIK+L            + E   +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 71

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             +++P++ +L+G C           L+ + M    L D++       +  +  L+  + 
Sbjct: 72  ASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQ 125

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
            A+G+ YL +    ++++RD  A NVL+      K++DFGLA+   ++G         G 
Sbjct: 126 IAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK---LLGAEEKEYHAEGG 179

Query: 254 ---FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 288
                + A + I     T +SDVWS+GV ++E++T G +
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  133 bits (337), Expect = 3e-36
 Identities = 65/209 (31%), Positives = 96/209 (45%), Gaps = 29/209 (13%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW--VAEVQFLGVLEHPNLVK 143
            IG+G FG V           G      VA+K +  D      +AE   +  L H NLV+
Sbjct: 28  TIGKGEFGDVML---------GDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQ 78

Query: 144 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE 203
           L+G   V+ + G+   +V E+M   SL D+L +R    L     L   L   E + YL  
Sbjct: 79  LLGVI-VEEKGGL--YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135

Query: 204 GLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAPD 260
                 ++RD  A NVL+ E+   K+SDFGL +E         S+          + AP+
Sbjct: 136 ---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--------ASSTQDTGKLPVKWTAPE 184

Query: 261 YIETGHLTAKSDVWSFGVVLYEMLT-GRR 288
            +     + KSDVWSFG++L+E+ + GR 
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRV 213

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  135 bits (341), Expect = 5e-36
 Identities = 87/389 (22%), Positives = 142/389 (36%), Gaps = 60/389 (15%)

Query: 10  KKLRRREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVF 69
               RR    A  +  PR S    G  S   + +S      S     +       +L   
Sbjct: 12  HHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSAL 71

Query: 70  SYSEMRQATNDFSRML---------KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN 120
           +  E+ QA                  IG G FG VY  ++     D   +    A+K LN
Sbjct: 72  N-PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLL----DNDGKKIHCAVKSLN 126

Query: 121 -----RDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF 175
                 +  Q++ E   +    HPN++ L+G C          L+V  +M +  L + + 
Sbjct: 127 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLVVLPYMKHGDLRNFIR 183

Query: 176 NRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA 235
           N        K  +   L  A+G+ +L      + ++RD  A N +LDE F  K++DFGLA
Sbjct: 184 NET-HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLA 239

Query: 236 REGPMVGHTHVSTAVVGTFG-----YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRS 289
           R+   +      +    T       + A + ++T   T KSDVWSFGV+L+E++T G   
Sbjct: 240 RD---MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA-- 294

Query: 290 LERNRP---KTEQRLLEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSK 345
                P        +  ++ Q        G  +  P             +  +   C   
Sbjct: 295 ----PPYPDVNTFDITVYLLQ--------GRRLLQPE-------YCPDPLYEVMLKCWHP 335

Query: 346 SSKDRPKMSQVVERLKQIVQVSNEGDSFD 374
            ++ RP  S++V R+  I           
Sbjct: 336 KAEMRPSFSELVSRISAIFSTFIGEHYVH 364

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  132 bits (335), Expect = 5e-36
 Identities = 72/300 (24%), Positives = 119/300 (39%), Gaps = 46/300 (15%)

Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWV 127
           M     D+  +  IG G +G   K   K       S+  ++  K+L+   +        V
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRK-------SDGKILVWKELDYGSMTEAEKQMLV 53

Query: 128 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHL--FNRAFPPLPW 184
           +EV  L  L+HPN+V+   Y     +R    L +V E+     L   +    +    L  
Sbjct: 54  SEVNLLRELKHPNIVR---YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE 110

Query: 185 KTRLHIILGAAEGLAYLHE--GLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 242
           +  L ++      L   H        V++RD K +NV LD     KL DFGLAR   +  
Sbjct: 111 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNH 168

Query: 243 HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP---KTEQ 299
            T  +   VGT  Y +P+ +       KSD+WS G +LYE+           P    +++
Sbjct: 169 DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQK 222

Query: 300 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER 359
            L   +++        G     R+   YS +E  +   +    L+     RP + +++E 
Sbjct: 223 ELAGKIRE--------GKF--RRIPYRYS-DELNE---IITRMLNLKDYHRPSVEEILEN 268

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  136 bits (345), Expect = 5e-36
 Identities = 74/301 (24%), Positives = 118/301 (39%), Gaps = 48/301 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGVLEHPNLV 142
           K+G+G FG V+  +            T VAIK L    +    ++ E Q +  L H  LV
Sbjct: 191 KLGQGCFGEVWMGTWNGT--------TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 242

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +L    + +        +V E+M   SL D L       L     + +    A G+AY+ 
Sbjct: 243 QLYAVVSEE-----PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297

Query: 203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAAP 259
               +  ++RD +A+N+L+ EN   K++DFGLAR   +            +  T    AP
Sbjct: 298 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----AP 350

Query: 260 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM 319
           +    G  T KSDVWSFG++L E+ T  R         E  +L+ V++        G  M
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVER--------GYRM 400

Query: 320 D-PRL--EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSFDKT 376
             P    E  + +            C  K  ++RP    +   L+     +       + 
Sbjct: 401 PCPPECPESLHDLMC---------QCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 451

Query: 377 F 377
            
Sbjct: 452 L 452

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  132 bits (335), Expect = 7e-36
 Identities = 74/295 (25%), Positives = 121/295 (41%), Gaps = 50/295 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
            IG G FG VY  ++     D   +    A+K LN      +  Q++ E   +    HPN
Sbjct: 32  VIGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           ++ L+G C          L+V  +M +  L + + N        K  +   L  A+G+ Y
Sbjct: 88  VLSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKY 143

Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG----- 255
           L      + ++RD  A N +LDE F  K++DFGLAR+   +      +    T       
Sbjct: 144 LAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARD---MYDKEYYSVHNKTGAKLPVK 197

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---KTEQRLLEWVQQYPAD 311
           + A + ++T   T KSDVWSFGV+L+E++T G        P        +  ++ Q    
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGA------PPYPDVNTFDITVYLLQ---- 247

Query: 312 SKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
               G  +  P             +  +   C    ++ RP  S++V R+  I  
Sbjct: 248 ----GRRLLQPE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  136 bits (344), Expect = 2e-35
 Identities = 74/301 (24%), Positives = 118/301 (39%), Gaps = 48/301 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGVLEHPNLV 142
           K+G+G FG V+  +            T VAIK L    +    ++ E Q +  L H  LV
Sbjct: 274 KLGQGCFGEVWMGTWNGT--------TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 325

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +L    + +        +V E+M   SL D L       L     + +    A G+AY+ 
Sbjct: 326 QLYAVVSEE-----PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380

Query: 203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAAP 259
               +  ++RD +A+N+L+ EN   K++DFGLAR   +            +  T    AP
Sbjct: 381 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----AP 433

Query: 260 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM 319
           +    G  T KSDVWSFG++L E+ T  R         E  +L+ V++        G  M
Sbjct: 434 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVER--------GYRM 483

Query: 320 D-PRL--EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSFDKT 376
             P    E  + +            C  K  ++RP    +   L+     +       + 
Sbjct: 484 PCPPECPESLHDLMC---------QCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 534

Query: 377 F 377
            
Sbjct: 535 L 535

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  131 bits (331), Expect = 3e-35
 Identities = 76/307 (24%), Positives = 132/307 (42%), Gaps = 54/307 (17%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGVLEHPNLV 142
           K+G G +G VY+       G     +  VA+K L  D ++   ++ E   +  ++HPNLV
Sbjct: 20  KLGGGQYGEVYE-------GVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +L+G C  +        ++ EFM   +L D+L       +     L++    +  + YL 
Sbjct: 73  QLLGVCTREP----PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128

Query: 203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAP 259
           +      I+RD  A N L+ EN   K++DFGL+R    +      TA  G      + AP
Sbjct: 129 K---KNFIHRDLAARNCLVGENHLVKVADFGLSR----LMTGDTYTAHAGAKFPIKWTAP 181

Query: 260 DYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---KTEQRLLEWVQQYPADSKKF 315
           + +     + KSDVW+FGV+L+E+ T G        P       ++ E +++        
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGM------SPYPGIDLSQVYELLEK-------- 227

Query: 316 GLIMD-PRL--EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDS 372
              M+ P    EK Y +            C   +  DRP  +++ +  + + Q S+  D 
Sbjct: 228 DYRMERPEGCPEKVYELMR---------ACWQWNPSDRPSFAEIHQAFETMFQESSISDE 278

Query: 373 FDKTFEE 379
            +K   +
Sbjct: 279 VEKELGK 285

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  134 bits (339), Expect = 4e-35
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 25/209 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGVLEHPNLV 142
           K+G G FG V+ ++            T VA+K +    +    ++AE   +  L+H  LV
Sbjct: 195 KLGAGQFGEVWMATYNKH--------TKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLV 246

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           KL      +        ++ EFM   SL D L +      P    +      AEG+A++ 
Sbjct: 247 KLHAVVTKEP-----IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301

Query: 203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY--AAPD 260
           +      I+RD +A+N+L+  +   K++DFGLAR    +     +      F     AP+
Sbjct: 302 Q---RNYIHRDLRAANILVSASLVCKIADFGLARV---IEDNEYTAREGAKFPIKWTAPE 355

Query: 261 YIETGHLTAKSDVWSFGVVLYEMLT-GRR 288
            I  G  T KSDVWSFG++L E++T GR 
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRI 384

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  130 bits (330), Expect = 4e-35
 Identities = 63/221 (28%), Positives = 92/221 (41%), Gaps = 26/221 (11%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW-------VAEVQ 131
            D   + K+G+G FG V +      +G   S    VA+K L  D L         + EV 
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS----VAVKCLKPDVLSQPEAMDDFIREVN 73

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 191
            +  L+H NL++L G         ++  +V E     SL D L           T     
Sbjct: 74  AMHSLDHRNLIRLYGVVL---TPPMK--MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYA 127

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 251
           +  AEG+ YL      + I+RD  A N+LL      K+ DFGL R   +  +        
Sbjct: 128 VQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR--ALPQNDDHYVMQE 182

Query: 252 GT---FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 288
                F + AP+ ++T   +  SD W FGV L+EM T G+ 
Sbjct: 183 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  130 bits (329), Expect = 6e-35
 Identities = 68/305 (22%), Positives = 117/305 (38%), Gaps = 53/305 (17%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW-----VAEVQFL 133
            DF  +  +G GGFG V+++  K    D        AIK++     +      + EV+ L
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKV---DDC----NYAIKRIRLPNRELAREKVMREVKAL 57

Query: 134 GVLEHPNLVKLIGY-----CAVDGERGIQRLLVY---EFMLNRSLEDHLFNR-AFPPLPW 184
             LEHP +V+              +    ++ +Y   +     +L+D +  R        
Sbjct: 58  AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117

Query: 185 KTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE------- 237
              LHI L  AE + +LH      +++RD K SN+    +   K+ DFGL          
Sbjct: 118 SVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174

Query: 238 ---GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNR 294
                 +      T  VGT  Y +P+ I     + K D++S G++L+E+L    S +  R
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-PFSTQMER 233

Query: 295 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS 354
            +T   +     ++P    +                E   +       LS S  +RP+  
Sbjct: 234 VRTLTDVRN--LKFPPLFTQ------------KYPCEYVMVQD----MLSPSPMERPEAI 275

Query: 355 QVVER 359
            ++E 
Sbjct: 276 NIIEN 280

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  130 bits (328), Expect = 7e-35
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 27/213 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFL------GVLEHP 139
           ++G G FG+V K   +            VA+K L  +      + + L        L++P
Sbjct: 24  ELGSGNFGTVKKGYYQ-----MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 78

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
            +V++IG C  +       +LV E      L  +L  +    +  K  + ++   + G+ 
Sbjct: 79  YIVRMIGICEAE-----SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMK 131

Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGY 256
           YL E      ++RD  A NVLL      K+SDFGL++   +    +   A         +
Sbjct: 132 YLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKA--LRADENYYKAQTHGKWPVKW 186

Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 288
            AP+ I     ++KSDVWSFGV+++E  + G++
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  130 bits (329), Expect = 1e-34
 Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 24/219 (10%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW-----VAEVQFL 133
            +F ++  +G G FG+VYK    P   +G      VAIK+L            + E   +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 71

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             +++P++ +L+G C           L+ + M    L D++       +  +  L+  + 
Sbjct: 72  ASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQ 125

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
            A+G+ YL +    ++++RD  A NVL+      K++DFGLA+   ++G         G 
Sbjct: 126 IAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK---LLGAEEKEYHAEGG 179

Query: 254 ---FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 288
                + A + I     T +SDVWS+GV ++E++T G +
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  128 bits (325), Expect = 1e-34
 Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 24/211 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW-----VAEVQFLGVLEHPN 140
            +GEG FG VY+       G+  +    VA+K   +D         ++E   +  L+HP+
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKIN----VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 74

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           +VKLIG    +        ++ E      L  +L       L   T +   L   + +AY
Sbjct: 75  IVKLIGIIEEE-----PTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAY 128

Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAA 258
           L     +  ++RD    N+L+      KL DFGL+R    +       A V      + +
Sbjct: 129 LES---INCVHRDIAVRNILVASPECVKLGDFGLSRY---IEDEDYYKASVTRLPIKWMS 182

Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 288
           P+ I     T  SDVW F V ++E+L+ G++
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQ 213

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  128 bits (325), Expect = 1e-34
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 27/214 (12%)

Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFL------GVLEH 138
           +++G G FGSV +   +            VAIK L + G +     + +        L++
Sbjct: 16  IELGCGNFGSVRQGVYRMRKKQ-----IDVAIKVL-KQGTEKADTEEMMREAQIMHQLDN 69

Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 198
           P +V+LIG C  +       +LV E      L   L  +    +P      ++   + G+
Sbjct: 70  PYIVRLIGVCQAE-----ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGM 123

Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FG 255
            YL E      ++RD  A NVLL      K+SDFGL++   +       TA         
Sbjct: 124 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKA--LGADDSYYTARSAGKWPLK 178

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 288
           + AP+ I     +++SDVWS+GV ++E L+ G++
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  130 bits (328), Expect = 2e-34
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 24/212 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVLEHPN 140
            +G G FG+V+K    P   +G S    V IK +     +         +  +G L+H +
Sbjct: 20  VLGSGVFGTVHKGVWIP---EGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           +V+L+G C           LV +++   SL DH+       L  +  L+  +  A+G+ Y
Sbjct: 77  IVRLLGLCPGS-----SLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYY 130

Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYA 257
           L E     +++R+  A NVLL    + +++DFG+A    ++                 + 
Sbjct: 131 LEE---HGMVHRNLAARNVLLKSPSQVQVADFGVAD---LLPPDDKQLLYSEAKTPIKWM 184

Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 288
           A + I  G  T +SDVWS+GV ++E++T G  
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  128 bits (324), Expect = 2e-34
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 25/209 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGVLEHPNLV 142
           ++G G FG V+               T VA+K L +  +    ++AE   +  L+H  LV
Sbjct: 20  RLGAGQFGEVWMGYYNGH--------TKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +L        +  I   ++ E+M N SL D L   +   L     L +    AEG+A++ 
Sbjct: 72  RLYAVVT---QEPI--YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY--AAPD 260
           E      I+RD +A+N+L+ +    K++DFGLAR    +     +      F     AP+
Sbjct: 127 E---RNYIHRDLRAANILVSDTLSCKIADFGLARL---IEDNEYTAREGAKFPIKWTAPE 180

Query: 261 YIETGHLTAKSDVWSFGVVLYEMLT-GRR 288
            I  G  T KSDVWSFG++L E++T GR 
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRI 209

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  129 bits (327), Expect = 2e-34
 Identities = 66/214 (30%), Positives = 98/214 (45%), Gaps = 27/214 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
            IG G  G V    ++            VAIK L      R    +++E   +G  +HPN
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVP----VAIKALKAGYTERQRRDFLSEASIMGQFDHPN 111

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           +++L G       RG   ++V E+M N SL+  L             + ++ G   G+ Y
Sbjct: 112 IIRLEGVVT----RGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRY 166

Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG----- 255
           L +   +  ++RD  A NVL+D N   K+SDFGL+R    V       A   T G     
Sbjct: 167 LSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSR----VLEDDPDAAYTTTGGKIPIR 219

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 288
           + AP+ I     ++ SDVWSFGVV++E+L  G R
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  128 bits (325), Expect = 3e-34
 Identities = 78/323 (24%), Positives = 139/323 (43%), Gaps = 58/323 (17%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
           ++G+G FG VY+   K    D     T VAIK +N     R+ ++++ E   +      +
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDE--PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------FNRAFPPLPWKTRLHIIL 192
           +V+L+G  +    +G   L++ E M    L+ +L         N    P      + +  
Sbjct: 90  VVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
             A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+ R+   +  T       G
Sbjct: 146 EIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRD---IYET--DYYRKG 197

Query: 253 TFGY-----AAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---KTEQRLLE 303
             G       +P+ ++ G  T  SDVWSFGVVL+E+ T         +P    + +++L 
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE------QPYQGLSNEQVLR 251

Query: 304 WVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ 362
           +V +        G ++D P        N    +  L   C   + K RP   +++  +K+
Sbjct: 252 FVME--------GGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 296

Query: 363 IVQVSNEGDSFDKTFEEICEEDP 385
            ++      SF  + E    E  
Sbjct: 297 EMEPGFREVSFYYSEENKLPEPE 319

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  128 bits (323), Expect = 3e-34
 Identities = 59/211 (27%), Positives = 88/211 (41%), Gaps = 24/211 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
            IGEG FG V++             A  VAIK            +++ E   +   +HP+
Sbjct: 22  CIGEGQFGDVHQGIYMSPEN----PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 77

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           +VKLIG    +        ++ E      L   L  R    L   + +      +  LAY
Sbjct: 78  IVKLIGVITEN-----PVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAY 131

Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAA 258
           L      + ++RD  A NVL+  N   KL DFGL+R    +  +    A  G     + A
Sbjct: 132 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMA 185

Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 288
           P+ I     T+ SDVW FGV ++E+L  G +
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVK 216

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  128 bits (323), Expect = 4e-34
 Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 24/210 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
            IG+G FG VY         D        AIK L+     +    ++ E   +  L HPN
Sbjct: 28  VIGKGHFGVVYHGEYI----DQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           ++ LIG             ++  +M +  L   + +        K  +   L  A G+ Y
Sbjct: 84  VLALIGIMLPPEGL---PHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEY 139

Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG----- 255
           L E    + ++RD  A N +LDE+F  K++DFGLAR+   +      +            
Sbjct: 140 LAE---QKFVHRDLAARNCMLDESFTVKVADFGLARD---ILDREYYSVQQHRHARLPVK 193

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLT 285
           + A + ++T   T KSDVWSFGV+L+E+LT
Sbjct: 194 WTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  128 bits (324), Expect = 4e-34
 Identities = 68/303 (22%), Positives = 127/303 (41%), Gaps = 58/303 (19%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHP 139
            +GEG FGSV + ++K         +  VA+K +  D        ++++E   +    HP
Sbjct: 41  ILGEGEFGSVMEGNLK----QEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96

Query: 140 NLVKLIGYCAVDGERGIQRLLV-YEFMLNRSLEDHLFNRAFP----PLPWKTRLHIILGA 194
           N+++L+G C     +GI + +V   FM    L  +L           +P +T L  ++  
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156

Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 254
           A G+ YL        ++RD  A N +L ++    ++DFGL+++   +          G  
Sbjct: 157 ALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKK---IYSGDYYRQ--GRI 208

Query: 255 G-----YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---KTEQRLLEWV 305
                 + A + +     T+KSDVW+FGV ++E+ T G        P        + +++
Sbjct: 209 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGM------TPYPGVQNHEMYDYL 262

Query: 306 QQYPADSKKFGLIMD-PR--LEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ 362
                     G  +  P   L++ Y I           +C      DRP  S +  +L++
Sbjct: 263 LH--------GHRLKQPEDCLDELYEIMY---------SCWRTDPLDRPTFSVLRLQLEK 305

Query: 363 IVQ 365
           +++
Sbjct: 306 LLE 308

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  127 bits (321), Expect = 6e-34
 Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 24/210 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFLGVLEHP 139
           +IG G F +VYK       G  T     VA  +L    L      ++  E + L  L+HP
Sbjct: 33  EIGRGSFKTVYK-------GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 85

Query: 140 NLVKLIGYCAVDGERGIQRLLVY-EFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 198
           N+V+          +G + +++  E M + +L+ +L  + F  +  K          +GL
Sbjct: 86  NIVRFYDSW-ESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGL 142

Query: 199 AYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
            +LH      +I+RD K  N+ +       K+ D GLA     +     + AV+GT  + 
Sbjct: 143 QFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFM 197

Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
           AP+  E  +     DV++FG+ + EM T  
Sbjct: 198 APEMYEEKY-DESVDVYAFGMCMLEMATSE 226

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  129 bits (326), Expect = 6e-34
 Identities = 62/238 (26%), Positives = 109/238 (45%), Gaps = 32/238 (13%)

Query: 69  FSYSEMRQATNDFSRML---------KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL 119
            ++ +  Q  ++F++ L          +G G FG V    +K  +    S    VAIK L
Sbjct: 26  HTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEIS----VAIKTL 81

Query: 120 N-----RDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL 174
                 +    ++ E   +G  +HPN+++L G       +    ++V E+M N SL+  L
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEYMENGSLDSFL 137

Query: 175 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 234
                        + ++ G A G+ YL +   +  ++RD  A N+L++ N   K+SDFGL
Sbjct: 138 RKHD-AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGL 193

Query: 235 AREGPMVGHTHVSTAVVGT---FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 288
            R   +      +    G      + +P+ I     T+ SDVWS+G+VL+E+++ G R
Sbjct: 194 GRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  127 bits (321), Expect = 9e-34
 Identities = 76/305 (24%), Positives = 121/305 (39%), Gaps = 47/305 (15%)

Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL----- 124
            Y+ +     +F    KIG G F  VY+            +   VA+KK+    L     
Sbjct: 27  GYNTL----ANFRIEKKIGRGQFSEVYR-------AACLLDGVPVALKKVQIFDLMDAKA 75

Query: 125 --QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFP 180
               + E+  L  L HPN++K       D E  I    V E      L   +  F +   
Sbjct: 76  RADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI----VLELADAGDLSRMIKHFKKQKR 131

Query: 181 PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
            +P +T     +     L ++H     +V++RD K +NV +      KL D GL R    
Sbjct: 132 LIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF--F 186

Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR 300
              T  + ++VGT  Y +P+ I       KSD+WS G +LYEM   +     +       
Sbjct: 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLYS 245

Query: 301 LLEWVQQ--YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
           L + ++Q  YP           P     YS  E R+   L + C++   + RP ++ V +
Sbjct: 246 LCKKIEQCDYP-----------PLPSDHYS-EELRQ---LVNMCINPDPEKRPDVTYVYD 290

Query: 359 RLKQI 363
             K++
Sbjct: 291 VAKRM 295

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  127 bits (322), Expect = 1e-33
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 20/211 (9%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
            IG G FG VYK  +K        +   VAIK L      +  + ++ E   +G   H N
Sbjct: 51  VIGAGEFGEVYKGMLK---TSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           +++L G  +    +    +++ E+M N +L+  L  +          + ++ G A G+ Y
Sbjct: 108 IIRLEGVIS----KYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKY 162

Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY--AA 258
           L     +  ++RD  A N+L++ N   K+SDFGL+R           T   G       A
Sbjct: 163 LAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV-LEDDPEATYTTSGGKIPIRWTA 218

Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 288
           P+ I     T+ SDVWSFG+V++E++T G R
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGER 249

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  126 bits (318), Expect = 2e-33
 Identities = 50/223 (22%), Positives = 85/223 (38%), Gaps = 40/223 (17%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW----VAEVQFLGVLEHPNL 141
            +G+G F  ++K   +     G    T V +K L++    +          +  L H +L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 201
           V   G C      G + +LV EF+   SL+ +L       +    +L +    A  + +L
Sbjct: 75  VLNYGVCV----CGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFL 129

Query: 202 HEGLEVQVIYRDFKASNVLLDENFRP--------KLSDFGLAREGPMVGHTHVSTAVVGT 253
            E     +I+ +  A N+LL              KLSD G++              V+  
Sbjct: 130 EE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPK 174

Query: 254 FGY------AAPDYIETG-HLTAKSDVWSFGVVLYEMLT-GRR 288
                      P+ IE   +L   +D WSFG  L+E+ + G +
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  126 bits (319), Expect = 2e-33
 Identities = 59/304 (19%), Positives = 111/304 (36%), Gaps = 52/304 (17%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN---RDGLQWVAEVQFLG 134
            +DF  +  +G+G FG V K+           ++   AIKK+          ++EV  L 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNA-------LDSRYYAIKKIRHTEEKLSTILSEVMLLA 57

Query: 135 VLEHPNLVKLIG-YCAVDGERGIQRL--------LVYEFMLNRSLEDHLFNRAFPPLPWK 185
            L H  +V+    +                    +  E+  N +L D + +         
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN-QQRD 116

Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--------- 236
               +     E L+Y+H      +I+RD K  N+ +DE+   K+ DFGLA+         
Sbjct: 117 EYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173

Query: 237 ---EGPMVGHTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGRRSLER 292
                 + G +   T+ +GT  Y A + ++ TGH   K D++S G++ +EM+        
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-----F 228

Query: 293 NRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK 352
           +       +L+ ++          +   P  +        +K   +    +      RP 
Sbjct: 229 STGMERVNILKKLRSVS-------IEFPPDFDDNKM-KVEKK---IIRLLIDHDPNKRPG 277

Query: 353 MSQV 356
              +
Sbjct: 278 ARTL 281

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  131 bits (330), Expect = 3e-33
 Identities = 51/209 (24%), Positives = 83/209 (39%), Gaps = 27/209 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVLEHPN 140
            I  GG G +Y       A D       V +K L   G        +AE QFL  + HP+
Sbjct: 87  CIAHGGLGWIYL------ALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPS 140

Query: 141 LVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           +V++  +       G     +V E++  +SL+          LP    +  +L     L+
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALS 196

Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 259
           YLH    + ++Y D K  N++L E  + KL D G       +        + GT G+ AP
Sbjct: 197 YLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSR---INSF---GYLYGTPGFQAP 246

Query: 260 DYIETGHLTAKSDVWSFGVVLYEMLTGRR 288
           + I     T  +D+++ G  L  +     
Sbjct: 247 E-IVRTGPTVATDIYTVGRTLAALTLDLP 274

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  125 bits (315), Expect = 8e-33
 Identities = 66/313 (21%), Positives = 119/313 (38%), Gaps = 55/313 (17%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN------RDGLQWVAEVQFLGVLEHP 139
            +G+G FGSV ++ +K            VA+K L        D  +++ E   +   +HP
Sbjct: 30  MLGKGEFGSVREAQLK----QEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85

Query: 140 NLVKLIGYCAVDGERGIQR--LLVYEFMLNRSLEDHLFNRAFP----PLPWKTRLHIILG 193
           ++ KL+G       +G     +++  FM +  L   L           LP +T +  ++ 
Sbjct: 86  HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
            A G+ YL        I+RD  A N +L E+    ++DFGL+R+   +          G 
Sbjct: 146 IACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRK---IYSGDYYRQ--GC 197

Query: 254 FG-----YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---KTEQRLLEW 304
                  + A + +     T  SDVW+FGV ++E++T G+       P        +  +
Sbjct: 198 ASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ------TPYAGIENAEIYNY 251

Query: 305 VQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
           +          G  +  P            ++  L   C S   K RP  + +   L+ I
Sbjct: 252 LIG--------GNRLKQPP-------ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296

Query: 364 VQVSNEGDSFDKT 376
           +   +   +    
Sbjct: 297 LGHLSVLSTSQDP 309

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  123 bits (311), Expect = 1e-32
 Identities = 70/289 (24%), Positives = 121/289 (41%), Gaps = 48/289 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGVLEHPNLV 142
           ++G G FG V     K            VA+K +    +    +  E Q +  L HP LV
Sbjct: 15  ELGSGQFGVVKLGKWK--------GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLV 66

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           K  G C+    +     +V E++ N  L ++L +     L     L +     EG+A+L 
Sbjct: 67  KFYGVCS----KEYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLE 121

Query: 203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY--AAPD 260
                Q I+RD  A N L+D +   K+SDFG+ R    V      ++V   F    +AP+
Sbjct: 122 S---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRY---VLDDQYVSSVGTKFPVKWSAPE 175

Query: 261 YIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM 319
                  ++KSDVW+FG++++E+ + G+   +     T   ++  V Q        G  +
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL---YTNSEVVLKVSQ--------GHRL 224

Query: 320 D-PRL--EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
             P L  +  Y I           +C  +  + RP   Q++  ++ + +
Sbjct: 225 YRPHLASDTIYQIMY---------SCWHELPEKRPTFQQLLSSIEPLRE 264

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  125 bits (315), Expect = 1e-32
 Identities = 68/306 (22%), Positives = 122/306 (39%), Gaps = 52/306 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN----RDGLQWVAEVQFLGVLEHPNL 141
           ++GEG FG V+ +       +   +  +VA+K L          +  E + L +L+H ++
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQ--DKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-------------FNRAFPPLPWKTRL 188
           V+  G C          L+V+E+M +  L   L              + A  PL     L
Sbjct: 106 VRFFGVCTEGR----PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161

Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 248
            +    A G+ YL     +  ++RD    N L+ +    K+ DFG++R+     +  V  
Sbjct: 162 AVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 218

Query: 249 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---KTEQRLLEW 304
             +    +  P+ I     T +SDVWSFGVVL+E+ T G+      +P    +    ++ 
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK------QPWYQLSNTEAIDC 272

Query: 305 VQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
           + Q        G  ++ PR           ++  +   C  +  + R  +  V  RL+ +
Sbjct: 273 ITQ--------GRELERPR-------ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317

Query: 364 VQVSNE 369
            Q    
Sbjct: 318 AQAPPV 323

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  123 bits (312), Expect = 1e-32
 Identities = 67/296 (22%), Positives = 122/296 (41%), Gaps = 56/296 (18%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGVLEHPNLV 142
           ++G G FG V     +            VAIK +    +    ++ E + +  L H  LV
Sbjct: 31  ELGTGQFGVVKYGKWR--------GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLV 82

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +L G C     +     ++ E+M N  L ++L          +  L +     E + YL 
Sbjct: 83  QLYGVCT----KQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLE 137

Query: 203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAP 259
                Q ++RD  A N L+++    K+SDFGL+R           T+ VG+     ++ P
Sbjct: 138 S---KQFLHRDLAARNCLVNDQGVVKVSDFGLSR----YVLDDEYTSSVGSKFPVRWSPP 190

Query: 260 DYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---KTEQRLLEWVQQYPADSKKF 315
           + +     ++KSD+W+FGV+++E+ + G+       P    T     E + Q        
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGK------MPYERFTNSETAEHIAQ-------- 236

Query: 316 GLIMD-PRL--EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN 368
           GL +  P L  EK Y+I           +C  + + +RP    ++  +  ++   +
Sbjct: 237 GLRLYRPHLASEKVYTIMY---------SCWHEKADERPTFKILLSNILDVMDEES 283

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  128 bits (324), Expect = 2e-32
 Identities = 68/291 (23%), Positives = 111/291 (38%), Gaps = 47/291 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
            IGEG FG V++             A  VAIK            +++ E   +   +HP+
Sbjct: 397 CIGEGQFGDVHQGIYMSPEN----PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 452

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           +VKLIG    +        ++ E      L   L  R    L   + +      +  LAY
Sbjct: 453 IVKLIGVITEN-----PVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAY 506

Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAA 258
           L      + ++RD  A NVL+  N   KL DFGL+R    +  +    A  G     + A
Sbjct: 507 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMA 560

Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---KTEQRLLEWVQQYPADSKK 314
           P+ I     T+ SDVW FGV ++E+L  G       +P        ++  ++        
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGV------KPFQGVKNNDVIGRIEN------- 607

Query: 315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
            G  +          N    +  L   C +     RP+ +++  +L  I++
Sbjct: 608 -GERLPM------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  122 bits (309), Expect = 2e-32
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 27/210 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGVLEHPNLV 142
           +IG G FG V+                 VAIK +    +    ++ E + +  L HP LV
Sbjct: 15  EIGSGQFGLVHLGYWLNK--------DKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLV 66

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +L G C           LV EFM +  L D+L  +       +T L + L   EG+AYL 
Sbjct: 67  QLYGVCL----EQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE 121

Query: 203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAAP 259
           E     VI+RD  A N L+ EN   K+SDFG+ R           T+  GT     +A+P
Sbjct: 122 E---ACVIHRDLAARNCLVGENQVIKVSDFGMTR----FVLDDQYTSSTGTKFPVKWASP 174

Query: 260 DYIETGHLTAKSDVWSFGVVLYEMLT-GRR 288
           +       ++KSDVWSFGV+++E+ + G+ 
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  123 bits (311), Expect = 2e-32
 Identities = 61/276 (22%), Positives = 103/276 (37%), Gaps = 39/276 (14%)

Query: 75  RQATNDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGL-----QW 126
           +  +N    +   +G+G   +V++         G  + T  + AIK  N           
Sbjct: 4   QSTSNHLWLLSDILGQGATANVFR---------GRHKKTGDLFAIKVFNNISFLRPVDVQ 54

Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWK 185
           + E + L  L H N+VKL  +   +      ++L+ EF    SL   L   +    LP  
Sbjct: 55  MREFEVLKKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES 112

Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL----DENFRPKLSDFGLAREGPMV 241
             L ++     G+ +L E     +++R+ K  N++     D     KL+DFG ARE   +
Sbjct: 113 EFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---L 166

Query: 242 GHTHVSTAVVGTFGYAAPDYIETGHL--------TAKSDVWSFGVVLYEMLTGRRS-LER 292
                  ++ GT  Y  PD  E   L         A  D+WS GV  Y   TG       
Sbjct: 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226

Query: 293 NRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYS 328
             P+  + ++  +          G+        ++S
Sbjct: 227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWS 262

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  123 bits (312), Expect = 3e-32
 Identities = 81/314 (25%), Positives = 126/314 (40%), Gaps = 71/314 (22%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVL-EHP 139
            IGEG FG V K+ IK             AIK++       D   +  E++ L  L  HP
Sbjct: 32  VIGEGNFGQVLKARIK-----KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 86

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------------FNRAFPPLPWK 185
           N++ L+G C   G       L  E+  + +L D L               N     L  +
Sbjct: 87  NIINLLGACEHRG----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142

Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
             LH     A G+ YL +    Q I+RD  A N+L+ EN+  K++DFGL+R         
Sbjct: 143 QLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ------- 192

Query: 246 VSTAVVGTFG-----YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---K 296
               V  T G     + A + +     T  SDVWS+GV+L+E+++ G        P    
Sbjct: 193 -EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG------TPYCGM 245

Query: 297 TEQRLLEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 355
           T   L E + Q        G  ++ P        N   ++  L   C  +   +RP  +Q
Sbjct: 246 TCAELYEKLPQ--------GYRLEKPL-------NCDDEVYDLMRQCWREKPYERPSFAQ 290

Query: 356 VVERLKQIVQVSNE 369
           ++  L ++++    
Sbjct: 291 ILVSLNRMLEERKT 304

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  123 bits (311), Expect = 3e-32
 Identities = 67/323 (20%), Positives = 108/323 (33%), Gaps = 50/323 (15%)

Query: 46  SASVTSPRGIPE-LYEEKAHNLRVFSYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPA 103
           S     PR +       +      +  S         F R+ ++G G +G V+K   K  
Sbjct: 22  SMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSK-- 79

Query: 104 AGDGTSEATVVAIKKLN------RDGLQWVAEVQFLGVL-EHPNLVKLIGYCAVDGERGI 156
             DG     + A+K+        +D  + +AEV     + +HP  V+L       G    
Sbjct: 80  -EDGR----LYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG---- 130

Query: 157 QRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFK 215
             L L  E     SL+ H        LP       +      LA+LH      +++ D K
Sbjct: 131 -ILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVK 184

Query: 216 ASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWS 275
            +N+ L    R KL DFGL  E   +G         G   Y AP+ ++  +    +DV+S
Sbjct: 185 PANIFLGPRGRCKLGDFGLLVE---LGTAGAGEVQEGDPRYMAPELLQGSY-GTAADVFS 240

Query: 276 FGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKI 335
            G+ + E+           P                 +     + P      S +E R  
Sbjct: 241 LGLTILEVACNME-----LPH----------GGEGWQQLRQGYLPPEFTAGLS-SELRS- 283

Query: 336 GRLADNCLSKSSKDRPKMSQVVE 358
             +    L    K R     ++ 
Sbjct: 284 --VLVMMLEPDPKLRATAEALLA 304

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  123 bits (311), Expect = 3e-32
 Identities = 81/328 (24%), Positives = 126/328 (38%), Gaps = 69/328 (21%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
            +G G FG VY+  +     D +     VA+K L      +D L ++ E   +    H N
Sbjct: 37  GLGHGAFGEVYEGQVSGMPNDPSP--LQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-----AFPPLPWKTRLHIILGAA 195
           +V+ IG       + + R ++ E M    L+  L            L     LH+    A
Sbjct: 95  IVRCIGVSL----QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150

Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLAREGPMVGHTHVSTA--- 249
            G  YL E      I+RD  A N LL         K+ DFG+AR+        +  A   
Sbjct: 151 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--------IYRASYY 199

Query: 250 VVGTFGY-----AAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---KTEQR 300
             G           P+    G  T+K+D WSFGV+L+E+ + G        P   K+ Q 
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY------MPYPSKSNQE 253

Query: 301 LLEWVQQYPADSKKFGLIMD-PR--LEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 357
           +LE+V          G  MD P+      Y I            C     +DRP  + ++
Sbjct: 254 VLEFVTS--------GGRMDPPKNCPGPVYRIMTQ---------CWQHQPEDRPNFAIIL 296

Query: 358 ERLKQIVQVSNEGD-SFDKTFEEICEED 384
           ER++   Q  +  + +    +  + EE+
Sbjct: 297 ERIEYCTQDPDVINTALPIEYGPLVEEE 324

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  126 bits (318), Expect = 9e-32
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 25/212 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVLEHPN 140
           ++G G FGSV +   +            VAIK L +   +      + E Q +  L++P 
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQ-----IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPY 397

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           +V+LIG C  +       +LV E      L   L  +    +P      ++   + G+ Y
Sbjct: 398 IVRLIGVCQAE-----ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKY 451

Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYA 257
           L E      ++R+  A NVLL      K+SDFGL++   +       TA         + 
Sbjct: 452 LEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKA--LGADDSYYTARSAGKWPLKWY 506

Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 288
           AP+ I     +++SDVWS+GV ++E L+ G++
Sbjct: 507 APECINFRKFSSRSDVWSYGVTMWEALSYGQK 538

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  121 bits (306), Expect = 1e-31
 Identities = 68/318 (21%), Positives = 122/318 (38%), Gaps = 79/318 (24%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN----RDGLQWVAEVQFLGVLEHPNL 141
           ++GEG FG V+ +     +     +  +VA+K L          +  E + L  L+H ++
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTK--DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79

Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR--------------AFPPLPWKTR 187
           VK  G C          ++V+E+M +  L   L                 A   L     
Sbjct: 80  VKFYGVCGDGD----PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135

Query: 188 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 247
           LHI    A G+ YL        ++RD    N L+  N   K+ DFG++R+          
Sbjct: 136 LHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRD---------- 182

Query: 248 TAVVGTFGY-------------AAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERN 293
              V +  Y               P+ I     T +SDVWSFGV+L+E+ T G+      
Sbjct: 183 ---VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK------ 233

Query: 294 RP---KTEQRLLEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKD 349
           +P    +   ++E + Q        G +++ PR          +++  +   C  +  + 
Sbjct: 234 QPWFQLSNTEVIECITQ--------GRVLERPR-------VCPKEVYDVMLGCWQREPQQ 278

Query: 350 RPKMSQVVERLKQIVQVS 367
           R  + ++ + L  + + +
Sbjct: 279 RLNIKEIYKILHALGKAT 296

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  122 bits (307), Expect = 1e-31
 Identities = 52/230 (22%), Positives = 90/230 (39%), Gaps = 42/230 (18%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQF 132
             +S + +IG GG   V++        +   +  + AIK +N +            E+ +
Sbjct: 28  RIYSILKQIGSGGSSKVFQ------VLNEKKQ--IYAIKYVNLEEADNQTLDSYRNEIAY 79

Query: 133 LGVLEHPNL--VKLIGYCAVDGERGIQRLLVYEFM--LNRSLEDHLFNRAFPPLPWKTRL 188
           L  L+  +   ++L  Y   D         +Y  M   N  L   L  +    +    R 
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQY-------IYMVMECGNIDLNSWL--KKKKSIDPWERK 130

Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 248
                  E +  +H+     +++ D K +N L+ +    KL DFG+A +      + V  
Sbjct: 131 SYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD 186

Query: 249 AVVGTFGYAAPDYIE-----------TGHLTAKSDVWSFGVVLYEMLTGR 287
           + VGT  Y  P+ I+              ++ KSDVWS G +LY M  G+
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  123 bits (311), Expect = 1e-31
 Identities = 65/323 (20%), Positives = 112/323 (34%), Gaps = 49/323 (15%)

Query: 75  RQATNDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGL-----QW 126
           +  +N    +   +G+G   +V++         G  + T  + AIK  N           
Sbjct: 4   QSTSNHLWLLSDILGQGATANVFR---------GRHKKTGDLFAIKVFNNISFLRPVDVQ 54

Query: 127 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWK 185
           + E + L  L H N+VKL  +   +      ++L+ EF    SL   L   +    LP  
Sbjct: 55  MREFEVLKKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES 112

Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL----DENFRPKLSDFGLAREGPMV 241
             L ++     G+ +L E     +++R+ K  N++     D     KL+DFG ARE   +
Sbjct: 113 EFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---L 166

Query: 242 GHTHVSTAVVGTFGYAAPDYIETGHL--------TAKSDVWSFGVVLYEMLTGRRS-LER 292
                  ++ GT  Y  PD  E   L         A  D+WS GV  Y   TG       
Sbjct: 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226

Query: 293 NRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINE----------ARKIGRLADNC 342
             P+  + ++  +          G+        ++S +              +  +  N 
Sbjct: 227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI 286

Query: 343 LSKSSKDRPKMSQVVERLKQIVQ 365
           L    +      Q       I+ 
Sbjct: 287 LEADQEKCWGFDQFFAETSDILH 309

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  122 bits (308), Expect = 1e-31
 Identities = 57/222 (25%), Positives = 88/222 (39%), Gaps = 23/222 (10%)

Query: 72  SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQ 131
            E R+  +  +   ++G G FG V++          T      A+KK+  +  + V E+ 
Sbjct: 51  YEYREEVHWMTHQPRVGRGSFGEVHR-----MKDKQTGF--QCAVKKVRLEVFR-VEELV 102

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 191
               L  P +V L G         I      E +   SL   +  +    LP    L+ +
Sbjct: 103 ACAGLSSPRIVPLYGAVREGPWVNI----FMELLEGGSLGQLI--KQMGCLPEDRALYYL 156

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAR---EGPMVGHTHVS 247
             A EGL YLH     ++++ D KA NVLL  +  R  L DFG A       +       
Sbjct: 157 GQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213

Query: 248 TAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGRR 288
             + GT  + AP+ +       AK D+WS   ++  ML G  
Sbjct: 214 DYIPGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGCH 254

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  121 bits (305), Expect = 2e-31
 Identities = 55/213 (25%), Positives = 84/213 (39%), Gaps = 30/213 (14%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFL----------GV 135
            +G GG G VY+      A D T    +VA+K ++       ++  F           G 
Sbjct: 41  LVGRGGMGDVYE------AED-TVRERIVALKLMSET---LSSDPVFRTRMQREARTAGR 90

Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
           L+ P++V +  +    GE   Q  +    +    L   L  R   PL     + I+    
Sbjct: 91  LQEPHVVPIHDF----GEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIG 144

Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
             L   H        +RD K  N+L+  +    L DFG+A        T +    VGT  
Sbjct: 145 SALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLY 200

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRR 288
           Y AP+     H T ++D+++   VLYE LTG  
Sbjct: 201 YMAPERFSESHATYRADIYALTCVLYECLTGSP 233

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  121 bits (306), Expect = 2e-31
 Identities = 52/230 (22%), Positives = 90/230 (39%), Gaps = 42/230 (18%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQF 132
             +S + +IG GG   V++        +   +  + AIK +N +            E+ +
Sbjct: 9   RIYSILKQIGSGGSSKVFQ------VLNEKKQ--IYAIKYVNLEEADNQTLDSYRNEIAY 60

Query: 133 LGVLEHPNL--VKLIGYCAVDGERGIQRLLVYEFM--LNRSLEDHLFNRAFPPLPWKTRL 188
           L  L+  +   ++L  Y   D         +Y  M   N  L   L  +    +    R 
Sbjct: 61  LNKLQQHSDKIIRLYDYEITDQY-------IYMVMECGNIDLNSWL--KKKKSIDPWERK 111

Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 248
                  E +  +H+     +++ D K +N L+ +    KL DFG+A +      + V  
Sbjct: 112 SYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD 167

Query: 249 AVVGTFGYAAPDYIE-----------TGHLTAKSDVWSFGVVLYEMLTGR 287
           + VGT  Y  P+ I+              ++ KSDVWS G +LY M  G+
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  122 bits (307), Expect = 3e-31
 Identities = 80/325 (24%), Positives = 123/325 (37%), Gaps = 63/325 (19%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
            +G G FG VY+  +     D       VA+K L      +D L ++ E   +    H N
Sbjct: 78  GLGHGAFGEVYEGQVSGMPNDP--SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-----AFPPLPWKTRLHIILGAA 195
           +V+ IG       + + R ++ E M    L+  L            L     LH+    A
Sbjct: 136 IVRCIGVSL----QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191

Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
            G  YL E      I+RD  A N LL         K+ DFG+AR+              G
Sbjct: 192 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-----RAGYYRKG 243

Query: 253 TFGY-----AAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---KTEQRLLE 303
                      P+    G  T+K+D WSFGV+L+E+ + G        P   K+ Q +LE
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY------MPYPSKSNQEVLE 297

Query: 304 WVQQYPADSKKFGLIMD-PRL--EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL 360
           +V          G  MD P+      Y I            C     +DRP  + ++ER+
Sbjct: 298 FVTS--------GGRMDPPKNCPGPVYRIMTQ---------CWQHQPEDRPNFAIILERI 340

Query: 361 KQIVQVSNEGD-SFDKTFEEICEED 384
           +   Q  +  + +    +  + EE+
Sbjct: 341 EYCTQDPDVINTALPIEYGPLVEEE 365

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  121 bits (305), Expect = 3e-31
 Identities = 80/319 (25%), Positives = 134/319 (42%), Gaps = 63/319 (19%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL-GVLEHP 139
            +GEG FG V  +       D   EA  VA+K L      +D    V+E++ +  + +H 
Sbjct: 42  PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR--------------AFPPLPWK 185
           N++ L+G C  DG       ++ E+    +L ++L  R                  + +K
Sbjct: 102 NIINLLGACTQDGP----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157

Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
             +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   + +  
Sbjct: 158 DLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARD---INNID 211

Query: 246 VSTAVVGTFG-----YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---K 296
                  T G     + AP+ +     T +SDVWSFGV+++E+ T G        P    
Sbjct: 212 YYKK--TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG------SPYPGI 263

Query: 297 TEQRLLEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 355
             + L + +++        G  MD P        N   ++  +  +C       RP   Q
Sbjct: 264 PVEELFKLLKE--------GHRMDKPA-------NCTNELYMMMRDCWHAVPSQRPTFKQ 308

Query: 356 VVERLKQIVQVSNEGDSFD 374
           +VE L +I+ ++   +  D
Sbjct: 309 LVEDLDRILTLTTNEEYLD 327

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  120 bits (303), Expect = 6e-31
 Identities = 65/305 (21%), Positives = 109/305 (35%), Gaps = 50/305 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL---NRDGLQWVA-EVQFLGVL-EHPN 140
            + EGGF  VY+                 A+K+L     +  + +  EV F+  L  HPN
Sbjct: 35  VLAEGGFAFVYE-------AQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPN 87

Query: 141 LVKLIGYCAVDGER---GIQRLLVYEFMLNRSLEDHLFNRAFP-PLPWKTRLHIILGAAE 196
           +V+     ++  E    G    L+   +    L + L       PL   T L I      
Sbjct: 88  IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE---GPMVGHTHVSTAVV-- 251
            + ++H   +  +I+RD K  N+LL      KL DFG A      P    +    A+V  
Sbjct: 148 AVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 252 -----GTFGYAAPDYIET---GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE 303
                 T  Y  P+ I+      +  K D+W+ G +LY +   +   E      + R++ 
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG---AKLRIVN 263

Query: 304 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
                P                            L    L  + ++R  +++VV +L++I
Sbjct: 264 GKYSIPPHDT-------------QY----TVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306

Query: 364 VQVSN 368
               N
Sbjct: 307 AAARN 311

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  118 bits (299), Expect = 9e-31
 Identities = 68/305 (22%), Positives = 118/305 (38%), Gaps = 64/305 (20%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
           ++GE  FG VYK  +   A     +   VAIK L          ++  E      L+HPN
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGE--QTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP--------------PLPWKT 186
           +V L+G    D        +++ +  +  L + L  R+                 L    
Sbjct: 74  VVCLLGVVTKDQ----PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129

Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
            +H++   A G+ YL       V+++D    NVL+ +    K+SD GL RE   V     
Sbjct: 130 FVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFRE---VYAA-- 181

Query: 247 STAVVGTFG-----YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---KT 297
               +         + AP+ I  G  +  SD+WS+GVVL+E+ + G       +P    +
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL------QPYCGYS 235

Query: 298 EQRLLEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 356
            Q ++E ++           ++  P        +    +  L   C ++    RP+   +
Sbjct: 236 NQDVVEMIRN--------RQVLPCPD-------DCPAWVYALMIECWNEFPSRRPRFKDI 280

Query: 357 VERLK 361
             RL+
Sbjct: 281 HSRLR 285

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  118 bits (299), Expect = 1e-30
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 26/214 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFL----------GV 135
            +G GG   V+       A D   +   VA+K L  D      +  F             
Sbjct: 19  ILGFGGMSEVHL------ARD-LRDHRDVAVKVLRAD---LARDPSFYLRFRREAQNAAA 68

Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
           L HP +V +      +   G    +V E++   +L D +      P+  K  + +I  A 
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADAC 126

Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST-AVVGTF 254
           + L + H+     +I+RD K +N+++      K+ DFG+AR     G++   T AV+GT 
Sbjct: 127 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183

Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRR 288
            Y +P+      + A+SDV+S G VLYE+LTG  
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  118 bits (297), Expect = 2e-30
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 30/213 (14%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFL----------GV 135
           K+G GG  +VY       A D T     VAIK +         + + L            
Sbjct: 18  KLGGGGMSTVYL------AED-TILNIKVAIKAIFIP---PREKEETLKRFEREVHNSSQ 67

Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
           L H N+V +I       E      LV E++   +L +++ +    PL   T ++      
Sbjct: 68  LSHQNIVSMIDV----DEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQIL 121

Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
           +G+ + H+   +++++RD K  N+L+D N   K+ DFG+A+       T  +  V+GT  
Sbjct: 122 DGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQ 177

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRR 288
           Y +P+  +       +D++S G+VLYEML G  
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  120 bits (302), Expect = 2e-30
 Identities = 51/230 (22%), Positives = 89/230 (38%), Gaps = 42/230 (18%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQF 132
             +S + +IG GG   V++        +   +  + AIK +N +            E+ +
Sbjct: 56  RIYSILKQIGSGGSSKVFQ------VLNEKKQ--IYAIKYVNLEEADNQTLDSYRNEIAY 107

Query: 133 LGVLEHPNL--VKLIGYCAVDGERGIQRLLVYEFM--LNRSLEDHLFNRAFPPLPWKTRL 188
           L  L+  +   ++L  Y   D         +Y  M   N  L   L  +    +    R 
Sbjct: 108 LNKLQQHSDKIIRLYDYEITDQY-------IYMVMECGNIDLNSWL--KKKKSIDPWERK 158

Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 248
                  E +  +H+     +++ D K +N L+ +    KL DFG+A +      + V  
Sbjct: 159 SYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD 214

Query: 249 AVVGTFGYAAPDYIE-----------TGHLTAKSDVWSFGVVLYEMLTGR 287
           + VG   Y  P+ I+              ++ KSDVWS G +LY M  G+
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  122 bits (306), Expect = 4e-30
 Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 32/218 (14%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQ-----WVAEVQFLGVLEH 138
           ++G GGFG V +            + T   VAIK+  ++        W  E+Q +  L H
Sbjct: 21  RLGTGGFGYVLR---------WIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNH 71

Query: 139 PNLVKLIGYCAVDGERGIQR----LLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILG 193
           PN+V        DG + +      LL  E+     L  +L        L       ++  
Sbjct: 72  PNVVSA--REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP---KLSDFGLAREGPMVGHTHVSTAV 250
            +  L YLHE    ++I+RD K  N++L    +    K+ D G A+E   +    + T  
Sbjct: 130 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE---LDQGELCTEF 183

Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRR 288
           VGT  Y AP+ +E    T   D WSFG + +E +TG R
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  118 bits (297), Expect = 7e-30
 Identities = 79/314 (25%), Positives = 133/314 (42%), Gaps = 63/314 (20%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVL-EHP 139
            +GEG FG V  +       D   EA  VA+K L      +D    V+E++ + ++ +H 
Sbjct: 88  PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR--------------AFPPLPWK 185
           N++ L+G C  DG       ++ E+    +L ++L  R                  + +K
Sbjct: 148 NIINLLGACTQDGP----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203

Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
             +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   + +  
Sbjct: 204 DLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARD---INNID 257

Query: 246 VSTAVVGTFG-----YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---K 296
                  T G     + AP+ +     T +SDVWSFGV+++E+ T G        P    
Sbjct: 258 YYKK--TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG------SPYPGI 309

Query: 297 TEQRLLEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 355
             + L + +++        G  MD P        N   ++  +  +C       RP   Q
Sbjct: 310 PVEELFKLLKE--------GHRMDKPA-------NCTNELYMMMRDCWHAVPSQRPTFKQ 354

Query: 356 VVERLKQIVQVSNE 369
           +VE L +I+ ++  
Sbjct: 355 LVEDLDRILTLTTN 368

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  118 bits (298), Expect = 7e-30
 Identities = 82/331 (24%), Positives = 135/331 (40%), Gaps = 64/331 (19%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFL-GVLEHP 139
            +GEG FG V  +       D  +  T VA+K L      +D    ++E++ +  + +H 
Sbjct: 76  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------------FNRAFPPLPWK 185
           N++ L+G C  DG       ++ E+    +L ++L               +     L  K
Sbjct: 136 NIINLLGACTQDGP----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
             +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR+   + H  
Sbjct: 192 DLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD---IHHID 245

Query: 246 VSTAVVGTFG-----YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---K 296
                  T G     + AP+ +     T +SDVWSFGV+L+E+ T G        P    
Sbjct: 246 YYKK--TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG------SPYPGV 297

Query: 297 TEQRLLEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 355
             + L + +++        G  MD P        N   ++  +  +C       RP   Q
Sbjct: 298 PVEELFKLLKE--------GHRMDKPS-------NCTNELYMMMRDCWHAVPSQRPTFKQ 342

Query: 356 VVERLKQIVQ-VSNEGDSFDKTFEEICEEDP 385
           +VE L +IV   SN+   +         + P
Sbjct: 343 LVEDLDRIVALTSNQEMGYYHHHHHHDYDIP 373

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  116 bits (294), Expect = 7e-30
 Identities = 70/316 (22%), Positives = 125/316 (39%), Gaps = 63/316 (19%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVL-EHP 139
            +G G FG V ++       D T+    VA+K L       +    ++E++ L  +  H 
Sbjct: 34  PLGRGAFGQVIEADAFGI--DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------------FNRAFPPLPWK 185
           N+V L+G C    + G   +++ EF    +L  +L               +     L  +
Sbjct: 92  NVVNLLGACT---KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
             +      A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+   +    
Sbjct: 149 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD---IYKDP 202

Query: 246 VSTAVVGTFG-----YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRR---SLERNRPK 296
                          + AP+ I     T +SDVWSFGV+L+E+ + G      ++ +   
Sbjct: 203 DYVR--KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--- 257

Query: 297 TEQRLLEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 355
             +     +++        G  M  P            ++ +   +C       RP  S+
Sbjct: 258 --EEFCRRLKE--------GTRMRAPD-------YTTPEMYQTMLDCWHGEPSQRPTFSE 300

Query: 356 VVERLKQIVQVSNEGD 371
           +VE L  ++Q + + D
Sbjct: 301 LVEHLGNLLQANAQQD 316

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  116 bits (293), Expect = 2e-29
 Identities = 77/321 (23%), Positives = 125/321 (38%), Gaps = 72/321 (22%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
            IGEG FG V+++             T+VA+K L           +  E   +   ++PN
Sbjct: 54  DIGEGAFGRVFQARAPGLLPYE--PFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR----------------------A 178
           +VKL+G CAV         L++E+M    L + L +                        
Sbjct: 112 IVKLLGVCAVGK----PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167

Query: 179 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 238
            PPL    +L I    A G+AYL E    + ++RD    N L+ EN   K++DFGL+R  
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN- 223

Query: 239 PMVGHTHVSTAVVGTFGY-----AAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLER 292
             +                      P+ I     T +SDVW++GVVL+E+ + G      
Sbjct: 224 --IYSA--DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL----- 274

Query: 293 NRP---KTEQRLLEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSK 348
            +P      + ++ +V+         G I+  P        N   ++  L   C SK   
Sbjct: 275 -QPYYGMAHEEVIYYVRD--------GNILACPE-------NCPLELYNLMRLCWSKLPA 318

Query: 349 DRPKMSQVVERLKQIVQVSNE 369
           DRP    +   L+++ + +  
Sbjct: 319 DRPSFCSIHRILQRMCERAEG 339

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  115 bits (290), Expect = 2e-29
 Identities = 67/317 (21%), Positives = 119/317 (37%), Gaps = 68/317 (21%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVL-EHP 139
            +G G FG V +++           A  VA+K L       +    ++E++ L  L  H 
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSD--AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR----------------AFPPLP 183
           N+V L+G C + G      L++ E+     L + L  +                    L 
Sbjct: 88  NIVNLLGACTIGGPT----LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
            +  L      A+G+A+L        I+RD  A N+LL      K+ DFGLAR+   + +
Sbjct: 144 LEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARD---IKN 197

Query: 244 THVSTAVVGTFG-----YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP-- 295
                            + AP+ I     T +SDVWS+G+ L+E+ + G        P  
Sbjct: 198 DSNYVV--KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS------SPYP 249

Query: 296 --KTEQRLLEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKDRPK 352
               + +  + +++        G  M  P        +   ++  +   C       RP 
Sbjct: 250 GMPVDSKFYKMIKE--------GFRMLSPE-------HAPAEMYDIMKTCWDADPLKRPT 294

Query: 353 MSQVVERLKQIVQVSNE 369
             Q+V+ +++ +  S  
Sbjct: 295 FKQIVQLIEKQISESTN 311

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  114 bits (288), Expect = 9e-29
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 24/214 (11%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFL 133
           +DF ++ ++G G  G V+K S KP     +    V+A K ++ +       Q + E+Q L
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKP-----SG--LVMARKLIHLEIKPAIRNQIIRELQVL 85

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
                P +V   G    DGE  I      E M   SL+  L  +    +P +    + + 
Sbjct: 86  HECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSLDQVL--KKAGRIPEQILGKVSIA 139

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
             +GL YL E  + ++++RD K SN+L++     KL DFG++ +   +  +  ++  VGT
Sbjct: 140 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ---LIDSMANS-FVGT 193

Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
             Y +P+ ++  H + +SD+WS G+ L EM  GR
Sbjct: 194 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  113 bits (285), Expect = 1e-28
 Identities = 76/317 (23%), Positives = 130/317 (41%), Gaps = 72/317 (22%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
            +GEG FG V K++     G   +  T VA+K L       +    ++E   L  + HP+
Sbjct: 30  TLGEGEFGKVVKATAFHLKGR--AGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR----------------------A 178
           ++KL G C+ DG      LL+ E+    SL   L                          
Sbjct: 88  VIKLYGACSQDGPL----LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143

Query: 179 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 238
              L     +      ++G+ YL E   +++++RD  A N+L+ E  + K+SDFGL+R+ 
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRD- 199

Query: 239 PMVGHTHVSTAVVGTFG-----YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLER 292
             V           + G     + A + +     T +SDVWSFGV+L+E++T G      
Sbjct: 200 --VYEEDSYVK--RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG----- 250

Query: 293 NRP---KTEQRLLEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSK 348
             P      +RL   ++         G  M+ P        N + ++ RL   C  +   
Sbjct: 251 -NPYPGIPPERLFNLLKT--------GHRMERPD-------NCSEEMYRLMLQCWKQEPD 294

Query: 349 DRPKMSQVVERLKQIVQ 365
            RP  + + + L++++ 
Sbjct: 295 KRPVFADISKDLEKMMV 311

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  114 bits (287), Expect = 1e-28
 Identities = 35/326 (10%), Positives = 71/326 (21%), Gaps = 67/326 (20%)

Query: 72  SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGL----- 124
           S + Q       +  +  G    V+                    A+K            
Sbjct: 55  SLLSQGERKLKLVEPLRVGDRSVVFL---------VRDVERLEDFALKVFTMGAENSRSE 105

Query: 125 --QWVAEVQFLGVLEHPNLVKLIGYC---------AVDGERGIQRL-------------L 160
             +          L   +  +              AV  +    +L             L
Sbjct: 106 LERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLL 165

Query: 161 VYEFM------LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDF 214
           +          L  +L+     R            +        A L       +++  F
Sbjct: 166 LMPAASVDLELLFSTLDFVYVFRG--DEGILALHILTAQLIRLAANLQS---KGLVHGHF 220

Query: 215 KASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL--TAKSD 272
              N+ +  + R  L D     +           A      YA  +++       T   +
Sbjct: 221 TPDNLFIMPDGRLMLGDVSALWK-----VGTRGPASSVPVTYAPREFLNASTATFTHALN 275

Query: 273 VWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEA 332
            W  G+ +Y +           P  +        + P                   + + 
Sbjct: 276 AWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTD-------SLAFGSCTPLPDF 328

Query: 333 RKIGRLADNCLSKSSKDRPKMSQVVE 358
            K   L    L+   + R    + +E
Sbjct: 329 VK--TLIGRFLNFDRRRRLLPLEAME 352

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  113 bits (285), Expect = 2e-28
 Identities = 68/327 (20%), Positives = 122/327 (37%), Gaps = 73/327 (22%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVL-EHP 139
            +G G FG V  ++    +  G   +  VA+K L       +    ++E++ +  L  H 
Sbjct: 52  VLGSGAFGKVMNATAYGISKTG--VSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR---------------------A 178
           N+V L+G C + G       L++E+     L ++L ++                      
Sbjct: 110 NIVNLLGACTLSGPI----YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165

Query: 179 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 238
              L ++  L      A+G+ +L        ++RD  A NVL+      K+ DFGLAR+ 
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD- 221

Query: 239 PMVGHTHVSTAVVGTFG-----YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLER 292
             +                   + AP+ +  G  T KSDVWS+G++L+E+ + G      
Sbjct: 222 --IMSDSNYVV--RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV----- 272

Query: 293 NRP----KTEQRLLEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSS 347
             P      +    + +Q         G  MD P            +I  +  +C +  S
Sbjct: 273 -NPYPGIPVDANFYKLIQN--------GFKMDQPF-------YATEEIYIIMQSCWAFDS 316

Query: 348 KDRPKMSQVVERLKQIVQVSNEGDSFD 374
           + RP    +   L   +  + E    +
Sbjct: 317 RKRPSFPNLTSFLGCQLADAEEAMYQN 343

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  113 bits (284), Expect = 2e-28
 Identities = 77/358 (21%), Positives = 138/358 (38%), Gaps = 49/358 (13%)

Query: 58  LYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIK 117
           +  E +  L++           D   + +IG G +GSV K   KP     +    ++A+K
Sbjct: 1   MSIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKP-----SG--QIMAVK 53

Query: 118 KLNRDG-----LQWVAEVQF-LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE 171
           ++          Q + ++   +   + P +V+  G    +G+  I      E M + S +
Sbjct: 54  RIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI----CMELM-STSFD 108

Query: 172 D---HLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK 228
               ++++     +P +    I L   + L +L E   +++I+RD K SN+LLD +   K
Sbjct: 109 KFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIK 166

Query: 229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL----TAKSDVWSFGVVLYEML 284
           L DFG++  G +V  +   T   G   Y AP+ I+          +SDVWS G+ LYE+ 
Sbjct: 167 LCDFGIS--GQLV-DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELA 223

Query: 285 TGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLS 344
           TGR      +  +    L  V +             P+L        +       + CL+
Sbjct: 224 TGRFPYP--KWNSVFDQLTQVVKGDP----------PQLSNSEEREFSPSFINFVNLCLT 271

Query: 345 KSSKDRPKMSQVVERLKQ---IVQVSNEGDSFDKTFEEICEEDPVEAQTKQKQHEPSE 399
           K    RPK  +    L +   I+              +I ++ P    +         
Sbjct: 272 KDESKRPKYKE----LLKHPFILMYEERAVEVACYVCKILDQMPATPSSPMYVDHHHH 325

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  111 bits (281), Expect = 3e-28
 Identities = 63/289 (21%), Positives = 116/289 (40%), Gaps = 44/289 (15%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQF- 132
           +D   ++++G G +G V K    P     +    ++A+K++          + + ++   
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVP-----SG--QIMAVKRIRATVNSQEQKRLLMDLDIS 59

Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHI 190
           +  ++ P  V   G    +G+  I      E M + SL+            +P      I
Sbjct: 60  MRTVDCPFTVTFYGALFREGDVWI----CMELM-DTSLDKFYKQVIDKGQTIPEDILGKI 114

Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
            +   + L +LH   ++ VI+RD K SNVL++   + K+ DFG++     +         
Sbjct: 115 AVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGY---LVDDVAKDID 169

Query: 251 VGTFGYAAPDYIETGHL----TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 306
            G   Y AP+ I         + KSD+WS G+ + E+   R   +     T  + L+ V 
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD--SWGTPFQQLKQVV 227

Query: 307 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 355
           + P+          P+L  +    E          CL K+SK+RP   +
Sbjct: 228 EEPS----------PQLPADKFSAEFV---DFTSQCLKKNSKERPTYPE 263

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  111 bits (280), Expect = 3e-28
 Identities = 65/226 (28%), Positives = 101/226 (44%), Gaps = 30/226 (13%)

Query: 72  SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGL----- 124
           + + +   DF     +G+G F  VY+           S  T   VAIK +++  +     
Sbjct: 4   TCIGEKIEDFKVGNLLGKGSFAGVYR---------AESIHTGLEVAIKMIDKKAMYKAGM 54

Query: 125 --QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPL 182
             +   EV+    L+HP++++L  Y   D        LV E   N  +  +L NR  P  
Sbjct: 55  VQRVQNEVKIHCQLKHPSILELYNYFE-DSNYVY---LVLEMCHNGEMNRYLKNRVKPFS 110

Query: 183 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 242
             + R H +     G+ YLH      +++RD   SN+LL  N   K++DFGLA +  M  
Sbjct: 111 ENEAR-HFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166

Query: 243 HTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGR 287
             H +    GT  Y +P+    + H   +SDVWS G + Y +L GR
Sbjct: 167 EKHYTLC--GTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGR 209

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  111 bits (280), Expect = 5e-28
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 36/216 (16%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVA----EVQFLGVLEHPN 140
           +G+G +G VY          G   +    +AIK++     ++      E+     L+H N
Sbjct: 30  LGKGTYGIVYA---------GRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN 80

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHI--ILGAAE 196
           +V+ +G  + +G   I      E +   SL   L ++             +   IL   E
Sbjct: 81  IVQYLGSFSENGFIKI----FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL---E 133

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
           GL YLH+    Q+++RD K  NVL++  +   K+SDFG ++   + G    +    GT  
Sbjct: 134 GLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQ 188

Query: 256 YAAPDYIE---TGHLTAKSDVWSFGVVLYEMLTGRR 288
           Y AP+ I+    G+    +D+WS G  + EM TG+ 
Sbjct: 189 YMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGKP 223

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  111 bits (281), Expect = 6e-28
 Identities = 72/309 (23%), Positives = 119/309 (38%), Gaps = 64/309 (20%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVL-EHP 139
            +G G FG V +++      +       VA+K L       +    ++E++ +  L +H 
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAV--LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL------------FNRAFPPLPWKTR 187
           N+V L+G C   G      L++ E+     L + L            F  A      +  
Sbjct: 111 NIVNLLGACTHGGPV----LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166

Query: 188 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 247
           LH     A+G+A+L        I+RD  A NVLL      K+ DFGLAR+   + +   S
Sbjct: 167 LHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARD---IMND--S 218

Query: 248 TAVVGTFG-----YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP----KT 297
             +V         + AP+ I     T +SDVWS+G++L+E+ + G        P      
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL------NPYPGILV 272

Query: 298 EQRLLEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 356
             +  + V+         G  M  P           + I  +   C +     RP   Q+
Sbjct: 273 NSKFYKLVKD--------GYQMAQPA-------FAPKNIYSIMQACWALEPTHRPTFQQI 317

Query: 357 VERLKQIVQ 365
              L++  Q
Sbjct: 318 CSFLQEQAQ 326

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  111 bits (280), Expect = 6e-28
 Identities = 72/290 (24%), Positives = 122/290 (42%), Gaps = 47/290 (16%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFL 133
           ND   + ++G G  G V+K   +      T    V+A+K++ R G      + + ++  +
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRK-----TGH--VIAVKQMRRSGNKEENKRILMDLDVV 77

Query: 134 -GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
               + P +V+  G    + +  I      E M     E  L  R   P+P +    + +
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDVFI----AMELM-GTCAEK-LKKRMQGPIPERILGKMTV 131

Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
              + L YL E  +  VI+RD K SN+LLDE  + KL DFG++  G +V          G
Sbjct: 132 AIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGIS--GRLV-DDKAKDRSAG 186

Query: 253 TFGYAAPDYIETGHL-----TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 307
              Y AP+ I+           ++DVWS G+ L E+ TG+   +  +   +  +L  V Q
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEVLTKVLQ 244

Query: 308 YPADSKKFGLIMDPRLEKE--YSINEARKIGRLADNCLSKSSKDRPKMSQ 355
                        P L     +S +    +     +CL+K  + RPK ++
Sbjct: 245 EEP----------PLLPGHMGFSGDFQSFV----KDCLTKDHRKRPKYNK 280

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  110 bits (278), Expect = 1e-27
 Identities = 80/298 (26%), Positives = 124/298 (41%), Gaps = 45/298 (15%)

Query: 63  AHNLRVFSYSEMRQATND----FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK 118
           AH+        M+    D    F+++ KIG+G FG V+K          T +  VVAIK 
Sbjct: 2   AHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNR-----TQK--VVAIKI 54

Query: 119 LNRDGLQ-----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDH 173
           ++ +  +        E+  L   + P + K  G    D +  I    + E++   S  D 
Sbjct: 55  IDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI----IMEYLGGGSALDL 110

Query: 174 LFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG 233
           L      PL       I+    +GL YLH     + I+RD KA+NVLL E+   KL+DFG
Sbjct: 111 LEPG---PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFG 164

Query: 234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 293
           +A  G +          VGT  + AP+ I+     +K+D+WS G+   E+  G       
Sbjct: 165 VA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222

Query: 294 RPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP 351
            P    ++L  + +             P LE  YS    + +    + CL+K    RP
Sbjct: 223 HP---MKVLFLIPKNNP----------PTLEGNYS----KPLKEFVEACLNKEPSFRP 263

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  112 bits (283), Expect = 1e-27
 Identities = 57/285 (20%), Positives = 109/285 (38%), Gaps = 48/285 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-EVQFL-GVLEHPNLVK 143
            +G G  G++           G  +   VA+K++  +   +   EVQ L    EHPN+++
Sbjct: 31  VLGHGAEGTIVYR--------GMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82

Query: 144 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE 203
              +C     +     +  E     +L++++  + F  L  +    ++     GLA+LH 
Sbjct: 83  Y--FCTEKDRQFQ--YIAIELC-AATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLHS 136

Query: 204 GLEVQVIYRDFKASNVLLDE-----NFRPKLSDFGLAR-EGPMVGHTHVSTAVVGTFGYA 257
              + +++RD K  N+L+         +  +SDFGL +            + V GT G+ 
Sbjct: 137 ---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193

Query: 258 APDYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP---KTEQRLLEWVQQYPAD 311
           AP+ +      + T   D++S G V Y +++         P     +++    +     D
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS-----HPFGKSLQRQANILLGACSLD 248

Query: 312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 356
                       EK      AR    L +  ++   + RP    V
Sbjct: 249 C--------LHPEKHED-VIAR---ELIEKMIAMDPQKRPSAKHV 281

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  109 bits (275), Expect = 2e-27
 Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 29/217 (13%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQ 131
            DF     +G+G FG+VY +  K      +    ++A+K L +  L       Q   EV+
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQ-----SKF--ILALKVLFKAQLEKAGVEHQLRREVE 61

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
               L HPN+++L GY          R+ L+ E+    ++   L  +       +     
Sbjct: 62  IQSHLRHPNILRLYGYFHDA-----TRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 114

Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +   T +
Sbjct: 115 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDL 167

Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            GT  Y  P+ IE      K D+WS GV+ YE L G+
Sbjct: 168 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  108 bits (273), Expect = 4e-27
 Identities = 66/225 (29%), Positives = 108/225 (48%), Gaps = 44/225 (19%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQWVA--EVQF 132
             +  + KIGEG +G VYK      A +   E    A+KK+      +G+      E+  
Sbjct: 2   EKYHGLEKIGEGTYGVVYK------AQNNYGE--TFALKKIRLEKEDEGIPSTTIREISI 53

Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLH 189
           L  L+H N+VKL  Y  +  ++ +  +LV+E +   L + L+          +  K+ L 
Sbjct: 54  LKELKHSNIVKL--YDVIHTKKRL--VLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLL 107

Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVS 247
            +L    G+AY H+    +V++RD K  N+L++     K++DFGLAR    P+  +TH  
Sbjct: 108 QLL---NGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE- 160

Query: 248 TAVVGTFGYAAPDYIETGHLTAKS-----DVWSFGVVLYEMLTGR 287
             +V T  Y APD +    + +K      D+WS G +  EM+ G 
Sbjct: 161 --IV-TLWYRAPDVL----MGSKKYSTTIDIWSVGCIFAEMVNGT 198

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  109 bits (275), Expect = 5e-27
 Identities = 58/316 (18%), Positives = 110/316 (34%), Gaps = 60/316 (18%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA---------- 128
           ND+  +  + +G F  +              +    A+KK  +  L+             
Sbjct: 31  NDYRIIRTLNQGKFNKIIL---------CEKDNKFYALKKYEKSLLEKKRDFTKSNNDKI 81

Query: 129 -----------EVQFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFN 176
                      E+Q +  +++   +   G            + ++YE+M N S+      
Sbjct: 82  SIKSKYDDFKNELQIITDIKNEYCLTCEGIITNY-----DEVYIIYEYMENDSILKFDEY 136

Query: 177 RAFPPLPWKTRL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS 230
                  +   +       II       +Y+H      + +RD K SN+L+D+N R KLS
Sbjct: 137 FFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLS 194

Query: 231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET--GHLTAKSDVWSFGVVLYEMLTGRR 288
           DFG +          +  +  GT+ +  P++      +  AK D+WS G+ LY M     
Sbjct: 195 DFGESEYMV---DKKIKGS-RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250

Query: 289 --SLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSI---NEARK-IGRLADNC 342
             SL+ +  +    +     +YP D   F   +  +     +    NE    +       
Sbjct: 251 PFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLF---- 306

Query: 343 LSKSSKDRPKMSQVVE 358
           L K+  +R      ++
Sbjct: 307 LRKNPAERITSEDALK 322

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  110 bits (277), Expect = 6e-27
 Identities = 30/249 (12%), Positives = 71/249 (28%), Gaps = 38/249 (15%)

Query: 72  SEMRQATNDFSRMLKIGEGGFGSVY-------------KSSIKPAAGDGTS------EAT 112
           SE+ +      R   +G+    +                           +      E  
Sbjct: 71  SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 130

Query: 113 VVAIKKLNRDGLQWVAEVQFLG---VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRS 169
            + + +  ++  Q    ++F+    +++ P   K+I     + +  +         +  +
Sbjct: 131 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 190

Query: 170 LEDHL-----FNRAFPPLPWKTRLHIILGAAEGLAYLHE-GLEVQVIYRDFKASNVLLDE 223
           L+         +     L    RL + L     LA LH  G    +++   +  +++LD+
Sbjct: 191 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQ 246

Query: 224 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP-----DYIETGHLTAKSDVWSFGV 278
                L+ F           +             A             +T   D W+ G+
Sbjct: 247 RGGVFLTGFEHLVRDGASAVS-PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305

Query: 279 VLYEMLTGR 287
            +Y +    
Sbjct: 306 AIYWIWCAD 314

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  110 bits (277), Expect = 6e-27
 Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 32/221 (14%)

Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA--EVQFLGVLEHPNLV 142
            K+G G +G VYK+  K        +    A+K++   G+   A  E+  L  L+HPN++
Sbjct: 27  CKVGRGTYGHVYKAKRKD---GKDDK--DYALKQIEGTGISMSACREIALLRELKHPNVI 81

Query: 143 KLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRA------FPPLPWKTRLHIILG 193
            L        +R +   L++++    L   ++ H  ++A       P    K+ L+ IL 
Sbjct: 82  SLQKVFLSHADRKV--WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL- 138

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLARE--GPMVGHTHVS 247
             +G+ YLH      V++RD K +N+L+          K++D G AR    P+     + 
Sbjct: 139 --DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193

Query: 248 TAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 287
             VV TF Y AP+ +    H T   D+W+ G +  E+LT  
Sbjct: 194 PVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  108 bits (273), Expect = 6e-27
 Identities = 70/225 (31%), Positives = 113/225 (50%), Gaps = 44/225 (19%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQWVA--EVQF 132
             + ++ K+GEG +G VYK      A D      +VA+K++      +G+   A  E+  
Sbjct: 21  EKYQKLEKVGEGTYGVVYK------AKDSQGR--IVALKRIRLDAEDEGIPSTAIREISL 72

Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLH 189
           L  L HPN+V L     +  ER +   LV+EFM   L + L+++           K  L+
Sbjct: 73  LKELHHPNIVSL--IDVIHSERCL--TLVFEFMEKDLKKVLDEN--KTGLQDSQIKIYLY 126

Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVS 247
            +L    G+A+ H+    ++++RD K  N+L++ +   KL+DFGLAR    P+  +TH  
Sbjct: 127 QLL---RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE- 179

Query: 248 TAVVGTFGYAAPDYIETGHLTAKS-----DVWSFGVVLYEMLTGR 287
             VV T  Y APD +    + +K      D+WS G +  EM+TG+
Sbjct: 180 --VV-TLWYRAPDVL----MGSKKYSTSVDIWSIGCIFAEMITGK 217

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  109 bits (273), Expect = 7e-27
 Identities = 64/349 (18%), Positives = 116/349 (33%), Gaps = 98/349 (28%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW-----VAEVQFL 133
            DF  +  +G GGFG V+++  K    D        AIK++     +      + EV+ L
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKV---DD----CNYAIKRIRLPNRELAREKVMREVKAL 58

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVY------------------------------- 162
             LEHP +V+             Q  +                                 
Sbjct: 59  AKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPF 118

Query: 163 ------EFMLNRSLEDHLF-----------------NRAFPPLPWKTRLHIILGAAEGLA 199
                   +   S + +L+                   +         LHI +  AE + 
Sbjct: 119 STKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVE 178

Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE----------GPMVGHTHVSTA 249
           +LH      +++RD K SN+    +   K+ DFGL                +      T 
Sbjct: 179 FLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235

Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP 309
            VGT  Y +P+ I   + + K D++S G++L+E+L    + +  R +    +     ++P
Sbjct: 236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST-QMERVRIITDVRN--LKFP 292

Query: 310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
               +                E   +     + LS S  +RP+ + ++E
Sbjct: 293 LLFTQ------------KYPQEHMMV----QDMLSPSPTERPEATDIIE 325

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  109 bits (273), Expect = 1e-26
 Identities = 40/250 (16%), Positives = 80/250 (32%), Gaps = 27/250 (10%)

Query: 56  PELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVA 115
           P  +E +     +   +E +  +        +GEG F  VY+++          +     
Sbjct: 42  PNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQ--KFV 99

Query: 116 IKKLNRDGLQ----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE 171
           +K                ++ L        +K   Y A   + G   +LV E     +L 
Sbjct: 100 LKVQKPANPWEFYIGTQLMERLKPSMQHMFMKF--YSAHLFQNGS--VLVGELYSYGTLL 155

Query: 172 DHL---FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP- 227
           + +    N     +P    +   +     +  +H+    ++I+ D K  N +L   F   
Sbjct: 156 NAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQ 212

Query: 228 ----------KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFG 277
                      L D G + +  +     + TA   T G+   + +       + D +   
Sbjct: 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVA 272

Query: 278 VVLYEMLTGR 287
             +Y ML G 
Sbjct: 273 ATVYCMLFGT 282

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  109 bits (273), Expect = 1e-26
 Identities = 44/328 (13%), Positives = 96/328 (29%), Gaps = 75/328 (22%)

Query: 72  SEMRQATNDFSRMLKIGEGGFGSVY-----------------KSSIKPAAGDGTSEATVV 114
           SE+ +      R   +G+    +                    +   P+      +  V+
Sbjct: 66  SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 125

Query: 115 AIKKLN--------RDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFML 166
            ++ L         +  L+++     +   +   ++++           + R  +Y  M 
Sbjct: 126 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLD--ERDMWVLSRFFLYPRMQ 183

Query: 167 NRSLE--DHLFNRAF--PPLPWKTRLHIILGAAEGLAYLHE-GLEVQVIYRDFKASNVLL 221
           +      + L + +     L    RL + L     LA LH  G    +++   +  +++L
Sbjct: 184 SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVL 239

Query: 222 DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI-----------ETGHLTAK 270
           D+     L+ F         G   VS     + G+  P+                 +T  
Sbjct: 240 DQRGGVFLTGFEHLVRD---GARVVS---SVSRGFEPPELEARRATISYHRDRRTLMTFS 293

Query: 271 SDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSIN 330
            D W+ G+V+Y +                         P          +       +I 
Sbjct: 294 FDAWALGLVIYWIWCAD--------------------LPITKDAALGGSEWIFRSCKNIP 333

Query: 331 EARKIGRLADNCLSKSSKDRPKMSQVVE 358
           +  +   L +  L    +DR    Q +E
Sbjct: 334 QPVR--ALLEGFLRYPKEDRLLPLQAME 359

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  109 bits (274), Expect = 1e-26
 Identities = 50/246 (20%), Positives = 93/246 (37%), Gaps = 31/246 (12%)

Query: 58  LYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEG--GFGSVYKSSIKPAAGDGTSEATVVA 115
            +     NL     S        +  +  IG+G     +V  +  KP     T E   V 
Sbjct: 4   HHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKP-----TGE--YVT 56

Query: 116 IKKLN-----RDGLQWV-AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNR 168
           ++++N      + + ++  E+    +  HPN+V        D E     L +V  FM   
Sbjct: 57  VRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE-----LWVVTSFMAYG 111

Query: 169 SLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK 228
           S +D +       +      +I+ G  + L Y+H    +  ++R  KAS++L+  + +  
Sbjct: 112 SAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVY 168

Query: 229 LSDFG----LAREGPMVGHTHV-STAVVGTFGYAAPDYIETGHL--TAKSDVWSFGVVLY 281
           LS       +   G      H      V    + +P+ ++       AKSD++S G+   
Sbjct: 169 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITAC 228

Query: 282 EMLTGR 287
           E+  G 
Sbjct: 229 ELANGH 234

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  107 bits (269), Expect = 1e-26
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 31/211 (14%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGL-------QWVAEVQFLGVLE 137
           +G+GGF   ++          +   T  V A K + +  L       +   E+     L 
Sbjct: 23  LGKGGFAKCFE---------ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73

Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 197
           H ++V   G+   D +      +V E    RSL +    R     P + R + +     G
Sbjct: 74  HQHVVGFHGFFE-DNDFVF---VVLELCRRRSLLELHKRRKALTEP-EAR-YYLRQIVLG 127

Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
             YLH     +VI+RD K  N+ L+E+   K+ DFGLA +    G         GT  Y 
Sbjct: 128 CQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYI 182

Query: 258 APDYIE-TGHLTAKSDVWSFGVVLYEMLTGR 287
           AP+ +   GH + + DVWS G ++Y +L G+
Sbjct: 183 APEVLSKKGH-SFEVDVWSIGCIMYTLLVGK 212

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  107 bits (270), Expect = 2e-26
 Identities = 64/229 (27%), Positives = 113/229 (49%), Gaps = 41/229 (17%)

Query: 76  QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKL---NRDGLQWVA-- 128
            +++ F ++ K+G G + +VYK         G ++ T   VA+K++   + +G    A  
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYK---------GLNKTTGVYVALKEVKLDSEEGTPSTAIR 52

Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWK 185
           E+  +  L+H N+V+L  Y  +  E  +   LV+EFM   L + ++          L   
Sbjct: 53  EISLMKELKHENIVRL--YDVIHTENKL--TLVFEFMDNDLKKYMDSRTVGNTPRGLELN 108

Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGH 243
              +      +GLA+ HE    ++++RD K  N+L+++  + KL DFGLAR    P+   
Sbjct: 109 LVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF 165

Query: 244 THVSTAVVGTFGYAAPDYIETGHLTAKS-----DVWSFGVVLYEMLTGR 287
           +     VV T  Y APD +    + +++     D+WS G +L EM+TG+
Sbjct: 166 SSE---VV-TLWYRAPDVL----MGSRTYSTSIDIWSCGCILAEMITGK 206

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  107 bits (270), Expect = 2e-26
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 31/211 (14%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGL-------QWVAEVQFLGVLE 137
           +G+GGF   ++          +   T  V A K + +  L       +   E+     L 
Sbjct: 49  LGKGGFAKCFE---------ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99

Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 197
           H ++V   G+   D +      +V E    RSL +    R     P + R + +     G
Sbjct: 100 HQHVVGFHGFFE-DNDFVF---VVLELCRRRSLLELHKRRKALTEP-EAR-YYLRQIVLG 153

Query: 198 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
             YLH     +VI+RD K  N+ L+E+   K+ DFGLA +    G         GT  Y 
Sbjct: 154 CQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYI 208

Query: 258 APDYIE-TGHLTAKSDVWSFGVVLYEMLTGR 287
           AP+ +   GH + + DVWS G ++Y +L G+
Sbjct: 209 APEVLSKKGH-SFEVDVWSIGCIMYTLLVGK 238

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  106 bits (268), Expect = 2e-26
 Identities = 64/230 (27%), Positives = 108/230 (46%), Gaps = 47/230 (20%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKL----NRDGLQWVA--EV 130
             + ++ KIGEG +G+V+K           +  T  +VA+K++    + +G+   A  E+
Sbjct: 2   QKYEKLEKIGEGTYGTVFK---------AKNRETHEIVALKRVRLDDDDEGVPSSALREI 52

Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTR 187
             L  L+H N+V+L  +  +  ++ +   LV+EF    L +  +    N    P   K+ 
Sbjct: 53  CLLKELKHKNIVRL--HDVLHSDKKL--TLVFEFCDQDLKKYFDSC--NGDLDPEIVKSF 106

Query: 188 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTH 245
           L  +L   +GL + H      V++RD K  N+L++ N   KL++FGLAR    P+  ++ 
Sbjct: 107 LFQLL---KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160

Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKS-----DVWSFGVVLYEMLTGRRSL 290
               VV T  Y  PD +      AK      D+WS G +  E+    R L
Sbjct: 161 E---VV-TLWYRPPDVL----FGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  106 bits (267), Expect = 4e-26
 Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 31/225 (13%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFL 133
           +D+     IG G    V  +   P       E   VAIK++N +  Q      + E+Q +
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAP-----KKE--KVAIKRINLEKCQTSMDELLKEIQAM 67

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRL---- 188
               HPN+V       V  E     L LV + +   S+ D + +           L    
Sbjct: 68  SQCHHPNIVSYYTSFVVKDE-----LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122

Query: 189 --HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA---REGPMVGH 243
              I+    EGL YLH+      I+RD KA N+LL E+   +++DFG++     G  +  
Sbjct: 123 IATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179

Query: 244 THVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGR 287
             V    VGT  + AP+ +E       K+D+WSFG+   E+ TG 
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  106 bits (267), Expect = 4e-26
 Identities = 64/230 (27%), Positives = 96/230 (41%), Gaps = 37/230 (16%)

Query: 76  QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKL----NRDGLQWVA- 128
            AT+ +  + +IG G +G+VYK              +   VA+K +       G   +  
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYK---------ARDPHSGHFVALKSVRVPNGGGGGGGLPI 56

Query: 129 ----EVQFLGVL---EHPNLVKLIGYCAVDGERGIQRL-LVYEFMLN--RSLEDHLFNRA 178
               EV  L  L   EHPN+V+L+  CA        ++ LV+E +    R+  D      
Sbjct: 57  STVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG 116

Query: 179 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE- 237
            P    K  +   L    GL +LH      +++RD K  N+L+      KL+DFGLAR  
Sbjct: 117 LPAETIKDLMRQFL---RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY 170

Query: 238 GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
              +  T V   VV T  Y AP+ +         D+WS G +  EM   +
Sbjct: 171 SYQMALTPV---VV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  105 bits (265), Expect = 4e-26
 Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 31/218 (14%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQ 131
           +DF     +G+G FG+VY +  K           ++A+K L +  L       Q   E++
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREK-----QNKF--IMALKVLFKSQLEKEGVEHQLRREIE 66

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
               L HPN++++  Y         +R+ L+ EF     L   L  +       +     
Sbjct: 67  IQSHLRHPNILRMYNYFHDR-----KRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATF 119

Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG-HTHVSTA 249
           +   A+ L Y HE    +VI+RD K  N+L+      K++DFG +   P +   T     
Sbjct: 120 MEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT----- 171

Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
           + GT  Y  P+ IE      K D+W  GV+ YE L G 
Sbjct: 172 MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  106 bits (267), Expect = 4e-26
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 45/226 (19%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQWVA--EVQF 132
             + ++ KIGEG +G V+K   +      T +  +VAIKK     +   ++ +A  E++ 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRD-----TGQ--IVAIKKFLESEDDPVIKKIALREIRM 55

Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFM---LNRSLEDHLFNRAFPPLPWKTRL 188
           L  L+HPNLV L+     +  R  +RL LV+E+    +   L+ +   R  P    K+  
Sbjct: 56  LKQLKHPNLVNLL-----EVFRRKRRLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSIT 108

Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHV 246
              L   + + + H+      I+RD K  N+L+ ++   KL DFG AR   GP   +   
Sbjct: 109 WQTL---QAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD- 161

Query: 247 STAVVGTFGYAAPDYIETGHLTAKS-----DVWSFGVVLYEMLTGR 287
               V T  Y +P+ +    +         DVW+ G V  E+L+G 
Sbjct: 162 ---EVATRWYRSPELL----VGDTQYGPPVDVWAIGCVFAELLSGV 200

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  106 bits (267), Expect = 5e-26
 Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 29/225 (12%)

Query: 76  QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQWVA--E 129
           +A   +  + +IGEG +G V+K      A D  +    VA+K++      +G+      E
Sbjct: 8   RADQQYECVAEIGEGAYGKVFK------ARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE 61

Query: 130 VQFLGVL---EHPNLVKLIGYCAVDGERGIQRL-LVYEFMLN--RSLEDHLFNRAFPPLP 183
           V  L  L   EHPN+V+L   C V       +L LV+E +     +  D +     P   
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 121

Query: 184 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVG 242
            K  +  +L    GL +LH     +V++RD K  N+L+  + + KL+DFGLAR     + 
Sbjct: 122 IKDMMFQLL---RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175

Query: 243 HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            T V   VV T  Y AP+ +         D+WS G +  EM   +
Sbjct: 176 LTSV---VV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  106 bits (268), Expect = 5e-26
 Identities = 65/242 (26%), Positives = 105/242 (43%), Gaps = 34/242 (14%)

Query: 63  AHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL--- 119
           A            +  + + ++ KIG+G FG V+K     A    T +   VA+KK+   
Sbjct: 2   AKQYDSVECPFCDEV-SKYEKLAKIGQGTFGEVFK-----ARHRKTGQ--KVALKKVLME 53

Query: 120 -NRDGLQWVA--EVQFLGVLEHPNLVKLIGYCAVDGERGIQRL----LVYEFM---LNRS 169
             ++G    A  E++ L +L+H N+V LI  C        +      LV++F    L   
Sbjct: 54  NEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL 113

Query: 170 LEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL 229
           L +      F     K  + ++L    GL Y+H     ++++RD KA+NVL+  +   KL
Sbjct: 114 LSNV--LVKFTLSEIKRVMQMLL---NGLYYIHRN---KILHRDMKAANVLITRDGVLKL 165

Query: 230 SDFGLARE--GPMVGHTHVSTAVVGTFGYAAPDYI--ETGHLTAKSDVWSFGVVLYEMLT 285
           +DFGLAR          +  T  V T  Y  P+ +  E  +     D+W  G ++ EM T
Sbjct: 166 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPP-IDLWGAGCIMAEMWT 224

Query: 286 GR 287
             
Sbjct: 225 RS 226

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  106 bits (266), Expect = 6e-26
 Identities = 69/224 (30%), Positives = 106/224 (47%), Gaps = 42/224 (18%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL---NRDGLQWVA--EVQFL 133
             + ++ K+GEG + +VYK   K      T    +VA+K++   + +G    A  EV  L
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKL-----TDN--LVALKEIRLEHEEGAPCTAIREVSLL 54

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHI 190
             L+H N+V L  +  +  E+ +   LV+E++   L + L+D            K  L  
Sbjct: 55  KDLKHANIVTL--HDIIHTEKSL--TLVFEYLDKDLKQYLDDC--GNIINMHNVKLFLFQ 108

Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVST 248
           +L    GLAY H     +V++RD K  N+L++E    KL+DFGLAR    P   + +   
Sbjct: 109 LL---RGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE-- 160

Query: 249 AVVGTFGYAAPDYIETGHLTAKS-----DVWSFGVVLYEMLTGR 287
            VV T  Y  PD +    L +       D+W  G + YEM TGR
Sbjct: 161 -VV-TLWYRPPDIL----LGSTDYSTQIDMWGVGCIFYEMATGR 198

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  105 bits (265), Expect = 8e-26
 Identities = 65/238 (27%), Positives = 99/238 (41%), Gaps = 23/238 (9%)

Query: 60  EEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL 119
           +  A +L     S +R     F  +  +G G +G VYK          T +  + AIK +
Sbjct: 5   DSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVK-----TGQ--LAAIKVM 57

Query: 120 NRDGLQW---VAEVQFLGVL-EHPNLVKLIG-YCAVDGERGIQRL-LVYEFMLNRSLEDH 173
           +  G +      E+  L     H N+    G +   +      +L LV EF    S+ D 
Sbjct: 58  DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL 117

Query: 174 LFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG 233
           + N     L  +   +I      GL++LH+    +VI+RD K  NVLL EN   KL DFG
Sbjct: 118 IKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 174

Query: 234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLT-----AKSDVWSFGVVLYEMLTG 286
           ++ +  +          +GT  + AP+ I            KSD+WS G+   EM  G
Sbjct: 175 VSAQ--LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  107 bits (269), Expect = 8e-26
 Identities = 66/270 (24%), Positives = 118/270 (43%), Gaps = 28/270 (10%)

Query: 26  PRKSADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRML 85
           PR ++     +  +   +  S  V+  +   ++    A           R     ++   
Sbjct: 5   PRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATP----GQGPDRPQEVSYTDTK 60

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
            IG G FG VY++ +       + E  +VAIKK+ +D      E+Q +  L+H N+V+L 
Sbjct: 61  VIGNGSFGVVYQAKLCD-----SGE--LVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 113

Query: 146 GYCAVDGERGIQRLL--VYEFM---LNRSLEDHLFNR-AFPPLPWKTRLHIILGAAEGLA 199
            +    GE+  +  L  V +++   + R    +   +   P +  K  ++ +      LA
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF---RSLA 170

Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
           Y+H      + +RD K  N+LLD +    KL DFG A++   +     + + + +  Y A
Sbjct: 171 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ---LVRGEPNVSYICSRYYRA 224

Query: 259 PDYIETG-HLTAKSDVWSFGVVLYEMLTGR 287
           P+ I      T+  DVWS G VL E+L G+
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  106 bits (266), Expect = 2e-25
 Identities = 62/254 (24%), Positives = 115/254 (45%), Gaps = 25/254 (9%)

Query: 42  KSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIK 101
            +  +A +   +  P     K   +         Q    ++    IG G FG V+++ + 
Sbjct: 3   FTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLV 62

Query: 102 PAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL-- 159
                 + E   VAIKK+ +D      E+Q + +++HPN+V L  +   +G++  +    
Sbjct: 63  E-----SDE---VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114

Query: 160 LVYEFM---LNRSLEDHL-FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFK 215
           LV E++   + R+   +    +  P L  K  ++ +L     LAY+H    + + +RD K
Sbjct: 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLL---RSLAYIHS---IGICHRDIK 168

Query: 216 ASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDV 273
             N+LLD      KL DFG A+   ++     + + + +  Y AP+ I    + T   D+
Sbjct: 169 PQNLLLDPPSGVLKLIDFGSAK---ILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDI 225

Query: 274 WSFGVVLYEMLTGR 287
           WS G V+ E++ G+
Sbjct: 226 WSTGCVMAELMQGQ 239

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  104 bits (263), Expect = 3e-25
 Identities = 71/236 (30%), Positives = 114/236 (48%), Gaps = 50/236 (21%)

Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKL-------NRDG 123
           +++     + ++  +GEG F +VYK            + T  +VAIKK+        +DG
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYK---------ARDKNTNQIVAIKKIKLGHRSEAKDG 54

Query: 124 LQWVA--EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRA 178
           +   A  E++ L  L HPN++ L    A   +  I   LV++FM   L   ++D+  +  
Sbjct: 55  INRTALREIKLLQELSHPNIIGL--LDAFGHKSNIS--LVFDFMETDLEVIIKDN--SLV 108

Query: 179 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE- 237
             P   K  + + L   +GL YLH+     +++RD K +N+LLDEN   KL+DFGLA+  
Sbjct: 109 LTPSHIKAYMLMTL---QGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162

Query: 238 -GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKS-----DVWSFGVVLYEMLTGR 287
             P   +TH    VV T  Y AP+ +      A+      D+W+ G +L E+L   
Sbjct: 163 GSPNRAYTHQ---VV-TRWYRAPELL----FGARMYGVGVDMWAVGCILAELLLRV 210

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  104 bits (262), Expect = 3e-25
 Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 41/224 (18%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKL----NRDGLQWVA--EV 130
             +  +  +GEG +G V K           ++ T  +VAIKK     +   ++ +A  E+
Sbjct: 25  EKYENLGLVGEGSYGMVMK---------CRNKDTGRIVAIKKFLESDDDKMVKKIAMREI 75

Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFM---LNRSLEDHLFNRAFPPLPWKT 186
           + L  L H NLV L+     +  +  +R  LV+EF+   +   LE             + 
Sbjct: 76  KLLKQLRHENLVNLL-----EVCKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQK 128

Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHT 244
            L  I+    G+ + H      +I+RD K  N+L+ ++   KL DFG AR    P   + 
Sbjct: 129 YLFQII---NGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD 182

Query: 245 HVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 287
                 V T  Y AP+ +          DVW+ G ++ EM  G 
Sbjct: 183 D----EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  103 bits (258), Expect = 4e-25
 Identities = 51/240 (21%), Positives = 85/240 (35%), Gaps = 51/240 (21%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQ 131
           T +F  + KIG G FGSV+K   +    DG     + AIK+  +           + EV 
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRL---DGC----IYAIKRSKKPLAGSVDEQNALREVY 62

Query: 132 FLGVL-EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 188
              VL +H ++V+     A D    IQ     E+    SL D +    R           
Sbjct: 63  AHAVLGQHSHVVRYFSAWAEDDHMLIQ----NEYCNGGSLADAISENYRIMSYFKEAELK 118

Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP-------------------KL 229
            ++L    GL Y+H    + +++ D K SN+ +     P                   K+
Sbjct: 119 DLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKI 175

Query: 230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI--ETGHLTAKSDVWSFGVVLYEMLTGR 287
            D G       +    V     G   + A + +     HL  K+D+++  + +       
Sbjct: 176 GDLGHVT---RISSPQV---EEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAE 228

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  105 bits (263), Expect = 7e-25
 Identities = 67/301 (22%), Positives = 119/301 (39%), Gaps = 59/301 (19%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-EVQFLG-VLEHPNLVK 143
            +G G  G+V           G+ +   VA+K++  D       E++ L    +HPN+++
Sbjct: 22  ILGYGSSGTVVFQ--------GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIR 73

Query: 144 LIGYCAVDGERGIQRLLVYEFMLNRSLED-----HLFNRAFPPLPWKTRLHIILGAAEGL 198
              YC+   +R +   +  E   N +L+D     ++ +           + ++   A G+
Sbjct: 74  Y--YCSETTDRFL--YIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128

Query: 199 AYLHEGLEVQVIYRDFKASNVLLD-------------ENFRPKLSDFGLAR---EGPMVG 242
           A+LH    +++I+RD K  N+L+              EN R  +SDFGL +    G    
Sbjct: 129 AHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185

Query: 243 HTHVSTAVVGTFGYAAPDYIE-------TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 295
            T+++    GT G+ AP+ +E          LT   D++S G V Y +L+  +    ++ 
Sbjct: 186 RTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244

Query: 296 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 355
             E  ++            F L     L     I EA     L    +      RP   +
Sbjct: 245 SRESNII---------RGIFSLDEMKCLHDRSLIAEATD---LISQMIDHDPLKRPTAMK 292

Query: 356 V 356
           V
Sbjct: 293 V 293

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  102 bits (257), Expect = 7e-25
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 31/217 (14%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----WVAEVQFL 133
              ++R  KIG+G  G+VY +         T +   VAI+++N          + E+  +
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDV-----ATGQ--EVAIRQMNLQQQPKKELIINEILVM 71

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI-- 190
              ++PN+V  +    V  E     L +V E++   SL D +               I  
Sbjct: 72  RENKNPNIVNYLDSYLVGDE-----LWVVMEYLAGGSLTDVVTETCM------DEGQIAA 120

Query: 191 -ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
                 + L +LH     QVI+RD K+ N+LL  +   KL+DFG      +       + 
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRST 175

Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           +VGT  + AP+ +       K D+WS G++  EM+ G
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  102 bits (257), Expect = 8e-25
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 19/208 (9%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK--LNRDGLQWVAEVQFLGVLEH 138
           F  + K+GEG +GSVYK+  K      T +  +VAIK+  +  D  + + E+  +   + 
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHK-----ETGQ--IVAIKQVPVESDLQEIIKEISIMQQCDS 83

Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 198
           P++VK  G    + +  I    V E+    S+ D +       L       I+    +GL
Sbjct: 84  PHVVKYYGSYFKNTDLWI----VMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGL 138

Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
            YLH     + I+RD KA N+LL+     KL+DFG+A  G +         V+GT  + A
Sbjct: 139 EYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA--GQLTDTMAKRNTVIGTPFWMA 193

Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           P+ I+       +D+WS G+   EM  G
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEG 221

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  102 bits (257), Expect = 5e-24
 Identities = 70/307 (22%), Positives = 119/307 (38%), Gaps = 60/307 (19%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVA-------EVQFLGVL 136
            +G+G FG V              + T    A+K +++  ++          EVQ L  L
Sbjct: 33  VLGKGSFGEVIL---------CKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83

Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
           +HPN++KL  +     E      LV E      L D + +R            II     
Sbjct: 84  DHPNIMKLYEFF----EDKGYFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQVLS 137

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
           G+ Y+H+    ++++RD K  N+LL    ++   ++ DFGL+        +      +GT
Sbjct: 138 GITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDKIGT 191

Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP---KTEQRLLEWVQQ--Y 308
             Y AP+ +  G    K DVWS GV+LY +L+G        P     E  +L+ V++  Y
Sbjct: 192 AYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGC------PPFNGANEYDILKKVEKGKY 244

Query: 309 PADSKKFG-------------LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 355
             +  ++              L   P      S  +A     +      + S D P +  
Sbjct: 245 TFELPQWKKVSESAKDLIRKMLTYVPS--MRISARDALDHEWIQTYTKEQISVDVPSLDN 302

Query: 356 VVERLKQ 362
            +  ++Q
Sbjct: 303 AILNIRQ 309

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  103 bits (258), Expect = 5e-24
 Identities = 73/273 (26%), Positives = 114/273 (41%), Gaps = 39/273 (14%)

Query: 57  ELYEEKAHNLRV--FSYSEMRQAT-NDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEAT 112
           + + +  + LR   + + E +    + F    + +G GGFG V+   +K      T +  
Sbjct: 160 QEFLDSLYFLRFLQWKWLEAQPMGEDWF-LDFRVLGRGGFGEVFACQMK-----ATGK-- 211

Query: 113 VVAIKKLN------RDGLQWV-AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEF 164
           + A KKLN      R G Q    E + L  +    +V L  Y           L LV   
Sbjct: 212 LYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKT----DLCLVMTI 266

Query: 165 MLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLL 221
           M    +  H++N       ++     I   A+   GL +LH   +  +IYRD K  NVLL
Sbjct: 267 MNGGDIRYHIYNVDEDNPGFQEP-RAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLL 322

Query: 222 DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLY 281
           D++   ++SD GLA E         +    GT G+ AP+ +         D ++ GV LY
Sbjct: 323 DDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLY 380

Query: 282 EMLTGR-----RSLERNRPKTEQRLLEWVQQYP 309
           EM+  R     R  +    + +QR+LE    YP
Sbjct: 381 EMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  101 bits (254), Expect = 5e-24
 Identities = 71/241 (29%), Positives = 109/241 (45%), Gaps = 34/241 (14%)

Query: 63  AHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL--- 119
           + N    +    R+  + F      G+G FG+V     K      T     VAIKK+   
Sbjct: 7   SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKS-----TGM--SVAIKKVIQD 59

Query: 120 ----NRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL---LVYEFM---LNRS 169
               NR+ LQ    +Q L VL HPN+V+L  Y    GER  + +   +V E++   L+R 
Sbjct: 60  PRFRNRE-LQ---IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRC 115

Query: 170 LEDHLFNR-AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRP 227
             ++   + A PP+  K  L  ++     +  LH    V V +RD K  NVL++  +   
Sbjct: 116 CRNYYRRQVAPPPILIKVFLFQLI---RSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTL 171

Query: 228 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTG 286
           KL DFG A+    +  +  + A + +  Y AP+ I    H T   D+WS G +  EM+ G
Sbjct: 172 KLCDFGSAK---KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

Query: 287 R 287
            
Sbjct: 229 E 229

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =   99 bits (250), Expect = 7e-24
 Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 35/222 (15%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQ 131
            DF     +GEG F +V  +         TS     AIK L +  +           E  
Sbjct: 30  EDFKFGKILGEGSFSTVVLAREL-----ATSR--EYAIKILEKRHIIKENKVPYVTRERD 82

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFN-RAFPPLPWKTRLH 189
            +  L+HP  VKL  +   D E+    L     +  N  L  ++    +F      TR +
Sbjct: 83  VMSRLDHPFFVKLY-FTFQDDEK----LYFGLSYAKNGELLKYIRKIGSFDE--TCTRFY 135

Query: 190 IILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
                AE    L YLH      +I+RD K  N+LL+E+   +++DFG A+          
Sbjct: 136 ----TAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 188

Query: 247 STAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGR 287
           + + VGT  Y +P+ +       + SD+W+ G ++Y+++ G 
Sbjct: 189 ANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGL 229

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  100 bits (251), Expect = 7e-24
 Identities = 56/229 (24%), Positives = 99/229 (43%), Gaps = 47/229 (20%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKL----NRDGLQWVA--EV 130
           + + R+ K+GEG +G VYK              T   VAIK++      +G+   A  EV
Sbjct: 34  DRYRRITKLGEGTYGEVYK---------AIDTVTNETVAIKRIRLEHEEEGVPGTAIREV 84

Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTR 187
             L  L+H N+++L     +     +   L++E+    L + ++ +           K+ 
Sbjct: 85  SLLKELQHRNIIEL--KSVIHHNHRL--HLIFEYAENDLKKYMDKN---PDVSMRVIKSF 137

Query: 188 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP-----KLSDFGLARE--GPM 240
           L+ ++    G+ + H     + ++RD K  N+LL  +        K+ DFGLAR    P+
Sbjct: 138 LYQLI---NGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI 191

Query: 241 VGHTHVSTAVVGTFGYAAPDYI--ETGHLTAKSDVWSFGVVLYEMLTGR 287
              TH    ++ T  Y  P+ +     + T+  D+WS   +  EML   
Sbjct: 192 RQFTHE---II-TLWYRPPEILLGSRHYSTS-VDIWSIACIWAEMLMKT 235

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 98.9 bits (247), Expect = 1e-23
 Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 26/215 (12%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN---RDGLQ-WVAEVQFLGVL 136
           +  + ++G+G FG VYK+  K      T    + A K +     + L+ ++ E++ L   
Sbjct: 21  WEIVGELGDGAFGKVYKAKNK-----ETGA--LAAAKVIETKSEEELEDYIVEIEILATC 73

Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
           +HP +VKL+G    DG+  I    + EF    +++  +       L       +     E
Sbjct: 74  DHPYIVKLLGAYYHDGKLWI----MIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLE 128

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            L +LH     ++I+RD KA NVL+      +L+DFG++     +       + +GT  +
Sbjct: 129 ALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYW 183

Query: 257 AAPDYIETGHLT-----AKSDVWSFGVVLYEMLTG 286
            AP+ +    +       K+D+WS G+ L EM   
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 99.4 bits (248), Expect = 2e-23
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 23/210 (10%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----WVAEVQFLGVL 136
               +KIGEG  G V  +  K      +     VA+K ++    Q       EV  +   
Sbjct: 47  LDSYVKIGEGSTGIVCLAREK-----HSGR--QVAVKMMDLRKQQRRELLFNEVVIMRDY 99

Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
           +H N+V++     V  E  +    + EF+   +L D +           T    +L   +
Sbjct: 100 QHFNVVEMYKSYLVGEELWV----LMEFLQGGALTDIVSQVRLNEEQIATVCEAVL---Q 152

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            LAYLH      VI+RD K+ ++LL  + R KLSDFG      +        ++VGT  +
Sbjct: 153 ALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYW 207

Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            AP+ I       + D+WS G+++ EM+ G
Sbjct: 208 MAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  102 bits (255), Expect = 2e-23
 Identities = 72/258 (27%), Positives = 111/258 (43%), Gaps = 38/258 (14%)

Query: 69  FSYSEMRQAT-NDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN------ 120
           + + E +  T N F R  + +G+GGFG V    ++      T +  + A KKL       
Sbjct: 173 WKWLERQPVTKNTF-RQYRVLGKGGFGEVCACQVR-----ATGK--MYACKKLEKKRIKK 224

Query: 121 RDGLQWV-AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAF 179
           R G      E Q L  +    +V L  Y     +      LV   M    L+ H+++   
Sbjct: 225 RKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDA---LCLVLTLMNGGDLKFHIYHMGQ 280

Query: 180 PPLPWKTRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 236
              P       +  AAE   GL  LH     +++YRD K  N+LLD++   ++SD GLA 
Sbjct: 281 AGFPEA---RAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAV 334

Query: 237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR-----RSLE 291
               V         VGT GY AP+ ++    T   D W+ G +LYEM+ G+     R  +
Sbjct: 335 H---VPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391

Query: 292 RNRPKTEQRLLEWVQQYP 309
             R + E+ + E  ++Y 
Sbjct: 392 IKREEVERLVKEVPEEYS 409

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  100 bits (252), Expect = 3e-23
 Identities = 71/312 (22%), Positives = 127/312 (40%), Gaps = 70/312 (22%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVA------EVQFLGVLE 137
           K+G G +G V              + T    AIK + +  +   +      EV  L +L+
Sbjct: 44  KLGSGAYGEVLL---------CRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94

Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 197
           HPN++KL  +     E      LV E      L D + +R            II     G
Sbjct: 95  HPNIMKLYDFF----EDKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSG 148

Query: 198 LAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 254
           + YLH+     +++RD K  N+LL   +++   K+ DFGL+    +  +       +GT 
Sbjct: 149 VTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSA---VFENQKKMKERLGTA 202

Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP---KTEQRLLEWVQQ--YP 309
            Y AP+ +       K DVWS GV+L+ +L G        P   +T+Q +L  V++  Y 
Sbjct: 203 YYIAPEVLR-KKYDEKCDVWSIGVILFILLAGY------PPFGGQTDQEILRKVEKGKYT 255

Query: 310 ADSKKFG-------------LIMDPRLEKEYSINEA------RKIGRLADNCLSKSSKDR 350
            DS ++              L  D +  +  S  +A      +++    ++ +     + 
Sbjct: 256 FDSPEWKNVSEGAKDLIKQMLQFDSQ--RRISAQQALEHPWIKEMCSKKESGI-----EL 308

Query: 351 PKMSQVVERLKQ 362
           P ++  +E +++
Sbjct: 309 PSLANAIENMRK 320

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 98.9 bits (247), Expect = 6e-23
 Identities = 93/372 (25%), Positives = 149/372 (40%), Gaps = 73/372 (19%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN------RDGLQWV-AEVQ 131
           + F  +  IG+G FG V            T +  + A+K +N      R+ ++ V  E+Q
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKN-----DTKK--MYAMKYMNKQKCVERNEVRNVFKELQ 67

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLF-NRAFPPLPWKTRLH 189
            +  LEHP LV L  Y   D E     + +V + +L   L  HL  N  F       +L 
Sbjct: 68  IMQGLEHPFLVNLW-YSFQDEED----MFMVVDLLLGGDLRYHLQQNVHFKE--ETVKLF 120

Query: 190 IILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
                 E    L YL      ++I+RD K  N+LLDE+    ++DF +A     +     
Sbjct: 121 ----ICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAM---LPRETQ 170

Query: 247 STAVVGTFGYAAP----DYIETGHLTAKSDVWSFGVVLYEMLTGRR----SLERNRPKTE 298
            T + GT  Y AP         G+  A  D WS GV  YE+L GRR        +  +  
Sbjct: 171 ITTMAGTKPYMAPEMFSSRKGAGYSFA-VDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229

Query: 299 QRLLEWVQQYPAD-SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 357
                 V  YP+  S++   ++   LE     N  ++  +L+D       ++ P M+ + 
Sbjct: 230 HTFETTVVTYPSAWSQEMVSLLKKLLEP----NPDQRFSQLSD------VQNFPYMNDIN 279

Query: 358 -ERL--KQI-------VQVSNEGDSFDKTF---EEICEEDPVEAQTKQKQHEPSEAWKRR 404
            + +  K++           N     D TF   E I E  P+  + K+   +  +  K  
Sbjct: 280 WDAVFQKRLIPGFIPNKGRLN----CDPTFELEEMILESKPLHKKKKRLAKKEKDMRKCD 335

Query: 405 MAHLAKLGEHVE 416
            +    L EH++
Sbjct: 336 SSQTCLLQEHLD 347

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 98.8 bits (246), Expect = 2e-22
 Identities = 69/251 (27%), Positives = 109/251 (43%), Gaps = 45/251 (17%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN------RDGLQWV-AEVQ 131
           NDFS    IG GGFG VY           T +  + A+K L+      + G      E  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKA-----DTGK--MYAMKCLDKKRIKMKQGETLALNERI 241

Query: 132 FLGVL---EHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFN-RAFPPLPWKT 186
            L ++   + P +V +  Y     ++    L  + + M    L  HL     F       
Sbjct: 242 MLSLVSTGDCPFIVCMS-YAFHTPDK----LSFILDLMNGGDLHYHLSQHGVFSEA---- 292

Query: 187 RLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
              +   AAE   GL ++H      V+YRD K +N+LLDE+   ++SD GLA +      
Sbjct: 293 --DMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KK 346

Query: 244 THVSTAVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG----RRSLERNRPKTE 298
            H   A VGT GY AP+ ++ G     S D +S G +L+++L G    R+   +++ + +
Sbjct: 347 PH---ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403

Query: 299 QRLLEWVQQYP 309
           +  L    + P
Sbjct: 404 RMTLTMAVELP 414

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 95.8 bits (239), Expect = 2e-22
 Identities = 51/218 (23%), Positives = 85/218 (38%), Gaps = 37/218 (16%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVA--------EVQFLGVL 136
           +GEG +G V +              T    A+K L +  L+ +         E+Q L  L
Sbjct: 13  LGEGSYGKVKE---------VLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63

Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE--DHLFNRAFPPLPWKTRLH---II 191
            H N+++L     +  E   +  +V E+ +    E  D +  + FP    +   +   +I
Sbjct: 64  RHKNVIQL--VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFP--VCQAHGYFCQLI 119

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 251
               +GL YLH      ++++D K  N+LL      K+S  G+A                
Sbjct: 120 ----DGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172

Query: 252 GTFGYAAPDYI--ETGHLTAKSDVWSFGVVLYEMLTGR 287
           G+  +  P+           K D+WS GV LY + TG 
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 97.8 bits (244), Expect = 3e-22
 Identities = 66/317 (20%), Positives = 114/317 (35%), Gaps = 70/317 (22%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVA--------------- 128
           K+G G +G V              +      AIK + +                      
Sbjct: 43  KLGSGAYGEVLL---------CKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93

Query: 129 --EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKT 186
             E+  L  L+HPN++KL        E      LV EF     L + + NR         
Sbjct: 94  YNEISLLKSLDHPNIIKLFDVF----EDKKYFYLVTEFYEGGELFEQIINRHK--FDECD 147

Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGH 243
             +I+     G+ YLH+     +++RD K  N+LL   +     K+ DFGL+        
Sbjct: 148 AANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSS---FFSK 201

Query: 244 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP---KTEQR 300
            +     +GT  Y AP+ ++      K DVWS GV++Y +L G        P   + +Q 
Sbjct: 202 DYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYP------PFGGQNDQD 254

Query: 301 LLEWVQQ--YPADSKKFG-------------LIMDPRLEKEYSINEARKIGRLADNCLSK 345
           +++ V++  Y  D   +              L  D    K  +  EA     +     + 
Sbjct: 255 IIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYN--KRCTAEEALNSRWIKKYANNI 312

Query: 346 SSKDRPKMSQVVERLKQ 362
           +  D+  +   +  +++
Sbjct: 313 NKSDQKTLCGALSNMRK 329

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 95.4 bits (238), Expect = 4e-22
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 46/218 (21%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLGVLEHPN 140
           IG+G F  V     K A    T     VAIK +++  L   +      EV+ + +L HPN
Sbjct: 23  IGKGNFAKV-----KLARHILTGRE--VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH----------I 190
           +VKL  +  ++ E+ +   L+ E+     + D+L            R+           I
Sbjct: 76  IVKL--FEVIETEKTL--YLIMEYASGGEVFDYLVA--------HGRMKEKEARSKFRQI 123

Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +      + Y H+    ++++RD KA N+LLD +   K++DFG + E        +    
Sbjct: 124 V----SAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAF- 173

Query: 251 VGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGR 287
            G   YAAP+  +   +   + DVWS GV+LY +++G 
Sbjct: 174 CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 95.6 bits (238), Expect = 4e-22
 Identities = 78/269 (28%), Positives = 111/269 (41%), Gaps = 35/269 (13%)

Query: 31  DYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATN---DFSRMLKI 87
            Y       +   +           P     +A +L+    +E+    +    FS + +I
Sbjct: 3   YYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREI 62

Query: 88  GEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQW-------VAEVQFLGVLEHPN 140
           G G FG+VY +          SE  VVAIKK++  G Q        + EV+FL  L HPN
Sbjct: 63  GHGSFGAVYFARDV-----RNSE--VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
            ++  G    +    +    V E+ L  S  D L      PL       +  GA +GLAY
Sbjct: 116 TIQYRGCYLREHTAWL----VMEYCLG-SASDLLEVHK-KPLQEVEIAAVTHGALQGLAY 169

Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 260
           LH      +I+RD KA N+LL E    KL DFG A           + + VGT  + AP+
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANSFVGTPYWMAPE 220

Query: 261 YI---ETGHLTAKSDVWSFGVVLYEMLTG 286
            I   + G    K DVWS G+   E+   
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAER 249

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 96.7 bits (241), Expect = 8e-22
 Identities = 69/312 (22%), Positives = 112/312 (35%), Gaps = 70/312 (22%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIK-----KLNRDGLQWVA-EVQFLGVLE 137
            +G+G FG V K              T    A+K              +  EV+ L  L+
Sbjct: 29  MLGKGSFGEVLK---------CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79

Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 197
           HPN++KL      +        +V E      L D +  R            II     G
Sbjct: 80  HPNIMKLFEIL--EDSSSFY--IVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSG 133

Query: 198 LAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 254
           + Y+H+     +++RD K  N+LL   +++   K+ DFGL+               +GT 
Sbjct: 134 ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMKDRIGTA 187

Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP---KTEQRLLEWVQQ--YP 309
            Y AP+ +  G    K DVWS GV+LY +L+G        P   K E  +L+ V+   Y 
Sbjct: 188 YYIAPEVLR-GTYDEKCDVWSAGVILYILLSGT------PPFYGKNEYDILKRVETGKYA 240

Query: 310 ADSKKFG-------------LIMDPRLEKEYSINEARKIGRLAD------NCLSKSSKDR 350
            D  ++              L   P      +  +      L        +  + +  D 
Sbjct: 241 FDLPQWRTISDDAKDLIRKMLTFHPS--LRITATQC-----LEHPWIQKYSSETPTISDL 293

Query: 351 PKMSQVVERLKQ 362
           P +   +  ++Q
Sbjct: 294 PSLESAMTNIRQ 305

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 92.7 bits (231), Expect = 1e-21
 Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 27/209 (12%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-------EVQFLGVLEHP 139
           +G G FG V     K      T     VA+K LNR  ++ +        E+Q L +  HP
Sbjct: 19  LGVGTFGKV-----KIGEHQLTGHK--VAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           +++KL  Y  +         +V E++    L D++       +       +       + 
Sbjct: 72  HIIKL--YQVISTPTDF--FMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVD 125

Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 259
           Y H      V++RD K  NVLLD +   K++DFGL+    M     + T+  G+  YAAP
Sbjct: 126 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRTS-CGSPNYAAP 179

Query: 260 DYIE-TGHLTAKSDVWSFGVVLYEMLTGR 287
           + I    +   + D+WS GV+LY +L G 
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGT 208

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 57/227 (25%), Positives = 90/227 (39%), Gaps = 44/227 (19%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQ 131
              +  +  IG G  G V       AA D   E   VAIKKL+R         +   E+ 
Sbjct: 24  LKRYQNLKPIGSGAQGIVC------AAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELV 76

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQR--LLVYEFM---LNRSLEDHLFNRAFPPLPWKT 186
            +  + H N++ L+            +   +V E M   L + ++  L            
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMEL-----------D 125

Query: 187 RLHI------ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
              +      +L    G+ +LH      +I+RD K SN+++  +   K+ DFGLAR    
Sbjct: 126 HERMSYLLYQML---CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---T 176

Query: 241 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            G + + T  V T  Y AP+ I         D+WS G ++ EM+ G 
Sbjct: 177 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 66/231 (28%), Positives = 100/231 (43%), Gaps = 37/231 (16%)

Query: 72  SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQ 131
            ++R    D+  +  IG G FG V     K      T +  V A+K L++  +   ++  
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHK-----STRK--VYAMKLLSKFEMIKRSDSA 114

Query: 132 F-------LGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLP 183
           F       +     P +V+L  Y   D       L +V E+M    L + + N   P   
Sbjct: 115 FFWEERDIMAFANSPWVVQLF-YAFQDDRY----LYMVMEYMPGGDLVNLMSNYDVPE-K 168

Query: 184 WKTRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
           W  R +     AE    L  +H    +  I+RD K  N+LLD++   KL+DFG   +   
Sbjct: 169 W-ARFY----TAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220

Query: 241 VGHTHVSTAVVGTFGYAAPDYIET----GHLTAKSDVWSFGVVLYEMLTGR 287
            G     TAV GT  Y +P+ +++    G+   + D WS GV LYEML G 
Sbjct: 221 EGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 92.3 bits (230), Expect = 3e-21
 Identities = 57/246 (23%), Positives = 92/246 (37%), Gaps = 74/246 (30%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVA---------------- 128
           IG+G +G V             +E      A+K L++  L   A                
Sbjct: 21  IGKGSYGVVKL---------AYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71

Query: 129 --------------EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL 174
                         E+  L  L+HPN+VKL     +D        +V+E +    + +  
Sbjct: 72  GCIQPRGPIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVME-- 127

Query: 175 FNRAFPPLPWKTRLH----------IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN 224
                  +P    L           +I G    + YLH     ++I+RD K SN+L+ E+
Sbjct: 128 -------VPTLKPLSEDQARFYFQDLIKG----IEYLHY---QKIIHRDIKPSNLLVGED 173

Query: 225 FRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLT---AKSDVWSFGVVLY 281
              K++DFG++ E        +S   VGT  + AP+ +            DVW+ GV LY
Sbjct: 174 GHIKIADFGVSNE-FKGSDALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231

Query: 282 EMLTGR 287
             + G+
Sbjct: 232 CFVFGQ 237

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 53/221 (23%), Positives = 87/221 (39%), Gaps = 42/221 (19%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVA------------EVQ 131
            +G G  G V                T   VAI+ +++      +            E++
Sbjct: 142 TLGSGACGEVKL---------AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 192

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 191
            L  L HP ++K+  +   +        +V E M    L D +       L   T     
Sbjct: 193 ILKKLNHPCIIKIKNFFDAE-----DYYIVLELMEGGELFDKVVGNKR--LKEATCKLYF 245

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVST 248
                 + YLHE     +I+RD K  NVLL   +E+   K++DFG ++   ++G T +  
Sbjct: 246 YQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETSLMR 299

Query: 249 AVVGTFGYAAPDYIETGHL---TAKSDVWSFGVVLYEMLTG 286
            + GT  Y AP+ + +          D WS GV+L+  L+G
Sbjct: 300 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 91.9 bits (229), Expect = 3e-21
 Identities = 59/226 (26%), Positives = 84/226 (37%), Gaps = 60/226 (26%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGVLEHPNL 141
           +GEG +G V       A    T EA  VA+K ++             E+    +L H N+
Sbjct: 15  LGEGAYGEVQL-----AVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67

Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRS-----LE----DHLFNRAFPPLPWKTRLH--- 189
           VK                  Y      +     LE      LF+R  P       +    
Sbjct: 68  VKF-----------------YGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPD 106

Query: 190 -------IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 242
                  ++     G+ YLH    + + +RD K  N+LLDE    K+SDFGLA       
Sbjct: 107 AQRFFHQLM----AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159

Query: 243 HTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGR 287
              +   + GT  Y AP+ ++         DVWS G+VL  ML G 
Sbjct: 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 92.9 bits (231), Expect = 4e-21
 Identities = 48/226 (21%), Positives = 81/226 (35%), Gaps = 55/226 (24%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------------EVQFLG 134
           +G G FG V       A     ++   V +K + ++ +                E+  L 
Sbjct: 32  LGSGAFGFV-----WTAVDKEKNKE--VVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRS-----LEDH-----LFNR--AFPPL 182
            +EH N++K+                  +   N+      +E H     LF      P L
Sbjct: 85  RVEHANIIKV-----------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRL 127

Query: 183 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 242
                 +I       + YL       +I+RD K  N+++ E+F  KL DFG A       
Sbjct: 128 DEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK 184

Query: 243 HTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGR 287
             +      GT  Y AP+ +    +   + ++WS GV LY ++   
Sbjct: 185 LFYTF---CGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 60/229 (26%), Positives = 84/229 (36%), Gaps = 66/229 (28%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGVLEHPNL 141
           +GEG +G V       A    T EA  VA+K ++             E+    +L H N+
Sbjct: 15  LGEGAYGEVQL-----AVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67

Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRS-----LE----DHLFNRAFPPLPWKTRLH--- 189
           VK                  Y      +     LE      LF+R  P       +    
Sbjct: 68  VKF-----------------YGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPD 106

Query: 190 -------IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA---REGP 239
                  ++     G+ YLH    + + +RD K  N+LLDE    K+SDFGLA   R   
Sbjct: 107 AQRFFHQLM----AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159

Query: 240 MVGHTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGR 287
                +      GT  Y AP+ ++         DVWS G+VL  ML G 
Sbjct: 160 RERLLNKM---CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 54/232 (23%), Positives = 91/232 (39%), Gaps = 36/232 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA----EVQFLGVLEHPNL 141
            IG G +G V  +  K             A KK+ +  ++ V     E++ +  L+HPN+
Sbjct: 16  TIGRGSWGEVKIAVQK-------GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNI 68

Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 201
           ++L        E      LV E      L + + ++            I+      +AY 
Sbjct: 69  IRLYETF----EDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYC 122

Query: 202 HEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
           H+   + V +RD K  N L      +   KL DFGLA          +    VGT  Y +
Sbjct: 123 HK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRTKVGTPYYVS 176

Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP---KTEQRLLEWVQQ 307
           P  +E  +   + D WS GV++Y +L G        P    T+  ++  +++
Sbjct: 177 PQVLEGLY-GPECDEWSAGVMMYVLLCGY------PPFSAPTDSEVMLKIRE 221

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 90.7 bits (225), Expect = 2e-20
 Identities = 54/253 (21%), Positives = 87/253 (34%), Gaps = 63/253 (24%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVA---------EVQFLG 134
            IG+G +G V                T  + AIK +N++ ++ +          EV+ + 
Sbjct: 33  AIGQGSYGVVRV---------AIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83

Query: 135 VLEHPNLVKLIG-------------YCA---------VDGERGIQRLLVYEFMLNRSLED 172
            L HPN+ +L                C          V  +    +  +           
Sbjct: 84  KLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143

Query: 173 HLFNRAFPPLPWKTRL------------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVL 220
                A        R             +I+      L YLH      + +RD K  N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFL 200

Query: 221 L--DENFRPKLSDFGLAR--EGPMVGHTHVSTAVVGTFGYAAPDYIETGHL--TAKSDVW 274
              +++F  KL DFGL++       G  +  T   GT  + AP+ + T +     K D W
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260

Query: 275 SFGVVLYEMLTGR 287
           S GV+L+ +L G 
Sbjct: 261 SAGVLLHLLLMGA 273

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 59/236 (25%), Positives = 91/236 (38%), Gaps = 42/236 (17%)

Query: 72  SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQ 131
            E+R   +DF  +  IG G F  V    +K      T +  V A+K +N+  +    EV 
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMK-----QTGQ--VYAMKIMNKWDMLKRGEVS 106

Query: 132 F-------LGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHL--FNRAFPP 181
                   L   +   + +L  + A   E     L LV E+ +   L   L  F     P
Sbjct: 107 CFREERDVLVNGDRRWITQL--HFAFQDEN---YLYLVMEYYVGGDLLTLLSKFGERI-P 160

Query: 182 LPWKTRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 238
                R +     AE    +  +H    +  ++RD K  N+LLD     +L+DFG   + 
Sbjct: 161 AEM-ARFY----LAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL 212

Query: 239 PMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKS-------DVWSFGVVLYEMLTGR 287
              G      A VGT  Y +P+ ++       +       D W+ GV  YEM  G+
Sbjct: 213 RADGTVRSLVA-VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 88.8 bits (221), Expect = 5e-20
 Identities = 57/245 (23%), Positives = 94/245 (38%), Gaps = 57/245 (23%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAI--KKLNRDGLQWVA-EVQFLGVLEHPNLV 142
           K+G G FG V+    +      +    V+    K  ++  ++ +  E++ L  L+HPN++
Sbjct: 29  KLGSGAFGDVHLVEER-----SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSL--------EDHLFNRAFPPLPWKTRL------ 188
           K+                V+E   N  +        E  L  R          L      
Sbjct: 84  KIFE--------------VFEDYHNMYIVMETCEGGE--LLERIVSAQARGKALSEGYVA 127

Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTH 245
            ++      LAY H      V+++D K  N+L      +   K+ DFGLA    +     
Sbjct: 128 ELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKSDE 181

Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP---KTEQRLL 302
            ST   GT  Y AP+  +   +T K D+WS GVV+Y +LTG        P    + + + 
Sbjct: 182 HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGC------LPFTGTSLEEVQ 234

Query: 303 EWVQQ 307
           +    
Sbjct: 235 QKATY 239

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 89.7 bits (223), Expect = 5e-20
 Identities = 45/207 (21%), Positives = 74/207 (35%), Gaps = 23/207 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVAEVQFLG-VLEHPNLV 142
            +G G  G V +              T    A+K L         EV         P++V
Sbjct: 36  VLGLGVNGKVLE---------CFHRRTGQKCALKLLYDSPKAR-QEVDHHWQASGGPHIV 85

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
            ++             L++ E M    L   +  R       +    I+      + +LH
Sbjct: 86  CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145

Query: 203 EGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 259
                 + +RD K  N+L    +++   KL+DFG A+E        + T    T  Y AP
Sbjct: 146 S---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE---TTQNALQT-PCYTPYYVAP 198

Query: 260 DYIETGHLTAKSDVWSFGVVLYEMLTG 286
           + +         D+WS GV++Y +L G
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIMYILLCG 225

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 90.6 bits (225), Expect = 5e-20
 Identities = 62/234 (26%), Positives = 91/234 (38%), Gaps = 40/234 (17%)

Query: 72  SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQ 131
            +MR    DF  +  IG G FG V    +K        +  V A+K LN+  +   AE  
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLK-----NADK--VFAMKILNKWEMLKRAETA 119

Query: 132 F-------LGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHL--FNRAFPP 181
                   L   +   +  L  Y   D       L LV ++ +   L   L  F    P 
Sbjct: 120 CFREERDVLVNGDSKWITTLH-YAFQDDN----NLYLVMDYYVGGDLLTLLSKFEDRLPE 174

Query: 182 LPWKTRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 238
                R +     AE    +  +H   ++  ++RD K  N+L+D N   +L+DFG   + 
Sbjct: 175 -EM-ARFY----LAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 225

Query: 239 PMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKS-----DVWSFGVVLYEMLTGR 287
              G    S A VGT  Y +P+ ++             D WS GV +YEML G 
Sbjct: 226 MEDGTVQSSVA-VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 89.7 bits (223), Expect = 5e-20
 Identities = 58/228 (25%), Positives = 84/228 (36%), Gaps = 51/228 (22%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA---------------EV 130
            I  G +G+V       A  D       VAIK++                        E+
Sbjct: 29  FISSGSYGAVC------AGVDSEGI--PVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFM---LNRSLEDHLFNRAFPPLPWKT 186
           + L    HPN++ L        E  + +L LV E M   L +     + +     +   +
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQ-----VIHDQRIVI---S 132

Query: 187 RLHI------ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
             HI      IL    GL  LHE     V++RD    N+LL +N    + DF LARE   
Sbjct: 133 PQHIQYFMYHIL---LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLARE--- 183

Query: 241 VGHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 287
                  T  V    Y AP+ + +    T   D+WS G V+ EM   +
Sbjct: 184 DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 90.3 bits (224), Expect = 8e-20
 Identities = 57/218 (26%), Positives = 90/218 (41%), Gaps = 44/218 (20%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLGVLEHPN 140
           IG G  G V       AA D   +   VAIKKL+R         +   E+  +  + H N
Sbjct: 70  IGSGAQGIVC------AAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 122

Query: 141 LVKLIG-YCAVDGERGIQRL-LVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHI----- 190
           ++ L+  +         Q + LV E M   L + ++  L               +     
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----------DHERMSYLLY 171

Query: 191 -ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
            +L    G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T 
Sbjct: 172 QML---CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTP 222

Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            V T  Y AP+ I         D+WS G ++ EM+  +
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 89.0 bits (221), Expect = 1e-19
 Identities = 56/217 (25%), Positives = 86/217 (39%), Gaps = 45/217 (20%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGVLEHPNLVK 143
           IG G FG       +      T E   VA+K + R          E+     L HPN+V+
Sbjct: 28  IGSGNFGVA-----RLMRDKLTKEL--VAVKYIERGAAIDENVQREIINHRSLRHPNIVR 80

Query: 144 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH----------IILG 193
                 +     +   ++ E+     L + + N          R            ++ G
Sbjct: 81  F--KEVILTPTHL--AIIMEYASGGELYERICN--------AGRFSEDEARFFFQQLLSG 128

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP--KLSDFGLAREGPMVGHTHVSTAVV 251
               ++Y H    +Q+ +RD K  N LLD +  P  K+ DFG ++    V H+   + V 
Sbjct: 129 ----VSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKSTV- 178

Query: 252 GTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGR 287
           GT  Y AP+ +    +    +DVWS GV LY ML G 
Sbjct: 179 GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 28/209 (13%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-------EVQFLGVLEHP 139
           +GEG FG V     K A    T +   VA+K ++R  L+          E+ +L +L HP
Sbjct: 17  LGEGSFGKV-----KLATHYKTQQK--VALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           +++KL  Y  +     I  ++V E+     L D++  +    +               + 
Sbjct: 70  HIIKL--YDVITTPTDI--VMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIE 122

Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 259
           Y H     ++++RD K  N+LLD+N   K++DFGL+    M     + T+  G+  YAAP
Sbjct: 123 YCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNI--MTDGNFLKTS-CGSPNYAAP 176

Query: 260 DYIE-TGHLTAKSDVWSFGVVLYEMLTGR 287
           + I    +   + DVWS G+VLY ML GR
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 88.0 bits (219), Expect = 1e-19
 Identities = 70/221 (31%), Positives = 106/221 (47%), Gaps = 33/221 (14%)

Query: 79  NDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN------RDGLQWVAEVQ 131
           + F  +LK +G+G FG V+   +K  +G    +  + A+K L       RD ++   E  
Sbjct: 24  SQF-ELLKVLGQGSFGKVFL--VKKISGSDARQ--LYAMKVLKKATLKVRDRVRTKMERD 78

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
            L  + HP +VKL  Y      +    L L+ +F+    L   L            + + 
Sbjct: 79  ILVEVNHPFIVKLH-YAFQTEGK----LYLILDFLRGGDLFTRLSKEVMFTEED-VKFY- 131

Query: 191 ILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 247
               AE    L +LH    + +IYRD K  N+LLDE    KL+DFGL++E   + H   +
Sbjct: 132 ---LAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKA 183

Query: 248 TAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 287
            +  GT  Y AP+ +   GH T  +D WSFGV+++EMLTG 
Sbjct: 184 YSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGT 223

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 89.5 bits (222), Expect = 1e-19
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 51/221 (23%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVA-------EVQFLGVLE 137
           +G G FG V           G  E T   VA+K LNR  ++ +        E+Q L +  
Sbjct: 24  LGVGTFGKVKV---------GKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74

Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH-------- 189
           HP+++KL  Y  +     I   +V E++    L D++            RL         
Sbjct: 75  HPHIIKL--YQVISTPSDI--FMVMEYVSGGELFDYICK--------NGRLDEKESRRLF 122

Query: 190 --IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 247
             I+     G+ Y H      V++RD K  NVLLD +   K++DFGL+    M     + 
Sbjct: 123 QQIL----SGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLR 173

Query: 248 TAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGR 287
           T+  G+  YAAP+ I    +   + D+WS GV+LY +L G 
Sbjct: 174 TS-CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 48/242 (19%), Positives = 97/242 (40%), Gaps = 56/242 (23%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
            +G G FG V +          + +    A+KK+ +D      E+  + VL+H N++KL+
Sbjct: 14  TLGTGSFGIVCEVFDIE-----SGK--RFALKKVLQDPRYKNRELDIMKVLDHVNIIKLV 66

Query: 146 GYCAVDGERGIQRL----------------------------------LVYEFM---LNR 168
            Y    G+   +                                    ++ E++   L++
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126

Query: 169 SLEDHL-FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFR 226
            L+  +   R+ P       ++ +      + ++H    + + +RD K  N+L++ ++  
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLF---RAVGFIHS---LGICHRDIKPQNLLVNSKDNT 180

Query: 227 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLT 285
            KL DFG A+    +  +  S A + +  Y AP+ +      T   D+WS G V  E++ 
Sbjct: 181 LKLCDFGSAK---KLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237

Query: 286 GR 287
           G+
Sbjct: 238 GK 239

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 51/223 (22%), Positives = 85/223 (38%), Gaps = 47/223 (21%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVAEVQFLGVLE------- 137
           +G+GGFG+V+          G        VAIK + R+ +   + +              
Sbjct: 39  LGKGGFGTVFA---------GHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLW 89

Query: 138 -------HPNLVKLIGYCAVDGERGIQRLLVYEFMLN-RSLEDHLFNRAFPPLPWKTRLH 189
                  HP +++L      + + G   +LV E  L  + L D++  +   PL       
Sbjct: 90  KVGAGGGHPGVIRL--LDWFETQEGF--MLVLERPLPAQDLFDYITEKG--PLGEGPSRC 143

Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLA---REGPMVGHTH 245
                   + + H      V++RD K  N+L+D      KL DFG      + P      
Sbjct: 144 FFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY--TDF 198

Query: 246 VSTAVVGTFGYAAPDYIETGHLT-AKSDVWSFGVVLYEMLTGR 287
                 GT  Y+ P++I         + VWS G++LY+M+ G 
Sbjct: 199 D-----GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 86.1 bits (214), Expect = 4e-19
 Identities = 63/236 (26%), Positives = 96/236 (40%), Gaps = 42/236 (17%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVA------EVQFLGVLE 137
            +G+G FG V K              T    A+K +N+   +         EV+ L  L+
Sbjct: 29  MLGKGSFGEVLK---------CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79

Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 197
           HPN++KL        E      +V E      L D +  R            II     G
Sbjct: 80  HPNIMKLFEIL----EDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSG 133

Query: 198 LAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 254
           + Y+H+     +++RD K  N+LL   +++   K+ DFGL+               +GT 
Sbjct: 134 ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMKDRIGTA 187

Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP---KTEQRLLEWVQQ 307
            Y AP+ +  G    K DVWS GV+LY +L+G        P   K E  +L+ V+ 
Sbjct: 188 YYIAPEVLR-GTYDEKCDVWSAGVILYILLSGT------PPFYGKNEYDILKRVET 236

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 86.1 bits (214), Expect = 6e-19
 Identities = 50/210 (23%), Positives = 83/210 (39%), Gaps = 31/210 (14%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGL----QWVAEVQFLGVLEHP 139
            +G G F  V+               T  + A+K + +           E+  L  ++H 
Sbjct: 16  VLGSGAFSEVFL---------VKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHE 66

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           N+V L        E      LV + +    L D +  R       K    +I      + 
Sbjct: 67  NIVTLEDIY----ESTTHYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLSAVK 120

Query: 200 YLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           YLHE     +++RD K  N+L    +EN +  ++DFGL++    +    + +   GT GY
Sbjct: 121 YLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSK----MEQNGIMSTACGTPGY 173

Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            AP+ +     +   D WS GV+ Y +L G
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 86.6 bits (215), Expect = 6e-19
 Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 34/211 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
           ++G G    VY+   K   G     A  V  K +++  ++   E+  L  L HPN++KL 
Sbjct: 60  ELGRGATSIVYRCKQK---GTQKPYALKVLKKTVDKKIVR--TEIGVLLRLSHPNIIKLK 114

Query: 146 GYCAVDGERGIQRLLVYEFM-LNRSLEDHLFNRAFPPLPWKTRL------HIILGAAEGL 198
                  E       +   + L    E  LF+R    +  K           +    E +
Sbjct: 115 EIFETPTE-------ISLVLELVTGGE--LFDR----IVEKGYYSERDAADAVKQILEAV 161

Query: 199 AYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
           AYLHE     +++RD K  N+L      +   K++DFGL++   +V H  +   V GT G
Sbjct: 162 AYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSK---IVEHQVLMKTVCGTPG 215

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           Y AP+ +       + D+WS G++ Y +L G
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 86.2 bits (214), Expect = 6e-19
 Identities = 53/222 (23%), Positives = 83/222 (37%), Gaps = 47/222 (21%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVA----------EVQFLG 134
           +G GGFGSVY          G   +    VAIK + +D +              EV  L 
Sbjct: 51  LGSGGFGSVYS---------GIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 101

Query: 135 VLEH--PNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPPLPWKTRLHII 191
            +      +++L      +       +L+ E       L D +  R    L  +      
Sbjct: 102 KVSSGFSGVIRL--LDWFERPDSF--VLILERPEPVQDLFDFITERG--ALQEELARSFF 155

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLA---REGPMVGHTHVS 247
               E + + H      V++RD K  N+L+D N    KL DFG     ++          
Sbjct: 156 WQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFD- 209

Query: 248 TAVVGTFGYAAPDYIETGHL--TAKSDVWSFGVVLYEMLTGR 287
               GT  Y+ P++I   H      + VWS G++LY+M+ G 
Sbjct: 210 ----GTRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGD 246

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 85.7 bits (213), Expect = 9e-19
 Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 35/223 (15%)

Query: 79  NDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-------NRDGLQWV-AE 129
             F  +L+ +G+GG+G V++  ++   G  T +  + A+K L       N        AE
Sbjct: 17  ECF-ELLRVLGKGGYGKVFQ--VRKVTGANTGK--IFAMKVLKKAMIVRNAKDTAHTKAE 71

Query: 130 VQFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
              L  ++HP +V LI Y    G +    L L+ E++    L   L              
Sbjct: 72  RNILEEVKHPFIVDLI-YAFQTGGK----LYLILEYLSGGELFMQLEREGIFMED-TACF 125

Query: 189 HIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
           +     AE    L +LH+     +IYRD K  N++L+     KL+DFGL +E   +    
Sbjct: 126 Y----LAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKES--IHDGT 176

Query: 246 VSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 287
           V+    GT  Y AP+ +  +GH     D WS G ++Y+MLTG 
Sbjct: 177 VTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGA 218

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 57/227 (25%), Positives = 91/227 (40%), Gaps = 54/227 (23%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVA------------EVQ 131
            +G G  G V                T   VAIK +++      +            E++
Sbjct: 17  TLGSGACGEVKL---------AFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL--- 188
            L  L HP ++K+  +   D E      +V E M     E  LF++    +    RL   
Sbjct: 68  ILKKLNHPCIIKIKNF--FDAEDYY---IVLELM--EGGE--LFDK----VVGNKRLKEA 114

Query: 189 ---HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVG 242
                       + YLHE     +I+RD K  NVLL   +E+   K++DFG ++   ++G
Sbjct: 115 TCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILG 168

Query: 243 HTHVSTAVVGTFGYAAPDYIETGHL---TAKSDVWSFGVVLYEMLTG 286
            T +   + GT  Y AP+ + +          D WS GV+L+  L+G
Sbjct: 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 64/227 (28%), Positives = 100/227 (44%), Gaps = 40/227 (17%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-----DGLQWVAEVQF 132
              ++ +  IGEG +G V       +A D  ++   VAIKK++         + + E++ 
Sbjct: 26  GPRYTNLSYIGEGAYGMVC------SAYDNLNK-VRVAIKKISPFEHQTYCQRTLREIKI 78

Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFM---LNRSLEDHLFNRAFPPLPWKTRL 188
           L    H N++ +           ++ + +V + M   L + L+          L   +  
Sbjct: 79  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ-------HL---SND 128

Query: 189 HI------ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMV 241
           HI      IL    GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P  
Sbjct: 129 HICYFLYQIL---RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182

Query: 242 GHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 287
            HT   T  V T  Y AP+ +  +   T   D+WS G +L EML+ R
Sbjct: 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 67/312 (21%), Positives = 121/312 (38%), Gaps = 66/312 (21%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVA---------EVQFLG 134
            IG+G F  V +           +  T    A+K ++                 E     
Sbjct: 31  VIGKGPFSVVRR---------CINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICH 81

Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL--HIIL 192
           +L+HP++V+L+              +V+EFM    L   +  RA     +   +  H + 
Sbjct: 82  MLKHPHIVELLETY----SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137

Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTA 249
              E L Y H+     +I+RD K   VLL   + +   KL  FG+A +  +     V+  
Sbjct: 138 QILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGG 192

Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP--KTEQRLLEWVQ- 306
            VGT  + AP+ ++        DVW  GV+L+ +L+G        P   T++RL E +  
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGC------LPFYGTKERLFEGIIK 246

Query: 307 -QYPADSKKFG-------------LIMDPRLEKEYSINEARKIGRLADN--CLSKSSKDR 350
            +Y  + +++              L++DP   +  ++ EA     L             +
Sbjct: 247 GKYKMNPRQWSHISESAKDLVRRMLMLDPA--ERITVYEA-----LNHPWLKERDRYAYK 299

Query: 351 PKMSQVVERLKQ 362
             + + VE+L++
Sbjct: 300 IHLPETVEQLRK 311

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 68/276 (24%), Positives = 111/276 (40%), Gaps = 38/276 (13%)

Query: 30  ADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQAT-NDFSRMLK-I 87
             +   E       +   S     G  +L   K             +    +F  +LK +
Sbjct: 4   HHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENF-ELLKVL 62

Query: 88  GEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQ---------FLGVLEH 138
           G G +G V+   ++  +G  T +  + A+K L +  +   A+              + + 
Sbjct: 63  GTGAYGKVFL--VRKISGHDTGK--LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 118

Query: 139 PNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE- 196
           P LV L  Y      +    L L+ +++    L  HL  R         +++      E 
Sbjct: 119 PFLVTLH-YAFQTETK----LHLILDYINGGELFTHLSQRERFTEHE-VQIY----VGEI 168

Query: 197 --GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 254
              L +LH+   + +IYRD K  N+LLD N    L+DFGL++E  +   T  +    GT 
Sbjct: 169 VLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDFCGTI 224

Query: 255 GYAAP---DYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            Y AP      ++GH  A  D WS GV++YE+LTG 
Sbjct: 225 EYMAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGA 259

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 62/228 (27%), Positives = 92/228 (40%), Gaps = 47/228 (20%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQ 131
              +     +G G +GSV        A D  S    VAIKKL+R         +   E+ 
Sbjct: 23  PKTYVSPTHVGSGAYGSVCS------AIDKRSG-EKVAIKKLSRPFQSEIFAKRAYRELL 75

Query: 132 FLGVLEHPNLVKLIG-YCAVDGERGIQRL-LVYEFM---LNRSLEDHLFNRAFPPLPWKT 186
            L  ++H N++ L+  +      R      LV  FM   L + +               +
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKF-----------S 124

Query: 187 RLHI------ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
              I      +L   +GL Y+H      V++RD K  N+ ++E+   K+ DFGLAR    
Sbjct: 125 EEKIQYLVYQML---KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR---- 174

Query: 241 VGHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 287
                  T  V T  Y AP+ I    H     D+WS G ++ EMLTG+
Sbjct: 175 -HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 75/260 (28%), Positives = 105/260 (40%), Gaps = 36/260 (13%)

Query: 41  VKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLK-IGEGGFGSVYKSS 99
           +K   +A +    G P             +  + R   N+F   LK +G+G FG V    
Sbjct: 110 LKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEF-EYLKLLGKGTFGKVILVK 168

Query: 100 IKPAAGDGTSEATVVAIKKL------NRDGLQW-VAEVQFLGVLEHPNLVKLIGYCAVDG 152
            K      T      A+K L       +D +   + E + L    HP L  L  Y     
Sbjct: 169 EK-----ATGR--YYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTH 220

Query: 153 ERGIQRL-LVYEFMLNRSLEDHLFN-RAFPPLPWKTRLHIILGAAE---GLAYLHEGLEV 207
           +R    L  V E+     L  HL   R F     + R +     AE    L YLH   E 
Sbjct: 221 DR----LCFVMEYANGGELFFHLSRERVFSE--DRARFY----GAEIVSALDYLHS--EK 268

Query: 208 QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL 267
            V+YRD K  N++LD++   K++DFGL +EG  +          GT  Y AP+ +E    
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKTFCGTPEYLAPEVLEDNDY 326

Query: 268 TAKSDVWSFGVVLYEMLTGR 287
               D W  GVV+YEM+ GR
Sbjct: 327 GRAVDWWGLGVVMYEMMCGR 346

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 84.3 bits (209), Expect = 3e-18
 Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 27/208 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVAEVQFLG-VLEHPNLV 142
            IG G +    +            +AT    A+K +++       E++ L    +HPN++
Sbjct: 29  DIGVGSYSVCKR---------CIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNII 79

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
            L        + G    +V E M    L D +  + F     +    ++    + + YLH
Sbjct: 80  TLKDVY----DDGKYVYVVTELMKGGELLDKILRQKF--FSEREASAVLFTITKTVEYLH 133

Query: 203 EGLEVQVIYRDFKASNVLL---DENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
                 V++RD K SN+L      N    ++ DFG A++  +     +      T  + A
Sbjct: 134 A---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ--LRAENGLLMTPCYTANFVA 188

Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           P+ +E     A  D+WS GV+LY MLTG
Sbjct: 189 PEVLERQGYDAACDIWSLGVLLYTMLTG 216

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 84.3 bits (209), Expect = 3e-18
 Identities = 59/309 (19%), Positives = 111/309 (35%), Gaps = 54/309 (17%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVA-EVQFLGVL-EHPNL 141
            +GEG F    K            + +    A+K +++        E+  L +   HPN+
Sbjct: 18  PLGEGSFSICRK---------CVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNI 68

Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 201
           VKL           +   LV E +    L + +  +           +I+      ++++
Sbjct: 69  VKLHEVF----HDQLHTFLVMELLNGGELFERIKKKKH--FSETEASYIMRKLVSAVSHM 122

Query: 202 HEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
           H   +V V++RD K  N+L    ++N   K+ DFG AR                T  YAA
Sbjct: 123 H---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL--KPPDNQPLKTPCFTLHYAA 177

Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLTG----RRSLERNRPKTEQRLLEWVQ--QYPADS 312
           P+ +         D+WS GV+LY ML+G    +         +   +++ ++   +  + 
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237

Query: 313 KKFG-------------LIMDPRLEKEYSINEA------RKIGRLADNCLSKSSKDRPKM 353
           + +              L +DP   K   ++        +   +L+ N L          
Sbjct: 238 EAWKNVSQEAKDLIQGLLTVDP--NKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSG 295

Query: 354 SQVVERLKQ 362
           + V   +K 
Sbjct: 296 AAVHTCVKA 304

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 84.8 bits (210), Expect = 4e-18
 Identities = 58/247 (23%), Positives = 90/247 (36%), Gaps = 59/247 (23%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLGVLEHP 139
            IG G +G VY       A D  +E   VAIKK+NR      D  + + E+  L  L+  
Sbjct: 33  LIGRGSYGYVYL------AYDKNTE-KNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85

Query: 140 NLVKLIGYCAVDGERGIQRL-LVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHI----- 190
            +++L      D       L +V E     L +        +    L   T  HI     
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF------KTPIFL---TEEHIKTILY 136

Query: 191 -ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
            +L    G  ++HE     +I+RD K +N LL+++   K+ DFGLAR       T++   
Sbjct: 137 NLL---LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190

Query: 250 VVGTFGYAAPDYIETGHLT---------------------AKSDVWSFGVVLYEMLTGRR 288
           +         +      LT                        D+WS G +  E+L   +
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250

Query: 289 SLERNRP 295
           S   +  
Sbjct: 251 SHINDPT 257

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 84.2 bits (209), Expect = 4e-18
 Identities = 64/226 (28%), Positives = 98/226 (43%), Gaps = 44/226 (19%)

Query: 79  NDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQ------ 131
            DF  + K +G+G FG V+ +  K      T++    AIK L +D +    +V+      
Sbjct: 17  EDF-ILHKMLGKGSFGKVFLAEFK-----KTNQ--FFAIKALKKDVVLMDDDVECTMVEK 68

Query: 132 --FLGVLEHPNLVKLIGYCAVDGERGIQ---RL-LVYEFMLNRSLEDHLFN-RAFPPLPW 184
                  EHP L  +            Q    L  V E++    L  H+ +   F     
Sbjct: 69  RVLSLAWEHPFLTHMF-CT-------FQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-- 118

Query: 185 KTRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMV 241
           +   +    AAE   GL +LH      ++YRD K  N+LLD++   K++DFG+ +E   +
Sbjct: 119 RATFY----AAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKEN--M 169

Query: 242 GHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
                +    GT  Y AP+ +         D WSFGV+LYEML G+
Sbjct: 170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 83.5 bits (207), Expect = 4e-18
 Identities = 53/223 (23%), Positives = 86/223 (38%), Gaps = 43/223 (19%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVA-------------EV 130
            +G G    V +            + T    A+K ++  G    +             EV
Sbjct: 24  ILGRGVSSVVRR---------CIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74

Query: 131 QFL-GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 189
             L  V  HPN+++L      +        LV++ M    L D+L  +    L  K    
Sbjct: 75  DILRKVSGHPNIIQLKDTY--ETNTFF--FLVFDLMKKGELFDYLTEKVT--LSEKETRK 128

Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
           I+    E +  LH+   + +++RD K  N+LLD++   KL+DFG +     +        
Sbjct: 129 IMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLRE 182

Query: 250 VVGTFGYAAP------DYIETGHLTAKSDVWSFGVVLYEMLTG 286
           V GT  Y AP                + D+WS GV++Y +L G
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 83.9 bits (208), Expect = 5e-18
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 40/222 (18%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQ 131
           + F R+  +G G FG V     K             A+K L++  +         + E +
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHK-------ESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFN-RAFPPLPWKTRLH 189
            L  +  P LVKL  +   D       L +V E++    +  HL     F       R +
Sbjct: 94  ILQAVNFPFLVKLE-FSFKDNSN----LYMVMEYVAGGEMFSHLRRIGRFSEP--HARFY 146

Query: 190 IILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
               AA+      YLH    + +IYRD K  N+L+D+    +++DFG A+       T  
Sbjct: 147 ----AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-- 197

Query: 247 STAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGR 287
              + GT    AP+ I + G+  A  D W+ GV++YEM  G 
Sbjct: 198 ---LCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGY 235

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 83.4 bits (207), Expect = 6e-18
 Identities = 68/225 (30%), Positives = 92/225 (40%), Gaps = 43/225 (19%)

Query: 79  NDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL------NRDGLQWV-AEV 130
           NDF   LK +G+G FG V     K      T      A+K L       +D +     E 
Sbjct: 5   NDF-DYLKLLGKGTFGKVILVREK-----ATGR--YYAMKILRKEVIIAKDEVAHTVTES 56

Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQ---RL-LVYEFMLNRSLEDHLFNRAFPPLPWKT 186
           + L    HP L  L  Y         Q   RL  V E+     L  HL          + 
Sbjct: 57  RVLQNTRHPFLTALK-YA-------FQTHDRLCFVMEYANGGELFFHLSRERVFTEE-RA 107

Query: 187 RLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 243
           R +     AE    L YLH      V+YRD K  N++LD++   K++DFGL +EG  +  
Sbjct: 108 RFY----GAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISD 158

Query: 244 THVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 287
                   GT  Y AP+ + +  +     D W  GVV+YEM+ GR
Sbjct: 159 GATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGR 202

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 83.6 bits (207), Expect = 7e-18
 Identities = 63/307 (20%), Positives = 108/307 (35%), Gaps = 55/307 (17%)

Query: 8   KEKKLRRREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLR 67
             +++R     +  + +   +S     ++S   +  +   +   P+G   LY +      
Sbjct: 22  ARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPED 81

Query: 68  VFSYSEMRQATNDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGL 124
                   +           IG G    V +             AT    A+K +     
Sbjct: 82  ELPDWAAAKEFYQKYDPKDVIGRGVSSVVRR---------CVHRATGHEFAVKIMEVTAE 132

Query: 125 QWVA------------EVQFL-GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE 171
           +               E   L  V  HP+++ LI       E      LV++ M  R  E
Sbjct: 133 RLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY----ESSSFMFLVFDLM--RKGE 186

Query: 172 DHLFNRAFPPLPWKTRL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF 225
             LF+     L  K  L       I+    E +++LH      +++RD K  N+LLD+N 
Sbjct: 187 --LFDY----LTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNM 237

Query: 226 RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP------DYIETGHLTAKSDVWSFGVV 279
           + +LSDFG +     +        + GT GY AP                + D+W+ GV+
Sbjct: 238 QIRLSDFGFSC---HLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294

Query: 280 LYEMLTG 286
           L+ +L G
Sbjct: 295 LFTLLAG 301

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 83.1 bits (206), Expect = 7e-18
 Identities = 46/210 (21%), Positives = 90/210 (42%), Gaps = 25/210 (11%)

Query: 86  KIGEGGFGSVY----KSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-EVQFLGVLEH-P 139
           ++G G F  V     KS+ +  A      A  +  ++  +D    +  E+  L + +  P
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYA------AKFLKKRRRGQDCRAEILHEIAVLELAKSCP 89

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
            ++ L  +   +    I  +L+ E+     +           +     + +I    EG+ 
Sbjct: 90  RVINL--HEVYENTSEI--ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVY 145

Query: 200 YLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           YLH+     +++ D K  N+LL         K+ DFG++R    +GH      ++GT  Y
Sbjct: 146 YLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR---KIGHACELREIMGTPEY 199

Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
            AP+ +    +T  +D+W+ G++ Y +LT 
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIAYMLLTH 229

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 83.4 bits (207), Expect = 8e-18
 Identities = 68/227 (29%), Positives = 102/227 (44%), Gaps = 46/227 (20%)

Query: 79  NDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQ------ 131
           ++F   ++ +G+G FG V  + +K      T +  + A+K L +D +    +V+      
Sbjct: 23  DNF-EFIRVLGKGSFGKVMLARVK-----ETGD--LYAVKVLKKDVILQDDDVECTMTEK 74

Query: 132 --FLGVLEHPNLVKLIGYCAVDGERGIQ---RL-LVYEFMLNRSLEDHLFN-RAFPPLPW 184
                   HP L +L   C        Q   RL  V EF+    L  H+   R F     
Sbjct: 75  RILSLARNHPFLTQLF-CC-------FQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA-- 124

Query: 185 KTRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMV 241
           + R +    AAE    L +LH+     +IYRD K  NVLLD     KL+DFG+ +EG  +
Sbjct: 125 RARFY----AAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG--I 175

Query: 242 GHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 287
            +   +    GT  Y AP+ + E  +     D W+ GV+LYEML G 
Sbjct: 176 CNGVTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGH 221

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 83.6 bits (207), Expect = 8e-18
 Identities = 48/209 (22%), Positives = 89/209 (42%), Gaps = 28/209 (13%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVA----EVQFLGVLEHP 139
           ++G G FG V++            +AT  V   K +N            E+  +  L HP
Sbjct: 58  ELGSGAFGVVHR---------CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHP 108

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
            L+ L        E   + +L+ EF+    L D +    +  +     ++ +  A EGL 
Sbjct: 109 KLINLHDAF----EDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLK 163

Query: 200 YLHEGLEVQVIYRDFKASNVLL--DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 257
           ++HE     +++ D K  N++    +    K+ DFGLA     +    +      T  +A
Sbjct: 164 HMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFA 217

Query: 258 APDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           AP+ ++   +   +D+W+ GV+ Y +L+G
Sbjct: 218 APEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 83.6 bits (207), Expect = 8e-18
 Identities = 63/283 (22%), Positives = 113/283 (39%), Gaps = 41/283 (14%)

Query: 14  RREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSE 73
           R     A E+       +    +S R    +             +   K   +  F Y  
Sbjct: 33  RSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSF-Y-- 89

Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVA--- 128
                   S+   +G G FG V+K             AT   +A K +   G++      
Sbjct: 90  ------TVSKTEILGGGRFGQVHK---------CEETATGLKLAAKIIKTRGMKDKEEVK 134

Query: 129 -EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTR 187
            E+  +  L+H NL++L  Y A + +  I  +LV E++    L D + + ++      T 
Sbjct: 135 NEISVMNQLDHANLIQL--YDAFESKNDI--VLVMEYVDGGELFDRIIDESYNLTELDTI 190

Query: 188 LHI--ILGAAEGLAYLHEGLEVQVIYRDFKASNVLL--DENFRPKLSDFGLAREGPMVGH 243
           L +  I    EG+ ++H+   + +++ D K  N+L    +  + K+ DFGLAR       
Sbjct: 191 LFMKQIC---EGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLAR---RYKP 241

Query: 244 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
                   GT  + AP+ +    ++  +D+WS GV+ Y +L+G
Sbjct: 242 REKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 83.1 bits (206), Expect = 8e-18
 Identities = 43/207 (20%), Positives = 87/207 (42%), Gaps = 25/207 (12%)

Query: 86  KIGEGGFGSVY----KSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNL 141
            +G G FG V+     SS K         A  V +K  ++  ++   E+  L +  H N+
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYM------AKFVKVKGTDQVLVK--KEISILNIARHRNI 63

Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 201
           + L        E   + ++++EF+    + + +   AF  L  +  +  +    E L +L
Sbjct: 64  LHLHESF----ESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFL 118

Query: 202 HEGLEVQVIYRDFKASNVLL--DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 259
           H      + + D +  N++     +   K+ +FG AR    +        +     Y AP
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNFRLLFTAPEYYAP 172

Query: 260 DYIETGHLTAKSDVWSFGVVLYEMLTG 286
           +  +   ++  +D+WS G ++Y +L+G
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSG 199

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 82.2 bits (204), Expect = 9e-18
 Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 44/218 (20%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVA------EVQFLGVLE 137
           ++G+G F  V +            + T    A K +N   L          E +    L+
Sbjct: 13  ELGKGAFSVVRR---------CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63

Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL------HII 191
           HPN+V+L        +      LV++ +     E  LF      +  +         H I
Sbjct: 64  HPNIVRLHDSI----QEESFHYLVFDLV--TGGE--LFED----IVAREFYSEADASHCI 111

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVST 248
               E +AY H      +++R+ K  N+LL    +    KL+DFGLA E   V  +    
Sbjct: 112 QQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWH 165

Query: 249 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
              GT GY +P+ ++    +   D+W+ GV+LY +L G
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 57/226 (25%), Positives = 88/226 (38%), Gaps = 47/226 (20%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-----RDGLQWVAEVQFLGVLEHPN 140
            +GEG +G V        A    +   +VAIKK+         L+ + E++ L   +H N
Sbjct: 18  LLGEGAYGVVCS------ATHKPTG-EIVAIKKIEPFDKPLFALRTLREIKILKHFKHEN 70

Query: 141 LVKLIGYCAVDGERGIQRL-LVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHI------ 190
           ++ +      D       + ++ E M   L+R +           L   +  HI      
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ-------ML---SDDHIQYFIYQ 120

Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--------EGPMVG 242
            L     +  LH      VI+RD K SN+L++ N   K+ DFGLAR             G
Sbjct: 121 TL---RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174

Query: 243 HTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 287
                   V T  Y AP+ +  +   +   DVWS G +L E+   R
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 44/226 (19%)

Query: 79  NDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQ------ 131
            DF  +L+ IG G +  V    +K      T    + A+K + ++ +    ++       
Sbjct: 9   QDF-DLLRVIGRGSYAKVLLVRLK-----KTDR--IYAMKVVKKELVNDDEDIDWVQTEK 60

Query: 132 --FLGVLEHPNLVKLIGYCAVDGERGIQ---RL-LVYEFMLNRSLEDHLFNRAFPPLPWK 185
             F     HP LV L   C        Q   RL  V E++    L  H+  +   P    
Sbjct: 61  HVFEQASNHPFLVGLH-SC-------FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH- 111

Query: 186 TRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 242
            R +    +AE    L YLHE     +IYRD K  NVLLD     KL+D+G+ +EG  + 
Sbjct: 112 ARFY----SAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LR 162

Query: 243 HTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 287
               ++   GT  Y AP+ +    +     D W+ GV+++EM+ GR
Sbjct: 163 PGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGR 207

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 84.1 bits (208), Expect = 1e-17
 Identities = 55/283 (19%), Positives = 109/283 (38%), Gaps = 31/283 (10%)

Query: 15  REERSAPEL------KEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRV 68
           + +   P         E ++   Y   E  + V+   + S      + +++++       
Sbjct: 90  QSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149

Query: 69  FSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVA--IKKLNRDGLQW 126
             +  +      +    ++G G FG V++        +  +     A  +   +    + 
Sbjct: 150 IKHDHVLD---HYDIHEELGTGAFGVVHR------VTERATGNNFAAKFVMTPHESDKET 200

Query: 127 VA-EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 185
           V  E+Q + VL HP LV L        E   + +++YEFM    L + + +     +   
Sbjct: 201 VRKEIQTMSVLRHPTLVNLHDAF----EDDNEMVMIYEFMSGGELFEKVADEHNK-MSED 255

Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL--DENFRPKLSDFGLAREGPMVGH 243
             +  +    +GL ++HE      ++ D K  N++     +   KL DFGL      +  
Sbjct: 256 EAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDP 309

Query: 244 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
                   GT  +AAP+  E   +   +D+WS GV+ Y +L+G
Sbjct: 310 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 70/315 (22%), Positives = 118/315 (37%), Gaps = 79/315 (25%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVA------EVQFLGVLE 137
           ++G+G F  V +            + T    A K +N   L          E +    L+
Sbjct: 36  ELGKGAFSVVRR---------CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 86

Query: 138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL------HII 191
           HPN+V+L        E      LV++ +     E  LF      +  +         H I
Sbjct: 87  HPNIVRLHDSI--QEESFHY--LVFDLV--TGGE--LFED----IVAREFYSEADASHCI 134

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVST 248
               E +AY H      +++R+ K  N+LL    +    KL+DFGLA E   V  +    
Sbjct: 135 QQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWH 188

Query: 249 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP---KTEQRLLEWV 305
              GT GY +P+ ++    +   D+W+ GV+LY +L G        P   + + RL   +
Sbjct: 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY------PPFWDEDQHRLYAQI 242

Query: 306 Q--QYPADSKKFG-------------LIMDPRLEKEYSINEARK---IGRLADNCLSKSS 347
           +   Y   S ++              L ++P+  K  + ++A K   I      C  +  
Sbjct: 243 KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPK--KRITADQALKVPWI------CNRERV 294

Query: 348 KDRPKMSQVVERLKQ 362
                    V+ LK+
Sbjct: 295 ASAIHRQDTVDCLKK 309

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 67/226 (29%), Positives = 95/226 (42%), Gaps = 44/226 (19%)

Query: 79  NDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQ------ 131
            DF   L  +G+G FG V  S  K     GT E  + A+K L +D +    +V+      
Sbjct: 20  TDF-NFLMVLGKGSFGKVMLSERK-----GTDE--LYAVKILKKDVVIQDDDVECTMVEK 71

Query: 132 --FLGVLEHPNLVKLIGYCAVDGERGIQ---RL-LVYEFMLNRSLEDHLFNRAFPPLPWK 185
                  + P L +L   C        Q   RL  V E++    L  H+        P  
Sbjct: 72  RVLALPGKPPFLTQLH-SC-------FQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-H 122

Query: 186 TRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 242
              +    AAE   GL +L       +IYRD K  NV+LD     K++DFG+ +E   + 
Sbjct: 123 AVFY----AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN--IW 173

Query: 243 HTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 287
               +    GT  Y AP+ I    +     D W+FGV+LYEML G+
Sbjct: 174 DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQ 218

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 60/228 (26%), Positives = 95/228 (41%), Gaps = 49/228 (21%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQWVAEVQFLGVLEHPNL 141
            +G GG G V+       A D   +   VAIKK+     +     + E++ +  L+H N+
Sbjct: 18  PLGCGGNGLVFS------AVDNDCD-KRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI 70

Query: 142 VKLIGYCAVDGERGIQRL----------LVYEFM---LNRSLEDHLFNRAFPPLPWKTRL 188
           VK+       G +    +          +V E+M   L   LE         PL      
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG-------PL---LEE 120

Query: 189 HI------ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLAR-EGPM 240
           H       +L    GL Y+H      V++RD K +N+ ++ E+   K+ DFGLAR   P 
Sbjct: 121 HARLFMYQLL---RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH 174

Query: 241 VGHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 287
             H    +  + T  Y +P  +    + T   D+W+ G +  EMLTG+
Sbjct: 175 YSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 81.5 bits (202), Expect = 1e-17
 Identities = 52/217 (23%), Positives = 85/217 (39%), Gaps = 37/217 (17%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVA----------EVQFL 133
           ++G G F  V K            + T    A K + +  L              EV  L
Sbjct: 12  ELGSGQFAIVRK---------CRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             + HPN++ L        E     +L+ E +    L D L  +    L        +  
Sbjct: 63  REIRHPNIITLHDIF----ENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQ 116

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLL----DENFRPKLSDFGLAREGPMVGHTHVSTA 249
             +G+ YLH     ++ + D K  N++L      N R KL DFG+A     +   +    
Sbjct: 117 ILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH---KIEAGNEFKN 170

Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 82.2 bits (204), Expect = 2e-17
 Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 40/222 (18%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQWV----AEVQ 131
            DF  +  +G G FG V+    +             A+K L ++    L+ V     E  
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSR-----HNGR--YYAMKVLKKEIVVRLKQVEHTNDERL 58

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFN-RAFPPLPWKTRLH 189
            L ++ HP ++++      D ++    + ++ +++    L   L   + FP      + +
Sbjct: 59  MLSIVTHPFIIRMW-GTFQDAQQ----IFMIMDYIEGGELFSLLRKSQRFPNP--VAKFY 111

Query: 190 IILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 246
               AAE    L YLH      +IYRD K  N+LLD+N   K++DFG A+  P V +T  
Sbjct: 112 ----AAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-- 162

Query: 247 STAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGR 287
              + GT  Y AP+ + T  +  +  D WSFG+++YEML G 
Sbjct: 163 ---LCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGY 200

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 30/219 (13%), Positives = 60/219 (27%), Gaps = 54/219 (24%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-------WVAEVQFLGVLEH 138
             G       ++      A D T+    VA+  ++  G+         ++    L  ++ 
Sbjct: 38  FHGGVPPLQFWQ------ALD-TALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90

Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 198
           P + +++             L+V E++   SL++        P P    +  +   A   
Sbjct: 91  PGVARVLDV----VHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGA-IRAMQSLAAAA 142

Query: 199 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
              H      V       S V +  +                 G       V+       
Sbjct: 143 DAAHR---AGVALSIDHPSRVRVSID-----------------GD-----VVLAYPATMP 177

Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT 297
                      + D+   G  LY +L  R  L     ++
Sbjct: 178 DA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRS 209

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 83.9 bits (207), Expect = 2e-17
 Identities = 73/279 (26%), Positives = 111/279 (39%), Gaps = 48/279 (17%)

Query: 26  PRKSADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRML 85
           P + ++ +     +F ++       +P         K  N    + +  R    DF   L
Sbjct: 292 PPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDN----NGNRDRMKLTDF-NFL 346

Query: 86  K-IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQ--------FLGVL 136
             +G+G FG V  S  K     GT E  + A+K L +D +    +V+             
Sbjct: 347 MVLGKGSFGKVMLSERK-----GTDE--LYAVKILKKDVVIQDDDVECTMVEKRVLALPG 399

Query: 137 EHPNLVKLIGYCAVDGERGIQ---RL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
           + P L +L   C        Q   RL  V E++    L  H+        P     +   
Sbjct: 400 KPPFLTQLH-SC-------FQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-HAVFY--- 447

Query: 193 GAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
            AAE   GL +L       +IYRD K  NV+LD     K++DFG+ +E   +     +  
Sbjct: 448 -AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN--IWDGVTTKT 501

Query: 250 VVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 287
             GT  Y AP+ I    +     D W+FGV+LYEML G+
Sbjct: 502 FCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQ 539

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 61/228 (26%), Positives = 94/228 (41%), Gaps = 46/228 (20%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQ 131
              +  +  +G G +G+V       +A DG +    VAIKKL R         +   E++
Sbjct: 24  RAVYRDLQPVGSGAYGAVC------SAVDGRTG-AKVAIKKLYRPFQSELFAKRAYRELR 76

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQR--LLVYEFM---LNRSLEDHLFNRAFPPLPWKT 186
            L  + H N++ L+     D          LV  FM   L + ++          L    
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-------KL---G 126

Query: 187 RLHI------ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
              I      +L   +GL Y+H      +I+RD K  N+ ++E+   K+ DFGLAR    
Sbjct: 127 EDRIQFLVYQML---KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR---- 176

Query: 241 VGHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 287
                  T  V T  Y AP+ I      T   D+WS G ++ EM+TG+
Sbjct: 177 -QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 64/306 (20%), Positives = 115/306 (37%), Gaps = 60/306 (19%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA------EVQFLGVLEHP 139
           ++G+G F  V +                 A   +N   L          E +   +L+HP
Sbjct: 18  ELGKGAFSVVRRCVKV-------LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           N+V+L    + +G       L+++ +    L + +  R +         H I    E + 
Sbjct: 71  NIVRLHDSISEEGHH----YLIFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVL 124

Query: 200 YLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           + H+   + V++R+ K  N+LL    +    KL+DFGLA E  + G         GT GY
Sbjct: 125 HCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAWFGFAGTPGY 179

Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP---KTEQRLLEWVQ--QYPAD 311
            +P+ +         D+W+ GV+LY +L G        P   + + RL + ++   Y   
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILLVGY------PPFWDEDQHRLYQQIKAGAYDFP 233

Query: 312 SKKFG-------------LIMDPRLEKEYSINEARKIGRLADN--CLSKSSKDRPKMSQV 356
           S ++              L ++P   K  +  EA     L         +        + 
Sbjct: 234 SPEWDTVTPEAKDLINKMLTINPS--KRITAAEA-----LKHPWISHRSTVASCMHRQET 286

Query: 357 VERLKQ 362
           V+ LK+
Sbjct: 287 VDCLKK 292

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 67/224 (29%), Positives = 96/224 (42%), Gaps = 40/224 (17%)

Query: 79  NDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQ------ 131
           +DF   LK IG+G FG V  +  K             A+K L +  +    E +      
Sbjct: 38  SDF-HFLKVIGKGSFGKVLLARHK-----AEEV--FYAVKVLQKKAILKKKEEKHIMSER 89

Query: 132 --FLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFN-RAFPPLPWKTR 187
              L  ++HP LV L  +     ++    L  V +++    L  HL   R F   P   R
Sbjct: 90  NVLLKNVKHPFLVGLH-FSFQTADK----LYFVLDYINGGELFYHLQRERCFL-EPR-AR 142

Query: 188 LHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT 244
            +    AAE    L YLH    + ++YRD K  N+LLD      L+DFGL +E   + H 
Sbjct: 143 FY----AAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN--IEHN 193

Query: 245 HVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 287
             ++   GT  Y AP+ + +  +     D W  G VLYEML G 
Sbjct: 194 STTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGL 236

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 62/226 (27%), Positives = 97/226 (42%), Gaps = 44/226 (19%)

Query: 79  NDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQ------ 131
            DF  +L+ IG G +  V    +K      T    + A++ + ++ +    ++       
Sbjct: 52  QDF-DLLRVIGRGSYAKVLLVRLK-----KTDR--IYAMRVVKKELVNDDEDIDWVQTEK 103

Query: 132 --FLGVLEHPNLVKLIGYCAVDGERGIQ---RL-LVYEFMLNRSLEDHLFNRAFPPLPWK 185
             F     HP LV L   C        Q   RL  V E++    L  H+  +   P    
Sbjct: 104 HVFEQASNHPFLVGLH-SC-------FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH- 154

Query: 186 TRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 242
            R +    +AE    L YLHE     +IYRD K  NVLLD     KL+D+G+ +EG  + 
Sbjct: 155 ARFY----SAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LR 205

Query: 243 HTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 287
               ++   GT  Y AP+ +    +     D W+ GV+++EM+ GR
Sbjct: 206 PGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGR 250

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 80.8 bits (200), Expect = 4e-17
 Identities = 50/217 (23%), Positives = 83/217 (38%), Gaps = 37/217 (17%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVA----------EVQFL 133
           ++G G F  V K            ++T    A K + +   +             EV  L
Sbjct: 19  ELGSGQFAIVKK---------CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             + H N++ L        E     +L+ E +    L D L  +    L  +     I  
Sbjct: 70  RQVLHHNVITLHDVY----ENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQ 123

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLL----DENFRPKLSDFGLAREGPMVGHTHVSTA 249
             +G+ YLH     ++ + D K  N++L          KL DFGLA     +        
Sbjct: 124 ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKN 177

Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 81.7 bits (202), Expect = 4e-17
 Identities = 48/207 (23%), Positives = 80/207 (38%), Gaps = 22/207 (10%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVAEVQFLG-VLEHPNLV 142
            +G G  G V +           ++ T    A+K L         EV+      + P++V
Sbjct: 69  VLGLGINGKVLQ---------IFNKRTQEKFALKMLQDCPKAR-REVELHWRASQCPHIV 118

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +++             L+V E +    L   + +R       +    I+    E + YLH
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 178

Query: 203 EGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 259
               + + +RD K  N+L      N   KL+DFG A+E       +  T    T  Y AP
Sbjct: 179 S---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---TTSHNSLTTPCYTPYYVAP 232

Query: 260 DYIETGHLTAKSDVWSFGVVLYEMLTG 286
           + +         D+WS GV++Y +L G
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIMYILLCG 259

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 81.2 bits (201), Expect = 4e-17
 Identities = 51/214 (23%), Positives = 83/214 (38%), Gaps = 31/214 (14%)

Query: 86  KIGEGGFGSVY----KSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-----EVQFLGVL 136
           ++G G F  V     KS+    A      A  +  ++               EV  L  +
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYA------AKFIKKRQSRASRRGVCREEIEREVSILRQV 72

Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
            HPN++ L        E     +L+ E +    L D L  +    L  +     I    +
Sbjct: 73  LHPNIITLHDVY----ENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILD 126

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLL----DENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
           G+ YLH     ++ + D K  N++L          KL DFGLA     +        + G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFG 180

Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           T  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 81.8 bits (202), Expect = 5e-17
 Identities = 60/310 (19%), Positives = 96/310 (30%), Gaps = 64/310 (20%)

Query: 29  SADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIG 88
           S + + A+          +         + +        +       Q  + +     IG
Sbjct: 3   SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIG 62

Query: 89  EGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLGVLEHPNLV 142
            G +G V +      A D   E  VVAIKK+ R      D  + + E+  L  L H ++V
Sbjct: 63  TGSYGHVCE------AYD-KLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVV 115

Query: 143 KLIGYCAVDGERGIQRL-LVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHI------IL 192
           K++             L +V E       +        R    L   T LHI      +L
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIADSDFKKLF------RTPVYL---TELHIKTLLYNLL 166

Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGHTHVS 247
               G+ Y+H      +++RD K +N L++++   K+ DFGLAR     E          
Sbjct: 167 ---VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220

Query: 248 TAVVGTFGYAAPDYIETGHLT---------------------AKSDVWSFGVVLYEMLTG 286
                              LT                        DVWS G +  E+L  
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280

Query: 287 RRSLERNRPK 296
            +        
Sbjct: 281 IKENVAYHAD 290

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 50/224 (22%), Positives = 91/224 (40%), Gaps = 38/224 (16%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA-EVQFLGVL 136
            +D+  + K+G G +  V+++          +E   V +K L     + +  E++ L  L
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINIT-----NNE--KVVVKILKPVKKKKIKREIKILENL 87

Query: 137 -EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI----- 190
              PN++ L     V         LV+E      + +  F + +  L   T   I     
Sbjct: 88  RGGPNIITL--ADIVKDPVSRTPALVFEH-----VNNTDFKQLYQTL---TDYDIRFYMY 137

Query: 191 -ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLAREG-PMVGHTHVS 247
            IL   + L Y H      +++RD K  NV++D E+ + +L D+GLA    P   +    
Sbjct: 138 EIL---KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR- 190

Query: 248 TAVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGRRSL 290
              V +  +  P+ +    +   S D+WS G +L  M+  +   
Sbjct: 191 ---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 51/217 (23%), Positives = 87/217 (40%), Gaps = 37/217 (17%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVA----------EVQFL 133
           ++G G F  V K            ++T    A K + +   +             EV  L
Sbjct: 18  ELGSGQFAVVKK---------CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             ++HPN++ L        E     +L+ E +    L D L  +    L  +     +  
Sbjct: 69  KEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQ 122

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLL----DENFRPKLSDFGLAREGPMVGHTHVSTA 249
              G+ YLH    +Q+ + D K  N++L        R K+ DFGLA     +   +    
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKN 176

Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 286
           + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 59/228 (25%), Positives = 94/228 (41%), Gaps = 46/228 (20%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQ 131
              +  +  +G G +GSV  +               VA+KKL+R         +   E++
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTG-------LRVAVKKLSRPFQSIIHAKRTYRELR 80

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQR--LLVYEFM---LNRSL------EDHLFNRAFP 180
            L  ++H N++ L+                LV   M   LN  +      +DH+  +   
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--QFL- 137

Query: 181 PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 240
                  ++ IL    GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 138 -------IYQIL---RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 180

Query: 241 VGHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 287
                  T  V T  Y AP+ +    H     D+WS G ++ E+LTGR
Sbjct: 181 -HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 78.4 bits (193), Expect = 4e-16
 Identities = 51/209 (24%), Positives = 84/209 (40%), Gaps = 38/209 (18%)

Query: 171 EDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS 230
           E+   +     L  +  +      A+G+ +L      + I+RD  A N+LL E    K+ 
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKIC 235

Query: 231 DFGLAREGPMVGHTHVSTAVVGTFGYA-----APDYIETGHLTAKSDVWSFGVVLYEMLT 285
           DFGLAR+            V            AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 236 DFGLARD-----IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

Query: 286 GRRSLERNRPKTEQRLLEWVQQYP---ADSKKFGLIMD-PRLEK-EYSINEARKIGRLAD 340
              S     P            YP    D +    + +  R+   +Y+  E   + +   
Sbjct: 291 LGAS-----P------------YPGVKIDEEFCRRLKEGTRMRAPDYTTPE---MYQTML 330

Query: 341 NCLSKSSKDRPKMSQVVERLKQIVQVSNE 369
           +C       RP  S++VE L  ++Q + +
Sbjct: 331 DCWHGEPSQRPTFSELVEHLGNLLQANAQ 359

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 76.9 bits (190), Expect = 9e-16
 Identities = 53/221 (23%), Positives = 84/221 (38%), Gaps = 40/221 (18%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVA----EVQFLG-VLEHP 139
           +GEG    V             +  T    A+K + +      +    EV+ L     H 
Sbjct: 21  LGEGAHARVQT---------CINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHR 71

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-AFPPLPWKTRLHIILGAAEGL 198
           N+++LI +     E   +  LV+E M   S+  H+  R  F  L     +  +  A   L
Sbjct: 72  NVLELIEFF----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASA---L 124

Query: 199 AYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAR-----EGPMVGHTHVSTAV 250
            +LH      + +RD K  N+L    ++    K+ DF L              T      
Sbjct: 125 DFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181

Query: 251 VGTFGYAAPDYIETGHLTAKS-----DVWSFGVVLYEMLTG 286
            G+  Y AP+ +E     A       D+WS GV+LY +L+G
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 77.4 bits (191), Expect = 9e-16
 Identities = 59/238 (24%), Positives = 98/238 (41%), Gaps = 61/238 (25%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLGVL-EH 138
           K+G+G +G V+K      + D      VVA+KK+        D  +   E+  L  L  H
Sbjct: 16  KLGKGAYGIVWK------SID-RRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68

Query: 139 PNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHI----- 190
            N+V L+     D +R +   LV+++M   L+  +      RA   L     +H      
Sbjct: 69  ENIVNLLNVLRADNDRDV--YLVFDYMETDLHAVI------RA-NIL---EPVHKQYVVY 116

Query: 191 -ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
            ++   + + YLH G    +++RD K SN+LL+     K++DFGL+R    +     +  
Sbjct: 117 QLI---KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170

Query: 250 VVGTFGYAAP--------DYIET------------GHLTAKSDVWSFGVVLYEMLTGR 287
           +                 DY+ T               T   D+WS G +L E+L G+
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 72.4 bits (178), Expect = 4e-14
 Identities = 47/222 (21%), Positives = 87/222 (39%), Gaps = 35/222 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIK---KLNRDGLQWVAEVQFLGVL------ 136
           K+G G F +V+       A D     T VA+K              E++ L  +      
Sbjct: 26  KLGWGHFSTVWL------AKD-MVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT 78

Query: 137 -----EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 191
                   +++KL+ +    G  G+  ++V+E +L  +L   +       +P      I 
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQIS 137

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP------KLSDFGLAREGPMVGHTH 245
                GL Y+H      +I+ D K  NVL++    P      K++D G A         H
Sbjct: 138 KQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEH 191

Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            + ++     Y +P+ +        +D+WS   +++E++TG 
Sbjct: 192 YTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 48/227 (21%), Positives = 82/227 (36%), Gaps = 35/227 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLI 145
            IG+GGFG +Y + +   + +         +K    D      E++F      P  ++  
Sbjct: 42  PIGQGGFGCIYLADMN--SSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKW 99

Query: 146 GYCAVDGERGIQRLL----------VYEFM----LNRSLEDHLFNRAFPPLPWKTRLHII 191
                    G+ +             Y FM        L+  ++         KT L + 
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQK-IYEANAKRFSRKTVLQLS 158

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK--LSDFGLARE-GPMVGHTHVS- 247
           L   + L Y+H   E + ++ D KASN+LL+     +  L D+GLA    P   H   + 
Sbjct: 159 LRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAA 215

Query: 248 ---TAVVGTFGYAAPDYIETGHL----TAKSDVWSFGVVLYEMLTGR 287
                  GT  + + D     H     + + D+   G  + + LTG 
Sbjct: 216 DPKRCHDGTIEFTSID----AHNGVAPSRRGDLEILGYCMIQWLTGH 258

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 46/229 (20%), Positives = 81/229 (35%), Gaps = 44/229 (19%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQWVAEVQFLG-VLEHPNLV 142
            +G G  G V +           ++ T    A+K L +D  +   EV+      + P++V
Sbjct: 25  VLGLGINGKVLQ---------IFNKRTQEKFALKML-QDCPKARREVELHWRASQCPHIV 74

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           +++             L+V E +    L   + +R       +    I+    E + YLH
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134

Query: 203 EGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 259
               + + +RD K  N+L      N   KL+DFG A+E              G   Y   
Sbjct: 135 S---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE------------TTGE-KY--- 175

Query: 260 DYIETGHLTAKSDVWSFGVVLYEMLTGRRS-LERNRPKTEQRLLEWVQQ 307
                       D+WS GV++Y +L G       +       +   ++ 
Sbjct: 176 --------DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 216

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 65.3 bits (158), Expect = 6e-12
 Identities = 49/333 (14%), Positives = 87/333 (26%), Gaps = 88/333 (26%)

Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------------- 123
            T    R  KIGEG FG V++           ++ T VAIK +  +G             
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQ---------TIADHTPVAIKIIAIEGPDLVNGSHQKTFE 68

Query: 124 --------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF 175
                    + ++ +           + L     V G      L  ++   +     +  
Sbjct: 69  EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128

Query: 176 NRAFPP-----------------------LPWKTRLHIILGAAEGLAYLHEGLEVQVIYR 212
              F                             T   I+      LA       ++  +R
Sbjct: 129 PDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHR 186

Query: 213 DFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP--DYIETGHLTAK 270
           D    NVLL +    KL      +           ++ + + G      DY  +      
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGK-----------SSTIPSCGLQVSIIDYTLSRLERDG 235

Query: 271 SDVWSFGVVLYEMLTGRRSLERN----------------RPKTEQRLLEWVQQYPADSKK 314
             V+    +  ++ TG    + +                 P +    L ++         
Sbjct: 236 IVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT 295

Query: 315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSS 347
           F    +    K+      RKI       L+ SS
Sbjct: 296 FKTKCNTPAMKQI----KRKIQEFHRTMLNFSS 324

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 65.1 bits (159), Expect = 8e-12
 Identities = 40/236 (16%), Positives = 74/236 (31%), Gaps = 53/236 (22%)

Query: 86  KIGEGGFGSVYK-SSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKL 144
                  G +Y+ +       D   +    ++K   +DG +   E  F      P  V  
Sbjct: 49  FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDG-RLFNEQNFFQRAAKPLQVNK 107

Query: 145 IGYCAVDGERGIQRLL-------VYEFM----LNRSLEDHLFN----RAFPPLPWKTRLH 189
                      I   +        Y F+    L RSL+    +            ++ L 
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQS-ALDVSPKHVLSE---RSVLQ 163

Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK--LSDFGLA------------ 235
           +     + L +LH   E + ++ +  A N+ +D   + +  L+ +G A            
Sbjct: 164 VACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY 220

Query: 236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHL----TAKSDVWSFGVVLYEMLTGR 287
            EG    H        G   + + D     H     + +SD+ S G  + + L G 
Sbjct: 221 VEGSRSPHE-------GDLEFISMD----LHKGCGPSRRSDLQSLGYCMLKWLYGF 265

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 56/216 (25%), Positives = 83/216 (38%), Gaps = 33/216 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIK--KLNRDGLQWVAEVQFLGVLEH-PNLV 142
           KIG G FG +Y        G   +    VAIK   +     Q   E +   +++    + 
Sbjct: 16  KIGSGSFGDIYL-------GTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 68

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
            +       G  G   ++V E +L  SLED LFN        KT L +       + Y+H
Sbjct: 69  TIRWC----GAEGDYNVMVME-LLGPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYIH 122

Query: 203 EGLEVQVIYRDFKASNVLLDENFRPK---LSDFGLARE-GPMVGHTHV----STAVVGTF 254
                  I+RD K  N L+    +     + DFGLA++      H H+    +  + GT 
Sbjct: 123 ---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179

Query: 255 GYA---APDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            YA       IE    + + D+ S G VL     G 
Sbjct: 180 RYASINTHLGIE---QSRRDDLESLGYVLMYFNLGS 212

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 59/217 (27%), Positives = 89/217 (41%), Gaps = 35/217 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIK--KLNRDGLQWVAEVQFLGVLE-HPNLV 142
           KIG G FG +Y        G        VAIK   +     Q + E +   +L+    + 
Sbjct: 14  KIGSGSFGEIYL-------GTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIP 66

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
            +  +    G  G   +LV + +L  SLED LFN     L  KT L +       + ++H
Sbjct: 67  NVRWF----GVEGDYNVLVMD-LLGPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 203 EGLEVQVIYRDFKASNVLLDENFRPK---LSDFGLARE-GPMVGHTHV----STAVVGTF 254
                  ++RD K  N L+    R     + DFGLA++      H H+    +  + GT 
Sbjct: 121 ---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177

Query: 255 GYAAPDYIETGHL----TAKSDVWSFGVVLYEMLTGR 287
            YA+   + T HL    + + D+ S G VL   L G 
Sbjct: 178 RYAS---VNT-HLGIEQSRRDDLESLGYVLMYFLRGS 210

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 62.8 bits (153), Expect = 4e-11
 Identities = 52/219 (23%), Positives = 82/219 (37%), Gaps = 37/219 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIK--KLNRDGLQWVAEVQFLGVLEH-PNLV 142
           +IGEG FG +++       G        VAIK      D  Q   E +   +L     + 
Sbjct: 17  RIGEGSFGVIFE-------GTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 69

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
            +  +    G+ G+  +LV + +L  SLED L +        KT           +  +H
Sbjct: 70  NVYYF----GQEGLHNVLVID-LLGPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQSIH 123

Query: 203 EGLEVQVIYRDFKASNVLLDENFRPK-----LSDFGLARE-GPMVGHTHV----STAVVG 252
              E  ++YRD K  N L+            + DFG+ +     V   H+       + G
Sbjct: 124 ---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180

Query: 253 TFGYAAPDYIETGHL----TAKSDVWSFGVVLYEMLTGR 287
           T  Y +   I T HL    + + D+ + G V    L G 
Sbjct: 181 TARYMS---INT-HLGREQSRRDDLEALGHVFMYFLRGS 215

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 47/231 (20%), Positives = 82/231 (35%), Gaps = 46/231 (19%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATV--VAIKKLNRDGLQWVAEVQFLGVLEHPNLV- 142
           KIG GGFG +Y       A             +K   ++     +E++F   +   + + 
Sbjct: 44  KIGSGGFGLIYL------AFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97

Query: 143 --------------KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-FNRAFPPLPWKTR 187
                            G    + +    R +V E  L   L+     N  F      T 
Sbjct: 98  KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVME-RLGIDLQKISGQNGTFKK---STV 153

Query: 188 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK--LSDFGLARE-GPMVGHT 244
           L + +   + L Y+H   E + ++ D KA+N+LL      +  L+D+GL+    P   H 
Sbjct: 154 LQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210

Query: 245 HVS----TAVVGTFGYAAPDYIETGHL----TAKSDVWSFGVVLYEMLTGR 287
                      GT  + +   ++  H     + +SDV   G  +   L G+
Sbjct: 211 QYQENPRKGHNGTIEFTS---LDA-HKGVALSRRSDVEILGYCMLRWLCGK 257

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 61.4 bits (148), Expect = 3e-10
 Identities = 55/414 (13%), Positives = 112/414 (27%), Gaps = 128/414 (30%)

Query: 12  LRRREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNL----R 67
           L  ++E    +  E     +Y       F+ S        P  +  +Y E+   L    +
Sbjct: 71  LLSKQEEMVQKFVEEVLRINYK------FLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQ 124

Query: 68  VFS---------YSEMRQATNDFSRMLKI---GEGGFGSVYKSSIKPAAGDGTSEATVVA 115
           VF+         Y ++RQA  +      +   G  G G   K+ +   A D      V  
Sbjct: 125 VFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---KTWV---ALDVCLSYKV-- 176

Query: 116 IKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL--LVYEFMLN-RSLED 172
            +      + W+                 +  C       ++ L  L+Y+   N  S  D
Sbjct: 177 -QCKMDFKIFWLN----------------LKNCNSPETV-LEMLQKLLYQIDPNWTSRSD 218

Query: 173 HLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF 232
           H  N        +  L  +L +          L   ++  + + +       F     + 
Sbjct: 219 HSSNIKLRIHSIQAELRRLLKSKP----YENCL---LVLLNVQNAKAW--NAF-----NL 264

Query: 233 G-----LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
                   R         V+  +             T H++      +            
Sbjct: 265 SCKILLTTRF------KQVTDFLSAA---------TTTHISLDHHSMTL----------- 298

Query: 288 RSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSS 347
                   + +  LL+++     D +   L   PR        E         + +++S 
Sbjct: 299 -----TPDEVKSLLLKYL-----DCRPQDL---PR--------EVLTTNPRRLSIIAESI 337

Query: 348 KDRPKMSQ-----VVERLKQIVQVSNEG---DSFDKTFEE--ICEED-PVEAQT 390
           +D             ++L  I++ S        + K F+   +      +    
Sbjct: 338 RDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL 391

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 47/263 (17%), Positives = 84/263 (31%), Gaps = 75/263 (28%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEH------- 138
           K+G G F +V+       + D       VA+K +          +  + +L+        
Sbjct: 44  KLGWGHFSTVWL------SWD-IQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96

Query: 139 ----PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 194
                 +V+L+    + G  G    +V+E +L   L   +    +  LP      II   
Sbjct: 97  DPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQV 155

Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVLL--------------------------------- 221
            +GL YLH   + ++I+ D K  N+LL                                 
Sbjct: 156 LQGLDYLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213

Query: 222 ----------------DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG 265
                            E  + K++D G A            T  + T  Y + + +   
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH-----KHFTEDIQTRQYRSLEVLIGS 268

Query: 266 HLTAKSDVWSFGVVLYEMLTGRR 288
                +D+WS   + +E+ TG  
Sbjct: 269 GYNTPADIWSTACMAFELATGDY 291

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 60.1 bits (146), Expect = 5e-10
 Identities = 54/219 (24%), Positives = 84/219 (38%), Gaps = 45/219 (20%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-NRDGL--QWVAEVQFLGVL------E 137
           IG+G FG V K      A D       VA+K + N      Q   E++ L  L       
Sbjct: 105 IGKGSFGQVVK------AYDHKVH-QHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDN 157

Query: 138 HPNLVKLIGY-------CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
             N++ ++         C           + +E +L+ +L + +    F           
Sbjct: 158 TMNVIHMLENFTFRNHIC-----------MTFE-LLSMNLYELIKKNKFQGFSLPLVRKF 205

Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP--KLSDFGLAREGPMVGHTHVST 248
                + L  LH+    ++I+ D K  N+LL +  R   K+ DFG +       H  V T
Sbjct: 206 AHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYT 258

Query: 249 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
            +   F Y AP+ I         D+WS G +L E+LTG 
Sbjct: 259 YIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 59.7 bits (145), Expect = 6e-10
 Identities = 57/220 (25%), Positives = 84/220 (38%), Gaps = 43/220 (19%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-NRDGL--QWVAEVQFLGVL------ 136
            IG+G FG V K      A D   +   VAIK + N+     Q   EV+ L ++      
Sbjct: 61  LIGKGSFGQVVK------AYDRVEQ-EWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113

Query: 137 EHPNLVKLIGY-------CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 189
               +V L  +       C           LV+E ML+ +L D L N  F  +       
Sbjct: 114 MKYYIVHLKRHFMFRNHLC-----------LVFE-MLSYNLYDLLRNTNFRGVSLNLTRK 161

Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP--KLSDFGLAREGPMVGHTHVS 247
                   L +L    E+ +I+ D K  N+LL    R   K+ DFG +          + 
Sbjct: 162 FAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIY 216

Query: 248 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 287
             +   F Y +P+ +         D+WS G +L EM TG 
Sbjct: 217 QYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 58.9 bits (143), Expect = 8e-10
 Identities = 56/219 (25%), Positives = 82/219 (37%), Gaps = 37/219 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIK--KLNRDGLQWVAEVQFLGVLEH-PNLV 142
           KIG G FG +         G        VAIK   +     Q   E +F   L     + 
Sbjct: 16  KIGCGNFGELRL-------GKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIP 68

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
           ++  +    G  G    +V E +L  SLED LF+        KT L I +     + Y+H
Sbjct: 69  QVYYF----GPCGKYNAMVLE-LLGPSLED-LFDLCDRTFSLKTVLMIAIQLISRMEYVH 122

Query: 203 EGLEVQVIYRDFKASNVLLDENFRPK-----LSDFGLARE-GPMVGHTHV----STAVVG 252
                 +IYRD K  N L+            + DF LA+E        H+      ++ G
Sbjct: 123 ---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTG 179

Query: 253 TFGYAAPDYIETGHL----TAKSDVWSFGVVLYEMLTGR 287
           T  Y +   I T HL    + + D+ + G +    L G 
Sbjct: 180 TARYMS---INT-HLGKEQSRRDDLEALGHMFMYFLRGS 214

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 52/240 (21%), Positives = 79/240 (32%), Gaps = 69/240 (28%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIK------KLNRDGLQWVAEVQFLGVL--- 136
            +GEG FG V +        D     + VA+K      K          E+  L  +   
Sbjct: 26  NLGEGTFGKVVE------CLDHARGKSQVALKIIRNVGKYREAARL---EINVLKKIKEK 76

Query: 137 ---EHPNLVKLIGY-------CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKT 186
                   V +  +       C           + +E +L ++  + L    F P P   
Sbjct: 77  DKENKFLCVLMSDWFNFHGHMC-----------IAFE-LLGKNTFEFLKENNFQPYPLPH 124

Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP------------------- 227
             H+       L +LHE    Q+ + D K  N+L   +                      
Sbjct: 125 VRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181

Query: 228 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTG 286
           +++DFG A       H H +T V     Y  P+ I E G      DVWS G +L+E   G
Sbjct: 182 RVADFGSA----TFDHEHHTTIVATRH-YRPPEVILELGWAQP-CDVWSIGCILFEYYRG 235

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 50.0 bits (120), Expect = 6e-07
 Identities = 51/240 (21%), Positives = 78/240 (32%), Gaps = 69/240 (28%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIK------KLNRDGLQWVAEVQFLGVL--- 136
            +GEG FG V +        D  +    VA+K      +          E+Q L  L   
Sbjct: 21  TLGEGAFGKVVE------CIDHKAGGRHVAVKIVKNVDRYCEAARS---EIQVLEHLNTT 71

Query: 137 ---EHPNLVKLIGY-------CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKT 186
                   V+++ +       C           +V+E +L  S  D +    F P     
Sbjct: 72  DPNSTFRCVQMLEWFEHHGHIC-----------IVFE-LLGLSTYDFIKENGFLPFRLDH 119

Query: 187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP------------------- 227
              +     + + +LH     ++ + D K  N+L  ++                      
Sbjct: 120 IRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176

Query: 228 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTG 286
           K+ DFG A         H ST V     Y AP+ I   G      DVWS G +L E   G
Sbjct: 177 KVVDFGSA----TYDDEHHSTLVSTRH-YRAPEVILALGWSQP-CDVWSIGCILIEYYLG 230

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 53/245 (21%), Positives = 83/245 (33%), Gaps = 75/245 (30%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIK------KLNRDGLQWVAEVQFLGVL--- 136
           K+G+G FG V             ++    A+K      K  R       E   L  +   
Sbjct: 42  KMGDGTFGRVLL------CQHIDNK-KYYAVKVVRNIKKYTRSAKI---EADILKKIQND 91

Query: 137 --EHPNLVKLIGY-------CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTR 187
              + N+VK  G        C           L++E  L  SL + +    +     +  
Sbjct: 92  DINNNNIVKYHGKFMYYDHMC-----------LIFE-PLGPSLYEIITRNNYNGFHIEDI 139

Query: 188 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP-------------------- 227
               +   + L YL +   + + + D K  N+LLD+ +                      
Sbjct: 140 KLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196

Query: 228 -----KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLY 281
                KL DFG A         +  + +     Y AP+ I   G   + SD+WSFG VL 
Sbjct: 197 KSTGIKLIDFGCA----TFKSDYHGSIINTRQ-YRAPEVILNLGWDVS-SDMWSFGCVLA 250

Query: 282 EMLTG 286
           E+ TG
Sbjct: 251 ELYTG 255

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	432
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.83
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.72
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.42
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.2
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.18
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.05
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.73
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.49
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.43
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.38
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.38
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.37
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.16
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.07
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.86
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.82
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.59
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.54
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.51
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.44
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.39
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.38
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.37
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.16
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.1
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.0
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.46
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.38
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.13
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.24
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	92.27
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	88.38
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	83.27

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=8.6e-59  Score=445.40  Aligned_cols=263  Identities=25%  Similarity=0.434  Sum_probs=206.4

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      .+|.+.+.||+|+||+||+|+++...  ...++..||||+++...    ..|.+|+++|++++|||||+++|+|.+... 
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~--~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~-  117 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLL--PEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP-  117 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSC--C---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS-
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcc--cCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-
Confidence            46788889999999999999986321  23467899999997643    348899999999999999999999976553 


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEE
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRA-------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL  221 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill  221 (432)
                         .+||||||++|+|.++|....             ..+++|.+++.|+.||+.||.|||+.   +|+||||||+||||
T Consensus       118 ---~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl  191 (329)
T 4aoj_A          118 ---LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLV  191 (329)
T ss_dssp             ---EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             ---EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEE
Confidence               599999999999999997542             24699999999999999999999998   99999999999999


Q ss_pred             cCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 014034          222 DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQR  300 (432)
Q Consensus       222 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~  300 (432)
                      +.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.....   
T Consensus       192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---  268 (329)
T 4aoj_A          192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---  268 (329)
T ss_dssp             ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---
T ss_pred             CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---
Confidence            9999999999999986433333333445679999999999999999999999999999999999 899998765432   


Q ss_pred             HHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhc
Q 014034          301 LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  367 (432)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  367 (432)
                      +...+....          ..    ..+..++..+.+||.+||+.||++|||+.+|+++|+.+.+..
T Consensus       269 ~~~~i~~g~----------~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p  321 (329)
T 4aoj_A          269 AIDCITQGR----------EL----ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP  321 (329)
T ss_dssp             HHHHHHHTC----------CC----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred             HHHHHHcCC----------CC----CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence            222222110          01    112233467889999999999999999999999999987653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7.3e-59  Score=440.05  Aligned_cols=264  Identities=25%  Similarity=0.416  Sum_probs=212.1

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      ++|.+.+.||+|+||+||+|++....  ...++..||||+++...    ..|.+|+++|++++|||||+++|+|.+.+. 
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~--~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~-   89 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLC--PEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP-   89 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC------CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS-
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcc--cCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE-
Confidence            46888999999999999999986322  22467899999997643    348899999999999999999999986553 


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRA-----------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  223 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~  223 (432)
                         .+||||||++|+|.++|....           ...++|..++.|+.||+.||.|||++   +|+||||||+||||+.
T Consensus        90 ---~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~  163 (299)
T 4asz_A           90 ---LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGE  163 (299)
T ss_dssp             ---EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred             ---EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECC
Confidence               599999999999999997532           34799999999999999999999998   9999999999999999


Q ss_pred             CCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHH
Q 014034          224 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLL  302 (432)
Q Consensus       224 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~  302 (432)
                      ++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.....   +.
T Consensus       164 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~  240 (299)
T 4asz_A          164 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VI  240 (299)
T ss_dssp             GGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HH
T ss_pred             CCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HH
Confidence            99999999999975322222223344579999999999999999999999999999999999 899998765432   32


Q ss_pred             HHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhcc
Q 014034          303 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  368 (432)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  368 (432)
                      ..+.....          +    ..+..++..+.+||.+||+.||++|||+.+|++.|+.+.+..+
T Consensus       241 ~~i~~~~~----------~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p  292 (299)
T 4asz_A          241 ECITQGRV----------L----QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP  292 (299)
T ss_dssp             HHHHHTCC----------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             HHHHcCCC----------C----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence            22222110          0    1122345678899999999999999999999999998876543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.1e-58  Score=438.71  Aligned_cols=258  Identities=25%  Similarity=0.408  Sum_probs=208.5

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      +++.++.||+|+||+||+|.+....  ...+++.||||+++..     ...|.+|+.+|++++|||||+++|+|..++. 
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~--~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~-  103 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPA--PGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP-  103 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC---------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCc--cCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE-
Confidence            5677889999999999999985211  2246789999998643     3468999999999999999999999987654 


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceE
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVL  220 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nil  220 (432)
                         .+||||||++|+|.++|..+.              ...++|..++.|+.|||.||+|||++   +|+||||||+|||
T Consensus       104 ---~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NIL  177 (308)
T 4gt4_A          104 ---LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVL  177 (308)
T ss_dssp             ---CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             ---EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceE
Confidence               399999999999999996532              23689999999999999999999998   9999999999999


Q ss_pred             EcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhH
Q 014034          221 LDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQ  299 (432)
Q Consensus       221 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~  299 (432)
                      |++++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||++|||+| |..||.+....   
T Consensus       178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---  254 (308)
T 4gt4_A          178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---  254 (308)
T ss_dssp             ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---
T ss_pred             ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---
Confidence            99999999999999985322222233445689999999999999999999999999999999999 89999876543   


Q ss_pred             HHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          300 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                      .+...+.....              ...+..++..+.+||.+||+.||.+|||+.+|+++|+.+
T Consensus       255 ~~~~~i~~~~~--------------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          255 DVVEMIRNRQV--------------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHHHHHHTTCC--------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHHHcCCC--------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            23333322110              011233456788999999999999999999999999865

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-57  Score=432.31  Aligned_cols=256  Identities=27%  Similarity=0.453  Sum_probs=201.0

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      +++.+.+.||+|+||+||+|++.          ..||||.++..      ...|.+|+.+|++++|||||+++|++..+ 
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~----------~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~-  104 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWH----------GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD-  104 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESS----------SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-
T ss_pred             HHeEEeeEEeeCCCcEEEEEEEC----------CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC-
Confidence            57888999999999999999864          24899988632      23488999999999999999999988543 


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..+||||||++|+|.++|.... .++++..+..|+.||+.||+|||++   +|+||||||+||||+.++.+||+||
T Consensus       105 ----~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DF  176 (307)
T 3omv_A          105 ----NLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDF  176 (307)
T ss_dssp             ----SCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCC
T ss_pred             ----eEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeec
Confidence                2489999999999999997654 4699999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCcccccc---CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIET---GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      |+|+..............+||+.|||||++.+   +.|+.++|||||||++|||+||+.||.+......  +...+....
T Consensus       177 Gla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~--~~~~~~~~~  254 (307)
T 3omv_A          177 GLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ--IIFMVGRGY  254 (307)
T ss_dssp             SSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHHHHHTTC
T ss_pred             cCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH--HHHHHhcCC
Confidence            99986433233334456789999999999964   4689999999999999999999999987654322  111111110


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                               ..+.+. ..+..++..+.+||.+||+.||.+|||+.+|+++|+.+..
T Consensus       255 ---------~~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          255 ---------ASPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             ---------CCCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             ---------CCCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                     011111 1223345678899999999999999999999999987754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=5.5e-58  Score=440.52  Aligned_cols=249  Identities=24%  Similarity=0.399  Sum_probs=202.5

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|++++.||+|+||+||+|+++       .+++.||||+++..      ...+.+|+.+|++|+|||||++++++.++
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~   95 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKST-------EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN   95 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEET-------TTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             ccceEEeEEEecCCCeEEEEEEEC-------CCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence            358999999999999999999976       56789999998643      23488999999999999999999999876


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ..|||||||+||+|.++|..+....+++..++.|+.||+.||.|||++   +|+||||||+||||+.+|.+||+|
T Consensus        96 ~----~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~D  168 (350)
T 4b9d_A           96 G----SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGD  168 (350)
T ss_dssp             T----EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECS
T ss_pred             C----EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcc
Confidence            5    459999999999999999876666789999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ||+|+...  .........+||+.|||||++.+..|+.++|||||||++|||+||..||.+.+...   +...+..... 
T Consensus       169 FGla~~~~--~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i~~~~~-  242 (350)
T 4b9d_A          169 FGIARVLN--STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN---LVLKIISGSF-  242 (350)
T ss_dssp             TTEESCCC--HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHTCC-
T ss_pred             cccceeec--CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHHHcCCC-
Confidence            99998631  12223345789999999999999999999999999999999999999998765432   2222221110 


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                               +    ..+...+..+.+||.+||+.||.+|||+.|++++
T Consensus       243 ---------~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          243 ---------P----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             ---------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---------C----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                     0    0112234678899999999999999999999886

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.7e-57  Score=438.56  Aligned_cols=273  Identities=25%  Similarity=0.350  Sum_probs=219.1

Q ss_pred             HHHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCC-Cccceee
Q 014034           72 SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEH-PNLVKLI  145 (432)
Q Consensus        72 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h-pniv~l~  145 (432)
                      ++.....++|++.+.||+|+||+||+|.+....  .....+.||||.+....     ..+.+|+.+|.++.| ||||+++
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~--~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID--KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSS--STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCC--cccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            333445578999999999999999999987332  33466899999987532     348899999999965 9999999


Q ss_pred             eEEeecCCcceeEEEEEeecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceee
Q 014034          146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIY  211 (432)
Q Consensus       146 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH  211 (432)
                      |+|..++.   .+++|||||++|+|.++|....              ...+++..+..++.|||.||+|||++   +|||
T Consensus       135 g~~~~~~~---~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiH  208 (353)
T 4ase_A          135 GACTKPGG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIH  208 (353)
T ss_dssp             EEECCTTS---CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             EEEEecCC---EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---Ceec
Confidence            99976532   2489999999999999997532              23589999999999999999999998   9999


Q ss_pred             cCCCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 014034          212 RDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSL  290 (432)
Q Consensus       212 ~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf  290 (432)
                      |||||+|||++.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |..||
T Consensus       209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf  288 (353)
T 4ase_A          209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY  288 (353)
T ss_dssp             SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence            99999999999999999999999986543333334456789999999999999999999999999999999998 99999


Q ss_pred             CCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhcc
Q 014034          291 ERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  368 (432)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  368 (432)
                      .+......  +...+....          .+    ..+..++..+.+||.+||+.||.+|||+.+|+++|+.+++...
T Consensus       289 ~~~~~~~~--~~~~i~~g~----------~~----~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~  350 (353)
T 4ase_A          289 PGVKIDEE--FCRRLKEGT----------RM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  350 (353)
T ss_dssp             TTCCCSHH--HHHHHHHTC----------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             CCCCHHHH--HHHHHHcCC----------CC----CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence            87653321  222221110          01    1122334678899999999999999999999999999987543

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.8e-57  Score=432.72  Aligned_cols=259  Identities=24%  Similarity=0.262  Sum_probs=209.6

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHHHHHHHhcccCCCccceeeeEEeecCCccee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQ  157 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~  157 (432)
                      .+.|...++||+|+||.||+|+++       .+++.||||+++.+.. ..+|+.+|+.++|||||++++++.+++    .
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~-------~~g~~vAiK~i~~~~~-~~~E~~il~~l~HpnIV~l~~~~~~~~----~  124 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDK-------QTGFQCAVKKVRLEVF-RVEELVACAGLSSPRIVPLYGAVREGP----W  124 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEETTTC-CTHHHHTTTTCCCTTBCCEEEEEEETT----E
T ss_pred             hhheEeCcEeccCCCeEEEEEEEC-------CCCCEEEEEEECHHHh-HHHHHHHHHhCCCCCCCcEEEEEEECC----E
Confidence            356888899999999999999976       5678999999976432 357999999999999999999998755    4


Q ss_pred             EEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC-ceeeccccCCc
Q 014034          158 RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF-RPKLSDFGLAR  236 (432)
Q Consensus       158 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~DfG~a~  236 (432)
                      .|||||||+||+|.++|....  .+++..+..++.||+.||+|||++   +|+||||||+||||+.+| .+||+|||+|+
T Consensus       125 ~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~  199 (336)
T 4g3f_A          125 VNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHAL  199 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred             EEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence            599999999999999997653  799999999999999999999998   999999999999999988 59999999998


Q ss_pred             CCCCCCCc---ccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          237 EGPMVGHT---HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       237 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      ........   ......+||+.|||||++.+..|+.++|||||||++|||+||..||.+.......   ..+...+..  
T Consensus       200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~i~~~~~~--  274 (336)
T 4g3f_A          200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC---LKIASEPPP--  274 (336)
T ss_dssp             EC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH---HHHHHSCCG--
T ss_pred             EccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH---HHHHcCCCC--
Confidence            64322111   1223468999999999999999999999999999999999999999875543221   111111110  


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhcc
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  368 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  368 (432)
                       +         ...+...+..+.+||.+||+.||.+|||+.||+++|..+++...
T Consensus       275 -~---------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~  319 (336)
T 4g3f_A          275 -I---------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG  319 (336)
T ss_dssp             -G---------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             -c---------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence             0         01223345678899999999999999999999999998876543

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.2e-57  Score=433.69  Aligned_cols=247  Identities=25%  Similarity=0.398  Sum_probs=206.0

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC----hHHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      ..|+.++.||+|+||+||+|+++       .+++.||||+++..    ...+.+|+.+|+.++|||||++++++.+++  
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~-------~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--  144 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVR-------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--  144 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT--
T ss_pred             HhcEEeEEeecCcCeEEEEEEEC-------CCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--
Confidence            56999999999999999999976       56789999998542    234789999999999999999999998765  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        .+|||||||+||+|.+++...   .+++..+..++.||+.||+|||++   +|+||||||+||||+.+|.+||+|||+
T Consensus       145 --~~~ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGl  216 (346)
T 4fih_A          145 --ELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGF  216 (346)
T ss_dssp             --EEEEEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             --EEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcC
Confidence              459999999999999999753   599999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      |+....  ........+||+.|||||++.+..|+.++|||||||++|||++|..||.+......   ...+.....    
T Consensus       217 a~~~~~--~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~~~i~~~~~----  287 (346)
T 4fih_A          217 CAQVSK--EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRDNLP----  287 (346)
T ss_dssp             CEECCS--SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHHSSC----
T ss_pred             ceecCC--CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHHHcCCC----
Confidence            986322  22334567899999999999999999999999999999999999999987654332   222222110    


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                            +.+  ......+..+.+||.+||..||.+|||+.|++++
T Consensus       288 ------~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          288 ------PRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             ------CCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ------CCC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                  000  1112234678899999999999999999999876

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=7.3e-57  Score=425.85  Aligned_cols=247  Identities=21%  Similarity=0.295  Sum_probs=207.0

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|++++.||+|+||+||+|+++       .+++.||||++++.       ...+.+|+++|+.++|||||++++++.++
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~-------~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  104 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLAREL-------ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD  104 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccEEEEEEecccCeEEEEEEEC-------CCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence            47999999999999999999976       56789999998643       23488999999999999999999999765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ..||||||++||+|.++|....  .+++..+..++.||+.||.|||++   +|+||||||+||||+.++.+||+|
T Consensus       105 ~----~~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~D  175 (311)
T 4aw0_A          105 E----KLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITD  175 (311)
T ss_dssp             S----EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred             C----EEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEE
Confidence            4    4599999999999999997643  799999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ||+|+..............+||+.|||||++.+..|+.++|||||||++|+|+||..||.+.+...   +...+..... 
T Consensus       176 FGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~~~~~-  251 (311)
T 4aw0_A          176 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---IFAKIIKLEY-  251 (311)
T ss_dssp             CTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHTCC-
T ss_pred             cCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHcCCC-
Confidence            999986543333344556789999999999999999999999999999999999999998754332   2222222110 


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                .+    +...+..+.+||.+||..||.+|||+.|++.+
T Consensus       252 ----------~~----p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          252 ----------DF----PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             ----------CC----CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             ----------CC----CcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence                      11    11224568899999999999999999987544

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.5e-56  Score=421.34  Aligned_cols=246  Identities=23%  Similarity=0.352  Sum_probs=198.1

Q ss_pred             ccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           82 SRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        82 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      ...+.||+|+||+||+|.++       .++..||+|.+...      ...+.+|+.+|++|+|||||++++++.......
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~  101 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDT-------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTE
T ss_pred             EeeeEEecCcCcEEEEEEEC-------CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCC
Confidence            55667999999999999976       56789999998542      234889999999999999999999987644434


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCc--eeecCCCCCceEEc-CCCceeeccc
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQ--VIYRDFKASNVLLD-ENFRPKLSDF  232 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~--ivH~Dikp~Nill~-~~~~~kl~Df  232 (432)
                      ..++||||||+||+|.+++.+.  ..+++..+..|+.||+.||+|||++   +  |+||||||+||||+ .+|.+||+||
T Consensus       102 ~~~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DF  176 (290)
T 3fpq_A          102 KCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDL  176 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred             cEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeC
Confidence            4679999999999999999764  3799999999999999999999997   6  99999999999998 4899999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      |+|+...    .......+||+.|||||++.+ .|+.++|||||||++|||+||..||.+.....  .+...+.....  
T Consensus       177 Gla~~~~----~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~--~~~~~i~~~~~--  247 (290)
T 3fpq_A          177 GLATLKR----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVTSGVK--  247 (290)
T ss_dssp             TGGGGCC----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHTTTCC--
T ss_pred             cCCEeCC----CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH--HHHHHHHcCCC--
Confidence            9997532    123345789999999999875 69999999999999999999999997654322  22222221110  


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                             .+.+...    .+..+.+||.+||+.||.+|||+.+++++
T Consensus       248 -------~~~~~~~----~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          248 -------PASFDKV----AIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             -------CGGGGGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -------CCCCCcc----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                   0111111    23468899999999999999999999876

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.9e-56  Score=422.85  Aligned_cols=267  Identities=23%  Similarity=0.326  Sum_probs=203.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHH-H--HHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-W--VAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~--~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      .+|.+.+.||+|+||+||+|++.         ++.||||+++..... +  ..|+..+.+++|||||+++++|..++...
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~---------g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~   73 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR---------GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW   73 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET---------TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC---------CEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCc
Confidence            45778899999999999999863         688999999765432 3  44566667899999999999998876655


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCceeecCCCCCceEEcCCCceeec
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL-----EVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~-----~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      ..++||||||++|+|.++|...   +++|..+..++.|++.||+|||+++     .++|+||||||+||||+.++.+||+
T Consensus        74 ~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~  150 (303)
T 3hmm_A           74 TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  150 (303)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             eEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEE
Confidence            6779999999999999999764   5899999999999999999999752     3589999999999999999999999


Q ss_pred             cccCCcCCCCCCCc--ccccccccCCCccCccccccC------CCCchhhhHHHHHHHHHHHhCCCCCCCCCchh-----
Q 014034          231 DFGLAREGPMVGHT--HVSTAVVGTFGYAAPDYIETG------HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT-----  297 (432)
Q Consensus       231 DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg~~pf~~~~~~~-----  297 (432)
                      |||+|+........  ......+||+.|||||++.+.      .++.++|||||||++|||+||..||.......     
T Consensus       151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~  230 (303)
T 3hmm_A          151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence            99999753222211  122346799999999999764      36779999999999999999988775432210     


Q ss_pred             -------hHHHHHHHhhcccCccccccccCccccCc-CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          298 -------EQRLLEWVQQYPADSKKFGLIMDPRLEKE-YSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       298 -------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                             ...+...+..         ...++.+... .+.+.+..+.+||.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       231 ~~~~~~~~~~~~~~~~~---------~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          231 LVPSDPSVEEMRKVVCE---------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TSCSSCCHHHHHHHHTT---------SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cccccchHHHHHHHHhc---------ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence                   0011111100         0112222211 2335667899999999999999999999999999988753

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=7.7e-56  Score=435.15  Aligned_cols=247  Identities=25%  Similarity=0.398  Sum_probs=206.1

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC----hHHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      +.|+.++.||+|+||.||+|.++       .+++.||||++...    ...+.+|+.+|+.++|||||++++++...+  
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~-------~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--  221 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVR-------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--  221 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT--
T ss_pred             HhcEeeeEeccCcCcEEEEEEEC-------CCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC--
Confidence            56999999999999999999976       56789999998542    334889999999999999999999998765  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        .+|||||||+||+|.+++...   .+++..+..|+.||+.||+|||++   +|+||||||+||||+.+|.+||+|||+
T Consensus       222 --~~~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGl  293 (423)
T 4fie_A          222 --ELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGF  293 (423)
T ss_dssp             --EEEEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTT
T ss_pred             --EEEEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCcc
Confidence              459999999999999999653   599999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      |+....  ........+||+.|||||++.+..|+.++|||||||++|||++|..||.+......   ...+.....    
T Consensus       294 a~~~~~--~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~~~i~~~~~----  364 (423)
T 4fie_A          294 CAQVSK--EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRDNLP----  364 (423)
T ss_dssp             CEECCS--SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHHSCC----
T ss_pred             ceECCC--CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHHHcCCC----
Confidence            986322  22334567899999999999999999999999999999999999999987654332   222222110    


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                            +.+.  .....+..+.+||.+||..||.+|||+.|++++
T Consensus       365 ------~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          365 ------PRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             ------CCCS--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ------CCCc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                  0010  111234678899999999999999999999876

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.1e-55  Score=410.23  Aligned_cols=243  Identities=24%  Similarity=0.397  Sum_probs=190.4

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|++++.||+|+||+||+|.++       .+++.||||.+++..       ..+.+|+.+|+.++|||||++++++.++
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   85 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHT-------TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK   85 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECT-------TTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             eCeEEEEEEecCcCeEEEEEEEC-------CCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence            68999999999999999999865       568899999986432       2488999999999999999999998765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ..++||||+ +|+|.+++..+.  .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        86 ~----~~~ivmEy~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~D  155 (275)
T 3hyh_A           86 D----EIIMVIEYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIAD  155 (275)
T ss_dssp             S----EEEEEEECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECC
T ss_pred             C----EEEEEEeCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEee
Confidence            4    459999999 789999997654  799999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      ||+|+...   ........+||+.|||||++.+..| +.++|||||||++|+|+||..||.+.+...   +...+.....
T Consensus       156 FGla~~~~---~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---~~~~i~~~~~  229 (275)
T 3hyh_A          156 FGLSNIMT---DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---LFKNISNGVY  229 (275)
T ss_dssp             SSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHTCC
T ss_pred             cCCCeecC---CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHcCCC
Confidence            99997532   2223345789999999999998876 579999999999999999999998654322   2222222110


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                 .+    +...+..+.+||.+||+.||.+|||+.|++++
T Consensus       230 -----------~~----p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          230 -----------TL----PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             -----------CC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             -----------CC----CCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                       11    11224678899999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=9.8e-56  Score=417.96  Aligned_cols=248  Identities=26%  Similarity=0.392  Sum_probs=197.8

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      ++|++++.||+|+||+||+|+...    +..+++.||||.+++.      ...+.+|+.+|++++|||||++++++.+++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   99 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKIS----GSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG   99 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECS----STTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred             cccEEEEEEecCCCeEEEEEEEcc----CCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            479999999999999999998642    2346789999998643      235788999999999999999999998765


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..|+|||||+||+|.++|.+..  .+++..+..++.||+.||+|||++   +|+||||||+|||++.+|.+||+||
T Consensus       100 ----~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DF  170 (304)
T 3ubd_A          100 ----KLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDF  170 (304)
T ss_dssp             ----EEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESS
T ss_pred             ----EEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEeccc
Confidence                3599999999999999997653  799999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      |+|+....  ........+||+.|||||++.+..|+.++|||||||++|||+||..||.+.+...   +...+.....  
T Consensus       171 Gla~~~~~--~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i~~~~~--  243 (304)
T 3ubd_A          171 GLSKESID--HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---TMTMILKAKL--  243 (304)
T ss_dssp             EEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCCC--
T ss_pred             ccceeccC--CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH---HHHHHHcCCC--
Confidence            99985321  2223445789999999999999999999999999999999999999998765432   2222221110  


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM-----SQVVER  359 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~~  359 (432)
                               .    .+...+..+.+||.+||+.||.+|||+     +|++++
T Consensus       244 ---------~----~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          244 ---------G----MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             ---------C----CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             ---------C----CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence                     0    112234678899999999999999985     566654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.2e-54  Score=406.32  Aligned_cols=253  Identities=25%  Similarity=0.369  Sum_probs=189.2

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|++++.||+|+||+||+|+++       .+++.||||+++...     ..+.+|+.+|+.++|||||++++++.+.+
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~   76 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNK-------VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKN   76 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEET-------TTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC
T ss_pred             chhCEEeeEEecCCCeEEEEEEEC-------CCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecC
Confidence            357999999999999999999976       567899999986422     24789999999999999999999987654


Q ss_pred             C--------cceeEEEEEeecCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC
Q 014034          153 E--------RGIQRLLVYEFMLNRSLEDHLFNRAF-PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  223 (432)
Q Consensus       153 ~--------~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~  223 (432)
                      .        ....+|+|||||.+|+|.+++..+.. ...++..++.++.||+.||+|||++   +|+||||||+||||+.
T Consensus        77 ~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~  153 (299)
T 4g31_A           77 TTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTM  153 (299)
T ss_dssp             ----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred             ccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECC
Confidence            3        12346899999999999999976542 2356677889999999999999998   9999999999999999


Q ss_pred             CCceeeccccCCcCCCCCCCc----------ccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 014034          224 NFRPKLSDFGLAREGPMVGHT----------HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN  293 (432)
Q Consensus       224 ~~~~kl~DfG~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~  293 (432)
                      ++.+||+|||+|+........          ......+||+.|||||++.+..|+.++|||||||++|||++   ||...
T Consensus       154 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~  230 (299)
T 4g31_A          154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ  230 (299)
T ss_dssp             TCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             CCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence            999999999999864222111          12234679999999999999999999999999999999996   77532


Q ss_pred             CchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          294 RPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .  ........+.....             + .........+.+||.+||+.||.+|||+.+++++
T Consensus       231 ~--~~~~~~~~~~~~~~-------------p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          231 M--ERVRTLTDVRNLKF-------------P-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             H--HHHHHHHHHHTTCC-------------C-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             c--HHHHHHHHHhcCCC-------------C-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1  11112211111110             0 0112223456789999999999999999999875

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.8e-52  Score=407.87  Aligned_cols=268  Identities=24%  Similarity=0.319  Sum_probs=205.0

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      ++|++++.||+|+||+||+|.++       .+++.||||+++...      ..+.+|+.+|+.++|||||++++++....
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~-------~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  126 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRR-------LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV  126 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS
T ss_pred             CCeEEEEEEecccCeEEEEEEEC-------CCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc
Confidence            57999999999999999999976       568899999986432      24778999999999999999999886542


Q ss_pred             --CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          153 --ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       153 --~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                        .....+|||||||. |+|.+++...  .++++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+
T Consensus       127 ~~~~~~~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~  200 (398)
T 4b99_A          127 PYGEFKSVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIG  200 (398)
T ss_dssp             CTTTCCCEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEEC
T ss_pred             ccccCCEEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEe
Confidence              12345799999995 6899999654  4799999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCC--CcccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 014034          231 DFGLAREGPMVG--HTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  307 (432)
Q Consensus       231 DfG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  307 (432)
                      |||+|+......  ........+||+.|||||++.+. .++.++||||+||++|||++|..||.+.+.......+.....
T Consensus       201 DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g  280 (398)
T 4b99_A          201 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG  280 (398)
T ss_dssp             CCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC
T ss_pred             ecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence            999998642221  12234467899999999998775 569999999999999999999999988765544333322222


Q ss_pred             cccCcccc-------cc---ccCccccC---cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          308 YPADSKKF-------GL---IMDPRLEK---EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       308 ~~~~~~~~-------~~---~~~~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .+......       ..   ...+....   ......+..+.+||.+||..||.+|||+.|+++|
T Consensus       281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            11110000       00   00000000   0001124568899999999999999999999987

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=9.7e-51  Score=394.91  Aligned_cols=204  Identities=26%  Similarity=0.376  Sum_probs=170.0

Q ss_pred             HhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC--hHHHHHHHHHhccc-CCCccceeeeEEeecC
Q 014034           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQWVAEVQFLGVL-EHPNLVKLIGYCAVDG  152 (432)
Q Consensus        76 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  152 (432)
                      ...+.|++.+.||+|+||+||+|+.+.    ...+++.||+|.+.+.  ...+.+|+++|+.+ +||||+++++++...+
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~----~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQL----QVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEB----TTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcc----cCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            456789999999999999999998652    2246789999988654  34578999999988 6999999999997654


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCC-Cceeecc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSD  231 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~D  231 (432)
                          ..++||||+++|+|.+++.     .+++..+..++.||+.||.|||++   ||+||||||+|||++.+ +.+||+|
T Consensus        94 ----~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~D  161 (361)
T 4f9c_A           94 ----HVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVD  161 (361)
T ss_dssp             ----EEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECC
T ss_pred             ----EEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECc
Confidence                4599999999999999983     589999999999999999999998   99999999999999876 8999999


Q ss_pred             ccCCcCCCCCCC--------------------------cccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHH
Q 014034          232 FGLAREGPMVGH--------------------------THVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEML  284 (432)
Q Consensus       232 fG~a~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell  284 (432)
                      ||+|+.......                          .......+||+.|||||++.+. .|+.++||||+||++|||+
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell  241 (361)
T 4f9c_A          162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL  241 (361)
T ss_dssp             CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred             CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence            999974322110                          0112345799999999999775 5899999999999999999


Q ss_pred             hCCCCCCCCCc
Q 014034          285 TGRRSLERNRP  295 (432)
Q Consensus       285 tg~~pf~~~~~  295 (432)
                      ||+.||.....
T Consensus       242 ~G~~Pf~~~~~  252 (361)
T 4f9c_A          242 SGRYPFYKASD  252 (361)
T ss_dssp             HTCSSSSCCSS
T ss_pred             HCCCCCCCCCC
Confidence            99999965443

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.4e-50  Score=415.31  Aligned_cols=247  Identities=24%  Similarity=0.365  Sum_probs=201.5

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-------HHH---HHHHHhcccCCCccceeeeE
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWV---AEVQFLGVLEHPNLVKLIGY  147 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~---~E~~~l~~l~hpniv~l~~~  147 (432)
                      .++|++++.||+|+||+||+|+.+       .+++.||||++.+...       ...   .++.+++.++|||||+++++
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~-------~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~  260 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKA-------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA  260 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEEC-------CCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEE
Confidence            478999999999999999999976       5789999999865321       233   34677788899999999999


Q ss_pred             EeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCce
Q 014034          148 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP  227 (432)
Q Consensus       148 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~  227 (432)
                      +.+.+    .+||||||++||+|.++|....  .+++..+..++.||+.||.|||++   +|+||||||+||||+.+|.+
T Consensus       261 f~~~~----~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~v  331 (689)
T 3v5w_A          261 FHTPD----KLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHV  331 (689)
T ss_dssp             EECSS----EEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCE
T ss_pred             EEECC----EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCE
Confidence            97755    4599999999999999997653  699999999999999999999998   99999999999999999999


Q ss_pred             eeccccCCcCCCCCCCcccccccccCCCccCccccc-cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 014034          228 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  306 (432)
Q Consensus       228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  306 (432)
                      ||+|||+|+....    ......+||+.|||||++. +..|+.++|||||||++|||++|..||.+........+...+.
T Consensus       332 KL~DFGlA~~~~~----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~  407 (689)
T 3v5w_A          332 RISDLGLACDFSK----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL  407 (689)
T ss_dssp             EECCCTTCEECSS----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH
T ss_pred             EecccceeeecCC----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Confidence            9999999986322    1234578999999999996 4689999999999999999999999997654433333333222


Q ss_pred             hcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 014034          307 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-----MSQVVER  359 (432)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  359 (432)
                      ....               .++...+..+.+||.+||..||.+|++     +.+|++|
T Consensus       408 ~~~~---------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          408 TMAV---------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             HCCC---------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             CCCC---------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence            2111               112223467889999999999999998     6888876

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.2e-50  Score=412.29  Aligned_cols=250  Identities=22%  Similarity=0.328  Sum_probs=205.5

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      .++|++++.||+|+||.||+|.++       .+++.||+|.+....    ..+.+|+.+|+.|+|||||++++++.+++ 
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~-------~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-  227 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTER-------ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-  227 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS-
T ss_pred             ccccEEEEEEeeccCeEEEEEEEC-------CCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-
Confidence            468999999999999999999976       567899999986533    34789999999999999999999997654 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCC--Cceeecc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN--FRPKLSD  231 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~--~~~kl~D  231 (432)
                         .++||||||.||+|.++|.... ..+++..+..++.||+.||.|||++   +|+||||||+|||++.+  +.+||+|
T Consensus       228 ---~~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~D  300 (573)
T 3uto_A          228 ---EMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLID  300 (573)
T ss_dssp             ---EEEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECC
T ss_pred             ---EEEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEee
Confidence               4599999999999999996543 4699999999999999999999998   99999999999999854  8999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ||+|+....   .......+||+.|||||++.+..|+.++|||||||++|||++|..||.+......   ...+......
T Consensus       301 FG~a~~~~~---~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~---~~~i~~~~~~  374 (573)
T 3uto_A          301 FGLTAHLDP---KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---LRNVKSCDWN  374 (573)
T ss_dssp             CSSCEECCT---TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHHTTCCC
T ss_pred             ccceeEccC---CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHHHhCCCC
Confidence            999986422   2233456899999999999999999999999999999999999999987654332   2222221110


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                 +........+..+.+||.+||..||.+|||+.|+++|
T Consensus       375 -----------~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          375 -----------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             -----------CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -----------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                       0001111234568899999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.8e-49  Score=379.98  Aligned_cols=283  Identities=39%  Similarity=0.728  Sum_probs=230.9

Q ss_pred             cCHHHHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCcccee
Q 014034           69 FSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNLVKL  144 (432)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpniv~l  144 (432)
                      +++.++...+++|...+.||+|+||.||+|.+.        ++..||+|++....    ..+.+|+.+++.++||||+++
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~  100 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR--------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSL  100 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT--------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCE
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEEC--------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeE
Confidence            344455667889999999999999999999853        46789999886432    358899999999999999999


Q ss_pred             eeEEeecCCcceeEEEEEeecCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc
Q 014034          145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD  222 (432)
Q Consensus       145 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~  222 (432)
                      ++++...+.    .++||||+.+|+|.+++....  ...+++..++.++.|++.||.|||+.   +|+||||||+|||++
T Consensus       101 ~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~  173 (321)
T 2qkw_B          101 IGFCDERNE----MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLD  173 (321)
T ss_dssp             EEECCCTTC----CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEEC
T ss_pred             EEEEcCCCe----EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEEC
Confidence            999876554    499999999999999997543  23589999999999999999999998   999999999999999


Q ss_pred             CCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014034          223 ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  302 (432)
Q Consensus       223 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  302 (432)
                      .++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++|..||.+..+.......
T Consensus       174 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~  253 (321)
T 2qkw_B          174 ENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA  253 (321)
T ss_dssp             TTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHH
T ss_pred             CCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHH
Confidence            99999999999997533222223334456899999999999899999999999999999999999999876654444444


Q ss_pred             HHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhc
Q 014034          303 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  367 (432)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  367 (432)
                      .|...... ...+...+++.+........+..+.+++.+||+.||.+|||+.+++++|+.++...
T Consensus       254 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          254 EWAVESHN-NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             HHTHHHHT-TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HHhhhccc-cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence            43322111 12233345566666677888999999999999999999999999999999987643

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=6.2e-48  Score=377.95  Aligned_cols=267  Identities=27%  Similarity=0.424  Sum_probs=216.5

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhccc-CCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVL-EHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~hpniv~l~~~~~~~  151 (432)
                      .++|.+.+.||+|+||.||+|.+..........+..||+|.+....     ..+.+|+.+|+.+ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            4679999999999999999999864444445678899999997542     2478999999999 899999999999765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCC
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKAS  217 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~  217 (432)
                      +.    .++||||+.+|+|.+++....              ...+++..++.++.||+.||.|||++   +|+||||||+
T Consensus       160 ~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~  232 (370)
T 2psq_A          160 GP----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR  232 (370)
T ss_dssp             SS----CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGG
T ss_pred             CC----EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchh
Confidence            54    499999999999999997643              13588999999999999999999998   9999999999


Q ss_pred             ceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCch
Q 014034          218 NVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPK  296 (432)
Q Consensus       218 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~  296 (432)
                      ||||+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus       233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~  312 (370)
T 2psq_A          233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  312 (370)
T ss_dssp             GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            99999999999999999985433222223344567889999999999999999999999999999999 99999876543


Q ss_pred             hhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhcc
Q 014034          297 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  368 (432)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  368 (432)
                      ...   ..+....          ..    ..+...+..+.+||.+||+.||.+|||+.++++.|+.++....
T Consensus       313 ~~~---~~~~~~~----------~~----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          313 ELF---KLLKEGH----------RM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             GHH---HHHHTTC----------CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHH---HHHhcCC----------CC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            322   1111110          00    1122334678899999999999999999999999999986543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.2e-48  Score=370.74  Aligned_cols=285  Identities=41%  Similarity=0.708  Sum_probs=232.9

Q ss_pred             cCcccCHHHHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-----HHHHHHHHhcccCCC
Q 014034           65 NLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-----QWVAEVQFLGVLEHP  139 (432)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~hp  139 (432)
                      .+..++..++....++|...+.||+|+||.||+|.+.        ++..||+|++.....     .+.+|+.+++.++||
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~   87 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA--------DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHR   87 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS--------SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCT
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec--------CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCC
Confidence            3566889999999999999999999999999999743        477899999875432     588999999999999


Q ss_pred             ccceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCC
Q 014034          140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKAS  217 (432)
Q Consensus       140 niv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~  217 (432)
                      ||+++++++......    ++||||+.+|+|.+++....  ..++++..+..++.|++.||.|||+.+..+|+||||||+
T Consensus        88 ~iv~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~  163 (326)
T 3uim_A           88 NLLRLRGFCMTPTER----LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAA  163 (326)
T ss_dssp             TBCCCCEEECCSSCC----EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGG
T ss_pred             CccceEEEEecCCce----EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchh
Confidence            999999999766543    89999999999999997653  335999999999999999999999976669999999999


Q ss_pred             ceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCc--
Q 014034          218 NVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP--  295 (432)
Q Consensus       218 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~--  295 (432)
                      |||++.++.+||+|||++...... .........||+.|+|||++.+..++.++|||||||++|+|++|..||.....  
T Consensus       164 Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  242 (326)
T 3uim_A          164 NILLDEEFEAVVGDFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN  242 (326)
T ss_dssp             GEEECTTCCEEECCCSSCEECCSS-SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT
T ss_pred             hEEECCCCCEEeccCccccccCcc-cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccc
Confidence            999999999999999999754222 22233445699999999999988999999999999999999999999963111  


Q ss_pred             hhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          296 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                      ........|+..... ......+.+..+....+...+..+.+++.+||+.||.+|||+.+|+++|+..
T Consensus       243 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          243 DDDVMLLDWVKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TSCSBHHHHHTTTTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             ccchhHHHHHHHHhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            111223344433322 2233445566666777888899999999999999999999999999999753

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.2e-48  Score=372.04  Aligned_cols=277  Identities=25%  Similarity=0.325  Sum_probs=211.1

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH---HHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      .++|++.+.||+|+||.||+|++.         ++.||||++.....   ....|+.+++.++||||+++++++......
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL---------NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV   93 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET---------TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             hhhchhhheecccCceEEEEEEEC---------CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence            467999999999999999999853         68999999976543   356688889999999999999999887655


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-------CCceeecCCCCCceEEcCCCce
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL-------EVQVIYRDFKASNVLLDENFRP  227 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~-------~~~ivH~Dikp~Nill~~~~~~  227 (432)
                      ....++||||+++|+|.+++...   .+++..++.++.|++.||.|||+..       ..+|+||||||+|||++.++.+
T Consensus        94 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~  170 (322)
T 3soc_A           94 DVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA  170 (322)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred             CceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence            55679999999999999999764   5899999999999999999999841       2389999999999999999999


Q ss_pred             eeccccCCcCCCCCCCcccccccccCCCccCccccccC-----CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014034          228 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-----HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  302 (432)
Q Consensus       228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  302 (432)
                      ||+|||+++...............||+.|+|||++.+.     .++.++|||||||++|||+||..||.+..........
T Consensus       171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~  250 (322)
T 3soc_A          171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE  250 (322)
T ss_dssp             EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred             EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence            99999999753322222233446799999999999863     4556889999999999999999999865432211111


Q ss_pred             HHHhhcccCcccccc----ccCccccCc-CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          303 EWVQQYPADSKKFGL----IMDPRLEKE-YSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       303 ~~~~~~~~~~~~~~~----~~~~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                      ......+........    ...+.+... .....+..+.+||.+||+.||.+|||+.+|++.|+.+...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            111000000000000    011111111 1234567799999999999999999999999999998754

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=8.4e-47  Score=358.88  Aligned_cols=248  Identities=23%  Similarity=0.373  Sum_probs=204.1

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc----ChHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR----DGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      .++|+..+.||+|+||.||+|...       .+++.||+|.+..    ....+.+|+.+++.++||||+++++++...+ 
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDV-------ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-   90 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBT-------TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred             hhceeeeeeeccCCCeEEEEEEEC-------CCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC-
Confidence            468999999999999999999864       5678999999753    2345789999999999999999999998755 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+.+++|.+++...   .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        91 ---~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg  161 (297)
T 3fxz_A           91 ---ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG  161 (297)
T ss_dssp             ---EEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             ---EEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCC
Confidence               359999999999999999764   589999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      ++.....  .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+...........  ......  
T Consensus       162 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~--~~~~~~--  235 (297)
T 3fxz_A          162 FCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA--TNGTPE--  235 (297)
T ss_dssp             TCEECCS--TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--HHCSCC--
T ss_pred             CceecCC--cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCC--
Confidence            9875322  2223345679999999999999999999999999999999999999998765433222111  111000  


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                 ...+...+..+.+|+.+||+.||.+|||+.+++++
T Consensus       236 -----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          236 -----------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             -----------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -----------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                       01112234668899999999999999999999876

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.2e-46  Score=359.91  Aligned_cols=255  Identities=27%  Similarity=0.434  Sum_probs=199.6

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|++.+.||+|+||.||+|.+         .+..||+|.+....      ..+.+|+.++++++||||+++++++...
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW---------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP  106 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE---------TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             hhHceeeeEeecCCCeEEEEEEE---------CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            46799999999999999999975         36789999986432      2478899999999999999999999765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCc--eeecCCCCCceEEcCCCcee
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAF-PPLPWKTRLHIILGAAEGLAYLHEGLEVQ--VIYRDFKASNVLLDENFRPK  228 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~--ivH~Dikp~Nill~~~~~~k  228 (432)
                      +.    .++||||+.+|+|.+++..... ..+++..++.++.|++.||.|||+.   +  |+||||||+|||++.++.+|
T Consensus       107 ~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~k  179 (309)
T 3p86_A          107 PN----LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVK  179 (309)
T ss_dssp             TC----CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEE
T ss_pred             Cc----eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEE
Confidence            54    4999999999999999976431 2389999999999999999999998   8  99999999999999999999


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      |+|||+++...  ..........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........   +...
T Consensus       180 L~Dfg~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~---~~~~  254 (309)
T 3p86_A          180 VCDFGLSRLKA--STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA---VGFK  254 (309)
T ss_dssp             ECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH---HHHS
T ss_pred             ECCCCCCcccc--ccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhc
Confidence            99999997522  112223456799999999999999999999999999999999999999987654332211   1111


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                      ..         ..    ..+...+..+.+||.+||+.||.+|||+.+|++.|+.++..
T Consensus       255 ~~---------~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          255 CK---------RL----EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             CC---------CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             CC---------CC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            00         01    11222346788999999999999999999999999998764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=368.28  Aligned_cols=267  Identities=27%  Similarity=0.418  Sum_probs=217.5

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhccc-CCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVL-EHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~hpniv~l~~~~~~~  151 (432)
                      .++|.+.+.||+|+||.||+|.+..........+..||+|++....     ..+.+|+.+++.+ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            3579999999999999999999875544455667899999987532     3478999999999 999999999999766


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCC
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKAS  217 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~  217 (432)
                      +.    .++||||+.+|+|.+++....              ...+++..++.++.||+.||.|||+.   +|+||||||+
T Consensus       148 ~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~  220 (382)
T 3tt0_A          148 GP----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR  220 (382)
T ss_dssp             SS----CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred             Cc----eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcc
Confidence            54    399999999999999997654              23589999999999999999999998   9999999999


Q ss_pred             ceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCch
Q 014034          218 NVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPK  296 (432)
Q Consensus       218 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~  296 (432)
                      ||||+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus       221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~  300 (382)
T 3tt0_A          221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  300 (382)
T ss_dssp             GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999986433322233344567889999999999999999999999999999999 99999876543


Q ss_pred             hhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhcc
Q 014034          297 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  368 (432)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  368 (432)
                      ..   ...+.....          .    ..+...+..+.+|+.+||+.||.+|||+.+|+++|+.++....
T Consensus       301 ~~---~~~~~~~~~----------~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          301 EL---FKLLKEGHR----------M----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             HH---HHHHHTTCC----------C----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             HH---HHHHHcCCC----------C----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            22   222221110          0    0111234678899999999999999999999999999987654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=8.5e-47  Score=360.79  Aligned_cols=259  Identities=26%  Similarity=0.377  Sum_probs=206.6

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      ++|...+.||+|+||.||+|.+.       .++..||+|.+....    ..+.+|+.+++.++||||+++++++..++  
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~-------~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--   80 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHR-------ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK--   80 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEET-------TTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--
T ss_pred             hHeeccceecCCCCEEEEEEEEC-------CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC--
Confidence            57999999999999999999875       467899999875532    24789999999999999999999998754  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        ..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        81 --~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~  154 (310)
T 3s95_A           81 --RLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGL  154 (310)
T ss_dssp             --EEEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTT
T ss_pred             --eeEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeeccc
Confidence              3599999999999999997643 4699999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCc------------ccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014034          235 AREGPMVGHT------------HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  302 (432)
Q Consensus       235 a~~~~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  302 (432)
                      +.........            .......||+.|+|||++.+..++.++||||||+++|+|++|..||........... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~-  233 (310)
T 3s95_A          155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG-  233 (310)
T ss_dssp             CEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS-
T ss_pred             ceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh-
Confidence            9753221111            011146799999999999999999999999999999999999999876433211000 


Q ss_pred             HHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhc
Q 014034          303 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  367 (432)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  367 (432)
                                .........    ..+...+..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus       234 ----------~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          234 ----------LNVRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             ----------BCHHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----------hhhhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence                      000000000    111222356889999999999999999999999999887543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.3e-47  Score=368.93  Aligned_cols=274  Identities=24%  Similarity=0.353  Sum_probs=217.5

Q ss_pred             cCHHHHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhccc-CCCccc
Q 014034           69 FSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVL-EHPNLV  142 (432)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~hpniv  142 (432)
                      +...+.....++|.+.+.||+|+||.||+|.+....  ...+++.||||.+....     ..+.+|+.++..+ +||||+
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv   89 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID--KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV   89 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSS--STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEecccc--ccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence            344555556789999999999999999999875321  33577999999997532     2488999999999 799999


Q ss_pred             eeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCC-------------------------------------------
Q 014034          143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAF-------------------------------------------  179 (432)
Q Consensus       143 ~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------  179 (432)
                      ++++++...+.   ..++||||+.+|+|.+++.....                                           
T Consensus        90 ~~~~~~~~~~~---~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (359)
T 3vhe_A           90 NLLGACTKPGG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSG  166 (359)
T ss_dssp             CEEEEECSTTS---CCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------
T ss_pred             eeeeeeecCCC---ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccc
Confidence            99999876543   24899999999999999976432                                           


Q ss_pred             ---------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCC
Q 014034          180 ---------------------PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG  238 (432)
Q Consensus       180 ---------------------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~  238 (432)
                                           ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  243 (359)
T 3vhe_A          167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDI  243 (359)
T ss_dssp             -----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred             cccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeee
Confidence                                 1288999999999999999999998   9999999999999999999999999999864


Q ss_pred             CCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcccccc
Q 014034          239 PMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGL  317 (432)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (432)
                      .............||+.|+|||++.+..++.++|||||||++|+|+| |..||.+......  ....+.....       
T Consensus       244 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~~~~~~~-------  314 (359)
T 3vhe_A          244 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRLKEGTR-------  314 (359)
T ss_dssp             TSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHHHHHHTCC-------
T ss_pred             cccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HHHHHHcCCC-------
Confidence            33333334445678999999999999999999999999999999998 9999987654322  1111111100       


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          318 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       318 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                         .    ..+...+..+.+|+.+||+.||.+|||+.+|+++|+.+++.
T Consensus       315 ---~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          315 ---M----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             ---C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence               0    11112235688999999999999999999999999998864

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.1e-45  Score=352.44  Aligned_cols=279  Identities=36%  Similarity=0.629  Sum_probs=222.5

Q ss_pred             cCcccCHHHHHHhhcCCccc------cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC--------hHHHHHHH
Q 014034           65 NLRVFSYSEMRQATNDFSRM------LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--------GLQWVAEV  130 (432)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--------~~~~~~E~  130 (432)
                      ....|++.++..++++|...      +.||+|+||.||+|.+         ++..||+|.+...        ...+.+|+
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~E~   81 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV---------NNTTVAVKKLAAMVDITTEELKQQFDQEI   81 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES---------SSCEEEEEEECCCTTSCTTTHHHHHHHHH
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE---------CCceEEEEEEecccCcchHHHHHHHHHHH
Confidence            34568999999999998877      8899999999999974         4678999987542        23488999


Q ss_pred             HHhcccCCCccceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCce
Q 014034          131 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQV  209 (432)
Q Consensus       131 ~~l~~l~hpniv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~i  209 (432)
                      .+++.++||||+++++++...+.    .++||||+++++|.+++... ...++++..++.++.|++.||.|||+.   +|
T Consensus        82 ~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i  154 (307)
T 2nru_A           82 KVMAKCQHENLVELLGFSSDGDD----LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HH  154 (307)
T ss_dssp             HHHHHCCCTTBCCEEEEECSSSS----CEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             HHHHhcCCCCeEEEEEEEecCCc----eEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---Ce
Confidence            99999999999999999876554    49999999999999998643 234699999999999999999999998   99


Q ss_pred             eecCCCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCC
Q 014034          210 IYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRS  289 (432)
Q Consensus       210 vH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p  289 (432)
                      +||||||+|||++.++.+||+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|..|
T Consensus       155 ~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p  233 (307)
T 2nru_A          155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPA  233 (307)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCS
T ss_pred             ecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCC
Confidence            9999999999999999999999999975433222233345679999999999875 578999999999999999999999


Q ss_pred             CCCCCchhh-HHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 014034          290 LERNRPKTE-QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  364 (432)
Q Consensus       290 f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  364 (432)
                      |........ ..+.....   .....+...+++.+ ...+...+..+.+++.+||+.||.+|||+.+|+++|+.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          234 VDEHREPQLLLDIKEEIE---DEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             BCTTBSSSBTTHHHHHHH---TTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             cccCcchHHHHHHHHHhh---hhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            986543221 11111111   11111222233322 2345677888999999999999999999999999999875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.1e-46  Score=363.00  Aligned_cols=246  Identities=24%  Similarity=0.389  Sum_probs=203.3

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEee
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      ..++|.+++.||+|+||.||+|.+.       .+++.||||++....      ..+.+|+.+|+.++||||+++++++..
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~   85 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHI-------LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET   85 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEEC-------CCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            4568999999999999999999875       467899999986431      247789999999999999999999876


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .+    ..++||||+++++|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        86 ~~----~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~  156 (328)
T 3fe3_A           86 EK----TLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIA  156 (328)
T ss_dssp             SS----EEEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred             CC----EEEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEe
Confidence            54    4599999999999999997653  699999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLT-AKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      |||++.....   .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.......   ..+....
T Consensus       157 DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~i~~~~  230 (328)
T 3fe3_A          157 DFGFSNEFTV---GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR---ERVLRGK  230 (328)
T ss_dssp             STTCCGGGSS---SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHCC
T ss_pred             eccCceecCC---CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHH---HHHHhCC
Confidence            9999975322   2234557899999999999888775 7899999999999999999999876543322   2111110


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .               ..+...+..+.+|+.+||..||.+|||+.+++++
T Consensus       231 ~---------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          231 Y---------------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             C---------------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             C---------------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0               0111224568899999999999999999999886

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.2e-46  Score=359.48  Aligned_cols=262  Identities=27%  Similarity=0.410  Sum_probs=208.8

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|.+.+.||+|+||.||+|.+...    ...+..||||.+...     ...+.+|+.+++.++||||+++++++....
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  123 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVP----GQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR  123 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCT----TSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecC----CCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            35799999999999999999998622    235678999998753     234889999999999999999999987654


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                      .    .++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       124 ~----~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df  195 (325)
T 3kul_A          124 L----AMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDF  195 (325)
T ss_dssp             C----CEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             c----cEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCC
Confidence            3    499999999999999996543 4699999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCC-cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhccc
Q 014034          233 GLAREGPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       233 G~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      |+++....... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........   +.... 
T Consensus       196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~---~~~~~-  271 (325)
T 3kul_A          196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS---VEEGY-  271 (325)
T ss_dssp             SSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH---HHTTC-
T ss_pred             CcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH---HHcCC-
Confidence            99986422211 112233456788999999998999999999999999999999 9999987654332211   11110 


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhcc
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  368 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  368 (432)
                                   ....+...+..+.+|+.+||..||.+|||+.+|++.|+.++....
T Consensus       272 -------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          272 -------------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             -------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             -------------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence                         001122334678899999999999999999999999999986543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.5e-46  Score=353.19  Aligned_cols=262  Identities=24%  Similarity=0.380  Sum_probs=203.8

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-HHHHHHHHhcc--cCCCccceeeeEEeecCCc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QWVAEVQFLGV--LEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~--l~hpniv~l~~~~~~~~~~  154 (432)
                      .++|++.+.||+|+||.||+|.+         ++..||||++..... .+..|.+++..  ++||||+++++++......
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~   77 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW---------QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHS   77 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE---------TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE---------CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence            46899999999999999999985         478899999876543 45667777665  7999999999998776555


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCceeecCCCCCceEEcCCCc
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH--------EGLEVQVIYRDFKASNVLLDENFR  226 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH--------~~~~~~ivH~Dikp~Nill~~~~~  226 (432)
                      ....++||||+.+|+|.+++..   ..+++..++.++.|++.||.|||        +.   +|+||||||+|||++.++.
T Consensus        78 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~  151 (301)
T 3q4u_A           78 STQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQ  151 (301)
T ss_dssp             EEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSC
T ss_pred             CceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCC
Confidence            5667999999999999999954   36899999999999999999999        76   9999999999999999999


Q ss_pred             eeeccccCCcCCCCCCCc--ccccccccCCCccCccccccC------CCCchhhhHHHHHHHHHHHhC----------CC
Q 014034          227 PKLSDFGLAREGPMVGHT--HVSTAVVGTFGYAAPDYIETG------HLTAKSDVWSFGVVLYEMLTG----------RR  288 (432)
Q Consensus       227 ~kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg----------~~  288 (432)
                      +||+|||+++........  .......||+.|+|||++.+.      .++.++|||||||++|||++|          ..
T Consensus       152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~  231 (301)
T 3q4u_A          152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP  231 (301)
T ss_dssp             EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence            999999999642221111  112335799999999999876      445789999999999999999          78


Q ss_pred             CCCCCCchhh--HHHHHHHhhcccCccccccccCcccc-CcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          289 SLERNRPKTE--QRLLEWVQQYPADSKKFGLIMDPRLE-KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       289 pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                      ||....+...  ..+........         ..+.+. ...+...+..+.+|+.+||+.||.+|||+.+|++.|+.+
T Consensus       232 pf~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          232 PFYDVVPNDPSFEDMRKVVCVDQ---------QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSC---------CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccCCCCcchhhhhHHHhccC---------CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            8865433211  11111111100         011111 112345678899999999999999999999999999875

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3e-46  Score=364.28  Aligned_cols=249  Identities=23%  Similarity=0.331  Sum_probs=202.9

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC----------hHHHHHHHHHhcccCCCccceeeeE
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----------GLQWVAEVQFLGVLEHPNLVKLIGY  147 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~hpniv~l~~~  147 (432)
                      .+.|.+.+.||+|+||.||+|..+       .++..||+|.+...          ...+.+|+.+|+.++||||++++++
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~-------~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~   83 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREK-------STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDV   83 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEEC-------CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEE
Confidence            467999999999999999999876       46789999998642          2458899999999999999999999


Q ss_pred             EeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC--
Q 014034          148 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF--  225 (432)
Q Consensus       148 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~--  225 (432)
                      +....    ..++||||+.+|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++  
T Consensus        84 ~~~~~----~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~  154 (361)
T 2yab_A           84 YENRT----DVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIP  154 (361)
T ss_dssp             EECSS----EEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSS
T ss_pred             EEeCC----EEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCC
Confidence            87654    459999999999999999654  4799999999999999999999998   999999999999998777  


Q ss_pred             --ceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 014034          226 --RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE  303 (432)
Q Consensus       226 --~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~  303 (432)
                        .+||+|||++.....   ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+......   ..
T Consensus       155 ~~~vkl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~---~~  228 (361)
T 2yab_A          155 IPHIKLIDFGLAHEIED---GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LA  228 (361)
T ss_dssp             SCCEEECCCSSCEECCT---TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HH
T ss_pred             ccCEEEEecCCceEcCC---CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH---HH
Confidence              799999999976322   1223456799999999999999999999999999999999999999987544322   22


Q ss_pred             HHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          304 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .+......       .++..    ....+..+.+||.+||..||.+|||+.+++++
T Consensus       229 ~i~~~~~~-------~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          229 NITAVSYD-------FDEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             HHHTTCCC-------CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHhcCCC-------CCchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            22111100       00000    11123568899999999999999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.1e-46  Score=370.11  Aligned_cols=256  Identities=27%  Similarity=0.445  Sum_probs=206.3

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|.+.+.||+|+||.||+|.+.       .++..||||.+....     ..+.+|+.+|+.++||||+++++++...+
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  185 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLR-------ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ  185 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEe-------cCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence            457889999999999999999975       357899999987542     23778999999999999999999997655


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                      .    .++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       186 ~----~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~Df  257 (377)
T 3cbl_A          186 P----IYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDF  257 (377)
T ss_dssp             S----CEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCG
T ss_pred             C----cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcC
Confidence            4    499999999999999997543 3589999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      |+++...............+++.|+|||++.++.++.++|||||||++|||+| |..||.+.......   ..+..... 
T Consensus       258 G~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~---~~~~~~~~-  333 (377)
T 3cbl_A          258 GMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR---EFVEKGGR-  333 (377)
T ss_dssp             GGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH---HHHHTTCC-
T ss_pred             CCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHcCCC-
Confidence            99975321111111122335678999999998899999999999999999998 99999876543322   22211100 


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                               .    ..+...+..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       334 ---------~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          334 ---------L----PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             ---------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------C----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence                     0    1112234678899999999999999999999999998864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.5e-45  Score=356.18  Aligned_cols=246  Identities=28%  Similarity=0.392  Sum_probs=203.7

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .++|++++.||+|+||.||+|..+       .+++.||+|.+.+.       ...+.+|+.+++.++||||+++++++..
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~   76 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREK-------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT   76 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEC-------CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe
Confidence            367999999999999999999875       46789999998653       2347889999999999999999999976


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .+    ..++||||+++|+|.+++....  .+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+
T Consensus        77 ~~----~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~  147 (337)
T 1o6l_A           77 HD----RLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKIT  147 (337)
T ss_dssp             SS----EEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             CC----EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEe
Confidence            54    4599999999999999997543  689999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      |||+++....  ........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.....   +...+.... 
T Consensus       148 DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i~~~~-  221 (337)
T 1o6l_A          148 DFGLCKEGIS--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELILMEE-  221 (337)
T ss_dssp             CCTTCBCSCC--TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCC-
T ss_pred             eccchhhccc--CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH---HHHHHHcCC-
Confidence            9999975322  2223345789999999999999999999999999999999999999998654332   222111110 


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  359 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  359 (432)
                                ..    ++...+..+.+||.+||+.||.+||     ++.+|+++
T Consensus       222 ----------~~----~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          222 ----------IR----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ----------CC----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ----------CC----CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence                      01    1122346788999999999999999     89999886

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.2e-46  Score=359.67  Aligned_cols=258  Identities=23%  Similarity=0.382  Sum_probs=204.2

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|...+.||+|+||.||+|.+...   +.....+||+|.+...     ...+.+|+.+++.++||||+++++++.... 
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPE---GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC-------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCC---CceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence            5799999999999999999997522   2223456899988542     345889999999999999999999997543 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                          .++|++|+.+|+|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        91 ----~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg  162 (327)
T 3poz_A           91 ----VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFG  162 (327)
T ss_dssp             ----EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTT
T ss_pred             ----eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCc
Confidence                489999999999999997654 4699999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      +++...............||+.|+|||++.+..++.++|||||||++|+|+| |..||.+................    
T Consensus       163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~----  238 (327)
T 3poz_A          163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL----  238 (327)
T ss_dssp             HHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC----
T ss_pred             ceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC----
Confidence            9975332222223334567889999999999999999999999999999999 99999876554433222211000    


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                                   ..+...+..+.+|+.+||+.||.+|||+.+++++|+.+..
T Consensus       239 -------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          239 -------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             -------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             -------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                         1112234578899999999999999999999999998864

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.5e-46  Score=356.69  Aligned_cols=263  Identities=27%  Similarity=0.404  Sum_probs=212.5

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ..++|.+.+.||+|+||.||+|.+....  +..++..||+|.+....     ..+.+|+.+++.++||||+++++++...
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   98 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLK--GRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD   98 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGG--GCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccC--cccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence            3467999999999999999999875221  22456899999987532     3478899999999999999999998765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCce
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAF----------------------PPLPWKTRLHIILGAAEGLAYLHEGLEVQV  209 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~i  209 (432)
                      +.    .++||||+.+++|.+++.....                      ..+++..++.++.||+.||.|||++   +|
T Consensus        99 ~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i  171 (314)
T 2ivs_A           99 GP----LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KL  171 (314)
T ss_dssp             SS----CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             Cc----eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CC
Confidence            54    4999999999999999976432                      2488999999999999999999998   99


Q ss_pred             eecCCCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCC
Q 014034          210 IYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRR  288 (432)
Q Consensus       210 vH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~  288 (432)
                      +||||||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus       172 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  251 (314)
T 2ivs_A          172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN  251 (314)
T ss_dssp             ECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999975433322233344567889999999999899999999999999999999 999


Q ss_pred             CCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          289 SLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       289 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                      ||.+.........   +.....          .    ..+...+..+.+|+.+||+.||.+|||+.+|+++|+.++.
T Consensus       252 p~~~~~~~~~~~~---~~~~~~----------~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          252 PYPGIPPERLFNL---LKTGHR----------M----ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             SSTTCCGGGHHHH---HHTTCC----------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHH---hhcCCc----------C----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9987655432222   111110          0    1112234678899999999999999999999999999875

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3e-45  Score=351.51  Aligned_cols=272  Identities=23%  Similarity=0.270  Sum_probs=212.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|.+.+.||+|+||.||+|.+.       .+++.||||++...     ...+.+|+.+++.++||||+++++++.....
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHK-------KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT   81 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred             CCEEEEEEecCCCCeEEEEEEEC-------CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCC
Confidence            57999999999999999999976       45789999998753     2457899999999999999999999876543


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEE----cCCCcee
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL----DENFRPK  228 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill----~~~~~~k  228 (432)
                      .  ..++||||+.+++|.+++.... ...+++..++.++.||+.||.|||+.   +|+||||||+|||+    +.++.+|
T Consensus        82 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~k  156 (319)
T 4euu_A           82 R--HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYK  156 (319)
T ss_dssp             C--CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEE
T ss_pred             c--eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEE
Confidence            2  4589999999999999997643 23489999999999999999999998   99999999999999    7888899


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCccccc--------cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchh-hH
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE--------TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT-EQ  299 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~-~~  299 (432)
                      |+|||+++.....   .......||+.|+|||++.        +..++.++|||||||++|||++|..||....... ..
T Consensus       157 L~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  233 (319)
T 4euu_A          157 LTDFGAARELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK  233 (319)
T ss_dssp             ECCCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH
T ss_pred             EccCCCceecCCC---CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH
Confidence            9999999763222   2233467999999999986        5788999999999999999999999997544322 12


Q ss_pred             HH-HHHHhhcccCcc-ccccc------c--CccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          300 RL-LEWVQQYPADSK-KFGLI------M--DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       300 ~~-~~~~~~~~~~~~-~~~~~------~--~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                      .. .......+.... .....      .  ........+...+..+.+|+.+||+.||.+|||+.|++++..+...
T Consensus       234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             HHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            22 222222221110 00000      0  1111224456778889999999999999999999999999876643

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.3e-46  Score=353.42  Aligned_cols=262  Identities=23%  Similarity=0.361  Sum_probs=205.2

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .++|++++.||+|+||.||+|...       .++..||+|.+...       ...+.+|+.++..++||||+++++++..
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~   82 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDT-------ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE   82 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEET-------TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC
T ss_pred             hccEEEEEEEccCCCEEEEEEEEC-------CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee
Confidence            357999999999999999999865       46788999987421       1347899999999999999999999876


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .+    ..++||||+++++|.+++....  ++++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        83 ~~----~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~  153 (294)
T 4eqm_A           83 DD----CYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIF  153 (294)
T ss_dssp             SS----EEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEEC
T ss_pred             CC----eEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEE
Confidence            54    4599999999999999997653  699999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      |||++...... .........||+.|+|||++.+..++.++||||||+++|+|++|..||.+......  ....+.... 
T Consensus       154 Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--~~~~~~~~~-  229 (294)
T 4eqm_A          154 DFGIAKALSET-SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIKHIQDSV-  229 (294)
T ss_dssp             CCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH--HHHHHSSCC-
T ss_pred             eCCCccccccc-cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhhccC-
Confidence            99999753211 11223345799999999999999999999999999999999999999987654322  111111110 


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHhhhccC
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-KMSQVVERLKQIVQVSNE  369 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~~~~~~~~  369 (432)
                                +..........+..+.+++.+||+.||.+|| ++.++.+.|+.++.....
T Consensus       230 ----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~  279 (294)
T 4eqm_A          230 ----------PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA  279 (294)
T ss_dssp             ----------CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred             ----------CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence                      0000111222346788999999999999999 899999999888765443

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.5e-45  Score=355.38  Aligned_cols=265  Identities=19%  Similarity=0.194  Sum_probs=210.9

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC--hHHHHHHHHHhccc-CCCccceeeeEEeecCCc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQWVAEVQFLGVL-EHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~  154 (432)
                      .++|.+.+.||+|+||.||+|...       .+++.||||.+...  ...+.+|+.+++.+ +||||+++++++....  
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~--   78 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNL-------YTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGK--   78 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEET-------TTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETT--
T ss_pred             cCCeEEEEEeeccCCceEEEEEEC-------CCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCC--
Confidence            357999999999999999999865       46799999998543  23488999999999 9999999999987754  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCc-----eee
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR-----PKL  229 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~-----~kl  229 (432)
                        ..++||||+ +++|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.     +||
T Consensus        79 --~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl  151 (330)
T 2izr_A           79 --YNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHI  151 (330)
T ss_dssp             --EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEE
T ss_pred             --ccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEE
Confidence              459999999 99999999764 34799999999999999999999998   9999999999999998887     999


Q ss_pred             ccccCCcCCCCCCCc-----ccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 014034          230 SDFGLAREGPMVGHT-----HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  304 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  304 (432)
                      +|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|..||.+............
T Consensus       152 ~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~  231 (330)
T 2izr_A          152 IDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK  231 (330)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH
T ss_pred             EEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH
Confidence            999999853222111     112456899999999999999999999999999999999999999987654443333322


Q ss_pred             HhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhccC
Q 014034          305 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNE  369 (432)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~  369 (432)
                      +....... ..     ..+    ....+ .+.+|+..||+.||.+||++.+|++.|+.+....+.
T Consensus       232 i~~~~~~~-~~-----~~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~  285 (330)
T 2izr_A          232 IGDTKRAT-PI-----EVL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY  285 (330)
T ss_dssp             HHHHHHHS-CH-----HHH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             HHhhhccC-CH-----HHH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence            21110000 00     000    00112 788999999999999999999999999998876543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9.9e-46  Score=346.07  Aligned_cols=253  Identities=30%  Similarity=0.443  Sum_probs=207.0

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---hHHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      ++|+..+.||+|+||.||+|.+.        ++..||+|++...   ...+.+|+.++++++||||+++++++...+.  
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--   79 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWL--------NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP--   79 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--------TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS--
T ss_pred             hhceeeheecCCCccEEEEEEec--------CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc--
Confidence            57999999999999999999874        4667999998753   4568999999999999999999999876543  


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCC
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  235 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a  235 (432)
                        .++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        80 --~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~  153 (269)
T 4hcu_A           80 --ICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT  153 (269)
T ss_dssp             --EEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGG
T ss_pred             --eEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccc
Confidence              499999999999999996544 4689999999999999999999998   9999999999999999999999999999


Q ss_pred             cCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      ..... ..........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.........   ..+....     
T Consensus       154 ~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~---~~~~~~~-----  224 (269)
T 4hcu_A          154 RFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV---EDISTGF-----  224 (269)
T ss_dssp             GGBCC-HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHHHTTC-----
T ss_pred             ccccc-cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH---HHHhcCc-----
Confidence            75321 11122234556788999999999999999999999999999999 99999876543221   1111110     


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                           ..    ..+...+..+.+|+.+||+.||.+|||+.+++++|+.+.+
T Consensus       225 -----~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          225 -----RL----YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             -----CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----cC----CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence                 00    1111224568899999999999999999999999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.6e-45  Score=347.84  Aligned_cols=249  Identities=29%  Similarity=0.548  Sum_probs=201.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----------HHHHHHHHHhcccCCCccceeeeE
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----------LQWVAEVQFLGVLEHPNLVKLIGY  147 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----------~~~~~E~~~l~~l~hpniv~l~~~  147 (432)
                      ++|.+.+.||+|+||.||+|.+.       .++..||+|.+....           ..+.+|+.+++.++||||++++++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   91 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLV-------KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL   91 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEET-------TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ccceehhccccCCceeEEEEEEc-------CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhee
Confidence            57999999999999999999875       467889999985321           457899999999999999999999


Q ss_pred             EeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCc--eeecCCCCCceEEcCCC
Q 014034          148 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQ--VIYRDFKASNVLLDENF  225 (432)
Q Consensus       148 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~--ivH~Dikp~Nill~~~~  225 (432)
                      +....      ++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.   +  |+||||||+|||++.++
T Consensus        92 ~~~~~------~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~  161 (287)
T 4f0f_A           92 MHNPP------RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLD  161 (287)
T ss_dssp             ETTTT------EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCC
T ss_pred             ecCCC------eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccC
Confidence            85432      79999999999999887654 4799999999999999999999998   8  99999999999998877


Q ss_pred             c-----eeeccccCCcCCCCCCCcccccccccCCCccCcccc--ccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhh
Q 014034          226 R-----PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI--ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE  298 (432)
Q Consensus       226 ~-----~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~  298 (432)
                      .     +||+|||+++...     .......||+.|+|||++  ....++.++|||||||++|+|++|..||........
T Consensus       162 ~~~~~~~kl~Dfg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  236 (287)
T 4f0f_A          162 ENAPVCAKVADFGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI  236 (287)
T ss_dssp             TTCSCCEEECCCTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH
T ss_pred             CCCceeEEeCCCCcccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH
Confidence            6     9999999997521     123446799999999998  445678999999999999999999999987654332


Q ss_pred             HHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          299 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                      ..... .....         ..+    ..+...+..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus       237 ~~~~~-~~~~~---------~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          237 KFINM-IREEG---------LRP----TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHHH-HHHSC---------CCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHHHH-HhccC---------CCC----CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            21111 11111         011    11223346788999999999999999999999998753

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-46  Score=366.73  Aligned_cols=263  Identities=26%  Similarity=0.424  Sum_probs=207.0

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|.+++.||+|+||.||+|.+....  +..++..||||++...     ...+.+|+.+++.++||||+++++++....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMP--NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCC--CCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            357999999999999999999975221  2346789999998643     224788999999999999999999987655


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC--
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRA-----FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF--  225 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~--  225 (432)
                      ..    ++||||+.+|+|.+++....     ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++  
T Consensus       148 ~~----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~  220 (367)
T 3l9p_A          148 PR----FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPG  220 (367)
T ss_dssp             SC----EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTT
T ss_pred             CC----EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCC
Confidence            43    99999999999999997532     23589999999999999999999998   999999999999999555  


Q ss_pred             -ceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHH
Q 014034          226 -RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLE  303 (432)
Q Consensus       226 -~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~  303 (432)
                       .+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.......   +..
T Consensus       221 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---~~~  297 (367)
T 3l9p_A          221 RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLE  297 (367)
T ss_dssp             CCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHH
T ss_pred             ceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH
Confidence             599999999963211111222334568999999999999999999999999999999998 999998765432   222


Q ss_pred             HHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          304 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                      .+.....          .    ..+...+..+.+|+.+||+.||.+|||+.+|+++|+.+.+.
T Consensus       298 ~i~~~~~----------~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          298 FVTSGGR----------M----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             HHHTTCC----------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHcCCC----------C----CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            2221110          0    11122345688999999999999999999999999988654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-46  Score=357.13  Aligned_cols=251  Identities=18%  Similarity=0.273  Sum_probs=204.2

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH---HHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      .++|.+.+.||+|+||.||+|...       .++..||+|.+.....   .+.+|+.+++.++||||+++++++...+  
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--   74 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVET-------SSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESME--   74 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT--
T ss_pred             hhceEeeeEEecCCCeEEEEEEEC-------CCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC--
Confidence            468999999999999999999865       5678999999875432   4789999999999999999999997654  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC--CCceeeccc
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE--NFRPKLSDF  232 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~--~~~~kl~Df  232 (432)
                        ..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.  ++.+||+||
T Consensus        75 --~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Df  148 (321)
T 1tki_A           75 --ELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEF  148 (321)
T ss_dssp             --EEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred             --EEEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEEC
Confidence              4599999999999999996543 4689999999999999999999998   9999999999999987  789999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      |++.....   ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....   ....+...... 
T Consensus       149 g~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~-  221 (321)
T 1tki_A          149 GQARQLKP---GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIENIMNAEYT-  221 (321)
T ss_dssp             TTCEECCT---TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHHTCCC-
T ss_pred             CCCeECCC---CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH---HHHHHHcCCCC-
Confidence            99986422   222344679999999999998889999999999999999999999998754432   22211111100 


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                            .....    ....+..+.+|+.+||..||.+|||+.+++++-
T Consensus       222 ------~~~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          222 ------FDEEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             ------CCHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             ------CChhh----hccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence                  00000    011245788999999999999999999999873

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-46  Score=359.09  Aligned_cols=264  Identities=24%  Similarity=0.376  Sum_probs=209.9

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhccc-CCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVL-EHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~hpniv~l~~~~~~~  151 (432)
                      .++|.+.+.||+|+||.||+|.+....  ....+..||+|.+....     ..+.+|+.++.++ +||||+++++++...
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGIS--KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCS--SSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccc--cCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            467999999999999999999975221  23467899999986532     3488999999999 899999999999765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCcee
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAF---------------------PPLPWKTRLHIILGAAEGLAYLHEGLEVQVI  210 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~iv  210 (432)
                      +.    .++||||+++|+|.+++.....                     ..+++..++.++.||+.||.|||+.   +|+
T Consensus       122 ~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv  194 (344)
T 1rjb_A          122 GP----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV  194 (344)
T ss_dssp             SS----CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             Cc----cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence            54    4999999999999999976532                     2479999999999999999999998   999


Q ss_pred             ecCCCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCC
Q 014034          211 YRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRS  289 (432)
Q Consensus       211 H~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p  289 (432)
                      ||||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|+| |..|
T Consensus       195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999999975332222223344567889999999999999999999999999999998 9999


Q ss_pred             CCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          290 LERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       290 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                      |.+......  ....+....              ....+...+..+.+|+.+||..||.+|||+.+|+++|+.++..
T Consensus       275 ~~~~~~~~~--~~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          275 YPGIPVDAN--FYKLIQNGF--------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             STTCCCSHH--HHHHHHTTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             cccCCcHHH--HHHHHhcCC--------------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            987654322  111111110              0011122346788999999999999999999999999988754

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.3e-45  Score=352.65  Aligned_cols=265  Identities=25%  Similarity=0.377  Sum_probs=213.2

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhccc-CCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVL-EHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~hpniv~l~~~~~~~  151 (432)
                      .++|.+.+.||+|+||.||+|++...  ....++..||+|.+....     ..+.+|+.++.++ +||||+++++++...
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGL--IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESS--SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeec--cccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            45799999999999999999986421  123567899999987542     3478999999999 999999999999765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCC----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCC
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAF----------------PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFK  215 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dik  215 (432)
                      +.    .++||||+++|+|.+++.....                ..+++..++.++.||+.||.|||+.   +|+|||||
T Consensus       100 ~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlk  172 (313)
T 1t46_A          100 GP----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA  172 (313)
T ss_dssp             SS----CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             CC----cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCc
Confidence            54    3999999999999999976542                2589999999999999999999998   99999999


Q ss_pred             CCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCC
Q 014034          216 ASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNR  294 (432)
Q Consensus       216 p~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~  294 (432)
                      |+|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|+| |..||.+..
T Consensus       173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            9999999999999999999986433332233344567889999999999999999999999999999999 999998765


Q ss_pred             chhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhc
Q 014034          295 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  367 (432)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  367 (432)
                      ....  ....+.....          .    ..+...+..+.+|+.+||+.||.+|||+.+++++|+.++...
T Consensus       253 ~~~~--~~~~~~~~~~----------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          253 VDSK--FYKMIKEGFR----------M----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             SSHH--HHHHHHHTCC----------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             chhH--HHHHhccCCC----------C----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence            4322  1111111100          0    111223467889999999999999999999999999988653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.6e-45  Score=354.02  Aligned_cols=258  Identities=24%  Similarity=0.369  Sum_probs=208.3

Q ss_pred             ccCHHHHHHhhcC----------CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC----hHHHHHHHHHh
Q 014034           68 VFSYSEMRQATND----------FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVAEVQFL  133 (432)
Q Consensus        68 ~~~~~~~~~~~~~----------~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l  133 (432)
                      .++++++..+++.          |...+.||+|+||.||+|...       .+++.||||.+...    ...+.+|+.++
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~-------~~g~~vavK~~~~~~~~~~~~~~~E~~~l   96 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK-------HSGRQVAVKMMDLRKQQRRELLFNEVVIM   96 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEETTTCCSHHHHHHHHHHH
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEEC-------CCCcEEEEEEEeccchhHHHHHHHHHHHH
Confidence            3667777776654          667789999999999999865       46789999998542    34588999999


Q ss_pred             cccCCCccceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecC
Q 014034          134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRD  213 (432)
Q Consensus       134 ~~l~hpniv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~D  213 (432)
                      +.++||||+++++++...+    ..++||||+.+++|.+++..   ..+++..+..++.|++.||.|||+.   +|+|||
T Consensus        97 ~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~D  166 (321)
T 2c30_A           97 RDYQHFNVVEMYKSYLVGE----ELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRD  166 (321)
T ss_dssp             TTCCCTTBCCEEEEEEETT----EEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HhCCCCCcceEEEEEEECC----EEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence            9999999999999998754    35999999999999999864   3689999999999999999999998   999999


Q ss_pred             CCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 014034          214 FKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN  293 (432)
Q Consensus       214 ikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~  293 (432)
                      |||+|||++.++.+||+|||++.....  .........||+.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus       167 lkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~  244 (321)
T 2c30_A          167 IKSDSILLTLDGRVKLSDFGFCAQISK--DVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD  244 (321)
T ss_dssp             CSGGGEEECTTCCEEECCCTTCEECCS--SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             CCHHHEEECCCCcEEEeeeeeeeeccc--CccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999875322  122234567999999999999999999999999999999999999999865


Q ss_pred             CchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          294 RPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .....   ...+......          .+.  .....+..+.+|+.+||+.||.+|||+.+++++
T Consensus       245 ~~~~~---~~~~~~~~~~----------~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          245 SPVQA---MKRLRDSPPP----------KLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             CHHHH---HHHHHHSSCC----------CCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CHHHH---HHHHhcCCCC----------CcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            44322   2222221111          000  011224568899999999999999999999886

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-45  Score=357.65  Aligned_cols=266  Identities=28%  Similarity=0.454  Sum_probs=210.6

Q ss_pred             HhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEee
Q 014034           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        76 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      ...++|.+.+.||+|+||.||+|.+....  ...++..||+|.+....     ..+.+|+.+++.++||||+++++++..
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLL--PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSS--TTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcC--CCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            34578999999999999999999976221  12456899999987542     347899999999999999999999976


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCc
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRA----------------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQ  208 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~  208 (432)
                      .+.    .++||||+.+++|.+++....                      ...+++..++.++.||+.||.|||++   +
T Consensus       122 ~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~  194 (343)
T 1luf_A          122 GKP----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---K  194 (343)
T ss_dssp             SSS----CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             CCc----eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence            554    499999999999999997642                      15789999999999999999999998   9


Q ss_pred             eeecCCCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CC
Q 014034          209 VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GR  287 (432)
Q Consensus       209 ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~  287 (432)
                      |+||||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus       195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~  274 (343)
T 1luf_A          195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL  274 (343)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence            99999999999999999999999999874321111122334568899999999999999999999999999999999 99


Q ss_pred             CCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhc
Q 014034          288 RSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  367 (432)
Q Consensus       288 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  367 (432)
                      .||.+.....   +...+.....          .    ..+...+..+.+|+.+||+.||.+|||+.+|++.|+.+.+..
T Consensus       275 ~p~~~~~~~~---~~~~~~~~~~----------~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          275 QPYYGMAHEE---VIYYVRDGNI----------L----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             CTTTTSCHHH---HHHHHHTTCC----------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             CcCCCCChHH---HHHHHhCCCc----------C----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            9998754432   2222211100          0    111223467889999999999999999999999999887543

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.5e-45  Score=356.04  Aligned_cols=268  Identities=27%  Similarity=0.432  Sum_probs=213.2

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhccc-CCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVL-EHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~hpniv~l~~~~~~~  151 (432)
                      .++|.+.+.||+|+||.||+|.+.........++..||+|.+....     ..+.+|+.+++.+ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            3579999999999999999999864444444577899999987542     2478899999999 899999999999765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCC
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAF--------------PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKAS  217 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~  217 (432)
                      +.    .++||||+.+++|.+++.....              ..+++..++.++.||+.||.|||+.   +|+||||||+
T Consensus       114 ~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~  186 (334)
T 2pvf_A          114 GP----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR  186 (334)
T ss_dssp             SC----CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred             Cc----eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccc
Confidence            54    4999999999999999976432              2489999999999999999999998   9999999999


Q ss_pred             ceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCch
Q 014034          218 NVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPK  296 (432)
Q Consensus       218 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~  296 (432)
                      |||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+....
T Consensus       187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  266 (334)
T 2pvf_A          187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  266 (334)
T ss_dssp             GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence            99999999999999999976433222223344567889999999998889999999999999999999 99999876543


Q ss_pred             hhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhccC
Q 014034          297 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNE  369 (432)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~  369 (432)
                      ..   ...+.....          .    ..+...+..+.+|+.+||+.||.+|||+.++++.|+.++.....
T Consensus       267 ~~---~~~~~~~~~----------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~  322 (334)
T 2pvf_A          267 EL---FKLLKEGHR----------M----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN  322 (334)
T ss_dssp             HH---HHHHHHTCC----------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             HH---HHHHhcCCC----------C----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence            22   222211110          0    11122346788999999999999999999999999999876543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.8e-46  Score=351.43  Aligned_cols=249  Identities=26%  Similarity=0.376  Sum_probs=197.0

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------------------------------HHHH
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------------------------------LQWV  127 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------------------------------~~~~  127 (432)
                      .++|.+.+.||+|+||.||+|...       .+++.||+|.+....                              ..+.
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNE-------NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVY   84 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEET-------TTTEEEEEEEEECC-------------------------------CHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEEC-------CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHH
Confidence            358999999999999999999865       567899999986432                              3478


Q ss_pred             HHHHHhcccCCCccceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 014034          128 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEV  207 (432)
Q Consensus       128 ~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~  207 (432)
                      +|+.+++.++||||+++++++.....  ...++||||+.+++|.+++..   .++++..++.++.||+.||.|||+.   
T Consensus        85 ~E~~~l~~l~h~~iv~~~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---  156 (298)
T 2zv2_A           85 QEIAILKKLDHPNVVKLVEVLDDPNE--DHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQ---  156 (298)
T ss_dssp             HHHHHHHTCCCTTBCCEEEEEECSSS--SEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             HHHHHHHhCCCCCCCeEEEEEEcCCC--CEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            89999999999999999999876432  356999999999999887532   4699999999999999999999998   


Q ss_pred             ceeecCCCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCC---CCchhhhHHHHHHHHHHH
Q 014034          208 QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH---LTAKSDVWSFGVVLYEML  284 (432)
Q Consensus       208 ~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~ell  284 (432)
                      +|+||||||+|||++.++.+||+|||++.....  .........||+.|+|||++.+..   ++.++|||||||++|+|+
T Consensus       157 ~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~  234 (298)
T 2zv2_A          157 KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG--SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV  234 (298)
T ss_dssp             TEECCCCCGGGEEECTTSCEEECCCTTCEECSS--SSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred             CeeccCCCHHHEEECCCCCEEEecCCCcccccc--ccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH
Confidence            999999999999999999999999999975322  122234567999999999998765   377899999999999999


Q ss_pred             hCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          285 TGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       285 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      +|..||.......   +...+......   +     +     .....+..+.+|+.+||+.||.+|||+.+++++
T Consensus       235 ~g~~pf~~~~~~~---~~~~~~~~~~~---~-----~-----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          235 FGQCPFMDERIMC---LHSKIKSQALE---F-----P-----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             HSSCSSCCSSHHH---HHHHHHHCCCC---C-----C-----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             HCCCCCCCccHHH---HHHHHhcccCC---C-----C-----CccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            9999998654322   11111111000   0     0     011223568899999999999999999999865

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=362.85  Aligned_cols=247  Identities=26%  Similarity=0.389  Sum_probs=202.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|.+++.||+|+||.||+|...       .++..||+|.+.+..       ..+.+|+.+|+.++||||+++++++...
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~-------~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~   87 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKN-------DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE   87 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             HHeEEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            57999999999999999999875       467899999986432       3578899999999999999999999765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      .    ..++||||+.+|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+||||+.+|.+||+|
T Consensus        88 ~----~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~D  158 (384)
T 4fr4_A           88 E----DMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITD  158 (384)
T ss_dssp             S----EEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             C----EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEec
Confidence            4    359999999999999999764  3699999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCcccccc---CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET---GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      ||++....   .........||+.|+|||++.+   ..++.++|||||||++|+|++|..||..........+...+...
T Consensus       159 FG~a~~~~---~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~  235 (384)
T 4fr4_A          159 FNIAAMLP---RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT  235 (384)
T ss_dssp             CTTCEECC---TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC
T ss_pred             cceeeecc---CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc
Confidence            99997532   2223355789999999999963   46899999999999999999999999865544433333332221


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-MSQVVER  359 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~~  359 (432)
                      ..               .++...+..+.+||.+||+.||.+||+ +.+|+.+
T Consensus       236 ~~---------------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h  272 (384)
T 4fr4_A          236 VV---------------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF  272 (384)
T ss_dssp             CC---------------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred             cc---------------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence            11               112223467889999999999999998 7777653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=368.37  Aligned_cols=251  Identities=21%  Similarity=0.316  Sum_probs=202.2

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEee
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      ..++|++.+.||+|+||.||+|...       .++..||+|.+....      ..+.+|+.+++.++||||+++++++..
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~-------~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~   81 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKV-------LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE   81 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEET-------TTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEEC-------CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE
Confidence            4567999999999999999999865       567899999986432      247899999999999999999999876


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc---CCCce
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRP  227 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~---~~~~~  227 (432)
                      .+    ..++||||+.+|+|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||++   .++.+
T Consensus        82 ~~----~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~v  152 (444)
T 3soa_A           82 EG----HHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAV  152 (444)
T ss_dssp             SS----EEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCE
T ss_pred             CC----EEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcE
Confidence            54    4599999999999999997654  699999999999999999999998   999999999999998   56889


Q ss_pred             eeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 014034          228 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  307 (432)
Q Consensus       228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  307 (432)
                      ||+|||++.....  .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+......   ...+..
T Consensus       153 kL~DFG~a~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~---~~~i~~  227 (444)
T 3soa_A          153 KLADFGLAIEVEG--EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL---YQQIKA  227 (444)
T ss_dssp             EECCCSSCBCCCT--TCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHH
T ss_pred             EEccCceeEEecC--CCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHh
Confidence            9999999976322  22223456799999999999999999999999999999999999999986543322   222211


Q ss_pred             cccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ....           +........+..+.+||.+||+.||.+|||+.+++++
T Consensus       228 ~~~~-----------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          228 GAYD-----------FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             TCCC-----------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCC-----------CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            1100           0000111224678899999999999999999999987

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.2e-46  Score=356.39  Aligned_cols=248  Identities=24%  Similarity=0.344  Sum_probs=201.6

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC----------hHHHHHHHHHhcccCCCccceeeeEE
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----------GLQWVAEVQFLGVLEHPNLVKLIGYC  148 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~hpniv~l~~~~  148 (432)
                      +.|.+.+.||+|+||.||+|...       .++..||+|.+...          ...+.+|+.+++.++||||+++++++
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   83 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREK-------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY   83 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEET-------TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEEC-------CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            46999999999999999999875       46789999988542          34588999999999999999999998


Q ss_pred             eecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC---
Q 014034          149 AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF---  225 (432)
Q Consensus       149 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~---  225 (432)
                      ....    ..++||||+.+++|.+++...  ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++   
T Consensus        84 ~~~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~  154 (326)
T 2y0a_A           84 ENKT----DVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPK  154 (326)
T ss_dssp             ECSS----EEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSS
T ss_pred             EeCC----EEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCC
Confidence            7644    459999999999999999654  4799999999999999999999998   999999999999999887   


Q ss_pred             -ceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 014034          226 -RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  304 (432)
Q Consensus       226 -~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  304 (432)
                       .+||+|||++......   .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........   
T Consensus       155 ~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---  228 (326)
T 2y0a_A          155 PRIKIIDFGLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN---  228 (326)
T ss_dssp             CCEEECCCTTCEECCTT---SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH---
T ss_pred             CCEEEEECCCCeECCCC---CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH---
Confidence             7999999999763221   123346799999999999999999999999999999999999999986544322111   


Q ss_pred             HhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          305 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      +......       ...    ......+..+.+|+.+||..||.+|||+.+++++
T Consensus       229 ~~~~~~~-------~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          229 VSAVNYE-------FED----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             HHHTCCC-------CCH----HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHhcCCC-------cCc----cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1111000       000    0001123568899999999999999999999886

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.4e-46  Score=354.96  Aligned_cols=276  Identities=25%  Similarity=0.386  Sum_probs=207.0

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH----HHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL----QWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      .++|++++.||+|+||.||+|.+..   .+..++..||+|++.....    .+.+|+.+++.++||||+++++++...+.
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   85 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDP---LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   85 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECT---TCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEec---ccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            3579999999999999999998642   1335789999999876442    47899999999999999999999865433


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                      .  ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        86 ~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg  159 (295)
T 3ugc_A           86 R--NLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG  159 (295)
T ss_dssp             T--SCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             C--ceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCc
Confidence            2  3489999999999999997653 3589999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCC-cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          234 LAREGPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       234 ~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      ++........ ........++..|+|||++.+..++.++||||||+++|+|+||..||......    ........+...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~  235 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQ  235 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCTH
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCccccc
Confidence            9985422211 12223345777899999999999999999999999999999999998643211    111110000000


Q ss_pred             cc---cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          313 KK---FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       313 ~~---~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                      ..   ....+........+...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          236 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            00   0000000001112233456788999999999999999999999999998753

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.1e-45  Score=369.17  Aligned_cols=252  Identities=29%  Similarity=0.438  Sum_probs=207.3

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC--hHHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      ..++|.+.+.||+|+||.||+|.+.         +..||||.++..  ...+.+|+.+|++++||||+++++++..... 
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~---------~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-  260 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR---------GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG-  260 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET---------TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS-
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec---------CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC-
Confidence            3467889999999999999999863         578999998764  3468999999999999999999999876442 


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        ..++||||+.+|+|.+++.......+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       261 --~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~  335 (450)
T 1k9a_A          261 --GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL  335 (450)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             --ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCC
Confidence              359999999999999999876555689999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      ++....     ......+++.|+|||++.+..++.++|||||||++|||+| |..||.+.........   +...     
T Consensus       336 a~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~---i~~~-----  402 (450)
T 1k9a_A          336 TKEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---VEKG-----  402 (450)
T ss_dssp             CEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH---HHTT-----
T ss_pred             cccccc-----cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHcC-----
Confidence            975321     1122357889999999999999999999999999999998 9999987654332211   1110     


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                               .....+..++..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       403 ---------~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          403 ---------YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence                     0001122335678899999999999999999999999998865

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.3e-45  Score=361.80  Aligned_cols=261  Identities=26%  Similarity=0.432  Sum_probs=198.5

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|.+.+.||+|+||.||+|++...    ...+..||||.+...     ...+.+|+.++++++||||+++++++....
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  119 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLP----SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK  119 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCT----TSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecC----CCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            35799999999999999999986521    235678999998653     234889999999999999999999997654


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                      .    .++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       120 ~----~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df  191 (373)
T 2qol_A          120 P----VMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDF  191 (373)
T ss_dssp             S----CEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             c----eEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcC
Confidence            3    499999999999999997543 4689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCc-ccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhccc
Q 014034          233 GLAREGPMVGHT-HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       233 G~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      |+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||........   ...+.... 
T Consensus       192 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~---~~~i~~~~-  267 (373)
T 2qol_A          192 GLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV---IKAVDEGY-  267 (373)
T ss_dssp             ----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH---HHHHHTTE-
T ss_pred             ccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCC-
Confidence            999753221111 11122345778999999999999999999999999999998 9999987654322   22111110 


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhc
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  367 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  367 (432)
                                   ....+...+..+.+|+.+||+.||.+||++.+|++.|+.+....
T Consensus       268 -------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          268 -------------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             -------------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             -------------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence                         00112233467889999999999999999999999999987643

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.8e-45  Score=359.77  Aligned_cols=279  Identities=20%  Similarity=0.235  Sum_probs=210.2

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHH---------------HHHHHhcccCCCccc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWV---------------AEVQFLGVLEHPNLV  142 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~---------------~E~~~l~~l~hpniv  142 (432)
                      .++|.+.+.||+|+||.||+|.+...  .....++.||||.+......+.               .|+..+..++||||+
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSS--ESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCS--SCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCc--cccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            45799999999999999999987622  1223468899999876554333               344556677899999


Q ss_pred             eeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc
Q 014034          143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD  222 (432)
Q Consensus       143 ~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~  222 (432)
                      ++++++..........++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~  186 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN  186 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence            99999987654445679999999 999999997643 4799999999999999999999998   999999999999999


Q ss_pred             --CCCceeeccccCCcCCCCCCC-----cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCc
Q 014034          223 --ENFRPKLSDFGLAREGPMVGH-----THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP  295 (432)
Q Consensus       223 --~~~~~kl~DfG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~  295 (432)
                        .++.+||+|||+++.......     ........||+.|+|||++.+..++.++|||||||++|||+||..||.+...
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              899999999999975321111     1112345699999999999999999999999999999999999999986433


Q ss_pred             hhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhccCC
Q 014034          296 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEG  370 (432)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~  370 (432)
                      ........ ...+..   ....++++.+..   ...+..+.+|+..||+.||.+||++.+|++.|+.++...+..
T Consensus       267 ~~~~~~~~-~~~~~~---~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~  334 (364)
T 3op5_A          267 DPKYVRDS-KIRYRE---NIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK  334 (364)
T ss_dssp             CHHHHHHH-HHHHHH---CHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             CHHHHHHH-HHHhhh---hHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence            22111100 000100   011111111110   112467889999999999999999999999999998766543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=8e-46  Score=356.58  Aligned_cols=258  Identities=25%  Similarity=0.377  Sum_probs=204.7

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|++.+.||+|+||.||+|.+...   +......||+|.+....     ..+.+|+.+++.++||||+++++++...  
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--   87 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPE---GESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS--   87 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCT---TCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBS--
T ss_pred             hHceeeeeeeecCCceEEEEEEcCC---CceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--
Confidence            5799999999999999999997622   22345568999875432     2467899999999999999999988532  


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        88 ---~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg  160 (325)
T 3kex_A           88 ---SLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFG  160 (325)
T ss_dssp             ---SEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCS
T ss_pred             ---ccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCC
Confidence               3589999999999999997643 4689999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      +++...............||..|+|||++.+..++.++|||||||++|+|+| |..||.+.................   
T Consensus       161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---  237 (325)
T 3kex_A          161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLA---  237 (325)
T ss_dssp             GGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCC---
T ss_pred             cccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCC---
Confidence            9986543333333445678889999999999999999999999999999999 999998765543332222110000   


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                                    .+...+..+.+|+.+||..||.+|||+.+++++|+.+..
T Consensus       238 --------------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          238 --------------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             --------------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             --------------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                          011112346689999999999999999999999998864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.8e-46  Score=357.90  Aligned_cols=251  Identities=24%  Similarity=0.338  Sum_probs=202.2

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|++.+.||+|+||.||+|...       .+++.||+|.+....     ..+.+|+.+++.++||||+++++++...+
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~   78 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNR-------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN   78 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhceeeeEEecCCCEEEEEEEEC-------CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            468999999999999999999865       467899999985432     23789999999999999999999987654


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..++||||+.+++|.+++...  ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        79 ----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Df  149 (323)
T 3tki_A           79 ----IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDF  149 (323)
T ss_dssp             ----EEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             ----eEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEe
Confidence                459999999999999998654  3699999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      |++................||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ ....+.......
T Consensus       150 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~  228 (323)
T 3tki_A          150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKKTYL  228 (323)
T ss_dssp             TTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHTTCTTS
T ss_pred             eccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhcccccC
Confidence            99975322222233345689999999999987765 7789999999999999999999986554322 122221111000


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                              .      .....+..+.+|+.+||..||.+|||+.+++++
T Consensus       229 --------~------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          229 --------N------PWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             --------T------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --------C------ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                    0      011224567899999999999999999999876

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.8e-45  Score=362.36  Aligned_cols=249  Identities=24%  Similarity=0.390  Sum_probs=200.9

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhccc-CCCccceeeeEEe
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVL-EHPNLVKLIGYCA  149 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~hpniv~l~~~~~  149 (432)
                      .++|.+++.||+|+||.||+|+.+       .+++.||+|++.+..       ..+..|..++.++ +||||+++++++.
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~-------~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~  123 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLK-------KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ  123 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE
Confidence            457999999999999999999976       467899999986532       2377899999877 8999999999987


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      ...    ..++||||+.+|+|..++....  .+++..+..++.||+.||.|||+.   +|+||||||+||||+.+|.+||
T Consensus       124 ~~~----~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL  194 (396)
T 4dc2_A          124 TES----RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKL  194 (396)
T ss_dssp             CSS----EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred             ECC----EEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEE
Confidence            654    4599999999999999997643  699999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchh------hHHHHH
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT------EQRLLE  303 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~------~~~~~~  303 (432)
                      +|||+++....  ........+||+.|+|||++.+..++.++|||||||++|||++|..||.......      ...+..
T Consensus       195 ~DFGla~~~~~--~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~  272 (396)
T 4dc2_A          195 TDYGMCKEGLR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ  272 (396)
T ss_dssp             CCCTTCBCCCC--TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHH
T ss_pred             eecceeeeccc--CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHH
Confidence            99999985221  2223456789999999999999999999999999999999999999997532211      111111


Q ss_pred             HHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 014034          304 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM------SQVVER  359 (432)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~eil~~  359 (432)
                      .+....           .    ..+...+..+.+||.+||+.||.+||++      .+|+++
T Consensus       273 ~i~~~~-----------~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          273 VILEKQ-----------I----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             HHHHCC-----------C----CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             HHhccc-----------c----CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence            111110           0    1122234678899999999999999985      577665

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.9e-45  Score=346.11  Aligned_cols=265  Identities=18%  Similarity=0.190  Sum_probs=210.9

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh--HHHHHHHHHhccc-CCCccceeeeEEeecCCc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQWVAEVQFLGVL-EHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~  154 (432)
                      .++|.+.+.||+|+||.||+|...       .++..||+|.+....  ..+.+|+.++..+ +|+|++++++++....  
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~--   79 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNL-------LNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL--   79 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEET-------TTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT--
T ss_pred             ccceEEEEEEeecCCEEEEEEEEC-------CCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc--
Confidence            457999999999999999999864       467899999986433  3488999999999 7999999999987554  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCc-----eee
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR-----PKL  229 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~-----~kl  229 (432)
                        ..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.     +||
T Consensus        80 --~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl  152 (298)
T 1csn_A           80 --HNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYV  152 (298)
T ss_dssp             --EEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             --eeEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEE
Confidence              459999999 999999997653 3699999999999999999999998   9999999999999987776     999


Q ss_pred             ccccCCcCCCCCCCc-----ccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 014034          230 SDFGLAREGPMVGHT-----HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  304 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  304 (432)
                      +|||++.........     .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+............
T Consensus       153 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (298)
T 1csn_A          153 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER  232 (298)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred             EECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH
Confidence            999999753222111     123456799999999999999999999999999999999999999987654333322222


Q ss_pred             HhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhcc
Q 014034          305 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  368 (432)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  368 (432)
                      +....... .     .+.+    ....+..+.+|+.+||+.||.+|||+.+|++.|+.++...+
T Consensus       233 ~~~~~~~~-~-----~~~~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          233 IGEKKQST-P-----LREL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             HHHHHHHS-C-----HHHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHhhccCc-c-----HHHH----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence            21110000 0     0000    11224678899999999999999999999999999987654

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.8e-45  Score=345.51  Aligned_cols=255  Identities=23%  Similarity=0.370  Sum_probs=204.8

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---hHHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      .++|++++.||+|+||.||+|.+.        ++..||+|.+...   ...+.+|+.++..++||||+++++++..... 
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-   93 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWR--------GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP-   93 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEET--------TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS-
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEc--------CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCC-
Confidence            357999999999999999999875        4677999998753   4568899999999999999999999876543 


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                         .++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        94 ---~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~  166 (283)
T 3gen_A           94 ---IFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGL  166 (283)
T ss_dssp             ---EEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred             ---eEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccc
Confidence               599999999999999997633 3699999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      +...... .........+|+.|+|||++.+..++.++||||||+++|+|+| |..||...........+   ....    
T Consensus       167 ~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~---~~~~----  238 (283)
T 3gen_A          167 SRYVLDD-EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---AQGL----  238 (283)
T ss_dssp             GGGBCCH-HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH---HTTC----
T ss_pred             ccccccc-ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH---hccc----
Confidence            9753211 1122233456788999999999999999999999999999998 99999876543322211   1110    


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                            ..    ..+...+..+.+|+.+||+.||.+|||+.+++++|..++..
T Consensus       239 ------~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          239 ------RL----YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             ------CC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------CC----CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence                  00    01111235788999999999999999999999999998753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=359.23  Aligned_cols=246  Identities=25%  Similarity=0.391  Sum_probs=198.1

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhccc-CCCccceeeeEEe
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVL-EHPNLVKLIGYCA  149 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~hpniv~l~~~~~  149 (432)
                      .++|++++.||+|+||.||+|+++       .+++.||+|++.+..       ..+.+|..++..+ +||||+++++++.
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~   94 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVK-------ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ   94 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEc-------CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE
Confidence            468999999999999999999976       467899999987532       2367899999988 7999999999987


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      ..+    ..++||||+.+|+|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+||||+.++.+||
T Consensus        95 ~~~----~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL  165 (353)
T 3txo_A           95 TPD----RLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKL  165 (353)
T ss_dssp             CSS----EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred             eCC----EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEE
Confidence            654    4599999999999999997643  699999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      +|||+++....  ........+||+.|+|||++.+..++.++|||||||++|||++|..||.+......   ...+....
T Consensus       166 ~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~~~i~~~~  240 (353)
T 3txo_A          166 ADFGMCKEGIC--NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL---FEAILNDE  240 (353)
T ss_dssp             CCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHCC
T ss_pred             ccccceeeccc--CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH---HHHHHcCC
Confidence            99999975321  22334457899999999999998999999999999999999999999987654322   22221110


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM------SQVVER  359 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~eil~~  359 (432)
                                 .    .++...+..+.+|+.+||..||.+||++      .+|+++
T Consensus       241 -----------~----~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          241 -----------V----VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             -----------C----CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             -----------C----CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence                       0    0111233568899999999999999998      778765

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.1e-45  Score=375.35  Aligned_cols=257  Identities=26%  Similarity=0.405  Sum_probs=211.9

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ...+|.+.+.||+|+||.||+|.+.       ..+..||||.+...   ...+.+|+.+|++++||||++++++|.....
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  290 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP  290 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEG-------GGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEc-------CCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            3457888999999999999999976       45789999998754   3568999999999999999999999976554


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                          .++||||+.+|+|.+++.......+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|||
T Consensus       291 ----~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG  363 (495)
T 1opk_A          291 ----FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFG  363 (495)
T ss_dssp             ----CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTT
T ss_pred             ----EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecc
Confidence                49999999999999999876656799999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      +++..... .........+++.|+|||++.+..++.++|||||||++|||+| |..||.+.......   ..+...    
T Consensus       364 ~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~---~~~~~~----  435 (495)
T 1opk_A          364 LSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---ELLEKD----  435 (495)
T ss_dssp             CEECCTTC-CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---HHHHTT----
T ss_pred             cceeccCC-ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHcC----
Confidence            99864221 1122233456789999999998999999999999999999999 99999876543322   222111    


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                                .....+...+..+.+||.+||+.||.+|||+.+|++.|+.+.+
T Consensus       436 ----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          436 ----------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             ----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             ----------CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence                      0011122334678899999999999999999999999988764

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.8e-45  Score=348.27  Aligned_cols=269  Identities=27%  Similarity=0.380  Sum_probs=204.8

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---------hHHHHHHHHHhcccC---CCcccee
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---------GLQWVAEVQFLGVLE---HPNLVKL  144 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~---hpniv~l  144 (432)
                      ..++|++.+.||+|+||.||+|.+.       .+++.||+|.+...         ...+.+|+.+++.+.   ||||+++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~   79 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDP-------HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRL   79 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECT-------TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCE
T ss_pred             cccceEEEEEEecCCCeEEEEEEEC-------CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEe
Confidence            3578999999999999999999854       56789999998632         235678888877764   9999999


Q ss_pred             eeEEeecCC-cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC
Q 014034          145 IGYCAVDGE-RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  223 (432)
Q Consensus       145 ~~~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~  223 (432)
                      ++++..... .....++||||+. ++|.+++.......+++..++.++.||+.||.|||+.   +|+||||||+|||++.
T Consensus        80 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~  155 (308)
T 3g33_A           80 MDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTS  155 (308)
T ss_dssp             EEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECT
T ss_pred             eeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcC
Confidence            999976543 2335689999996 6999999877666699999999999999999999998   9999999999999999


Q ss_pred             CCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH-
Q 014034          224 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL-  302 (432)
Q Consensus       224 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~-  302 (432)
                      ++.+||+|||+++...   .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+ 
T Consensus       156 ~~~~kl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~  232 (308)
T 3g33_A          156 GGTVKLADFGLARIYS---YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF  232 (308)
T ss_dssp             TSCEEECSCSCTTTST---TCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHH
T ss_pred             CCCEEEeeCccccccC---CCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999997532   222234567999999999999999999999999999999999999999876554332222 


Q ss_pred             HHHhhcccCcccccccc-CccccC-------cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          303 EWVQQYPADSKKFGLIM-DPRLEK-------EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       303 ~~~~~~~~~~~~~~~~~-~~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ......+.......... ...+..       ......+..+.+|+.+||+.||.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            21111111111000000 000000       0011234678899999999999999999999876

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.8e-45  Score=344.03  Aligned_cols=254  Identities=24%  Similarity=0.371  Sum_probs=206.8

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---hHHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      .++|++.+.||+|+||.||+|.+.        ++..||+|.+...   ...+.+|+.++..++||||+++++++..... 
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-   77 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK--------GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP-   77 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET--------TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-
T ss_pred             hhheeeeeeeccCCCceEEEEEec--------CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCc-
Confidence            457999999999999999999865        4567999998753   4568899999999999999999999865543 


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                         .++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        78 ---~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~  150 (268)
T 3sxs_A           78 ---IYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGM  150 (268)
T ss_dssp             ---EEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTC
T ss_pred             ---eEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCcc
Confidence               599999999999999997643 3589999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      +...... .........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.............  ....    
T Consensus       151 ~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~--~~~~----  223 (268)
T 3sxs_A          151 TRYVLDD-QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS--QGHR----  223 (268)
T ss_dssp             EEECCTT-CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH--TTCC----
T ss_pred             ceecchh-hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH--cCCC----
Confidence            9753222 1222334456778999999998899999999999999999999 999998665433221111  1100    


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                             .    ..+...+..+.+++.+||+.||.+|||+.+++++|+.+.+
T Consensus       224 -------~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          224 -------L----YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             -------C----CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             -------C----CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence                   0    0011123568899999999999999999999999988764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2e-45  Score=359.07  Aligned_cols=250  Identities=24%  Similarity=0.350  Sum_probs=202.0

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEee
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      ..++|.+.+.||+|+||.||+|.+.       .++..||+|.+....      ..+.+|+.+++.++||||+++++++..
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~   99 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHK-------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE   99 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             cccCeEEeeEEecCCCeEEEEEEEC-------CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence            3467999999999999999999875       467899999986432      347889999999999999999999876


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCC---Cce
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN---FRP  227 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~---~~~  227 (432)
                      .+    ..++||||+.+|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.+   +.+
T Consensus       100 ~~----~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~  170 (362)
T 2bdw_A          100 ES----FHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAV  170 (362)
T ss_dssp             SS----EEEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCE
T ss_pred             CC----EEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCE
Confidence            54    359999999999999999654  3689999999999999999999998   99999999999999765   459


Q ss_pred             eeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 014034          228 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  307 (432)
Q Consensus       228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  307 (432)
                      ||+|||++.....   ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....   +...+..
T Consensus       171 kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~~i~~  244 (362)
T 2bdw_A          171 KLADFGLAIEVND---SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYAQIKA  244 (362)
T ss_dssp             EECCCTTCBCCTT---CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH
T ss_pred             EEeecCcceEecC---CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHh
Confidence            9999999976322   122334679999999999999999999999999999999999999998654332   2222211


Q ss_pred             cccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ....           +........+..+.+||.+||..||.+|||+.+++++
T Consensus       245 ~~~~-----------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          245 GAYD-----------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             TCCC-----------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CCCC-----------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1000           0000011224678899999999999999999999987

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=7.7e-46  Score=361.60  Aligned_cols=274  Identities=22%  Similarity=0.268  Sum_probs=211.6

Q ss_pred             CcccCHHHHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH---HHHHHHHHhcccC-----
Q 014034           66 LRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGVLE-----  137 (432)
Q Consensus        66 ~~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~-----  137 (432)
                      ...+++.+.....++|.+++.||+|+||.||+|.+.       .++..||||.+.....   .+..|+.+++.+.     
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~   94 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHI-------DNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDIN   94 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTT
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEEC-------CCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCC
Confidence            445666666677789999999999999999999875       4678999999975433   3677999998886     


Q ss_pred             CCccceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCC
Q 014034          138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKAS  217 (432)
Q Consensus       138 hpniv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~  217 (432)
                      ||||+++++++...+    ..++||||+ +++|.+++.......+++..+..++.||+.||.|||+.   +|+||||||+
T Consensus        95 h~~iv~~~~~~~~~~----~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~  166 (360)
T 3llt_A           95 NNNIVKYHGKFMYYD----HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPE  166 (360)
T ss_dssp             GGGBCCEEEEEEETT----EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred             CCCeecccceeeECC----eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcc
Confidence            999999999998754    459999999 99999999887666799999999999999999999998   9999999999


Q ss_pred             ceEEcC-------------------------CCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhh
Q 014034          218 NVLLDE-------------------------NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD  272 (432)
Q Consensus       218 Nill~~-------------------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  272 (432)
                      |||++.                         ++.+||+|||++.....     ......||+.|+|||++.+..++.++|
T Consensus       167 NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~D  241 (360)
T 3llt_A          167 NILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSD  241 (360)
T ss_dssp             GEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHH
T ss_pred             cEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccc
Confidence            999975                         78999999999975221     223467999999999999999999999


Q ss_pred             hHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc--------ccccccCcc----ccCcCC------------
Q 014034          273 VWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK--------KFGLIMDPR----LEKEYS------------  328 (432)
Q Consensus       273 vwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~----l~~~~~------------  328 (432)
                      ||||||++|+|++|..||.+.........+...........        .........    +.....            
T Consensus       242 iwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  321 (360)
T 3llt_A          242 MWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCL  321 (360)
T ss_dssp             HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCC
T ss_pred             hHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcc
Confidence            99999999999999999987655433322222111100000        000000000    000000            


Q ss_pred             ----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          329 ----INEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       329 ----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                          ......+.+|+.+||+.||.+|||+.+++++
T Consensus       322 ~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          322 PLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             CHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             cccccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence                0012567799999999999999999999865

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.5e-45  Score=361.96  Aligned_cols=259  Identities=21%  Similarity=0.248  Sum_probs=196.7

Q ss_pred             hcCCccc-cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHHHHHHHhc-ccCCCccceeeeEEeecCCcc
Q 014034           78 TNDFSRM-LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG-VLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        78 ~~~~~~~-~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~~~~~~  155 (432)
                      .++|.+. +.||+|+||+||+|.+.       .++..||||++... ..+.+|+.++. ..+||||+++++++.......
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~-------~~~~~vAiK~~~~~-~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~  131 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNK-------RTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLYAGR  131 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             cccceeccceeeeccCeEEEEEEEC-------CCCCEEEEEEeCcc-hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence            4567776 68999999999999875       46789999999643 46778998874 458999999999987533334


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC---CCceeeccc
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE---NFRPKLSDF  232 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~Df  232 (432)
                      ...++||||+.+|+|.+++.......+++..+..++.||+.||.|||+.   +|+||||||+|||++.   ++.+||+||
T Consensus       132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEec
Confidence            4679999999999999999876556799999999999999999999998   9999999999999987   789999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhh-HHHHHHHhhcccC
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-QRLLEWVQQYPAD  311 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~  311 (432)
                      |+++....   .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+...... ......+..... 
T Consensus       209 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~-  284 (400)
T 1nxk_A          209 GFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-  284 (400)
T ss_dssp             TTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC-
T ss_pred             ccccccCC---CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc-
Confidence            99985321   2223456789999999999999999999999999999999999999976543221 001111111000 


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                                .+........+..+.+||.+||..||.+|||+.+++++-.
T Consensus       285 ----------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~  324 (400)
T 1nxk_A          285 ----------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW  324 (400)
T ss_dssp             ----------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             ----------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence                      0000011123467889999999999999999999999843

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-45  Score=353.29  Aligned_cols=260  Identities=23%  Similarity=0.376  Sum_probs=203.5

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc-----ChHHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-----DGLQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|++++.||+|+||.||+|.+...   +.....+||+|.+..     ....+.+|+.+++.++||||+++++++....
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPE---GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCT---TCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCC---CceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence            35799999999999999999997632   223345688998753     3346889999999999999999999987543


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                           .++|++|+.+|+|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        91 -----~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~Df  161 (327)
T 3lzb_A           91 -----VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDF  161 (327)
T ss_dssp             -----EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCT
T ss_pred             -----ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccC
Confidence                 489999999999999997654 4689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      |+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+...........   .... 
T Consensus       162 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~---~~~~-  237 (327)
T 3lzb_A          162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---KGER-  237 (327)
T ss_dssp             TC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---TTCC-
T ss_pred             cceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH---cCCC-
Confidence            99986433222233334567889999999999999999999999999999999 999998765544332222   1100 


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                                   ...+...+..+.+|+.+||..||.+|||+.++++.|+.+...
T Consensus       238 -------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          238 -------------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             -------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             -------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                         011122345688999999999999999999999999988743

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.2e-45  Score=344.91  Aligned_cols=258  Identities=25%  Similarity=0.340  Sum_probs=197.5

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|++.+.||+|+||.||+|.+...    ...+..||+|.+...     ...+.+|+.+++.++||||+++++++.. +
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~   88 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSP----ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N   88 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-S
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecC----CCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-C
Confidence            35799999999999999999987521    234678999998653     2247889999999999999999999743 2


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        89 ----~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df  160 (281)
T 1mp8_A           89 ----PVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDF  160 (281)
T ss_dssp             ----SCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-
T ss_pred             ----ccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcc
Confidence                2489999999999999997653 3689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      |+++...... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.......   ..+..... 
T Consensus       161 g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---~~i~~~~~-  235 (281)
T 1mp8_A          161 GLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIENGER-  235 (281)
T ss_dssp             -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHHTTCC-
T ss_pred             ccccccCccc-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH---HHHHcCCC-
Confidence            9997532211 112233457789999999999999999999999999999997 99999876543322   21111100 


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                               .    ..+...+..+.+++.+||+.||.+|||+.++++.|+.+++.
T Consensus       236 ---------~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          236 ---------L----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             ---------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------C----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                     0    11222346788999999999999999999999999998753

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.4e-45  Score=350.11  Aligned_cols=263  Identities=25%  Similarity=0.352  Sum_probs=198.9

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|++++.||+|+||.||+|...        +++.||+|++....      ..+.+|+.+++.++||||+++++++...
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   91 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS--------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE   91 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET--------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC--------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence            468999999999999999999864        47889999986432      3478999999999999999999998765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      .    ..++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        92 ~----~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~D  162 (311)
T 3niz_A           92 R----CLTLVFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLAD  162 (311)
T ss_dssp             S----CEEEEEECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred             C----EEEEEEcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEcc
Confidence            4    3599999997 48888876543 4699999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      ||+++....  .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......+.
T Consensus       163 fg~a~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  240 (311)
T 3niz_A          163 FGLARAFGI--PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN  240 (311)
T ss_dssp             CTTCEETTS--CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCC
T ss_pred             CcCceecCC--CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCC
Confidence            999975321  1222344578999999999876 5689999999999999999999999987655443322221111111


Q ss_pred             Cc-c-cccc----------ccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          311 DS-K-KFGL----------IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       311 ~~-~-~~~~----------~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .. . ....          ..............+..+.+|+.+||+.||.+|||+.+++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          241 PREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             TTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            10 0 0000          000000000011223568899999999999999999999876

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.5e-45  Score=352.57  Aligned_cols=274  Identities=25%  Similarity=0.353  Sum_probs=216.9

Q ss_pred             HHHHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhccc-CCCcccee
Q 014034           71 YSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVL-EHPNLVKL  144 (432)
Q Consensus        71 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~hpniv~l  144 (432)
                      ..+.....++|.+.+.||+|+||.||+|.+...  ....+++.||+|.+....     ..+.+|+.++..+ +||||+++
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI--DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESS--SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecC--CccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            444445567899999999999999999986522  133577999999987532     2478899999999 79999999


Q ss_pred             eeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCcee
Q 014034          145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAF--------------PPLPWKTRLHIILGAAEGLAYLHEGLEVQVI  210 (432)
Q Consensus       145 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~iv  210 (432)
                      ++++...+.   ..++||||+.+++|.+++.....              ..+++..++.++.|++.||.|||+.   +|+
T Consensus        97 ~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~  170 (316)
T 2xir_A           97 LGACTKPGG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCI  170 (316)
T ss_dssp             EEEECCTTS---CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             EEEEecCCC---ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence            999876543   35899999999999999976542              1278999999999999999999998   999


Q ss_pred             ecCCCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCC
Q 014034          211 YRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRS  289 (432)
Q Consensus       211 H~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p  289 (432)
                      ||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|+| |..|
T Consensus       171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p  250 (316)
T 2xir_A          171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP  250 (316)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             cccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999986433333333445668899999999999999999999999999999998 9999


Q ss_pred             CCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhcc
Q 014034          290 LERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  368 (432)
Q Consensus       290 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  368 (432)
                      |.+......  ....+.....          .    ..+...+..+.+++.+||+.||.+|||+.+|+++|+.+++...
T Consensus       251 ~~~~~~~~~--~~~~~~~~~~----------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  313 (316)
T 2xir_A          251 YPGVKIDEE--FCRRLKEGTR----------M----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  313 (316)
T ss_dssp             STTCCCSHH--HHHHHHHTCC----------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             CcccchhHH--HHHHhccCcc----------C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            987553322  1111111100          0    0111224568899999999999999999999999999987543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.1e-45  Score=345.90  Aligned_cols=258  Identities=27%  Similarity=0.410  Sum_probs=214.0

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh---HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ..++|.+.+.||+|+||.||+|.+.       .++..||+|.+..+.   ..+.+|+.+++.++||||+++++++...+.
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   83 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   83 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEG-------GGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             cccceeEEeecCCCCceeEEEeEec-------CCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            4567999999999999999999976       568899999987653   348899999999999999999999876543


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                          .++||||+.+++|.+++.......+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        84 ----~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg  156 (288)
T 3kfa_A           84 ----FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFG  156 (288)
T ss_dssp             ----EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             ----EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCc
Confidence                49999999999999999876666799999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      ++...... .........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+...........   ...   
T Consensus       157 ~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~---~~~---  229 (288)
T 3kfa_A          157 LSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---KDY---  229 (288)
T ss_dssp             GGGTSCSS-SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---TTC---
T ss_pred             cceeccCC-ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh---ccC---
Confidence            99764322 2223334567889999999999999999999999999999999 999998765443222221   110   


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                                 ....+...+..+.+|+.+||..||.+|||+.++++.|+.+.+.
T Consensus       230 -----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          230 -----------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             -----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence                       0011222346788999999999999999999999999988764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.2e-45  Score=356.50  Aligned_cols=245  Identities=23%  Similarity=0.358  Sum_probs=200.7

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .++|.+.+.||+|+||.||+|.+.       .+++.||+|.+...       ...+.+|+.+++.++||||+++++++..
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~   80 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHY-------KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT   80 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             cCCEEEEEEEecCCCeEEEEEEEC-------CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence            468999999999999999999975       46789999998643       2357899999999999999999999976


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      ..    ..++||||+ +|+|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        81 ~~----~~~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~  150 (336)
T 3h4j_B           81 PT----DIVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIA  150 (336)
T ss_dssp             SS----EEEEEECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEEC
T ss_pred             CC----EEEEEEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEE
Confidence            54    359999999 789999886643  699999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      |||++....   ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+......           
T Consensus       151 DFG~s~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-----------  216 (336)
T 3h4j_B          151 DFGLSNIMT---DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-----------  216 (336)
T ss_dssp             CSSCTBTTT---TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-----------
T ss_pred             Eeccceecc---CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-----------
Confidence            999997532   2223345679999999999988776 6899999999999999999999976432110           


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                           +..+...  ....+...+..+.+|+.+||..||.+|||+.+++++-
T Consensus       217 -----~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  260 (336)
T 3h4j_B          217 -----FKKVNSC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP  260 (336)
T ss_dssp             -----BCCCCSS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred             -----HHHHHcC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence                 0000000  0011222346788999999999999999999999873

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.7e-45  Score=358.12  Aligned_cols=251  Identities=25%  Similarity=0.333  Sum_probs=200.7

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc---------ChHHHHHHHHHhcccCCCccceeeeEE
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR---------DGLQWVAEVQFLGVLEHPNLVKLIGYC  148 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~---------~~~~~~~E~~~l~~l~hpniv~l~~~~  148 (432)
                      .+.|++.+.||+|+||.||+|..+       .+++.||+|.+..         ....+.+|+.+++.++||||+++++++
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~   95 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINR-------ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY   95 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEEC-------CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            357999999999999999999875       4678999999853         234588999999999999999999999


Q ss_pred             eecCCcceeEEEEEeecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCc
Q 014034          149 AVDGERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR  226 (432)
Q Consensus       149 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~  226 (432)
                      ...+    ..++||||+.+++|.+++...  ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.
T Consensus        96 ~~~~----~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~  168 (351)
T 3c0i_A           96 SSDG----MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKEN  168 (351)
T ss_dssp             EETT----EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSST
T ss_pred             EeCC----EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCC
Confidence            8754    359999999999999888643  233589999999999999999999998   9999999999999986655


Q ss_pred             ---eeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 014034          227 ---PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE  303 (432)
Q Consensus       227 ---~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~  303 (432)
                         +||+|||++.....  .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+...    .+..
T Consensus       169 ~~~vkl~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~  242 (351)
T 3c0i_A          169 SAPVKLGGFGVAIQLGE--SGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFE  242 (351)
T ss_dssp             TCCEEECCCTTCEECCT--TSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHH
T ss_pred             CCcEEEecCcceeEecC--CCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHH
Confidence               99999999976322  12223456799999999999999999999999999999999999999986422    1211


Q ss_pred             HHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          304 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .+......       ..+...    ...+..+.+||.+||..||.+|||+.+++++
T Consensus       243 ~i~~~~~~-------~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          243 GIIKGKYK-------MNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             HHHHTCCC-------CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHcCCCC-------CCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11111000       000000    1123578899999999999999999999986

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.2e-45  Score=351.79  Aligned_cols=268  Identities=24%  Similarity=0.353  Sum_probs=196.7

Q ss_pred             HhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEe
Q 014034           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCA  149 (432)
Q Consensus        76 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~  149 (432)
                      ...++|.+.+.||+|+||.||+|.+....    .....||+|.+...      ...+.+|+.+++.++||||+++++++.
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   95 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQED----GSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL   95 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-----------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccC----CcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence            34568999999999999999999875211    12237999998653      234889999999999999999999987


Q ss_pred             ecCCcc--eeEEEEEeecCCCCHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC
Q 014034          150 VDGERG--IQRLLVYEFMLNRSLEDHLFNRA----FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  223 (432)
Q Consensus       150 ~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~  223 (432)
                      .....+  ...++||||+.+|+|.+++....    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.
T Consensus        96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~  172 (323)
T 3qup_A           96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAE  172 (323)
T ss_dssp             CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT
T ss_pred             ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcC
Confidence            654321  12389999999999999986432    22589999999999999999999998   9999999999999999


Q ss_pred             CCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHH
Q 014034          224 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLL  302 (432)
Q Consensus       224 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~  302 (432)
                      ++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+......... 
T Consensus       173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~-  251 (323)
T 3qup_A          173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY-  251 (323)
T ss_dssp             TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-
T ss_pred             CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH-
Confidence            99999999999975432222223334567889999999999999999999999999999999 9999987654432221 


Q ss_pred             HHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhc
Q 014034          303 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  367 (432)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  367 (432)
                        +.....          .    ..+...+..+.+|+.+||+.||.+|||+.++++.|+.++...
T Consensus       252 --~~~~~~----------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          252 --LIGGNR----------L----KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             --HHTTCC----------C----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             --HhcCCC----------C----CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence              111100          0    111223467889999999999999999999999999998654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.5e-45  Score=370.71  Aligned_cols=257  Identities=26%  Similarity=0.375  Sum_probs=208.2

Q ss_pred             HhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---hHHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        76 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      ...++|.+.+.||+|+||.||+|.+.        .+..||||.+...   ...+.+|+.+|+.++||||+++++++.. .
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~  255 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYN--------KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E  255 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEET--------TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred             echHHeEEEEEcccCCceEEEEEEEC--------CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEeC-C
Confidence            34567899999999999999999875        4678999998753   4568999999999999999999999862 2


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..++||||+.+|+|.+++.......+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus       256 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DF  328 (454)
T 1qcf_A          256 ----PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADF  328 (454)
T ss_dssp             ----SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECST
T ss_pred             ----ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeC
Confidence                248999999999999999765434688999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      |+++..... .........+|+.|+|||++.+..++.++|||||||++|||+| |..||.+.......   ..+..... 
T Consensus       329 G~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~---~~i~~~~~-  403 (454)
T 1qcf_A          329 GLARVIEDN-EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---RALERGYR-  403 (454)
T ss_dssp             TGGGGBCCH-HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HHHHHTCC-
T ss_pred             CCceEcCCC-ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHcCCC-
Confidence            999753211 1111233456788999999998999999999999999999999 99999876543322   22211100 


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                               .    ..+...+..+.+||.+||+.||.+|||+.+|++.|+.+...
T Consensus       404 ---------~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          404 ---------M----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             ---------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             ---------C----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence                     0    11222346788999999999999999999999999988653

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.7e-45  Score=354.42  Aligned_cols=248  Identities=25%  Similarity=0.399  Sum_probs=202.3

Q ss_pred             HhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhccc-CCCccceeeeE
Q 014034           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVL-EHPNLVKLIGY  147 (432)
Q Consensus        76 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l-~hpniv~l~~~  147 (432)
                      ...++|.+.+.||+|+||.||+|+++       .+++.||+|.+++.       ...+..|..++..+ +||||++++++
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~   86 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFK-------KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT   86 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEET-------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEE
Confidence            44578999999999999999999976       46789999998653       23467899998876 89999999999


Q ss_pred             EeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCce
Q 014034          148 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP  227 (432)
Q Consensus       148 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~  227 (432)
                      +....    ..++||||+++|+|.+++....  .+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+
T Consensus        87 ~~~~~----~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~v  157 (345)
T 1xjd_A           87 FQTKE----NLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHI  157 (345)
T ss_dssp             EECSS----EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred             EEeCC----EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCE
Confidence            87654    4599999999999999997643  689999999999999999999998   99999999999999999999


Q ss_pred             eeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 014034          228 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  307 (432)
Q Consensus       228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  307 (432)
                      ||+|||+++....  ........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.....   +...+..
T Consensus       158 kL~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i~~  232 (345)
T 1xjd_A          158 KIADFGMCKENML--GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSIRM  232 (345)
T ss_dssp             EECCCTTCBCCCC--TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH
T ss_pred             EEeEChhhhhccc--CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHh
Confidence            9999999975321  1223455789999999999999999999999999999999999999998754432   2222211


Q ss_pred             cccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHHH
Q 014034          308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS-QVVER  359 (432)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~~  359 (432)
                      ..           +.+    +...+..+.+||.+||..||.+||++. +|+++
T Consensus       233 ~~-----------~~~----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          233 DN-----------PFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             CC-----------CCC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             CC-----------CCC----CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence            10           111    112246788999999999999999997 77654

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=8.2e-46  Score=358.89  Aligned_cols=255  Identities=22%  Similarity=0.327  Sum_probs=205.8

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHHHHHHHhccc-CCCccceeeeEEeecCCcc
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVL-EHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~  155 (432)
                      ..++|.+.+.||+|+||.||+|..+       .++..||+|.+.+......+|++++.++ +||||+++++++.+..   
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~---   89 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHK-------ATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGK---   89 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSS---
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEEC-------CCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCC---
Confidence            3567999999999999999999975       4678999999987666677899999888 7999999999987644   


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCC----Cceeecc
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN----FRPKLSD  231 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~----~~~kl~D  231 (432)
                       ..++||||+.+|+|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||+..+    +.+||+|
T Consensus        90 -~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~D  163 (342)
T 2qr7_A           90 -YVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICD  163 (342)
T ss_dssp             -EEEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECC
T ss_pred             -EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEE
Confidence             4599999999999999997653  699999999999999999999998   99999999999998433    3599999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ||+++.....  ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+........+...+......
T Consensus       164 fg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  241 (342)
T 2qr7_A          164 FGFAKQLRAE--NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS  241 (342)
T ss_dssp             CTTCEECBCT--TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCC
T ss_pred             CCCcccCcCC--CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcc
Confidence            9999753221  22234567999999999998888999999999999999999999999865443434444333321110


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                                 +........+..+.+||.+||..||.+|||+.+++++-
T Consensus       242 -----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  279 (342)
T 2qr7_A          242 -----------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP  279 (342)
T ss_dssp             -----------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred             -----------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence                       11111223346788999999999999999999999873

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.4e-45  Score=350.24  Aligned_cols=265  Identities=25%  Similarity=0.380  Sum_probs=188.3

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|++++.||+|+||.||+|...       .++..||+|.+...     ...+.+|+.+++.++||||+++++++..++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   76 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNK-------TTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTEN   76 (317)
T ss_dssp             ---------------CEEEEEECS-------SSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT
T ss_pred             ccceeEeeEECCCCCEEEEEEEEC-------CCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECC
Confidence            457999999999999999999864       56789999988543     245889999999999999999999987654


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCcee
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRA----FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  228 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k  228 (432)
                          ..++||||+. ++|.+++....    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        77 ----~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~k  148 (317)
T 2pmi_A           77 ----KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLK  148 (317)
T ss_dssp             ----EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred             ----eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEE
Confidence                4599999997 69999886432    23589999999999999999999998   999999999999999999999


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  307 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  307 (432)
                      |+|||++......  ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.....
T Consensus       149 l~Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~  226 (317)
T 2pmi_A          149 LGDFGLARAFGIP--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMG  226 (317)
T ss_dssp             ECCCSSCEETTSC--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ECcCccceecCCC--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9999999753211  122334578999999999976 4689999999999999999999999987655433222211111


Q ss_pred             cccCc-cc-cccc--cCccc------------cCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          308 YPADS-KK-FGLI--MDPRL------------EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       308 ~~~~~-~~-~~~~--~~~~l------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .+... .. ....  ..+.+            ........+..+.+|+.+||+.||.+|||+.+++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          227 TPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             SCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            11100 00 0000  00000            000111234578899999999999999999999876

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5e-45  Score=340.93  Aligned_cols=249  Identities=19%  Similarity=0.326  Sum_probs=202.8

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      ++|.+.+.||+|+||.||+|.+.         +..||+|.+....      ..+.+|+.+++.++||||+++++++....
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   80 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ---------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP   80 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET---------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC---------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence            57999999999999999999863         6789999986432      34889999999999999999999987653


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCc--eeecCCCCCceEEcCCCceeec
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQ--VIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~--ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .  ...++||||+++|+|.+++.......+++..++.++.|++.||.|||+.   +  |+||||||+|||++.++.++|+
T Consensus        81 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~  155 (271)
T 3kmu_A           81 A--PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARIS  155 (271)
T ss_dssp             S--SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEE
T ss_pred             C--CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEE
Confidence            2  2459999999999999999876655799999999999999999999997   7  9999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCCCc---hhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTA---KSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  307 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  307 (432)
                      |||++...       ......||+.|+|||++.+..++.   ++||||||+++|+|++|..||.+..........  ...
T Consensus       156 ~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~~~  226 (271)
T 3kmu_A          156 MADVKFSF-------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV--ALE  226 (271)
T ss_dssp             GGGSCCTT-------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH--HHS
T ss_pred             eccceeee-------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH--Hhc
Confidence            99887532       123356899999999998765544   799999999999999999999876543321111  111


Q ss_pred             cccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 014034          308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  364 (432)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  364 (432)
                      .          ..+    ..+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       227 ~----------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          227 G----------LRP----TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             C----------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             C----------CCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            0          011    112223467889999999999999999999999998875

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.1e-45  Score=344.83  Aligned_cols=262  Identities=25%  Similarity=0.346  Sum_probs=195.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      ++|++++.||+|+||.||+|...        ++..||+|++....      ..+.+|+.+++.++||||+++++++...+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   73 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN--------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK   73 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET--------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS
T ss_pred             ccchhhhhcccCCCEEEEEEEcC--------CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC
Confidence            57999999999999999999863        46789999986432      35789999999999999999999997654


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..++||||+.+ +|.+++.... ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        74 ----~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df  144 (288)
T 1ob3_A           74 ----RLVLVFEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADF  144 (288)
T ss_dssp             ----CEEEEEECCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCT
T ss_pred             ----eEEEEEEecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeEC
Confidence                35999999975 9999886543 4689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH-HHHhhccc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL-EWVQQYPA  310 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~-~~~~~~~~  310 (432)
                      |++.....  .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.......... ........
T Consensus       145 g~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  222 (288)
T 1ob3_A          145 GLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS  222 (288)
T ss_dssp             THHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             ccccccCc--cccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCCh
Confidence            99874211  1122334578999999999976 45899999999999999999999999876543322111 11111110


Q ss_pred             Ccc-cccc--ccCcccc-------CcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          311 DSK-KFGL--IMDPRLE-------KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       311 ~~~-~~~~--~~~~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ... ....  ..++.+.       .......+..+.+|+.+||+.||.+|||+.+++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             TTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000 0000  0000000       01111234678899999999999999999999875

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-45  Score=348.00  Aligned_cols=243  Identities=25%  Similarity=0.404  Sum_probs=201.8

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .++|++++.||+|+||.||+|..+       .+++.||+|.+.+.       ...+.+|..+++.++||||+++++++..
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~   77 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSR-------HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD   77 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe
Confidence            357999999999999999999875       46789999998653       2347789999999999999999999876


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      ..    ..++||||+.+|+|.+++....  .+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+
T Consensus        78 ~~----~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~  148 (318)
T 1fot_A           78 AQ----QIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKIT  148 (318)
T ss_dssp             SS----EEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred             CC----EEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEe
Confidence            54    4599999999999999997643  689999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      |||+++....     .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+......   ...+.... 
T Consensus       149 Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~-  219 (318)
T 1fot_A          149 DFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT---YEKILNAE-  219 (318)
T ss_dssp             CCSSCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHHCC-
T ss_pred             ecCcceecCC-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHHHhCC-
Confidence            9999975321     22356799999999999999999999999999999999999999986543322   11111110 


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  359 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  359 (432)
                                ..    ++...+..+.+|+.+||..||.+||     ++.+|+++
T Consensus       220 ----------~~----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          220 ----------LR----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             ----------CC----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ----------CC----CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence                      00    1112235788999999999999999     88999876

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.3e-45  Score=352.84  Aligned_cols=261  Identities=25%  Similarity=0.392  Sum_probs=200.3

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .++|++.+.||+|+||.||+|.+.       .+++.||+|.+....       ..+.+|+.+++.++||||+++++++..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   83 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDL-------RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA   83 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEEC-------CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeec
Confidence            357999999999999999999865       468899999986532       247889999999999999999999987


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      ....+...++||||+++++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~  158 (311)
T 3ork_A           84 ETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVM  158 (311)
T ss_dssp             EETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEEC
T ss_pred             cCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEe
Confidence            7665556699999999999999997543  689999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCC-cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          231 DFGLAREGPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       231 DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      |||++........ ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......  ........
T Consensus       159 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~--~~~~~~~~  236 (311)
T 3ork_A          159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA--YQHVREDP  236 (311)
T ss_dssp             CCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHCCC
T ss_pred             eccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHhcCCC
Confidence            9999975322211 12233457999999999999999999999999999999999999999876543221  11111111


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH-HHHHh
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER-LKQIV  364 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~-L~~~~  364 (432)
                      ....            ......+..+.+|+.+||+.||.+||++.+++.+ |..+.
T Consensus       237 ~~~~------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          237 IPPS------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             CCHH------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCcc------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            1000            0011124578899999999999999977666544 44443

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7.6e-45  Score=344.28  Aligned_cols=263  Identities=23%  Similarity=0.329  Sum_probs=197.2

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      ++|++++.||+|+||+||+|...       .+++.||+|++....      ..+.+|+.+++.++||||+++++++....
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   74 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNR-------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK   74 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             CCceeeeEecCCCCeEEEEEEEC-------CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC
Confidence            57999999999999999999875       467899999985322      34789999999999999999999997654


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..++||||+.+ +|.+++.... ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        75 ----~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Df  145 (292)
T 3o0g_A           75 ----KLTLVFEFCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANF  145 (292)
T ss_dssp             ----EEEEEEECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             ----EEEEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence                45999999975 6666655433 4799999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCCchhh-HHH-HHHHhhcc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH-LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-QRL-LEWVQQYP  309 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~-~~~-~~~~~~~~  309 (432)
                      |++.....  .........||+.|+|||++.+.. ++.++|||||||++|+|++|..||........ ... ........
T Consensus       146 g~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~  223 (292)
T 3o0g_A          146 GLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT  223 (292)
T ss_dssp             TTCEECCS--CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             ccceecCC--ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence            99975321  222334567899999999997765 89999999999999999998888644332221 111 11111111


Q ss_pred             cCcc-ccccccC---------ccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ADSK-KFGLIMD---------PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~~~-~~~~~~~---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .... ......+         ...........+..+.+|+.+||+.||.+|||+.+++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            1000 0000000         000001112345678899999999999999999999876

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-45  Score=358.51  Aligned_cols=250  Identities=22%  Similarity=0.341  Sum_probs=202.7

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC----hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      .++|.+++.||+|+||.||+|...       .++..||+|.+...    ...+.+|+.+|+.++||||+++++++.... 
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~-------~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-  121 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEK-------ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY-  121 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS-
T ss_pred             ccceEEEEEEecCCCEEEEEEEEC-------CCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC-
Confidence            467999999999999999999875       46789999998654    234789999999999999999999987654 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc--CCCceeecc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD--ENFRPKLSD  231 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~--~~~~~kl~D  231 (432)
                         ..++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++  .++.+||+|
T Consensus       122 ---~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~D  194 (387)
T 1kob_A          122 ---EMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIID  194 (387)
T ss_dssp             ---EEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECC
T ss_pred             ---EEEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEe
Confidence               4599999999999999986543 3689999999999999999999998   999999999999997  457899999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ||+++.....   .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+......   ...+......
T Consensus       195 FG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---~~~i~~~~~~  268 (387)
T 1kob_A          195 FGLATKLNPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---LQNVKRCDWE  268 (387)
T ss_dssp             CTTCEECCTT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHHHCCCC
T ss_pred             cccceecCCC---cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH---HHHHHhCCCC
Confidence            9999863221   222345799999999999999999999999999999999999999987544322   2212111100


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                             ...    ......+..+.+||.+||..||.+|||+.+++++
T Consensus       269 -------~~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          269 -------FDE----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             -------CCS----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -------CCc----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                   011    1112234678899999999999999999999886

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=345.82  Aligned_cols=256  Identities=29%  Similarity=0.434  Sum_probs=199.5

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh--HHHHHHHHHhcccCCCccceeeeEEeecCCcce
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~  156 (432)
                      ++|.+.+.||+|+||.||+|.+.         +..||+|.+....  ..+.+|+.++++++||||+++++++.+.     
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----   73 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR---------AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNP-----   73 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET---------TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTT-----
T ss_pred             hHeeeeeEeecCCCceEEEEEEC---------CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-----
Confidence            47899999999999999999863         5789999997653  3488999999999999999999987632     


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCc-eeeccccC
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAF-PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR-PKLSDFGL  234 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~-~kl~DfG~  234 (432)
                       .++||||+++++|.+++..... ..+++..++.++.|++.||.|||+....+|+||||||+|||++.++. +||+|||+
T Consensus        74 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~  152 (307)
T 2eva_A           74 -VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT  152 (307)
T ss_dssp             -TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred             -cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence             3899999999999999976432 24788999999999999999999932239999999999999998886 79999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      +.....     ......||+.|+|||++.+..++.++||||||+++|+|++|..||......... .........     
T Consensus       153 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~-----  221 (307)
T 2eva_A          153 ACDIQT-----HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IMWAVHNGT-----  221 (307)
T ss_dssp             -----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-HHHHHHTTC-----
T ss_pred             cccccc-----ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-HHHHHhcCC-----
Confidence            875321     123346999999999999999999999999999999999999999765432221 111111100     


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhccC
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNE  369 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~  369 (432)
                           .+.+.    ...+..+.+|+.+||+.||.+|||+.++++.|+.+.+....
T Consensus       222 -----~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  267 (307)
T 2eva_A          222 -----RPPLI----KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG  267 (307)
T ss_dssp             -----CCCCB----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred             -----CCCcc----cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence                 01111    12235688999999999999999999999999998766543

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.6e-44  Score=345.36  Aligned_cols=269  Identities=22%  Similarity=0.360  Sum_probs=202.7

Q ss_pred             HHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEE
Q 014034           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYC  148 (432)
Q Consensus        75 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~  148 (432)
                      ....++|.+.+.||+|+||.||+|.+..    ....+..||+|.+....      ..+.+|+.+++.++||||+++++++
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQ----EDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEEC----TTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEec----cCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            3345689999999999999999998762    22457799999986431      2478899999999999999999998


Q ss_pred             eecCCcc-eeEEEEEeecCCCCHHHHhhc----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC
Q 014034          149 AVDGERG-IQRLLVYEFMLNRSLEDHLFN----RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  223 (432)
Q Consensus       149 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~----~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~  223 (432)
                      ......+ ...++||||+.+++|.+++..    .....+++..++.++.||+.||.|||+.   +|+||||||+|||++.
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~  182 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRD  182 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECT
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcC
Confidence            7654321 235899999999999999853    2335799999999999999999999998   9999999999999999


Q ss_pred             CCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHH
Q 014034          224 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLL  302 (432)
Q Consensus       224 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~  302 (432)
                      ++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+......... 
T Consensus       183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-  261 (313)
T 3brb_A          183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY-  261 (313)
T ss_dssp             TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-
T ss_pred             CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH-
Confidence            99999999999975432222223334567889999999999999999999999999999999 8999987654332211 


Q ss_pred             HHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhc
Q 014034          303 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  367 (432)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  367 (432)
                        +....          ..    ..+...+..+.+|+.+||..||.+|||+.+++++|+.+++..
T Consensus       262 --~~~~~----------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          262 --LLHGH----------RL----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             --HHTTC----------CC----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             --HHcCC----------CC----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence              11110          00    111223457889999999999999999999999999998654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=9.2e-45  Score=351.97  Aligned_cols=248  Identities=25%  Similarity=0.394  Sum_probs=199.6

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhccc-CCCccceeeeEEee
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVL-EHPNLVKLIGYCAV  150 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~hpniv~l~~~~~~  150 (432)
                      ++|.+++.||+|+||.||+|+++       .+++.||+|.+.+..       ..+.+|..++..+ +||||+++++++..
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~   81 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLK-------KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT   81 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             hheEEEEEEEecCCeEEEEEEEC-------CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe
Confidence            57999999999999999999976       467899999986532       2367899999887 89999999999876


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      ..    ..++||||+.+|+|.+++....  .+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        82 ~~----~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~  152 (345)
T 3a8x_A           82 ES----RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLT  152 (345)
T ss_dssp             SS----EEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             CC----EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEE
Confidence            54    4599999999999999997643  699999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchh------hHHHHHH
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT------EQRLLEW  304 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~------~~~~~~~  304 (432)
                      |||+++....  ........+||+.|+|||++.+..++.++|||||||++|||++|..||.......      ...+...
T Consensus       153 DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  230 (345)
T 3a8x_A          153 DYGMCKEGLR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV  230 (345)
T ss_dssp             CGGGCBCSCC--TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH
T ss_pred             eccccccccC--CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH
Confidence            9999975321  1223445689999999999999999999999999999999999999997532211      1111111


Q ss_pred             HhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 014034          305 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM------SQVVER  359 (432)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~eil~~  359 (432)
                      +....           .    ..+...+..+.+||.+||..||.+||++      .+|+++
T Consensus       231 i~~~~-----------~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          231 ILEKQ-----------I----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             HHHCC-----------C----CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             HHcCC-----------C----CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence            11110           0    1122234678899999999999999995      677665

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.7e-45  Score=353.83  Aligned_cols=264  Identities=25%  Similarity=0.370  Sum_probs=209.3

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhccc-CCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVL-EHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~hpniv~l~~~~~~~  151 (432)
                      .++|.+.+.||+|+||.||+|.+....  .......||+|.+....     ..+.+|+.+++.+ +||||+++++++...
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLG--KEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCS--SSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCC--cccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            468999999999999999999976332  12345689999987542     3478999999999 899999999999765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCce
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRA------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNV  219 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Ni  219 (432)
                      +.    .++||||+++|+|.+++....            ...+++..++.++.||+.||.|||+.   +|+||||||+||
T Consensus       123 ~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI  195 (333)
T 2i1m_A          123 GP----VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNV  195 (333)
T ss_dssp             SS----CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGC
T ss_pred             Cc----eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceE
Confidence            54    499999999999999986531            34689999999999999999999998   999999999999


Q ss_pred             EEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhh
Q 014034          220 LLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTE  298 (432)
Q Consensus       220 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~  298 (432)
                      |++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|+| |..||.+......
T Consensus       196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  275 (333)
T 2i1m_A          196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK  275 (333)
T ss_dssp             EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred             EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence            999999999999999975322222222334567889999999999999999999999999999999 9999987544322


Q ss_pred             HHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          299 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                      .  .........          .    ..+...+..+.+|+.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       276 ~--~~~~~~~~~----------~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          276 F--YKLVKDGYQ----------M----AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             H--HHHHHHTCC----------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H--HHHHhcCCC----------C----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence            1  111111100          0    01112246788999999999999999999999999988653

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.1e-44  Score=341.15  Aligned_cols=258  Identities=25%  Similarity=0.349  Sum_probs=205.9

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|.+.+.||+|+||.||+|.+...    ...+..||+|.+...     ...+.+|+.+++.++||||+++++++....
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   86 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNH----KGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP   86 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECT----TCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSS
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCC----CCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC
Confidence            45799999999999999999987622    235678999998764     234788999999999999999999975432


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                           .++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        87 -----~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df  157 (281)
T 3cc6_A           87 -----TWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDF  157 (281)
T ss_dssp             -----CEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCC
T ss_pred             -----CEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCcc
Confidence                 389999999999999997543 4689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      |++...... .........+|+.|+|||++.+..++.++||||||+++|+|++ |..||..................   
T Consensus       158 g~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~---  233 (281)
T 3cc6_A          158 GLSRYIEDE-DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL---  233 (281)
T ss_dssp             CGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC---
T ss_pred             CCCcccccc-cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC---
Confidence            999753221 1112234557889999999998999999999999999999998 99999765544332222111000   


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                                    ..+...+..+.+|+.+||..||.+|||+.+++++|+.+.+.
T Consensus       234 --------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          234 --------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence                          01112245688999999999999999999999999998764

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7.2e-45  Score=340.36  Aligned_cols=250  Identities=29%  Similarity=0.479  Sum_probs=193.3

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC--------hHHHHHHHHHhcccCCCccceeeeEEe
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--------GLQWVAEVQFLGVLEHPNLVKLIGYCA  149 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~hpniv~l~~~~~  149 (432)
                      .++|...+.||+|+||.||+|.+.         +..||+|.+...        ...+.+|+.+++.++||||+++++++.
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   76 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI---------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL   76 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET---------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc---------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            357999999999999999999853         678999998643        234788999999999999999999997


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC------
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE------  223 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~------  223 (432)
                      ..+.    .++||||+.+++|.+++..   ..+++..++.++.|++.||.|||++...+|+||||||+|||++.      
T Consensus        77 ~~~~----~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~  149 (271)
T 3dtc_A           77 KEPN----LCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGD  149 (271)
T ss_dssp             CC------CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSC
T ss_pred             cCCc----eEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccc
Confidence            6554    4999999999999999853   36899999999999999999999982122999999999999986      


Q ss_pred             --CCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHH
Q 014034          224 --NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL  301 (432)
Q Consensus       224 --~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~  301 (432)
                        ++.+||+|||++.....    .......||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.........
T Consensus       150 ~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  225 (271)
T 3dtc_A          150 LSNKILKITDFGLAREWHR----TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG  225 (271)
T ss_dssp             CSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH
T ss_pred             ccCcceEEccCCccccccc----ccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Confidence              77899999999975321    112345799999999999999999999999999999999999999987654322111


Q ss_pred             HHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          302 LEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                      .   ...             ......+...+..+.+++.+||+.||.+|||+.+++++|+.+
T Consensus       226 ~---~~~-------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          226 V---AMN-------------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             H---HTS-------------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             h---hcC-------------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            1   100             000111222346788999999999999999999999999753

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.3e-44  Score=351.58  Aligned_cols=243  Identities=23%  Similarity=0.336  Sum_probs=202.3

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .++|.+++.||+|+||.||+|...       .++..||+|.+.+..       ..+.+|+.+++.++||||+++++++..
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  112 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHK-------ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD  112 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             HHHCEEEEEeecCcCcEEEEEEEC-------CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            368999999999999999999875       467899999986432       347889999999999999999999876


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      ..    ..++||||+++|+|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.+|.+||+
T Consensus       113 ~~----~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~  183 (350)
T 1rdq_E          113 NS----NLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVT  183 (350)
T ss_dssp             SS----EEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             CC----EEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEc
Confidence            54    4599999999999999997643  689999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      |||+++....     .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....   +...+.... 
T Consensus       184 DFg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i~~~~-  254 (350)
T 1rdq_E          184 DFGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYEKIVSGK-  254 (350)
T ss_dssp             CCTTCEECSS-----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCC-
T ss_pred             ccccceeccC-----CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH---HHHHHHcCC-
Confidence            9999985321     2235679999999999999999999999999999999999999998654432   222221110 


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-----MSQVVER  359 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  359 (432)
                                ..    ++...+..+.+||.+||+.||.+||+     +.+|+++
T Consensus       255 ----------~~----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          255 ----------VR----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ----------CC----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ----------CC----CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence                      00    11123467889999999999999998     8888876

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.2e-44  Score=340.71  Aligned_cols=256  Identities=29%  Similarity=0.513  Sum_probs=192.7

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|++.+.||+|+||.||+|.+.          ..||+|.+....      ..+.+|+.+++.++||||+++++++...
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~----------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   92 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH----------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP   92 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS----------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc----------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCC
Confidence            357999999999999999999853          249999886422      3478999999999999999999976432


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                           ..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        93 -----~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~D  163 (289)
T 3og7_A           93 -----QLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGD  163 (289)
T ss_dssp             -----SCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECC
T ss_pred             -----ccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEcc
Confidence                 2489999999999999996543 4689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      ||++................||+.|+|||++.   +..++.++||||||+++|+|++|..||........  +...+...
T Consensus       164 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~  241 (289)
T 3og7_A          164 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVGRG  241 (289)
T ss_dssp             CC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHHHT
T ss_pred             ceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhccc
Confidence            99997533222233334567999999999986   66788999999999999999999999987554322  22222211


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  364 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  364 (432)
                      ...         +.+. ......+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus       242 ~~~---------~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          242 SLS---------PDLS-KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             SCC---------CCTT-SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ccC---------cchh-hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            110         0000 111223467889999999999999999999999998875

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.7e-44  Score=350.85  Aligned_cols=247  Identities=26%  Similarity=0.392  Sum_probs=202.1

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhccc-CCCccceeeeEE
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVL-EHPNLVKLIGYC  148 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~hpniv~l~~~~  148 (432)
                      ..++|.+++.||+|+||.||+|..+       .+++.||+|.+.+..       ..+..|..++..+ +||||+++++++
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~   90 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERK-------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF   90 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEET-------TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence            3468999999999999999999875       568999999986532       3477899999887 899999999998


Q ss_pred             eecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCcee
Q 014034          149 AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  228 (432)
Q Consensus       149 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k  228 (432)
                      ...+    ..++||||++||+|.+++....  .+++..++.++.||+.||.|||+.   +|+||||||+|||++.+|.+|
T Consensus        91 ~~~~----~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vk  161 (353)
T 2i0e_A           91 QTMD----RLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIK  161 (353)
T ss_dssp             ECSS----EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred             EcCC----EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEE
Confidence            7654    4599999999999999997543  689999999999999999999998   999999999999999999999


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      |+|||+++....  ........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.....   +...+...
T Consensus       162 L~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~~i~~~  236 (353)
T 2i0e_A          162 IADFGMCKENIW--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIMEH  236 (353)
T ss_dssp             ECCCTTCBCCCC--TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHC
T ss_pred             EEeCCccccccc--CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---HHHHHHhC
Confidence            999999985321  1223445789999999999999999999999999999999999999998654332   22222211


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-----MSQVVER  359 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  359 (432)
                      .           .    .++...+..+.+||.+||..||.+||+     +.+|+++
T Consensus       237 ~-----------~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          237 N-----------V----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             C-----------C----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             C-----------C----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            0           0    011223467889999999999999995     5777765

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.1e-45  Score=363.70  Aligned_cols=255  Identities=24%  Similarity=0.300  Sum_probs=205.3

Q ss_pred             HHHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCcccee
Q 014034           72 SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKL  144 (432)
Q Consensus        72 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l  144 (432)
                      .++....++|.+++.||+|+||.||+|.++       .++..||+|++.+..       ..+.+|+.++..++||||+++
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~-------~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l  134 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHK-------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL  134 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCE
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEEC-------CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            344456789999999999999999999976       467899999986532       237889999999999999999


Q ss_pred             eeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCC
Q 014034          145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN  224 (432)
Q Consensus       145 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~  224 (432)
                      ++++.+..    ..++||||++||+|.+++...   .+++..+..++.||+.||.|||+.   +|+||||||+|||++.+
T Consensus       135 ~~~~~~~~----~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~  204 (410)
T 3v8s_A          135 FYAFQDDR----YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKS  204 (410)
T ss_dssp             EEEEECSS----EEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred             EEEEEECC----EEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCC
Confidence            99997654    459999999999999999753   589999999999999999999998   99999999999999999


Q ss_pred             CceeeccccCCcCCCCCCCcccccccccCCCccCccccccCC----CCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 014034          225 FRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH----LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR  300 (432)
Q Consensus       225 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~  300 (432)
                      |.+||+|||+++..... ........+||+.|+|||++.+..    ++.++|||||||++|||++|..||.+........
T Consensus       205 g~ikL~DFG~a~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~  283 (410)
T 3v8s_A          205 GHLKLADFGTCMKMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS  283 (410)
T ss_dssp             SCEEECCCTTCEECCTT-SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred             CCEEEeccceeEeeccC-CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHH
Confidence            99999999999753222 122334678999999999997655    7899999999999999999999998765433221


Q ss_pred             H-HHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 014034          301 L-LEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKD--RPKMSQVVER  359 (432)
Q Consensus       301 ~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~  359 (432)
                      . .........          +     .....+..+.+||.+||..+|.+  ||++.+|+++
T Consensus       284 ~i~~~~~~~~~----------p-----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          284 KIMNHKNSLTF----------P-----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HHHTHHHHCCC----------C-----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             HHHhccccccC----------C-----CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            1 111111100          0     00112357889999999999988  9999999987

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5.4e-45  Score=363.54  Aligned_cols=260  Identities=22%  Similarity=0.300  Sum_probs=208.2

Q ss_pred             CHHHHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-------HHHHHHHHhcccCCCccc
Q 014034           70 SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQFLGVLEHPNLV  142 (432)
Q Consensus        70 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~hpniv  142 (432)
                      .+.++....++|++++.||+|+||+||+|.++       .+++.||+|++.+...       .+.+|..++..++||||+
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv  137 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLK-------NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWIT  137 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBC
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEc-------CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEE
Confidence            34555566789999999999999999999976       4678999999865321       278899999999999999


Q ss_pred             eeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc
Q 014034          143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD  222 (432)
Q Consensus       143 ~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~  222 (432)
                      ++++++.+..    ..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.   +|+||||||+||||+
T Consensus       138 ~l~~~~~~~~----~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~  209 (437)
T 4aw2_A          138 TLHYAFQDDN----NLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMD  209 (437)
T ss_dssp             CEEEEEECSS----EEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred             EEEEEEeeCC----EEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEc
Confidence            9999997654    4599999999999999997632 4699999999999999999999998   999999999999999


Q ss_pred             CCCceeeccccCCcCCCCCCCcccccccccCCCccCccccc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchh
Q 014034          223 ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE-----TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT  297 (432)
Q Consensus       223 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~  297 (432)
                      .++.+||+|||+++..... ........+||+.|+|||++.     ...++.++|||||||++|||++|..||.+.....
T Consensus       210 ~~g~vkL~DFGla~~~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~  288 (437)
T 4aw2_A          210 MNGHIRLADFGSCLKLMED-GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE  288 (437)
T ss_dssp             TTSCEEECCCTTCEECCTT-SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             CCCCEEEcchhhhhhcccC-CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH
Confidence            9999999999999753222 222334468999999999996     5678999999999999999999999998765433


Q ss_pred             hHHH-HHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 014034          298 EQRL-LEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKD--RPKMSQVVER  359 (432)
Q Consensus       298 ~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~  359 (432)
                      .... ..+...+..          +..    ....+..+.+||.+||..+|.+  ||++.+++++
T Consensus       289 ~~~~i~~~~~~~~~----------p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          289 TYGKIMNHKERFQF----------PTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HHHHHHTHHHHCCC----------CSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             HHHhhhhccccccC----------Ccc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            2211 111111110          000    0112456889999999988888  9999999987

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.5e-45  Score=366.32  Aligned_cols=256  Identities=27%  Similarity=0.373  Sum_probs=203.9

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ..++|.+.+.||+|+||.||+|.+.        .+..||||.+...   ...+.+|+.+|+.++||||+++++++.. . 
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~-  251 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWN--------GTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E-  251 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--------TTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S-
T ss_pred             ChhHceeeeeecCCCCeEEEEEEEC--------CCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C-
Confidence            3467889999999999999999875        3467999998753   3568999999999999999999999864 2 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+.+|+|.+++.......+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus       252 ---~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG  325 (452)
T 1fmk_A          252 ---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG  325 (452)
T ss_dssp             ---SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             ---ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCc
Confidence               248999999999999999754444689999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      +++..... .........++..|+|||++.+..++.++|||||||++|||++ |..||.+......   ...+....   
T Consensus       326 ~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~~i~~~~---  398 (452)
T 1fmk_A          326 LARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQVERGY---  398 (452)
T ss_dssp             TTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHHTTC---
T ss_pred             cceecCCC-ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCC---
Confidence            99753211 1112233457789999999999999999999999999999999 9999987654322   22211110   


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                                 ....+...+..+.+||.+||+.||.+|||+.+|++.|+.+...
T Consensus       399 -----------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          399 -----------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             -----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                       0011223346788999999999999999999999999988754

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.1e-44  Score=344.55  Aligned_cols=273  Identities=25%  Similarity=0.374  Sum_probs=206.5

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ..|+.++.||+|+||.||+|.+.   ..+..++..||+|.+....     ..+.+|+.+++.++||||+++++++...+.
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~---~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   97 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYD---PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   97 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEC---TTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred             hhhhhhhccCCCCceEEEEEEEc---cccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            35889999999999999999864   2234578999999987543     458899999999999999999999987543


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                      .  ..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        98 ~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg  171 (302)
T 4e5w_A           98 N--GIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFG  171 (302)
T ss_dssp             C--CEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             c--eEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccc
Confidence            3  3589999999999999996543 3689999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCc-ccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          234 LAREGPMVGHT-HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       234 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      ++......... .......||..|+|||++.+..++.++||||||+++|+|++|..|+......    ............
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~  247 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL----FLKMIGPTHGQM  247 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHHCSCCGGG
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH----HhhccCCccccc
Confidence            99764322211 2234456888999999999999999999999999999999999987532110    000000000000


Q ss_pred             c--ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 014034          313 K--KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  364 (432)
Q Consensus       313 ~--~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  364 (432)
                      .  .....+........+...+..+.+|+.+||+.||.+|||+.++++.|+.++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          248 TVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            0  000000000111122334567889999999999999999999999999876

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.9e-45  Score=355.29  Aligned_cols=251  Identities=23%  Similarity=0.331  Sum_probs=189.9

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh--HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      ..++|.+.+.||+|+||.||+|...       .+++.||+|.+....  ..+.+|+.+++.++||||+++++++....  
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--  121 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQK-------GTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPT--  121 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSS--
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEEC-------CCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCC--
Confidence            4568999999999999999999975       456889999987543  34788999999999999999999997654  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC---CCceeecc
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE---NFRPKLSD  231 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~D  231 (432)
                        ..++||||+.+++|.+++...  ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.   ++.+||+|
T Consensus       122 --~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~D  194 (349)
T 2w4o_A          122 --EISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIAD  194 (349)
T ss_dssp             --EEEEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred             --eEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEcc
Confidence              459999999999999999654  3689999999999999999999998   9999999999999975   88999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ||+++...   .........||+.|+|||++.+..++.++|||||||++|+|++|..||........  ....+......
T Consensus       195 fg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~i~~~~~~  269 (349)
T 2w4o_A          195 FGLSKIVE---HQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFRRILNCEYY  269 (349)
T ss_dssp             CC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHHHHHTTCCC
T ss_pred             CccccccC---cccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHHHHHhCCCc
Confidence            99997532   12223456799999999999999999999999999999999999999976544321  11111111000


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                 .........+..+.+|+.+||..||.+|||+.+++++
T Consensus       270 -----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          270 -----------FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             -----------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -----------cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                       0001112234678899999999999999999999876

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.7e-44  Score=362.01  Aligned_cols=264  Identities=22%  Similarity=0.260  Sum_probs=198.2

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|++++.||+|+||.||+|...       .+++.||||++...      ...+.+|+.+|+.++||||+++++++...
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~-------~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  133 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDA-------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ  133 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEET-------TTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEEC-------CCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccC
Confidence            578999999999999999999865       56789999998643      23478999999999999999999998764


Q ss_pred             C--CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          152 G--ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       152 ~--~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      .  ......++||||+.+ +|.+.+..    .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||
T Consensus       134 ~~~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl  205 (464)
T 3ttj_A          134 KTLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKI  205 (464)
T ss_dssp             CSTTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEE
T ss_pred             CccccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEE
Confidence            3  223456999999965 57676643    489999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      +|||+++...   ........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.......+......+
T Consensus       206 ~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p  282 (464)
T 3ttj_A          206 LDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP  282 (464)
T ss_dssp             CCCCCC--------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred             EEEEeeeecC---CCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999997532   2223345689999999999999999999999999999999999999998765443322211111110


Q ss_pred             cC---------------------ccccccccCccccCc---CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 AD---------------------SKKFGLIMDPRLEKE---YSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~---------------------~~~~~~~~~~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ..                     ...+.......+...   .....+..+.+|+.+||..||.+|||+.|++++
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00                     000000000000000   011225678999999999999999999999987

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-44  Score=340.35  Aligned_cols=262  Identities=25%  Similarity=0.404  Sum_probs=208.5

Q ss_pred             cCCcccc-ccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           79 NDFSRML-KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~-~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      ++|.+.. .||+|+||.||+|.+.     ....+..||+|.+...     ...+.+|+.+++.++||||+++++++.. +
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~   82 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYR-----MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E   82 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC--------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred             HHhhhhhccccccCceeEEEeEec-----cCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC-C
Confidence            4566666 8999999999999865     2235788999998763     2347899999999999999999999843 2


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        83 ----~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Df  154 (287)
T 1u59_A           83 ----ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF  154 (287)
T ss_dssp             ----SEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred             ----CcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcc
Confidence                2599999999999999996543 4699999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCC-cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhccc
Q 014034          233 GLAREGPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       233 G~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      |++........ ........||+.|+|||++.+..++.++||||||+++|+|++ |..||........   ...+.... 
T Consensus       155 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~i~~~~-  230 (287)
T 1u59_A          155 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MAFIEQGK-  230 (287)
T ss_dssp             TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---HHHHHTTC-
T ss_pred             cceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH---HHHHhcCC-
Confidence            99975422221 112233457889999999998889999999999999999998 9999987654332   22221110 


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhccCCC
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGD  371 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~  371 (432)
                               .+    ..+...+..+.+||.+||..||.+|||+.+++++|+.+........
T Consensus       231 ---------~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~  278 (287)
T 1u59_A          231 ---------RM----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV  278 (287)
T ss_dssp             ---------CC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred             ---------cC----CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence                     01    1122334678899999999999999999999999999987655433

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.3e-45  Score=358.35  Aligned_cols=270  Identities=21%  Similarity=0.280  Sum_probs=203.3

Q ss_pred             HhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHHHHHHHhcccCCCccceeeeEEeecCC--
Q 014034           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE--  153 (432)
Q Consensus        76 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--  153 (432)
                      ...++|.+.+.||+|+||.||+|...       .+++.||||++..+.....+|+.+|+.++||||+++++++...+.  
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~-------~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDI-------ESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEET-------TTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred             cccceEEEEEEEEeccCEEEEEEEEC-------CCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence            44578999999999999999999865       467899999997776666789999999999999999999865432  


Q ss_pred             --------------------------------cceeEEEEEeecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHH
Q 014034          154 --------------------------------RGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLA  199 (432)
Q Consensus       154 --------------------------------~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~l~~~l~  199 (432)
                                                      .....++||||+. ++|.+.+..  .....+++..+..++.||+.||.
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                            2334689999997 588777753  23357999999999999999999


Q ss_pred             HhhcCCCCceeecCCCCCceEEc-CCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccC-CCCchhhhHHHH
Q 014034          200 YLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFG  277 (432)
Q Consensus       200 ~LH~~~~~~ivH~Dikp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG  277 (432)
                      |||+.   +|+||||||+|||++ .++.+||+|||+++....   ........||+.|+|||++.+. .++.++||||||
T Consensus       156 ~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG  229 (383)
T 3eb0_A          156 FIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG  229 (383)
T ss_dssp             HHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCT---TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred             HHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCC---CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence            99998   999999999999997 689999999999975322   2223446789999999998765 589999999999


Q ss_pred             HHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc-----------cccccccCccccCcCCHHHHHHHHHHHHHhccCC
Q 014034          278 VVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS-----------KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKS  346 (432)
Q Consensus       278 vil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~d  346 (432)
                      |++|+|++|..||.+.........+......+...           ..+..+....+....+...+..+.+|+.+||..|
T Consensus       230 ~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  309 (383)
T 3eb0_A          230 CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE  309 (383)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence            99999999999998765443322211111111000           0000001111111122334567889999999999


Q ss_pred             CCCCCCHHHHHHH
Q 014034          347 SKDRPKMSQVVER  359 (432)
Q Consensus       347 P~~RPs~~eil~~  359 (432)
                      |.+|||+.+++++
T Consensus       310 P~~R~t~~e~l~h  322 (383)
T 3eb0_A          310 PDLRINPYEAMAH  322 (383)
T ss_dssp             GGGSCCHHHHHTS
T ss_pred             hhhCCCHHHHhcC
Confidence            9999999999976

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=8.3e-45  Score=348.43  Aligned_cols=274  Identities=28%  Similarity=0.406  Sum_probs=207.6

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      |++++.||+|+||.||++.+..   .+..+++.||+|++....     ..+.+|+.+++.++||||+++++++...+.. 
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~---~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-  108 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDP---TNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA-  108 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECS---CC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT-
T ss_pred             HhhhheecCCCCeEEEEEEEcc---CCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc-
Confidence            4899999999999999987752   234578999999997642     3478999999999999999999999875433 


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCC
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  235 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a  235 (432)
                       ..++||||+++++|.+++...   .+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       109 -~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a  181 (318)
T 3lxp_A          109 -SLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA  181 (318)
T ss_dssp             -EEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred             -eEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccc
Confidence             568999999999999999764   489999999999999999999998   9999999999999999999999999999


Q ss_pred             cCCCCCCCc-ccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          236 REGPMVGHT-HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       236 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      ......... .......||..|+|||++.+..++.++||||||+++|+|++|..||......... ...+..... ....
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~-~~~~  259 (318)
T 3lxp_A          182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE-LIGIAQGQM-TVLR  259 (318)
T ss_dssp             EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HHCSCCHHH-HHHH
T ss_pred             ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh-hhcccccch-hHHH
Confidence            864322211 2234456888999999999989999999999999999999999999753211000 000000000 0000


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhc
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  367 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  367 (432)
                      ....+........+...+..+.+||.+||+.||.+|||+.++++.|+.+.+..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  312 (318)
T 3lxp_A          260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY  312 (318)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence            00001111111122334567899999999999999999999999999887543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.4e-44  Score=339.93  Aligned_cols=256  Identities=27%  Similarity=0.402  Sum_probs=207.4

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---hHHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      .++|.+.+.||+|+||.||+|.+.        .+..||+|.+...   ...+.+|+.+++.++||||+++++++...   
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---   80 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYN--------GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE---   80 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET--------TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             HHhhhheeeecCCCCeEEEEEEEc--------CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcCC---
Confidence            457999999999999999999864        4578999998653   45688999999999999999999987632   


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        ..++||||+.+++|.+++.......+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        81 --~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~  155 (279)
T 1qpc_A           81 --PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGL  155 (279)
T ss_dssp             --SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             --CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcc
Confidence              248999999999999999654333689999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      +...... .........+++.|+|||++.+..++.++||||||+++|+|++ |..||.+......   ...+....    
T Consensus       156 ~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~~~~~~----  227 (279)
T 1qpc_A          156 ARLIEDN-EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---IQNLERGY----  227 (279)
T ss_dssp             CEECSSS-CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHHTTC----
T ss_pred             cccccCc-ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH---HHHHhccc----
Confidence            9754221 1122234457889999999998899999999999999999999 9999987554322   22111110    


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhc
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  367 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  367 (432)
                            ..    ..+...+..+.+|+.+||..||.+|||+.++++.|+.+....
T Consensus       228 ------~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          228 ------RM----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             ------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ------CC----CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence                  00    111223467889999999999999999999999999987653

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.7e-45  Score=356.34  Aligned_cols=251  Identities=22%  Similarity=0.338  Sum_probs=192.3

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---hHHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      .++|.+++.||+|+||.||++...       .+++.||+|.+...   ...+.+|+.+++.++||||+++++++....  
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--   89 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDK-------LTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPT--   89 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEET-------TTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred             CCcEEEEEEeccCCCEEEEEEEEC-------CCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC--
Confidence            357999999999999999999875       46789999998653   345889999999999999999999997654  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCc--eeeccc
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR--PKLSDF  232 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~--~kl~Df  232 (432)
                        ..++||||+.+|+|.+++....  .+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.  +||+||
T Consensus        90 --~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Df  162 (361)
T 3uc3_A           90 --HLAIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDF  162 (361)
T ss_dssp             --EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCC
T ss_pred             --EEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeec
Confidence              4599999999999999996543  699999999999999999999998   9999999999999987765  999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCch-hhhHHHHHHHHHHHhCCCCCCCCCchhh-HHHHHHHhhccc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAK-SDVWSFGVVLYEMLTGRRSLERNRPKTE-QRLLEWVQQYPA  310 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGvil~elltg~~pf~~~~~~~~-~~~~~~~~~~~~  310 (432)
                      |+++...   .........||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+...... ......+.....
T Consensus       163 g~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~  239 (361)
T 3uc3_A          163 GYSKSSV---LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY  239 (361)
T ss_dssp             CCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC
T ss_pred             Ccccccc---ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC
Confidence            9997421   1222344679999999999988887665 8999999999999999999986543221 122221111110


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                      .           +  ......+..+.+||.+||..||.+|||+.+++++-
T Consensus       240 ~-----------~--~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp  276 (361)
T 3uc3_A          240 S-----------I--PDDIRISPECCHLISRIFVADPATRISIPEIKTHS  276 (361)
T ss_dssp             C-----------C--CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred             C-----------C--CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence            0           0  00111235688999999999999999999999873

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=356.74  Aligned_cols=273  Identities=23%  Similarity=0.271  Sum_probs=213.6

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|.+.+.||+|+||.||+|.+.       .++..||||++...     ...+.+|+.+++.++||||+++++++...+.
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   81 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHK-------KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT   81 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred             CceEEEEEEEcCCCeEEEEEEEC-------CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC
Confidence            57999999999999999999975       45789999998753     2457899999999999999999999876543


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEE----cCCCcee
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL----DENFRPK  228 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill----~~~~~~k  228 (432)
                      .  ..++||||+.+|+|.+++.... ...+++..++.++.||+.||.|||+.   +|+||||||+|||+    +.++.+|
T Consensus        82 ~--~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~k  156 (396)
T 4eut_A           82 R--HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYK  156 (396)
T ss_dssp             C--CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEE
T ss_pred             C--eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEE
Confidence            2  4599999999999999997643 22489999999999999999999998   99999999999999    7888899


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCcccccc--------CCCCchhhhHHHHHHHHHHHhCCCCCCCCCch-hhH
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET--------GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK-TEQ  299 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvil~elltg~~pf~~~~~~-~~~  299 (432)
                      |+|||+++...   .........||+.|+|||++.+        ..++.++|||||||++|||++|..||...... ...
T Consensus       157 L~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~  233 (396)
T 4eut_A          157 LTDFGAARELE---DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK  233 (396)
T ss_dssp             ECCGGGCEECC---CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH
T ss_pred             EecCCCceEcc---CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH
Confidence            99999997532   2223345679999999999865        56778999999999999999999999754322 112


Q ss_pred             H-HHHHHhhcccCcc-cccc--------ccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          300 R-LLEWVQQYPADSK-KFGL--------IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       300 ~-~~~~~~~~~~~~~-~~~~--------~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                      . +.......+.... ....        .-........+...+..+.+++.+||..||++|||+.++++.+..++..
T Consensus       234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             HHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            2 2222222221110 0000        0011112234567788899999999999999999999999999998764

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.6e-45  Score=351.20  Aligned_cols=265  Identities=24%  Similarity=0.405  Sum_probs=209.5

Q ss_pred             HHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEe
Q 014034           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCA  149 (432)
Q Consensus        75 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~  149 (432)
                      ....++|.+.+.||+|+||.||+|.+....  ....+..||+|.+....     ..+.+|+.+++.++||||+++++++.
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVV--KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEE--TTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCcc--CCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            344568999999999999999999865211  12357889999987532     24789999999999999999999987


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEE
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRA--------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL  221 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill  221 (432)
                      ..+.    .++||||+.+|+|.+++....        ...+++..++.++.||+.||.|||++   +|+||||||+|||+
T Consensus        99 ~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli  171 (322)
T 1p4o_A           99 QGQP----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV  171 (322)
T ss_dssp             SSSS----CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred             cCCc----cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence            6543    499999999999999986421        24678999999999999999999998   99999999999999


Q ss_pred             cCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 014034          222 DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQR  300 (432)
Q Consensus       222 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~  300 (432)
                      +.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.+......  
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--  249 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV--  249 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH--
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH--
Confidence            9999999999999975322222222334567889999999999999999999999999999999 8999987544322  


Q ss_pred             HHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          301 LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                       ...+.....          .    ..+...+..+.+|+.+||+.||.+|||+.+++++|+.++.
T Consensus       250 -~~~~~~~~~----------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          250 -LRFVMEGGL----------L----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             -HHHHHTTCC----------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -HHHHHcCCc----------C----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence             221111100          0    0112234678899999999999999999999999987754

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.5e-45  Score=345.58  Aligned_cols=255  Identities=25%  Similarity=0.353  Sum_probs=208.8

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHHHHHHHhcccCCCccceeeeEEeecC----
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDG----  152 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----  152 (432)
                      ..++|+..+.||+|+||.||+|.+.       .+++.||+|.+......+.+|+.+++.++||||+++++++....    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHR-------IDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE   81 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEET-------TTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred             hccccceeeeeccCCceEEEEEEEc-------CCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence            3467999999999999999999875       46789999999877778899999999999999999999886421    


Q ss_pred             --------CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCC
Q 014034          153 --------ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN  224 (432)
Q Consensus       153 --------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~  224 (432)
                              ......++||||+++++|.+++.......+++..++.++.||+.||.|||+.   +|+||||||+|||++.+
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT  158 (284)
T ss_dssp             -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred             cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence                    1133468999999999999999765556799999999999999999999998   99999999999999999


Q ss_pred             CceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 014034          225 FRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  304 (432)
Q Consensus       225 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  304 (432)
                      +.+||+|||++......   .......||+.|+|||++.+..++.++||||||+++|+|++|..|+...     ......
T Consensus       159 ~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~~~  230 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKFFTD  230 (284)
T ss_dssp             TEEEECCCTTCEESSCC---SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHHHHH
T ss_pred             CCEEECcchhheecccc---ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHHHHH
Confidence            99999999998753221   1233456999999999999999999999999999999999999887421     111111


Q ss_pred             HhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          305 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                      +..             ..+...    .+..+.+|+.+||+.||.+|||+.+++++|..+...
T Consensus       231 ~~~-------------~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          231 LRD-------------GIISDI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             HHT-------------TCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             hhc-------------cccccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence            111             111111    235678999999999999999999999999888643

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.4e-44  Score=356.55  Aligned_cols=266  Identities=18%  Similarity=0.274  Sum_probs=202.6

Q ss_pred             hcCCccccccccC--CceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEe
Q 014034           78 TNDFSRMLKIGEG--GFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCA  149 (432)
Q Consensus        78 ~~~~~~~~~lg~G--~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~  149 (432)
                      .++|++++.||+|  +||.||+|...       .++..||||++....      ..+.+|+.+++.++||||+++++++.
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   96 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYK-------PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI   96 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEET-------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEc-------CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE
Confidence            4679999999999  99999999976       467899999986432      24778999999999999999999998


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      ..+    ..++||||+.+|+|.+++.......+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||
T Consensus        97 ~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl  169 (389)
T 3gni_B           97 ADN----ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYL  169 (389)
T ss_dssp             ETT----EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEE
T ss_pred             ECC----EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence            755    359999999999999999877556799999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCC-----cccccccccCCCccCcccccc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014034          230 SDFGLAREGPMVGH-----THVSTAVVGTFGYAAPDYIET--GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  302 (432)
Q Consensus       230 ~DfG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  302 (432)
                      +|||++......+.     ........||+.|+|||++.+  ..++.++|||||||++|+|++|..||.+.......  .
T Consensus       170 ~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~  247 (389)
T 3gni_B          170 SGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--L  247 (389)
T ss_dssp             CCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--H
T ss_pred             cccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--H
Confidence            99998864211111     111233478999999999987  67899999999999999999999999875443221  1


Q ss_pred             HHHhhcccC--------ccccc-------------ccc---------CccccCcCCHHHHHHHHHHHHHhccCCCCCCCC
Q 014034          303 EWVQQYPAD--------SKKFG-------------LIM---------DPRLEKEYSINEARKIGRLADNCLSKSSKDRPK  352 (432)
Q Consensus       303 ~~~~~~~~~--------~~~~~-------------~~~---------~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs  352 (432)
                      .........        ...+.             ...         ........+...+..+.+||.+||+.||.+|||
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt  327 (389)
T 3gni_B          248 EKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS  327 (389)
T ss_dssp             HC--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCC
T ss_pred             HHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCC
Confidence            100000000        00000             000         000000112233467889999999999999999


Q ss_pred             HHHHHHH
Q 014034          353 MSQVVER  359 (432)
Q Consensus       353 ~~eil~~  359 (432)
                      +.+++++
T Consensus       328 a~ell~h  334 (389)
T 3gni_B          328 ASTLLNH  334 (389)
T ss_dssp             HHHHTTS
T ss_pred             HHHHhcC
Confidence            9999976

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.1e-44  Score=363.73  Aligned_cols=247  Identities=26%  Similarity=0.373  Sum_probs=196.7

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEe
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCA  149 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~  149 (432)
                      ..++|++++.||+|+||.||+|...       .++..||||.+....       ..+.+|+.+++.++||||+++++++.
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~  218 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEK-------ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ  218 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEc-------CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe
Confidence            3468999999999999999999865       567899999986432       23678999999999999999999998


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCceeecCCCCCceEEcCCCcee
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE-GLEVQVIYRDFKASNVLLDENFRPK  228 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~~k  228 (432)
                      ..+    ..++||||+++|+|.+++....  .+++..+..++.||+.||.|||+ .   +|+||||||+||||+.++.+|
T Consensus       219 ~~~----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~k  289 (446)
T 4ejn_A          219 THD----RLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIK  289 (446)
T ss_dssp             ETT----EEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEE
T ss_pred             eCC----EEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEE
Confidence            765    3599999999999999997643  68999999999999999999998 7   999999999999999999999


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      |+|||+++....  .........||+.|+|||++.+..++.++|||||||++|||++|..||.+......   ...+...
T Consensus       290 l~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~i~~~  364 (446)
T 4ejn_A          290 ITDFGLCKEGIK--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELILME  364 (446)
T ss_dssp             ECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHC
T ss_pred             EccCCCceeccC--CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HHHHHhC
Confidence            999999975321  22234457899999999999999999999999999999999999999986544322   2211111


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  359 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  359 (432)
                      .           ..    ++...+..+.+||.+||+.||.+||     ++.+++++
T Consensus       365 ~-----------~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          365 E-----------IR----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             C-----------CC----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             C-----------CC----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence            0           00    1112246788999999999999999     99999876

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.3e-44  Score=336.03  Aligned_cols=253  Identities=30%  Similarity=0.438  Sum_probs=206.6

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---hHHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      ++|...+.||+|+||.||+|.+.        ++..||+|.+...   ...+.+|+.+++.++||||+++++++...+.  
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--   77 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL--------NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP--   77 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET--------TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS--
T ss_pred             hheeeeeEecCCCceeEEEEEec--------CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC--
Confidence            57999999999999999999874        4578999998754   3468899999999999999999999976554  


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCC
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  235 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a  235 (432)
                        .++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        78 --~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~  151 (267)
T 3t9t_A           78 --ICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT  151 (267)
T ss_dssp             --CEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGG
T ss_pred             --eEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccc
Confidence              499999999999999997653 4689999999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      ..... ..........+++.|+|||++.+..++.++||||||+++|+|++ |..||........   ...+.....    
T Consensus       152 ~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~i~~~~~----  223 (267)
T 3t9t_A          152 RFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---VEDISTGFR----  223 (267)
T ss_dssp             GGBCC-HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHHTTCC----
T ss_pred             ccccc-ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH---HHHHhcCCc----
Confidence            75321 11112233457789999999998999999999999999999999 8999987544322   221111100    


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                            .    ..+...+..+.+|+.+||+.||.+|||+.+++++|+.+.+
T Consensus       224 ------~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          224 ------L----YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             ------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------C----CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                  0    0111224578899999999999999999999999998875

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.9e-44  Score=341.34  Aligned_cols=257  Identities=25%  Similarity=0.378  Sum_probs=205.3

Q ss_pred             hcCCcccc-ccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEee
Q 014034           78 TNDFSRML-KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        78 ~~~~~~~~-~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .++|.+.. .||+|+||.||+|.+.     ....+..||+|.+...      ...+.+|+.+++.++||||+++++++. 
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-   88 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQ-----MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-   88 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEE-----CSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-
T ss_pred             chhhhhccCccccccCeeeEeeeec-----CCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-
Confidence            45788887 9999999999999764     2346789999998754      234889999999999999999999983 


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .+    ..++||||+.+++|.+++...  ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        89 ~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~  159 (291)
T 1xbb_A           89 AE----SWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKIS  159 (291)
T ss_dssp             SS----SEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEEC
T ss_pred             CC----CcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEc
Confidence            22    348999999999999999764  3689999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCc-ccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhc
Q 014034          231 DFGLAREGPMVGHT-HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       231 DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      |||++......... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+......   ...+...
T Consensus       160 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~~~  236 (291)
T 1xbb_A          160 DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TAMLEKG  236 (291)
T ss_dssp             CCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHHTT
T ss_pred             cCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHHcC
Confidence            99999754322221 12223456789999999998889999999999999999999 9999987654332   2222111


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                      ..          +    ..+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       237 ~~----------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          237 ER----------M----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             CC----------C----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CC----------C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            10          1    11223346788999999999999999999999999998754

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-43  Score=342.25  Aligned_cols=272  Identities=22%  Similarity=0.332  Sum_probs=205.5

Q ss_pred             HhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-HHHHHHHHhccc--CCCccceeeeEEeecC
Q 014034           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QWVAEVQFLGVL--EHPNLVKLIGYCAVDG  152 (432)
Q Consensus        76 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~l--~hpniv~l~~~~~~~~  152 (432)
                      ...++|++.+.||+|+||.||+|.+.         +..||||++..... .+..|.+++..+  +||||+++++++....
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR---------GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET---------TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC---------CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            34568999999999999999999853         78899999865433 355666666554  8999999999998765


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCceeecCCCCCceEEcCCCce
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL-----EVQVIYRDFKASNVLLDENFRP  227 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~-----~~~ivH~Dikp~Nill~~~~~~  227 (432)
                      ......++||||+.+|+|.+++...   .+++..++.++.|++.||.|||+..     ..+|+||||||+|||++.++.+
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             CCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence            4445679999999999999999654   5899999999999999999999751     2389999999999999999999


Q ss_pred             eeccccCCcCCCCCCCc--ccccccccCCCccCccccccCCCCch------hhhHHHHHHHHHHHhC----------CCC
Q 014034          228 KLSDFGLAREGPMVGHT--HVSTAVVGTFGYAAPDYIETGHLTAK------SDVWSFGVVLYEMLTG----------RRS  289 (432)
Q Consensus       228 kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlGvil~elltg----------~~p  289 (432)
                      ||+|||++.........  .......||+.|+|||++.+..++..      +|||||||++|||+||          ..|
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            99999999753222111  11234579999999999987766654      9999999999999999          666


Q ss_pred             CCCCCchhh--HHHHHHHhhcccCccccccccCccccC-cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          290 LERNRPKTE--QRLLEWVQQYPADSKKFGLIMDPRLEK-EYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       290 f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                      |........  ..........         ...+.+.. ......+..+.+|+.+||+.||.+|||+.+|+++|+.+.+.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  332 (337)
T 3mdy_A          262 YHDLVPSDPSYEDMREIVCIK---------KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES  332 (337)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTS---------CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HhhhcCCCCchhhhHHHHhhh---------ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence            654322111  1111111000         01111111 11236678899999999999999999999999999999865


Q ss_pred             cc
Q 014034          367 SN  368 (432)
Q Consensus       367 ~~  368 (432)
                      .+
T Consensus       333 ~~  334 (337)
T 3mdy_A          333 QD  334 (337)
T ss_dssp             TT
T ss_pred             cc
Confidence            43

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-44  Score=346.06  Aligned_cols=262  Identities=26%  Similarity=0.440  Sum_probs=202.8

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|...+.||+|+||.||+|.+....   ...+..||+|.+...     ...+.+|+.+++.++||||+++++++...+ 
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-  119 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSS---GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK-  119 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCC---CCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC-
Confidence            46888899999999999999876321   224578999998753     224788999999999999999999987544 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       120 ---~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  192 (333)
T 1mqb_A          120 ---PMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFG  192 (333)
T ss_dssp             ---SEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             ---CcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCC
Confidence               3599999999999999997643 4689999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCC-cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          234 LAREGPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       234 ~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ++........ ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......   +...+..... 
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~~~~~~~~~-  268 (333)
T 1mqb_A          193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VMKAINDGFR-  268 (333)
T ss_dssp             C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTTCC-
T ss_pred             cchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHCCCc-
Confidence            9975322111 111223456789999999999999999999999999999999 999997654432   2222211100 


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhcc
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  368 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  368 (432)
                               .    ..+...+..+.+|+.+||+.||.+||++.+|++.|+.++....
T Consensus       269 ---------~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          269 ---------L----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             ---------C----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             ---------C----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence                     0    1112234678899999999999999999999999999886543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=7.5e-45  Score=343.46  Aligned_cols=256  Identities=23%  Similarity=0.377  Sum_probs=200.6

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      .++|.+.+.||+|+||.||+|............+..||+|.+....    ..+.+|+.+++.++||||+++++++...+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3579999999999999999998763221122234789999986533    358899999999999999999999987554


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCc-------
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR-------  226 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~-------  226 (432)
                      .    ++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.       
T Consensus        87 ~----~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~  158 (289)
T 4fvq_A           87 N----ILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP  158 (289)
T ss_dssp             C----EEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred             C----EEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence            3    89999999999999997653 3489999999999999999999998   9999999999999998887       


Q ss_pred             -eeeccccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCC-CCCCCCCchhhHHHHH
Q 014034          227 -PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGR-RSLERNRPKTEQRLLE  303 (432)
Q Consensus       227 -~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~-~pf~~~~~~~~~~~~~  303 (432)
                       +||+|||++....      ......||+.|+|||++.+ ..++.++|||||||++|+|++|. .||...........  
T Consensus       159 ~~kl~Dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~--  230 (289)
T 4fvq_A          159 FIKLSDPGISITVL------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF--  230 (289)
T ss_dssp             EEEECCCCSCTTTS------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH--
T ss_pred             eeeeccCccccccc------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH--
Confidence             9999999986421      1233458999999999987 77899999999999999999955 44444332221111  


Q ss_pred             HHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          304 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                       ......            +...    .+..+.+|+.+||+.||.+|||+.+++++|+.++..
T Consensus       231 -~~~~~~------------~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          231 -YEDRHQ------------LPAP----KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             -HHTTCC------------CCCC----SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             -hhccCC------------CCCC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence             111110            0001    123577999999999999999999999999988753

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.3e-44  Score=346.49  Aligned_cols=253  Identities=25%  Similarity=0.389  Sum_probs=196.3

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|++.+.||+|+||.||+|+++       .+++.||||++...     ...+.+|+.+++.++||||+++++++.+..
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   77 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNK-------VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETP   77 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEET-------TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECC
T ss_pred             hhcCceeeEecCCCCeEEEEEEEc-------CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEec
Confidence            467999999999999999999975       46789999998532     235889999999999999999999987643


Q ss_pred             Cc-----------------------------------------------------ceeEEEEEeecCCCCHHHHhhcCC-
Q 014034          153 ER-----------------------------------------------------GIQRLLVYEFMLNRSLEDHLFNRA-  178 (432)
Q Consensus       153 ~~-----------------------------------------------------~~~~~lv~e~~~~gsL~~~l~~~~-  178 (432)
                      ..                                                     ....++||||+.+++|.+++.... 
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~  157 (332)
T 3qd2_B           78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS  157 (332)
T ss_dssp             SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred             cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence            21                                                     123699999999999999997653 


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCCCCCC----------ccccc
Q 014034          179 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH----------THVST  248 (432)
Q Consensus       179 ~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~----------~~~~~  248 (432)
                      ....++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.......          .....
T Consensus       158 ~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T 3qd2_B          158 LEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT  234 (332)
T ss_dssp             GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCC
T ss_pred             ccchhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccc
Confidence            23456677899999999999999998   999999999999999999999999999986432211          11223


Q ss_pred             ccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCC
Q 014034          249 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYS  328 (432)
Q Consensus       249 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  328 (432)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|..|+..     .............          +    ...
T Consensus       235 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~----------~----~~~  295 (332)
T 3qd2_B          235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKF----------P----LLF  295 (332)
T ss_dssp             SCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCC----------C----HHH
T ss_pred             ccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCC----------C----ccc
Confidence            45799999999999999999999999999999999998766431     1111111111100          0    011


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          329 INEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       329 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ......+.+|+.+||+.||.+|||+.+++++
T Consensus       296 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          296 TQKYPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             ccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            2334567899999999999999999999875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=7.1e-44  Score=337.65  Aligned_cols=268  Identities=21%  Similarity=0.262  Sum_probs=206.8

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh--HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      ..++|.+.+.||+|+||.||+|...       .+++.||+|.+....  ..+.+|+.+++.++|++++..+..+..... 
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~-   78 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDI-------AAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGD-   78 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEET-------TTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETT-
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEc-------CCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCC-
Confidence            4578999999999999999999865       467899999865432  348899999999999998888877755432 


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEE---cCCCceeecc
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSD  231 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill---~~~~~~kl~D  231 (432)
                        ..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||+   +.++.+||+|
T Consensus        79 --~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~D  151 (296)
T 4hgt_A           79 --YNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIID  151 (296)
T ss_dssp             --EEEEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECC
T ss_pred             --ceEEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEec
Confidence              458999999 999999987543 3699999999999999999999998   99999999999999   7899999999


Q ss_pred             ccCCcCCCCCCCc-----ccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 014034          232 FGLAREGPMVGHT-----HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  306 (432)
Q Consensus       232 fG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  306 (432)
                      ||++.........     .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+............+.
T Consensus       152 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  231 (296)
T 4hgt_A          152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS  231 (296)
T ss_dssp             CTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred             CccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh
Confidence            9999753222111     12235679999999999999999999999999999999999999998754432222211111


Q ss_pred             hcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhccC
Q 014034          307 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNE  369 (432)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~  369 (432)
                      ...... .     .+.+    ....+..+.+|+.+||+.||.+|||+.+|++.|+.+.+..+.
T Consensus       232 ~~~~~~-~-----~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~  284 (296)
T 4hgt_A          232 EKKMST-P-----IEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             HHHHHS-C-----HHHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             cccccc-h-----hhhh----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence            100000 0     0000    011235788999999999999999999999999999876553

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.3e-44  Score=344.86  Aligned_cols=248  Identities=25%  Similarity=0.397  Sum_probs=195.3

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh--------HHHHHHHHHhcccCCCccceeeeEEee
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--------LQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      ++|.+.+.||+|+||.||+|....    +..++..||+|++.+..        ..+.+|+.+++.++||||+++++++..
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVT----GANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT   92 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECS----STTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEec----cCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence            579999999999999999998641    22467899999987532        236789999999999999999999976


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .+    ..++||||+.+++|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        93 ~~----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~  163 (327)
T 3a62_A           93 GG----KLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLT  163 (327)
T ss_dssp             SS----CEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEEC
T ss_pred             CC----EEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEE
Confidence            54    3599999999999999997543  689999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      |||+++....  .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+......   ...+.... 
T Consensus       164 Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~-  237 (327)
T 3a62_A          164 DFGLCKESIH--DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT---IDKILKCK-  237 (327)
T ss_dssp             CCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHTC-
T ss_pred             eCCccccccc--CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHhCC-
Confidence            9999875221  12223456799999999999999999999999999999999999999986544322   11111110 


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  359 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  359 (432)
                                ..    .+...+..+.+|+.+||..||.+||     ++.+++++
T Consensus       238 ----------~~----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          238 ----------LN----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             ----------CC----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             ----------CC----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence                      00    1112246788999999999999999     77888876

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.7e-44  Score=338.76  Aligned_cols=249  Identities=23%  Similarity=0.349  Sum_probs=201.0

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|++.+.||+|+||.||+|.+.       .++..||+|.+....      ..+.+|+.+++.++||||+++++++...
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHK-------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE   77 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEc-------CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC
Confidence            468999999999999999999875       467889999986432      3477899999999999999999998765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCc---ee
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR---PK  228 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~---~k  228 (432)
                      +    ..++||||+.+++|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.   +|
T Consensus        78 ~----~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~k  148 (284)
T 3kk8_A           78 S----FHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVK  148 (284)
T ss_dssp             S----EEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEE
T ss_pred             C----EEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEE
Confidence            4    3599999999999999887653  689999999999999999999998   9999999999999976655   99


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      |+|||++.....   ........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.........   +...
T Consensus       149 l~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~  222 (284)
T 3kk8_A          149 LADFGLAIEVND---SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ---IKAG  222 (284)
T ss_dssp             ECCCTTCEECCS---SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHT
T ss_pred             EeeceeeEEccc---CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHH---HHhc
Confidence            999999975321   2223346799999999999999999999999999999999999999987544322211   1111


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ...           .........+..+.+|+.+||+.||.+|||+.+++++
T Consensus       223 ~~~-----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          223 AYD-----------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             CCC-----------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ccc-----------CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            000           0000011223568899999999999999999999986

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.9e-45  Score=357.54  Aligned_cols=267  Identities=24%  Similarity=0.373  Sum_probs=193.9

Q ss_pred             HhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccC-CCccceeeeEE
Q 014034           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLE-HPNLVKLIGYC  148 (432)
Q Consensus        76 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~-hpniv~l~~~~  148 (432)
                      ...++|++++.||+|+||.||+|.+.       .+++.||||++...      ...+.+|+.++..+. ||||+++++++
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~   78 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDR-------RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVL   78 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEET-------TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEEC-------CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEE
Confidence            34578999999999999999999865       56789999998542      224678999999997 99999999999


Q ss_pred             eecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCcee
Q 014034          149 AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  228 (432)
Q Consensus       149 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k  228 (432)
                      ..++..  ..++||||+. ++|..++...   .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        79 ~~~~~~--~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~k  149 (388)
T 3oz6_A           79 RADNDR--DVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVK  149 (388)
T ss_dssp             ECTTSS--CEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred             ecCCCC--EEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEE
Confidence            765432  4699999996 6999998763   689999999999999999999998   999999999999999999999


Q ss_pred             eccccCCcCCCCC-------------------CCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCC
Q 014034          229 LSDFGLAREGPMV-------------------GHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRR  288 (432)
Q Consensus       229 l~DfG~a~~~~~~-------------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~  288 (432)
                      |+|||+++.....                   .........+||+.|+|||++.+ ..++.++|||||||++|||++|..
T Consensus       150 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~  229 (388)
T 3oz6_A          150 VADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP  229 (388)
T ss_dssp             ECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCC
Confidence            9999999753211                   01112334689999999999976 678999999999999999999999


Q ss_pred             CCCCCCchhhHHHHHHHhhcccCcccccccc------------------CccccCc------------CCHHHHHHHHHH
Q 014034          289 SLERNRPKTEQRLLEWVQQYPADSKKFGLIM------------------DPRLEKE------------YSINEARKIGRL  338 (432)
Q Consensus       289 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~l~~~------------~~~~~~~~l~~l  338 (432)
                      ||.+.........+......+... ....+.                  .......            .....+..+.+|
T Consensus       230 pf~~~~~~~~~~~i~~~~~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl  308 (388)
T 3oz6_A          230 IFPGSSTMNQLERIIGVIDFPSNE-DVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDL  308 (388)
T ss_dssp             SCCCSSHHHHHHHHHHHHCCCCHH-HHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHhcCCCCHH-HHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHH
Confidence            998766544332222111111110 000000                  0000000            000224568899


Q ss_pred             HHHhccCCCCCCCCHHHHHHH
Q 014034          339 ADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       339 i~~cl~~dP~~RPs~~eil~~  359 (432)
                      +.+||..||.+|||+.+++++
T Consensus       309 l~~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          309 LDKLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHhhccCcccCCCHHHHhCC
Confidence            999999999999999999987

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.8e-44  Score=346.43  Aligned_cols=249  Identities=23%  Similarity=0.318  Sum_probs=202.0

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC----------hHHHHHHHHHhcccCCCccceeeeE
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----------GLQWVAEVQFLGVLEHPNLVKLIGY  147 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~hpniv~l~~~  147 (432)
                      .++|.+.+.||+|+||.||+|...       .++..||+|.+...          ...+.+|+.+++.++||||++++++
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   83 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREK-------STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDV   83 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEEC-------CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            357999999999999999999875       46789999988542          3458899999999999999999999


Q ss_pred             EeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC--
Q 014034          148 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF--  225 (432)
Q Consensus       148 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~--  225 (432)
                      +....    ..++||||+.+++|.+++...  ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++  
T Consensus        84 ~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~  154 (321)
T 2a2a_A           84 YENRT----DVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIP  154 (321)
T ss_dssp             EECSS----EEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSS
T ss_pred             EecCC----EEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCC
Confidence            87654    459999999999999999754  3689999999999999999999998   999999999999999888  


Q ss_pred             --ceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 014034          226 --RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE  303 (432)
Q Consensus       226 --~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~  303 (432)
                        .+||+|||++.....   ........||+.|+|||++.+..++.++||||||+++|+|++|..||.+......   ..
T Consensus       155 ~~~~kl~Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~  228 (321)
T 2a2a_A          155 IPHIKLIDFGLAHEIED---GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LA  228 (321)
T ss_dssp             SCCEEECCCTTCEECCT---TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HH
T ss_pred             cCCEEEccCccceecCc---cccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH---HH
Confidence              799999999975322   1223446799999999999999999999999999999999999999986543322   11


Q ss_pred             HHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          304 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .+......       .++.+.    ...+..+.+|+.+||..||.+|||+.+++++
T Consensus       229 ~i~~~~~~-------~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          229 NITSVSYD-------FDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             HHHTTCCC-------CCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             HHHhcccc-------cChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            11111100       000000    1123568899999999999999999999876

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-44  Score=353.19  Aligned_cols=262  Identities=27%  Similarity=0.376  Sum_probs=197.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ..|...+.||+|+||.||+|.+...    ......||+|.+...     ...+.+|+.+++.++||||+++++++.....
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  164 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDN----DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  164 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEET----TTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECC----CCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC
Confidence            3467788999999999999987521    234567999998642     2348899999999999999999998765432


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       165 ---~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG  237 (373)
T 3c1x_A          165 ---SPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFG  237 (373)
T ss_dssp             ---CCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             ---CeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecc
Confidence               2489999999999999997543 4688999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCC--cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhccc
Q 014034          234 LAREGPMVGH--THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       234 ~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      +++.......  ........+|+.|+|||++.+..++.++|||||||++|||+| |..||...........   +.....
T Consensus       238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~---~~~~~~  314 (373)
T 3c1x_A          238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LLQGRR  314 (373)
T ss_dssp             --------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH---HHTTCC
T ss_pred             ccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH---HHcCCC
Confidence            9975322111  112233457889999999999999999999999999999999 7778876544322211   111100


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhcc
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  368 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  368 (432)
                                .    ..+...+..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus       315 ----------~----~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          315 ----------L----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             ----------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             ----------C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence                      0    0111234678899999999999999999999999999986654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.8e-44  Score=370.78  Aligned_cols=258  Identities=25%  Similarity=0.412  Sum_probs=203.5

Q ss_pred             CCcccc-ccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           80 DFSRML-KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        80 ~~~~~~-~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++.+.. .||+|+||.||+|.++     ....+..||||.++..     ...+.+|+.+|+.++||||+++++++..+  
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~-----~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--  408 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYR-----MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE--  408 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEE-----CSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS--
T ss_pred             ceeEcCcEEecCCCcEEEEEEEe-----cCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC--
Confidence            344444 7999999999999876     2235678999998753     34689999999999999999999998642  


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+.+|+|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|||
T Consensus       409 ---~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFG  481 (613)
T 2ozo_A          409 ---ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFG  481 (613)
T ss_dssp             ---SEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCS
T ss_pred             ---CeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeecc
Confidence               259999999999999999654 34699999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCC-cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          234 LAREGPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       234 ~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      +++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+......   ...+....  
T Consensus       482 la~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~---~~~i~~~~--  556 (613)
T 2ozo_A          482 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MAFIEQGK--  556 (613)
T ss_dssp             TTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH---HHHHHTTC--
T ss_pred             CcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---HHHHHcCC--
Confidence            9986422111 111223346789999999999999999999999999999998 9999987655432   22222110  


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhcc
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  368 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  368 (432)
                                  ....+..++..+.+||.+||..||.+|||+.+|++.|+.+.....
T Consensus       557 ------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~  601 (613)
T 2ozo_A          557 ------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  601 (613)
T ss_dssp             ------------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred             ------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence                        001122345678899999999999999999999999999876544

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5.8e-44  Score=338.98  Aligned_cols=262  Identities=27%  Similarity=0.386  Sum_probs=202.7

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      ..+|.+.+.||+|+||.||+|.+..    .......||+|.+....     ..+.+|+.++++++||||+++++++....
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   99 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLD----NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE   99 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC---------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred             ceehhhcceeeecCCceEEEEEEec----CCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence            3568889999999999999998752    22345679999986532     34789999999999999999999876543


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                      .   ..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       100 ~---~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Df  172 (298)
T 3f66_A          100 G---SPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADF  172 (298)
T ss_dssp             S---CCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSC
T ss_pred             C---ceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcc
Confidence            2   3489999999999999997543 4689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCC--cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcc
Q 014034          233 GLAREGPMVGH--THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       233 G~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      |+++.......  ........||+.|+|||.+.+..++.++||||||+++|+|++ |.+||...........   .....
T Consensus       173 g~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~---~~~~~  249 (298)
T 3f66_A          173 GLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LLQGR  249 (298)
T ss_dssp             GGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH---HHTTC
T ss_pred             cccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH---HhcCC
Confidence            99975322111  112234567889999999999999999999999999999999 5666665443322111   11100


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhc
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  367 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  367 (432)
                      .          .    ..+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus       250 ~----------~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          250 R----------L----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             C----------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             C----------C----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            0          0    001122356889999999999999999999999999987643

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=348.07  Aligned_cols=263  Identities=25%  Similarity=0.394  Sum_probs=196.5

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-----HHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-----QWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|.+++.||+|+||.||+|...       .++..||+|.+.....     .+.+|+.+++.++||||+++++++...+.
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSK-------LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS   74 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSC
T ss_pred             CceEEEEEEcCCCCEEEEEEEEC-------CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCE
Confidence            57999999999999999999875       4678999999875433     24579999999999999999999976543


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                          .++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        75 ----~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  145 (324)
T 3mtl_A           75 ----LTLVFEYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFG  145 (324)
T ss_dssp             ----EEEEEECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSS
T ss_pred             ----EEEEecccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCc
Confidence                499999996 59999887654 4689999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      ++.....  .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......+...
T Consensus       146 ~a~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  223 (324)
T 3mtl_A          146 LARAKSI--PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEE  223 (324)
T ss_dssp             EEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccC--CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChH
Confidence            9975321  1222344578999999999876 578999999999999999999999998876544333322222211111


Q ss_pred             ccccccc--------CccccC----cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          313 KKFGLIM--------DPRLEK----EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       313 ~~~~~~~--------~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .......        .+....    ......+..+.+|+.+||+.||.+|||+.+++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          224 TWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             TSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0000000        000000    0011224568899999999999999999999986

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.8e-45  Score=351.20  Aligned_cols=247  Identities=24%  Similarity=0.342  Sum_probs=177.8

Q ss_pred             ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-HHHHHHHHHhcccC-CCccceeeeEEeecCCcceeEEEE
Q 014034           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQWVAEVQFLGVLE-HPNLVKLIGYCAVDGERGIQRLLV  161 (432)
Q Consensus        84 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~~~lv  161 (432)
                      .+.||+|+||.||+|.+.       .+++.||+|.+.... ..+.+|+.+++.+. ||||+++++++.+..    ..++|
T Consensus        16 ~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~----~~~lv   84 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHK-------KSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQL----HTFLV   84 (325)
T ss_dssp             SCCSEEETTEEEEEEEET-------TTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----EEEEE
T ss_pred             CCccccCCCeEEEEEEEC-------CCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC----EEEEE
Confidence            478999999999999975       467899999997654 45789999999997 999999999997654    45999


Q ss_pred             EeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC---ceeeccccCCcCC
Q 014034          162 YEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF---RPKLSDFGLAREG  238 (432)
Q Consensus       162 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~---~~kl~DfG~a~~~  238 (432)
                      |||+.+|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++   .+||+|||+++..
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~  159 (325)
T 3kn6_A           85 MELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK  159 (325)
T ss_dssp             ECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred             EEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence            9999999999999765  3799999999999999999999998   999999999999997665   8999999999753


Q ss_pred             CCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchh----hHHHHHHHhhcccCccc
Q 014034          239 PMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT----EQRLLEWVQQYPADSKK  314 (432)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~----~~~~~~~~~~~~~~~~~  314 (432)
                      ..  .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....    ...+...+.....    
T Consensus       160 ~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~----  233 (325)
T 3kn6_A          160 PP--DNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF----  233 (325)
T ss_dssp             CC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC----
T ss_pred             CC--CCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC----
Confidence            22  2223345678999999999999999999999999999999999999998654321    1112221111100    


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                             .+........+..+.+||.+||..||.+|||+.+++++
T Consensus       234 -------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          234 -------SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             -------CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             -------CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence                   00000011234678899999999999999999999866

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.2e-44  Score=343.96  Aligned_cols=264  Identities=24%  Similarity=0.327  Sum_probs=197.3

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|++++.||+|+||.||+|...       .++..||+|++....      ..+.+|+.+++.++||||+++++++...
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   74 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNR-------DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK   74 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             cccceEeeEEeecCCeEEEEEEeC-------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC
Confidence            357999999999999999999875       457899999875432      2367899999999999999999999765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ..++||||+.+++|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        75 ~----~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~D  145 (311)
T 4agu_A           75 R----RLHLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCD  145 (311)
T ss_dssp             T----EEEEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             C----eEEEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEee
Confidence            4    359999999999999988654  3689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc-c
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY-P  309 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~-~  309 (432)
                      ||++.....  .........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+................ .
T Consensus       146 fg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  223 (311)
T 4agu_A          146 FGFARLLTG--PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLI  223 (311)
T ss_dssp             CTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             CCCchhccC--cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccc
Confidence            999975321  2222344578999999999976 67899999999999999999999999876654433222211100 0


Q ss_pred             c-------CccccccccCccccCcCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 A-------DSKKFGLIMDPRLEKEYS-----INEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~-------~~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .       ....+.....+......+     ...+..+.+|+.+||+.||.+|||+.+++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          224 PRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             HHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0       000000000000000000     1234568899999999999999999999976

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.2e-44  Score=336.20  Aligned_cols=246  Identities=28%  Similarity=0.433  Sum_probs=200.4

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEe
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCA  149 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~  149 (432)
                      ..++|++.+.||+|+||.||+|...       .++..||+|.+...       ...+.+|+.+++.++||||+++++++.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   79 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREK-------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH   79 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEc-------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe
Confidence            3468999999999999999999875       46788999998543       234788999999999999999999987


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      ..+    ..++||||+++++|.+++....  .+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||
T Consensus        80 ~~~----~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l  150 (279)
T 3fdn_A           80 DAT----RVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKI  150 (279)
T ss_dssp             CSS----EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEE
T ss_pred             cCC----EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEE
Confidence            654    3599999999999999997643  689999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      +|||++....    ........||+.|+|||.+.+..++.++||||||+++|+|++|..||...........   +....
T Consensus       151 ~Dfg~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~  223 (279)
T 3fdn_A          151 ADFGWSVHAP----SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR---ISRVE  223 (279)
T ss_dssp             CSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---HHHTC
T ss_pred             EeccccccCC----cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHH---HHhCC
Confidence            9999986422    1223446799999999999999999999999999999999999999986554332211   11111


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                      .               ..+...+..+.+|+.+||+.||.+|||+.+++++-
T Consensus       224 ~---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          224 F---------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             C---------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred             C---------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence            0               01112235688999999999999999999999873

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.3e-44  Score=369.66  Aligned_cols=251  Identities=27%  Similarity=0.448  Sum_probs=206.6

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEe
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCA  149 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~  149 (432)
                      ..++|...+.||+|+||.||+|.++       .+++.||+|++.+.       ...+.+|+.+|+.++||||+++++++.
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~-------~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~  254 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVR-------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE  254 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEEC-------CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe
Confidence            3467999999999999999999975       46789999998643       234788999999999999999999987


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      ..+    ..++||||++||+|.+++.......+++..++.++.||+.||.|||++   +|+||||||+||||+.+|.+||
T Consensus       255 ~~~----~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL  327 (576)
T 2acx_A          255 TKD----ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRI  327 (576)
T ss_dssp             CSS----EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEE
T ss_pred             eCC----EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEE
Confidence            654    459999999999999999876655699999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchh-hHHHHHHHhhc
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT-EQRLLEWVQQY  308 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~-~~~~~~~~~~~  308 (432)
                      +|||+++.....   ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+..... ...+...+...
T Consensus       328 ~DFGla~~~~~~---~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~  404 (576)
T 2acx_A          328 SDLGLAVHVPEG---QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV  404 (576)
T ss_dssp             CCCTTCEECCTT---CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC
T ss_pred             EecccceecccC---ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc
Confidence            999999863221   22344689999999999999899999999999999999999999998754321 12222222222


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  359 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  359 (432)
                      +.               .++...+..+.+||.+||..||.+||     ++.+|+++
T Consensus       405 ~~---------------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          405 PE---------------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             CC---------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             cc---------------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            11               11122346788999999999999999     78899876

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.4e-45  Score=359.29  Aligned_cols=259  Identities=22%  Similarity=0.288  Sum_probs=205.5

Q ss_pred             CHHHHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccc
Q 014034           70 SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLV  142 (432)
Q Consensus        70 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv  142 (432)
                      ...+.....++|++++.||+|+||.||+|..+       .+++.||+|++++..       ..+.+|..++..++||||+
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~-------~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv  124 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMK-------QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT  124 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBC
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCee
Confidence            34455566789999999999999999999975       467899999987532       1278899999999999999


Q ss_pred             eeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc
Q 014034          143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD  222 (432)
Q Consensus       143 ~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~  222 (432)
                      ++++++.+.+    ..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.   +|+||||||+|||++
T Consensus       125 ~l~~~~~~~~----~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld  196 (412)
T 2vd5_A          125 QLHFAFQDEN----YLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLD  196 (412)
T ss_dssp             CEEEEEECSS----EEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred             eEEEEEeeCC----EEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeec
Confidence            9999987654    4599999999999999997542 3689999999999999999999998   999999999999999


Q ss_pred             CCCceeeccccCCcCCCCCCCcccccccccCCCccCccccc-------cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCc
Q 014034          223 ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE-------TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP  295 (432)
Q Consensus       223 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlGvil~elltg~~pf~~~~~  295 (432)
                      .++.+||+|||+++...... .......+||+.|+|||++.       +..++.++|||||||++|||++|..||.+...
T Consensus       197 ~~g~vkL~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~  275 (412)
T 2vd5_A          197 RCGHIRLADFGSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST  275 (412)
T ss_dssp             TTSCEEECCCTTCEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             CCCCEEEeechhheeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH
Confidence            99999999999997642221 12233468999999999997       35789999999999999999999999987654


Q ss_pred             hhhHH-HHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCC---CCHHHHHHH
Q 014034          296 KTEQR-LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDR---PKMSQVVER  359 (432)
Q Consensus       296 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~eil~~  359 (432)
                      ..... +..+.....          .+.+    ....+..+.+||.+||. +|.+|   |++.+|+++
T Consensus       276 ~~~~~~i~~~~~~~~----------~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          276 AETYGKIVHYKEHLS----------LPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HHHHHHHHTHHHHCC----------CC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             HHHHHHHHhcccCcC----------CCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            33211 111111110          0101    11224678899999999 99998   589999877

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.2e-44  Score=352.98  Aligned_cols=245  Identities=21%  Similarity=0.293  Sum_probs=192.6

Q ss_pred             cccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCccceeeeEEeecCCcceeE
Q 014034           83 RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQR  158 (432)
Q Consensus        83 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~  158 (432)
                      ..+.||+|+||.||+|...       .++..||+|.+....    ..+.+|+.+++.++||||+++++++...+    ..
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~-------~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~  161 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEET-------ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN----DI  161 (373)
T ss_dssp             EEEECC-----CEEEEEET-------TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS----EE
T ss_pred             cceEEecCcCEEEEEEEEc-------CCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC----EE
Confidence            3567999999999999865       467899999987542    34889999999999999999999997654    45


Q ss_pred             EEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEE--cCCCceeeccccCCc
Q 014034          159 LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL--DENFRPKLSDFGLAR  236 (432)
Q Consensus       159 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill--~~~~~~kl~DfG~a~  236 (432)
                      ++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||+  +.++.+||+|||+++
T Consensus       162 ~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~  237 (373)
T 2x4f_A          162 VLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLAR  237 (373)
T ss_dssp             EEEEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCE
T ss_pred             EEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCce
Confidence            99999999999999987543 3689999999999999999999998   99999999999999  677899999999998


Q ss_pred             CCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  316 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (432)
                      ....   ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......  ..........     
T Consensus       238 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~i~~~~~~~-----  307 (373)
T 2x4f_A          238 RYKP---REKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL--NNILACRWDL-----  307 (373)
T ss_dssp             ECCT---TCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HHHHHTCCCS-----
T ss_pred             ecCC---ccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhccCCC-----
Confidence            6322   12233457999999999999999999999999999999999999999876543221  1111111000     


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       317 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                         ..    ......+..+.+||.+||+.||.+|||+.+++++
T Consensus       308 ---~~----~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          308 ---ED----EEFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             ---CS----GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---Ch----hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               00    0011224678899999999999999999999986

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=349.81  Aligned_cols=250  Identities=24%  Similarity=0.388  Sum_probs=192.1

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCC--CccceeeeEEe
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEH--PNLVKLIGYCA  149 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h--pniv~l~~~~~  149 (432)
                      .++|++++.||+|+||.||+|...        ++..||||++....      ..+.+|+.+|..++|  |||+++++++.
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~   79 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE--------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI   79 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT--------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC--------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe
Confidence            356999999999999999999753        46789999885421      347889999999976  99999999987


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      ...    ..++|||+ .+++|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||++ ++.+||
T Consensus        80 ~~~----~~~lv~e~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl  148 (343)
T 3dbq_A           80 TDQ----YIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKL  148 (343)
T ss_dssp             CSS----EEEEEECC-CSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEE
T ss_pred             eCC----EEEEEEeC-CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEE
Confidence            654    45999995 5889999997653  789999999999999999999998   999999999999997 678999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCcccccc-----------CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhh
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-----------GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE  298 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~  298 (432)
                      +|||+++...............||+.|+|||++.+           ..++.++|||||||++|+|++|..||........
T Consensus       149 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  228 (343)
T 3dbq_A          149 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS  228 (343)
T ss_dssp             CCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH
T ss_pred             eecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH
Confidence            99999986433222223345679999999999865           6789999999999999999999999976433211


Q ss_pred             HHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          299 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                       .+...+              ++......+...+..+.+|+.+||+.||.+|||+.+++++..
T Consensus       229 -~~~~~~--------------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~  276 (343)
T 3dbq_A          229 -KLHAII--------------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY  276 (343)
T ss_dssp             -HHHHHH--------------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             -HHHHHh--------------cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence             111111              111111112222356889999999999999999999998843

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.3e-44  Score=347.10  Aligned_cols=263  Identities=22%  Similarity=0.313  Sum_probs=193.9

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH------HHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|++++.||+|+||.||+|...       .+++.||+|++.....      .+.+|+.+++.++||||+++++++...
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDT-------VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN  105 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET-------TTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred             hhhEEEEEEEEecCCeEEEEEEEC-------CCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence            457999999999999999999865       5688999999864322      367899999999999999999999865


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEE-----cCCCc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL-----DENFR  226 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill-----~~~~~  226 (432)
                      .    ..++||||+. ++|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||+     +.++.
T Consensus       106 ~----~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~  175 (329)
T 3gbz_A          106 H----RLHLIFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPV  175 (329)
T ss_dssp             T----EEEEEEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCE
T ss_pred             C----EEEEEEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccce
Confidence            5    3599999997 59999997654  689999999999999999999998   99999999999999     45556


Q ss_pred             eeeccccCCcCCCCCCCcccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 014034          227 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  305 (432)
Q Consensus       227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  305 (432)
                      +||+|||++.....  .........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.............
T Consensus       176 ~kl~Dfg~a~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  253 (329)
T 3gbz_A          176 LKIGDFGLARAFGI--PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEV  253 (329)
T ss_dssp             EEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             EEECcCCCccccCC--cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHH
Confidence            99999999975211  12223445789999999999874 5899999999999999999999999876544332222111


Q ss_pred             hhcccCccccc------------cccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          306 QQYPADSKKFG------------LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       306 ~~~~~~~~~~~------------~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ...+.......            ......+........+..+.+|+.+||+.||.+|||+.+++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          254 LGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             HCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            11111110000            0000000000111134678899999999999999999999875

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-43  Score=336.32  Aligned_cols=261  Identities=26%  Similarity=0.347  Sum_probs=204.6

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      .|...+.||+|+||.||+|.+..    ....+..||+|.+....     ..+.+|+.+++.++||||+++++++...+. 
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-   96 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYID----QAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG-   96 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEEC----SSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS-
T ss_pred             EEccCceeccCCCceEEEEEEec----CCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC-
Confidence            46667899999999999998752    22456689999987532     347899999999999999999999875443 


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        ..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        97 --~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~  170 (298)
T 3pls_A           97 --LPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGL  170 (298)
T ss_dssp             --CCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred             --CcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCC
Confidence              2389999999999999997643 4689999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCC--CcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCC-CCCCCchhhHHHHHHHhhcccC
Q 014034          235 AREGPMVG--HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRS-LERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       235 a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p-f~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ++......  .........+|+.|+|||.+.+..++.++||||||+++|+|++|..| |.........   ..+..... 
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~---~~~~~~~~-  246 (298)
T 3pls_A          171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT---HFLAQGRR-  246 (298)
T ss_dssp             SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHH---HHHHTTCC-
T ss_pred             cccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHH---HHhhcCCC-
Confidence            97532211  11122345678899999999999999999999999999999995555 4444332222   21111110 


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhcc
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  368 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  368 (432)
                               .    ..+...+..+.+|+.+||+.||.+|||+.++++.|+.++....
T Consensus       247 ---------~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          247 ---------L----PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             ---------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             ---------C----CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence                     0    0111224578899999999999999999999999999987543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.1e-44  Score=348.76  Aligned_cols=276  Identities=25%  Similarity=0.346  Sum_probs=209.3

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH----HHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL----QWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      ++|++.+.||+|+||.||+|.+..   .+...+..||+|++.....    .+.+|+.+++.++||||+++++++...+. 
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-   98 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDP---LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR-   98 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECT---TSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS-
T ss_pred             hhhhhhhhccCCCCeEEEEEEecc---CCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC-
Confidence            579999999999999999998642   2335789999999876533    37899999999999999999999875443 


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                       ...++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        99 -~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~  173 (327)
T 3lxl_A           99 -QSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGL  173 (327)
T ss_dssp             -CEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred             -ceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccc
Confidence             24689999999999999997533 3589999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCc-ccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC--
Q 014034          235 AREGPMVGHT-HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD--  311 (432)
Q Consensus       235 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--  311 (432)
                      +......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||........    .........  
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~----~~~~~~~~~~~  249 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL----RMMGCERDVPA  249 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH----HHCC----CCH
T ss_pred             ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhh----hhccccccccc
Confidence            9864322221 223345688899999999999999999999999999999999999875322110    000000000  


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhc
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  367 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  367 (432)
                      .......+........+...+..+.+|+.+||+.||.+|||+.+++++|+.+....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          250 LSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             HHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            00000001111111223334567889999999999999999999999999886543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.4e-44  Score=344.64  Aligned_cols=256  Identities=30%  Similarity=0.452  Sum_probs=205.0

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccE--EEEEEecCcC-----hHHHHHHHHHhccc-CCCccceeeeEEee
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRD-----GLQWVAEVQFLGVL-EHPNLVKLIGYCAV  150 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~--~vaiK~~~~~-----~~~~~~E~~~l~~l-~hpniv~l~~~~~~  150 (432)
                      ++|.+.+.||+|+||.||+|.+.       .++.  .||+|.+...     ...+.+|+.+++.+ +||||+++++++..
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~   97 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   97 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEE-------ETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEc-------cCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee
Confidence            47999999999999999999876       2344  4599987642     23488999999999 89999999999976


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCC
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKA  216 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp  216 (432)
                      .+    ..++||||+++++|.+++....              ...+++..++.++.||+.||.|||+.   +|+||||||
T Consensus        98 ~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp  170 (327)
T 1fvr_A           98 RG----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAA  170 (327)
T ss_dssp             TT----EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred             CC----ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCcc
Confidence            54    3599999999999999997643              24689999999999999999999998   999999999


Q ss_pred             CceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCc
Q 014034          217 SNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP  295 (432)
Q Consensus       217 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~  295 (432)
                      +|||++.++.+||+|||+++...   .........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus       171 ~NIl~~~~~~~kL~Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~  247 (327)
T 1fvr_A          171 RNILVGENYVAKIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC  247 (327)
T ss_dssp             GGEEECGGGCEEECCTTCEESSC---EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             ceEEEcCCCeEEEcccCcCcccc---ccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH
Confidence            99999999999999999987421   1222234457889999999998889999999999999999998 9999987654


Q ss_pred             hhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhcc
Q 014034          296 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  368 (432)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  368 (432)
                      ..   +...+....          ..    ..+...+..+.+|+.+||..||.+|||+.+++++|+.++....
T Consensus       248 ~~---~~~~~~~~~----------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          248 AE---LYEKLPQGY----------RL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             HH---HHHHGGGTC----------CC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             HH---HHHHhhcCC----------CC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence            32   222111100          00    1122234678899999999999999999999999999987544

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.1e-44  Score=358.99  Aligned_cols=245  Identities=25%  Similarity=0.347  Sum_probs=202.2

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .++|.+.+.||+|+||.||+|.+.       .+++.||||++....       ..+.+|+.+++.++||||+++++++..
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~-------~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~   87 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHE-------LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST   87 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEET-------TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            368999999999999999999875       467899999986532       347899999999999999999999876


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .+    ..++||||+.+|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        88 ~~----~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~  158 (476)
T 2y94_A           88 PS----DIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIA  158 (476)
T ss_dssp             SS----EEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred             CC----EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEE
Confidence            54    459999999999999999654  4699999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      |||++.....   .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+......   ...+....
T Consensus       159 DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~---~~~i~~~~  232 (476)
T 2y94_A          159 DFGLSNMMSD---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL---FKKICDGI  232 (476)
T ss_dssp             CCSSCEECCT---TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH---HHHHHTTC
T ss_pred             eccchhhccc---cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH---HHHHhcCC
Confidence            9999986322   222345679999999999988765 6899999999999999999999986544322   11111110


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .               ..+...+..+.+||.+||..||.+|||+.+|+++
T Consensus       233 ~---------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          233 F---------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             C---------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             c---------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence            0               0011123568899999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.6e-44  Score=339.42  Aligned_cols=252  Identities=29%  Similarity=0.430  Sum_probs=200.4

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh--HHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      .++|.+.+.||+|+||.||+|.+         .+..||+|.+....  ..+.+|+.+++.++||||+++++++.....  
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--   88 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY---------RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG--   88 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE---------TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC----
T ss_pred             hhhceEEeEEecCCCceEEEEEE---------cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC--
Confidence            35799999999999999999975         36789999987643  458899999999999999999998765432  


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCC
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  235 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a  235 (432)
                       ..++||||+.+++|.+++.......+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        89 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~  164 (278)
T 1byg_A           89 -GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT  164 (278)
T ss_dssp             -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             -ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccc
Confidence             348999999999999999765433488999999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      .....     ......+++.|+|||++.+..++.++||||||+++|+|++ |..||........   ...+....     
T Consensus       165 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~~~~~~-----  231 (278)
T 1byg_A          165 KEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVEKGY-----  231 (278)
T ss_dssp             ----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHHHTTTC-----
T ss_pred             ccccc-----cccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHhcCC-----
Confidence            75321     1223467889999999999999999999999999999998 9999986544322   11111100     


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                           ..    ..+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       232 -----~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          232 -----KM----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             -----CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----CC----CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence                 01    11222346788999999999999999999999999988653

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-44  Score=350.10  Aligned_cols=258  Identities=24%  Similarity=0.261  Sum_probs=197.9

Q ss_pred             HHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh---------HHHHHHHHHhcccCCCcccee
Q 014034           74 MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---------LQWVAEVQFLGVLEHPNLVKL  144 (432)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~hpniv~l  144 (432)
                      +....++|.+.+.||+|+||.||+|...       .++..||+|.+....         ..+.+|+.+++.++||||+++
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~   93 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIEN-------QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL   93 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEEC-------CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCccee
Confidence            3455678999999999999999999865       567899999885432         348889999999999999999


Q ss_pred             eeEEeecCCcceeEEEEEeecCCCCHHHHhhcCC--------------------------------------CCCCCHHH
Q 014034          145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA--------------------------------------FPPLPWKT  186 (432)
Q Consensus       145 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------~~~l~~~~  186 (432)
                      ++++...+    ..++||||+++|+|.+++....                                      ...+++..
T Consensus        94 ~~~~~~~~----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (345)
T 3hko_A           94 YEVYEDEQ----YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKL  169 (345)
T ss_dssp             EEEEECSS----EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHH
T ss_pred             ehhhccCC----eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHH
Confidence            99997654    4599999999999999985210                                      11235677


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC--ceeeccccCCcCCCCC--CCcccccccccCCCccCcccc
Q 014034          187 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF--RPKLSDFGLAREGPMV--GHTHVSTAVVGTFGYAAPDYI  262 (432)
Q Consensus       187 ~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~--~~kl~DfG~a~~~~~~--~~~~~~~~~~gt~~y~aPE~~  262 (432)
                      ++.++.||+.||.|||+.   +|+||||||+|||++.++  .+||+|||++......  ..........||+.|+|||++
T Consensus       170 ~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  246 (345)
T 3hko_A          170 ISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL  246 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhh
Confidence            889999999999999998   999999999999998776  8999999999743211  111123456799999999999


Q ss_pred             cc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHH
Q 014034          263 ET--GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLAD  340 (432)
Q Consensus       263 ~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~  340 (432)
                      .+  ..++.++|||||||++|+|++|..||.+.......  ..........            ........+..+.+||.
T Consensus       247 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~------------~~~~~~~~~~~~~~li~  312 (345)
T 3hko_A          247 NTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTI--SQVLNKKLCF------------ENPNYNVLSPLARDLLS  312 (345)
T ss_dssp             TCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHCCCCT------------TSGGGGGSCHHHHHHHH
T ss_pred             ccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHH--HHHHhccccc------------CCcccccCCHHHHHHHH
Confidence            65  67899999999999999999999999876543321  1111111000            00001112457889999


Q ss_pred             HhccCCCCCCCCHHHHHHH
Q 014034          341 NCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       341 ~cl~~dP~~RPs~~eil~~  359 (432)
                      +||+.||.+|||+.+++++
T Consensus       313 ~~l~~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          313 NLLNRNVDERFDAMRALQH  331 (345)
T ss_dssp             HHSCSCTTTSCCHHHHHHS
T ss_pred             HHcCCChhHCCCHHHHhcC
Confidence            9999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.9e-44  Score=340.49  Aligned_cols=260  Identities=25%  Similarity=0.378  Sum_probs=196.4

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .++|.+.+.||+|+||.||+|...       .++..||+|.+...       ...+.+|+.+++.++||||+++++++..
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~  103 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACL-------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE  103 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEET-------TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEc-------CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence            357999999999999999999865       46789999988641       2247889999999999999999999987


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCcee
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  228 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k  228 (432)
                      .+    ..++||||+.+++|.+++..  .....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus       104 ~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~k  176 (310)
T 2wqm_A          104 DN----ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVK  176 (310)
T ss_dssp             TT----EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred             CC----cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEE
Confidence            55    35999999999999999864  2234689999999999999999999998   999999999999999999999


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      |+|||++.....  .........||+.|+|||++.+..++.++||||||+++|+|++|..||.+...... .+...+...
T Consensus       177 l~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~  253 (310)
T 2wqm_A          177 LGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCKKIEQC  253 (310)
T ss_dssp             ECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HHHHHHHTT
T ss_pred             EEeccceeeecC--CCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HHHHHhhcc
Confidence            999999875321  12222345789999999999999999999999999999999999999976433221 122222111


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhc
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  367 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  367 (432)
                      ..         .+    ......+..+.+|+.+||..||.+|||+.+|++.|+.+....
T Consensus       254 ~~---------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          254 DY---------PP----LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             CS---------CC----CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cC---------CC----CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence            10         00    001122457889999999999999999999999999987543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.4e-43  Score=342.87  Aligned_cols=269  Identities=23%  Similarity=0.344  Sum_probs=209.5

Q ss_pred             HHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-HHHHHHHHhcc--cCCCccceeeeEEeec
Q 014034           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QWVAEVQFLGV--LEHPNLVKLIGYCAVD  151 (432)
Q Consensus        75 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~--l~hpniv~l~~~~~~~  151 (432)
                      ....++|.+.+.||+|+||.||+|.+         +++.||+|.+..... .+.+|.+++..  ++||||+++++++...
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW---------RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE---------TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE---------cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            34556899999999999999999985         378999999976543 47788888876  7999999999999876


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCceeecCCCCCceEEcC
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH--------EGLEVQVIYRDFKASNVLLDE  223 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH--------~~~~~~ivH~Dikp~Nill~~  223 (432)
                      .......++||||+.+|+|.+++...   .+++..++.++.|++.||.|||        +.   +|+||||||+|||++.
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~  182 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKK  182 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECT
T ss_pred             CCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECC
Confidence            54434579999999999999999753   5899999999999999999999        66   9999999999999999


Q ss_pred             CCceeeccccCCcCCCCCCCc--ccccccccCCCccCccccccCC------CCchhhhHHHHHHHHHHHhC---------
Q 014034          224 NFRPKLSDFGLAREGPMVGHT--HVSTAVVGTFGYAAPDYIETGH------LTAKSDVWSFGVVLYEMLTG---------  286 (432)
Q Consensus       224 ~~~~kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltg---------  286 (432)
                      ++.+||+|||++.........  .......||+.|+|||++.+..      ++.++|||||||++|+|+||         
T Consensus       183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~  262 (342)
T 1b6c_B          183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED  262 (342)
T ss_dssp             TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence            999999999999753222111  1224457999999999997652      33689999999999999999         


Q ss_pred             -CCCCCCCCchh--hHHHHHHHhhcccCccccccccCccccCc-CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 014034          287 -RRSLERNRPKT--EQRLLEWVQQYPADSKKFGLIMDPRLEKE-YSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  362 (432)
Q Consensus       287 -~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  362 (432)
                       ..||.......  ...+...+...         ...+.+... .....+..+.+|+.+||+.||.+|||+.+|+++|+.
T Consensus       263 ~~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~  333 (342)
T 1b6c_B          263 YQLPYYDLVPSDPSVEEMRKVVCEQ---------KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  333 (342)
T ss_dssp             CCCTTTTTSCSSCCHHHHHHHHTTS---------CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             cccCccccCcCcccHHHHHHHHHHH---------HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence             77886543321  11111111110         011111111 234667789999999999999999999999999999


Q ss_pred             Hhhhc
Q 014034          363 IVQVS  367 (432)
Q Consensus       363 ~~~~~  367 (432)
                      +.+..
T Consensus       334 i~~~~  338 (342)
T 1b6c_B          334 LSQQE  338 (342)
T ss_dssp             HHHTT
T ss_pred             HHHHh
Confidence            87643

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=7.4e-44  Score=337.68  Aligned_cols=267  Identities=21%  Similarity=0.262  Sum_probs=209.1

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC--hHHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      .++|.+.+.||+|+||.||+|...       .+++.||+|.+...  ...+.+|+.+++.++|++++..+.++...+.  
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~--   78 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDI-------AAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGD--   78 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEET-------TTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETT--
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEc-------CCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCC--
Confidence            468999999999999999999865       46789999987543  3468899999999999998888777655432  


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEE---cCCCceeeccc
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDF  232 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill---~~~~~~kl~Df  232 (432)
                       ..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||++   +|+||||||+|||+   +.++.+||+||
T Consensus        79 -~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df  152 (296)
T 3uzp_A           79 -YNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDF  152 (296)
T ss_dssp             -EEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred             -ceEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence             468999999 999999997443 4699999999999999999999998   99999999999999   48899999999


Q ss_pred             cCCcCCCCCCCc-----ccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 014034          233 GLAREGPMVGHT-----HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  307 (432)
Q Consensus       233 G~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  307 (432)
                      |++.........     .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+............+..
T Consensus       153 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  232 (296)
T 3uzp_A          153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE  232 (296)
T ss_dssp             TTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred             CCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc
Confidence            999753222111     112456799999999999999999999999999999999999999987543322211111111


Q ss_pred             cccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhccC
Q 014034          308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNE  369 (432)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~  369 (432)
                      ..... .     .+.+    ....+..+.+|+.+||+.||.+|||+.+|++.|+.+....+.
T Consensus       233 ~~~~~-~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  284 (296)
T 3uzp_A          233 KKMST-P-----IEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             HHHHS-C-----HHHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             cccCC-c-----hHHH----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence            00000 0     0000    011235788999999999999999999999999999876543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-43  Score=357.04  Aligned_cols=268  Identities=23%  Similarity=0.309  Sum_probs=186.0

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|.+++.||+|+||.||+|.+.       .+++.||||++...      ...+.+|+.+|+.++||||+++++++...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  124 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDK-------LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPK  124 (458)
T ss_dssp             CTTEEECCC-------CEEEEEEC-------C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             CCCeEEeeEeeecCCeEEEEEEEC-------CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecC
Confidence            468999999999999999999865       46789999998652      23478999999999999999999998654


Q ss_pred             C-CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          152 G-ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       152 ~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      . ......++||||+ +++|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+||||+.++.+||+
T Consensus       125 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~  198 (458)
T 3rp9_A          125 DVEKFDELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVC  198 (458)
T ss_dssp             CTTTCCCEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEEC
T ss_pred             CcccCceEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeec
Confidence            3 2234579999998 67999998654  3699999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCc-------------------------ccccccccCCCccCcccc-ccCCCCchhhhHHHHHHHHHHH
Q 014034          231 DFGLAREGPMVGHT-------------------------HVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEML  284 (432)
Q Consensus       231 DfG~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~ell  284 (432)
                      |||+++........                         ......+||+.|+|||++ .+..++.++|||||||++|||+
T Consensus       199 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ell  278 (458)
T 3rp9_A          199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL  278 (458)
T ss_dssp             CCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             ccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHH
Confidence            99999864221110                         123446789999999976 5667999999999999999999


Q ss_pred             h-----------CCCCCCCCCchh-----------------hHHHHHHHh---hcccCc----------ccccccc----
Q 014034          285 T-----------GRRSLERNRPKT-----------------EQRLLEWVQ---QYPADS----------KKFGLIM----  319 (432)
Q Consensus       285 t-----------g~~pf~~~~~~~-----------------~~~~~~~~~---~~~~~~----------~~~~~~~----  319 (432)
                      +           |.++|.+.....                 ....+..+.   ..+...          ..+....    
T Consensus       279 tg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~  358 (458)
T 3rp9_A          279 NMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKRE  358 (458)
T ss_dssp             TTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCC
T ss_pred             HhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCC
Confidence            9           667775543210                 000000000   000000          0000000    


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          320 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       320 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ...+... ....+..+.+|+.+||..||.+|||+.|++++
T Consensus       359 ~~~~~~~-~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          359 GTDLAER-FPASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             CCCGGGG-STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCHHHH-CCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            0000001 11224678899999999999999999999987

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=9.6e-45  Score=346.93  Aligned_cols=242  Identities=23%  Similarity=0.290  Sum_probs=188.8

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhccc-CCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVL-EHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l-~hpniv~l~~~~~~~  151 (432)
                      ++|+..+.||+|+||+||+|.+.       .+++.||||++....      .....|+..+..+ +||||+++++++...
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~  129 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSK-------EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG  129 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEET-------TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             hheeeeheeccCCCeEEEEEEEC-------CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence            57999999999999999999875       467899999875421      1244555555544 899999999999765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus       130 ~----~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~D  200 (311)
T 3p1a_A          130 G----ILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGD  200 (311)
T ss_dssp             T----EEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECC
T ss_pred             C----EEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEcc
Confidence            4    359999999 779999887653 4699999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ||++....   .........||+.|+|||++.+ .++.++|||||||++|||++|..|+.+...     .......    
T Consensus       201 FG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----~~~~~~~----  267 (311)
T 3p1a_A          201 FGLLVELG---TAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----WQQLRQG----  267 (311)
T ss_dssp             CTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----HHHHTTT----
T ss_pred             ceeeeecc---cCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHhcc----
Confidence            99987532   2223344569999999999876 789999999999999999999777653211     1111000    


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                            ...+.+    +...+..+.+|+.+||+.||.+|||+.+++++
T Consensus       268 ------~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          268 ------YLPPEF----TAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             ------CCCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ------CCCccc----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence                  001111    11224678899999999999999999999875

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.1e-44  Score=358.71  Aligned_cols=265  Identities=25%  Similarity=0.320  Sum_probs=200.4

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHHHHHHHhcccCCCccceeeeEEeecCC--cce
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE--RGI  156 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--~~~  156 (432)
                      .+|...+.||+|+||.||+|.+.       .++..||||++..+.....+|+++|+.++||||+++++++...+.  ...
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLC-------DSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEEC-------CCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            46999999999999999999975       457899999997766556789999999999999999999875432  234


Q ss_pred             eEEEEEeecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCC-Cceeecccc
Q 014034          157 QRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFG  233 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~DfG  233 (432)
                      ..++||||+.+ +|.+.+..  .....+++..+..++.||+.||.|||+.   +|+||||||+||||+.+ +.+||+|||
T Consensus       127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccch
Confidence            46799999975 66666542  2335799999999999999999999998   99999999999999955 678999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      +++.....   .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.......  ...+.......
T Consensus       203 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l--~~i~~~lg~p~  277 (420)
T 1j1b_A          203 SAKQLVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL--VEIIKVLGTPT  277 (420)
T ss_dssp             TCEECCTT---CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCSCC
T ss_pred             hhhhcccC---CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCC
Confidence            99853221   123346789999999999764 7899999999999999999999999876543322  22111110000


Q ss_pred             --------cccccccCccc-----cCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          313 --------KKFGLIMDPRL-----EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       313 --------~~~~~~~~~~l-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                              ..+.....+.+     ...++...+..+.+||.+||..||.+|||+.+++++
T Consensus       278 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          278 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence                    00000000111     001122334678899999999999999999999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.2e-44  Score=345.81  Aligned_cols=279  Identities=22%  Similarity=0.354  Sum_probs=200.4

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-HHHHHHHH--hcccCCCccceeeeEEeecC-C
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QWVAEVQF--LGVLEHPNLVKLIGYCAVDG-E  153 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~--l~~l~hpniv~l~~~~~~~~-~  153 (432)
                      .++|++.+.||+|+||.||+|++         ++..||||++..... .+..|.++  +..++||||+++++.+.... .
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~   82 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL---------DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD   82 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE---------TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred             hHHhheeeecccCCCeEEEEEEE---------CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence            46899999999999999999975         468999999875443 34455555  45689999999998765432 2


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC------CCceeecCCCCCceEEcCCCce
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL------EVQVIYRDFKASNVLLDENFRP  227 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~------~~~ivH~Dikp~Nill~~~~~~  227 (432)
                      .....++||||+++|+|.+++...   ..++..++.++.||+.||.|||+..      ..+|+||||||+|||++.++.+
T Consensus        83 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  159 (336)
T 3g2f_A           83 GRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC  159 (336)
T ss_dssp             SCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred             CCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence            233568999999999999999764   3589999999999999999999852      2289999999999999999999


Q ss_pred             eeccccCCcCCCCCC------CcccccccccCCCccCcccccc-------CCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Q 014034          228 KLSDFGLAREGPMVG------HTHVSTAVVGTFGYAAPDYIET-------GHLTAKSDVWSFGVVLYEMLTGRRSLERNR  294 (432)
Q Consensus       228 kl~DfG~a~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~elltg~~pf~~~~  294 (432)
                      ||+|||+++......      .........||+.|+|||++.+       ..++.++|||||||++|||++|..||....
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  239 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE  239 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence            999999997532211      1122234579999999999976       356678999999999999999987764332


Q ss_pred             chhhH--HHHHHHhhcccCccc----cccccCccccCc--CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          295 PKTEQ--RLLEWVQQYPADSKK----FGLIMDPRLEKE--YSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       295 ~~~~~--~~~~~~~~~~~~~~~----~~~~~~~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                      .....  .........+.....    ......+.+...  .....+..+.+||.+||+.||.+|||+.++++.|+.++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence            21100  000000000000000    000001111111  1234667899999999999999999999999999999865


Q ss_pred             cc
Q 014034          367 SN  368 (432)
Q Consensus       367 ~~  368 (432)
                      ..
T Consensus       320 ~~  321 (336)
T 3g2f_A          320 WE  321 (336)
T ss_dssp             CC
T ss_pred             HH
Confidence            44

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.7e-44  Score=351.89  Aligned_cols=242  Identities=27%  Similarity=0.395  Sum_probs=191.1

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHH-hcccCCCccceeeeEEe
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQF-LGVLEHPNLVKLIGYCA  149 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~-l~~l~hpniv~l~~~~~  149 (432)
                      .++|++++.||+|+||.||+|+.+       .++..||+|++.+..       ..+..|..+ ++.++||||+++++++.
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~  109 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHK-------AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ  109 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEET-------TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEc-------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE
Confidence            357999999999999999999976       467899999986532       235566666 57789999999999987


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      ..+    ..++||||+.||+|.+++....  .+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||
T Consensus       110 ~~~----~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL  180 (373)
T 2r5t_A          110 TAD----KLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVL  180 (373)
T ss_dssp             CSS----EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEE
T ss_pred             eCC----EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEE
Confidence            654    4599999999999999997643  689999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      +|||+++....  ........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.....   +...+....
T Consensus       181 ~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~~i~~~~  255 (373)
T 2r5t_A          181 TDFGLCKENIE--HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNILNKP  255 (373)
T ss_dssp             CCCCBCGGGBC--CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH---HHHHHHHSC
T ss_pred             eeCcccccccc--CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHhcc
Confidence            99999975211  1223445789999999999999999999999999999999999999998654332   222121111


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ  355 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  355 (432)
                      .           .+    +...+..+.+||.+||+.||.+||++.+
T Consensus       256 ~-----------~~----~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          256 L-----------QL----KPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             C-----------CC----CSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             c-----------CC----CCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence            0           01    1122356889999999999999999853

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.2e-44  Score=340.51  Aligned_cols=258  Identities=21%  Similarity=0.304  Sum_probs=198.1

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .++|.+.+.||+|+||.||+|...       .+++.||+|.+....       ..+.+|+.+++.++||||+++++++..
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~  105 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDT-------VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI  105 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEET-------TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEc-------CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee
Confidence            468999999999999999999865       467899999986532       347889999999999999999999977


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      ++    ..++||||+.+++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus       106 ~~----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~  176 (309)
T 2h34_A          106 DG----QLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLV  176 (309)
T ss_dssp             TT----EEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred             CC----eEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEe
Confidence            54    3599999999999999997643  689999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      |||++...... .........||+.|+|||++.+..++.++||||||+++|+|++|..||.+....   .+...+.....
T Consensus       177 Dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~  252 (309)
T 2h34_A          177 DFGIASATTDE-KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMGAHINQAIP  252 (309)
T ss_dssp             SCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHHHHHHSCCC
T ss_pred             cCccCcccccc-ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHHHHhccCCC
Confidence            99998753221 112233457999999999999999999999999999999999999999865432   12121111111


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHhhhc
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-KMSQVVERLKQIVQVS  367 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~~~~~~  367 (432)
                      ..        .    ..+...+..+.+|+.+||+.||.+|| |+.++++.|+.++...
T Consensus       253 ~~--------~----~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          253 RP--------S----TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             CG--------G----GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             Cc--------c----ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            00        0    11122235688999999999999999 9999999999886543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=348.95  Aligned_cols=240  Identities=22%  Similarity=0.329  Sum_probs=198.4

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------------HHHHHHHHHhcccCCCcccee
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------------LQWVAEVQFLGVLEHPNLVKL  144 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~hpniv~l  144 (432)
                      ..++|.+.+.||+|+||.||+|...       .++..||||.+....            ..+.+|+.+++.++||||+++
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~   94 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDK-------EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKV   94 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEET-------TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCE
T ss_pred             cccceEEEeEEEecCCEEEEEEEEC-------CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeE
Confidence            4568999999999999999999865       568999999986532            136789999999999999999


Q ss_pred             eeEEeecCCcceeEEEEEeecCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC
Q 014034          145 IGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  223 (432)
Q Consensus       145 ~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~  223 (432)
                      ++++...+    ..++||||+.+| +|.+++....  .+++..++.++.||+.||.|||+.   +|+||||||+|||++.
T Consensus        95 ~~~~~~~~----~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~  165 (335)
T 3dls_A           95 LDIFENQG----FFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAE  165 (335)
T ss_dssp             EEEEECSS----EEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT
T ss_pred             EEEEeeCC----EEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcC
Confidence            99997654    458999999776 9999997543  699999999999999999999998   9999999999999999


Q ss_pred             CCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014034          224 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  302 (432)
Q Consensus       224 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  302 (432)
                      ++.+||+|||++.....   ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......     
T Consensus       166 ~~~~kL~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----  237 (335)
T 3dls_A          166 DFTIKLIDFGSAAYLER---GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-----  237 (335)
T ss_dssp             TSCEEECCCTTCEECCT---TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-----
T ss_pred             CCcEEEeecccceECCC---CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-----
Confidence            99999999999975322   222334679999999999988776 789999999999999999999997522110     


Q ss_pred             HHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          303 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                       .....  .+...+..+.+|+.+||+.||.+|||+.+++++
T Consensus       238 -----------------~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          238 -----------------EAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -----------------TTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -----------------hhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                             00000  011124568899999999999999999999987

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.1e-44  Score=348.38  Aligned_cols=268  Identities=19%  Similarity=0.180  Sum_probs=199.6

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH---------------HHHHHHHHhcccCCCccce
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---------------QWVAEVQFLGVLEHPNLVK  143 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---------------~~~~E~~~l~~l~hpniv~  143 (432)
                      ++|.+.+.||+|+||.||+|.....    ...+..||+|.+.....               .+.+|+.++..++||||++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~  112 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNK----PEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL  112 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSS----CGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCC----CCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence            5799999999999999999997621    23678899999865432               2556778888899999999


Q ss_pred             eeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC
Q 014034          144 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  223 (432)
Q Consensus       144 l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~  223 (432)
                      +++++..........++||||+ +++|.+++....  .+++..++.++.||+.||.|||+.   +|+||||||+|||++.
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~  186 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGY  186 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEES
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEcc
Confidence            9999987544455679999999 999999997654  799999999999999999999998   9999999999999988


Q ss_pred             CC--ceeeccccCCcCCCCCC-----CcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCch
Q 014034          224 NF--RPKLSDFGLAREGPMVG-----HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK  296 (432)
Q Consensus       224 ~~--~~kl~DfG~a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~  296 (432)
                      ++  .+||+|||+++......     .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+....
T Consensus       187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~  266 (345)
T 2v62_A          187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD  266 (345)
T ss_dssp             SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred             CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence            77  99999999997532111     111224567999999999999999999999999999999999999999653222


Q ss_pred             hhHHHHHHHhhc-ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 014034          297 TEQRLLEWVQQY-PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  364 (432)
Q Consensus       297 ~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  364 (432)
                      ... ........ ...+.......    .   ....+..+.+|+.+||..||.+|||+.+|++.|+.+.
T Consensus       267 ~~~-~~~~~~~~~~~~~~~~~~~~----~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          267 PVA-VQTAKTNLLDELPQSVLKWA----P---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHH-HHHHHHHHHHTTTHHHHHHS----C---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             cHH-HHHHHHhhcccccHHHHhhc----c---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            111 11111110 00000000000    0   0023457889999999999999999999999998764

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.3e-44  Score=344.77  Aligned_cols=263  Identities=23%  Similarity=0.357  Sum_probs=203.2

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      .++|.+.+.||+|+||.||++...       .+++.||+|.+....    ..+.+|+.+++.++||||+++++++.....
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGL-------HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERG  100 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEET-------TTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET
T ss_pred             CeEEEEEEEecCCCCeEEEEEEec-------CCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC
Confidence            457999999999999999999865       467899999885432    347899999999999999999999976544


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      .....++||||+.+++|.+++...  ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus       101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~d  177 (317)
T 2buj_A          101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMD  177 (317)
T ss_dssp             TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred             CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEe
Confidence            445679999999999999998752  335799999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCc-------ccccccccCCCccCccccccCC---CCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHH
Q 014034          232 FGLAREGPMVGHT-------HVSTAVVGTFGYAAPDYIETGH---LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL  301 (432)
Q Consensus       232 fG~a~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~  301 (432)
                      ||++.........       .......||+.|+|||++.+..   ++.++||||||+++|+|++|..||........ ..
T Consensus       178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~  256 (317)
T 2buj_A          178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SV  256 (317)
T ss_dssp             CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CH
T ss_pred             cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hh
Confidence            9998753211000       0112345799999999997654   68899999999999999999999963211100 01


Q ss_pred             HHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          302 LEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                      .......              .........+..+.+|+.+||+.||.+|||+.+++++|+.+..
T Consensus       257 ~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          257 ALAVQNQ--------------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             HHHHHCC----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             hHHhhcc--------------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence            1111110              0001112234678899999999999999999999999988754

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.8e-44  Score=349.00  Aligned_cols=245  Identities=34%  Similarity=0.470  Sum_probs=197.7

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      +.|..++.||+|+||.||+|...       .++..||||++....       ..+.+|+.+++.++||||+++++++...
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  126 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDV-------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE  126 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             hheeeeeEEccCCCEEEEEEEEc-------cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            45899999999999999999865       468899999985421       2478999999999999999999999875


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ..++||||+. |+|.+++.... .++++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus       127 ~----~~~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D  197 (348)
T 1u5q_A          127 H----TAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGD  197 (348)
T ss_dssp             T----EEEEEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECC
T ss_pred             C----eEEEEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEee
Confidence            4    3599999996 68888875433 4799999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      ||++....      ......||+.|+|||++.   ++.++.++|||||||++|||++|..||.+......  +.......
T Consensus       198 fG~a~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~~~~~~~  269 (348)
T 1u5q_A          198 FGSASIMA------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQNE  269 (348)
T ss_dssp             CTTCBSSS------SBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHSC
T ss_pred             ccCceecC------CCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhcC
Confidence            99997532      123467999999999984   56789999999999999999999999986544322  11111111


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                      .           +.+   .+...+..+.+||.+||+.||.+|||+.+++++..
T Consensus       270 ~-----------~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~  308 (348)
T 1u5q_A          270 S-----------PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  308 (348)
T ss_dssp             C-----------CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred             C-----------CCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence            0           000   01122356889999999999999999999998743

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4e-44  Score=353.28  Aligned_cols=248  Identities=24%  Similarity=0.386  Sum_probs=192.1

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccC--CCccceeeeEEee
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLE--HPNLVKLIGYCAV  150 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~--hpniv~l~~~~~~  150 (432)
                      .+|.+++.||+|+||.||+|...        .+..||||++....      ..+.+|+.+|+.+.  ||||+++++++..
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~  127 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNE--------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT  127 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT--------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             CceEEEEEEccCCCeEEEEEEcC--------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec
Confidence            45999999999999999999854        37789999985432      34789999999996  5999999999876


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .+    ..++||| +.+++|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||++ ++.+||+
T Consensus       128 ~~----~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~  196 (390)
T 2zmd_A          128 DQ----YIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLI  196 (390)
T ss_dssp             SS----EEEEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEEC
T ss_pred             CC----EEEEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEE
Confidence            54    3599999 56889999997654  789999999999999999999998   999999999999996 5899999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCcccccc-----------CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhH
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-----------GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ  299 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~  299 (432)
                      |||+++...............||+.|+|||++.+           ..++.++|||||||++|+|++|..||........ 
T Consensus       197 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-  275 (390)
T 2zmd_A          197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-  275 (390)
T ss_dssp             CCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-
T ss_pred             ecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH-
Confidence            9999986432222223345679999999999865           4688999999999999999999999976543211 


Q ss_pred             HHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          300 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                      .+...+.              +......+...+..+.+||.+||..||.+|||+.+++++.
T Consensus       276 ~~~~~~~--------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          276 KLHAIID--------------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             HHHHHHC--------------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HHHHHhC--------------ccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence            1111111              1111111111235688999999999999999999999874

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.8e-44  Score=336.13  Aligned_cols=247  Identities=27%  Similarity=0.434  Sum_probs=180.8

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .++|.+.+.||+|+||.||+|...       .++..||+|.+....       ..+.+|+.+++.++||||+++++++..
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   82 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESI-------HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED   82 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC
T ss_pred             cccceeeeeecCCCceEEEEEEEc-------cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc
Confidence            467999999999999999999864       467899999986432       357899999999999999999999876


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .+    ..++||||+.+++|.+++.... .++++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        83 ~~----~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~  154 (278)
T 3cok_A           83 SN----YVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIA  154 (278)
T ss_dssp             SS----EEEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEEC
T ss_pred             CC----eEEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEE
Confidence            44    4599999999999999997643 4789999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      |||++......  ........||+.|+|||.+.+..++.++||||||+++|+|++|..||.........   .   .   
T Consensus       155 dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~---~---  223 (278)
T 3cok_A          155 DFGLATQLKMP--HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---N---K---  223 (278)
T ss_dssp             CCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------
T ss_pred             eecceeeccCC--CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---H---H---
Confidence            99999753221  12223457899999999999989999999999999999999999999765432110   0   0   


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                             +.....  ..+...+..+.+|+.+||+.||.+|||+.+++++
T Consensus       224 -------~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          224 -------VVLADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             -------CCSSCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -------Hhhccc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence                   000000  1112234578899999999999999999999875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2e-44  Score=369.45  Aligned_cols=256  Identities=27%  Similarity=0.373  Sum_probs=207.2

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ..++|.+.+.||+|+||.||+|.+.        .+..||||++...   ...+.+|+.+|+.++||||+++++++.. . 
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~-  334 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWN--------GTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E-  334 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--------TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S-
T ss_pred             chhhhhhheecccCCCeEEEEEEEC--------CCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-c-
Confidence            3467888999999999999999875        3467999998753   3568999999999999999999999864 2 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+.+|+|.+++.......+++..++.|+.||+.||.|||++   +|+||||||+||||+.++.+||+|||
T Consensus       335 ---~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG  408 (535)
T 2h8h_A          335 ---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG  408 (535)
T ss_dssp             ---SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTT
T ss_pred             ---cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccc
Confidence               248999999999999999754444689999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      +++..... .........++..|+|||++.+..++.++|||||||++|||++ |..||.+......   ...+....   
T Consensus       409 ~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~---~~~i~~~~---  481 (535)
T 2h8h_A          409 LARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQVERGY---  481 (535)
T ss_dssp             STTTCCCH-HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH---HHHHHTTC---
T ss_pred             cceecCCC-ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCC---
Confidence            99753211 1111223456789999999999999999999999999999999 9999987654322   22221110   


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                                 ....+..++..+.+||.+||+.||++|||+.+|++.|+.+...
T Consensus       482 -----------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          482 -----------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             -----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence                       0011223346788999999999999999999999999988653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6.2e-44  Score=363.72  Aligned_cols=251  Identities=25%  Similarity=0.366  Sum_probs=203.2

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .++|...+.||+|+||.||+|+++       .+++.||+|++.+..       ..+.+|+.+++.++||||+++++++..
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~-------~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~  256 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMK-------ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET  256 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEC-------CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee
Confidence            468999999999999999999975       467899999986432       347889999999999999999999876


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCcee
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  228 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k  228 (432)
                      ..    ..++||||++||+|.+++....  ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.+|.+|
T Consensus       257 ~~----~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vk  329 (543)
T 3c4z_A          257 KT----DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVR  329 (543)
T ss_dssp             SS----EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEE
T ss_pred             CC----EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEE
Confidence            54    4599999999999999997643  44699999999999999999999998   999999999999999999999


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCch-hhHHHHHHHhh
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK-TEQRLLEWVQQ  307 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~-~~~~~~~~~~~  307 (432)
                      |+|||+++.....  .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.... ....+...+..
T Consensus       330 L~DFGla~~~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~  407 (543)
T 3c4z_A          330 ISDLGLAVELKAG--QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE  407 (543)
T ss_dssp             ECCCTTCEECCTT--CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH
T ss_pred             EeecceeeeccCC--CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh
Confidence            9999999863221  12234468999999999999999999999999999999999999999865332 11222222211


Q ss_pred             cccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 014034          308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM-----SQVVER  359 (432)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~~  359 (432)
                      ..           .    .++...+..+.+||.+||..||.+||++     .+|+++
T Consensus       408 ~~-----------~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          408 QA-----------V----TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             CC-----------C----CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             cc-----------c----CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence            11           0    1122234678899999999999999975     667654

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.1e-44  Score=347.84  Aligned_cols=275  Identities=17%  Similarity=0.244  Sum_probs=207.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCC-CCCcccEEEEEEecCcChHHHHHHHHHhcccCCCccce--------------
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVK--------------  143 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~-~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~hpniv~--------------  143 (432)
                      ++|.+.+.||+|+||.||+|....+.. .....+..||+|.+... ..+.+|+.+++.++||||++              
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~  120 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP  120 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence            579999999999999999999762110 00014788999998765 46789999999999999998              


Q ss_pred             -eeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc
Q 014034          144 -LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD  222 (432)
Q Consensus       144 -l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~  222 (432)
                       +++++...+   ...++||||+ +++|.+++.......+++..++.++.||+.||.|||++   +|+||||||+|||++
T Consensus       121 ~~~~~~~~~~---~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~  193 (352)
T 2jii_A          121 TCMGFGVHQD---KYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVD  193 (352)
T ss_dssp             CCCEEEEETT---TEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEE
T ss_pred             chhhccccCC---cEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEc
Confidence             566665522   2469999999 99999999876445799999999999999999999998   999999999999999


Q ss_pred             CCC--ceeeccccCCcCCCCCCC-----cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCc
Q 014034          223 ENF--RPKLSDFGLAREGPMVGH-----THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP  295 (432)
Q Consensus       223 ~~~--~~kl~DfG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~  295 (432)
                      .++  .+||+|||+++.......     ........||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  273 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP  273 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence            998  899999999975321111     1112345799999999999999999999999999999999999999987543


Q ss_pred             hhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhcc
Q 014034          296 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  368 (432)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  368 (432)
                      ... .+......+......+   ......   ....+..+.+|+.+||..||.+|||+.+|++.|+.+++..+
T Consensus       274 ~~~-~~~~~~~~~~~~~~~~---~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          274 NTE-DIMKQKQKFVDKPGPF---VGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             CHH-HHHHHHHHHHHSCCCE---ECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             CHH-HHHHHHHhccCChhhh---hhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence            221 1222222111111110   010000   01123678899999999999999999999999999987654

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.1e-43  Score=335.72  Aligned_cols=248  Identities=23%  Similarity=0.343  Sum_probs=198.9

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      .|.+.+.||+|+||.||+|...       .++..||+|.+...      ...+.+|+.+++.++||||+++++++.....
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   99 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDT-------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK   99 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred             eEEeeeeccCCCCeEEEEeEec-------CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence            4777889999999999999865       46788999987542      1247889999999999999999999887655


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCc--eeecCCCCCceEEc-CCCceeec
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQ--VIYRDFKASNVLLD-ENFRPKLS  230 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~--ivH~Dikp~Nill~-~~~~~kl~  230 (432)
                      .....++||||+.+++|.+++...  ..+++..++.++.||+.||.|||+.   +  |+||||||+|||++ .++.+||+
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~  174 (290)
T 1t4h_A          100 GKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIG  174 (290)
T ss_dssp             SCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred             CCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEe
Confidence            556679999999999999999764  3689999999999999999999998   7  99999999999997 88999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      |||++.....    .......||+.|+|||++. +.++.++||||||+++|+|++|..||........  ....+.....
T Consensus       175 Dfg~~~~~~~----~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~  247 (290)
T 1t4h_A          175 DLGLATLKRA----SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVTSGVK  247 (290)
T ss_dssp             CTTGGGGCCT----TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHHTTTCC
T ss_pred             eCCCcccccc----cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH--HHHHHhccCC
Confidence            9999974321    1233457999999999887 4589999999999999999999999986543322  1111111100


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                               ...+...    .+..+.+|+.+||+.||.+|||+.+++++
T Consensus       248 ---------~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          248 ---------PASFDKV----AIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             ---------CGGGGGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ---------ccccCCC----CCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                     0111111    12568899999999999999999999875

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.2e-44  Score=335.26  Aligned_cols=252  Identities=23%  Similarity=0.343  Sum_probs=201.7

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ..++|++.+.||+|+||.||+|...       .++..||+|.+....     ..+.+|+.+++.++||||+++++++...
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNR-------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG   77 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             eecceEEEEEeecCCCcEEEEEEEC-------CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC
Confidence            3467999999999999999999865       467889999985432     3578999999999999999999998765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ..++||||+.+++|.+++...  ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus        78 ~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d  148 (276)
T 2yex_A           78 N----IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISD  148 (276)
T ss_dssp             T----EEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             C----EEEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEee
Confidence            4    358999999999999998654  3689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      ||++................||+.|+|||++.+..+ +.++||||||+++|+|++|..||........ ....+......
T Consensus       149 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~  227 (276)
T 2yex_A          149 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKKTY  227 (276)
T ss_dssp             CTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHTTCTT
T ss_pred             CCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhhcccc
Confidence            999875322222222345679999999999987665 6789999999999999999999987544221 12222211100


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                              ..      .....+..+.+|+.+||+.||.+|||+.+++++
T Consensus       228 --------~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          228 --------LN------PWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             --------ST------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --------cC------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence                    00      011224568899999999999999999999865

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-43  Score=344.27  Aligned_cols=267  Identities=25%  Similarity=0.314  Sum_probs=196.9

Q ss_pred             HHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh---------HHHHHHHHHhcccCCCccceee
Q 014034           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---------LQWVAEVQFLGVLEHPNLVKLI  145 (432)
Q Consensus        75 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~hpniv~l~  145 (432)
                      ....++|.+.+.||+|+||.||+|.+.       .++..||+|.+....         ..+.+|+.+++.++||||++++
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   78 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDK-------NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL   78 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECS-------SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEE
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEEC-------CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEE
Confidence            344578999999999999999999865       467899999986421         2477899999999999999999


Q ss_pred             eEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC
Q 014034          146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF  225 (432)
Q Consensus       146 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~  225 (432)
                      +++...+.    .++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++
T Consensus        79 ~~~~~~~~----~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~  149 (346)
T 1ua2_A           79 DAFGHKSN----ISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENG  149 (346)
T ss_dssp             EEECCTTC----CEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTC
T ss_pred             EEEeeCCc----eEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCC
Confidence            99876554    4999999975 8988886543 4688999999999999999999998   999999999999999999


Q ss_pred             ceeeccccCCcCCCCCCCcccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 014034          226 RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  304 (432)
Q Consensus       226 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  304 (432)
                      .+||+|||+++....  .........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+..
T Consensus       150 ~~kl~Dfg~a~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~  227 (346)
T 1ua2_A          150 VLKLADFGLAKSFGS--PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE  227 (346)
T ss_dssp             CEEECCCGGGSTTTS--CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CEEEEecccceeccC--CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence            999999999976322  12223456789999999999754 589999999999999999999999987654332221111


Q ss_pred             HhhcccCc-c-ccccc---cCccccCcCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          305 VQQYPADS-K-KFGLI---MDPRLEKEYS-----INEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       305 ~~~~~~~~-~-~~~~~---~~~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ....+... . .....   .........+     ...+..+.+||.+||..||.+|||+.+++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          228 TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             HHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             HcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            11111110 0 00000   0000000001     2234678899999999999999999999987

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=6.6e-44  Score=336.79  Aligned_cols=248  Identities=27%  Similarity=0.362  Sum_probs=194.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|.+.+.||+|+||.||+|...       .++..||+|.+....     ..+.+|+.+++.++||||+++++++.... 
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   93 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEER-------SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH-   93 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred             hheeecceeccCCCeEEEEEEEc-------cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCC-
Confidence            47999999999999999999865       467889999986432     46889999999999999999999997644 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEE---cCCCcee
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPK  228 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill---~~~~~~k  228 (432)
                         ..++||||+.+++|.+++...  ....+++..++.++.||+.||.|||+.   +|+||||||+|||+   +.++.+|
T Consensus        94 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~k  167 (285)
T 3is5_A           94 ---NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIK  167 (285)
T ss_dssp             ---EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEE
T ss_pred             ---eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEE
Confidence               359999999999999998542  234799999999999999999999998   99999999999999   4568899


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      |+|||++.....   ........||+.|+|||++. +.++.++||||||+++|+|++|..||.+............   .
T Consensus       168 l~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~---~  240 (285)
T 3is5_A          168 IIDFGLAELFKS---DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY---K  240 (285)
T ss_dssp             ECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---C
T ss_pred             EEeeecceecCC---cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc---C
Confidence            999999975321   22234567999999999986 5689999999999999999999999987654332222111   1


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ...   +.    . ....    .+..+.+|+.+||+.||.+|||+.+++++
T Consensus       241 ~~~---~~----~-~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          241 EPN---YA----V-ECRP----LTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             CCC---CC----C---CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             Ccc---cc----c-ccCc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000   00    0 0001    23567899999999999999999999865

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.7e-44  Score=344.44  Aligned_cols=262  Identities=26%  Similarity=0.418  Sum_probs=201.2

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|.+.+.||+|+||.||+|.+....  +..++..||+|.+...     ...+.+|+.+++.++||||+++++++.....
T Consensus        30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           30 KNITLIRGLGHGAFGEVYEGQVSGMP--NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             GGCEEEEECC--CSSCEEEEEC----------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hheEEEEEEcCCCCeeEEEEEEcCCC--CCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            47999999999999999999864211  2346778999998643     2247889999999999999999999876554


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC---CC
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAF-----PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE---NF  225 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~  225 (432)
                      .    ++||||+++++|.+++.....     ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.   +.
T Consensus       108 ~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~  180 (327)
T 2yfx_A          108 R----FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR  180 (327)
T ss_dssp             C----EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred             c----EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcc
Confidence            3    999999999999999976532     3589999999999999999999998   9999999999999984   45


Q ss_pred             ceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHH
Q 014034          226 RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEW  304 (432)
Q Consensus       226 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~  304 (432)
                      .+||+|||++................||+.|+|||++.+..++.++||||||+++|+|+| |..||.......   ....
T Consensus       181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~  257 (327)
T 2yfx_A          181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLEF  257 (327)
T ss_dssp             CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHH
T ss_pred             eEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---HHHH
Confidence            699999999864211112222334568999999999998999999999999999999998 999998654332   2222


Q ss_pred             HhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          305 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                      +.....          ..    .+...+..+.+|+.+||+.||.+|||+.+|+++|+.+.+.
T Consensus       258 ~~~~~~----------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          258 VTSGGR----------MD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             HHTTCC----------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HhcCCC----------CC----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            221110          00    1112345788999999999999999999999999988653

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.2e-44  Score=336.62  Aligned_cols=248  Identities=23%  Similarity=0.348  Sum_probs=198.4

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC----------hHHHHHHHHHhcccCCCccceeeeEE
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----------GLQWVAEVQFLGVLEHPNLVKLIGYC  148 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~hpniv~l~~~~  148 (432)
                      ++|.+.+.||+|+||.||+|...       .++..||+|.+...          ...+.+|+.+++.++||||+++++++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   77 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQK-------GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF   77 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEc-------CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhee
Confidence            56999999999999999999875       45788999987542          34588999999999999999999998


Q ss_pred             eecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC---
Q 014034          149 AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF---  225 (432)
Q Consensus       149 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~---  225 (432)
                      ....    ..++||||+.+++|.+++...  ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++   
T Consensus        78 ~~~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~  148 (283)
T 3bhy_A           78 ENKT----DVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPN  148 (283)
T ss_dssp             ECSS----EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSS
T ss_pred             cCCC----eEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCC
Confidence            7654    459999999999999999654  3689999999999999999999998   999999999999998877   


Q ss_pred             -ceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 014034          226 -RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  304 (432)
Q Consensus       226 -~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  304 (432)
                       .+||+|||++.....   ........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.......   ..
T Consensus       149 ~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~  222 (283)
T 3bhy_A          149 PRIKLIDFGIAHKIEA---GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL---TN  222 (283)
T ss_dssp             CCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HH
T ss_pred             CceEEEecccceeccC---CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH---HH
Confidence             899999999975321   12233456999999999999999999999999999999999999999875443221   11


Q ss_pred             HhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          305 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      +......       .....    ....+..+.+|+.+||..||.+|||+.+++++
T Consensus       223 ~~~~~~~-------~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          223 ISAVNYD-------FDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             HHTTCCC-------CCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             hHhcccC-------Ccchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence            1111100       00000    01123568899999999999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=8.3e-44  Score=355.33  Aligned_cols=262  Identities=21%  Similarity=0.275  Sum_probs=202.1

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH---HHHHHHHHhccc------CCCccceeeeEE
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGVL------EHPNLVKLIGYC  148 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l------~hpniv~l~~~~  148 (432)
                      ..+|++++.||+|+||.||+|...       .++..||||++.....   .+.+|+.+++.+      +|+||+++++++
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~-------~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~  168 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDH-------KVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF  168 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEET-------TTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEEC-------CCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence            457999999999999999999865       4678999999987543   467788888776      678999999999


Q ss_pred             eecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCc--
Q 014034          149 AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR--  226 (432)
Q Consensus       149 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~--  226 (432)
                      ....    ..++||||+. ++|.+++.......+++..+..++.||+.||.|||+.   +|+||||||+||||+.++.  
T Consensus       169 ~~~~----~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~  240 (429)
T 3kvw_A          169 TFRN----HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSG  240 (429)
T ss_dssp             EETT----EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCC
T ss_pred             ccCC----eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcc
Confidence            7754    4599999995 6999999877666799999999999999999999998   9999999999999999887  


Q ss_pred             eeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 014034          227 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  306 (432)
Q Consensus       227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  306 (432)
                      +||+|||++....     .......||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+....
T Consensus       241 vkL~DFG~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~  315 (429)
T 3kvw_A          241 IKVIDFGSSCYEH-----QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELL  315 (429)
T ss_dssp             EEECCCTTCEETT-----CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             eEEeecccceecC-----CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence            9999999997522     12234679999999999999999999999999999999999999998765543322211111


Q ss_pred             hcccCc--------------cc------cccccC-----------------cc----ccCcCCHHHHHHHHHHHHHhccC
Q 014034          307 QYPADS--------------KK------FGLIMD-----------------PR----LEKEYSINEARKIGRLADNCLSK  345 (432)
Q Consensus       307 ~~~~~~--------------~~------~~~~~~-----------------~~----l~~~~~~~~~~~l~~li~~cl~~  345 (432)
                      ..+...              ..      ...+.+                 +.    +........+..+.+||.+||+.
T Consensus       316 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~  395 (429)
T 3kvw_A          316 GMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEW  395 (429)
T ss_dssp             CCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCS
T ss_pred             CCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCC
Confidence            111000              00      000000                 00    00000111145688999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 014034          346 SSKDRPKMSQVVER  359 (432)
Q Consensus       346 dP~~RPs~~eil~~  359 (432)
                      ||.+|||+.|++++
T Consensus       396 dP~~Rpta~e~L~H  409 (429)
T 3kvw_A          396 DPAVRMTPGQALRH  409 (429)
T ss_dssp             STTTSCCHHHHHTS
T ss_pred             ChhhCCCHHHHhCC
Confidence            99999999999986

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=7.3e-44  Score=334.71  Aligned_cols=249  Identities=24%  Similarity=0.304  Sum_probs=200.2

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc----ChHHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR----DGLQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      ..++|.+.+.||+|+||.||+|...       .++..||+|++..    ....+.+|+.+++.++||||+++++++....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQK-------GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT   79 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeC-------CCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            3457999999999999999999875       4567899998754    3456889999999999999999999997654


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEE---cCCCceee
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKL  229 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill---~~~~~~kl  229 (432)
                          ..++||||+.+++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+|||+   +.++.+||
T Consensus        80 ----~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l  150 (277)
T 3f3z_A           80 ----DIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKL  150 (277)
T ss_dssp             ----EEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEE
T ss_pred             ----eEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEE
Confidence                3599999999999999987643  689999999999999999999998   99999999999999   78899999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      +|||++.....   ........||+.|+|||++.+. ++.++||||||+++|+|++|..||..........  .......
T Consensus       151 ~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~--~~~~~~~  224 (277)
T 3f3z_A          151 IDFGLAARFKP---GKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVML--KIREGTF  224 (277)
T ss_dssp             CCCTTCEECCT---TSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHCCC
T ss_pred             EecccceeccC---ccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHH--HHHhCCC
Confidence            99999975322   2223446799999999998754 8999999999999999999999998754432211  1111110


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ..+.            ......+..+.+|+.+||+.||.+|||+.+++++
T Consensus       225 ~~~~------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          225 TFPE------------KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             CCCH------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             CCCc------------hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000            0000124578899999999999999999999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8.4e-44  Score=347.99  Aligned_cols=260  Identities=15%  Similarity=0.188  Sum_probs=205.4

Q ss_pred             HhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-HHHHHHHHHhcccC---CCccceeeeEEeec
Q 014034           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQWVAEVQFLGVLE---HPNLVKLIGYCAVD  151 (432)
Q Consensus        76 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~---hpniv~l~~~~~~~  151 (432)
                      ...++|.+.+.||+|+||.||+|.+...  .....++.||+|.+.... ..+..|+.++..++   |+||+.+++++...
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDL--NDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC---------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCC--cccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            3456799999999999999999965321  123567899999997654 35778888888776   99999999999876


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC-----
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNR---AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE-----  223 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~-----  223 (432)
                      +.    .++||||+++|+|.+++...   ....+++..++.|+.||+.||.|||+.   +|+||||||+||||+.     
T Consensus       140 ~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          140 NG----SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             SC----EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC
T ss_pred             CC----cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCc
Confidence            54    49999999999999999642   235799999999999999999999998   9999999999999998     


Q ss_pred             ------CCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchh
Q 014034          224 ------NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT  297 (432)
Q Consensus       224 ------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~  297 (432)
                            ++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+||..||.......
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  292 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE  292 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred             cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence                  89999999999964322223334456789999999999999999999999999999999999999996432210


Q ss_pred             hHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCC-CCHHHHHHHHHHHhhh
Q 014034          298 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDR-PKMSQVVERLKQIVQV  366 (432)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~eil~~L~~~~~~  366 (432)
                                     ..    ....+...   .....+.+++..|++.+|.+| |++.++.+.|+.+++.
T Consensus       293 ---------------~~----~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          293 ---------------CK----PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             ---------------EE----ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ---------------ee----echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence                           00    11111111   124567789999999999999 5788888899888764

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.4e-43  Score=359.52  Aligned_cols=248  Identities=26%  Similarity=0.371  Sum_probs=199.1

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc------ChHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|.+++.||+|+||.||+|...       .++..||+|++..      ....+.+|+.+++.++||||+++++++...
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   93 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDR-------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS   93 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEET-------TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hcceEEeEEEeecCCEEEEEEEEC-------CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC
Confidence            357999999999999999999875       4678999999843      344588999999999999999999998765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc---CCCcee
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPK  228 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~---~~~~~k  228 (432)
                      .    ..++||||+.+++|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||++   .++.+|
T Consensus        94 ~----~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~k  164 (486)
T 3mwu_A           94 S----SFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIK  164 (486)
T ss_dssp             S----EEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEE
T ss_pred             C----EEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEE
Confidence            4    4599999999999999986653  689999999999999999999998   999999999999995   566799


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      |+|||++.....   ........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......   ...+...
T Consensus       165 l~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~  237 (486)
T 3mwu_A          165 IIDFGLSTCFQQ---NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI---LKRVETG  237 (486)
T ss_dssp             ECSCSCTTTBCC---C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHT
T ss_pred             EEECCcCeECCC---CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhC
Confidence            999999975321   222345679999999999976 589999999999999999999999987654332   2222111


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ....       .    .......+..+.+||.+||..||.+|||+.+++++
T Consensus       238 ~~~~-------~----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          238 KYAF-------D----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             CCCS-------C----SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CCCC-------C----CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1000       0    00011234678899999999999999999999987

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.1e-44  Score=345.00  Aligned_cols=255  Identities=21%  Similarity=0.318  Sum_probs=201.9

Q ss_pred             HHHhhcCCccc-cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhccc-CCCccceee
Q 014034           74 MRQATNDFSRM-LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVL-EHPNLVKLI  145 (432)
Q Consensus        74 ~~~~~~~~~~~-~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l-~hpniv~l~  145 (432)
                      .....+.|.+. +.||+|+||.||+|...       .+++.||+|.+...      ...+.+|+.++..+ +||||++++
T Consensus        23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~   95 (327)
T 3lm5_A           23 MENFNNFYILTSKELGRGKFAVVRQCISK-------STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH   95 (327)
T ss_dssp             HHHHHHHEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             HHhhhhEEeeccceeCCCCCeEEEEEEEC-------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence            34555678887 88999999999999875       46789999998642      34588999999998 569999999


Q ss_pred             eEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC--
Q 014034          146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE--  223 (432)
Q Consensus       146 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~--  223 (432)
                      +++....    ..++||||+.+|+|.+++.......+++..++.++.||+.||.|||+.   +|+||||||+|||++.  
T Consensus        96 ~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~  168 (327)
T 3lm5_A           96 EVYENTS----EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIY  168 (327)
T ss_dssp             EEEECSS----EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBT
T ss_pred             EEEEeCC----eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCC
Confidence            9987654    359999999999999999776566899999999999999999999998   9999999999999987  


Q ss_pred             -CCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014034          224 -NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  302 (432)
Q Consensus       224 -~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  302 (432)
                       ++.+||+|||+++...   .........||+.|+|||++.+..++.++||||||+++|+|++|..||.+..........
T Consensus       169 ~~~~~kL~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  245 (327)
T 3lm5_A          169 PLGDIKIVDFGMSRKIG---HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI  245 (327)
T ss_dssp             TBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCCcEEEeeCccccccC---CccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Confidence             7899999999997532   122233467999999999999999999999999999999999999999876543322111


Q ss_pred             HHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          303 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                         ......           .........+..+.+||.+||+.||.+|||+.+++++
T Consensus       246 ---~~~~~~-----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          246 ---SQVNVD-----------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             ---HHTCCC-----------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             ---Hhcccc-----------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence               111100           0011112234668899999999999999999999876

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=8.4e-43  Score=331.99  Aligned_cols=251  Identities=21%  Similarity=0.281  Sum_probs=200.5

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh--------HHHHHHHHHhcccCCCccceeeeEEe
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--------LQWVAEVQFLGVLEHPNLVKLIGYCA  149 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~hpniv~l~~~~~  149 (432)
                      .++|.+.+.||+|+||.||+|...       .++..||+|.+....        ..+.+|+.+++.++||||+++++++.
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   76 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDS-------ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLY   76 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBT-------TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             ccceeEeeEEecCCCeEEEEEEEC-------CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence            468999999999999999999864       467899999986532        34789999999999999999999986


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      ....  ...++||||+.++ |.+++.......+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||
T Consensus        77 ~~~~--~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl  150 (305)
T 2wtk_C           77 NEEK--QKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKI  150 (305)
T ss_dssp             CC-----CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred             cCCC--CeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEe
Confidence            4332  2459999999776 77777765556799999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCccccccCCC--CchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL--TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  307 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  307 (432)
                      +|||++................||+.|+|||++.+...  +.++||||||+++|+|++|..||.+.....   ....+..
T Consensus       151 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~i~~  227 (305)
T 2wtk_C          151 SALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK---LFENIGK  227 (305)
T ss_dssp             CCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHH
T ss_pred             eccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH---HHHHHhc
Confidence            99999976432223333345679999999999976543  779999999999999999999998654322   2221111


Q ss_pred             cccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ..           ..+    +...+..+.+|+.+||..||.+|||+.+++++
T Consensus       228 ~~-----------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          228 GS-----------YAI----PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             CC-----------CCC----CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             CC-----------CCC----CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            10           001    11223568899999999999999999999987

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=8.6e-44  Score=347.95  Aligned_cols=256  Identities=22%  Similarity=0.356  Sum_probs=202.7

Q ss_pred             HHHHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------------HHHHHHHHHhccc-C
Q 014034           71 YSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------------LQWVAEVQFLGVL-E  137 (432)
Q Consensus        71 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l-~  137 (432)
                      ........++|.+.+.||+|+||.||+|.+.       .++..||||++....            ..+.+|+.+++.+ +
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~  158 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHR-------ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG  158 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEEC-------CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcC
Confidence            3344556678999999999999999999875       457899999875432            2367899999999 7


Q ss_pred             CCccceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCC
Q 014034          138 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKAS  217 (432)
Q Consensus       138 hpniv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~  217 (432)
                      ||||+++++++...+    ..++||||+.+++|.+++...  ..+++..+..++.||+.||.|||+.   ||+||||||+
T Consensus       159 hp~iv~~~~~~~~~~----~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~  229 (365)
T 2y7j_A          159 HPHIITLIDSYESSS----FMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPE  229 (365)
T ss_dssp             CTTBCCEEEEEEBSS----EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred             CCCEeEEEEEEeeCC----EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence            999999999987644    459999999999999999754  3689999999999999999999998   9999999999


Q ss_pred             ceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCcccccc------CCCCchhhhHHHHHHHHHHHhCCCCCC
Q 014034          218 NVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET------GHLTAKSDVWSFGVVLYEMLTGRRSLE  291 (432)
Q Consensus       218 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltg~~pf~  291 (432)
                      |||++.++.+||+|||++.....   ........||+.|+|||++.+      ..++.++|||||||++|+|++|..||.
T Consensus       230 NIl~~~~~~ikl~DfG~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~  306 (365)
T 2y7j_A          230 NILLDDNMQIRLSDFGFSCHLEP---GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW  306 (365)
T ss_dssp             GEEECTTCCEEECCCTTCEECCT---TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             HEEECCCCCEEEEecCcccccCC---CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCC
Confidence            99999999999999999875322   122345679999999999863      358889999999999999999999998


Q ss_pred             CCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          292 RNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .......   ...+.......      ..+..     ...+..+.+|+.+||+.||.+|||+.+++++
T Consensus       307 ~~~~~~~---~~~i~~~~~~~------~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          307 HRRQILM---LRMIMEGQYQF------SSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             CSSHHHH---HHHHHHTCCCC------CHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCHHHH---HHHHHhCCCCC------CCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            6543322   11111110000      00000     0123568899999999999999999999875

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.2e-43  Score=353.05  Aligned_cols=251  Identities=24%  Similarity=0.353  Sum_probs=191.8

Q ss_pred             HhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------------HHHHHHHHHhcccCCCccce
Q 014034           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------------LQWVAEVQFLGVLEHPNLVK  143 (432)
Q Consensus        76 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~hpniv~  143 (432)
                      ...++|.+.+.||+|+||.||+|...       .++..||+|.+....            ..+.+|+.+|++++||||++
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  204 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFER-------KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK  204 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCC
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEEC-------CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEee
Confidence            34678999999999999999999875       467899999986432            12788999999999999999


Q ss_pred             eeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC
Q 014034          144 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  223 (432)
Q Consensus       144 l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~  223 (432)
                      +++++...     ..++||||+.+|+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.
T Consensus       205 l~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~  274 (419)
T 3i6u_A          205 IKNFFDAE-----DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSS  274 (419)
T ss_dssp             CCEEEESS-----EEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESS
T ss_pred             EEEEEecC-----ceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEec
Confidence            99997432     258999999999999998654  4799999999999999999999998   9999999999999975


Q ss_pred             CC---ceeeccccCCcCCCCCCCcccccccccCCCccCcccccc---CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchh
Q 014034          224 NF---RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET---GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT  297 (432)
Q Consensus       224 ~~---~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~  297 (432)
                      ++   .+||+|||+++...   .........||+.|+|||++.+   ..++.++|||||||++|+|++|..||.......
T Consensus       275 ~~~~~~~kl~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~  351 (419)
T 3i6u_A          275 QEEDCLIKITDFGHSKILG---ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV  351 (419)
T ss_dssp             SSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC
T ss_pred             CCCcceEEEeecccceecC---CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH
Confidence            44   59999999998632   2223345679999999999853   678889999999999999999999997643321


Q ss_pred             hHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          298 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .  +...+......       ..+..    ....+..+.+|+.+||+.||.+|||+.+++++
T Consensus       352 ~--~~~~i~~~~~~-------~~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          352 S--LKDQITSGKYN-------FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             C--HHHHHHTTCCC-------CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             H--HHHHHhcCCCC-------CCchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            1  11111110000       00000    01124578899999999999999999999876

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.7e-43  Score=347.59  Aligned_cols=267  Identities=21%  Similarity=0.308  Sum_probs=206.3

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh---HHHHHHHHHhcccC--------CCccceeee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQWVAEVQFLGVLE--------HPNLVKLIG  146 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~--------hpniv~l~~  146 (432)
                      .++|.+.+.||+|+||.||+|...       .+++.||||++....   ..+.+|+.+++.+.        ||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~  108 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDI-------QGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD  108 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEec-------CCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence            368999999999999999999865       467999999998654   34788999999885        788999999


Q ss_pred             EEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC-
Q 014034          147 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF-  225 (432)
Q Consensus       147 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-  225 (432)
                      ++...+......++||||+ +++|.+++.......+++..++.++.||+.||.|||+++  +|+||||||+||||+.++ 
T Consensus       109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~  185 (397)
T 1wak_A          109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQ  185 (397)
T ss_dssp             EEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHH
T ss_pred             ceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccch
Confidence            9986554556779999999 677777776665567999999999999999999999852  899999999999999775 


Q ss_pred             ------------------------------------------------ceeeccccCCcCCCCCCCcccccccccCCCcc
Q 014034          226 ------------------------------------------------RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA  257 (432)
Q Consensus       226 ------------------------------------------------~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~  257 (432)
                                                                      .+||+|||++....     .......||+.|+
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~-----~~~~~~~gt~~y~  260 (397)
T 1wak_A          186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH-----KHFTEDIQTRQYR  260 (397)
T ss_dssp             HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT-----BCSCSCCSCGGGC
T ss_pred             hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc-----ccCccCCCCCccc
Confidence                                                            79999999997532     1233457999999


Q ss_pred             CccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhh----H---HHHHHHhhcccC--------------ccccc
Q 014034          258 APDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE----Q---RLLEWVQQYPAD--------------SKKFG  316 (432)
Q Consensus       258 aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~----~---~~~~~~~~~~~~--------------~~~~~  316 (432)
                      |||++.+..++.++|||||||++|+|++|..||........    .   .+.......+..              .....
T Consensus       261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  340 (397)
T 1wak_A          261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK  340 (397)
T ss_dssp             CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred             CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence            99999999999999999999999999999999986543211    1   111111111100              00000


Q ss_pred             cccCcc---------ccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          317 LIMDPR---------LEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       317 ~~~~~~---------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .+....         -....+...+..+.+||.+||+.||.+|||+.+++++
T Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            000000         0012356677889999999999999999999999875

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-43  Score=346.15  Aligned_cols=262  Identities=24%  Similarity=0.333  Sum_probs=196.6

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|..++.||+|+||.||+|...       .++..||||++...      ...+.+|+.+++.++||||+++++++...
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~   96 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDG-------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD   96 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEET-------TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred             cceEEEeEEeeecCCeEEEEEEEC-------CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecC
Confidence            467999999999999999999865       46789999998542      23478899999999999999999998765


Q ss_pred             CCc--ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          152 GER--GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       152 ~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      ...  ....++||||+ +++|.+++...   .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl  169 (367)
T 1cm8_A           97 ETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKI  169 (367)
T ss_dssp             SSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEE
T ss_pred             CccccCceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEE
Confidence            321  23459999999 88999998763   589999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      +|||+++....     ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......
T Consensus       170 ~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~  244 (367)
T 1cm8_A          170 LDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT  244 (367)
T ss_dssp             CCCTTCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             Eeeeccccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999986321     1334678999999999877 68999999999999999999999999876554332221111111


Q ss_pred             ccCcc--------------ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 PADSK--------------KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 ~~~~~--------------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      +....              .+.......+. ......+..+.+|+.+||..||.+|||+.+++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             CCHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCHHHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            10000              00000000000 1112234678899999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.5e-43  Score=369.14  Aligned_cols=249  Identities=26%  Similarity=0.416  Sum_probs=198.8

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecCCcceeE
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQR  158 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~  158 (432)
                      +.||+|+||.||+|.+.     ....+..||||+++...      ..+.+|+.+|+.++||||+++++++..+     ..
T Consensus       375 ~~LG~G~fG~Vy~~~~~-----~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~  444 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQ-----MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-----SW  444 (635)
T ss_dssp             EEEEECSSEEEEEEEEE-----CSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----SE
T ss_pred             CEeccCCCEEEEEEEEc-----CCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CE
Confidence            47999999999999765     23467899999987532      4588999999999999999999998532     24


Q ss_pred             EEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCC
Q 014034          159 LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG  238 (432)
Q Consensus       159 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~  238 (432)
                      ++||||+.+|+|.+++...  ..+++..++.|+.||+.||.|||++   +|+||||||+||||+.++.+||+|||+++..
T Consensus       445 ~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~  519 (635)
T 4fl3_A          445 MLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL  519 (635)
T ss_dssp             EEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred             EEEEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence            8999999999999999754  3689999999999999999999998   9999999999999999999999999999753


Q ss_pred             CCCCC-cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 014034          239 PMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFG  316 (432)
Q Consensus       239 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (432)
                      ..... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.........   +.....      
T Consensus       520 ~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~---i~~~~~------  590 (635)
T 4fl3_A          520 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM---LEKGER------  590 (635)
T ss_dssp             TC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---HHTTCC------
T ss_pred             ccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHcCCC------
Confidence            22211 122233457889999999999999999999999999999998 9999987655432222   211100      


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       317 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                              ...+...+..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       591 --------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          591 --------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             --------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                    01122334678899999999999999999999999998764

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.6e-44  Score=345.11  Aligned_cols=264  Identities=24%  Similarity=0.384  Sum_probs=198.0

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|++++.||+|+||.||+|...       .++..||+|++....      ..+.+|+.+++.++||||+++++++...
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   96 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNK-------DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK   96 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEET-------TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             hhhheeeeEEeecCCEEEEEEEEC-------CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC
Confidence            357999999999999999999875       467899999874321      2367899999999999999999999765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ..++||||+.+++|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        97 ~----~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~D  167 (331)
T 4aaa_A           97 K----RWYLVFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCD  167 (331)
T ss_dssp             T----EEEEEEECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred             C----EEEEEEecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEe
Confidence            4    3599999999999988875443  699999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHH-HHhhcc
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE-WVQQYP  309 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~-~~~~~~  309 (432)
                      ||++.....  .........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+........... ......
T Consensus       168 fg~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  245 (331)
T 4aaa_A          168 FGFARTLAA--PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLI  245 (331)
T ss_dssp             CTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             CCCceeecC--CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Confidence            999975321  12223446799999999999875 78999999999999999999999998765433221111 000000


Q ss_pred             cC-------ccccccccCccccCcCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 AD-------SKKFGLIMDPRLEKEYS-----INEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~-------~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ..       ...+.....+.+....+     ...+..+.+|+.+||+.||.+|||+.+++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          246 PRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             HHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             hhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            00       00000011111111111     1235678999999999999999999999886

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.2e-44  Score=353.02  Aligned_cols=268  Identities=24%  Similarity=0.306  Sum_probs=198.4

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHHHHHHHhcccCCCccceeeeEEeecCC--cc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE--RG  155 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--~~  155 (432)
                      ..+|...+.||+|+||.||+|.+.        .+..||+|++........+|+.+++.++||||+++++++...+.  ..
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~--------~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~  110 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLV--------ESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE  110 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEET--------TTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred             cceEEEeEEEeeCCCeEEEEEEEC--------CCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence            357999999999999999999875        23348888886655555689999999999999999999976543  23


Q ss_pred             eeEEEEEeecCCCCHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc-CCCceeecccc
Q 014034          156 IQRLLVYEFMLNRSLEDHLF-NRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFG  233 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~~kl~DfG  233 (432)
                      ...++||||+.++.+..... ......+++..+..++.||+.||.|||+.   +|+||||||+||||+ .++.+||+|||
T Consensus       111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence            44689999997654433321 12234799999999999999999999998   999999999999999 89999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC-
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD-  311 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-  311 (432)
                      +++....   ........||+.|+|||++.+. .++.++|||||||++|||++|..||.+.........+......+.. 
T Consensus       188 ~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~  264 (394)
T 4e7w_A          188 SAKILIA---GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE  264 (394)
T ss_dssp             TCEECCT---TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             CcccccC---CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            9975322   1223346789999999998764 5899999999999999999999999876544332211111111000 


Q ss_pred             ----------ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 ----------SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ----------~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                ...+.......+...+....+..+.+|+.+||..||.+|||+.+++++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence                      000000000111111222244678999999999999999999999987

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-44  Score=345.63  Aligned_cols=259  Identities=29%  Similarity=0.390  Sum_probs=200.1

Q ss_pred             HHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc---ChHHHHHHHHHhccc-CCCccceeeeEE
Q 014034           73 EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR---DGLQWVAEVQFLGVL-EHPNLVKLIGYC  148 (432)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~---~~~~~~~E~~~l~~l-~hpniv~l~~~~  148 (432)
                      ++....++|++.+.||+|+||.||+|.+.       .++..||+|.+..   ....+.+|+.+++.+ +||||+++++++
T Consensus        18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   90 (326)
T 2x7f_A           18 ALRDPAGIFELVELVGNGTYGQVYKGRHV-------KTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF   90 (326)
T ss_dssp             CCCCCTTTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred             hccCCCCcEEEEEEeccCCCEEEEEEEEC-------CCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence            33445678999999999999999999875       4678999999754   345688999999998 799999999999


Q ss_pred             eecCCc--ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCc
Q 014034          149 AVDGER--GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR  226 (432)
Q Consensus       149 ~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~  226 (432)
                      ......  ....++||||+.+++|.+++.......+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~  167 (326)
T 2x7f_A           91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAE  167 (326)
T ss_dssp             EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCC
T ss_pred             eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCC
Confidence            864311  23569999999999999999876555799999999999999999999998   9999999999999999999


Q ss_pred             eeeccccCCcCCCCCCCcccccccccCCCccCccccc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHH
Q 014034          227 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE-----TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL  301 (432)
Q Consensus       227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~  301 (432)
                      +||+|||++.....  .........||+.|+|||++.     +..++.++|||||||++|+|++|..||.........  
T Consensus       168 ~kl~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--  243 (326)
T 2x7f_A          168 VKLVDFGVSAQLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL--  243 (326)
T ss_dssp             EEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--
T ss_pred             EEEeeCcCceecCc--CccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH--
Confidence            99999999875321  112233457999999999986     567899999999999999999999999765543221  


Q ss_pred             HHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          302 LEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                       ..+...+.          +.+   .....+..+.+||.+||..||.+|||+.+++++
T Consensus       244 -~~~~~~~~----------~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          244 -FLIPRNPA----------PRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             -HHHHHSCC----------CCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             -HHhhcCcc----------ccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence             11111110          000   011123578899999999999999999999886

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.9e-43  Score=342.24  Aligned_cols=270  Identities=24%  Similarity=0.368  Sum_probs=202.6

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|++++.||+|+||.||+|...       .+++.||+|++...      ...+.+|+.+++.++||||+++++++...
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   88 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHR-------KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK   88 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEET-------TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred             ccceeEEEEEecCCCcEEEEEEEC-------CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecc
Confidence            357999999999999999999975       46789999988543      23578999999999999999999998764


Q ss_pred             CC----cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCce
Q 014034          152 GE----RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP  227 (432)
Q Consensus       152 ~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~  227 (432)
                      ..    .....++||||+.+ +|.+.+.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+
T Consensus        89 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~  163 (351)
T 3mi9_A           89 ASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVL  163 (351)
T ss_dssp             --------CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred             ccccccCCceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCE
Confidence            32    12356999999964 7877776543 4699999999999999999999998   99999999999999999999


Q ss_pred             eeccccCCcCCCCCC--CcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 014034          228 KLSDFGLAREGPMVG--HTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  304 (432)
Q Consensus       228 kl~DfG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  304 (432)
                      ||+|||+++......  .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..
T Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~  243 (351)
T 3mi9_A          164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ  243 (351)
T ss_dssp             EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             EEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            999999997533211  1222345678999999999876 5689999999999999999999999988665444333322


Q ss_pred             Hhh-cccCccc----cccccCccc--cCcCCHH-------HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          305 VQQ-YPADSKK----FGLIMDPRL--EKEYSIN-------EARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       305 ~~~-~~~~~~~----~~~~~~~~l--~~~~~~~-------~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ... .+.....    .........  .......       .+..+.+||.+||+.||.+|||+.+++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            221 1111000    000000000  0000000       13458899999999999999999999987

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=6.7e-44  Score=361.72  Aligned_cols=248  Identities=26%  Similarity=0.385  Sum_probs=201.4

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc-------ChHHHHHHHHHhcccCCCccceeeeEEee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-------DGLQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~-------~~~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .++|.+.+.||+|+||.||+|...       .++..||||++..       ....+.+|+.+++.++||||+++++++..
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   97 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDK-------ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED   97 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             cCceEEeeEEecCCCEEEEEEEEC-------CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            357999999999999999999875       4678999999743       23458899999999999999999999976


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEE---cCCCce
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRP  227 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill---~~~~~~  227 (432)
                      .+    ..++||||+.+++|.+++....  .+++..++.++.||+.||.|||++   +|+||||||+|||+   +.++.+
T Consensus        98 ~~----~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~  168 (484)
T 3nyv_A           98 KG----YFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANI  168 (484)
T ss_dssp             SS----EEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCE
T ss_pred             CC----EEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcE
Confidence            54    4599999999999999997653  699999999999999999999998   99999999999999   567899


Q ss_pred             eeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 014034          228 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  307 (432)
Q Consensus       228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  307 (432)
                      ||+|||++......   .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......   ...+..
T Consensus       169 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~  241 (484)
T 3nyv_A          169 RIIDFGLSTHFEAS---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI---LKKVEK  241 (484)
T ss_dssp             EECCTTHHHHBCCC---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH
T ss_pred             EEEeeeeeEEcccc---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHHc
Confidence            99999999753221   22344579999999999976 689999999999999999999999987654332   222221


Q ss_pred             cccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ....   +        ........+..+.+||.+||+.||.+|||+.+++++
T Consensus       242 ~~~~---~--------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          242 GKYT---F--------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             CCCC---C--------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCC---C--------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            1100   0        000111234678899999999999999999999987

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.3e-43  Score=336.04  Aligned_cols=248  Identities=23%  Similarity=0.376  Sum_probs=201.3

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      .++|.+.+.||+|+||.||+|...       .+++.||+|.+....    ..+.+|+.+++.++||||+++++++...+ 
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   79 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQR-------LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT-   79 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred             hccceeeeeccCCCCceEEEEEEC-------CCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCC-
Confidence            457999999999999999999865       467899999986532    34789999999999999999999987654 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEE---cCCCceeec
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLS  230 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill---~~~~~~kl~  230 (432)
                         ..++||||+.+++|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||+   +.++.+||+
T Consensus        80 ---~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~  151 (304)
T 2jam_A           80 ---HYYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMIT  151 (304)
T ss_dssp             ---EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBC
T ss_pred             ---EEEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEc
Confidence               4599999999999999986543  689999999999999999999998   99999999999999   788999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      |||++....    ........||+.|+|||++.+..++.++||||||+++|+|++|..||.......   +...+.....
T Consensus       152 Dfg~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~  224 (304)
T 2jam_A          152 DFGLSKMEQ----NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK---LFEKIKEGYY  224 (304)
T ss_dssp             SCSTTCCCC----CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHCCC
T ss_pred             cCCcceecC----CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHcCCC
Confidence            999987522    112234569999999999999999999999999999999999999998654432   2221211110


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .           +........+..+.+|+.+||..||.+|||+.+++++
T Consensus       225 ~-----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          225 E-----------FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             C-----------CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             C-----------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            0           0001112234678899999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4e-44  Score=336.74  Aligned_cols=253  Identities=25%  Similarity=0.363  Sum_probs=201.5

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|++.+.||+|+||.||+|...       .+++.||+|.+...      ...+.+|+.+++.++||||+++++++...
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRK-------SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR   77 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG
T ss_pred             hhheeeehhccCCCCcEEEEEEEC-------CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC
Confidence            467999999999999999999875       46789999998642      22478899999999999999999988654


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCc-----eeecCCCCCceEEcCC
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQ-----VIYRDFKASNVLLDEN  224 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~-----ivH~Dikp~Nill~~~  224 (432)
                      ..  ...++||||+++++|.+++...  ....+++..++.++.|++.||.|||+.   +     |+||||||+|||++.+
T Consensus        78 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~  152 (279)
T 2w5a_A           78 TN--TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGK  152 (279)
T ss_dssp             GG--TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSS
T ss_pred             CC--ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCC
Confidence            32  2469999999999999999653  234589999999999999999999998   7     9999999999999999


Q ss_pred             CceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 014034          225 FRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  304 (432)
Q Consensus       225 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  304 (432)
                      +.+||+|||++.....  .........||+.|+|||++.+..++.++||||||+++|+|++|..||.......   +...
T Consensus       153 ~~~kl~dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~  227 (279)
T 2w5a_A          153 QNVKLGDFGLARILNH--DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGK  227 (279)
T ss_dssp             SCEEECCCCHHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH
T ss_pred             CCEEEecCchheeecc--ccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HHHH
Confidence            9999999999875321  1222334578999999999999899999999999999999999999998764332   2222


Q ss_pred             HhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          305 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                      +.....          +.+    +...+..+.+|+.+||+.||.+|||+.+|++++.
T Consensus       228 i~~~~~----------~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          228 IREGKF----------RRI----PYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             HHHTCC----------CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             Hhhccc----------ccC----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence            211110          011    1123467889999999999999999999998753

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.6e-43  Score=359.81  Aligned_cols=248  Identities=27%  Similarity=0.390  Sum_probs=196.5

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .+.|++++.||+|+||.||+|..+       .++..||+|.+...      ...+.+|+.+++.++||||+++++++...
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  108 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDK-------VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK  108 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEET-------TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             hcCeEEeeEEecCCCEEEEEEEEC-------CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence            346999999999999999999975       46788999998643      34588999999999999999999999765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC---CCcee
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE---NFRPK  228 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~k  228 (432)
                      .    ..++||||+.+|+|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.   ++.+|
T Consensus       109 ~----~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~k  179 (494)
T 3lij_A          109 R----NYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIK  179 (494)
T ss_dssp             S----EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEE
T ss_pred             C----EEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEE
Confidence            4    4599999999999999887653  689999999999999999999998   9999999999999976   45599


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      |+|||++....   .........||+.|+|||++. +.++.++|||||||++|+|++|..||.+......   ...+...
T Consensus       180 l~DfG~a~~~~---~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~  252 (494)
T 3lij_A          180 IVDFGLSAVFE---NQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI---LRKVEKG  252 (494)
T ss_dssp             ECCCTTCEECB---TTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHT
T ss_pred             EEECCCCeECC---CCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhC
Confidence            99999997532   122334567999999999986 5689999999999999999999999987654332   2222211


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ....      ..+.     ....+..+.+||.+||+.||.+|||+.+++++
T Consensus       253 ~~~~------~~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          253 KYTF------DSPE-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             CCCC------CSGG-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             CCCC------Cchh-----cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            1000      0000     11224568899999999999999999999976

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=6.4e-43  Score=329.59  Aligned_cols=244  Identities=25%  Similarity=0.396  Sum_probs=201.9

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .++|.+.+.||+|+||.||+|...       .++..||+|.+...       ...+.+|+.+++.++||||+++++++..
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   85 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREK-------QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD   85 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hhhceeeheecCCCCeEEEEEEEc-------CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence            357999999999999999999865       46789999998543       2357899999999999999999999876


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .+    ..++||||+++++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        86 ~~----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~  156 (284)
T 2vgo_A           86 RK----RIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIA  156 (284)
T ss_dssp             SS----EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred             CC----EEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEe
Confidence            44    4599999999999999997643  689999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      |||++.....    .......||+.|+|||++.+..++.++||||||+++|+|++|..||.........   ..+...  
T Consensus       157 Dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~--  227 (284)
T 2vgo_A          157 DFGWSVHAPS----LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH---RRIVNV--  227 (284)
T ss_dssp             CCTTCEECSS----SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHHHTT--
T ss_pred             cccccccCcc----cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH---HHHhcc--
Confidence            9999865321    1223467999999999999999999999999999999999999999865433221   111111  


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                               +..    .+...+..+.+||.+||..||.+|||+.+++++
T Consensus       228 ---------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          228 ---------DLK----FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             ---------CCC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             ---------ccC----CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence                     011    111224578899999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.2e-43  Score=344.54  Aligned_cols=274  Identities=22%  Similarity=0.240  Sum_probs=201.4

Q ss_pred             CHHHHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---------------hHHHHHHHHHhc
Q 014034           70 SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---------------GLQWVAEVQFLG  134 (432)
Q Consensus        70 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---------------~~~~~~E~~~l~  134 (432)
                      ...++....++|.+.+.||+|+||.||+|...        .+..||||++...               ...+.+|+.+++
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   84 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDS--------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLN   84 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECT--------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECC--------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHH
Confidence            35677888899999999999999999999853        4788999988532               145889999999


Q ss_pred             ccCCCccceeeeEEeecC-CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecC
Q 014034          135 VLEHPNLVKLIGYCAVDG-ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRD  213 (432)
Q Consensus       135 ~l~hpniv~l~~~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~D  213 (432)
                      .++||||+++++++.... ......++||||+. |+|.+++.... ..+++..+..++.||+.||.|||+.   +|+|||
T Consensus        85 ~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~D  159 (362)
T 3pg1_A           85 HFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEA---GVVHRD  159 (362)
T ss_dssp             HCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCC
T ss_pred             hCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecC
Confidence            999999999999987643 23345799999997 68888887543 4699999999999999999999998   999999


Q ss_pred             CCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 014034          214 FKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLER  292 (432)
Q Consensus       214 ikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~  292 (432)
                      |||+|||++.++.+||+|||++....   .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+
T Consensus       160 lkp~NIl~~~~~~~kl~Dfg~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  236 (362)
T 3pg1_A          160 LHPGNILLADNNDITICDFNLAREDT---ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG  236 (362)
T ss_dssp             CCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CChHHEEEcCCCCEEEEecCcccccc---cccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999997422   2222344678999999999876 6789999999999999999999999987


Q ss_pred             CCchhhHHHHHHHhhcccCcc-------ccccccCccc---c----CcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 014034          293 NRPKTEQRLLEWVQQYPADSK-------KFGLIMDPRL---E----KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE  358 (432)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l---~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  358 (432)
                      .........+......+....       .........+   .    .......+..+.+|+.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          237 STFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            654332221111111100000       0000000000   0    0011122456889999999999999999999998


Q ss_pred             H
Q 014034          359 R  359 (432)
Q Consensus       359 ~  359 (432)
                      +
T Consensus       317 h  317 (362)
T 3pg1_A          317 H  317 (362)
T ss_dssp             S
T ss_pred             C
Confidence            6

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.3e-43  Score=359.50  Aligned_cols=249  Identities=24%  Similarity=0.353  Sum_probs=199.0

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----------------hHHHHHHHHHhcccCCC
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----------------GLQWVAEVQFLGVLEHP  139 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----------------~~~~~~E~~~l~~l~hp  139 (432)
                      ..++|.+++.||+|+||.||+|..+       .++..||+|.+...                 ...+.+|+.+++.++||
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp  106 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEK-------NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHP  106 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEET-------TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCT
T ss_pred             cccceEEEeEecccCCeEEEEEEEC-------CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCC
Confidence            3568999999999999999999975       46788999998642                 23478899999999999


Q ss_pred             ccceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCce
Q 014034          140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNV  219 (432)
Q Consensus       140 niv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Ni  219 (432)
                      ||+++++++....    ..++||||+.+|+|.+++....  .+++..++.++.||+.||.|||+.   +|+||||||+||
T Consensus       107 niv~~~~~~~~~~----~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Ni  177 (504)
T 3q5i_A          107 NIIKLFDVFEDKK----YFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENI  177 (504)
T ss_dssp             TBCCEEEEEECSS----EEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             CCCeEEEEEEcCC----EEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHE
Confidence            9999999997654    4599999999999999987643  699999999999999999999998   999999999999


Q ss_pred             EEcCCC---ceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCch
Q 014034          220 LLDENF---RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK  296 (432)
Q Consensus       220 ll~~~~---~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~  296 (432)
                      |++.++   .+||+|||++.....   ........||+.|+|||++. +.++.++|||||||++|+|++|..||.+....
T Consensus       178 l~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  253 (504)
T 3q5i_A          178 LLENKNSLLNIKIVDFGLSSFFSK---DYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ  253 (504)
T ss_dssp             EESSTTCCSSEEECCCTTCEECCT---TSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             EEecCCCCccEEEEECCCCEEcCC---CCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            998776   699999999975322   22234567999999999987 46899999999999999999999999876543


Q ss_pred             hhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          297 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ..   ...+......       ....    .....+..+.+||.+||..||.+|||+.+++++
T Consensus       254 ~~---~~~i~~~~~~-------~~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          254 DI---IKKVEKGKYY-------FDFN----DWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             HH---HHHHHHCCCC-------CCHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HH---HHHHHcCCCC-------CCcc----ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            32   2222211100       0000    001123578899999999999999999999987

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.2e-43  Score=340.33  Aligned_cols=260  Identities=23%  Similarity=0.330  Sum_probs=186.7

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccC-CCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLE-HPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~-hpniv~l~~~~~~~~  152 (432)
                      ..+|++.+.||+|+||.||+|.+.       .++..||+|++....    ..+.+|+.++..+. ||||+++++++....
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~   99 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDV-------GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK   99 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEET-------TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred             CceEEEEEEEccCCceEEEEEEEC-------CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence            357999999999999999999875       467899999885433    24788999999995 999999999986422


Q ss_pred             ----CcceeEEEEEeecCCCCHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCc--eeecCCCCCceEEcCCC
Q 014034          153 ----ERGIQRLLVYEFMLNRSLEDHLFN-RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQ--VIYRDFKASNVLLDENF  225 (432)
Q Consensus       153 ----~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~--ivH~Dikp~Nill~~~~  225 (432)
                          ......++||||+. |+|.+++.. .....+++..++.++.||+.||.|||+.   +  |+||||||+|||++.++
T Consensus       100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~  175 (337)
T 3ll6_A          100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQG  175 (337)
T ss_dssp             TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTS
T ss_pred             cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCC
Confidence                22345689999995 799998864 2234699999999999999999999998   7  99999999999999999


Q ss_pred             ceeeccccCCcCCCCCCCc----------ccccccccCCCccCcccc---ccCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 014034          226 RPKLSDFGLAREGPMVGHT----------HVSTAVVGTFGYAAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLER  292 (432)
Q Consensus       226 ~~kl~DfG~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltg~~pf~~  292 (432)
                      .+||+|||++.........          .......||+.|+|||++   .+..++.++|||||||++|+|++|..||..
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  255 (337)
T 3ll6_A          176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED  255 (337)
T ss_dssp             CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            9999999999764322111          011245689999999998   567789999999999999999999999975


Q ss_pred             CCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhcc
Q 014034          293 NRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  368 (432)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  368 (432)
                      .....   +...  ..           ..    ......+..+.+|+.+||+.||.+|||+.+++++|+.+....+
T Consensus       256 ~~~~~---~~~~--~~-----------~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          256 GAKLR---IVNG--KY-----------SI----PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             ---------------C-----------CC----CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             hhHHH---hhcC--cc-----------cC----CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence            43211   1100  00           00    0001112347789999999999999999999999999876543

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.7e-44  Score=347.52  Aligned_cols=263  Identities=26%  Similarity=0.402  Sum_probs=200.7

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|++.+.||+|+||.||+|.+.       .++..||+|.+...     ...+.+|+.+++.++||||+++++++...+
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  104 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHK-------PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG  104 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT
T ss_pred             cccceeeeeecCCCCeEEEEEEEC-------CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC
Confidence            367999999999999999999875       46789999998653     234789999999999999999999998754


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..++||||+++++|.+++....  .+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+||
T Consensus       105 ----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Df  176 (360)
T 3eqc_A          105 ----EISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDF  176 (360)
T ss_dssp             ----EEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCC
T ss_pred             ----EEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEEC
Confidence                3599999999999999997643  689999999999999999999983  17999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh--cc-
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ--YP-  309 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~--~~-  309 (432)
                      |++....    ........||+.|+|||++.+..++.++|||||||++|+|++|..||.................  .. 
T Consensus       177 g~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3eqc_A          177 GVSGQLI----DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE  252 (360)
T ss_dssp             CCCHHHH----HHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------
T ss_pred             CCCcccc----cccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCC
Confidence            9986321    1122345799999999999999999999999999999999999999987654332211100000  00 


Q ss_pred             ----------------cC---ccc----cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ----------------AD---SKK----FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ----------------~~---~~~----~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                      ..   ...    ...+.............+..+.+|+.+||+.||.+|||+.+++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             ---------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                            00   000    000000000001111234578899999999999999999999987

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.3e-43  Score=335.21  Aligned_cols=259  Identities=26%  Similarity=0.382  Sum_probs=197.4

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|++.+.||+|+||.||+|.+...    ......||+|.+...       ...+.+|+.+++.++||||+++++++...
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAP----SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECT----TSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hHeeeeeeecCCCceeEEEEEeccC----CCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            5799999999999999999987522    234567999998643       13478999999999999999999998754


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      .     .++||||+.+++|.+++.... ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        94 ~-----~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~D  164 (291)
T 1u46_A           94 P-----MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGD  164 (291)
T ss_dssp             S-----CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECC
T ss_pred             C-----ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcc
Confidence            3     389999999999999997643 3689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCc-ccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcc
Q 014034          232 FGLAREGPMVGHT-HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       232 fG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      ||++......... .......+|..|+|||++.+..++.++||||||+++|+|++ |..||.+.....   ....+....
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~~~  241 (291)
T 1u46_A          165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKIDKEG  241 (291)
T ss_dssp             CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTSC
T ss_pred             ccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH---HHHHHHccC
Confidence            9999764322221 12234567889999999998889999999999999999999 999998765432   222221110


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                      ..         .    ..+...+..+.+++.+||..||.+|||+.++++.|+.+...
T Consensus       242 ~~---------~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          242 ER---------L----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             CC---------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             CC---------C----CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence            00         0    11122346788999999999999999999999999887643

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.9e-43  Score=334.84  Aligned_cols=254  Identities=23%  Similarity=0.330  Sum_probs=193.3

Q ss_pred             cCCccc-cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC----hHHHHHHHHHhccc-CCCccceeeeEEeecC
Q 014034           79 NDFSRM-LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVAEVQFLGVL-EHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~-~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  152 (432)
                      +.|.+. +.||+|+||.||+|...       .++..||||++...    ...+.+|+.++.++ +||||+++++++...+
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~   84 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINL-------ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED   84 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECS-------SSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             eeEEecCceecCCceEEEEEEEEc-------CCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            468874 78999999999999854       56789999998643    34588999999885 7999999999998754


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCc---eee
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR---PKL  229 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~---~kl  229 (432)
                          ..++||||+.+++|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.   +||
T Consensus        85 ----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl  155 (316)
T 2ac3_A           85 ----RFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKI  155 (316)
T ss_dssp             ----EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEE
T ss_pred             ----EEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEE
Confidence                4599999999999999997643  689999999999999999999998   9999999999999998776   999


Q ss_pred             ccccCCcCCCCCCC-----cccccccccCCCccCcccccc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchh--
Q 014034          230 SDFGLAREGPMVGH-----THVSTAVVGTFGYAAPDYIET-----GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT--  297 (432)
Q Consensus       230 ~DfG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~--  297 (432)
                      +|||++........     ........||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+.....  
T Consensus       156 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  235 (316)
T 2ac3_A          156 CDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG  235 (316)
T ss_dssp             CCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC
T ss_pred             EEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc
Confidence            99999875322111     111224569999999999975     567899999999999999999999998654321  


Q ss_pred             ----------hHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          298 ----------EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       298 ----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                ...+...+......           +........+..+.+|+.+||+.||.+|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~i~~~~~~-----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          236 WDRGEACPACQNMLFESIQEGKYE-----------FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             C----CCHHHHHHHHHHHHHCCCC-----------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ccccccchhHHHHHHHHHhccCcc-----------cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence                      11111111111000           0000001124578899999999999999999999886

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.6e-43  Score=334.41  Aligned_cols=247  Identities=28%  Similarity=0.412  Sum_probs=202.8

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ..|..++.||+|+||.||+|...       .++..||+|.+...     ...+.+|+.+++.++||||+++++++.... 
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   93 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDN-------RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-   93 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred             HHHHHhhhhcccCCeEEEEEEEC-------CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence            46999999999999999999865       46789999998543     345889999999999999999999998754 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+.+++|.+++..   .++++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        94 ---~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg  164 (303)
T 3a7i_A           94 ---KLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFG  164 (303)
T ss_dssp             ---EEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ---eEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecc
Confidence               35999999999999999854   3689999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      ++.....  .........||+.|+|||++.+..++.++||||||+++|+|++|..||.........   ..+....    
T Consensus       165 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~----  235 (303)
T 3a7i_A          165 VAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---FLIPKNN----  235 (303)
T ss_dssp             TCEECBT--TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHHHSC----
T ss_pred             cceecCc--cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH---HHhhcCC----
Confidence            9975321  122234567999999999999999999999999999999999999999865543221   1111110    


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  361 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  361 (432)
                            .+.+...    .+..+.+|+.+||+.||.+|||+.+++++..
T Consensus       236 ------~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~  273 (303)
T 3a7i_A          236 ------PPTLEGN----YSKPLKEFVEACLNKEPSFRPTAKELLKHKF  273 (303)
T ss_dssp             ------CCCCCSS----CCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred             ------CCCCccc----cCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence                  1111112    2356889999999999999999999998753

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.7e-43  Score=349.23  Aligned_cols=200  Identities=29%  Similarity=0.350  Sum_probs=164.5

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|.+.+.||+|+||.||+|.+.       .+++.||||++...      ...+.+|+.+|+.++||||+++++++...
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~-------~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~   97 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDK-------NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPD   97 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEET-------TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             cCCEEEEEEEeecCCEEEEEEEEC-------CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecC
Confidence            458999999999999999999875       56789999998652      23478999999999999999999998765


Q ss_pred             CC-cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          152 GE-RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       152 ~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .. .....++||||+. ++|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+||||+.++.+||+
T Consensus        98 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~  171 (432)
T 3n9x_A           98 DLLKFDELYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVC  171 (432)
T ss_dssp             CTTTCCCEEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred             CCCcCCeEEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEc
Confidence            32 1135699999985 6999999754  3699999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCc--------------------ccccccccCCCccCcccc-ccCCCCchhhhHHHHHHHHHHHhCCCC
Q 014034          231 DFGLAREGPMVGHT--------------------HVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRS  289 (432)
Q Consensus       231 DfG~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltg~~p  289 (432)
                      |||+++........                    ......+||+.|+|||++ .+..++.++|||||||++|||++|..|
T Consensus       172 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p  251 (432)
T 3n9x_A          172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS  251 (432)
T ss_dssp             CCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred             cCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence            99999854222111                    123567899999999986 566799999999999999999985444


Q ss_pred             C
Q 014034          290 L  290 (432)
Q Consensus       290 f  290 (432)
                      |
T Consensus       252 ~  252 (432)
T 3n9x_A          252 H  252 (432)
T ss_dssp             T
T ss_pred             c
Confidence            4

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.6e-43  Score=335.30  Aligned_cols=251  Identities=27%  Similarity=0.397  Sum_probs=198.6

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC--hHHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      ..++|.+.+.||+|+||.||+|.+.       .++..||+|.+...  ...+.+|+.+++.++||||+++++++...+  
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   97 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHK-------ETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNT--   97 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEET-------TTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETT--
T ss_pred             chhhhhhheeeccCCCeEEEEEEEC-------CCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC--
Confidence            4568999999999999999999875       45789999998653  356889999999999999999999997654  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        ..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||+
T Consensus        98 --~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~  171 (314)
T 3com_A           98 --DLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGV  171 (314)
T ss_dssp             --EEEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             --EEEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeeccc
Confidence              3599999999999999986432 4689999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      +.....  .........||+.|+|||++.+..++.++||||||+++|+|++|..||..........   ........   
T Consensus       172 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~---  243 (314)
T 3com_A          172 AGQLTD--TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF---MIPTNPPP---  243 (314)
T ss_dssp             CEECBT--TBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHHSCCC---
T ss_pred             chhhhh--hccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHhcCCCc---
Confidence            975321  1222344578999999999999999999999999999999999999998655432211   11111100   


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                             .+  ..+...+..+.+|+.+||..||.+|||+.+++++
T Consensus       244 -------~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          244 -------TF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             -------CC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             -------cc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                   00  0111224578899999999999999999999886

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.8e-43  Score=331.55  Aligned_cols=247  Identities=23%  Similarity=0.357  Sum_probs=201.8

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .++|.+.+.||+|+||.||+|...       .++..||+|.+...       ...+.+|+.+++.++||||+++++++..
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   86 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDA-------DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED   86 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             ccceEEEEEEeecCCEEEEEEEEC-------CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence            357999999999999999999875       45788999987543       2347889999999999999999999876


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .+    ..++||||+.+++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        87 ~~----~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~  157 (294)
T 2rku_A           87 ND----FVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIG  157 (294)
T ss_dssp             SS----EEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred             CC----EEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEE
Confidence            44    4599999999999999986543  689999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      |||++......  ........||+.|+|||++.+..++.++||||||+++|+|++|..||.........   ..+.... 
T Consensus       158 dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~-  231 (294)
T 2rku_A          158 DFGLATKVEYD--GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY---LRIKKNE-  231 (294)
T ss_dssp             CCTTCEECCST--TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHHHTTC-
T ss_pred             eccCceecccC--ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHhhcc-
Confidence            99999753221  12234467999999999999989999999999999999999999999865433221   1111100 


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                                ..+    +...+..+.+|+.+||+.||.+|||+.+++++-
T Consensus       232 ----------~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~  267 (294)
T 2rku_A          232 ----------YSI----PKHINPVAASLIQKMLQTDPTARPTINELLNDE  267 (294)
T ss_dssp             ----------CCC----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             ----------CCC----ccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence                      001    112235688999999999999999999999863

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-43  Score=338.59  Aligned_cols=275  Identities=25%  Similarity=0.393  Sum_probs=206.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      ++|++++.||+|+||.||+|.+..   ....++..||+|.+....    ..+.+|+.+++.++||||+++++++...+..
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  117 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDP---LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR  117 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECT---TSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred             HHceeeeeeccCCCeEEEEEEecc---ccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence            468999999999999999998642   123468999999987543    2478999999999999999999998765422


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        ..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       118 --~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          118 --NLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL  191 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             --ceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence              3489999999999999997653 3689999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCc-ccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 014034          235 AREGPMVGHT-HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       235 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      +......... .......++..|+|||.+.+..++.++||||||+++|+|+||..||......    .............
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~----~~~~~~~~~~~~~  267 (326)
T 2w1i_A          192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQM  267 (326)
T ss_dssp             CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH----HHHHHCTTCCTHH
T ss_pred             hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH----HHHhhccccchhh
Confidence            9864322211 1123345778899999999888999999999999999999999998642110    0000000000000


Q ss_pred             ---ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          314 ---KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       314 ---~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                         .+...+........+...+..+.+||.+||+.||.+|||+.+|++.|+.+...
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          268 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence               00000000000111223456788999999999999999999999999988653

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=7.6e-43  Score=336.13  Aligned_cols=261  Identities=20%  Similarity=0.299  Sum_probs=199.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-hHHHHHHHHHhcccC-CCccceeeeEEeecCCcce
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQWVAEVQFLGVLE-HPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~  156 (432)
                      ++|++.+.||+|+||.||+|...       .+++.||+|.+... ...+.+|+.+++.+. ||||+++++++......  
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~--  106 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINI-------TNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSR--  106 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC--
T ss_pred             CceEEEEEecccCCeEEEEEEEC-------CCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC--
Confidence            67999999999999999999865       46789999998754 456889999999997 99999999998764332  


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC-ceeeccccCC
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF-RPKLSDFGLA  235 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~DfG~a  235 (432)
                      ..++||||+.+++|.+++.     .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++ .+||+|||++
T Consensus       107 ~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a  178 (330)
T 3nsz_A          107 TPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLA  178 (330)
T ss_dssp             CEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             ceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence            4589999999999999984     488999999999999999999998   999999999999999776 8999999999


Q ss_pred             cCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhH-----------HHHH
Q 014034          236 REGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-----------RLLE  303 (432)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-----------~~~~  303 (432)
                      +.....   .......||..|+|||++.+ ..++.++|||||||++|+|++|..||.........           ....
T Consensus       179 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~  255 (330)
T 3nsz_A          179 EFYHPG---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD  255 (330)
T ss_dssp             EECCTT---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred             eEcCCC---CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhh
Confidence            753221   22344578999999999977 67899999999999999999999999654332211           0111


Q ss_pred             HHhhcccC-ccccccc--------cCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          304 WVQQYPAD-SKKFGLI--------MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       304 ~~~~~~~~-~~~~~~~--------~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ++...... ...+...        .............+..+.+||.+||+.||.+|||+.+++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            11111000 0000000        00001111112235678899999999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=8.2e-43  Score=341.80  Aligned_cols=262  Identities=23%  Similarity=0.287  Sum_probs=193.7

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|.+++.||+|+||.||+|...       .++..||||++...      ...+.+|+.+++.++||||+++++++...
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   96 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDA-------ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ   96 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSC
T ss_pred             hhheeEeeeeEecCCEEEEEEEEC-------CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccc
Confidence            468999999999999999999865       46789999998642      12477899999999999999999998765


Q ss_pred             C--CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          152 G--ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       152 ~--~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      .  ......++||||+. ++|.+++..    .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||
T Consensus        97 ~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl  168 (371)
T 2xrw_A           97 KSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKI  168 (371)
T ss_dssp             CSTTTCCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred             cccccccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEE
Confidence            4  12235699999996 578888853    589999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      +|||+++...   .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+........  ..+....
T Consensus       169 ~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~i~~~~~  243 (371)
T 2xrw_A          169 LDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN--KVIEQLG  243 (371)
T ss_dssp             CCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHC-CC
T ss_pred             EEeecccccc---cccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhC
Confidence            9999997532   1222344679999999999999999999999999999999999999998765432211  1111110


Q ss_pred             cCc-----------------------cccccccCccccC---cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ADS-----------------------KKFGLIMDPRLEK---EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~~-----------------------~~~~~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ...                       ..+..........   ......+..+.+|+.+||..||.+|||+.+++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             CCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence            000                       0000000000000   0112336678999999999999999999999987

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.4e-43  Score=338.94  Aligned_cols=246  Identities=24%  Similarity=0.362  Sum_probs=201.9

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .++|.+.+.||+|+||.||++...       .++..||+|.+...       ...+.+|+.+++.++||||+++++++..
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  112 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDA-------DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED  112 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            357999999999999999999875       46788999997643       2347889999999999999999999876


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .+    ..++||||+.+++|.+++...  ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+
T Consensus       113 ~~----~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~  183 (335)
T 2owb_A          113 ND----FVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIG  183 (335)
T ss_dssp             SS----EEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEEC
T ss_pred             CC----eEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEe
Confidence            54    459999999999999998654  3689999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      |||++......  ........||+.|+|||++.+..++.++||||||+++|+|++|..||...........   +.... 
T Consensus       184 Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~-  257 (335)
T 2owb_A          184 DFGLATKVEYD--GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR---IKKNE-  257 (335)
T ss_dssp             CCTTCEECCST--TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---HHHTC-
T ss_pred             eccCceecccC--cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHH---HhcCC-
Confidence            99999753222  1223446799999999999998999999999999999999999999986543322111   11110 


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                ..+    +...+..+.+||.+||+.||.+|||+.+++++
T Consensus       258 ----------~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          258 ----------YSI----PKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             ----------CCC----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ----------CCC----CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                      001    11223567899999999999999999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6.3e-43  Score=366.90  Aligned_cols=247  Identities=26%  Similarity=0.389  Sum_probs=202.9

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhccc-CCCccceeeeEE
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVL-EHPNLVKLIGYC  148 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~hpniv~l~~~~  148 (432)
                      ..++|.+++.||+|+||.||+|..+       .+++.||||++.+..       ..+..|..++..+ +||||+.+++++
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~-------~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~  411 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERK-------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF  411 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEES-------SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC
T ss_pred             cccceEEEEEEccCCCEEEEEEEEC-------CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE
Confidence            4578999999999999999999976       467899999987532       3477899999887 799999999988


Q ss_pred             eecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCcee
Q 014034          149 AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  228 (432)
Q Consensus       149 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k  228 (432)
                      ...+    .++|||||+.+|+|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+||||+.++.+|
T Consensus       412 ~~~~----~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ik  482 (674)
T 3pfq_A          412 QTMD----RLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIK  482 (674)
T ss_dssp             BCSS----EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEE
T ss_pred             EeCC----EEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEE
Confidence            6544    4599999999999999997653  699999999999999999999998   999999999999999999999


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      |+|||+++.....  .......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+...   +...+...
T Consensus       483 L~DFGla~~~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~---~~~~i~~~  557 (674)
T 3pfq_A          483 IADFGMCKENIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIMEH  557 (674)
T ss_dssp             ECCCTTCEECCCT--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHSS
T ss_pred             EeecceeeccccC--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH---HHHHHHhC
Confidence            9999999853222  223456789999999999999999999999999999999999999998754432   22222111


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM-----SQVVER  359 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~~  359 (432)
                      .           .    .++...+..+.+||.+||+.||.+||++     .+|+++
T Consensus       558 ~-----------~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          558 N-----------V----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             C-----------C----CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             C-----------C----CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence            0           0    1122234678899999999999999998     777765

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.5e-43  Score=340.87  Aligned_cols=258  Identities=19%  Similarity=0.224  Sum_probs=180.7

Q ss_pred             hcCCcccc-ccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHHHHHHHhcccCCCccceeeeEEeecCCcce
Q 014034           78 TNDFSRML-KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        78 ~~~~~~~~-~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~  156 (432)
                      .++|.+.+ .||+|+||.||+|.+.       .+++.||+|++.............++.+.||||+++++++........
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   99 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHR-------RTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKR   99 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEEC-------CCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence            45799865 5999999999999876       467899999997765544444455677899999999999876544445


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC---CCceeecccc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE---NFRPKLSDFG  233 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~DfG  233 (432)
                      ..++||||+.+|+|.+++.......+++..++.++.||+.||.|||+.   +|+||||||+|||++.   ++.+||+|||
T Consensus       100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence            579999999999999999877666799999999999999999999998   9999999999999976   4559999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHH-HHHHhhcccCc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL-LEWVQQYPADS  312 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~-~~~~~~~~~~~  312 (432)
                      ++....    ........||+.|+|||++.+..++.++|||||||++|+|++|..||........... ...+..     
T Consensus       177 ~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----  247 (336)
T 3fhr_A          177 FAKETT----QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL-----  247 (336)
T ss_dssp             TCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred             cceecc----ccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc-----
Confidence            997532    1122346789999999999888899999999999999999999999976543221100 000000     


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                            ....+........+..+.+|+.+||+.||.+|||+.+++++-
T Consensus       248 ------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          248 ------GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             ---------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             ------cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence                  000001111122346788999999999999999999999873

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-43  Score=345.48  Aligned_cols=254  Identities=26%  Similarity=0.374  Sum_probs=199.9

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC--------hHHHHHHHHHhccc-CCCccceeeeEE
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--------GLQWVAEVQFLGVL-EHPNLVKLIGYC  148 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l-~hpniv~l~~~~  148 (432)
                      .++|.+++.||+|+||.||+|....    +..+++.||||++...        ...+.+|+.++..+ +||||+++++++
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  128 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKIS----GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF  128 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECS----STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcc----cCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence            3579999999999999999998741    2246789999998642        23467899999999 699999999998


Q ss_pred             eecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCcee
Q 014034          149 AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  228 (432)
Q Consensus       149 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k  228 (432)
                      ....    ..++||||+.+++|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+|
T Consensus       129 ~~~~----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~k  199 (355)
T 1vzo_A          129 QTET----KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVV  199 (355)
T ss_dssp             EETT----EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred             eeCc----eEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEE
Confidence            7654    3599999999999999997643  689999999999999999999998   999999999999999999999


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCcccccc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhh-HHHHHHH
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET--GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-QRLLEWV  305 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~-~~~~~~~  305 (432)
                      |+|||+++..... .........||+.|+|||++.+  ..++.++|||||||++|+|++|..||........ ..+...+
T Consensus       200 l~DfG~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  278 (355)
T 1vzo_A          200 LTDFGLSKEFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI  278 (355)
T ss_dssp             ESCSSEEEECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH
T ss_pred             EeeCCCCeecccC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH
Confidence            9999999753211 1222334679999999999986  3478999999999999999999999975433221 1222211


Q ss_pred             hhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHH
Q 014034          306 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVERL  360 (432)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L  360 (432)
                      ....           +    ..+...+..+.+||.+||..||.+||     |+.+++++.
T Consensus       279 ~~~~-----------~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          279 LKSE-----------P----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             HHCC-----------C----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             hccC-----------C----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            1110           1    11222345688999999999999999     999998874

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.9e-42  Score=332.69  Aligned_cols=270  Identities=26%  Similarity=0.386  Sum_probs=204.5

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhccc---CCCccceeeeE
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVL---EHPNLVKLIGY  147 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l---~hpniv~l~~~  147 (432)
                      ..++|.+.+.||+|+||.||+|...      ..++..||+|.+...      ...+.+|+.+++.+   +||||++++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~   82 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDL------KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV   82 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEET------TTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEec------CCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeee
Confidence            4578999999999999999999863      135789999988532      12467788887766   89999999999


Q ss_pred             EeecC-CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCc
Q 014034          148 CAVDG-ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR  226 (432)
Q Consensus       148 ~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~  226 (432)
                      +.... ......++||||+. |+|.+++.......+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~  158 (326)
T 1blx_A           83 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQ  158 (326)
T ss_dssp             EEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCC
T ss_pred             eeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCC
Confidence            87321 23345699999997 6999999876656799999999999999999999998   9999999999999999999


Q ss_pred             eeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 014034          227 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  306 (432)
Q Consensus       227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  306 (432)
                      +||+|||++....   .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+....
T Consensus       159 ~kl~Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  235 (326)
T 1blx_A          159 IKLADFGLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI  235 (326)
T ss_dssp             EEECSCCSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             EEEecCccccccc---CCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHc
Confidence            9999999997532   2223345678999999999999999999999999999999999999998765433221111111


Q ss_pred             hcccC-cccc-----ccccC---ccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          307 QYPAD-SKKF-----GLIMD---PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       307 ~~~~~-~~~~-----~~~~~---~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ..+.. ....     .....   ...........+..+.+|+.+||..||.+|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            11100 0000     00000   000011122334678899999999999999999999875

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6e-43  Score=365.97  Aligned_cols=258  Identities=25%  Similarity=0.349  Sum_probs=205.2

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ..++|.+.+.||+|+||.||+|.+...    ...+..||+|.+....     ..+.+|+.+++.++||||+++++++.. 
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-  462 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSP----ENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-  462 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCS----SSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecC----CCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-
Confidence            346799999999999999999998622    2346789999986532     347899999999999999999999843 


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ..++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus       463 ~----~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~D  534 (656)
T 2j0j_A          463 N----PVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD  534 (656)
T ss_dssp             S----SCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred             C----ceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEe
Confidence            2    2489999999999999997653 3689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhccc
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      ||+++..... .........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+......   ...+.....
T Consensus       535 FG~a~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~~~i~~~~~  610 (656)
T 2j0j_A          535 FGLSRYMEDS-TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIENGER  610 (656)
T ss_dssp             CCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHHHTCC
T ss_pred             cCCCeecCCC-cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHcCCC
Confidence            9999864221 1122233457889999999999999999999999999999997 9999987654332   222211100


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                                .    ..+...+..+.+||.+||..||.+|||+.+|++.|+.+++
T Consensus       611 ----------~----~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          611 ----------L----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             ----------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------C----CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence                      0    1112234678899999999999999999999999999875

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.3e-42  Score=335.07  Aligned_cols=263  Identities=22%  Similarity=0.310  Sum_probs=204.6

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh---HHHHHHHHHhcccCCC------ccceeeeEE
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQWVAEVQFLGVLEHP------NLVKLIGYC  148 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~hp------niv~l~~~~  148 (432)
                      .++|++.+.||+|+||.||+|...      ..++..||+|++....   ..+.+|+.+++.++|+      +|+++++++
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~   86 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDH------KAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF   86 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEET------TTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEec------CCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence            458999999999999999999863      2367899999997654   3478899999888765      499999998


Q ss_pred             eecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC-----
Q 014034          149 AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE-----  223 (432)
Q Consensus       149 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~-----  223 (432)
                      ...+    ..++||||+ +++|.+++......++++..+..++.||+.||.|||++   +|+||||||+|||++.     
T Consensus        87 ~~~~----~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~  158 (339)
T 1z57_A           87 EHHG----HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTE  158 (339)
T ss_dssp             EETT----EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEE
T ss_pred             ccCC----cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEecccccc
Confidence            7655    459999999 89999999877666799999999999999999999998   9999999999999987     


Q ss_pred             --------------CCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCC
Q 014034          224 --------------NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRS  289 (432)
Q Consensus       224 --------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p  289 (432)
                                    ++.+||+|||++.....     ......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus       159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  233 (339)
T 1z57_A          159 AYNPKIKRDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV  233 (339)
T ss_dssp             EEC----CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccCCccccccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence                          67899999999975221     22346799999999999999999999999999999999999999


Q ss_pred             CCCCCchhhHHHHHHHhh-cccCc-------ccc-----------------ccccCccc-cCcCCHHHHHHHHHHHHHhc
Q 014034          290 LERNRPKTEQRLLEWVQQ-YPADS-------KKF-----------------GLIMDPRL-EKEYSINEARKIGRLADNCL  343 (432)
Q Consensus       290 f~~~~~~~~~~~~~~~~~-~~~~~-------~~~-----------------~~~~~~~l-~~~~~~~~~~~l~~li~~cl  343 (432)
                      |................. .+...       ..+                 .....+.. ........+..+.+|+.+||
T Consensus       234 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  313 (339)
T 1z57_A          234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML  313 (339)
T ss_dssp             CCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHh
Confidence            987655443322222111 11000       000                 00000000 01123455678999999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 014034          344 SKSSKDRPKMSQVVER  359 (432)
Q Consensus       344 ~~dP~~RPs~~eil~~  359 (432)
                      +.||.+|||+.+++++
T Consensus       314 ~~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          314 EYDPAKRITLREALKH  329 (339)
T ss_dssp             CSSTTTSCCHHHHTTS
T ss_pred             CcCcccccCHHHHhcC
Confidence            9999999999999876

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.2e-42  Score=350.70  Aligned_cols=266  Identities=22%  Similarity=0.276  Sum_probs=206.4

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC--hHHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      .++|.+++.||+|+||.||+|.+.       .++..||||++...  ...+..|+.+++.+.|++++..+.++....   
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~---   75 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNI-------QTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEG---   75 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEET-------TTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEET---
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEEC-------CCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeC---
Confidence            468999999999999999999865       46789999987543  335889999999998755555444443332   


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEE---cCCCceeeccc
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDF  232 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill---~~~~~~kl~Df  232 (432)
                      ...++||||+ +++|.+++.... ..+++..++.|+.||+.||.|||+.   +|+||||||+||||   +.++.+||+||
T Consensus        76 ~~~~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DF  150 (483)
T 3sv0_A           76 DYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDF  150 (483)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred             CEEEEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeC
Confidence            2458999999 999999997543 4699999999999999999999998   99999999999999   68899999999


Q ss_pred             cCCcCCCCCCCc-----ccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 014034          233 GLAREGPMVGHT-----HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  307 (432)
Q Consensus       233 G~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  307 (432)
                      |+++........     .......||+.|+|||++.+..++.++|||||||++|||++|..||.+............+..
T Consensus       151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~  230 (483)
T 3sv0_A          151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE  230 (483)
T ss_dssp             TTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH
T ss_pred             CcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh
Confidence            999854322211     122356799999999999999999999999999999999999999988665443333322221


Q ss_pred             cccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhcc
Q 014034          308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  368 (432)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  368 (432)
                      ..... ..     ..+...    .+..+.+|+..||+.||.+||++.+|++.|+.++....
T Consensus       231 ~~~~~-~~-----~~l~~~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~  281 (483)
T 3sv0_A          231 KKVAT-SI-----EALCRG----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG  281 (483)
T ss_dssp             HHHHS-CH-----HHHHTT----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             ccccc-cH-----HHHhcC----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence            11000 00     000011    23578899999999999999999999999999987554

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=9.3e-43  Score=326.89  Aligned_cols=245  Identities=24%  Similarity=0.360  Sum_probs=192.6

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .++|.+.+.||+|+||.||+|.+.       .+++.||+|.+....       ..+.+|+.+++.++||||+++++++..
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   82 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQ-------LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST   82 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             eccEEEEeeecCCCCeEEEEEEEC-------CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            468999999999999999999875       467899999986432       247889999999999999999999876


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .+    ..++||||+.+++|.+++....  .+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.+||+
T Consensus        83 ~~----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~  153 (276)
T 2h6d_A           83 PT----DFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIA  153 (276)
T ss_dssp             SS----EEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEEC
T ss_pred             CC----eEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEe
Confidence            54    4599999999999999997643  689999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      |||++.....   ........||+.|+|||.+.+..+ +.++||||||+++|+|++|..||.......   ....+....
T Consensus       154 dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~  227 (276)
T 2h6d_A          154 DFGLSNMMSD---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT---LFKKIRGGV  227 (276)
T ss_dssp             CCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCC
T ss_pred             ecccccccCC---CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HHHHhhcCc
Confidence            9999975322   122334578999999999987765 589999999999999999999997654322   222111110


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .           .+    +...+..+.+++.+||+.||.+|||+.+++++
T Consensus       228 ~-----------~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          228 F-----------YI----PEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             C-----------CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             c-----------cC----chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            0           01    11123568899999999999999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5.8e-43  Score=341.98  Aligned_cols=267  Identities=25%  Similarity=0.316  Sum_probs=202.0

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|++++.||+|+||.||+|...       .++..||+|++....     ..+.+|+.++..++||||+++++++....
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   98 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDN-------LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT   98 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred             cccEEEEEEeecCCCeEEEEEEEC-------CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCC
Confidence            458999999999999999999865       567899999986432     34789999999999999999999987643


Q ss_pred             -CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          153 -ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       153 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                       ......++||||+. ++|.+++...   .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        99 ~~~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~D  171 (364)
T 3qyz_A           99 IEQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICD  171 (364)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred             ccccceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEe
Confidence             22235699999996 5999998653   589999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCC-cccccccccCCCccCccccc-cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          232 FGLAREGPMVGH-THVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       232 fG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      ||++........ ........||+.|+|||++. +..++.++|||||||++|+|++|..||.+.........+......+
T Consensus       172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  251 (364)
T 3qyz_A          172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP  251 (364)
T ss_dssp             CTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSC
T ss_pred             CcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCC
Confidence            999975322111 11124457999999999875 4568999999999999999999999998766544322221111111


Q ss_pred             cCcccccccc---------CccccCc-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ADSKKFGLIM---------DPRLEKE-----YSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~~~~~~~~~---------~~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .. .....+.         .......     .....+..+.+|+.+||+.||.+|||+.+++++
T Consensus       252 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          252 SQ-EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             CH-HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CH-HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00 0000000         0000000     011224568899999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8.7e-43  Score=330.14  Aligned_cols=249  Identities=23%  Similarity=0.360  Sum_probs=195.3

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC----hHHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      +|.....||+|+||.||+|...       .++..||+|.+...    ...+.+|+.+++.++||||+++++++...+   
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---   92 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDL-------SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG---   92 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEET-------TTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETT---
T ss_pred             CCCCcEEEeecCcEEEEEEEEC-------CCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC---
Confidence            4556668999999999999865       46789999998643    235789999999999999999999997654   


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC-CCceeecccc
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE-NFRPKLSDFG  233 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~DfG  233 (432)
                       ..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.   +|+||||||+|||++. ++.+||+|||
T Consensus        93 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg  168 (295)
T 2clq_A           93 -FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFG  168 (295)
T ss_dssp             -EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTT
T ss_pred             -cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecc
Confidence             3599999999999999997653 23567899999999999999999998   9999999999999987 8999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCC--CCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH--LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ++.....  .........||+.|+|||++.+..  ++.++||||||+++|+|++|..||......... ... .....  
T Consensus       169 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~-~~~~~--  242 (295)
T 2clq_A          169 TSKRLAG--INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-MFK-VGMFK--  242 (295)
T ss_dssp             TCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-HHH-HHHHC--
T ss_pred             cccccCC--CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-HHh-hcccc--
Confidence            9975321  122234467999999999997643  889999999999999999999999754332211 111 00000  


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                             ..+.+    +...+..+.+|+.+||+.||.+|||+.+++++
T Consensus       243 -------~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          243 -------VHPEI----PESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             -------CCCCC----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             -------ccccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                   01111    22234678899999999999999999999875

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=9.8e-43  Score=330.40  Aligned_cols=250  Identities=23%  Similarity=0.317  Sum_probs=200.4

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------------HHHHHHHHHhcccC-CCccc
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------------LQWVAEVQFLGVLE-HPNLV  142 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------------~~~~~E~~~l~~l~-hpniv  142 (432)
                      ..++|.+.+.||+|+||.||+|.+.       .+++.||+|.+....             ..+.+|+.+++++. ||||+
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~   87 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHK-------PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII   87 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred             hhhccceeeeecCCCceEEEEEEEc-------CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEe
Confidence            3468999999999999999999875       467899999985431             23678999999995 99999


Q ss_pred             eeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc
Q 014034          143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD  222 (432)
Q Consensus       143 ~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~  222 (432)
                      ++++++....    ..++||||+.+++|.+++...  ..+++..++.++.||+.||.|||+.   +|+||||||+|||++
T Consensus        88 ~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~  158 (298)
T 1phk_A           88 QLKDTYETNT----FFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLD  158 (298)
T ss_dssp             CEEEEEECSS----EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             eeeeeeccCC----eEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEc
Confidence            9999987544    459999999999999999764  3689999999999999999999998   999999999999999


Q ss_pred             CCCceeeccccCCcCCCCCCCcccccccccCCCccCccccc------cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCch
Q 014034          223 ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE------TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK  296 (432)
Q Consensus       223 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~  296 (432)
                      .++.+||+|||++.....   ........||+.|+|||++.      ...++.++||||||+++|+|++|..||......
T Consensus       159 ~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  235 (298)
T 1phk_A          159 DDMNIKLTDFGFSCQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM  235 (298)
T ss_dssp             TTCCEEECCCTTCEECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             CCCcEEEecccchhhcCC---CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH
Confidence            999999999999975322   12234467899999999985      456889999999999999999999999765443


Q ss_pred             hhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          297 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ...   ..+......           .........+..+.+|+.+||+.||.+|||+.+++++
T Consensus       236 ~~~---~~~~~~~~~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          236 LML---RMIMSGNYQ-----------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             HHH---HHHHHTCCC-----------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHH---HHHhcCCcc-----------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            221   111111000           0000011234678899999999999999999999875

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.4e-44  Score=353.47  Aligned_cols=243  Identities=17%  Similarity=0.195  Sum_probs=186.1

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHH---HHhcccCCCccceee--
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEV---QFLGVLEHPNLVKLI--  145 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~---~~l~~l~hpniv~l~--  145 (432)
                      .++|.+.+.||+|+||.||+|.+.       .+++.||||++...       ...+.+|+   .+++.++||||++++  
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~  144 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQ-------ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR  144 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC--------CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHC
T ss_pred             CceEEEcceeecCCCEEEEEEEEC-------CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhh
Confidence            467889999999999999999864       46789999998532       23478999   455566899999998  


Q ss_pred             -----eEEeecCC----------cc---eeEEEEEeecCCCCHHHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHhh
Q 014034          146 -----GYCAVDGE----------RG---IQRLLVYEFMLNRSLEDHLFNRA-----FPPLPWKTRLHIILGAAEGLAYLH  202 (432)
Q Consensus       146 -----~~~~~~~~----------~~---~~~~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~l~~~l~~LH  202 (432)
                           +++...+.          ..   ...++||||+ +|+|.+++....     ...+++..++.|+.||+.||.|||
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  223 (377)
T 3byv_A          145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH  223 (377)
T ss_dssp             BCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence                 55544321          00   1258999999 689999997532     112345888899999999999999


Q ss_pred             cCCCCceeecCCCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccC-----------CCCchh
Q 014034          203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-----------HLTAKS  271 (432)
Q Consensus       203 ~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~  271 (432)
                      ++   +|+||||||+||||+.++.+||+|||+++..     ........| +.|+|||++.+.           .++.++
T Consensus       224 ~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~-----~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~  294 (377)
T 3byv_A          224 HY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD-----GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSF  294 (377)
T ss_dssp             HT---TEECSCCCGGGEEECTTCCEEECCGGGCEET-----TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHH
T ss_pred             hC---CeecCCCCHHHEEEcCCCCEEEEechhheec-----CCcccCCCC-cCccChhhhcccccccccccccccCChhh
Confidence            98   9999999999999999999999999999852     112345567 999999999887           899999


Q ss_pred             hhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC
Q 014034          272 DVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP  351 (432)
Q Consensus       272 DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP  351 (432)
                      |||||||++|||++|..||.+......                ...+...      ....+..+.+||.+||+.||.+||
T Consensus       295 DvwSlG~il~elltg~~Pf~~~~~~~~----------------~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rp  352 (377)
T 3byv_A          295 DAWALGLVIYWIWCADLPITKDAALGG----------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRL  352 (377)
T ss_dssp             HHHHHHHHHHHHHHSSCCC------CC----------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCC
T ss_pred             hHHHHHHHHHHHHHCCCCCcccccccc----------------hhhhhhh------ccCCCHHHHHHHHHHcCCCchhCC
Confidence            999999999999999999975432110                0001110      012236788999999999999999


Q ss_pred             CHHHHHHH
Q 014034          352 KMSQVVER  359 (432)
Q Consensus       352 s~~eil~~  359 (432)
                      |+.+++++
T Consensus       353 t~~e~l~h  360 (377)
T 3byv_A          353 LPLQAMET  360 (377)
T ss_dssp             CHHHHHTS
T ss_pred             CHHHHhhC
Confidence            99999875

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.1e-42  Score=334.24  Aligned_cols=250  Identities=24%  Similarity=0.358  Sum_probs=196.5

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------------HHHHHHHHHhcccCCCcccee
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------------LQWVAEVQFLGVLEHPNLVKL  144 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~hpniv~l  144 (432)
                      ..++|.+.+.||+|+||.||+|...       .++..||||.+....            ..+.+|+.+++.++||||+++
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   80 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFER-------KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI   80 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCE
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEc-------CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceE
Confidence            3467999999999999999999875       467899999986432            137889999999999999999


Q ss_pred             eeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCC
Q 014034          145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN  224 (432)
Q Consensus       145 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~  224 (432)
                      ++++....     .++||||+.+++|.+++...  ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.+
T Consensus        81 ~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~  150 (322)
T 2ycf_A           81 KNFFDAED-----YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQ  150 (322)
T ss_dssp             EEEEESSS-----EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSS
T ss_pred             eeEEcCCc-----eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecC
Confidence            99986432     49999999999999998654  4799999999999999999999998   99999999999999876


Q ss_pred             Cc---eeeccccCCcCCCCCCCcccccccccCCCccCccccc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhh
Q 014034          225 FR---PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE  298 (432)
Q Consensus       225 ~~---~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~  298 (432)
                      +.   +||+|||++....   .........||+.|+|||++.   ...++.++|||||||++|+|++|..||........
T Consensus       151 ~~~~~~kl~Dfg~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  227 (322)
T 2ycf_A          151 EEDCLIKITDFGHSKILG---ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS  227 (322)
T ss_dssp             SSSCCEEECCCTTCEECC---CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC
T ss_pred             CCCCeEEEccCccceecc---cccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH
Confidence            54   9999999997532   222233467999999999973   56789999999999999999999999976543221


Q ss_pred             HHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          299 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                        +...+......       ..+...    ...+..+.+|+.+||..||.+|||+.+++++
T Consensus       228 --~~~~~~~~~~~-------~~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          228 --LKDQITSGKYN-------FIPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             --HHHHHHHTCCC-------CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             --HHHHHHhCccc-------cCchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence              11111111000       000000    1124578899999999999999999999875

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.7e-43  Score=334.73  Aligned_cols=261  Identities=27%  Similarity=0.385  Sum_probs=186.5

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ..++|.+.+.||+|+||.||+|...       .++..||+|.+....     ..+.+|+.+++.++||||+++++++...
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   85 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCA-------PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK   85 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC-----------CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS
T ss_pred             chhhhhhhheeccccceEEEEEEEC-------CCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence            3468999999999999999999854       467899999986432     3477899999999999999999999765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFN------RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF  225 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~  225 (432)
                      +.    .++||||+.+++|.+++..      .....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++
T Consensus        86 ~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~  158 (303)
T 2vwi_A           86 DE----LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDG  158 (303)
T ss_dssp             SC----EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTC
T ss_pred             CC----cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCC
Confidence            53    4999999999999999864      1234689999999999999999999998   999999999999999999


Q ss_pred             ceeeccccCCcCCCCCCC---cccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHH
Q 014034          226 RPKLSDFGLAREGPMVGH---THVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL  301 (432)
Q Consensus       226 ~~kl~DfG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~  301 (432)
                      .+||+|||++........   ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.........  
T Consensus       159 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--  236 (303)
T 2vwi_A          159 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL--  236 (303)
T ss_dssp             CEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH--
T ss_pred             CEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH--
Confidence            999999999875322111   112234579999999999875 56899999999999999999999999876543321  


Q ss_pred             HHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          302 LEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .......+...  .....++.....    .+..+.+|+.+||+.||.+|||+.+++++
T Consensus       237 ~~~~~~~~~~~--~~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          237 MLTLQNDPPSL--ETGVQDKEMLKK----YGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             HHHHTSSCCCT--TC-----CCCCC----CCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHhccCCCcc--ccccccchhhhh----hhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            11111111100  000111111112    23568899999999999999999999875

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.5e-42  Score=338.04  Aligned_cols=272  Identities=27%  Similarity=0.338  Sum_probs=191.8

Q ss_pred             HHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh---HHHHHHHHHhcccCCCccceeeeEEee
Q 014034           74 MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .....++|.+.+.||+|+||.||+|.+.       .++..||||++..+.   ....+|+..+..++||||+++++++..
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~   90 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEK-------STGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYT   90 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEET-------TTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEEC-------CCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhc
Confidence            4556789999999999999999999875       467899999885442   346778888888999999999999876


Q ss_pred             cCC---cceeEEEEEeecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhh--cCCCCceeecCCCCCceEEcC
Q 014034          151 DGE---RGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLAYLH--EGLEVQVIYRDFKASNVLLDE  223 (432)
Q Consensus       151 ~~~---~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~l~~~l~~LH--~~~~~~ivH~Dikp~Nill~~  223 (432)
                      .+.   .....++||||+.+ +|...+..  .....+++..+..++.|++.||.|||  +.   +|+||||||+|||++.
T Consensus        91 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~  166 (360)
T 3e3p_A           91 LGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNE  166 (360)
T ss_dssp             ECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEET
T ss_pred             cccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeC
Confidence            432   23346899999976 55554432  23457899999999999999999999  76   9999999999999996


Q ss_pred             -CCceeeccccCCcCCCCCCCcccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHH
Q 014034          224 -NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL  301 (432)
Q Consensus       224 -~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~  301 (432)
                       ++.+||+|||++.....   ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........
T Consensus       167 ~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~  243 (360)
T 3e3p_A          167 ADGTLKLCDFGSAKKLSP---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE  243 (360)
T ss_dssp             TTTEEEECCCTTCBCCCT---TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CCCcEEEeeCCCceecCC---CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHH
Confidence             89999999999986322   2223446789999999998654 489999999999999999999999987654433222


Q ss_pred             HHHHhhccc---------CccccccccCc-----cccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          302 LEWVQQYPA---------DSKKFGLIMDP-----RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       302 ~~~~~~~~~---------~~~~~~~~~~~-----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      +......+.         ...........     ..........+..+.+|+.+||+.||.+|||+.+++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            111111100         00000000000     00001122245789999999999999999999999987

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.6e-43  Score=333.42  Aligned_cols=243  Identities=21%  Similarity=0.302  Sum_probs=193.5

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhccc-CCCccceeeeEEe
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVL-EHPNLVKLIGYCA  149 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l-~hpniv~l~~~~~  149 (432)
                      ..++|.+.+.||+|+||.||+|...       .++..||+|.+...      ...+.+|+..+..+ +||||+++++++.
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~   81 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKR-------LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA   81 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEc-------CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence            3467999999999999999999875       46789999998642      23478899999988 9999999999997


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCC---
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN---  224 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~---  224 (432)
                      ..+    ..++||||+++++|.+++....  ...+++..++.++.||+.||.|||++   +|+||||||+|||++.+   
T Consensus        82 ~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~  154 (289)
T 1x8b_A           82 EDD----HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIP  154 (289)
T ss_dssp             ETT----EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----
T ss_pred             cCC----eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCC
Confidence            655    4599999999999999997532  24689999999999999999999998   99999999999999844   


Q ss_pred             ----------------CceeeccccCCcCCCCCCCcccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCC
Q 014034          225 ----------------FRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGR  287 (432)
Q Consensus       225 ----------------~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~  287 (432)
                                      ..+||+|||++.....      .....||+.|+|||++.+. .++.++|||||||++|+|++|.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~  228 (289)
T 1x8b_A          155 NAASEEGDEDDWASNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE  228 (289)
T ss_dssp             ---------------CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCC
T ss_pred             cccccccccccccCCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCC
Confidence                            4799999999875321      1234599999999999765 5668999999999999999998


Q ss_pred             CCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          288 RSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       288 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .|+.....     ........           .+.+.    ...+..+.+|+.+||+.||.+|||+.+++++
T Consensus       229 ~~~~~~~~-----~~~~~~~~-----------~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          229 PLPRNGDQ-----WHEIRQGR-----------LPRIP----QVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             CCCSSSHH-----HHHHHTTC-----------CCCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             CCCcchhH-----HHHHHcCC-----------CCCCC----cccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            87753311     11111100           01111    1224678899999999999999999999876

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.2e-43  Score=343.96  Aligned_cols=262  Identities=25%  Similarity=0.361  Sum_probs=185.1

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|.+++.||+|+||.||+|...       .++..||||++...      ...+.+|+.+++.++||||+++++++...
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  100 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDT-------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA  100 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEET-------TTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             CCceEEeeEEeecCCeEEEEEEEC-------CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            468999999999999999999865       56889999998643      23477899999999999999999998654


Q ss_pred             CC--cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          152 GE--RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       152 ~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      ..  .....++||||+ +++|.+++..   ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||
T Consensus       101 ~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL  173 (367)
T 2fst_X          101 RSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKI  173 (367)
T ss_dssp             SSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred             CccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEE
Confidence            21  123458999999 7899998864   3699999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      +|||+++...     .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......
T Consensus       174 ~DFG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~  248 (367)
T 2fst_X          174 LDFGLARHTA-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT  248 (367)
T ss_dssp             CC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred             eecccccccc-----ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9999997532     12344679999999999877 67899999999999999999999999876654332222111111


Q ss_pred             ccCcccccccc--------C--ccccC----cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 PADSKKFGLIM--------D--PRLEK----EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 ~~~~~~~~~~~--------~--~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      +.. .....+.        .  +....    ......+..+.+|+.+||..||.+|||+.+++++
T Consensus       249 p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          249 PGA-ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             CCH-HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCH-HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            100 0000000        0  00000    0001124568899999999999999999999987

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.4e-43  Score=345.55  Aligned_cols=255  Identities=13%  Similarity=0.083  Sum_probs=181.5

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhccc--CCCccceee----
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVL--EHPNLVKLI----  145 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l--~hpniv~l~----  145 (432)
                      .+|...+.||+|+||.||+|.+.       .+++.||+|++....       ..+.+|+.+++.|  +||||++++    
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~  134 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDV-------ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLL  134 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBC
T ss_pred             eeeeeeeeccCCCCEEEEEEEEC-------CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEE
Confidence            45899999999999999999975       467899999987632       1356775444444  699988755    


Q ss_pred             ---eEEeecCCc-------------ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHH------HHHHHHHHHHHHHhhc
Q 014034          146 ---GYCAVDGER-------------GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTR------LHIILGAAEGLAYLHE  203 (432)
Q Consensus       146 ---~~~~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~l~~~l~~LH~  203 (432)
                         +++...+..             ....++||||+. |+|.+++.... ..+++..+      ..++.||+.||.|||+
T Consensus       135 ~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~  212 (371)
T 3q60_A          135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQS  212 (371)
T ss_dssp             CCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             eeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHH
Confidence               444433321             134699999998 89999997642 23455566      7788999999999999


Q ss_pred             CCCCceeecCCCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCcccccc--CCCCchhhhHHHHHHHH
Q 014034          204 GLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET--GHLTAKSDVWSFGVVLY  281 (432)
Q Consensus       204 ~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~  281 (432)
                      +   +|+||||||+||||+.++.+||+|||+++...     .......+|+.|+|||++.+  ..++.++|||||||++|
T Consensus       213 ~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~  284 (371)
T 3q60_A          213 K---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIY  284 (371)
T ss_dssp             T---TEEETTCSGGGEEECTTSCEEECCGGGEEETT-----CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHH
T ss_pred             C---CCccCcCCHHHEEECCCCCEEEEecceeeecC-----CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHH
Confidence            8   99999999999999999999999999998531     11224567799999999987  67999999999999999


Q ss_pred             HHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          282 EMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       282 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      +|++|..||.+..+.....       +..  ..........+........+..+.+||.+||+.||.+|||+.+++++
T Consensus       285 elltg~~Pf~~~~~~~~~~-------~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          285 RVWCLFLPFGLVTPGIKGS-------WKR--PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             HHHHSSCSTTBCCTTCTTC-------CCB--CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             HHHhCCCCCCCcCcccccc-------hhh--hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            9999999998764321110       000  00000001111111112345678899999999999999999999875

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.3e-43  Score=340.38  Aligned_cols=260  Identities=20%  Similarity=0.279  Sum_probs=202.8

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh---------------------HHHHHHHHHhccc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---------------------LQWVAEVQFLGVL  136 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---------------------~~~~~E~~~l~~l  136 (432)
                      .++|.+.+.||+|+||.||+|..         ++..||+|.+....                     ..+.+|+.+++.+
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  100 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK---------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI  100 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE---------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc---------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC
Confidence            46899999999999999999984         57899999986432                     6689999999999


Q ss_pred             CCCccceeeeEEeecCCcceeEEEEEeecCCCCHHHH------hhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCce
Q 014034          137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDH------LFNRAFPPLPWKTRLHIILGAAEGLAYLHE-GLEVQV  209 (432)
Q Consensus       137 ~hpniv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~-~~~~~i  209 (432)
                      +||||+++++++...+    ..++||||+++++|.++      +.......+++..++.++.|++.||.|||+ .   +|
T Consensus       101 ~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i  173 (348)
T 2pml_X          101 KNEYCLTCEGIITNYD----EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NI  173 (348)
T ss_dssp             CCTTBCCCSEEEESSS----EEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CE
T ss_pred             CCCCcceEEEEEeeCC----eEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CE
Confidence            9999999999987654    45999999999999999      655445689999999999999999999998 7   99


Q ss_pred             eecCCCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccC-CCCc-hhhhHHHHHHHHHHHhCC
Q 014034          210 IYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTA-KSDVWSFGVVLYEMLTGR  287 (432)
Q Consensus       210 vH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlGvil~elltg~  287 (432)
                      +||||||+|||++.++.+||+|||++......    ......||+.|+|||++.+. .++. ++||||||+++|+|++|.
T Consensus       174 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~  249 (348)
T 2pml_X          174 CHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV  249 (348)
T ss_dssp             ECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSS
T ss_pred             eecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999753211    33456799999999999877 6666 999999999999999999


Q ss_pred             CCCCCCCchhhHHHHHHHhhccc-CccccccccCccc---cCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          288 RSLERNRPKTEQRLLEWVQQYPA-DSKKFGLIMDPRL---EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       288 ~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .||......  ......+..... .+........+..   ........+..+.+|+.+||+.||.+|||+.+++++
T Consensus       250 ~pf~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          250 VPFSLKISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             CSSCCSSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCCCCCCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            999875542  122222221110 0000000000000   000112234678899999999999999999999875

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.8e-43  Score=334.79  Aligned_cols=250  Identities=24%  Similarity=0.402  Sum_probs=196.2

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC----hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      .++|++.+.||+|+||.||+|.+.       .++..||+|.+...    ...+.+|+.+++.++||||+++++++...+ 
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   89 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNK-------ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG-   89 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEET-------TTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC--
T ss_pred             ccceeecceeccCCCeEEEEEEEc-------CCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC-
Confidence            467999999999999999999875       45789999998643    345889999999999999999999997654 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        90 ---~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  162 (302)
T 2j7t_A           90 ---KLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFG  162 (302)
T ss_dssp             ---CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCH
T ss_pred             ---eEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECC
Confidence               3599999999999999986533 4689999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCcccc-----ccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYI-----ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      ++...  ...........||+.|+|||++     .+..++.++||||||+++|+|++|..||........  ........
T Consensus       163 ~~~~~--~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~  238 (302)
T 2j7t_A          163 VSAKN--LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKSD  238 (302)
T ss_dssp             HHHHH--HHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHSC
T ss_pred             CCccc--cccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HHHHhccC
Confidence            87521  0011112345789999999998     467789999999999999999999999987654322  11111111


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ...      .       ..+...+..+.+|+.+||+.||.+|||+.+++++
T Consensus       239 ~~~------~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          239 PPT------L-------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             CCC------C-------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             Ccc------c-------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            100      0       0112224568899999999999999999999875

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.1e-42  Score=328.53  Aligned_cols=250  Identities=22%  Similarity=0.330  Sum_probs=185.1

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-----H-HHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-----Q-WVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~-~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|++.+.||+|+||.||+|...       .+++.||+|++.....     . +..+...++.++||||+++++++...
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~   78 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHV-------PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE   78 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEec-------CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc
Confidence            467999999999999999999865       4689999999865321     1 34455568889999999999999865


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      +.    .++||||+. |+|.+++..  .....+++..++.++.|++.||.|||++  .+|+||||||+|||++.++.+||
T Consensus        79 ~~----~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl  151 (290)
T 3fme_A           79 GD----VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKM  151 (290)
T ss_dssp             SS----EEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEB
T ss_pred             CC----EEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEE
Confidence            53    499999996 588887754  1335799999999999999999999984  28999999999999999999999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCcccc----ccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI----ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  305 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  305 (432)
                      +|||++.....   ........||+.|+|||++    .+..++.++|||||||++|+|++|..||........ .+....
T Consensus       152 ~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~  227 (290)
T 3fme_A          152 CDFGISGYLVD---DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QLKQVV  227 (290)
T ss_dssp             CCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HHHHHH
T ss_pred             eecCCcccccc---cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HHHHHh
Confidence            99999975321   2223345799999999996    566789999999999999999999999986433222 122211


Q ss_pred             hhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          306 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .....           .   ......+..+.+|+.+||+.||.+|||+.+++++
T Consensus       228 ~~~~~-----------~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          228 EEPSP-----------Q---LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             HSCCC-----------C---CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ccCCC-----------C---cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence            11110           0   0011224568899999999999999999999985

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=343.40  Aligned_cols=270  Identities=24%  Similarity=0.352  Sum_probs=185.0

Q ss_pred             cCCcc-ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC--hHHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           79 NDFSR-MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        79 ~~~~~-~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      +.|.. .++||+|+||.||+|.++     +..++..||+|++...  ...+.+|+.+|+.++||||+++++++...... 
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~-   93 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRK-----DGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADR-   93 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEES-----SSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT-
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEc-----cCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC-
Confidence            44665 457999999999999975     2345788999998754  34688999999999999999999999764433 


Q ss_pred             eeEEEEEeecCCCCHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEE----cCC
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNR-------AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL----DEN  224 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill----~~~  224 (432)
                       ..++||||+. ++|.+++...       ....+++..++.++.||+.||.|||+.   +|+||||||+||||    +.+
T Consensus        94 -~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~  168 (405)
T 3rgf_A           94 -KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPER  168 (405)
T ss_dssp             -EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTT
T ss_pred             -eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCC
Confidence             5699999995 5888877521       123589999999999999999999998   99999999999999    778


Q ss_pred             CceeeccccCCcCCCCCC-CcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchh-----
Q 014034          225 FRPKLSDFGLAREGPMVG-HTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT-----  297 (432)
Q Consensus       225 ~~~kl~DfG~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~-----  297 (432)
                      +.+||+|||+++...... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.....     
T Consensus       169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~  248 (405)
T 3rgf_A          169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP  248 (405)
T ss_dssp             TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred             CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence            999999999997532211 1122345679999999999987 458999999999999999999999997654321     


Q ss_pred             --hHHHHHHHh--hcccCc-cc-cccc---------cCccccCcCC---------HHHHHHHHHHHHHhccCCCCCCCCH
Q 014034          298 --EQRLLEWVQ--QYPADS-KK-FGLI---------MDPRLEKEYS---------INEARKIGRLADNCLSKSSKDRPKM  353 (432)
Q Consensus       298 --~~~~~~~~~--~~~~~~-~~-~~~~---------~~~~l~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~  353 (432)
                        ...+...+.  ..+... .. +..+         ..........         ...+..+.+||.+||..||.+|||+
T Consensus       249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta  328 (405)
T 3rgf_A          249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS  328 (405)
T ss_dssp             CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred             chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence              111111111  111110 00 0000         0000000000         0113467899999999999999999


Q ss_pred             HHHHHH
Q 014034          354 SQVVER  359 (432)
Q Consensus       354 ~eil~~  359 (432)
                      .+++++
T Consensus       329 ~e~L~h  334 (405)
T 3rgf_A          329 EQAMQD  334 (405)
T ss_dssp             HHHHTS
T ss_pred             HHHhcC
Confidence            999987

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.8e-42  Score=339.29  Aligned_cols=267  Identities=23%  Similarity=0.266  Sum_probs=202.6

Q ss_pred             HHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH---HHHHHHHHhcccC-CC-----ccceee
Q 014034           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGVLE-HP-----NLVKLI  145 (432)
Q Consensus        75 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~-hp-----niv~l~  145 (432)
                      ....++|.+.+.||+|+||.||+|...       .+++.||||++.....   .+..|+.++..++ |+     +|++++
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~  122 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDR-------VEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK  122 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEET-------TTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEc-------CCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence            445678999999999999999999865       4678999999986543   3667888888774 44     499999


Q ss_pred             eEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc--C
Q 014034          146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD--E  223 (432)
Q Consensus       146 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~--~  223 (432)
                      +++...+    ..++||||+. ++|.+++.......+++..+..++.|++.||.|||++ ..+|+||||||+||||+  .
T Consensus       123 ~~~~~~~----~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~  196 (382)
T 2vx3_A          123 RHFMFRN----HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPK  196 (382)
T ss_dssp             EEEEETT----EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTT
T ss_pred             eeeccCC----ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCC
Confidence            9987754    4599999995 5999999877666799999999999999999999952 23899999999999994  5


Q ss_pred             CCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 014034          224 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE  303 (432)
Q Consensus       224 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~  303 (432)
                      ++.+||+|||+++....     ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+.
T Consensus       197 ~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~  271 (382)
T 2vx3_A          197 RSAIKIVDFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV  271 (382)
T ss_dssp             SCCEEECCCTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCcEEEEeccCceeccc-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            78899999999975321     2234679999999999999999999999999999999999999998765543322211


Q ss_pred             HHhhcccCc-----c----ccccccC-----------------cc--------------------ccCcCCHHHHHHHHH
Q 014034          304 WVQQYPADS-----K----KFGLIMD-----------------PR--------------------LEKEYSINEARKIGR  337 (432)
Q Consensus       304 ~~~~~~~~~-----~----~~~~~~~-----------------~~--------------------l~~~~~~~~~~~l~~  337 (432)
                      .....+...     .    .+..+.+                 +.                    -...........+.+
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  351 (382)
T 2vx3_A          272 EVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKD  351 (382)
T ss_dssp             HHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHH
T ss_pred             HHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHH
Confidence            111110000     0    0000000                 00                    000112334467899


Q ss_pred             HHHHhccCCCCCCCCHHHHHHH
Q 014034          338 LADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       338 li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ||.+||+.||.+|||+.+++++
T Consensus       352 li~~mL~~dP~~Rpta~e~L~h  373 (382)
T 2vx3_A          352 LILRMLDYDPKTRIQPYYALQH  373 (382)
T ss_dssp             HHHHHTCSCTTTSCCHHHHTTS
T ss_pred             HHHHhcCCChhhCCCHHHHhcC
Confidence            9999999999999999999876

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=8.7e-43  Score=341.30  Aligned_cols=266  Identities=21%  Similarity=0.325  Sum_probs=204.0

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh---HHHHHHHHHhcccC-----------CCcccee
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQWVAEVQFLGVLE-----------HPNLVKL  144 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----------hpniv~l  144 (432)
                      ++|.+.+.||+|+||.||+|...       .+++.||||.+....   ..+.+|+.+++.++           ||||+++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDM-------VNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             CeEEEEEeeeecCCeEEEEEEec-------CCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            57999999999999999999865       467899999998654   34778999998876           8999999


Q ss_pred             eeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc--
Q 014034          145 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD--  222 (432)
Q Consensus       145 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~--  222 (432)
                      ++++...+..+...++||||+ +++|.+++.......+++..+..++.||+.||.|||++  .+|+||||||+|||++  
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~  168 (373)
T 1q8y_A           92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIV  168 (373)
T ss_dssp             CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEE
T ss_pred             HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEecc
Confidence            999987665556779999999 99999999876656799999999999999999999994  2899999999999994  


Q ss_pred             ----CCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchh-
Q 014034          223 ----ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT-  297 (432)
Q Consensus       223 ----~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~-  297 (432)
                          ..+.+||+|||++.....     ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... 
T Consensus       169 ~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  243 (373)
T 1q8y_A          169 DSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY  243 (373)
T ss_dssp             ETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CCCcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence                445899999999975321     2234578999999999999999999999999999999999999998654221 


Q ss_pred             ---hHHH---HHHHhhcccC--------------ccccccccCc---------cccCcCCHHHHHHHHHHHHHhccCCCC
Q 014034          298 ---EQRL---LEWVQQYPAD--------------SKKFGLIMDP---------RLEKEYSINEARKIGRLADNCLSKSSK  348 (432)
Q Consensus       298 ---~~~~---~~~~~~~~~~--------------~~~~~~~~~~---------~l~~~~~~~~~~~l~~li~~cl~~dP~  348 (432)
                         ...+   .......+..              ......+...         .-....+...+..+.+||.+||+.||.
T Consensus       244 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  323 (373)
T 1q8y_A          244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR  323 (373)
T ss_dssp             -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred             CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence               1111   1111111100              0000000000         001124567788899999999999999


Q ss_pred             CCCCHHHHHHH
Q 014034          349 DRPKMSQVVER  359 (432)
Q Consensus       349 ~RPs~~eil~~  359 (432)
                      +|||+.+++++
T Consensus       324 ~Rpt~~ell~h  334 (373)
T 1q8y_A          324 KRADAGGLVNH  334 (373)
T ss_dssp             TCBCHHHHHTC
T ss_pred             ccCCHHHHhhC
Confidence            99999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.2e-42  Score=337.86  Aligned_cols=268  Identities=25%  Similarity=0.310  Sum_probs=200.5

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|.+.+.||+|+||.||+|.+.       .++..||||.+....     ..+.+|+.+++.++||||+++++++....
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   82 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHK-------PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDS   82 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEEC-------CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccc
Confidence            468999999999999999999875       467899999986432     24678999999999999999999886542


Q ss_pred             -CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          153 -ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       153 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                       ......++||||+. ++|.+++...   .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        83 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~D  155 (353)
T 2b9h_A           83 FENFNEVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCD  155 (353)
T ss_dssp             STTCCCEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECC
T ss_pred             cCccceEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEe
Confidence             11235699999996 6999998763   689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCc--------ccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014034          232 FGLAREGPMVGHT--------HVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  302 (432)
Q Consensus       232 fG~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  302 (432)
                      ||++.........        .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+
T Consensus       156 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  235 (353)
T 2b9h_A          156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI  235 (353)
T ss_dssp             CTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence            9999753221111        11223578999999998754 77899999999999999999999999876543332222


Q ss_pred             HHHhhcccCccccccccCc----------ccc----CcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          303 EWVQQYPADSKKFGLIMDP----------RLE----KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~----------~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ......+........+...          ...    .......+..+.+|+.+||+.||.+|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            1111111111000000000          000    00011234678899999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3e-42  Score=327.19  Aligned_cols=255  Identities=22%  Similarity=0.369  Sum_probs=193.6

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH---HHHHHHHHhcccCCCccceeeeEEeecC--
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGVLEHPNLVKLIGYCAVDG--  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~hpniv~l~~~~~~~~--  152 (432)
                      .++|++++.||+|+||.||+|...       .++..||+|.+.....   .+.+|+.+++.++||||+++++++....  
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   77 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNA-------LDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNF   77 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCC
T ss_pred             cccchhhheeccCCcEEEEEEEEc-------CCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcch
Confidence            467999999999999999999865       4678999999875433   4788999999999999999999886532  


Q ss_pred             -------CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC
Q 014034          153 -------ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF  225 (432)
Q Consensus       153 -------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~  225 (432)
                             ......++||||+++++|.+++.... ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++
T Consensus        78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~  153 (303)
T 1zy4_A           78 VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESR  153 (303)
T ss_dssp             CC------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTS
T ss_pred             hhhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCC
Confidence                   12346799999999999999997543 3678899999999999999999998   999999999999999999


Q ss_pred             ceeeccccCCcCCCCCC------------CcccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCC
Q 014034          226 RPKLSDFGLAREGPMVG------------HTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLER  292 (432)
Q Consensus       226 ~~kl~DfG~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~  292 (432)
                      .+||+|||++.......            .........||+.|+|||++.+. .++.++|||||||++|+|++   ||..
T Consensus       154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~  230 (303)
T 1zy4_A          154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST  230 (303)
T ss_dssp             CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence            99999999997532111            01122345789999999999764 78999999999999999998   5542


Q ss_pred             CCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          293 NRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .  .........+....           ..+....+...+..+.+|+.+||+.||.+|||+.+++++
T Consensus       231 ~--~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          231 G--MERVNILKKLRSVS-----------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             H--HHHHHHHHHHHSTT-----------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             c--hhHHHHHHhccccc-----------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            1  11122222222110           111122233344678899999999999999999999876

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.5e-42  Score=332.93  Aligned_cols=263  Identities=22%  Similarity=0.358  Sum_probs=201.5

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH---HHHHHHHHhcccCCCc------cceeeeEE
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGVLEHPN------LVKLIGYC  148 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~hpn------iv~l~~~~  148 (432)
                      .++|.+.+.||+|+||.||+|....      ..+..||+|.+.....   .+.+|+.+++.+.|++      ++.+++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~   91 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHA------RGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF   91 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT------TTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecC------CCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence            3689999999999999999998651      2347899999976433   4778999999887665      88888888


Q ss_pred             eecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEE-------
Q 014034          149 AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL-------  221 (432)
Q Consensus       149 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill-------  221 (432)
                      ...+    ..++||||+ +++|.+++.......+++..++.++.||+.||.|||+.   +|+||||||+|||+       
T Consensus        92 ~~~~----~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~  163 (355)
T 2eu9_A           92 NFHG----HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFET  163 (355)
T ss_dssp             EETT----EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEE
T ss_pred             eeCC----eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccc
Confidence            7655    459999999 77888888776656799999999999999999999998   99999999999999       


Q ss_pred             ------------cCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCC
Q 014034          222 ------------DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRS  289 (432)
Q Consensus       222 ------------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p  289 (432)
                                  +.++.+||+|||++....     .......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus       164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  238 (355)
T 2eu9_A          164 LYNEHKSCEEKSVKNTSIRVADFGSATFDH-----EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTL  238 (355)
T ss_dssp             EECCC-CCCEEEESCCCEEECCCTTCEETT-----SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccccccccccccCCCcEEEeecCcccccc-----ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCC
Confidence                        568899999999997522     122346799999999999999999999999999999999999999


Q ss_pred             CCCCCchhhHHHHHHHhh-cccCc------ccc----ccc--------------cCc-cccCcCCHHHHHHHHHHHHHhc
Q 014034          290 LERNRPKTEQRLLEWVQQ-YPADS------KKF----GLI--------------MDP-RLEKEYSINEARKIGRLADNCL  343 (432)
Q Consensus       290 f~~~~~~~~~~~~~~~~~-~~~~~------~~~----~~~--------------~~~-~l~~~~~~~~~~~l~~li~~cl  343 (432)
                      |...........+..... .+...      ..+    ...              ..+ ..........+..+.+|+.+||
T Consensus       239 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  318 (355)
T 2eu9_A          239 FQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRML  318 (355)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred             CCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHh
Confidence            987654433222222111 11000      000    000              000 0000112344668899999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 014034          344 SKSSKDRPKMSQVVER  359 (432)
Q Consensus       344 ~~dP~~RPs~~eil~~  359 (432)
                      +.||.+|||+.+++++
T Consensus       319 ~~dP~~Rpt~~e~l~h  334 (355)
T 2eu9_A          319 EFDPAQRITLAEALLH  334 (355)
T ss_dssp             CSSTTTSCCHHHHTTS
T ss_pred             cCChhhCcCHHHHhcC
Confidence            9999999999999875

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.5e-42  Score=337.27  Aligned_cols=260  Identities=25%  Similarity=0.344  Sum_probs=197.2

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|...+.||+|+||.||+|...       .+++.||+|++...      ...+.+|+.+++.++||||+++++++...
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  113 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDK-------RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA  113 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             cccEEEEeEEecCCCeEEEEEEEC-------CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheecc
Confidence            468999999999999999999865       56889999998753      23478899999999999999999999765


Q ss_pred             CCc--ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          152 GER--GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       152 ~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      +..  ....++||||+. ++|.+++.    ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||
T Consensus       114 ~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL  185 (371)
T 4exu_A          114 SSLRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKI  185 (371)
T ss_dssp             SSSTTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEE
T ss_pred             CCcccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEE
Confidence            432  122389999996 68888873    2489999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      +|||+++...     .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......
T Consensus       186 ~Dfg~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~  260 (371)
T 4exu_A          186 LDFGLARHAD-----AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV  260 (371)
T ss_dssp             CSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EecCcccccc-----cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            9999997532     12344678999999999977 68899999999999999999999999876543322211111111


Q ss_pred             ccCccccccc------------cCccccC---cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 PADSKKFGLI------------MDPRLEK---EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 ~~~~~~~~~~------------~~~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      +.  ..+...            .......   ......+..+.+||.+||+.||.+|||+.+++++
T Consensus       261 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          261 PG--TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             CC--HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             Cc--HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            10  000000            0000000   0011224678899999999999999999999987

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.8e-42  Score=331.28  Aligned_cols=253  Identities=24%  Similarity=0.378  Sum_probs=192.3

Q ss_pred             HHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccC--CCccceee
Q 014034           74 MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLE--HPNLVKLI  145 (432)
Q Consensus        74 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~--hpniv~l~  145 (432)
                      +....++|.+++.||+|+||.||+|...        ++..||+|.+...      ...+.+|+.++..+.  ||||++++
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~   94 (313)
T 3cek_A           23 MSVKGRIYSILKQIGSGGSSKVFQVLNE--------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY   94 (313)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECT--------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred             eeeccceEEEEEEecCCCCEEEEEEEcC--------CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEE
Confidence            3344567999999999999999999853        4678999998532      134788999999997  59999999


Q ss_pred             eEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC
Q 014034          146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF  225 (432)
Q Consensus       146 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~  225 (432)
                      +++...+    ..++||| +.+++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+|||+++ +
T Consensus        95 ~~~~~~~----~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~  163 (313)
T 3cek_A           95 DYEITDQ----YIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-G  163 (313)
T ss_dssp             EEEECSS----EEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-T
T ss_pred             EEeecCC----EEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-C
Confidence            9987654    3599999 55889999997653  689999999999999999999998   9999999999999964 8


Q ss_pred             ceeeccccCCcCCCCCCCcccccccccCCCccCcccccc-----------CCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Q 014034          226 RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-----------GHLTAKSDVWSFGVVLYEMLTGRRSLERNR  294 (432)
Q Consensus       226 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltg~~pf~~~~  294 (432)
                      .+||+|||++................||+.|+|||++.+           ..++.++||||||+++|+|++|..||....
T Consensus       164 ~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (313)
T 3cek_A          164 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  243 (313)
T ss_dssp             EEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence            999999999976432222222344579999999999875           478889999999999999999999997654


Q ss_pred             chhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          295 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                      .... .+.....              +......+...+..+.+|+.+||+.||.+|||+.+++++.
T Consensus       244 ~~~~-~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          244 NQIS-KLHAIID--------------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             SHHH-HHHHHHC--------------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HHHH-HHHHHHh--------------cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence            3221 1111111              1001111111235788999999999999999999999874

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.6e-42  Score=328.69  Aligned_cols=266  Identities=23%  Similarity=0.313  Sum_probs=193.4

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCccceeeeEEeecC-
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNLVKLIGYCAVDG-  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~~-  152 (432)
                      .++|.+++.||+|+||.||+|...       .+++.||+|.+....    ..+.+|+.+++.++||||+++++++...+ 
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   82 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDN-------DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS   82 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEET-------TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred             CCceeEEEEeccCCCeEEEEEEEC-------CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence            468999999999999999999875       467899999886443    34788999999999999999999885432 


Q ss_pred             ---------CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc-
Q 014034          153 ---------ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-  222 (432)
Q Consensus       153 ---------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~-  222 (432)
                               ......++||||+. |+|.+++..   .++++..++.++.|++.||.|||+.   +|+||||||+|||++ 
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~  155 (320)
T 2i6l_A           83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINT  155 (320)
T ss_dssp             BCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEET
T ss_pred             ccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcC
Confidence                     12345699999997 699999854   3689999999999999999999998   999999999999997 


Q ss_pred             CCCceeeccccCCcCCCCCC-CcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 014034          223 ENFRPKLSDFGLAREGPMVG-HTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR  300 (432)
Q Consensus       223 ~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~  300 (432)
                      .++.+||+|||++....... .........+|..|+|||.+.+ ..++.++|||||||++|+|++|..||.+........
T Consensus       156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  235 (320)
T 2i6l_A          156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ  235 (320)
T ss_dssp             TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            56799999999998532111 1122234567999999998865 678999999999999999999999998765432211


Q ss_pred             HHHHHhhcccCcccc-cc-------ccCcccc-C-----cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          301 LLEWVQQYPADSKKF-GL-------IMDPRLE-K-----EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       301 ~~~~~~~~~~~~~~~-~~-------~~~~~l~-~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                        ......+...... ..       ....... .     ......+..+.+|+.+||+.||.+|||+.+++++
T Consensus       236 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          236 --LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             --HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             --HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence              1111111100000 00       0000000 0     0011234678899999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=333.13  Aligned_cols=255  Identities=21%  Similarity=0.322  Sum_probs=195.7

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEee
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      ..++|.+.+.||+|+||.||+|.+.          ..||+|.+....      ..+.+|+.+++.++||||+++++++..
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~----------~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWH----------GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS  100 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEES----------SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEc----------CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            3568999999999999999999864          138999886432      236789999999999999999999986


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .+.    .++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++ ++.+||+
T Consensus       101 ~~~----~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~  171 (319)
T 2y4i_B          101 PPH----LAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVIT  171 (319)
T ss_dssp             SSC----EEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEEC
T ss_pred             CCc----eEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEe
Confidence            553    599999999999999996543 4689999999999999999999998   999999999999998 6899999


Q ss_pred             cccCCcCCCCCC---CcccccccccCCCccCcccccc---------CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhh
Q 014034          231 DFGLAREGPMVG---HTHVSTAVVGTFGYAAPDYIET---------GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE  298 (432)
Q Consensus       231 DfG~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~  298 (432)
                      |||++.......   .........||+.|+|||++.+         ..++.++||||||+++|+|++|..||........
T Consensus       172 Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~  251 (319)
T 2y4i_B          172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI  251 (319)
T ss_dssp             CCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH
T ss_pred             ecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999986432111   1122234568999999999864         4578899999999999999999999987654322


Q ss_pred             HHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          299 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                      .   ..+....          .+.+.   ....+..+.+|+.+||..||.+|||+.++++.|+.+...
T Consensus       252 ~---~~~~~~~----------~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          252 I---WQMGTGM----------KPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             H---HHHHTTC----------CCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             H---HHhccCC----------CCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            1   1111110          00000   001224578999999999999999999999999887654

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=330.82  Aligned_cols=261  Identities=25%  Similarity=0.329  Sum_probs=197.0

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|...+.||+|+||.||+|.+.       .++..||||.+....      ..+.+|+.+++.++||||+++++++...
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   95 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDK-------RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA   95 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             CceEEEeeeEecCCCeEEEEEEEC-------CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecc
Confidence            367999999999999999999865       468899999986531      3478899999999999999999998765


Q ss_pred             CCc--ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          152 GER--GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       152 ~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      ...  ....++||||+. ++|.+++..    .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl  167 (353)
T 3coi_A           96 SSLRNFYDFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKI  167 (353)
T ss_dssp             SSGGGCCCCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEE
T ss_pred             cccccceeEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEE
Confidence            432  123489999996 688887732    589999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      +|||++....     .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......
T Consensus       168 ~Dfg~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~  242 (353)
T 3coi_A          168 LDFGLARHAD-----AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV  242 (353)
T ss_dssp             CSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCB
T ss_pred             eecccccCCC-----CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9999997532     12234578999999999876 67899999999999999999999999876543322111111111


Q ss_pred             ccCc-------c-------ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 PADS-------K-------KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 ~~~~-------~-------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      +...       .       .+.......+. ......+..+.+|+.+||..||.+|||+.+++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             CCHHHHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCHHHHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0000       0       00000000000 1112335678899999999999999999999876

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.2e-42  Score=322.98  Aligned_cols=250  Identities=26%  Similarity=0.378  Sum_probs=198.4

Q ss_pred             HhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc------ChHHHHHHHHHhcccCCCccceeeeEEe
Q 014034           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQWVAEVQFLGVLEHPNLVKLIGYCA  149 (432)
Q Consensus        76 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~  149 (432)
                      ...++|.+.+.||+|+||.||+|...       .++..||+|.+..      ....+.+|+.+++.++||||+++++++.
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~-------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   91 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDR-------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE   91 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEc-------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe
Confidence            34568999999999999999999865       4678899999753      2345889999999999999999999987


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCC---Cc
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN---FR  226 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~---~~  226 (432)
                      ..+    ..++||||+.+++|.+++....  .+++..++.++.||+.||.|||+.   +|+||||||+|||++.+   +.
T Consensus        92 ~~~----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~  162 (287)
T 2wei_A           92 DSS----SFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCD  162 (287)
T ss_dssp             CSS----EEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCC
T ss_pred             CCC----eEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCccc
Confidence            644    4599999999999999886543  689999999999999999999998   99999999999999754   46


Q ss_pred             eeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 014034          227 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  306 (432)
Q Consensus       227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  306 (432)
                      +||+|||++......   .......||+.|+|||.+.+ .++.++||||||+++|+|++|..||.+.....   +...+.
T Consensus       163 ~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~  235 (287)
T 2wei_A          163 IKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILKRVE  235 (287)
T ss_dssp             EEECSTTGGGTBCCC---SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred             EEEeccCcceeecCC---CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH
Confidence            999999998753211   12233458899999999875 48999999999999999999999998765432   222221


Q ss_pred             hcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          307 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .....   +    +...    ....+..+.+|+.+||..||.+|||+.+++++
T Consensus       236 ~~~~~---~----~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          236 TGKYA---F----DLPQ----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             HCCCC---C----CSGG----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             cCCCC---C----Cchh----hhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            11100   0    0000    01123568899999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.5e-41  Score=326.92  Aligned_cols=253  Identities=26%  Similarity=0.392  Sum_probs=175.6

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHH-HhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQ-FLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~-~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|...+.||+|+||.||+|...       .+++.||||.+....     ..+..|+. +++.++||||+++++++...
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~   93 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHK-------PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE   93 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEET-------TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred             HHHhhehheeccCCCEEEEEEEEc-------CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence            357999999999999999999875       467899999986532     13455555 77888999999999999765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhc---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCcee
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFN---RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  228 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k  228 (432)
                      +    ..++||||+.+ +|.+++..   .....+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+|
T Consensus        94 ~----~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~k  166 (327)
T 3aln_A           94 G----DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIK  166 (327)
T ss_dssp             S----EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEE
T ss_pred             C----ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEE
Confidence            4    45999999975 88777652   2245789999999999999999999984  3899999999999999999999


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCcccc----ccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI----ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  304 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  304 (432)
                      |+|||++.....   ........||+.|+|||++    .+..++.++|||||||++|+|++|..||........     .
T Consensus       167 l~Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~  238 (327)
T 3aln_A          167 LCDFGISGQLVD---SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----Q  238 (327)
T ss_dssp             ECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------
T ss_pred             EccCCCceeccc---ccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----H
Confidence            999999975321   1222334799999999998    456789999999999999999999999976432110     0


Q ss_pred             HhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          305 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ......       ...+.+........+..+.+|+.+||+.||.+|||+.+|+++
T Consensus       239 ~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          239 LTQVVK-------GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             -CCCCC-------SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHhc-------CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            000000       001111111112234678899999999999999999999886

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.1e-42  Score=332.03  Aligned_cols=244  Identities=25%  Similarity=0.380  Sum_probs=195.7

Q ss_pred             HHHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----------HHHHHHHHHhcccC--CC
Q 014034           72 SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----------LQWVAEVQFLGVLE--HP  139 (432)
Q Consensus        72 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~--hp  139 (432)
                      .+.....++|++.+.||+|+||.||+|...       .++..||||.+....          ..+.+|+.+++.+.  ||
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~  108 (320)
T 3a99_A           36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRV-------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS  108 (320)
T ss_dssp             ----CCTTTEEEEEECSSSSSCEEEEEEET-------TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSC
T ss_pred             cccCCccCceEEEEEEeeCCCeEEEEEEEC-------CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCC
Confidence            334455678999999999999999999865       467999999986532          23667999999996  59


Q ss_pred             ccceeeeEEeecCCcceeEEEEEeecCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCc
Q 014034          140 NLVKLIGYCAVDGERGIQRLLVYEFMLN-RSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASN  218 (432)
Q Consensus       140 niv~l~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~N  218 (432)
                      ||+++++++...+    ..++||||+.+ ++|.+++...  ..+++..++.++.||+.||.|||+.   +|+||||||+|
T Consensus       109 ~i~~~~~~~~~~~----~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~N  179 (320)
T 3a99_A          109 GVIRLLDWFERPD----SFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDEN  179 (320)
T ss_dssp             SBCCEEEEEECSS----EEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred             CceEEEEEEecCC----cEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHH
Confidence            9999999997654    35999999976 8999999764  3689999999999999999999998   99999999999


Q ss_pred             eEEc-CCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCch
Q 014034          219 VLLD-ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPK  296 (432)
Q Consensus       219 ill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~  296 (432)
                      ||++ .++.+||+|||++.....    .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||....  
T Consensus       180 Ill~~~~~~~kL~Dfg~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--  253 (320)
T 3a99_A          180 ILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--  253 (320)
T ss_dssp             EEEETTTTEEEECCCTTCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--
T ss_pred             EEEeCCCCCEEEeeCcccccccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--
Confidence            9999 789999999999975321    12234579999999999987665 678999999999999999999997421  


Q ss_pred             hhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          297 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                         ...   ....            .+...    .+..+.+||.+||+.||.+|||+.+|+++
T Consensus       254 ---~~~---~~~~------------~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          254 ---EII---RGQV------------FFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             ---HHH---HCCC------------CCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---hhh---cccc------------ccccc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               111   0000            01111    23568899999999999999999999875

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.9e-42  Score=327.42  Aligned_cols=241  Identities=25%  Similarity=0.411  Sum_probs=189.8

Q ss_pred             HHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----------HHHHHHHHHhccc----CCCc
Q 014034           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----------LQWVAEVQFLGVL----EHPN  140 (432)
Q Consensus        75 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l----~hpn  140 (432)
                      ....++|.+.+.||+|+||.||+|...       .++..||+|.+....          ..+.+|+.++..+    +|||
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~   99 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRL-------TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG   99 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECT-------TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSS
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEc-------cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCC
Confidence            345678999999999999999999854       467899999986542          1255789999888    8999


Q ss_pred             cceeeeEEeecCCcceeEEEEEee-cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCce
Q 014034          141 LVKLIGYCAVDGERGIQRLLVYEF-MLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNV  219 (432)
Q Consensus       141 iv~l~~~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Ni  219 (432)
                      |+++++++...+.    .++|||| +.+++|.+++....  .+++..++.++.||+.||.|||+.   +|+||||||+||
T Consensus       100 i~~~~~~~~~~~~----~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni  170 (312)
T 2iwi_A          100 VIRLLDWFETQEG----FMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENI  170 (312)
T ss_dssp             BCCEEEEC---------CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGE
T ss_pred             eeeEEEEEecCCe----EEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhE
Confidence            9999999876543    3899999 78999999997643  689999999999999999999998   999999999999


Q ss_pred             EEc-CCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCchh
Q 014034          220 LLD-ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLT-AKSDVWSFGVVLYEMLTGRRSLERNRPKT  297 (432)
Q Consensus       220 ll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~pf~~~~~~~  297 (432)
                      |++ .++.+||+|||++.....    .......||..|+|||++.+..+. .++||||||+++|+|++|..||....   
T Consensus       171 l~~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---  243 (312)
T 2iwi_A          171 LIDLRRGCAKLIDFGSGALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---  243 (312)
T ss_dssp             EEETTTTEEEECCCSSCEECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---
T ss_pred             EEeCCCCeEEEEEcchhhhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---
Confidence            999 899999999999975322    122346699999999999876664 58999999999999999999997421   


Q ss_pred             hHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          298 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                        ....   ..            ..    .+...+..+.+||.+||+.||.+|||+.+++++
T Consensus       244 --~~~~---~~------------~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          244 --EILE---AE------------LH----FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             --HHHH---TC------------CC----CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             --HHhh---hc------------cC----CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              1111   00            00    111224568899999999999999999999876

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.6e-41  Score=336.81  Aligned_cols=251  Identities=21%  Similarity=0.291  Sum_probs=183.6

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-HHHHHHHHHhccc-CCCccceeeeEEeecCCccee
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQWVAEVQFLGVL-EHPNLVKLIGYCAVDGERGIQ  157 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~  157 (432)
                      .|...+.||+|+||+||.+..        .+++.||||++..+. ..+.+|+.++..+ +||||+++++++....    .
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~--------~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~----~   83 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGS--------FQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDR----F   83 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEE--------SSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSS----E
T ss_pred             eeeccCeEeeCCCeEEEEEEE--------ECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCC----e
Confidence            455568899999999986532        357899999987654 3478899999876 8999999999886544    4


Q ss_pred             EEEEEeecCCCCHHHHhhcCCCCC-----CCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCC--------
Q 014034          158 RLLVYEFMLNRSLEDHLFNRAFPP-----LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN--------  224 (432)
Q Consensus       158 ~~lv~e~~~~gsL~~~l~~~~~~~-----l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~--------  224 (432)
                      .++||||+. |+|.+++.......     .++..++.++.||+.||.|||+.   +|+||||||+|||++.+        
T Consensus        84 ~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~  159 (434)
T 2rio_A           84 LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQ  159 (434)
T ss_dssp             EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCT
T ss_pred             EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccc
Confidence            599999995 69999997654211     12334578999999999999998   99999999999999754        


Q ss_pred             -----CceeeccccCCcCCCCCCCc--ccccccccCCCccCcccccc-------CCCCchhhhHHHHHHHHHHHh-CCCC
Q 014034          225 -----FRPKLSDFGLAREGPMVGHT--HVSTAVVGTFGYAAPDYIET-------GHLTAKSDVWSFGVVLYEMLT-GRRS  289 (432)
Q Consensus       225 -----~~~kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-g~~p  289 (432)
                           +.+||+|||+++........  .......||+.|+|||++.+       ..++.++|||||||++|||+| |..|
T Consensus       160 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P  239 (434)
T 2rio_A          160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP  239 (434)
T ss_dssp             TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred             cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence                 48999999999864322111  12234679999999999975       678999999999999999999 9999


Q ss_pred             CCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          290 LERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       290 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      |....... ..+..   ....         .+.+........+..+.+||.+||+.||.+|||+.+|+++
T Consensus       240 f~~~~~~~-~~i~~---~~~~---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          240 FGDKYSRE-SNIIR---GIFS---------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             TCSTTTHH-HHHHH---TCCC---------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCchhhH-HHHhc---CCCC---------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            97654322 11111   1100         0111112234567789999999999999999999999874

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3e-41  Score=322.98  Aligned_cols=249  Identities=27%  Similarity=0.441  Sum_probs=177.5

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-----H-HHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-----Q-WVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~-~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|..++.||+|+||.||+|.+.       .++..||+|.+.....     . +..+..+++.++||||+++++++...
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~   96 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFR-------KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN   96 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEET-------TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             hccccccceeeecCCeeEEEEEEe-------cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Confidence            467999999999999999999875       4678999999865321     1 34455568888999999999999765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCceeecCCCCCceEEcCCCceeec
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE-GLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      +    ..++||||+ ++.+..+... ....+++..++.++.|++.||.|||+ .   +|+||||||+|||++.++.+||+
T Consensus        97 ~----~~~lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~  167 (318)
T 2dyl_A           97 T----DVFIAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLC  167 (318)
T ss_dssp             S----EEEEEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEEC
T ss_pred             C----cEEEEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEE
Confidence            4    459999999 5555555433 23478999999999999999999998 5   89999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE-----TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  305 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  305 (432)
                      |||++.....   ........||+.|+|||++.     +..++.++||||||+++|+|++|..||........ .+....
T Consensus       168 dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~  243 (318)
T 2dyl_A          168 DFGISGRLVD---DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-VLTKVL  243 (318)
T ss_dssp             CCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-HHHHHH
T ss_pred             ECCCchhccC---CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-HHHHHh
Confidence            9999875321   12233457999999999994     55788999999999999999999999986433221 111111


Q ss_pred             hhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          306 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ...+.           .+..  ....+..+.+|+.+||+.||.+|||+.+++++
T Consensus       244 ~~~~~-----------~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          244 QEEPP-----------LLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             HSCCC-----------CCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccCCC-----------CCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            11110           0000  01123568899999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=8.1e-41  Score=345.28  Aligned_cols=269  Identities=26%  Similarity=0.349  Sum_probs=200.8

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecC-
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDG-  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-  152 (432)
                      ++|++.+.||+|+||.||+|.+.       .++..||||.+...     ...+.+|+.+++.++||||+++++++.... 
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~-------~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~   86 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQ-------DTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK   86 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCT-------TTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEEC-------CCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence            68999999999999999998754       56788999998754     234788999999999999999999875411 


Q ss_pred             -CcceeEEEEEeecCCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCc---e
Q 014034          153 -ERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR---P  227 (432)
Q Consensus       153 -~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~---~  227 (432)
                       ......++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.   +
T Consensus        87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~v  163 (676)
T 3qa8_A           87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIH  163 (676)
T ss_dssp             CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEE
T ss_pred             ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeE
Confidence             11234589999999999999997643 33689999999999999999999998   9999999999999997765   8


Q ss_pred             eeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 014034          228 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  307 (432)
Q Consensus       228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  307 (432)
                      ||+|||++.....   ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....     .|...
T Consensus       164 KL~DFG~a~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~  235 (676)
T 3qa8_A          164 KIIDLGYAKELDQ---GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGK  235 (676)
T ss_dssp             EECSCCCCCBTTS---CCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTT
T ss_pred             EEccccccccccc---ccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhh
Confidence            9999999986322   222345679999999999999999999999999999999999999997643211     11111


Q ss_pred             cccC-----------ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHH-----HHHHHHHHhh
Q 014034          308 YPAD-----------SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ-----VVERLKQIVQ  365 (432)
Q Consensus       308 ~~~~-----------~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----il~~L~~~~~  365 (432)
                      ....           ....................+..+.+|+.+||..||.+|||+.+     +.+.++.++.
T Consensus       236 i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          236 VREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             CC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             hhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence            1000           00000000001112234456788999999999999999999988     4455666554

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.5e-41  Score=333.52  Aligned_cols=249  Identities=21%  Similarity=0.328  Sum_probs=184.3

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-HHHHHHHHHhccc-CCCccceeeeEEeecCCcce
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQWVAEVQFLGVL-EHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~  156 (432)
                      .+|...+.||+|+||+||....        .+++.||||++.... ..+.+|+.+|+.+ +||||+++++++....    
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~--------~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~----   91 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGM--------FDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQ----   91 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEE--------SSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETT----
T ss_pred             EEEecCCeeecCcCEEEEEEEE--------eCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCC----
Confidence            4688999999999999654322        357889999986543 2367899999999 7999999999987654    


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC-----CCceeecc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE-----NFRPKLSD  231 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~-----~~~~kl~D  231 (432)
                      ..++||||+. |+|.+++..... .+.+..++.++.||+.||.|||+.   +|+||||||+|||++.     ...+||+|
T Consensus        92 ~~~lv~E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~D  166 (432)
T 3p23_A           92 FQYIAIELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISD  166 (432)
T ss_dssp             EEEEEEECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred             EEEEEEECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEec
Confidence            3599999995 699999976543 355556778999999999999998   9999999999999953     33578999


Q ss_pred             ccCCcCCCCCCC-cccccccccCCCccCccccc---cCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHh
Q 014034          232 FGLAREGPMVGH-THVSTAVVGTFGYAAPDYIE---TGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQ  306 (432)
Q Consensus       232 fG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~  306 (432)
                      ||+++....... ........||+.|+|||++.   ...++.++|||||||++|||++ |..||.........   ....
T Consensus       167 FG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~---~~~~  243 (432)
T 3p23_A          167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN---ILLG  243 (432)
T ss_dssp             TTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH---HHTT
T ss_pred             ccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH---HHhc
Confidence            999986432211 12234567999999999997   4567889999999999999999 99999654332211   1111


Q ss_pred             hcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          307 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ....          ..+  ......+..+.+||.+||+.||.+|||+.+++++
T Consensus       244 ~~~~----------~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          244 ACSL----------DCL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             CCCC----------TTS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cCCc----------ccc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            1000          000  1122345668899999999999999999999964

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.2e-40  Score=346.31  Aligned_cols=242  Identities=24%  Similarity=0.387  Sum_probs=191.5

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|++.+.||+|+||.||+|.+..      .+++.||||.+....     ..+.+|+.++..++||||+++++++...+
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  152 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRN------VNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD  152 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGG------GTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcC------CCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence            4789999999999999999998751      257899999886432     24788999999999999999999998765


Q ss_pred             Ccce-eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          153 ERGI-QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       153 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      ..+. ..++||||++|++|.+++..    .+++..++.++.||+.||.|||++   +|+||||||+|||++.+ .+||+|
T Consensus       153 ~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~D  224 (681)
T 2pzi_A          153 RHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLID  224 (681)
T ss_dssp             TTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECC
T ss_pred             CCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEe
Confidence            4322 25999999999999987743    689999999999999999999998   99999999999999975 899999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ||+++.....      ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+....          ..+  
T Consensus       225 FG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~--  285 (681)
T 2pzi_A          225 LGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLP--  285 (681)
T ss_dssp             CTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCC--
T ss_pred             cccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc----------ccc--
Confidence            9999763211      4467999999999997654 88999999999999999999888642110          000  


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHHHHHHh
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-MSQVVERLKQIV  364 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~~L~~~~  364 (432)
                                  ........+..+.+||.+||+.||.+||+ +.++...|..++
T Consensus       286 ------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          286 ------------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             ------------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ------------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                        00011223457889999999999999995 566666666553

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=7.1e-40  Score=311.31  Aligned_cols=234  Identities=22%  Similarity=0.281  Sum_probs=183.2

Q ss_pred             hcCCccc-cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHHHHHHHh-cccCCCccceeeeEEeecCCcc
Q 014034           78 TNDFSRM-LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFL-GVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        78 ~~~~~~~-~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l-~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      .++|.+. +.||+|+||.||+|...       .++..||+|.+... ..+.+|+.++ +.++||||+++++++.......
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   87 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNK-------RTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLYAGR   87 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEc-------CCCcEEEEEEeccc-HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence            3568777 77999999999999865       46789999998654 4677899888 6669999999999987633334


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC---CCceeeccc
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE---NFRPKLSDF  232 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~Df  232 (432)
                      ...++||||+.+++|.+++.......+++..++.++.|++.||.|||+.   +|+||||||+|||++.   ++.+||+||
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecc
Confidence            4579999999999999999887666799999999999999999999998   9999999999999998   789999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      |++....                        +..++.++|||||||++|+|++|..||.+.......      ...    
T Consensus       165 g~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------~~~----  210 (299)
T 3m2w_A          165 GFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------PGM----  210 (299)
T ss_dssp             TTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------CCS----
T ss_pred             ccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh------HHH----
Confidence            9986421                        245678999999999999999999999764322100      000    


Q ss_pred             cccccccCccccCcCC----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 014034          313 KKFGLIMDPRLEKEYS----INEARKIGRLADNCLSKSSKDRPKMSQVVERL  360 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  360 (432)
                        ...+.....  ..+    ...+..+.+|+.+||+.||.+|||+.+++++-
T Consensus       211 --~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp  258 (299)
T 3m2w_A          211 --KTRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  258 (299)
T ss_dssp             --CCSSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             --HHHHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence              000000000  011    12346788999999999999999999999873

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.6e-39  Score=306.88  Aligned_cols=227  Identities=13%  Similarity=0.113  Sum_probs=180.2

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|++.+.||+|+||.||+|.+.       .+++.||+|.+....       ..+.+|+.++..++||||+++++++...
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~  103 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDT-------ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR  103 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEET-------TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             CcEEEEEEEcccCCeEEEEEEec-------CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC
Confidence            57999999999999999999865       467899999997532       3588999999999999999999999875


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ..++||||+.|++|.+++...    .....+..++.||+.||.|||++   ||+||||||+|||++.+|.+||++
T Consensus       104 ~----~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~  172 (286)
T 3uqc_A          104 A----GGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAY  172 (286)
T ss_dssp             T----EEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECS
T ss_pred             C----cEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEe
Confidence            4    359999999999999998532    35557889999999999999998   999999999999999999999985


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      +|.                      ++       .++.++|||||||++|+|+||..||.+........           
T Consensus       173 ~~~----------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-----------  212 (286)
T 3uqc_A          173 PAT----------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-----------  212 (286)
T ss_dssp             CCC----------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-----------
T ss_pred             ccc----------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-----------
Confidence            542                      22       36889999999999999999999998754321100           


Q ss_pred             ccccccccCccc--cCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          312 SKKFGLIMDPRL--EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       312 ~~~~~~~~~~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                        ..........  ........+..+.+|+.+||+.||.+| |+.++++.|+.+...
T Consensus       213 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          213 --PAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             --ECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             --HHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence              0000000000  001112234678899999999999999 999999999988654

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-39  Score=323.48  Aligned_cols=244  Identities=17%  Similarity=0.183  Sum_probs=181.1

Q ss_pred             hhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCC-Cccce-----
Q 014034           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEH-PNLVK-----  143 (432)
Q Consensus        77 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h-pniv~-----  143 (432)
                      ...+|...+.||+|+||.||+|.+.       .+++.||||++...       ...+.+|+.+++.+.| +|+..     
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~  148 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQ-------ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL  148 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHT
T ss_pred             CceeEEEecccccCCCEEEEEEEec-------CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhc
Confidence            3455788899999999999999965       46789999998722       2357899999999977 32211     


Q ss_pred             ----eeeEEee------------cC-CcceeEEEEEeecCCCCHHHHhh-----cCCCCCCCHHHHHHHHHHHHHHHHHh
Q 014034          144 ----LIGYCAV------------DG-ERGIQRLLVYEFMLNRSLEDHLF-----NRAFPPLPWKTRLHIILGAAEGLAYL  201 (432)
Q Consensus       144 ----l~~~~~~------------~~-~~~~~~~lv~e~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~l~~~l~~L  201 (432)
                          .......            .. ......+++|+++ +++|.+++.     ......+++..++.++.||+.||.||
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  227 (413)
T 3dzo_A          149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL  227 (413)
T ss_dssp             CBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHH
Confidence                1111111            00 1122346777765 789999884     22334678889999999999999999


Q ss_pred             hcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCcccc----------ccCCCCchh
Q 014034          202 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI----------ETGHLTAKS  271 (432)
Q Consensus       202 H~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~  271 (432)
                      |+.   +|+||||||+||||+.++.+||+|||+++...     .......| +.|+|||++          .+..++.++
T Consensus       228 H~~---~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~  298 (413)
T 3dzo_A          228 HHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAF  298 (413)
T ss_dssp             HHT---TEECSCCCGGGEEECTTCCEEECCGGGCEETT-----EEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHH
T ss_pred             HhC---CcccCCcccceEEEecCCeEEEEeccceeecC-----CccccCCC-CceeCchhhhccccccccccCcCCCchh
Confidence            998   99999999999999999999999999987521     12345677 999999999          555688899


Q ss_pred             hhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC
Q 014034          272 DVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP  351 (432)
Q Consensus       272 DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP  351 (432)
                      |||||||++|||++|..||........                ...++...  .    ..+..+.+||.+||+.||.+||
T Consensus       299 DvwSlGvil~elltg~~Pf~~~~~~~~----------------~~~~~~~~--~----~~~~~~~~li~~~l~~dP~~Rp  356 (413)
T 3dzo_A          299 DTWTLGLAIYWIWCADLPNTDDAALGG----------------SEWIFRSC--K----NIPQPVRALLEGFLRYPKEDRL  356 (413)
T ss_dssp             HHHHHHHHHHHHHHSSCCCCTTGGGSC----------------SGGGGSSC--C----CCCHHHHHHHHHHTCSSGGGSC
T ss_pred             hHHHHHHHHHHHHHCCCCCCCcchhhh----------------HHHHHhhc--c----cCCHHHHHHHHHHccCChhhCc
Confidence            999999999999999999976432211                00011100  0    1236788999999999999999


Q ss_pred             CHHHHHHH
Q 014034          352 KMSQVVER  359 (432)
Q Consensus       352 s~~eil~~  359 (432)
                      |+.+++++
T Consensus       357 t~~~~l~~  364 (413)
T 3dzo_A          357 LPLQAMET  364 (413)
T ss_dssp             CHHHHTTS
T ss_pred             CHHHHHhC
Confidence            98888654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.9e-38  Score=304.29  Aligned_cols=244  Identities=20%  Similarity=0.181  Sum_probs=182.9

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------------HHHHHHHHHhcccC--------
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------------LQWVAEVQFLGVLE--------  137 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~--------  137 (432)
                      .++|++++.||+|+||.||+|++         +++.||||++....            ..+.+|+.+++.++        
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~---------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~   89 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA---------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCN   89 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE---------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSS
T ss_pred             cccchheeeecccCceEEEEEEe---------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccc
Confidence            45799999999999999999985         36899999987542            56888999988875        


Q ss_pred             -CCccceeeeEEeecCC--------------------------cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHH
Q 014034          138 -HPNLVKLIGYCAVDGE--------------------------RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI  190 (432)
Q Consensus       138 -hpniv~l~~~~~~~~~--------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i  190 (432)
                       ||||+++++++...+.                          .....++||||+.+|++.+.+.+   ..+++..+..+
T Consensus        90 ~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i  166 (336)
T 2vuw_A           90 RTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSI  166 (336)
T ss_dssp             BCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHH
T ss_pred             cCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHH
Confidence             7777777776542210                          13357999999999977777643   36899999999


Q ss_pred             HHHHHHHHHHhh-cCCCCceeecCCCCCceEEcCCC--------------------ceeeccccCCcCCCCCCCcccccc
Q 014034          191 ILGAAEGLAYLH-EGLEVQVIYRDFKASNVLLDENF--------------------RPKLSDFGLAREGPMVGHTHVSTA  249 (432)
Q Consensus       191 ~~~l~~~l~~LH-~~~~~~ivH~Dikp~Nill~~~~--------------------~~kl~DfG~a~~~~~~~~~~~~~~  249 (432)
                      +.||+.||.||| +.   +|+||||||+||||+.++                    .+||+|||+|+...       ...
T Consensus       167 ~~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~-------~~~  236 (336)
T 2vuw_A          167 LHQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER-------DGI  236 (336)
T ss_dssp             HHHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE-------TTE
T ss_pred             HHHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC-------CCc
Confidence            999999999999 87   999999999999999887                    89999999997531       123


Q ss_pred             cccCCCccCccccccCCCCchhhhHHHHHH-HHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCC
Q 014034          250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVV-LYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYS  328 (432)
Q Consensus       250 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvi-l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  328 (432)
                      ..||+.|+|||++.+.. +.++|||||+++ .+++++|..||.....  .......+.....        ..........
T Consensus       237 ~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~--------~~~~~~~~~~  305 (336)
T 2vuw_A          237 VVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--LHYLTDKMLKQMT--------FKTKCNTPAM  305 (336)
T ss_dssp             EECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH--HHHHHHHHHHTCC--------CSSCCCSHHH
T ss_pred             EEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh--hhHHHHhhhhhhc--------cCcccchhhh
Confidence            57999999999998766 889999998777 7778889998853100  0111111110000        0011111123


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCHHHHH-HH
Q 014034          329 INEARKIGRLADNCLSKSSKDRPKMSQVV-ER  359 (432)
Q Consensus       329 ~~~~~~l~~li~~cl~~dP~~RPs~~eil-~~  359 (432)
                      ...+..+.+||.+||+.|     |+.+++ ++
T Consensus       306 ~~~s~~~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          306 KQIKRKIQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             hhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence            456788999999999976     999988 54

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=1.7e-32  Score=281.97  Aligned_cols=181  Identities=18%  Similarity=0.086  Sum_probs=125.1

Q ss_pred             cccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh--------------HHHHHHHHHhccc-CCCccceeeeEEeec
Q 014034           87 IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--------------LQWVAEVQFLGVL-EHPNLVKLIGYCAVD  151 (432)
Q Consensus        87 lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--------------~~~~~E~~~l~~l-~hpniv~l~~~~~~~  151 (432)
                      .+.|++|.+..++..       ..+..+++|.+.++.              ..+.+|+++|+++ .|+||+++++++.++
T Consensus       242 ~~~~~~~~h~~~rr~-------~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~  314 (569)
T 4azs_A          242 PYAGAGLAHKRSRRY-------FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA  314 (569)
T ss_dssp             -C--------CCEEE-------EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS
T ss_pred             cccCCcccccccccc-------cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC
Confidence            455666655544432       457789999885431              2488999999999 799999999999776


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +.    .||||||++|++|.++|....  +++..   .|+.||+.||+|||++   |||||||||+||||+.+|.+||+|
T Consensus       315 ~~----~yLVMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~D  382 (569)
T 4azs_A          315 QS----GWLVMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLID  382 (569)
T ss_dssp             SE----EEEEEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECC
T ss_pred             CE----EEEEEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEee
Confidence            54    599999999999999997653  56654   5899999999999999   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRS  289 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p  289 (432)
                      ||+|+....  ........+||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus       383 FGlAr~~~~--~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          383 FGSIVTTPQ--DCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             CTTEESCC-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             cccCeeCCC--CCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            999986422  2223445789999999999976 467789999999998887665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=7.9e-29  Score=253.31  Aligned_cols=182  Identities=18%  Similarity=0.212  Sum_probs=139.0

Q ss_pred             ccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------------hHHHHHHHHHhcccCCCccceeeeEEe
Q 014034           82 SRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------------GLQWVAEVQFLGVLEHPNLVKLIGYCA  149 (432)
Q Consensus        82 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------------~~~~~~E~~~l~~l~hpniv~l~~~~~  149 (432)
                      ...+.||+|+||.||+|..         .+..+++|+....            ...+.+|+.++++++||||+++..++.
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  409 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY---------LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV  409 (540)
T ss_dssp             ---------CCEEEEEEEC---------SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE---------CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE
Confidence            4456899999999999964         3567788875321            123789999999999999996555555


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      .....    ++||||+++++|.+++..          +..++.|++.||.|||++   +|+||||||+|||++.  .+||
T Consensus       410 ~~~~~----~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL  470 (540)
T 3en9_A          410 DLDNK----RIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYI  470 (540)
T ss_dssp             ETTTT----EEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEE
T ss_pred             eCCcc----EEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEE
Confidence            54433    999999999999999854          558999999999999998   9999999999999998  9999


Q ss_pred             ccccCCcCCCCCCCcc-----cccccccCCCccCcccccc--CCCCchhhhHHHHHHHHHHHhCCCCCC
Q 014034          230 SDFGLAREGPMVGHTH-----VSTAVVGTFGYAAPDYIET--GHLTAKSDVWSFGVVLYEMLTGRRSLE  291 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~  291 (432)
                      +|||+++.........     ......||+.|||||++.+  ..|+..+|+||..+-..+.+.++.+|.
T Consensus       471 ~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          471 IDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             EECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            9999998642211111     1235689999999999976  667888999999999888888776663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=5.3e-25  Score=206.82  Aligned_cols=147  Identities=14%  Similarity=0.052  Sum_probs=117.0

Q ss_pred             HHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC----------------------hHHHHHHH
Q 014034           73 EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----------------------GLQWVAEV  130 (432)
Q Consensus        73 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~----------------------~~~~~~E~  130 (432)
                      .+......|.+.+.||+|+||.||+|.+.        ++..||+|.++..                      ...+.+|+
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~--------~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~  155 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYSE--------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF  155 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEET--------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHH
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEeC--------CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHH
Confidence            33444556777899999999999999862        5789999998642                      23478999


Q ss_pred             HHhcccCCCccceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcee
Q 014034          131 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVI  210 (432)
Q Consensus       131 ~~l~~l~hpniv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~iv  210 (432)
                      .+|+.++  | +++++++.. +.    .++||||++|++|.+ +..        .....++.|++.||.|||+.   +|+
T Consensus       156 ~~l~~l~--~-~~v~~~~~~-~~----~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---gii  215 (282)
T 1zar_A          156 RALQKLQ--G-LAVPKVYAW-EG----NAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIV  215 (282)
T ss_dssp             HHHHHTT--T-SSSCCEEEE-ET----TEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             HHHHhcc--C-CCcCeEEec-cc----eEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCE
Confidence            9999998  4 666665433 22    399999999999998 421        12446999999999999998   999


Q ss_pred             ecCCCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccc
Q 014034          211 YRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE  263 (432)
Q Consensus       211 H~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~  263 (432)
                      ||||||+|||++ ++.+||+|||+++.               +..|+|||++.
T Consensus       216 HrDlkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          216 HGDLSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             CSCCSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred             eCCCCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence            999999999999 99999999999863               44578899874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.83  E-value=6.2e-21  Score=176.75  Aligned_cols=132  Identities=17%  Similarity=0.143  Sum_probs=103.2

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEE--EEEEecCcCh----------------------------HHHHHHH
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATV--VAIKKLNRDG----------------------------LQWVAEV  130 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~--vaiK~~~~~~----------------------------~~~~~E~  130 (432)
                      |.+.+.||+|+||.||+|.+.       .++..  ||||.++...                            ..+.+|+
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~-------~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~  121 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGV-------FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEF  121 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEE-------ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEc-------CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHH
Confidence            667889999999999999863       25677  9999864321                            1467899


Q ss_pred             HHhcccCCCcc--ceeeeEEeecCCcceeEEEEEeecCC-C----CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhh-
Q 014034          131 QFLGVLEHPNL--VKLIGYCAVDGERGIQRLLVYEFMLN-R----SLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH-  202 (432)
Q Consensus       131 ~~l~~l~hpni--v~l~~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH-  202 (432)
                      .+|..+.|+++  +.++++  .  .    .+|||||+.+ |    +|.++...     .++..+..++.|++.||.||| 
T Consensus       122 ~~l~~l~~~~i~~p~~~~~--~--~----~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~  188 (258)
T 1zth_A          122 RNLERAKEAGVSVPQPYTY--M--K----NVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQ  188 (258)
T ss_dssp             HHHHHHHHTTCCCCCEEEE--E--T----TEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCCeEEEc--C--C----CEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHH
Confidence            99999988864  334432  1  1    2899999942 3    77776532     234567789999999999999 


Q ss_pred             cCCCCceeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          203 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       203 ~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      +.   +|+||||||+|||++.  .++|+|||+|..
T Consensus       189 ~~---givHrDlkp~NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          189 EA---ELVHADLSEYNIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             TS---CEECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred             HC---CEEeCCCCHHHEEEcC--cEEEEECccccc
Confidence            87   9999999999999998  999999999864

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.72  E-value=6.2e-18  Score=163.37  Aligned_cols=134  Identities=14%  Similarity=0.120  Sum_probs=97.7

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------------------HH--------HHHHHHH
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------------------LQ--------WVAEVQF  132 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------------------~~--------~~~E~~~  132 (432)
                      .-|.+...||.|+||.||+|...        +++.||||+++...                  ..        ..+|...
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~--------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~n  166 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADE--------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAF  166 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECT--------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHH
T ss_pred             CEEEecCEeeeCCceEEEEEECC--------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHH
Confidence            34899999999999999999853        57889999864210                  01        2356666


Q ss_pred             hcccCCCccceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeec
Q 014034          133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYR  212 (432)
Q Consensus       133 l~~l~hpniv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~  212 (432)
                      |.++.+.++....-+...  .    .+|||||+.|++|.++..      .+  ....++.||+.+|.|||..   |||||
T Consensus       167 L~rL~~~gv~vp~p~~~~--~----~~LVME~i~G~~L~~l~~------~~--~~~~l~~qll~~l~~lH~~---gIVHr  229 (397)
T 4gyi_A          167 MKALYEEGFPVPEPIAQS--R----HTIVMSLVDALPMRQVSS------VP--DPASLYADLIALILRLAKH---GLIHG  229 (397)
T ss_dssp             HHHHHHTTCSCCCEEEEE--T----TEEEEECCSCEEGGGCCC------CS--CHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             HHHHHhcCCCCCeeeecc--C----ceEEEEecCCccHhhhcc------cH--HHHHHHHHHHHHHHHHHHC---CCcCC
Confidence            777754443222111111  1    289999999988876532      11  2356889999999999998   99999


Q ss_pred             CCCCCceEEcCCC----------ceeeccccCCcC
Q 014034          213 DFKASNVLLDENF----------RPKLSDFGLARE  237 (432)
Q Consensus       213 Dikp~Nill~~~~----------~~kl~DfG~a~~  237 (432)
                      ||||.||||+++|          .+.|+||+-+..
T Consensus       230 DLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          230 DFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            9999999998776          389999997753

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.42  E-value=7.3e-13  Score=122.40  Aligned_cols=142  Identities=16%  Similarity=0.096  Sum_probs=109.5

Q ss_pred             HHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc----ChHHHHHHHHHhcccC-CCccceeeeEEe
Q 014034           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR----DGLQWVAEVQFLGVLE-HPNLVKLIGYCA  149 (432)
Q Consensus        75 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~E~~~l~~l~-hpniv~l~~~~~  149 (432)
                      ......|.....++.|+++.||++..         .+..+++|....    ....+.+|+.+++.+. +.++.++++++.
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~---------~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~   80 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVG---------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER   80 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEEC---------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEEC---------CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe
Confidence            34456788888899999999999863         256899999864    2335889999999884 677888998876


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-------------------------
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG-------------------------  204 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~-------------------------  204 (432)
                      ..+    ..++||||++|.+|.+.+.       +......++.+++.+|..||+.                         
T Consensus        81 ~~~----~~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (263)
T 3tm0_A           81 HDG----WSNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNND  149 (263)
T ss_dssp             ETT----EEEEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTT
T ss_pred             cCC----ceEEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcc
Confidence            543    3489999999999987642       1122346888999999999981                         


Q ss_pred             -------------------------------CCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          205 -------------------------------LEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       205 -------------------------------~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                                                     ....++|+|++|.|||+++++.+.|+||+.+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          150 LADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                           01369999999999999876667899999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.20  E-value=3.5e-11  Score=110.56  Aligned_cols=135  Identities=14%  Similarity=0.086  Sum_probs=95.1

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-HHHHHHHHHhcccCCCc--cceeeeEEeecCCcce
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQWVAEVQFLGVLEHPN--LVKLIGYCAVDGERGI  156 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~~  156 (432)
                      ++......+.|..+.||++...        ++..+++|...... ..+..|+.+++.+.+.+  +.+++++....+    
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~--------~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~----   88 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQ--------GRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAG----   88 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECT--------TSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS----
T ss_pred             CCceEecccCCCCceEEEEecC--------CCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCC----
Confidence            4544333345667999998632        35679999876542 34778999999886444  456887765443    


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-------------------------------
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL-------------------------------  205 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~-------------------------------  205 (432)
                      ..++||||++|.+|.  ..     ...   ...++.+++..|..||+..                               
T Consensus        89 ~~~~v~e~i~G~~l~--~~-----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (264)
T 1nd4_A           89 RDWLLLGEVPGQDLL--SS-----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL  158 (264)
T ss_dssp             CEEEEEECCSSEETT--TS-----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred             CCEEEEEecCCcccC--cC-----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhh
Confidence            249999999998884  21     112   2356778888888888742                               


Q ss_pred             ------------------------CCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          206 ------------------------EVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       206 ------------------------~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                                              ...++|+|++|.|||+++++.+.|+|||.+.
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          159 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                    1239999999999999887767899999874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.18  E-value=9.9e-11  Score=113.24  Aligned_cols=143  Identities=14%  Similarity=0.176  Sum_probs=105.9

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecC--cC-----hHHHHHHHHHhcccC--CCccceeeeEEeec
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN--RD-----GLQWVAEVQFLGVLE--HPNLVKLIGYCAVD  151 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~--~~-----~~~~~~E~~~l~~l~--hpniv~l~~~~~~~  151 (432)
                      ...++.|+.|.++.||+....         +..+++|+..  ..     ...+.+|+.+++.+.  +..+++++.++...
T Consensus        40 ~~~~~~l~~G~sn~~y~v~~~---------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~  110 (359)
T 3dxp_A           40 PLSVEQFKGGQSNPTFKLVTP---------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE  110 (359)
T ss_dssp             CCEEEECCC-CCSCEEEEECS---------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred             CceEEEcCCcccceEEEEEEC---------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence            334678999999999998742         3568888876  32     234788999999886  45678888887654


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--------------------------
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL--------------------------  205 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~--------------------------  205 (432)
                      ... ...++||||++|..+.+..    ...++......++.+++..|..||+..                          
T Consensus       111 ~~~-g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (359)
T 3dxp_A          111 SVI-GRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQ  185 (359)
T ss_dssp             TTT-SSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHH
T ss_pred             Ccc-CCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHH
Confidence            221 2348999999998875422    234678888899999999999999720                          


Q ss_pred             -----------------------------CCceeecCCCCCceEEcCCCc--eeeccccCCcC
Q 014034          206 -----------------------------EVQVIYRDFKASNVLLDENFR--PKLSDFGLARE  237 (432)
Q Consensus       206 -----------------------------~~~ivH~Dikp~Nill~~~~~--~kl~DfG~a~~  237 (432)
                                                   ...++|||++|.|||++.++.  +.|+||+.+..
T Consensus       186 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          186 YKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                         247999999999999987753  68999998853

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.05  E-value=2.3e-10  Score=108.04  Aligned_cols=184  Identities=18%  Similarity=0.170  Sum_probs=119.5

Q ss_pred             ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC--hHHHHHHHHHhcccC-CCc--cceeeeEEeecCCcceeE
Q 014034           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQWVAEVQFLGVLE-HPN--LVKLIGYCAVDGERGIQR  158 (432)
Q Consensus        84 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~-hpn--iv~l~~~~~~~~~~~~~~  158 (432)
                      ++.++.|.+..||+..            ..+++|.....  ...+.+|+.+|+.+. +..  +..++......+ .....
T Consensus        25 i~~~~~G~~n~v~~v~------------~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~-~~~~~   91 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN------------RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSE-TYQMS   91 (304)
T ss_dssp             CCEEEECSSEEEEEST------------TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCS-SCSCS
T ss_pred             eEecCCCCcceEEEEC------------CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCC-CCCcc
Confidence            4568999999999852            34888886544  345788999998873 332  344444332221 11223


Q ss_pred             EEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 014034          159 LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG----------------------------------  204 (432)
Q Consensus       159 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~----------------------------------  204 (432)
                      |+||++++|.+|.....    ..++..++..++.+++..|..||+.                                  
T Consensus        92 ~~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           92 FAGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             CEEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             eEEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            78999999988876432    2467777888888888888888861                                  


Q ss_pred             ---------------------CCCceeecCCCCCceEEcC--CCceeeccccCCcCCCCCCCcccccccccCCCc---cC
Q 014034          205 ---------------------LEVQVIYRDFKASNVLLDE--NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY---AA  258 (432)
Q Consensus       205 ---------------------~~~~ivH~Dikp~Nill~~--~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y---~a  258 (432)
                                           ....++|+|++|.||+++.  +..+.|+||+.+.........      .....+   ..
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl------~~~~~~~~~~~  241 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF------ISLMEDDEEYG  241 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH------HTTCCTTTSCC
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH------HHHHhhccccC
Confidence                                 1135899999999999998  566899999988642111000      000011   22


Q ss_pred             cccccc-----CCC---------CchhhhHHHHHHHHHHHhCCCCC
Q 014034          259 PDYIET-----GHL---------TAKSDVWSFGVVLYEMLTGRRSL  290 (432)
Q Consensus       259 PE~~~~-----~~~---------~~~~DvwSlGvil~elltg~~pf  290 (432)
                      |+....     +..         ....+.|++|.++|.+.+|..+|
T Consensus       242 ~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          242 MEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            222110     111         12268999999999999998776

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.49  E-value=4.1e-07  Score=83.84  Aligned_cols=134  Identities=19%  Similarity=0.109  Sum_probs=92.3

Q ss_pred             ccccCCce-EEEEEEecCCCCCCCcccEEEEEEecCcCh-HHHHHHHHHhcccC-CCccceeeeEEeecCCcceeEEEEE
Q 014034           86 KIGEGGFG-SVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQWVAEVQFLGVLE-HPNLVKLIGYCAVDGERGIQRLLVY  162 (432)
Q Consensus        86 ~lg~G~fg-~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~~~lv~  162 (432)
                      .+..|..| .||+....       ..+..+++|.-.... ..+.+|..+|+.+. +--+.++++++.+.+.    .++||
T Consensus        31 ~~~~G~S~~~v~rl~~~-------~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~----~~lvm   99 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGK-------PNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDD----AWLLT   99 (272)
T ss_dssp             EEECSSSSCEEEEEECC-------TTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTE----EEEEE
T ss_pred             EccCCCcCCeEEEEEec-------CCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCe----EEEEE
Confidence            34555554 68986532       345668888865433 34788999998774 3336677888766543    49999


Q ss_pred             eecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-------------------------------------
Q 014034          163 EFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL-------------------------------------  205 (432)
Q Consensus       163 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~-------------------------------------  205 (432)
                      |+++|.++.+.....      ......+..+++..|.-||...                                     
T Consensus       100 e~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (272)
T 4gkh_A          100 TAIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG  173 (272)
T ss_dssp             ECCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred             EeeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence            999998887765321      1223456666777777777421                                     


Q ss_pred             ------------------CCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          206 ------------------EVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       206 ------------------~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                                        ...++|+|+.+.|||+++++.+-|+||+.+.
T Consensus       174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                              1247999999999999988777899999874

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.38  E-value=1.1e-06  Score=84.60  Aligned_cols=87  Identities=6%  Similarity=-0.012  Sum_probs=54.9

Q ss_pred             cccc-ccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccC-C--CccceeeeEEeecC
Q 014034           84 MLKI-GEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLE-H--PNLVKLIGYCAVDG  152 (432)
Q Consensus        84 ~~~l-g~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~-h--pniv~l~~~~~~~~  152 (432)
                      .+.| +.|....+|+...... .++...+..+++|......       ..+.+|+.+++.|. +  -.+.+++.++....
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~-~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~  103 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQ-QDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD  103 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEE-ETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred             EEECCCCCccceEEEEEEecc-cCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence            4567 8888999998753200 0000025678889876433       34788999998884 2  35677877765432


Q ss_pred             CcceeEEEEEeecCCCCHHH
Q 014034          153 ERGIQRLLVYEFMLNRSLED  172 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~  172 (432)
                      .. ...++||||++|..+.+
T Consensus       104 ~~-g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          104 VL-GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TT-SSCEEEEECCCCBCCCB
T ss_pred             cc-CCceEEEEecCCCChhh
Confidence            11 12389999998877653

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.38  E-value=1.4e-06  Score=82.01  Aligned_cols=135  Identities=17%  Similarity=0.108  Sum_probs=91.4

Q ss_pred             ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC--hHHHHHHHHHhcccCCC---ccceeeeEEeecCCcceeE
Q 014034           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQWVAEVQFLGVLEHP---NLVKLIGYCAVDGERGIQR  158 (432)
Q Consensus        84 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~hp---niv~l~~~~~~~~~~~~~~  158 (432)
                      +..++.|....||+.            +..+++|.....  ...+.+|+.+|+.+.+.   .+.+++.++....   ...
T Consensus        24 v~~l~~G~~n~v~~v------------g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~---g~~   88 (306)
T 3tdw_A           24 VESLGEGFRNYAILV------------NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSD---GNP   88 (306)
T ss_dssp             EEEEEECSSEEEEEE------------TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTT---SCE
T ss_pred             eeecCCCcceeEEEE------------CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCC---Cce
Confidence            456888988999985            234777875432  23578999999998642   3556666654221   124


Q ss_pred             EEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 014034          159 LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG----------------------------------  204 (432)
Q Consensus       159 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~----------------------------------  204 (432)
                      ++||+|++|.+|......    .++......++.+++..|..||+.                                  
T Consensus        89 ~~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l  164 (306)
T 3tdw_A           89 FVGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL  164 (306)
T ss_dssp             EEEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGS
T ss_pred             EEEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccccc
Confidence            899999999888764221    244555556666666666666642                                  


Q ss_pred             -----------------------CCCceeecCCCCCceEEcC---CCc-eeeccccCCcC
Q 014034          205 -----------------------LEVQVIYRDFKASNVLLDE---NFR-PKLSDFGLARE  237 (432)
Q Consensus       205 -----------------------~~~~ivH~Dikp~Nill~~---~~~-~kl~DfG~a~~  237 (432)
                                             ....++|+|++|.|||++.   ++. +.|+||+.+..
T Consensus       165 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          165 DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             CHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             chhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                   1235699999999999987   455 48999998753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.16  E-value=8.5e-06  Score=79.50  Aligned_cols=73  Identities=15%  Similarity=0.038  Sum_probs=46.8

Q ss_pred             cccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----------hHHHHHHHHHhcccCC--C-ccceeeeEE
Q 014034           83 RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----------GLQWVAEVQFLGVLEH--P-NLVKLIGYC  148 (432)
Q Consensus        83 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----------~~~~~~E~~~l~~l~h--p-niv~l~~~~  148 (432)
                      ..+.||.|.++.||++...       ..+..+++|.....           ...+..|.++++.+..  | .+.+++.+.
T Consensus        34 ~~~~lg~G~~n~vyrv~~~-------~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d  106 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQ-------EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD  106 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC-----------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE
T ss_pred             EEEECCCCceEEEEEEEEC-------CCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc
Confidence            3567999999999998643       23567999975321           1245779888887742  3 344565432


Q ss_pred             eecCCcceeEEEEEeecCCC
Q 014034          149 AVDGERGIQRLLVYEFMLNR  168 (432)
Q Consensus       149 ~~~~~~~~~~~lv~e~~~~g  168 (432)
                        ...    .++||||+.+.
T Consensus       107 --~~~----~~lvmE~l~g~  120 (397)
T 2olc_A          107 --TEM----AVTVMEDLSHL  120 (397)
T ss_dssp             --TTT----TEEEECCCTTS
T ss_pred             --CCc----cEEEEEeCCCc
Confidence              222    28999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.07  E-value=1.6e-05  Score=75.61  Aligned_cols=140  Identities=17%  Similarity=0.212  Sum_probs=78.9

Q ss_pred             ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHHHHHHHhcccCC--CccceeeeE-----E-eecCCcc
Q 014034           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEH--PNLVKLIGY-----C-AVDGERG  155 (432)
Q Consensus        84 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~-----~-~~~~~~~  155 (432)
                      +..|+.|..+.||+....         +..+++|...........|+.+++.|..  -.+.+++..     + ...    
T Consensus        37 ~~~l~gG~~n~~~~v~~~---------~~~~vlk~~~~~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~----  103 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD---------SGAVCLKRIHRPEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHG----  103 (346)
T ss_dssp             EEECC----CEEEEEEET---------TEEEEEEEECSCHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEET----
T ss_pred             eeeccccccCcEEEEEeC---------CCCEEEEecCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEEC----
Confidence            345666778999998642         2348999988765555566666665531  123333321     1 111    


Q ss_pred             eeEEEEEeecCCCCHH-----H---------Hhhc--CCC--C--------CCCHHHH----------------------
Q 014034          156 IQRLLVYEFMLNRSLE-----D---------HLFN--RAF--P--------PLPWKTR----------------------  187 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~-----~---------~l~~--~~~--~--------~l~~~~~----------------------  187 (432)
                      ...+++|+|++|..+.     .         .++.  ...  .        .-.|...                      
T Consensus       104 ~~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  183 (346)
T 2q83_A          104 SFLFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDP  183 (346)
T ss_dssp             TEEEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCH
T ss_pred             CEEEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCc
Confidence            2358999999986542     0         1111  100  0        0122211                      


Q ss_pred             ---------HHHHHHHHHHHHHhhc----------CCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          188 ---------LHIILGAAEGLAYLHE----------GLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       188 ---------~~i~~~l~~~l~~LH~----------~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                               ..+...+..++.+|+.          .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          184 FSQLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence                     0111223345666653          013589999999999999888899999999874

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.86  E-value=7.1e-05  Score=70.35  Aligned_cols=138  Identities=14%  Similarity=0.120  Sum_probs=87.5

Q ss_pred             ccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-HHHHHHHHHhcccC---CCccceeeeEEeecCCccee
Q 014034           82 SRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQWVAEVQFLGVLE---HPNLVKLIGYCAVDGERGIQ  157 (432)
Q Consensus        82 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~~~  157 (432)
                      .....|+.|.+..+|+...         .+..+++|...... ..+..|+..|+.|.   ...+++++.++...+    .
T Consensus        39 ~~~~~l~gG~~n~~y~v~~---------~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g----~  105 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND---------EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQG----H  105 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES---------SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSS----E
T ss_pred             eeeEEeCCccceeeeEEEE---------CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCC----c
Confidence            3456789999999999762         24568888876543 34788999988873   356778887766543    3


Q ss_pred             EEEEEeecCCCCHHH-----------HhhcCCC-C-------------------CCCHHHHH---HHH------------
Q 014034          158 RLLVYEFMLNRSLED-----------HLFNRAF-P-------------------PLPWKTRL---HII------------  191 (432)
Q Consensus       158 ~~lv~e~~~~gsL~~-----------~l~~~~~-~-------------------~l~~~~~~---~i~------------  191 (432)
                      .++||||+++..+..           .|+.... .                   .-+|....   ++.            
T Consensus       106 ~~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~  185 (312)
T 3jr1_A          106 SFLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLI  185 (312)
T ss_dssp             EEEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCC
T ss_pred             eEEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCC
Confidence            499999999876521           1222111 0                   01343321   011            


Q ss_pred             ----HHHHHHH-HHhhc-CCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          192 ----LGAAEGL-AYLHE-GLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       192 ----~~l~~~l-~~LH~-~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                          ..++..+ ..|.. ...+.++|+|+.+.|++++.++ +.|+||.
T Consensus       186 ~~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          186 FGNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             CSCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             hHHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence                1122122 23421 1246899999999999999887 8899984

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.82  E-value=0.00011  Score=72.11  Aligned_cols=30  Identities=13%  Similarity=0.203  Sum_probs=26.9

Q ss_pred             CceeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          207 VQVIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       207 ~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      ..++|+|++|.|||++.++ ++|+||+.+..
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            4899999999999999877 99999998864

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.59  E-value=0.00015  Score=71.35  Aligned_cols=80  Identities=19%  Similarity=0.195  Sum_probs=51.1

Q ss_pred             cccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc-Ch-HHHHHHHHHhcccCCCc-cceeeeEEeecCCcceeEE
Q 014034           83 RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DG-LQWVAEVQFLGVLEHPN-LVKLIGYCAVDGERGIQRL  159 (432)
Q Consensus        83 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~-~~-~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~~~~~  159 (432)
                      .++.|+.|....||+.............+..+++|+... .. ..+..|+.+++.|...+ ..++++.+.    .    .
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~----~----g  148 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFS----G----G  148 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----T----E
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeC----C----C
Confidence            356788888999999875411111111246788998754 33 56678999988885333 356666542    1    4


Q ss_pred             EEEeecCCCCH
Q 014034          160 LVYEFMLNRSL  170 (432)
Q Consensus       160 lv~e~~~~gsL  170 (432)
                      +||+|++|.+|
T Consensus       149 ~v~e~l~G~~l  159 (429)
T 1nw1_A          149 RLEEYIPSRPL  159 (429)
T ss_dssp             EEECCCCEEEC
T ss_pred             EEEEEeCCccc
Confidence            79999986444

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.54  E-value=0.0004  Score=60.75  Aligned_cols=98  Identities=16%  Similarity=0.081  Sum_probs=64.3

Q ss_pred             CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCCCCCCccccc
Q 014034          169 SLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST  248 (432)
Q Consensus       169 sL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  248 (432)
                      +|.+.|...+ .++++.++|.++.|.+.+|.-+-...  .-..+=+-|..|++..+|.|.+.+ +.+.            
T Consensus        34 SL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           34 SLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             cHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc------------
Confidence            7888887654 58999999999999999987762110  111233446899999999988774 2211            


Q ss_pred             ccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh
Q 014034          249 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT  285 (432)
Q Consensus       249 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt  285 (432)
                        .....+.|||... ...+.+.=|||||+++|..+-
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence              1223456888763 345678899999999999886

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.51  E-value=0.00035  Score=64.71  Aligned_cols=75  Identities=20%  Similarity=0.270  Sum_probs=52.8

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCC---CccceeeeEEeecC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEH---PNLVKLIGYCAVDG  152 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h---pniv~l~~~~~~~~  152 (432)
                      ....+..+|.|..+.||+.+..        +++.|++|+.....    ..+..|+..|+.|.-   --+.+++++.    
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~--------DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----   83 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELA--------DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----   83 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEET--------TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----
T ss_pred             CeEEEEecCCCCCeEEEEEEEC--------CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----
Confidence            4555678999999999999863        67889999865332    247889999888742   2344555432    


Q ss_pred             CcceeEEEEEeecCCCCH
Q 014034          153 ERGIQRLLVYEFMLNRSL  170 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL  170 (432)
                      ..    ++||||+.++..
T Consensus        84 ~~----~lv~e~l~~~~~   97 (288)
T 3f7w_A           84 DR----TLAMEWVDERPP   97 (288)
T ss_dssp             TT----EEEEECCCCCCC
T ss_pred             Cc----eEEEEeecccCC
Confidence            12    899999987654

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.44  E-value=0.00032  Score=66.41  Aligned_cols=31  Identities=32%  Similarity=0.372  Sum_probs=27.2

Q ss_pred             CceeecCCCCCceEEcCC----CceeeccccCCcC
Q 014034          207 VQVIYRDFKASNVLLDEN----FRPKLSDFGLARE  237 (432)
Q Consensus       207 ~~ivH~Dikp~Nill~~~----~~~kl~DfG~a~~  237 (432)
                      ..++|||+.+.|||++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            489999999999999874    6789999998864

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.39  E-value=0.00056  Score=63.77  Aligned_cols=69  Identities=7%  Similarity=0.065  Sum_probs=43.1

Q ss_pred             cccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH---HHHHHHHHhcccCCCcc-ceeeeEEeecCCcceeE
Q 014034           83 RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGVLEHPNL-VKLIGYCAVDGERGIQR  158 (432)
Q Consensus        83 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~~~~  158 (432)
                      -++.|+.|....+|+.             ..+++|+......   ...+|+.+++.+..-.+ .++++++..  ..    
T Consensus        22 ~i~~l~gG~tN~~~~~-------------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~----   82 (301)
T 3dxq_A           22 GPLERLGGLTNLVFRA-------------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVDPA--TG----   82 (301)
T ss_dssp             SCEEEESCSSEEEEEE-------------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TC----
T ss_pred             ceeEcCCcccccccee-------------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEECC--CC----
Confidence            3677999999999986             2377887664322   23578888877642222 455554321  11    


Q ss_pred             EEEEeec-CCCCH
Q 014034          159 LLVYEFM-LNRSL  170 (432)
Q Consensus       159 ~lv~e~~-~~gsL  170 (432)
                      ++++||+ +|.+|
T Consensus        83 ~~v~e~i~~g~~l   95 (301)
T 3dxq_A           83 VMVTRYIAGAQTM   95 (301)
T ss_dssp             CEEEECCTTCEEC
T ss_pred             EEEEeecCCCccC
Confidence            7899999 66554

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.38  E-value=0.00059  Score=64.11  Aligned_cols=157  Identities=18%  Similarity=0.165  Sum_probs=83.5

Q ss_pred             cCHHHHHHhhcCCcc-----ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc--ChHHHHHHHHHhcccCCCc-
Q 014034           69 FSYSEMRQATNDFSR-----MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQWVAEVQFLGVLEHPN-  140 (432)
Q Consensus        69 ~~~~~~~~~~~~~~~-----~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~hpn-  140 (432)
                      ++.+++......|..     ++.|+.|....+|+....        ++ .+++|....  ....+..|+.++..|.... 
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~--------~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~   77 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT--------KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGL   77 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES--------SC-CEEEEEECC---CCHHHHHHHHHHHHHHTTC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC--------Cc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCC
Confidence            344555555555544     345677888999998642        22 578898775  3345677888877663212 


Q ss_pred             -cceeeeEEeecCC----cceeEEEEEeecCCCCHHH--------------Hhhc--CCC-CC----C---CHHHHHH--
Q 014034          141 -LVKLIGYCAVDGE----RGIQRLLVYEFMLNRSLED--------------HLFN--RAF-PP----L---PWKTRLH--  189 (432)
Q Consensus       141 -iv~l~~~~~~~~~----~~~~~~lv~e~~~~gsL~~--------------~l~~--~~~-~~----l---~~~~~~~--  189 (432)
                       +.+++...  ++.    .....+++|+|++|..+..              .++.  ... .+    .   .|.....  
T Consensus        78 ~vP~~~~~~--~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~  155 (322)
T 2ppq_A           78 SCPLPLPRK--DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKS  155 (322)
T ss_dssp             CCCCBCCBT--TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHH
T ss_pred             CCCcccCCC--CCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHH
Confidence             23333210  110    0113489999998865421              0111  010 00    1   1221100  


Q ss_pred             ----------HHHHHHHHHHHhhc----CCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          190 ----------IILGAAEGLAYLHE----GLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       190 ----------i~~~l~~~l~~LH~----~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                                +...+...+.++..    ....+++|+|+.+.|||+++++.+.|+||+.+.
T Consensus       156 ~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          156 EERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                      00113334444442    123479999999999999987666899998764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.37  E-value=0.00084  Score=64.76  Aligned_cols=145  Identities=14%  Similarity=0.129  Sum_probs=83.0

Q ss_pred             ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc---ChHHHHHHHHHhcccC-CCccceeeeEEeecCCcceeEE
Q 014034           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR---DGLQWVAEVQFLGVLE-HPNLVKLIGYCAVDGERGIQRL  159 (432)
Q Consensus        84 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~---~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~~~  159 (432)
                      ++.|..|-...+|+............++..+++|+...   ......+|..+++.|. +.-..++++++.  +      .
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~------g  126 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E------G  126 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T------E
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C------c
Confidence            45677788889999875311111112346788998644   3445678999998774 333456666543  1      3


Q ss_pred             EEEeecCCCCHHHH-----------------hhcCC---CCCC--CHHHHHHHHHHHHH-------------------HH
Q 014034          160 LVYEFMLNRSLEDH-----------------LFNRA---FPPL--PWKTRLHIILGAAE-------------------GL  198 (432)
Q Consensus       160 lv~e~~~~gsL~~~-----------------l~~~~---~~~l--~~~~~~~i~~~l~~-------------------~l  198 (432)
                      +||||++|.+|..-                 |+...   .+..  -+.++..+..++..                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            79999988665421                 11111   1111  23455555544322                   12


Q ss_pred             HHhh----c-CCCCceeecCCCCCceEEcCC----CceeeccccCCc
Q 014034          199 AYLH----E-GLEVQVIYRDFKASNVLLDEN----FRPKLSDFGLAR  236 (432)
Q Consensus       199 ~~LH----~-~~~~~ivH~Dikp~Nill~~~----~~~kl~DfG~a~  236 (432)
                      ..|.    . .....++|+|+.+.|||++.+    +.+.|+||..+.
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            2222    1 123479999999999999876    789999998874

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.16  E-value=0.00086  Score=66.41  Aligned_cols=72  Identities=18%  Similarity=0.094  Sum_probs=46.3

Q ss_pred             ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH---HHHHHHHHhcccCCCcc-ceeeeEEeecCCcceeEE
Q 014034           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGVLEHPNL-VKLIGYCAVDGERGIQRL  159 (432)
Q Consensus        84 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~~~~~  159 (432)
                      ++.|+.|-...+|+....       ..+..+++|+......   ...+|+.+++.|...++ .++++++.    .    .
T Consensus       113 i~~lsgG~tN~~y~v~~~-------~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~----~----G  177 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDM-------SKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT----N----G  177 (458)
T ss_dssp             EEEECC--CEEEEEEEET-------TTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET----T----E
T ss_pred             EEEcCCCeEeEEEEEEEC-------CCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC----C----e
Confidence            456888888999998753       1236788888654322   23589999988864444 56776652    1    3


Q ss_pred             EEEeecCCCCH
Q 014034          160 LVYEFMLNRSL  170 (432)
Q Consensus       160 lv~e~~~~gsL  170 (432)
                      +||||++|.+|
T Consensus       178 ~v~e~I~G~~l  188 (458)
T 2qg7_A          178 RIEEFMDGYAL  188 (458)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEeeCCccC
Confidence            59999987554

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.10  E-value=0.00087  Score=64.41  Aligned_cols=79  Identities=14%  Similarity=0.178  Sum_probs=44.2

Q ss_pred             ccccccCCceEEEEEEecCCC-CCCCcccEEEEEEecCcChHH---HHHHHHHhcccCCCc-cceeeeEEeecCCcceeE
Q 014034           84 MLKIGEGGFGSVYKSSIKPAA-GDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGVLEHPN-LVKLIGYCAVDGERGIQR  158 (432)
Q Consensus        84 ~~~lg~G~fg~Vy~~~~~~~~-~~~~~~~~~vaiK~~~~~~~~---~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~~~~  158 (432)
                      ...|+.|....+|+....... .+....+..+++|+.......   ...|..+++.+...+ +.++++..  .+      
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~------  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG------  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT------
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC------
Confidence            456788888999998753100 000001257888887654332   367888888774333 44666543  21      


Q ss_pred             EEEEeecCCCCH
Q 014034          159 LLVYEFMLNRSL  170 (432)
Q Consensus       159 ~lv~e~~~~gsL  170 (432)
                      ++||+|++|..+
T Consensus       110 ~~v~e~i~G~~l  121 (369)
T 3c5i_A          110 GRIEEWLYGDPL  121 (369)
T ss_dssp             EEEEECCCSEEC
T ss_pred             cEEEEEecCCcC
Confidence            789999987544

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.00  E-value=0.0094  Score=55.89  Aligned_cols=139  Identities=17%  Similarity=0.171  Sum_probs=76.4

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc---ChHHHHHHHHHhcccCCC--ccceeeeEEeecCCc----c
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR---DGLQWVAEVQFLGVLEHP--NLVKLIGYCAVDGER----G  155 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~---~~~~~~~E~~~l~~l~hp--niv~l~~~~~~~~~~----~  155 (432)
                      ..|+ |....||+...        .++..+++|..+.   ....+..|..++..|...  .+++++..   ++..    .
T Consensus        32 ~~l~-g~~n~~y~v~~--------~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~---~g~~~~~~~   99 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD--------EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF---NGQTLLNHQ   99 (328)
T ss_dssp             EEEC-CSSSEEEEECC--------TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB---TTBSCEEET
T ss_pred             Eeec-CcccceEEEEc--------CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec---CCcEEEEEC
Confidence            4566 78889998753        2345689999863   344577788888777421  23444432   1110    1


Q ss_pred             eeEEEEEeecCCCCHH-----HH---------hh----cCC---CCCCCHHHH----------------------HHHHH
Q 014034          156 IQRLLVYEFMLNRSLE-----DH---------LF----NRA---FPPLPWKTR----------------------LHIIL  192 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~-----~~---------l~----~~~---~~~l~~~~~----------------------~~i~~  192 (432)
                      ...+++|+|++|..+.     ..         ++    ...   .....+...                      ...+.
T Consensus       100 g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  179 (328)
T 1zyl_A          100 GFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATD  179 (328)
T ss_dssp             TEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHH
T ss_pred             CEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHH
Confidence            2347899999875432     10         11    000   011121110                      11112


Q ss_pred             HHHHHHHHhhc-CCCCceeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          193 GAAEGLAYLHE-GLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       193 ~l~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      .++..+.-+-. .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       180 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          180 ELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            22222222111 1234789999999999999 4 899999988753

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.38  E-value=0.013  Score=55.40  Aligned_cols=31  Identities=19%  Similarity=0.145  Sum_probs=27.6

Q ss_pred             CceeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          207 VQVIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       207 ~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4799999999999999888899999987753

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.13  E-value=0.02  Score=55.98  Aligned_cols=144  Identities=14%  Similarity=0.115  Sum_probs=83.4

Q ss_pred             ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH---HHHHHHHHhcccC-CCccceeeeEEeecCCcceeEE
Q 014034           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGVLE-HPNLVKLIGYCAVDGERGIQRL  159 (432)
Q Consensus        84 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~~~  159 (432)
                      ++.|..|-...+|+.......+.....+..+++++......   ...+|..+++.+. +.-..++++.+  .+      +
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~------~  146 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE------G  146 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT------E
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC------C
Confidence            45677788899999876411110011156788888654332   2467888888874 33345566533  22      7


Q ss_pred             EEEeecCCCCHHHH--------------h---hc----C-------CCCCCCHHHHHHHHHHH-----------------
Q 014034          160 LVYEFMLNRSLEDH--------------L---FN----R-------AFPPLPWKTRLHIILGA-----------------  194 (432)
Q Consensus       160 lv~e~~~~gsL~~~--------------l---~~----~-------~~~~l~~~~~~~i~~~l-----------------  194 (432)
                      +||+|++|.+|..-              +   +.    .       ...+..+.++..+..++                 
T Consensus       147 ~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~  226 (424)
T 3mes_A          147 RIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYS  226 (424)
T ss_dssp             EEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHH
T ss_pred             EEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHH
Confidence            89999998664210              0   00    0       11122244444443322                 


Q ss_pred             --HHHHHHhh---------------------cCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          195 --AEGLAYLH---------------------EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       195 --~~~l~~LH---------------------~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                        ...+..|.                     ......++|+|+.+.||+ +.++.+.|+||..+.
T Consensus       227 ~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~  290 (424)
T 3mes_A          227 KILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA  290 (424)
T ss_dssp             HHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence              12222322                     111347899999999999 888899999998874

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.24  E-value=0.16  Score=49.10  Aligned_cols=29  Identities=28%  Similarity=0.364  Sum_probs=24.8

Q ss_pred             ceeecCCCCCceEE------cCCCceeeccccCCc
Q 014034          208 QVIYRDFKASNVLL------DENFRPKLSDFGLAR  236 (432)
Q Consensus       208 ~ivH~Dikp~Nill------~~~~~~kl~DfG~a~  236 (432)
                      .++|+|+.+.|||+      +++..+.++||-+|.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            46899999999999      456779999998874

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=92.27  E-value=0.66  Score=40.34  Aligned_cols=116  Identities=8%  Similarity=0.089  Sum_probs=76.4

Q ss_pred             CCCccceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCC
Q 014034          137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKA  216 (432)
Q Consensus       137 ~hpniv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp  216 (432)
                      .||+++.. .+-..++      -++..|-...+...|-.   ...++...+++++..|+....++++     -+|--|.|
T Consensus        43 ~~~~Fl~~-~I~e~eD------~v~~~y~~~~~~~~f~~---ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P  107 (215)
T 4ann_A           43 HSPYFIDA-ELTELRD------SFQIHYDINDNHTPFDN---IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAP  107 (215)
T ss_dssp             CCTTBCCE-EEEECSS------EEEEEECCCTTSEEGGG---GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSG
T ss_pred             cCCcccce-EEEEccc------EEEEEEEcCcccCCHHH---HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEec
Confidence            58888876 3333332      23444443333333321   1357889999999999988866664     36778999


Q ss_pred             CceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 014034          217 SNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE  291 (432)
Q Consensus       217 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~  291 (432)
                      +||+++.++.+++.-.|+-..                   ++|.     .++...=.-.+=+++..+++++..|.
T Consensus       108 ~NL~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          108 DELFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             GGEEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             ceEEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999999998887432                   2232     11222223457888999999988875

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=88.38  E-value=3.7  Score=35.73  Aligned_cols=82  Identities=9%  Similarity=0.144  Sum_probs=60.1

Q ss_pred             CCCHHHHHHHHHHHHHHHH-HhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCc
Q 014034          181 PLPWKTRLHIILGAAEGLA-YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP  259 (432)
Q Consensus       181 ~l~~~~~~~i~~~l~~~l~-~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aP  259 (432)
                      .++...+++++..|+.... ++++     -+|--|.|+||+++.++.++|.-.|+-..                   ++|
T Consensus        81 ~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~f~~~~~p~i~hRGi~~~-------------------lpP  136 (219)
T 4ano_A           81 KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLMFNRALEPFFLHVGVKES-------------------LPP  136 (219)
T ss_dssp             TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEEECTTCCEEESCCEETTT-------------------BSS
T ss_pred             hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEEEeCCCcEEEEEcCCccc-------------------CCC
Confidence            4788899999999988777 6664     46778999999999999999998887432                   233


Q ss_pred             cccccCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 014034          260 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE  291 (432)
Q Consensus       260 E~~~~~~~~~~~DvwSlGvil~elltg~~pf~  291 (432)
                      .-+     +..-=.-++=+++..++.++..|.
T Consensus       137 ~e~-----~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          137 DEW-----DDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             CSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             CCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence            221     111223357788888999888775

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=83.27  E-value=0.15  Score=50.41  Aligned_cols=58  Identities=12%  Similarity=0.159  Sum_probs=17.8

Q ss_pred             cccccccCCceEEEEEEecCCCCCCCcccEEEEE------EecCcCh------HHHHHHHHHhcccCCCccceeeeEEee
Q 014034           83 RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAI------KKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        83 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vai------K~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      ..+.||   ||.||+|.+..       ...+||+      |......      ..+.+|..+++.++|||+++.+++...
T Consensus       146 l~~~lG---fG~v~~g~~~~-------~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYK-------KHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             STTTSS---BCCC----------------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             ccccCC---chhhhcccccc-------cCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            345666   99999998852       2346777      6554311      236778889999999999999887654

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	432
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-66
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-63
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-63
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-61
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-60
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-60
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-59
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-59
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	9e-59
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-58
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-58
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-58
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-58
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-57
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-57
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-57
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-57
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-56
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-55
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-55
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-55
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-54
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-53
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-53
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-52
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-52
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-51
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-51
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-51
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-50
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-49
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-48
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-47
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-47
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-44
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-44
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-44
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-43
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-43
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-42
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-42
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-42
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-41
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-41
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-41
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-40
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	8e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-39
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	8e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-38
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-38
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-37
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-35
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-34
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-32
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-31
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-31
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-29
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-14

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (534), Expect = 8e-66
 Identities = 73/296 (24%), Positives = 122/296 (41%), Gaps = 40/296 (13%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQF 132
              +   +IG G FG+VYK                VA+K LN           +  EV  
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWH----------GDVAVKMLNVTAPTPQQLQAFKNEVGV 57

Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
           L    H N++  +GY         Q  +V ++    SL  HL             + I  
Sbjct: 58  LRKTRHVNILLFMGYS-----TAPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIAR 111

Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
             A+G+ YLH      +I+RD K++N+ L E+   K+ DFGLA        +H    + G
Sbjct: 112 QTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 168

Query: 253 TFGYAAPDYIET---GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP 309
           +  + AP+ I        + +SDV++FG+VLYE++TG+            +++  V +  
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIFMVGRG- 225

Query: 310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
                    + P L  +   N  + + RL   CL K   +RP   Q++  ++ + +
Sbjct: 226 --------YLSPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  204 bits (520), Expect = 2e-63
 Identities = 78/318 (24%), Positives = 137/318 (43%), Gaps = 45/318 (14%)

Query: 69  FSYSEMRQATNDFSRML---------KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL 119
           F++ +  +A  +F++ +          IG G FG V    +K            VAIK L
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLK----LPGKREIFVAIKTL 62

Query: 120 NRDGL-----QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL 174
                      +++E   +G  +HPN++ L G            +++ EFM N SL D  
Sbjct: 63  KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV----MIITEFMENGSL-DSF 117

Query: 175 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 234
             +          + ++ G A G+ YL +   +  ++RD  A N+L++ N   K+SDFGL
Sbjct: 118 LRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGL 174

Query: 235 AREGPMVGHTHVSTAVVG---TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 291
           +R           T+ +G      + AP+ I+    T+ SDVWS+G+V++E+++      
Sbjct: 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 234

Query: 292 RNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP 351
            +   T Q ++  ++Q            D RL        A  + +L  +C  K    RP
Sbjct: 235 WD--MTNQDVINAIEQ------------DYRLPPPMDCPSA--LHQLMLDCWQKDRNHRP 278

Query: 352 KMSQVVERLKQIVQVSNE 369
           K  Q+V  L ++++  N 
Sbjct: 279 KFGQIVNTLDKMIRNPNS 296

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 2e-63
 Identities = 64/301 (21%), Positives = 121/301 (40%), Gaps = 34/301 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWV---AEVQFLGVLEHPNLV 142
            IG+G FG V++         G      VA+K  +    +     AE+    +L H N++
Sbjct: 10  SIGKGRFGEVWR---------GKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL 60

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
             I     D     Q  LV ++  + SL D+L       +  +  + + L  A GLA+LH
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLH 117

Query: 203 EGLEVQ-----VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT--HVSTAVVGTFG 255
             +        + +RD K+ N+L+ +N    ++D GLA        T        VGT  
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 256 YAAPDYIET------GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP 309
           Y AP+ ++            ++D+++ G+V +E+     S+       +    + V   P
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR-CSIGGIHEDYQLPYYDLVPSDP 236

Query: 310 ADSKKFGLI----MDPRLEKEYSINEA-RKIGRLADNCLSKSSKDRPKMSQVVERLKQIV 364
           +  +   ++    + P +   +   EA R + ++   C   +   R    ++ + L Q+ 
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296

Query: 365 Q 365
           Q
Sbjct: 297 Q 297

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 2e-61
 Identities = 73/287 (25%), Positives = 118/287 (41%), Gaps = 38/287 (13%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--WVAEVQFLGVL 136
            +   +  IG+G FG V           G      VA+K +  D     ++AE   +  L
Sbjct: 7   KELKLLQTIGKGEFGDVML---------GDYRGNKVAVKCIKNDATAQAFLAEASVMTQL 57

Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
            H NLV+L+G    +        +V E+M   SL D+L +R    L     L   L   E
Sbjct: 58  RHSNLVQLLGVIVEEKGG---LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
            + YL        ++RD  A NVL+ E+   K+SDFGL +E      T           +
Sbjct: 115 AMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKW 166

Query: 257 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG 316
            AP+ +     + KSDVWSFG++L+E+ +  R      P   + ++  V++         
Sbjct: 167 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRVEK--------- 215

Query: 317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
                +++       A  +  +  NC    +  RP   Q+ E+L+ I
Sbjct: 216 ---GYKMDAPDGCPPA--VYEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 3e-60
 Identities = 70/288 (24%), Positives = 121/288 (42%), Gaps = 36/288 (12%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGV 135
                + ++G G FG V+               T VA+K L +  +    ++AE   +  
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYN--------GHTKVAVKSLKQGSMSPDAFLAEANLMKQ 64

Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
           L+H  LV+L      +        ++ E+M N SL D L   +   L     L +    A
Sbjct: 65  LQHQRLVRLYAVVTQE-----PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119

Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
           EG+A++ E      I+RD +A+N+L+ +    K++DFGLAR                   
Sbjct: 120 EGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIK 175

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF 315
           + AP+ I  G  T KSDVWSFG++L E++T  R        T   +++ +++        
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG--MTNPEVIQNLER-------- 225

Query: 316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
                 R+ +  +  E  ++ +L   C  +  +DRP    +   L+  
Sbjct: 226 ----GYRMVRPDNCPE--ELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 7e-60
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 36/290 (12%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGV 135
           ++ + + +IG G FG V+                 VAIK +    +    ++ E + +  
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWL--------NKDKVAIKTIREGAMSEEDFIEEAEVMMK 56

Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
           L HP LV+L G C           LV+EFM +  L D+L  +       +T L + L   
Sbjct: 57  LSHPKLVQLYGVCLEQAPI----CLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVC 111

Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
           EG+AYL E     VI+RD  A N L+ EN   K+SDFG+ R          ST       
Sbjct: 112 EGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVK 167

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF 315
           +A+P+       ++KSDVWSFGV+++E+ +  +    NR  +E  ++E +          
Sbjct: 168 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGFR----- 220

Query: 316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
             +  PRL   +          + ++C  +  +DRP  S+++ +L +I +
Sbjct: 221 --LYKPRLASTHVYQ-------IMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 2e-59
 Identities = 67/285 (23%), Positives = 120/285 (42%), Gaps = 36/285 (12%)

Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVLEHP 139
           +++G G FGSV +   +        +   VAIK L +   +      + E Q +  L++P
Sbjct: 15  IELGCGNFGSVRQGVYR-----MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 69

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
            +V+LIG C     +    +LV E      L   L  +    +P      ++   + G+ 
Sbjct: 70  YIVRLIGVC-----QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMK 123

Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAVVGTFGYAA 258
           YL E      ++RD  A NVLL      K+SDFGL++  G    +    +A      + A
Sbjct: 124 YLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180

Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 318
           P+ I     +++SDVWS+GV ++E L+  +   +        ++ +++Q           
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK--MKGPEVMAFIEQ----------- 227

Query: 319 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
              R+E         ++  L  +C     +DRP    V +R++  
Sbjct: 228 -GKRMECPPECPP--ELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 7e-59
 Identities = 71/316 (22%), Positives = 126/316 (39%), Gaps = 50/316 (15%)

Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-----QWVA 128
           M    +DF ++ ++G G  G V+K S KP          V+A K ++ +       Q + 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKP-------SGLVMARKLIHLEIKPAIRNQIIR 53

Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           E+Q L     P +V   G    DGE      +  E M   SL+  L       +P +   
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEI----SICMEHMDGGSLDQVLKKAG--RIPEQILG 107

Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 248
            + +   +GL YL E  + ++++RD K SN+L++     KL DFG++ +        ++ 
Sbjct: 108 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMAN 161

Query: 249 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY 308
           + VGT  Y +P+ ++  H + +SD+WS G+ L EM  GR  +     K  + +     + 
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 221

Query: 309 PADSKKFGLIMDPRLEKEYSINEARKIGR--------------------------LADNC 342
            A           R    Y ++    +                              + C
Sbjct: 222 DAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 281

Query: 343 LSKSSKDRPKMSQVVE 358
           L K+  +R  + Q++ 
Sbjct: 282 LIKNPAERADLKQLMV 297

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  192 bits (488), Expect = 9e-59
 Identities = 73/323 (22%), Positives = 124/323 (38%), Gaps = 52/323 (16%)

Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---- 125
               +    N+   +  IGEG FG V+++             T+VA+K L  +       
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPF--TMVAVKMLKEEASADMQA 61

Query: 126 -WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR------- 177
            +  E   +   ++PN+VKL+G CAV         L++E+M    L + L +        
Sbjct: 62  DFQREAALMAEFDNPNIVKLLGVCAVGKPM----CLLFEYMAYGDLNEFLRSMSPHTVCS 117

Query: 178 ---------------AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD 222
                            PPL    +L I    A G+AYL E    + ++RD    N L+ 
Sbjct: 118 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVG 174

Query: 223 ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYE 282
           EN   K++DFGL+R      +            +  P+ I     T +SDVW++GVVL+E
Sbjct: 175 ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 234

Query: 283 MLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNC 342
           + +             + ++ +             + D  +      N   ++  L   C
Sbjct: 235 IFSYGLQPYYG--MAHEEVIYY-------------VRDGNIL-ACPENCPLELYNLMRLC 278

Query: 343 LSKSSKDRPKMSQVVERLKQIVQ 365
            SK   DRP    +   L+++ +
Sbjct: 279 WSKLPADRPSFCSIHRILQRMCE 301

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  191 bits (487), Expect = 1e-58
 Identities = 72/300 (24%), Positives = 124/300 (41%), Gaps = 34/300 (11%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---WVAEVQFLGV 135
            D +   K+G G +G VY+       G     +  VA+K L  D ++   ++ E   +  
Sbjct: 17  TDITMKHKLGGGQYGEVYE-------GVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 69

Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
           ++HPNLV+L+G C  +    I      EFM   +L D+L       +     L++    +
Sbjct: 70  IKHPNLVQLLGVCTREPPFYII----TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 125

Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
             + YL +      I+RD  A N L+ EN   K++DFGL+R                   
Sbjct: 126 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIK 181

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF 315
           + AP+ +     + KSDVW+FGV+L+E+ T   S          ++ E            
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG--IDLSQVYE------------ 227

Query: 316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSFDK 375
             +++     E       K+  L   C   +  DRP  +++ +  + + Q S+  D  +K
Sbjct: 228 --LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 285

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 2e-58
 Identities = 57/288 (19%), Positives = 112/288 (38%), Gaps = 36/288 (12%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGV 135
            D + + ++G G FG V     +            VAIK +    +   +++ E + +  
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWR--------GQYDVAIKMIKEGSMSEDEFIEEAKVMMN 55

Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
           L H  LV+L G C           ++ E+M N  L ++L          +  L +     
Sbjct: 56  LSHEKLVQLYGVCTKQRPI----FIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVC 110

Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
           E + YL      Q ++RD  A N L+++    K+SDFGL+R          S        
Sbjct: 111 EAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVR 166

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF 315
           ++ P+ +     ++KSD+W+FGV+++E+ +  +      P       E  +         
Sbjct: 167 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK-----MPYERFTNSETAEH-------- 213

Query: 316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
              +   L        + K+  +  +C  + + +RP    ++  +  +
Sbjct: 214 ---IAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 4e-58
 Identities = 69/290 (23%), Positives = 111/290 (38%), Gaps = 36/290 (12%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGV 135
                 +K+G+G FG V+  +            T VAIK L    +    ++ E Q +  
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWN--------GTTRVAIKTLKPGTMSPEAFLQEAQVMKK 68

Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
           L H  LV+L    + +        +V E+M   SL D L       L     + +    A
Sbjct: 69  LRHEKLVQLYAVVSEE-----PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 123

Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
            G+AY+     +  ++RD +A+N+L+ EN   K++DFGLAR                   
Sbjct: 124 SGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIK 179

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF 315
           + AP+    G  T KSDVWSFG++L E+ T  R          + +L+ V++        
Sbjct: 180 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG--MVNREVLDQVER-------- 229

Query: 316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
                              +  L   C  K  ++RP    +   L+    
Sbjct: 230 ------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 4e-58
 Identities = 67/311 (21%), Positives = 115/311 (36%), Gaps = 46/311 (14%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFL 133
           N  S    +G G FG V +++         +    VA+K L            ++E++ L
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAM--TVAVKMLKPSAHLTEREALMSELKVL 80

Query: 134 GVLE-HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR--------------- 177
             L  H N+V L+G C + G      L++ E+     L + L  +               
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPT----LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136

Query: 178 -AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 236
                L  +  L      A+G+A+L        I+RD  A N+LL      K+ DFGLAR
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR 193

Query: 237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK 296
           +     +  V         + AP+ I     T +SDVWS+G+ L+E+ +   S     P 
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253

Query: 297 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 356
             +               F  ++          +   ++  +   C       RP   Q+
Sbjct: 254 DSK---------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298

Query: 357 VERLKQIVQVS 367
           V+ +++ +  S
Sbjct: 299 VQLIEKQISES 309

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 4e-57
 Identities = 68/293 (23%), Positives = 118/293 (40%), Gaps = 39/293 (13%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFLGVLEHP 139
           ++G G FG+V K                VA+K L  +        + +AE   +  L++P
Sbjct: 14  ELGSGNFGTVKK-----GYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 68

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
            +V++IG C  +       +LV E      L  +L       +  K  + ++   + G+ 
Sbjct: 69  YIVRMIGICEAES-----WMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMK 121

Query: 200 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAVVGTFGYAA 258
           YL E      ++RD  A NVLL      K+SDFGL++       +    T       + A
Sbjct: 122 YLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178

Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 318
           P+ I     ++KSDVWSFGV+++E  +  +   R        +   +++           
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG--MKGSEVTAMLEK----------- 225

Query: 319 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI-VQVSNEG 370
              R+          ++  L + C +   ++RP  + V  RL+     V NEG
Sbjct: 226 -GERMGCPAGCPR--EMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 275

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 4e-57
 Identities = 61/280 (21%), Positives = 108/280 (38%), Gaps = 37/280 (13%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFLGVLEHP 139
           +IG G F +VYK       G  T     VA  +L    L      ++  E + L  L+HP
Sbjct: 16  EIGRGSFKTVYK-------GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68

Query: 140 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 199
           N+V+         +     +LV E M + +L+ +L       +  K          +GL 
Sbjct: 69  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQ 126

Query: 200 YLHEGLEVQVIYRDFKASNVLL-DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 258
           +LH      +I+RD K  N+ +       K+ D GLA     +     + AV+GT  + A
Sbjct: 127 FLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMA 181

Query: 259 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 318
           P+  E        DV++FG+ + EM T        +     ++   V             
Sbjct: 182 PEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGV--------- 229

Query: 319 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
             P    + +I E +    + + C+ ++  +R  +  ++ 
Sbjct: 230 -KPASFDKVAIPEVK---EIIEGCIRQNKDERYSIKDLLN 265

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 5e-57
 Identities = 82/317 (25%), Positives = 131/317 (41%), Gaps = 41/317 (12%)

Query: 56  PELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVA 115
           PEL +   H   V   S +      F+    IG G FG VY  ++     D   +    A
Sbjct: 11  PELVQAVQH--VVIGPSSLIV---HFNE--VIGRGHFGCVYHGTLL----DNDGKKIHCA 59

Query: 116 IKKLNRDGL-----QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL 170
           +K LNR        Q++ E   +    HPN++ L+G C          L+V  +M +  L
Sbjct: 60  VKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS---PLVVLPYMKHGDL 116

Query: 171 EDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS 230
            + + N    P   K  +   L  A+G+ +L      + ++RD  A N +LDE F  K++
Sbjct: 117 RNFIRNETHNP-TVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVA 172

Query: 231 DFGLARE--GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRR 288
           DFGLAR+         H  T       + A + ++T   T KSDVWSFGV+L+E++T   
Sbjct: 173 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 232

Query: 289 SLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSK 348
                 P  +    +             L+   RL +     +   +  +   C    ++
Sbjct: 233 -----PPYPDVNTFDITVY---------LLQGRRLLQPEYCPD--PLYEVMLKCWHPKAE 276

Query: 349 DRPKMSQVVERLKQIVQ 365
            RP  S++V R+  I  
Sbjct: 277 MRPSFSELVSRISAIFS 293

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 6e-57
 Identities = 67/297 (22%), Positives = 125/297 (42%), Gaps = 33/297 (11%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFL 133
           +  +R   IG G FG VYK  +K        +   VAIK L         + ++ E   +
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLK---TSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
           G   H N+++L G  +         +++ E+M N +L+  L  +          + ++ G
Sbjct: 64  GQFSHHNIIRLEGVISKYKPM----MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRG 118

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAVVG 252
            A G+ YL     +  ++RD  A N+L++ N   K+SDFGL+R        T+ ++    
Sbjct: 119 IAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175

Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 312
              + AP+ I     T+ SDVWSFG+V++E++T               +++ +       
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMKAI------- 226

Query: 313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNE 369
                  +        ++    I +L   C  +    RPK + +V  L ++++  + 
Sbjct: 227 -------NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 4e-56
 Identities = 72/293 (24%), Positives = 112/293 (38%), Gaps = 36/293 (12%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQ 131
            D   + K+G+G FG V +      +G        VA+K L  D L        ++ EV 
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTV----SVAVKCLKPDVLSQPEAMDDFIREVN 63

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 191
            +  L+H NL++L G       +     +V E     SL D L           T     
Sbjct: 64  AMHSLDHRNLIRLYGVVLTPPMK-----MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYA 117

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV-STAV 250
           +  AEG+ YL      + I+RD  A N+LL      K+ DFGL R  P     +V     
Sbjct: 118 VQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174

Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA 310
              F + AP+ ++T   +  SD W FGV L+EM T  +           ++L  + +   
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--NGSQILHKIDK--- 229

Query: 311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 363
                      RL +     +   I  +   C +   +DRP    + + L + 
Sbjct: 230 --------EGERLPRPEDCPQ--DIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 1e-55
 Identities = 63/310 (20%), Positives = 115/310 (37%), Gaps = 51/310 (16%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFL 133
            +      +G G FG V  ++        T  +  VA+K L            ++E++ +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAY--GISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 94

Query: 134 GVLE-HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR--------------- 177
             L  H N+V L+G C + G       L++E+     L ++L ++               
Sbjct: 95  TQLGSHENIVNLLGACTLSG----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150

Query: 178 ------AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD 231
                     L ++  L      A+G+ +L        ++RD  A NVL+      K+ D
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICD 207

Query: 232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 291
           FGLAR+     +  V         + AP+ +  G  T KSDVWS+G++L+E+ +   +  
Sbjct: 208 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267

Query: 292 RNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP 351
              P                   F  ++    + +       +I  +  +C +  S+ RP
Sbjct: 268 PGIPVDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP 312

Query: 352 KMSQVVERLK 361
               +   L 
Sbjct: 313 SFPNLTSFLG 322

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 2e-55
 Identities = 77/307 (25%), Positives = 125/307 (40%), Gaps = 51/307 (16%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-----QWVAEVQFL 133
           ND      IGEG FG V K+ IK             AIK++           +  E++ L
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIK-----KDGLRMDAAIKRMKEYASKDDHRDFAGELEVL 64

Query: 134 GVLE-HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP------------ 180
             L  HPN++ L+G C   G       L  E+  + +L D L                  
Sbjct: 65  CKLGHHPNIINLLGACEHRGYL----YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 120

Query: 181 --PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 238
              L  +  LH     A G+ YL +    Q I+RD  A N+L+ EN+  K++DFGL+R  
Sbjct: 121 ASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-- 175

Query: 239 PMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE 298
                    T       + A + +     T  SDVWS+GV+L+E+++   +     P   
Sbjct: 176 -GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCG 229

Query: 299 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
               E  ++         L    RLEK  + ++  ++  L   C  +   +RP  +Q++ 
Sbjct: 230 MTCAELYEK---------LPQGYRLEKPLNCDD--EVYDLMRQCWREKPYERPSFAQILV 278

Query: 359 RLKQIVQ 365
            L ++++
Sbjct: 279 SLNRMLE 285

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 3e-55
 Identities = 66/289 (22%), Positives = 114/289 (39%), Gaps = 38/289 (13%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFL 133
           D+  +  IG G +G   K           S+  ++  K+L+   +        V+EV  L
Sbjct: 5   DYEVLYTIGTGSYGRCQK-------IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLL 57

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHII 191
             L+HPN+V+            +   +V E+     L   +    +    L  +  L ++
Sbjct: 58  RELKHPNIVRYYDRIIDRTNTTL--YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115

Query: 192 LGAAEGLAYLHEGLEV--QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
                 L   H   +    V++RD K +NV LD     KL DFGLAR   +   T  + A
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKA 173

Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP 309
            VGT  Y +P+ +       KSD+WS G +LYE+             +++ L   +++  
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGKIREGK 230

Query: 310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
                       R+   YS +E  +   +    L+     RP + +++E
Sbjct: 231 ----------FRRIPYRYS-DELNE---IITRMLNLKDYHRPSVEEILE 265

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 2e-54
 Identities = 60/291 (20%), Positives = 120/291 (41%), Gaps = 33/291 (11%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-----QWVAEVQFLG 134
           +F ++  +G G FG+VYK    P   +G      VAIK+L          + + E   + 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66

Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 194
            +++P++ +L+G C     +     L+ + M    L D++          +  L+  +  
Sbjct: 67  SVDNPHVCRLLGICLTSTVQ-----LITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQI 120

Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 254
           A+G+ YL +    ++++RD  A NVL+      K++DFGLA+        + +       
Sbjct: 121 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

Query: 255 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 314
            + A + I     T +SDVWS+GV ++E++T         P     +   +++       
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILEK------- 228

Query: 315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
                  RL +         +  +   C    +  RPK  +++    ++ +
Sbjct: 229 -----GERLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  179 bits (455), Expect = 1e-53
 Identities = 87/325 (26%), Positives = 133/325 (40%), Gaps = 50/325 (15%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-------WVAEVQFL 133
           FS + +IG G FG+VY              + VVAIKK++  G Q        + EV+FL
Sbjct: 17  FSDLREIGHGSFGAVYF-------ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L HPN ++  G    +        LV E+ L  + +    ++   PL       +  G
Sbjct: 70  QKLRHPNTIQYRGCYLREHTA----WLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHG 123

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
           A +GLAYLH      +I+RD KA N+LL E    KL DFG A           + + VGT
Sbjct: 124 ALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANSFVGT 174

Query: 254 FGYAAPDYIET---GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA 310
             + AP+ I     G    K DVWS G+   E+   +  L           L  + Q   
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIAQNE- 230

Query: 311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER--LKQIVQVSN 368
                     P L+  +     R      D+CL K  +DRP    +++   + +    + 
Sbjct: 231 ---------SPALQSGHWSEYFRN---FVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV 278

Query: 369 EGDSFDKTFEEICEEDPVEAQTKQK 393
             D   +T + + E D ++ +  +K
Sbjct: 279 IMDLIQRTKDAVRELDNLQYRKMKK 303

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 6e-53
 Identities = 63/286 (22%), Positives = 102/286 (35%), Gaps = 37/286 (12%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-----QWVAEVQFL 133
            D+  +  +GEG +G V                  VA+K ++             E+   
Sbjct: 5   EDWDLVQTLGEGAYGEVQL-------AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN 57

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
            +L H N+VK  G+      +     L  E+     L D +       +P          
Sbjct: 58  KMLNHENVVKFYGHRREGNIQ----YLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQ 111

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
              G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT
Sbjct: 112 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168

Query: 254 FGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 312
             Y AP+ ++         DVWS G+VL  ML G    ++    + Q   +W ++     
Sbjct: 169 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD-SCQEYSDWKEK----- 222

Query: 313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
                     L     I+ A     L    L ++   R  +  + +
Sbjct: 223 -------KTYLNPWKKIDSAPL--ALLHKILVENPSARITIPDIKK 259

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 3e-52
 Identities = 68/308 (22%), Positives = 130/308 (42%), Gaps = 38/308 (12%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFL 133
              +   ++G+G FG VY+   K    D     T VAIK +N        ++++ E   +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPE--TRVAIKTVNEAASMRERIEFLNEASVM 77

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF--------NRAFPPLPWK 185
                 ++V+L+G  +         L++ E M    L+ +L         N    P    
Sbjct: 78  KEFNCHHVVRLLGVVSQGQPT----LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133

Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
             + +    A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+ R+     +  
Sbjct: 134 KMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190

Query: 246 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 305
                +    + +P+ ++ G  T  SDVWSFGVVL+E+ T      +    + +++L +V
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG--LSNEQVLRFV 248

Query: 306 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
            +               L+K  +  +   +  L   C   + K RP   +++  +K+ ++
Sbjct: 249 ME------------GGLLDKPDNCPD--MLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

Query: 366 VSNEGDSF 373
                 SF
Sbjct: 295 PGFREVSF 302

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 3e-52
 Identities = 71/287 (24%), Positives = 112/287 (39%), Gaps = 45/287 (15%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQ 131
            DF     +G+G FG+VY                ++A+K L +  L       Q   EV+
Sbjct: 6   EDFEIGRPLGKGKFGNVYL-------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 58

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 191
               L HPN+++L GY        +    + E+    ++   L  +       +     I
Sbjct: 59  IQSHLRHPNILRLYGYFHDATRVYL----ILEYAPLGTVYREL--QKLSKFDEQRTATYI 112

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 251
              A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +   T + 
Sbjct: 113 TELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLC 165

Query: 252 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 311
           GT  Y  P+ IE      K D+WS GV+ YE L G+   E N   T Q   + + +    
Sbjct: 166 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQETYKRISR---- 218

Query: 312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
                  ++       +   AR    L    L  +   RP + +V+E
Sbjct: 219 -------VEFTFPDFVT-EGARD---LISRLLKHNPSQRPMLREVLE 254

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 1e-51
 Identities = 65/289 (22%), Positives = 115/289 (39%), Gaps = 42/289 (14%)

Query: 80  DFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWV----AEVQFLG 134
           DF  ++  +G+G FG VYK             + + A K ++    + +     E+  L 
Sbjct: 12  DFWEIIGELGDGAFGKVYK-------AQNKETSVLAAAKVIDTKSEEELEDYMVEIDILA 64

Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 194
             +HPN+VKL+     +        ++ EF    +++  +      PL       +    
Sbjct: 65  SCDHPNIVKLLDAFYYENNL----WILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQT 119

Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 254
            + L YLH+    ++I+RD KA N+L   +   KL+DFG++ +           + +GT 
Sbjct: 120 LDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTP 174

Query: 255 GYAAPDYI-----ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP 309
            + AP+ +     +      K+DVWS G+ L EM           P   + LL+  +  P
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--MRVLLKIAKSEP 232

Query: 310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
                      P L +    +   K       CL K+   R   SQ+++
Sbjct: 233 -----------PTLAQPSRWSSNFK--DFLKKCLEKNVDARWTTSQLLQ 268

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 2e-51
 Identities = 74/309 (23%), Positives = 133/309 (43%), Gaps = 43/309 (13%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFL 133
           +       +GEG FG V  +       D  +  T VA+K L  D  +      ++E++ +
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 134 GVL-EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPP----------- 181
            ++ +H N++ L+G C     +     ++ E+    +L ++L  R  P            
Sbjct: 73  KMIGKHKNIINLLGAC----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128

Query: 182 ---LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 238
              L  K  +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR+ 
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDI 185

Query: 239 PMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE 298
             + +   +T       + AP+ +     T +SDVWSFGV+L+E+ T   S     P   
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--V 243

Query: 299 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
           + L + +++              R++K  +     ++  +  +C       RP   Q+VE
Sbjct: 244 EELFKLLKE------------GHRMDKPSNCTN--ELYMMMRDCWHAVPSQRPTFKQLVE 289

Query: 359 RLKQIVQVS 367
            L +IV ++
Sbjct: 290 DLDRIVALT 298

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 6e-51
 Identities = 72/310 (23%), Positives = 122/310 (39%), Gaps = 45/310 (14%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFL 133
           +       +G G FG V ++       D T+    VA+K L            ++E++ L
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAF--GIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70

Query: 134 G-VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR--------------A 178
             +  H N+V L+G C   G      +++ EF    +L  +L ++               
Sbjct: 71  IHIGHHLNVVNLLGACTKPGGP---LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 127

Query: 179 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 238
              L  +  +      A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+ 
Sbjct: 128 KDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDI 184

Query: 239 PMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE 298
                            + AP+ I     T +SDVWSFGV+L+E+ +   S     P   
Sbjct: 185 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPG 239

Query: 299 QRLLEWVQQYPADSKKFGLIMDPRLEK-EYSINEARKIGRLADNCLSKSSKDRPKMSQVV 357
            ++ E   +         L    R+   +Y+  E  +      +C       RP  S++V
Sbjct: 240 VKIDEEFCRR--------LKEGTRMRAPDYTTPEMYQ---TMLDCWHGEPSQRPTFSELV 288

Query: 358 ERLKQIVQVS 367
           E L  ++Q +
Sbjct: 289 EHLGNLLQAN 298

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 4e-50
 Identities = 64/285 (22%), Positives = 108/285 (37%), Gaps = 35/285 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQFLGVLEHPN 140
            IGEG FG V++           + A  VAIK             ++ E   +   +HP+
Sbjct: 14  CIGEGQFGDVHQGIYM----SPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 69

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           +VKLIG    +        ++ E      L   L  R    L   + +      +  LAY
Sbjct: 70  IVKLIGVITEN-----PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAY 123

Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 260
           L      + ++RD  A NVL+  N   KL DFGL+R        + ++       + AP+
Sbjct: 124 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPE 179

Query: 261 YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMD 320
            I     T+ SDVW FGV ++E+L       +        ++  ++              
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV--KNNDVIGRIEN------------G 225

Query: 321 PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 365
            RL    +      +  L   C +     RP+ +++  +L  I++
Sbjct: 226 ERLPMPPNCPPT--LYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (425), Expect = 2e-49
 Identities = 60/285 (21%), Positives = 111/285 (38%), Gaps = 38/285 (13%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----WVAEVQFL 133
              ++R  KIG+G  G+VY            +    VAI+++N          + E+  +
Sbjct: 19  KKKYTRFEKIGQGASGTVYT-------AMDVATGQEVAIRQMNLQQQPKKELIINEILVM 71

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
              ++PN+V  +    V  E      +V E++   SL D +       +       +   
Sbjct: 72  RENKNPNIVNYLDSYLVGDEL----WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRE 124

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
             + L +LH     QVI+RD K+ N+LL  +   KL+DFG   +  +       + +VGT
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGT 179

Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK 313
             + AP+ +       K D+WS G++  EM+ G         +   R L  +        
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN---ENPLRALYLIATNG---- 232

Query: 314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
                  P L+    ++   +     + CL    + R    ++++
Sbjct: 233 ------TPELQNPEKLSAIFR--DFLNRCLDMDVEKRGSAKELLQ 269

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  163 bits (413), Expect = 5e-48
 Identities = 66/295 (22%), Positives = 122/295 (41%), Gaps = 35/295 (11%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEV 130
           ++ +     +G GG   V+                 VA+K L  D         ++  E 
Sbjct: 6   SDRYELGEILGFGGMSEVHL-------ARDLRLHRDVAVKVLRADLARDPSFYLRFRREA 58

Query: 131 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
           Q    L HP +V +      +   G    +V E++   +L D +      P+  K  + +
Sbjct: 59  QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEV 116

Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST-A 249
           I  A + L + H+     +I+RD K +N+++      K+ DFG+AR     G++   T A
Sbjct: 117 IADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 173

Query: 250 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP 309
           V+GT  Y +P+      + A+SDV+S G VLYE+LTG      + P       + V++ P
Sbjct: 174 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--VSVAYQHVREDP 231

Query: 310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-MSQVVERLKQI 363
                    +   L+             +    L+K+ ++R +  +++   L ++
Sbjct: 232 IPPSARHEGLSADLD------------AVVLKALAKNPENRYQTAAEMRADLVRV 274

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 1e-47
 Identities = 69/300 (23%), Positives = 122/300 (40%), Gaps = 30/300 (10%)

Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---------LQWV 127
           A   +  + +IGEG +G V+K      A D  +    VA+K++             ++ V
Sbjct: 5   ADQQYECVAEIGEGAYGKVFK------ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 58

Query: 128 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTR 187
           A ++ L   EHPN+V+L   C V       +L +    +++ L  +L     P +P +T 
Sbjct: 59  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 118

Query: 188 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 247
             ++     GL +LH     +V++RD K  N+L+  + + KL+DFGLAR   +       
Sbjct: 119 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMAL 172

Query: 248 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 307
           T+VV T  Y AP+ +         D+WS G +  EM   +     +    +   +  V  
Sbjct: 173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 232

Query: 308 YPADSKKFGLIMDPRLE---------KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
            P +      +  PR           +++  +       L   CL+ +   R      + 
Sbjct: 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 5e-47
 Identities = 55/289 (19%), Positives = 104/289 (35%), Gaps = 41/289 (14%)

Query: 75  RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWV 127
           ++   DF     +GEG F +V             + +   AIK L +  +          
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVL-------ARELATSREYAIKILEKRHIIKENKVPYVT 56

Query: 128 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTR 187
            E   +  L+HP  VKL      D +          +  N  L  ++             
Sbjct: 57  RERDVMSRLDHPFFVKLYFTFQDDEKL----YFGLSYAKNGELLKYIRK--IGSFDETCT 110

Query: 188 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 247
                     L YLH      +I+RD K  N+LL+E+   +++DFG A+          +
Sbjct: 111 RFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167

Query: 248 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 307
            + VGT  Y +P+ +        SD+W+ G ++Y+++ G       R   E  + + + +
Sbjct: 168 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIFQKIIK 224

Query: 308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 356
                      ++    +++   +AR    L +  L   +  R    ++
Sbjct: 225 -----------LEYDFPEKFF-PKAR---DLVEKLLVLDATKRLGCEEM 258

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  156 bits (395), Expect = 2e-44
 Identities = 59/286 (20%), Positives = 103/286 (36%), Gaps = 38/286 (13%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA----EVQFLG 134
           + +    ++G G FG V++           +     A K +             E+Q + 
Sbjct: 26  DHYDIHEELGTGAFGVVHR-------VTERATGNNFAAKFVMTPHESDKETVRKEIQTMS 78

Query: 135 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 194
           VL HP LV L      D E     +++YEFM    L + + +     +     +  +   
Sbjct: 79  VLRHPTLVNLHDAFEDDNEM----VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQV 133

Query: 195 AEGLAYLHEGLEVQVIYRDFKASNVLL--DENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
            +GL ++HE      ++ D K  N++     +   KL DFGL      +          G
Sbjct: 134 CKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTG 187

Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 312
           T  +AAP+  E   +   +D+WS GV+ Y +L+G         + +   L  V+    + 
Sbjct: 188 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG---GENDDETLRNVKSCDWN- 243

Query: 313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
                 MD       S  + +         L      R  + Q +E
Sbjct: 244 ------MDDSAFSGIS-EDGKD---FIRKLLLADPNTRMTIHQALE 279

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  153 bits (386), Expect = 9e-44
 Identities = 49/305 (16%), Positives = 98/305 (32%), Gaps = 39/305 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQWVAEVQFLGVLEHPNLVK 143
           +IGEG FG +++       G        VAIK   R  D  Q   E +   +L     + 
Sbjct: 12  RIGEGSFGVIFE-------GTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 64

Query: 144 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE 203
            + Y    G+ G+  +LV + +      + L +        KT           +  +HE
Sbjct: 65  NVYYF---GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 204 GLEVQVIYRDFKASNVLLDENFRP-----KLSDFGLAR-----EGPMVGHTHVSTAVVGT 253
                ++YRD K  N L+            + DFG+ +                  + GT
Sbjct: 120 ---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176

Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK 313
             Y + +       + + D+ + G V    L G    +  +  T ++  E + +      
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK---- 232

Query: 314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSF 373
                      +E       +  +      + +    P    +     ++++      + 
Sbjct: 233 ------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE--RLNTTE 284

Query: 374 DKTFE 378
           D+ F+
Sbjct: 285 DENFD 289

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  153 bits (387), Expect = 9e-44
 Identities = 55/278 (19%), Positives = 101/278 (36%), Gaps = 35/278 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWV-----AEVQFLGVLEHPN 140
            +G G F  V          +      +VAIK + +  L+        E+  L  ++HPN
Sbjct: 16  VLGTGAFSEVIL-------AEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPN 68

Query: 141 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 200
           +V L       G       L+ + +    L D +  +       +    +I    + + Y
Sbjct: 69  IVALDDIYESGGHL----YLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKY 122

Query: 201 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 260
           LH+   V    +        LDE+ +  +SDFGL++   M     V +   GT GY AP+
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPE 179

Query: 261 YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMD 320
            +     +   D WS GV+ Y +L G         + + +L E + +            +
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD---ENDAKLFEQILK-----------AE 225

Query: 321 PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
              +  Y  + +        + + K  + R    Q ++
Sbjct: 226 YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 2e-43
 Identities = 57/278 (20%), Positives = 106/278 (38%), Gaps = 37/278 (13%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVA---EVQFLGVLEHPNLV 142
            +G G FG V++          TS       K +   G   V    E+  L +  H N++
Sbjct: 12  DLGRGEFGIVHR-------CVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64

Query: 143 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 202
            L        E     ++++EF+    + + +   AF  L  +  +  +    E L +LH
Sbjct: 65  HLHESFESMEEL----VMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLH 119

Query: 203 EGLEVQVIYRDFKASNVLLD--ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 260
                 + + D +  N++     +   K+ +FG AR+   +        +     Y AP+
Sbjct: 120 S---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ---LKPGDNFRLLFTAPEYYAPE 173

Query: 261 YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMD 320
             +   ++  +D+WS G ++Y +L+G         +T Q+++E +              D
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFL---AETNQQIIENIMNAE-------YTFD 223

Query: 321 PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
               KE S  EA       D  L K  K R   S+ ++
Sbjct: 224 EEAFKEIS-IEAM---DFVDRLLVKERKSRMTASEALQ 257

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 3e-43
 Identities = 81/368 (22%), Positives = 138/368 (37%), Gaps = 53/368 (14%)

Query: 43  SSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKP 102
           S  +  V +P   P+  +E        SY++ +           IG G FG VY++ +  
Sbjct: 1   SKVTTVVATPGQGPDRPQE-------VSYTDTK----------VIGNGSFGVVYQAKLC- 42

Query: 103 AAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG--IQRLL 160
                     +VAIKK+ +D      E+Q +  L+H N+V+L  +    GE+   +   L
Sbjct: 43  ------DSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96

Query: 161 VYEFMLNRSLEDHL-FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNV 219
           V +++          ++RA   LP       +      LAY+H      + +RD K  N+
Sbjct: 97  VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNL 153

Query: 220 LLD-ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGV 278
           LLD +    KL DFG A++  +V      + +   +  A          T+  DVWS G 
Sbjct: 154 LLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGC 211

Query: 279 VLYEMLTGRRSLERNRPKTEQRLLEWVQQYP-----------ADSKKFGLIMDPRLEKEY 327
           VL E+L G+     +    +   +  V   P               KF  I      K +
Sbjct: 212 VLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVF 271

Query: 328 SINEARKIGRLADNCLSKSSKDRPKMSQVVER--LKQI----VQVSNEGDS---FDKTFE 378
                 +   L    L  +   R    +        ++    V++ N  D+   F+ T +
Sbjct: 272 RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQ 331

Query: 379 EICEEDPV 386
           E+    P+
Sbjct: 332 ELSSNPPL 339

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  150 bits (381), Expect = 2e-42
 Identities = 55/279 (19%), Positives = 111/279 (39%), Gaps = 38/279 (13%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR----DGLQWVAEVQFLGVLEHPNL 141
           ++G G FG V++           +   V   K +N     D      E+  +  L HP L
Sbjct: 36  ELGSGAFGVVHR-------CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 142 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 201
           + L        E     +L+ EF+    L D +    +  +     ++ +  A EGL ++
Sbjct: 89  INLHDAFEDKYEM----VLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHM 143

Query: 202 HEGLEVQVIYRDFKASNVLLD--ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 259
           HE     +++ D K  N++ +  +    K+ DFGLA +   +    +      T  +AAP
Sbjct: 144 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATK---LNPDEIVKVTTATAEFAAP 197

Query: 260 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM 319
           + ++   +   +D+W+ GV+ Y +L+G         + +   L+ V++            
Sbjct: 198 EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG---EDDLETLQNVKR-----------C 243

Query: 320 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
           D   +++   + + +      N L K  + R  +   +E
Sbjct: 244 DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  149 bits (376), Expect = 2e-42
 Identities = 62/303 (20%), Positives = 107/303 (35%), Gaps = 37/303 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QWVAEVQFLGVLEHPNLVK 143
           KIG G FG +Y        G   +    VAIK         Q   E +   +++    + 
Sbjct: 14  KIGSGSFGDIYL-------GTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 66

Query: 144 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE 203
            I +C  +G+     ++V E +      + LFN        KT L +       + Y+H 
Sbjct: 67  TIRWCGAEGDY---NVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121

Query: 204 GLEVQVIYRDFKASNVL---LDENFRPKLSDFGLAR-----EGPMVGHTHVSTAVVGTFG 255
                 I+RD K  N L     +     + DFGLA+               +  + GT  
Sbjct: 122 ---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178

Query: 256 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF 315
           YA+ +       + + D+ S G VL     G    +  +  T+++  E + +        
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS---- 234

Query: 316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSFDK 375
                  L K Y      +     + C S    D+P  S + +  + +     +G S+D 
Sbjct: 235 --TPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH--RQGFSYDY 286

Query: 376 TFE 378
            F+
Sbjct: 287 VFD 289

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 8e-42
 Identities = 69/329 (20%), Positives = 112/329 (34%), Gaps = 64/329 (19%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQ------- 131
            DF     +G+G FG V+         +        AIK L +D +    +V+       
Sbjct: 2   EDFILHKMLGKGSFGKVFL-------AEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR 54

Query: 132 -FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
                 EHP L  +                  E++    L  H+ +              
Sbjct: 55  VLSLAWEHPFLTHMFCTFQTKENLFFV----MEYLNGGDLMYHIQSC--HKFDLSRATFY 108

Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
                 GL +LH      ++YRD K  N+LLD++   K++DFG+ +E  +          
Sbjct: 109 AAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTF 163

Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA 310
            GT  Y AP+ +         D WSFGV+LYEML G+        + E+ L   ++    
Sbjct: 164 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH---GQDEEELFHSIRM--- 217

Query: 311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV-----------ER 359
                    +P   +     EA+    L      +  + R  +   +           E 
Sbjct: 218 --------DNPFYPRWLE-KEAKD---LLVKLFVREPEKRLGVRGDIRQHPLFREINWEE 265

Query: 360 LKQ-------IVQVSNEGDS--FDKTFEE 379
           L++         +V +  D   FDK F  
Sbjct: 266 LERKEIDPPFRPKVKSPFDCSNFDKEFLN 294

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 2e-41
 Identities = 71/351 (20%), Positives = 125/351 (35%), Gaps = 46/351 (13%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----WVAEVQF 132
              ++ +  IGEG +G V                  VAIKK++    Q      + E++ 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCS-------AYDNVNKVRVAIKKISPFEHQTYCQRTLREIKI 59

Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
           L    H N++ +           ++ + +   ++   L   L  +    L      + + 
Sbjct: 60  LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLY 116

Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAVV 251
               GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T  V
Sbjct: 117 QILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 173

Query: 252 GTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA 310
            T  Y AP+ +      T   D+WS G +L EML+ R          +   +  +   P+
Sbjct: 174 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 233

Query: 311 DSKKFGLIMDPRLEKEYSINEARKIG-------------RLADNCLSKSSKDRPKMSQVV 357
                 +I         S+    K+               L D  L+ +   R ++ Q +
Sbjct: 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293

Query: 358 ERLKQIVQVSNEGDSFDKTFEEICEEDPVEAQTKQKQHEPSEAWKRRMAHL 408
                          + + + +  +E P+     +   E  +  K ++  L
Sbjct: 294 A------------HPYLEQYYDPSDE-PIAEAPFKFDMELDDLPKEKLKEL 331

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  148 bits (375), Expect = 2e-41
 Identities = 63/288 (21%), Positives = 102/288 (35%), Gaps = 46/288 (15%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----------LQWVA 128
           NDFS    IG GGFG VY                + A+K L++            L    
Sbjct: 4   NDFSVHRIIGRGGFGEVYG-------CRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 56

Query: 129 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
            +  +   + P +V +        +       + + M    L  HL              
Sbjct: 57  MLSLVSTGDCPFIVCMSYAFHTPDKL----SFILDLMNGGDLHYHLSQH--GVFSEADMR 110

Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 248
                   GL ++H      V+YRD K +N+LLDE+   ++SD GLA +           
Sbjct: 111 FYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPH 163

Query: 249 AVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 307
           A VGT GY AP+ ++ G    + +D +S G +L+++L G     +++ K +  +      
Sbjct: 164 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 223

Query: 308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 355
                          L   +S  E R    L +  L +    R     
Sbjct: 224 MA-----------VELPDSFS-PELRS---LLEGLLQRDVNRRLGCLG 256

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  145 bits (367), Expect = 3e-41
 Identities = 62/299 (20%), Positives = 110/299 (36%), Gaps = 53/299 (17%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------------QW 126
           ++     +G G    V +   KP            A+K ++  G                
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKP---TCK----EYAVKIIDVTGGGSFSAEEVQELREAT 56

Query: 127 VAEVQFLGVL-EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 185
           + EV  L  +  HPN+++L        E      LV++ M    L D+L  +    L  K
Sbjct: 57  LKEVDILRKVSGHPNIIQLKDTY----ETNTFFFLVFDLMKKGELFDYLTEK--VTLSEK 110

Query: 186 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 245
               I+    E +  LH+   + +++RD K  N+LLD++   KL+DFG + +   +    
Sbjct: 111 ETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGE 164

Query: 246 VSTAVVGTFGYAAPDYIETGHL------TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ 299
               V GT  Y AP+ IE            + D+WS GV++Y +L G        P   +
Sbjct: 165 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHR 218

Query: 300 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
           + +  ++   + + +FG                  +  L    L    + R    + + 
Sbjct: 219 KQMLMLRMIMSGNYQFGSPEWDDYSDT--------VKDLVSRFLVVQPQKRYTAEEALA 269

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 4e-40
 Identities = 66/296 (22%), Positives = 112/296 (37%), Gaps = 33/296 (11%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQFL 133
           +F ++ KIGEG +G VYK               VVA+KK+  D          + E+  L
Sbjct: 3   NFQKVEKIGEGTYGVVYK-------ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 55

Query: 134 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
             L HPN+VKL+     +      +L +    L++ L+  +   A   +P       +  
Sbjct: 56  KELNHPNIVKLLDVIHTEN-----KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 253
             +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    V     +  VV  
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARA-FGVPVRTYTHEVVTL 166

Query: 254 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK 313
           +  A    +   + +   D+WS G +  EM+T R     +    +   +      P +  
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 226

Query: 314 KFGLIMDPRLEKEYSINEARKIGR-----------LADNCLSKSSKDRPKMSQVVE 358
             G+   P  +  +     +   +           L    L      R      + 
Sbjct: 227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  142 bits (360), Expect = 8e-40
 Identities = 62/239 (25%), Positives = 99/239 (41%), Gaps = 29/239 (12%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQ 131
            DF  +  +G G FG V+                  A+K L ++ +           E  
Sbjct: 4   QDFQILRTLGTGSFGRVHL-------IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL 56

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 191
            L ++ HP ++++ G          Q  ++ +++    L   L        P        
Sbjct: 57  MLSIVTHPFIIRMWGTFQDAQ----QIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYA 110

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 251
                 L YLH      +IYRD K  N+LLD+N   K++DFG A+  P V +T     + 
Sbjct: 111 AEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LC 162

Query: 252 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL-ERNRPKTEQRLLEWVQQYP 309
           GT  Y AP+ + T       D WSFG+++YEML G     + N  KT +++L    ++P
Sbjct: 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP 221

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 7e-39
 Identities = 66/293 (22%), Positives = 106/293 (36%), Gaps = 38/293 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---------QWVAEVQFLGVL 136
            +GEG F +VYK           +   +VAIKK+                + E++ L  L
Sbjct: 5   FLGEGQFATVYK-------ARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 57

Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
            HPN++ L+              LV++FM          N     L        +L   +
Sbjct: 58  SHPNIIGLLDAFGHKSNI----SLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQ 111

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 256
           GL YLH+     +++RD K +N+LLDEN   KL+DFGLA+           T  V T  Y
Sbjct: 112 GLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWY 166

Query: 257 AAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF 315
            AP+ +    +     D+W+ G +L E+L     L  +    +   +      P + +  
Sbjct: 167 RAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 226

Query: 316 GLIMDPRLEKEYSINEARKIGR----------LADNCLSKSSKDRPKMSQVVE 358
            +   P      S                   L       +   R   +Q ++
Sbjct: 227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  139 bits (350), Expect = 8e-39
 Identities = 62/297 (20%), Positives = 109/297 (36%), Gaps = 35/297 (11%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQF 132
             +  + KIGEG +G VYK      A +   E    A+KK+  +          + E+  
Sbjct: 2   EKYHGLEKIGEGTYGVVYK------AQNNYGE--TFALKKIRLEKEDEGIPSTTIREISI 53

Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
           L  L+H N+VKL            + +LV+E +     +          L   T    +L
Sbjct: 54  LKELKHSNIVKLYDVI----HTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLL 107

Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
               G+AY H+    +V++RD K  N+L++     K++DFGLAR   +    +    +V 
Sbjct: 108 QLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVT 163

Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 312
            +  A    + +   +   D+WS G +  EM+ G           +   +  +   P   
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK 223

Query: 313 KKFGLIMDPRLEKEYSINEARKIGR-----------LADNCLSKSSKDRPKMSQVVE 358
               +   P+ +  +++ E                 L    L      R    Q +E
Sbjct: 224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 3e-38
 Identities = 62/287 (21%), Positives = 106/287 (36%), Gaps = 47/287 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL----------QWVAEVQFLGV 135
           ++G G F  V K           S     A K + +                 EV  L  
Sbjct: 17  ELGSGQFAVVKK-------CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 136 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 195
           ++HPN++ L        +     +L+ E +    L D L  +    L  +     +    
Sbjct: 70  IQHPNVITLHEVYENKTDV----ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQIL 123

Query: 196 EGLAYLHEGLEVQVIYRDFKASNVLLDEN----FRPKLSDFGLAREGPMVGHTHVSTAVV 251
            G+ YLH    +Q+ + D K  N++L +      R K+ DFGLA +   +   +    + 
Sbjct: 124 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIF 177

Query: 252 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 311
           GT  + AP+ +    L  ++D+WS GV+ Y +L+G      +   T+Q  L  V      
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSA---- 230

Query: 312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
                  ++   E EY  N +          L K  K R  +   ++
Sbjct: 231 -------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 5e-38
 Identities = 57/276 (20%), Positives = 95/276 (34%), Gaps = 28/276 (10%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLG-VLEHPNLVKLI 145
           +G G  G V +                 A+K L +D  +   EV+      + P++V+++
Sbjct: 20  LGLGINGKVLQ-------IFNKRTQEKFALKML-QDCPKARREVELHWRASQCPHIVRIV 71

Query: 146 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL 205
                        L+V E +    L   + +R       +    I+    E + YLH   
Sbjct: 72  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-- 129

Query: 206 EVQVIYRDFKASNVLLD---ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI 262
            + + +RD K  N+L      N   KL+DFG A+E       +  T    T  Y AP+ +
Sbjct: 130 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---TTSHNSLTTPCYTPYYVAPEVL 185

Query: 263 ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPR 322
                    D+WS GV++Y +L G        P      L          +         
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGY------PPFYSNHGLAISPGMKTRIRMGQYEFPNP 239

Query: 323 LEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
              E S  E +    L  N L      R  +++ + 
Sbjct: 240 EWSEVS-EEVK---MLIRNLLKTEPTQRMTITEFMN 271

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 4e-37
 Identities = 62/307 (20%), Positives = 112/307 (36%), Gaps = 39/307 (12%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQF 132
           + + ++ KIG+G FG V+K                VA+KK+  +          + E++ 
Sbjct: 10  SKYEKLAKIGQGTFGEVFK-------ARHRKTGQKVALKKVLMENEKEGFPITALREIKI 62

Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQR----LLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 188
           L +L+H N+V LI  C        +      LV++F  +              L    R+
Sbjct: 63  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV 122

Query: 189 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS- 247
                    L  L+     ++++RD KA+NVL+  +   KL+DFGLAR   +  ++  + 
Sbjct: 123 -----MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177

Query: 248 -TAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 305
            T  V T  Y  P+ +          D+W  G ++ EM T    ++ N  + +  L+  +
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237

Query: 306 QQYPADSKKFGLIMDPRLEKEYSINEARKIGR--------------LADNCLSKSSKDRP 351
                      +      EK   +   ++  +              L D  L      R 
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297

Query: 352 KMSQVVE 358
                + 
Sbjct: 298 DSDDALN 304

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 8e-37
 Identities = 71/284 (25%), Positives = 99/284 (34%), Gaps = 43/284 (15%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQ 131
           NDF  +  +G+G FG V             +     A+K L ++ +         V E +
Sbjct: 5   NDFDYLKLLGKGTFGKVIL-------VREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 191
            L    HP L  L                  E+     L  HL          +      
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFV----MEYANGGELFFHLSRE--RVFTEERARFYG 111

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 251
                 L YLH      V+YRD K  N++LD++   K++DFGL +EG   G T       
Sbjct: 112 AEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFC 166

Query: 252 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 311
           GT  Y AP+ +E        D W  GVV+YEM+ GR        +  +RL E +      
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELILMEE-- 221

Query: 312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 355
                     R  +  S  EA+    L    L K  K R     
Sbjct: 222 ---------IRFPRTLS-PEAK---SLLAGLLKKDPKQRLGGGP 252

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 2e-35
 Identities = 60/287 (20%), Positives = 103/287 (35%), Gaps = 57/287 (19%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL----------QWVAEVQFLGV 135
            +G GGFGSVY        G   S+   VAIK + +D +          +   EV  L  
Sbjct: 11  LLGSGGFGSVYS-------GIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 136 L--EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 193
           +      +++L+ +           +L+ E                  L  +        
Sbjct: 64  VSSGFSGVIRLLDWFERPD----SFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQ 118

Query: 194 AAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPMVGHTHVSTAVVG 252
             E + + H      V++RD K  N+L+D N    KL DFG       +    V T   G
Sbjct: 119 VLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGA----LLKDTVYTDFDG 171

Query: 253 TFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 311
           T  Y+ P++I    +    + VWS G++LY+M+ G    E +  +  +  + + Q+  ++
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE-HDEEIIRGQVFFRQRVSSE 230

Query: 312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 358
            +                        L   CL+    DRP   ++  
Sbjct: 231 CQH-----------------------LIRWCLALRPSDRPTFEEIQN 254

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 8e-35
 Identities = 59/325 (18%), Positives = 118/325 (36%), Gaps = 39/325 (12%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQF 132
             +  +  +G G +G+V                  VAIKKL R         +   E++ 
Sbjct: 18  AVYRDLQPVGSGAYGAVCS-------AVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70

Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
           L  + H N++ L+     D                 +    L       L       ++ 
Sbjct: 71  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVY 128

Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
              +GL Y+H      +I+RD K  N+ ++E+   K+ DFGLAR+      + ++  VV 
Sbjct: 129 QMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVT 181

Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR------------RSLERNRPKTEQR 300
            +  A    +     T   D+WS G ++ EM+TG+            + + +        
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241

Query: 301 LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGR-LADNCLSKSSKDRPKMSQVVER 359
            ++ +Q   A +   GL    + +    +  A  +   L +  L   ++ R    + +  
Sbjct: 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301

Query: 360 --LKQIVQVSNEGD--SFDKTFEEI 380
              + +    +E     +D +F+++
Sbjct: 302 PYFESLHDTEDEPQVQKYDDSFDDV 326

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 1e-34
 Identities = 58/298 (19%), Positives = 104/298 (34%), Gaps = 35/298 (11%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQF 132
             + ++ KIGEG +G+V+K               +VA+K++  D          + E+  
Sbjct: 2   QKYEKLEKIGEGTYGTVFK-------AKNRETHEIVALKRVRLDDDDEGVPSSALREICL 54

Query: 133 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 192
           L  L+H N+V+L            +  LV+EF      +             +     + 
Sbjct: 55  LKELKHKNIVRLHDVL----HSDKKLTLVFEFCDQDLKKYFDSCNGDLD--PEIVKSFLF 108

Query: 193 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 252
              +GL + H      V++RD K  N+L++ N   KL++FGLAR    +     S  VV 
Sbjct: 109 QLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARA-FGIPVRCYSAEVVT 164

Query: 253 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 312
            +             +   D+WS G +  E+    R L       +Q    +        
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224

Query: 313 KKFGLIMDPRLEKEYSINEARKIGR------------LADNCLSKSSKDRPKMSQVVE 358
           +++  +      K Y +  A                 L  N L  +   R    + ++
Sbjct: 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  122 bits (306), Expect = 5e-32
 Identities = 55/304 (18%), Positives = 104/304 (34%), Gaps = 44/304 (14%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QWVAEVQFLGVL- 136
           +D+  + K+G G +  V++           +    V +K L      +   E++ L  L 
Sbjct: 35  DDYQLVRKLGRGKYSEVFE-------AINITNNEKVVVKILKPVKKKKIKREIKILENLR 87

Query: 137 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 196
             PN++ L         R     LV+E + N   +          L        +    +
Sbjct: 88  GGPNIITLADIVKDPVSRTPA--LVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILK 140

Query: 197 GLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 255
            L Y H    + +++RD K  NV++D E+ + +L D+GLA               V +  
Sbjct: 141 ALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE---FYHPGQEYNVRVASRY 194

Query: 256 YAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-----------RLLE 303
           +  P+  ++        D+WS G +L  M+  +          +Q            L +
Sbjct: 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254

Query: 304 WVQQY-----PADSKKFGLIMDPRLEKEYSINEARKIGRLA----DNCLSKSSKDRPKMS 354
           ++ +Y     P  +   G     R E+         +   A    D  L    + R    
Sbjct: 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314

Query: 355 QVVE 358
           + +E
Sbjct: 315 EAME 318

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 1e-31
 Identities = 69/325 (21%), Positives = 120/325 (36%), Gaps = 39/325 (12%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQ 131
              +  +  +G G +GSV            T     VA+KKL+R         +   E++
Sbjct: 17  PERYQNLSPVGSGAYGSVCA-------AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 69

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 191
            L  ++H N++ L+              +     L  +  +++       L       +I
Sbjct: 70  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLI 127

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 251
                GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR        +V+T   
Sbjct: 128 YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT--- 181

Query: 252 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR------------RSLERNRPKTEQ 299
             +  A    +   H     D+WS G ++ E+LTGR            + + R       
Sbjct: 182 -RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240

Query: 300 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGR-LADNCLSKSSKDRPKMSQVVE 358
            LL+ +    A +    L   P++        A  +   L +  L   S  R   +Q + 
Sbjct: 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300

Query: 359 R--LKQIVQVSNE--GDSFDKTFEE 379
                Q     +E   D +D++FE 
Sbjct: 301 HAYFAQYHDPDDEPVADPYDQSFES 325

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  121 bits (304), Expect = 1e-31
 Identities = 66/347 (19%), Positives = 112/347 (32%), Gaps = 70/347 (20%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVAEVQ 131
           + F R+  +G G FG V                   A+K L++  +         + E +
Sbjct: 41  DQFDRIKTLGTGSFGRVML-------VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 191
            L  +  P LVKL        +      +V E++    +  HL                 
Sbjct: 94  ILQAVNFPFLVKLEFSF----KDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYA 147

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 251
                   YLH    + +IYRD K  N+L+D+    +++DFG A+       T     + 
Sbjct: 148 AQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LC 199

Query: 252 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 311
           GT    AP+ I +       D W+ GV++YEM  G             ++ E +      
Sbjct: 200 GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF---ADQPIQIYEKIVS---- 252

Query: 312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-MSQVVERLKQ-------- 362
                     R    +S      +  L  N L      R   +   V  +K         
Sbjct: 253 -------GKVRFPSHFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301

Query: 363 -------------IVQVSNEGDSFDKTFEEICEEDPVEAQTKQKQHE 396
                        I +    GD+ +  F++  EE+   +  ++   E
Sbjct: 302 WIAIYQRKVEAPFIPKFKGPGDTSN--FDDYEEEEIRVSINEKCGKE 346

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 1e-29
 Identities = 62/312 (19%), Positives = 108/312 (34%), Gaps = 50/312 (16%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QWVAEVQF 132
             +  +  IG G  G V                  VAIKKL+R         +   E+  
Sbjct: 17  KRYQNLKPIGSGAQGIVCA-------AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69

Query: 133 LGVLEHPNLVKLIGYCAVDG--ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 190
           +  + H N++ L+         E      LV E M     +             +   ++
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYL 124

Query: 191 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 250
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 125 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPY 178

Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR----------------RSLERNR 294
           V T  Y AP+ I         D+WS G ++ EM+  +                  L    
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238

Query: 295 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGR--------LADNCLSKS 346
           P+  ++L   V+ Y  +  K+  +  P+L  +       +  +        L    L   
Sbjct: 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298

Query: 347 SKDRPKMSQVVE 358
              R  +   ++
Sbjct: 299 PAKRISVDDALQ 310

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 2e-29
 Identities = 68/288 (23%), Positives = 105/288 (36%), Gaps = 39/288 (13%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--------QWVAEV 130
            +F  +  +G G +G V+          G     + A+K L +  +            E 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGK----LYAMKVLKKATIVQKAKTTEHTRTER 79

Query: 131 QFLGVLEH-PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 189
           Q L  +   P LV L      + +  +      +++    L  HL  R            
Sbjct: 80  QVLEHIRQSPFLVTLHYAFQTETKLHLI----LDYINGGELFTHLSQRERFTEHE----- 130

Query: 190 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 249
           + +   E +  L    ++ +IYRD K  N+LLD N    L+DFGL++E      T  +  
Sbjct: 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ETERAYD 189

Query: 250 VVGTFGYAAPDYIETGH--LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 307
             GT  Y APD +  G        D WS GV++YE+LTG      +  K  Q  +     
Sbjct: 190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI----- 244

Query: 308 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 355
                 +  L  +P   +E S   A+    L    L K  K R     
Sbjct: 245 -----SRRILKSEPPYPQEMS-ALAK---DLIQRLLMKDPKKRLGCGP 283

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  103 bits (257), Expect = 4e-25
 Identities = 46/238 (19%), Positives = 89/238 (37%), Gaps = 25/238 (10%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGVLEHPNL- 141
           K+G G F +V+               T VA+K +  D +       E++ L  +   +  
Sbjct: 20  KLGWGHFSTVWL-------AKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT 72

Query: 142 ----------VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 191
                     +KL+ +    G  G+  ++V+E +    L           +P      I 
Sbjct: 73  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE-HRGIPLIYVKQIS 131

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLAREGPMVGHTHVSTAV 250
                GL Y+H      +I+ D K  NVL++  +    L    +A  G    +    T  
Sbjct: 132 KQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189

Query: 251 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY 308
           + T  Y +P+ +        +D+WS   +++E++TG    E +   +  +  + + Q 
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 68.3 bits (166), Expect = 4e-14
 Identities = 25/166 (15%), Positives = 46/166 (27%), Gaps = 35/166 (21%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--------------GLQWVAEVQ 131
            +GEG   +V+                   +K                    L +     
Sbjct: 7   LMGEGKESAVFN------CYSEKFG--ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAI 58

Query: 132 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 191
                E   L KL G              VY +  N  L + +  +    +  +    ++
Sbjct: 59  RSARNEFRALQKLQGLAVPK---------VYAWEGNAVLMELIDAKELYRVRVENPDEVL 109

Query: 192 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE 237
               E +A  +      +++ D    NVL+ E     + DF  + E
Sbjct: 110 DMILEEVAKFY---HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVE 151

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	432
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.59
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.01
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.87
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.15
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.44
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.44

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-56  Score=413.56  Aligned_cols=258  Identities=28%  Similarity=0.458  Sum_probs=202.4

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|++.+.||+|+||+||+|+++          ..||||+++..      ...+.+|+.+|++++|||||++++++..+
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~----------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~   76 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH----------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP   76 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS----------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC----------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc
Confidence            467999999999999999999853          24999998632      23588999999999999999999987542


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                           ..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||++   +|+||||||+||||+.++.+||+|
T Consensus        77 -----~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~D  147 (276)
T d1uwha_          77 -----QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGD  147 (276)
T ss_dssp             -----SCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECC
T ss_pred             -----EEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEcc
Confidence                 2489999999999999997544 4699999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCcccccc---CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET---GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      ||+|+...............||+.|||||++.+   ..|+.++|||||||++|||+||+.||.+.......  ...+...
T Consensus       148 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~--~~~~~~~  225 (276)
T d1uwha_         148 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IFMVGRG  225 (276)
T ss_dssp             CCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHHHHHT
T ss_pred             ccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH--HHHHhcC
Confidence            999986433333334456789999999999864   35899999999999999999999999876544322  1212211


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                      ..         .+.+ ...+...+..+.+||.+||+.||.+|||+.+|+++|+.+.+.
T Consensus       226 ~~---------~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         226 YL---------SPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             SC---------CCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CC---------CCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            11         0100 011223346789999999999999999999999999988753

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-56  Score=415.29  Aligned_cols=251  Identities=24%  Similarity=0.341  Sum_probs=203.4

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|++++.||+|+||+||+|+++       .+++.||||+++...     ..+.+|+.+|+.++|||||++++++.+++
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~   76 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNR-------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN   76 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             CcceEEEEEEecCcCeEEEEEEEC-------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc
Confidence            457999999999999999999976       467899999986432     23789999999999999999999998765


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..++||||+++|+|.+++...  ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        77 ----~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DF  147 (271)
T d1nvra_          77 ----IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDF  147 (271)
T ss_dssp             ----EEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCC
T ss_pred             ----eeEEEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccc
Confidence                459999999999999999654  4799999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      |+|+..............+||+.|||||++.+..+ +.++|||||||++|||+||..||......... ...+...... 
T Consensus       148 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~~~~~~~-  225 (271)
T d1nvra_         148 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKKTY-  225 (271)
T ss_dssp             TTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHHHTTCTT-
T ss_pred             hhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHHHhcCCCC-
Confidence            99986433333333456789999999999988776 57899999999999999999999765443221 1111111100 


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .             ......+..+.+|+.+||+.||.+|||+.|++++
T Consensus       226 ~-------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         226 L-------------NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             S-------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             C-------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            0             0011224567899999999999999999999765

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.9e-55  Score=414.44  Aligned_cols=260  Identities=26%  Similarity=0.433  Sum_probs=200.4

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|++.+.||+|+||+||+|.++..+    .....||||.+...     ...|.+|+.+|++++|||||+++|++...+.
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPG----KREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP  101 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC-------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCC----CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            46777889999999999999986221    23457999998643     2248899999999999999999999976654


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                          .++||||+++|+|.+++.... ..+++.++..++.||+.||.|||++   +|+||||||+||||+.++.+||+|||
T Consensus       102 ----~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG  173 (299)
T d1jpaa_         102 ----VMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFG  173 (299)
T ss_dssp             ----CEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             ----EEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcc
Confidence                499999999999999887543 4699999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCc---ccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcc
Q 014034          234 LAREGPMVGHT---HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       234 ~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      +++........   .......||+.|||||.+.++.++.++|||||||++|||+| |..||.+.....   +...+....
T Consensus       174 la~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~~~i~~~~  250 (299)
T d1jpaa_         174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VINAIEQDY  250 (299)
T ss_dssp             ----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTTC
T ss_pred             cceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCC
Confidence            99853222111   11223457899999999999999999999999999999998 899998765432   222222111


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhc
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  367 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  367 (432)
                      .              ...+...+..+.+||.+||+.||.+|||+.+|++.|+.+++..
T Consensus       251 ~--------------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p  294 (299)
T d1jpaa_         251 R--------------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP  294 (299)
T ss_dssp             C--------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             C--------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence            0              0112234567889999999999999999999999999988643

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-55  Score=414.62  Aligned_cols=257  Identities=26%  Similarity=0.401  Sum_probs=211.4

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---hHHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      .++|++.+.||+|+||+||+|.++       .+++.||||+++.+   ...+.+|+.+|++++|||||+++++|.+.+. 
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-   87 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-   87 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEG-------GGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEC-------CCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCe-
Confidence            357899999999999999999976       56789999998653   3468999999999999999999999976554 


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                         .++||||+++|+|.+++.......+++..+..++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+
T Consensus        88 ---~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~  161 (287)
T d1opja_          88 ---FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGL  161 (287)
T ss_dssp             ---CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred             ---eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccc
Confidence               49999999999999999877667899999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      |+..... .........||+.|+|||++.+..|+.++|||||||++|||++|..||.......  .+...+...      
T Consensus       162 a~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~--~~~~~i~~~------  232 (287)
T d1opja_         162 SRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKD------  232 (287)
T ss_dssp             TTTCCSS-SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHTT------
T ss_pred             eeecCCC-CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH--HHHHHHhcC------
Confidence            9864322 2222334568999999999999999999999999999999999776664433221  222222211      


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                              .....+...+..+.+||.+||+.||.+|||+.+|++.|+.+.+
T Consensus       233 --------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         233 --------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             --------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                    0111222334678999999999999999999999999988764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-55  Score=406.66  Aligned_cols=254  Identities=29%  Similarity=0.433  Sum_probs=198.7

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---hHHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      ++|+.++.||+|+||+||+|.+.        ++..||||+++..   ...+.+|++++++++|||||+++|+|..++.  
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~--------~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~--   74 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL--------NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP--   74 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET--------TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC--------CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCc--
Confidence            47899999999999999999875        4568999998753   3568999999999999999999999987654  


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCC
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  235 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a  235 (432)
                        .++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|||++
T Consensus        75 --~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla  148 (263)
T d1sm2a_          75 --ICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT  148 (263)
T ss_dssp             --CEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--
T ss_pred             --eEEEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchh
Confidence              399999999999999987643 4689999999999999999999998   9999999999999999999999999999


Q ss_pred             cCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhC-CCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG-RRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      +...... ........||+.|+|||++.+..++.++|||||||++|||+|+ .+||......   .+...+.....    
T Consensus       149 ~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~---~~~~~i~~~~~----  220 (263)
T d1sm2a_         149 RFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDISTGFR----  220 (263)
T ss_dssp             -----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH---HHHHHHHHTCC----
T ss_pred             eeccCCC-ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH---HHHHHHHhcCC----
Confidence            8542221 2223346789999999999999999999999999999999995 5555543322   22222222110    


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                            .    ..+...+..+.+||.+||+.||.+|||+.+|+++|+++.++
T Consensus       221 ------~----~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         221 ------L----YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             ------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------C----CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence                  0    11122346788999999999999999999999999998764

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-55  Score=404.81  Aligned_cols=243  Identities=28%  Similarity=0.434  Sum_probs=204.0

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|++++.||+|+||+||+|+++       .+++.||+|++.+.       ...+.+|+.+++.++|||||++++++.++
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~   78 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREK-------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA   78 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hHeEEEEEEecCCCcEEEEEEEC-------CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC
Confidence            47999999999999999999976       46789999998642       23478999999999999999999999865


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ..++||||+++|+|.+++....  .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        79 ~----~~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~D  149 (263)
T d2j4za1          79 T----RVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD  149 (263)
T ss_dssp             S----EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred             C----EEEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecc
Confidence            4    3599999999999999997643  699999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ||+|+....    .......||+.|||||++.+..++.++|||||||++|+|++|..||.+.....   +...+....  
T Consensus       150 FG~a~~~~~----~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i~~~~--  220 (263)
T d2j4za1         150 FGWSVHAPS----SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYKRISRVE--  220 (263)
T ss_dssp             CCSCSCCCC----CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHTTC--
T ss_pred             cceeeecCC----CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH---HHHHHHcCC--
Confidence            999976432    12345679999999999999999999999999999999999999998765432   222222111  


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                               ..    .+...+..+.+|+.+||+.||.+|||+.|++++
T Consensus       221 ---------~~----~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         221 ---------FT----FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             ---------CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             ---------CC----CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence                     01    112234678899999999999999999999876

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-55  Score=410.07  Aligned_cols=247  Identities=23%  Similarity=0.370  Sum_probs=204.7

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc----ChHHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR----DGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      ++|++++.||+|+||+||+|..+       .+++.||||++..    ....+.+|+.+|+.++|||||++++++..++  
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~-------~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--   90 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDV-------ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD--   90 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBT-------TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--
T ss_pred             cccEEEEEEecCcCcEEEEEEEC-------CCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC--
Confidence            47999999999999999999865       5678999999853    2345889999999999999999999998765  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        ..++||||++||+|.+++...   .+++..+..++.||+.||.|||++   ||+||||||+|||++.+|.+||+|||+
T Consensus        91 --~~~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~  162 (293)
T d1yhwa1          91 --ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF  162 (293)
T ss_dssp             --EEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             --EEEEEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchh
Confidence              359999999999999988653   599999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      |+....  ........+||+.|||||++.+..++.++|||||||++|+|+||..||.+.......  ..........   
T Consensus       163 a~~~~~--~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~~~~~~~~~---  235 (293)
T d1yhwa1         163 CAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLIATNGTPE---  235 (293)
T ss_dssp             CEECCS--TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHHHHHCSCC---
T ss_pred             heeecc--ccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHH--HHHHhCCCCC---
Confidence            986322  222345568999999999999999999999999999999999999999876543321  1111111100   


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                              +  ..+...+..+.+||.+||+.||.+|||+.|++++
T Consensus       236 --------~--~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         236 --------L--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             --------C--SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             --------C--CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                    0  1122234678899999999999999999999876

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-55  Score=408.96  Aligned_cols=255  Identities=27%  Similarity=0.392  Sum_probs=206.7

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---hHHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      .++|++.+.||+|+||.||+|.++        ++..||||+++..   ...+.+|+.+|++++|||||+++|++..+ . 
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~--------~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~-   81 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN--------GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-P-   81 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET--------TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S-
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC--------CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeeccC-C-
Confidence            357899999999999999999975        4678999998653   34589999999999999999999987543 2 


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                         .++||||+++|+|.+++.......+++..++.|+.||+.||.|||++   +|+||||||+||||+.++.+||+|||+
T Consensus        82 ---~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGl  155 (272)
T d1qpca_          82 ---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGL  155 (272)
T ss_dssp             ---CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             ---eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccc
Confidence               38999999999999988765555699999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCC-CCCCchhhHHHHHHHhhcccCcc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL-ERNRPKTEQRLLEWVQQYPADSK  313 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~  313 (432)
                      |+..... .........||+.|||||++.++.++.++|||||||++|||+||..|+ ......   .+...+....    
T Consensus       156 a~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~---~~~~~i~~~~----  227 (272)
T d1qpca_         156 ARLIEDN-EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQNLERGY----  227 (272)
T ss_dssp             CEECSSS-CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHTTC----
T ss_pred             eEEccCC-ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH---HHHHHHHhcC----
Confidence            9864322 222334567899999999999999999999999999999999965554 433322   2222222110    


Q ss_pred             ccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          314 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       314 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                            .+    ..+...+..+.+||.+||+.||++|||+.+|++.|+++..+
T Consensus       228 ------~~----~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         228 ------RM----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             ------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------CC----CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                  01    11222346788999999999999999999999999988653

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-55  Score=408.96  Aligned_cols=253  Identities=26%  Similarity=0.366  Sum_probs=192.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      ++|++++.||+|+||+||+|+.+       .+++.||+|.+....      ..+.+|+++|++++|||||++++++.+..
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   76 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRK-------SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT   76 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC--
T ss_pred             hhCEEeEEEecCCCeEEEEEEEC-------CCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC
Confidence            57999999999999999999976       467899999986432      23789999999999999999999987543


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCceeecCCCCCceEEcCCCcee
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGL--EVQVIYRDFKASNVLLDENFRPK  228 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~l~~~l~~LH~~~--~~~ivH~Dikp~Nill~~~~~~k  228 (432)
                      ..  ..++||||+++|+|.+++...  ....+++..++.++.||+.||.|||+..  ..+|+||||||+||||+.++.+|
T Consensus        77 ~~--~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk  154 (269)
T d2java1          77 NT--TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK  154 (269)
T ss_dssp             ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred             CC--EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence            22  458999999999999998642  2357999999999999999999999861  11499999999999999999999


Q ss_pred             eccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          229 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      |+|||+|+....  .........||+.|||||++.+..|+.++|||||||++|||+||..||.+.+...   +...+...
T Consensus       155 l~DFG~a~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~~~i~~~  229 (269)
T d2java1         155 LGDFGLARILNH--DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGKIREG  229 (269)
T ss_dssp             ECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHT
T ss_pred             Eeeccceeeccc--CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HHHHHHcC
Confidence            999999986322  2223345789999999999999999999999999999999999999998754432   22222211


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ..          +.+    +...+..+.+||.+||+.||.+|||+.||+++
T Consensus       230 ~~----------~~~----~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         230 KF----------RRI----PYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             CC----------CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CC----------CCC----CcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            10          011    12234578899999999999999999999865

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=414.86  Aligned_cols=259  Identities=24%  Similarity=0.396  Sum_probs=208.1

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhccc-CCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVL-EHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  152 (432)
                      ++|++.+.||+|+||+||+|++....  .......||+|.+....     ..+.+|+.+|.++ +|||||++++++...+
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGIS--KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCS--SSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCC--cccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            57999999999999999999987332  23456789999986432     2478999999988 8999999999998765


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceee
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRA---------------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIY  211 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~---------------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH  211 (432)
                      .    .++||||+++|+|.++|..+.                     ...+++..++.++.||+.||.|||++   +|+|
T Consensus       115 ~----~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiH  187 (325)
T d1rjba_         115 P----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH  187 (325)
T ss_dssp             S----CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             e----EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence            4    499999999999999997643                     23589999999999999999999998   9999


Q ss_pred             cCCCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 014034          212 RDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSL  290 (432)
Q Consensus       212 ~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf  290 (432)
                      |||||+|||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |..||
T Consensus       188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence            99999999999999999999999986433333333445678999999999999999999999999999999998 89999


Q ss_pred             CCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 014034          291 ERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  362 (432)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  362 (432)
                      .+......  +...+....              ....+...+..+.+||.+||+.||++|||+.+|+++|..
T Consensus       268 ~~~~~~~~--~~~~~~~~~--------------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         268 PGIPVDAN--FYKLIQNGF--------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             TTCCCSHH--HHHHHHTTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCHHHH--HHHHHhcCC--------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            87554322  222221110              111122334678999999999999999999999999864

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-55  Score=408.54  Aligned_cols=249  Identities=24%  Similarity=0.406  Sum_probs=202.5

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC----hHHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      +.|++++.||+|+||+||+|.++       .++..||+|+++..    ...+.+|+++|++++|||||++++++.+++  
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--   82 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNK-------ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN--   82 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT--
T ss_pred             cCeEEeEEEeeCCCcEEEEEEEC-------CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--
Confidence            46899999999999999999976       46789999998643    234889999999999999999999998765  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccC
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  234 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~  234 (432)
                        ..++||||+++|+|.+++.+.. .++++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        83 --~~~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~  156 (288)
T d2jfla1          83 --NLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGV  156 (288)
T ss_dssp             --EEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             --eEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechh
Confidence              3599999999999999976543 4699999999999999999999998   999999999999999999999999999


Q ss_pred             CcCCCCCCCcccccccccCCCccCccccc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          235 AREGPMVGHTHVSTAVVGTFGYAAPDYIE-----TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      |+..  ...........||+.|||||++.     +..|+.++|||||||++|||+||..||.+.......  .......+
T Consensus       157 a~~~--~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~--~~i~~~~~  232 (288)
T d2jfla1         157 SAKN--TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL--LKIAKSEP  232 (288)
T ss_dssp             CEEC--HHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH--HHHHHSCC
T ss_pred             hhcc--CCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH--HHHHcCCC
Confidence            9742  11122334578999999999984     456899999999999999999999999876543321  11111111


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .           .+  ..+...+..+.+||.+||+.||.+|||+.|++++
T Consensus       233 ~-----------~~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         233 P-----------TL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             C-----------CC--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             C-----------CC--CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0           00  1112334678899999999999999999999875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-54  Score=403.52  Aligned_cols=256  Identities=26%  Similarity=0.432  Sum_probs=205.7

Q ss_pred             cCCcccc-ccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           79 NDFSRML-KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~-~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      ++|.... .||+|+||.||+|.++     ...++..||||.++...     ..+.+|+++|++++|||||+++|++..+ 
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~-----~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-   81 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYR-----MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-   81 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC--------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             cCeEECCcEEecccCeEEEEEEEe-----cCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-
Confidence            4566666 4999999999999876     23356789999986432     3488999999999999999999998643 


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++   +|+||||||+||||+.++.+||+||
T Consensus        82 ----~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DF  153 (285)
T d1u59a_          82 ----ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF  153 (285)
T ss_dssp             ----SEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred             ----eEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccc
Confidence                2489999999999999986543 4799999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCC-cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhccc
Q 014034          233 GLAREGPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       233 G~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      |+++....... ........||+.|||||++.++.++.++|||||||++|||+| |..||.+.....   +...+.... 
T Consensus       154 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~~~i~~~~-  229 (285)
T d1u59a_         154 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQGK-  229 (285)
T ss_dssp             TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHHHTTC-
T ss_pred             hhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCC-
Confidence            99986433222 222334568999999999999999999999999999999998 999998765432   222222110 


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                               .+    ..+...+..+.+||.+||+.||++|||+.+|++.|+....
T Consensus       230 ---------~~----~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         230 ---------RM----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             ---------CC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CC----CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                     01    1122344678899999999999999999999999987754

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-54  Score=401.49  Aligned_cols=248  Identities=26%  Similarity=0.419  Sum_probs=199.9

Q ss_pred             cccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecCCcceeE
Q 014034           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQR  158 (432)
Q Consensus        85 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~  158 (432)
                      ++||+|+||+||+|.+.     ....++.||||+++...      ..+.+|+.+|++++|||||+++|+|..+     ..
T Consensus        13 k~iG~G~fG~Vy~~~~~-----~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-----~~   82 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQ-----MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-----SW   82 (277)
T ss_dssp             EEEEECSSEEEEEEEEE-----CSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-----SE
T ss_pred             CCcccCCCeEEEEEEEc-----cCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-----CE
Confidence            46999999999999876     33467899999986432      2488999999999999999999998543     24


Q ss_pred             EEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCC
Q 014034          159 LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG  238 (432)
Q Consensus       159 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~  238 (432)
                      ++||||+++|+|.+++....  .+++..++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++..
T Consensus        83 ~lvmE~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~  157 (277)
T d1xbba_          83 MLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL  157 (277)
T ss_dssp             EEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEcCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhc
Confidence            89999999999999997654  699999999999999999999998   9999999999999999999999999999864


Q ss_pred             CCCCC-cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 014034          239 PMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFG  316 (432)
Q Consensus       239 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (432)
                      ..... ........||+.|||||++.+..++.++|||||||++|||+| |..||.+.....   +...+....       
T Consensus       158 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~~~~i~~~~-------  227 (277)
T d1xbba_         158 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLEKGE-------  227 (277)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHTTC-------
T ss_pred             cccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---HHHHHHcCC-------
Confidence            32222 222334678999999999999999999999999999999998 899998765432   222222110       


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 014034          317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  364 (432)
Q Consensus       317 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  364 (432)
                         .+    ..+...+..+.+||.+||+.||.+|||+.+|++.|+...
T Consensus       228 ---~~----~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         228 ---RM----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             ---CC----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ---CC----CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence               01    112233467889999999999999999999999988764

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-54  Score=399.81  Aligned_cols=246  Identities=23%  Similarity=0.352  Sum_probs=197.5

Q ss_pred             ccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           82 SRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        82 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      +....||+|+||+||+|.+.       .++..||+|.+...      ...+.+|+++|++++|||||++++++.......
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~-------~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   84 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDT-------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK   84 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred             EeeeEEecCcCcEEEEEEEC-------CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence            45668999999999999975       46788999987542      124789999999999999999999987654445


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCc--eeecCCCCCceEEc-CCCceeeccc
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQ--VIYRDFKASNVLLD-ENFRPKLSDF  232 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~--ivH~Dikp~Nill~-~~~~~kl~Df  232 (432)
                      ...++||||+++|+|.+++.+..  .+++..+..++.||+.||+|||++   +  |+||||||+|||++ .++.+||+||
T Consensus        85 ~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DF  159 (270)
T d1t4ha_          85 KCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDL  159 (270)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             CEEEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeec
Confidence            56799999999999999997643  699999999999999999999997   6  99999999999996 5889999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      |+|+...    ........||+.|||||++.+ .++.++|||||||++|||++|+.||.+.....  .+...+.....  
T Consensus       160 Gla~~~~----~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~~~~i~~~~~--  230 (270)
T d1t4ha_         160 GLATLKR----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVTSGVK--  230 (270)
T ss_dssp             TGGGGCC----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHTTTCC--
T ss_pred             Ccceecc----CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HHHHHHHcCCC--
Confidence            9997522    122345689999999999875 59999999999999999999999997654322  22222221111  


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                             ...+...    .+..+.+||.+||+.||++|||+.|++++
T Consensus       231 -------~~~~~~~----~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         231 -------PASFDKV----AIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             -------CGGGGGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -------CcccCcc----CCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence                   0111111    23468899999999999999999999875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-54  Score=395.78  Aligned_cols=250  Identities=24%  Similarity=0.376  Sum_probs=207.6

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc---ChHHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR---DGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      ++|+.++.||+|+||+||+|+++        ++..||||.++.   ....+.+|+.++++++||||++++|+|..++.  
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~--------~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~--   73 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR--------GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP--   73 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET--------TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSS--
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC--------CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc--
Confidence            58999999999999999999975        567899999865   34569999999999999999999999976553  


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCC
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  235 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a  235 (432)
                        .++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        74 --~~iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a  147 (258)
T d1k2pa_          74 --IFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLS  147 (258)
T ss_dssp             --EEEEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSC
T ss_pred             --eEEEEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhh
Confidence              599999999999999976544 4689999999999999999999998   9999999999999999999999999999


Q ss_pred             cCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccc
Q 014034          236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKK  314 (432)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  314 (432)
                      +..... .........||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.....   +...+.....    
T Consensus       148 ~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~~~~i~~~~~----  219 (258)
T d1k2pa_         148 RYVLDD-EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAEHIAQGLR----  219 (258)
T ss_dssp             CBCSSS-SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHHHTTCC----
T ss_pred             eeccCC-CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---HHHHHHhCCC----
Confidence            753322 2223334678999999999999999999999999999999998 899998775433   2222221100    


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 014034          315 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  362 (432)
Q Consensus       315 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  362 (432)
                            .    ..+...+..+.+||.+||+.||++|||+.+|+++|.+
T Consensus       220 ------~----~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         220 ------L----YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             ------C----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             ------C----CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence                  0    1122234678899999999999999999999999864

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-54  Score=402.09  Aligned_cols=262  Identities=26%  Similarity=0.417  Sum_probs=201.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|+..+.||+|+||.||+|.++..+   ......||||+++...     ..+.+|+.+|++++|||||+++|++...+.
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~---~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~   83 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSS---GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP   83 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCC---CEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence            46888999999999999999987322   2345789999986432     247899999999999999999999976553


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                          .++||||+.+++|.+++.... ..+++..+..++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||
T Consensus        84 ----~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG  155 (283)
T d1mqba_          84 ----MMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFG  155 (283)
T ss_dssp             ----EEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             ----eEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccc
Confidence                489999999999999887654 4799999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCC-cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          234 LAREGPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       234 ~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      +++....... ........||+.|||||++.++.++.++|||||||++|||++|..|+......  ..+...+....   
T Consensus       156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~i~~~~---  230 (283)
T d1mqba_         156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAINDGF---  230 (283)
T ss_dssp             C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTTC---
T ss_pred             hhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHHHHhccC---
Confidence            9986322211 12233456899999999999999999999999999999999966555433222  22222222110   


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhc
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  367 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  367 (432)
                                 ....+...+..+.+||.+||+.||++|||+.+|++.|+.+++..
T Consensus       231 -----------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         231 -----------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             -----------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             -----------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence                       11122234467889999999999999999999999999988643

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-54  Score=404.79  Aligned_cols=247  Identities=21%  Similarity=0.295  Sum_probs=201.4

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|++++.||+|+||+||+|.++       .+++.||||++.+.       ...+.+|+++|++++||||+++++++.++
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~   80 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLAREL-------ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD   80 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS
T ss_pred             CCCEEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC
Confidence            47999999999999999999975       46788999998642       23488999999999999999999999765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ..++||||+++|+|.+++....  .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus        81 ~----~~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~D  151 (288)
T d1uu3a_          81 E----KLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITD  151 (288)
T ss_dssp             S----EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred             C----EEEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecc
Confidence            4    3599999999999999987653  799999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ||+|+...............||+.|||||++.+..++.++|||||||++|||++|..||.+.+...   +...+....  
T Consensus       152 FG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i~~~~--  226 (288)
T d1uu3a_         152 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---IFQKIIKLE--  226 (288)
T ss_dssp             CTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHTTC--
T ss_pred             cccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH---HHHHHHcCC--
Confidence            999986433333334455789999999999999999999999999999999999999998764432   222222111  


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                               ..+    +...+..+.+||.+||+.||.+|||+.|++.+
T Consensus       227 ---------~~~----p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         227 ---------YDF----PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             ---------CCC----CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             ---------CCC----CccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence                     011    11234568899999999999999999998665

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.8e-54  Score=407.21  Aligned_cols=249  Identities=22%  Similarity=0.361  Sum_probs=191.2

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .+.|++.+.||+|+||+||+|.++       .+++.||||.+.+..     ..+.+|+.+|+.++|||||++++++.+++
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   80 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDK-------RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG   80 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEET-------TTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEEEEeeccCeEEEEEEEC-------CCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            356999999999999999999875       467899999986432     23678999999999999999999997654


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc---CCCceee
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKL  229 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~---~~~~~kl  229 (432)
                          ..++||||++||+|.+++...  ..+++..+..++.||+.||.|||++   +|+||||||+|||+.   +++.+||
T Consensus        81 ----~~~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl  151 (307)
T d1a06a_          81 ----HLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMI  151 (307)
T ss_dssp             ----EEEEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred             ----EEEEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEE
Confidence                459999999999999999764  3799999999999999999999998   999999999999994   5789999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      +|||+|+...   ........+||+.|||||++.+..|+.++|||||||++|+|++|..||.+.....   +...+....
T Consensus       152 ~DFG~a~~~~---~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i~~~~  225 (307)
T d1a06a_         152 SDFGLSKMED---PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LFEQILKAE  225 (307)
T ss_dssp             CCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHTTC
T ss_pred             eccceeEEcc---CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHhccC
Confidence            9999997532   2223345689999999999999999999999999999999999999998754432   222221111


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .           .+........+..+.+|+.+||+.||.+|||+.|++++
T Consensus       226 ~-----------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         226 Y-----------EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             C-----------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             C-----------CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            0           01111122334678899999999999999999999886

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=413.99  Aligned_cols=263  Identities=27%  Similarity=0.415  Sum_probs=201.6

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .++|++++.||+|+||+||+|.++       .++..||+|+++..     ...+.+|+.+|+.++|||||+++++|.+++
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   77 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHK-------PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG   77 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEET-------TTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS
T ss_pred             ccCCEEEEEEecCCCeEEEEEEEC-------CCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            468999999999999999999975       56899999998543     235889999999999999999999998655


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..++||||+++|+|.+++.+..  .+++..+..++.||+.||.|||++  .+|+||||||+||||+.+|.+||+||
T Consensus        78 ----~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DF  149 (322)
T d1s9ja_          78 ----EISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDF  149 (322)
T ss_dssp             ----EEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCC
T ss_pred             ----EEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeC
Confidence                4599999999999999997653  699999999999999999999973  18999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH-HhhcccC
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW-VQQYPAD  311 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~-~~~~~~~  311 (432)
                      |+|+...    .......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+............ .......
T Consensus       150 Gla~~~~----~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~  225 (322)
T d1s9ja_         150 GVSGQLI----DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE  225 (322)
T ss_dssp             CCCHHHH----HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------
T ss_pred             CCccccC----CCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCccc
Confidence            9997421    1223456899999999999999999999999999999999999999987544322111000 0000000


Q ss_pred             ----ccc---------------------cccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 ----SKK---------------------FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ----~~~---------------------~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                          ...                     ...+.............+..+.+|+.+||..||.+|||+.|+++|
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             --------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                000                     000000000000001123568899999999999999999999987

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.7e-54  Score=405.26  Aligned_cols=242  Identities=33%  Similarity=0.478  Sum_probs=198.9

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      .|+.++.||+|+||+||+|++.       .+++.||||++....       ..+.+|+.+|++++|||||++++++.+++
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   88 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDV-------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH   88 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEET-------TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             hcEeeEEEecCCCeEEEEEEEC-------CCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC
Confidence            4999999999999999999875       568899999986432       23788999999999999999999998755


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..++|||||.+|+|..++...  .++++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+||
T Consensus        89 ----~~~iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DF  159 (309)
T d1u5ra_          89 ----TAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDF  159 (309)
T ss_dssp             ----EEEEEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCC
T ss_pred             ----EEEEEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeec
Confidence                359999999999998776554  3799999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCcccccc---CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIET---GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      |+|+...      ......||+.|||||++.+   +.|+.++|||||||++|||++|..||.+......  +........
T Consensus       160 G~a~~~~------~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~--~~~i~~~~~  231 (309)
T d1u5ra_         160 GSASIMA------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQNES  231 (309)
T ss_dssp             TTCBSSS------SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHSCC
T ss_pred             ccccccC------CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHhCCC
Confidence            9998532      1234679999999999864   4689999999999999999999999987654322  111111110


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                 +.+   .+...+..+.+||.+||+.||.+|||+.+++++
T Consensus       232 -----------~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         232 -----------PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             -----------CCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             -----------CCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence                       000   111224678899999999999999999999876

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.4e-53  Score=407.43  Aligned_cols=250  Identities=22%  Similarity=0.331  Sum_probs=204.8

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH----HHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL----QWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      .++|++++.||+|+||.||+|..+       .++..||||++.....    .+.+|+.+|++++|||||++++++.+++ 
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~-------~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-   96 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTER-------ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-   96 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEET-------TTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT-
T ss_pred             ccCeEEEEEEecCcCeEEEEEEEC-------CCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-
Confidence            458999999999999999999975       5689999999875432    3788999999999999999999998765 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc--CCCceeecc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD--ENFRPKLSD  231 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~--~~~~~kl~D  231 (432)
                         ..++||||++||+|.+++.... ..+++..+..++.||+.||.|||++   +|+||||||+|||++  .++.+||+|
T Consensus        97 ---~~~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~D  169 (350)
T d1koaa2          97 ---EMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLID  169 (350)
T ss_dssp             ---EEEEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECC
T ss_pred             ---EEEEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEee
Confidence               4599999999999999986543 4699999999999999999999998   999999999999995  468899999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ||+|+...   .........||+.|||||++.+..++.++|||||||++|+|++|..||.+.+....   ...+......
T Consensus       170 FG~a~~~~---~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~~i~~~~~~  243 (350)
T d1koaa2         170 FGLTAHLD---PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---LRNVKSCDWN  243 (350)
T ss_dssp             CTTCEECC---TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHTCCC
T ss_pred             cchheecc---cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH---HHHHHhCCCC
Confidence            99998632   22233457899999999999999999999999999999999999999987654322   2222111110


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                 +........+..+.+||.+||..||.+|||+.|++++
T Consensus       244 -----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         244 -----------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             -----------SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             -----------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                       0001111234578899999999999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-53  Score=400.63  Aligned_cols=265  Identities=25%  Similarity=0.347  Sum_probs=202.5

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhccc-CCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVL-EHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~hpniv~l~~~~~~~  151 (432)
                      .++|++++.||+|+||.||+|.+....  ...+++.||||+++...     ..+.+|..++.++ +||||+.+++++..+
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~--~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGID--KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTT--SSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCC--cccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence            367999999999999999999986332  33567899999987532     2367777777766 689999999988665


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCC
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKAS  217 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~  217 (432)
                      +.   ..++||||+++|+|.+++....              ...+++..++.++.||+.||.|||++   +|+||||||+
T Consensus        90 ~~---~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~  163 (299)
T d1ywna1          90 GG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR  163 (299)
T ss_dssp             TS---CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred             CC---eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcc
Confidence            43   3589999999999999996532              23588999999999999999999998   9999999999


Q ss_pred             ceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhC-CCCCCCCCch
Q 014034          218 NVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG-RRSLERNRPK  296 (432)
Q Consensus       218 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~pf~~~~~~  296 (432)
                      ||||+.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+|| ..||.+....
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~  243 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  243 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999999864333333344556899999999999999999999999999999999996 4677765432


Q ss_pred             hhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          297 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                      ..  +...+....          .+    ..+...+..+.+||.+||+.||.+|||+.+|+++|+.++++
T Consensus       244 ~~--~~~~~~~~~----------~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         244 EE--FCRRLKEGT----------RM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             HH--HHHHHHHTC----------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HH--HHHHHhcCC----------CC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            21  222111110          01    11222346788999999999999999999999999999875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-53  Score=402.27  Aligned_cols=258  Identities=23%  Similarity=0.379  Sum_probs=205.2

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      .+|++++.||+|+||+||+|.+...   +...+.+||+|.++..     ...+.+|+.+|++++|||||+++|+|.+.. 
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-   84 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPE---GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   84 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC-------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCC---CCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence            4699999999999999999997622   2234567999988643     335899999999999999999999997543 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                          .+++|||+.+|+|.+++.... ..+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|||
T Consensus        85 ----~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFG  156 (317)
T d1xkka_          85 ----VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFG  156 (317)
T ss_dssp             ----EEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCS
T ss_pred             ----eeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccc
Confidence                378999999999999887654 4799999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      +|+...............||+.|||||++.++.++.++|||||||++|||+| |..||.+.........+.   ....  
T Consensus       157 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~---~~~~--  231 (317)
T d1xkka_         157 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---KGER--  231 (317)
T ss_dssp             HHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH---HTCC--
T ss_pred             cceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH---cCCC--
Confidence            9986433333333445578999999999999999999999999999999998 899998765443322221   1100  


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                              +    ..+...+..+.+|+.+||+.||.+|||+.+|+++|+.+..
T Consensus       232 --------~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         232 --------L----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             --------C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------C----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence                    0    1122334678899999999999999999999999988754

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7.3e-53  Score=406.18  Aligned_cols=249  Identities=21%  Similarity=0.342  Sum_probs=204.7

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      ++|++++.||+|+||.||+|..+       .+++.||||+++...    ..+.+|+.+|++++|||||++++++.+++  
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--   99 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEK-------ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY--   99 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS--
T ss_pred             cceEEEEEEecCCCeEEEEEEEC-------CCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--
Confidence            47999999999999999999875       467899999986543    24788999999999999999999997654  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc--CCCceeeccc
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD--ENFRPKLSDF  232 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~--~~~~~kl~Df  232 (432)
                        ..++||||++||+|.+++.... .++++..++.|+.||+.||.|||++   ||+||||||+||||+  .++.+||+||
T Consensus       100 --~~~ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DF  173 (352)
T d1koba_         100 --EMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDF  173 (352)
T ss_dssp             --EEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCC
T ss_pred             --EEEEEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeec
Confidence              4599999999999999876543 4699999999999999999999998   999999999999997  6789999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      |+|+....   ........||+.|||||++.+..++.++|||||||++|+|+||..||.+......   ...+.....  
T Consensus       174 Gla~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~~i~~~~~--  245 (352)
T d1koba_         174 GLATKLNP---DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---LQNVKRCDW--  245 (352)
T ss_dssp             TTCEECCT---TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHHHCCC--
T ss_pred             ccceecCC---CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhCCC--
Confidence            99986422   2233456799999999999999999999999999999999999999987654332   222221110  


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                               .+........+..+.+||.+||+.||.+|||+.|++++
T Consensus       246 ---------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         246 ---------EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             ---------CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ---------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                     01111122334678899999999999999999999886

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-53  Score=392.55  Aligned_cols=257  Identities=25%  Similarity=0.349  Sum_probs=198.8

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|++.+.||+|+||.||+|++...    ...+..||||.++...     ..+.+|+.+|++++|||||++++++.+ + 
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~----~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~-   80 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSP----ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N-   80 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-S-
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecC----CceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C-
Confidence            5799999999999999999987622    2345789999986432     248899999999999999999999853 2 


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                         ..++||||+++|+|.+++.... .++++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        81 ---~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG  153 (273)
T d1mp8a_          81 ---PVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG  153 (273)
T ss_dssp             ---SCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--
T ss_pred             ---eEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccch
Confidence               2499999999999999876544 4789999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      +|+..... .........||+.|+|||++.+..++.++|||||||++|||+| |..||.+......   ...+.....  
T Consensus       154 ~a~~~~~~-~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~---~~~i~~~~~--  227 (273)
T d1mp8a_         154 LSRYMEDS-TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIENGER--  227 (273)
T ss_dssp             ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHHTTCC--
T ss_pred             hheeccCC-cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH---HHHHHcCCC--
Confidence            99853221 2223345678999999999999999999999999999999998 8999987655432   222221110  


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                              +    ..+...+..+.+||.+||+.||.+|||+.+|+++|+.+++.
T Consensus       228 --------~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         228 --------L----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             --------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------C----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                    0    11223346789999999999999999999999999998754

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-53  Score=397.01  Aligned_cols=248  Identities=25%  Similarity=0.358  Sum_probs=203.1

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC----------hHHHHHHHHHhcccCCCccceeeeEE
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----------GLQWVAEVQFLGVLEHPNLVKLIGYC  148 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~hpniv~l~~~~  148 (432)
                      +.|++++.||+|+||+||+|.++       .+++.||||++.+.          ...+.+|+.+|++++|||||++++++
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~-------~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~   82 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREK-------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY   82 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEEC-------CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            57999999999999999999975       46789999987532          24588999999999999999999999


Q ss_pred             eecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC---
Q 014034          149 AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF---  225 (432)
Q Consensus       149 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~---  225 (432)
                      .+.+    ..++||||+++|+|.+++....  .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++   
T Consensus        83 ~~~~----~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~  153 (293)
T d1jksa_          83 ENKT----DVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPK  153 (293)
T ss_dssp             ECSS----EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSS
T ss_pred             EECC----EEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcc
Confidence            7654    4599999999999999997653  699999999999999999999998   999999999999998776   


Q ss_pred             -ceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 014034          226 -RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  304 (432)
Q Consensus       226 -~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  304 (432)
                       .+||+|||+|.....   ........||+.|+|||++.+..++.++|||||||++|||++|..||.+.+....   ...
T Consensus       154 ~~vkl~DfG~a~~~~~---~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~~  227 (293)
T d1jksa_         154 PRIKIIDFGLAHKIDF---GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LAN  227 (293)
T ss_dssp             CCEEECCCTTCEECTT---SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH
T ss_pred             cceEecchhhhhhcCC---CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH---HHH
Confidence             499999999976322   2233456799999999999999999999999999999999999999987554322   222


Q ss_pred             HhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          305 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      +......           +....+...+..+.+||.+||+.||.+|||+.+++++
T Consensus       228 i~~~~~~-----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         228 VSAVNYE-----------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             HHTTCCC-----------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHhcCCC-----------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            2211110           0000111224578899999999999999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-53  Score=395.77  Aligned_cols=255  Identities=27%  Similarity=0.363  Sum_probs=201.7

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC---hHHHHHHHHHhcccCCCccceeeeEEeecCCcc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      ++|++.+.||+|+||+||+|.++        ++..||||+++..   ...|.+|+.+|++++|||||+++|++.. +.  
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~--------~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~--   85 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWN--------GTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP--   85 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--------TTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS--
T ss_pred             HHEEEeeEEeeCCCeEEEEEEEC--------CCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CC--
Confidence            47999999999999999999875        3457999998754   3469999999999999999999999853 22  


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCC
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  235 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a  235 (432)
                        .++||||+++|+|..++.......++|..++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||++
T Consensus        86 --~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla  160 (285)
T d1fmka3          86 --IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA  160 (285)
T ss_dssp             --CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             --eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchh
Confidence              38999999999999998765555799999999999999999999998   9999999999999999999999999999


Q ss_pred             cCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccc
Q 014034          236 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF  315 (432)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  315 (432)
                      +..... .........||+.|+|||++.++.++.++|||||||++|||+||..|+......  ..+...+....      
T Consensus       161 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~~~~------  231 (285)
T d1fmka3         161 RLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERGY------  231 (285)
T ss_dssp             C---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTC------
T ss_pred             hhccCC-CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHhcC------
Confidence            753221 122334467899999999999999999999999999999999976665443322  22223222110      


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       316 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                          ..    ..+...+..+.+||.+||+.||++|||+.+|++.|++....
T Consensus       232 ----~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         232 ----RM----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             ----CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             ----CC----CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence                01    11223346788999999999999999999999999887643

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.5e-53  Score=398.78  Aligned_cols=263  Identities=28%  Similarity=0.443  Sum_probs=210.3

Q ss_pred             HhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEee
Q 014034           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        76 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      ...++|++++.||+|+||+||+|+++..  ....+++.||||+++...     ..+.+|+.+|+.++||||++++++|..
T Consensus        10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~--~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_          10 YPRNNIEYVRDIGEGAFGRVFQARAPGL--LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETS--STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CCHHHcEEeEEEeeCCCeEEEEEEECCC--ccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            3456899999999999999999998632  233567899999987532     348999999999999999999999987


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCc
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRA----------------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQ  208 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~  208 (432)
                      .+.    .++||||+.+|+|.+++....                      ...+++..++.|+.|++.||+|||+.   +
T Consensus        88 ~~~----~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~  160 (301)
T d1lufa_          88 GKP----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---K  160 (301)
T ss_dssp             SSS----CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             CCc----eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---C
Confidence            654    399999999999999986432                      23588999999999999999999998   9


Q ss_pred             eeecCCCCCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCC-
Q 014034          209 VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR-  287 (432)
Q Consensus       209 ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-  287 (432)
                      |+||||||+||||+.++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||++|. 
T Consensus       161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~  240 (301)
T d1lufa_         161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL  240 (301)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence            9999999999999999999999999997532222233334567899999999999999999999999999999999985 


Q ss_pred             CCCCCCCchhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 014034          288 RSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  364 (432)
Q Consensus       288 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  364 (432)
                      +||.+.....   +...+.....          +    ..+...+..+.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus       241 ~p~~~~~~~e---~~~~v~~~~~----------~----~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         241 QPYYGMAHEE---VIYYVRDGNI----------L----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             CTTTTSCHHH---HHHHHHTTCC----------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCCHHH---HHHHHHcCCC----------C----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            5777654432   2222222110          1    112233467889999999999999999999999999875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.6e-52  Score=390.55  Aligned_cols=261  Identities=25%  Similarity=0.382  Sum_probs=205.5

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .++|++.+.||+|+||.||+|.+.       .+++.||||.++...       ..+.+|+.+|+.++||||+++++++..
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~   78 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDL-------RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA   78 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeee
Confidence            357999999999999999999975       568999999986432       247899999999999999999999988


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      ++......|+||||++|++|.+++....  ++++..+..++.||+.||.|||++   +|+||||||+|||++.++..+|+
T Consensus        79 ~~~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~  153 (277)
T d1o6ya_          79 ETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVM  153 (277)
T ss_dssp             ECSSSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEEC
T ss_pred             ccCCCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceee
Confidence            7766666799999999999999986653  699999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCC-CcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          231 DFGLAREGPMVG-HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       231 DfG~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      |||.+....... .........||+.|||||++.+..++.++|||||||++|+|+||..||.+......  ....+...+
T Consensus       154 d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~~~~~~~~~  231 (277)
T d1o6ya_         154 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQHVREDP  231 (277)
T ss_dssp             CCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHCCC
T ss_pred             hhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH--HHHHHhcCC
Confidence            999987432221 12234456899999999999999999999999999999999999999987654322  111122111


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHh
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-KMSQVVERLKQIV  364 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~~~  364 (432)
                      ...            .......+..+.+||.+||+.||.+|| |+++++..|..+.
T Consensus       232 ~~~------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         232 IPP------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             CCG------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCC------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            110            011112346788999999999999999 8999999887764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-53  Score=390.70  Aligned_cols=250  Identities=29%  Similarity=0.450  Sum_probs=201.1

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh--HHHHHHHHHhcccCCCccceeeeEEeecCCcce
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~  156 (432)
                      ++|+.++.||+|+||.||+|.++         +..||||+++.+.  ..+.+|++++++++||||++++|+|.++..   
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~---   74 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR---------GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG---   74 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET---------TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC-----
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC---------CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC---
Confidence            46888999999999999999864         5789999997653  458999999999999999999999865432   


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      ..++||||+++|+|.++|..+....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~  151 (262)
T d1byga_          75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK  151 (262)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccce
Confidence            248999999999999999765444689999999999999999999998   99999999999999999999999999997


Q ss_pred             CCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcccc
Q 014034          237 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKF  315 (432)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  315 (432)
                      ...     .......+|+.|+|||++.+..++.++|||||||++|||+| |..||.......   +...+...       
T Consensus       152 ~~~-----~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i~~~-------  216 (262)
T d1byga_         152 EAS-----STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKG-------  216 (262)
T ss_dssp             ---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHTTT-------
T ss_pred             ecC-----CCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHcC-------
Confidence            532     12234568999999999999999999999999999999998 788887654332   33333211       


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          316 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       316 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                         ..+    ..+...+..+.+||.+||+.||.+|||+.+|+++|+.+..
T Consensus       217 ---~~~----~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         217 ---YKM----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             ---CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCC----CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence               011    1122334678899999999999999999999999998864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-52  Score=397.27  Aligned_cols=246  Identities=28%  Similarity=0.386  Sum_probs=205.5

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAV  150 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~  150 (432)
                      .++|++++.||+|+||.||+|+.+       .+++.||||++++.       ...+.+|+.+|+.++||||+++++++.+
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~-------~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~   76 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREK-------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT   76 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred             hHhcEEEEEEecCcCeEEEEEEEC-------CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence            467999999999999999999976       56789999998643       2347899999999999999999999986


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      ..    .+++||||++||+|.+++....  .+++..+..++.||+.||+|||++   +|+||||||+|||++.+|.+||+
T Consensus        77 ~~----~~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~  147 (337)
T d1o6la_          77 HD----RLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKIT  147 (337)
T ss_dssp             SS----EEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             cc----ccccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEe
Confidence            55    4599999999999999987654  689999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      |||+|+....  ........+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+...   +...+.... 
T Consensus       148 DFG~a~~~~~--~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~~i~~~~-  221 (337)
T d1o6la_         148 DFGLCKEGIS--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELILMEE-  221 (337)
T ss_dssp             CCTTCBCSCC--TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCC-
T ss_pred             eccccccccc--CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---HHHHHhcCC-
Confidence            9999986322  2233455789999999999999999999999999999999999999998765432   222222111 


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-----MSQVVER  359 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  359 (432)
                                ..+    +...+..+.+||.+||+.||.+||+     +.+|++|
T Consensus       222 ----------~~~----p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         222 ----------IRF----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ----------CCC----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ----------CCC----CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence                      111    1223456889999999999999995     8888875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-52  Score=393.70  Aligned_cols=265  Identities=28%  Similarity=0.427  Sum_probs=208.9

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhccc-CCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVL-EHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~hpniv~l~~~~~~~  151 (432)
                      .++|++++.||+|+||.||+|+....+......+..||||+++.+.     ..+.+|...+.++ +|||||+++++|..+
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            3579999999999999999999876554455667899999996543     2477888888888 799999999999876


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCC
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKAS  217 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~  217 (432)
                      +.    .++||||+.+|+|.++|..+.              ...+++..++.++.||+.||+|||+.   +|+||||||+
T Consensus        92 ~~----~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~  164 (299)
T d1fgka_          92 GP----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR  164 (299)
T ss_dssp             SS----CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             Ce----EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccc
Confidence            53    499999999999999997543              23589999999999999999999998   9999999999


Q ss_pred             ceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCch
Q 014034          218 NVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPK  296 (432)
Q Consensus       218 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~  296 (432)
                      |||++.++.+||+|||+++...............||+.|+|||.+.++.|+.++|||||||++|||++ |..||.+....
T Consensus       165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~  244 (299)
T d1fgka_         165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  244 (299)
T ss_dssp             GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence            99999999999999999986433333334455678999999999999999999999999999999998 78888766543


Q ss_pred             hhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          297 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                      .   +...+....          .+    ..+...+..+.+||.+||+.||.+|||+.+|++.|+.++..
T Consensus       245 ~---~~~~i~~~~----------~~----~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         245 E---LFKLLKEGH----------RM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             H---HHHHHHTTC----------CC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H---HHHHHHcCC----------CC----CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence            2   222222111          01    11122346788999999999999999999999999998753

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-52  Score=390.35  Aligned_cols=256  Identities=27%  Similarity=0.390  Sum_probs=197.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|++++.||+|+||.||+|++...    ......||||++.+..       ..+.+|+.+|++++||||++++|++.+.
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~----~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~   83 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAP----SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   83 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECT----TSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECC----CCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec
Confidence            5799999999999999999987632    2345689999986431       2488999999999999999999999643


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                       .    .++||||+++|+|.+++..+. ..+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|
T Consensus        84 -~----~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~D  154 (273)
T d1u46a_          84 -P----MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGD  154 (273)
T ss_dssp             -S----CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECC
T ss_pred             -c----hheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeecc
Confidence             2    389999999999999887644 3699999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCC-cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcc
Q 014034          232 FGLAREGPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       232 fG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      ||+++....... ........|+..|+|||++.+..++.++|||||||++|||+| |..||.+.+...   ...++....
T Consensus       155 fGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~~~i~~~~  231 (273)
T d1u46a_         155 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKIDKEG  231 (273)
T ss_dssp             CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTSC
T ss_pred             chhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HHHHHHhCC
Confidence            999986433322 223334567889999999999999999999999999999998 899998765433   223222211


Q ss_pred             cCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 014034          310 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  363 (432)
Q Consensus       310 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  363 (432)
                      .             ....+...+..+.+||.+||+.||++|||+.+|++.|+++
T Consensus       232 ~-------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         232 E-------------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             C-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C-------------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            1             0011223346788999999999999999999999988764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-52  Score=398.17  Aligned_cols=258  Identities=21%  Similarity=0.249  Sum_probs=204.1

Q ss_pred             hcCCcccc-ccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHHHHHHHhcc-cCCCccceeeeEEeecCCcc
Q 014034           78 TNDFSRML-KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGV-LEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        78 ~~~~~~~~-~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~~  155 (432)
                      .++|.++. .||+|+||.||+|.+.       .+++.||||+++.. ..+.+|+.++.+ ++|||||++++++.+.....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~-------~~~~~vAiK~i~~~-~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~   81 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNK-------RTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLYAGR   81 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEEC-------CCCCEEEEEEECCc-HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence            46898875 5999999999999975       46789999999654 467889998765 48999999999987644444


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC---CCceeeccc
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE---NFRPKLSDF  232 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~Df  232 (432)
                      ...|+|||||+||+|.++|..+....+++..+..|+.||+.||+|||+.   +|+||||||+|||++.   ++.+||+||
T Consensus        82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence            5679999999999999999876666899999999999999999999998   9999999999999975   567999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      |+|+....   ........||+.|||||++.+..|+.++|||||||++|+|+||..||.+.........+.  .....  
T Consensus       159 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~--~~i~~--  231 (335)
T d2ozaa1         159 GFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--TRIRM--  231 (335)
T ss_dssp             TTCEECCC---CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCS--
T ss_pred             ceeeeccC---CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH--HHHhc--
Confidence            99986322   222345689999999999999999999999999999999999999997654322111100  00000  


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                            ....+........+..+.+||.+||+.||.+|||+.|++++
T Consensus       232 ------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         232 ------GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             ------CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ------CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                  00011111112345678999999999999999999999986

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.8e-51  Score=391.02  Aligned_cols=242  Identities=25%  Similarity=0.401  Sum_probs=202.5

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|++++.||+|+||+||+|+++       .+++.||||++++.       ...+.+|+.+|+.++|||||++++++.+.
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~-------~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   76 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSR-------HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA   76 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred             hHeEEEEEEecCcCcEEEEEEEC-------CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC
Confidence            57999999999999999999976       46789999998643       23478999999999999999999999765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      +    ..++||||+.||+|..++....  .+++..+..++.||+.||.|||++   +|+||||||+||||+.+|.+||+|
T Consensus        77 ~----~~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~D  147 (316)
T d1fota_          77 Q----QIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITD  147 (316)
T ss_dssp             S----EEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred             C----eeeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEec
Confidence            4    4599999999999999987654  688999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ||+|+....     .....+||+.|||||++.+..|+.++|||||||++|+|+||..||.+.+....   ...+....  
T Consensus       148 FG~a~~~~~-----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~i~~~~--  217 (316)
T d1fota_         148 FGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT---YEKILNAE--  217 (316)
T ss_dssp             CSSCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHHCC--
T ss_pred             CccceEecc-----ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH---HHHHHcCC--
Confidence            999986321     23457899999999999999999999999999999999999999987654322   22111111  


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  359 (432)
                               .    ..+...+..+.+++.+||..||.+||     |+.+|++|
T Consensus       218 ---------~----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         218 ---------L----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             ---------C----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ---------C----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                     0    11122335688999999999999996     89999876

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-51  Score=390.00  Aligned_cols=264  Identities=25%  Similarity=0.390  Sum_probs=212.3

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhccc-CCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVL-EHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~hpniv~l~~~~~~~  151 (432)
                      .++|++.+.||+|+||.||+|++....  +..+++.||||+++...     ..+.+|+.+++.+ +|||||+++++|...
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~--~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLI--KSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSS--STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccc--cCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            357999999999999999999986322  33578999999987532     2478899999999 699999999999766


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCC
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRA----------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFK  215 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dik  215 (432)
                      ..    .++||||+++|+|.+++....                ...+++..+..++.||+.||+|||++   +|+|||||
T Consensus       100 ~~----~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLK  172 (311)
T d1t46a_         100 GP----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA  172 (311)
T ss_dssp             SS----CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             CE----EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccc
Confidence            54    499999999999999997542                23688999999999999999999998   99999999


Q ss_pred             CCceEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCC
Q 014034          216 ASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNR  294 (432)
Q Consensus       216 p~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~  294 (432)
                      |+|||++.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |.+||.+..
T Consensus       173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~  252 (311)
T d1t46a_         173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (311)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999986544434444556789999999999999999999999999999999999 555565544


Q ss_pred             chhhHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          295 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                      ....  +...+...              .....+...+..+.+||.+||+.||.+|||+.+|++.|++++..
T Consensus       253 ~~~~--~~~~i~~~--------------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         253 VDSK--FYKMIKEG--------------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             SSHH--HHHHHHHT--------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHH--HHHHHhcC--------------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            3222  11111111              01111222346788999999999999999999999999987654

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.2e-51  Score=397.82  Aligned_cols=247  Identities=24%  Similarity=0.359  Sum_probs=199.7

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH-------HHHH---HHHHhcccCCCccceeeeE
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QWVA---EVQFLGVLEHPNLVKLIGY  147 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~---E~~~l~~l~hpniv~l~~~  147 (432)
                      .++|++++.||+|+||.||+|++.       .+++.||||++.+...       .+.+   |+.+++.++|||||+++++
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~-------~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~   75 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKA-------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA   75 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEEC-------CCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEE
Confidence            368999999999999999999976       4678999999864321       2333   4777888899999999999


Q ss_pred             EeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCce
Q 014034          148 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP  227 (432)
Q Consensus       148 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~  227 (432)
                      +..++    ..++||||++||+|.++|....  .+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+
T Consensus        76 ~~~~~----~~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~i  146 (364)
T d1omwa3          76 FHTPD----KLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHV  146 (364)
T ss_dssp             EECSS----EEEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCE
T ss_pred             EEECC----EEEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcE
Confidence            97654    3599999999999999997653  689999999999999999999998   99999999999999999999


Q ss_pred             eeccccCCcCCCCCCCcccccccccCCCccCccccc-cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 014034          228 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  306 (432)
Q Consensus       228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  306 (432)
                      ||+|||+|+....    .......||+.|||||++. +..|+.++|||||||++|||+||..||.+........+.....
T Consensus       147 Kl~DFGla~~~~~----~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~  222 (364)
T d1omwa3         147 RISDLGLACDFSK----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL  222 (364)
T ss_dssp             EECCCTTCEECSS----SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS
T ss_pred             EEeeeceeeecCC----CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence            9999999985322    1234567999999999986 4578999999999999999999999998765443333322211


Q ss_pred             hcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 014034          307 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-----MSQVVER  359 (432)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  359 (432)
                      ..+           ..    .+...+..+.+||.+||+.||.+|||     +.++++|
T Consensus       223 ~~~-----------~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         223 TMA-----------VE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             SCC-----------CC----CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             cCC-----------CC----CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence            111           11    11223467889999999999999999     6888876

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=389.29  Aligned_cols=268  Identities=22%  Similarity=0.305  Sum_probs=204.5

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHH-HHH--HHHHhcccCCCccceeeeEEeecCCcc
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-WVA--EVQFLGVLEHPNLVKLIGYCAVDGERG  155 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~--E~~~l~~l~hpniv~l~~~~~~~~~~~  155 (432)
                      .+|.+.+.||+|+||.||+|++         ++..||||+++..... +..  |+..+..++||||+++++++..++...
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~---------~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~   73 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW---------RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW   73 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE---------TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE---------CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcc
Confidence            3577888999999999999986         4689999999765443 334  455556789999999999999877666


Q ss_pred             eeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----CCCceeecCCCCCceEEcCCCceeec
Q 014034          156 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG-----LEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       156 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~-----~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      ...++||||+++|+|.++|.+.   +++|..++.++.|++.||.|||+.     ...+|+||||||+||||+.++.+||+
T Consensus        74 ~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~  150 (303)
T d1vjya_          74 TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  150 (303)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             eEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence            6789999999999999999764   589999999999999999999973     12499999999999999999999999


Q ss_pred             cccCCcCCCCCCCc--ccccccccCCCccCccccccCC------CCchhhhHHHHHHHHHHHhCCCCCCCCCchhh----
Q 014034          231 DFGLAREGPMVGHT--HVSTAVVGTFGYAAPDYIETGH------LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE----  298 (432)
Q Consensus       231 DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltg~~pf~~~~~~~~----  298 (432)
                      |||+++........  .......||+.|||||++.+..      ++.++|||||||++|||+||..||........    
T Consensus       151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~  230 (303)
T d1vjya_         151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence            99999853222221  1234568999999999987643      56789999999999999999988754322110    


Q ss_pred             --------HHHHHHHhhcccCccccccccCccccCc-CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhc
Q 014034          299 --------QRLLEWVQQYPADSKKFGLIMDPRLEKE-YSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  367 (432)
Q Consensus       299 --------~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  367 (432)
                              ..+.....         ....++.+... .+......+.+|+.+||+.||.+|||+.||++.|+.+.+..
T Consensus       231 ~~~~~~~~~~~~~~~~---------~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  299 (303)
T d1vjya_         231 LVPSDPSVEEMRKVVC---------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             TSCSSCCHHHHHHHHT---------TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cccccchHHHHHHHHh---------ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence                    00110000         00112222221 13345667999999999999999999999999999887643

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-51  Score=389.15  Aligned_cols=257  Identities=29%  Similarity=0.429  Sum_probs=205.5

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhccc-CCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVL-EHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  152 (432)
                      ++|++.+.||+|+||.||+|+++.     +.....||||++...     ...+.+|+++|.++ +|||||+++|+|...+
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   84 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKK-----DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   84 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEE-----TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECC-----CCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence            578999999999999999999872     223356889987532     22489999999998 7999999999998765


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNR--------------AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASN  218 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~N  218 (432)
                          ..++||||+++|+|.++|...              ....+++..++.++.||+.||.|||+.   +|+||||||+|
T Consensus        85 ----~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~N  157 (309)
T d1fvra_          85 ----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARN  157 (309)
T ss_dssp             ----EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred             ----eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---Cccccccccce
Confidence                359999999999999999654              235799999999999999999999998   99999999999


Q ss_pred             eEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCC-CCCCCCCchh
Q 014034          219 VLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR-RSLERNRPKT  297 (432)
Q Consensus       219 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-~pf~~~~~~~  297 (432)
                      ||++.++.+||+|||+++...   .........||..|+|||.+.++.++.++|||||||++|||++|. .||.+.+.. 
T Consensus       158 IL~~~~~~~kl~DfG~a~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~-  233 (309)
T d1fvra_         158 ILVGENYVAKIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-  233 (309)
T ss_dssp             EEECGGGCEEECCTTCEESSC---EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-
T ss_pred             EEEcCCCceEEcccccccccc---ccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH-
Confidence            999999999999999997532   222223456899999999999999999999999999999999976 567654432 


Q ss_pred             hHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhc
Q 014034          298 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  367 (432)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  367 (432)
                        .+...+....          .+    ..+...+..+.+||.+||+.||++|||+.+|+++|+.+++..
T Consensus       234 --~~~~~i~~~~----------~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         234 --ELYEKLPQGY----------RL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             --HHHHHGGGTC----------CC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             --HHHHHHHhcC----------CC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence              2333222110          01    112233467889999999999999999999999999998643

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.4e-51  Score=381.89  Aligned_cols=249  Identities=23%  Similarity=0.324  Sum_probs=202.6

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------------HHHHHHHHHhcccC-CCccce
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------------LQWVAEVQFLGVLE-HPNLVK  143 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------------~~~~~E~~~l~~l~-hpniv~  143 (432)
                      .++|++.+.||+|+||+||+|+..       .+++.||||++.+..             ..+.+|+.+|++++ ||||++
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~-------~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~   74 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHK-------PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQ   74 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             cccCEEceEEecCcCeEEEEEEEC-------CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Confidence            358999999999999999999875       468999999985431             13778999999997 999999


Q ss_pred             eeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC
Q 014034          144 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  223 (432)
Q Consensus       144 l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~  223 (432)
                      +++++.+++    ..++||||+++|+|.++|..+.  ++++..+..++.||+.||+|||++   +|+||||||+||||+.
T Consensus        75 ~~~~~~~~~----~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~  145 (277)
T d1phka_          75 LKDTYETNT----FFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDD  145 (277)
T ss_dssp             EEEEEECSS----EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT
T ss_pred             EEeecccCc----ceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcC
Confidence            999998654    4599999999999999997654  799999999999999999999998   9999999999999999


Q ss_pred             CCceeeccccCCcCCCCCCCcccccccccCCCccCcccccc------CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchh
Q 014034          224 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET------GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT  297 (432)
Q Consensus       224 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~  297 (432)
                      ++.+||+|||+++....   ........||+.|+|||++.+      ..++.++||||+||++|+|++|..||.+.....
T Consensus       146 ~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~  222 (277)
T d1phka_         146 DMNIKLTDFGFSCQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML  222 (277)
T ss_dssp             TCCEEECCCTTCEECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             CCCeEEccchheeEccC---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH
Confidence            99999999999986322   223345789999999999853      356889999999999999999999998765433


Q ss_pred             hHHHHHHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          298 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ..   ..+......           +........+..+.+|+.+||+.||.+|||+.||+++
T Consensus       223 ~~---~~i~~~~~~-----------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         223 ML---RMIMSGNYQ-----------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HH---HHHHHTCCC-----------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HH---HHHHhCCCC-----------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            22   111111100           0111122334678899999999999999999999765

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.3e-51  Score=393.05  Aligned_cols=242  Identities=24%  Similarity=0.337  Sum_probs=202.6

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      ++|++++.||+|+||.||+|.++       .+++.||||++.+.       ...+.+|+.+|+.++|||||++++++...
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~-------~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~  113 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHK-------ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN  113 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cCeEEEEEeecCcCcEEEEEEEC-------CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc
Confidence            57999999999999999999976       46789999998643       23478999999999999999999998765


Q ss_pred             CCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecc
Q 014034          152 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  231 (432)
Q Consensus       152 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D  231 (432)
                      .    ..++||||+.+|+|..++....  .+++..+..++.||+.||.|||++   +|+||||||+||||+.+|.+||+|
T Consensus       114 ~----~~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~D  184 (350)
T d1rdqe_         114 S----NLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTD  184 (350)
T ss_dssp             S----EEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             c----ccccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeee
Confidence            4    3599999999999999997654  699999999999999999999998   999999999999999999999999


Q ss_pred             ccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          232 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      ||+|+....     ......||+.|||||++.+..++.++|||||||++|||+||..||.+.....   +...+..... 
T Consensus       185 FG~a~~~~~-----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i~~~~~-  255 (350)
T d1rdqe_         185 FGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYEKIVSGKV-  255 (350)
T ss_dssp             CTTCEECSS-----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCCC-
T ss_pred             ceeeeeccc-----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH---HHHHHhcCCC-
Confidence            999986321     2235679999999999999999999999999999999999999998764432   2222221110 


Q ss_pred             ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  359 (432)
                                .    .+...+..+.+||.+||..||.+|+     |+.+|++|
T Consensus       256 ----------~----~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         256 ----------R----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ----------C----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ----------C----CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence                      0    1122345788999999999999994     89999875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-51  Score=390.23  Aligned_cols=250  Identities=18%  Similarity=0.277  Sum_probs=204.1

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH---HHHHHHHHhcccCCCccceeeeEEeecCCc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGVLEHPNLVKLIGYCAVDGER  154 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  154 (432)
                      .++|++++.||+|+||+||+|.++       .+++.||||.++....   .+.+|+++|+.++|||||++++++.+++  
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~-------~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--   74 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVET-------SSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESME--   74 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT--
T ss_pred             ccceEEEEEEecCCCeEEEEEEEC-------CCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--
Confidence            467999999999999999999976       5678999999986544   3789999999999999999999998765  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC--CCceeeccc
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE--NFRPKLSDF  232 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~--~~~~kl~Df  232 (432)
                        ..|+|||||.||+|.++|.... ..+++.++..++.||+.||.|||+.   +|+||||||+|||++.  .+.+||+||
T Consensus        75 --~~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DF  148 (321)
T d1tkia_          75 --ELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEF  148 (321)
T ss_dssp             --EEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred             --EEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEccc
Confidence              4599999999999999996543 3699999999999999999999998   9999999999999985  457999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      |+++....   ........||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.....   ....+...... 
T Consensus       149 G~~~~~~~---~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~---~~~~i~~~~~~-  221 (321)
T d1tkia_         149 GQARQLKP---GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIENIMNAEYT-  221 (321)
T ss_dssp             TTCEECCT---TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHHTCCC-
T ss_pred             chhhcccc---CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCCC-
Confidence            99986322   223345679999999999999999999999999999999999999998765432   22222111100 


Q ss_pred             cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          313 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       313 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                            .+...    ....+..+.+||.+||..||.+|||+.|++++
T Consensus       222 ------~~~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         222 ------FDEEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ------CCHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ------CChhh----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  00000    01123568899999999999999999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=382.20  Aligned_cols=264  Identities=27%  Similarity=0.387  Sum_probs=200.6

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      ++|++++.||+|+||+||+|.+.       .+++.||||++...      ...+.+|+.+|++++|||||++++++.+.+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~   74 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN   74 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             CCCEeccEEecCcCeEEEEEEEC-------CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc
Confidence            58999999999999999999975       46789999998643      235889999999999999999999998765


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                          ..++||||+.+ ++.+++.......+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        75 ----~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DF  146 (298)
T d1gz8a_          75 ----KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADF  146 (298)
T ss_dssp             ----EEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECST
T ss_pred             ----ceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccC
Confidence                45999999964 555566555556899999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH-LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      |+|+....  .........||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..............+..
T Consensus       147 G~a~~~~~--~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~  224 (298)
T d1gz8a_         147 GLARAFGV--PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE  224 (298)
T ss_dssp             THHHHHCC--CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             CcceeccC--CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCch
Confidence            99975321  223344568999999999886655 578999999999999999999999876543322211111111111


Q ss_pred             ccccccccCccccCc-----------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 SKKFGLIMDPRLEKE-----------YSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~~~~~~~~~~~l~~~-----------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ...-.....+.....           .....+..+.+|+.+||..||.+|||+.|++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         225 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            000000000000000           011224578899999999999999999999886

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=383.10  Aligned_cols=259  Identities=25%  Similarity=0.281  Sum_probs=195.1

Q ss_pred             cccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh---------HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           83 RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---------LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        83 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      .++.||+|+||+||+|.++       .+++.||||+++...         ..+.+|+.+|+.++|||||++++++..++.
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~   74 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDK-------NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   74 (299)
T ss_dssp             EEEEEEEETTEEEEEEECS-------SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             cceEeccCcCeEEEEEEEC-------CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCc
Confidence            4678999999999999865       567899999986432         247899999999999999999999987654


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeecccc
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  233 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG  233 (432)
                          .++||||+.++++...+..  ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        75 ----~~ivmE~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG  145 (299)
T d1ua2a_          75 ----ISLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFG  145 (299)
T ss_dssp             ----CEEEEECCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred             ----eeehhhhhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCc
Confidence                4999999988777766533  34689999999999999999999998   99999999999999999999999999


Q ss_pred             CCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 014034          234 LAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  312 (432)
Q Consensus       234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  312 (432)
                      +|+....  ........+||+.|+|||++.+ ..|+.++|||||||++|||+||..||.+.........+......+...
T Consensus       146 ~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~  223 (299)
T d1ua2a_         146 LAKSFGS--PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE  223 (299)
T ss_dssp             GGSTTTS--CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             cccccCC--CcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            9976322  2223345679999999999865 467999999999999999999999998765544322221111111110


Q ss_pred             -cc----c-ccccCccccC----cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          313 -KK----F-GLIMDPRLEK----EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       313 -~~----~-~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                       ..    . ..........    ......+..+.+|+.+||+.||.+|||+.|++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence             00    0 0000000000    0011224678899999999999999999999876

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=385.32  Aligned_cols=245  Identities=24%  Similarity=0.401  Sum_probs=201.0

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-------HHHHHHHHHhc-ccCCCccceeeeEEee
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-------LQWVAEVQFLG-VLEHPNLVKLIGYCAV  150 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~-~l~hpniv~l~~~~~~  150 (432)
                      ++|++++.||+|+||+||+|+++       .+++.||||+++++.       ..+..|..++. .++|||||++++++.+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~-------~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~   74 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFK-------KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT   74 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEET-------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             CCeEEeeEEecCCCcEEEEEEEC-------CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc
Confidence            57999999999999999999976       568999999986432       23566777665 6899999999999987


Q ss_pred             cCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          151 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       151 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .+    ..++||||+++|+|.+++....  .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+
T Consensus        75 ~~----~~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~  145 (320)
T d1xjda_          75 KE----NLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIA  145 (320)
T ss_dssp             SS----EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             CC----ceeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceecc
Confidence            55    3599999999999999997644  689999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      |||+++....  .........||+.|+|||++.+..++.++|||||||++|+|+||..||.+.+....   ...+...  
T Consensus       146 DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~~~i~~~--  218 (320)
T d1xjda_         146 DFGMCKENML--GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL---FHSIRMD--  218 (320)
T ss_dssp             CCTTCBCCCC--TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHC--
T ss_pred             ccchhhhccc--ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH---HHHHHcC--
Confidence            9999986322  22333456899999999999999999999999999999999999999987654332   2222111  


Q ss_pred             CccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHHH
Q 014034          311 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS-QVVER  359 (432)
Q Consensus       311 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~~  359 (432)
                               .+.+    +...+..+.+||.+||..||.+|||+. +++++
T Consensus       219 ---------~~~~----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         219 ---------NPFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             ---------CCCC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             ---------CCCC----CccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence                     1111    122346688999999999999999995 67654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-50  Score=381.91  Aligned_cols=256  Identities=27%  Similarity=0.401  Sum_probs=200.4

Q ss_pred             ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-----hHHHHHHHHHhcccCCCccceeeeEEeecCCcceeE
Q 014034           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQR  158 (432)
Q Consensus        84 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~~  158 (432)
                      .++||+|+||+||+|++...+    .....||||+++..     ...+.+|+++|++++||||++++|++.....   ..
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~----~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~---~~  104 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDND----GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SP  104 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC--------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTT---EE
T ss_pred             ceEEeecCCeEEEEEEEECCC----CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCC---ce
Confidence            467999999999999986221    23457999998642     1348999999999999999999999875432   35


Q ss_pred             EEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccccCCcCC
Q 014034          159 LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG  238 (432)
Q Consensus       159 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~  238 (432)
                      ++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+||||++++.+||+|||+++..
T Consensus       105 ~lv~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~  180 (311)
T d1r0pa_         105 LVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM  180 (311)
T ss_dssp             EEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred             EEEEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhc
Confidence            89999999999999987654 4678899999999999999999998   9999999999999999999999999999864


Q ss_pred             CCCCC--cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 014034          239 PMVGH--THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  316 (432)
Q Consensus       239 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (432)
                      .....  ........||+.|+|||.+.+..++.++||||||+++|||+||..||......  ..+..++.....      
T Consensus       181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i~~g~~------  252 (311)
T d1r0pa_         181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQGRR------  252 (311)
T ss_dssp             TTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTCC------
T ss_pred             cccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCCC------
Confidence            32211  12233457899999999999999999999999999999999988887643221  112222211100      


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhh
Q 014034          317 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  366 (432)
Q Consensus       317 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~  366 (432)
                          +    ..+...+..+.+||.+||+.||++|||+.||+++|+.+++.
T Consensus       253 ----~----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         253 ----L----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             ----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ----C----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence                0    11122346788999999999999999999999999999864

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=383.64  Aligned_cols=261  Identities=24%  Similarity=0.408  Sum_probs=208.6

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecCC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  153 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  153 (432)
                      ++|.+.+.||+|+||+||+|.++...  ....++.||||+++...     ..+.+|+.++++++||||+++++++..+..
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~--~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~   97 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVV--KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   97 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEE--TTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcc--cCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence            57899999999999999999875211  12346889999997532     237899999999999999999999976554


Q ss_pred             cceeEEEEEeecCCCCHHHHhhcC--------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC
Q 014034          154 RGIQRLLVYEFMLNRSLEDHLFNR--------AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF  225 (432)
Q Consensus       154 ~~~~~~lv~e~~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~  225 (432)
                      .    ++||||+.+|+|.+++...        ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++
T Consensus        98 ~----~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          98 T----LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             C----EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred             e----eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence            3    9999999999999988532        223578999999999999999999998   999999999999999999


Q ss_pred             ceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCC-CCCCCCCchhhHHHHHH
Q 014034          226 RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR-RSLERNRPKTEQRLLEW  304 (432)
Q Consensus       226 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-~pf~~~~~~~~~~~~~~  304 (432)
                      ++||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||+||. .||.+.....   ....
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~---~~~~  247 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---VLRF  247 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---HHHH
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH---HHHH
Confidence            99999999998543333333344567899999999999999999999999999999999984 7776554322   2222


Q ss_pred             HhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 014034          305 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  365 (432)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  365 (432)
                      +.....          +    ..+...+..+.+||.+||+.||++|||+.+|+++|+..++
T Consensus       248 i~~~~~----------~----~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         248 VMEGGL----------L----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHTTCC----------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHhCCC----------C----CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            221100          0    1122234679999999999999999999999999987754

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=378.02  Aligned_cols=269  Identities=25%  Similarity=0.360  Sum_probs=203.8

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhccc---CCCccceeeeEE
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVL---EHPNLVKLIGYC  148 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l---~hpniv~l~~~~  148 (432)
                      .++|++++.||+|+||+||+|.+..      .+++.||||+++..      ...+.+|+.+|+.|   +||||++++++|
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~   79 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLK------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVC   79 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEEC------CCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeee
Confidence            4689999999999999999998641      24678999998532      22367888887766   799999999998


Q ss_pred             eecC-CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCce
Q 014034          149 AVDG-ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP  227 (432)
Q Consensus       149 ~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~  227 (432)
                      .... ......+++|||+.++++..... .....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+
T Consensus        80 ~~~~~~~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~  155 (305)
T d1blxa_          80 TVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQI  155 (305)
T ss_dssp             EEEECSSEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred             cccccccCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCe
Confidence            6532 23456799999998876655443 3445799999999999999999999998   99999999999999999999


Q ss_pred             eeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 014034          228 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  307 (432)
Q Consensus       228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  307 (432)
                      ||+|||+++..   ..........||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+.......+.....
T Consensus       156 kl~dfg~~~~~---~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  232 (305)
T d1blxa_         156 KLADFGLARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG  232 (305)
T ss_dssp             EECSCCSCCCC---CGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             eecchhhhhhh---cccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhC
Confidence            99999998752   233445567899999999999999999999999999999999999999987765443322222111


Q ss_pred             cccC-cccc-----cccc---CccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          308 YPAD-SKKF-----GLIM---DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       308 ~~~~-~~~~-----~~~~---~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .+.. ....     ....   ............+..+.+|+.+||+.||.+|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            1110 0000     0000   0000111222334678899999999999999999999876

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5e-49  Score=369.90  Aligned_cols=262  Identities=24%  Similarity=0.324  Sum_probs=196.5

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      ++|++++.||+|+||+||+|+++        +++.||||++...      ...+.+|+.+|+.++||||+++++++..++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~--------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~   73 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN--------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK   73 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET--------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS
T ss_pred             CCceeccEEecCCCcEEEEEEeC--------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC
Confidence            57999999999999999999864        5688999998653      235889999999999999999999998765


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                      .    .+++|||+.++.+..+....  ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        74 ~----~~i~~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~Df  144 (286)
T d1ob3a_          74 R----LVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADF  144 (286)
T ss_dssp             C----EEEEEECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCT
T ss_pred             c----eeEEEEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEeccc
Confidence            4    48999999777666665433  4799999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  311 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  311 (432)
                      |++.....  .........|++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+................+..
T Consensus       145 G~a~~~~~--~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~  222 (286)
T d1ob3a_         145 GLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS  222 (286)
T ss_dssp             THHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             ccceeccc--CccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCCh
Confidence            99975321  1222344578999999999865 45789999999999999999999999876543332221111111110


Q ss_pred             c-c----cccc------ccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          312 S-K----KFGL------IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       312 ~-~----~~~~------~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      . .    ....      ...+..........+..+.+|+.+||+.||++|||+.|++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             TTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0 0    0000      000000011122234678899999999999999999999865

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=377.44  Aligned_cols=238  Identities=25%  Similarity=0.384  Sum_probs=193.4

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----------HHHHHHHHHhcccC--CCccceee
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----------LQWVAEVQFLGVLE--HPNLVKLI  145 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~--hpniv~l~  145 (432)
                      .++|++.+.||+|+||.||+|+..       .+++.||||++.+..          ..+.+|+.+|++++  |||||+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~   75 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRV-------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL   75 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEE
Confidence            368999999999999999999975       467899999986432          12568999999986  89999999


Q ss_pred             eEEeecCCcceeEEEEEeecCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC-
Q 014034          146 GYCAVDGERGIQRLLVYEFMLN-RSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE-  223 (432)
Q Consensus       146 ~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~-  223 (432)
                      +++..++    ..++||||+.+ +++.+++....  .+++..+..++.||+.||.|||++   +|+||||||+|||++. 
T Consensus        76 ~~~~~~~----~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~  146 (273)
T d1xwsa_          76 DWFERPD----SFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLN  146 (273)
T ss_dssp             EEEECSS----EEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETT
T ss_pred             EEEeeCC----eEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecC
Confidence            9997655    35999999976 57878876543  699999999999999999999998   9999999999999985 


Q ss_pred             CCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014034          224 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  302 (432)
Q Consensus       224 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  302 (432)
                      ++.+||+|||+|+....    .......||+.|+|||++.+..+ +.++|||||||++|||+||..||.+..     .+.
T Consensus       147 ~~~vkl~DFG~a~~~~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~  217 (273)
T d1xwsa_         147 RGELKLIDFGSGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EII  217 (273)
T ss_dssp             TTEEEECCCTTCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH
T ss_pred             CCeEEECccccceeccc----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HHh
Confidence            57999999999975321    22345689999999999987765 567999999999999999999997521     111


Q ss_pred             HHHhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          303 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .   ..            ..+...    .+..+.+||.+||+.||.+|||+.|++++
T Consensus       218 ~---~~------------~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         218 R---GQ------------VFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             H---CC------------CCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             h---cc------------cCCCCC----CCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            1   00            011112    23578899999999999999999999876

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-49  Score=380.02  Aligned_cols=267  Identities=25%  Similarity=0.297  Sum_probs=199.4

Q ss_pred             CCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChHHHHHHHHHhcccCCCccceeeeEEeecCC--ccee
Q 014034           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQWVAEVQFLGVLEHPNLVKLIGYCAVDGE--RGIQ  157 (432)
Q Consensus        80 ~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--~~~~  157 (432)
                      +|..++.||+|+||+||+|++.       .+++.||||++..+.....+|+.+|+.++||||+++++++.....  ....
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~-------~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLC-------DSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred             CcEeeeEEeeCcCeEEEEEEEC-------CCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence            5888999999999999999976       467899999998776667789999999999999999999876432  3345


Q ss_pred             EEEEEeecCCCCHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC-ceeeccccCC
Q 014034          158 RLLVYEFMLNRSLEDHLF-NRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF-RPKLSDFGLA  235 (432)
Q Consensus       158 ~~lv~e~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~DfG~a  235 (432)
                      .++||||+.++.+..... ......+++..+..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||++
T Consensus        94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a  170 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA  170 (350)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred             EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence            689999997654443322 12345799999999999999999999998   999999999999999775 8999999999


Q ss_pred             cCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc------
Q 014034          236 REGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY------  308 (432)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~------  308 (432)
                      +....   ........||+.|+|||.+.+ ..++.++|||||||++|||++|..||...........+......      
T Consensus       171 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  247 (350)
T d1q5ka_         171 KQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  247 (350)
T ss_dssp             EECCT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             hhccC---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhh
Confidence            75322   222345679999999998765 57899999999999999999999999876543322111111000      


Q ss_pred             ---ccC--ccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 ---PAD--SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 ---~~~--~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                         ...  ...+.......+........+..+.+|+.+||..||.+|||+.|++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               000  000000000011111122334678899999999999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=375.33  Aligned_cols=269  Identities=24%  Similarity=0.314  Sum_probs=199.7

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh-----HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      +.+|++++.||+|+||+||+|..+       .+++.||||++++..     ..+.+|+.+|+.++||||+++++++..+.
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~   79 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDN-------VNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT   79 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEET-------TTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred             CCCeEEEEEEeeccCeEEEEEEEC-------CCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecc
Confidence            357999999999999999999865       567899999987532     24788999999999999999999997765


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                      ......+++++|+.+|+|.+++...   .+++..+..++.||+.||+|||++   +|+||||||+||||+.++.+||+||
T Consensus        80 ~~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~Df  153 (345)
T d1pmea_          80 IEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDF  153 (345)
T ss_dssp             TTTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             ccccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEccc
Confidence            4333345666777799999999754   599999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCC-cccccccccCCCccCccccc-cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 014034          233 GLAREGPMVGH-THVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  310 (432)
Q Consensus       233 G~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  310 (432)
                      |+++....... .......+||+.|+|||++. +..++.++||||+||++|+|++|..||.+................+.
T Consensus       154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~  233 (345)
T d1pmea_         154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS  233 (345)
T ss_dssp             TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             CceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCC
Confidence            99975322211 12234567999999999984 55678999999999999999999999987655433222221111111


Q ss_pred             Ccccc--------cccc-CccccC----cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          311 DSKKF--------GLIM-DPRLEK----EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       311 ~~~~~--------~~~~-~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      .....        .... .+....    ......+..+.+|+.+||..||.+|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000        0000 000000    0011123468899999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-47  Score=363.94  Aligned_cols=270  Identities=22%  Similarity=0.322  Sum_probs=198.4

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|.+++.||+|+||+||+|++.       .+++.||||++...      ...+.+|+.+|+.++||||+++++++...
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~   81 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHR-------KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK   81 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred             cCCEEEEEEEecCcCeEEEEEEEC-------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecc
Confidence            368999999999999999999975       56789999997543      23478999999999999999999998653


Q ss_pred             CC----cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCce
Q 014034          152 GE----RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP  227 (432)
Q Consensus       152 ~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~  227 (432)
                      ..    .....++||||+.++.+.....  ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+
T Consensus        82 ~~~~~~~~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~  156 (318)
T d3blha1          82 ASPYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVL  156 (318)
T ss_dssp             ---------CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCE
T ss_pred             cccccccCceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcE
Confidence            21    1234689999998776665443  334789999999999999999999998   99999999999999999999


Q ss_pred             eeccccCCcCCCCCCC--cccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 014034          228 KLSDFGLAREGPMVGH--THVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  304 (432)
Q Consensus       228 kl~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  304 (432)
                      ||+|||+++.......  .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+..
T Consensus       157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~  236 (318)
T d3blha1         157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ  236 (318)
T ss_dssp             EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHH
Confidence            9999999975332211  1223345799999999998765 689999999999999999999999987665444333322


Q ss_pred             Hhh-cccCcc-cc-----ccccCccccCcCCH-------HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          305 VQQ-YPADSK-KF-----GLIMDPRLEKEYSI-------NEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       305 ~~~-~~~~~~-~~-----~~~~~~~l~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ... ...... ..     ..............       .....+.+||.+||+.||++|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            221 111100 00     00000000001111       113456789999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-47  Score=361.18  Aligned_cols=264  Identities=22%  Similarity=0.264  Sum_probs=199.6

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh--HHHHHHHHHhcccCCCccceeeeEEeecCCcce
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~  156 (432)
                      ++|++.+.||+|+||.||+|++.       .+++.||||.+....  ..+..|+++++.++|+|++..+..+..++.   
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~-------~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~---   76 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDI-------AAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGD---   76 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEET-------TTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETT---
T ss_pred             CEEEEeEEEeeCCCcEEEEEEEC-------CCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCC---
Confidence            57999999999999999999875       467899999876433  358899999999988887776666554433   


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEc---CCCceeecccc
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFG  233 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~---~~~~~kl~DfG  233 (432)
                      ..++||||+ +++|.+.+.... ..+++..+..++.|++.||+|||++   +|+||||||+|||++   .+..+||+|||
T Consensus        77 ~~~ivme~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG  151 (299)
T d1ckia_          77 YNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG  151 (299)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred             EEEEEEEEc-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccC
Confidence            458999999 667777665433 4799999999999999999999998   999999999999986   45579999999


Q ss_pred             CCcCCCCCCC-----cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          234 LAREGPMVGH-----THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       234 ~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      +|+.......     ........||+.|||||++.+..++.++|||||||++|||+||..||..................
T Consensus       152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~  231 (299)
T d1ckia_         152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK  231 (299)
T ss_dssp             SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH
T ss_pred             cceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc
Confidence            9986432211     12234568999999999999999999999999999999999999999876544332221111100


Q ss_pred             ccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhc
Q 014034          309 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  367 (432)
Q Consensus       309 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~  367 (432)
                      ...      ...+.+    ....+..+.+|+..||+.||++||++.+|.+.|+.+....
T Consensus       232 ~~~------~~~~~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         232 KMS------TPIEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             HHH------SCHHHH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cCC------CChhHh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            000      000001    1122366889999999999999999999999998876543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=370.40  Aligned_cols=262  Identities=24%  Similarity=0.338  Sum_probs=196.0

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|++++.||+|+||+||+|..+       .+++.||||++++..      ..+.+|+.+|+.++|||||+++++|...
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~   89 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDG-------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD   89 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEET-------TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEEC-------CCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccC
Confidence            468999999999999999999975       467899999987431      2478899999999999999999999765


Q ss_pred             CC--cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          152 GE--RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       152 ~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      +.  .....++||||+ +.+|..++...   .+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||
T Consensus        90 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl  162 (346)
T d1cm8a_          90 ETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKI  162 (346)
T ss_dssp             SSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEE
T ss_pred             ccccccceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccc
Confidence            42  223459999999 67888877543   699999999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCcccccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  308 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  308 (432)
                      +|||+|+...     .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+................
T Consensus       163 ~Dfg~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~  237 (346)
T d1cm8a_         163 LDFGLARQAD-----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT  237 (346)
T ss_dssp             CCCTTCEECC-----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             ccccceeccC-----CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCC
Confidence            9999998632     12345679999999999876 45789999999999999999999999876544332222111111


Q ss_pred             ccCc--------------cccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          309 PADS--------------KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       309 ~~~~--------------~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      +...              ..+.......+. ......+..+.+||.+||..||.+|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             CCHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CcHHHHhhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0000              000000000000 1112234567899999999999999999999987

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.6e-47  Score=357.35  Aligned_cols=265  Identities=18%  Similarity=0.190  Sum_probs=208.6

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh--HHHHHHHHHhcccCC-CccceeeeEEeecCCc
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQWVAEVQFLGVLEH-PNLVKLIGYCAVDGER  154 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~  154 (432)
                      .++|++++.||+|+||+||+|++.       .+++.||||.++...  ..+.+|+++++.+.| +|++.+++++....  
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~-------~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~--   74 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNL-------LNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL--   74 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEET-------TTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT--
T ss_pred             CCceEEEEEEecCCCeEEEEEEEC-------CCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCC--
Confidence            357999999999999999999975       468899999875433  347889999999965 89999999887654  


Q ss_pred             ceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC-----CCceee
Q 014034          155 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE-----NFRPKL  229 (432)
Q Consensus       155 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~-----~~~~kl  229 (432)
                        ..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+.   ||+||||||+|||++.     ++.+||
T Consensus        75 --~~~~vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl  147 (293)
T d1csna_          75 --HNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYV  147 (293)
T ss_dssp             --EEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             --ccEEEEEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEE
Confidence              349999998 789999886544 4689999999999999999999998   9999999999999964     578999


Q ss_pred             ccccCCcCCCCCCC-----cccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 014034          230 SDFGLAREGPMVGH-----THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  304 (432)
Q Consensus       230 ~DfG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  304 (432)
                      +|||+|+.......     ........||+.|||||++.+..++.++|||||||++|||+||..||.+............
T Consensus       148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~  227 (293)
T d1csna_         148 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER  227 (293)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred             cccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH
Confidence            99999985322111     1223456899999999999999999999999999999999999999987655443322222


Q ss_pred             HhhcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhhcc
Q 014034          305 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  368 (432)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  368 (432)
                      +....... ..     +.+...    .+..+.+++..||..+|++||+++.+.+.|+++++..+
T Consensus       228 i~~~~~~~-~~-----~~l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~  281 (293)
T d1csna_         228 IGEKKQST-PL-----RELCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  281 (293)
T ss_dssp             HHHHHHHS-CH-----HHHTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHhccCCC-Ch-----HHhcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence            21110000 00     011111    23568899999999999999999999999998876554

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=8.9e-47  Score=361.44  Aligned_cols=261  Identities=20%  Similarity=0.296  Sum_probs=199.4

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC-hHHHHHHHHHhcccC-CCccceeeeEEeecCCcce
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQWVAEVQFLGVLE-HPNLVKLIGYCAVDGERGI  156 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~  156 (432)
                      ++|++++.||+|+||+||+|++.       .+++.||||+++.. ...+.+|+.+|+.++ ||||+++++++......  
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~-------~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~--  105 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINI-------TNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSR--  105 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC--
T ss_pred             cCeEEEEEEecCcCeEEEEEEEC-------CCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC--
Confidence            57999999999999999999975       57899999998764 456889999999995 99999999998764433  


Q ss_pred             eEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCC-ceeeccccCC
Q 014034          157 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF-RPKLSDFGLA  235 (432)
Q Consensus       157 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~DfG~a  235 (432)
                      ..++||||+.+++|..+.     ..+++..+..++.||+.||.|||++   +|+||||||+||||+.++ .+||+|||+|
T Consensus       106 ~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a  177 (328)
T d3bqca1         106 TPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLA  177 (328)
T ss_dssp             SEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGC
T ss_pred             ceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccc
Confidence            469999999999997764     3689999999999999999999998   999999999999998655 6999999999


Q ss_pred             cCCCCCCCcccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHH--H---------H
Q 014034          236 REGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL--L---------E  303 (432)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~--~---------~  303 (432)
                      +....   ........||+.|+|||.+.+. .++.++|||||||++|+|++|..||...........  .         .
T Consensus       178 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~  254 (328)
T d3bqca1         178 EFYHP---GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD  254 (328)
T ss_dssp             EECCT---TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred             eeccC---CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhh
Confidence            75322   2233456799999999998765 579999999999999999999999976554332111  1         1


Q ss_pred             HHhhcccC-ccccccccC--------ccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          304 WVQQYPAD-SKKFGLIMD--------PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       304 ~~~~~~~~-~~~~~~~~~--------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      +....... ...+.....        ...........+..+.+||.+||..||.+|||+.|++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             HHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11111000 000100000        001111112234568899999999999999999999875

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=354.76  Aligned_cols=263  Identities=23%  Similarity=0.307  Sum_probs=199.9

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC------hHHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------GLQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      ++|++++.||+|+||+||+|++.       .+++.||||+++..      ...+.+|+.+|+.++||||+++++++....
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~   74 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNR-------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK   74 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             CCCEeeeEEecCcCeEEEEEEEC-------CCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc
Confidence            57999999999999999999975       56789999997532      235789999999999999999999997755


Q ss_pred             CcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeeccc
Q 014034          153 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  232 (432)
Q Consensus       153 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  232 (432)
                      .    .++|++++.+++|..++...  +.+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        75 ~----~~iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DF  145 (292)
T d1unla_          75 K----LTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANF  145 (292)
T ss_dssp             E----EEEEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred             c----eeEEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeec
Confidence            3    48999999999988877544  4789999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcCCCCCCCcccccccccCCCccCccccccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCCchhh-HHHHHHHhhccc
Q 014034          233 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH-LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-QRLLEWVQQYPA  310 (432)
Q Consensus       233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~-~~~~~~~~~~~~  310 (432)
                      |.++.....  ........+++.|+|||++.+.. ++.++|||||||++|||++|..||........ ...+......+.
T Consensus       146 G~a~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  223 (292)
T d1unla_         146 GLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT  223 (292)
T ss_dssp             TTCEECCSC--CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             chhhcccCC--CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCC
Confidence            999864322  22233456788999999987654 68999999999999999999999754433222 111111111111


Q ss_pred             Ccc--cccc---------ccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          311 DSK--KFGL---------IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       311 ~~~--~~~~---------~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ...  ....         .....-........+..+.+|+.+||+.||.+|||+.|++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000  0000         000000011122334578899999999999999999999876

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-46  Score=363.26  Aligned_cols=263  Identities=22%  Similarity=0.255  Sum_probs=193.0

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeecC
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVDG  152 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~~  152 (432)
                      ++|++++.||+|+||+||+|.+.       .+++.||||++....      ..+.+|+.+|++++||||+++++++...+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~-------~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~   89 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDA-------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK   89 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEET-------TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred             CCeEEEEEeecCcCeEEEEEEEC-------CCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccc
Confidence            67999999999999999999875       568999999986431      24789999999999999999999997653


Q ss_pred             C--cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          153 E--RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       153 ~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .  .....|+||||+.++.+ +.+.    ..+++..++.++.||+.||.|||+.   ||+||||||+|||++.++.+|++
T Consensus        90 ~~~~~~~~~iv~Ey~~~~l~-~~~~----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~  161 (355)
T d2b1pa1          90 TLEEFQDVYLVMELMDANLC-QVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL  161 (355)
T ss_dssp             STTTCCEEEEEEECCSEEHH-HHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEEC
T ss_pred             ccccCceeEEEEeccchHHH-Hhhh----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeee
Confidence            2  34577999999966544 4442    3589999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHH-HHh---
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE-WVQ---  306 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~-~~~---  306 (432)
                      |||+++...   .........||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+. ...   
T Consensus       162 df~~~~~~~---~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~  238 (355)
T d2b1pa1         162 DFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC  238 (355)
T ss_dssp             CCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             chhhhhccc---cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCC
Confidence            999987532   2334455679999999999999999999999999999999999999998765433221111 000   


Q ss_pred             ----------------hcc-cCccccccccCccccC---cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          307 ----------------QYP-ADSKKFGLIMDPRLEK---EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       307 ----------------~~~-~~~~~~~~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                                      ..+ ................   ......+..+.+|+.+||..||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                            000 0000000011111111   1123456788999999999999999999999987

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-47  Score=361.18  Aligned_cols=252  Identities=27%  Similarity=0.381  Sum_probs=199.7

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcC--------hHHHHHHHHHhcccCC-CccceeeeEEe
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--------GLQWVAEVQFLGVLEH-PNLVKLIGYCA  149 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h-pniv~l~~~~~  149 (432)
                      ++|++++.||+|+||+||+|....    +..+++.||||.+++.        ...+.+|+++|++++| |||+++++++.
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~   99 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKIS----GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ   99 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECS----STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             hceEEEEEEecCCCeEEEEEEECc----cCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence            579999999999999999998642    2346889999998642        2347789999999976 89999999987


Q ss_pred             ecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceee
Q 014034          150 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  229 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl  229 (432)
                      ...    ..++||||+.+|+|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||
T Consensus       100 ~~~----~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL  170 (322)
T d1vzoa_         100 TET----KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVL  170 (322)
T ss_dssp             ETT----EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEE
T ss_pred             cCC----ceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEE
Confidence            765    3599999999999999997654  578899999999999999999998   9999999999999999999999


Q ss_pred             ccccCCcCCCCCCCcccccccccCCCccCccccccC--CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH-HHHh
Q 014034          230 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG--HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL-EWVQ  306 (432)
Q Consensus       230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~-~~~~  306 (432)
                      +|||+++..... .........|++.|+|||.+.+.  .++.++|||||||+||+|++|..||.+.........+ ....
T Consensus       171 ~DFG~a~~~~~~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~  249 (322)
T d1vzoa_         171 TDFGLSKEFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL  249 (322)
T ss_dssp             SCSSEEEECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred             eeccchhhhccc-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc
Confidence            999999753221 22234456899999999999754  4688999999999999999999999776543322221 1111


Q ss_pred             hcccCccccccccCccccCcCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 014034          307 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-----MSQVVER  359 (432)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  359 (432)
                      ...           +    ..+...+..+.+|+.+||+.||.+|||     ++|++++
T Consensus       250 ~~~-----------~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         250 KSE-----------P----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             HCC-----------C----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             cCC-----------C----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence            110           1    112233567889999999999999994     7888765

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-45  Score=356.00  Aligned_cols=264  Identities=24%  Similarity=0.353  Sum_probs=196.7

Q ss_pred             hcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh------HHHHHHHHHhcccCCCccceeeeEEeec
Q 014034           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQWVAEVQFLGVLEHPNLVKLIGYCAVD  151 (432)
Q Consensus        78 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~~  151 (432)
                      .++|++++.||+|+||+||+|...       .+++.||||++.+..      ..+.+|+.+|+.++|||||++++++...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~   89 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDT-------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   89 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEET-------TTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEEC-------CCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeec
Confidence            468999999999999999999865       578999999987532      2478899999999999999999998653


Q ss_pred             CC-cceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcCCCceeec
Q 014034          152 GE-RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  230 (432)
Q Consensus       152 ~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~  230 (432)
                      .. .....+++|+|+.+|+|.+++..   ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+|++
T Consensus        90 ~~~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~  163 (348)
T d2gfsa1          90 RSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL  163 (348)
T ss_dssp             SSTTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cccccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCcccccccccccccc
Confidence            22 11223667778889999999854   3699999999999999999999998   99999999999999999999999


Q ss_pred             cccCCcCCCCCCCcccccccccCCCccCccccccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 014034          231 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  309 (432)
Q Consensus       231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  309 (432)
                      |||++...     ........||+.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+.......+......+
T Consensus       164 dfg~a~~~-----~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~  238 (348)
T d2gfsa1         164 DFGLARHT-----DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP  238 (348)
T ss_dssp             CC----CC-----TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccchhccc-----CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99998652     2334456799999999987665 56889999999999999999999998765443322221111110


Q ss_pred             cCc-cc------cccccC--ccccC----cCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 014034          310 ADS-KK------FGLIMD--PRLEK----EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  359 (432)
Q Consensus       310 ~~~-~~------~~~~~~--~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  359 (432)
                      ... ..      ......  .....    ......+..+.+||.+||..||.+|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence            000 00      000000  00000    0001224567899999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.6e-42  Score=330.70  Aligned_cols=265  Identities=20%  Similarity=0.273  Sum_probs=191.7

Q ss_pred             cCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcChH---HHHHHHHHhcccC-----------CCcccee
Q 014034           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QWVAEVQFLGVLE-----------HPNLVKL  144 (432)
Q Consensus        79 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~-----------hpniv~l  144 (432)
                      ++|++++.||+|+||+||+|+..       .+++.||||+++++..   .+.+|+.+++.++           ||||+++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~-------~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~   85 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDM-------VNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   85 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             CcEEEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence            35999999999999999999865       5789999999987643   4678998888775           5789999


Q ss_pred             eeEEeecCCcceeEEEEEeecCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCceEEcC
Q 014034          145 IGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  223 (432)
Q Consensus       145 ~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~Nill~~  223 (432)
                      ++++...+....  +++|+++..+ +............+++..+..++.||+.||.|||+.  .||+||||||+||||+.
T Consensus        86 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~  161 (362)
T d1q8ya_          86 LDHFNHKGPNGV--HVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEI  161 (362)
T ss_dssp             CEEEEEEETTEE--EEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEE
T ss_pred             EEEeeeccccce--eeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeec
Confidence            999876654433  4555555333 344444445556789999999999999999999983  29999999999999986


Q ss_pred             CCc------eeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchh
Q 014034          224 NFR------PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT  297 (432)
Q Consensus       224 ~~~------~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~  297 (432)
                      ++.      ++++|||.+....     .......||+.|+|||++.+..++.++||||+||++++|++|+.||.......
T Consensus       162 ~~~~~~~~~~kl~dfg~s~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~  236 (362)
T d1q8ya_         162 VDSPENLIQIKIADLGNACWYD-----EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS  236 (362)
T ss_dssp             EETTTTEEEEEECCCTTCEETT-----BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCcccccceeeEeecccccccc-----cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccc
Confidence            653      9999999987532     22345679999999999999999999999999999999999999997543221


Q ss_pred             h----HHHHHHHhhcccCc--------------------cccccccCc------cccCcCCHHHHHHHHHHHHHhccCCC
Q 014034          298 E----QRLLEWVQQYPADS--------------------KKFGLIMDP------RLEKEYSINEARKIGRLADNCLSKSS  347 (432)
Q Consensus       298 ~----~~~~~~~~~~~~~~--------------------~~~~~~~~~------~l~~~~~~~~~~~l~~li~~cl~~dP  347 (432)
                      .    ..+...+..+...+                    .........      ..........+..+.+|+.+||..||
T Consensus       237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP  316 (362)
T d1q8ya_         237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP  316 (362)
T ss_dssp             --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred             ccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence            1    11111111100000                    000000000      00112345667889999999999999


Q ss_pred             CCCCCHHHHHHH
Q 014034          348 KDRPKMSQVVER  359 (432)
Q Consensus       348 ~~RPs~~eil~~  359 (432)
                      .+|||+.|++++
T Consensus       317 ~~Rpta~e~L~H  328 (362)
T d1q8ya_         317 RKRADAGGLVNH  328 (362)
T ss_dssp             TTCBCHHHHHTC
T ss_pred             hHCcCHHHHhcC
Confidence            999999999886

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=4.6e-25  Score=193.08  Aligned_cols=165  Identities=16%  Similarity=0.072  Sum_probs=116.2

Q ss_pred             CccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----------------------HHHHHHHHHhcccCC
Q 014034           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----------------------LQWVAEVQFLGVLEH  138 (432)
Q Consensus        81 ~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----------------------~~~~~E~~~l~~l~h  138 (432)
                      +.+.++||+|+||.||+|...        ++..||||.++...                      .....|+..+.++.|
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~--------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~   73 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE--------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG   73 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET--------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred             chhCCEeeeCcceEEEEEECC--------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccC
Confidence            346789999999999999853        57889999864211                      124568889999999


Q ss_pred             CccceeeeEEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecCCCCCc
Q 014034          139 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASN  218 (432)
Q Consensus       139 pniv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~ivH~Dikp~N  218 (432)
                      ++++..+++..    .    +++|||+.+..+.+         ++......++.|++.+|.|||+.   +|+||||||+|
T Consensus        74 ~~v~~~~~~~~----~----~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~N  133 (191)
T d1zara2          74 LAVPKVYAWEG----N----AVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYN  133 (191)
T ss_dssp             SSSCCEEEEET----T----EEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred             CCcceEEEecC----C----EEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhh
Confidence            99999876531    1    79999998765543         33444567999999999999998   99999999999


Q ss_pred             eEEcCCCceeeccccCCcCCCCCCCcccccccccCCCccCccccccCCCCchhhhHHHHHH
Q 014034          219 VLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVV  279 (432)
Q Consensus       219 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvi  279 (432)
                      ||+++++ ++|+|||+|...............+..    -.+. ....|+.++|+||..--
T Consensus       134 ILv~~~~-~~liDFG~a~~~~~~~~~~~l~rd~~~----~~~~-f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         134 VLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRN----IITY-FSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             EEEETTE-EEECCCTTCEETTSTTHHHHHHHHHHH----HHHH-HHHHHCCCCCHHHHHHH
T ss_pred             eeeeCCC-EEEEECCCcccCCCCCcHHHHHHHHHH----HHHH-HcCCCCCcccHHHHHHH
Confidence            9999655 899999998753211110000000000    0011 13567888999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.59  E-value=1.4e-07  Score=84.30  Aligned_cols=145  Identities=17%  Similarity=0.117  Sum_probs=96.7

Q ss_pred             HHHHHhhcCCccccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCcCh----HHHHHHHHHhcccC-CCccceeee
Q 014034           72 SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQWVAEVQFLGVLE-HPNLVKLIG  146 (432)
Q Consensus        72 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~-hpniv~l~~  146 (432)
                      .++......|+..+..+.++.+.||+...         .+..+++|+.....    ..+.+|...+..+. +--+.+++.
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~---------~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~   77 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG---------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLH   77 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC---------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe---------CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEE
Confidence            35566667788777655555678998752         34557788775432    23678888887763 333566776


Q ss_pred             EEeecCCcceeEEEEEeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC---------------------
Q 014034          147 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL---------------------  205 (432)
Q Consensus       147 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~~~---------------------  205 (432)
                      +...++    ..++||++++|.++.......       .....++.+++..+..||+..                     
T Consensus        78 ~~~~~~----~~~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~  146 (263)
T d1j7la_          78 FERHDG----WSNLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLL  146 (263)
T ss_dssp             EEEETT----EEEEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHH
T ss_pred             EEecCC----ceEEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHH
Confidence            665544    348999999998887654211       112334555666666666421                     


Q ss_pred             -----------------------------------CCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          206 -----------------------------------EVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       206 -----------------------------------~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                                                         ...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         147 NNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                               1247999999999999987777899999874

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.01  E-value=6.1e-06  Score=72.87  Aligned_cols=129  Identities=16%  Similarity=0.124  Sum_probs=80.4

Q ss_pred             ccccCC-ceEEEEEEecCCCCCCCcccEEEEEEecCcChH-HHHHHHHHhcccCC--CccceeeeEEeecCCcceeEEEE
Q 014034           86 KIGEGG-FGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QWVAEVQFLGVLEH--PNLVKLIGYCAVDGERGIQRLLV  161 (432)
Q Consensus        86 ~lg~G~-fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~~~~~lv  161 (432)
                      .+..|. -+.||+....        .+..+++|....... .+..|+..++.+..  -.+.+++.+....+    ..++|
T Consensus        17 ~~~~G~s~~~v~r~~~~--------~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~----~~~~v   84 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ--------GRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAG----RDWLL   84 (255)
T ss_dssp             ECSCTTSSCEEEEEECT--------TSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS----CEEEE
T ss_pred             EcCCcccCCeEEEEEeC--------CCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeeccccc----ceEEE
Confidence            344554 3678987642        455688888665433 36788888877743  23566776665443    34899


Q ss_pred             EeecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc--------------------------------------
Q 014034          162 YEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE--------------------------------------  203 (432)
Q Consensus       162 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~l~~~l~~LH~--------------------------------------  203 (432)
                      |++++|.++....       ...   ..++.+++..|.-||+                                      
T Consensus        85 ~~~i~G~~~~~~~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (255)
T d1nd4a_          85 LGEVPGQDLLSSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  154 (255)
T ss_dssp             EECCSSEETTTSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             EEeeecccccccc-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhh
Confidence            9999887664321       111   1112233333333332                                      


Q ss_pred             -------------C----CCCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          204 -------------G----LEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       204 -------------~----~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                                   .    ....++|+|+.|.|||++++..+-|+||+.+.
T Consensus       155 ~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         155 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                         1    11248999999999999987777899998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.87  E-value=2.7e-05  Score=73.51  Aligned_cols=74  Identities=15%  Similarity=0.051  Sum_probs=46.3

Q ss_pred             ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc-----------ChHHHHHHHHHhcccC-C--CccceeeeEEe
Q 014034           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-----------DGLQWVAEVQFLGVLE-H--PNLVKLIGYCA  149 (432)
Q Consensus        84 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~-----------~~~~~~~E~~~l~~l~-h--pniv~l~~~~~  149 (432)
                      .+.||.|....||+....       .+++.|++|.-..           ...+...|++.|+.+. +  ..+++++.+. 
T Consensus        31 ~~eig~G~~N~vfrV~~~-------~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-  102 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQ-------EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-  102 (392)
T ss_dssp             EEECCSSSSEEEEEEEC-----------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-
T ss_pred             EEEeCCCceEeEEEEEeC-------CCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-
Confidence            457899999999998743       3456788886432           1223566888887662 2  3456666543 


Q ss_pred             ecCCcceeEEEEEeecCCCCH
Q 014034          150 VDGERGIQRLLVYEFMLNRSL  170 (432)
Q Consensus       150 ~~~~~~~~~~lv~e~~~~gsL  170 (432)
                       ....    ++|||++.+..+
T Consensus       103 -~~~~----~lvmE~L~~~~~  118 (392)
T d2pula1         103 -TEMA----VTVMEDLSHLKI  118 (392)
T ss_dssp             -TTTT----EEEECCCTTSEE
T ss_pred             -CCCC----EEEEeccCCccc
Confidence             2222    899999977543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.15  E-value=0.00053  Score=64.31  Aligned_cols=80  Identities=19%  Similarity=0.181  Sum_probs=52.3

Q ss_pred             ccccccCCceEEEEEEecCCCCCCCcccEEEEEEecCc--ChHHHHHHHHHhcccC-CCccceeeeEEeecCCcceeEEE
Q 014034           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQWVAEVQFLGVLE-HPNLVKLIGYCAVDGERGIQRLL  160 (432)
Q Consensus        84 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~~~l  160 (432)
                      ++.|+.|-.-.+|+................|.+++...  ......+|..+++.+. +.-..++++++.  +      .+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~------g~  118 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFS--G------GR  118 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T------EE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C------ce
Confidence            46788888999999887643322223445677776542  2234667998888874 444457777763  1      68


Q ss_pred             EEeecCCCCHH
Q 014034          161 VYEFMLNRSLE  171 (432)
Q Consensus       161 v~e~~~~gsL~  171 (432)
                      ||||++|..|.
T Consensus       119 I~efi~g~~l~  129 (395)
T d1nw1a_         119 LEEYIPSRPLS  129 (395)
T ss_dssp             EECCCCEEECC
T ss_pred             EEEEeccccCC
Confidence            99999875543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.44  E-value=0.0039  Score=56.07  Aligned_cols=31  Identities=29%  Similarity=0.225  Sum_probs=27.9

Q ss_pred             CCceeecCCCCCceEEcCCCceeeccccCCc
Q 014034          206 EVQVIYRDFKASNVLLDENFRPKLSDFGLAR  236 (432)
Q Consensus       206 ~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~  236 (432)
                      +.++||+|+.++||+++++...-|+||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            4589999999999999998878999999874

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.44  E-value=0.0053  Score=55.51  Aligned_cols=134  Identities=19%  Similarity=0.159  Sum_probs=71.9

Q ss_pred             ceEEEEEEecCCCCCCCcccEEEEEEecCc---ChHHHHHHHHHhcccCCCcc-----ceeeeEEeecCCcceeEEEEEe
Q 014034           92 FGSVYKSSIKPAAGDGTSEATVVAIKKLNR---DGLQWVAEVQFLGVLEHPNL-----VKLIGYCAVDGERGIQRLLVYE  163 (432)
Q Consensus        92 fg~Vy~~~~~~~~~~~~~~~~~vaiK~~~~---~~~~~~~E~~~l~~l~hpni-----v~l~~~~~~~~~~~~~~~lv~e  163 (432)
                      --.||+++..        ++..+++|..+.   ...++..|+..+..|....|     +..-+-...  ......+.+++
T Consensus        35 EN~vy~v~~~--------dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~--~~~~~~~~l~~  104 (325)
T d1zyla1          35 ENRVYQFQDE--------DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLL--NHQGFYFAVFP  104 (325)
T ss_dssp             SSEEEEECCT--------TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCE--EETTEEEEEEE
T ss_pred             cceeEEEEcC--------CCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeee--eeeeEEEEEEe
Confidence            3579998643        677899999765   34567889888877742222     111110000  01223578899


Q ss_pred             ecCCCCHH-----HHh-------------hcCC---CCCCCH-------------------H---HHHHHHHHHHHHHHH
Q 014034          164 FMLNRSLE-----DHL-------------FNRA---FPPLPW-------------------K---TRLHIILGAAEGLAY  200 (432)
Q Consensus       164 ~~~~gsL~-----~~l-------------~~~~---~~~l~~-------------------~---~~~~i~~~l~~~l~~  200 (432)
                      ++.|..+.     .+-             ....   ...+..                   .   .....+..+...+.-
T Consensus       105 ~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~  184 (325)
T d1zyla1         105 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA  184 (325)
T ss_dssp             CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred             ecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence            98764432     110             0000   001111                   1   112223333333322


Q ss_pred             h-hcCCCCceeecCCCCCceEEcCCCceeeccccCCcC
Q 014034          201 L-HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  237 (432)
Q Consensus       201 L-H~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~  237 (432)
                      + .+....+++|+|+.+.|||++++  ..++||+-+..
T Consensus       185 ~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         185 HWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             HCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             hccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            2 22234589999999999999743  45899998753